Psyllid ID: psy6044

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280--
Protein Sequence
MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKSERCQ
Secondary Structure (PSIPRED)
cEEEccccccccEEEEEEEEccccccccHHHHHHHHHHccccccccEEEEEEEEEccEEEEEEEEcccHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccEEEcccccccccccccccccccEEEccccccHHcccccccccHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHcccccccccccccccccccccccccccccHHHHcccccHHHHHHHHHcccccccccccHHHHHcccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cEEEEEccccccEEEEEEEEcccccEccHHHHHHHHHHcccccccEccEEEEEEccccEEEEEEcccEEHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEcccccEccccccccHHHccHHHHccccEccHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHccccHHHHHHHcHcccccccccccccccHHHHcccccHHHHHHHHHHccccccccccHHHHHHcHHHHHccccccccccc
Coil and Loop (DISEMBL)
mftsgvdrtpntalaikgthlvgnegvpssALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAfchsrnvlhrdlkpqnllinkngelkladfglarafgipvkcysaevvtlwyrppdvlfgaKLYTTSIDMWSAGCIFAELanagrplfpgsdvdDQLKRIFKLlgtptedtwpgmnllpdfkpfpmyhpsmsfsqvapKLTAKGRDLLQRLLVcnpvqrmsaedAMSHIYFSDLNVaiksercq
Flexible Loop (DISEMBL)
mftsgvdrtpntalaikgthlvgnegvpsSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLlgtptedtwpgmNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLnvaiksercq
Low Complexity Region (SEG)
MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKSERCQ
Disordered region (IsUnstruct)
*************LAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI******
Disordered Region (DISOPRED)
MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL**********
Disordered Region (DISEMBL)
********TPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKSERCQ
Disordered Region (DISPRO)
MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV********
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKSERCQ
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	282	2.2.26 [Sep-21-2011]
P51166	292	Cyclin-dependent kinase 5	N/A	N/A	0.943	0.910	0.790	1e-123
P49615	292	Cyclin-dependent kinase 5	yes	N/A	0.943	0.910	0.786	1e-122
Q02399	292	Cyclin-dependent kinase 5	yes	N/A	0.943	0.910	0.786	1e-122
Q00535	292	Cyclin-dependent kinase 5	yes	N/A	0.943	0.910	0.786	1e-122
Q03114	292	Cyclin-dependent kinase 5	yes	N/A	0.943	0.910	0.782	1e-122
Q2PQN9	292	Cyclin-dependent kinase 5	N/A	N/A	0.946	0.914	0.776	1e-120
P48609	294	Cyclin-dependent kinase 5	yes	N/A	0.946	0.908	0.764	1e-118
P34117	292	Cyclin-dependent kinase 5	yes	N/A	0.879	0.849	0.641	5e-91
Q27032	298	Cell division control pro	yes	N/A	0.882	0.835	0.604	2e-86
Q26671	298	Cell division control pro	yes	N/A	0.882	0.835	0.6	6e-86

>sp|P51166|CDK5_XENLA Cyclin-dependent kinase 5 OS=Xenopus laevis GN=cdk5 PE=2 SV=1

 Score =  441 bits (1134), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 211/267 (79%), Positives = 236/267 (88%), Gaps = 1/267 (0%)

Query: 7   DRTPNTALAIKGTHLVGN-EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           +R  +  +A+K   L  + EGVPSSALREICLLKELKHKNIVRL+DVLHS+KKLTLVFE 
Sbjct: 23  NRDTHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82

Query: 66  CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
           CDQDLKKYFDS NG++D +IVKSFMYQLL+GLAFCHSRNVLHRDLKPQNLLIN+NGELKL
Sbjct: 83  CDQDLKKYFDSCNGDLDPEIVKSFMYQLLKGLAFCHSRNVLHRDLKPQNLLINRNGELKL 142

Query: 126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
           ADFGLARAFGIPV+CYSAEVVTLWYRPPDVLFGAKLY+TSIDMWSAGCIFAELANAGRPL
Sbjct: 143 ADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

Query: 186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
           FPG+DVDDQLKRIF+LLGTPTE+ WP M  LPD+KP+PMY  +MS   V PKL A GRDL
Sbjct: 203 FPGNDVDDQLKRIFRLLGTPTEEQWPAMTKLPDYKPYPMYPATMSLVNVVPKLNATGRDL 262

Query: 246 LQRLLVCNPVQRMSAEDAMSHIYFSDL 272
           LQ LL CNPVQR+ A++A+ H YF+D 
Sbjct: 263 LQNLLKCNPVQRICADEALQHPYFADF 289

Proline-directed serine/threonine-protein kinase essential for neuronal cell cycle arrest and differentiation and may be involved in apoptotic cell death in neuronal diseases by triggering abortive cell cycle re-entry. Interacts with D1 and D3-type G1 cyclins. Regulates several neuronal development and physiological processes including neuronal survival, migration and differentiation, axonal and neurite growth, synaptogenesis, oligodendrocytes differentiation, synaptic plasticity and neurotransmission, by phosphorylating key proteins. In the mature central nervous system (CNS), regulates neurotransmitter movements by phosphorylating substrates associated with neurotransmitter release and synapse plasticity; synaptic vesicle exocytosis, vesicles fusion with the presynaptic membrane, and endocytosis. May regulate endothelial cell migration and angiogenesis via the modulation of lamellipodia formation.
Xenopus laevis (taxid: 8355)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 2

>sp|P49615|CDK5_MOUSE Cyclin-dependent kinase 5 OS=Mus musculus GN=Cdk5 PE=1 SV=1

 Score =  439 bits (1129), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 210/267 (78%), Positives = 235/267 (88%), Gaps = 1/267 (0%)

Query: 7   DRTPNTALAIKGTHLVGN-EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           +R  +  +A+K   L  + EGVPSSALREICLLKELKHKNIVRL+DVLHS+KKLTLVFE 
Sbjct: 23  NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82

Query: 66  CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
           CDQDLKKYFDS NG++D +IVKSF++QLL+GL FCHSRNVLHRDLKPQNLLIN+NGELKL
Sbjct: 83  CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKL 142

Query: 126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
           ADFGLARAFGIPV+CYSAEVVTLWYRPPDVLFGAKLY+TSIDMWSAGCIFAELANAGRPL
Sbjct: 143 ADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

Query: 186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
           FPG+DVDDQLKRIF+LLGTPTE+ WP M  LPD+KP+PMY  + S   V PKL A GRDL
Sbjct: 203 FPGNDVDDQLKRIFRLLGTPTEEQWPAMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDL 262

Query: 246 LQRLLVCNPVQRMSAEDAMSHIYFSDL 272
           LQ LL CNPVQR+SAE+A+ H YFSD 
Sbjct: 263 LQNLLKCNPVQRISAEEALQHPYFSDF 289

Proline-directed serine/threonine-protein kinase essential for neuronal cell cycle arrest and differentiation and may be involved in apoptotic cell death in neuronal diseases by triggering abortive cell cycle re-entry. Interacts with D1 and D3-type G1 cyclins. Phosphorylates SRC, NOS3, VIM/vimentin, p35/CDK5R1, MEF2A, SIPA1L1, SH3GLB1, PXN, PAK1, MCAM/MUC18, SEPT5, SYN1, DNM1, AMPH, SYNJ1, CDK16, RAC1, RHOA, CDC42, TONEBP/NFAT5, MAPT/TAU, MAP1B, histone H1, p53/TP53, HDAC1, APEX1, PTK2/FAK1, huntingtin/HTT, ATM, MAP2, NEFH and NEFM. Regulates several neuronal development and physiological processes including neuronal survival, migration and differentiation, axonal and neurite growth, synaptogenesis, oligodendrocytes differentiation, synaptic plasticity and neurotransmission, by phosphorylating key proteins. Activated by interaction with CDK5R1 (p35) and ATP6V0D1 (p39), especially in post-mitotic neurons, and promotes CDK5R1 (p35) expression in an autostimulation loop. Phosphorylates many downstream substrates such as Rho and Ras family small GTPases (e.g. PAK1, RAC1, RHOA, CDC42) or microtubule-binding proteins (e.g. MAPT/TAU, MAP2, MAP1B), and modulates actin dynamics to regulate neurite growth and/or spine morphogenesis. Phosphorylates also exocytosis associated proteins such as MCAM/MUC18, SEPT5, SYN1, and PCTAIRE 1/CDK16 as well as endocytosis associated proteins such as DNM1, AMPH and SYNJ1 at synaptic terminals. In the mature central nervous system (CNS), regulates neurotransmitter movements by phosphorylating substrates associated with neurotransmitter release and synapse plasticity; synaptic vesicle exocytosis, vesicles fusion with the presynaptic membrane, and endocytosis. Promotes cell survival by activating anti-apoptotic proteins BCL2 and STAT3, and negatively regulating of JNK3/MAPK10 activity. Phosphorylation of p53/TP53 in response to genotoxic and oxidative stresses enhances its stabilization by preventing ubiquitin ligase-mediated proteasomal degradation, and induces transactivation of p53/TP53 target genes, thus regulating apoptosis. Phosphorylation of p35/CDK5R1 enhances its stabilization by preventing calpain-mediated proteolysis producing p25/CDK5R1 and avoiding ubiquitin ligase-mediated proteasomal degradation. During aberrant cell-cycle activity and DNA damage, p25/CDK5 activity elicites cell-cycle activity and double-strand DNA breaks that precedes neuronal death by deregulating HDAC1. DNA damage triggered phosphorylation of huntingtin/HTT in nuclei of neurons protects neurons against polyglutamine expansion as well as DNA damage mediated toxicity. Phosphorylation of PXN reduces its interaction with PTK2/FAK1 in matrix-cell focal adhesions (MCFA) during oligodendrocytes (OLs) differentiation. Negative regulator of Wnt/beta-catenin signaling pathway. Activator of the GAIT (IFN-gamma-activated inhibitor of translation) pathway, which suppresses expression of a post-transcriptional regulon of proinflammatory genes in myeloid cells; phosphorylates the linker domain of glutamyl-prolyl tRNA synthetase (EPRS) in a IFN-gamma-dependent manner, the initial event in assembly of the GAIT complex. Phosphorylation of SH3GLB1 is required for autophagy induction in starved neurons. Phosphorylation of TONEBP/NFAT5 in response to osmotic stress mediates its rapid nuclear localization. MEF2 is inactivated by phosphorylation in nucleus in response to neurotoxin, thus leading to neuronal apoptosis. APEX1 AP-endodeoxyribonuclease is repressed by phosphorylation, resulting in accumulation of DNA damage and contributing to neuronal death. NOS3 phosphorylation down regulates NOS3-derived nitrite (NO) levels. SRC phosphorylation mediates its ubiquitin-dependent degradation and thus leads to cytoskeletal reorganization. May regulate endothelial cell migration and angiogenesis via the modulation of lamellipodia formation. Involved in dendritic spine morphogenesis by mediating the EFNA1-EPHA4 signaling.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q02399|CDK5_BOVIN Cyclin-dependent kinase 5 OS=Bos taurus GN=CDK5 PE=1 SV=2

 Score =  439 bits (1129), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 210/267 (78%), Positives = 235/267 (88%), Gaps = 1/267 (0%)

Query: 7   DRTPNTALAIKGTHLVGN-EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           +R  +  +A+K   L  + EGVPSSALREICLLKELKHKNIVRL+DVLHS+KKLTLVFE 
Sbjct: 23  NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82

Query: 66  CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
           CDQDLKKYFDS NG++D +IVKSF++QLL+GL FCHSRNVLHRDLKPQNLLIN+NGELKL
Sbjct: 83  CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKL 142

Query: 126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
           ADFGLARAFGIPV+CYSAEVVTLWYRPPDVLFGAKLY+TSIDMWSAGCIFAELANAGRPL
Sbjct: 143 ADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

Query: 186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
           FPG+DVDDQLKRIF+LLGTPTE+ WP M  LPD+KP+PMY  + S   V PKL A GRDL
Sbjct: 203 FPGNDVDDQLKRIFRLLGTPTEEQWPAMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDL 262

Query: 246 LQRLLVCNPVQRMSAEDAMSHIYFSDL 272
           LQ LL CNPVQR+SAE+A+ H YFSD 
Sbjct: 263 LQNLLKCNPVQRISAEEALQHPYFSDF 289

Proline-directed serine/threonine-protein kinase essential for neuronal cell cycle arrest and differentiation and may be involved in apoptotic cell death in neuronal diseases by triggering abortive cell cycle re-entry. Interacts with D1 and D3-type G1 cyclins. Phosphorylates SRC, NOS3, VIM/vimentin, p35/CDK5R1, MEF2A, SIPA1L1, SH3GLB1, PXN, PAK1, MCAM/MUC18, SEPT5, SYN1, DNM1, AMPH, SYNJ1, CDK16, RAC1, RHOA, CDC42, TONEBP/NFAT5, MAPT/TAU, MAP1B, histone H1, p53/TP53, HDAC1, APEX1, PTK2/FAK1, huntingtin/HTT, ATM, MAP2, NEFH and NEFM. Regulates several neuronal development and physiological processes including neuronal survival, migration and differentiation, axonal and neurite growth, synaptogenesis, oligodendrocytes differentiation, synaptic plasticity and neurotransmission, by phosphorylating key proteins. Activated by interaction with CDK5R1 (p35) and ATP6V0D1 (p39), especially in post-mitotic neurons, and promotes CDK5R1 (p35) expression in an autostimulation loop. Phosphorylates many downstream substrates such as Rho and Ras family small GTPases (e.g. PAK1, RAC1, RHOA, CDC42) or microtubule-binding proteins (e.g. MAPT/TAU, MAP2, MAP1B), and modulates actin dynamics to regulate neurite growth and/or spine morphogenesis. Phosphorylates also exocytosis associated proteins such as MCAM/MUC18, SEPT5, SYN1, and PCTAIRE 1/CDK16 as well as endocytosis associated proteins such as DNM1, AMPH and SYNJ1 at synaptic terminals. In the mature central nervous system (CNS), regulates neurotransmitter movements by phosphorylating substrates associated with neurotransmitter release and synapse plasticity; synaptic vesicle exocytosis, vesicles fusion with the presynaptic membrane, and endocytosis. Promotes cell survival by activating anti-apoptotic proteins BCL2 and STAT3, and negatively regulating of JNK3/MAPK10 activity. Phosphorylation of p53/TP53 in response to genotoxic and oxidative stresses enhances its stabilization by preventing ubiquitin ligase-mediated proteasomal degradation, and induces transactivation of p53/TP53 target genes, thus regulating apoptosis. Phosphorylation of p35/CDK5R1 enhances its stabilization by preventing calpain-mediated proteolysis producing p25/CDK5R1 and avoiding ubiquitin ligase-mediated proteasomal degradation. During aberrant cell-cycle activity and DNA damage, p25/CDK5 activity elicites cell-cycle activity and double-strand DNA breaks that precedes neuronal death by deregulating HDAC1. DNA damage triggered phosphorylation of huntingtin/HTT in nuclei of neurons protects neurons against polyglutamine expansion as well as DNA damage mediated toxicity. Phosphorylation of PXN reduces its interaction with PTK2/FAK1 in matrix-cell focal adhesions (MCFA) during oligodendrocytes (OLs) differentiation. Negative regulator of Wnt/beta-catenin signaling pathway. Activator of the GAIT (IFN-gamma-activated inhibitor of translation) pathway, which suppresses expression of a post-transcriptional regulon of proinflammatory genes in myeloid cells; phosphorylates the linker domain of glutamyl-prolyl tRNA synthetase (EPRS) in a IFN-gamma-dependent manner, the initial event in assembly of the GAIT complex. Phosphorylation of SH3GLB1 is required for autophagy induction in starved neurons. Phosphorylation of TONEBP/NFAT5 in response to osmotic stress mediates its rapid nuclear localization. MEF2 is inactivated by phosphorylation in nucleus in response to neurotoxin, thus leading to neuronal apoptosis. APEX1 AP-endodeoxyribonuclease is repressed by phosphorylation, resulting in accumulation of DNA damage and contributing to neuronal death. NOS3 phosphorylation down regulates NOS3-derived nitrite (NO) levels. SRC phosphorylation mediates its ubiquitin-dependent degradation and thus leads to cytoskeletal reorganization. May regulate endothelial cell migration and angiogenesis via the modulation of lamellipodia formation. Involved in dendritic spine morphogenesis by mediating the EFNA1-EPHA4 signaling.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q00535|CDK5_HUMAN Cyclin-dependent kinase 5 OS=Homo sapiens GN=CDK5 PE=1 SV=3

 Score =  439 bits (1128), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 210/267 (78%), Positives = 235/267 (88%), Gaps = 1/267 (0%)

Query: 7   DRTPNTALAIKGTHLVGN-EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           +R  +  +A+K   L  + EGVPSSALREICLLKELKHKNIVRL+DVLHS+KKLTLVFE 
Sbjct: 23  NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82

Query: 66  CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
           CDQDLKKYFDS NG++D +IVKSF++QLL+GL FCHSRNVLHRDLKPQNLLIN+NGELKL
Sbjct: 83  CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKL 142

Query: 126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
           ADFGLARAFGIPV+CYSAEVVTLWYRPPDVLFGAKLY+TSIDMWSAGCIFAELANAGRPL
Sbjct: 143 ADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

Query: 186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
           FPG+DVDDQLKRIF+LLGTPTE+ WP M  LPD+KP+PMY  + S   V PKL A GRDL
Sbjct: 203 FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDL 262

Query: 246 LQRLLVCNPVQRMSAEDAMSHIYFSDL 272
           LQ LL CNPVQR+SAE+A+ H YFSD 
Sbjct: 263 LQNLLKCNPVQRISAEEALQHPYFSDF 289

Proline-directed serine/threonine-protein kinase essential for neuronal cell cycle arrest and differentiation and may be involved in apoptotic cell death in neuronal diseases by triggering abortive cell cycle re-entry. Interacts with D1 and D3-type G1 cyclins. Phosphorylates SRC, NOS3, VIM/vimentin, p35/CDK5R1, MEF2A, SIPA1L1, SH3GLB1, PXN, PAK1, MCAM/MUC18, SEPT5, SYN1, DNM1, AMPH, SYNJ1, CDK16, RAC1, RHOA, CDC42, TONEBP/NFAT5, MAPT/TAU, MAP1B, histone H1, p53/TP53, HDAC1, APEX1, PTK2/FAK1, huntingtin/HTT, ATM, MAP2, NEFH and NEFM. Regulates several neuronal development and physiological processes including neuronal survival, migration and differentiation, axonal and neurite growth, synaptogenesis, oligodendrocytes differentiation, synaptic plasticity and neurotransmission, by phosphorylating key proteins. Activated by interaction with CDK5R1 (p35) and ATP6V0D1 (p39), especially in post-mitotic neurons, and promotes CDK5R1 (p35) expression in an autostimulation loop. Phosphorylates many downstream substrates such as Rho and Ras family small GTPases (e.g. PAK1, RAC1, RHOA, CDC42) or microtubule-binding proteins (e.g. MAPT/TAU, MAP2, MAP1B), and modulates actin dynamics to regulate neurite growth and/or spine morphogenesis. Phosphorylates also exocytosis associated proteins such as MCAM/MUC18, SEPT5, SYN1, and PCTAIRE 1/CDK16 as well as endocytosis associated proteins such as DNM1, AMPH and SYNJ1 at synaptic terminals. In the mature central nervous system (CNS), regulates neurotransmitter movements by phosphorylating substrates associated with neurotransmitter release and synapse plasticity; synaptic vesicle exocytosis, vesicles fusion with the presynaptic membrane, and endocytosis. Promotes cell survival by activating anti-apoptotic proteins BCL2 and STAT3, and negatively regulating of JNK3/MAPK10 activity. Phosphorylation of p53/TP53 in response to genotoxic and oxidative stresses enhances its stabilization by preventing ubiquitin ligase-mediated proteasomal degradation, and induces transactivation of p53/TP53 target genes, thus regulating apoptosis. Phosphorylation of p35/CDK5R1 enhances its stabilization by preventing calpain-mediated proteolysis producing p25/CDK5R1 and avoiding ubiquitin ligase-mediated proteasomal degradation. During aberrant cell-cycle activity and DNA damage, p25/CDK5 activity elicites cell-cycle activity and double-strand DNA breaks that precedes neuronal death by deregulating HDAC1. DNA damage triggered phosphorylation of huntingtin/HTT in nuclei of neurons protects neurons against polyglutamine expansion as well as DNA damage mediated toxicity. Phosphorylation of PXN reduces its interaction with PTK2/FAK1 in matrix-cell focal adhesions (MCFA) during oligodendrocytes (OLs) differentiation. Negative regulator of Wnt/beta-catenin signaling pathway. Activator of the GAIT (IFN-gamma-activated inhibitor of translation) pathway, which suppresses expression of a post-transcriptional regulon of proinflammatory genes in myeloid cells; phosphorylates the linker domain of glutamyl-prolyl tRNA synthetase (EPRS) in a IFN-gamma-dependent manner, the initial event in assembly of the GAIT complex. Phosphorylation of SH3GLB1 is required for autophagy induction in starved neurons. Phosphorylation of TONEBP/NFAT5 in response to osmotic stress mediates its rapid nuclear localization. MEF2 is inactivated by phosphorylation in nucleus in response to neurotoxin, thus leading to neuronal apoptosis. APEX1 AP-endodeoxyribonuclease is repressed by phosphorylation, resulting in accumulation of DNA damage and contributing to neuronal death. NOS3 phosphorylation down regulates NOS3-derived nitrite (NO) levels. SRC phosphorylation mediates its ubiquitin-dependent degradation and thus leads to cytoskeletal reorganization. May regulate endothelial cell migration and angiogenesis via the modulation of lamellipodia formation. Involved in dendritic spine morphogenesis by mediating the EFNA1-EPHA4 signaling.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q03114|CDK5_RAT Cyclin-dependent kinase 5 OS=Rattus norvegicus GN=Cdk5 PE=1 SV=1

 Score =  437 bits (1123), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 209/267 (78%), Positives = 234/267 (87%), Gaps = 1/267 (0%)

Query: 7   DRTPNTALAIKGTHLVGN-EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           +R  +  +A+K   L  + EGVPSSALREICLLKELKHKNIVRL+DVLHS+KKLTLVFE 
Sbjct: 23  NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82

Query: 66  CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
           CDQDLKKYFDS NG++D +IVKS ++QLL+GL FCHSRNVLHRDLKPQNLLIN+NGELKL
Sbjct: 83  CDQDLKKYFDSCNGDLDPEIVKSLLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKL 142

Query: 126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
           ADFGLARAFGIPV+CYSAEVVTLWYRPPDVLFGAKLY+TSIDMWSAGCIFAELANAGRPL
Sbjct: 143 ADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

Query: 186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
           FPG+DVDDQLKRIF+LLGTPTE+ WP M  LPD+KP+PMY  + S   V PKL A GRDL
Sbjct: 203 FPGNDVDDQLKRIFRLLGTPTEEQWPAMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDL 262

Query: 246 LQRLLVCNPVQRMSAEDAMSHIYFSDL 272
           LQ LL CNPVQR+SAE+A+ H YFSD 
Sbjct: 263 LQNLLKCNPVQRISAEEALQHPYFSDF 289

Proline-directed serine/threonine-protein kinase essential for neuronal cell cycle arrest and differentiation and may be involved in apoptotic cell death in neuronal diseases by triggering abortive cell cycle re-entry. Interacts with D1 and D3-type G1 cyclins. Phosphorylates SRC, NOS3, VIM/vimentin, p35/CDK5R1, MEF2A, SIPA1L1, SH3GLB1, PXN, PAK1, MCAM/MUC18, SEPT5, SYN1, DNM1, AMPH, SYNJ1, CDK16, RAC1, RHOA, CDC42, TONEBP/NFAT5, MAPT/TAU, MAP1B, histone H1, p53/TP53, HDAC1, APEX1, PTK2/FAK1, huntingtin/HTT, ATM, MAP2, NEFH and NEFM. Regulates several neuronal development and physiological processes including neuronal survival, migration and differentiation, axonal and neurite growth, synaptogenesis, oligodendrocytes differentiation, synaptic plasticity and neurotransmission, by phosphorylating key proteins. Activated by interaction with CDK5R1 (p35) and ATP6V0D1 (p39), especially in post-mitotic neurons, and promotes CDK5R1 (p35) expression in an autostimulation loop. Phosphorylates many downstream substrates such as Rho and Ras family small GTPases (e.g. PAK1, RAC1, RHOA, CDC42) or microtubule-binding proteins (e.g. MAPT/TAU, MAP2, MAP1B), and modulates actin dynamics to regulate neurite growth and/or spine morphogenesis. Phosphorylates also exocytosis associated proteins such as MCAM/MUC18, SEPT5, SYN1, and PCTAIRE 1/CDK16 as well as endocytosis associated proteins such as DNM1, AMPH and SYNJ1 at synaptic terminals. In the mature central nervous system (CNS), regulates neurotransmitter movements by phosphorylating substrates associated with neurotransmitter release and synapse plasticity; synaptic vesicle exocytosis, vesicles fusion with the presynaptic membrane, and endocytosis. Promotes cell survival by activating anti-apoptotic proteins BCL2 and STAT3, and negatively regulating of JNK3/MAPK10 activity. Phosphorylation of p53/TP53 in response to genotoxic and oxidative stresses enhances its stabilization by preventing ubiquitin ligase-mediated proteasomal degradation, and induces transactivation of p53/TP53 target genes, thus regulating apoptosis. Phosphorylation of p35/CDK5R1 enhances its stabilization by preventing calpain-mediated proteolysis producing p25/CDK5R1 and avoiding ubiquitin ligase-mediated proteasomal degradation. During aberrant cell-cycle activity and DNA damage, p25/CDK5 activity elicites cell-cycle activity and double-strand DNA breaks that precedes neuronal death by deregulating HDAC1. DNA damage triggered phosphorylation of huntingtin/HTT in nuclei of neurons protects neurons against polyglutamine expansion as well as DNA damage mediated toxicity. Phosphorylation of PXN reduces its interaction with PTK2/FAK1 in matrix-cell focal adhesions (MCFA) during oligodendrocytes (OLs) differentiation. Negative regulator of Wnt/beta-catenin signaling pathway. Activator of the GAIT (IFN-gamma-activated inhibitor of translation) pathway, which suppresses expression of a post-transcriptional regulon of proinflammatory genes in myeloid cells; phosphorylates the linker domain of glutamyl-prolyl tRNA synthetase (EPRS) in a IFN-gamma-dependent manner, the initial event in assembly of the GAIT complex. Phosphorylation of SH3GLB1 is required for autophagy induction in starved neurons. Phosphorylation of TONEBP/NFAT5 in response to osmotic stress mediates its rapid nuclear localization. MEF2 is inactivated by phosphorylation in nucleus in response to neurotoxin, thus leading to neuronal apoptosis. APEX1 AP-endodeoxyribonuclease is repressed by phosphorylation, resulting in accumulation of DNA damage and contributing to neuronal death. NOS3 phosphorylation down regulates NOS3-derived nitrite (NO) levels. SRC phosphorylation mediates its ubiquitin-dependent degradation and thus leads to cytoskeletal reorganization. May regulate endothelial cell migration and angiogenesis via the modulation of lamellipodia formation. Involved in dendritic spine morphogenesis by mediating the EFNA1-EPHA4 signaling.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q2PQN9|CDK5_GLOMM Cyclin-dependent kinase 5 homolog OS=Glossina morsitans morsitans GN=Cdk5 PE=2 SV=1

 Score =  431 bits (1109), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 208/268 (77%), Positives = 233/268 (86%), Gaps = 1/268 (0%)

Query: 5   GVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF 63
           G +R     +A+K   L   +EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF
Sbjct: 21  GRNRETLEIVALKRVRLDEDDEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF 80

Query: 64  EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL 123
           EHCDQDLKKYFDSLNG+ID+ + +SFM QLLRGLAFCHS NVLHRDLKPQNLLINKNGEL
Sbjct: 81  EHCDQDLKKYFDSLNGDIDMAVCRSFMLQLLRGLAFCHSHNVLHRDLKPQNLLINKNGEL 140

Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELA+AGR
Sbjct: 141 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELADAGR 200

Query: 184 PLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGR 243
           PLFPGSDV DQL +IF++LGTPTE++WPG+  L D+   P +    S+SQ+ P+L++KGR
Sbjct: 201 PLFPGSDVLDQLMKIFRVLGTPTEESWPGVTHLSDYVALPHFPAITSWSQIVPRLSSKGR 260

Query: 244 DLLQRLLVCNPVQRMSAEDAMSHIYFSD 271
           DLLQ+LLVC P QR+SAE AM H YF+D
Sbjct: 261 DLLQKLLVCRPNQRVSAEQAMQHPYFTD 288

Probably involved in the control of the cell cycle. Interacts with D1 and D3-type G1 cyclins. Possible regulator of neuronal differentiation and/or development.

Glossina morsitans morsitans (taxid: 37546)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|P48609|CDK5_DROME Cyclin-dependent kinase 5 homolog OS=Drosophila melanogaster GN=Cdk5 PE=1 SV=2

 Score =  424 bits (1090), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 205/268 (76%), Positives = 230/268 (85%), Gaps = 1/268 (0%)

Query: 5   GVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF 63
           G +R     +A+K   L   +EGVPSSALREICLLKELKHKNIVRL DVLHS+KKLTLVF
Sbjct: 21  GRNRDTMEIVALKRVRLDEDDEGVPSSALREICLLKELKHKNIVRLIDVLHSDKKLTLVF 80

Query: 64  EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL 123
           EHCDQDLKKYFDSLNGEID+ + +SFM QLLRGLAFCHS NVLHRDLKPQNLLINKNGEL
Sbjct: 81  EHCDQDLKKYFDSLNGEIDMAVCRSFMLQLLRGLAFCHSHNVLHRDLKPQNLLINKNGEL 140

Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCI AELA+AGR
Sbjct: 141 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCILAELADAGR 200

Query: 184 PLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGR 243
           PLFPGSDV DQL +IF++LGTP ED+WPG++ L D+   P +    S+SQ+ P+L +KGR
Sbjct: 201 PLFPGSDVLDQLMKIFRVLGTPNEDSWPGVSHLSDYVALPSFPAITSWSQLVPRLNSKGR 260

Query: 244 DLLQRLLVCNPVQRMSAEDAMSHIYFSD 271
           DLLQ+LL+C P QR+SAE AM H YF+D
Sbjct: 261 DLLQKLLICRPNQRISAEAAMQHPYFTD 288

Probably involved in the control of the cell cycle. Interacts with D1 and D3-type G1 cyclins. Possible regulator of neuronal differentiation and/or development.

Drosophila melanogaster (taxid: 7227)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|P34117|CDK5_DICDI Cyclin-dependent kinase 5 homolog OS=Dictyostelium discoideum GN=cdk5 PE=2 SV=2

 Score =  334 bits (856), Expect = 5e-91,   Method: Compositional matrix adjust.
 Identities = 161/251 (64%), Positives = 196/251 (78%), Gaps = 3/251 (1%)

Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL 83
           +EGVP +A+REI LLKELKH NIVRL+DV+H+E+KLTLVFE+ DQDLKKY D   GEI  
Sbjct: 41  DEGVPCTAIREISLLKELKHPNIVRLHDVIHTERKLTLVFEYLDQDLKKYLDECGGEISK 100

Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
             +KSFMYQLL+G+AFCH   VLHRDLKPQNLLIN+ GELKLADFGLARAFGIPV+ YS 
Sbjct: 101 PTIKSFMYQLLKGVAFCHDHRVLHRDLKPQNLLINRKGELKLADFGLARAFGIPVRTYSH 160

Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
           EVVTLWYR PDVL G++ Y+T ID+WSAGCIFAE+A +GRPLFPGS   DQL RIFK+LG
Sbjct: 161 EVVTLWYRAPDVLMGSRKYSTPIDIWSAGCIFAEMA-SGRPLFPGSGTSDQLFRIFKILG 219

Query: 204 TPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAED 262
           TP E++WP +  LP++K  FP+ HP+   S +   L  KG +LL ++L  +P QR++A  
Sbjct: 220 TPNEESWPSITELPEYKTDFPV-HPAHQLSSIVHGLDEKGLNLLSKMLQYDPNQRITAAA 278

Query: 263 AMSHIYFSDLN 273
           A+ H YF  L 
Sbjct: 279 ALKHPYFDGLE 289

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q27032|CDC2H_THEPA Cell division control protein 2 homolog OS=Theileria parva GN=CRK2 PE=3 SV=1

 Score =  319 bits (817), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 151/250 (60%), Positives = 192/250 (76%), Gaps = 1/250 (0%)

Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL 83
           +EG+PS+A+REI LLKEL H NIV L DV+HSEK LTLVFE+ DQDLKK  D+ +G ++ 
Sbjct: 40  DEGIPSTAIREISLLKELHHPNIVWLRDVIHSEKCLTLVFEYLDQDLKKLLDACDGGLEP 99

Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
              KSF+YQ+LRG+++CH   +LHRDLKPQNLLIN+ G LKLADFGLARAF IPV+ Y+ 
Sbjct: 100 TTAKSFLYQILRGISYCHDHRILHRDLKPQNLLINREGVLKLADFGLARAFAIPVRSYTH 159

Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
           EVVTLWYR PDVL G+K Y+T++D+WS GCIFAE+ N G PLFPG    DQLKRIFK+LG
Sbjct: 160 EVVTLWYRAPDVLMGSKKYSTAVDIWSVGCIFAEMIN-GVPLFPGISEQDQLKRIFKILG 218

Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           TP+ D+WP +  LP + P   Y+   S+S + PKL   G DL+ R+L  +PVQR+SA++A
Sbjct: 219 TPSVDSWPQVVNLPAYNPDFSYYEKQSWSSIVPKLNESGIDLISRMLQLDPVQRISAKEA 278

Query: 264 MSHIYFSDLN 273
           + H YF DL+
Sbjct: 279 LKHDYFKDLH 288

Plays a key role in the control of the eukaryotic cell cycle. It is required in higher cells for entry into S-phase and mitosis. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II.

Theileria parva (taxid: 5875)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q26671|CDC2H_THEAN Cell division control protein 2 homolog OS=Theileria annulata GN=CRK2 PE=2 SV=1

 Score =  317 bits (812), Expect = 6e-86,   Method: Compositional matrix adjust.
 Identities = 150/250 (60%), Positives = 191/250 (76%), Gaps = 1/250 (0%)

Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL 83
           +EG+PS+A+REI LLKEL H NIV L DV+HSEK LTLVFE+ DQDLKK  D+ +G ++ 
Sbjct: 40  DEGIPSTAIREISLLKELHHPNIVWLRDVIHSEKCLTLVFEYLDQDLKKLLDACDGGLEP 99

Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
              KSF+YQ+LRG+++CH   +LHRDLKPQNLLIN+ G LKLADFGLARAF IPV+ Y+ 
Sbjct: 100 TTAKSFLYQILRGISYCHDHRILHRDLKPQNLLINREGVLKLADFGLARAFAIPVRSYTH 159

Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
           EVVTLWYR PDVL G+K Y+T++D+WS GCIFAE+ N G PLFPG    DQLKRIFK+LG
Sbjct: 160 EVVTLWYRAPDVLMGSKKYSTAVDIWSVGCIFAEMIN-GVPLFPGISEQDQLKRIFKILG 218

Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           TP  D+WP +  LP + P   Y+   ++S + PKL   G DL+ R+L  +PVQR+SA++A
Sbjct: 219 TPNVDSWPQVVNLPAYNPDFCYYEKQAWSSIVPKLNESGIDLISRMLQLDPVQRISAKEA 278

Query: 264 MSHIYFSDLN 273
           + H YF DL+
Sbjct: 279 LKHDYFKDLH 288

Plays a key role in the control of the eukaryotic cell cycle. It is required in higher cells for entry into S-phase and mitosis. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II.

Theileria annulata (taxid: 5874)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	282
270010353	298	hypothetical protein TcasGA2_TC009740 [T	0.975	0.922	0.851	1e-136
332030625	299	Cell division protein kinase 5 [Acromyrm	0.978	0.923	0.837	1e-136
270289764	299	cyclin-dependent kinase 5 [Apis mellifer	0.978	0.923	0.830	1e-135
307200677	299	Cell division protein kinase 5 [Harpegna	0.978	0.923	0.830	1e-135
340720501	299	PREDICTED: cyclin-dependent kinase 5-lik	0.978	0.923	0.823	1e-134
266634748	299	cyclin-dependent kinase 5 [Nasonia vitri	0.978	0.923	0.823	1e-134
274318357	298	cyclin dependent kinase 5 [Bombyx mori]	0.914	0.865	0.868	1e-133
442749137	296	Putative cyclin-dependent kinase cdk5 [I	0.964	0.918	0.835	1e-132
427792673	324	Putative cyclin-dependent kinase 5, part	0.964	0.839	0.827	1e-132
357614087	298	cyclin dependent kinase 5 [Danaus plexip	0.975	0.922	0.822	1e-132

>gi|270010353|gb|EFA06801.1| hypothetical protein TcasGA2_TC009740 [Tribolium castaneum]

 Score =  491 bits (1263), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 235/276 (85%), Positives = 254/276 (92%), Gaps = 1/276 (0%)

Query: 7   DRTPNTALAIKGTHLVGN-EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           +R  +  +A+K   L  + EGVPSSALREICLLKELKHKNIVRLYDVLHS+KKLTLVFEH
Sbjct: 23  NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEH 82

Query: 66  CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
           CDQDLKKYFDSLNG+IDLD+VKSFMYQLLRGLAFCHS NVLHRDLKPQNLLINKNGELKL
Sbjct: 83  CDQDLKKYFDSLNGDIDLDVVKSFMYQLLRGLAFCHSHNVLHRDLKPQNLLINKNGELKL 142

Query: 126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
           ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL
Sbjct: 143 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 202

Query: 186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
           FPGSDVDDQL+RIFKLLGTPTE+TW GM  LPD+KPFP+Y P+MS SQV PKL  +GRDL
Sbjct: 203 FPGSDVDDQLRRIFKLLGTPTEETWSGMTQLPDYKPFPLYQPNMSLSQVVPKLGNRGRDL 262

Query: 246 LQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKSERC 281
           LQRLLVCNP+ RMSA+DAM+H YFSDLN AIK++RC
Sbjct: 263 LQRLLVCNPMGRMSADDAMAHAYFSDLNPAIKNDRC 298

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|332030625|gb|EGI70313.1| Cell division protein kinase 5 [Acromyrmex echinatior]

 Score =  489 bits (1258), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 232/277 (83%), Positives = 254/277 (91%), Gaps = 1/277 (0%)

Query: 7   DRTPNTALAIKGTHLVGN-EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           +R  +  +A+K   L  + EGVPSSALREICLLKELKHKNIVRLYDVLHS+KKLTLVFEH
Sbjct: 23  NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEH 82

Query: 66  CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
           CDQDLKKYFDSLNGEIDLD+VKSF+YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL
Sbjct: 83  CDQDLKKYFDSLNGEIDLDVVKSFLYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 142

Query: 126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
           ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL
Sbjct: 143 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 202

Query: 186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
           FPGSDVDDQLKRIFK+LGTPTE+TWP +  LPD+KPFP YHPS   +QV PKLT++G+DL
Sbjct: 203 FPGSDVDDQLKRIFKMLGTPTEETWPDLTTLPDYKPFPQYHPSQGLAQVTPKLTSRGKDL 262

Query: 246 LQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKSERCQ 282
           LQRLLVCNP  R+SAE+AM+H YF+DLN  IK++RCQ
Sbjct: 263 LQRLLVCNPALRLSAEEAMAHPYFNDLNPVIKNDRCQ 299

Source: Acromyrmex echinatior

Species: Acromyrmex echinatior

Genus: Acromyrmex

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|270289764|ref|NP_001161897.1| cyclin-dependent kinase 5 [Apis mellifera] gi|380018685|ref|XP_003693255.1| PREDICTED: cyclin-dependent kinase 5-like [Apis florea]

 Score =  486 bits (1252), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 230/277 (83%), Positives = 254/277 (91%), Gaps = 1/277 (0%)

Query: 7   DRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           +R  +  +A+K   L   +EGVPSSALREICLLKELKHKN+VRLYDVLHS+KKLTLVFEH
Sbjct: 23  NRETHEIVALKRVRLDEDDEGVPSSALREICLLKELKHKNVVRLYDVLHSDKKLTLVFEH 82

Query: 66  CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
           CDQDLKKYFDSLNGEIDLD+VKSF+YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL
Sbjct: 83  CDQDLKKYFDSLNGEIDLDVVKSFLYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 142

Query: 126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
           ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL
Sbjct: 143 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 202

Query: 186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
           FPGSDVDDQLKRIFK+LGTPTE+TWP    LPD+KPFP+YHP+   +QV PKL ++GRDL
Sbjct: 203 FPGSDVDDQLKRIFKMLGTPTEETWPDFTTLPDYKPFPLYHPAQGLAQVTPKLNSRGRDL 262

Query: 246 LQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKSERCQ 282
           LQRLLVCNP  R+SA++AM+H YF+DLN AIK++RCQ
Sbjct: 263 LQRLLVCNPALRLSADEAMAHPYFNDLNPAIKNDRCQ 299

Source: Apis mellifera

Species: Apis mellifera

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307200677|gb|EFN80780.1| Cell division protein kinase 5 [Harpegnathos saltator]

 Score =  485 bits (1249), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 230/277 (83%), Positives = 254/277 (91%), Gaps = 1/277 (0%)

Query: 7   DRTPNTALAIKGTHLVGN-EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           +R  +  +A+K   L  + EGVPSSALREICLLKELKHKNIVRLYDVLHS+KKLTLVFEH
Sbjct: 23  NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEH 82

Query: 66  CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
           CDQDLKKYFDSLNGEIDLDIVKSF+YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL
Sbjct: 83  CDQDLKKYFDSLNGEIDLDIVKSFLYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 142

Query: 126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
           ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL
Sbjct: 143 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 202

Query: 186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
           FPGSDVDDQLKRIFK+LGTP E+TWP +  LPD+KPFP YHP+   +QV PKL+++G+DL
Sbjct: 203 FPGSDVDDQLKRIFKMLGTPNEETWPDLTTLPDYKPFPQYHPTQGLAQVTPKLSSRGKDL 262

Query: 246 LQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKSERCQ 282
           LQRLLVCNP  R+SAE+AM+H YF+DLN A+K++RCQ
Sbjct: 263 LQRLLVCNPALRLSAEEAMAHPYFNDLNPAMKNDRCQ 299

Source: Harpegnathos saltator

Species: Harpegnathos saltator

Genus: Harpegnathos

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|340720501|ref|XP_003398675.1| PREDICTED: cyclin-dependent kinase 5-like [Bombus terrestris]

 Score =  482 bits (1241), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 228/277 (82%), Positives = 252/277 (90%), Gaps = 1/277 (0%)

Query: 7   DRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           +R  +  +A+K   L   +EGVPSSALREICLLKELKHKN+VRLYDVLHS+KKLTLVFEH
Sbjct: 23  NRETHEIVALKRVRLDEDDEGVPSSALREICLLKELKHKNVVRLYDVLHSDKKLTLVFEH 82

Query: 66  CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
           CDQDLKKYFDSLNGEIDLD+VKSF+YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL
Sbjct: 83  CDQDLKKYFDSLNGEIDLDVVKSFLYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 142

Query: 126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
           ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL
Sbjct: 143 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 202

Query: 186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
           FPGSDVDDQLKRIFK+LGTP E+TWP    LPD+KPFP+YHP+   +QV PKL ++GRDL
Sbjct: 203 FPGSDVDDQLKRIFKMLGTPVEETWPDFTTLPDYKPFPLYHPAQGLAQVTPKLNSRGRDL 262

Query: 246 LQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKSERCQ 282
           LQ+LLVCNP  R+SA++AM H YF+DLN AIK++RCQ
Sbjct: 263 LQKLLVCNPALRLSADEAMVHPYFNDLNPAIKNDRCQ 299

Source: Bombus terrestris

Species: Bombus terrestris

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|266634748|ref|NP_001161184.1| cyclin-dependent kinase 5 [Nasonia vitripennis]

 Score =  482 bits (1241), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 228/277 (82%), Positives = 254/277 (91%), Gaps = 1/277 (0%)

Query: 7   DRTPNTALAIKGTHLVGN-EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           +R  +  +A+K   L  + EGVPSSALREICLLKELKHKNIVRLYDVLHS+KKLTLVFEH
Sbjct: 23  NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEH 82

Query: 66  CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
           CDQDLKKYFDSLNG IDLD+VKSF+YQLLRGLAFCHSRNVLHRDLKPQNLLIN+NGELKL
Sbjct: 83  CDQDLKKYFDSLNGVIDLDVVKSFLYQLLRGLAFCHSRNVLHRDLKPQNLLINENGELKL 142

Query: 126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
           ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL
Sbjct: 143 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 202

Query: 186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
           FPGSDVDDQLKRIFK+LGTPTE+TWP ++ LPD++PFP YHP+   +QV PKLTA+G+DL
Sbjct: 203 FPGSDVDDQLKRIFKMLGTPTEETWPDISTLPDYRPFPQYHPTQGLAQVTPKLTARGKDL 262

Query: 246 LQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKSERCQ 282
           L RLLVCNP  R+SAE+AM+H YF+DLN AI+++RCQ
Sbjct: 263 LARLLVCNPALRLSAEEAMAHPYFNDLNPAIRNDRCQ 299

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|274318357|ref|NP_001162053.1| cyclin dependent kinase 5 [Bombyx mori] gi|254839141|gb|ACT83401.1| cyclin dependent kinase 5 [Bombyx mori]

 Score =  478 bits (1231), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 224/258 (86%), Positives = 240/258 (93%)

Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL 83
           +EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL
Sbjct: 41  DEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL 100

Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
           D+VKSFMYQLLRGLAFCHS NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA
Sbjct: 101 DVVKSFMYQLLRGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 160

Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
           EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN+GRPLFPGSDVDDQLKRIFKLLG
Sbjct: 161 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANSGRPLFPGSDVDDQLKRIFKLLG 220

Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           TP EDTWPG+  LPD+KP P+Y PS+  +QV P+L A+GRDLL RLL CNP  RM A+DA
Sbjct: 221 TPNEDTWPGVTQLPDYKPLPVYQPSLGLAQVVPRLPARGRDLLARLLTCNPALRMPADDA 280

Query: 264 MSHIYFSDLNVAIKSERC 281
           M+H YF DLN ++K++RC
Sbjct: 281 MAHAYFHDLNPSVKNDRC 298

Source: Bombyx mori

Species: Bombyx mori

Genus: Bombyx

Family: Bombycidae

Order: Lepidoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|442749137|gb|JAA66728.1| Putative cyclin-dependent kinase cdk5 [Ixodes ricinus]

 Score =  478 bits (1231), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 228/273 (83%), Positives = 249/273 (91%), Gaps = 1/273 (0%)

Query: 7   DRTPNTALAIKGTHLVGN-EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           +R     +A+K   L  + EGVPSSALREICLLKELKHKNIVRL+DVLHSEKKLTLVFEH
Sbjct: 23  NRETQEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSEKKLTLVFEH 82

Query: 66  CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
           CDQDLKKYFDSLNGEIDL++VKSFM+QLLRGLAFCHS N+LHRDLKPQNLLINKNGELKL
Sbjct: 83  CDQDLKKYFDSLNGEIDLEVVKSFMFQLLRGLAFCHSNNILHRDLKPQNLLINKNGELKL 142

Query: 126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
           ADFGLARAFGIPV+CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL
Sbjct: 143 ADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 202

Query: 186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
           FPGSDVDDQLKRIFKLLGTPTEDTW GM  LPD+KPFPMYHP+ SF+QV PKL+ KGRDL
Sbjct: 203 FPGSDVDDQLKRIFKLLGTPTEDTWSGMTQLPDYKPFPMYHPTTSFAQVVPKLSCKGRDL 262

Query: 246 LQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKS 278
           LQ+LLVCNP  R+SA++AM H YFSDL  +I++
Sbjct: 263 LQKLLVCNPAIRVSADEAMQHPYFSDLPTSIRN 295

Source: Ixodes ricinus

Species: Ixodes ricinus

Genus: Ixodes

Family: Ixodidae

Order: Ixodida

Class: Arachnida

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|427792673|gb|JAA61788.1| Putative cyclin-dependent kinase 5, partial [Rhipicephalus pulchellus]

 Score =  476 bits (1226), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 226/273 (82%), Positives = 249/273 (91%), Gaps = 1/273 (0%)

Query: 7   DRTPNTALAIKGTHLVGN-EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           +R     +A+K   L  + EGVPSSALREICLLKELKHKNIVRL+DVLHSEKKLTLVFEH
Sbjct: 51  NRETQEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSEKKLTLVFEH 110

Query: 66  CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
           CDQDLKKYFDSLNGEIDL++VKSFM+QLLRGLAFCHS N+LHRDLKPQNLLINKNGELKL
Sbjct: 111 CDQDLKKYFDSLNGEIDLEVVKSFMFQLLRGLAFCHSNNILHRDLKPQNLLINKNGELKL 170

Query: 126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
           ADFGLARAFGIPV+CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL
Sbjct: 171 ADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 230

Query: 186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
           FPGSDVDDQLKRIFKLLGTPTEDTWPGM  LPD+K FP+YHP+ SF+QV PKL+ +GRDL
Sbjct: 231 FPGSDVDDQLKRIFKLLGTPTEDTWPGMTQLPDYKSFPLYHPTTSFAQVVPKLSCRGRDL 290

Query: 246 LQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKS 278
           LQ+LLVCNP  R+SA++AM H YFSDL  +I++
Sbjct: 291 LQKLLVCNPSMRLSADEAMQHPYFSDLPSSIRN 323

Source: Rhipicephalus pulchellus

Species: Rhipicephalus pulchellus

Genus: Rhipicephalus

Family: Ixodidae

Order: Ixodida

Class: Arachnida

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|357614087|gb|EHJ68899.1| cyclin dependent kinase 5 [Danaus plexippus]

 Score =  476 bits (1225), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 227/276 (82%), Positives = 247/276 (89%), Gaps = 1/276 (0%)

Query: 7   DRTPNTALAIKGTHLVGN-EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           +R  +  +A+K   L  + EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH
Sbjct: 23  NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 82

Query: 66  CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
           CDQDLKKYFDSLN EIDLD+VKSFMYQLLRGLAFCHS NVLHRDLKPQNLLINKNGELKL
Sbjct: 83  CDQDLKKYFDSLNDEIDLDVVKSFMYQLLRGLAFCHSHNVLHRDLKPQNLLINKNGELKL 142

Query: 126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
           ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN+GRPL
Sbjct: 143 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANSGRPL 202

Query: 186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
           FPGSDVDDQLKRIFKLLGTP EDTWPG+  LPD+KP P+Y PS+  +QV P+L A+GRDL
Sbjct: 203 FPGSDVDDQLKRIFKLLGTPNEDTWPGVTQLPDYKPLPVYQPSLGLAQVVPRLPARGRDL 262

Query: 246 LQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKSERC 281
           L RLL CNP  RM A+DAM+H YF DLN ++K++RC
Sbjct: 263 LARLLTCNPALRMPADDAMAHAYFHDLNPSVKNDRC 298

Source: Danaus plexippus

Species: Danaus plexippus

Genus: Danaus

Family: Nymphalidae

Order: Lepidoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	282
UNIPROTKB|P51166	292	cdk5 "Cyclin-dependent kinase	0.939	0.907	0.793	5.8e-114
ZFIN|ZDB-GENE-010131-2	292	cdk5 "cyclin-dependent protein	0.939	0.907	0.793	7.3e-114
UNIPROTKB|Q02399	292	CDK5 "Cyclin-dependent kinase	0.939	0.907	0.789	2.5e-113
UNIPROTKB|E2RGN2	295	CDK5 "Uncharacterized protein"	0.939	0.898	0.789	2.5e-113
UNIPROTKB|J9NWG1	311	CDK5 "Uncharacterized protein"	0.939	0.852	0.789	2.5e-113
UNIPROTKB|Q00535	292	CDK5 "Cyclin-dependent kinase	0.939	0.907	0.789	2.5e-113
UNIPROTKB|Q197W4	292	CDK5 "Cyclin-dependent kinase	0.939	0.907	0.789	2.5e-113
MGI|MGI:101765	292	Cdk5 "cyclin-dependent kinase	0.939	0.907	0.789	2.5e-113
RGD|70514	292	Cdk5 "cyclin-dependent kinase	0.939	0.907	0.785	1.1e-112
FB|FBgn0013762	294	Cdk5 "Cyclin-dependent kinase	0.946	0.908	0.764	2.4e-108

UNIPROTKB|P51166 cdk5 "Cyclin-dependent kinase 5" [Xenopus laevis (taxid:8355)]

 Score = 1124 (400.7 bits), Expect = 5.8e-114, P = 5.8e-114
 Identities = 211/266 (79%), Positives = 236/266 (88%)

Query:     7 DRTPNTALAIKGTHLVGN-EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
             +R  +  +A+K   L  + EGVPSSALREICLLKELKHKNIVRL+DVLHS+KKLTLVFE 
Sbjct:    23 NRDTHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82

Query:    66 CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
             CDQDLKKYFDS NG++D +IVKSFMYQLL+GLAFCHSRNVLHRDLKPQNLLIN+NGELKL
Sbjct:    83 CDQDLKKYFDSCNGDLDPEIVKSFMYQLLKGLAFCHSRNVLHRDLKPQNLLINRNGELKL 142

Query:   126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
             ADFGLARAFGIPV+CYSAEVVTLWYRPPDVLFGAKLY+TSIDMWSAGCIFAELANAGRPL
Sbjct:   143 ADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

Query:   186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
             FPG+DVDDQLKRIF+LLGTPTE+ WP M  LPD+KP+PMY  +MS   V PKL A GRDL
Sbjct:   203 FPGNDVDDQLKRIFRLLGTPTEEQWPAMTKLPDYKPYPMYPATMSLVNVVPKLNATGRDL 262

Query:   246 LQRLLVCNPVQRMSAEDAMSHIYFSD 271
             LQ LL CNPVQR+ A++A+ H YF+D
Sbjct:   263 LQNLLKCNPVQRICADEALQHPYFAD 288

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005176 "ErbB-2 class receptor binding" evidence=ISS

GO:0005634 "nucleus" evidence=ISS

GO:0005737 "cytoplasm" evidence=ISS

GO:0009790 "embryo development" evidence=ISS

GO:0014069 "postsynaptic density" evidence=ISS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0030182 "neuron differentiation" evidence=ISS

GO:0030424 "axon" evidence=ISS

GO:0030425 "dendrite" evidence=ISS

GO:0030426 "growth cone" evidence=ISS

GO:0030549 "acetylcholine receptor activator activity" evidence=ISS

GO:0031175 "neuron projection development" evidence=ISS

GO:0031594 "neuromuscular junction" evidence=ISS

GO:0043025 "neuronal cell body" evidence=ISS

GO:0043125 "ErbB-3 class receptor binding" evidence=ISS

GO:0043525 "positive regulation of neuron apoptotic process" evidence=ISS

GO:0050321 "tau-protein kinase activity" evidence=ISS

GO:0061001 "regulation of dendritic spine morphogenesis" evidence=ISS

ZFIN|ZDB-GENE-010131-2 cdk5 "cyclin-dependent protein kinase 5" [Danio rerio (taxid:7955)]

 Score = 1123 (400.4 bits), Expect = 7.3e-114, P = 7.3e-114
 Identities = 211/266 (79%), Positives = 238/266 (89%)

Query:     7 DRTPNTALAIKGTHLVGN-EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
             +R  +  +A+K   L  + EGVPSSALREICLLKELKHKNIVRL+DVLHS+KKLTLVFE+
Sbjct:    23 NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEY 82

Query:    66 CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
             CDQDLKKYFDS NG++D +IVKSFMYQLL+GLAFCHSRNVLHRDLKPQNLLIN+NGELKL
Sbjct:    83 CDQDLKKYFDSCNGDLDPEIVKSFMYQLLKGLAFCHSRNVLHRDLKPQNLLINRNGELKL 142

Query:   126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
             ADFGLARAFGIPV+CYSAEVVTLWYRPPDVLFGAKLY+TSIDMWSAGCIFAELANAGRPL
Sbjct:   143 ADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

Query:   186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
             FPG+DVDDQLKRIF+LLGTPTE+ W  MN LPD+KP+PMY  + S   V PKL++ GRDL
Sbjct:   203 FPGNDVDDQLKRIFRLLGTPTEEQWQTMNKLPDYKPYPMYPATTSLVNVVPKLSSTGRDL 262

Query:   246 LQRLLVCNPVQRMSAEDAMSHIYFSD 271
             LQ LL CNPVQR+SAE+A+ H YF+D
Sbjct:   263 LQNLLKCNPVQRISAEEALQHPYFAD 288

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0035173 "histone kinase activity" evidence=IMP;IDA

GO:0043524 "negative regulation of neuron apoptotic process" evidence=IMP;IDA

GO:0021634 "optic nerve formation" evidence=IMP

GO:0030182 "neuron differentiation" evidence=IMP

GO:0060059 "embryonic retina morphogenesis in camera-type eye" evidence=IMP

GO:0010842 "retina layer formation" evidence=IMP

GO:0000166 "nucleotide binding" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0048935 "peripheral nervous system neuron development" evidence=IMP

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IMP

GO:0021954 "central nervous system neuron development" evidence=IMP

UNIPROTKB|Q02399 CDK5 "Cyclin-dependent kinase 5" [Bos taurus (taxid:9913)]

 Score = 1118 (398.6 bits), Expect = 2.5e-113, P = 2.5e-113
 Identities = 210/266 (78%), Positives = 235/266 (88%)

Query:     7 DRTPNTALAIKGTHLVGN-EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
             +R  +  +A+K   L  + EGVPSSALREICLLKELKHKNIVRL+DVLHS+KKLTLVFE 
Sbjct:    23 NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82

Query:    66 CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
             CDQDLKKYFDS NG++D +IVKSF++QLL+GL FCHSRNVLHRDLKPQNLLIN+NGELKL
Sbjct:    83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKL 142

Query:   126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
             ADFGLARAFGIPV+CYSAEVVTLWYRPPDVLFGAKLY+TSIDMWSAGCIFAELANAGRPL
Sbjct:   143 ADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

Query:   186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
             FPG+DVDDQLKRIF+LLGTPTE+ WP M  LPD+KP+PMY  + S   V PKL A GRDL
Sbjct:   203 FPGNDVDDQLKRIFRLLGTPTEEQWPAMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDL 262

Query:   246 LQRLLVCNPVQRMSAEDAMSHIYFSD 271
             LQ LL CNPVQR+SAE+A+ H YFSD
Sbjct:   263 LQNLLKCNPVQRISAEEALQHPYFSD 288

GO:0016572 "histone phosphorylation" evidence=TAS

GO:0031175 "neuron projection development" evidence=ISS

GO:0050321 "tau-protein kinase activity" evidence=ISS

GO:0043025 "neuronal cell body" evidence=ISS

GO:0031594 "neuromuscular junction" evidence=ISS

GO:0030426 "growth cone" evidence=ISS

GO:0030425 "dendrite" evidence=ISS

GO:0030424 "axon" evidence=ISS

GO:0030182 "neuron differentiation" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS

GO:0009790 "embryo development" evidence=ISS

GO:0005737 "cytoplasm" evidence=ISS

GO:0005634 "nucleus" evidence=ISS

GO:0030549 "acetylcholine receptor activator activity" evidence=ISS

GO:0030334 "regulation of cell migration" evidence=ISS

GO:0030175 "filopodium" evidence=ISS

GO:0030027 "lamellipodium" evidence=ISS

GO:0016477 "cell migration" evidence=ISS

GO:0007409 "axonogenesis" evidence=ISS

GO:0007160 "cell-matrix adhesion" evidence=ISS

GO:0005829 "cytosol" evidence=ISS

GO:0005176 "ErbB-2 class receptor binding" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0048167 "regulation of synaptic plasticity" evidence=ISS

GO:0014069 "postsynaptic density" evidence=ISS

GO:0061001 "regulation of dendritic spine morphogenesis" evidence=ISS

GO:0035173 "histone kinase activity" evidence=TAS

GO:0043125 "ErbB-3 class receptor binding" evidence=ISS

GO:0043525 "positive regulation of neuron apoptotic process" evidence=ISS

GO:0043204 "perikaryon" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0090314 "positive regulation of protein targeting to membrane" evidence=IEA

GO:0070509 "calcium ion import" evidence=IEA

GO:0060079 "regulation of excitatory postsynaptic membrane potential" evidence=IEA

GO:0051402 "neuron apoptotic process" evidence=IEA

GO:0048813 "dendrite morphogenesis" evidence=IEA

GO:0048709 "oligodendrocyte differentiation" evidence=IEA

GO:0048148 "behavioral response to cocaine" evidence=IEA

GO:0046826 "negative regulation of protein export from nucleus" evidence=IEA

GO:0045956 "positive regulation of calcium ion-dependent exocytosis" evidence=IEA

GO:0045892 "negative regulation of transcription, DNA-dependent" evidence=IEA

GO:0045860 "positive regulation of protein kinase activity" evidence=IEA

GO:0045786 "negative regulation of cell cycle" evidence=IEA

GO:0043113 "receptor clustering" evidence=IEA

GO:0035418 "protein localization to synapse" evidence=IEA

GO:0035249 "synaptic transmission, glutamatergic" evidence=IEA

GO:0033136 "serine phosphorylation of STAT3 protein" evidence=IEA

GO:0032801 "receptor catabolic process" evidence=IEA

GO:0032092 "positive regulation of protein binding" evidence=IEA

GO:0031914 "negative regulation of synaptic plasticity" evidence=IEA

GO:0031397 "negative regulation of protein ubiquitination" evidence=IEA

GO:0022038 "corpus callosum development" evidence=IEA

GO:0021954 "central nervous system neuron development" evidence=IEA

GO:0021819 "layer formation in cerebral cortex" evidence=IEA

GO:0021766 "hippocampus development" evidence=IEA

GO:0021697 "cerebellar cortex formation" evidence=IEA

GO:0019233 "sensory perception of pain" evidence=IEA

GO:0018107 "peptidyl-threonine phosphorylation" evidence=IEA

GO:0014044 "Schwann cell development" evidence=IEA

GO:0008542 "visual learning" evidence=IEA

GO:0008045 "motor neuron axon guidance" evidence=IEA

GO:0007519 "skeletal muscle tissue development" evidence=IEA

GO:0007416 "synapse assembly" evidence=IEA

GO:0006886 "intracellular protein transport" evidence=IEA

GO:0002039 "p53 binding" evidence=IEA

GO:0001963 "synaptic transmission, dopaminergic" evidence=IEA

GO:0001764 "neuron migration" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0045211 "postsynaptic membrane" evidence=IEA

GO:0030054 "cell junction" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|E2RGN2 CDK5 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 1118 (398.6 bits), Expect = 2.5e-113, P = 2.5e-113
 Identities = 210/266 (78%), Positives = 235/266 (88%)

Query:     7 DRTPNTALAIKGTHLVGN-EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
             +R  +  +A+K   L  + EGVPSSALREICLLKELKHKNIVRL+DVLHS+KKLTLVFE 
Sbjct:    26 NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 85

Query:    66 CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
             CDQDLKKYFDS NG++D +IVKSF++QLL+GL FCHSRNVLHRDLKPQNLLIN+NGELKL
Sbjct:    86 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKL 145

Query:   126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
             ADFGLARAFGIPV+CYSAEVVTLWYRPPDVLFGAKLY+TSIDMWSAGCIFAELANAGRPL
Sbjct:   146 ADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 205

Query:   186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
             FPG+DVDDQLKRIF+LLGTPTE+ WP M  LPD+KP+PMY  + S   V PKL A GRDL
Sbjct:   206 FPGNDVDDQLKRIFRLLGTPTEEQWPAMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDL 265

Query:   246 LQRLLVCNPVQRMSAEDAMSHIYFSD 271
             LQ LL CNPVQR+SAE+A+ H YFSD
Sbjct:   266 LQNLLKCNPVQRISAEEALQHPYFSD 291

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|J9NWG1 CDK5 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 1118 (398.6 bits), Expect = 2.5e-113, P = 2.5e-113
 Identities = 210/266 (78%), Positives = 235/266 (88%)

Query:     7 DRTPNTALAIKGTHLVGN-EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
             +R  +  +A+K   L  + EGVPSSALREICLLKELKHKNIVRL+DVLHS+KKLTLVFE 
Sbjct:    42 NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 101

Query:    66 CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
             CDQDLKKYFDS NG++D +IVKSF++QLL+GL FCHSRNVLHRDLKPQNLLIN+NGELKL
Sbjct:   102 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKL 161

Query:   126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
             ADFGLARAFGIPV+CYSAEVVTLWYRPPDVLFGAKLY+TSIDMWSAGCIFAELANAGRPL
Sbjct:   162 ADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 221

Query:   186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
             FPG+DVDDQLKRIF+LLGTPTE+ WP M  LPD+KP+PMY  + S   V PKL A GRDL
Sbjct:   222 FPGNDVDDQLKRIFRLLGTPTEEQWPAMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDL 281

Query:   246 LQRLLVCNPVQRMSAEDAMSHIYFSD 271
             LQ LL CNPVQR+SAE+A+ H YFSD
Sbjct:   282 LQNLLKCNPVQRISAEEALQHPYFSD 307

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|Q00535 CDK5 "Cyclin-dependent kinase 5" [Homo sapiens (taxid:9606)]

 Score = 1118 (398.6 bits), Expect = 2.5e-113, P = 2.5e-113
 Identities = 210/266 (78%), Positives = 235/266 (88%)

Query:     7 DRTPNTALAIKGTHLVGN-EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
             +R  +  +A+K   L  + EGVPSSALREICLLKELKHKNIVRL+DVLHS+KKLTLVFE 
Sbjct:    23 NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82

Query:    66 CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
             CDQDLKKYFDS NG++D +IVKSF++QLL+GL FCHSRNVLHRDLKPQNLLIN+NGELKL
Sbjct:    83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKL 142

Query:   126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
             ADFGLARAFGIPV+CYSAEVVTLWYRPPDVLFGAKLY+TSIDMWSAGCIFAELANAGRPL
Sbjct:   143 ADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

Query:   186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
             FPG+DVDDQLKRIF+LLGTPTE+ WP M  LPD+KP+PMY  + S   V PKL A GRDL
Sbjct:   203 FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDL 262

Query:   246 LQRLLVCNPVQRMSAEDAMSHIYFSD 271
             LQ LL CNPVQR+SAE+A+ H YFSD
Sbjct:   263 LQNLLKCNPVQRISAEEALQHPYFSD 288

GO:0045211 "postsynaptic membrane" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0030054 "cell junction" evidence=IEA

GO:0001963 "synaptic transmission, dopaminergic" evidence=IEA

GO:0002039 "p53 binding" evidence=IEA

GO:0006886 "intracellular protein transport" evidence=IEA

GO:0006913 "nucleocytoplasmic transport" evidence=IEA

GO:0007160 "cell-matrix adhesion" evidence=IEA

GO:0007519 "skeletal muscle tissue development" evidence=IEA

GO:0008045 "motor neuron axon guidance" evidence=IEA

GO:0008542 "visual learning" evidence=IEA

GO:0014044 "Schwann cell development" evidence=IEA

GO:0016533 "cyclin-dependent protein kinase 5 holoenzyme complex" evidence=IEA

GO:0018107 "peptidyl-threonine phosphorylation" evidence=IEA

GO:0019233 "sensory perception of pain" evidence=IEA

GO:0021697 "cerebellar cortex formation" evidence=IEA

GO:0021766 "hippocampus development" evidence=IEA

GO:0021819 "layer formation in cerebral cortex" evidence=IEA

GO:0021954 "central nervous system neuron development" evidence=IEA

GO:0022038 "corpus callosum development" evidence=IEA

GO:0030175 "filopodium" evidence=IEA

GO:0030334 "regulation of cell migration" evidence=IEA

GO:0030866 "cortical actin cytoskeleton organization" evidence=IEA

GO:0031397 "negative regulation of protein ubiquitination" evidence=IEA

GO:0031914 "negative regulation of synaptic plasticity" evidence=IEA

GO:0032092 "positive regulation of protein binding" evidence=IEA

GO:0032801 "receptor catabolic process" evidence=IEA

GO:0033136 "serine phosphorylation of STAT3 protein" evidence=IEA

GO:0035249 "synaptic transmission, glutamatergic" evidence=IEA

GO:0035418 "protein localization to synapse" evidence=IEA

GO:0043113 "receptor clustering" evidence=IEA

GO:0045055 "regulated secretory pathway" evidence=IEA

GO:0045786 "negative regulation of cell cycle" evidence=IEA

GO:0045860 "positive regulation of protein kinase activity" evidence=IEA

GO:0045956 "positive regulation of calcium ion-dependent exocytosis" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0046826 "negative regulation of protein export from nucleus" evidence=IEA

GO:0046875 "ephrin receptor binding" evidence=IEA

GO:0048148 "behavioral response to cocaine" evidence=IEA

GO:0048813 "dendrite morphogenesis" evidence=IEA

GO:0060079 "regulation of excitatory postsynaptic membrane potential" evidence=IEA

GO:0070509 "calcium ion import" evidence=IEA

GO:0090314 "positive regulation of protein targeting to membrane" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0030027 "lamellipodium" evidence=IEA

GO:0043204 "perikaryon" evidence=IEA

GO:0045892 "negative regulation of transcription, DNA-dependent" evidence=IMP

GO:0016310 "phosphorylation" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS;IDA;TAS

GO:0050321 "tau-protein kinase activity" evidence=ISS

GO:0009790 "embryo development" evidence=ISS

GO:0016020 "membrane" evidence=ISS

GO:0031594 "neuromuscular junction" evidence=ISS

GO:0030182 "neuron differentiation" evidence=ISS;TAS

GO:0030424 "axon" evidence=ISS

GO:0030426 "growth cone" evidence=ISS

GO:0031175 "neuron projection development" evidence=ISS

GO:0043025 "neuronal cell body" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0005634 "nucleus" evidence=ISS

GO:0043525 "positive regulation of neuron apoptotic process" evidence=ISS

GO:0030549 "acetylcholine receptor activator activity" evidence=ISS

GO:0043125 "ErbB-3 class receptor binding" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0030425 "dendrite" evidence=ISS

GO:0005737 "cytoplasm" evidence=ISS

GO:0005176 "ErbB-2 class receptor binding" evidence=ISS

GO:0018105 "peptidyl-serine phosphorylation" evidence=IDA

GO:0048167 "regulation of synaptic plasticity" evidence=ISS;TAS

GO:0061001 "regulation of dendritic spine morphogenesis" evidence=ISS

GO:0014069 "postsynaptic density" evidence=ISS

GO:0071156 "regulation of cell cycle arrest" evidence=TAS

GO:0051402 "neuron apoptotic process" evidence=TAS

GO:0001764 "neuron migration" evidence=TAS

GO:0007416 "synapse assembly" evidence=TAS

GO:0048675 "axon extension" evidence=TAS

GO:0048709 "oligodendrocyte differentiation" evidence=IDA

GO:0007268 "synaptic transmission" evidence=TAS

GO:2000251 "positive regulation of actin cytoskeleton reorganization" evidence=TAS

GO:0048488 "synaptic vesicle endocytosis" evidence=TAS

GO:0016079 "synaptic vesicle exocytosis" evidence=TAS

GO:0042981 "regulation of apoptotic process" evidence=TAS

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0004672 "protein kinase activity" evidence=TAS

GO:0008283 "cell proliferation" evidence=TAS

GO:0007411 "axon guidance" evidence=TAS

GO:0007596 "blood coagulation" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

UNIPROTKB|Q197W4 CDK5 "Cyclin-dependent kinase 5" [Sus scrofa (taxid:9823)]

 Score = 1118 (398.6 bits), Expect = 2.5e-113, P = 2.5e-113
 Identities = 210/266 (78%), Positives = 235/266 (88%)

Query:     7 DRTPNTALAIKGTHLVGN-EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
             +R  +  +A+K   L  + EGVPSSALREICLLKELKHKNIVRL+DVLHS+KKLTLVFE 
Sbjct:    23 NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82

Query:    66 CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
             CDQDLKKYFDS NG++D +IVKSF++QLL+GL FCHSRNVLHRDLKPQNLLIN+NGELKL
Sbjct:    83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKL 142

Query:   126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
             ADFGLARAFGIPV+CYSAEVVTLWYRPPDVLFGAKLY+TSIDMWSAGCIFAELANAGRPL
Sbjct:   143 ADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

Query:   186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
             FPG+DVDDQLKRIF+LLGTPTE+ WP M  LPD+KP+PMY  + S   V PKL A GRDL
Sbjct:   203 FPGNDVDDQLKRIFRLLGTPTEEQWPAMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDL 262

Query:   246 LQRLLVCNPVQRMSAEDAMSHIYFSD 271
             LQ LL CNPVQR+SAE+A+ H YFSD
Sbjct:   263 LQNLLKCNPVQRISAEEALQHPYFSD 288

GO:0002039 "p53 binding" evidence=IEA

GO:0001963 "synaptic transmission, dopaminergic" evidence=IEA

GO:0001764 "neuron migration" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0090314 "positive regulation of protein targeting to membrane" evidence=IEA

GO:0070509 "calcium ion import" evidence=IEA

GO:0061001 "regulation of dendritic spine morphogenesis" evidence=IEA

GO:0060079 "regulation of excitatory postsynaptic membrane potential" evidence=IEA

GO:0051402 "neuron apoptotic process" evidence=IEA

GO:0048813 "dendrite morphogenesis" evidence=IEA

GO:0048709 "oligodendrocyte differentiation" evidence=IEA

GO:0048148 "behavioral response to cocaine" evidence=IEA

GO:0046826 "negative regulation of protein export from nucleus" evidence=IEA

GO:0045956 "positive regulation of calcium ion-dependent exocytosis" evidence=IEA

GO:0045892 "negative regulation of transcription, DNA-dependent" evidence=IEA

GO:0045860 "positive regulation of protein kinase activity" evidence=IEA

GO:0045786 "negative regulation of cell cycle" evidence=IEA

GO:0043125 "ErbB-3 class receptor binding" evidence=IEA

GO:0043113 "receptor clustering" evidence=IEA

GO:0035418 "protein localization to synapse" evidence=IEA

GO:0035249 "synaptic transmission, glutamatergic" evidence=IEA

GO:0033136 "serine phosphorylation of STAT3 protein" evidence=IEA

GO:0032801 "receptor catabolic process" evidence=IEA

GO:0032092 "positive regulation of protein binding" evidence=IEA

GO:0031914 "negative regulation of synaptic plasticity" evidence=IEA

GO:0031397 "negative regulation of protein ubiquitination" evidence=IEA

GO:0030549 "acetylcholine receptor activator activity" evidence=IEA

GO:0030334 "regulation of cell migration" evidence=IEA

GO:0030175 "filopodium" evidence=IEA

GO:0030027 "lamellipodium" evidence=IEA

GO:0022038 "corpus callosum development" evidence=IEA

GO:0021954 "central nervous system neuron development" evidence=IEA

GO:0021819 "layer formation in cerebral cortex" evidence=IEA

GO:0021766 "hippocampus development" evidence=IEA

GO:0021697 "cerebellar cortex formation" evidence=IEA

GO:0019233 "sensory perception of pain" evidence=IEA

GO:0018107 "peptidyl-threonine phosphorylation" evidence=IEA

GO:0014044 "Schwann cell development" evidence=IEA

GO:0008542 "visual learning" evidence=IEA

GO:0008045 "motor neuron axon guidance" evidence=IEA

GO:0007519 "skeletal muscle tissue development" evidence=IEA

GO:0007416 "synapse assembly" evidence=IEA

GO:0007160 "cell-matrix adhesion" evidence=IEA

GO:0006886 "intracellular protein transport" evidence=IEA

GO:0005829 "cytosol" evidence=IEA

GO:0005176 "ErbB-2 class receptor binding" evidence=IEA

MGI|MGI:101765 Cdk5 "cyclin-dependent kinase 5" [Mus musculus (taxid:10090)]

 Score = 1118 (398.6 bits), Expect = 2.5e-113, P = 2.5e-113
 Identities = 210/266 (78%), Positives = 235/266 (88%)

Query:     7 DRTPNTALAIKGTHLVGN-EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
             +R  +  +A+K   L  + EGVPSSALREICLLKELKHKNIVRL+DVLHS+KKLTLVFE 
Sbjct:    23 NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82

Query:    66 CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
             CDQDLKKYFDS NG++D +IVKSF++QLL+GL FCHSRNVLHRDLKPQNLLIN+NGELKL
Sbjct:    83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKL 142

Query:   126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
             ADFGLARAFGIPV+CYSAEVVTLWYRPPDVLFGAKLY+TSIDMWSAGCIFAELANAGRPL
Sbjct:   143 ADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

Query:   186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
             FPG+DVDDQLKRIF+LLGTPTE+ WP M  LPD+KP+PMY  + S   V PKL A GRDL
Sbjct:   203 FPGNDVDDQLKRIFRLLGTPTEEQWPAMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDL 262

Query:   246 LQRLLVCNPVQRMSAEDAMSHIYFSD 271
             LQ LL CNPVQR+SAE+A+ H YFSD
Sbjct:   263 LQNLLKCNPVQRISAEEALQHPYFSD 288

GO:0000166 "nucleotide binding" evidence=IEA

GO:0001764 "neuron migration" evidence=IMP

GO:0001963 "synaptic transmission, dopaminergic" evidence=IMP

GO:0002039 "p53 binding" evidence=IPI

GO:0004672 "protein kinase activity" evidence=ISO;IMP;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO;IDA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISO

GO:0005176 "ErbB-2 class receptor binding" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO;IDA

GO:0005730 "nucleolus" evidence=IDA

GO:0005737 "cytoplasm" evidence=ISO;IDA

GO:0005829 "cytosol" evidence=IDA

GO:0005856 "cytoskeleton" evidence=ISO

GO:0005886 "plasma membrane" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=ISO;IMP;IDA

GO:0006886 "intracellular protein transport" evidence=IMP

GO:0006887 "exocytosis" evidence=ISO

GO:0006913 "nucleocytoplasmic transport" evidence=ISO

GO:0006915 "apoptotic process" evidence=IDA

GO:0007049 "cell cycle" evidence=IEA

GO:0007160 "cell-matrix adhesion" evidence=IDA

GO:0007399 "nervous system development" evidence=IEA

GO:0007409 "axonogenesis" evidence=IMP

GO:0007416 "synapse assembly" evidence=IMP

GO:0007519 "skeletal muscle tissue development" evidence=IDA

GO:0008045 "motor neuron axon guidance" evidence=IMP

GO:0008219 "cell death" evidence=IEA

GO:0008306 "associative learning" evidence=IMP

GO:0008542 "visual learning" evidence=IMP

GO:0009611 "response to wounding" evidence=ISO

GO:0009790 "embryo development" evidence=ISO

GO:0014044 "Schwann cell development" evidence=IMP

GO:0014069 "postsynaptic density" evidence=ISO

GO:0016020 "membrane" evidence=ISO

GO:0016301 "kinase activity" evidence=ISO

GO:0016310 "phosphorylation" evidence=ISO

GO:0016477 "cell migration" evidence=IMP;IDA

GO:0016533 "cyclin-dependent protein kinase 5 holoenzyme complex" evidence=ISO

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0018105 "peptidyl-serine phosphorylation" evidence=ISO;IMP;IDA

GO:0018107 "peptidyl-threonine phosphorylation" evidence=IDA

GO:0019233 "sensory perception of pain" evidence=IMP

GO:0021537 "telencephalon development" evidence=IMP

GO:0021549 "cerebellum development" evidence=IMP

GO:0021695 "cerebellar cortex development" evidence=IMP

GO:0021697 "cerebellar cortex formation" evidence=IMP

GO:0021766 "hippocampus development" evidence=IMP

GO:0021819 "layer formation in cerebral cortex" evidence=IMP

GO:0021954 "central nervous system neuron development" evidence=IMP

GO:0021987 "cerebral cortex development" evidence=IMP

GO:0022038 "corpus callosum development" evidence=IMP

GO:0030027 "lamellipodium" evidence=IDA

GO:0030054 "cell junction" evidence=IEA

GO:0030175 "filopodium" evidence=IDA

GO:0030182 "neuron differentiation" evidence=ISO;ISA;IMP

GO:0030334 "regulation of cell migration" evidence=IMP

GO:0030424 "axon" evidence=ISO;IDA

GO:0030425 "dendrite" evidence=ISO

GO:0030426 "growth cone" evidence=ISO

GO:0030517 "negative regulation of axon extension" evidence=IGI

GO:0030549 "acetylcholine receptor activator activity" evidence=IDA

GO:0030866 "cortical actin cytoskeleton organization" evidence=ISO

GO:0030900 "forebrain development" evidence=IMP

GO:0031175 "neuron projection development" evidence=ISO

GO:0031397 "negative regulation of protein ubiquitination" evidence=IMP

GO:0031594 "neuromuscular junction" evidence=ISO

GO:0031914 "negative regulation of synaptic plasticity" evidence=IMP

GO:0032092 "positive regulation of protein binding" evidence=IMP

GO:0032801 "receptor catabolic process" evidence=IMP

GO:0033136 "serine phosphorylation of STAT3 protein" evidence=IDA

GO:0035249 "synaptic transmission, glutamatergic" evidence=IMP

GO:0035418 "protein localization to synapse" evidence=IMP

GO:0042220 "response to cocaine" evidence=IMP

GO:0042995 "cell projection" evidence=IEA

GO:0043025 "neuronal cell body" evidence=ISO

GO:0043113 "receptor clustering" evidence=IMP

GO:0043125 "ErbB-3 class receptor binding" evidence=IDA

GO:0043525 "positive regulation of neuron apoptotic process" evidence=ISO

GO:0044428 "nuclear part" evidence=ISO

GO:0045055 "regulated secretory pathway" evidence=ISO

GO:0045202 "synapse" evidence=IEA

GO:0045211 "postsynaptic membrane" evidence=IEA

GO:0045786 "negative regulation of cell cycle" evidence=IMP

GO:0045860 "positive regulation of protein kinase activity" evidence=IMP

GO:0045892 "negative regulation of transcription, DNA-dependent" evidence=ISO

GO:0045956 "positive regulation of calcium ion-dependent exocytosis" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=ISO

GO:0046826 "negative regulation of protein export from nucleus" evidence=IMP

GO:0046875 "ephrin receptor binding" evidence=ISO

GO:0048148 "behavioral response to cocaine" evidence=IMP

GO:0048167 "regulation of synaptic plasticity" evidence=ISO

GO:0048488 "synaptic vesicle endocytosis" evidence=ISO

GO:0048709 "oligodendrocyte differentiation" evidence=ISO

GO:0048812 "neuron projection morphogenesis" evidence=ISO

GO:0048813 "dendrite morphogenesis" evidence=IMP

GO:0050321 "tau-protein kinase activity" evidence=ISO

GO:0051301 "cell division" evidence=IEA

GO:0051402 "neuron apoptotic process" evidence=ISO;IMP

GO:0060078 "regulation of postsynaptic membrane potential" evidence=IMP

GO:0060079 "regulation of excitatory postsynaptic membrane potential" evidence=IMP

GO:0061001 "regulation of dendritic spine morphogenesis" evidence=IMP

GO:0070509 "calcium ion import" evidence=IMP

GO:0090314 "positive regulation of protein targeting to membrane" evidence=IMP

GO:2000273 "positive regulation of receptor activity" evidence=IDA

RGD|70514 Cdk5 "cyclin-dependent kinase 5" [Rattus norvegicus (taxid:10116)]

 Score = 1112 (396.5 bits), Expect = 1.1e-112, P = 1.1e-112
 Identities = 209/266 (78%), Positives = 234/266 (87%)

Query:     7 DRTPNTALAIKGTHLVGN-EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
             +R  +  +A+K   L  + EGVPSSALREICLLKELKHKNIVRL+DVLHS+KKLTLVFE 
Sbjct:    23 NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82

Query:    66 CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
             CDQDLKKYFDS NG++D +IVKS ++QLL+GL FCHSRNVLHRDLKPQNLLIN+NGELKL
Sbjct:    83 CDQDLKKYFDSCNGDLDPEIVKSLLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKL 142

Query:   126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
             ADFGLARAFGIPV+CYSAEVVTLWYRPPDVLFGAKLY+TSIDMWSAGCIFAELANAGRPL
Sbjct:   143 ADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

Query:   186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
             FPG+DVDDQLKRIF+LLGTPTE+ WP M  LPD+KP+PMY  + S   V PKL A GRDL
Sbjct:   203 FPGNDVDDQLKRIFRLLGTPTEEQWPAMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDL 262

Query:   246 LQRLLVCNPVQRMSAEDAMSHIYFSD 271
             LQ LL CNPVQR+SAE+A+ H YFSD
Sbjct:   263 LQNLLKCNPVQRISAEEALQHPYFSD 288

GO:0001764 "neuron migration" evidence=IEA;ISO

GO:0001963 "synaptic transmission, dopaminergic" evidence=IEA;ISO

GO:0002039 "p53 binding" evidence=IEA;ISO

GO:0004672 "protein kinase activity" evidence=ISO;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO;IDA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IDA

GO:0005176 "ErbB-2 class receptor binding" evidence=ISO;ISS

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO;IDA

GO:0005737 "cytoplasm" evidence=ISO;IDA

GO:0005829 "cytosol" evidence=IEA;ISO

GO:0005856 "cytoskeleton" evidence=IDA

GO:0005886 "plasma membrane" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=ISO;IDA

GO:0006886 "intracellular protein transport" evidence=IEA;ISO

GO:0006887 "exocytosis" evidence=IMP

GO:0006913 "nucleocytoplasmic transport" evidence=IMP

GO:0006915 "apoptotic process" evidence=ISO

GO:0007160 "cell-matrix adhesion" evidence=IEA;ISO

GO:0007409 "axonogenesis" evidence=ISO

GO:0007416 "synapse assembly" evidence=IEA;ISO

GO:0007417 "central nervous system development" evidence=TAS

GO:0007519 "skeletal muscle tissue development" evidence=ISO;IEP;TAS

GO:0008045 "motor neuron axon guidance" evidence=IEA;ISO

GO:0008306 "associative learning" evidence=ISO

GO:0008542 "visual learning" evidence=IEA;ISO

GO:0009611 "response to wounding" evidence=IMP

GO:0009790 "embryo development" evidence=IDA

GO:0014044 "Schwann cell development" evidence=IEA;ISO

GO:0014069 "postsynaptic density" evidence=IDA

GO:0016020 "membrane" evidence=IDA

GO:0016301 "kinase activity" evidence=IDA

GO:0016310 "phosphorylation" evidence=ISO

GO:0016477 "cell migration" evidence=ISO

GO:0016533 "cyclin-dependent protein kinase 5 holoenzyme complex" evidence=IDA

GO:0018105 "peptidyl-serine phosphorylation" evidence=ISO;IDA

GO:0018107 "peptidyl-threonine phosphorylation" evidence=IEA;ISO

GO:0019233 "sensory perception of pain" evidence=IEA;ISO

GO:0021537 "telencephalon development" evidence=ISO

GO:0021549 "cerebellum development" evidence=ISO

GO:0021695 "cerebellar cortex development" evidence=ISO

GO:0021697 "cerebellar cortex formation" evidence=IEA;ISO

GO:0021766 "hippocampus development" evidence=IEA;ISO

GO:0021819 "layer formation in cerebral cortex" evidence=IEA;ISO

GO:0021954 "central nervous system neuron development" evidence=IEA;ISO

GO:0021987 "cerebral cortex development" evidence=ISO

GO:0022038 "corpus callosum development" evidence=IEA;ISO

GO:0030027 "lamellipodium" evidence=IEA;ISO

GO:0030054 "cell junction" evidence=TAS

GO:0030175 "filopodium" evidence=IEA;ISO

GO:0030182 "neuron differentiation" evidence=ISO;IDA

GO:0030334 "regulation of cell migration" evidence=IEA;ISO

GO:0030424 "axon" evidence=ISO;IDA

GO:0030425 "dendrite" evidence=IDA

GO:0030426 "growth cone" evidence=IDA

GO:0030517 "negative regulation of axon extension" evidence=ISO

GO:0030549 "acetylcholine receptor activator activity" evidence=ISO;ISS

GO:0030866 "cortical actin cytoskeleton organization" evidence=IMP

GO:0030900 "forebrain development" evidence=ISO

GO:0031175 "neuron projection development" evidence=IMP

GO:0031397 "negative regulation of protein ubiquitination" evidence=IEA;ISO

GO:0031594 "neuromuscular junction" evidence=IDA

GO:0031914 "negative regulation of synaptic plasticity" evidence=IEA;ISO

GO:0032092 "positive regulation of protein binding" evidence=IEA;ISO

GO:0032801 "receptor catabolic process" evidence=IEA;ISO

GO:0033136 "serine phosphorylation of STAT3 protein" evidence=IEA;ISO

GO:0035249 "synaptic transmission, glutamatergic" evidence=IEA;ISO

GO:0035418 "protein localization to synapse" evidence=IEA;ISO

GO:0042220 "response to cocaine" evidence=ISO

GO:0043025 "neuronal cell body" evidence=IDA

GO:0043113 "receptor clustering" evidence=IEA;ISO

GO:0043125 "ErbB-3 class receptor binding" evidence=ISO;ISS

GO:0043204 "perikaryon" evidence=IEA

GO:0043525 "positive regulation of neuron apoptotic process" evidence=IDA

GO:0044428 "nuclear part" evidence=IDA

GO:0045055 "regulated secretory pathway" evidence=IMP

GO:0045211 "postsynaptic membrane" evidence=IEA

GO:0045786 "negative regulation of cell cycle" evidence=IEA;ISO

GO:0045860 "positive regulation of protein kinase activity" evidence=IEA;ISO

GO:0045892 "negative regulation of transcription, DNA-dependent" evidence=IEA;ISO

GO:0045956 "positive regulation of calcium ion-dependent exocytosis" evidence=IEA;ISO

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0046826 "negative regulation of protein export from nucleus" evidence=IEA;ISO

GO:0046875 "ephrin receptor binding" evidence=IPI

GO:0048148 "behavioral response to cocaine" evidence=IEA;ISO

GO:0048167 "regulation of synaptic plasticity" evidence=IMP

GO:0048488 "synaptic vesicle endocytosis" evidence=IMP

GO:0048675 "axon extension" evidence=TAS

GO:0048709 "oligodendrocyte differentiation" evidence=IEA;ISO

GO:0048812 "neuron projection morphogenesis" evidence=IMP

GO:0048813 "dendrite morphogenesis" evidence=IEA;ISO

GO:0050321 "tau-protein kinase activity" evidence=IDA

GO:0051301 "cell division" evidence=IEA

GO:0051402 "neuron apoptotic process" evidence=ISO;IMP

GO:0060078 "regulation of postsynaptic membrane potential" evidence=ISO

GO:0060079 "regulation of excitatory postsynaptic membrane potential" evidence=IEA;ISO

GO:0061001 "regulation of dendritic spine morphogenesis" evidence=ISO;ISS

GO:0070509 "calcium ion import" evidence=IEA;ISO

GO:0090314 "positive regulation of protein targeting to membrane" evidence=IEA;ISO

GO:2000273 "positive regulation of receptor activity" evidence=ISO

GO:0005730 "nucleolus" evidence=ISO

FB|FBgn0013762 Cdk5 "Cyclin-dependent kinase 5" [Drosophila melanogaster (taxid:7227)]

 Score = 1071 (382.1 bits), Expect = 2.4e-108, P = 2.4e-108
 Identities = 205/268 (76%), Positives = 230/268 (85%)

Query:     5 GVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF 63
             G +R     +A+K   L   +EGVPSSALREICLLKELKHKNIVRL DVLHS+KKLTLVF
Sbjct:    21 GRNRDTMEIVALKRVRLDEDDEGVPSSALREICLLKELKHKNIVRLIDVLHSDKKLTLVF 80

Query:    64 EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL 123
             EHCDQDLKKYFDSLNGEID+ + +SFM QLLRGLAFCHS NVLHRDLKPQNLLINKNGEL
Sbjct:    81 EHCDQDLKKYFDSLNGEIDMAVCRSFMLQLLRGLAFCHSHNVLHRDLKPQNLLINKNGEL 140

Query:   124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
             KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCI AELA+AGR
Sbjct:   141 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCILAELADAGR 200

Query:   184 PLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGR 243
             PLFPGSDV DQL +IF++LGTP ED+WPG++ L D+   P +    S+SQ+ P+L +KGR
Sbjct:   201 PLFPGSDVLDQLMKIFRVLGTPNEDSWPGVSHLSDYVALPSFPAITSWSQLVPRLNSKGR 260

Query:   244 DLLQRLLVCNPVQRMSAEDAMSHIYFSD 271
             DLLQ+LL+C P QR+SAE AM H YF+D
Sbjct:   261 DLLQKLLICRPNQRISAEAAMQHPYFTD 288

GO:0006468 "protein phosphorylation" evidence=ISS;NAS;IDA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA;NAS

GO:0030332 "cyclin binding" evidence=NAS

GO:0007409 "axonogenesis" evidence=IGI;IMP

GO:0016533 "cyclin-dependent protein kinase 5 holoenzyme complex" evidence=IPI

GO:0007269 "neurotransmitter secretion" evidence=NAS

GO:0007049 "cell cycle" evidence=IMP

GO:0005524 "ATP binding" evidence=IEA

GO:0008045 "motor neuron axon guidance" evidence=IMP

GO:0008340 "determination of adult lifespan" evidence=IMP

GO:0007629 "flight behavior" evidence=IMP

GO:0008344 "adult locomotory behavior" evidence=IMP

GO:0008582 "regulation of synaptic growth at neuromuscular junction" evidence=IMP

GO:0035011 "melanotic encapsulation of foreign target" evidence=IMP

GO:0070059 "intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress" evidence=IGI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q63699	CDK2_RAT	2, ., 7, ., 1, 1, ., 2, 2	0.5653	0.9007	0.8523	no	N/A
P43063	CDK1_CANAL	2, ., 7, ., 1, 1, ., 2, 2	0.5606	0.9113	0.8107	N/A	N/A
Q00526	CDK3_HUMAN	2, ., 7, ., 1, 1, ., 2, 2	0.5692	0.9290	0.8590	no	N/A
Q27032	CDC2H_THEPA	2, ., 7, ., 1, 1, ., 2, 3	0.604	0.8829	0.8355	yes	N/A
Q26671	CDC2H_THEAN	2, ., 7, ., 1, 1, ., 2, 3	0.6	0.8829	0.8355	yes	N/A
P48609	CDK5_DROME	2, ., 7, ., 1, 1, ., 2, 2	0.7649	0.9468	0.9081	yes	N/A
O55076	CDK2_CRIGR	2, ., 7, ., 1, 1, ., 2, 2	0.5675	0.9042	0.8557	no	N/A
Q2PQN9	CDK5_GLOMM	2, ., 7, ., 1, 1, ., 2, 2	0.7761	0.9468	0.9143	N/A	N/A
Q751E8	PHO85_ASHGO	2, ., 7, ., 1, 1, ., 2, 2	0.5467	0.9397	0.8803	yes	N/A
Q9XZD6	CDC2H_PLAVI	2, ., 7, ., 1, 1, ., 2, 3	0.576	0.8829	0.8645	N/A	N/A
P23111	CDC2_MAIZE	2, ., 7, ., 1, 1, ., 2, 3	0.5309	0.9539	0.9149	N/A	N/A
Q6BRY2	PHO85_DEBHA	2, ., 7, ., 1, 1, ., 2, 2	0.5535	0.9503	0.8121	yes	N/A
Q7RM49	CDC2H_PLAYO	2, ., 7, ., 1, 1, ., 2, 3	0.5714	0.8794	0.8581	N/A	N/A
P49615	CDK5_MOUSE	2, ., 7, ., 1, 1, ., 2, 2	0.7865	0.9432	0.9109	yes	N/A
Q07785	CDC2H_PLAFK	2, ., 7, ., 1, 1, ., 2, 3	0.5776	0.8794	0.8611	N/A	N/A
Q9HGY5	PHO85_CANAX	2, ., 7, ., 1, 1, ., 2, 2	0.5457	0.9503	0.8220	N/A	N/A
P24923	CDC21_MEDSA	2, ., 7, ., 1, 1, ., 2, 3	0.5608	0.9397	0.9106	N/A	N/A
P24100	CDKA1_ARATH	2, ., 7, ., 1, 1, ., 2, 3	0.5350	0.9397	0.9013	yes	N/A
Q6C7U8	PHO85_YARLI	2, ., 7, ., 1, 1, ., 2, 2	0.5629	0.9397	0.9013	yes	N/A
Q38772	CDC2A_ANTMA	2, ., 7, ., 1, 1, ., 2, 3	0.5571	0.9397	0.9013	N/A	N/A
Q92241	PHO85_KLULA	2, ., 7, ., 1, 1, ., 2, 2	0.5302	0.9574	0.8881	yes	N/A
Q02399	CDK5_BOVIN	2, ., 7, ., 1, 1, ., 2, 2	0.7865	0.9432	0.9109	yes	N/A
P93101	CDC2_CHERU	2, ., 7, ., 1, 1, ., 2, 3	0.5518	0.9361	0.8979	N/A	N/A
Q41639	CDC2_VIGAC	2, ., 7, ., 1, 1, ., 2, 3	0.5535	0.9397	0.9013	N/A	N/A
P61075	CDC2H_PLAF7	2, ., 7, ., 1, 1, ., 2, 3	0.5776	0.8794	0.8611	yes	N/A
Q00535	CDK5_HUMAN	2, ., 7, ., 1, 1, ., 2, 2	0.7865	0.9432	0.9109	yes	N/A
P48963	CDK2_MESAU	2, ., 7, ., 1, 1, ., 2, 2	0.5675	0.9042	0.8557	N/A	N/A
P29618	CDKA1_ORYSJ	2, ., 7, ., 1, 1, ., 2, 3	0.5274	0.9468	0.9081	no	N/A
P29619	CDKA2_ORYSJ	2, ., 7, ., 1, 1, ., 2, 3	0.5547	0.9539	0.9212	yes	N/A
P34117	CDK5_DICDI	2, ., 7, ., 1, 1, ., 2, 2	0.6414	0.8794	0.8493	yes	N/A
P24941	CDK2_HUMAN	2, ., 7, ., 1, 1, ., 2, 2	0.5692	0.9007	0.8523	no	N/A
Q4Y4B1	CDC2H_PLACH	2, ., 7, ., 1, 1, ., 2, 3	0.5783	0.8723	0.8541	N/A	N/A
P17157	PHO85_YEAST	2, ., 7, ., 1, 1, ., 2, 2	0.5379	0.9432	0.8721	yes	N/A
P23437	CDK2_XENLA	2, ., 7, ., 1, 1, ., 2, 2	0.5518	0.9397	0.8922	N/A	N/A
Q6FKD4	PHO85_CANGA	2, ., 7, ., 1, 1, ., 2, 2	0.5415	0.9432	0.8807	yes	N/A
Q5E9Y0	CDK2_BOVIN	2, ., 7, ., 1, 1, ., 2, 2	0.5692	0.9007	0.8523	no	N/A
P51166	CDK5_XENLA	2, ., 7, ., 1, 1, ., 2, 2	0.7902	0.9432	0.9109	N/A	N/A
Q03114	CDK5_RAT	2, ., 7, ., 1, 1, ., 2, 2	0.7827	0.9432	0.9109	yes	N/A
O96821	CDC2H_PLAKH	2, ., 7, ., 1, 1, ., 2, 3	0.5783	0.8723	0.8541	yes	N/A
P43450	CDK2_CARAU	2, ., 7, ., 1, 1, ., 2, 2	0.5431	0.9609	0.9093	N/A	N/A
Q4Z6R1	CDC2H_PLABA	2, ., 7, ., 1, 1, ., 2, 3	0.5776	0.8794	0.8611	N/A	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.22	0.979
3rd Layer	2.7.11	0.983

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	282
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	0.0
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-154
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-137
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-136
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-128
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-121
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-121
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-119
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-111
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-110
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-110
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-106
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-103
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-102
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-101
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-98
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-97
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-95
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	7e-95
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-94
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-88
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-87
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-84
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-84
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-81
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	8e-77
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-76
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-74
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-72
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-71
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-70
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-69
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-68
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-68
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-67
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	8e-67
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-64
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-62
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-60
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	9e-60
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-58
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-57
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-57
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-57
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-55
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-54
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-53
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-51
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-51
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-50
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-50
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	9e-49
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-48
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-47
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-46
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	9e-44
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-42
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-41
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-40
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-39
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-38
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	9e-38
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-32
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-31
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-31
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-31
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-30
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-29
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-29
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-29
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-28
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-28
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-28
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-27
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-27
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-26
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-25
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-25
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-25
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	8e-25
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-24
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-24
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-24
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-24
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-24
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-23
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-23
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-22
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-22
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-22
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-22
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-21
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-21
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-21
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-21
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	9e-21
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-20
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-20
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-20
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-20
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-20
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-19
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-19
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-19
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-19
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-19
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-19
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-18
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-18
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-18
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-17
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-17
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-17
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-17
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-17
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-17
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-16
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-16
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-16
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-16
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-16
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-16
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	7e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	8e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-16
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-15
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-15
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-15
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-15
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-15
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-15
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-15
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-15
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	7e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	8e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-14
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-14
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-14
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-14
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-14
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-14
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-14
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-14
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-14
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-14
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-14
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-14
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-14
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	8e-14
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-14
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	9e-14
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-13
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-13
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-13
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-13
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-13
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-13
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-13
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-13
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-13
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-13
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-13
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	8e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	9e-13
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-12
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-12
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-12
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-12
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-12
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-12
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-12
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-12
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-11
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-11
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-11
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-11
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-11
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-11
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	7e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-10
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-10
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-10
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	7e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	8e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	9e-10
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-09
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-09
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-09
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	8e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	8e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	9e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-08
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-08
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-08
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-08
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-08
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-06
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-06
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-05
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-05
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	2e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	6e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.001
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.001
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	0.001
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	0.002
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	0.003
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.003

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  513 bits (1322), Expect = 0.0
 Identities = 212/266 (79%), Positives = 238/266 (89%), Gaps = 1/266 (0%)

Query: 5   GVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF 63
             +R  +  +A+K   L   +EGVPSSALREICLLKELKHKNIVRLYDVLHS+KKLTLVF
Sbjct: 19  AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF 78

Query: 64  EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL 123
           E+CDQDLKKYFDS NG+ID +IVKSFM+QLL+GLAFCHS NVLHRDLKPQNLLINKNGEL
Sbjct: 79  EYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGEL 138

Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           KLADFGLARAFGIPV+CYSAEVVTLWYRPPDVLFGAKLY+TSIDMWSAGCIFAELANAGR
Sbjct: 139 KLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 198

Query: 184 PLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGR 243
           PLFPG+DVDDQLKRIF+LLGTPTE++WPG++ LPD+KP+PMY  + S   V PKL + GR
Sbjct: 199 PLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGR 258

Query: 244 DLLQRLLVCNPVQRMSAEDAMSHIYF 269
           DLLQ LLVCNPVQR+SAE+A+ H YF
Sbjct: 259 DLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  432 bits (1113), Expect = e-154
 Identities = 154/267 (57%), Positives = 203/267 (76%), Gaps = 4/267 (1%)

Query: 5   GVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF 63
             D+     +A+K   L    EG+PS+ALREI LLKELKH NIV+L DV+H+E+KL LVF
Sbjct: 18  ARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF 77

Query: 64  EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL 123
           E+CD DLKKY D   G +  +++KS MYQLLRGLA+CHS  +LHRDLKPQN+LIN++G L
Sbjct: 78  EYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVL 137

Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           KLADFGLARAFGIP++ Y+ EVVTLWYR P++L G+K Y+T++D+WS GCIFAE+   G+
Sbjct: 138 KLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMIT-GK 196

Query: 184 PLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKG 242
           PLFPG    DQL +IF++LGTPTE++WPG+  LPD+KP FP + P     +V P+L  +G
Sbjct: 197 PLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPK-DLEKVLPRLDPEG 255

Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYF 269
            DLL ++L  NP +R+SA++A+ H YF
Sbjct: 256 IDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  387 bits (997), Expect = e-137
 Identities = 154/266 (57%), Positives = 194/266 (72%), Gaps = 5/266 (1%)

Query: 7   DRTPNTALAIKGTHLVG-NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           D+     +A+K   L   +EGVPS+A+REI LLKEL H NIVRL DV+HSE KL LVFE 
Sbjct: 20  DKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79

Query: 66  CDQDLKKYFDSL-NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELK 124
            D DLKKY DS     +D  ++KS++YQLL+G+A+CHS  VLHRDLKPQNLLI++ G LK
Sbjct: 80  LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALK 139

Query: 125 LADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRP 184
           LADFGLARAFG+PV+ Y+ EVVTLWYR P++L G++ Y+T +D+WS GCIFAE+ N  RP
Sbjct: 140 LADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198

Query: 185 LFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGR 243
           LFPG    DQL RIF+ LGTP ED WPG+  LPD+KP FP +      S+V P L   G 
Sbjct: 199 LFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWAR-QDLSKVVPNLDEDGL 257

Query: 244 DLLQRLLVCNPVQRMSAEDAMSHIYF 269
           DLL ++LV +P +R+SA+ A+ H YF
Sbjct: 258 DLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  384 bits (988), Expect = e-136
 Identities = 164/268 (61%), Positives = 203/268 (75%), Gaps = 5/268 (1%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
           G +RT    +A+K  HL   EG PS+A+REI L+KELKH+NIVRL+DV+H+E KL LVFE
Sbjct: 19  GRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78

Query: 65  HCDQDLKKYFDS--LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           + D+DLKKY D+  + G +D + VKSF YQLL+G+AFCH   VLHRDLKPQNLLINK GE
Sbjct: 79  YMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE 138

Query: 123 LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
           LKLADFGLARAFGIPV  +S EVVTLWYR PDVL G++ Y+TSID+WS GCI AE+   G
Sbjct: 139 LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMI-TG 197

Query: 183 RPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAK 241
           RPLFPG++ +DQL +IF+++GTPTE TWPG++ LP++KP FP Y P     Q+ P     
Sbjct: 198 RPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRY-PPQDLQQLFPHADPL 256

Query: 242 GRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
           G DLL RLL  NP  R+SA DA+ H +F
Sbjct: 257 GIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  364 bits (937), Expect = e-128
 Identities = 152/270 (56%), Positives = 192/270 (71%), Gaps = 7/270 (2%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
           G  +     +A+K   L   EG P +A+RE  LLK+LKH NIV L+D++H++K LTLVFE
Sbjct: 24  GRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83

Query: 65  HCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELK 124
           + D DLK+Y D   G + +  V+ F++QLLRGLA+CH R VLHRDLKPQNLLI++ GELK
Sbjct: 84  YLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELK 143

Query: 125 LADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRP 184
           LADFGLARA  +P K YS EVVTLWYRPPDVL G+  Y+TS+DMW  GCIF E+A  GRP
Sbjct: 144 LADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMA-TGRP 202

Query: 185 LFPGS-DVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP--FPMYHPSMSFSQVAPKL--T 239
           LFPGS DV+DQL +IF++LGTPTE+TWPG++  P+FKP  FP Y P       AP+L   
Sbjct: 203 LFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPR-PLINHAPRLDRI 261

Query: 240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
             G +L  + L   P +R+SA +AM H YF
Sbjct: 262 PHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  348 bits (895), Expect = e-121
 Identities = 149/266 (56%), Positives = 191/266 (71%), Gaps = 5/266 (1%)

Query: 7   DRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           ++     +A+K   L    EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE 
Sbjct: 21  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80

Query: 66  CDQDLKKYFDSLN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELK 124
             QDLKK+ D+     I L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +K
Sbjct: 81  LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIK 140

Query: 125 LADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRP 184
           LADFGLARAFG+PV+ Y+ EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R 
Sbjct: 141 LADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RA 199

Query: 185 LFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGR 243
           LFPG    DQL RIF+ LGTP E  WPG+  LPD+KP FP +     FS+V P L   GR
Sbjct: 200 LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKW-ARQDFSKVVPPLDEDGR 258

Query: 244 DLLQRLLVCNPVQRMSAEDAMSHIYF 269
           DLL ++L  +P +R+SA+ A++H +F
Sbjct: 259 DLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  346 bits (890), Expect = e-121
 Identities = 147/269 (54%), Positives = 190/269 (70%), Gaps = 6/269 (2%)

Query: 5   GVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF 63
           G ++     +A+K   L    EGVPS+A+REI LLKEL+H NIV L DVL  E +L L+F
Sbjct: 19  GRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIF 78

Query: 64  EHCDQDLKKYFDSL--NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG 121
           E    DLKKY DSL     +D ++VKS++YQ+L+G+ FCHSR VLHRDLKPQNLLI+  G
Sbjct: 79  EFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG 138

Query: 122 ELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANA 181
            +KLADFGLARAFGIPV+ Y+ EVVTLWYR P+VL G+  Y+T +D+WS G IFAE+A  
Sbjct: 139 VIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATK 198

Query: 182 GRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTA 240
            +PLF G    DQL RIF++LGTPTED WPG+  LPD+K  FP +      S V   L  
Sbjct: 199 -KPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAV-KNLDE 256

Query: 241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
            G DLL+++L+ +P +R+SA+ A++H YF
Sbjct: 257 DGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  344 bits (884), Expect = e-119
 Identities = 148/273 (54%), Positives = 199/273 (72%), Gaps = 6/273 (2%)

Query: 7   DRTPNTALAIKGTHLVG-NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           DR  N  +A+K   L   +EGVPS+A+REI LLKE++H NIVRL DV+HSEK+L LVFE+
Sbjct: 23  DRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY 82

Query: 66  CDQDLKKYFDSL-NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK-NGEL 123
            D DLKK+ DS  +   +  ++K+++YQ+LRG+A+CHS  VLHRDLKPQNLLI++    L
Sbjct: 83  LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNAL 142

Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           KLADFGLARAFGIPV+ ++ EVVTLWYR P++L G++ Y+T +D+WS GCIFAE+ N  +
Sbjct: 143 KLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQ-K 201

Query: 184 PLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFK-PFPMYHPSMSFSQVAPKLTAKG 242
           PLFPG    D+L +IF++LGTP E+TWPG+  LPD+K  FP + P    + V P L   G
Sbjct: 202 PLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKW-PPKDLATVVPTLEPAG 260

Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA 275
            DLL ++L  +P +R++A  A+ H YF DL  A
Sbjct: 261 VDLLSKMLRLDPSKRITARAALEHEYFKDLGDA 293

Length = 294

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  323 bits (830), Expect = e-111
 Identities = 130/273 (47%), Positives = 165/273 (60%), Gaps = 12/273 (4%)

Query: 5   GVDRTPNTALAIK----GTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT 60
             D+     +AIK    G      +G+  +ALREI LL+ELKH NI+ L DV   +  + 
Sbjct: 19  ARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNIN 78

Query: 61  LVFEHCDQDLKKYFDSLNGEIDL---DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI 117
           LVFE  + DL+K     +  I L   DI KS+M   LRGL + HS  +LHRDLKP NLLI
Sbjct: 79  LVFEFMETDLEKVIK--DKSIVLTPADI-KSYMLMTLRGLEYLHSNWILHRDLKPNNLLI 135

Query: 118 NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAE 177
             +G LKLADFGLAR+FG P +  + +VVT WYR P++LFGA+ Y   +DMWS GCIFAE
Sbjct: 136 ASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAE 195

Query: 178 LANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK 237
           L     P  PG    DQL +IF+ LGTPTE+ WPG+  LPD+  F    P     Q+ P 
Sbjct: 196 LLL-RVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF-KPFPPTPLKQIFPA 253

Query: 238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            +    DLLQRLL  NP +R++A  A+ H YFS
Sbjct: 254 ASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  321 bits (824), Expect = e-110
 Identities = 154/276 (55%), Positives = 194/276 (70%), Gaps = 4/276 (1%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
           G  +     +A+K   L   EG P +A+RE+ LLK+LKH NIV L+D++H++K LTLVFE
Sbjct: 25  GRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84

Query: 65  HCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELK 124
           + D+DLK+Y D     + +  VK F+YQ+LRGLA+CH R VLHRDLKPQNLLIN+ GELK
Sbjct: 85  YLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELK 144

Query: 125 LADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRP 184
           LADFGLARA  +P K YS EVVTLWYRPPDVL G+  Y+T IDMW  GCIF E+A +GRP
Sbjct: 145 LADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMA-SGRP 203

Query: 185 LFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP--FPMYHPSMSFSQVAPKLTAKG 242
           LFPGS V+D+L  IF+LLGTPTE+TWPG++   +FK   FP Y P       AP+L  +G
Sbjct: 204 LFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQ-PLINHAPRLDTEG 262

Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKS 278
            +LL + L     +R+SAE+AM H YF  L   I S
Sbjct: 263 IELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIHS 298

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  319 bits (819), Expect = e-110
 Identities = 150/270 (55%), Positives = 192/270 (71%), Gaps = 4/270 (1%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
           G  +  +  +A+K   L   EG P +A+RE+ LLK+LKH NIV L+D++H+EK LTLVFE
Sbjct: 25  GRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84

Query: 65  HCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELK 124
           + D+DLK+Y D     I++  VK F++QLLRGL +CH R VLHRDLKPQNLLIN+ GELK
Sbjct: 85  YLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELK 144

Query: 125 LADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRP 184
           LADFGLARA  IP K YS EVVTLWYRPPD+L G+  Y+T IDMW  GCIF E++  GRP
Sbjct: 145 LADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMS-TGRP 203

Query: 185 LFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP--FPMYHPSMSFSQVAPKLTAKG 242
           LFPGS V++QL  IF++LGTPTE+TWPG+    +FK   +P Y      +  AP+L + G
Sbjct: 204 LFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNH-APRLDSDG 262

Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
            +LL +LL     +R+SAE+AM H YF  L
Sbjct: 263 AELLSKLLQFEGRKRISAEEAMKHPYFHCL 292

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  309 bits (793), Expect = e-106
 Identities = 145/258 (56%), Positives = 182/258 (70%), Gaps = 4/258 (1%)

Query: 14  LAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKY 73
           +A+K   L   EG P +A+RE+ LLK LKH NIV L+D++H+E+ LTLVFE+ D DLK+Y
Sbjct: 33  VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQY 92

Query: 74  FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARA 133
            D+    + +  VK FM+QLLRGL++CH R +LHRDLKPQNLLIN+ GELKLADFGLARA
Sbjct: 93  LDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARA 152

Query: 134 FGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDD 193
             +P K YS EVVTLWYRPPDVL G+  Y+T IDMW  GCI  E+A  GRP+FPGS V +
Sbjct: 153 KSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMA-TGRPMFPGSTVKE 211

Query: 194 QLKRIFKLLGTPTEDTWPGMNLLPDFKP--FPMYHPSMSFSQVAPKLTAKGRDLLQRLLV 251
           +L  IF+LLGTPTE+TWPG+    +F+   FP Y      +  AP+L   G DLL  LL+
Sbjct: 212 ELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINH-APRLDTDGIDLLSSLLL 270

Query: 252 CNPVQRMSAEDAMSHIYF 269
                R+SAE A+ H YF
Sbjct: 271 YETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  301 bits (772), Expect = e-103
 Identities = 139/275 (50%), Positives = 182/275 (66%), Gaps = 14/275 (5%)

Query: 7   DRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKN-IVRLYDVLHSEKK-----L 59
           D+     +A+K T L +  EG+P +ALREI LL+ L     IVRL DV H E+K     L
Sbjct: 22  DKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81

Query: 60  TLVFEHCDQDLKKYFDSLNGE----IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            LVFE+ D DLKK+ DS        +    +KSFMYQLL+G+A CH   V+HRDLKPQNL
Sbjct: 82  YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNL 141

Query: 116 LINKNGE-LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCI 174
           L++K    LK+AD GL RAF IPVK Y+ E+VTLWYR P+VL G+  Y+T +D+WS GCI
Sbjct: 142 LVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCI 201

Query: 175 FAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV 234
           FAE++   +PLFPG     QL  IFKLLGTPTE  WPG++ L D+  FP + P    S+ 
Sbjct: 202 FAEMSR-KQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKP-QDLSRA 259

Query: 235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
            P L+ +G DLLQ++L  +P +R+SA+ A++H YF
Sbjct: 260 VPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  299 bits (768), Expect = e-102
 Identities = 126/248 (50%), Positives = 167/248 (67%), Gaps = 4/248 (1%)

Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL 83
           +EG+P +ALREI LLKEL H NI++L DV   +  L LVFE  D DL K        +  
Sbjct: 38  SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPE 97

Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
            ++KS++YQLL+GLAFCHS  +LHRDLKP+NLLIN  G LKLADFGLAR+FG PV+ Y+ 
Sbjct: 98  SLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157

Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
            VVT WYR P++L G K Y+T +D+WS GCIFAEL +  RPLFPG    DQL +IF+ LG
Sbjct: 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLS-RRPLFPGKSEIDQLFKIFRTLG 216

Query: 204 TPTEDTWPGM-NLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAE 261
           TP  + WP   +L  ++K  FP     M   ++ P  + +  DLL ++L  +P +R++AE
Sbjct: 217 TPDPEVWPKFTSLARNYKFSFPKKAG-MPLPKLFPNASPQALDLLSQMLHYDPHKRITAE 275

Query: 262 DAMSHIYF 269
            A++H YF
Sbjct: 276 QALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  297 bits (764), Expect = e-101
 Identities = 111/252 (44%), Positives = 157/252 (62%), Gaps = 6/252 (2%)

Query: 23  GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT--LVFEHCDQDLKKYFDSLNGE 80
             EG P +A+REI LL++L+H NIVRL +++ S+ K +  +VFE+ D DL    DS   +
Sbjct: 37  EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK 96

Query: 81  IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVK 139
                +K +M QLL GL + HS  +LHRD+K  N+LIN +G LKLADFGLAR +      
Sbjct: 97  FTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156

Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF 199
            Y+  V+TLWYRPP++L GA  Y   +DMWS GCI AEL   G+P+F GS   +QL++IF
Sbjct: 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFL-GKPIFQGSTELEQLEKIF 215

Query: 200 KLLGTPTEDTWPGMNLLPDFKPF-PMYHPSMSFSQV-APKLTAKGRDLLQRLLVCNPVQR 257
           +L G+PT++ WPG++ LP F+   P         +     +     DLL +LL  +P +R
Sbjct: 216 ELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKR 275

Query: 258 MSAEDAMSHIYF 269
           +SA+ A+ H YF
Sbjct: 276 ISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  289 bits (743), Expect = 2e-98
 Identities = 129/274 (47%), Positives = 169/274 (61%), Gaps = 17/274 (6%)

Query: 7   DRTPNTALAIKGTHLVGNE-GVPSSALREICLLKELK---HKNIVRLYDVLH-----SEK 57
           D      +A+K   +  +E G+P S LREI LLK+L+   H NIVRL DV H      E 
Sbjct: 20  DLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79

Query: 58  KLTLVFEHCDQDLKKYFDSL--NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
           KLTLVFEH DQDL  Y       G +  + +K  M QLLRG+ F HS  ++HRDLKPQN+
Sbjct: 80  KLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNI 138

Query: 116 LINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIF 175
           L+  +G++K+ADFGLAR +   +   S  VVTLWYR P+VL  +  Y T +DMWS GCIF
Sbjct: 139 LVTSDGQVKIADFGLARIYSFEMALTSV-VVTLWYRAPEVLLQSS-YATPVDMWSVGCIF 196

Query: 176 AELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA 235
           AEL    RPLF G+   DQL +IF ++G P+E+ WP    LP    FP Y P  SF    
Sbjct: 197 AELFRR-RPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP-RSSFPSYTPR-SFKSFV 253

Query: 236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
           P++  +G DLL+++L  NP +R+SA +A+ H YF
Sbjct: 254 PEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  286 bits (734), Expect = 4e-97
 Identities = 138/270 (51%), Positives = 186/270 (68%), Gaps = 7/270 (2%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
           G+ R     +A+K   +   EGVP +A+RE  LLK LKH NIV L+D++H+++ LT VFE
Sbjct: 24  GISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83

Query: 65  HCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELK 124
           +   DL +Y     G +    V+ FM+QLLRGLA+ H +++LHRDLKPQNLLI+  GELK
Sbjct: 84  YMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELK 143

Query: 125 LADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRP 184
           LADFGLARA  IP + YS+EVVTLWYRPPDVL GA  Y++++D+W AGCIF E+   G+P
Sbjct: 144 LADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQ-GQP 202

Query: 185 LFPG-SDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP--FPMYHPSMSFSQVAPKLT-- 239
            FPG SDV +QL++I+ +LG PTEDTWPG++ LP++KP  F    P      V  +L+  
Sbjct: 203 AFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQ-QLRVVWKRLSRP 261

Query: 240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
            K  DL  ++L+  P  R+SA+DA+ H YF
Sbjct: 262 PKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  282 bits (724), Expect = 2e-95
 Identities = 122/250 (48%), Positives = 158/250 (63%), Gaps = 6/250 (2%)

Query: 25  EGVPSSALREICLLKELKHKNIVRLYDVLHSEK--KLTLVFEHCDQDLKKYFDSLNGEID 82
           EG P ++LREI +L +L+H NIV + +V+      K+ +V E+ + DLK   +++     
Sbjct: 45  EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFL 104

Query: 83  LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS 142
              VK  M QLL G+A  H   +LHRDLK  NLL+N  G LK+ DFGLAR +G P+K Y+
Sbjct: 105 QSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT 164

Query: 143 AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
             VVTLWYR P++L GAK Y+T+IDMWS GCIFAEL    +PLFPG    DQL +IFKLL
Sbjct: 165 QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELL-TKKPLFPGKSEIDQLNKIFKLL 223

Query: 203 GTPTEDTWPGMNLLPDFKPF-PMYHPSMSFSQVAP--KLTAKGRDLLQRLLVCNPVQRMS 259
           GTPTE  WPG + LP  K      +P     +  P   L+  G DLL RLL  +P +R+S
Sbjct: 224 GTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS 283

Query: 260 AEDAMSHIYF 269
           AEDA+ H YF
Sbjct: 284 AEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  280 bits (719), Expect = 7e-95
 Identities = 113/268 (42%), Positives = 161/268 (60%), Gaps = 6/268 (2%)

Query: 6   VDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            DR     +A+K   L     G+P+ ALREI  L+  +H  +V+L DV        LV E
Sbjct: 20  KDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79

Query: 65  HCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELK 124
           +   DL +        +    VKS+M  LL+G+A+ H+  ++HRDLKP NLLI+ +G LK
Sbjct: 80  YMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLK 139

Query: 125 LADFGLARAF-GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           +ADFGLAR F     + YS +V T WYR P++L+GA+ Y   +D+W+ GCIFAEL N G 
Sbjct: 140 IADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLN-GS 198

Query: 184 PLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP--FPMYHPSMSFSQVAPKLTAK 241
           PLFPG +  +QL  +F+ LGTP E+TWPG+  LPD+    FP     +   ++ P  + +
Sbjct: 199 PLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFP-ESKPIPLEEIFPDASPE 257

Query: 242 GRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
             DLL+ LLV +P +R+SA +A+ H YF
Sbjct: 258 ALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  280 bits (718), Expect = 1e-94
 Identities = 144/273 (52%), Positives = 182/273 (66%), Gaps = 7/273 (2%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
           G  +     +A+K   L   EG P +A+RE  LLK LKH NIV L+D++H+++ LTLVFE
Sbjct: 24  GKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83

Query: 65  HCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELK 124
           +   DL +Y D   G +  + VK F++QLLRGL++ H R +LHRDLKPQNLLI+  GELK
Sbjct: 84  YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELK 143

Query: 125 LADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRP 184
           LADFGLARA  +P   YS EVVTLWYRPPDVL G+  Y+T +DMW  GCIF E+   G  
Sbjct: 144 LADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQ-GVA 202

Query: 185 LFPG-SDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP--FPMYHPSMSFSQVAPKLT-- 239
            FPG  D+ DQL+RIF +LGTP EDTWPG++ LP FKP  F +Y    +  Q   KL+  
Sbjct: 203 AFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLY-SPKNLRQAWNKLSYV 261

Query: 240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
               DL  +LL C P  R+SA+ A+SH YFSDL
Sbjct: 262 NHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  265 bits (681), Expect = 2e-88
 Identities = 102/261 (39%), Positives = 146/261 (55%), Gaps = 30/261 (11%)

Query: 31  ALREICLLKELKHKNIVRLYDVLHSEKKLT-----LVFEHCDQDLKKYFDSLNGEIDLDI 85
            LREI LL+ L+H+NI+ L D+L            +V E  + DL K   S    +  D 
Sbjct: 46  ILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS-PQPLTDDH 104

Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA-- 143
           ++ F+YQ+LRGL + HS NV+HRDLKP N+L+N N +LK+ DFGLAR             
Sbjct: 105 IQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164

Query: 144 -EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
             VVT WYR P++L  +  YT +ID+WS GCIFAEL    +PLFPG D  DQL  I ++L
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT-RKPLFPGRDYIDQLNLIVEVL 223

Query: 203 GTPTEDTWPGMNLLPDFKPFP-----------MYHPSMSFSQVAPKLTAKGRDLLQRLLV 251
           GTP+E+         D K                 P    S++ P  + +  DLL+++LV
Sbjct: 224 GTPSEE---------DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLV 274

Query: 252 CNPVQRMSAEDAMSHIYFSDL 272
            +P +R++A++A++H Y + L
Sbjct: 275 FDPKKRITADEALAHPYLAQL 295

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  262 bits (672), Expect = 2e-87
 Identities = 113/250 (45%), Positives = 151/250 (60%), Gaps = 4/250 (1%)

Query: 25  EGVPSSALREICLLKELKHKNIVRLYDVL--HSEKKLTLVFEHCDQDLKKYFDSLNGEID 82
           +G+P S+LREI LL  L+H NIV L +V+       + LV E+C+QDL    D++     
Sbjct: 47  DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFS 106

Query: 83  LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS 142
              VK  M QLLRGL + H   ++HRDLK  NLL+   G LK+ADFGLAR +G+P K  +
Sbjct: 107 ESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT 166

Query: 143 AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
            +VVTLWYR P++L G   YTT+IDMW+ GCI AEL  A +PL PG    +QL  I +LL
Sbjct: 167 PKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELL-AHKPLLPGKSEIEQLDLIIQLL 225

Query: 203 GTPTEDTWPGMNLLPDFKPFPMYH-PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAE 261
           GTP E  WPG + LP    F +   P  +     P L+  G  LL  LL+ +P +R +AE
Sbjct: 226 GTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAE 285

Query: 262 DAMSHIYFSD 271
           +A+   YF +
Sbjct: 286 EALESSYFKE 295

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  256 bits (655), Expect = 1e-84
 Identities = 110/295 (37%), Positives = 168/295 (56%), Gaps = 33/295 (11%)

Query: 7   DRTPNTALAIKG--THLVGNEGVPSSALREICLLKELKHKNIVRLYDVL--HSEKKLTLV 62
           +       AIK          G+  SA REI LL+ELKH+N+V L +V   H++K + L+
Sbjct: 23  NGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL 82

Query: 63  FEHCDQDL----KKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI- 117
           F++ + DL    K +  +    I   +VKS ++Q+L G+ + HS  VLHRDLKP N+L+ 
Sbjct: 83  FDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVM 142

Query: 118 ---NKNGELKLADFGLARAFGIPVKCYSAE---VVTLWYRPPDVLFGAKLYTTSIDMWSA 171
               + G +K+ D GLAR F  P+K  +     VVT+WYR P++L GA+ YT +ID+W+ 
Sbjct: 143 GEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAI 202

Query: 172 GCIFAELANAGRPLFPGSDVD---------DQLKRIFKLLGTPTEDTWPGMNLLPDFKPF 222
           GCIFAEL     P+F G +           DQL+RIF++LGTPTE  WP +  +P++   
Sbjct: 203 GCIFAELLTL-EPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTL 261

Query: 223 PMYHPSMSFS--------QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
                + ++         +   K  ++G DLL++LL  +P +R++AE+A+ H YF
Sbjct: 262 MKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  251 bits (644), Expect = 6e-84
 Identities = 98/266 (36%), Positives = 142/266 (53%), Gaps = 30/266 (11%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
             D+     +AIK       +      LREI +LK+LKH NIVRLYDV   E KL LV E
Sbjct: 18  ARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVME 77

Query: 65  HCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL 123
           +C+  DL        G +  D  + ++ Q+L  L + HS+ ++HRDLKP+N+L++++G +
Sbjct: 78  YCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHV 136

Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           KLADFGLAR      K  +  V T  Y  P+VL G K Y  ++D+WS G I  EL   G+
Sbjct: 137 KLADFGLARQLDPGEKLTT-FVGTPEYMAPEVLLG-KGYGKAVDIWSLGVILYELL-TGK 193

Query: 184 PLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGR 243
           P FPG   DDQL  +FK +G P     P    +                        + +
Sbjct: 194 PPFPG---DDQLLELFKKIGKPKPPFPPPEWDISP----------------------EAK 228

Query: 244 DLLQRLLVCNPVQRMSAEDAMSHIYF 269
           DL+++LLV +P +R++AE+A+ H +F
Sbjct: 229 DLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  246 bits (630), Expect = 8e-81
 Identities = 115/269 (42%), Positives = 152/269 (56%), Gaps = 21/269 (7%)

Query: 17  KGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS 76
           K   LVG  G+  + LRE+ ++ E+KH+NI+ L DV      + LV +    DLKK  D 
Sbjct: 53  KDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDR 112

Query: 77  LNGEIDLDI--VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF 134
              +I L    VK  + Q+L GL   H    +HRDL P N+ IN  G  K+ADFGLAR +
Sbjct: 113 ---KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRY 169

Query: 135 GIPVKC--------------YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           G P                  +++VVTLWYR P++L GA+ Y  ++DMWS GCIFAEL  
Sbjct: 170 GYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229

Query: 181 AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA 240
            G+PLFPG +  DQL RIF+LLGTP ED WP    LP +  F    P      + P  + 
Sbjct: 230 -GKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPK-DLKTIFPNASD 287

Query: 241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
              DLLQ LL  NP++R+SA++A+ H YF
Sbjct: 288 DAIDLLQSLLKLNPLERISAKEALKHEYF 316

Length = 335

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  235 bits (602), Expect = 8e-77
 Identities = 110/288 (38%), Positives = 158/288 (54%), Gaps = 26/288 (9%)

Query: 5   GVDRTPNTALAIKG-THLVGNEGVPSSALREICLLKELKHKNIVRLYD--VLHSEKKLT- 60
                    +A+K        +G P +ALREI +LK+LKH N+V L D  V   +K    
Sbjct: 27  ARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86

Query: 61  -----LVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
                +V  + D DL    ++ + ++    +K +M QLL G+ + H  ++LHRD+K  N+
Sbjct: 87  RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANI 146

Query: 116 LINKNGELKLADFGLARAF-----------GIPVKCYSAEVVTLWYRPPDVLFGAKLYTT 164
           LI+  G LK+ADFGLAR +           G   + Y+  VVT WYRPP++L G + YTT
Sbjct: 147 LIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTT 206

Query: 165 SIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLP---DFKP 221
           ++D+W  GC+FAE+    RP+  G    DQL  IFKL GTPTE+TWPG   LP       
Sbjct: 207 AVDIWGIGCVFAEMFT-RRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHS 265

Query: 222 FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
           F  Y  ++   +   KL  +G DLL +LL  +P +R++A DA+ H YF
Sbjct: 266 FTNYPRTL--EERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  231 bits (592), Expect = 6e-76
 Identities = 89/257 (34%), Positives = 132/257 (51%), Gaps = 26/257 (10%)

Query: 15  AIKGTHLVG-NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKK 72
           A+K             +A REI +L+ L H NIVRL D    +  L LV E+C+  DL  
Sbjct: 28  AVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFD 87

Query: 73  YFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR 132
           Y  S  G +  D  K    Q+LRGL + HS  ++HRDLKP+N+L+++NG +K+ADFGLA+
Sbjct: 88  Y-LSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAK 146

Query: 133 AFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD 192
                    +  V T WY  P+VL G   Y   +D+WS G I  EL   G+P F G ++ 
Sbjct: 147 KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLT-GKPPFSGENIL 205

Query: 193 DQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVC 252
           DQL+ I ++LG P E   P  +   +                      + +DL+++ L  
Sbjct: 206 DQLQLIRRILGPPLEFDEPKWSSGSE----------------------EAKDLIKKCLNK 243

Query: 253 NPVQRMSAEDAMSHIYF 269
           +P +R +AE+ + H +F
Sbjct: 244 DPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  228 bits (582), Expect = 8e-74
 Identities = 106/268 (39%), Positives = 151/268 (56%), Gaps = 22/268 (8%)

Query: 21  LVGN--EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT--------LVFEHCDQDL 70
           L+ N  EG P +ALREI +L+ LKH+N+V L ++  ++            LVFE C+ DL
Sbjct: 46  LMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDL 105

Query: 71  KKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGL 130
                + N +  L  +K  M  LL GL + H   +LHRD+K  N+LI K+G LKLADFGL
Sbjct: 106 AGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165

Query: 131 ARAFGIPVK----CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           ARAF +        Y+  VVTLWYRPP++L G + Y   IDMW AGCI AE+     P+ 
Sbjct: 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR-SPIM 224

Query: 187 PGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGR--- 243
            G+    QL  I +L G+ T + WPG++ L  FK   +  P     +V  +L    +   
Sbjct: 225 QGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMEL--PQGQKRKVKERLKPYVKDPH 282

Query: 244 --DLLQRLLVCNPVQRMSAEDAMSHIYF 269
             DL+ +LLV +P +R+ A+ A++H +F
Sbjct: 283 ALDLIDKLLVLDPAKRIDADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  225 bits (576), Expect = 2e-72
 Identities = 101/263 (38%), Positives = 148/263 (56%), Gaps = 41/263 (15%)

Query: 33  REICLLKELK-HKNIVRLYDVLHSE--KKLTLVFEHCDQDL----KKYFDSLNGEIDLDI 85
           REI  L+EL  H NIV+L +V+ +E  K + LVFE+ + DL    +         I  D+
Sbjct: 55  REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRA-------NILEDV 107

Query: 86  VKSF-MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-------GIP 137
            K + MYQLL+ L + HS NV+HRDLKP N+L+N +  +KLADFGLAR+          P
Sbjct: 108 HKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENP 167

Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
           V      V T WYR P++L G+  YT  +DMWS GCI  E+   G+PLFPG+   +QL++
Sbjct: 168 VLTDY--VATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL-GKPLFPGTSTLNQLEK 224

Query: 198 IFKLLGTPTED---------TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQR 248
           I +++G P+ +             ++ LP     P         ++ PK +    DLL++
Sbjct: 225 IIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKP-------LDELLPKASDDALDLLKK 277

Query: 249 LLVCNPVQRMSAEDAMSHIYFSD 271
           LLV NP +R++AE+A+ H Y + 
Sbjct: 278 LLVFNPNKRLTAEEALEHPYVAQ 300

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  221 bits (564), Expect = 2e-71
 Identities = 119/273 (43%), Positives = 159/273 (58%), Gaps = 15/273 (5%)

Query: 7   DRTPNTALAIKGTHLVGNE-GVPSSALREICLLKELK---HKNIVRLYDVLHS-----EK 57
           D      +A+K   +  NE G+P S +RE+ LLK L+   H NIVRL DV  +     E 
Sbjct: 21  DPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80

Query: 58  KLTLVFEHCDQDLKKYFDSLNGE-IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLL 116
           K+TLVFEH DQDL+ Y D +    +  + +K  M Q LRGL F H+  ++HRDLKP+N+L
Sbjct: 81  KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENIL 140

Query: 117 INKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFA 176
           +   G++KLADFGLAR +   +   +  VVTLWYR P+VL  +  Y T +DMWS GCIFA
Sbjct: 141 VTSGGQVKLADFGLARIYSCQM-ALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFA 198

Query: 177 ELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP 236
           E+    +PLF G+   DQL +IF L+G P ED WP    LP    F    P      V P
Sbjct: 199 EMFRR-KPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR-GAFSPRGPR-PVQSVVP 255

Query: 237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
           ++   G  LL  +L  NP +R+SA  A+ H +F
Sbjct: 256 EIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  217 bits (554), Expect = 8e-70
 Identities = 96/269 (35%), Positives = 153/269 (56%), Gaps = 8/269 (2%)

Query: 7   DRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           ++     +AIK       +E V  +ALRE+ +L++L+H+NIV L +    + +L LVFE+
Sbjct: 22  NKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81

Query: 66  CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
            ++ L +  ++  G +  D V+S+++QLL+ +A+CHS N++HRD+KP+N+L++++G LKL
Sbjct: 82  VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKL 141

Query: 126 ADFGLARAF-GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRP 184
            DFG ARA    P    +  V T WYR P++L G   Y   +D+W+ GCI AEL   G P
Sbjct: 142 CDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELL-DGEP 200

Query: 185 LFPG-SDVDDQLKRIFKLLGTPTEDTWPGMNLLPDF---KPFPMYHPSMSFSQVAPKLTA 240
           LFPG SD+ DQL  I K LG          +  P F          P     +   K+++
Sbjct: 201 LFPGDSDI-DQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSS 259

Query: 241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
              D L+  L  +P +R++ ++ + H YF
Sbjct: 260 PALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  214 bits (547), Expect = 7e-69
 Identities = 96/246 (39%), Positives = 145/246 (58%), Gaps = 15/246 (6%)

Query: 32  LREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE-IDLDIVKSF 89
           LRE+  L++L  H NIV+L +V     +L  VFE+ + +L +      G+     +++S 
Sbjct: 45  LREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSI 104

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC---YSAEVV 146
           +YQ+L+GLA  H     HRDLKP+NLL++    +K+ADFGLAR     ++    Y+  V 
Sbjct: 105 IYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR----EIRSRPPYTDYVS 160

Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P++L  +  Y++ +D+W+ GCI AEL    RPLFPGS   DQL +I  +LGTPT
Sbjct: 161 TRWYRAPEILLRSTSYSSPVDIWALGCIMAELYT-LRPLFPGSSEIDQLYKICSVLGTPT 219

Query: 207 EDTWP-GMNLLPD--FKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           +  WP G  L     F+ FP + P+ S  Q+ P  + +  DL++ +L  +P +R +A  A
Sbjct: 220 KQDWPEGYKLASKLGFR-FPQFAPT-SLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQA 277

Query: 264 MSHIYF 269
           + H YF
Sbjct: 278 LQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  213 bits (544), Expect = 2e-68
 Identities = 114/256 (44%), Positives = 155/256 (60%), Gaps = 18/256 (7%)

Query: 25  EGVPSSALREICLLKELK---HKNIVRLYDV-----LHSEKKLTLVFEHCDQDLKKYFDS 76
           EG+P S +RE+ +L+ L+   H N+VRL+DV        E KLTLVFEH DQDL  Y D 
Sbjct: 42  EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK 101

Query: 77  L-NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG 135
           +    +  + +K  M+QLLRGL F HS  V+HRDLKPQN+L+  +G++KLADFGLAR + 
Sbjct: 102 VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 161

Query: 136 IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL 195
             +   ++ VVTLWYR P+VL  +  Y T +D+WS GCIFAE+    +PLF GS   DQL
Sbjct: 162 FQM-ALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRR-KPLFRGSSDVDQL 218

Query: 196 KRIFKLLGTPTEDTWPGMNLLPD--FKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCN 253
            +I  ++G P E+ WP    LP   F        +    +    +   G+DLL + L  N
Sbjct: 219 GKILDVIGLPGEEDWPRDVALPRQAFHS----KSAQPIEKFVTDIDELGKDLLLKCLTFN 274

Query: 254 PVQRMSAEDAMSHIYF 269
           P +R+SA  A+SH YF
Sbjct: 275 PAKRISAYSALSHPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  214 bits (547), Expect = 3e-68
 Identities = 100/285 (35%), Positives = 157/285 (55%), Gaps = 27/285 (9%)

Query: 4   SGVDRTPNTALAIKGTHLVGNE-GVPSSA---LREICLLKELKHKNIVRLYDVLHSE--- 56
           S +D      +AIK    + +   VP+ A   LRE+ +L+  KH NI+ + D+L      
Sbjct: 23  SAIDTRSGKKVAIKK---IPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGAD 79

Query: 57  -KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            K + +V +  + DL     S +  +  + ++ F+YQLLRGL + HS NV+HRDLKP NL
Sbjct: 80  FKDVYVVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNL 138

Query: 116 LINKNGELKLADFGLARA---FGIPVKCYSAE-VVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           L+N++ EL++ DFG+AR         K +  E V T WYR P++L     YTT+IDMWS 
Sbjct: 139 LVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSV 198

Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGM------NLLPDFKPFPMY 225
           GCIFAE+    R LFPG +   QLK I  +LG+P+E+    +        + +       
Sbjct: 199 GCIFAEML-GRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPR---- 253

Query: 226 HPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
              + +S++ PK + +  DLL ++L  +P +R++ E A+ H + +
Sbjct: 254 KQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  211 bits (540), Expect = 4e-67
 Identities = 101/282 (35%), Positives = 154/282 (54%), Gaps = 17/282 (6%)

Query: 1   MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE---- 56
           M  S   +     +AIK      ++      LREI +L+  KH+NI+ + D++       
Sbjct: 20  MVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79

Query: 57  -KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
              + +V E  + DL K   + +  +  D ++ F+YQ+LRGL + HS NVLHRDLKP NL
Sbjct: 80  FNDVYIVQELMETDLYKLIKTQH--LSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNL 137

Query: 116 LINKNGELKLADFGLARAFGIPVKCYSAE----VVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           L+N N +LK+ DFGLAR    P   ++      V T WYR P+++  +K YT +ID+WS 
Sbjct: 138 LLNTNCDLKICDFGLARI-ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSV 196

Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPG---MNLLPDFKPFPMYHPS 228
           GCI AE+ +  RPLFPG D   QL  I  +LGTP+++       +      K  P   P 
Sbjct: 197 GCILAEMLS-NRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFK-PK 254

Query: 229 MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
           + ++++ P    K  DLL ++L  NP +R++ E+A++H Y  
Sbjct: 255 VPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE 296

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  211 bits (538), Expect = 8e-67
 Identities = 111/279 (39%), Positives = 159/279 (56%), Gaps = 14/279 (5%)

Query: 4   SGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKK---- 58
           S  +   N  +AIK       N       LREI LL+ L H+N++ + D++    +    
Sbjct: 23  SAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82

Query: 59  -LTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI 117
            + +V+E  D DL +   S +  +  D  + F+YQLLRGL + HS NVLHRDLKP NLL+
Sbjct: 83  DVYIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL 141

Query: 118 NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAE 177
           N N +LK+ DFGLAR         +  VVT WYR P++L     YTT+ID+WS GCIFAE
Sbjct: 142 NANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAE 201

Query: 178 LANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPF----PMYHPSMSFSQ 233
           L    +PLFPG D   QLK I +LLG+P+E+   G       + +    P Y P  SF++
Sbjct: 202 LLG-RKPLFPGKDYVHQLKLITELLGSPSEEDL-GFIRNEKARRYIRSLP-YTPRQSFAR 258

Query: 234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
           + P       DLL+++LV +P +R++ E+A++H Y + L
Sbjct: 259 LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  204 bits (521), Expect = 1e-64
 Identities = 101/258 (39%), Positives = 147/258 (56%), Gaps = 21/258 (8%)

Query: 25  EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT----------LVFEHCDQDLKKYF 74
           EG P +A+REI +L++L H+NIV L +++  ++             LVFE+ D DL    
Sbjct: 47  EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL 106

Query: 75  DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF 134
           +S       D +KSFM QLL GL +CH +N LHRD+K  N+L+N  G++KLADFGLAR +
Sbjct: 107 ESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLY 166

Query: 135 GIPVK-CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDD 193
                  Y+ +V+TLWYRPP++L G + Y  +ID+WS GCI  EL    +P+F  +    
Sbjct: 167 NSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTK-KPIFQANQELA 225

Query: 194 QLKRIFKLLGTPTEDTWPGMNLLPDF---KPFPMYHPSM--SFSQVAPKLTAKGRDLLQR 248
           QL+ I +L G+P    WP +  LP F   KP   Y   +   FS +         DLL  
Sbjct: 226 QLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPAL----DLLDH 281

Query: 249 LLVCNPVQRMSAEDAMSH 266
           +L  +P +R +AE+A++ 
Sbjct: 282 MLTLDPSKRCTAEEALNS 299

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  198 bits (505), Expect = 6e-62
 Identities = 107/278 (38%), Positives = 151/278 (54%), Gaps = 16/278 (5%)

Query: 6   VDRTPNTALAIKG-THLVGNEGVPSSALREICLLKELK-HKNIVRLYD---VLHSE-KKL 59
            + +    +AIK  T++   + +   ALRE+ LL+  + HKNI  LYD   V      +L
Sbjct: 22  AETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81

Query: 60  TLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK 119
            L  E  + DL +   S     D    +SF+YQ+L GL + HS NVLHRDLKP NLL+N 
Sbjct: 82  YLYEELMEADLHQIIRSGQPLTDAHF-QSFIYQILCGLKYIHSANVLHRDLKPGNLLVNA 140

Query: 120 NGELKLADFGLARAFGI-PVKC--YSAE-VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIF 175
           + ELK+ DFGLAR F   P +   +  E V T WYR P+++   + YT +ID+WS GCI 
Sbjct: 141 DCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCIL 200

Query: 176 AELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDT---WPGMNLLPDFKPFPMYHPSMSFS 232
           AEL    +P+F G D  DQL +I ++LGTP E+T             +  P   P   F 
Sbjct: 201 AELL-GRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNI-PKKPFE 258

Query: 233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            + P       DLL++LL  +P +R+S E+A+ H Y +
Sbjct: 259 SIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  194 bits (495), Expect = 3e-60
 Identities = 93/255 (36%), Positives = 135/255 (52%), Gaps = 32/255 (12%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDS--LNGEIDLD 84
           RE+ LLK + H+N++ L DV      L       LV      DL        L+     D
Sbjct: 63  RELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSD----D 118

Query: 85  IVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE 144
            ++  +YQ+LRGL + HS  ++HRDLKP N+ +N++ ELK+ DFGLAR     +  Y   
Sbjct: 119 HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY--- 175

Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
           V T WYR P+++     Y  ++D+WS GCI AEL   G+ LFPGSD  DQLKRI  L+GT
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGKTLFPGSDHIDQLKRIMNLVGT 234

Query: 205 PTEDTWPGMNL---------LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPV 255
           P E+    ++          LP         P   F +V         DLL+++LV +P 
Sbjct: 235 PDEELLQKISSESARNYIQSLP-------QMPKKDFKEVFSGANPLAIDLLEKMLVLDPD 287

Query: 256 QRMSAEDAMSHIYFS 270
           +R++A +A++H Y +
Sbjct: 288 KRITAAEALAHPYLA 302

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  191 bits (486), Expect = 9e-60
 Identities = 94/251 (37%), Positives = 139/251 (55%), Gaps = 23/251 (9%)

Query: 31  ALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFM 90
           ALREI +LK+LKH N+V L +V   ++KL LVFE+CD  +    +     +   ++K  +
Sbjct: 47  ALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKII 106

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWY 150
           +Q L+ + FCH  N +HRD+KP+N+LI K G++KL DFG AR    P   Y+  V T WY
Sbjct: 107 WQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWY 166

Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG-SDVDDQLKRIFKLLGT----- 204
           R P++L G   Y   +D+W+ GC+FAEL   G+PL+PG SDV DQL  I K LG      
Sbjct: 167 RAPELLVGDTQYGPPVDVWAIGCVFAELLT-GQPLWPGKSDV-DQLYLIRKTLGDLIPRH 224

Query: 205 ----PTEDTWPGMNLL--PDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
                T   + G+++      +P     P++S   +           L+  L  +P +R+
Sbjct: 225 QQIFSTNQFFKGLSIPEPETREPLESKFPNISSPAL---------SFLKGCLQMDPTERL 275

Query: 259 SAEDAMSHIYF 269
           S E+ + H YF
Sbjct: 276 SCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  186 bits (475), Expect = 4e-58
 Identities = 96/257 (37%), Positives = 139/257 (54%), Gaps = 36/257 (14%)

Query: 31  ALREICLLKELK-HKNIVRLYDVLHSEK--KLTLVFEHCDQDL-------KKYFDSLNGE 80
            LREI  L+ L  H NI+RL +VL   K  +L LVFE  D +L       K+        
Sbjct: 44  NLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKR-- 101

Query: 81  IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC 140
                VKS+MYQLL+ L   H   + HRD+KP+N+LI  +  LKLADFG  R  GI  K 
Sbjct: 102 -----VKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKP 153

Query: 141 -YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF 199
            Y+  + T WYR P+ L     Y   +D+W+ GC+F E+  +  PLFPG++  DQ+ +I 
Sbjct: 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEIL-SLFPLFPGTNELDQIAKIH 212

Query: 200 KLLGTPTEDTWPGMNLLPDFKP-------FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVC 252
            +LGTP  +      +L  F+        FP    +    ++ P  +A+G DLL++LL  
Sbjct: 213 DVLGTPDAE------VLKKFRKSRHMNYNFPSKKGT-GLRKLLPNASAEGLDLLKKLLAY 265

Query: 253 NPVQRMSAEDAMSHIYF 269
           +P +R++A+ A+ H YF
Sbjct: 266 DPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  187 bits (476), Expect = 2e-57
 Identities = 105/287 (36%), Positives = 153/287 (53%), Gaps = 23/287 (8%)

Query: 4   SGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE------- 56
           S VD   +  +A+K   L   + V   ALREI +++ L H NIV++Y+VL          
Sbjct: 23  SAVDSDCDKRVAVKKIVLTDPQSV-KHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81

Query: 57  -------KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRD 109
                    + +V E+ + DL    +   G +  +  + FMYQLLRGL + HS NVLHRD
Sbjct: 82  VGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRD 139

Query: 110 LKPQNLLINKNG-ELKLADFGLARAFG--IPVKCYSAE-VVTLWYRPPDVLFGAKLYTTS 165
           LKP N+ IN     LK+ DFGLAR        K Y +E +VT WYR P +L     YT +
Sbjct: 140 LKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKA 199

Query: 166 IDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG-TPTEDTWPGMNLLPDFKPFPM 224
           IDMW+AGCIFAE+   G+PLF G+   +Q++ I + +     ED    +N++P F     
Sbjct: 200 IDMWAAGCIFAEML-TGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDG 258

Query: 225 YHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD 271
             P      + P +  +  D L+++L  NP+ R++AE+A+ H Y S 
Sbjct: 259 GEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  184 bits (470), Expect = 3e-57
 Identities = 95/247 (38%), Positives = 141/247 (57%), Gaps = 15/247 (6%)

Query: 31  ALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ----DLKKYFDSLNGEIDLDIV 86
           A+REI +LK+L+H+N+V L +V   +K+L LVFE  D     DL+KY    NG +D   V
Sbjct: 47  AMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY---PNG-LDESRV 102

Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           + +++Q+LRG+ FCHS N++HRD+KP+N+L++++G +KL DFG AR    P + Y+  V 
Sbjct: 103 RKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA 162

Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P++L G   Y  ++D+W+ GC+  E+   G PLFPG    DQL  I K LG   
Sbjct: 163 TRWYRAPELLVGDTKYGRAVDIWAVGCLVTEML-TGEPLFPGDSDIDQLYHIIKCLGNLI 221

Query: 207 EDTWPGMNLLPDFKPFPMYHPSM----SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAED 262
                     P F    M  P +       +  PKL+    DL ++ L  +P  R S+  
Sbjct: 222 PRHQEIFQKNPLFA--GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQ 279

Query: 263 AMSHIYF 269
            + H +F
Sbjct: 280 LLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  185 bits (471), Expect = 5e-57
 Identities = 104/278 (37%), Positives = 153/278 (55%), Gaps = 28/278 (10%)

Query: 4   SGVDRTPNTALAIKGTHLVGNEGVPSSA---LREICLLKELKHKNIVRLYDVLHSEKK-L 59
           S  D+     +AIK   ++     P  A    RE+ LLK L+H+NI+ L D+  S  + +
Sbjct: 28  SARDQLTGQNVAIK--KIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85

Query: 60  TLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK 119
             V E    DL +   S    ++   ++ F+YQ+LRGL + HS  V+HRDLKP N+LIN+
Sbjct: 86  YFVTELLGTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINE 143

Query: 120 NGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELA 179
           N +LK+ DFGLAR     +  Y   V T +YR P+++   + Y   +D+WSAGCIFAE+ 
Sbjct: 144 NCDLKICDFGLARIQDPQMTGY---VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200

Query: 180 NAGRPLFPGSDVDDQLKRIFKLLGTP---------TEDTWPGMNLLPDFKPFPMYHPSMS 230
             G+PLFPG D  +Q   I  LLGTP         +E+T   +  LP  +P P       
Sbjct: 201 E-GKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVP------- 252

Query: 231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIY 268
           FS+          DLL+++LV +P +R+SA +A++H Y
Sbjct: 253 FSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  180 bits (458), Expect = 7e-55
 Identities = 109/297 (36%), Positives = 158/297 (53%), Gaps = 26/297 (8%)

Query: 4   SGVDRTPNTALAIKGTHLVGNEGVPSSA--LREICLLKELKHKNIVRLYDVL-----HSE 56
           S +D      +AIK  + V  E V  +   LREI LL+ L+H +IV +  ++        
Sbjct: 18  SAIDTHTGEKVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 76

Query: 57  KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLL 116
           K + +VFE  + DL +   + N ++  +  + F+YQLLR L + H+ NV HRDLKP+N+L
Sbjct: 77  KDIYVVFELMESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNIL 135

Query: 117 INKNGELKLADFGLAR-AF--GIPVKCYSAEVVTLWYRPPDVL--FGAKLYTTSIDMWSA 171
            N + +LK+ DFGLAR AF        ++  V T WYR P++   F +K YT +ID+WS 
Sbjct: 136 ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSI 194

Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN------LLPDFKPFPMY 225
           GCIFAE+   G+PLFPG +V  QL  I  LLGTP+ +T   +        L   +     
Sbjct: 195 GCIFAEVL-TGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRK---- 249

Query: 226 HPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKSERCQ 282
              + FSQ  P        LL+RLL  +P  R +AE+A++  YF  L    +    Q
Sbjct: 250 KQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQ 306

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  173 bits (442), Expect = 7e-54
 Identities = 66/176 (37%), Positives = 94/176 (53%), Gaps = 2/176 (1%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
             D+     +AIK      +  +    LREI +LK+L H NIV+LY V   E  L LV E
Sbjct: 12  ARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVME 71

Query: 65  HCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK-NGE 122
           +C+   LK       G++  D +   + Q+L GL + HS  ++HRDLKP+N+L++  NG+
Sbjct: 72  YCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGK 131

Query: 123 LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
           +KLADFGL++            V T  Y  P+VL G   Y+   D+WS G I  EL
Sbjct: 132 VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  176 bits (449), Expect = 4e-53
 Identities = 93/249 (37%), Positives = 135/249 (54%), Gaps = 15/249 (6%)

Query: 31  ALREICLLKELKHKNIVRLYDVLHSE-----KKLTLVFEHCDQDLKKYFDSLNGEIDLDI 85
             RE+ +L   KH N++   D+L        +++ +V E    DL K   S    +  D 
Sbjct: 46  VFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVS-PQPLSSDH 104

Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY-SAE 144
           VK F+YQ+LRGL + HS  +LHRD+KP NLL+N N  LK+ DFGLAR        + + E
Sbjct: 105 VKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQE 164

Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
           VVT +YR P++L G++ YT+++D+WS GCIFAEL    R LF       QL  I  LLGT
Sbjct: 165 VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELL-GRRILFQAQSPIQQLDLITDLLGT 223

Query: 205 PTEDTWPG-----MNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
           P+ +            +      P   P +    ++ + T +   LL R+LV +P +R+S
Sbjct: 224 PSLEAMRSACEGARAHILRGPHKPPSLPVLYT--LSSQATHEAVHLLCRMLVFDPDKRIS 281

Query: 260 AEDAMSHIY 268
           A DA++H Y
Sbjct: 282 AADALAHPY 290

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  169 bits (429), Expect = 4e-51
 Identities = 97/258 (37%), Positives = 145/258 (56%), Gaps = 20/258 (7%)

Query: 23  GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEID 82
            NE V  + LRE+ +L+ LK +NIV L +      KL LVFE+ ++++ +  + +   + 
Sbjct: 39  ENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVP 98

Query: 83  LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC-Y 141
            + V+S++YQL++ + +CH  +++HRD+KP+NLLI+ N  LKL DFG AR         Y
Sbjct: 99  PEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158

Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
           +  V T WYR P++L GA  Y  ++DMWS GCI  EL++ G+PLFPG    DQL  I K+
Sbjct: 159 TEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSD-GQPLFPGESEIDQLFTIQKV 216

Query: 202 LGT-PTEDTWPGMNLLPDFKPFPMYH----PSMSFSQVAPK-----LTAKGRDLLQRLLV 251
           LG  P E     M L   F   P +H    P+++  Q   +     L+    DL++ LL 
Sbjct: 217 LGPLPAEQ----MKL---FYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLK 269

Query: 252 CNPVQRMSAEDAMSHIYF 269
            NP  R   E  ++H  F
Sbjct: 270 LNPTDRYLTEQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  170 bits (432), Expect = 5e-51
 Identities = 97/279 (34%), Positives = 146/279 (52%), Gaps = 18/279 (6%)

Query: 4   SGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDV------LHSE 56
           S +D+     +AIK       +E     A RE+ LLK ++H+N++ L DV          
Sbjct: 33  SAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92

Query: 57  KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLL 116
           +   LV  +   DL+K    +   +  D V+  +YQ+L GL + HS  ++HRDLKP NL 
Sbjct: 93  QDFYLVMPYMQTDLQKI---MGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLA 149

Query: 117 INKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFA 176
           +N++ ELK+ DFGLAR     +  Y   VVT WYR P+V+     Y  ++D+WS GCI A
Sbjct: 150 VNEDCELKILDFGLARHADAEMTGY---VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMA 206

Query: 177 ELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPD---FKPFPMYHPSMSFSQ 233
           E+   G+ LF G D  DQL +I K+ G P  +    +         K  P Y P   FS 
Sbjct: 207 EMLT-GKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKY-PRKDFST 264

Query: 234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
           + PK + +  DLL+++L  +  +R++A +A+ H YF   
Sbjct: 265 LFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  169 bits (429), Expect = 1e-50
 Identities = 99/285 (34%), Positives = 150/285 (52%), Gaps = 29/285 (10%)

Query: 4   SGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT-- 60
           S +DR     +AIK  +    +E     A RE+ LLK +KH+N++ L DV   +  L   
Sbjct: 33  SALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92

Query: 61  ----LVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLL 116
               LV      DL K     + ++  D ++  +YQ+L+GL + H+  ++HRDLKP NL 
Sbjct: 93  HDFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLA 150

Query: 117 INKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFA 176
           +N++ ELK+ DFGLAR     +  Y   VVT WYR P+V+     YT ++D+WS GCI A
Sbjct: 151 VNEDCELKILDFGLARQTDSEMTGY---VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMA 207

Query: 177 ELANAGRPLFPGSDVDDQLKRIFKLLGTPT---------EDTWPGMNLLPDFKPFPMYHP 227
           E+   G+PLF G D  DQL  I K+ GTP+         ED    +  LP F+       
Sbjct: 208 EML-TGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFR------- 259

Query: 228 SMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
              F  + P       ++L+++LV +   R++A +A++H YF + 
Sbjct: 260 KKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  166 bits (422), Expect = 8e-50
 Identities = 104/281 (37%), Positives = 157/281 (55%), Gaps = 40/281 (14%)

Query: 26  GVPSSALREICLLKELKHKNIVRLYDVL--HSEKKLTLVFEHCDQDL---KKYFDSLNG- 79
           G+  SA REI LL+ELKH N++ L  V   H+++K+ L+F++ + DL    K+  +    
Sbjct: 40  GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN 99

Query: 80  ----EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI----NKNGELKLADFGLA 131
               ++   +VKS +YQ+L G+ + H+  VLHRDLKP N+L+     + G +K+AD G A
Sbjct: 100 KKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159

Query: 132 RAFGIPVKCYS---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
           R F  P+K  +     VVT WYR P++L GA+ YT +ID+W+ GCIFAEL  +  P+F  
Sbjct: 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHC 218

Query: 189 SDVD---------DQLKRIFKLLGTPTEDTWPGMNLLP-------DFKPFPMYHPS---- 228
              D         DQL RIF ++G P +  W  +  +P       DF+     + S    
Sbjct: 219 RQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKY 278

Query: 229 MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
           M   +V P   +K   LLQ+LL  +P++R+++E AM   YF
Sbjct: 279 MEKHKVKPD--SKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  164 bits (415), Expect = 9e-49
 Identities = 104/281 (37%), Positives = 156/281 (55%), Gaps = 40/281 (14%)

Query: 26  GVPSSALREICLLKELKHKNIVRLYDVL--HSEKKLTLVFEHCDQDL---KKYFDSLNG- 79
           G+  SA REI LL+ELKH N++ L  V   HS++K+ L+F++ + DL    K+  +    
Sbjct: 40  GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN 99

Query: 80  ----EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI----NKNGELKLADFGLA 131
               ++   +VKS +YQ+L G+ + H+  VLHRDLKP N+L+     + G +K+AD G A
Sbjct: 100 KKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159

Query: 132 RAFGIPVKCYS---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
           R F  P+K  +     VVT WYR P++L GA+ YT +ID+W+ GCIFAEL  +  P+F  
Sbjct: 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHC 218

Query: 189 SDVD---------DQLKRIFKLLGTPTEDTWPGMNLLP-------DFKPFPMYHPS---- 228
              D         DQL RIF ++G P +  W  +  +P       DF+     + S    
Sbjct: 219 RQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKY 278

Query: 229 MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
           M   +V P   +K   LLQ+LL  +P +R+++E A+   YF
Sbjct: 279 MEKHKVKPD--SKVFLLLQKLLTMDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  162 bits (413), Expect = 4e-48
 Identities = 93/261 (35%), Positives = 142/261 (54%), Gaps = 32/261 (12%)

Query: 31  ALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLD 84
           A RE+ L+K + HKNI+ L +V   +K L       LV E  D +L +    +  ++D +
Sbjct: 62  AYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQV---IQMDLDHE 118

Query: 85  IVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE 144
            +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G      +  
Sbjct: 119 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-MTPY 177

Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
           VVT +YR P+V+ G   Y  ++D+WS GCI  E+   G  LFPG+D  DQ  +I + LGT
Sbjct: 178 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIR-GTVLFPGTDHIDQWNKIIEQLGT 235

Query: 205 PTEDTWPGMNLL-----------PDFK--PFPMYHPSMSF---SQVAPKLTA-KGRDLLQ 247
           P+++    M+ L           P +    F    P + F   S+   KL A + RDLL 
Sbjct: 236 PSDEF---MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLS 292

Query: 248 RLLVCNPVQRMSAEDAMSHIY 268
           ++LV +P +R+S +DA+ H Y
Sbjct: 293 KMLVIDPEKRISVDDALQHPY 313

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  160 bits (406), Expect = 4e-47
 Identities = 94/253 (37%), Positives = 137/253 (54%), Gaps = 28/253 (11%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 65  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 122

Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 123 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 179

Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP- 205
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GTP 
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGTPG 238

Query: 206 --------TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQR 257
                   +E     +  L          P M+F+ V         DLL+++LV +  +R
Sbjct: 239 AELLKKISSESARNYIQSLT-------QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 291

Query: 258 MSAEDAMSHIYFS 270
           ++A  A++H YF+
Sbjct: 292 ITAAQALAHAYFA 304

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  157 bits (399), Expect = 3e-46
 Identities = 88/247 (35%), Positives = 140/247 (56%), Gaps = 16/247 (6%)

Query: 33  REICLLKELKHKNIVRLYDV------LHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV      + +  ++ LV      DL         ++  + V
Sbjct: 63  RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC--QKLSDEHV 120

Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQLLRGL + HS  ++HRDLKP N+ +N++ EL++ DFGLAR     +  Y   V 
Sbjct: 121 QFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGY---VA 177

Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   G+ LFPG+D  DQLKRI +++GTP+
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLK-GKALFPGNDYIDQLKRIMEVVGTPS 236

Query: 207 EDTWPGMN---LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
            +    ++        +  P + P     ++         DLL+++LV +  +R+SA +A
Sbjct: 237 PEVLKKISSEHARKYIQSLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEA 295

Query: 264 MSHIYFS 270
           ++H YFS
Sbjct: 296 LAHPYFS 302

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  154 bits (389), Expect = 9e-44
 Identities = 101/260 (38%), Positives = 144/260 (55%), Gaps = 20/260 (7%)

Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSE--KK------LTLVFEHCDQDLKKY---FDS 76
           P    RE+ ++K L H NI+ L D  ++E  KK      L +V E   Q + KY   +  
Sbjct: 103 PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYAR 162

Query: 77  LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE-LKLADFGLARAFG 135
            N  + L +VK + YQL R LA+ HS+ + HRDLKPQNLLI+ N   LKL DFG A+   
Sbjct: 163 NNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL 222

Query: 136 IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL 195
              +  S  + + +YR P+++ GA  YTT ID+WS GCI AE+   G P+F G    DQL
Sbjct: 223 AGQRSVSY-ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI-LGYPIFSGQSSVDQL 280

Query: 196 KRIFKLLGTPTEDTWPGMNLLPDFK--PFPMYHPSMSFSQVAPKLTA-KGRDLLQRLLVC 252
            RI ++LGTPTED    MN  P++    FP   P     +V PK T     + + + L  
Sbjct: 281 VRIIQVLGTPTEDQLKEMN--PNYADIKFPDVKPK-DLKKVFPKGTPDDAINFISQFLKY 337

Query: 253 NPVQRMSAEDAMSHIYFSDL 272
            P++R++  +A++  +F DL
Sbjct: 338 EPLKRLNPIEALADPFFDDL 357

Length = 440

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  147 bits (371), Expect = 6e-42
 Identities = 94/270 (34%), Positives = 147/270 (54%), Gaps = 33/270 (12%)

Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ LLK + HKNI+ L +V   +K L       LV E  D +L +    +
Sbjct: 60  NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQV---I 116

Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
           + E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR     
Sbjct: 117 HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176

Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  EL   G  +F G+D  DQ  +
Sbjct: 177 FM-MTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVK-GSVIFQGTDHIDQWNK 233

Query: 198 IFKLLGTPTEDTWPGMN-LLPDFKPF----PMYHPSMSFSQVAP-----------KL-TA 240
           + + LGTP+ +    MN L P  + +    P Y   +SF ++ P           KL T+
Sbjct: 234 VIEQLGTPSAEF---MNRLQPTVRNYVENRPQYP-GISFEELFPDWIFPSESERDKLKTS 289

Query: 241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
           + RDLL ++LV +P +R+S ++A+ H Y +
Sbjct: 290 QARDLLSKMLVIDPDKRISVDEALRHPYIT 319

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  146 bits (368), Expect = 3e-41
 Identities = 75/265 (28%), Positives = 115/265 (43%), Gaps = 30/265 (11%)

Query: 30  SALREICLLKELKH-KNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSL--NGEIDLDI 85
             LREI +L  L H  NIV+LYD    E  L LV E+ D   L+     +   G +    
Sbjct: 43  RFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESE 102

Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG-ELKLADFGLARAFG------IPV 138
               + Q+L  L + HS+ ++HRD+KP+N+L++++G  +KL DFGLA+            
Sbjct: 103 ALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIP 162

Query: 139 KCYSAEVVTLWYRPPDVLFGAKL--YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
              S  V T  Y  P+VL G  L   ++S D+WS G    EL   G P F G        
Sbjct: 163 ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLT-GLPPFEGEKNSSATS 221

Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
           +  K++          + L       P+             ++    DLL++LL  +P  
Sbjct: 222 QTLKII----------LELPTPSLASPLSP------SNPELISKAASDLLKKLLAKDPKN 265

Query: 257 RMSAEDAMSHIYFSDLNVAIKSERC 281
           R+S+   +SH   + L +       
Sbjct: 266 RLSSSSDLSHDLLAHLKLKESDLSD 290

Length = 384

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  142 bits (358), Expect = 5e-40
 Identities = 91/266 (34%), Positives = 141/266 (53%), Gaps = 25/266 (9%)

Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       LV E  D +L +    +
Sbjct: 56  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQV---I 112

Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 113 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172

Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  E+    + LFPG D  DQ  +
Sbjct: 173 FM-MTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRH-KILFPGRDYIDQWNK 229

Query: 198 IFKLLGTPTED----TWPGMNLLPDFKP------FPMYHPSMSFSQVAP--KLTA-KGRD 244
           + + LGTP  +      P +    + +P      FP   P   F   +   KL A + RD
Sbjct: 230 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 289

Query: 245 LLQRLLVCNPVQRMSAEDAMSHIYFS 270
           LL ++LV +P +R+S ++A+ H Y +
Sbjct: 290 LLSKMLVIDPAKRISVDEALQHPYIN 315

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  140 bits (355), Expect = 1e-39
 Identities = 90/268 (33%), Positives = 141/268 (52%), Gaps = 29/268 (10%)

Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       +V E  D +L +    +
Sbjct: 63  NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV---I 119

Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179

Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  E+   G  LFPG+D  DQ  +
Sbjct: 180 FM-MTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNK 236

Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHPS---MSFSQVAP-----------KLTA-KG 242
           + + LGTP  +      L P  + +    P     SF ++ P           KL A + 
Sbjct: 237 VIEQLGTPCPEFMK--KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQA 294

Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
           RDLL ++LV +  +R+S ++A+ H Y +
Sbjct: 295 RDLLSKMLVIDASKRISVDEALQHPYIN 322

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  135 bits (342), Expect = 2e-38
 Identities = 75/271 (27%), Positives = 128/271 (47%), Gaps = 41/271 (15%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSAL-REICLLKELKHKNIVRLYDVLHSEKK--LTL 61
            +D+     +A+K   L G+      AL REI +L  L+H NIVR Y     E+K  L +
Sbjct: 19  ALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI 78

Query: 62  VFEHCD----QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI 117
             E+        L K F  L  E    +++ +  Q+L GLA+ HS  ++HRD+K  N+L+
Sbjct: 79  FLEYVSGGSLSSLLKKFGKLP-E---PVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV 134

Query: 118 NKNGELKLADFGLARAFG-IPVKCYSAEVV-TLWYRPPDVLFGAKLYTTSIDMWSAGCIF 175
           + +G +KLADFG A+  G I     +  V  T ++  P+V+ G + Y  + D+WS GC  
Sbjct: 135 DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTV 193

Query: 176 AELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA 235
            E+A    P    S++ + +  ++K+  +                  P     +S     
Sbjct: 194 IEMATGKPPW---SELGNPMAALYKIGSSGEP---------------PEIPEHLS----- 230

Query: 236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                + +D L++ L  +P +R +A++ + H
Sbjct: 231 ----EEAKDFLRKCLRRDPKKRPTADELLQH 257

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  133 bits (337), Expect = 9e-38
 Identities = 69/236 (29%), Positives = 108/236 (45%), Gaps = 34/236 (14%)

Query: 31  ALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDL---DIV 86
           AL E+ +LK+L H NI++ Y+    + KL +V E+ D  DL +       E      + +
Sbjct: 46  ALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI 105

Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
             +  QL   L + HSR +LHRD+KPQN+ +  NG +KL DFG+++     V      V 
Sbjct: 106 LDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVG 165

Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T +Y  P++    K Y    D+WS GC+  EL    +  F G ++ +   +I K      
Sbjct: 166 TPYYLSPELCQN-KPYNYKSDIWSLGCVLYELC-TLKHPFEGENLLELALKILKG----- 218

Query: 207 EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAED 262
                       + P P        SQ + +L    R+L+  LL  +P +R S   
Sbjct: 219 -----------QYPPIP--------SQYSSEL----RNLVSSLLQKDPEERPSIAQ 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  119 bits (301), Expect = 3e-32
 Identities = 60/164 (36%), Positives = 84/164 (51%), Gaps = 13/164 (7%)

Query: 34  EICLLKELKHKNIVRLYD--VLHSEKKLTLVFEHCD----QDLKKYFDSLNGEIDLDIVK 87
           E+ +L+ELKH NIVR YD  +  S + L +V E+C+      L +        I+ + + 
Sbjct: 49  EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW 108

Query: 88  SFMYQLLRGLAFCHSRN-----VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS 142
             + QLL  L  CH+R+     VLHRDLKP N+ ++ N  +KL DFGLA+  G       
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK 168

Query: 143 AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             V T +Y  P+ L     Y    D+WS GC+  EL  A  P F
Sbjct: 169 TYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELC-ALSPPF 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  116 bits (294), Expect = 2e-31
 Identities = 73/262 (27%), Positives = 120/262 (45%), Gaps = 42/262 (16%)

Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEID 82
            +      L E  +L + +   +V+LY     +K L LV E+    DL    +++ G +D
Sbjct: 33  RKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENV-GSLD 91

Query: 83  LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARA--------F 134
            D+ + ++ +++  L + HS  ++HRDLKP N+LI+ NG LKL DFGL++          
Sbjct: 92  EDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151

Query: 135 GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQ 194
               K     V T  Y  P+V+ G + ++ ++D WS GCI  E    G P F G   +  
Sbjct: 152 NDDEKEDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFL-VGIPPFHGETPE-- 207

Query: 195 LKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNP 254
              IF              N+L     +P     +  S  A        DL+ +LLV +P
Sbjct: 208 --EIF-------------QNILNGKIEWPED---VEVSDEA-------IDLISKLLVPDP 242

Query: 255 VQRM---SAEDAMSHIYFSDLN 273
            +R+   S E+  +H +F  ++
Sbjct: 243 EKRLGAKSIEEIKNHPFFKGID 264

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  116 bits (293), Expect = 3e-31
 Identities = 79/273 (28%), Positives = 129/273 (47%), Gaps = 49/273 (17%)

Query: 4   SGVDRTPNTALAIKGTHLVGNEGVPSSAL----REICLLKELKHKNIVRLYDVLHSEKKL 59
            G++      +AIK    +  E +   AL    +EI LLK LKH NIV+    + +   L
Sbjct: 18  KGLNLETGDFVAIK---QISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSL 74

Query: 60  TLVFEHCD----QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            ++ E+ +    + + K F     E    +V  ++YQ+L+GLA+ H + V+HRD+K  N+
Sbjct: 75  YIILEYAENGSLRQIIKKFGPFP-E---SLVAVYVYQVLQGLAYLHEQGVIHRDIKAANI 130

Query: 116 LINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIF 175
           L  K+G +KLADFG+A       K  ++ V T ++  P+V+  +   +T+ D+WS GC  
Sbjct: 131 LTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA-STASDIWSLGCTV 189

Query: 176 AELANAGRPLFPGSDVDDQ--LKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ 233
            EL   G P  P  D++    L RI        +D  P         P P          
Sbjct: 190 IELL-TGNP--PYYDLNPMAALFRI-------VQDDHP---------PLP--------EG 222

Query: 234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
           ++P+L    +D L +    +P  R +A+  + H
Sbjct: 223 ISPEL----KDFLMQCFQKDPNLRPTAKQLLKH 251

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  116 bits (292), Expect = 4e-31
 Identities = 64/237 (27%), Positives = 108/237 (45%), Gaps = 38/237 (16%)

Query: 38  LKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRG 96
           L  + H  IV+L+    +E+KL LV E+    +L  +     G    +  + +  +++  
Sbjct: 47  LSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSK-EGRFSEERARFYAAEIVLA 105

Query: 97  LAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG-IPVKCYSAEVVTLWYRPPDV 155
           L + HS  +++RDLKP+N+L++ +G +KL DFGLA+       +  +    T  Y  P+V
Sbjct: 106 LEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF-CGTPEYLAPEV 164

Query: 156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNL 215
           L G   Y  ++D WS G +  E+   G+P F   D  +  ++I K               
Sbjct: 165 LLGKG-YGKAVDWWSLGVLLYEML-TGKPPFYAEDRKEIYEKILK--DPLR--------- 211

Query: 216 LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM---SAEDAMSHIYF 269
                 FP +      S  A       RDL+  LL  +P +R+    AE+  +H +F
Sbjct: 212 ------FPEF-----LSPEA-------RDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  114 bits (288), Expect = 1e-30
 Identities = 74/236 (31%), Positives = 114/236 (48%), Gaps = 30/236 (12%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           + EI +LK+ KH NIV+ Y     + +L +V E C    LK    S N  +    +    
Sbjct: 45  INEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVC 104

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWY 150
            +LL+GL + HS  ++HRD+K  N+L+  +GE+KL DFGL+ A     K  +  V T ++
Sbjct: 105 KELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLS-AQLSDTKARNTMVGTPYW 163

Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTW 210
             P+V+ G K Y    D+WS G    ELA  G+P  P S+    +K +FK     T    
Sbjct: 164 MAPEVING-KPYDYKADIWSLGITAIELAE-GKP--PYSE-LPPMKALFK---IATNG-- 213

Query: 211 PGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                     P  + +P         K + + +D L++ L  NP +R +AE  + H
Sbjct: 214 ----------PPGLRNPE--------KWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  111 bits (281), Expect = 2e-29
 Identities = 51/179 (28%), Positives = 90/179 (50%), Gaps = 23/179 (12%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           LRE  ++++L H N+V+L  V   E+ L +V E+ +  DL  Y      ++ L  + SF 
Sbjct: 49  LREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFA 108

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG-----------IPVK 139
            Q+ RG+ +  S+N +HRDL  +N L+ +N  +K++DFGL+R              +P++
Sbjct: 109 LQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR 168

Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRI 198
                    W   P+ L     +T+  D+WS G +  E+   G   +PG   ++ L+ +
Sbjct: 169 ---------WM-APESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYL 216

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  111 bits (281), Expect = 2e-29
 Identities = 69/291 (23%), Positives = 117/291 (40%), Gaps = 60/291 (20%)

Query: 7   DRTPNTALAIK--GTHLVGNEGVPSSALRE-ICLLKELKHKNIVRLYDVLHSEKKLTLVF 63
           ++  N   AIK      +  E        E   L +   H  I++LY     E+ L  V 
Sbjct: 22  EKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81

Query: 64  EHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           E+    +L +Y     G +D    + +  ++L  L + HS+ ++HRDLKP+N+L++K+  
Sbjct: 82  EYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH 140

Query: 123 LKLADFGLARAFGIPVKCYSAEVV--------------------TLWYRPPDVLFGAKLY 162
           +K+ DFG A+         S +                      T  Y  P++L   K  
Sbjct: 141 IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL-NEKPA 199

Query: 163 TTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPF 222
             S D+W+ GCI  ++   G+P F GS+     ++I KL                     
Sbjct: 200 GKSSDLWALGCIIYQML-TGKPPFRGSNEYLTFQKILKL--------------------- 237

Query: 223 PMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM----SAEDAMSHIYF 269
                  SF    P      +DL+++LLV +P  R+      ++  +H +F
Sbjct: 238 -----EYSFPPNFPPDA---KDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  110 bits (278), Expect = 4e-29
 Identities = 70/274 (25%), Positives = 120/274 (43%), Gaps = 49/274 (17%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSAL----REICLLKELKHKNIVRLYDVLHSEKKLT 60
           G++       A+K   L  +      A+    +EI LL +L+H NIV+       E  L 
Sbjct: 19  GLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLY 78

Query: 61  LVFEHCDQD-----LKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
           +  E          LKKY     G     +++ +  Q+L GL + H RN +HRD+K  N+
Sbjct: 79  IFLELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANI 133

Query: 116 LINKNGELKLADFGLAR---AFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAG 172
           L++ NG +KLADFG+A+    F            + ++  P+V+     Y  + D+WS G
Sbjct: 134 LVDTNGVVKLADFGMAKQVVEFSFAKSF----KGSPYWMAPEVIAQQGGYGLAADIWSLG 189

Query: 173 CIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS 232
           C   E+A  G+P  P S + + +  +FK+  +        +  +PD              
Sbjct: 190 CTVLEMAT-GKP--PWSQL-EGVAAVFKIGRSKE------LPPIPD-------------- 225

Query: 233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                L+ + +D + + L  +P  R +A + + H
Sbjct: 226 ----HLSDEAKDFILKCLQRDPSLRPTAAELLEH 255

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  109 bits (275), Expect = 1e-28
 Identities = 53/180 (29%), Positives = 89/180 (49%), Gaps = 24/180 (13%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF-DSLNGEIDLDIVKSF 89
           LRE  ++++L H NIV+L  V   E+ L +V E+    DL  Y   +   E+ L  + SF
Sbjct: 49  LREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSF 108

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG-----------IPV 138
             Q+ RG+ +  S+N +HRDL  +N L+ +N  +K++DFGL+R              +P+
Sbjct: 109 ALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPI 168

Query: 139 KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRI 198
           +         W   P+ L     +T+  D+WS G +  E+   G   +PG    + L+ +
Sbjct: 169 R---------WM-APESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYL 217

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  108 bits (272), Expect = 4e-28
 Identities = 75/259 (28%), Positives = 124/259 (47%), Gaps = 37/259 (14%)

Query: 14  LAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD----QD 69
            A+K  H+ G+E      LRE+  L+  +   +V+ Y   + E ++++V E+ D     D
Sbjct: 29  YALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLAD 88

Query: 70  LKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADF 128
           L K      G+I   ++     Q+L+GL + H+ R+++HRD+KP NLLIN  GE+K+ADF
Sbjct: 89  LLKK----VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADF 144

Query: 129 GLARAF-GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFP 187
           G+++       +C +  V T+ Y  P+     + Y+ + D+WS G    E A  G+  FP
Sbjct: 145 GISKVLENTLDQCNTF-VGTVTYMSPE-RIQGESYSYAADIWSLGLTLLECA-LGK--FP 199

Query: 188 GSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQ 247
                      F   G P    +  M  + D  P  +  P+  FS        + RD + 
Sbjct: 200 -----------FLPPGQP--SFFELMQAICDGPPPSL--PAEEFSP-------EFRDFIS 237

Query: 248 RLLVCNPVQRMSAEDAMSH 266
             L  +P +R SA + + H
Sbjct: 238 ACLQKDPKKRPSAAELLQH 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  108 bits (272), Expect = 5e-28
 Identities = 74/274 (27%), Positives = 121/274 (44%), Gaps = 41/274 (14%)

Query: 4   SGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF 63
              DR     +AIK   L   +      + EI ++K+ KH NIV  YD      +L +V 
Sbjct: 37  KATDRATGKEVAIKKMRL--RKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94

Query: 64  EHCDQD-----LKKYFDSLN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI 117
           E+ D       + + F  +N  +I          ++L+GL + HS+NV+HRD+K  N+L+
Sbjct: 95  EYMDGGSLTDIITQNFVRMNEPQI-----AYVCREVLQGLEYLHSQNVIHRDIKSDNILL 149

Query: 118 NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAE 177
           +K+G +KLADFG A          ++ V T ++  P+V+   K Y   +D+WS G +  E
Sbjct: 150 SKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIE 208

Query: 178 LANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK 237
           +A    P        +   R   L+ T           +P  K                K
Sbjct: 209 MAEGEPPYL-----REPPLRALFLITT---------KGIPPLKN-------------PEK 241

Query: 238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD 271
            + + +D L + LV +P +R SAE+ + H +   
Sbjct: 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  107 bits (269), Expect = 1e-27
 Identities = 68/244 (27%), Positives = 113/244 (46%), Gaps = 40/244 (16%)

Query: 33  REICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY 91
            E+ +L+ LKH N+V+ Y V +H EK + +  E+C     +        +D  +++ +  
Sbjct: 48  DEMKVLELLKHPNLVKYYGVEVHREK-VYIFMEYCSGGTLEELLEHGRILDEHVIRVYTL 106

Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL--- 148
           QLL GLA+ HS  ++HRD+KP N+ ++ NG +KL DFG A            EV +L   
Sbjct: 107 QLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166

Query: 149 -WYRPPDVLFGAKL--YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
             Y  P+V+ G K   +  + D+WS GC+  E+A  G+  +   D + Q+          
Sbjct: 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMA-TGKRPWSELDNEFQI---------- 215

Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP---KLTAKGRDLLQRLLVCNPVQRMSAED 262
                             M+H         P   +L+ +G+D L R L  +P +R +A +
Sbjct: 216 ------------------MFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASE 257

Query: 263 AMSH 266
            + H
Sbjct: 258 LLQH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  106 bits (267), Expect = 1e-27
 Identities = 67/232 (28%), Positives = 99/232 (42%), Gaps = 35/232 (15%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLK---KYFDSLNGEIDLDIVK 87
           L+EI LLK+L H N+++         +L +V E  D  DL    K+F      I    + 
Sbjct: 50  LKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW 109

Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT 147
            +  QL   L   HS+ ++HRD+KP N+ I   G +KL D GL R F        + V T
Sbjct: 110 KYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGT 169

Query: 148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD--DQLKRIFKLLGTP 205
            +Y  P+ +     Y    D+WS GC+  E+A    P F G  ++     K+I K     
Sbjct: 170 PYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSP-FYGDKMNLYSLCKKIEKC---- 223

Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQR 257
                       D+ P P  H S            + RDL+ R +  +P +R
Sbjct: 224 ------------DYPPLPADHYS-----------EELRDLVSRCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 4e-26
 Identities = 70/243 (28%), Positives = 111/243 (45%), Gaps = 32/243 (13%)

Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSFMYQ 92
           EI +L E KH NIV LY+    E KL ++ E CD   L      L   +    ++    Q
Sbjct: 52  EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ 111

Query: 93  LLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRP 152
           +L  L F HS  V+HRDLK  N+L+  +G++KLADFG++      ++     + T ++  
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMA 171

Query: 153 PDVL----FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTED 208
           P+V+    F    Y    D+WS G    ELA    P  P  ++ + ++ + K+L +    
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQ-MEP--PHHEL-NPMRVLLKILKSE--- 224

Query: 209 TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIY 268
                       P  +  PS        K ++   D L+  LV +P  R +A + + H +
Sbjct: 225 ------------PPTLDQPS--------KWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF 264

Query: 269 FSD 271
            SD
Sbjct: 265 VSD 267

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  101 bits (253), Expect = 2e-25
 Identities = 72/249 (28%), Positives = 118/249 (47%), Gaps = 40/249 (16%)

Query: 30  SALR-EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-----LKKYFDSLNGEIDL 83
            ALR EI  LK+L H NIV+      +E+ L++  E+         L+ Y     G  + 
Sbjct: 53  KALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-----GRFEE 107

Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR----AFGIPVK 139
            +V+ F  Q+L GLA+ HS+ +LHRDLK  NLL++ +G  K++DFG+++     +    +
Sbjct: 108 QLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYD-NDQ 166

Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF 199
             S +    W  P  +   ++ Y+  +D+WS GC+  E+  AGR   P SD ++ +  +F
Sbjct: 167 NMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMF-AGRR--PWSD-EEAIAAMF 222

Query: 200 KLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
           KL     + + P         P P          V+  L+    D L      NP  R +
Sbjct: 223 KLG---NKRSAP---------PIP--------PDVSMNLSPVALDFLNACFTINPDNRPT 262

Query: 260 AEDAMSHIY 268
           A + + H +
Sbjct: 263 ARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  100 bits (252), Expect = 3e-25
 Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 26/185 (14%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY--------FDSLNGEID 82
           L+E  ++K+L H N+VRL  V   E+ L LV E+ +  DL  Y               + 
Sbjct: 44  LKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLS 103

Query: 83  LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS 142
           L  + SF  Q+ +G+ +  S+  +HRDL  +N L+ ++  +K++DFGL+R        Y 
Sbjct: 104 LKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSR------DVYD 157

Query: 143 AEVVTL---------WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDD 193
            +             W   P+ L    ++T+  D+WS G +  E+   G   +PG   ++
Sbjct: 158 DDYYRKKTGGKLPIRWM-APESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE 215

Query: 194 QLKRI 198
            L+ +
Sbjct: 216 VLEYL 220

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 99.6 bits (249), Expect = 6e-25
 Identities = 66/250 (26%), Positives = 115/250 (46%), Gaps = 43/250 (17%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSL--NGEIDLDIVKSF 89
           +EI  L+E  H  IV+LY     +K + ++ E+C   +L   +  L   G  D    + +
Sbjct: 44  KEI--LEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL---WTILRDRGLFDEYTARFY 98

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW 149
           +  ++    + H+R +++RDLKP+NLL++ NG +KL DFG A+      K ++    T  
Sbjct: 99  IACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF-CGTPE 157

Query: 150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTED- 208
           Y  P+++   K Y  S+D WS G +  EL   GRP F G D +D ++ I+  +       
Sbjct: 158 YVAPEIILN-KGYDFSVDYWSLGILLYELLT-GRPPF-GEDDEDPME-IYNDILKGNGKL 213

Query: 209 TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM-----SAEDA 263
            +P                          +    +DL+++LL  NP +R+       +D 
Sbjct: 214 EFP------------------------NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDI 249

Query: 264 MSHIYFSDLN 273
             H +F+  +
Sbjct: 250 KKHKWFNGFD 259

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 99.5 bits (248), Expect = 8e-25
 Identities = 65/237 (27%), Positives = 98/237 (41%), Gaps = 44/237 (18%)

Query: 45  NIVRLYDVLHSEKKLTLVFEH-----CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAF 99
            + +LY    S+  L LV E+     C   +K       G +  D  K ++ +++ G+  
Sbjct: 58  YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-----GGLPEDWAKQYIAEVVLGVED 112

Query: 100 CHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA 159
            H R ++HRD+KP+NLLI++ G LKL DFGL+R      K     V T  Y  P+ + G 
Sbjct: 113 LHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF----VGTPDYLAPETILG- 167

Query: 160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDF 219
                  D WS GC+  E    G P F     D     I           WP        
Sbjct: 168 VGDDKMSDWWSLGCVIFEFL-FGYPPFHAETPDAVFDNILS-----RRINWP-------- 213

Query: 220 KPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA---EDAMSHIYFSDLN 273
                        +V    + +  DL+ RLL  +P +R+ A   ++  SH +F  +N
Sbjct: 214 ------------EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score =   99 bits (249), Expect = 3e-24
 Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 26/266 (9%)

Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDI 85
           G   + L E  LL+ + H +++R+ D L S     +V  H   DL  Y    +  + +D 
Sbjct: 99  GQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQ 158

Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEV 145
                 Q+L GL + H++ ++HRD+K +N+ IN   ++ + D G A+ F +    +    
Sbjct: 159 ALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPAFLGLA 217

Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF--PGSDVDD-------QLK 196
            T+    P+VL   K Y +  D+WSAG +  E+      +F  P S  ++        L 
Sbjct: 218 GTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLL 276

Query: 197 RIFKLLGTPTED--TWPGMNLLPDF--------KPFPMYHPSMSFSQVAPKLTAKGRDLL 246
           +I   L    E+    PG  L+  F        +P+  Y     F +V   L   G  L+
Sbjct: 277 KIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYP---CFQRV--NLPIDGEFLV 331

Query: 247 QRLLVCNPVQRMSAEDAMSHIYFSDL 272
            ++L  +   R SAE+ +++  F+ L
Sbjct: 332 HKMLTFDAAMRPSAEEILNYPMFAQL 357

Length = 357

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 98.0 bits (244), Expect = 4e-24
 Identities = 68/248 (27%), Positives = 116/248 (46%), Gaps = 45/248 (18%)

Query: 30  SAL-REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKS 88
            AL REI LLKEL+H+NIV+          L +  E+          +  G  +  +V++
Sbjct: 51  DALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRN 110

Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL 148
           F+ Q+L+GL + H+R ++HRD+K  N+L++  G +K++DFG+++     ++  S    T 
Sbjct: 111 FVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK----LEANSLSTKTN 166

Query: 149 WYRP----------PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRI 198
             RP          P+V+     YT   D+WS GC+  E+     P FP      QL+ I
Sbjct: 167 GARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHP-FPDC---TQLQAI 221

Query: 199 FKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
           FK+          G N  P+        PS         ++++  D L++    +  +R 
Sbjct: 222 FKI----------GENASPEI-------PS--------NISSEAIDFLEKTFEIDHNKRP 256

Query: 259 SAEDAMSH 266
           +A + + H
Sbjct: 257 TAAELLKH 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 97.4 bits (243), Expect = 6e-24
 Identities = 62/199 (31%), Positives = 93/199 (46%), Gaps = 24/199 (12%)

Query: 14  LAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKK 72
           +A+K   L  NE +    LRE+ +L +     IV  Y   ++   +++  E+ D   L K
Sbjct: 29  MAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDK 88

Query: 73  YFDSLNGEIDLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFG-- 129
               + G I   I+      +L+GL + H    ++HRD+KP N+L+N  G++KL DFG  
Sbjct: 89  ILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVS 148

Query: 130 ------LARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
                 LA+ F   V   S       Y  P+ + G   Y+   D+WS G    ELA  GR
Sbjct: 149 GQLVNSLAKTF---VGTSS-------YMAPERIQGND-YSVKSDIWSLGLSLIELA-TGR 196

Query: 184 PLFPGSDVDDQLKRIFKLL 202
             FP    +D    IF+LL
Sbjct: 197 --FPYPPENDPPDGIFELL 213

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 97.2 bits (243), Expect = 6e-24
 Identities = 50/182 (27%), Positives = 85/182 (46%), Gaps = 24/182 (13%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           L E  ++K+L H NIVRL  V    + L +V E+    DL  +      ++ L  +    
Sbjct: 49  LEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMA 108

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG------------IPV 138
            Q+ +G+ +  S+N +HRDL  +N L+ +N  +K++DFGL+R               +P+
Sbjct: 109 LQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPI 168

Query: 139 KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRI 198
           K         W   P+ L   K  + S D+WS G +  E+   G   +PG   ++ L+ +
Sbjct: 169 K---------WM-APESLKDGKFTSKS-DVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL 217

Query: 199 FK 200
             
Sbjct: 218 ED 219

Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 96.6 bits (241), Expect = 8e-24
 Identities = 71/264 (26%), Positives = 116/264 (43%), Gaps = 46/264 (17%)

Query: 11  NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD--- 67
              +AIK   +V  E      ++EI +LK+     IV+ Y        L +V E+C    
Sbjct: 28  GQVVAIK---VVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGS 84

Query: 68  -QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLA 126
             D+ K     N  +  + + + +YQ L+GL + HS   +HRD+K  N+L+N+ G+ KLA
Sbjct: 85  VSDIMK---ITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLA 141

Query: 127 DFGLARAFGIPVKCY-SAEVV--TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           DFG++   G           V  T ++  P+V+     Y    D+WS G    E+A  G+
Sbjct: 142 DFGVS---GQLTDTMAKRNTVIGTPFWMAPEVIQEIG-YNNKADIWSLGITAIEMAE-GK 196

Query: 184 PLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFK-PFPMYHPSMSFSQVAPKLTAKG 242
           P  P SD+   ++ IF +         P     P    P           + +P+     
Sbjct: 197 P--PYSDI-HPMRAIFMI------PNKPP----PTLSDP----------EKWSPEFN--- 230

Query: 243 RDLLQRLLVCNPVQRMSAEDAMSH 266
            D +++ LV +P +R SA   + H
Sbjct: 231 -DFVKKCLVKDPEERPSAIQLLQH 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 95.8 bits (238), Expect = 2e-23
 Identities = 54/156 (34%), Positives = 82/156 (52%), Gaps = 4/156 (2%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEI-DLDIVKSFM 90
           +E+ LL ++KH NIV  +       +L +V E+CD  DL K  +   G +   D + S+ 
Sbjct: 48  KEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF 107

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL-KLADFGLARAFGIPVKCYSAEVVTLW 149
            Q+  GL   H R +LHRD+K QN+ ++KNG + KL DFG+AR     ++     V T +
Sbjct: 108 VQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPY 167

Query: 150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
           Y  P++    + Y    D+WS GC+  EL     P 
Sbjct: 168 YLSPEIC-QNRPYNNKTDIWSLGCVLYELCTLKHPF 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 94.9 bits (237), Expect = 6e-23
 Identities = 63/253 (24%), Positives = 116/253 (45%), Gaps = 51/253 (20%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFM 90
           L E  +L+ ++H  +V LY     +  L LV E+    +L  +    +G     + + + 
Sbjct: 49  LNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK-SGRFPEPVARFYA 107

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA-----RAFGIPVKCYSAEV 145
            Q++  L + HS ++++RDLKP+NLL++ +G +K+ DFG A     R + +   C + E 
Sbjct: 108 AQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTL---CGTPE- 163

Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
               Y  P+++   K Y  ++D W+ G +  E+  AG P F     DD   +I++     
Sbjct: 164 ----YLAPEIILS-KGYGKAVDWWALGILIYEML-AGYPPF----FDDNPIQIYE----- 208

Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM-----SA 260
                    +L     FP +     FS  A       +DL++ LL  +  +R+       
Sbjct: 209 --------KILEGKVRFPSF-----FSPDA-------KDLIRNLLQVDLTKRLGNLKNGV 248

Query: 261 EDAMSHIYFSDLN 273
            D  +H +F+ ++
Sbjct: 249 NDIKNHPWFAGID 261

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 92.7 bits (230), Expect = 2e-22
 Identities = 53/159 (33%), Positives = 81/159 (50%), Gaps = 3/159 (1%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEI-DLDIVKSFM 90
           +E  LL ++KH NIV   +   ++  L +V E+CD  DL +      G++   D +  + 
Sbjct: 47  KEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF 106

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWY 150
            Q+  G+   H + VLHRD+K +N+ + +NG++KL DFG AR    P       V T +Y
Sbjct: 107 VQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYY 166

Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGS 189
            PP++ +    Y    D+WS GCI  EL     P    S
Sbjct: 167 VPPEI-WENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 96.0 bits (238), Expect = 3e-22
 Identities = 64/198 (32%), Positives = 96/198 (48%), Gaps = 35/198 (17%)

Query: 34  EICLLKELKHKNIVRLYDVL--HSEKKLTLVFEHCD-----QDLKKYFDSLNGEIDLDIV 86
           E+ +++ELKHKNIVR  D     + +KL ++ E CD     ++++K +  + G+I+   +
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCY-KMFGKIEEHAI 120

Query: 87  KSFMYQLLRGLAFCHS-------RNVLHRDLKPQNLLI---------------NKNGE-- 122
                QLL  LA+CH+         VLHRDLKPQN+ +               N NG   
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180

Query: 123 LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
            K+ DFGL++  GI    +S      ++ P  +L   K Y    DMW+ GCI  EL +  
Sbjct: 181 AKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Query: 183 RPLFPG---SDVDDQLKR 197
            P       S +  +LKR
Sbjct: 241 TPFHKANNFSQLISELKR 258

Length = 1021

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 92.4 bits (230), Expect = 4e-22
 Identities = 63/246 (25%), Positives = 106/246 (43%), Gaps = 46/246 (18%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD----QDLKKYFDSLNGEIDLDIVKS 88
           +EI +LKE +H NIV  +       KL +V E+C     QD+ +      G +    +  
Sbjct: 49  QEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQV---TRGPLSELQIAY 105

Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL 148
              + L+GLA+ H    +HRD+K  N+L+ ++G++KLADFG++      +    + + T 
Sbjct: 106 VCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTP 165

Query: 149 WYRPPDVLFGAKL--YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           ++  P+V    +   Y    D+W+ G    ELA    P+F                    
Sbjct: 166 YWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF-------------------- 205

Query: 207 EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGR------DLLQRLLVCNPVQRMSA 260
            D  P M  L     F +     +F    PKL  K +      D +++ L  +P +R +A
Sbjct: 206 -DLHP-MRAL-----FLI--SKSNF--PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTA 254

Query: 261 EDAMSH 266
              + H
Sbjct: 255 TKLLQH 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 92.2 bits (229), Expect = 4e-22
 Identities = 66/240 (27%), Positives = 108/240 (45%), Gaps = 34/240 (14%)

Query: 30  SALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF-DSLNGEIDLDIVK 87
           +A  E  +LK L H NI+  Y+    +K L +V E+     L +Y     N  +D D + 
Sbjct: 45  AAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTIL 104

Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE-LKLADFGLARAFGIPVKCYSAEVV 146
            F  Q+L  L   H++ +LHRDLK QN+L++K+   +K+ DFG+++      K Y+  V 
Sbjct: 105 HFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV-VG 163

Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T  Y  P++  G K Y    D+W+ GC+  ELA               LKR F+    P 
Sbjct: 164 TPCYISPELCEG-KPYNQKSDIWALGCVLYELA--------------SLKRAFEAANLPA 208

Query: 207 EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                            +   S +F+ ++ + +   R L+  +L  +P +R      M+ 
Sbjct: 209 ---------------LVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 92.9 bits (231), Expect = 6e-22
 Identities = 64/243 (26%), Positives = 105/243 (43%), Gaps = 28/243 (11%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFE-HCDQDLKKYFDSLNGEIDLDIVKSFM 90
           L E  +L   K + +V+L      ++ L L  E     D +    +  G +  D  + +M
Sbjct: 49  LTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL-NNLGVLSEDHARFYM 107

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWY 150
            ++   +   H    +HRDLKP+N LI+ +G +KL DFGL++  GI     S  V +  Y
Sbjct: 108 AEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK--GIVTYANSV-VGSPDY 164

Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTW 210
             P+VL G   Y  ++D WS GC+  E    G P F GS  ++  + +           W
Sbjct: 165 MAPEVLRGKG-YDFTVDYWSLGCMLYEFL-CGFPPFSGSTPNETWENLKY---------W 213

Query: 211 PGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
                 P +       P  + S  A        DL+ +L+     +  S ED  +H +F 
Sbjct: 214 KETLQRPVYD-----DPRFNLSDEA-------WDLITKLINDPSRRFGSLEDIKNHPFFK 261

Query: 271 DLN 273
           +++
Sbjct: 262 EVD 264

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 90.5 bits (224), Expect = 2e-21
 Identities = 60/185 (32%), Positives = 99/185 (53%), Gaps = 18/185 (9%)

Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE----IDL 83
           P + L+E  ++K+L+H+ +V+LY V+ SE+ + +V E+  +      D L GE    + L
Sbjct: 45  PEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKG--SLLDFLKGEMGKYLRL 101

Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS- 142
             +     Q+  G+A+    N +HRDL+  N+L+ +N   K+ADFGLAR   I    Y+ 
Sbjct: 102 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTA 159

Query: 143 ---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLK 196
              A+    W  P   L+G   +T   D+WS G +  EL   GR  +PG    +V DQ++
Sbjct: 160 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 217

Query: 197 RIFKL 201
           R +++
Sbjct: 218 RGYRM 222

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 90.3 bits (224), Expect = 2e-21
 Identities = 75/276 (27%), Positives = 118/276 (42%), Gaps = 52/276 (18%)

Query: 12  TALAIKGTHLVGN-----EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE-- 64
           T +A+K    V N     E V  +  +EI L+  L H +I+R+      +    L  E  
Sbjct: 26  TLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWM 85

Query: 65  ---HCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG 121
                   L KY     G     ++ ++  QLLRGL++ H   ++HRD+K  NLLI+  G
Sbjct: 86  AGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTG 140

Query: 122 E-LKLADFGLA---RAFGIPVKCYSAEVV-TLWYRPPDVLFGAKLYTTSIDMWSAGCIFA 176
           + L++ADFG A    A G     +  +++ T+ +  P+VL G + Y  S D+WS GC+  
Sbjct: 141 QRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVII 199

Query: 177 ELANAGRPLFPGSDVDDQLKRIFKL---LGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ 233
           E+A   +P +      + L  IFK+      P                 P          
Sbjct: 200 EMA-TAKPPWNAEKHSNHLALIFKIASATTAP---------------SIP--------EH 235

Query: 234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
           ++P L    RD+  R L   P  R  + + + H  F
Sbjct: 236 LSPGL----RDVTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 90.4 bits (225), Expect = 3e-21
 Identities = 69/266 (25%), Positives = 118/266 (44%), Gaps = 38/266 (14%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            +D+  N  +AIK   L   E       +EI  L + +   I + Y       KL ++ E
Sbjct: 20  AIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79

Query: 65  HCD----QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN 120
           +C      DL K      G++D   +   + ++L GL + H    +HRD+K  N+L+++ 
Sbjct: 80  YCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEE 134

Query: 121 GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           G++KLADFG++      +   +  V T ++  P+V+  +  Y    D+WS G    ELA 
Sbjct: 135 GDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAK 193

Query: 181 AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA 240
            G P  P SD+   ++ +F               L+P   P     PS+       K + 
Sbjct: 194 -GEP--PLSDL-HPMRVLF---------------LIPKNNP-----PSLE----GNKFSK 225

Query: 241 KGRDLLQRLLVCNPVQRMSAEDAMSH 266
             +D +   L  +P +R SA++ + H
Sbjct: 226 PFKDFVSLCLNKDPKERPSAKELLKH 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 90.1 bits (223), Expect = 3e-21
 Identities = 54/159 (33%), Positives = 77/159 (48%), Gaps = 5/159 (3%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLK---KYFDSLNGEIDLDIVK 87
           ++EI LLK+L H N+++  D    + +L +V E  D  DL    KYF      I    V 
Sbjct: 50  VKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW 109

Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT 147
            +  QL   +   HSR V+HRD+KP N+ I   G +KL D GL R F        + V T
Sbjct: 110 KYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGT 169

Query: 148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
            +Y  P+ +     Y    D+WS GC+  E+A    P +
Sbjct: 170 PYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 89.4 bits (222), Expect = 4e-21
 Identities = 52/182 (28%), Positives = 76/182 (41%), Gaps = 26/182 (14%)

Query: 30  SALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYF---DSLNGEIDLDI 85
            A+ EI +L  + H NI+   +      KL +V E+    DL K           I    
Sbjct: 45  DAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQE 104

Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF---------GI 136
           +     QLLRGL   H + +LHRDLK  N+L+  N  +K+ D G+++           G 
Sbjct: 105 IWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGT 164

Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           P   Y A  V  W   P        Y+   D+WS GC+  E+A    P F    + D   
Sbjct: 165 P--HYMAPEV--WKGRP--------YSYKSDIWSLGCLLYEMA-TFAPPFEARSMQDLRY 211

Query: 197 RI 198
           ++
Sbjct: 212 KV 213

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 89.5 bits (222), Expect = 4e-21
 Identities = 68/245 (27%), Positives = 112/245 (45%), Gaps = 44/245 (17%)

Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC------DQDLKKYFDSLNGEIDLDIVK 87
           EI LLK L+H+ IV+ Y  L  ++ L++  E+       DQ LK Y     G +   + +
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQ-LKAY-----GALTETVTR 107

Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA-RAFGIPVKCYSAEVV 146
            +  Q+L G+ + HS  ++HRD+K  N+L +  G +KL DFG + R   I       + V
Sbjct: 108 KYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSV 167

Query: 147 --TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
             T ++  P+V+ G   Y    D+WS GC   E+    +P  P ++  + +  IFK+   
Sbjct: 168 TGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTE-KP--PWAEF-EAMAAIFKIATQ 222

Query: 205 PTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAM 264
           PT                          Q+   ++   R+ L+R  V N  +R SAE+ +
Sbjct: 223 PTN------------------------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELL 258

Query: 265 SHIYF 269
            H + 
Sbjct: 259 RHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 88.7 bits (220), Expect = 9e-21
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 9/153 (5%)

Query: 31  ALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-----QDLKKYFDSLNGEIDLDI 85
           AL EI +L  L+H NI+  Y+    +  L +  E+ +       + +    L  E   ++
Sbjct: 46  ALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEE---EM 102

Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEV 145
           V  +++Q++  +++ H   +LHRD+K  N+ + K G +KL DFG+++  G         V
Sbjct: 103 VLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV 162

Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
            T +Y  P++  G K Y    D+W+ GC+  EL
Sbjct: 163 GTPYYMSPELCQGVK-YNFKSDIWALGCVLYEL 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 87.9 bits (218), Expect = 1e-20
 Identities = 61/231 (26%), Positives = 96/231 (41%), Gaps = 36/231 (15%)

Query: 31  ALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE-IDLDIVKS 88
           A+ E  +L +L    I+R Y+    + KL +V E+ +  DL K      G  +  D V  
Sbjct: 46  AIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWR 105

Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL 148
           F  Q+L GLA  HS+ +LHRD+K  NL ++    +K+ D G+A+         +  V T 
Sbjct: 106 FFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTP 165

Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL-GTPTE 207
           +Y  P+ L   K Y    D+W+ G +  E      P     D ++Q   I K++ G    
Sbjct: 166 YYLSPE-LCEDKPYNEKSDVWALGVVLYECCTGKHPF----DANNQGALILKIIRGV--- 217

Query: 208 DTWPGMNLLPDFKPFP-MYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQR 257
                      F P   MY   ++              L+ + L  +  QR
Sbjct: 218 -----------FPPVSQMYSQQLA-------------QLIDQCLTKDYRQR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 88.2 bits (218), Expect = 2e-20
 Identities = 54/159 (33%), Positives = 77/159 (48%), Gaps = 5/159 (3%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLK---KYFDSLNGEIDLDIVK 87
           ++EI LLK+L H N+++ Y     + +L +V E  D  DL    K+F      I    V 
Sbjct: 50  IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW 109

Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT 147
            +  QL   L   HSR V+HRD+KP N+ I   G +KL D GL R F        + V T
Sbjct: 110 KYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGT 169

Query: 148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
            +Y  P+ +     Y    D+WS GC+  E+A    P +
Sbjct: 170 PYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 87.4 bits (216), Expect = 2e-20
 Identities = 72/251 (28%), Positives = 114/251 (45%), Gaps = 52/251 (20%)

Query: 30  SALR-EICLLKELKHKNIVRLYDVL--HSEKKLTLVFEHC------DQDLKKYFDSLNGE 80
           SAL  EI LLK L+H+ IV+ Y  L   +EK LT+  E+       DQ LK Y     G 
Sbjct: 49  SALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQ-LKAY-----GA 102

Query: 81  IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC 140
           +   + + +  Q+L G+++ HS  ++HRD+K  N+L +  G +KL DFG ++   +   C
Sbjct: 103 LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR--LQTIC 160

Query: 141 YSAEVV-----TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL 195
            S   +     T ++  P+V+ G   Y    D+WS GC   E+    +P  P ++  + +
Sbjct: 161 MSGTGIRSVTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTE-KP--PWAEY-EAM 215

Query: 196 KRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPV 255
             IFK+   PT                P +            ++   RD L  + V    
Sbjct: 216 AAIFKIATQPTN------------PQLPSH------------ISEHARDFLGCIFV-EAR 250

Query: 256 QRMSAEDAMSH 266
            R SAE+ + H
Sbjct: 251 HRPSAEELLRH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 87.7 bits (218), Expect = 2e-20
 Identities = 70/284 (24%), Positives = 110/284 (38%), Gaps = 56/284 (19%)

Query: 4   SGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLY------DVLHSE 56
               +     +AIK   ++ +E        E  +L++   H NI   Y      +   ++
Sbjct: 24  KARHKKTGQLVAIKIMDIIEDEEE--EIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81

Query: 57  KKLTLVFEHCD----QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKP 112
            +L LV E C      DL K        +  + +   + + LRGLA+ H   V+HRD+K 
Sbjct: 82  DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKG 141

Query: 113 QNLLINKNGELKLADFGLA---------RAFGIPVKCYSA-EVVTLWYRPPDVLFGAKLY 162
           QN+L+ KN E+KL DFG++         R   I    + A EV+    +P         Y
Sbjct: 142 QNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDAS------Y 195

Query: 163 TTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPF 222
               D+WS G    ELA+ G+P  P  D+             P       +  +P   P 
Sbjct: 196 DARSDVWSLGITAIELAD-GKP--PLCDMH------------PMR----ALFKIPRNPPP 236

Query: 223 PMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
            +  P           + K  D +   L+ N  QR   E+ + H
Sbjct: 237 TLKSPE--------NWSKKFNDFISECLIKNYEQRPFMEELLEH 272

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 86.3 bits (214), Expect = 9e-20
 Identities = 66/237 (27%), Positives = 103/237 (43%), Gaps = 40/237 (16%)

Query: 33  REICLLKELKH---KNIVRLYDVLHSEKKLTLVFEHCD----QDLKKYFDSLNGEIDLDI 85
           RE+ LL +L+     NI + Y       +L ++ E+ +    + L K      G I    
Sbjct: 48  REVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK-----AGPIAEKY 102

Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEV 145
           +   + ++L  L + H   V+HRD+K  N+L+   G +KL DFG+A          S  V
Sbjct: 103 ISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV 162

Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
            T ++  P+V+   K Y T  D+WS G    E+A  G P  P SDV D  +         
Sbjct: 163 GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMAT-GNP--PYSDV-DAFR--------- 209

Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAED 262
                  M L+P  KP     P +  +  +  L    R+ +   L   P +R+SAE+
Sbjct: 210 ------AMMLIPKSKP-----PRLEDNGYSKLL----REFVAACLDEEPKERLSAEE 251

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 85.3 bits (211), Expect = 1e-19
 Identities = 45/150 (30%), Positives = 79/150 (52%), Gaps = 3/150 (2%)

Query: 31  ALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEI-DLDIVKS 88
           + +E+ +L  +KH NIV+  +       L +V ++C+  DL K  ++  G +   D +  
Sbjct: 46  SRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILD 105

Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL 148
           +  Q+   L   H R +LHRD+K QN+ + K+G +KL DFG+AR     V+     + T 
Sbjct: 106 WFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTP 165

Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
           +Y  P++    + Y    D+W+ GC+  E+
Sbjct: 166 YYLSPEIC-ENRPYNNKSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 84.7 bits (210), Expect = 2e-19
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)

Query: 30  SALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLK-----KYFDSLNGEIDLD 84
           + L E  +L+EL H  +V L+     E+ + LV      DL      +Y  S   +   +
Sbjct: 46  NVLNERRILQELNHPFLVNLWYSFQDEENMYLVV-----DLLLGGDLRYHLSQKVKFSEE 100

Query: 85  IVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE 144
            VK ++ +++  L + HS+ ++HRD+KP N+L+++ G + + DF +A          +  
Sbjct: 101 QVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLTTS 158

Query: 145 VV-TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSD--VDDQLKRIFKL 201
              T  Y  P+VL     Y+ ++D WS G    E     RP + G    + DQ++   + 
Sbjct: 159 TSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRP-YRGHSRTIRDQIRAKQET 216

Query: 202 LGTPTEDTWP-----GMNLLPDFKP 221
                  TW       +N L +  P
Sbjct: 217 ADVLYPATWSTEAIDAINKLLERDP 241

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 85.2 bits (211), Expect = 2e-19
 Identities = 51/171 (29%), Positives = 82/171 (47%), Gaps = 28/171 (16%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKK--LTLVFEHCD----QDLKKYFDSLNGEIDLDI 85
           LRE+ + K  K   IV+ Y     E    + +  E+C+      + K      G I   +
Sbjct: 47  LRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKV 106

Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEV 145
           +      +L+GL++ HSR ++HRD+KP N+L+ + G++KL DFG+           S E+
Sbjct: 107 LGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGV-----------SGEL 155

Query: 146 V---------TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFP 187
           V         T +Y  P+ + G K Y+ + D+WS G    E+A   R  FP
Sbjct: 156 VNSLAGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQ-NRFPFP 204

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 83.9 bits (207), Expect = 5e-19
 Identities = 67/247 (27%), Positives = 111/247 (44%), Gaps = 49/247 (19%)

Query: 34  EICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQ-----DLKKYFDSLNGEIDLDIV 86
           EI LLK L H+ IV+ Y  L    E+ L++  EH         LK Y     G +  ++ 
Sbjct: 54  EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY-----GALTENVT 108

Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           + +  Q+L G+++ HS  ++HRD+K  N+L +  G +KL DFG ++   +   C S   +
Sbjct: 109 RKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKR--LQTICLSGTGM 166

Query: 147 -----TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
                T ++  P+V+ G   Y    D+WS GC   E+    +P  P ++  + +  IFK+
Sbjct: 167 KSVTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTE-KP--PWAEF-EAMAAIFKI 221

Query: 202 LGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAE 261
              PT    P                        P ++   RD L+R+ V     R SA+
Sbjct: 222 ATQPTNPVLP------------------------PHVSDHCRDFLKRIFV-EAKLRPSAD 256

Query: 262 DAMSHIY 268
           + + H +
Sbjct: 257 ELLRHTF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 85.1 bits (210), Expect = 5e-19
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 38/281 (13%)

Query: 14  LAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH-----CDQ 68
           +A K  HL     + +  +RE+ +L E     IV  Y   +S+ ++++  EH      DQ
Sbjct: 33  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 92

Query: 69  DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN-VLHRDLKPQNLLINKNGELKLAD 127
            LKK      G I   I+      +++GL +   ++ ++HRD+KP N+L+N  GE+KL D
Sbjct: 93  VLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCD 147

Query: 128 FGLARAFGIPVKCYSAEVV-TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           FG++   G  +   +   V T  Y  P+ L G   Y+   D+WS G    E+A  GR   
Sbjct: 148 FGVS---GQLIDSMANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMA-IGRYPI 202

Query: 187 PGSDVDDQLKRIF--KLLGTPTEDTWPGMNLLPDFKPFPMY----HPSMSFSQV------ 234
           P  D   +L+ +F   + G P E         P  +P   Y     P M+  ++      
Sbjct: 203 PPPDA-KELELMFGCPVEGDPAESETSPRPRPPG-RPLSSYGPDSRPPMAIFELLDYIVN 260

Query: 235 --APKL-----TAKGRDLLQRLLVCNPVQRMSAEDAMSHIY 268
              PKL      A+ +D + + L+ NP +R   +  M H +
Sbjct: 261 EPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 84.3 bits (208), Expect = 5e-19
 Identities = 61/246 (24%), Positives = 112/246 (45%), Gaps = 49/246 (19%)

Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVK------ 87
           E+ ++++ +H+N+V +Y      ++L ++ E            L G    DIV       
Sbjct: 68  EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF-----------LQGGALTDIVSQTRLNE 116

Query: 88  ----SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +    +L+ L + HS+ V+HRD+K  ++L+  +G +KL+DFG        V    +
Sbjct: 117 EQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 176

Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
            V T ++  P+V+     Y T +D+WS G +  E+ +   P F  S V   +KR+     
Sbjct: 177 LVGTPYWMAPEVI-SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-QAMKRL----- 229

Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
               D+ P     P  K         +  +++P L    RD L+R+L   P +R +A++ 
Sbjct: 230 ---RDSPP-----PKLK---------NAHKISPVL----RDFLERMLTREPQERATAQEL 268

Query: 264 MSHIYF 269
           + H + 
Sbjct: 269 LDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 83.1 bits (206), Expect = 8e-19
 Identities = 56/191 (29%), Positives = 94/191 (49%), Gaps = 29/191 (15%)

Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH-CDQDLKKYFDSLNGEIDLDIV 86
           P + L+E  ++K+L+H  +V+LY V   E+ + +V E+     L  +  S  G   L + 
Sbjct: 45  PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEG-KKLRLP 103

Query: 87  K--SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF---------- 134
           +      Q+  G+A+  SRN +HRDL  +N+L+ +N   K+ADFGLAR            
Sbjct: 104 QLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREG 163

Query: 135 -GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SD 190
              P+K         W  P    +G   +T   D+WS G +  E+   GR  +PG    +
Sbjct: 164 AKFPIK---------WTAPEAANYGR--FTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE 212

Query: 191 VDDQLKRIFKL 201
           V +Q++R +++
Sbjct: 213 VLEQVERGYRM 223

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 82.9 bits (205), Expect = 1e-18
 Identities = 73/287 (25%), Positives = 115/287 (40%), Gaps = 56/287 (19%)

Query: 4   SGVDRTP-NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLV 62
           S V   P  T +A K  H+     V    LRE+ ++ E +   IV  Y    +E  + + 
Sbjct: 22  SKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81

Query: 63  FEHCDQD-----LKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN-VLHRDLKPQNLL 116
            E  D        KK      G I ++I+      ++ GL + ++ + ++HRD+KP N+L
Sbjct: 82  MEFMDCGSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNIL 136

Query: 117 INKNGELKLADFGLARAFGIPVKCYSAEVV---------TLWYRPPDVLFGAKLYTTSID 167
           +N  G++KL DFG+           S E++         T  Y  P+ + G K YT   D
Sbjct: 137 VNSRGQIKLCDFGV-----------SGELINSIADTFVGTSTYMSPERIQGGK-YTVKSD 184

Query: 168 MWSAGCIFAELANAGRPL-FPGSDVDDQLKR--IFKLLGTPTEDTWPGMNLLPDFKPFPM 224
           +WS G    ELA    P  F   D D Q     I  LL    ++  P +           
Sbjct: 185 VWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL----------- 233

Query: 225 YHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD 271
             PS  F +         RD +   L+ +P +R + +   +   F  
Sbjct: 234 --PSSDFPEDL-------RDFVDACLLKDPTERPTPQQLCAMPPFIQ 271

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.8 bits (204), Expect = 1e-18
 Identities = 60/191 (31%), Positives = 97/191 (50%), Gaps = 26/191 (13%)

Query: 34  EICLLKELKHKNIVRLYDVL--HSEKKLTLVFEHC------DQDLKKYFDSLNGEIDLDI 85
           EI LLK L+H  IV+ Y  L    EKKL++  E+       DQ LK Y     G +  ++
Sbjct: 54  EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQ-LKAY-----GALTENV 107

Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEV 145
            + +  Q+L+G+++ HS  ++HRD+K  N+L +  G +KL DFG ++   I   C S   
Sbjct: 108 TRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR--IQTICMSGTG 165

Query: 146 V-----TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           +     T ++  P+V+ G   Y    D+WS  C   E+    +P  P ++  + +  IFK
Sbjct: 166 IKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTE-KP--PWAEY-EAMAAIFK 220

Query: 201 LLGTPTEDTWP 211
           +   PT+   P
Sbjct: 221 IATQPTKPMLP 231

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 82.4 bits (203), Expect = 2e-18
 Identities = 57/179 (31%), Positives = 97/179 (54%), Gaps = 13/179 (7%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG-EIDLDIVKSF 89
           L E  L+K L+H  +VRLY V+  E+ + ++ E+  +  L  +  S  G ++ L  +  F
Sbjct: 49  LEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF 108

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS----AEV 145
             Q+  G+A+   +N +HRDL+  N+L++++   K+ADFGLAR   I    Y+    A+ 
Sbjct: 109 SAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARV--IEDNEYTAREGAKF 166

Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKRIFKL 201
              W  P  + FG+  +T   D+WS G +  E+   G+  +PG   SDV   L+R +++
Sbjct: 167 PIKWTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM 223

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 82.1 bits (203), Expect = 3e-18
 Identities = 57/240 (23%), Positives = 113/240 (47%), Gaps = 37/240 (15%)

Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD----QDLKKYFDSLNGEIDLDIVKSF 89
           E+ ++++ +H NIV +Y       +L +V E  +     D+  +       ++ + + + 
Sbjct: 66  EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATV 120

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW 149
              +L+ L+F H++ V+HRD+K  ++L+  +G +KL+DFG        V    + V T +
Sbjct: 121 CLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY 180

Query: 150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDT 209
           +  P+V+     Y T +D+WS G +  E+ +   P F     ++           P +  
Sbjct: 181 WMAPEVI-SRLPYGTEVDIWSLGIMVIEMVDGEPPYF-----NEP----------PLQ-- 222

Query: 210 WPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
              M  + D  P  + +      +V+P+L    R  L R+LV +P QR +A + ++H + 
Sbjct: 223 --AMKRIRDNLPPKLKNL----HKVSPRL----RSFLDRMLVRDPAQRATAAELLNHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 80.8 bits (199), Expect = 6e-18
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 16/200 (8%)

Query: 11  NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-D 69
           NT +A+K   L      P S L E  ++K+L+H  +V+LY V+ SE+ + +V E+  +  
Sbjct: 30  NTKVAVKT--LKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV-SEEPIYIVTEYMSKGS 86

Query: 70  LKKYFDSLNGE-IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADF 128
           L  +     G  + L  +     Q+  G+A+    N +HRDL+  N+L+      K+ADF
Sbjct: 87  LLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADF 146

Query: 129 GLARAFGIPVKCYS----AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRP 184
           GLAR   I    Y+    A+    W  P   L+G   +T   D+WS G +  EL   GR 
Sbjct: 147 GLARL--IEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRV 202

Query: 185 LFPG---SDVDDQLKRIFKL 201
            +PG    +V +Q++R +++
Sbjct: 203 PYPGMNNREVLEQVERGYRM 222

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 80.3 bits (198), Expect = 8e-18
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 23/213 (10%)

Query: 11  NTALAIKGTHLVGNEGV--PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ 68
           +T +AIK       +G   P + L E  L+K+L+H  +VRLY V+  E    +     + 
Sbjct: 30  HTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMENG 85

Query: 69  DLKKYFDSLNGEIDLDIVK--SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLA 126
            L  +  +  G I L I K      Q+  G+AF   +N +HRDL+  N+L+++    K+A
Sbjct: 86  SLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIA 144

Query: 127 DFGLARAFGIPVKCYSAE----VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
           DFGLAR   I    Y+A         W  P  + +G   +T   D+WS G +  E+   G
Sbjct: 145 DFGLARL--IEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTYG 200

Query: 183 RPLFPG---SDVDDQLKRIFKLLGTPTEDTWPG 212
           R  +PG    +V   L+R +++   P  D  P 
Sbjct: 201 RIPYPGMTNPEVIQNLERGYRM---PRPDNCPE 230

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 80.1 bits (197), Expect = 3e-17
 Identities = 80/285 (28%), Positives = 128/285 (44%), Gaps = 44/285 (15%)

Query: 14  LAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH-----CDQ 68
           +A K  HL     + +  +RE+ +L E     IV  Y   +S+ ++++  EH      DQ
Sbjct: 33  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 92

Query: 69  DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN-VLHRDLKPQNLLINKNGELKLAD 127
            LK+        I  +I+      +LRGLA+   ++ ++HRD+KP N+L+N  GE+KL D
Sbjct: 93  VLKE-----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCD 147

Query: 128 FGLARAFGIPVKCYSAEVV-TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           FG++   G  +   +   V T  Y  P+ L G   Y+   D+WS G    ELA  GR   
Sbjct: 148 FGVS---GQLIDSMANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELA-IGRYPI 202

Query: 187 PGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM----------YHPSMSFSQV-- 234
           P  D   +L+ IF   G P  D   G       +P P             P+M+  ++  
Sbjct: 203 PPPDA-KELEAIF---GRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLD 258

Query: 235 ------APKL-----TAKGRDLLQRLLVCNPVQRMSAEDAMSHIY 268
                  PKL     T   ++ + + L+ NP +R   +  M+H +
Sbjct: 259 YIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 80.7 bits (199), Expect = 3e-17
 Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 12/177 (6%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQ 92
           REI +LK + H+ I+ L      +  + +V      DL  Y D   G + L+   +   +
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRS-GPLPLEQAITIQRR 193

Query: 93  LLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---KCYSAEVVTLW 149
           LL  LA+ H R ++HRD+K +N+ +++     L DFG A          +CY     TL 
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCY-GWSGTLE 252

Query: 150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF----PGSDVDDQLKRIFKLL 202
              P++L     Y    D+WSAG +  E++     LF      S    QL+ I + +
Sbjct: 253 TNSPELL-ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS--SSQLRSIIRCM 306

Length = 392

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 78.9 bits (194), Expect = 3e-17
 Identities = 65/244 (26%), Positives = 109/244 (44%), Gaps = 39/244 (15%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQ 92
           +EI ++KE KH NIV  +    S +KL +  E+C     +    + G +    +     +
Sbjct: 55  QEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRE 114

Query: 93  LLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRP 152
            L+GLA+ HS+  +HRD+K  N+L+  NG++KLADFG+A      +    + + T ++  
Sbjct: 115 TLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMA 174

Query: 153 PDVLFGAKL--YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTW 210
           P+V    K   Y    D+W+ G    ELA    P+F     D    R   L+        
Sbjct: 175 PEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF-----DLHPMRALFLMSK------ 223

Query: 211 PGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGR------DLLQRLLVCNPVQRMSAEDAM 264
                  +F+P              PKL  K +      + ++  L  NP +R +AE  +
Sbjct: 224 ------SNFQP--------------PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLL 263

Query: 265 SHIY 268
           +H++
Sbjct: 264 THLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 79.4 bits (196), Expect = 3e-17
 Identities = 62/249 (24%), Positives = 116/249 (46%), Gaps = 53/249 (21%)

Query: 37  LLKELKHKNIVRLYDVLHSEKKLTLVFEH-CDQDLKKYFDSLNGEIDLDIVKSFMYQLLR 95
           +LKE+ H  I+RL+   H ++ L ++ E+    +L  Y  + +G         +  +++ 
Sbjct: 54  VLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVC 112

Query: 96  GLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA-----RAFGIPVKCYSAEVVTLWY 150
            L + HS+ +++RDLKP+N+L++K G +KL DFG A     R + +   C + E     Y
Sbjct: 113 ALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL---CGTPE-----Y 164

Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF-KLLGTPTEDT 209
             P+V+  +K +  ++D W+ G +  E+   G P F     DD    I+ K+L    E  
Sbjct: 165 LAPEVI-QSKGHNKAVDWWALGILIYEML-VGYPPF----FDDNPFGIYEKILAGKLE-- 216

Query: 210 WPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM-----SAEDAM 264
           +P                 +             +DL+++LLV +  +R+      A+D  
Sbjct: 217 FP---------------RHLDLY---------AKDLIKKLLVVDRTRRLGNMKNGADDVK 252

Query: 265 SHIYFSDLN 273
           +H +F  ++
Sbjct: 253 NHRWFKSVD 261

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 79.4 bits (196), Expect = 3e-17
 Identities = 76/283 (26%), Positives = 118/283 (41%), Gaps = 48/283 (16%)

Query: 14  LAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH-----CDQ 68
           +A K  HL     + +  +RE+ +L E     IV  Y   +S+ ++++  EH      DQ
Sbjct: 29  MARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 88

Query: 69  DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLAD 127
            LKK      G I  +I+      +LRGL +      ++HRD+KP N+L+N  GE+KL D
Sbjct: 89  VLKKA-----GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCD 143

Query: 128 FG--------LARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELA 179
           FG        +A +F          V T  Y  P+ L G   YT   D+WS G    E+A
Sbjct: 144 FGVSGQLIDSMANSF----------VGTRSYMSPERLQGTH-YTVQSDIWSLGLSLVEMA 192

Query: 180 NAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSF-------- 231
             GR   P  D     K +  + G P  +     +  P     P     M+         
Sbjct: 193 -IGRYPIPPPDA----KELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIV 247

Query: 232 SQVAPKLTAKG-----RDLLQRLLVCNPVQRMSAEDAMSHIYF 269
           ++  PKL +       +D + + L  NP +R   ++   H + 
Sbjct: 248 NEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 78.6 bits (194), Expect = 4e-17
 Identities = 61/248 (24%), Positives = 106/248 (42%), Gaps = 33/248 (13%)

Query: 30  SALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ----DLKKYFDSLNGEIDLDI 85
              +E+  + +  H N+V+ Y       +L LV  +       D+ K      G +D  I
Sbjct: 45  ELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAI 103

Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE- 144
           + + + ++L+GL + HS   +HRD+K  N+L+ ++G +K+ADFG++ +            
Sbjct: 104 IATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVR 163

Query: 145 ---VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
              V T  +  P+V+     Y    D+WS G    ELA  G    P S     +K +   
Sbjct: 164 KTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELAT-GAA--PYSKY-PPMKVLMLT 219

Query: 202 LGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAE 261
           L        P +    D+K +     S SF           R ++   L  +P +R +AE
Sbjct: 220 LQNDP----PSLETGADYKKY-----SKSF-----------RKMISLCLQKDPSKRPTAE 259

Query: 262 DAMSHIYF 269
           + + H +F
Sbjct: 260 ELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 78.2 bits (192), Expect = 5e-17
 Identities = 57/183 (31%), Positives = 96/183 (52%), Gaps = 14/183 (7%)

Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE-IDLDI 85
           P + L+E  ++K+L+H  +V LY V+ SE+ + +V E   +  L  +    +G+ + L  
Sbjct: 45  PEAFLQEAQIMKKLRHDKLVPLYAVV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQ 103

Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS--- 142
           +     Q+  G+A+    N +HRDL+  N+L+  N   K+ADFGLAR   I    Y+   
Sbjct: 104 LVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQ 161

Query: 143 -AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKRI 198
            A+    W  P   L+G   +T   D+WS G +  EL   GR  +PG    +V +Q++R 
Sbjct: 162 GAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG 219

Query: 199 FKL 201
           +++
Sbjct: 220 YRM 222

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 29/208 (13%)

Query: 1   MFTSGVDRTPNTA--LAIKGTH----------LVGNEGVPSSALREICLLKELKHKNIVR 48
           + T+ V R P TA  +A +G+           ++ +E   + A  E+  L    H  IV+
Sbjct: 70  VLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVK 129

Query: 49  LYDVLHSEKKLTLVFEH---------CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAF 99
            +D   S+ KL L+ E+           Q LK++      E+ L       YQ++  L  
Sbjct: 130 HFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL-----LFYQIVLALDE 184

Query: 100 CHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVKCYSAEVVTLWYRPPDVLF 157
            HSR ++HRDLK  N+ +   G +KL DFG ++ +   + +   S+   T +Y  P+ L+
Sbjct: 185 VHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE-LW 243

Query: 158 GAKLYTTSIDMWSAGCIFAELANAGRPL 185
             K Y+   DMWS G I  EL    RP 
Sbjct: 244 ERKRYSKKADMWSLGVILYELLTLHRPF 271

Length = 478

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 76.4 bits (188), Expect = 2e-16
 Identities = 48/183 (26%), Positives = 88/183 (48%), Gaps = 13/183 (7%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH-CDQDLKKYFDSLNGEIDLDIVKSFM 90
           L+E  ++KE+KH N+V+L  V   E    ++ E     +L  Y    N +    +V  +M
Sbjct: 50  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 109

Query: 91  -YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEV---- 145
             Q+   + +   +N +HRDL  +N L+ +N  +K+ADFGL+R   +    Y+A      
Sbjct: 110 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKF 167

Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKRIFKLL 202
              W  P  + +    ++   D+W+ G +  E+A  G   +PG   S V + L++ +++ 
Sbjct: 168 PIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRME 225

Query: 203 GTP 205
              
Sbjct: 226 RPE 228

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 76.7 bits (189), Expect = 3e-16
 Identities = 54/177 (30%), Positives = 84/177 (47%), Gaps = 9/177 (5%)

Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQ-DLK 71
           A+K  +  G E   S   REI +L+ L H+NIV+   V      + L L+ E+     L+
Sbjct: 37  AVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLR 96

Query: 72  KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA 131
            Y      +I+L  +  F  Q+ +G+ +  S+  +HRDL  +N+L+     +K++DFGLA
Sbjct: 97  DYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA 156

Query: 132 RAFGIPVKCYSA----EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRP 184
           +        Y      E    WY  P+ L  +K  + S D+WS G    EL   G P
Sbjct: 157 KVLPEDKDYYYVKEPGESPIFWY-APECLRTSKFSSAS-DVWSFGVTLYELFTYGDP 211

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 76.8 bits (189), Expect = 3e-16
 Identities = 56/187 (29%), Positives = 87/187 (46%), Gaps = 36/187 (19%)

Query: 37  LLKELK-------HKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE--IDLDIV 86
           L+ ELK       H+NIV L         + ++ E+C   DL  +      E  + L+ +
Sbjct: 85  LMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRR-KRESFLTLEDL 143

Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR-------------A 133
            SF YQ+ +G+AF  S+N +HRDL  +N+L+     +K+ DFGLAR             A
Sbjct: 144 LSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNA 203

Query: 134 FGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDD 193
             +PVK         W  P  +     +YT   D+WS G +  E+ + G   +PG  VD 
Sbjct: 204 R-LPVK---------WMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS 251

Query: 194 QLKRIFK 200
           +  ++ K
Sbjct: 252 KFYKLIK 258

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 75.5 bits (186), Expect = 5e-16
 Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 34/179 (18%)

Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKY---FDSLNGE---- 80
           P   L E  ++K+L+H  +++LY V   E+ + +V E     L KY    + L G     
Sbjct: 45  PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE-----LMKYGSLLEYLQGGAGRA 99

Query: 81  IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG----- 135
           + L  +     Q+  G+A+  ++N +HRDL  +N+L+ +N   K+ADFGLAR        
Sbjct: 100 LKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159

Query: 136 ------IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
                  P+K         W  P   L+    ++   D+WS G +  E+   GR  +PG
Sbjct: 160 AREGAKFPIK---------WTAPEAALYNR--FSIKSDVWSFGILLTEIVTYGRMPYPG 207

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 75.4 bits (185), Expect = 5e-16
 Identities = 54/189 (28%), Positives = 93/189 (49%), Gaps = 11/189 (5%)

Query: 29  SSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG-EIDLDIV 86
            + L E  ++K L+H  +V+L+ V+  E  + ++ E   +  L  +  S  G +  L  +
Sbjct: 46  EAFLAEANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKL 104

Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS---- 142
             F  Q+  G+AF   RN +HRDL+  N+L++ +   K+ADFGLAR   I    Y+    
Sbjct: 105 IDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREG 162

Query: 143 AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
           A+    W  P  + FG+  +T   D+WS G +  E+   GR  +PG    + ++ + +  
Sbjct: 163 AKFPIKWTAPEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY 220

Query: 203 GTPTEDTWP 211
             P  +  P
Sbjct: 221 RMPRPENCP 229

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 75.9 bits (187), Expect = 5e-16
 Identities = 59/190 (31%), Positives = 87/190 (45%), Gaps = 45/190 (23%)

Query: 42  KHKNIVRLYDVLHSEKKLTLVFEHCDQ--------------DLKKYFDSLNGEIDL---D 84
           KHKNI+ L  V   E  L +V E+                 +     D    E  L   D
Sbjct: 74  KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133

Query: 85  IVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG--------- 135
           +V SF YQ+ RG+ F  S+  +HRDL  +N+L+ ++  +K+ADFGLAR            
Sbjct: 134 LV-SFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192

Query: 136 ---IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD 192
              +PVK          +  P+ LF  ++YT   D+WS G +  E+   G   +PG  V+
Sbjct: 193 NGRLPVK----------WMAPEALF-DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241

Query: 193 DQLKRIFKLL 202
           +    +FKLL
Sbjct: 242 E----LFKLL 247

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 76.2 bits (188), Expect = 6e-16
 Identities = 54/204 (26%), Positives = 79/204 (38%), Gaps = 60/204 (29%)

Query: 101 HSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG------------------------- 135
           H    +HRD+KP N+LI+ +G +KLADFGL +                            
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177

Query: 136 -----IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSD 190
                  V+  S  V T  Y  P+VL G   Y    D WS G I  E+   G P F    
Sbjct: 178 RDHKQRRVRANST-VGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEML-YGFPPFYSDT 234

Query: 191 VDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLL 250
           + +   +I              +N     + FP   P          ++ +  DL+ RLL
Sbjct: 235 LQETYNKI--------------INWKESLR-FPPDPP----------VSPEAIDLICRLL 269

Query: 251 VCNPVQRM-SAEDAMSHIYFSDLN 273
            C+P  R+ S E+  SH +F  ++
Sbjct: 270 -CDPEDRLGSFEEIKSHPFFKGID 292

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 76.0 bits (187), Expect = 7e-16
 Identities = 71/247 (28%), Positives = 115/247 (46%), Gaps = 46/247 (18%)

Query: 37  LLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLNGEIDL--DIVKSFMYQL 93
           +L E+ H  IV+L+    +E KL L+ +     DL   F  L+ E+    + VK ++ +L
Sbjct: 51  ILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYLAEL 107

Query: 94  LRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR-AFGIPVKCYSAEVVTLWYRP 152
              L   HS  +++RDLKP+N+L+++ G +KL DFGL++ +     K YS    T+ Y  
Sbjct: 108 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF-CGTVEYMA 166

Query: 153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL-LGTPTEDTWP 211
           P+V+   + +T S D WS G +  E+     P F G D  + +  I K  LG        
Sbjct: 167 PEVV-NRRGHTQSADWWSFGVLMFEMLTGSLP-FQGKDRKETMTMILKAKLG-------- 216

Query: 212 GMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA-----EDAMSH 266
               +P F                  L+ + + LL+ L   NP  R+ A     E+   H
Sbjct: 217 ----MPQF------------------LSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254

Query: 267 IYFSDLN 273
            +FS ++
Sbjct: 255 PFFSTID 261

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 75.8 bits (186), Expect = 8e-16
 Identities = 51/160 (31%), Positives = 82/160 (51%), Gaps = 12/160 (7%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC---DQDLKKYFDSLNGEIDLDIVKS 88
           ++E+  L++LKH N +        E    LV E+C     DL +       E++   + +
Sbjct: 69  IKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVE---IAA 125

Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL 148
             +  L+GLA+ HS N++HRD+K  N+L+ + G++KLADFG A +   P   +   V T 
Sbjct: 126 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSA-SKSSPANSF---VGTP 181

Query: 149 WYRPPDVLFGAK--LYTTSIDMWSAGCIFAELANAGRPLF 186
           ++  P+V+       Y   +D+WS G    ELA    PLF
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 221

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 75.5 bits (185), Expect = 9e-16
 Identities = 56/187 (29%), Positives = 89/187 (47%), Gaps = 14/187 (7%)

Query: 7   DRTPNTALAIKGTHLVGNEGVP--SSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
           D   N  +AIK     G +        ++E+  L+ +KH N +        E    LV E
Sbjct: 46  DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105

Query: 65  HC---DQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG 121
           +C     DL +       E++   + +  +  L+GLA+ HS N++HRD+K  N+L+ + G
Sbjct: 106 YCLGSASDLLEVHKKPLQEVE---IAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG 162

Query: 122 ELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK--LYTTSIDMWSAGCIFAELA 179
           ++KLADFG A +   P   +   V T ++  P+V+       Y   +D+WS G    ELA
Sbjct: 163 QVKLADFGSA-SIASPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 218

Query: 180 NAGRPLF 186
               PLF
Sbjct: 219 ERKPPLF 225

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 74.2 bits (182), Expect = 1e-15
 Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 7/175 (4%)

Query: 30  SALREICLLKELKHKNIVRLYDVLHSEK-KLTLVFEHCDQ-DLKKYFDSLNGEIDLD--I 85
           +A +E  LL +LKH NIV   +    E   L +V   C+  DL        G++  +  +
Sbjct: 45  AAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQV 104

Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEV 145
           V+ F+ Q+   L + H +++LHRDLK QN+ + +   +K+ D G+AR         S  +
Sbjct: 105 VEWFV-QIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI 163

Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
            T +Y  P+ LF  K Y    D+W+ GC   E+A   +  F   D++  + RI +
Sbjct: 164 GTPYYMSPE-LFSNKPYNYKSDVWALGCCVYEMATL-KHAFNAKDMNSLVYRIIE 216

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 74.0 bits (182), Expect = 2e-15
 Identities = 44/178 (24%), Positives = 79/178 (44%), Gaps = 7/178 (3%)

Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE--HCDQDLKKYFDSLNGEIDL 83
            +    L+E  ++  L H+N++RLY V+ +   L +V E       L +      G   +
Sbjct: 38  DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLI 96

Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
             +  +  Q+  G+ +  S+  +HRDL  +N+L+  + ++K+ DFGL RA       Y  
Sbjct: 97  STLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156

Query: 144 EV---VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRI 198
           E    V   +  P+ L     ++ + D+W  G    E+   G   + G      LK+I
Sbjct: 157 EEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 74.1 bits (182), Expect = 2e-15
 Identities = 74/255 (29%), Positives = 117/255 (45%), Gaps = 45/255 (17%)

Query: 31  ALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFM 90
           AL E  +L+++  + IV L     ++  L LV    +    KY     GE      ++  
Sbjct: 40  ALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIF 99

Query: 91  Y--QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVKCYSAEVV 146
           Y  Q++ GL   H R +++RDLKP+N+L++ +G ++++D GLA     G  +K       
Sbjct: 100 YAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AG 156

Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFP--GSDVD-DQLKRIFKLLG 203
           T  Y  P+VL G ++Y  S+D ++ GC   E+  AGR  F      V+ ++LKR  + L 
Sbjct: 157 TPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMI-AGRSPFRQRKEKVEKEELKR--RTLE 212

Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM----- 258
              E         PD            FS  A       +DL + LL  +P +R+     
Sbjct: 213 MAVE--------YPD-----------KFSPEA-------KDLCEALLQKDPEKRLGCRGG 246

Query: 259 SAEDAMSHIYFSDLN 273
           SA++   H  F DLN
Sbjct: 247 SADEVREHPLFKDLN 261

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 74.0 bits (182), Expect = 2e-15
 Identities = 49/171 (28%), Positives = 84/171 (49%), Gaps = 8/171 (4%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           L+E  ++++  H +IV+L  V+ +E  + +V E     +L+ Y       +DL  +  + 
Sbjct: 55  LQEAYIMRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYS 113

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL-- 148
           YQL   LA+  S+  +HRD+  +N+L++    +KL DFGL+R        Y A    L  
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPI 172

Query: 149 -WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRI 198
            W  P  + F  + +T++ D+W  G    E+   G   F G   +D + RI
Sbjct: 173 KWMAPESINF--RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI 221

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 74.9 bits (184), Expect = 2e-15
 Identities = 46/144 (31%), Positives = 75/144 (52%), Gaps = 17/144 (11%)

Query: 16  IKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFD 75
           I G H    + V     REI +L+++ H N+V+ +D+     ++ ++ E  D        
Sbjct: 107 IYGNH---EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG------ 157

Query: 76  SLNG-----EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGL 130
           SL G     E  L  V     Q+L G+A+ H R+++HRD+KP NLLIN    +K+ADFG+
Sbjct: 158 SLEGTHIADEQFLADVA---RQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGV 214

Query: 131 ARAFGIPVKCYSAEVVTLWYRPPD 154
           +R     +   ++ V T+ Y  P+
Sbjct: 215 SRILAQTMDPCNSSVGTIAYMSPE 238

Length = 353

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 73.8 bits (181), Expect = 2e-15
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 9/153 (5%)

Query: 33  REICLLKELKHKNIVRLYDVLHSE--KKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSF 89
           +EI +L+ L H+NIV+   +   +    + L+ E      LK+Y      +I+L     +
Sbjct: 55  KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKY 114

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA----EV 145
             Q+ +G+ +  SR  +HRDL  +N+L+    ++K+ DFGL +A     + Y+     + 
Sbjct: 115 AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDS 174

Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              WY  P+ L  +K Y  S D+WS G    EL
Sbjct: 175 PVFWY-APECLIQSKFYIAS-DVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 73.7 bits (181), Expect = 3e-15
 Identities = 68/235 (28%), Positives = 107/235 (45%), Gaps = 34/235 (14%)

Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVF-EHC-DQDLKKYFDSLNGEIDL--DIVKSF 89
           EI L   LKH+NIV+ Y    SE     +F E      L     S  G +      +  +
Sbjct: 55  EIALHSYLKHRNIVQ-YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFY 113

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVKCYSAEVVTL 148
             Q+L GL + H   ++HRD+K  N+L+N  +G +K++DFG ++       C      TL
Sbjct: 114 TKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTL 173

Query: 149 WYRPPDVL-FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTE 207
            Y  P+V+  G + Y    D+WS GC   E+A  G+P  P  ++ +    +FK+      
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMA-TGKP--PFIELGEPQAAMFKV------ 224

Query: 208 DTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAED 262
               GM     FK     HP     ++   L+A+ ++ + R    +P +R SA D
Sbjct: 225 ----GM-----FK----IHP-----EIPESLSAEAKNFILRCFEPDPDKRASAHD 261

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 73.6 bits (181), Expect = 3e-15
 Identities = 58/227 (25%), Positives = 97/227 (42%), Gaps = 35/227 (15%)

Query: 8   RTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD 67
           R   T++AIK         V     +E  L+ +L+H NIV L  V   E+   ++FE+  
Sbjct: 32  RLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLA 91

Query: 68  Q-DLKKYF-------DSLNGEIDLDIVKSF--------MYQLLRGLAFCHSRNVLHRDLK 111
             DL ++        D      D  +  S           Q+  G+ +  S + +HRDL 
Sbjct: 92  HGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLA 151

Query: 112 PQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL---------WYRPPDVLFGAKLY 162
            +N L+ +   +K++DFGL+R        YSA+   +         W  P  +L+G   +
Sbjct: 152 ARNCLVGEGLTVKISDFGLSR------DIYSADYYRVQSKSLLPVRWMPPEAILYGK--F 203

Query: 163 TTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK--LLGTPTE 207
           TT  D+WS G +  E+ + G   + G    + ++ I    LL  P +
Sbjct: 204 TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPED 250

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 73.7 bits (181), Expect = 3e-15
 Identities = 59/234 (25%), Positives = 105/234 (44%), Gaps = 34/234 (14%)

Query: 42  KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFC 100
           +H  +  L+    +++ L  V E+ +  DL  +  S +G  D    + +  +++ GL F 
Sbjct: 54  EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS-SGRFDEARARFYAAEIICGLQFL 112

Query: 101 HSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           H + +++RDLK  N+L++K+G +K+ADFG+ +         S    T  Y  P++L G K
Sbjct: 113 HKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK 172

Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFK 220
            Y  S+D WS G +  E+   G+  F G D D+    I                 L D  
Sbjct: 173 -YNESVDWWSFGVLLYEML-IGQSPFHGEDEDELFDSI-----------------LNDRP 213

Query: 221 PFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM-SAEDAMSHIYFSDLN 273
            FP +            ++ + +D L +L   +P +R+    D   H +F  ++
Sbjct: 214 HFPRW------------ISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID 255

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 73.8 bits (181), Expect = 4e-15
 Identities = 67/262 (25%), Positives = 111/262 (42%), Gaps = 35/262 (13%)

Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYF 74
            I+  H+V    V +  L E  +L ++    IV L     S +KL LV    +     + 
Sbjct: 25  TIRKAHIVSRSEV-THTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHH 83

Query: 75  DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF 134
               G  DL   + +  +LL  L   H  NV++RDLKP+N+L++  G + L DFGL +  
Sbjct: 84  LQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLN 143

Query: 135 GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQ 194
                  +    T  Y  P++L G   YT ++D W+ G +  E+   G P F   +V++ 
Sbjct: 144 MKDDDKTNTFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEML-TGLPPFYDENVNEM 201

Query: 195 LKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNP 254
            ++I +                      P+  P               +DLL  LL  +P
Sbjct: 202 YRKILQE---------------------PLRFPD--------GFDRDAKDLLIGLLSRDP 232

Query: 255 VQRM---SAEDAMSHIYFSDLN 273
            +R+    A++  +H +FS L+
Sbjct: 233 TRRLGYNGAQEIKNHPFFSQLS 254

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 73.5 bits (180), Expect = 4e-15
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 44/203 (21%)

Query: 29  SSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDS---LNGEIDL 83
           S  + E+ ++K + KHKNI+ L      +  L ++ E+  + +L++Y  +      E   
Sbjct: 65  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 124

Query: 84  DIVK------------SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA 131
           DI +            S  YQ+ RG+ +  S+  +HRDL  +N+L+ +N  +K+ADFGLA
Sbjct: 125 DIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 184

Query: 132 RAFG------------IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELA 179
           R               +PVK          +  P+ LF  ++YT   D+WS G +  E+ 
Sbjct: 185 RDVNNIDYYKKTTNGRLPVK----------WMAPEALFD-RVYTHQSDVWSFGVLMWEIF 233

Query: 180 NAGRPLFPGSDVDDQLKRIFKLL 202
             G   +PG  V++    +FKLL
Sbjct: 234 TLGGSPYPGIPVEE----LFKLL 252

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 73.7 bits (181), Expect = 4e-15
 Identities = 60/244 (24%), Positives = 101/244 (41%), Gaps = 44/244 (18%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY 91
           ++E+  L++L+H N +        E    LV E+C        +     +    + +  +
Sbjct: 63  IKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICH 122

Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYR 151
             L+GLA+ HS   +HRD+K  N+L+ + G +KLADFG A +   P   +   V T ++ 
Sbjct: 123 GALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSA-SLVSPANSF---VGTPYWM 178

Query: 152 PPDVLFGAK--LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDT 209
            P+V+       Y   +D+WS G    ELA    PLF                       
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF----------------------- 215

Query: 210 WPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKG-----RDLLQRLLVCNPVQRMSAEDAM 264
              MN +       +YH + + S   P L++       R+ +   L   P  R S+E+ +
Sbjct: 216 --NMNAMS-----ALYHIAQNDS---PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELL 265

Query: 265 SHIY 268
            H +
Sbjct: 266 KHRF 269

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 73.1 bits (179), Expect = 4e-15
 Identities = 61/248 (24%), Positives = 106/248 (42%), Gaps = 38/248 (15%)

Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDI----VKSF 89
           EI +L    H  IV+L    + + KL ++ E C        D++  E+D  +    ++  
Sbjct: 59  EIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGA---VDAIMLELDRGLTEPQIQVI 115

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW 149
             Q+L  L + HS  ++HRDLK  N+L+  +G++KLADFG++      ++   + + T +
Sbjct: 116 CRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPY 175

Query: 150 YRPPDVLFGAKL----YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
           +  P+V+    +    Y    D+WS G    E+A    P         +L  +  LL   
Sbjct: 176 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP-------HHELNPMRVLLKIA 228

Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS 265
             +            P  +  PS        K + + RD L+  L  +P  R SA   + 
Sbjct: 229 KSE------------PPTLSQPS--------KWSMEFRDFLKTALDKHPETRPSAAQLLE 268

Query: 266 HIYFSDLN 273
           H + S + 
Sbjct: 269 HPFVSSVT 276

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 73.5 bits (180), Expect = 5e-15
 Identities = 61/235 (25%), Positives = 110/235 (46%), Gaps = 36/235 (15%)

Query: 42  KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFC 100
           +H  +  LY    +++ L  V E+ +  DL  +  S + + DL     +  +++ GL F 
Sbjct: 54  EHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFL 112

Query: 101 HSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           HS+ +++RDLK  N+L++ +G +K+ADFG+ +   +          T  Y  P++L G K
Sbjct: 113 HSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK 172

Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFK 220
            Y TS+D WS G +  E+     P F G D ++  + I        ++            
Sbjct: 173 -YNTSVDWWSFGVLLYEMLIGQSP-FHGHDEEELFQSI------RMDN------------ 212

Query: 221 PFPMYHPSMSFSQVAPK-LTAKGRDLLQRLLVCNPVQRMSAE-DAMSHIYFSDLN 273
             P Y          P+ LT + +D+L +L V  P +R+  + D   H +F +++
Sbjct: 213 --PCY----------PRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 72.5 bits (178), Expect = 6e-15
 Identities = 43/159 (27%), Positives = 81/159 (50%), Gaps = 8/159 (5%)

Query: 34  EICLLKE-LKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSL---NGEIDLDIVKS 88
           E+ ++KE L+H NIVR Y       +L +V +  +   L ++F+SL         + + +
Sbjct: 58  EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117

Query: 89  FMYQLLRGLAFCH-SRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT 147
              Q++  L + H  + ++HRDL P N+++ ++ ++ + DFGLA+      K  S  V T
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSV-VGT 176

Query: 148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           + Y  P+++     Y    D+W+ GCI  ++     P +
Sbjct: 177 ILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFY 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 72.5 bits (178), Expect = 7e-15
 Identities = 54/236 (22%), Positives = 103/236 (43%), Gaps = 37/236 (15%)

Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL--NGEIDLDIVKSFMYQLLRGLAFCHSR 103
           +V L+    ++ KL L+ ++ +    + F  L          V+ ++ +++  L   H  
Sbjct: 67  LVTLHYAFQTDTKLHLILDYVNGG--ELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL 124

Query: 104 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--CYSAEVVTLWYRPPDVLFGAKL 161
            +++RD+K +N+L++  G + L DFGL++ F    +   YS    T+ Y  P+V+ G   
Sbjct: 125 GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSF-CGTIEYMAPEVIRGGSG 183

Query: 162 -YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFK 220
            +  ++D WS G +  EL     P F      +    I + +                 K
Sbjct: 184 GHDKAVDWWSLGVLTFELLTGASP-FTVDGEQNSQSEISRRI----------------LK 226

Query: 221 PFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA---MSHIYFSDLN 273
             P +  +MS         A+ RD +Q+LL  +P +R+ A  A    +H +F  ++
Sbjct: 227 SKPPFPKTMS---------AEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 72.8 bits (178), Expect = 7e-15
 Identities = 54/187 (28%), Positives = 89/187 (47%), Gaps = 14/187 (7%)

Query: 7   DRTPNTALAIKGTHLVGNEGVP--SSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
           D   +  +AIK     G +        ++E+  L++L+H N ++       E    LV E
Sbjct: 36  DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95

Query: 65  HC---DQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG 121
           +C     DL +       E++   + +  +  L+GLA+ HS N++HRD+K  N+L+++ G
Sbjct: 96  YCLGSASDLLEVHKKPLQEVE---IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG 152

Query: 122 ELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK--LYTTSIDMWSAGCIFAELA 179
            +KL DFG A     P   +   V T ++  P+V+       Y   +D+WS G    ELA
Sbjct: 153 LVKLGDFGSASIMA-PANXF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 208

Query: 180 NAGRPLF 186
               PLF
Sbjct: 209 ERKPPLF 215

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 72.0 bits (177), Expect = 8e-15
 Identities = 52/177 (29%), Positives = 81/177 (45%), Gaps = 12/177 (6%)

Query: 4   SGVDRTPNT---ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT 60
            GV    +     +A+K              LRE  ++ +L H  IVRL  V   E  L 
Sbjct: 13  KGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEP-LM 71

Query: 61  LVFEHCDQD-LKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK 119
           LV E      L KY      EI +  +K   +Q+  G+A+  S++ +HRDL  +N+L+  
Sbjct: 72  LVMELAPLGPLLKYLKK-RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVN 130

Query: 120 NGELKLADFGLARAFGIPVKCYSAEVV----TLWYRPPDVLFGAKLYTTSIDMWSAG 172
             + K++DFG++RA G     Y A         WY P  + +G   +++  D+WS G
Sbjct: 131 RHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK--FSSKSDVWSYG 185

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 72.0 bits (176), Expect = 1e-14
 Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 2/156 (1%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQ 92
           +EI ++K+ KH NIV  +       KL +  E C     +    + G +    +     +
Sbjct: 55  QEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRE 114

Query: 93  LLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRP 152
            L+GL + HS+  +HRD+K  N+L+  NG +KLADFG++      +    + + T ++  
Sbjct: 115 TLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMA 174

Query: 153 PDVLFGAKL--YTTSIDMWSAGCIFAELANAGRPLF 186
           P+V    +   Y    D+W+ G    ELA    P+F
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 72.3 bits (177), Expect = 1e-14
 Identities = 39/115 (33%), Positives = 66/115 (57%), Gaps = 5/115 (4%)

Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR-AFGIP--VKCYSAEV 145
           + +Q+ RG+ F  SR  +HRDL  +N+L+++N  +K+ DFGLAR  +  P  V+  SA +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
              W  P  +    K+YTT  D+WS G +  E+ + G   +PG  ++++  +  K
Sbjct: 239 PLKWMAPESIF--DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK 291

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 71.5 bits (175), Expect = 1e-14
 Identities = 51/160 (31%), Positives = 81/160 (50%), Gaps = 10/160 (6%)

Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSL--NGE 80
           NE V   A +E  LL +L H  IV+ +          ++ E+C  +DL    + L   G+
Sbjct: 44  NETV--QANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGK 101

Query: 81  I--DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 138
              +  + + F+ QLL G+ + H R +LHRDLK +N+ + KN  LK+ DFG++R      
Sbjct: 102 TLSENQVCEWFI-QLLLGVHYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSC 159

Query: 139 KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              +    T +Y  P+ L   + Y +  D+WS GCI  E+
Sbjct: 160 DLATTFTGTPYYMSPEAL-KHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 71.3 bits (175), Expect = 2e-14
 Identities = 44/170 (25%), Positives = 87/170 (51%), Gaps = 7/170 (4%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE-IDLDIVKSFM 90
           +E+  LK L+HK+++ L+ V    + + ++ E  ++  L  +  S  G+ + +  +    
Sbjct: 51  KEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMA 110

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWY 150
            Q+  G+A+   +N +HRDL  +N+L+ ++   K+ADFGLAR     V  Y +    + Y
Sbjct: 111 CQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV--YLSSDKKIPY 168

Query: 151 R--PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRI 198
           +   P+       ++T  D+WS G +  E+   G+  +PG +  +   +I
Sbjct: 169 KWTAPEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 72.6 bits (178), Expect = 2e-14
 Identities = 57/183 (31%), Positives = 86/183 (46%), Gaps = 15/183 (8%)

Query: 29  SSALREICLLKELKHKNIVRLYDVLHSEKKLT-LVFEHCDQDLKKYFDSLNGEIDLDIVK 87
           +S++ E  LL+ L H  ++ L DV      LT LV      DL  Y  +    + L  V 
Sbjct: 205 ASSVHEARLLRRLSHPAVLALLDV-RVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVT 263

Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA----RAFGIPVKCYSA 143
           +   QLL  + + H   ++HRD+K +N+L+N   ++ L DFG A     ++  P   +  
Sbjct: 264 AVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF--HYG 321

Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSD------VDDQLKR 197
              T+    P+VL G   YT S+D+WSAG +  E A     LF  S        D Q+ R
Sbjct: 322 IAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILR 380

Query: 198 IFK 200
           I +
Sbjct: 381 IIR 383

Length = 461

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 71.8 bits (176), Expect = 2e-14
 Identities = 65/254 (25%), Positives = 107/254 (42%), Gaps = 53/254 (20%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDLDIVKSF 89
            +E  +L EL H  IV +      E ++  + E       + F  L   G    D+ K +
Sbjct: 66  AQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGG--ELFTHLRKAGRFPNDVAKFY 123

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA-----RAFGIPVKCYSAE 144
             +L+    + HS+++++RDLKP+NLL++  G +K+ DFG A     R F +   C + E
Sbjct: 124 HAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL---CGTPE 180

Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
                Y  P+V+  +K +  ++D W+ G +  E   AG P F     DD   RI+     
Sbjct: 181 -----YLAPEVI-QSKGHGKAVDWWTMGVLLYEFI-AGYPPF----FDDTPFRIY----- 224

Query: 205 PTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA---- 260
             E    G    P++                     + RDL++ LL  +  +R+      
Sbjct: 225 --EKILAGRLKFPNW------------------FDGRARDLVKGLLQTDHTKRLGTLKGG 264

Query: 261 -EDAMSHIYFSDLN 273
             D  +H YF   N
Sbjct: 265 VADVKNHPYFHGAN 278

Length = 329

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 71.4 bits (175), Expect = 2e-14
 Identities = 52/184 (28%), Positives = 82/184 (44%), Gaps = 45/184 (24%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDS--------------- 76
           RE  L+ E  H NIV+L  V    K + L+FE+    DL ++                  
Sbjct: 57  REAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116

Query: 77  ----------LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLA 126
                     L+    L I K    Q+  G+A+   R  +HRDL  +N L+ +N  +K+A
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAK----QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 172

Query: 127 DFGLARAFGIPVKCYSA--------EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
           DFGL+R        YSA        + + + + PP+ +F  + YTT  D+W+ G +  E+
Sbjct: 173 DFGLSR------NIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEI 225

Query: 179 ANAG 182
            + G
Sbjct: 226 FSYG 229

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 70.6 bits (173), Expect = 3e-14
 Identities = 46/195 (23%), Positives = 91/195 (46%), Gaps = 28/195 (14%)

Query: 24  NEGVPSSA--LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLNGE 80
            EG  S    + E  ++ +L H N+V+LY V   ++ + +V E+     L  Y     G+
Sbjct: 37  REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGK 96

Query: 81  IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR-------- 132
           +  + +      +   + +  S   +HRDL  +N L+ ++  +K++DFGLAR        
Sbjct: 97  LGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156

Query: 133 -AFG--IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG- 188
            + G   PVK          + PP+V   ++ +++  D+WS G +  E+ + G+  +   
Sbjct: 157 SSQGTKFPVK----------WAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERF 205

Query: 189 --SDVDDQLKRIFKL 201
             S+V + +   ++L
Sbjct: 206 SNSEVVESVSAGYRL 220

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 70.3 bits (172), Expect = 3e-14
 Identities = 48/170 (28%), Positives = 84/170 (49%), Gaps = 20/170 (11%)

Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-----DQDLKKYFDSLNGEIDLDIVKS 88
           E+ LLK LKH NIV+       +  +++  E          L ++     G +   +   
Sbjct: 52  EVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF-----GPLPEPVFCK 106

Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG-IPVKCYSAEVV- 146
           +  Q+L G+A+ H+  V+HRD+K  N+++  NG +KL DFG AR    + +    + ++ 
Sbjct: 107 YTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK 166

Query: 147 ----TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD 192
               T ++  P+V+  +  Y    D+WS GC   E+A  G+P  P + +D
Sbjct: 167 SMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMA-TGKP--PLASMD 212

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 70.7 bits (173), Expect = 3e-14
 Identities = 65/240 (27%), Positives = 105/240 (43%), Gaps = 39/240 (16%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEI-----DLDIV 86
           + EI +++E KH NIV   D      +L +V E+          SL   +     D   +
Sbjct: 64  INEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGG------SLTDVVTETCMDEGQI 117

Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
            +   + L+ L F HS  V+HRD+K  N+L+  +G +KL DFG            S  V 
Sbjct: 118 AAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 177

Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T ++  P+V+   K Y   +D+WS G +  E+   G P +    +++   R   L+ T  
Sbjct: 178 TPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVE-GEPPY----LNENPLRALYLIAT-- 229

Query: 207 EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                  N  P+ +     +P         KL+A  RD L R L  +  +R SA++ + H
Sbjct: 230 -------NGTPELQ-----NPE--------KLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 70.8 bits (173), Expect = 4e-14
 Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 29/221 (13%)

Query: 5   GVDR-TPN--TALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLT 60
           G+D+  PN  T +A+K       E   S  + E+ ++K + KHKNI+ L      +  L 
Sbjct: 41  GLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 100

Query: 61  LVFEHCDQ-DLKKYFD-------------SLNGEIDLDI--VKSFMYQLLRGLAFCHSRN 104
           ++ E+  + +L++Y               +   E  L    + S  YQ+ RG+ +  S+ 
Sbjct: 101 VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK 160

Query: 105 VLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVKCYSAEVVTLWYRPPDVLFGAKL 161
            +HRDL  +N+L+ ++  +K+ADFGLAR         K  +  +   W   P+ LF  ++
Sbjct: 161 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-RI 218

Query: 162 YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
           YT   D+WS G +  E+   G   +PG  V++    +FKLL
Sbjct: 219 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----LFKLL 255

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 70.9 bits (174), Expect = 4e-14
 Identities = 49/183 (26%), Positives = 81/183 (44%), Gaps = 36/183 (19%)

Query: 96  GLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDV 155
           GL + H   +++RDLK  NLL++  G +K+ADFGL +         S    T  +  P+V
Sbjct: 113 GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEV 172

Query: 156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNL 215
           L     YT ++D W  G +  E+   G   FPG D ++    +F              ++
Sbjct: 173 LTETS-YTRAVDWWGLGVLIYEML-VGESPFPGDDEEE----VFD-------------SI 213

Query: 216 LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFS 270
           + D   +P +            L+ +   +++RLL  NP +R+      AED     +F 
Sbjct: 214 VNDEVRYPRF------------LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFR 261

Query: 271 DLN 273
           D+N
Sbjct: 262 DIN 264

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 70.4 bits (172), Expect = 4e-14
 Identities = 55/243 (22%), Positives = 114/243 (46%), Gaps = 41/243 (16%)

Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD----QDLKKYFDSLNGEIDLDIVKSF 89
           E+ ++++ +H+N+V +Y+      +L +V E  +     D+  +       ++ + + + 
Sbjct: 67  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAV 121

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW 149
              +L+ L+  H++ V+HRD+K  ++L+  +G +KL+DFG        V    + V T +
Sbjct: 122 CLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY 181

Query: 150 YRPPDVLFGAKL-YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTED 208
           +  P+++  ++L Y   +D+WS G +  E+ +   P F                    E 
Sbjct: 182 WMAPELI--SRLPYGPEVDIWSLGIMVIEMVDGEPPYF-------------------NEP 220

Query: 209 TWPGMNLLPDFKPFPMYHPSM-SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHI 267
               M ++ D  P     P + +  +V+P L    +  L RLLV +P QR +A + + H 
Sbjct: 221 PLKAMKMIRDNLP-----PKLKNLHKVSPSL----KGFLDRLLVRDPAQRATAAELLKHP 271

Query: 268 YFS 270
           + +
Sbjct: 272 FLA 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 70.8 bits (173), Expect = 4e-14
 Identities = 56/189 (29%), Positives = 90/189 (47%), Gaps = 43/189 (22%)

Query: 42  KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL---NGEIDLDIVK---------- 87
           KHKNI+ L  V   E  L ++ E+  + +L+++  +      +   DI K          
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 88  --SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG---------- 135
             S  YQ+ RG+ +  SR  +HRDL  +N+L+ ++  +K+ADFGLAR             
Sbjct: 136 LVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195

Query: 136 --IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDD 193
             +PVK          +  P+ LF  ++YT   D+WS G +  E+   G   +PG  V++
Sbjct: 196 GRLPVK----------WMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244

Query: 194 QLKRIFKLL 202
               +FKLL
Sbjct: 245 ----LFKLL 249

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 70.6 bits (173), Expect = 6e-14
 Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 34/234 (14%)

Query: 46  IVRLYDVLHSEKKLTLVFE-HCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN 104
           I +L      +  L LV E     DL    +    + D D+ + ++ +L+  +   H   
Sbjct: 63  IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122

Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS-AEVVTLWYRPPDVL-----FG 158
            +HRD+KP+N+LI++ G +KLADFG A          S   V T  Y  P+VL      G
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182

Query: 159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPD 218
              Y    D WS G I  E+     P   G+      K    ++               +
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA----KTYNNIM---------------N 223

Query: 219 FKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
           F+ F      + F +  PK+++   DL+Q LL C   +R+  E    H +FS +
Sbjct: 224 FQRF------LKFPE-DPKVSSDFLDLIQSLL-CGQKERLGYEGLCCHPFFSKI 269

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 70.1 bits (171), Expect = 6e-14
 Identities = 51/181 (28%), Positives = 86/181 (47%), Gaps = 4/181 (2%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
           G+D      +AIK   L   E       +EI +L +     + + Y     + KL ++ E
Sbjct: 23  GIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82

Query: 65  HCDQDLKKYFDSLN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL 123
           +         D L  G +D   + + + ++L+GL + HS   +HRD+K  N+L++++GE+
Sbjct: 83  YLGGG--SALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEV 140

Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           KLADFG+A          +  V T ++  P+V+     Y +  D+WS G    ELA    
Sbjct: 141 KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELAKGEP 199

Query: 184 P 184
           P
Sbjct: 200 P 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 70.8 bits (173), Expect = 7e-14
 Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 26/204 (12%)

Query: 20  HLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG 79
           H+V   G       E  +L+ + H +I++L       K   L+      DL  Y  +   
Sbjct: 119 HVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRN 178

Query: 80  EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK 139
               DI+ +    +LR + + H   ++HRD+K +N+ IN  G++ L DFG A        
Sbjct: 179 IAICDIL-AIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAA-------- 229

Query: 140 CYSAEVV---------TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFP--- 187
           C+  ++          T+    P++L     Y  ++D+WSAG +  E+A     LF    
Sbjct: 230 CFPVDINANKYYGWAGTIATNAPELL-ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDG 288

Query: 188 ---GSDVDDQLKRIFKLLGT-PTE 207
                D D Q+K I +  GT P E
Sbjct: 289 LDGDCDSDRQIKLIIRRSGTHPNE 312

Length = 391

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 69.6 bits (170), Expect = 7e-14
 Identities = 53/195 (27%), Positives = 93/195 (47%), Gaps = 11/195 (5%)

Query: 5   GVDRTP---NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTL 61
           G+ + P     A+AIK       E      L E  ++ +  H NI+RL  V+   K   +
Sbjct: 24  GILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83

Query: 62  VFEHCDQD-LKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN 120
           + E+ +   L KY    +GE     +   +  +  G+ +    N +HRDL  +N+L+N N
Sbjct: 84  ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSN 143

Query: 121 GELKLADFGLARAF-GIPVKCYS---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFA 176
            E K++DFGL+R     P   Y+    ++   W  P  + +  + +T++ D+WS G +  
Sbjct: 144 LECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMW 201

Query: 177 ELANAG-RPLFPGSD 190
           E+ + G RP +  S+
Sbjct: 202 EVMSFGERPYWDMSN 216

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 70.0 bits (171), Expect = 8e-14
 Identities = 58/236 (24%), Positives = 103/236 (43%), Gaps = 32/236 (13%)

Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNV 105
           +  LY    +++ L  V E  +     +     G  DL     +  +++ GL F HS+ +
Sbjct: 58  LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGI 117

Query: 106 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTS 165
           ++RDLK  N++++++G +K+ADFG+ +         S    T  Y  P++L G K YT S
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLK-YTFS 176

Query: 166 IDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY 225
           +D WS G +  E+     P F G D D+  + I   + TP    W               
Sbjct: 177 VDWWSFGVLLYEMLIGQSP-FHGDDEDELFESI--RVDTPHYPRW--------------- 218

Query: 226 HPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS-HIYFSDLNVAIKSER 280
                       +T + +D+L++L   +P +R+     +  H +F  +N     +R
Sbjct: 219 ------------ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWTALEKR 262

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 70.3 bits (172), Expect = 8e-14
 Identities = 41/116 (35%), Positives = 66/116 (56%), Gaps = 5/116 (4%)

Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR-AFGIP--VKCYSAE 144
           S+ +Q+ RG+ F  SR  +HRDL  +N+L+++N  +K+ DFGLAR  +  P  V+   A 
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236

Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           +   W  P  +    K+YTT  D+WS G +  E+ + G   +PG  +D++  R  K
Sbjct: 237 LPLKWMAPESIF--DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK 290

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 70.1 bits (171), Expect = 9e-14
 Identities = 37/115 (32%), Positives = 64/115 (55%), Gaps = 5/115 (4%)

Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR-AFGIP--VKCYSAEV 145
           + +Q+ +G+ F  SR  +HRDL  +N+L+++N  +K+ DFGLAR  +  P  V+   A +
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243

Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
              W  P  +    ++YT   D+WS G +  E+ + G   +PG  +D++  R  K
Sbjct: 244 PLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 296

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 69.9 bits (171), Expect = 1e-13
 Identities = 46/152 (30%), Positives = 76/152 (50%), Gaps = 22/152 (14%)

Query: 81  IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC 140
           +D + + SF YQ+ +G++F  S+N +HRDL  +N+L+      K+ DFGLAR     ++ 
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLAR----DIRN 266

Query: 141 YSAEVVT------LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQ 194
            S  VV       + +  P+ +F   +YT   D+WS G +  E+ + G   +PG  VD +
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK 325

Query: 195 LKRIFKLLGTPTEDTWPGMNLL-PDFKPFPMY 225
             ++ K           G  +L P+  P  MY
Sbjct: 326 FYKMIK----------EGYRMLSPECAPSEMY 347

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 69.7 bits (170), Expect = 1e-13
 Identities = 61/221 (27%), Positives = 108/221 (48%), Gaps = 29/221 (13%)

Query: 5   GVDR-TPN--TALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLT 60
           G+D+  PN    +A+K       +   S  + E+ ++K + KHKNI+ L      +  L 
Sbjct: 35  GIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 94

Query: 61  LVFEHCDQ-DLKKY------------FDSL---NGEIDLDIVKSFMYQLLRGLAFCHSRN 104
           ++ E+  + +L++Y            FD+      ++    + S  YQ+ RG+ +  S+ 
Sbjct: 95  VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK 154

Query: 105 VLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVKCYSAEVVTLWYRPPDVLFGAKL 161
            +HRDL  +N+L+ ++  +K+ADFGLAR         K  +  +   W   P+ LF  ++
Sbjct: 155 CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWM-APEALFD-RV 212

Query: 162 YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
           YT   D+WS G +  E+   G   +PG  V++    +FKLL
Sbjct: 213 YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE----LFKLL 249

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 69.7 bits (170), Expect = 1e-13
 Identities = 53/164 (32%), Positives = 75/164 (45%), Gaps = 29/164 (17%)

Query: 42  KHKNIVR-LYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFC 100
           K+ +I R  YD   S K            L    D   G   LD++ SF YQ+ RG+ F 
Sbjct: 199 KYSDIQRSNYDRPASYKGSND--SEVKNLLSD--DGSEGLTTLDLL-SFTYQVARGMEFL 253

Query: 101 HSRNVLHRDLKPQNLLINKNGELKLADFGLAR------------AFGIPVKCYSAEVVTL 148
            S+N +HRDL  +N+L+ +   +K+ DFGLAR            +  +PVK         
Sbjct: 254 ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK--------- 304

Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD 192
           W  P  +     LYTT  D+WS G +  E+ + G   +PG  VD
Sbjct: 305 WMAPESIF--DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 68.6 bits (168), Expect = 1e-13
 Identities = 47/178 (26%), Positives = 83/178 (46%), Gaps = 20/178 (11%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE-IDLDIVKSF 89
           L E  ++  L+H N+V+L  V+     L +V E+  +  L  Y  S     I L     F
Sbjct: 48  LAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGF 107

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG-------IPVKCYS 142
              +  G+ +   +N +HRDL  +N+L++++   K++DFGLA+          +PVK  +
Sbjct: 108 ALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTA 167

Query: 143 AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
            E +             K ++T  D+WS G +  E+ + GR  +P   + D +  + K
Sbjct: 168 PEALRE-----------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK 214

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 68.5 bits (167), Expect = 1e-13
 Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 16/218 (7%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           L E  +LK+  H NIV+L  V    + + +V E     D   +      E+    +  F 
Sbjct: 40  LSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFA 99

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVKCYSAEVVTL 148
                G+A+  S+N +HRDL  +N L+ +N  LK++DFG++R    GI       ++   
Sbjct: 100 LDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK 159

Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKRIFKLLGTP 205
           W  P  + +G   Y++  D+WS G +  E  + G   +PG       +Q+++ ++ +  P
Sbjct: 160 WTAPEALNYGR--YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR-MSCP 216

Query: 206 T---EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA 240
               +D +  M    D+KP         FS++  +L A
Sbjct: 217 QKCPDDVYKVMQRCWDYKP----ENRPKFSELQKELAA 250

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 16/186 (8%)

Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEID------LDIVK 87
           EI  L  L H+NI+++ ++L SE    ++ +  D DL  +    +   D      L   +
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFM--YDEAFDWKDRPLLKQTR 270

Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS-AEVV 146
           + M QLL  + + H + ++HRD+K +N+ +N +G++ L DFG A  F    + +    V 
Sbjct: 271 AIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVG 330

Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFP----GSDVDDQLKRIFKLL 202
           T+    P++L G   Y    D+WS G I  ++ +      P    G     QL +I   L
Sbjct: 331 TVATNSPEILAGDG-YCEITDIWSCGLILLDMLS--HDFCPIGDGGGKPGKQLLKIIDSL 387

Query: 203 GTPTED 208
               E+
Sbjct: 388 SVCDEE 393

Length = 501

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 68.5 bits (167), Expect = 2e-13
 Identities = 51/167 (30%), Positives = 80/167 (47%), Gaps = 17/167 (10%)

Query: 34  EICLLKELKH-KNIVRLYDVL------HSEKKLTLVFEHCD----QDLKKYFDSLNGEID 82
           EI +LK+  H +NI   Y           + +L LV E C      DL K  ++    + 
Sbjct: 62  EINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVK--NTKGNALK 119

Query: 83  LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS 142
            D +     ++LRGLA  H+  V+HRD+K QN+L+ +N E+KL DFG++      V   +
Sbjct: 120 EDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 179

Query: 143 AEVVTLWYRPPDVLFGAK----LYTTSIDMWSAGCIFAELANAGRPL 185
             + T ++  P+V+   +     Y    D+WS G    E+A    PL
Sbjct: 180 TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 68.5 bits (167), Expect = 2e-13
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 32/179 (17%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF-----DSL--------- 77
           RE  LL  L+H++IV+ Y V      L +VFE+    DL K+      D++         
Sbjct: 56  REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 115

Query: 78  -NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGI 136
             GE+ L  +     Q+  G+ +  S++ +HRDL  +N L+  N  +K+ DFG++R    
Sbjct: 116 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR---- 171

Query: 137 PVKCYSAE--------VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR-PLF 186
               YS +        ++ + + PP+ +   K +TT  D+WS G I  E+   G+ P F
Sbjct: 172 --DVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWF 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 68.8 bits (168), Expect = 2e-13
 Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 39/203 (19%)

Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
            G    D  K ++ +L+  L   H  ++++RDLKP+N+L++  G + L DFGL++A    
Sbjct: 90  EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD 149

Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
            K  +    T  Y  P+VL   K YT  +D WS G +  E+     P +      +  ++
Sbjct: 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA-----EDTQQ 204

Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA-PK--LTAKGRDLLQRLLVCNP 254
           +++ +                           +F +V  PK  L+ +GR  ++ LL  NP
Sbjct: 205 MYRNI---------------------------AFGKVRFPKNVLSDEGRQFVKGLLNRNP 237

Query: 255 VQRMSA----EDAMSHIYFSDLN 273
             R+ A     +   H +F+D++
Sbjct: 238 QHRLGAHRDAVELKEHPFFADID 260

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 68.9 bits (168), Expect = 2e-13
 Identities = 64/243 (26%), Positives = 104/243 (42%), Gaps = 39/243 (16%)

Query: 37  LLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY--QLL 94
           LLK +KH  +V L+    +  KL  V ++ +    + F  L  E      ++  Y  ++ 
Sbjct: 49  LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG--ELFYHLQRERCFLEPRARFYAAEIA 106

Query: 95  RGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPD 154
             L + HS N+++RDLKP+N+L++  G + L DFGL +         S    T  Y  P+
Sbjct: 107 SALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPE 166

Query: 155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN 214
           VL   + Y  ++D W  G +  E+   G P F   +  +    I                
Sbjct: 167 VLH-KQPYDRTVDWWCLGAVLYEML-YGLPPFYSRNTAEMYDNILN-------------- 210

Query: 215 LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAM----SHIYFS 270
                KP           Q+ P +T   R LL+ LL  +  +R+ A+D      +HI+FS
Sbjct: 211 -----KPL----------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFS 255

Query: 271 DLN 273
            +N
Sbjct: 256 PIN 258

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 68.2 bits (166), Expect = 3e-13
 Identities = 54/188 (28%), Positives = 88/188 (46%), Gaps = 7/188 (3%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
           G+D      +AIK   L   E       +EI +L +     + + Y       KL ++ E
Sbjct: 23  GIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82

Query: 65  HCDQDLKKYFDSLN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL 123
           +         D L  G  D   + + + ++L+GL + HS   +HRD+K  N+L+++ G++
Sbjct: 83  YLGGG--SALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDV 140

Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           KLADFG+A          +  V T ++  P+V+     Y +  D+WS G    ELA  G 
Sbjct: 141 KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYDSKADIWSLGITAIELAK-GE 198

Query: 184 PLFPGSDV 191
           P  P SD+
Sbjct: 199 P--PNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 3e-13
 Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 64/278 (23%)

Query: 31  ALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGE-IDLDIVKS 88
            L E  +L  L H  +  LY    +E  L LV ++C   +L +      G+ +  ++ + 
Sbjct: 48  VLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARF 107

Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA----------------- 131
           +  ++L  L + H   +++RDLKP+N+L++++G + L+DF L+                 
Sbjct: 108 YAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167

Query: 132 ----RAFGIPVKCYSAE--------VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELA 179
                   IP + +S E        V T  Y  P+V+ G   + +++D W+ G +  E+ 
Sbjct: 168 SRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEML 226

Query: 180 NAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT 239
             G   F GS+ D+    I K     T               FP   P          ++
Sbjct: 227 -YGTTPFKGSNRDETFSNILK--KEVT---------------FPGSPP----------VS 258

Query: 240 AKGRDLLQRLLVCNPVQRM----SAEDAMSHIYFSDLN 273
           +  RDL+++LLV +P +R+     A +   H +F  +N
Sbjct: 259 SSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 68.1 bits (166), Expect = 3e-13
 Identities = 56/241 (23%), Positives = 111/241 (46%), Gaps = 39/241 (16%)

Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD----QDLKKYFDSLNGEIDLDIVKSF 89
           E+ ++++  H+N+V +Y+      +L +V E  +     D+  +       ++ + + + 
Sbjct: 69  EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATV 123

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW 149
              +LR L++ H++ V+HRD+K  ++L+  +G +KL+DFG        V    + V T +
Sbjct: 124 CLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPY 183

Query: 150 YRPPDVLFGAKL-YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTED 208
           +  P+V+  ++L Y T +D+WS G +  E+ +   P F                    E 
Sbjct: 184 WMAPEVI--SRLPYGTEVDIWSLGIMVIEMIDGEPPYF-------------------NEP 222

Query: 209 TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIY 268
               M  + D  P     P +  S    K+++  R  L  +LV  P QR +A++ + H +
Sbjct: 223 PLQAMRRIRDNLP-----PRVKDSH---KVSSVLRGFLDLMLVREPSQRATAQELLQHPF 274

Query: 269 F 269
            
Sbjct: 275 L 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 66.9 bits (163), Expect = 5e-13
 Identities = 58/231 (25%), Positives = 107/231 (46%), Gaps = 39/231 (16%)

Query: 32  LREICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVK--S 88
           L E  ++ +L HKN+VRL  V LH+   L +V E   +     F    G   + +++   
Sbjct: 47  LEETAVMTKLHHKNLVRLLGVILHN--GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQ 104

Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG-------IPVKCY 141
           F   +  G+ +  S+ ++HRDL  +N+L++++G  K++DFGLAR          +PVK  
Sbjct: 105 FSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-- 162

Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKRI 198
                   +  P+ L   K +++  D+WS G +  E+ + GR  +P     +V + +++ 
Sbjct: 163 --------WTAPEALKHKK-FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG 213

Query: 199 FKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRL 249
           +++   P           P+  P  +Y    S  +  PK       L ++L
Sbjct: 214 YRM--EP-----------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKL 251

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 66.9 bits (163), Expect = 6e-13
 Identities = 56/220 (25%), Positives = 94/220 (42%), Gaps = 55/220 (25%)

Query: 25  EGVPSSALR----EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-------------- 66
           E   SS LR    E  LLK++ H ++++LY     +  L L+ E+               
Sbjct: 40  ENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRK 99

Query: 67  --------DQDLKKYFDSLNGE--IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLL 116
                   D +    +     E  + +  + SF +Q+ RG+ +     ++HRDL  +N+L
Sbjct: 100 VGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159

Query: 117 INKNGELKLADFGLARAF------------GIPVKCYSAEVVTLWYRPPDVLFGAKLYTT 164
           + +  ++K++DFGL+R               IPVK          +   + LF   +YTT
Sbjct: 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVK----------WMAIESLFD-HIYTT 208

Query: 165 SIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
             D+WS G +  E+   G   +PG       +R+F LL T
Sbjct: 209 QSDVWSFGVLLWEIVTLGGNPYPGI----APERLFNLLKT 244

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 66.5 bits (162), Expect = 7e-13
 Identities = 49/184 (26%), Positives = 84/184 (45%), Gaps = 26/184 (14%)

Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSFMYQ 92
           E  ++ +L H  +V+LY V      + LVFE  +   L  Y  +  G+   + +      
Sbjct: 49  EAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLD 108

Query: 93  LLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR-----------AFGIPVKCY 141
           +  G+A+  S NV+HRDL  +N L+ +N  +K++DFG+ R               PVK  
Sbjct: 109 VCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWS 168

Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRI 198
           S EV +         F    Y++  D+WS G +  E+ + G+  +     S+V + +   
Sbjct: 169 SPEVFS---------FSK--YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG 217

Query: 199 FKLL 202
           F+L 
Sbjct: 218 FRLY 221

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 67.0 bits (163), Expect = 7e-13
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 16/222 (7%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
           G+D      +AIK   L   E       +EI +L +     I R Y       KL ++ E
Sbjct: 23  GIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82

Query: 65  HCDQ----DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN 120
           +       DL K      G ++   + + + ++L+GL + HS   +HRD+K  N+L+++ 
Sbjct: 83  YLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ 137

Query: 121 GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           G++KLADFG+A          +  V T ++  P+V+     Y    D+WS G    ELA 
Sbjct: 138 GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYDFKADIWSLGITAIELAK 196

Query: 181 AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPF 222
            G P  P SD+     R+  L+   +  T  G    P FK F
Sbjct: 197 -GEP--PNSDLHPM--RVLFLIPKNSPPTLEGQYSKP-FKEF 232

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 66.7 bits (162), Expect = 7e-13
 Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 19/186 (10%)

Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKH-KNIVRLYDVLHS------EKKLTLVFEHCD 67
           AIK   + G+E       +EI +LK+  H +NI   Y           + +L LV E C 
Sbjct: 35  AIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCG 92

Query: 68  ----QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL 123
                DL K  ++    +  + +     ++LRGL+  H   V+HRD+K QN+L+ +N E+
Sbjct: 93  AGSVTDLIK--NTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEV 150

Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK----LYTTSIDMWSAGCIFAELA 179
           KL DFG++      V   +  + T ++  P+V+   +     Y    D+WS G    E+A
Sbjct: 151 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 210

Query: 180 NAGRPL 185
               PL
Sbjct: 211 EGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 66.8 bits (163), Expect = 7e-13
 Identities = 51/158 (32%), Positives = 79/158 (50%), Gaps = 13/158 (8%)

Query: 29  SSALREICLLKELKHKNIVRLYDVLHSE---KKLTLVFEHCD-QDLKKYFDSLNGEIDLD 84
           S   +EI +LK L H+NIV+ Y    SE   K L L+ E+     L+ Y       ++L 
Sbjct: 51  SGWKKEINILKTLYHENIVK-YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLA 107

Query: 85  IVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY--- 141
            +  F  Q+  G+A+ HS++ +HRDL  +N+L++ +  +K+ DFGLA+A     + Y   
Sbjct: 108 QLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR 167

Query: 142 -SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              +    WY   + L   K    S D+WS G    EL
Sbjct: 168 EDGDSPVFWY-AVECLKENKFSYAS-DVWSFGVTLYEL 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 67.1 bits (164), Expect = 8e-13
 Identities = 62/243 (25%), Positives = 104/243 (42%), Gaps = 39/243 (16%)

Query: 37  LLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY--QLL 94
           LLK +KH  +V L+    +  KL  V ++ +    + F  L  E      ++  Y  ++ 
Sbjct: 49  LLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG--ELFFHLQRERSFPEPRARFYAAEIA 106

Query: 95  RGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPD 154
             L + HS N+++RDLKP+N+L++  G + L DFGL +      K  S    T  Y  P+
Sbjct: 107 SALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPE 166

Query: 155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN 214
           VL   + Y  ++D W  G +  E+   G P F   D  +    I                
Sbjct: 167 VLR-KQPYDRTVDWWCLGAVLYEMLY-GLPPFYSRDTAEMYDNILN-------------- 210

Query: 215 LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA----EDAMSHIYFS 270
                KP           ++ P ++   R LL+ LL  +  +R+ A     +  +H++FS
Sbjct: 211 -----KPL----------RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFS 255

Query: 271 DLN 273
            +N
Sbjct: 256 SIN 258

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 66.8 bits (163), Expect = 9e-13
 Identities = 57/228 (25%), Positives = 91/228 (39%), Gaps = 28/228 (12%)

Query: 8   RTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD 67
           R     +A+K   L  +E   +  + E+ +L +     IV  Y     E  + +  E+ D
Sbjct: 23  RPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82

Query: 68  Q-DLKKYFD--SLNGEIDLDIVKSFMYQLLRGLAFCHSR-NVLHRDLKPQNLLINKNGEL 123
              L K +        I  D+++   Y +++GL F     N++HRD+KP N+L+N NG++
Sbjct: 83  AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQV 142

Query: 124 KLADFGL-----ARAFGIPVKCYSAEVVTLWYRPPDVL-----FGAKLYTTSIDMWSAGC 173
           KL DFG+     A      + C S       Y  P+ +          YT   D+WS G 
Sbjct: 143 KLCDFGVSGNLVASLAKTNIGCQS-------YMAPERIKSGGPNQNPTYTVQSDVWSLGL 195

Query: 174 IFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP 221
              E+A    P  P     +    IF  L    +   P   L   +  
Sbjct: 196 SILEMALGRYPYPP-----ETYANIFAQLSAIVDGDPPT--LPSGYSD 236

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 67.2 bits (164), Expect = 9e-13
 Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 34/158 (21%)

Query: 81  IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF------ 134
           +DLD +  F  Q+ +G+ F  S+N +HRD+  +N+L+      K+ DFGLAR        
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268

Query: 135 ------GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
                  +PVK         W  P  +     +YT   D+WS G +  E+ + G+  +PG
Sbjct: 269 VVKGNARLPVK---------WMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGKSPYPG 317

Query: 189 SDVDDQLKRIFKLLGTPTEDTWPGMNL-LPDFKPFPMY 225
             V+ +  ++ K           G  +  PDF P  +Y
Sbjct: 318 ILVNSKFYKMVK----------RGYQMSRPDFAPPEIY 345

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 66.7 bits (163), Expect = 1e-12
 Identities = 64/244 (26%), Positives = 106/244 (43%), Gaps = 40/244 (16%)

Query: 37  LLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE-IDL-DIVKSFMYQLL 94
           +L+ +KH  IV L     +  KL L+ E+      + F  L  E I + D    ++ ++ 
Sbjct: 53  ILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGG--ELFMHLEREGIFMEDTACFYLSEIS 110

Query: 95  RGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPD 154
             L   H + +++RDLKP+N+L++  G +KL DFGL +              T+ Y  P+
Sbjct: 111 LALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPE 170

Query: 155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN 214
           +L  +  +  ++D WS G +  ++   G P F   +    + +I K           G  
Sbjct: 171 ILMRSG-HGKAVDWWSLGALMYDML-TGAPPFTAENRKKTIDKILK-----------GKL 217

Query: 215 LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYF 269
            LP                  P LT + RDLL++LL  NP  R+      A +  SH +F
Sbjct: 218 NLP------------------PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259

Query: 270 SDLN 273
             +N
Sbjct: 260 RHVN 263

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 65.7 bits (160), Expect = 1e-12
 Identities = 50/177 (28%), Positives = 82/177 (46%), Gaps = 9/177 (5%)

Query: 14  LAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKK 72
           +AIK       + V    +RE  ++ +L +  IVR+  V  +E  L LV E      L K
Sbjct: 25  VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEA-LMLVMEMASGGPLNK 83

Query: 73  YFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR 132
           +      EI +  V   M+Q+  G+ +   +N +HRDL  +N+L+      K++DFGL++
Sbjct: 84  FLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSK 143

Query: 133 AFGIPVKCYSAEVV----TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAE-LANAGRP 184
           A G     Y A         WY P  + F  + +++  D+WS G    E  +   +P
Sbjct: 144 ALGADDSYYKARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 66.3 bits (161), Expect = 1e-12
 Identities = 63/239 (26%), Positives = 104/239 (43%), Gaps = 31/239 (12%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE-IDLDIVKSFM 90
           + EI ++KELK+ NIV   D      +L +V E+         D +    +D   + +  
Sbjct: 64  INEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGG--SLTDVVTETCMDEAQIAAVC 121

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWY 150
            + L+ L F H+  V+HRD+K  N+L+  +G +KL DFG            S  V T ++
Sbjct: 122 RECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181

Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTW 210
             P+V+   K Y   +D+WS G +  E+   G P +    +++   R   L+ T      
Sbjct: 182 MAPEVV-TRKAYGPKVDIWSLGIMAIEMVE-GEPPY----LNENPLRALYLIAT------ 229

Query: 211 PGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
              N  P+              Q   KL+   RD L R L  +  +R SA++ + H + 
Sbjct: 230 ---NGTPEL-------------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 66.4 bits (162), Expect = 1e-12
 Identities = 53/190 (27%), Positives = 92/190 (48%), Gaps = 42/190 (22%)

Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVKCYSAEVVTL 148
           +++  L + HS +V++RDLK +NL+++K+G +K+ DFGL +   + G  +K +     T 
Sbjct: 103 EIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG---TP 159

Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTED 208
            Y  P+VL     Y  ++D W  G +  E+   GR  F   D +    ++F+L+      
Sbjct: 160 EYLAPEVLEDND-YGRAVDWWGLGVVMYEMM-CGRLPFYNQDHE----KLFELI------ 207

Query: 209 TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA--EDA--- 263
                 L+ + + FP              L+ + + LL  LL  +P QR+    EDA   
Sbjct: 208 ------LMEEIR-FPR------------TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEI 248

Query: 264 MSHIYFSDLN 273
           M H +F+ +N
Sbjct: 249 MEHRFFASIN 258

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 66.1 bits (161), Expect = 1e-12
 Identities = 64/243 (26%), Positives = 104/243 (42%), Gaps = 39/243 (16%)

Query: 37  LLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY--QLL 94
           LLK LKH  +V L+    + +KL  V ++ +    + F  L  E      ++  Y  ++ 
Sbjct: 49  LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG--ELFFHLQRERCFLEPRARFYAAEVA 106

Query: 95  RGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPD 154
             + + HS N+++RDLKP+N+L++  G + L DFGL +    P +  S    T  Y  P+
Sbjct: 107 SAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPE 166

Query: 155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN 214
           VL   + Y  ++D W  G +  E+   G P F   DV      I                
Sbjct: 167 VL-RKEPYDRTVDWWCLGAVLYEMLY-GLPPFYSRDVSQMYDNILH-------------- 210

Query: 215 LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAE----DAMSHIYFS 270
                KP           Q+    T    DLL  LL  +  +R+ A+    +  +H++FS
Sbjct: 211 -----KPL----------QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFS 255

Query: 271 DLN 273
            +N
Sbjct: 256 PIN 258

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 57/250 (22%), Positives = 100/250 (40%), Gaps = 50/250 (20%)

Query: 46  IVRLYDVLHSEKKLTLV---------FEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRG 96
           +V L+    +E KL L+         F H  Q  +  F         D V+ +  +++  
Sbjct: 67  LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ--RDNFSE-------DEVRFYSGEIILA 117

Query: 97  LAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWYRPPDV 155
           L   H   +++RD+K +N+L++  G + L DFGL++ F    K  +     T+ Y  P++
Sbjct: 118 LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177

Query: 156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNL 215
           + G   +  ++D WS G +  EL     P              F L G     +     +
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASP--------------FTLEGERNTQSEVSRRI 223

Query: 216 LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFS 270
           L    PFP              +  + +DLL +LL  +P +R+      A +   H +F 
Sbjct: 224 LKCDPPFP------------SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271

Query: 271 DLNVAIKSER 280
            L+    + R
Sbjct: 272 GLDWEALALR 281

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 65.9 bits (160), Expect = 2e-12
 Identities = 63/240 (26%), Positives = 107/240 (44%), Gaps = 33/240 (13%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE-IDLDIVKSFM 90
           + EI +++E K+ NIV   D      +L +V E+         D +    +D   + +  
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVC 122

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLW 149
            + L+ L F HS  V+HRD+K  N+L+  +G +KL DFG       P +   + +V T +
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSTMVGTPY 181

Query: 150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDT 209
           +  P+V+   K Y   +D+WS G +  E+   G P +    +++   R   L+ T     
Sbjct: 182 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMIE-GEPPY----LNENPLRALYLIAT----- 230

Query: 210 WPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
               N  P+              Q   KL+A  RD L R L  +  +R SA++ + H + 
Sbjct: 231 ----NGTPEL-------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 65.8 bits (160), Expect = 2e-12
 Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 17/176 (9%)

Query: 43  HKNIVRLYDVLHSEKKLT-----LVFEHCD----QDLKKYFDSLNGEIDLDIVKSFMYQL 93
           H N+V+ Y + +   KL      LV E C+     +L K        +D  ++   +Y  
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137

Query: 94  LRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP 153
           L GL   H+  ++HRD+K  N+L+   G +KL DFG++          +  V T ++  P
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 197

Query: 154 DVLFGAKLYTTS----IDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
           +V+   + Y  S     D+WS G    EL +   PLF    V    K +FK+   P
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV----KTLFKIPRNP 249

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 65.8 bits (160), Expect = 2e-12
 Identities = 44/159 (27%), Positives = 76/159 (47%), Gaps = 11/159 (6%)

Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDI----VKSF 89
           EI +L    H NIV+L D  + E  L ++ E C        D++  E++  +    ++  
Sbjct: 52  EIDILASCDHPNIVKLLDAFYYENNLWILIEFC---AGGAVDAVMLELERPLTEPQIRVV 108

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW 149
             Q L  L + H   ++HRDLK  N+L   +G++KLADFG++      ++   + + T +
Sbjct: 109 CKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPY 168

Query: 150 YRPPDVLF----GAKLYTTSIDMWSAGCIFAELANAGRP 184
           +  P+V+       + Y    D+WS G    E+A    P
Sbjct: 169 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 65.9 bits (160), Expect = 2e-12
 Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 28/172 (16%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDS--------LNGEIDL 83
           RE  LL  L+H++IV+ Y V      L +VFE+    DL K+  +          G    
Sbjct: 56  REAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPA 115

Query: 84  DIVKSFMY----QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK 139
           ++ +S M     Q+  G+ +  S++ +HRDL  +N L+ +N  +K+ DFG++R       
Sbjct: 116 ELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR------D 169

Query: 140 CYSAE--------VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
            YS +        ++ + + PP+ +   K +TT  D+WS G +  E+   G+
Sbjct: 170 VYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGK 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 66.3 bits (161), Expect = 2e-12
 Identities = 58/250 (23%), Positives = 109/250 (43%), Gaps = 36/250 (14%)

Query: 29  SSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKS 88
           +  L E  +LK  +H  +  L     ++ +L  V E+ +     +  S       D  + 
Sbjct: 40  AHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF 99

Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL 148
           +  +++  L + HS  +++RDLK +NL+++K+G +K+ DFGL +              T 
Sbjct: 100 YGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP 159

Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTED 208
            Y  P+VL     Y  ++D W  G +  E+     P +     +   +++F+L+      
Sbjct: 160 EYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY-----NQDHEKLFELI------ 207

Query: 209 TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM-----SAEDA 263
                 L+ D K FP              L+A  + LL  LL+ +P +R+      A++ 
Sbjct: 208 ------LMEDIK-FPR------------TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEI 248

Query: 264 MSHIYFSDLN 273
           M H +F+ +N
Sbjct: 249 MRHSFFTGVN 258

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 65.8 bits (160), Expect = 2e-12
 Identities = 56/241 (23%), Positives = 108/241 (44%), Gaps = 45/241 (18%)

Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL--DIVKSFMYQLLRGLAFCHSR 103
           +V L+    ++ KL L+ ++ +    + F  L+         V+ +  +++  L   H  
Sbjct: 67  LVTLHYAFQTDTKLHLILDYINGG--ELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL 124

Query: 104 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--KCYSAEVVTLWYRPPDVLFGAKL 161
            +++RD+K +N+L++ NG + L DFGL++ F      + YS    T+ Y  PD++ G   
Sbjct: 125 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSF-CGTIEYMAPDIVRGGDG 183

Query: 162 -YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL---KRIFKLLGTPTEDTWPGMNLLP 217
            +  ++D WS G +  EL     P     + + Q    +RI K    P            
Sbjct: 184 GHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK--SEP------------ 229

Query: 218 DFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDL 272
              P+P             +++A  +D++QRLL+ +P +R+      A++   H +F  +
Sbjct: 230 ---PYPQ------------EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274

Query: 273 N 273
           N
Sbjct: 275 N 275

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 65.3 bits (159), Expect = 2e-12
 Identities = 52/187 (27%), Positives = 87/187 (46%), Gaps = 29/187 (15%)

Query: 14  LAIKGTHLVGNEGVPSSA--LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-L 70
           +AIK      NEG  S    + E  ++ +L H  +V+LY V   +K L +V E  +   L
Sbjct: 31  VAIKAI----NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCL 86

Query: 71  KKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGL 130
             Y     G++  D++ S    +  G+ +    + +HRDL  +N L++  G +K++DFG+
Sbjct: 87  LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGM 146

Query: 131 AR---------AFG--IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELA 179
            R         + G   PVK          + PP+V F    Y++  D+WS G +  E+ 
Sbjct: 147 TRYVLDDEYTSSSGAKFPVK----------WSPPEV-FNFSKYSSKSDVWSFGVLMWEVF 195

Query: 180 NAGRPLF 186
             G+  F
Sbjct: 196 TEGKMPF 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 65.5 bits (160), Expect = 3e-12
 Identities = 60/251 (23%), Positives = 107/251 (42%), Gaps = 47/251 (18%)

Query: 42  KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFC 100
           KH  + +L+    ++ +L  V E+ +  DL  +     G  D    + +  +++ GL F 
Sbjct: 54  KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFL 112

Query: 101 HSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW----YRPPDVL 156
           H R +++RDLK  N+L++  G +K+ADFG+ +  GI          T      Y  P++L
Sbjct: 113 HERGIIYRDLKLDNVLLDSEGHIKIADFGMCKE-GI---LGGVTTSTFCGTPDYIAPEIL 168

Query: 157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLL 216
                Y  ++D W+ G +  E+  AG+  F G D D+  + I        ED        
Sbjct: 169 SYQP-YGPAVDWWALGVLLYEML-AGQSPFEGDDEDELFQSIL-------EDE------- 212

Query: 217 PDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA-----EDAMSHIYFSD 271
                   Y   +S          + + +L+  L  NP +R+       +D   H +F +
Sbjct: 213 ------VRYPRWLS---------KEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257

Query: 272 LNVAIKSERCQ 282
           ++   K ER +
Sbjct: 258 IDWD-KLERKE 267

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 64.9 bits (158), Expect = 3e-12
 Identities = 52/180 (28%), Positives = 80/180 (44%), Gaps = 33/180 (18%)

Query: 32  LREICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQDLKKYFD-------SLNGE--- 80
           LRE   +KE  H N+++L  V L S  K  L          K+ D       S  GE   
Sbjct: 49  LREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPF 108

Query: 81  -IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK 139
            + L  +  FM  +  G+ +  S+N +HRDL  +N ++N+N  + +ADFGL++      K
Sbjct: 109 TLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK------K 162

Query: 140 CYSAEVVTLWYR-------PPDVL----FGAKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
            YS +    +YR       P   L        +YTT  D+W+ G    E+   G+  + G
Sbjct: 163 IYSGD----YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 64.7 bits (158), Expect = 4e-12
 Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 33/179 (18%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE---------I 81
           L E  ++KE    ++VRL  V+ + +   +V E   + DLK Y  S   E          
Sbjct: 57  LNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPP 116

Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L        ++  G+A+  ++  +HRDL  +N ++ ++  +K+ DFG+ R        Y
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI------Y 170

Query: 142 SAEVVTLWYRP------------PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
             +    +YR             P+ L     +TT  D+WS G +  E+A      + G
Sbjct: 171 ETD----YYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQG 224

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 65.0 bits (158), Expect = 4e-12
 Identities = 59/245 (24%), Positives = 111/245 (45%), Gaps = 42/245 (17%)

Query: 37  LLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRG 96
           +L+  +H  +  L     +  +L  V E+ +     +  S       +  + +  +++  
Sbjct: 48  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA 107

Query: 97  LAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVKCYSAEVVTLWYRPP 153
           L + HSR+V++RD+K +NL+++K+G +K+ DFGL +   + G  +K +     T  Y  P
Sbjct: 108 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG---TPEYLAP 164

Query: 154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGM 213
           +VL     Y  ++D W  G +  E+   GR  F   D +    R+F+L+           
Sbjct: 165 EVLEDND-YGRAVDWWGLGVVMYEMM-CGRLPFYNQDHE----RLFELI----------- 207

Query: 214 NLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIY 268
            L+ + + FP              L+ + + LL  LL  +P QR+      A++ M H +
Sbjct: 208 -LMEEIR-FPR------------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 253

Query: 269 FSDLN 273
           F  +N
Sbjct: 254 FLSIN 258

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 64.4 bits (157), Expect = 4e-12
 Identities = 55/230 (23%), Positives = 97/230 (42%), Gaps = 39/230 (16%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLNGEIDLDIVKSFM 90
           L+E  +LK+  H NIV+L  V   ++ + +V E      L  +       + +  +    
Sbjct: 40  LQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMS 99

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR--AFG----------IPV 138
                G+ +  S+N +HRDL  +N L+ +N  LK++DFG++R    G          IP+
Sbjct: 100 LDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI 159

Query: 139 KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQL 195
           K         W  P  + +G   YT+  D+WS G +  E  + G   +PG       +++
Sbjct: 160 K---------WTAPEALNYGR--YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI 208

Query: 196 KRIFKLLGTPTEDTWPG-----MNLLPDFKPFPMYHPSMSFSQVAPKLTA 240
           +  +++   P     P      M     +   P   P  SFS++  +L  
Sbjct: 209 ESGYRM---PAPQLCPEEIYRLMLQCWAYD--PENRP--SFSEIYNELQI 251

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 64.5 bits (157), Expect = 5e-12
 Identities = 57/252 (22%), Positives = 109/252 (43%), Gaps = 39/252 (15%)

Query: 31  ALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL-NGEIDLDIVKS 88
           AL E  +L+++  + +V L     ++  L LV    +  DLK +  ++ N   D +    
Sbjct: 47  ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF 106

Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVKCYSAEVV 146
           +  ++  GL   H   +++RDLKP+N+L++  G ++++D GLA     G  ++     V 
Sbjct: 107 YAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR---GRVG 163

Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T+ Y  P+V+   + YT S D W  GC+  E+   G+  F       + + + + +    
Sbjct: 164 TVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMI-EGKSPFRQRKEKVKREEVERRVKEDQ 221

Query: 207 EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM-----SAE 261
           E                         + + K +   R + ++LL  +P  R+      AE
Sbjct: 222 E-------------------------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAE 256

Query: 262 DAMSHIYFSDLN 273
           +  +H +F   N
Sbjct: 257 EVKAHPFFRTAN 268

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 64.7 bits (157), Expect = 5e-12
 Identities = 62/239 (25%), Positives = 104/239 (43%), Gaps = 31/239 (12%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE-IDLDIVKSFM 90
           + EI +++E K+ NIV   D      +L +V E+         D +    +D   + +  
Sbjct: 64  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVC 121

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWY 150
            + L+ L F HS  V+HRD+K  N+L+  +G +KL DFG            S  V T ++
Sbjct: 122 RECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181

Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTW 210
             P+V+   K Y   +D+WS G +  E+   G P +    +++   R   L+ T      
Sbjct: 182 MAPEVV-TRKAYGPKVDIWSLGIMAIEMVE-GEPPY----LNENPLRALYLIAT------ 229

Query: 211 PGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
              N  P+              Q   +L+A  RD L R L  +  +R SA++ + H + 
Sbjct: 230 ---NGTPEL-------------QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 63.9 bits (155), Expect = 5e-12
 Identities = 46/188 (24%), Positives = 86/188 (45%), Gaps = 6/188 (3%)

Query: 4   SGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF 63
           SG  R  NT +A+K         + +  L+E  +LK+  H NIVRL  V   ++ + +V 
Sbjct: 13  SGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 72

Query: 64  EHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           E     D   +  +    + +  +   +     G+ +  S++ +HRDL  +N L+ +   
Sbjct: 73  ELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV 132

Query: 123 LKLADFGLARAFGIPVKCYSA---EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELA 179
           LK++DFG++R     V   +    ++   W  P  + +G   Y++  D+WS G +  E  
Sbjct: 133 LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR--YSSESDVWSFGILLWEAF 190

Query: 180 NAGRPLFP 187
           + G   + 
Sbjct: 191 SLGAVPYA 198

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 64.3 bits (156), Expect = 5e-12
 Identities = 42/140 (30%), Positives = 71/140 (50%), Gaps = 2/140 (1%)

Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNV 105
           IV +    H+  KL  + +  +     Y  S +G      ++ +  +++ GL   H+R V
Sbjct: 59  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFV 118

Query: 106 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTS 165
           ++RDLKP N+L++++G ++++D GLA  F    K   A V T  Y  P+VL     Y +S
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPHASVGTHGYMAPEVLQKGTAYDSS 176

Query: 166 IDMWSAGCIFAELANAGRPL 185
            D +S GC+  +L     P 
Sbjct: 177 ADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 63.8 bits (155), Expect = 6e-12
 Identities = 48/189 (25%), Positives = 90/189 (47%), Gaps = 21/189 (11%)

Query: 22  VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK-KLTLVFEHCDQ-DLKKYFDSLNG 79
           + N+    + L E  ++ +L+H N+V+L  V+  EK  L +V E+  +  L  Y  S   
Sbjct: 37  IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR 96

Query: 80  E-IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG--- 135
             +  D +  F   +   + +  + N +HRDL  +N+L++++   K++DFGL +      
Sbjct: 97  SVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156

Query: 136 ----IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDV 191
               +PVK  + E +             K ++T  D+WS G +  E+ + GR  +P   +
Sbjct: 157 DTGKLPVKWTAPEALR-----------EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205

Query: 192 DDQLKRIFK 200
            D + R+ K
Sbjct: 206 KDVVPRVEK 214

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 64.3 bits (156), Expect = 6e-12
 Identities = 51/193 (26%), Positives = 87/193 (45%), Gaps = 38/193 (19%)

Query: 32  LREICLLKELKHKNIVRLYDVL--HSEKK------LTLVF-EHCDQDLKKYFDSLNGE-- 80
           L E   +KE  H N++RL  V     E +      + L F +H D      +  L     
Sbjct: 48  LSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ 107

Query: 81  -IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA-------- 131
            +   ++  FM  +  G+ +  S++ +HRDL  +N ++N+N  + +ADFGL+        
Sbjct: 108 YLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDY 167

Query: 132 ----RAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFP 187
               R   +PVK  + E +             ++YTT  D+WS G    E+A  G+  +P
Sbjct: 168 YRQGRIAKMPVKWIAIESL-----------ADRVYTTKSDVWSFGVTMWEIATRGQTPYP 216

Query: 188 G---SDVDDQLKR 197
           G   S++ D L++
Sbjct: 217 GVENSEIYDYLRQ 229

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 63.8 bits (155), Expect = 8e-12
 Identities = 48/160 (30%), Positives = 81/160 (50%), Gaps = 6/160 (3%)

Query: 29  SSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL-NGEIDLDIV 86
           S AL E  +L+++  + +V L     ++  L LV    +  DLK +  ++ N   + +  
Sbjct: 45  SMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERA 104

Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEV 145
             +  ++L GL   H  N ++RDLKP+N+L++  G ++++D GL  A  IP  +     V
Sbjct: 105 LFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGL--AVKIPEGESIRGRV 162

Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
            T+ Y  P+VL   + YT S D W  GC+  E+     P 
Sbjct: 163 GTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 63.6 bits (155), Expect = 1e-11
 Identities = 64/258 (24%), Positives = 102/258 (39%), Gaps = 70/258 (27%)

Query: 46  IVRLYDVLHSEKKLTLVFEH-----CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFC 100
           +V ++    +++ L +V E+     C   LK       G + +D+ + +  + +  L + 
Sbjct: 63  VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI-----GALPVDMARMYFAETVLALEYL 117

Query: 101 HSRNVLHRDLKPQNLLINKNGELKLADFGL--------------------ARAFGIPVKC 140
           H+  ++HRDLKP NLLI   G +KL DFGL                     R F     C
Sbjct: 118 HNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177

Query: 141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
            + E     Y  P+V+   + Y   +D W+ G I  E      P F   D  ++L     
Sbjct: 178 GTPE-----YIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFF--GDTPEEL----- 224

Query: 201 LLGTPTEDT-WP-GMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
                ++D  WP G   LP                      A  +DL+ RLL  NP++R+
Sbjct: 225 FGQVISDDIEWPEGDEALP----------------------ADAQDLISRLLRQNPLERL 262

Query: 259 ---SAEDAMSHIYFSDLN 273
               A +   H +F  L+
Sbjct: 263 GTGGAFEVKQHRFFLGLD 280

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 63.1 bits (154), Expect = 1e-11
 Identities = 40/158 (25%), Positives = 78/158 (49%), Gaps = 7/158 (4%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           L E  ++ +  H NI+RL  V+   + + ++ E+ +   L K+    +G+  +  +   +
Sbjct: 53  LTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGML 112

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY---SAEVVT 147
             +  G+ +    N +HRDL  +N+L+N N   K++DFGL+R        Y     ++  
Sbjct: 113 RGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPI 172

Query: 148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RP 184
            W  P  + +    +T++ D+WS G +  E+ + G RP
Sbjct: 173 RWTAPEAIAYRK--FTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 62.6 bits (152), Expect = 2e-11
 Identities = 39/156 (25%), Positives = 81/156 (51%), Gaps = 7/156 (4%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSFM 90
           + E  ++ +L H+ +V+LY V   ++ + +V E+     L  Y            +    
Sbjct: 47  IEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMC 106

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW- 149
             +  G+A+  S+  +HRDL  +N L++  G +K++DFGL+R   +    Y++ V + + 
Sbjct: 107 KDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSSVGSKFP 164

Query: 150 --YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
             + PP+VL  +K +++  D+W+ G +  E+ + G+
Sbjct: 165 VRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGK 199

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 62.6 bits (152), Expect = 2e-11
 Identities = 42/139 (30%), Positives = 72/139 (51%), Gaps = 2/139 (1%)

Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNV 105
           IV +    H+  KL+ + +  +     Y  S +G      ++ +  +++ GL   H+R V
Sbjct: 59  IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFV 118

Query: 106 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTS 165
           ++RDLKP N+L++++G ++++D GLA  F    K   A V T  Y  P+VL     Y +S
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPHASVGTHGYMAPEVLQKGVAYDSS 176

Query: 166 IDMWSAGCIFAELANAGRP 184
            D +S GC+  +L     P
Sbjct: 177 ADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 62.3 bits (151), Expect = 2e-11
 Identities = 47/175 (26%), Positives = 81/175 (46%), Gaps = 32/175 (18%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN------------- 78
           RE  LL  L+H++IVR Y V    + L +VFE+    DL ++  S               
Sbjct: 56  REAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVA 115

Query: 79  -GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
            G++ L  + +   Q+  G+ +  S + +HRDL  +N L+ +   +K+ DFG++R     
Sbjct: 116 PGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI--- 172

Query: 138 VKCYSAEVVTL---------WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
              YS +   +         W  P  +L+  + +TT  D+WS G +  E+   G+
Sbjct: 173 ---YSTDYYRVGGRTMLPIRWMPPESILY--RKFTTESDIWSFGVVLWEIFTYGK 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 62.3 bits (151), Expect = 3e-11
 Identities = 47/160 (29%), Positives = 79/160 (49%), Gaps = 9/160 (5%)

Query: 31  ALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFM 90
           AL E  +L+++    IV L     S+  L LV    +    KY     GE  L++ +   
Sbjct: 40  ALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIH 99

Query: 91  Y--QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVKCYSAEVV 146
           Y  Q+  G+   HS ++++RD+KP+N+L++  G  +L+D GLA     G  +   +    
Sbjct: 100 YSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAG 156

Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           T  Y  P++L   + Y+  +D ++ GC   E+  AGR  F
Sbjct: 157 TNGYMAPEILK-EEPYSYPVDWFAMGCSIYEMV-AGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 62.2 bits (151), Expect = 3e-11
 Identities = 46/144 (31%), Positives = 71/144 (49%), Gaps = 14/144 (9%)

Query: 46  IVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN 104
           I+  Y     E ++++  E  D   L  Y      +I   ++      +++GL +  S  
Sbjct: 61  IIGFYGAFFVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLK 115

Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPPDVLFGAKLYT 163
           +LHRD+KP N+L+N  G++KL DFG++      + K Y   V T  Y  P+ + G + Y 
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY---VGTNAYMAPERISGEQ-YG 171

Query: 164 TSIDMWSAGCIFAELANAGRPLFP 187
              D+WS G  F ELA  GR  FP
Sbjct: 172 IHSDVWSLGISFMELA-LGR--FP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 33/105 (31%), Positives = 57/105 (54%), Gaps = 2/105 (1%)

Query: 96  GLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDV 155
           GL F H R +++RDLK  N++++  G +K+ADFG+ +   +          T  Y  P++
Sbjct: 113 GLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEI 172

Query: 156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           +   + Y  S+D W+ G +  E+  AG+P F G D D+  + I +
Sbjct: 173 I-AYQPYGKSVDWWAYGVLLYEML-AGQPPFDGEDEDELFQSIME 215

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 61.7 bits (150), Expect = 4e-11
 Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 9/153 (5%)

Query: 33  REICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHC-DQDLKKYFDSLNGEIDLDIVKSF 89
           REI +LK L+H NIV+   V +S   + L LV E+     L+ Y       +D   +  +
Sbjct: 54  REIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLY 113

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS----AEV 145
             Q+ +G+ +  S+  +HRDL  +N+L+     +K+ DFGL +      + Y      E 
Sbjct: 114 ASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES 173

Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              WY  P+ L  +K    S D+WS G +  EL
Sbjct: 174 PIFWY-APESLTESKFSVAS-DVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 61.6 bits (149), Expect = 5e-11
 Identities = 61/254 (24%), Positives = 112/254 (44%), Gaps = 39/254 (15%)

Query: 29  SSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVK 87
           S AL E  +L+++  + +V L     ++  L LV    +  DLK +   + GE   +  +
Sbjct: 45  SMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM-GEAGFEEGR 103

Query: 88  SFMY--QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAE 144
           +  Y  ++  GL   H   +++RDLKP+N+L++ +G ++++D GL  A  +P  +     
Sbjct: 104 AVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGL--AVHVPEGQTIKGR 161

Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
           V T+ Y  P+V+   + YT S D W+ GC+  E+     P         Q K+  K    
Sbjct: 162 VGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPF-------QQRKKKIK---- 209

Query: 205 PTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM-----S 259
             E+    +  + +              + + K +   R L + LL  +P +R+      
Sbjct: 210 -REEVERLVKEVQE--------------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGG 254

Query: 260 AEDAMSHIYFSDLN 273
           A +   H  F  +N
Sbjct: 255 AREVKEHPLFKQIN 268

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 62.6 bits (152), Expect = 5e-11
 Identities = 52/176 (29%), Positives = 84/176 (47%), Gaps = 13/176 (7%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTL-VFEHCDQDLKKYFDSLNGEIDLDIVKSFMY 91
           RE  L   L H NIV L D   +   L   VFE+      +   + +G +        M 
Sbjct: 27  RETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLML 86

Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNG---ELKLADFGL------ARAFGIPVKCYS 142
           Q+L  LA  H++ ++HRDLKPQN+++++ G     K+ DFG+       R   +     +
Sbjct: 87  QVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRT 146

Query: 143 AEVV-TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
            EV+ T  Y  P+ L G  + T + D+++ G IF E    G+ +  G+ V + L +
Sbjct: 147 TEVLGTPTYCAPEQLRGEPV-TPNSDLYAWGLIFLECL-TGQRVVQGASVAEILYQ 200

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 61.2 bits (148), Expect = 7e-11
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 36/223 (16%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF-----DSLNGEIDLD-I 85
            E  +   L+H NIV L  V+  E+ L+++F +C   DL ++       S  G  D D  
Sbjct: 57  HEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116

Query: 86  VKS------FMY---QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGI 136
           VKS      F++   Q+  G+ F  S +V+H+DL  +N+L+     +K++D GL R    
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFR---- 172

Query: 137 PVKCYSAEVVTL---------WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFP 187
             + Y+A+   L         W  P  +++G   ++   D+WS G +  E+ + G   + 
Sbjct: 173 --EVYAADYYKLMGNSLLPIRWMSPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPYC 228

Query: 188 GSDVDDQLKRIFKLLGTPTED---TWPGMNLLPDFKPFPMYHP 227
           G    D ++ I      P  D    W    +L  +  FP   P
Sbjct: 229 GYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 60.9 bits (148), Expect = 7e-11
 Identities = 46/174 (26%), Positives = 79/174 (45%), Gaps = 31/174 (17%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF-------------DSLN 78
           RE  LL   +H+NIV+ Y V        +VFE+ +  DL K+              DS  
Sbjct: 57  REAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPM 116

Query: 79  GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 138
           GE+ L  +     Q+  G+ +  S++ +HRDL  +N L+  +  +K+ DFG++R      
Sbjct: 117 GELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR------ 170

Query: 139 KCYSAEVVTL---------WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
             Y+ +   +         W  P  +++    +TT  D+WS G +  E+   G+
Sbjct: 171 DVYTTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSFGVVLWEIFTYGK 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 60.7 bits (147), Expect = 7e-11
 Identities = 42/167 (25%), Positives = 82/167 (49%), Gaps = 8/167 (4%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           L E  ++ +  H NI+ L  V+   K + +V E+ +   L  +    +G+  +  +   +
Sbjct: 53  LSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGML 112

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYS---AEVV 146
             +  G+ +      +HRDL  +N+L+N N   K++DFGL+R     P   Y+    ++ 
Sbjct: 113 RGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 172

Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPLFPGSDVD 192
             W  P  + +  + +T++ D+WS G +  E+ + G RP +  S+ D
Sbjct: 173 IRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD 217

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 61.2 bits (148), Expect = 7e-11
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 14/166 (8%)

Query: 34  EICLLKELK-HKNIVRLYDVLHSEK-----KLTLVFEHCD----QDLKKYFDSLNGEIDL 83
           E  +LK L  H N+V+ Y + + +      +L LV E C+     DL K F      ++ 
Sbjct: 64  EYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEE 123

Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
            I+   +++ L GL   H    +HRD+K  N+L+   G +KL DFG++          + 
Sbjct: 124 PIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 183

Query: 144 EVVTLWYRPPDVLFGAK----LYTTSIDMWSAGCIFAELANAGRPL 185
            V T ++  P+V+   +     Y    D+WS G    EL +   PL
Sbjct: 184 SVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 60.9 bits (148), Expect = 8e-11
 Identities = 64/247 (25%), Positives = 100/247 (40%), Gaps = 63/247 (25%)

Query: 45  NIVRLYDVLHSEKKLTLVFEHCDQDLKKYF-----------DSLNGEIDLDIVKSFMYQL 93
             V  Y  L  E  + +  E  D  L K++           + + G+I + IVK      
Sbjct: 61  YTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVK------ 114

Query: 94  LRGLAFCHSR-NVLHRDLKPQNLLINKNGELKLADFG--------LARAFGIPVKCYSA- 143
              L + HS+ +V+HRD+KP N+LIN+NG++KL DFG        +A+      K Y A 
Sbjct: 115 --ALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAP 172

Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
           E +      P++    K Y    D+WS G    ELA    P        D  K  F+ L 
Sbjct: 173 ERIN-----PEL--NQKGYDVKSDVWSLGITMIELATGRFPY-------DSWKTPFQQLK 218

Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
              E+  P +             P+  FS        + +D + + L  N  +R +  + 
Sbjct: 219 QVVEEPSPQL-------------PAEKFS-------PEFQDFVNKCLKKNYKERPNYPEL 258

Query: 264 MSHIYFS 270
           + H +F 
Sbjct: 259 LQHPFFE 265

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 60.7 bits (147), Expect = 1e-10
 Identities = 46/181 (25%), Positives = 83/181 (45%), Gaps = 16/181 (8%)

Query: 14  LAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKK 72
           +A+K      N+   +  L+EI ++  LK  NI+RL  V  +   L ++ E+ +  DL +
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 73  YFDSLNGEIDLDI----------VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           +      +   +           +     Q+  G+ +  S N +HRDL  +N L+ KN  
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT 168

Query: 123 LKLADFGLARAF--GIPVKCYSAEVVTL-WYRPPDVLFGAKLYTTSIDMWSAGCIFAELA 179
           +K+ADFG++R    G   +     V+ + W     +L G   +TT+ D+W+ G    E+ 
Sbjct: 169 IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK--FTTASDVWAFGVTLWEIL 226

Query: 180 N 180
            
Sbjct: 227 T 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 39/119 (32%), Positives = 64/119 (53%), Gaps = 7/119 (5%)

Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS--AEVV 146
           F YQ+  G+ F  S+N +HRDL  +N+LI +   +K+ DFGLAR         S  +  +
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303

Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQ----LKRIFKL 201
            L +  P+ +F   LYTT  D+WS G +  E+   G   +P   +++Q    +KR +++
Sbjct: 304 PLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM 361

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 34/108 (31%), Positives = 60/108 (55%), Gaps = 8/108 (7%)

Query: 96  GLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVKCYSAEVVTLWYRP 152
           GL F HS+ +++RDLK  N++++  G +K+ADFG+ +     G+  K +     T  Y  
Sbjct: 113 GLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCG---TPDYIA 169

Query: 153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           P+++   + Y  S+D W+ G +  E+  AG+  F G D D+  + I +
Sbjct: 170 PEII-AYQPYGKSVDWWAFGVLLYEML-AGQAPFEGEDEDELFQSIME 215

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 49/153 (32%), Positives = 74/153 (48%), Gaps = 11/153 (7%)

Query: 46  IVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN 104
           +V+L+     +K L +V E+    DL       N ++     K +  +++  L   HS  
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS--NYDVPEKWAKFYTAEVVLALDAIHSMG 162

Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVKCYSAEVVTLWYRPPDVLF---G 158
           ++HRD+KP N+L++K+G LKLADFG        G+ V+C +A V T  Y  P+VL    G
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTA-VGTPDYISPEVLKSQGG 220

Query: 159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDV 191
              Y    D WS G    E+     P +  S V
Sbjct: 221 DGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 59.6 bits (144), Expect = 2e-10
 Identities = 47/161 (29%), Positives = 80/161 (49%), Gaps = 8/161 (4%)

Query: 29  SSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVK 87
           + AL E  +L+++  + +V L     ++  L LV    +  DLK +  ++ G    D  +
Sbjct: 45  AMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM-GNPGFDEQR 103

Query: 88  SFMY--QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAE 144
           +  Y  +L  GL       +++RDLKP+N+L++  G ++++D GLA    IP  +     
Sbjct: 104 AIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQ--IPEGETVRGR 161

Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
           V T+ Y  P+V+   K YT S D W  GC+  E+     P 
Sbjct: 162 VGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 59.4 bits (144), Expect = 2e-10
 Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 39/211 (18%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVF--EHCDQDLKKYFDSLNGEIDLDIVKSF 89
           L+E  ++K+  H N++ L  +    +   LV        DL+ +  S      +  +  F
Sbjct: 44  LKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGF 103

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW 149
             Q+ +G+ +  S+  +HRDL  +N +++++  +K+ADFGLAR        Y  E     
Sbjct: 104 GLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLAR------DIYDKE----- 152

Query: 150 YRPPDVLFGAKL--------------YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL 195
           Y       GAKL              +TT  D+WS G +  EL   G P +P  D  D  
Sbjct: 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDIT 212

Query: 196 KRIFKLLGTPTEDTWPGMNLL-PDFKPFPMY 225
             + +           G  LL P++ P P+Y
Sbjct: 213 VYLLQ-----------GRRLLQPEYCPDPLY 232

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 59.7 bits (144), Expect = 2e-10
 Identities = 64/255 (25%), Positives = 112/255 (43%), Gaps = 40/255 (15%)

Query: 6   VDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           V   P T +AIK  +   +       L E  ++KE    ++VRL  V+   +   ++ E 
Sbjct: 31  VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 90

Query: 66  CDQ-DLKKYFDSLNGEIDLDIVKSF-----MYQLL----RGLAFCHSRNVLHRDLKPQNL 115
             + DLK Y  SL  E++ + V++      M Q+      G+A+ ++   +HRDL  +N 
Sbjct: 91  MTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNC 150

Query: 116 LINKNGELKLADFGLARAFG------------IPVKCYSAEVVTLWYRPPDVLFGAKLYT 163
           ++ ++  +K+ DFG+ R               +PV+         W  P  +  G  ++T
Sbjct: 151 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---------WMSPESLKDG--VFT 199

Query: 164 TSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK--LLGTPTEDTWPGMNLLPDFKP 221
           T  D+WS G +  E+A      + G   +  L+ + +  LL  P  D  P M L    + 
Sbjct: 200 TYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKP--DNCPDM-LFELMRM 256

Query: 222 FPMYHPSM--SFSQV 234
              Y+P M  SF ++
Sbjct: 257 CWQYNPKMRPSFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 59.4 bits (144), Expect = 3e-10
 Identities = 45/173 (26%), Positives = 82/173 (47%), Gaps = 10/173 (5%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFM 90
           L E  ++  + H ++VRL  +  S + + L+ +      L  Y  +    I    + ++ 
Sbjct: 57  LDEAYVMASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC 115

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVT 147
            Q+ +G+++   + ++HRDL  +N+L+     +K+ DFGLA+   +  K Y AE   V  
Sbjct: 116 VQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI 175

Query: 148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPL--FPGSDVDDQLKR 197
            W     +L    +YT   D+WS G    EL   G +P    P  ++ D L++
Sbjct: 176 KWMALESILHR--IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK 226

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 59.1 bits (144), Expect = 3e-10
 Identities = 50/167 (29%), Positives = 77/167 (46%), Gaps = 16/167 (9%)

Query: 42  KHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSL--NGEIDLDIVKSFMYQLLRGLA 98
            + N ++LY  + + K   L+ ++  D DL   FD L   G++    VK  + QL+  L 
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDL---FDLLKKEGKLSEAEVKKIIRQLVEALN 123

Query: 99  FCHSRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF 157
             H  N++H D+K +N+L +     + L D+GL +  G P  CY     TL Y  P+ + 
Sbjct: 124 DLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-SCYDG---TLDYFSPEKIK 179

Query: 158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSD----VDDQLKRIFK 200
           G   Y  S D W+ G +  EL     P     D    ++  LKR  K
Sbjct: 180 G-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK 225

Length = 267

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 59.8 bits (145), Expect = 3e-10
 Identities = 34/103 (33%), Positives = 57/103 (55%), Gaps = 2/103 (1%)

Query: 96  GLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDV 155
           GL F HS+ +++RDLK  N++++  G +K+ADFG+ +      K       T  Y  P++
Sbjct: 113 GLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEI 172

Query: 156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRI 198
           +   + Y  S+D W+ G +  E+  AG+P F G D D+  + I
Sbjct: 173 I-AYQPYGKSVDWWAFGVLLYEML-AGQPPFDGEDEDELFQSI 213

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 59.2 bits (143), Expect = 3e-10
 Identities = 55/204 (26%), Positives = 101/204 (49%), Gaps = 27/204 (13%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLD------- 84
           +E  L+ EL H NIV L  V+  E+ + ++FE+ +Q DL ++    +   D+        
Sbjct: 56  QEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDG 115

Query: 85  IVKS------FMY---QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG 135
            VKS      F++   Q+  G+ +  S   +H+DL  +N+LI +   +K++D GL+R   
Sbjct: 116 TVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREI- 174

Query: 136 IPVKCYSAEVVTL----WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPLFPGSD 190
                Y  +  +L    W  P  +++G   +++  D+WS G +  E+ + G +P +  S+
Sbjct: 175 YSADYYRVQPKSLLPIRWMPPEAIMYGK--FSSDSDIWSFGVVLWEIFSFGLQPYYGFSN 232

Query: 191 VD-DQLKRIFKLLGTPTEDTWPGM 213
            +  ++ R  +LL    ED  P M
Sbjct: 233 QEVIEMVRKRQLLPCS-EDCPPRM 255

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 59.4 bits (144), Expect = 4e-10
 Identities = 49/152 (32%), Positives = 71/152 (46%), Gaps = 9/152 (5%)

Query: 46  IVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN 104
           IV+L+     +K L +V E+    DL       N +I     + +  +++  L   HS  
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVNLMS--NYDIPEKWARFYTAEVVLALDAIHSMG 162

Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLF---GA 159
            +HRD+KP N+L++K+G LKLADFG          V+C +A V T  Y  P+VL    G 
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA-VGTPDYISPEVLKSQGGD 221

Query: 160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDV 191
             Y    D WS G    E+     P +  S V
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 59.3 bits (143), Expect = 4e-10
 Identities = 58/250 (23%), Positives = 111/250 (44%), Gaps = 43/250 (17%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY 91
           L E  +L+  +H  +  L     +  +L  V E+ +     +  S       D  + +  
Sbjct: 43  LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA 102

Query: 92  QLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVKCYSAEVVT 147
           +++  L + HS +NV++RDLK +NL+++K+G +K+ DFGL +     G  +K +     T
Sbjct: 103 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG---T 159

Query: 148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTE 207
             Y  P+VL     Y  ++D W  G +  E+     P +     +   +++F+L+     
Sbjct: 160 PEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY-----NQDHEKLFELI----- 208

Query: 208 DTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM-----SAED 262
                  L+ + + FP              L+ + + LL  LL  +P QR+      A++
Sbjct: 209 -------LMEEIR-FPR------------TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKE 248

Query: 263 AMSHIYFSDL 272
            M H +F+ +
Sbjct: 249 IMQHKFFAGI 258

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 59.1 bits (143), Expect = 5e-10
 Identities = 36/115 (31%), Positives = 61/115 (53%), Gaps = 18/115 (15%)

Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV----- 146
           Q+L  +   HS++++HRD+K  N+L+  NG +KL DFG +       K Y+A V      
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS-------KMYAATVSDDVGR 203

Query: 147 ----TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               T +Y  P++ +  K Y+   DM+S G +  EL    RP F G ++++ + +
Sbjct: 204 TFCGTPYYVAPEI-WRRKPYSKKADMFSLGVLLYELLTLKRP-FDGENMEEVMHK 256

Length = 496

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 58.5 bits (142), Expect = 5e-10
 Identities = 54/212 (25%), Positives = 84/212 (39%), Gaps = 29/212 (13%)

Query: 45  NIVRLYDVLHSEKKLTLVFEHCDQDLKKYF----DSLNGEIDLDIVKSFMYQLLRGLAFC 100
            IV+ Y  L  E    +  E  D  L K++    + L   I  +I+       ++ L + 
Sbjct: 64  YIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYL 123

Query: 101 HSR-NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRP---PDVL 156
                ++HRD+KP N+L+++NG +KL DFG++   G  V    A+      RP   P+ +
Sbjct: 124 KEELKIIHRDVKPSNILLDRNGNIKLCDFGIS---GQLVDSI-AKTRDAGCRPYMAPERI 179

Query: 157 --FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSD-VDDQLKRIFKLLGTPTEDTWPGM 213
                  Y    D+WS G    E+A  G+  +P  + V DQL ++ K  G P        
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVAT-GKFPYPKWNSVFDQLTQVVK--GDP-------- 228

Query: 214 NLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
              P          S SF         K    
Sbjct: 229 ---PILSNSEEREFSPSFVNFINLCLIKDESK 257

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 58.5 bits (141), Expect = 6e-10
 Identities = 59/244 (24%), Positives = 101/244 (41%), Gaps = 41/244 (16%)

Query: 37  LLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY--QLL 94
           LLK +KH  +V L+    + +KL  V +  +    + F  L  E      ++  Y  ++ 
Sbjct: 49  LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG--ELFFHLQRERSFPEPRARFYAAEIA 106

Query: 95  RGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWYRPP 153
             L + HS N+++RDLKP+N+L++  G + L DFGL +  GI     +     T  Y  P
Sbjct: 107 SALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAP 165

Query: 154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGM 213
           +V+   + Y  ++D W  G +  E+   G P F   DV +    I               
Sbjct: 166 EVI-RKQPYDNTVDWWCLGAVLYEML-YGLPPFYCRDVAEMYDNILH------------- 210

Query: 214 NLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAED----AMSHIYF 269
                 KP  +           P  +     +L+ LL  +  +R+ A++       H +F
Sbjct: 211 ------KPLVL----------RPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFF 254

Query: 270 SDLN 273
             L+
Sbjct: 255 ESLS 258

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 58.4 bits (141), Expect = 7e-10
 Identities = 44/168 (26%), Positives = 78/168 (46%), Gaps = 29/168 (17%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDI----- 85
           L+EI ++  LK+ NI+RL  V  S+  L ++ E+ +  DL ++      E          
Sbjct: 65  LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124

Query: 86  ---VKSFMY---QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK 139
              + + +Y   Q+  G+ +  S N +HRDL  +N L+  +  +K+ADFG++R       
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL----- 179

Query: 140 CYSAEVVTL---------WYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
            YS +   +         W     +L G   +TT+ D+W+ G    E+
Sbjct: 180 -YSGDYYRIQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 58.5 bits (141), Expect = 7e-10
 Identities = 38/141 (26%), Positives = 70/141 (49%), Gaps = 2/141 (1%)

Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNV 105
           +V L+    +  +L LV E+ +     +      ++  +  + +  ++   L F H R +
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGI 117

Query: 106 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTS 165
           ++RDLK  N+L++ +G +KL D+G+ +    P    S    T  Y  P++L G + Y  S
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFS 176

Query: 166 IDMWSAGCIFAELANAGRPLF 186
           +D W+ G +  E+  AGR  F
Sbjct: 177 VDWWALGVLMFEMM-AGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 57.9 bits (140), Expect = 8e-10
 Identities = 47/190 (24%), Positives = 84/190 (44%), Gaps = 38/190 (20%)

Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA---RAFGIPVKCYSAEVVTL 148
           Q++ GL   H R +++RDLKP+N+L++ +G ++++D GLA   +      K Y+    T 
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG---TP 161

Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTED 208
            +  P++L G + Y  S+D ++ G    E+  A  P              F+  G   E+
Sbjct: 162 GFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGP--------------FRARGEKVEN 206

Query: 209 TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA----- 263
                 +L D         S+++     K +   +   + LL  +P +R+   D      
Sbjct: 207 KELKQRILND---------SVTYPD---KFSPASKSFCEALLAKDPEKRLGFRDGNCDGL 254

Query: 264 MSHIYFSDLN 273
            +H  F DLN
Sbjct: 255 RTHPLFRDLN 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 58.1 bits (140), Expect = 9e-10
 Identities = 42/155 (27%), Positives = 73/155 (47%), Gaps = 5/155 (3%)

Query: 43  HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHS 102
           H  +V L+    +E +L  V E+ +     +      ++  +  + +  ++   L + H 
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 114

Query: 103 RNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLY 162
           R +++RDLK  N+L++  G +KL D+G+ +    P    S    T  Y  P++L G   Y
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-Y 173

Query: 163 TTSIDMWSAGCIFAELANAGRPLFP---GSDVDDQ 194
             S+D W+ G +  E+  AGR  F     SD  DQ
Sbjct: 174 GFSVDWWALGVLMFEMM-AGRSPFDIVGSSDNPDQ 207

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.9 bits (140), Expect = 1e-09
 Identities = 56/239 (23%), Positives = 95/239 (39%), Gaps = 39/239 (16%)

Query: 46  IVRLYDVLHSEKKLTLVFEH-CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN 104
           I  L+     E  L LV ++    DL          +  D+ + ++ +++  +   H   
Sbjct: 63  ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122

Query: 105 VLHRDLKPQNLLINKNGELKLADFGLA---RAFGIPVKCYSAEVVTLWYRPPDVLF---- 157
            +HRD+KP N+L++KNG ++LADFG      A G      +  V T  Y  P++L     
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS--NVAVGTPDYISPEILQAMED 180

Query: 158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLP 217
           G   Y    D WS G    E+     P +  S V+   K                MN   
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI---------------MN--- 222

Query: 218 DFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM---SAEDAMSHIYFSDLN 273
                  +     F      ++ + +DL++RL+ C+P  R+     +D   H +F  ++
Sbjct: 223 -------HKEHFQFPPDVTDVSEEAKDLIRRLI-CSPETRLGRNGLQDFKDHPFFEGID 273

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 57.4 bits (139), Expect = 1e-09
 Identities = 66/292 (22%), Positives = 116/292 (39%), Gaps = 51/292 (17%)

Query: 11  NTALAIKGTHLVGNEGVPSSAL----REICLLKELKHKNIVRLYDVLHSEKKLTLVFE-- 64
           NT +A+K  +L   +      L    +EI   ++L+H NI+        + +L +V    
Sbjct: 25  NTLVAVKKINL---DSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM 81

Query: 65  ---HCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG 121
               C+  LK +F    G  +L I    +  +L  L + HS+  +HR +K  ++L++ +G
Sbjct: 82  AYGSCEDLLKTHF--PEGLPELAI-AFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG 138

Query: 122 ELKLADFGLARAF------GIPVKCY--SAEVVTLWYRPPDVLFGAKL-YTTSIDMWSAG 172
           ++ L+    + +          V  +  S+     W   P+VL      Y    D++S G
Sbjct: 139 KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL-SPEVLQQNLQGYNEKSDIYSVG 197

Query: 173 CIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS 232
               ELAN   P     D+      + K+ GT          LL D   +P+Y  SMS S
Sbjct: 198 ITACELANGHVPF---KDMPATQMLLEKVRGTVP-------CLL-DKSTYPLYEDSMSQS 246

Query: 233 QVAPKLTAKGR---------------DLLQRLLVCNPVQRMSAEDAMSHIYF 269
           + + +                       ++  L  +P  R SA   ++H +F
Sbjct: 247 RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 56.8 bits (137), Expect = 2e-09
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 58/193 (30%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY 91
           L E  ++ +  H NI+ L  V+   + + ++ E  +          NG +D     SF+ 
Sbjct: 53  LSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFME----------NGALD-----SFLR 97

Query: 92  Q------------LLRGLA----FCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR--- 132
           Q            +LRG+A    +    N +HRDL  +N+L+N N   K++DFGL+R   
Sbjct: 98  QNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157

Query: 133 ----------AFG--IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
                     + G  IP++         W  P  + +  + +T++ D+WS G +  E+ +
Sbjct: 158 DDTSDPTYTSSLGGKIPIR---------WTAPEAIAY--RKFTSASDVWSYGIVMWEVMS 206

Query: 181 AG-RPLFPGSDVD 192
            G RP +  S+ D
Sbjct: 207 YGERPYWDMSNQD 219

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 57.8 bits (139), Expect = 2e-09
 Identities = 22/50 (44%), Positives = 36/50 (72%)

Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA 131
           D++++K  M Q+L GL   H   ++HRD+KP+NLL+  +G++K+ DFG A
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 46/152 (30%), Positives = 71/152 (46%), Gaps = 9/152 (5%)

Query: 46  IVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN 104
           +V+L+     ++ L +V E+    DL       N ++     + +  +++  L   HS  
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVLALDAIHSMG 162

Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLF---GA 159
            +HRD+KP N+L++K+G LKLADFG          V+C +A V T  Y  P+VL    G 
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTPDYISPEVLKSQGGD 221

Query: 160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDV 191
             Y    D WS G    E+     P +  S V
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 56.4 bits (136), Expect = 3e-09
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 2/102 (1%)

Query: 97  LAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL 156
           L F H   V++RDLK  N+L++  G  KLADFG+ +   +     +    T  Y  P++L
Sbjct: 109 LMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEIL 168

Query: 157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRI 198
              + Y  S+D W+ G +  E+  AG+P F   + DD  + I
Sbjct: 169 QELE-YGPSVDWWALGVLMYEMM-AGQPPFEADNEDDLFESI 208

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 56.6 bits (136), Expect = 3e-09
 Identities = 58/237 (24%), Positives = 97/237 (40%), Gaps = 35/237 (14%)

Query: 46  IVRLYDVLHSEKKLTLVFEH-CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN 104
           I  L+     E  L LV ++    DL          +  D+ + ++ +++  +   H  +
Sbjct: 63  ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122

Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWYRPPDVLF----GA 159
            +HRD+KP N+L++ NG ++LADFG            S+  V T  Y  P++L     G 
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182

Query: 160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDF 219
             Y    D WS G    E+     P +  S V+   K                MN    F
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI---------------MNHEERF 227

Query: 220 KPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA---EDAMSHIYFSDLN 273
           + FP +   +S          + +DL+QR L+C+  +R+     ED   H +F  ++
Sbjct: 228 Q-FPSHITDVS---------EEAKDLIQR-LICSRERRLGQNGIEDFKKHAFFEGID 273

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 56.8 bits (137), Expect = 3e-09
 Identities = 31/88 (35%), Positives = 49/88 (55%), Gaps = 2/88 (2%)

Query: 46  IVRLYDVLHSEKKLTLVFEH-CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN 104
           IV LY  L S   + LV E+    D+K     + G  D ++   ++ ++   L + H   
Sbjct: 66  IVHLYYSLQSANNVYLVMEYLIGGDVKSLL-HIYGYFDEEMAVKYISEVALALDYLHRHG 124

Query: 105 VLHRDLKPQNLLINKNGELKLADFGLAR 132
           ++HRDLKP N+LI+  G +KL DFGL++
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 56.2 bits (135), Expect = 4e-09
 Identities = 64/256 (25%), Positives = 111/256 (43%), Gaps = 29/256 (11%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSE--KKLTLVFEH-CDQDLKKYFDSLNGEIDLDIVKS 88
           + E  ++  + H ++VRL  V  S   + +T +  H C   L  Y       I   ++ +
Sbjct: 57  MDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGC---LLDYVHEHKDNIGSQLLLN 113

Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---V 145
           +  Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLAR      K Y+A+   +
Sbjct: 114 WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 173

Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN-AGRPL--FPGSDVDDQLKRIFKLL 202
              W     + +  + +T   D+WS G    EL    G+P    P  ++ D L++  +L 
Sbjct: 174 PIKWMALECIHY--RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLP 231

Query: 203 GTP--TEDTWPGM----NLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
             P  T D +  M     +  D +P         F ++A + +   RD  QR LV     
Sbjct: 232 QPPICTIDVYMVMVKCWMIDADSRP--------KFKELAAEFSRMARD-PQRYLVIQGDD 282

Query: 257 RMSAEDAMSHIYFSDL 272
           RM         +F +L
Sbjct: 283 RMKLPSPNDSKFFQNL 298

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 56.4 bits (136), Expect = 4e-09
 Identities = 47/189 (24%), Positives = 80/189 (42%), Gaps = 39/189 (20%)

Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           ++   L F H + +++RDLK  N+L++  G  KLADFG+ +  GI     ++    T  Y
Sbjct: 104 EITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GIFNGKTTSTFCGTPDY 162

Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTW 210
             P++L    LY  S+D W+ G +  E+     P F   + DD  + I        E  +
Sbjct: 163 IAPEIL-QEMLYGPSVDWWAMGVLLYEMLCGHAP-FEAENEDDLFEAILN-----DEVVY 215

Query: 211 PGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA-----EDA-M 264
           P                          L+    D+L+  +  NP  R+ +     E+A +
Sbjct: 216 PTW------------------------LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAIL 251

Query: 265 SHIYFSDLN 273
            H +F +L+
Sbjct: 252 RHPFFKELD 260

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 55.8 bits (134), Expect = 4e-09
 Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 2/95 (2%)

Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT 147
            F   + RG+ +   +  +HRDL  +N+L+ +N   K+ADFGL+R   + VK     +  
Sbjct: 128 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 187

Query: 148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
            W     + +   +YTT+ D+WS G +  E+ + G
Sbjct: 188 RWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLG 220

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 55.2 bits (133), Expect = 7e-09
 Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 35/181 (19%)

Query: 32  LREICLLKELKHKNIVRLYDV-LHSEKK-------LTLVFEHCDQDLKKY-FDSLNGE-- 80
           L E   +K+  H N+++L  V   +          + L F     DL  +   S  G   
Sbjct: 49  LSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMK-HGDLHSFLLYSRLGGLP 107

Query: 81  --IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 138
             + L  +  FM  +  G+ +  +RN +HRDL  +N ++ ++  + +ADFGL++      
Sbjct: 108 EKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK------ 161

Query: 139 KCYSAEVVTLWYRPPDVL-----------FGAKLYTTSIDMWSAGCIFAELANAGRPLFP 187
           K YS +    +YR   +               ++YT+  D+W+ G    E+A  G+  +P
Sbjct: 162 KIYSGD----YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYP 217

Query: 188 G 188
           G
Sbjct: 218 G 218

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 55.4 bits (134), Expect = 7e-09
 Identities = 50/215 (23%), Positives = 76/215 (35%), Gaps = 71/215 (33%)

Query: 101 HSRNVLHRDLKPQNLLINKNGELKLADFGLARAF--------------GIP--------- 137
           H    +HRD+KP NLL++  G +KL+DFGL                   +P         
Sbjct: 118 HKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISK 177

Query: 138 ----------------VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANA 181
                              YS  V T  Y  P+V F    Y    D WS G I  E+   
Sbjct: 178 PMSSKRKAETWKRNRRALAYST-VGTPDYIAPEV-FLQTGYNKECDWWSLGVIMYEML-V 234

Query: 182 GRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAK 241
           G P F   +  +  ++I              +N   +   FP   P          L+ +
Sbjct: 235 GYPPFCSDNPQETYRKI--------------IN-WKETLQFPDEVP----------LSPE 269

Query: 242 GRDLLQRLLVCNPVQRM---SAEDAMSHIYFSDLN 273
            +DL++RL  C   +R+      +  SH +F  ++
Sbjct: 270 AKDLIKRLC-CEAERRLGNNGVNEIKSHPFFKGVD 303

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 55.0 bits (132), Expect = 8e-09
 Identities = 42/168 (25%), Positives = 78/168 (46%), Gaps = 5/168 (2%)

Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL 83
           +  +    LRE  ++++L +  IVR+  +  +E    LV E  +      F   N  +  
Sbjct: 36  DPALKDELLREANVMQQLDNPYIVRMIGICEAES-WMLVMELAELGPLNKFLQKNKHVTE 94

Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
             +   ++Q+  G+ +    N +HRDL  +N+L+      K++DFGL++A G     Y A
Sbjct: 95  KNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154

Query: 144 EVVTLW---YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
           +    W   +  P+ +   K  + S D+WS G +  E  + G+  + G
Sbjct: 155 KTHGKWPVKWYAPECMNYYKFSSKS-DVWSFGVLMWEAFSYGQKPYKG 201

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 55.4 bits (133), Expect = 8e-09
 Identities = 41/150 (27%), Positives = 68/150 (45%), Gaps = 4/150 (2%)

Query: 37  LLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRG 96
           +L  + H   V LY     E  L LV E         F   N     D+   +  Q++  
Sbjct: 84  ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI 143

Query: 97  LAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL 156
             +  S N+++RDLKP+NLL++K+G +K+ DFG A+   +  + Y+    T  Y  P++L
Sbjct: 144 FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--VDTRTYTL-CGTPEYIAPEIL 200

Query: 157 FGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
                +  + D W+ G    E+     P +
Sbjct: 201 LNVG-HGKAADWWTLGIFIYEILVGCPPFY 229

Length = 340

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 54.9 bits (132), Expect = 8e-09
 Identities = 45/184 (24%), Positives = 79/184 (42%), Gaps = 21/184 (11%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDS----LNGEIDLDIV 86
           L+E+   +EL H N+++            LV E C   DLK Y  S    +      D++
Sbjct: 43  LQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVL 102

Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARA------------F 134
           +    ++  GL + H  + +H DL  +N  +  +  +K+ D+GLA               
Sbjct: 103 QRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCH 162

Query: 135 GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQ 194
            +P++  + E+V +  R  D+L   K  T   ++WS G    EL  A    +P    +  
Sbjct: 163 AVPLRWLAPELVEI--RGQDLL--PKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV 218

Query: 195 LKRI 198
           LK++
Sbjct: 219 LKQV 222

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 54.9 bits (132), Expect = 9e-09
 Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 24/204 (11%)

Query: 14  LAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKK 72
           +A+K      N+   +  L+E+ +L  LK  NI+RL  V   E  L ++ E+ +  DL +
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 73  YFDS---LNGE---------------IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
           +  S    + E               I    +     Q+  G+ +  S N +HRDL  +N
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRN 168

Query: 115 LLINKNGELKLADFGLARAF--GIPVKCYSAEVVTL-WYRPPDVLFGAKLYTTSIDMWSA 171
            L+ +N  +K+ADFG++R    G   +     V+ + W     +L G   +TT+ D+W+ 
Sbjct: 169 CLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK--FTTASDVWAF 226

Query: 172 GCIFAELANAGRPLFPGSDVDDQL 195
           G    E+    +    G   D+Q+
Sbjct: 227 GVTLWEILMLCKEQPYGELTDEQV 250

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 54.7 bits (131), Expect = 1e-08
 Identities = 58/240 (24%), Positives = 100/240 (41%), Gaps = 35/240 (14%)

Query: 43  HKNIVRLYDVLHSEKKLTLVFEH-CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           ++ I  L+     E  L LV ++    DL          +  D+ + ++ +++  +   H
Sbjct: 60  NQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119

Query: 102 SRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWYRPPDVLF--- 157
             + +HRD+KP N+L++ NG ++LADFG            S+  V T  Y  P++L    
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 179

Query: 158 -GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLL 216
            G   Y    D WS G    E+     P +  S V+   K                MN  
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI---------------MNHK 224

Query: 217 PDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA---EDAMSHIYFSDLN 273
             F+ FP        +QV   ++   +DL++R L+C+   R+     ED   H +F+ ++
Sbjct: 225 ERFQ-FP--------AQVT-DVSEDAKDLIRR-LICSREHRLGQNGIEDFKQHPFFTGID 273

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 54.0 bits (130), Expect = 2e-08
 Identities = 44/203 (21%), Positives = 91/203 (44%), Gaps = 23/203 (11%)

Query: 12  TALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDL 70
           T + +K      +E + S   RE+ + ++L HKN+VRL  +    +   ++ E+ D  DL
Sbjct: 36  TLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDL 95

Query: 71  KKYFDSLNGEIDLDIVK--------SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           K++  +   + +             +   Q+  G+    +   +HRDL  +N L++   E
Sbjct: 96  KQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE 155

Query: 123 LKLADFGLARAFGIPVKCYSAE-------VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIF 175
           +K++   L++        Y++E       ++ L +  P+ +     ++T  D+WS G + 
Sbjct: 156 VKVSLLSLSK------DVYNSEYYKLRNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLM 208

Query: 176 AELANAGRPLFPGSDVDDQLKRI 198
            E+   G   F G   ++ L R+
Sbjct: 209 WEVFTQGELPFYGLSDEEVLNRL 231

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 66/294 (22%), Positives = 111/294 (37%), Gaps = 88/294 (29%)

Query: 37  LLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDI-----VKSFMY 91
           +L E  ++ +V+LY     +  L  V ++         D ++  I +++      + ++ 
Sbjct: 54  ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGG-----DMMSLLIRMEVFPEVLARFYIA 108

Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-----------GIPVKC 140
           +L   +   H    +HRD+KP N+LI+ +G +KL DFGL   F           G  ++ 
Sbjct: 109 ELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQ 168

Query: 141 YSAEVVTLW------------------------------------YRPPDVLFGAKLYTT 164
            S E   LW                                    Y  P+VL   K YT 
Sbjct: 169 DSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQ 227

Query: 165 SIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM 224
             D WS G I  E+     P    +  + QLK I           W     +P       
Sbjct: 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVI----------NWENTLHIP------- 270

Query: 225 YHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM---SAEDAMSHIYFSDLNVA 275
                   QV  KL+ +  DL+ + L C+  +R+    A+D  +H +FS+++ +
Sbjct: 271 -------PQV--KLSPEAVDLITK-LCCSAEERLGRNGADDIKAHPFFSEVDFS 314

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 53.8 bits (129), Expect = 2e-08
 Identities = 36/112 (32%), Positives = 57/112 (50%), Gaps = 8/112 (7%)

Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLA+  G   K Y AE   V   
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176

Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPL--FPGSDVDDQLKR 197
           W     +L   ++YT   D+WS G    EL   G +P    P S++   L++
Sbjct: 177 WMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 226

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 55/226 (24%), Positives = 86/226 (38%), Gaps = 52/226 (23%)

Query: 21  LVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLNG 79
           L+ N+     A R+I  L E  ++ +VRLY     +  L  V ++    D+      + G
Sbjct: 40  LLRNQVAHVKAERDI--LAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-G 96

Query: 80  EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF----- 134
               D+ + ++ +L   +   H    +HRD+KP N+LI+++G +KL DFGL   F     
Sbjct: 97  IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156

Query: 135 ---------------------GIPVKCYSAE---------------------VVTLWYRP 152
                                G P  C   +                     V T  Y  
Sbjct: 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIA 216

Query: 153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRI 198
           P+VL     YT   D WS G I  E+     P    + ++ Q+K I
Sbjct: 217 PEVLLRTG-YTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVI 261

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 53.5 bits (129), Expect = 3e-08
 Identities = 57/229 (24%), Positives = 92/229 (40%), Gaps = 27/229 (11%)

Query: 8   RTPNTALAIKGTHLVGNEGVPSSALREI-CLLKELKHKNIVRLYDVLHSEKKLTLVFEHC 66
           +     +A+K     GN+      L ++  +LK      IV+ Y    ++  + +  E  
Sbjct: 37  KKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM 96

Query: 67  DQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSR-NVLHRDLKPQNLLINKNGELKL 125
              L K    + G I  DI+      +++ L +   +  V+HRD+KP N+L++ +G +KL
Sbjct: 97  STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKL 156

Query: 126 ADFGLA----------RAFGIPVKCYSA-EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCI 174
            DFG++          R+ G     Y A E +     PPD       Y    D+WS G  
Sbjct: 157 CDFGISGRLVDSKAKTRSAGCAA--YMAPERID----PPD---PNPKYDIRADVWSLGIS 207

Query: 175 FAELANAGRPLFPGSDVD-DQLKRIFKLLGTPTEDTWPGMNLLPDFKPF 222
             ELA    P +     + + L +I   L        P     PDF  F
Sbjct: 208 LVELATGQFP-YKNCKTEFEVLTKI---LQEEPPSLPPNEGFSPDFCSF 252

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 53.2 bits (127), Expect = 3e-08
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 9/98 (9%)

Query: 92  QLLR-------GLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE 144
           QLL        G+ +   +  +HRDL  +N+L+ +N   K+ADFGL+R   + VK     
Sbjct: 113 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 172

Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
           +   W     + +   +YTT+ D+WS G +  E+ + G
Sbjct: 173 LPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLG 208

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 53.3 bits (128), Expect = 4e-08
 Identities = 67/286 (23%), Positives = 108/286 (37%), Gaps = 78/286 (27%)

Query: 31  ALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLNGEIDLDIVKSF 89
           A R+I  L E  ++ +V+LY     +  L  V ++    D+      L G  + D+ + +
Sbjct: 50  AERDI--LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL-GIFEEDLARFY 106

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA------------------ 131
           + +L   +   H    +HRD+KP N+LI+++G +KL DFGL                   
Sbjct: 107 IAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHH 166

Query: 132 ------------------------RAFGIPVKCYSAEVV-TLWYRPPDVLFGAKLYTTSI 166
                                   R      +C +  +V T  Y  P+VL     YT   
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLC 225

Query: 167 DMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYH 226
           D WS G I  E+   G+P F              L  TP E     +N          + 
Sbjct: 226 DWWSVGVILYEML-VGQPPF--------------LADTPAETQLKVIN----------WE 260

Query: 227 PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM---SAEDAMSHIYF 269
            ++     A KL+ +  DL+ R L C    R+    A++  +H +F
Sbjct: 261 TTLHIPSQA-KLSREASDLILR-LCCGAEDRLGKNGADEIKAHPFF 304

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 53.1 bits (128), Expect = 4e-08
 Identities = 46/161 (28%), Positives = 72/161 (44%), Gaps = 28/161 (17%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFE-HCDQDLKKYFDSLNGEIDLDIVKS-- 88
           L+E+ +L  L   NI RL  V   +  L ++ E   + DL ++      E       S  
Sbjct: 67  LKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126

Query: 89  -----FMY---QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC 140
                 +Y   Q+  G+ +  S N +HRDL  +N L+ KN  +K+ADFG++R        
Sbjct: 127 LSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL------ 180

Query: 141 YSAEVVTLWYRPP---------DVLFGAKLYTTSIDMWSAG 172
           YS++   +  R P          VL G   +TT  D+W+ G
Sbjct: 181 YSSDYYRVQGRAPLPIRWMAWESVLLGK--FTTKSDVWAFG 219

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 52.9 bits (127), Expect = 5e-08
 Identities = 32/90 (35%), Positives = 48/90 (53%), Gaps = 2/90 (2%)

Query: 97  LAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL 156
           L F H R +++RDLK  N+L++  G +KL D+G+ +    P    S    T  Y  P++L
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL 168

Query: 157 FGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
            G   Y  S+D W+ G +  E+  AGR  F
Sbjct: 169 RGED-YGFSVDWWALGVLMFEMM-AGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 51.8 bits (124), Expect = 6e-08
 Identities = 60/231 (25%), Positives = 94/231 (40%), Gaps = 45/231 (19%)

Query: 45  NIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN 104
           N+V L+  + SE  + LV +H +        S    I  + VK +  +++  L   H   
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREG 105

Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTT 164
           ++ RDL P N+L++  G ++L  F   R   +   C   E V   Y  P+V  G    T 
Sbjct: 106 IVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSC-DGEAVENMYCAPEV-GGISEETE 161

Query: 165 SIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWP-GMNLLPDFKPFP 223
           + D WS G I  EL                      L G    +  P G+N         
Sbjct: 162 ACDWWSLGAILFEL----------------------LTGKTLVECHPSGINT-------- 191

Query: 224 MYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA-----EDAMSHIYF 269
             H +++  +    ++ + R LLQ+LL  NP +R+ A     ED  SH +F
Sbjct: 192 --HTTLNIPEW---VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 52.3 bits (125), Expect = 7e-08
 Identities = 33/116 (28%), Positives = 57/116 (49%), Gaps = 8/116 (6%)

Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE--- 144
           ++  Q+ +G+++     ++HRDL  +N+L+     +K+ DFGLAR   I    Y A+   
Sbjct: 113 NWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGK 172

Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPL--FPGSDVDDQLKR 197
           V   W     +L   + +T   D+WS G    EL   G +P    P  ++ D L++
Sbjct: 173 VPIKWMALESIL--HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK 226

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 51.9 bits (124), Expect = 8e-08
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 9/98 (9%)

Query: 92  QLLR-------GLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE 144
           QLL+       G+ +   +  +HRDL  +N+L+ +N   K+ADFGL+R   + VK     
Sbjct: 120 QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGR 179

Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
           +   W     + +   +YTT  D+WS G +  E+ + G
Sbjct: 180 LPVRWMAIESLNY--SVYTTKSDVWSFGVLLWEIVSLG 215

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 51.8 bits (124), Expect = 1e-07
 Identities = 19/51 (37%), Positives = 33/51 (64%)

Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF 134
           D+ + +M + +  +   H    +HRD+KP N+LI++ G +KL+DFGL+  F
Sbjct: 101 DVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 31/110 (28%), Positives = 51/110 (46%), Gaps = 22/110 (20%)

Query: 86  VKSFM---YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARA--------- 133
           V +F+   +++   + + HS+ VLHRDLKP N+L+   GE+ + D+G A           
Sbjct: 112 VGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLL 171

Query: 134 ---FGIPVKCYSAEVV------TLWYRPPDVLFGAKLYTTSIDMWSAGCI 174
                    CYS+  +      T  Y  P+ L G    + S D+++ G I
Sbjct: 172 DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVI 220

Length = 932

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 46/186 (24%), Positives = 78/186 (41%), Gaps = 42/186 (22%)

Query: 32  LREICLLKELKHKNIVRLYDVLH-----SEKKLTLVFEHCDQDLKKYFD-----SLNGEI 81
           L+E CLL  L H+NI+    +LH      E    L       +LK +         N   
Sbjct: 56  LQESCLLYGLSHQNILP---ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQ 112

Query: 82  DL---DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF---- 134
            L    +V     Q+  G+++ H R V+H+D+  +N +I++  ++K+ D  L+R      
Sbjct: 113 ALSTQQLV-HMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171

Query: 135 --------GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
                     PVK  + E +             K Y+++ D+WS G +  EL   G+   
Sbjct: 172 YHCLGDNENRPVKWMALESLV-----------NKEYSSASDVWSFGVLLWELMTLGQ--T 218

Query: 187 PGSDVD 192
           P  ++D
Sbjct: 219 PYVEID 224

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 46.9 bits (111), Expect = 5e-06
 Identities = 46/187 (24%), Positives = 80/187 (42%), Gaps = 33/187 (17%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFE-HCDQDLKKYFDSLNGEID-------- 82
           L E  ++K     ++VRL  V+   +   +V E     DLK Y  SL  E +        
Sbjct: 57  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116

Query: 83  -LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG------ 135
            L  +     ++  G+A+ +++  +HRDL  +N ++  +  +K+ DFG+ R         
Sbjct: 117 TLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR 176

Query: 136 ------IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGS 189
                 +PV+         W  P  +  G  ++TTS DMWS G +  E+ +     + G 
Sbjct: 177 KGGKGLLPVR---------WMAPESLKDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGL 225

Query: 190 DVDDQLK 196
             +  LK
Sbjct: 226 SNEQVLK 232

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 19/48 (39%), Positives = 31/48 (64%), Gaps = 1/48 (2%)

Query: 85  IVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN-KNGELKLADFGLA 131
           I+++ M Q+L  L   HS  ++HRD+KPQN++ +  +G  K+ D G A
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 45.2 bits (107), Expect = 1e-05
 Identities = 48/191 (25%), Positives = 82/191 (42%), Gaps = 21/191 (10%)

Query: 41  LKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF---DSLNGEIDLDIVKSFMYQLLRG 96
           L+H NI++            LVFE+C+  DLK Y            L +++    ++  G
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111

Query: 97  LAFCHSRNVLHRDLKPQNLLINKNGELKLADFGL--ARAFGIPVKCYSAEVVTLWYRPPD 154
           +   H  N LH DL  +N  +  +  +K+ D+G+  +R     ++    + V L +  P+
Sbjct: 112 VTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE 171

Query: 155 VL--FGAKLYTTS----IDMWSAGCIFAEL-ANAGRPLFPGSDVD-------DQLKRIFK 200
           ++  F   L T       ++W+ G    EL  NA +P    SD +       DQ  ++FK
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFK 231

Query: 201 -LLGTPTEDTW 210
             L  P  + W
Sbjct: 232 PQLELPYSERW 242

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 44.9 bits (106), Expect = 2e-05
 Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 10/164 (6%)

Query: 41  LKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAF 99
           L H  IVRL  +      L LV +      L  +       +D   + ++  Q+ +G+ +
Sbjct: 66  LDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYY 124

Query: 100 CHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY---SAEVVTLWYRPPDVL 156
                ++HR+L  +N+L+  +  +++ADFG+A       K Y     +    W     +L
Sbjct: 125 LEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184

Query: 157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKR 197
           FG   YT   D+WS G    E+ + G   + G    +V D L++
Sbjct: 185 FGR--YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK 226

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 44.8 bits (106), Expect = 2e-05
 Identities = 50/189 (26%), Positives = 76/189 (40%), Gaps = 51/189 (26%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE---------- 80
           L+E  L+    H NIV+L  V    +   ++ E  +  DL  Y      E          
Sbjct: 47  LKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLK 106

Query: 81  ----IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE-----LKLADFGLA 131
               I LD+ K  +Y  L  + F      +HRDL  +N L+++ G      +K+ DFGLA
Sbjct: 107 ELLDICLDVAKGCVY--LEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158

Query: 132 RAF------------GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELA 179
           R               +PV+         W  P  +L G   +TT  D+WS G +  E+ 
Sbjct: 159 RDIYKSDYYRKEGEGLLPVR---------WMAPESLLDG--KFTTQSDVWSFGVLMWEIL 207

Query: 180 NAGRPLFPG 188
             G+  +P 
Sbjct: 208 TLGQQPYPA 216

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 44.9 bits (106), Expect = 2e-05
 Identities = 39/176 (22%), Positives = 74/176 (42%), Gaps = 8/176 (4%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSFM 90
           L E   L +  H NIVRL  V+     + +V E+     L  +     G++    +   +
Sbjct: 54  LAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGML 113

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--KCYSAEVVTL 148
             L  G+ +      +H+ L    +L+N +   K++ F   +           S +   L
Sbjct: 114 PGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL 173

Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPLF--PGSDVDDQLKRIFKL 201
           W  P  + +    ++++ D+WS G +  E+ + G RP +   G DV   ++  F+L
Sbjct: 174 WAAPEAIQYHH--FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL 227

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 44.9 bits (106), Expect = 2e-05
 Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 10/108 (9%)

Query: 85  IVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC--YS 142
           ++K+ M  +L  L + H   + H D+KP+N++++ N    + D+G+A  F I  K   YS
Sbjct: 127 LIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYS 186

Query: 143 AEVV-----TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
            E       TL+Y   D   GA + T   D+ S G  +  L  AG  L
Sbjct: 187 KEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLG--YCMLKWAGIKL 231

Length = 294

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 44.5 bits (105), Expect = 2e-05
 Identities = 50/208 (24%), Positives = 77/208 (37%), Gaps = 36/208 (17%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSL----NGEIDLDIV 86
           L E    + L+H N+++            LV E C   DLK Y  S         D   +
Sbjct: 43  LEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTL 102

Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR------------AF 134
           +    ++  GL   H  N +H DL  +N L+  +  +K+ D+GL+               
Sbjct: 103 QRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL 162

Query: 135 GIPVKCYSAEVVTLWYRPPDVLFGAKLY---TTSIDMWSAGCIFAELANAGRPLFPG-SD 190
            +P++  + E+V       D + G  L    T   ++WS G    EL   G   +   SD
Sbjct: 163 WVPLRWIAPELV-------DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD 215

Query: 191 V--------DDQLKRIFKLLGTPTEDTW 210
                    + QLK     L  P  D W
Sbjct: 216 EQVLTYTVREQQLKLPKPRLKLPLSDRW 243

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 43.2 bits (102), Expect = 6e-05
 Identities = 37/156 (23%), Positives = 68/156 (43%), Gaps = 19/156 (12%)

Query: 34  EICLLKELKHKNIVRLY----DVLHSEKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVK- 87
           EI  L+ +   NI+++Y    D++    +L+L+ E+C +  L++    L+ E DL     
Sbjct: 68  EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREV---LDKEKDLSFKTK 124

Query: 88  -SFMYQLLRGL-AFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEV 145
                   +GL       N  +++L   + L+ +N +LK+   GL +    P       V
Sbjct: 125 LDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---FKNV 181

Query: 146 VTLWYRPPDVL---FGAKLYTTSIDMWSAGCIFAEL 178
             + Y    +L   F    YT   D++S G +  E+
Sbjct: 182 NFMVYFSYKMLNDIFSE--YTIKDDIYSLGVVLWEI 215

Length = 283

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 42/139 (30%), Positives = 67/139 (48%), Gaps = 29/139 (20%)

Query: 90  MYQLLRGLAFCHSR-NVLHRDLKPQNLLINKNG----------------ELKLADFGLAR 132
           ++Q    L + H+  +++H DLKP+N+L+  +                  +++ D G   
Sbjct: 237 IFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG--- 293

Query: 133 AFGIPVKCYS--AEVVTLWYRPPDVLFG-AKLYTTSIDMWSAGCIFAELANAGRPLFPGS 189
             G   + +S  A V T  YR P+V+ G   +Y+T  DMWS GCI  EL   G+ L+   
Sbjct: 294 --GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELY-TGKLLYDTH 348

Query: 190 DVDDQLKRIFKLLGT-PTE 207
           D  + L  + K LG  P+E
Sbjct: 349 DNLEHLHLMEKTLGRLPSE 367

Length = 467

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 16/30 (53%), Positives = 22/30 (73%)

Query: 101 HSRNVLHRDLKPQNLLINKNGELKLADFGL 130
           H    +HRD+KP NLL++  G +KL+DFGL
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 42.0 bits (98), Expect = 2e-04
 Identities = 16/30 (53%), Positives = 22/30 (73%)

Query: 101 HSRNVLHRDLKPQNLLINKNGELKLADFGL 130
           H    +HRD+KP NLL++  G +KL+DFGL
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 44/173 (25%), Positives = 72/173 (41%), Gaps = 17/173 (9%)

Query: 27  VPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDI 85
           +PSS   EI  + +L+H NIV+L  +  SEK   L+ E+ + ++L +   +L+ E    I
Sbjct: 729 IPSS---EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKI 785

Query: 86  VKSFMYQLLRGLAFCH---SRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS 142
                  + + L F H   S  V+  +L P+ ++I+   E  L    L        KC+ 
Sbjct: 786 AIG----IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFI 840

Query: 143 AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL 195
           +      Y  P+     K  T   D++  G I  EL     P      V   +
Sbjct: 841 SSA----YVAPETR-ETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSI 888

Length = 968

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 39.2 bits (91), Expect = 0.001
 Identities = 61/280 (21%), Positives = 104/280 (37%), Gaps = 59/280 (21%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLV-----FEHCDQDLKKYFDSLNGEIDLDIVK 87
            E+ L    +H NI+  + V  +   L ++     +   +  LK YF     E    ++ 
Sbjct: 48  NEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEA---LIG 104

Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEV-- 145
           + ++  LRGL + H    +HR++K  ++LI+ +G + L+  GL+  + +      A+V  
Sbjct: 105 NILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVY 162

Query: 146 --------VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
                   V  W  P  +      Y    D++S G    ELA    P     D+      
Sbjct: 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF---QDMLRTQML 219

Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ------VAPKLTAKG--------- 242
           + KL G P            D   FP     M  SQ      +   + A G         
Sbjct: 220 LQKLKG-PPYSPL-------DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSER 271

Query: 243 -------------RDLLQRLLVCNPVQRMSAEDAMSHIYF 269
                        ++L++  L  +P +R SA   +SH +F
Sbjct: 272 LRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF 311

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 39.5 bits (93), Expect = 0.001
 Identities = 24/85 (28%), Positives = 40/85 (47%), Gaps = 13/85 (15%)

Query: 49  LYDVLHSEKKLTLVFEHC-DQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLH 107
           +YDV   EK  T+V E+   +DLK           L+     + ++   +A  H   ++H
Sbjct: 403 IYDVDPEEK--TIVMEYIGGKDLKDV---------LEGNPELVRKVGEIVAKLHKAGIVH 451

Query: 108 RDLKPQNLLINKNGELKLADFGLAR 132
            DL   N ++ ++  L L DFGL +
Sbjct: 452 GDLTTSNFIV-RDDRLYLIDFGLGK 475

Length = 535

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 38.0 bits (89), Expect = 0.002
 Identities = 22/85 (25%), Positives = 41/85 (48%), Gaps = 12/85 (14%)

Query: 49  LYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLH 107
           +YDV       T+V E+ + + LK   +  N E+        + ++ R +   H   ++H
Sbjct: 64  VYDV--DPDNKTIVMEYIEGKPLKDVIEEGNDEL--------LREIGRLVGKLHKAGIVH 113

Query: 108 RDLKPQNLLINKNGELKLADFGLAR 132
            DL   N+++  + +L L DFGL +
Sbjct: 114 GDLTTSNIIVR-DDKLYLIDFGLGK 137

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 38.2 bits (89), Expect = 0.003
 Identities = 51/208 (24%), Positives = 80/208 (38%), Gaps = 53/208 (25%)

Query: 13  ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQDLK 71
            +A+K      +E   S  L E  ++ +  H+NIVRL  V      +  L+      DLK
Sbjct: 38  QVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLK 97

Query: 72  KYF----------------DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            +                 D L      D+ K        G  +    + +HRD+  +N 
Sbjct: 98  SFLRENRPRPERPSSLTMKDLLF--CARDVAK--------GCKYLEENHFIHRDIAARNC 147

Query: 116 LINKNGE---LKLADFGLARAFGIPVKCYSAEVVTLWYR------------PPDVLFGAK 160
           L+   G     K+ADFG+AR        Y A     +YR            PP+  F   
Sbjct: 148 LLTCKGPGRVAKIADFGMAR------DIYRAS----YYRKGGRAMLPIKWMPPEA-FLDG 196

Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPG 188
           ++T+  D+WS G +  E+ + G   +PG
Sbjct: 197 IFTSKTDVWSFGVLLWEIFSLGYMPYPG 224

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 37.0 bits (86), Expect = 0.003
 Identities = 23/106 (21%), Positives = 44/106 (41%), Gaps = 12/106 (11%)

Query: 33  REICLLKELKHKNIV--RLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSF 89
           RE+ +L+ L  K +   ++     S+    L+ E  + + L +  +    E   + +   
Sbjct: 40  REVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEVSEEEK-EDIAEQLAEL 98

Query: 90  MYQL--LRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARA 133
           + +L  L  L  CH       DL P N+L++    L + D+  A  
Sbjct: 99  LAKLHQLPLLVLCH------GDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	282
KOG0659|consensus	318		100.0
KOG0593|consensus	396		100.0
KOG0581|consensus	364		100.0
KOG0575|consensus	592		100.0
KOG0615|consensus	475		100.0
KOG0663|consensus	419		100.0
KOG0594|consensus	323		100.0
KOG0600|consensus	560		100.0
KOG0661|consensus	538		100.0
KOG0662|consensus	292		100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0592|consensus	604		100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0588|consensus	786		100.0
KOG0598|consensus	357		100.0
KOG0660|consensus	359		100.0
KOG0583|consensus	370		100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0658|consensus	364		100.0
KOG0595|consensus	429		100.0
KOG0578|consensus	550		100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0582|consensus	516		100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0597|consensus	808		100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0033|consensus	355		100.0
KOG0591|consensus	375		100.0
KOG0198|consensus	313		100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0616|consensus	355		100.0
KOG0605|consensus	550		100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0610|consensus	459		100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0599|consensus	411		100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0694|consensus	694		100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0585|consensus	576		100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0192|consensus	362		100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0032|consensus	382		100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG4717|consensus	864		100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0201|consensus	467		100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0667|consensus	586		100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0666|consensus	438		100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0197|consensus	468		100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0580|consensus	281		100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0589|consensus	426		100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0611|consensus	668		100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG0604|consensus	400		100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0669|consensus	376		100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0577|consensus	948		100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG4279|consensus	1226		100.0
KOG0574|consensus	502		100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0983|consensus	391		100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG4236|consensus	888		100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0579|consensus	1187		100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0586|consensus	596		100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0690|consensus	516		100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0607|consensus	463		100.0
KOG0596|consensus	677		100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG2345|consensus	302		100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG4721|consensus	904		100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG1026|consensus	774		100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG4645|consensus	1509		100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG0986|consensus	591		100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG0584|consensus	632		100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0193|consensus	678		100.0
KOG0603|consensus	612		100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG1035|consensus	1351		100.0
KOG0612|consensus	1317		100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG1989|consensus	738		100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0671|consensus	415		100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG1095|consensus	1025		100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0696|consensus	683		100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0194|consensus	474		100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG0668|consensus	338		100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG1187|consensus	361		100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG0665|consensus	369		100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG0695|consensus	593		100.0
KOG0196|consensus	996		100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0614|consensus	732		100.0
KOG4278|consensus	1157		100.0
KOG0664|consensus	449		100.0
KOG4257|consensus	974		100.0
KOG4250|consensus	732		100.0
KOG1006|consensus	361		100.0
KOG1027|consensus	903		100.0
KOG0199|consensus	1039		100.0
KOG1290|consensus	590		100.0
KOG0587|consensus	953		100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0670|consensus	752		100.0
KOG1094|consensus	807		100.0
KOG1151|consensus	775		100.0
KOG0608|consensus	1034		100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0200|consensus	609		100.0
KOG0576|consensus	829		100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1167|consensus	418		100.0
KOG1025|consensus	1177		100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG0984|consensus	282		99.98
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG3653|consensus	534		99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
KOG2052|consensus	513		99.97
KOG1152|consensus	772		99.97
KOG1024|consensus	563		99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG0590|consensus	601		99.95
KOG1345|consensus	378		99.95
KOG1240|consensus	1431		99.92
KOG0195|consensus	448		99.92
KOG0603|consensus	612		99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.9
KOG1164|consensus	322		99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.87
KOG4158|consensus	598		99.87
PRK09188	365	serine/threonine protein kinase; Provisional	99.87
KOG1163|consensus	341		99.86
KOG1023|consensus	484		99.86
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.84
KOG1165|consensus	449		99.84
KOG0606|consensus	1205		99.84
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.82
KOG1033|consensus	516		99.81
smart00090	237	RIO RIO-like kinase.	99.75
PRK10345	210	hypothetical protein; Provisional	99.75
KOG0601|consensus	524		99.73
KOG1166|consensus	974		99.72
KOG1266|consensus	458		99.71
PRK14879	211	serine/threonine protein kinase; Provisional	99.69
KOG1243|consensus	690		99.69
KOG0590|consensus	601		99.67
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.67
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.65
KOG3741|consensus	655		99.65
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.62
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.61
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.59
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.55
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.5
KOG0606|consensus	1205		99.48
KOG2137|consensus	700		99.37
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.34
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.33
KOG0601|consensus	524		99.31
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.24
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.23
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.22
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.22
KOG3087|consensus	229		99.21
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.17
COG4248	637	Uncharacterized protein with protein kinase and he	99.03
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.03
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.96
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.71
PRK09902	216	hypothetical protein; Provisional	98.68
KOG1035|consensus	1351		98.61
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.59
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.47
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.35
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.31
KOG1235|consensus	538		98.16
PF01636	239	APH: Phosphotransferase enzyme family This family	98.11
PLN02876	822	acyl-CoA dehydrogenase	98.1
KOG0576|consensus	829		98.1
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.88
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.81
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.73
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.71
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.56
KOG1093|consensus	725		97.55
KOG2270|consensus	520		97.53
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.51
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.47
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.42
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.38
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.24
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.18
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.15
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.14
PRK05231	319	homoserine kinase; Provisional	97.13
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	97.07
KOG1826|consensus	2724		96.94
PLN02236	344	choline kinase	96.84
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.83
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.77
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.59
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.47
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.47
KOG2268|consensus	465		96.39
PLN02756	418	S-methyl-5-thioribose kinase	96.32
PRK12396	409	5-methylribose kinase; Reviewed	96.25
PTZ00384	383	choline kinase; Provisional	95.87
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.62
PRK06148	1013	hypothetical protein; Provisional	95.53
PRK10271	188	thiK thiamine kinase; Provisional	94.68
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	94.59
PTZ00296	442	choline kinase; Provisional	94.56
PRK10593	297	hypothetical protein; Provisional	94.37
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	93.98
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	93.91

>KOG0659|consensus

Probab=100.00  E-value=6.9e-57  Score=341.03  Aligned_cols=273  Identities=44%  Similarity=0.793  Sum_probs=254.2

Q ss_pred             CeeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      +||+|++..||+.||||++.. ...++.....++|++.++.++|+||+.++++|.....+.+|+||++.++...+...+.
T Consensus        17 vVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~tdLe~vIkd~~i   96 (318)
T KOG0659|consen   17 VVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPTDLEVVIKDKNI   96 (318)
T ss_pred             EEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccccHHHHhccccc
Confidence            599999999999999999998 6677778889999999999999999999999999999999999999999999988888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .++...+..++.+++.||+|||+++|.|||+||.|++++++|.+||+|||+++..+.+.......+.|.+|+|||.+.+.
T Consensus        97 ~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGs  176 (318)
T KOG0659|consen   97 ILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGS  176 (318)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccc
Confidence            89999999999999999999999999999999999999999999999999999999888888777889999999999999


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      ..|+...|+||.||++.||+ .+.|+|++.++.|.+..+...++.|.++.|+.+..+.++..+...... ....+.+..+
T Consensus       177 r~Yg~~VDmWavGCI~AELl-lr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~-~~~~lf~aas  254 (318)
T KOG0659|consen  177 RQYGTGVDMWAVGCIFAELL-LRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKP-PLNNLFPAAS  254 (318)
T ss_pred             hhcCCcchhhhHHHHHHHHH-ccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCC-cccccccccc
Confidence            88999999999999999999 789999999999999999999999999999999999998776654444 3334777889


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      .++.+|+.+|+..||.+|+|+.|+|+|+||++.+.+
T Consensus       255 ~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p  290 (318)
T KOG0659|consen  255 SDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP  290 (318)
T ss_pred             HHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence            999999999999999999999999999999976543

>KOG0593|consensus

Probab=100.00  E-value=4e-57  Score=348.37  Aligned_cols=271  Identities=37%  Similarity=0.634  Sum_probs=237.5

Q ss_pred             CeeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      +||+|+++.||+.||||++.. ..+....+-.++|+.++++++|+|+|.++++|.....+++|+|||+.+.++.+.....
T Consensus        17 vV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe~~p~   96 (396)
T KOG0593|consen   17 VVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHELERYPN   96 (396)
T ss_pred             EEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHHHHhccC
Confidence            699999999999999999987 4456677889999999999999999999999999999999999999999999999888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .++.+.+..++.|++.|+.|+|+++++||||||+||+++.+|.+||+|||+++.+..+...++..+.|.||+|||.+.+.
T Consensus        97 G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGD  176 (396)
T KOG0593|consen   97 GVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGD  176 (396)
T ss_pred             CCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhccc
Confidence            89999999999999999999999999999999999999999999999999999998888999999999999999999998


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCC--CCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPG--MNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      .+|+...||||+||++.||++ +.|+|++.++.+.+..|+..++...+.-..-  .+-....-.++......+...-.+.
T Consensus       177 tqYG~pVDiWAiGCv~aEl~~-G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~  255 (396)
T KOG0593|consen  177 TQYGKPVDIWAIGCVFAELLT-GEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPK  255 (396)
T ss_pred             CcCCCcccchhhhHHHHHHhc-CCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhccc
Confidence            789999999999999999995 5778999999999999999998875532211  1111111122333333345555677


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      ++..+.+|++.||+.||.+|+|.+++|.||+|.+.
T Consensus       256 ~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~  290 (396)
T KOG0593|consen  256 ISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF  290 (396)
T ss_pred             chHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence            88999999999999999999999999999999654

>KOG0581|consensus

Probab=100.00  E-value=5.3e-56  Score=351.53  Aligned_cols=243  Identities=26%  Similarity=0.396  Sum_probs=211.9

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCe-EEEEEecCcccHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKK-LTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~-~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      +||+++++.|++.+|+|++....+....+.+.+|+++++..+|||||++|++|.++.. ++|+|||++|+.++.+....+
T Consensus        94 ~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g  173 (364)
T KOG0581|consen   94 TVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVG  173 (364)
T ss_pred             EEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcC
Confidence            4999999999999999999777777788999999999999999999999999999994 999999999888888877778


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      .++|.....++.+++.||.|||+ ++|+||||||+|++++..|.+||+|||.+..+...  ......||..|||||.+.+
T Consensus       174 ~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~a~tfvGT~~YMsPERi~g  251 (364)
T KOG0581|consen  174 RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--IANTFVGTSAYMSPERISG  251 (364)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--hcccccccccccChhhhcC
Confidence            99999999999999999999995 99999999999999999999999999999887644  3345688999999999988


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCC----CChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPG----SDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      .. |+.++||||||+.++|+.+|+.|+...    ....+.+..+..   .++                         +..
T Consensus       252 ~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~pp-------------------------P~l  302 (364)
T KOG0581|consen  252 ES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPP-------------------------PRL  302 (364)
T ss_pred             Cc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCC-------------------------CCC
Confidence            87 799999999999999999999996553    233444444433   111                         223


Q ss_pred             Cc-cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         235 AP-KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       235 ~~-~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      +. .+|++++.||..||++||.+|||++|+++|||+++...
T Consensus       303 P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  303 PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED  343 (364)
T ss_pred             CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence            33 38999999999999999999999999999999996643

>KOG0575|consensus

Probab=100.00  E-value=4.4e-55  Score=365.39  Aligned_cols=240  Identities=27%  Similarity=0.427  Sum_probs=219.7

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      +|.+++..+|+.||+|++.+  .......+.+.+|+++.++|+|||||+++++|++++++|||.|+|..+.+..+.+..+
T Consensus        34 cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk  113 (592)
T KOG0575|consen   34 CYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRK  113 (592)
T ss_pred             EEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcC
Confidence            69999999999999999998  5677778999999999999999999999999999999999999998777777777789


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      +++|.+++.+++||+.||.|||+++|+|||||..|++++++.++||+|||+++.+..+.......+|||.|.|||++...
T Consensus       114 ~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~  193 (592)
T KOG0575|consen  114 PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKS  193 (592)
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccC
Confidence            99999999999999999999999999999999999999999999999999999998776666777999999999999866


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      . ++..+||||+||++|.|++|+.| |...+..+....+..                             .-..+|.++|
T Consensus       194 g-HsfEvDiWSlGcvmYtLL~G~PP-Fetk~vkety~~Ik~-----------------------------~~Y~~P~~ls  242 (592)
T KOG0575|consen  194 G-HSFEVDIWSLGCVMYTLLVGRPP-FETKTVKETYNKIKL-----------------------------NEYSMPSHLS  242 (592)
T ss_pred             C-CCCchhhhhhhhHHHhhhhCCCC-cccchHHHHHHHHHh-----------------------------cCcccccccC
Confidence            6 79999999999999999966554 999999999998877                             3334566899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      .++++||.+||+.||.+|||++++|.|+||+..
T Consensus       243 ~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g  275 (592)
T KOG0575|consen  243 AEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG  275 (592)
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence            999999999999999999999999999999654

>KOG0615|consensus

Probab=100.00  E-value=5.8e-56  Score=354.59  Aligned_cols=246  Identities=27%  Similarity=0.412  Sum_probs=207.2

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCC------CCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEG------VPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~------~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~   74 (282)
                      |-+|..++||+.||||++++.....      ......+|+++|++++|||||+++++|+.+...|+|+||++| ++.+.+
T Consensus       188 Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~v  267 (475)
T KOG0615|consen  188 VKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKV  267 (475)
T ss_pred             EEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHH
Confidence            7789999999999999999822111      234467999999999999999999999999999999999976 555555


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC---CcEEEEecCCccccCCCcccccccccccccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN---GELKLADFGLARAFGIPVKCYSAEVVTLWYR  151 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  151 (282)
                      .. ++.+.++....+++|++.|+.|||++||+||||||+||++..+   -.+||.|||+++..+ ....+...+||+.|.
T Consensus       268 v~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g-~~sfm~TlCGTpsYv  345 (475)
T KOG0615|consen  268 VA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG-EGSFMKTLCGTPSYV  345 (475)
T ss_pred             Hh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc-cceehhhhcCCcccc
Confidence            54 8899999999999999999999999999999999999999776   679999999999887 556667789999999


Q ss_pred             ChhhhcCC--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         152 PPDVLFGA--KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSM  229 (282)
Q Consensus       152 aPE~~~~~--~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
                      |||++.+.  ..+..+.|+||+||++|-+++|..||-...++....+++.++.-...+..                    
T Consensus       346 APEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~--------------------  405 (475)
T KOG0615|consen  346 APEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ--------------------  405 (475)
T ss_pred             ChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh--------------------
Confidence            99999654  33456899999999999999888886555555556677766543333322                    


Q ss_pred             CccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                           ...+|++..+||.+||..||++|||+.++|+||||+..++
T Consensus       406 -----w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~  445 (475)
T KOG0615|consen  406 -----WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC  445 (475)
T ss_pred             -----hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence                 2458999999999999999999999999999999997764

>KOG0663|consensus

Probab=100.00  E-value=5.4e-54  Score=335.02  Aligned_cols=275  Identities=44%  Similarity=0.788  Sum_probs=243.8

Q ss_pred             CeeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC--CeEEEEEecCcccHHHHHHhc
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE--KKLTLVFEHCDQDLKKYFDSL   77 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~--~~~~iv~e~~~g~l~~~~~~~   77 (282)
                      +||+|+|++|++.||+|+++. ....+-.-..++|++++.+++|||||.+.+++.-.  +.+|+|||||+.++.+.+...
T Consensus        91 iVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~EhDLksl~d~m  170 (419)
T KOG0663|consen   91 VVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEHDLKSLMETM  170 (419)
T ss_pred             eEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHhhHHHHHHhc
Confidence            699999999999999999998 44555567789999999999999999999988744  579999999999999999988


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      ..++...++..+..|++.|++|||..+|+|||||++|++++..|.+||+|||+++..+.+...++..+.|.+|+|||++.
T Consensus       171 ~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLL  250 (419)
T KOG0663|consen  171 KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLL  250 (419)
T ss_pred             cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhc
Confidence            88999999999999999999999999999999999999999999999999999999999988899999999999999999


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCC-CCCCCCcc-ccC
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM-YHPSMSFS-QVA  235 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~  235 (282)
                      +...|+.+.|+||+||++.|++ .+.|.|++....+.+..+...++.|....|++.......+.... .+.-.... .+.
T Consensus       251 G~~tyst~iDMWSvGCI~aE~l-~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~  329 (419)
T KOG0663|consen  251 GAKTYSTAVDMWSVGCIFAELL-TQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFG  329 (419)
T ss_pred             CCcccCcchhhhhHHHHHHHHH-hcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhcc
Confidence            9988999999999999999999 67888999999999999999999999999999888776642111 11111111 222


Q ss_pred             cc-CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         236 PK-LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       236 ~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      .. +++...+|+..+|..||++|.|+++.|+|.||...+.+.
T Consensus       330 ~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~  371 (419)
T KOG0663|consen  330 ALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPI  371 (419)
T ss_pred             ccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCC
Confidence            22 679999999999999999999999999999999976544

>KOG0594|consensus

Probab=100.00  E-value=4.9e-53  Score=334.09  Aligned_cols=278  Identities=55%  Similarity=0.921  Sum_probs=254.9

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCC-CCCCccHHHHHHHHhhCCCCC-ccceeeeeeeCC------eEEEEEecCcccHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGN-EGVPSSALREICLLKELKHKN-IVRLYDVLHSEK------KLTLVFEHCDQDLKK   72 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~-i~~~~~~~~~~~------~~~iv~e~~~g~l~~   72 (282)
                      .||+|+++.+|+.||+|+++.... ++......+|+-+++.++|+| |+++++++.+++      .+++|+||.+-++..
T Consensus        26 ~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~DL~~  105 (323)
T KOG0594|consen   26 VVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDRDLKK  105 (323)
T ss_pred             EEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecccHHH
Confidence            499999999999999999999544 778899999999999999999 999999999887      899999999999999


Q ss_pred             HHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccccccccccc
Q psy6044          73 YFDSLN---GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW  149 (282)
Q Consensus        73 ~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~  149 (282)
                      ++....   ..++...++.++.||+.||+|||++||+||||||.|++++++|.+||+|||++...+.+...++...+|.+
T Consensus       106 ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlW  185 (323)
T KOG0594|consen  106 YMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLW  185 (323)
T ss_pred             HHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEee
Confidence            998876   35888999999999999999999999999999999999999999999999999988878788888999999


Q ss_pred             ccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCC-CCCCCCC
Q psy6044         150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP-FPMYHPS  228 (282)
Q Consensus       150 ~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  228 (282)
                      |+|||++.+...|+...||||+||++.||++ +.|+|++....+.+..+...++.|....|+......+++. ++.....
T Consensus       186 YRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~-~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~  264 (323)
T KOG0594|consen  186 YRAPEVLLGSTSYSTSVDIWSLGCIFAEMFT-RRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGP  264 (323)
T ss_pred             ccCHHHhcCCCcCCCCcchHhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCc
Confidence            9999999999779999999999999999995 7888999999999999999999999999999999999985 5555556


Q ss_pred             CCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccchhhh
Q psy6044         229 MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKSE  279 (282)
Q Consensus       229 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~  279 (282)
                      .......+..+++..+++.+||+.+|.+|.|++.+|+||||..++...+..
T Consensus       265 ~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~~~  315 (323)
T KOG0594|consen  265 KDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSSQL  315 (323)
T ss_pred             cchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchhhh
Confidence            666677777778999999999999999999999999999999997766544

>KOG0600|consensus

Probab=100.00  E-value=1.6e-53  Score=348.45  Aligned_cols=267  Identities=42%  Similarity=0.738  Sum_probs=237.7

Q ss_pred             eeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC--CeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE--KKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~--~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||+|++..+|+.||+|+++. ...++......+|+.++++|+||||+++.+.+.+.  ..+|+|+||++.+|.-.+....
T Consensus       133 VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~  212 (560)
T KOG0600|consen  133 VYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPG  212 (560)
T ss_pred             eeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCC
Confidence            89999999999999999999 44666778889999999999999999999999876  7999999999999999888766


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~  157 (282)
                      -.+++.++..+++||+.||.|+|++|+.|||||.+|||++.+|.+||+|||+++...... ..++..+.|++|+|||++.
T Consensus       213 vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLL  292 (560)
T KOG0600|consen  213 VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLL  292 (560)
T ss_pred             cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhc
Confidence            789999999999999999999999999999999999999999999999999999765443 3477778899999999999


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCC-CCCccccCc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHP-SMSFSQVAP  236 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  236 (282)
                      +...|+.+.|+||.|||+.||+ .+.|++++.+..+.+..|.+..+.|....|+ ...+..+..+..... ...+.+...
T Consensus       293 G~t~Yg~aVDlWS~GCIl~El~-~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~~kp~~~y~r~l~E~~~  370 (560)
T KOG0600|consen  293 GATSYGTAVDLWSVGCILAELF-LGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATIFKPQQPYKRRLRETFK  370 (560)
T ss_pred             CCcccccceeehhhhHHHHHHH-cCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCCcccccCCCCcccchHHHHhc
Confidence            9988999999999999999999 5677799999999999999999999999998 444444333332222 445566678


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS  270 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  270 (282)
                      .+++...+|+..||..||.+|.|+.++|+|+||+
T Consensus       371 ~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~  404 (560)
T KOG0600|consen  371 DFPASALDLLEKLLSLDPDKRGTASSALQSEYFT  404 (560)
T ss_pred             cCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence            8999999999999999999999999999999994

>KOG0661|consensus

Probab=100.00  E-value=2.7e-54  Score=350.59  Aligned_cols=269  Identities=35%  Similarity=0.590  Sum_probs=236.0

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCC-CCCccceeeeeeeCC-eEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK-HKNIVRLYDVLHSEK-KLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~-~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|+.+.+|+.||||.+....-.-....-++|+..+++++ ||||+++.+++.++. .+|+||||++.++.+.+..++.
T Consensus        26 V~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~NLYqLmK~R~r  105 (538)
T KOG0661|consen   26 VYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDCNLYQLMKDRNR  105 (538)
T ss_pred             EEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhhhHHHHHhhcCC
Confidence            89999999999999999987332222345678999999998 999999999999887 9999999999999999999888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .+++..+..|+.||+.||+|+|++|+.|||+||+||++..+..+||+|||+++.+. ....++..+.|.+|+|||++...
T Consensus       106 ~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~-SkpPYTeYVSTRWYRAPEvLLrs  184 (538)
T KOG0661|consen  106 LFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR-SKPPYTEYVSTRWYRAPEVLLRS  184 (538)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc-cCCCcchhhhcccccchHHhhhc
Confidence            99999999999999999999999999999999999999989999999999999876 45667888899999999999888


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCC-CCCCCCCccccCccC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFP-MYHPSMSFSQVAPKL  238 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  238 (282)
                      ..|+.+.|+||+||+++|+. .-+|+|++.+..|.+.++...++.|....|+....+...-.+. .......+....+..
T Consensus       185 ~~Ys~pvD~wA~GcI~aEl~-sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~  263 (538)
T KOG0661|consen  185 GYYSSPVDMWAVGCIMAELY-SLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNA  263 (538)
T ss_pred             cccCCchHHHHHHHHHHHHH-HhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCccc
Confidence            88999999999999999999 5688899999999999999999999988888743333322211 122333566666779


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      ++++.++|..||.+||.+|||+.++|+||||+.-
T Consensus       264 s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~  297 (538)
T KOG0661|consen  264 SSEAASLIERLLAWDPDKRPTASQALQHPFFQVG  297 (538)
T ss_pred             CHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence            9999999999999999999999999999999854

>KOG0662|consensus

Probab=100.00  E-value=6e-52  Score=298.08  Aligned_cols=272  Identities=77%  Similarity=1.284  Sum_probs=264.3

Q ss_pred             eeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      ||+|+++.+++.||+|.++. ..+++.....++|+-+++.++|.||++++++...++.+.+|+|+|..++..++...++.
T Consensus        18 vfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdqdlkkyfdslng~   97 (292)
T KOG0662|consen   18 VFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSLNGD   97 (292)
T ss_pred             eEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhHHHHHHHHhcCCc
Confidence            89999999999999999999 77788899999999999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      ++.+.+..++.|++.||.++|++++.|+|+||.|.+++.+|.+|+.|||+++..+.+...++....|.+|++|.++.+.+
T Consensus        98 ~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgak  177 (292)
T KOG0662|consen   98 LDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK  177 (292)
T ss_pred             CCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeee
Confidence            99999999999999999999999999999999999999999999999999999998888888889999999999999999


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                      .|+...|+||-||++.|+...+.|.|++.+..+.+.++...++.+..+.|+.+..++++++++.++.-.++.++-+.++.
T Consensus       178 ly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns  257 (292)
T KOG0662|consen  178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNS  257 (292)
T ss_pred             hhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcc
Confidence            89999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      .-++++.++|..+|.+|+++++.++||||.+..
T Consensus       258 ~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  258 TGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             hhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence            999999999999999999999999999998753

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.3e-50  Score=329.80  Aligned_cols=268  Identities=52%  Similarity=0.908  Sum_probs=223.7

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||+|.++.+++.||+|++...........+.+|+.++++++||||+++++++.+++..++|+||++|++.+.+......
T Consensus        20 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~   99 (288)
T cd07871          20 TVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNL   99 (288)
T ss_pred             EEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCcCHHHHHHhcCCC
Confidence            38999999999999999997654444456788999999999999999999999999999999999999988888776667


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..+..++.||+.||++||++||+|+||||+||+++.++.++|+|||.+..............++..|+|||.+.+..
T Consensus       100 ~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  179 (288)
T cd07871         100 MSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST  179 (288)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCc
Confidence            89999999999999999999999999999999999999999999999999876544333344456788999999987665


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCC-CCCCccccCccCC
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYH-PSMSFSQVAPKLT  239 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  239 (282)
                      .++.++|+||+|+++|+|++|..| |.+.+..+....+....+.++.+.|+......++....... ...........++
T Consensus       180 ~~~~~~DiwslG~~l~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (288)
T cd07871         180 EYSTPIDMWGVGCILYEMATGRPM-FPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLD  258 (288)
T ss_pred             ccCcHHHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCC
Confidence            579999999999999999988766 77888888888888888888888877655444433322111 1112223345688


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      +++.+||++||+.||.+|||++|+++||||
T Consensus       259 ~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         259 TDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             HHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0592|consensus

Probab=100.00  E-value=4.3e-51  Score=336.81  Aligned_cols=243  Identities=28%  Similarity=0.459  Sum_probs=216.0

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHhc
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSL   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~   77 (282)
                      |++|+++.+++.||||++.+  ...+.-.+-+..|-.+|.+| .||.|++++--|+++..+|+|+||++ |++++++.+ 
T Consensus        89 V~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K-  167 (604)
T KOG0592|consen   89 VVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKK-  167 (604)
T ss_pred             EEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHH-
Confidence            89999999999999999998  44555667888999999999 89999999999999999999999996 678887776 


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc-----------c--ccc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC-----------Y--SAE  144 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-----------~--~~~  144 (282)
                      -+.+++...+.++.+|+.||+|||++||+||||||+|||++.+++++|.|||.+..++.....           .  ...
T Consensus       168 ~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SF  247 (604)
T KOG0592|consen  168 YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSF  247 (604)
T ss_pred             hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccce
Confidence            699999999999999999999999999999999999999999999999999999887532111           1  335


Q ss_pred             cccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM  224 (282)
Q Consensus       145 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (282)
                      +||-.|.+||++.... .++.+|+|+|||++|+|+.| .|+|.+.+.--..+++++..                      
T Consensus       248 VGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG-~PPFra~NeyliFqkI~~l~----------------------  303 (604)
T KOG0592|consen  248 VGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAG-QPPFRAANEYLIFQKIQALD----------------------  303 (604)
T ss_pred             eeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcC-CCCCccccHHHHHHHHHHhc----------------------
Confidence            7889999999997776 69999999999999999955 55589998888899988843                      


Q ss_pred             CCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         225 YHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       225 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                             -+++..+++.+.+||+++|..||.+|+|+++|-+||||.+++++.
T Consensus       304 -------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  304 -------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             -------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence                   335567899999999999999999999999999999999999876

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=9.1e-50  Score=329.56  Aligned_cols=274  Identities=50%  Similarity=0.827  Sum_probs=220.1

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEI   81 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~   81 (282)
                      ||+|.++.+|+.||+|++...........+.+|+.+++.++||||+++++++.++...++|+||+++++.+.+....+.+
T Consensus        21 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~  100 (303)
T cd07869          21 VYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGL  100 (303)
T ss_pred             EEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCCcCHHHHHHhCCCCC
Confidence            89999999999999999986444444557889999999999999999999999999999999999999999888767789


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCCC
Q psy6044          82 DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKL  161 (282)
Q Consensus        82 ~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  161 (282)
                      ++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+..............+++.|+|||.+.+...
T Consensus       101 ~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  180 (303)
T cd07869         101 HPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE  180 (303)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCC
Confidence            99999999999999999999999999999999999999999999999998765433333344567889999999876655


Q ss_pred             CCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCC-CCCCCcccc--CccC
Q psy6044         162 YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY-HPSMSFSQV--APKL  238 (282)
Q Consensus       162 ~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~  238 (282)
                      ++.++|+||+||++|+|++|..|+....+..+....+....+.+....++.........+.... .........  ...+
T Consensus       181 ~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (303)
T cd07869         181 YSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSY  260 (303)
T ss_pred             CCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCC
Confidence            7899999999999999999988865555666777777777666666555544332222211000 000011111  1135


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ++.+.+|+.+||+.||++|||++++++||||++++..
T Consensus       261 ~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~~  297 (303)
T cd07869         261 VNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPPR  297 (303)
T ss_pred             ChHHHHHHHHHhccCchhccCHHHHhcCcccccCChh
Confidence            6889999999999999999999999999999998754

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0588|consensus

Probab=100.00  E-value=5.6e-51  Score=343.09  Aligned_cols=242  Identities=28%  Similarity=0.498  Sum_probs=215.2

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      |..|++..||+.+|||++.+  .........+.+|+-+|+.++|||++++++++++..++|+|.||++| .+.+++.. .
T Consensus        28 vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~-k  106 (786)
T KOG0588|consen   28 VRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVR-K  106 (786)
T ss_pred             ehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHh-h
Confidence            67899999999999999998  44555678899999999999999999999999999999999999986 55555554 8


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      |++++.++.++++||+.|+.|+|..+|+|+|+||+|++++..+++||+|||.+.... +.......+|+++|.+||++.+
T Consensus       107 G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-~gklLeTSCGSPHYA~PEIV~G  185 (786)
T KOG0588|consen  107 GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV-PGKLLETSCGSPHYAAPEIVSG  185 (786)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc-CCccccccCCCcccCCchhhcC
Confidence            999999999999999999999999999999999999999999999999999997654 3444556689999999999999


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      ..+.+.++||||.|+++|.|+||..| |++.+....+.+...                             +.-+++..+
T Consensus       186 ~pYdG~~sDVWSCGVILfALLtG~LP-FdDdNir~LLlKV~~-----------------------------G~f~MPs~I  235 (786)
T KOG0588|consen  186 RPYDGRPSDVWSCGVILFALLTGKLP-FDDDNIRVLLLKVQR-----------------------------GVFEMPSNI  235 (786)
T ss_pred             CCCCCCccccchhHHHHHHHHhCCCC-CCCccHHHHHHHHHc-----------------------------CcccCCCcC
Confidence            99889999999999999999999999 777777777777666                             444566789


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      |+++++||++||..||++|+|.++|+.|||+.+....
T Consensus       236 s~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~  272 (786)
T KOG0588|consen  236 SSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL  272 (786)
T ss_pred             CHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence            9999999999999999999999999999999976443

>KOG0598|consensus

Probab=100.00  E-value=8.1e-51  Score=321.94  Aligned_cols=247  Identities=27%  Similarity=0.404  Sum_probs=218.5

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||.++.+++++.||+|++++  ............|..++..++||.|++++-.|++.+.+|+|+||+.|+-+.+..+..+
T Consensus        41 V~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg  120 (357)
T KOG0598|consen   41 VFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREG  120 (357)
T ss_pred             EEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcC
Confidence            78999999999999999998  3344557889999999999999999999999999999999999999877777777789


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .++|+.+..++..|+.||.|||+.||+|||+||+|||++.+|.++|.|||+++..-.........+||+.|+|||++...
T Consensus       121 ~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~  200 (357)
T KOG0598|consen  121 RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGK  200 (357)
T ss_pred             CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcC
Confidence            99999999999999999999999999999999999999999999999999998654444445557899999999999888


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      . |+..+|.||||+++|+|++|..| |.+.+.....+.+.....                            ...+..++
T Consensus       201 g-y~~~vDWWsLGillYeML~G~pP-F~~~~~~~~~~~I~~~k~----------------------------~~~p~~ls  250 (357)
T KOG0598|consen  201 G-YDKAVDWWSLGILLYEMLTGKPP-FYAEDVKKMYDKILKGKL----------------------------PLPPGYLS  250 (357)
T ss_pred             C-CCcccchHhHHHHHHHHhhCCCC-CcCccHHHHHHHHhcCcC----------------------------CCCCccCC
Confidence            6 79999999999999999977666 888888888888877431                            22234489


Q ss_pred             HHHHHHHHHhcccCCCCCC----CHHHHhcCCCccCCccchhh
Q psy6044         240 AKGRDLLQRLLVCNPVQRM----SAEDAMSHIYFSDLNVAIKS  278 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rp----s~~~ll~h~~~~~~~~~~~~  278 (282)
                      .+.+++++++|..||++|.    ++++|-+||||++++++...
T Consensus       251 ~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~  293 (357)
T KOG0598|consen  251 EEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLL  293 (357)
T ss_pred             HHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHH
Confidence            9999999999999999996    79999999999999998654

>KOG0660|consensus

Probab=100.00  E-value=3.3e-51  Score=323.07  Aligned_cols=272  Identities=39%  Similarity=0.695  Sum_probs=232.0

Q ss_pred             CeeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeee-----CCeEEEEEecCcccHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHS-----EKKLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~-----~~~~~iv~e~~~g~l~~~~   74 (282)
                      +|.+|.++.+|+.||||++.. .......+..++|+.+++.++|+||+.+.+++..     -+.+|+|+|+++.+|...+
T Consensus        37 vVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMetDL~~ii  116 (359)
T KOG0660|consen   37 VVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELMETDLHQII  116 (359)
T ss_pred             eEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHhhHHHHHH
Confidence            589999999999999999986 4455567889999999999999999999999875     3689999999977776665


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCC--CccccccccccccccC
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGI--PVKCYSAEVVTLWYRP  152 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~~~a  152 (282)
                      .. +..++++.+..++.||+.||+|+|+.+++|||+||.|++++.+..+||+|||+++....  ....++..+.|.+|+|
T Consensus       117 k~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRA  195 (359)
T KOG0660|consen  117 KS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRA  195 (359)
T ss_pred             Hc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecC
Confidence            54 66699999999999999999999999999999999999999999999999999988753  2344566777999999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCC---CCCCCCCCCCCCCCC
Q psy6044         153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN---LLPDFKPFPMYHPSM  229 (282)
Q Consensus       153 PE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~  229 (282)
                      ||+......|+...||||+||++.||+ +++|.|++.+..+.++.+...++.++++......   ...-.+.++ .....
T Consensus       196 PElll~~~~Yt~aiDiWSvGCI~AEmL-~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp-~~p~~  273 (359)
T KOG0660|consen  196 PELLLNSSEYTKAIDIWSVGCILAEML-TGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLP-QIPKQ  273 (359)
T ss_pred             HHHHhccccccchhhhhhhhHHHHHHH-cCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCC-CCCCC
Confidence            999988877999999999999999999 6788899999999999999999999776554332   111111122 33344


Q ss_pred             CccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ++..+.++.++.+.+|+.+||..||.+|+|++|+|+||||...-++
T Consensus       274 ~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp  319 (359)
T KOG0660|consen  274 PFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP  319 (359)
T ss_pred             CHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence            6777788999999999999999999999999999999999987444

>KOG0583|consensus

Probab=100.00  E-value=2.3e-49  Score=330.22  Aligned_cols=239  Identities=31%  Similarity=0.528  Sum_probs=209.1

Q ss_pred             eeeeeeCCCCceEEEeeeecCC---C-CCCCccHHHHHHHHhhCC-CCCccceeeeeeeCCeEEEEEecCcc-cHHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG---N-EGVPSSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~---~-~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~   75 (282)
                      |+.|.+..+|+.||+|+++...   . ......+.+|+.+++.++ ||||+++++++.....+|+|||||.| ++++.+.
T Consensus        33 V~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~  112 (370)
T KOG0583|consen   33 VKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIV  112 (370)
T ss_pred             EEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHH
Confidence            8899999999999999777631   1 134566778999999998 99999999999999999999999985 8888887


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC-CcEEEEecCCccccCCCccccccccccccccChh
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPD  154 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE  154 (282)
                      . .+++.|..+..++.|+++|++|||++||+||||||+|++++.+ +++||+|||++.............+|++.|+|||
T Consensus       113 ~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPE  191 (370)
T KOG0583|consen  113 N-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPE  191 (370)
T ss_pred             H-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHH
Confidence            7 8999999999999999999999999999999999999999999 9999999999988743445556678999999999


Q ss_pred             hhcCCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         155 VLFGAK-LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       155 ~~~~~~-~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      ++.+.. +.+.++||||+|+++|.|++|..| |...+.......+..                             ....
T Consensus       192 vl~~~~~Y~g~~aDvWS~GViLy~ml~G~~P-F~d~~~~~l~~ki~~-----------------------------~~~~  241 (370)
T KOG0583|consen  192 VLSGKGTYSGKAADVWSLGVILYVLLCGRLP-FDDSNVPNLYRKIRK-----------------------------GEFK  241 (370)
T ss_pred             HhCCCCCcCCchhhhhhhHHHHHHHHhCCCC-CCCccHHHHHHHHhc-----------------------------CCcc
Confidence            998877 667999999999999999999999 666666666666544                             2233


Q ss_pred             cCccC-CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q psy6044         234 VAPKL-TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD  271 (282)
Q Consensus       234 ~~~~~-~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  271 (282)
                      ++..+ |++++.++++||..||.+|+|+.++++||||+.
T Consensus       242 ~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  242 IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            44556 999999999999999999999999999999997

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3e-49  Score=323.61  Aligned_cols=268  Identities=79%  Similarity=1.312  Sum_probs=228.0

Q ss_pred             eeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      ||+|+++.+|+.+|+|.+.. .........+.+|+.++++++||||+++++++.+....++++||+++++.+.+....+.
T Consensus        16 vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~   95 (284)
T cd07839          16 VFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGD   95 (284)
T ss_pred             EEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCCCHHHHHHhcCCC
Confidence            89999999999999999976 33344456788899999999999999999999999999999999999999888776778


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+...+..........++..|+|||.+.+..
T Consensus        96 ~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  175 (284)
T cd07839          96 IDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK  175 (284)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCc
Confidence            99999999999999999999999999999999999999999999999999876654433334455678899999987766


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                      .++.++|+||||+++|+|++|+.|++.+.+..+....+....+.+....++......+............+.+..+.+++
T Consensus       176 ~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (284)
T cd07839         176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNS  255 (284)
T ss_pred             ccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCH
Confidence            57899999999999999999999999888888888888887777766666554444444434333333344555667899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      ++.++|++||+.||.+|||++++++||||
T Consensus       256 ~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         256 TGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             HHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            99999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0658|consensus

Probab=100.00  E-value=3.4e-50  Score=317.85  Aligned_cols=269  Identities=38%  Similarity=0.585  Sum_probs=230.0

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC-----eEEEEEecCcccHHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK-----KLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~-----~~~iv~e~~~g~l~~~~~   75 (282)
                      +||+|....+++.||||+.-....     .-.+|+++|+.++||||+++.-+|....     ...+|+||++.++...+.
T Consensus        39 ~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~tL~~~~r  113 (364)
T KOG0658|consen   39 VVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPETLYRVIR  113 (364)
T ss_pred             eEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchHHHHHHHH
Confidence            599999999999999998865333     3347999999999999999999887542     456999999998888876


Q ss_pred             h---cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC-CcEEEEecCCccccCCCcccccccccccccc
Q psy6044          76 S---LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYR  151 (282)
Q Consensus        76 ~---~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  151 (282)
                      .   .+..++.-.++-+.+||++||+|||+.||+||||||.|+++|.+ |.+||+|||+++.+....++ .....+..|+
T Consensus       114 ~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn-iSYicSRyYR  192 (364)
T KOG0658|consen  114 HYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN-ISYICSRYYR  192 (364)
T ss_pred             HHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc-eeEEEecccc
Confidence            4   36778999999999999999999999999999999999999977 99999999999998755554 4457789999


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSF  231 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
                      |||.+.+...|+.+.||||.||++.||+ .+.|+|++.+..+.+..+.+.++.|..+....++-...-..++........
T Consensus       193 aPELifga~~Yt~~IDiWSaGCV~aELl-~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~  271 (364)
T KOG0658|consen  193 APELIFGATEYTTSIDIWSAGCVMAELL-KGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWH  271 (364)
T ss_pred             CHHHHcCccccCceeEEhhhhHHHHHHh-cCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccce
Confidence            9999999998999999999999999999 678889999999999999999999988877776655443334433333222


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      .-.....++++.+|+.++|..+|.+|.++.+++.||||..++.+.
T Consensus       272 ~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~  316 (364)
T KOG0658|consen  272 KVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN  316 (364)
T ss_pred             eecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence            336677999999999999999999999999999999999987763

>KOG0595|consensus

Probab=100.00  E-value=2.1e-49  Score=317.04  Aligned_cols=244  Identities=32%  Similarity=0.475  Sum_probs=209.2

Q ss_pred             CeeeeeeCCCCceEEEeeeecCC-CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVG-NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      +||+|++++++..||||.+.+.. ..+..+.+..|+.+++.++|||||.++++++.++.+|+|||||+|+-++.+....+
T Consensus        25 vVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~  104 (429)
T KOG0595|consen   25 VVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRG  104 (429)
T ss_pred             EEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcC
Confidence            59999999999999999999843 55567788999999999999999999999999999999999999665555666578


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC------CcEEEEecCCccccCCCccccccccccccccCh
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN------GELKLADFGLARAFGIPVKCYSAEVVTLWYRPP  153 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aP  153 (282)
                      .+++..++.++.||+.||++||+++|+||||||+||+++..      ..+||+|||+++.+. +..-....+|++-||||
T Consensus       105 ~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~-~~~~a~tlcGSplYMAP  183 (429)
T KOG0595|consen  105 RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ-PGSMAETLCGSPLYMAP  183 (429)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC-chhHHHHhhCCccccCH
Confidence            99999999999999999999999999999999999999765      468999999998886 33334456889999999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      |++.... |+.|+|+||+|+++|++++|..| |...+..+....+.+....                          ...
T Consensus       184 EV~~~~~-YdAKADLWSiG~Ilyq~l~g~~P-f~a~t~~eL~~~~~k~~~~--------------------------~~~  235 (429)
T KOG0595|consen  184 EVIMSQQ-YDAKADLWSIGTILYQCLTGKPP-FDAETPKELLLYIKKGNEI--------------------------VPV  235 (429)
T ss_pred             HHHHhcc-ccchhhHHHHHHHHHHHHhCCCC-ccccCHHHHHHHHhccccc--------------------------cCc
Confidence            9998777 79999999999999999987766 8888888888765553222                          122


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      .+...++.+.+++...+..+|.+|.++.+-+.|+++..-.
T Consensus       236 ~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  236 LPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             hhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            3344677778999999999999999999999999987654

>KOG0578|consensus

Probab=100.00  E-value=1.9e-49  Score=329.15  Aligned_cols=242  Identities=26%  Similarity=0.395  Sum_probs=208.0

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||.|+...+++.||||++...... ..+.+++|+.+|+..+|+|||++++.|.....+|+||||++|+.+..... ...
T Consensus       288 ~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt-~~~  365 (550)
T KOG0578|consen  288 GVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVT-KTR  365 (550)
T ss_pred             ceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhh-ccc
Confidence            4899999999999999999984433 35789999999999999999999999999999999999998766666555 456


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      ++|.++..++..++.||+|||.+||+|+|||.+||+++.+|.+||+|||++..+.........-+||+.|+|||+.....
T Consensus       366 ~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~  445 (550)
T KOG0578|consen  366 MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKP  445 (550)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcc
Confidence            99999999999999999999999999999999999999999999999999999987777778889999999999997776


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                       |+++.||||||++++||+.|..|++... .-..+..+... +.+.                         -..+..+|+
T Consensus       446 -YG~KVDIWSLGIMaIEMveGEPPYlnE~-PlrAlyLIa~n-g~P~-------------------------lk~~~klS~  497 (550)
T KOG0578|consen  446 -YGPKVDIWSLGIMAIEMVEGEPPYLNEN-PLRALYLIATN-GTPK-------------------------LKNPEKLSP  497 (550)
T ss_pred             -cCccccchhhhhHHHHHhcCCCCccCCC-hHHHHHHHhhc-CCCC-------------------------cCCccccCH
Confidence             7999999999999999998888866633 33333333331 1111                         123456999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      .+++|+.+||+.||.+|+++.+||+||||+.-
T Consensus       498 ~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  498 ELKDFLDRCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             HHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence            99999999999999999999999999999644

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.1e-48  Score=320.59  Aligned_cols=273  Identities=54%  Similarity=0.949  Sum_probs=224.1

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||+|+++.+++.||+|.+...........+.+|+.++++++||||+++++++..++..++|+||+++++.+.+......
T Consensus        21 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~  100 (309)
T cd07872          21 TVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNI  100 (309)
T ss_pred             EEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCCCHHHHHHhcCCC
Confidence            38999999999999999998754444556788999999999999999999999999999999999999999888776667


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+..
T Consensus       101 ~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  180 (309)
T cd07872         101 MSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSS  180 (309)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCC
Confidence            89999999999999999999999999999999999999999999999999876543333333445688899999987665


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCC--CCCCCCCCCccccCccC
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP--FPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  238 (282)
                      .++.++|+||+|+++|+|++|..| |.+.+..+....+....+.+....|+.......+..  ++.... .........+
T Consensus       181 ~~~~~~DiwslG~il~el~tg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  258 (309)
T cd07872         181 EYSTQIDMWGVGCIFFEMASGRPL-FPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKP-QPLINHAPRL  258 (309)
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCC-CchhhhccCC
Confidence            578999999999999999988666 788888888888888888777766655433222211  111111 1112233458


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ++++.++|++||+.||.+|||++++++||||+.+...
T Consensus       259 ~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  295 (309)
T cd07872         259 DTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTR  295 (309)
T ss_pred             CHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccc
Confidence            8999999999999999999999999999999987643

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0582|consensus

Probab=100.00  E-value=1.9e-48  Score=314.49  Aligned_cols=256  Identities=22%  Similarity=0.283  Sum_probs=206.0

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHhc-C
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSL-N   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~-~   78 (282)
                      .||+|++.-+++.||||+++.+.-....+.+.+|+..++.++||||++++..|..+..+|+||.++. |++++.+... .
T Consensus        41 ~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~  120 (516)
T KOG0582|consen   41 VVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYP  120 (516)
T ss_pred             EeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHcc
Confidence            4899999999999999999996555558999999999999999999999999999999999999997 5666665543 3


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccc----ccccccccccChh
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY----SAEVVTLWYRPPD  154 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~----~~~~~~~~~~aPE  154 (282)
                      ..++|..|..++++++.||.|||.+|.+|||+|+.||+++.+|.++|+|||.+..+.......    ....+++.|+|||
T Consensus       121 ~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPE  200 (516)
T KOG0582|consen  121 DGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPE  200 (516)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChH
Confidence            449999999999999999999999999999999999999999999999999876653332222    3447899999999


Q ss_pred             hh-cCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         155 VL-FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       155 ~~-~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      ++ .+..-|+.|+||||||++..|+.+|..| |....+...+-...+  +.++.-..                 ...-.+
T Consensus       201 vl~q~~~GYdfKaDIwSfGITA~ELA~G~aP-f~k~pPmkvLl~tLq--n~pp~~~t-----------------~~~~~d  260 (516)
T KOG0582|consen  201 VLMQQLHGYDFKADIWSFGITACELAHGHAP-FSKYPPMKVLLLTLQ--NDPPTLLT-----------------SGLDKD  260 (516)
T ss_pred             HhhhcccCccchhhhhhhhHHHHHHhcCCCC-cccCChHHHHHHHhc--CCCCCccc-----------------ccCChH
Confidence            95 4445589999999999999999988888 665555444333222  22221100                 001112


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      -...++..++++|..||..||.+|||++++|.|+||++.....
T Consensus       261 ~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~  303 (516)
T KOG0582|consen  261 EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKE  303 (516)
T ss_pred             HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchh
Confidence            2244788999999999999999999999999999999876543

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3e-47  Score=314.30  Aligned_cols=272  Identities=53%  Similarity=0.911  Sum_probs=222.0

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||+|+++.+++.||+|.+...........+.+|+.+++.++||||+++++++..++..++|+||+++++.+.+......
T Consensus        21 ~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~  100 (301)
T cd07873          21 TVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNS  100 (301)
T ss_pred             EEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccccCHHHHHHhcCCC
Confidence            38999999999999999998654444456788999999999999999999999999999999999999998888776678


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+..
T Consensus       101 ~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~  180 (301)
T cd07873         101 INMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGST  180 (301)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCC
Confidence            99999999999999999999999999999999999999999999999999876543333333445678899999987765


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCC-CCCCccccCccCC
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYH-PSMSFSQVAPKLT  239 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  239 (282)
                      .++.++|+||||+++|+|++|..| |...+..+....+......+....|+.......+....... ...........++
T Consensus       181 ~~~~~~Dv~slG~~l~el~tg~~~-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (301)
T cd07873         181 DYSTQIDMWGVGCIFYEMSTGRPL-FPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLD  259 (301)
T ss_pred             CCccHHHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCC
Confidence            578999999999999999987655 77777777788888877777666665432222221111100 0111122335688


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      +.+.+||.+||+.||.+|||++++++||||+.++
T Consensus       260 ~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         260 SDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            9999999999999999999999999999999876

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.5e-48  Score=323.56  Aligned_cols=245  Identities=23%  Similarity=0.320  Sum_probs=202.9

Q ss_pred             CeeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      .||+|.++.+|+.||+|++...  ........+.+|+.+++.++||||+++++++..++..++||||++|+.+......+
T Consensus        10 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   89 (323)
T cd05571          10 KVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE   89 (323)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc
Confidence            3899999999999999999862  22333456788999999999999999999999999999999999876555555557


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +.+++..+..++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++..............|++.|+|||.+.+
T Consensus        90 ~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  169 (323)
T cd05571          90 RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED  169 (323)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcC
Confidence            78999999999999999999999999999999999999999999999999998754333333344567899999999977


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||+||++|+|++|..| |...+.......+...                             ...++..+
T Consensus       170 ~~-~~~~~DiwSlG~il~elltg~~P-f~~~~~~~~~~~~~~~-----------------------------~~~~p~~~  218 (323)
T cd05571         170 ND-YGRAVDWWGLGVVMYEMMCGRLP-FYNQDHEKLFELILME-----------------------------EIRFPRTL  218 (323)
T ss_pred             CC-CCccccCcccchhhhhhhcCCCC-CCCCCHHHHHHHHHcC-----------------------------CCCCCCCC
Confidence            66 69999999999999999998888 5555544444443321                             11233458


Q ss_pred             CHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCccch
Q psy6044         239 TAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~  276 (282)
                      ++.+.+||++||+.||++||     ++.++++||||+++++..
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~  261 (323)
T cd05571         219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQD  261 (323)
T ss_pred             CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence            99999999999999999999     899999999999986543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0597|consensus

Probab=100.00  E-value=6.5e-49  Score=325.44  Aligned_cols=239  Identities=30%  Similarity=0.486  Sum_probs=211.4

Q ss_pred             CeeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      .||+|+.+.+.+.||+|.+.+ ...++..+.+.+|+++++.++||||+.++++|+...++++|+|||.|++...+.. ++
T Consensus        17 ~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g~L~~il~~-d~   95 (808)
T KOG0597|consen   17 RVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVGDLFTILEQ-DG   95 (808)
T ss_pred             eeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhhhHHHHHHh-cc
Confidence            389999999999999999998 5556677889999999999999999999999999999999999999977666555 89


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .++|+.+..++.+++.||.|||+.+|.|+|+||.||++...|.+|++|||+++.++......+..-||+.|+|||...+.
T Consensus        96 ~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~  175 (808)
T KOG0597|consen   96 KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQ  175 (808)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCC
Confidence            99999999999999999999999999999999999999999999999999999999888888888899999999999866


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      . |+..+|.||+||++||+++|+.||+ ..........|...                             -...+...|
T Consensus       176 p-yd~~sDlWslGcilYE~~~G~PPF~-a~si~~Lv~~I~~d-----------------------------~v~~p~~~S  224 (808)
T KOG0597|consen  176 P-YDHTSDLWSLGCILYELYVGQPPFY-ARSITQLVKSILKD-----------------------------PVKPPSTAS  224 (808)
T ss_pred             C-ccchhhHHHHHHHHHHHhcCCCCch-HHHHHHHHHHHhcC-----------------------------CCCCccccc
Confidence            5 8999999999999999998877754 44444444444331                             111234689


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD  271 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  271 (282)
                      ..+.+|+..+|.+||.+|.|..+++.|||.++
T Consensus       225 ~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~  256 (808)
T KOG0597|consen  225 SSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG  256 (808)
T ss_pred             HHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence            99999999999999999999999999999885

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.1e-47  Score=313.15  Aligned_cols=267  Identities=35%  Similarity=0.610  Sum_probs=208.3

Q ss_pred             CeeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      .||+|+++.+++.||+|++.. .........+.+|+.+++.++||||+++++++..++..++||||+++++++.+.....
T Consensus        16 ~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~   95 (287)
T cd07848          16 VVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPN   95 (287)
T ss_pred             EEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCC
Confidence            389999999999999999987 3334445678899999999999999999999999999999999999998888877667


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~  158 (282)
                      .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... .......+++.|+|||.+.+
T Consensus        96 ~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  175 (287)
T cd07848          96 GVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG  175 (287)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcC
Confidence            89999999999999999999999999999999999999999999999999987654321 22233457889999999977


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCC--CCCC-CCCCCccccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP--FPMY-HPSMSFSQVA  235 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~  235 (282)
                      .. ++.++|+||+|+++|+|++|..| |...+..+....+....+..+...+...........  .+.. ..........
T Consensus       176 ~~-~~~~~DiwslGvil~el~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (287)
T cd07848         176 AP-YGKAVDMWSVGCILGELSDGQPL-FPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYL  253 (287)
T ss_pred             CC-CCCchhHHhHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhh
Confidence            66 68999999999999999988765 776666665555555444433222111100000000  0000 0010111223


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      ..+|..+.+||++||+.||++|||++++++||||
T Consensus       254 ~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         254 GILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            4578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0033|consensus

Probab=100.00  E-value=2.9e-49  Score=296.79  Aligned_cols=246  Identities=28%  Similarity=0.412  Sum_probs=211.3

Q ss_pred             CeeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCccc-HHHHHHhcC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLN   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~-l~~~~~~~~   78 (282)
                      +||++.+..||+.+|+|+++. .......+.+.+|+.+-+.|+||||+++++.+.++...|+|+|++.|+ +-..+.. .
T Consensus        26 vVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~-R  104 (355)
T KOG0033|consen   26 VVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA-R  104 (355)
T ss_pred             HHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHH-H
Confidence            488999999999999999987 445557889999999999999999999999999999999999999874 4444444 4


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc---CCCcEEEEecCCccccCCCccccccccccccccChhh
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN---KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDV  155 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~  155 (282)
                      .-++|..+..++.||++||.|+|.+||+|+|+||.|+++-   ...-+||+|||.+..++ ....-.+..|+|.|+|||+
T Consensus       105 ~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g~~~~G~~GtP~fmaPEv  183 (355)
T KOG0033|consen  105 EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DGEAWHGFAGTPGYLSPEV  183 (355)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-CccccccccCCCcccCHHH
Confidence            6689999999999999999999999999999999999994   34569999999999887 4455566788999999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      +.... ++..+|||+-|+++|-++.|..| |-+.+.....+.+..+.-..++..|                         
T Consensus       184 vrkdp-y~kpvDiW~cGViLfiLL~G~~P-F~~~~~~rlye~I~~g~yd~~~~~w-------------------------  236 (355)
T KOG0033|consen  184 LKKDP-YSKPVDIWACGVILYILLVGYPP-FWDEDQHRLYEQIKAGAYDYPSPEW-------------------------  236 (355)
T ss_pred             hhcCC-CCCcchhhhhhHHHHHHHhCCCC-CCCccHHHHHHHHhccccCCCCccc-------------------------
Confidence            97776 79999999999999999988777 5555667777777776555444444                         


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ++++++.++||++||..||++|+|+.|.|+|||+.+-...
T Consensus       237 ~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~  276 (355)
T KOG0033|consen  237 DTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERV  276 (355)
T ss_pred             CcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHH
Confidence            5699999999999999999999999999999999876443

>KOG0591|consensus

Probab=100.00  E-value=5.1e-50  Score=306.24  Aligned_cols=229  Identities=29%  Similarity=0.494  Sum_probs=195.6

Q ss_pred             eeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceee-eeeeCC-eEEEEEecCcc-cHHHHHH--
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYD-VLHSEK-KLTLVFEHCDQ-DLKKYFD--   75 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~-~~~~~~-~~~iv~e~~~g-~l~~~~~--   75 (282)
                      ||++.+..+|..+|.|.+.. ..+....+....|+.++++|+||||+++++ .+.+++ -++||||+|++ ++...+.  
T Consensus        35 vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~  114 (375)
T KOG0591|consen   35 VYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHF  114 (375)
T ss_pred             eEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHH
Confidence            89999999999999999987 556667788999999999999999999998 555554 49999999975 5544433  


Q ss_pred             -hcCCCCCHHHHHHHHHHHHHHHHHHHh--CC--ccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccc
Q psy6044          76 -SLNGEIDLDIVKSFMYQLLRGLAFCHS--RN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWY  150 (282)
Q Consensus        76 -~~~~~~~~~~~~~~~~qi~~~l~~lh~--~~--i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  150 (282)
                       +....++|..+|+++.|++.||.++|+  ..  +.||||||.||+++.+|.+||+|||+++.+..........+|||.|
T Consensus       115 K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyY  194 (375)
T KOG0591|consen  115 KKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYY  194 (375)
T ss_pred             HhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcc
Confidence             224559999999999999999999998  44  8899999999999999999999999999988777777778999999


Q ss_pred             cChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMS  230 (282)
Q Consensus       151 ~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
                      ++||++.... |+++|||||+||++|||+.-..| |.+.+..+.-.+|..+                            .
T Consensus       195 MSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~P-F~g~n~~~L~~KI~qg----------------------------d  244 (375)
T KOG0591|consen  195 MSPERIHESG-YNFKSDIWSLGCLLYEMCALQSP-FYGDNLLSLCKKIEQG----------------------------D  244 (375)
T ss_pred             cCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCC-cccccHHHHHHHHHcC----------------------------C
Confidence            9999998887 79999999999999999976666 6666777776776654                            1


Q ss_pred             ccccC-ccCCHHHHHHHHHhcccCCCCCCCH
Q psy6044         231 FSQVA-PKLTAKGRDLLQRLLVCNPVQRMSA  260 (282)
Q Consensus       231 ~~~~~-~~~~~~l~~li~~~l~~dp~~Rps~  260 (282)
                      .+.++ ..+|.++.++|..|+..||..||+.
T Consensus       245 ~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  245 YPPLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             CCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            22233 5699999999999999999999985

>KOG0198|consensus

Probab=100.00  E-value=1.5e-48  Score=313.42  Aligned_cols=243  Identities=26%  Similarity=0.451  Sum_probs=195.8

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC--eEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK--KLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~--~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|.+.++|+..|||.+....... .+.+.+|+.++++++|||||++++......  .+++.|||++|+.+..+....+
T Consensus        33 V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g  111 (313)
T KOG0198|consen   33 VYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYG  111 (313)
T ss_pred             EEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcC
Confidence            8999999999999999988753222 567899999999999999999999855444  6999999998655555544444


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-CCcEEEEecCCccccCC---CccccccccccccccChh
Q psy6044          80 -EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK-NGELKLADFGLARAFGI---PVKCYSAEVVTLWYRPPD  154 (282)
Q Consensus        80 -~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~-~~~~~l~df~~~~~~~~---~~~~~~~~~~~~~~~aPE  154 (282)
                       ++++..+..+..||++||+|||++|++|+||||+||+++. ++.+||+|||.+.....   .........||+.|+|||
T Consensus       112 ~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPE  191 (313)
T KOG0198|consen  112 GKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPE  191 (313)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCch
Confidence             8999999999999999999999999999999999999999 79999999999877653   112233467899999999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCC-ChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGS-DVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      ++.......+++|||||||++.||+||..| |... ...+....+..   ..                        ..+.
T Consensus       192 vi~~g~~~~~~sDiWSlGCtVvEM~Tg~~P-W~~~~~~~~~~~~ig~---~~------------------------~~P~  243 (313)
T KOG0198|consen  192 VIRNGEVARRESDIWSLGCTVVEMLTGKPP-WSEFFEEAEALLLIGR---ED------------------------SLPE  243 (313)
T ss_pred             hhcCCCcCCccchhhhcCCEEEeccCCCCc-chhhcchHHHHHHHhc---cC------------------------CCCC
Confidence            998643234699999999999999988666 6653 22222222211   10                        2235


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      ++..+|+++++||.+|+..||++|||++++|+|||.++..
T Consensus       244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  244 IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            6778999999999999999999999999999999998643

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.9e-47  Score=311.23  Aligned_cols=268  Identities=53%  Similarity=0.903  Sum_probs=215.1

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC-
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN-   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~-   78 (282)
                      .||+|.++.+|+.||+|++... ........+.+|+.++++++|||++++++++.++...++|+||+++++.+.+.... 
T Consensus        15 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~~~~~~   94 (285)
T cd07861          15 VVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPK   94 (285)
T ss_pred             EEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCCCCHHHHHhcCCC
Confidence            3899999999999999998763 33334567889999999999999999999999999999999999998887765533 


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          79 -GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 -~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                       ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+...+..........+++.|+|||.+.
T Consensus        95 ~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  174 (285)
T cd07861          95 GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLL  174 (285)
T ss_pred             CCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhc
Confidence             5689999999999999999999999999999999999999999999999999876654433334445678899999987


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +...++.++|+||||+++|++++|+.| |.+....+....+....+.+....|+......+++.................
T Consensus       175 ~~~~~~~~~Dv~slG~il~~l~tg~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (285)
T cd07861         175 GSPRYSTPVDIWSIGTIFAEMATKKPL-FHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKN  253 (285)
T ss_pred             CCCCcCcHHHHHHHHHHHHHHHHCCCC-CCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCC
Confidence            665578999999999999999988665 6666666666666666666555555544333333222111122223333456


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      +++++.++|++||+.||.+|||+.++++||||
T Consensus       254 ~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         254 LDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             CCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            89999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0616|consensus

Probab=100.00  E-value=4.8e-48  Score=297.24  Aligned_cols=242  Identities=22%  Similarity=0.355  Sum_probs=213.1

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      |-+++.+.+|..+|+|++.+  .-.-...+...+|..+++.+.||.++++++.+.+...+|+||||++|+.+..+.+..+
T Consensus        60 V~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~  139 (355)
T KOG0616|consen   60 VHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSG  139 (355)
T ss_pred             EEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcC
Confidence            56788999999999999988  3333445678899999999999999999999999999999999999877777777789


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      ++++..++.++.||+.||+|||+++|++||+||+|||+|.+|.+||.|||++......+   ...+||+.|+|||++...
T Consensus       140 rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT---~TlCGTPeYLAPEii~sk  216 (355)
T KOG0616|consen  140 RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRT---WTLCGTPEYLAPEIIQSK  216 (355)
T ss_pred             CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCcE---EEecCCccccChHHhhcC
Confidence            99999999999999999999999999999999999999999999999999999887542   345889999999999877


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      . ++.++|-||||+++|||+.|..| |-..+.....++|.++                             .-.+|..++
T Consensus       217 ~-ynkavDWWalGVLIYEMlaG~pP-F~~~~~~~iY~KI~~~-----------------------------~v~fP~~fs  265 (355)
T KOG0616|consen  217 G-YNKAVDWWALGVLIYEMLAGYPP-FYDDNPIQIYEKILEG-----------------------------KVKFPSYFS  265 (355)
T ss_pred             C-CCcchhHHHHHHHHHHHHcCCCC-CcCCChHHHHHHHHhC-----------------------------cccCCcccC
Confidence            6 79999999999999999977777 5555557888888773                             334567899


Q ss_pred             HHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCccchh
Q psy6044         240 AKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~  277 (282)
                      +++++||+++|+.|-.+|.     ...+|..||||+++++...
T Consensus       266 ~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i  308 (355)
T KOG0616|consen  266 SDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAI  308 (355)
T ss_pred             HHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHH
Confidence            9999999999999999994     6789999999999988654

>KOG0605|consensus

Probab=100.00  E-value=2.4e-47  Score=314.51  Aligned_cols=249  Identities=24%  Similarity=0.359  Sum_probs=212.4

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|+.+.||..+|+|++++  -...+....++.|-.+|...++|+||+++-.|++..++||||||++|+-...+....+
T Consensus       157 VrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~  236 (550)
T KOG0605|consen  157 VRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKD  236 (550)
T ss_pred             EEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcC
Confidence            89999999999999999998  3345557888999999999999999999999999999999999999876666666689


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCC-----------------------
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGI-----------------------  136 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~-----------------------  136 (282)
                      .++++++..++.+++.|+..+|+.|++|+||||+|+++|..|.+||+|||++..+..                       
T Consensus       237 ~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~  316 (550)
T KOG0605|consen  237 TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPS  316 (550)
T ss_pred             cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCc
Confidence            999999999999999999999999999999999999999999999999999854311                       


Q ss_pred             Ccc------------------------ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChH
Q psy6044         137 PVK------------------------CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD  192 (282)
Q Consensus       137 ~~~------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~  192 (282)
                      ...                        .....+|||.|+|||++.+.. |+..+|.|||||++||||.|..| |.+.+..
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWSLG~ImyEmLvGyPP-F~s~tp~  394 (550)
T KOG0605|consen  317 DFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWSLGCIMYEMLVGYPP-FCSETPQ  394 (550)
T ss_pred             cccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCccccHHHHHHHHHHHHhCCCC-CCCCCHH
Confidence            000                        001136689999999999888 79999999999999999977666 8899999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCCc
Q psy6044         193 DQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM---SAEDAMSHIYF  269 (282)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~h~~~  269 (282)
                      +...++........-.                         .....++++.+||.+||. ||.+|.   +++||-.||||
T Consensus       395 ~T~rkI~nwr~~l~fP-------------------------~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF  448 (550)
T KOG0605|consen  395 ETYRKIVNWRETLKFP-------------------------EEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFF  448 (550)
T ss_pred             HHHHHHHHHhhhccCC-------------------------CcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcc
Confidence            9999988865322100                         012367999999999999 999999   59999999999


Q ss_pred             cCCccchhh
Q psy6044         270 SDLNVAIKS  278 (282)
Q Consensus       270 ~~~~~~~~~  278 (282)
                      ++++++-..
T Consensus       449 ~~v~W~~l~  457 (550)
T KOG0605|consen  449 KGVDWDHLR  457 (550)
T ss_pred             ccCCcchhh
Confidence            999987543

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-47  Score=313.54  Aligned_cols=242  Identities=23%  Similarity=0.330  Sum_probs=201.3

Q ss_pred             CeeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      .||+|.++.+|+.||+|++...  ........+.+|+.+++.++||||+++++++.+++..++||||++|+.+..+....
T Consensus        16 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~   95 (291)
T cd05612          16 RVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS   95 (291)
T ss_pred             EEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHc
Confidence            3899999999999999999762  12233456888999999999999999999999999999999999865444444446


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +.+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||++.......   ....+++.|+|||.+.+
T Consensus        96 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~  172 (291)
T cd05612          96 GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT---WTLCGTPEYLAPEVIQS  172 (291)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc---ccccCChhhcCHHHHcC
Confidence            789999999999999999999999999999999999999999999999999987654322   22357889999999977


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++||||||+++|+|++|..| |.+.+..+....+...                             ...++..+
T Consensus       173 ~~-~~~~~DiwSlG~il~~l~~g~~p-f~~~~~~~~~~~i~~~-----------------------------~~~~~~~~  221 (291)
T cd05612         173 KG-HNKAVDWWALGILIYEMLVGYPP-FFDDNPFGIYEKILAG-----------------------------KLEFPRHL  221 (291)
T ss_pred             CC-CCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhC-----------------------------CcCCCccC
Confidence            66 68999999999999999998887 5555555555555442                             11233457


Q ss_pred             CHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCccch
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMS-----AEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps-----~~~ll~h~~~~~~~~~~  276 (282)
                      ++.+.++|++||+.||.+||+     ++++++||||+.+++..
T Consensus       222 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~  264 (291)
T cd05612         222 DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDD  264 (291)
T ss_pred             CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHH
Confidence            889999999999999999995     99999999999887653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-47  Score=315.25  Aligned_cols=243  Identities=26%  Similarity=0.367  Sum_probs=200.9

Q ss_pred             CeeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      .||+|++..+++.||+|++...  ........+..|+.++++++||||+++++++.+++..++|+||++|+.+.......
T Consensus         8 ~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~   87 (312)
T cd05585           8 KVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQRE   87 (312)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhc
Confidence            3899999999999999999762  23334567788999999999999999999999999999999999875554444446


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..............|++.|+|||.+.+
T Consensus        88 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  167 (312)
T cd05585          88 GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG  167 (312)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcC
Confidence            78999999999999999999999999999999999999999999999999998754333333334567899999999977


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||+|+++|+|++|..| |...+..+....+...                             ...++..+
T Consensus       168 ~~-~~~~~DvwslGvil~el~tg~~p-f~~~~~~~~~~~~~~~-----------------------------~~~~~~~~  216 (312)
T cd05585         168 HG-YTKAVDWWTLGVLLYEMLTGLPP-FYDENVNEMYRKILQE-----------------------------PLRFPDGF  216 (312)
T ss_pred             CC-CCCccceechhHHHHHHHhCCCC-cCCCCHHHHHHHHHcC-----------------------------CCCCCCcC
Confidence            66 69999999999999999998888 5555555554444321                             11233458


Q ss_pred             CHHHHHHHHHhcccCCCCCC---CHHHHhcCCCccCCcc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRM---SAEDAMSHIYFSDLNV  274 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rp---s~~~ll~h~~~~~~~~  274 (282)
                      ++.+.++|.+||+.||.+||   ++.++++||||++.+.
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~  255 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW  255 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCH
Confidence            89999999999999999997   5799999999998743

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.2e-47  Score=317.57  Aligned_cols=240  Identities=23%  Similarity=0.319  Sum_probs=200.1

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|+++.+|+.||+|++...  ......+.+.+|+.++++++||||+++++++.+++..++||||++|+.+.......+
T Consensus        34 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  113 (329)
T PTZ00263         34 VRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG  113 (329)
T ss_pred             EEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcC
Confidence            899999999999999999862  233345678899999999999999999999999999999999998755544444467


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.......   ....+++.|+|||.+.+.
T Consensus       114 ~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~  190 (329)
T PTZ00263        114 RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT---FTLCGTPEYLAPEVIQSK  190 (329)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc---ceecCChhhcCHHHHcCC
Confidence            89999999999999999999999999999999999999999999999999987664322   224578899999999777


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      . ++.++|+|||||++|+|++|..| |.+....+....+...                             ...++..++
T Consensus       191 ~-~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~~~i~~~-----------------------------~~~~p~~~~  239 (329)
T PTZ00263        191 G-HGKAVDWWTMGVLLYEFIAGYPP-FFDDTPFRIYEKILAG-----------------------------RLKFPNWFD  239 (329)
T ss_pred             C-CCCcceeechHHHHHHHHcCCCC-CCCCCHHHHHHHHhcC-----------------------------CcCCCCCCC
Confidence            6 68999999999999999998888 4555555444444331                             111234478


Q ss_pred             HHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCccc
Q psy6044         240 AKGRDLLQRLLVCNPVQRMS-----AEDAMSHIYFSDLNVA  275 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps-----~~~ll~h~~~~~~~~~  275 (282)
                      ..+.+||++||+.||.+||+     ++++++||||++.++.
T Consensus       240 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~  280 (329)
T PTZ00263        240 GRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD  280 (329)
T ss_pred             HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence            89999999999999999997     7999999999987554

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.4e-47  Score=316.51  Aligned_cols=243  Identities=23%  Similarity=0.347  Sum_probs=201.5

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|.++.+|+.||+|++...  ........+.+|+.+++.++||||+++++++..+...++||||++|+.+........
T Consensus        11 Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~   90 (328)
T cd05593          11 VILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRER   90 (328)
T ss_pred             EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcC
Confidence            899999999999999999862  223344677889999999999999999999999999999999998755555555567


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..............+++.|+|||.+.+.
T Consensus        91 ~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  170 (328)
T cd05593          91 VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDN  170 (328)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCC
Confidence            89999999999999999999999999999999999999999999999999987543333333345678999999999776


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      . ++.++|+|||||++|+|++|..| |...+..+....+..                             ....++..++
T Consensus       171 ~-~~~~~DiwslGvil~elltG~~P-f~~~~~~~~~~~~~~-----------------------------~~~~~p~~~~  219 (328)
T cd05593         171 D-YGRAVDWWGLGVVMYEMMCGRLP-FYNQDHEKLFELILM-----------------------------EDIKFPRTLS  219 (328)
T ss_pred             C-CCccCCccccchHHHHHhhCCCC-CCCCCHHHHHHHhcc-----------------------------CCccCCCCCC
Confidence            6 69999999999999999998888 555554444443322                             1112345688


Q ss_pred             HHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCccc
Q psy6044         240 AKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~  275 (282)
                      +++.++|++||..||.+|+     ++.++++||||.+.++.
T Consensus       220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  260 (328)
T cd05593         220 ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQ  260 (328)
T ss_pred             HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            9999999999999999997     89999999999987654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=7.3e-47  Score=314.24  Aligned_cols=245  Identities=22%  Similarity=0.326  Sum_probs=203.4

Q ss_pred             CeeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhc
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL   77 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~   77 (282)
                      .||+|+++.+++.||+|++...  ........+..|..++..+ +||||+++++++...+.+|+||||++|+.+......
T Consensus        10 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~   89 (320)
T cd05590          10 KVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK   89 (320)
T ss_pred             EEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHH
Confidence            3899999999999999999862  2333456677888888876 799999999999999999999999987655555555


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..............|++.|+|||.+.
T Consensus        90 ~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~  169 (320)
T cd05590          90 SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQ  169 (320)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHc
Confidence            67899999999999999999999999999999999999999999999999999875433333334456789999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|+||||+++|+|++|..| |...+..+....+....                             ...+..
T Consensus       170 ~~~-~~~~~DiwslG~il~el~~g~~P-f~~~~~~~~~~~i~~~~-----------------------------~~~~~~  218 (320)
T cd05590         170 EML-YGPSVDWWAMGVLLYEMLCGHAP-FEAENEDDLFEAILNDE-----------------------------VVYPTW  218 (320)
T ss_pred             CCC-CCCccchhhhHHHHHHHhhCCCC-CCCCCHHHHHHHHhcCC-----------------------------CCCCCC
Confidence            665 68999999999999999998877 66666666665554311                             112345


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCH------HHHhcCCCccCCccch
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSA------EDAMSHIYFSDLNVAI  276 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~------~~ll~h~~~~~~~~~~  276 (282)
                      ++.++.++|++||+.||.+||++      +++++||||+++.+..
T Consensus       219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~  263 (320)
T cd05590         219 LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEK  263 (320)
T ss_pred             CCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHH
Confidence            78999999999999999999998      9999999999987544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.6e-47  Score=315.33  Aligned_cols=243  Identities=22%  Similarity=0.328  Sum_probs=201.5

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|+++.+|+.||+|++...  ........+.+|+.+++.++||||+++++++..+..+++||||++|+.+.......+
T Consensus        11 Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~   90 (323)
T cd05595          11 VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER   90 (323)
T ss_pred             EEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcC
Confidence            899999999999999999862  223334567789999999999999999999999999999999998765555555567


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..............+++.|+|||.+.+.
T Consensus        91 ~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  170 (323)
T cd05595          91 VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN  170 (323)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCC
Confidence            89999999999999999999999999999999999999999999999999886543333333345678999999999766


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      . ++.++|+||||+++|+|++|..| |...+..+....+...                             ...++..++
T Consensus       171 ~-~~~~~DiwSlGvil~ell~g~~P-f~~~~~~~~~~~~~~~-----------------------------~~~~p~~~~  219 (323)
T cd05595         171 D-YGRAVDWWGLGVVMYEMMCGRLP-FYNQDHERLFELILME-----------------------------EIRFPRTLS  219 (323)
T ss_pred             C-CCchhchhhhHHHHHHHHhCCCC-CCCCCHHHHHHHHhcC-----------------------------CCCCCCCCC
Confidence            5 69999999999999999998888 5555555544443321                             111334588


Q ss_pred             HHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCccc
Q psy6044         240 AKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~  275 (282)
                      +.+.++|++||+.||.+|+     ++.++++||||.++.+.
T Consensus       220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~  260 (323)
T cd05595         220 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  260 (323)
T ss_pred             HHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence            9999999999999999998     99999999999987643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.1e-47  Score=316.70  Aligned_cols=274  Identities=36%  Similarity=0.562  Sum_probs=207.1

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC-----CeEEEEEecCcccHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSE-----KKLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~-----~~~~iv~e~~~g~l~~~~   74 (282)
                      .||+|+++.+|+.||||++... ........+.+|+.+++.++||||+++++++...     ...|+|+||+++++.+.+
T Consensus        15 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l   94 (338)
T cd07859          15 VVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVI   94 (338)
T ss_pred             EEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCCCCHHHHH
Confidence            3899999999999999998752 2233345688999999999999999999988643     358999999998888776


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc---ccccccccccccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---KCYSAEVVTLWYR  151 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~  151 (282)
                      .. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+.......   .......+++.|+
T Consensus        95 ~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~  173 (338)
T cd07859          95 KA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR  173 (338)
T ss_pred             Hh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcC
Confidence            55 5679999999999999999999999999999999999999999999999999987543221   1123346788999


Q ss_pred             ChhhhcCC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCC--CCCCCCCC
Q psy6044         152 PPDVLFGA-KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFK--PFPMYHPS  228 (282)
Q Consensus       152 aPE~~~~~-~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  228 (282)
                      |||.+.+. ..++.++|||||||++|+|++|..| |.+.+.......+....+.++..............  ........
T Consensus       174 aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  252 (338)
T cd07859         174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQP  252 (338)
T ss_pred             CHHHHhccccccCchhHHHHHHHHHHHHHcCCCC-CCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCC
Confidence            99998652 3478999999999999999988666 77766666666666655554433221110000000  00000001


Q ss_pred             CCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         229 MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       229 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      .......+.+++.+.++|.+||+.||++|||++++++||||++++...
T Consensus       253 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~  300 (338)
T cd07859         253 VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE  300 (338)
T ss_pred             CchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccc
Confidence            112223345788999999999999999999999999999999876643

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.1e-45  Score=303.46  Aligned_cols=264  Identities=45%  Similarity=0.807  Sum_probs=207.8

Q ss_pred             CeeeeeeCC-CCceEEEeeeecC-CCCCCCccHHHHHHHHhhC---CCCCccceeeeee-----eCCeEEEEEecCcccH
Q psy6044           1 MFTSGVDRT-PNTALAIKGTHLV-GNEGVPSSALREICLLKEL---KHKNIVRLYDVLH-----SEKKLTLVFEHCDQDL   70 (282)
Q Consensus         1 ~vy~a~~~~-~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l---~h~~i~~~~~~~~-----~~~~~~iv~e~~~g~l   70 (282)
                      .||+|++.. +|+.||+|++... ........+.+|+.+++.+   +||||+++++++.     ....+++|+||+++++
T Consensus        16 ~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~l   95 (290)
T cd07862          16 KVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL   95 (290)
T ss_pred             EEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCCCCH
Confidence            389999865 4788999998863 3333345677788887776   6999999999885     3456899999999998


Q ss_pred             HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccccccccccc
Q psy6044          71 KKYFDSLN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW  149 (282)
Q Consensus        71 ~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~  149 (282)
                      .+.+.... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||.+...... .......+++.
T Consensus        96 ~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~  174 (290)
T cd07862          96 TTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLW  174 (290)
T ss_pred             HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCC-ccccccccccc
Confidence            88876543 45899999999999999999999999999999999999999999999999998765433 22334467889


Q ss_pred             ccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSM  229 (282)
Q Consensus       150 ~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
                      |+|||.+.+.. ++.++|+||||+++|+|++| .|+|.+....+....+....+.+.+..++........ .+. .....
T Consensus       175 y~aPE~~~~~~-~~~~~DiwslG~il~el~~g-~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~  250 (290)
T cd07862         175 YRAPEVLLQSS-YATPVDLWSVGCIFAEMFRR-KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ-AFH-SKSAQ  250 (290)
T ss_pred             ccChHHHhCCC-CCCccchHHHHHHHHHHHcC-CCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccch-hcc-CCCCC
Confidence            99999997665 68999999999999999965 5558888888888888887776666555443211111 010 11122


Q ss_pred             CccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      ....+.+.+++.+.+++.+||+.||++|||+.++|+||||
T Consensus       251 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         251 PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             CHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            3334456789999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3e-46  Score=310.88  Aligned_cols=244  Identities=21%  Similarity=0.297  Sum_probs=202.5

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||+|.++.+|+.||+|++...  ........+..|..++..+ +||||+++++++.+++.+++||||++|+.+.......
T Consensus        11 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~   90 (321)
T cd05591          11 VMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS   90 (321)
T ss_pred             EEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHc
Confidence            899999999999999999862  2333445677888888866 8999999999999999999999999875555444446


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||.+..............++..|+|||.+.+
T Consensus        91 ~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  170 (321)
T cd05591          91 RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE  170 (321)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCccccCHHHHcC
Confidence            78999999999999999999999999999999999999999999999999998754333333334467889999999977


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||||+++|+|++|..| |...+..+....+....                             ...+..+
T Consensus       171 ~~-~~~~~DvwslG~il~el~tg~~P-f~~~~~~~~~~~i~~~~-----------------------------~~~p~~~  219 (321)
T cd05591         171 LE-YGPSVDWWALGVLMYEMMAGQPP-FEADNEDDLFESILHDD-----------------------------VLYPVWL  219 (321)
T ss_pred             CC-CCCccceechhHHHHHHhcCCCC-CCCCCHHHHHHHHHcCC-----------------------------CCCCCCC
Confidence            66 69999999999999999988777 67777666666554411                             1122347


Q ss_pred             CHHHHHHHHHhcccCCCCCC-------CHHHHhcCCCccCCccch
Q psy6044         239 TAKGRDLLQRLLVCNPVQRM-------SAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rp-------s~~~ll~h~~~~~~~~~~  276 (282)
                      ++++.++|++||+.||.+||       +++++++||||+.+++..
T Consensus       220 ~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~  264 (321)
T cd05591         220 SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVL  264 (321)
T ss_pred             CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHH
Confidence            89999999999999999999       999999999999876553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0610|consensus

Probab=100.00  E-value=2.4e-46  Score=299.82  Aligned_cols=247  Identities=24%  Similarity=0.372  Sum_probs=208.2

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC-
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN-   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~-   78 (282)
                      ||+|..++++..+|+|++.+  ............|.++|..++||.++++|+.++.+...+++||||+|+-+..+.+.+ 
T Consensus        93 VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp  172 (459)
T KOG0610|consen   93 VYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQP  172 (459)
T ss_pred             EEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCC
Confidence            89999999999999999998  334555677888999999999999999999999999999999999876555554443 


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCC---------------------
Q psy6044          79 -GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGI---------------------  136 (282)
Q Consensus        79 -~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~---------------------  136 (282)
                       ..++++.++.++..++.||+|||-+||++|||||+|||+.++|.+.|+||.++.....                     
T Consensus       173 ~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~  252 (459)
T KOG0610|consen  173 GKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRS  252 (459)
T ss_pred             CCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCccccc
Confidence             4599999999999999999999999999999999999999999999999998743310                     


Q ss_pred             ------------C-c----------------------cccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhc
Q psy6044         137 ------------P-V----------------------KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANA  181 (282)
Q Consensus       137 ------------~-~----------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~  181 (282)
                                  . .                      ......+||..|+|||++.+.. .+.+.|-|+||+++|||+.|
T Consensus       253 ~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G-HgsAVDWWtfGIflYEmLyG  331 (459)
T KOG0610|consen  253 RQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG-HGSAVDWWTFGIFLYEMLYG  331 (459)
T ss_pred             ccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC-CCchhhHHHHHHHHHHHHhC
Confidence                        0 0                      0111235577899999999888 79999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCC--
Q psy6044         182 GRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS--  259 (282)
Q Consensus       182 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps--  259 (282)
                      ..| |.+.+..+.+.++...--..+                          +. +.++..+++||+++|.+||++|..  
T Consensus       332 ~TP-FKG~~~~~Tl~NIv~~~l~Fp--------------------------~~-~~vs~~akDLIr~LLvKdP~kRlg~~  383 (459)
T KOG0610|consen  332 TTP-FKGSNNKETLRNIVGQPLKFP--------------------------EE-PEVSSAAKDLIRKLLVKDPSKRLGSK  383 (459)
T ss_pred             CCC-cCCCCchhhHHHHhcCCCcCC--------------------------CC-CcchhHHHHHHHHHhccChhhhhccc
Confidence            888 888888888877765221111                          11 257899999999999999999998  


Q ss_pred             --HHHHhcCCCccCCccchh
Q psy6044         260 --AEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       260 --~~~ll~h~~~~~~~~~~~  277 (282)
                        +.||-+||||++++|...
T Consensus       384 rGA~eIK~HpFF~gVnWaLi  403 (459)
T KOG0610|consen  384 RGAAEIKRHPFFEGVNWALI  403 (459)
T ss_pred             cchHHhhcCccccCCChhhe
Confidence              999999999999999754

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.7e-46  Score=304.71  Aligned_cols=268  Identities=54%  Similarity=0.946  Sum_probs=213.9

Q ss_pred             CeeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhc-C
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL-N   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~-~   78 (282)
                      .||+|.++.+|+.||||.+.. .........+.+|++++++++||||+++++++.+....++|+||+++++...+... .
T Consensus        15 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~~~~~~   94 (284)
T cd07860          15 VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPL   94 (284)
T ss_pred             EEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccccCHHHHHHhCCC
Confidence            389999999999999999876 33334456788999999999999999999999999999999999998887776554 3


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+
T Consensus        95 ~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  174 (284)
T cd07860          95 SGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG  174 (284)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEec
Confidence            56899999999999999999999999999999999999999999999999998766544333344455788999998876


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      ...++.++|+||||+++|+++||+.| |...+..+....+....+.+....++......+...................+
T Consensus       175 ~~~~~~~~Dv~slG~il~~l~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (284)
T cd07860         175 CKYYSTAVDIWSLGCIFAEMVTRRAL-FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPL  253 (284)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCCCC-CCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccC
Confidence            65568899999999999999998877 66666666666666666666554444322222221111111122333444568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      ++.+.++|.+||+.||.+|||+++++.||||
T Consensus       254 ~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         254 DEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             CHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            8999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.7e-46  Score=312.75  Aligned_cols=240  Identities=23%  Similarity=0.308  Sum_probs=199.2

Q ss_pred             eeeeeeCCCC-ceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPN-TALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~-~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||+|.++.++ ..||+|++...  ........+.+|+.+++.++||||+++++++.+.+..++||||++|+.+..+...+
T Consensus        46 Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~  125 (340)
T PTZ00426         46 VILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN  125 (340)
T ss_pred             EEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc
Confidence            8999876655 78999998762  23334567888999999999999999999999999999999999865555555556


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +.+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.......   ....|++.|+|||.+.+
T Consensus       126 ~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~---~~~~gt~~y~aPE~~~~  202 (340)
T PTZ00426        126 KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT---YTLCGTPEYIAPEILLN  202 (340)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc---ceecCChhhcCHHHHhC
Confidence            789999999999999999999999999999999999999999999999999997664322   23467889999999977


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||+||++|+|++|..| |...+.......+...                             ....+..+
T Consensus       203 ~~-~~~~~DiwSlGvil~ell~G~~P-f~~~~~~~~~~~i~~~-----------------------------~~~~p~~~  251 (340)
T PTZ00426        203 VG-HGKAADWWTLGIFIYEILVGCPP-FYANEPLLIYQKILEG-----------------------------IIYFPKFL  251 (340)
T ss_pred             CC-CCccccccchhhHHHHHhcCCCC-CCCCCHHHHHHHHhcC-----------------------------CCCCCCCC
Confidence            66 68999999999999999988888 5555555555554431                             11233557


Q ss_pred             CHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCccc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~  275 (282)
                      ++.+.++|++||+.||++|+     |++++++||||+++++.
T Consensus       252 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~  293 (340)
T PTZ00426        252 DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV  293 (340)
T ss_pred             CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence            88999999999999999995     89999999999998654

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.5e-46  Score=313.13  Aligned_cols=243  Identities=23%  Similarity=0.329  Sum_probs=201.0

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|.++.+|+.||+|++...  ........+..|+.+++.++||||+++++++..+..+++||||++|+.+........
T Consensus        11 V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~   90 (325)
T cd05594          11 VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER   90 (325)
T ss_pred             EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC
Confidence            899999999999999999862  223334567789999999999999999999999999999999998766655555567


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      .+++..+..++.||+.||.|||+ .|++|+||||+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus        91 ~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  170 (325)
T cd05594          91 VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED  170 (325)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHcc
Confidence            89999999999999999999997 79999999999999999999999999998654323233334467899999999977


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||||+++|+|++|..| |.+.+..+....+...                             ...++..+
T Consensus       171 ~~-~~~~~DiwslG~il~el~tG~~P-f~~~~~~~~~~~i~~~-----------------------------~~~~p~~~  219 (325)
T cd05594         171 ND-YGRAVDWWGLGVVMYEMMCGRLP-FYNQDHEKLFELILME-----------------------------EIRFPRTL  219 (325)
T ss_pred             CC-CCCccccccccceeeeeccCCCC-CCCCCHHHHHHHHhcC-----------------------------CCCCCCCC
Confidence            66 69999999999999999998888 5555555444443221                             11123457


Q ss_pred             CHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCccc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~  275 (282)
                      ++++.++|++||+.||++|+     ++.++++||||+++.+.
T Consensus       220 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  261 (325)
T cd05594         220 SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ  261 (325)
T ss_pred             CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence            89999999999999999997     99999999999987544

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5.6e-46  Score=320.43  Aligned_cols=268  Identities=35%  Similarity=0.523  Sum_probs=205.4

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC--------CeEEEEEecCcccHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE--------KKLTLVFEHCDQDLKK   72 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~--------~~~~iv~e~~~g~l~~   72 (282)
                      .||+|.+..+++.||||++...     .....+|+.+++.++||||+++++++...        ..+++||||+++++.+
T Consensus        81 ~Vy~~~~~~~~~~vAiK~i~~~-----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~~l~~  155 (440)
T PTZ00036         81 VVYEAICIDTSEKVAIKKVLQD-----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHK  155 (440)
T ss_pred             EEEEEEECCCCCEEEEEEEecC-----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCccHHH
Confidence            3899999999999999988642     23456799999999999999999886432        2577999999998876


Q ss_pred             HHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC-cEEEEecCCccccCCCccccccccccc
Q psy6044          73 YFDS---LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG-ELKLADFGLARAFGIPVKCYSAEVVTL  148 (282)
Q Consensus        73 ~~~~---~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~  148 (282)
                      .+..   ....+++..++.++.||+.||+|||++||+||||||+||+++.++ .++|+|||++........ .....+++
T Consensus       156 ~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~-~~~~~~t~  234 (440)
T PTZ00036        156 YMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR-SVSYICSR  234 (440)
T ss_pred             HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCC-cccCCCCc
Confidence            6543   356799999999999999999999999999999999999998665 799999999986643222 22346688


Q ss_pred             cccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPS  228 (282)
Q Consensus       149 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
                      .|+|||.+.+...++.++|||||||++|+|++|..| |.+....+.+..+...++.+..+.+...+....-..++.....
T Consensus       235 ~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~p-f~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  313 (440)
T PTZ00036        235 FYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPI-FSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPK  313 (440)
T ss_pred             CccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCch
Confidence            999999987765589999999999999999988655 7777777777777777766544332211100000001111111


Q ss_pred             CCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         229 MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       229 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      .....++...++++.+||.+||..||.+|||+.++++||||+++..+
T Consensus       314 ~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~  360 (440)
T PTZ00036        314 DLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP  360 (440)
T ss_pred             hHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence            11122345678999999999999999999999999999999987653

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.9e-46  Score=314.90  Aligned_cols=267  Identities=23%  Similarity=0.337  Sum_probs=204.9

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||+|.+..+++.||+|...       ...+.+|++++++++||||+++++++..+...++|+|++.+++...+.. ...
T Consensus       107 ~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~  178 (391)
T PHA03212        107 FAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAA-KRN  178 (391)
T ss_pred             EEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCCCCHHHHHHh-cCC
Confidence            38999999999999999643       2457899999999999999999999999999999999999988887765 567


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCC-CccccccccccccccChhhhcCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGI-PVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      +++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..... .........|++.|+|||.+.+.
T Consensus       179 l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  258 (391)
T PHA03212        179 IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARD  258 (391)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCC
Confidence            89999999999999999999999999999999999999999999999999864322 11223345679999999999776


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCC------ChHHHHHHHHHHhCCCCCCCCCCCC-CCCC-C----CC-CCCCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGS------DVDDQLKRIFKLLGTPTEDTWPGMN-LLPD-F----KP-FPMYH  226 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~----~~-~~~~~  226 (282)
                      . ++.++|+||||+++|++++|..|+|...      .....+..+....+.++.+...... .... +    .. .....
T Consensus       259 ~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (391)
T PHA03212        259 P-YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPG  337 (391)
T ss_pred             C-CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCC
Confidence            5 7999999999999999999999887643      2334555566655554432211100 0000 0    00 00000


Q ss_pred             CCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccchh
Q psy6044         227 PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       227 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  277 (282)
                      ....+ .....++.++.+||.+||+.||++|||++++|+||||+.+..+.+
T Consensus       338 ~~~~~-~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~  387 (391)
T PHA03212        338 SRPLW-TNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPYP  387 (391)
T ss_pred             CCCCH-HHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCCC
Confidence            00001 111236778999999999999999999999999999999865543

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=7.7e-46  Score=307.59  Aligned_cols=244  Identities=24%  Similarity=0.366  Sum_probs=198.1

Q ss_pred             CeeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhc
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL   77 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~   77 (282)
                      .||+|.++.+|+.||+|++...  ...........|..++... +||||+++++++.+.+.+|+||||++|+.+......
T Consensus        10 ~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~   89 (316)
T cd05620          10 KVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD   89 (316)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHH
Confidence            3899999999999999999862  1223345667788887754 899999999999999999999999987554444444


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      .+.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+..............++..|+|||.+.
T Consensus        90 ~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~  169 (316)
T cd05620          90 KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQ  169 (316)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHc
Confidence            67899999999999999999999999999999999999999999999999998865332222333456789999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|+||+|+++|+|++|..| |.+.+..+....+...                             ....+..
T Consensus       170 ~~~-~~~~~DiwslGvil~el~~g~~P-f~~~~~~~~~~~~~~~-----------------------------~~~~~~~  218 (316)
T cd05620         170 GLK-YTFSVDWWSFGVLLYEMLIGQSP-FHGDDEDELFESIRVD-----------------------------TPHYPRW  218 (316)
T ss_pred             CCC-CCcccchhhhHHHHHHHHhCCCC-CCCCCHHHHHHHHHhC-----------------------------CCCCCCC
Confidence            766 79999999999999999998888 5555555555544321                             1112334


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCH-HHHhcCCCccCCccc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSA-EDAMSHIYFSDLNVA  275 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~-~~ll~h~~~~~~~~~  275 (282)
                      ++.++.++|++||+.||.+||++ +++++||||+.+++.
T Consensus       219 ~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~  257 (316)
T cd05620         219 ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWT  257 (316)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCHH
Confidence            78999999999999999999998 589999999998654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0599|consensus

Probab=100.00  E-value=2.5e-47  Score=290.67  Aligned_cols=246  Identities=26%  Similarity=0.465  Sum_probs=205.2

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCC-------CCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCc-ccHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEG-------VPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCD-QDLK   71 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~   71 (282)
                      +|.++.++.+|+.+|+|++.......       ..+.-.+|+.+++++ -||+|+++.++++.+..+++|+|.++ |.+.
T Consensus        32 ~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELF  111 (411)
T KOG0599|consen   32 VVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELF  111 (411)
T ss_pred             hhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHH
Confidence            36678899999999999998722211       133456789999999 69999999999999999999999997 5666


Q ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccccccccccccc
Q psy6044          72 KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYR  151 (282)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  151 (282)
                      +++.. .-.+++.....+++|+++|+.|||.++|+|+||||+||+++++.+++|+|||++..+. +.......+||++|+
T Consensus       112 DyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~-~GekLrelCGTPgYL  189 (411)
T KOG0599|consen  112 DYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE-PGEKLRELCGTPGYL  189 (411)
T ss_pred             HHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC-CchhHHHhcCCCccc
Confidence            66554 6789999999999999999999999999999999999999999999999999999886 456667789999999


Q ss_pred             ChhhhcC-----CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         152 PPDVLFG-----AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYH  226 (282)
Q Consensus       152 aPE~~~~-----~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (282)
                      |||.+..     ...|+...|+||.|+++|.++.|..|||... ..-.+..++.+.-...+..|                
T Consensus       190 APEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-QmlMLR~ImeGkyqF~speW----------------  252 (411)
T KOG0599|consen  190 APETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-QMLMLRMIMEGKYQFRSPEW----------------  252 (411)
T ss_pred             ChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-HHHHHHHHHhcccccCCcch----------------
Confidence            9999853     3348899999999999999997777765443 34455566665555544444                


Q ss_pred             CCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         227 PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       227 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                               .++|...++||.+||+.||.+|.|++++|.||||..+-.
T Consensus       253 ---------adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~  291 (411)
T KOG0599|consen  253 ---------ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ  291 (411)
T ss_pred             ---------hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence                     458899999999999999999999999999999976543

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6e-46  Score=304.15  Aligned_cols=249  Identities=22%  Similarity=0.318  Sum_probs=198.9

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHH-HHHHhc-
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLK-KYFDSL-   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~-~~~~~~-   77 (282)
                      ||+|.+..+|+.||+|.+...  ........+.+|+.+++.++|++|+++++++.+++..++|+||++|+.+ ..+... 
T Consensus        16 V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~   95 (285)
T cd05631          16 VCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG   95 (285)
T ss_pred             EEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhC
Confidence            899999999999999998762  2222335678899999999999999999999999999999999986544 444332 


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...... .......++..|+|||.+.
T Consensus        96 ~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~g~~~y~aPE~~~  174 (285)
T cd05631          96 NPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVRGRVGTVGYMAPEVIN  174 (285)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-CeecCCCCCCCccCHhhhc
Confidence            346899999999999999999999999999999999999999999999999998765422 2223446789999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++||||||+++|+|++|..| |...........+......                         .....+..
T Consensus       175 ~~~-~~~~~DvwslGvil~el~~g~~p-f~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~  227 (285)
T cd05631         175 NEK-YTFSPDWWGLGCLIYEMIQGQSP-FRKRKERVKREEVDRRVKE-------------------------DQEEYSEK  227 (285)
T ss_pred             CCC-CCcccCchhHHHHHHHHHhCCCC-CCCCCcchhHHHHHHHhhc-------------------------ccccCCcc
Confidence            766 79999999999999999998888 4443332222222221111                         11123456


Q ss_pred             CCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCccchhh
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMS-----AEDAMSHIYFSDLNVAIKS  278 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps-----~~~ll~h~~~~~~~~~~~~  278 (282)
                      +++.+.+||++||+.||.+|||     ++++++||||+++++....
T Consensus       228 ~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~  273 (285)
T cd05631         228 FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLE  273 (285)
T ss_pred             CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHH
Confidence            8999999999999999999997     8999999999999766543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.9e-46  Score=308.21  Aligned_cols=244  Identities=22%  Similarity=0.355  Sum_probs=201.4

Q ss_pred             CeeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhc
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL   77 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~   77 (282)
                      .||+|.++.+++.||+|++...  ........+..|..+++.+ +||||+++++++...+.+++||||++|+.+......
T Consensus        10 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~   89 (318)
T cd05570          10 KVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR   89 (318)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH
Confidence            3899999999999999999862  2333456677898999888 799999999999999999999999987655555555


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      .+.+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.
T Consensus        90 ~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~  169 (318)
T cd05570          90 SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILS  169 (318)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhc
Confidence            67899999999999999999999999999999999999999999999999998865322222223345788999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|+|||||++|+|++|..| |...+..+....+...                             ....+..
T Consensus       170 ~~~-~~~~~DiwslGvil~~l~~G~~p-f~~~~~~~~~~~i~~~-----------------------------~~~~~~~  218 (318)
T cd05570         170 YQP-YGPAVDWWALGVLLYEMLAGQSP-FEGDDEDELFQSILED-----------------------------EVRYPRW  218 (318)
T ss_pred             CCC-CCcchhhhhHHHHHHHHhhCCCC-CCCCCHHHHHHHHHcC-----------------------------CCCCCCc
Confidence            766 68999999999999999998887 6666655555444321                             1112345


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCccCCccc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSA-----EDAMSHIYFSDLNVA  275 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~~~~  275 (282)
                      ++..+.+||++||+.||.+|||+     .++++||||+++++.
T Consensus       219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~  261 (318)
T cd05570         219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWD  261 (318)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            78999999999999999999999     999999999997653

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1e-45  Score=306.89  Aligned_cols=245  Identities=24%  Similarity=0.368  Sum_probs=199.7

Q ss_pred             CeeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhc
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL   77 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~   77 (282)
                      .||+|.+..+++.||+|++...  ...........|..++... +||||+++++++.....+++||||++|+.+......
T Consensus        10 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~   89 (316)
T cd05592          10 KVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS   89 (316)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHH
Confidence            3899999999999999999862  2233344556677777654 899999999999999999999999987655555555


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      .+.+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..............|++.|+|||.+.
T Consensus        90 ~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~  169 (316)
T cd05592          90 SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILK  169 (316)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHc
Confidence            67899999999999999999999999999999999999999999999999999876433333334456789999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|+|||||++|+|++|..| |.+.+..+....+...                             ....+..
T Consensus       170 ~~~-~~~~~DvwslG~il~ell~G~~P-f~~~~~~~~~~~i~~~-----------------------------~~~~~~~  218 (316)
T cd05592         170 GQK-YNESVDWWSFGVLLYEMLIGQSP-FHGEDEDELFDSILND-----------------------------RPHFPRW  218 (316)
T ss_pred             CCC-CCCcccchhHHHHHHHHHhCCCC-CCCCCHHHHHHHHHcC-----------------------------CCCCCCC
Confidence            766 69999999999999999998877 6666665555544321                             1123345


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCH-HHHhcCCCccCCccch
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSA-EDAMSHIYFSDLNVAI  276 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~-~~ll~h~~~~~~~~~~  276 (282)
                      ++.++.++|.+||+.||.+||++ .++++||||+.+++..
T Consensus       219 ~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~~  258 (316)
T cd05592         219 ISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWER  258 (316)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCHHH
Confidence            78999999999999999999986 4899999999886543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-45  Score=300.45  Aligned_cols=269  Identities=52%  Similarity=0.930  Sum_probs=211.6

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||+|.++.+|+.||+|.+...........+.+|+.++++++||||+++++++.++...++|+||+++++.+.+......
T Consensus        20 ~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~   99 (291)
T cd07844          20 TVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGG   99 (291)
T ss_pred             EEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCCCHHHHHHhCCCC
Confidence            38999999999999999988744344445678899999999999999999999999999999999999988887776678


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+..
T Consensus       100 ~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  179 (291)
T cd07844         100 LSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST  179 (291)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCc
Confidence            89999999999999999999999999999999999999999999999998865433222222334577899999987655


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCC-CCCCCCccccCccCC
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM-YHPSMSFSQVAPKLT  239 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  239 (282)
                      .++.++|+||+|+++|+|++|..|+.......+....+.+..+.+.++.++......+...... .............++
T Consensus       180 ~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (291)
T cd07844         180 EYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLD  259 (291)
T ss_pred             ccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCC
Confidence            5789999999999999999987774444446666777777777666665554433222221111 001111122222344


Q ss_pred             --HHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         240 --AKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       240 --~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                        ..+.+++.+||+.+|.+|||+.++++||||
T Consensus       260 ~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         260 RIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             CchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence              888999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.8e-45  Score=301.25  Aligned_cols=267  Identities=59%  Similarity=0.998  Sum_probs=217.9

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC--C
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--G   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~--~   79 (282)
                      ||+|++..+|+.||+|++...........+.+|+.++++++||||+++++++.+.+..++|+||++|++.+.+....  .
T Consensus        16 v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~   95 (284)
T cd07836          16 VYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRG   95 (284)
T ss_pred             EEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCccHHHHHHhcCCCC
Confidence            89999999999999999987544445567889999999999999999999999999999999999998888776543  4


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .+++..+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|||.+..............++..|++||.+.+.
T Consensus        96 ~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~  175 (284)
T cd07836          96 ALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGS  175 (284)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCC
Confidence            58999999999999999999999999999999999999999999999999987654433333444567889999998766


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      ..++.++|+||||+++|++++|..| |.+.+..+....+......+....+.........................+..+
T Consensus       176 ~~~~~~~Dv~slG~~l~~l~~g~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (284)
T cd07836         176 RTYSTSIDIWSVGCIMAEMITGRPL-FPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHAD  254 (284)
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcC
Confidence            5578999999999999999988666 777777777777777777666655554443333332222222223333445678


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      ..+.++|.+||+.||.+||++.++++||||
T Consensus       255 ~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         255 PLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.4e-45  Score=302.53  Aligned_cols=274  Identities=46%  Similarity=0.775  Sum_probs=218.7

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCC----CCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHh
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGN----EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS   76 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~   76 (282)
                      .||+|.+..+|+.||+|.+.....    ......+..|+.+++.++|+||+++++++.+++..++|+||+.|++.+.+..
T Consensus        15 ~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~i~~   94 (298)
T cd07841          15 VVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKD   94 (298)
T ss_pred             EEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEcccCCCHHHHHhc
Confidence            389999999999999999987322    2234556789999999999999999999999999999999997777776655


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhh
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~  156 (282)
                      ....+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+
T Consensus        95 ~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  174 (298)
T cd07841          95 KSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELL  174 (298)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHH
Confidence            33379999999999999999999999999999999999999999999999999998776544444444557789999998


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       157 ~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      .+...++.++|+||||++++++++| .|+|.+.+..+....+....+.+....++............ ............
T Consensus       175 ~~~~~~~~~~Dv~slG~il~e~~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  252 (298)
T cd07841         175 FGARHYGVGVDMWSVGCIFAELLLR-VPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFK-PFPPTPLKQIFP  252 (298)
T ss_pred             hCCCCCCcHHHHHHHHHHHHHHHcC-CccccCCccHHHHHHHHHHcCCCchhhhhhccccccccccc-ccCCcchhhhcc
Confidence            7665578999999999999999988 66688777777777777766666555544332222222111 111122334445


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      ..+..+.++|.+||+.||.+|||+.++++|+||++...+-
T Consensus       253 ~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         253 AASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             cccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence            6789999999999999999999999999999999876554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.3e-46  Score=309.38  Aligned_cols=244  Identities=21%  Similarity=0.323  Sum_probs=196.5

Q ss_pred             CeeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhc
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL   77 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~   77 (282)
                      .||+|+++.+++.||+|++...  ........+..|..+++.+ +||||+++++++.+.+.+|+||||++|+.+......
T Consensus        10 ~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~   89 (329)
T cd05588          10 KVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQR   89 (329)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHH
Confidence            3899999999999999999872  2333345678899999988 799999999999999999999999987544444444


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      .+.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..............|++.|+|||.+.
T Consensus        90 ~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~  169 (329)
T cd05588          90 QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR  169 (329)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCccccCHHHHc
Confidence            67899999999999999999999999999999999999999999999999999865322223333456789999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC--------hHHH-HHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSD--------VDDQ-LKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPS  228 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~--------~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
                      +.. ++.++|+||||+++|++++|..|+ ....        ..+. .+.+..                            
T Consensus       170 ~~~-~~~~~DiwslG~~l~el~~g~~Pf-~~~~~~~~~~~~~~~~~~~~~~~----------------------------  219 (329)
T cd05588         170 GED-YGFSVDWWALGVLMFEMMAGRSPF-DIVGMSDNPDQNTEDYLFQVILE----------------------------  219 (329)
T ss_pred             CCC-CCCccceechHHHHHHHHHCCCCc-ccccccccccccchHHHHHHHHc----------------------------
Confidence            766 689999999999999999998884 3211        1111 111111                            


Q ss_pred             CCccccCccCCHHHHHHHHHhcccCCCCCCC------HHHHhcCCCccCCccc
Q psy6044         229 MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS------AEDAMSHIYFSDLNVA  275 (282)
Q Consensus       229 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps------~~~ll~h~~~~~~~~~  275 (282)
                       ....++..++..+.++|++||+.||.+|+|      ++++++||||+++++.
T Consensus       220 -~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~  271 (329)
T cd05588         220 -KQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD  271 (329)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence             111234558899999999999999999997      7899999999987654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.9e-45  Score=301.71  Aligned_cols=274  Identities=41%  Similarity=0.719  Sum_probs=218.7

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC--CeEEEEEecCcccHHHHHHhc
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSE--KKLTLVFEHCDQDLKKYFDSL   77 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~--~~~~iv~e~~~g~l~~~~~~~   77 (282)
                      .||+|.++.+|+.||+|.+... ...+......+|+.++++++|+|++++++++...  +..++|+||+.+++.+.+...
T Consensus        22 ~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~  101 (309)
T cd07845          22 IVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM  101 (309)
T ss_pred             EEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCCCHHHHHHhc
Confidence            3899999999999999999863 3333344567899999999999999999998765  578999999999888888776


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.
T Consensus       102 ~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  181 (309)
T cd07845         102 PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL  181 (309)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhc
Confidence            67899999999999999999999999999999999999999999999999999987654433333344577899999987


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCC-CCCccccCc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHP-SMSFSQVAP  236 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  236 (282)
                      +...++.++|+||+|+++|++++|..| |...+..+....+....+.+....++..........+..... .........
T Consensus       182 ~~~~~~~~~DvwslG~il~el~~g~~~-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (309)
T cd07845         182 GCTTYTTAIDMWAVGCILAELLAHKPL-LPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFP  260 (309)
T ss_pred             CCCCcCchHHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhcc
Confidence            665578999999999999999987655 778888888888888777776666554332222111111000 011122233


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ..++.+.++|.+||+.||++|||++++++||||++...+
T Consensus       261 ~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         261 WLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             ccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence            468999999999999999999999999999999976654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0694|consensus

Probab=100.00  E-value=2.9e-46  Score=316.24  Aligned_cols=244  Identities=24%  Similarity=0.347  Sum_probs=215.7

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      |++|..+.+++.+|||++++  .-..+..+..+.|..+++.. +||.++.++.+|+.+.++|+||||+.|+. -.+....
T Consensus       384 V~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggd-m~~~~~~  462 (694)
T KOG0694|consen  384 VLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGD-LMHHIHT  462 (694)
T ss_pred             EEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCc-EEEEEec
Confidence            88999999999999999998  44555678889999999888 59999999999999999999999998876 2233335


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +.+++..+..++..++.||.|||++||++||||.+||++|.+|.+||+|||+++..-......+..+||+.|+|||++.+
T Consensus       463 ~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e  542 (694)
T KOG0694|consen  463 DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTE  542 (694)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhcc
Confidence            78999999999999999999999999999999999999999999999999999876544455566789999999999988


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. |+.+.|-|||||++|||+.|..| |.+.+.++....|..                             .-...|..+
T Consensus       543 ~~-Yt~aVDWW~lGVLlyeML~Gq~P-F~gddEee~FdsI~~-----------------------------d~~~yP~~l  591 (694)
T KOG0694|consen  543 QS-YTRAVDWWGLGVLLYEMLVGESP-FPGDDEEEVFDSIVN-----------------------------DEVRYPRFL  591 (694)
T ss_pred             Cc-ccchhhHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHhc-----------------------------CCCCCCCcc
Confidence            88 79999999999999999988777 999999999988876                             222345669


Q ss_pred             CHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCccchh
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMS-----AEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps-----~~~ll~h~~~~~~~~~~~  277 (282)
                      |.+..++++++|..||++|..     +++|..||||+.|++..-
T Consensus       592 s~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L  635 (694)
T KOG0694|consen  592 SKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDL  635 (694)
T ss_pred             cHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHH
Confidence            999999999999999999995     589999999999997653

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.1e-45  Score=300.05  Aligned_cols=271  Identities=53%  Similarity=0.934  Sum_probs=217.2

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC-
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG-   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~-   79 (282)
                      ||+|.++.+|+.||+|.+... ........+.+|++++++++||||+++++++.++...++|+||+++++.+.+..... 
T Consensus        18 v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~   97 (294)
T PLN00009         18 VYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDF   97 (294)
T ss_pred             EEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecccccHHHHHHhCCCC
Confidence            899999999999999998763 333445678899999999999999999999999999999999999988887765433 


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-CCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      .+++..++.++.||+.||++||++|++|+||+|+||+++. ++.++|+|||.+..............++..|+|||.+.+
T Consensus        98 ~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  177 (294)
T PLN00009         98 AKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLG  177 (294)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhC
Confidence            3688999999999999999999999999999999999985 567999999999765443333344456788999999876


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      ...++.++|+||+|+++|++++|..| |...+..+....+....+.+....|.......+.................+.+
T Consensus       178 ~~~~~~~~Dv~slG~i~~~l~tg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (294)
T PLN00009        178 SRHYSTPVDIWSVGCIFAEMVNQKPL-FPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTL  256 (294)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCC
Confidence            65578999999999999999987666 66666667677777777777666665544444433222211122233334568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      ++.+.+++.+||+.+|++||++.++++||||++++
T Consensus       257 ~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        257 EPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             ChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence            89999999999999999999999999999999875

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.5e-45  Score=304.42  Aligned_cols=244  Identities=25%  Similarity=0.376  Sum_probs=198.8

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||+|.+..+++.||+|++...  ...........|..++... +||||+++++++.+...+++||||++|+.+.......
T Consensus        11 Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~   90 (316)
T cd05619          11 VFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSC   90 (316)
T ss_pred             EEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc
Confidence            899999999999999999862  2233345567788888764 9999999999999999999999999865555444446


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..............++..|+|||.+.+
T Consensus        91 ~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  170 (316)
T cd05619          91 HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG  170 (316)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcC
Confidence            78999999999999999999999999999999999999999999999999998654322222334467889999999977


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||+||++|+|++|..| |...+..+....+....                             ...+..+
T Consensus       171 ~~-~~~~~DvwslG~il~el~~G~~p-f~~~~~~~~~~~i~~~~-----------------------------~~~~~~~  219 (316)
T cd05619         171 QK-YNTSVDWWSFGVLLYEMLIGQSP-FHGHDEEELFQSIRMDN-----------------------------PCYPRWL  219 (316)
T ss_pred             CC-CCchhhhhhHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhCC-----------------------------CCCCccC
Confidence            66 79999999999999999998887 66666655555443210                             1122347


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHH-HHhcCCCccCCccch
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAE-DAMSHIYFSDLNVAI  276 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~-~ll~h~~~~~~~~~~  276 (282)
                      +..+.++|.+||+.||.+||++. ++++||||+.+++..
T Consensus       220 ~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~~  258 (316)
T cd05619         220 TREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWSA  258 (316)
T ss_pred             CHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHHH
Confidence            88999999999999999999997 999999999987653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=7.1e-46  Score=308.86  Aligned_cols=244  Identities=24%  Similarity=0.341  Sum_probs=197.6

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHH-HHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREIC-LLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~-~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||+|+++.+|+.||+|++...  ........+..|.. +++.++||||+++++.+.+.+..++||||++|+.+.......
T Consensus        11 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~   90 (323)
T cd05575          11 VLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRE   90 (323)
T ss_pred             EEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhc
Confidence            899999999999999999862  12222334555554 567789999999999999999999999999875555444556


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus        91 ~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  170 (323)
T cd05575          91 RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK  170 (323)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcC
Confidence            78999999999999999999999999999999999999999999999999998654333333344567889999999977


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||||+++|+|++|..| |...+..+....+...                             ....++.+
T Consensus       171 ~~-~~~~~DvwslG~il~ell~g~~p-f~~~~~~~~~~~i~~~-----------------------------~~~~~~~~  219 (323)
T cd05575         171 QP-YDRTVDWWCLGAVLYEMLYGLPP-FYSRDTAEMYDNILNK-----------------------------PLRLKPNI  219 (323)
T ss_pred             CC-CCccccccccchhhhhhhcCCCC-CCCCCHHHHHHHHHcC-----------------------------CCCCCCCC
Confidence            65 79999999999999999988887 5565655555554331                             11123457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCH----HHHhcCCCccCCccch
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSA----EDAMSHIYFSDLNVAI  276 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~----~~ll~h~~~~~~~~~~  276 (282)
                      ++.+.++|++||+.||.+||++    .++++||||..+++..
T Consensus       220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~  261 (323)
T cd05575         220 SVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDD  261 (323)
T ss_pred             CHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHH
Confidence            8999999999999999999987    6999999999876543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-45  Score=298.98  Aligned_cols=268  Identities=56%  Similarity=0.966  Sum_probs=215.5

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC-
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN-   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~-   78 (282)
                      .||+|.++.+|..||+|++... ........+.+|+.+++.++|||++++++++.+.+..++++||+++++.+.+.... 
T Consensus        14 ~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~   93 (283)
T cd07835          14 VVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPL   93 (283)
T ss_pred             EEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccCcCHHHHHhhCCC
Confidence            3899999999999999998863 23334567889999999999999999999999999999999999988877766533 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+
T Consensus        94 ~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  173 (283)
T cd07835          94 TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG  173 (283)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeec
Confidence            36899999999999999999999999999999999999999999999999998765433333333455788999998866


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      ...++.++|+||||+++|++++|..| |...+..+....+......+.+..++......++..................+
T Consensus       174 ~~~~~~~~Di~slG~~l~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (283)
T cd07835         174 SRQYSTPVDIWSIGCIFAEMVNRRPL-FPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNL  252 (283)
T ss_pred             CcccCcHHHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCC
Confidence            55568999999999999999988766 66666666666666766666665555443333332211111222333445678


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      +..+.++|.+||+.||.+|||++++++||||
T Consensus       253 ~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         253 DEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            8999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.9e-45  Score=306.40  Aligned_cols=242  Identities=24%  Similarity=0.326  Sum_probs=198.5

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHH---hhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHh
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLL---KELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS   76 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~---~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~   76 (282)
                      ||+|.+..+|+.||||++...  ........+.+|+.++   +.++||||+++++++.+.+..|+||||++|+.+.....
T Consensus        15 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~   94 (324)
T cd05589          15 VLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH   94 (324)
T ss_pred             EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhh
Confidence            899999999999999999862  2223345566676655   45689999999999999999999999998765555444


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhh
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~  156 (282)
                       .+.+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..............+++.|+|||.+
T Consensus        95 -~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~  173 (324)
T cd05589          95 -TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVL  173 (324)
T ss_pred             -cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHh
Confidence             4679999999999999999999999999999999999999999999999999886543333333445678899999999


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       157 ~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      .+.. ++.++|+||||+++|+|++|..| |.+.+..+....+....                             ...+.
T Consensus       174 ~~~~-~~~~~DiwslG~il~el~~G~~p-f~~~~~~~~~~~i~~~~-----------------------------~~~p~  222 (324)
T cd05589         174 TETS-YTRAVDWWGLGVLIYEMLVGESP-FPGDDEEEVFDSIVNDE-----------------------------VRYPR  222 (324)
T ss_pred             cCCC-CCcccchhhHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhCC-----------------------------CCCCC
Confidence            7766 68999999999999999998887 66666666655554421                             11234


Q ss_pred             cCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCccc
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~  275 (282)
                      .+++.+.++|++||+.||.+||     ++.++++||||++++..
T Consensus       223 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~  266 (324)
T cd05589         223 FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWD  266 (324)
T ss_pred             CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHH
Confidence            5789999999999999999999     79999999999987543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-45  Score=308.42  Aligned_cols=248  Identities=23%  Similarity=0.341  Sum_probs=203.5

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|++..+|+.||+|++...  ........+.+|+.+++.++||||+++++++.+....|+||||++|+.+..+....+
T Consensus        17 Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~   96 (333)
T cd05600          17 VFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG   96 (333)
T ss_pred             EEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC
Confidence            899999999999999999862  222344668889999999999999999999999999999999998755555555567


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .+++..+..++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++.....   ......+++.|+|||.+.+.
T Consensus        97 ~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~  173 (333)
T cd05600          97 VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANSVVGSPDYMAPEVLRGK  173 (333)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccCCcccCccccChhHhcCC
Confidence            899999999999999999999999999999999999999999999999999876543   22344678899999999777


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      . ++.++|+|||||++|+|++|..| |...+..+....+..........                     ........++
T Consensus       174 ~-~~~~~DvwslG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~---------------------~~~~~~~~~s  230 (333)
T cd05600         174 G-YDFTVDYWSLGCMLYEFLCGFPP-FSGSTPNETWENLKYWKETLQRP---------------------VYDDPRFNLS  230 (333)
T ss_pred             C-CCCccceecchHHHhhhhhCCCC-CCCCCHHHHHHHHHhccccccCC---------------------CCCccccccC
Confidence            5 79999999999999999988777 66666666655554321111000                     0000013478


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      +++.++|.+||..+|.+|||++++++||||+++++.
T Consensus       231 ~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~  266 (333)
T cd05600         231 DEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWN  266 (333)
T ss_pred             HHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHH
Confidence            999999999999999999999999999999987553

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.1e-45  Score=300.15  Aligned_cols=248  Identities=21%  Similarity=0.296  Sum_probs=197.1

Q ss_pred             CeeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHH-h-
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFD-S-   76 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~-~-   76 (282)
                      .||+|.++.+|+.||+|.+...  ........+..|+.+++.++||||+++.+++......++||||++|+.+.... . 
T Consensus         8 ~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~   87 (280)
T cd05608           8 EVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNV   87 (280)
T ss_pred             eEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhc
Confidence            3899999999999999998762  22223356778999999999999999999999999999999999865444332 2 


Q ss_pred             --cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChh
Q psy6044          77 --LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPD  154 (282)
Q Consensus        77 --~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE  154 (282)
                        .+..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+..............+++.|+|||
T Consensus        88 ~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE  167 (280)
T cd05608          88 DEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPE  167 (280)
T ss_pred             cccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHH
Confidence              245699999999999999999999999999999999999999999999999999876654333333456788999999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      .+.+.. ++.++|+||+|+++|++++|..|+ ..................                         .....
T Consensus       168 ~~~~~~-~~~~~DvwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~-------------------------~~~~~  220 (280)
T cd05608         168 LLQGEE-YDFSVDYFALGVTLYEMIAARGPF-RARGEKVENKELKQRILN-------------------------DSVTY  220 (280)
T ss_pred             HhcCCC-CCccccHHHHHHHHHHHHhCCCCC-CCCCcchhHHHHHHhhcc-------------------------cCCCC
Confidence            998776 689999999999999999988884 433221111111111100                         01122


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCccc
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~  275 (282)
                      +..+++.+.+++.+||+.||++||     |++++++||||+++++.
T Consensus       221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~  266 (280)
T cd05608         221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR  266 (280)
T ss_pred             cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence            345889999999999999999999     88999999999997654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.7e-45  Score=307.09  Aligned_cols=244  Identities=20%  Similarity=0.324  Sum_probs=196.2

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||+|+++.+++.||+|++...  ........+..|..++.++ +||||+++++++...+..++||||++|+.+.......
T Consensus        11 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~   90 (329)
T cd05618          11 VLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ   90 (329)
T ss_pred             EEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHc
Confidence            899999999999999999873  2333345677888888777 8999999999999999999999999875555555556


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..............|+..|+|||.+.+
T Consensus        91 ~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  170 (329)
T cd05618          91 RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG  170 (329)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcC
Confidence            78999999999999999999999999999999999999999999999999998654323233334567899999999977


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCC-------ChHHHH-HHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGS-------DVDDQL-KRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMS  230 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~-------~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
                      .. ++.++|+||||+++|+|++|..|+....       ...+.. +.+..                             .
T Consensus       171 ~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-----------------------------~  220 (329)
T cd05618         171 ED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-----------------------------K  220 (329)
T ss_pred             CC-CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-----------------------------C
Confidence            66 6899999999999999999988853110       111111 11111                             1


Q ss_pred             ccccCccCCHHHHHHHHHhcccCCCCCCC------HHHHhcCCCccCCccc
Q psy6044         231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMS------AEDAMSHIYFSDLNVA  275 (282)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps------~~~ll~h~~~~~~~~~  275 (282)
                      ...++..++..+.++|++||+.||.+|||      +.++++||||+++++.
T Consensus       221 ~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~  271 (329)
T cd05618         221 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  271 (329)
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence            11234568899999999999999999998      5899999999988654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.9e-45  Score=306.26  Aligned_cols=242  Identities=25%  Similarity=0.373  Sum_probs=199.1

Q ss_pred             eeeeee---CCCCceEEEeeeecC---CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHH
Q psy6044           2 FTSGVD---RTPNTALAIKGTHLV---GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         2 vy~a~~---~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~   75 (282)
                      ||+|++   ..+|+.||+|++...   ........+..|+.+++.++||||+++++++..++..|+||||++|+.+....
T Consensus        12 V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~   91 (323)
T cd05584          12 VFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHL   91 (323)
T ss_pred             EEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHH
Confidence            788875   357999999999862   22233456778999999999999999999999999999999999876555555


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhh
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDV  155 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~  155 (282)
                      ...+.+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..............+++.|+|||.
T Consensus        92 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  171 (323)
T cd05584          92 EREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI  171 (323)
T ss_pred             HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhh
Confidence            55778899999999999999999999999999999999999999999999999998654333333333467899999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      +.+.. ++.++||||||+++|+|++|..| |...+.......+...                             ...++
T Consensus       172 ~~~~~-~~~~~DiwslG~il~ell~G~~p-f~~~~~~~~~~~~~~~-----------------------------~~~~~  220 (323)
T cd05584         172 LMRSG-HGKAVDWWSLGALMYDMLTGAPP-FTAENRKKTIDKILKG-----------------------------KLNLP  220 (323)
T ss_pred             ccCCC-CCCcceecccHHHHHHHhcCCCC-CCCCCHHHHHHHHHcC-----------------------------CCCCC
Confidence            97766 68999999999999999988877 6666655555554431                             11233


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCcc
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNV  274 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~  274 (282)
                      ..+++.+.++|++||+.||++||     +++++++||||+...+
T Consensus       221 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~  264 (323)
T cd05584         221 PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW  264 (323)
T ss_pred             CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            45789999999999999999999     8999999999987654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0585|consensus

Probab=100.00  E-value=5.2e-46  Score=302.38  Aligned_cols=244  Identities=26%  Similarity=0.380  Sum_probs=197.4

Q ss_pred             CeeeeeeCCCCceEEEeeeecCC--------CCC-----CCccHHHHHHHHhhCCCCCccceeeeeeeC--CeEEEEEec
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVG--------NEG-----VPSSALREICLLKELKHKNIVRLYDVLHSE--KKLTLVFEH   65 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~--------~~~-----~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~--~~~~iv~e~   65 (282)
                      .|-+|++..+++.||||++.+..        ...     ..+...+|+.+++++.|||||+++++..+.  ..+|+|+||
T Consensus       112 kVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley  191 (576)
T KOG0585|consen  112 KVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEY  191 (576)
T ss_pred             eEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEe
Confidence            37899999999999999998721        111     124788999999999999999999999875  689999999


Q ss_pred             CcccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccC-----CCccc
Q psy6044          66 CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG-----IPVKC  140 (282)
Q Consensus        66 ~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~-----~~~~~  140 (282)
                      |..+.....-.....+++++++.++.+++.||.|||.+||+||||||+|++++.+|.+||+|||.+....     .....
T Consensus       192 ~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~  271 (576)
T KOG0585|consen  192 CSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQ  271 (576)
T ss_pred             ccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHH
Confidence            9865555443322339999999999999999999999999999999999999999999999999987651     22223


Q ss_pred             cccccccccccChhhhcC---CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCC
Q psy6044         141 YSAEVVTLWYRPPDVLFG---AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLP  217 (282)
Q Consensus       141 ~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  217 (282)
                      .....||+.|+|||....   ....+.+.||||+|+++|.++.|+.|| .+....+....|.+.--..+           
T Consensus       272 L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF-~~~~~~~l~~KIvn~pL~fP-----------  339 (576)
T KOG0585|consen  272 LSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF-FDDFELELFDKIVNDPLEFP-----------  339 (576)
T ss_pred             HhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc-ccchHHHHHHHHhcCcccCC-----------
Confidence            344688999999999866   334578999999999999999999995 45555566666655211111           


Q ss_pred             CCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         218 DFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                                      ..+.+.+++++||++||.+||.+|+++.+|..|||...-
T Consensus       340 ----------------~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  340 ----------------ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             ----------------CcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence                            112478999999999999999999999999999999855

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.1e-44  Score=297.24  Aligned_cols=264  Identities=44%  Similarity=0.765  Sum_probs=207.2

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhC---CCCCccceeeeeee-----CCeEEEEEecCcccHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKEL---KHKNIVRLYDVLHS-----EKKLTLVFEHCDQDLK   71 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l---~h~~i~~~~~~~~~-----~~~~~iv~e~~~g~l~   71 (282)
                      .||+|+++.+|+.||+|.+... ..........+|+.+++.+   +||||+++++++..     ...+++++|++++++.
T Consensus        15 ~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~   94 (288)
T cd07863          15 TVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLR   94 (288)
T ss_pred             EEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccccCHH
Confidence            3899999999999999998763 2333344566788877766   79999999998864     3468999999999888


Q ss_pred             HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccc
Q psy6044          72 KYFDSLN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWY  150 (282)
Q Consensus        72 ~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  150 (282)
                      +.+.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... .......++..|
T Consensus        95 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y  173 (288)
T cd07863          95 TYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ-MALTPVVVTLWY  173 (288)
T ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCc-ccCCCccccccc
Confidence            8776543 35899999999999999999999999999999999999999999999999998765422 222334568889


Q ss_pred             cChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMS  230 (282)
Q Consensus       151 ~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
                      +|||.+.+.. ++.++|+||+|+++|+|++| .|+|......+....+....+.+....++........  .........
T Consensus       174 ~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  249 (288)
T cd07863         174 RAPEVLLQST-YATPVDMWSVGCIFAEMFRR-KPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRG--AFSPRGPRP  249 (288)
T ss_pred             cCchHhhCCC-CCCcchhhhHHHHHHHHHhC-CcCcCCCCHHHHHHHHHHHhCCCChhhCccccccccc--ccCCCCCCc
Confidence            9999997766 79999999999999999965 5557777777778788777766655555432111110  011111223


Q ss_pred             ccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      .....+.++..+.++|.+||+.||++|||+.+++.||||
T Consensus       250 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         250 VQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             hHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            344556788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.8e-45  Score=305.39  Aligned_cols=243  Identities=21%  Similarity=0.314  Sum_probs=200.1

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCC-CCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKH-KNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h-~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||+|.++.+++.||+|++...  ........+..|..++..+.| ++|+++++++...+..|+||||++|+.+.......
T Consensus        16 Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~   95 (324)
T cd05587          16 VMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV   95 (324)
T ss_pred             EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHc
Confidence            899999999999999999862  233345677889999999976 45888999999999999999999875555555556


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..............|++.|+|||.+.+
T Consensus        96 ~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  175 (324)
T cd05587          96 GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY  175 (324)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcC
Confidence            78999999999999999999999999999999999999999999999999988654322233334467899999999977


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||+|+++|+|++|..| |.+.+..+....+...                             ....+..+
T Consensus       176 ~~-~~~~~DiwslGvil~elltG~~p-f~~~~~~~~~~~i~~~-----------------------------~~~~~~~~  224 (324)
T cd05587         176 QP-YGKSVDWWAFGVLLYEMLAGQPP-FDGEDEDELFQSIMEH-----------------------------NVSYPKSL  224 (324)
T ss_pred             CC-CCcccchhhhHHHHHHHHhCCCC-CCCCCHHHHHHHHHcC-----------------------------CCCCCCCC
Confidence            65 68999999999999999998777 6666666666555431                             11223457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCccCCccc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSA-----EDAMSHIYFSDLNVA  275 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~~~~  275 (282)
                      ++.+.+++++||..||.+|++.     +++++||||+.+++.
T Consensus       225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~  266 (324)
T cd05587         225 SKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWE  266 (324)
T ss_pred             CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            8999999999999999999976     899999999988654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=7.9e-45  Score=297.72  Aligned_cols=269  Identities=41%  Similarity=0.758  Sum_probs=218.8

Q ss_pred             CeeeeeeCCCCceEEEeeeecCC-CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVG-NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      .||+|.+..+|+.||+|++.... .......+.+|+.++++++||||+++++++......++|+||+.+++.+.+.....
T Consensus        15 ~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~   94 (286)
T cd07832          15 IVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEER   94 (286)
T ss_pred             EEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecccCCCHHHHHHhcCC
Confidence            38999999999999999998732 34446788999999999999999999999999999999999997778777766567


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~  158 (282)
                      .+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+
T Consensus        95 ~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  174 (286)
T cd07832          95 PLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG  174 (286)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeec
Confidence            799999999999999999999999999999999999999999999999999877653321 2334466888999999876


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCC-CCCCCccccCcc
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY-HPSMSFSQVAPK  237 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  237 (282)
                      ...++.++|+||+|++++++++| .|+|.+....+....+....+.+....++.............. .....+....+.
T Consensus       175 ~~~~~~~~Di~slG~~l~~l~tg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (286)
T cd07832         175 ARKYDPGVDLWAVGCIFAELLNG-SPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPD  253 (286)
T ss_pred             cccCCchhHHHHHHHHHHHHHcC-CcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCC
Confidence            66578999999999999999988 6668888877888888887777666555544333332221111 111123334456


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS  270 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  270 (282)
                      .+..+.++|.+||+.||++|||++++++||||.
T Consensus       254 ~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         254 ASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             ccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            789999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.8e-44  Score=296.33  Aligned_cols=268  Identities=49%  Similarity=0.796  Sum_probs=210.8

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEI   81 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~   81 (282)
                      ||+|.++.+|+.||+|++...........+.+|+.+++.++|+||+++++++..+...++|+||+++++++.+......+
T Consensus        21 v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~  100 (291)
T cd07870          21 VYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGL  100 (291)
T ss_pred             EEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecccCCHHHHHHhCCCCC
Confidence            89999999999999999977544455567889999999999999999999999999999999999999998887666678


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCCC
Q psy6044          82 DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKL  161 (282)
Q Consensus        82 ~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  161 (282)
                      ++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+...
T Consensus       101 ~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  180 (291)
T cd07870         101 HPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD  180 (291)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCC
Confidence            89999999999999999999999999999999999999999999999988765433333334456788999999876544


Q ss_pred             CCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCC-CCCCCccccC--ccC
Q psy6044         162 YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY-HPSMSFSQVA--PKL  238 (282)
Q Consensus       162 ~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~  238 (282)
                      ++.++|+||||+++|++++|..|+....+..+....+....+.+.+..++.............. ..........  ...
T Consensus       181 ~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (291)
T cd07870         181 YSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSR  260 (291)
T ss_pred             CCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCC
Confidence            6889999999999999999888754445555666666666666555544443332222211100 0011111111  124


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      +..+.+++.+||..||++|||+++++.||||
T Consensus       261 ~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         261 PPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            6789999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.2e-44  Score=295.03  Aligned_cols=267  Identities=33%  Similarity=0.590  Sum_probs=207.9

Q ss_pred             CeeeeeeCCCCceEEEeeeecCC-CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVG-NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      .||+|+++.+|+.||+|++.... .....+.+.+|+.++++++|||++++++++......++|+||+++++++.+.....
T Consensus        16 ~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~   95 (286)
T cd07847          16 VVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR   95 (286)
T ss_pred             EEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCC
Confidence            38999999999999999987632 23344567899999999999999999999999999999999999998888877677


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+.
T Consensus        96 ~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  175 (286)
T cd07847          96 GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGD  175 (286)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCC
Confidence            89999999999999999999999999999999999999999999999999998765443333344567889999998765


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCC---CCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTW---PGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      ..++.++|+||+|+++|++++|+.| |.+....+....+....+.......   ........ ...+.............
T Consensus       176 ~~~~~~~Di~slG~i~~~l~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  253 (286)
T cd07847         176 TQYGPPVDVWAIGCVFAELLTGQPL-WPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG-LSIPEPETREPLESKFP  253 (286)
T ss_pred             CCcCchhhhHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCChHHhhhccccccccc-ccCCCcccccCHHHHhc
Confidence            5578999999999999999988766 6666666666555554433221100   00000000 00111111112223345


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      .++..+.+||.+||+.||.+|||+.+++.||||
T Consensus       254 ~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         254 NISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=9e-45  Score=303.15  Aligned_cols=270  Identities=25%  Similarity=0.362  Sum_probs=201.1

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||+|++..+|..+|+|.+...........+.+|++++++++||||+++++++..++..++||||++|+.+..+......
T Consensus        20 ~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~   99 (331)
T cd06649          20 VVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR   99 (331)
T ss_pred             EEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCC
Confidence            38999999999999999988643333456789999999999999999999999999999999999987655555555677


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSR-NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      +++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+.......  .....++..|+|||.+.+.
T Consensus       100 ~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~g~~~y~aPE~~~~~  177 (331)
T cd06649         100 IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGT  177 (331)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc--cccCCCCcCcCCHhHhcCC
Confidence            99999999999999999999986 69999999999999999999999999987654322  2334578899999999776


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCC--CCCCC---CC---------
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPD--FKPFP---MY---------  225 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~---~~---------  225 (282)
                      . ++.++|+||||+++|++++|+.| |...+..+....+....................  .....   ..         
T Consensus       178 ~-~~~~~DiwslG~il~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T cd06649         178 H-YSVQSDIWSMGLSLVELAIGRYP-IPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFE  255 (331)
T ss_pred             C-CCchHhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHH
Confidence            6 79999999999999999999888 555554443332221111111110000000000  00000   00         


Q ss_pred             -----CCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         226 -----HPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       226 -----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                           ............+++++.+||++||+.||++|||++++++||||+....
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~  309 (331)
T cd06649         256 LLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV  309 (331)
T ss_pred             HHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence                 0000000011247899999999999999999999999999999987644

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0192|consensus

Probab=100.00  E-value=3.2e-45  Score=302.73  Aligned_cols=234  Identities=26%  Similarity=0.340  Sum_probs=194.4

Q ss_pred             eeeeeeCCCCce-EEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC-eEEEEEecCcccHHHHHHhc-
Q psy6044           2 FTSGVDRTPNTA-LAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK-KLTLVFEHCDQDLKKYFDSL-   77 (282)
Q Consensus         2 vy~a~~~~~~~~-vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~-~~~iv~e~~~g~l~~~~~~~-   77 (282)
                      ||+|..+  |.. ||+|++.. .........|.+|+.++.+++||||++++|++.++. .+.|||||++++.+..+... 
T Consensus        57 V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~  134 (362)
T KOG0192|consen   57 VYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK  134 (362)
T ss_pred             EEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc
Confidence            7888764  444 99999987 333333679999999999999999999999999988 79999999986555555544 


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCcEEEcCCC-cEEEEecCCccccCCCccccccccccccccChh
Q psy6044          78 -NGEIDLDIVKSFMYQLLRGLAFCHSRN-VLHRDLKPQNLLINKNG-ELKLADFGLARAFGIPVKCYSAEVVTLWYRPPD  154 (282)
Q Consensus        78 -~~~~~~~~~~~~~~qi~~~l~~lh~~~-i~H~dl~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE  154 (282)
                       ...++...+..++.+|+.|+.|||+++ |+|+||||+|++++.++ ++||+|||+++.........+...||..|+|||
T Consensus       135 ~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPE  214 (362)
T KOG0192|consen  135 RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPE  214 (362)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChh
Confidence             678999999999999999999999999 99999999999999998 999999999987764434455578899999999


Q ss_pred             hhcC-CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         155 VLFG-AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       155 ~~~~-~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      ++.+ ...++.++||||||+++||++||..| |.+..............                           ....
T Consensus       215 v~~~~~~~~~~K~DvySFgIvlWEl~t~~~P-f~~~~~~~~~~~v~~~~---------------------------~Rp~  266 (362)
T KOG0192|consen  215 VLRGEKSPYTEKSDVYSFGIVLWELLTGEIP-FEDLAPVQVASAVVVGG---------------------------LRPP  266 (362)
T ss_pred             hhcCCCCcCCccchhhhHHHHHHHHHHCCCC-CCCCCHHHHHHHHHhcC---------------------------CCCC
Confidence            9985 24489999999999999999999988 66666655555544322                           1222


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ++...++.+..++..||+.||.+||++.+++.
T Consensus       267 ~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  267 IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            34458899999999999999999999999876

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=9.5e-45  Score=298.31  Aligned_cols=268  Identities=46%  Similarity=0.767  Sum_probs=213.8

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC--CeEEEEEecCcccHHHHHHhc
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSE--KKLTLVFEHCDQDLKKYFDSL   77 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~--~~~~iv~e~~~g~l~~~~~~~   77 (282)
                      .||+|.+..+++.+++|.+... ........+.+|+.++++++||||+++++++...  ...++|+||+++++.+.+...
T Consensus        20 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~   99 (293)
T cd07843          20 VVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETM   99 (293)
T ss_pred             EEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCcCHHHHHHhc
Confidence            4899999999999999999863 2333344677899999999999999999998877  899999999999888877765


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      ...+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.
T Consensus       100 ~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~  179 (293)
T cd07843         100 KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLL  179 (293)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccccccccccccccCchhhc
Confidence            56799999999999999999999999999999999999999999999999999887765433344455678899999987


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCC-CCCCCCcc-ccC
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM-YHPSMSFS-QVA  235 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~  235 (282)
                      +...++.++|+||+|++++++++|..| |......+....+....+.+.+..|+............. ........ .++
T Consensus       180 ~~~~~~~~~Di~slG~~l~~l~~g~~~-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (293)
T cd07843         180 GAKEYSTAIDMWSVGCIFAELLTKKPL-FPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFP  258 (293)
T ss_pred             CCccccchhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhcccc
Confidence            665568999999999999999987665 777777777777777777666655554332222221000 00000111 122


Q ss_pred             cc-CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         236 PK-LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       236 ~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      .. +++.+.++|++||+.||++|||++|+++||||
T Consensus       259 ~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         259 ALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             ccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            22 58899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.7e-46  Score=307.47  Aligned_cols=243  Identities=26%  Similarity=0.309  Sum_probs=198.7

Q ss_pred             eeeeee---CCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhc
Q psy6044           2 FTSGVD---RTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL   77 (282)
Q Consensus         2 vy~a~~---~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~   77 (282)
                      ||++++   +.+|+.||+|++.. .........+..|++++++++||||+++++++.+++..|+|+||++|+.+......
T Consensus        12 Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   91 (318)
T cd05582          12 VFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK   91 (318)
T ss_pred             EEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHH
Confidence            677765   46899999999987 22222345677899999999999999999999999999999999976444444444


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.
T Consensus        92 ~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~  171 (318)
T cd05582          92 EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN  171 (318)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHc
Confidence            67799999999999999999999999999999999999999999999999999876543333333456788999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      ... ++.++|+||||+++|+|++|..| |...+..+....+...                             ...++..
T Consensus       172 ~~~-~~~~~DiwslG~il~el~tg~~p-~~~~~~~~~~~~i~~~-----------------------------~~~~p~~  220 (318)
T cd05582         172 RRG-HTQSADWWSFGVLMFEMLTGSLP-FQGKDRKETMTMILKA-----------------------------KLGMPQF  220 (318)
T ss_pred             CCC-CCCccceeccceEeeeeccCCCC-CCCCCHHHHHHHHHcC-----------------------------CCCCCCC
Confidence            765 68999999999999999988877 6666666655554331                             1123345


Q ss_pred             CCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCccc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMS-----AEDAMSHIYFSDLNVA  275 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps-----~~~ll~h~~~~~~~~~  275 (282)
                      +++.+.++|++||+.||.+|||     +.+++.||||+.+.+.
T Consensus       221 ~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~  263 (318)
T cd05582         221 LSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWN  263 (318)
T ss_pred             CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHH
Confidence            7899999999999999999999     7889999999987543

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-45  Score=310.41  Aligned_cols=246  Identities=26%  Similarity=0.393  Sum_probs=201.1

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      ||+|++..+|+.||+|++...  ........+..|+.++..++||||+++++++.+++..++||||++| ++.+.+.. .
T Consensus        17 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~   95 (350)
T cd05573          17 VWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR-K   95 (350)
T ss_pred             EEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHH-c
Confidence            899999999999999999862  2334456788999999999999999999999999999999999976 45554444 5


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc--------------------
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--------------------  138 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~--------------------  138 (282)
                      +.+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||.+.......                    
T Consensus        96 ~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (350)
T cd05573          96 DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV  175 (350)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccc
Confidence            789999999999999999999999999999999999999999999999999987665332                    


Q ss_pred             ---------cccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy6044         139 ---------KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDT  209 (282)
Q Consensus       139 ---------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  209 (282)
                               .......+++.|+|||.+.+.. ++.++|||||||++|+|++|..| |...+..+....+........   
T Consensus       176 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~P-f~~~~~~~~~~~i~~~~~~~~---  250 (350)
T cd05573         176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTP-YGLECDWWSLGVILYEMLYGFPP-FYSDTLQETYNKIINWKESLR---  250 (350)
T ss_pred             cccccccccccccccccCccccCHHHHcCCC-CCCceeeEecchhhhhhccCCCC-CCCCCHHHHHHHHhccCCccc---
Confidence                     1223446789999999998775 79999999999999999998888 555555555544443111100   


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCC-HHHHhcCCCccCCccch
Q psy6044         210 WPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS-AEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~ll~h~~~~~~~~~~  276 (282)
                                           .. ....+++.+.++|..||. ||.+||+ ++++++||||+++++..
T Consensus       251 ---------------------~p-~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~~  295 (350)
T cd05573         251 ---------------------FP-PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWEN  295 (350)
T ss_pred             ---------------------CC-CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHHH
Confidence                                 00 012278999999999998 9999999 99999999999986643

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0032|consensus

Probab=100.00  E-value=9.4e-45  Score=302.40  Aligned_cols=242  Identities=28%  Similarity=0.430  Sum_probs=208.3

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCC--CCCccHHHHHHHHhhCC-CCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHh
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNE--GVPSSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDS   76 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~   76 (282)
                      .||+|+++.+|+.+|+|++.+....  .....+.+|+.+|+++. ||||+.++++|++...+++|||+|.| .+.+.+..
T Consensus        50 ~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~  129 (382)
T KOG0032|consen   50 VVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVK  129 (382)
T ss_pred             EEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHH
Confidence            4899999999999999999983322  24578999999999998 99999999999999999999999975 67776666


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC----CcEEEEecCCccccCCCccccccccccccccC
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN----GELKLADFGLARAFGIPVKCYSAEVVTLWYRP  152 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~----~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~a  152 (282)
                      .  .+++..+..++.|++.+++|||+.|++|+|+||+|+++...    +.++++|||++..... .......+||+.|+|
T Consensus       130 ~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~-~~~~~~~~Gtp~y~A  206 (382)
T KOG0032|consen  130 K--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP-GERLHTIVGTPEYVA  206 (382)
T ss_pred             c--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-CceEeeecCCccccC
Confidence            4  49999999999999999999999999999999999999543    5799999999998876 556677899999999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       153 PE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      ||++.... ++...|+||+|+++|.|++|..| |.+.+..+....+..+......+.|                      
T Consensus       207 PEvl~~~~-y~~~~DiWS~Gvi~yiLL~G~~P-F~~~~~~~~~~~i~~~~~~f~~~~w----------------------  262 (382)
T KOG0032|consen  207 PEVLGGRP-YGDEVDVWSIGVILYILLSGVPP-FWGETEFEIFLAILRGDFDFTSEPW----------------------  262 (382)
T ss_pred             chhhcCCC-CCcccchhHHHHHHHHHhhCCCC-CcCCChhHHHHHHHcCCCCCCCCCc----------------------
Confidence            99997655 79999999999999999977667 5565555555566665544444444                      


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                         ..+|..+++||+.||..||.+|+|+.++|+|||+++.
T Consensus       263 ---~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  263 ---DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             ---cccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence               4589999999999999999999999999999999976

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8.3e-45  Score=306.99  Aligned_cols=248  Identities=19%  Similarity=0.270  Sum_probs=198.1

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|.++.+|+.||+|++...  ........+..|+.++..++||||+++++.+.+...+|+||||++|+.+..+....+
T Consensus        17 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~   96 (363)
T cd05628          17 VRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD   96 (363)
T ss_pred             EEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcC
Confidence            899999999999999999862  223334567889999999999999999999999999999999998755555554467


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--------------------
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--------------------  139 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--------------------  139 (282)
                      .+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++........                    
T Consensus        97 ~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (363)
T cd05628          97 TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM  176 (363)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccccccccccccccccccc
Confidence            899999999999999999999999999999999999999999999999999865432100                    


Q ss_pred             ---------------ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCC
Q psy6044         140 ---------------CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT  204 (282)
Q Consensus       140 ---------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~  204 (282)
                                     ......||+.|+|||.+.+.. ++.++|+|||||++|+|++|..| |.+.+..+....+......
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G~~P-f~~~~~~~~~~~i~~~~~~  254 (363)
T cd05628         177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPP-FCSETPQETYKKVMNWKET  254 (363)
T ss_pred             ccccccchhhhccccccccccCCccccCHHHHcCCC-CCCchhhhhhHHHHHHHHhCCCC-CCCCCHHHHHHHHHcCcCc
Confidence                           011246789999999997766 78999999999999999988877 6666666666555442111


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCC---CCCCHHHHhcCCCccCCccchh
Q psy6044         205 PTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPV---QRMSAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~---~Rps~~~ll~h~~~~~~~~~~~  277 (282)
                      ..                        .+. ...++++++++|.+|+. +|.   .||+++++++||||+++++...
T Consensus       255 ~~------------------------~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~~  304 (363)
T cd05628         255 LI------------------------FPP-EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEHI  304 (363)
T ss_pred             cc------------------------CCC-cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHHH
Confidence            00                        000 12378899999999775 454   4589999999999999977654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.7e-45  Score=312.30  Aligned_cols=271  Identities=36%  Similarity=0.524  Sum_probs=209.2

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC-----eEEEEEecCcccHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK-----KLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~-----~~~iv~e~~~g~l~~~~   74 (282)
                      .||+|.+..+|+.||+|++... ........+.+|+.+++.++||||+++++++....     ..|+|+||+.+++...+
T Consensus        15 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~   94 (372)
T cd07853          15 VVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKII   94 (372)
T ss_pred             EEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccccCHHHHH
Confidence            3899999999999999998752 22233467889999999999999999999998776     89999999999888776


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC-ccccccccccccccCh
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP-VKCYSAEVVTLWYRPP  153 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~aP  153 (282)
                      .. ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++...... ........++..|+||
T Consensus        95 ~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aP  173 (372)
T cd07853          95 VS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP  173 (372)
T ss_pred             hc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCH
Confidence            54 567999999999999999999999999999999999999999999999999998754322 1222334567889999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCC--CCCCCCCCC-CCCCCC
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNL--LPDFKPFPM-YHPSMS  230 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~-~~~~~~  230 (282)
                      |.+.+...++.++|+||+||++|+|++|..| |.+.+..+....+...++.+..+.+.....  ......... ......
T Consensus       174 E~~~~~~~~~~~~DiwslG~il~el~~g~~p-f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (372)
T cd07853         174 EILMGSRHYTSAVDIWSVGCIFAELLGRRIL-FQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPV  252 (372)
T ss_pred             HHHcCCCCCCcHHHHHhHHHHHHHHHcCCCC-CCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHH
Confidence            9998766578999999999999999987666 777777777777777666544322111000  000000000 000001


Q ss_pred             ccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      ........++++.+||.+||+.||++|||++++++||||++..
T Consensus       253 ~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         253 LYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             hcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence            1123345689999999999999999999999999999999854

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG4717|consensus

Probab=100.00  E-value=1.4e-45  Score=302.97  Aligned_cols=244  Identities=29%  Similarity=0.493  Sum_probs=219.3

Q ss_pred             CeeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      ||-+|++.-+|+.||||++.+ ..+.-....+++|+..|+.++|||||++|++...+..+|+|.|.-+| ++.+++.+..
T Consensus        33 VVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe  112 (864)
T KOG4717|consen   33 VVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHE  112 (864)
T ss_pred             hhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhh
Confidence            567899999999999999998 55666678899999999999999999999999999999999999975 8999998878


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc-CCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      ..+.|+.+.+++.||+.|+.|+|+..++|+||||+|+.+. .-|-+||.|||++..+. +.......+|++.|.|||++.
T Consensus       113 ~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-PG~kL~TsCGSLAYSAPEILL  191 (864)
T KOG4717|consen  113 EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-PGKKLTTSCGSLAYSAPEILL  191 (864)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC-CcchhhcccchhhccCchhhh
Confidence            8899999999999999999999999999999999999875 56999999999998876 445566678899999999999


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +..+..++.||||||+++|-|++|+.| |...++.+.+..|+.+.                             ..++.+
T Consensus       192 GDsYDAPAVDiWSLGVILyMLVCGq~P-FqeANDSETLTmImDCK-----------------------------YtvPsh  241 (864)
T KOG4717|consen  192 GDSYDAPAVDIWSLGVILYMLVCGQPP-FQEANDSETLTMIMDCK-----------------------------YTVPSH  241 (864)
T ss_pred             cCccCCcchhhhHHHHHHHHHHhCCCc-cccccchhhhhhhhccc-----------------------------ccCchh
Confidence            998888999999999999999976666 89999899888887743                             235678


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      +|.++++||..||.-||++|.|.++|..|+|++.++..
T Consensus       242 vS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~  279 (864)
T KOG4717|consen  242 VSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG  279 (864)
T ss_pred             hhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence            99999999999999999999999999999999988654

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7.2e-45  Score=302.82  Aligned_cols=245  Identities=20%  Similarity=0.287  Sum_probs=200.7

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||+|.++.+++.||+|++...  ...........|..++..+ .|++|+++++++...+.+++||||++|+.+.......
T Consensus        16 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~   95 (323)
T cd05616          16 VMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQV   95 (323)
T ss_pred             EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHc
Confidence            899999999999999999862  2223334567788888777 5899999999999999999999999864444444446


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..............|++.|+|||.+..
T Consensus        96 ~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  175 (323)
T cd05616          96 GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY  175 (323)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcC
Confidence            78999999999999999999999999999999999999999999999999998754333333334567899999999977


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+|||||++|+|++|..| |.+.+..+....+....                             ...+..+
T Consensus       176 ~~-~~~~~DiwSlGvil~elltg~~P-f~~~~~~~~~~~i~~~~-----------------------------~~~p~~~  224 (323)
T cd05616         176 QP-YGKSVDWWAFGVLLYEMLAGQAP-FEGEDEDELFQSIMEHN-----------------------------VAYPKSM  224 (323)
T ss_pred             CC-CCCccchhchhHHHHHHHhCCCC-CCCCCHHHHHHHHHhCC-----------------------------CCCCCcC
Confidence            66 79999999999999999998777 66666666666554421                             1123457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCccCCccchh
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSA-----EDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~~~~~~  277 (282)
                      ++++.+++.+||+.||.+|++.     .++++||||+.+++...
T Consensus       225 s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~  268 (323)
T cd05616         225 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL  268 (323)
T ss_pred             CHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence            8999999999999999999984     89999999999876543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6.7e-45  Score=303.35  Aligned_cols=247  Identities=20%  Similarity=0.297  Sum_probs=198.5

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||+|.++.+++.||+|++...  ........+.+|..++.++ .||+|+++++++.+.+.+++||||++|+.+.......
T Consensus        11 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~   90 (327)
T cd05617          11 VLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ   90 (327)
T ss_pred             EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc
Confidence            899999999999999999872  2233445678899999888 6999999999999999999999999875555544446


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..............|++.|+|||.+.+
T Consensus        91 ~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  170 (327)
T cd05617          91 RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG  170 (327)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCC
Confidence            78999999999999999999999999999999999999999999999999998754322233334567899999999977


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGS-----DVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      .. ++.++|+||||+++|+|++|..|+....     ...+........                            ....
T Consensus       171 ~~-~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~  221 (327)
T cd05617         171 EE-YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE----------------------------KPIR  221 (327)
T ss_pred             CC-CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh----------------------------CCCC
Confidence            66 6999999999999999999988853211     112222221111                            1112


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCC------HHHHhcCCCccCCccchh
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMS------AEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps------~~~ll~h~~~~~~~~~~~  277 (282)
                      ++..++..+.++|++||+.||.+|++      ++++++||||+.+++...
T Consensus       222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~  271 (327)
T cd05617         222 IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLL  271 (327)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHH
Confidence            34557899999999999999999998      579999999999876544

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.9e-45  Score=304.68  Aligned_cols=243  Identities=22%  Similarity=0.316  Sum_probs=196.1

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHH-HHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREIC-LLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~-~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||+|+++.+|+.||+|++...  ........+..|.. +++.++||||+++++++..++..++||||++|+.+.......
T Consensus        11 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   90 (325)
T cd05604          11 VLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE   90 (325)
T ss_pred             EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHc
Confidence            899999999999999999762  22223344555554 467789999999999999999999999999876555555557


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +.+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus        91 ~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  170 (325)
T cd05604          91 RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK  170 (325)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcC
Confidence            78999999999999999999999999999999999999999999999999998654333333344567899999999977


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||||+++|+|++|..| |...+..+....+...                             .....+..
T Consensus       171 ~~-~~~~~DvwslG~il~el~~G~~p-f~~~~~~~~~~~~~~~-----------------------------~~~~~~~~  219 (325)
T cd05604         171 QP-YDNTVDWWCLGAVLYEMLYGLPP-FYCRDVAEMYDNILHK-----------------------------PLVLRPGA  219 (325)
T ss_pred             CC-CCCcCccccccceehhhhcCCCC-CCCCCHHHHHHHHHcC-----------------------------CccCCCCC
Confidence            66 68999999999999999988887 5555555554444331                             01123457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCH----HHHhcCCCccCCccc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSA----EDAMSHIYFSDLNVA  275 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~----~~ll~h~~~~~~~~~  275 (282)
                      +..+.++|++||..||.+||++    .++++||||+++.+.
T Consensus       220 ~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~  260 (325)
T cd05604         220 SLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWT  260 (325)
T ss_pred             CHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHH
Confidence            8899999999999999999976    599999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-45  Score=307.65  Aligned_cols=246  Identities=22%  Similarity=0.334  Sum_probs=198.4

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|++..+|+.||||++...  ........+.+|+.+++.++||||+++++++.++...++||||++|+.+..+....+
T Consensus        17 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~   96 (364)
T cd05599          17 VRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD   96 (364)
T ss_pred             EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcC
Confidence            899999999999999999862  223334567889999999999999999999999999999999998765555555567


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--------------------
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--------------------  139 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--------------------  139 (282)
                      .+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++..+.....                    
T Consensus        97 ~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (364)
T cd05599          97 TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS  176 (364)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccccccccccccccccccc
Confidence            899999999999999999999999999999999999999999999999998865431110                    


Q ss_pred             ------------------ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q psy6044         140 ------------------CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL  201 (282)
Q Consensus       140 ------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~  201 (282)
                                        ......||+.|+|||.+.... ++.++|+|||||++|+|++|..| |...+..+....+...
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~G~~P-f~~~~~~~~~~~i~~~  254 (364)
T cd05599         177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEMLVGYPP-FCSDNPQETYRKIINW  254 (364)
T ss_pred             ccccccccccchhhcccccccccccCccccCHHHHcCCC-CCCeeeeecchhHHHHhhcCCCC-CCCCCHHHHHHHHHcC
Confidence                              001235789999999997766 79999999999999999988777 6665555555444331


Q ss_pred             hCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCccCCccc
Q psy6044         202 LGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS---AEDAMSHIYFSDLNVA  275 (282)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~~~  275 (282)
                      ....                        ... ....+++.+.++|++||. +|.+|++   ++++++||||+++++.
T Consensus       255 ~~~~------------------------~~~-~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~  305 (364)
T cd05599         255 KETL------------------------QFP-DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWE  305 (364)
T ss_pred             CCcc------------------------CCC-CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            1000                        000 012478999999999997 9999998   9999999999988654

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.8e-44  Score=294.42  Aligned_cols=267  Identities=51%  Similarity=0.902  Sum_probs=207.8

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCC-CCCccceeeeeeeCCe-----EEEEEecCcccHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELK-HKNIVRLYDVLHSEKK-----LTLVFEHCDQDLKKYF   74 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~-----~~iv~e~~~g~l~~~~   74 (282)
                      ||+|.+..+|+.||+|..... ........+.+|+.+++.+. ||||+++++++.....     .|+++||+++++.+.+
T Consensus        17 vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~   96 (295)
T cd07837          17 VYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFM   96 (295)
T ss_pred             EEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCcCHHHHH
Confidence            899999999999999998763 33334567888999999995 6999999999987665     8999999999888877


Q ss_pred             HhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-CCcEEEEecCCccccCCCcccccccccccc
Q psy6044          75 DSLN----GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVKCYSAEVVTLW  149 (282)
Q Consensus        75 ~~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~  149 (282)
                      ....    ..+++..++.++.||+.||.|||++|++|+||+|+||+++. ++.++|+|||.+..............+++.
T Consensus        97 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  176 (295)
T cd07837          97 DSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLW  176 (295)
T ss_pred             HHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccC
Confidence            6542    35899999999999999999999999999999999999998 889999999998765433333333455778


Q ss_pred             ccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSM  229 (282)
Q Consensus       150 ~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
                      |+|||.+.+...++.++|+||||+++|+|++|..| |.+.+..+....+......+....++...........+... ..
T Consensus       177 ~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  254 (295)
T cd07837         177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL-FPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWK-PQ  254 (295)
T ss_pred             CCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCccc-ch
Confidence            99999987655578999999999999999988666 66666666666666666655554444322222211111111 11


Q ss_pred             CccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q psy6044         230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS  270 (282)
Q Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  270 (282)
                      ......+.+++.+.+||.+||..||.+|||+++++.||||+
T Consensus       255 ~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         255 DLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            12223346899999999999999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-45  Score=306.38  Aligned_cols=246  Identities=24%  Similarity=0.318  Sum_probs=195.9

Q ss_pred             CeeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhC---CCCCccceeeeeeeCCeEEEEEecCcccHHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKEL---KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l---~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~   75 (282)
                      .||+|+++.+|+.||+|++...  ...........|..++...   .||||+++++++.+....|+||||++|+.+....
T Consensus         8 ~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l   87 (330)
T cd05586           8 QVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHL   87 (330)
T ss_pred             EEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHH
Confidence            3899999999999999998752  1222233455666776655   6999999999999999999999999865554444


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhh
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDV  155 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~  155 (282)
                      ...+.+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++..............|+..|+|||.
T Consensus        88 ~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~  167 (330)
T cd05586          88 QKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEV  167 (330)
T ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHH
Confidence            45778999999999999999999999999999999999999999999999999998754333333334567899999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      +.+...++.++|+||||+++|+|++|..| |...+..+....+.......                            ..
T Consensus       168 ~~~~~~~~~~~DvwslGvil~elltG~~P-f~~~~~~~~~~~i~~~~~~~----------------------------~~  218 (330)
T cd05586         168 LLDEKGYTKHVDFWSLGVLVFEMCCGWSP-FYAEDTQQMYRNIAFGKVRF----------------------------PK  218 (330)
T ss_pred             HcCCCCCCCccceeccccEEEEeccCCCC-CCCCCHHHHHHHHHcCCCCC----------------------------CC
Confidence            97665578999999999999999998888 55555555444443211000                            01


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCC----CHHHHhcCCCccCCccc
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRM----SAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rp----s~~~ll~h~~~~~~~~~  275 (282)
                      ..+++.+.++|++||+.||.+||    ++.++++||||++..+.
T Consensus       219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~  262 (330)
T cd05586         219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWD  262 (330)
T ss_pred             ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHH
Confidence            23788999999999999999998    79999999999987643

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.8e-44  Score=299.07  Aligned_cols=243  Identities=20%  Similarity=0.314  Sum_probs=199.4

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCC-CCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||+|.++.+|+.||+|++...  ........+..|..+++.+. |++|+++++++.+++.+|+||||++|+.+.......
T Consensus        16 Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~   95 (323)
T cd05615          16 VMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV   95 (323)
T ss_pred             EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHc
Confidence            899999999999999999862  22333456778889988885 577888999999999999999999875555555556


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..............|++.|+|||.+.+
T Consensus        96 ~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  175 (323)
T cd05615          96 GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAY  175 (323)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcC
Confidence            78999999999999999999999999999999999999999999999999998754333222333457899999999976


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||+|+++|+|++|..| |.+.+.......+....                             ...+..+
T Consensus       176 ~~-~~~~~DiwslGvil~elltG~~p-f~~~~~~~~~~~i~~~~-----------------------------~~~p~~~  224 (323)
T cd05615         176 QP-YGKSVDWWAYGVLLYEMLAGQPP-FDGEDEDELFQSIMEHN-----------------------------VSYPKSL  224 (323)
T ss_pred             CC-CCCccchhhhHHHHHHHHhCCCC-CCCCCHHHHHHHHHhCC-----------------------------CCCCccC
Confidence            65 78999999999999999988777 66666666555554411                             1123457


Q ss_pred             CHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCccc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMS-----AEDAMSHIYFSDLNVA  275 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps-----~~~ll~h~~~~~~~~~  275 (282)
                      +..+.+++.+||+.||.+|++     .+++++||||+.+++.
T Consensus       225 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~  266 (323)
T cd05615         225 SKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWD  266 (323)
T ss_pred             CHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHH
Confidence            889999999999999999997     5799999999998654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.2e-44  Score=304.91  Aligned_cols=244  Identities=23%  Similarity=0.322  Sum_probs=193.7

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEI   81 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~   81 (282)
                      ||+|++..+|+.||||++...........+.+|+++++.++|+||+++++++..++.+++|+||++|+.+..    ....
T Consensus        90 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~----~~~~  165 (353)
T PLN00034         90 VYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG----THIA  165 (353)
T ss_pred             EEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccc----cccC
Confidence            899999999999999998764444445678899999999999999999999999999999999998765532    2346


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC--
Q psy6044          82 DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA--  159 (282)
Q Consensus        82 ~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--  159 (282)
                      ++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..............++..|+|||.+...  
T Consensus       166 ~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  245 (353)
T PLN00034        166 DEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLN  245 (353)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccccccccCccccCccccccccc
Confidence            788889999999999999999999999999999999999999999999987765433333445678999999987432  


Q ss_pred             --CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         160 --KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       160 --~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                        ...+.++|||||||++|+|++|..|+. .....+...........                         ........
T Consensus       246 ~~~~~~~~~DvwslGvil~el~~g~~pf~-~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~  299 (353)
T PLN00034        246 HGAYDGYAGDIWSLGVSILEFYLGRFPFG-VGRQGDWASLMCAICMS-------------------------QPPEAPAT  299 (353)
T ss_pred             cCcCCCcchhHHHHHHHHHHHHhCCCCCC-CCCCccHHHHHHHHhcc-------------------------CCCCCCCc
Confidence              224569999999999999999988854 32222222111111000                         11122345


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ++.++.+||.+||+.||++|||+.++++||||.+....
T Consensus       300 ~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~  337 (353)
T PLN00034        300 ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG  337 (353)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence            78999999999999999999999999999999987544

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-44  Score=304.44  Aligned_cols=262  Identities=23%  Similarity=0.364  Sum_probs=198.5

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEI   81 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~   81 (282)
                      ||+|++..+++.||+|+...       .....|+.++++++||||+++++++......++|+|++.|++.+.+......+
T Consensus        82 Vy~~~~~~~~~~valK~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~  154 (357)
T PHA03209         82 VFVATKPGQPDPVVLKIGQK-------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPL  154 (357)
T ss_pred             EEEEEECCCCceEEEEeCCc-------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccCCcHHHHHHhccCCC
Confidence            89999999999999997432       33467999999999999999999999999999999999999999988777789


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCCC
Q psy6044          82 DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKL  161 (282)
Q Consensus        82 ~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  161 (282)
                      ++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+...... .......++..|+|||.+.+.. 
T Consensus       155 ~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-  232 (357)
T PHA03209        155 PIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLGLAGTVETNAPEVLARDK-  232 (357)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC-cccccccccccccCCeecCCCC-
Confidence            99999999999999999999999999999999999999999999999998653322 2223345788999999997766 


Q ss_pred             CCchhhHHHHHHHHHHHHhcCCCCCCCCCh---------HHHHHHHHHHhCCCCCCCCCC--CCCCCCCCCCCCC-CCCC
Q psy6044         162 YTTSIDMWSAGCIFAELANAGRPLFPGSDV---------DDQLKRIFKLLGTPTEDTWPG--MNLLPDFKPFPMY-HPSM  229 (282)
Q Consensus       162 ~~~~~Di~slG~ll~~ll~~~~p~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~-~~~~  229 (282)
                      ++.++|+|||||++|+|++++.++|.....         ...+..+...++..+......  ......+...... ..+.
T Consensus       233 ~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (357)
T PHA03209        233 YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPY  312 (357)
T ss_pred             CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcc
Confidence            799999999999999999988887765332         122333333333322221100  0000000000000 0000


Q ss_pred             Cc--cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         230 SF--SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       230 ~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      ..  ......++.++.+||.+||+.||++|||+.|+|+||||+++
T Consensus       313 ~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        313 TRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             cccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            00  00112467788899999999999999999999999999875

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.1e-44  Score=301.93  Aligned_cols=245  Identities=24%  Similarity=0.342  Sum_probs=197.6

Q ss_pred             CeeeeeeCCCCceEEEeeeecCC--CCCCCccHHHHH-HHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhc
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVG--NEGVPSSALREI-CLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL   77 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~-~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~   77 (282)
                      .||+|+++.+++.||+|++....  .......+..|. .+++.++||||+++++++...+..++||||++|+.+......
T Consensus        10 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~   89 (325)
T cd05602          10 KVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR   89 (325)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHh
Confidence            38999999999999999998621  122223444444 356778999999999999999999999999987655555555


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      .+.+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..............+++.|+|||.+.
T Consensus        90 ~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~  169 (325)
T cd05602          90 ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLH  169 (325)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHc
Confidence            67889999999999999999999999999999999999999999999999999875433333334456789999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|+||||+++|+|++|..| |.+.+..+....+...                             .....+.
T Consensus       170 ~~~-~~~~~DiwslG~il~el~~g~~p-f~~~~~~~~~~~i~~~-----------------------------~~~~~~~  218 (325)
T cd05602         170 KQP-YDRTVDWWCLGAVLYEMLYGLPP-FYSRNTAEMYDNILNK-----------------------------PLQLKPN  218 (325)
T ss_pred             CCC-CCCccccccccHHHHHHhcCCCC-CCCCCHHHHHHHHHhC-----------------------------CcCCCCC
Confidence            765 78999999999999999988877 5555655555554431                             0112345


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHH----HHhcCCCccCCccch
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAE----DAMSHIYFSDLNVAI  276 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~----~ll~h~~~~~~~~~~  276 (282)
                      +++.+.++|++||+.||.+|+++.    ++++|+||..+++..
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~  261 (325)
T cd05602         219 ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDD  261 (325)
T ss_pred             CCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHH
Confidence            889999999999999999999876    899999999876543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.9e-44  Score=305.07  Aligned_cols=246  Identities=23%  Similarity=0.295  Sum_probs=197.7

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|+++.+|+.||+|++...  ........+.+|+.+++.++||||+++++++.+++..++||||++|+.+..+.. +.
T Consensus        59 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~-~~  137 (370)
T cd05596          59 VQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMS-NY  137 (370)
T ss_pred             EEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHH-hc
Confidence            899999999999999999762  223334557789999999999999999999999999999999998654444444 35


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~  158 (282)
                      .+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||.+........ ......|++.|+|||.+.+
T Consensus       138 ~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  217 (370)
T cd05596         138 DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS  217 (370)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhcc
Confidence            689999999999999999999999999999999999999999999999999876643221 2233467899999999865


Q ss_pred             C---CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         159 A---KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       159 ~---~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      .   ..++.++|+|||||++|+|++|..| |.+.+.......+.......   .+                     + ..
T Consensus       218 ~~~~~~~~~~~DiwSlGvilyelltG~~P-f~~~~~~~~~~~i~~~~~~~---~~---------------------~-~~  271 (370)
T cd05596         218 QGGDGYYGRECDWWSVGVFLYEMLVGDTP-FYADSLVGTYSKIMDHKNSL---TF---------------------P-DD  271 (370)
T ss_pred             CCCCCCCCCceeeeehhHHHHHHHhCCCC-cCCCCHHHHHHHHHcCCCcC---CC---------------------C-Cc
Confidence            3   2368899999999999999998877 55555555555544321100   00                     0 01


Q ss_pred             ccCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCCcc
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQ--RMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~h~~~~~~~~  274 (282)
                      ..+|..+.+||++||+.+|.+  |+|++++++||||++.++
T Consensus       272 ~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~  312 (370)
T cd05596         272 IEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW  312 (370)
T ss_pred             CCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence            247899999999999999988  999999999999998654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0201|consensus

Probab=100.00  E-value=5.7e-47  Score=305.36  Aligned_cols=241  Identities=26%  Similarity=0.359  Sum_probs=208.0

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEI   81 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~   81 (282)
                      ||+|.+..+++.||+|++..+........+.+|+.++.+++++||.++|+.+.....++++||||.|+....+.+.+..+
T Consensus        29 Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~~  108 (467)
T KOG0201|consen   29 VYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNIL  108 (467)
T ss_pred             eeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCCC
Confidence            89999999999999999999877777889999999999999999999999999999999999999887666666656677


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCCC
Q psy6044          82 DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKL  161 (282)
Q Consensus        82 ~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  161 (282)
                      ++..+..++++++.||.|||+++.+|+|||+.||++..+|.++|+|||.+..+..........+||+.|||||++.... 
T Consensus       109 ~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~-  187 (467)
T KOG0201|consen  109 DEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSG-  187 (467)
T ss_pred             ccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhcccc-
Confidence            9999999999999999999999999999999999999999999999999988876666556778999999999998666 


Q ss_pred             CCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHH
Q psy6044         162 YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAK  241 (282)
Q Consensus       162 ~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (282)
                      |+.++||||||++.+||.+|..| +....+.-++..|-+                          .  ..+.....+|+.
T Consensus       188 Y~~KADIWSLGITaiEla~GePP-~s~~hPmrvlflIpk--------------------------~--~PP~L~~~~S~~  238 (467)
T KOG0201|consen  188 YDTKADIWSLGITAIELAKGEPP-HSKLHPMRVLFLIPK--------------------------S--APPRLDGDFSPP  238 (467)
T ss_pred             ccchhhhhhhhHHHHHHhcCCCC-CcccCcceEEEeccC--------------------------C--CCCccccccCHH
Confidence            89999999999999999977666 555554222221111                          0  111122368999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         242 GRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       242 l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      +++||..||+.||+.||||.++|.|+|++.-
T Consensus       239 ~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  239 FKEFVEACLDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             HHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence            9999999999999999999999999999973

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1e-44  Score=301.77  Aligned_cols=244  Identities=25%  Similarity=0.319  Sum_probs=195.5

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHH-HHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREIC-LLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~-~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||+|+++.+|+.||+|++...  ........+..|.. +++.++||||+++++++.+.+..++||||++|+.+.......
T Consensus        11 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   90 (321)
T cd05603          11 VLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE   90 (321)
T ss_pred             EEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc
Confidence            899999999999999999762  12222334555554 678889999999999999999999999999875555444446


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..............+++.|+|||.+.+
T Consensus        91 ~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  170 (321)
T cd05603          91 RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK  170 (321)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcC
Confidence            78999999999999999999999999999999999999999999999999998754322223334467889999999976


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+|||||++|+|++|..| |...+.......+...                             ...++...
T Consensus       171 ~~-~~~~~DiwslG~il~el~~g~~p-f~~~~~~~~~~~i~~~-----------------------------~~~~~~~~  219 (321)
T cd05603         171 EP-YDRTVDWWCLGAVLYEMLYGLPP-FYSRDVSQMYDNILHK-----------------------------PLQLPGGK  219 (321)
T ss_pred             CC-CCCcCcccccchhhhhhhcCCCC-CCCCCHHHHHHHHhcC-----------------------------CCCCCCCC
Confidence            65 78999999999999999988877 5555555544444321                             11233457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCH----HHHhcCCCccCCccch
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSA----EDAMSHIYFSDLNVAI  276 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~----~~ll~h~~~~~~~~~~  276 (282)
                      +..+.++|.+||+.||.+||++    .++++|+||..+++..
T Consensus       220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~  261 (321)
T cd05603         220 TVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDD  261 (321)
T ss_pred             CHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHH
Confidence            8899999999999999999975    5999999999876543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.9e-44  Score=302.00  Aligned_cols=265  Identities=32%  Similarity=0.546  Sum_probs=200.3

Q ss_pred             CeeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC------CeEEEEEecCcccHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE------KKLTLVFEHCDQDLKKY   73 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~------~~~~iv~e~~~g~l~~~   73 (282)
                      .||+|.+..+|+.||+|++.. .........+.+|+.+++.++||||+++++++...      ...|+||||+++++...
T Consensus        36 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~  115 (359)
T cd07876          36 IVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQV  115 (359)
T ss_pred             EEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCcCHHHH
Confidence            389999999999999999876 33334456788999999999999999999998654      35799999999988776


Q ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccCh
Q psy6044          74 FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP  153 (282)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aP  153 (282)
                      +.   ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||.+...... .......++..|+||
T Consensus       116 ~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aP  191 (359)
T cd07876         116 IH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN-FMMTPYVVTRYYRAP  191 (359)
T ss_pred             Hh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC-ccCCCCcccCCCCCc
Confidence            53   35889999999999999999999999999999999999999999999999998754322 222344668899999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCC--------CCCCCC-----
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN--------LLPDFK-----  220 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~-----  220 (282)
                      |.+.+.. ++.++|+||||+++|+|++|..| |.+.+..+....+....+.+.........        ......     
T Consensus       192 E~~~~~~-~~~~~DiwSlG~il~el~tg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (359)
T cd07876         192 EVILGMG-YKENVDIWSVGCIMGELVKGSVI-FQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFE  269 (359)
T ss_pred             hhccCCC-CCcchhhHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchh
Confidence            9997766 68999999999999999988777 66666655555555544443321110000        000000     


Q ss_pred             CCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q psy6044         221 PFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD  271 (282)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  271 (282)
                      .....-............++.+.+||.+||..||++|||+.|+|+||||+.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         270 ELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             hhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence            000000000111222346788999999999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=7.6e-44  Score=291.31  Aligned_cols=266  Identities=33%  Similarity=0.553  Sum_probs=204.6

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCC-CCCccceeeeeeeC--CeEEEEEecCcccHHHHHHhc
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK-HKNIVRLYDVLHSE--KKLTLVFEHCDQDLKKYFDSL   77 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~--~~~~iv~e~~~g~l~~~~~~~   77 (282)
                      .||+|.+..+++.||+|++.............+|+.+++++. |+|++++++++.++  +..++|+||++|++++.+...
T Consensus        14 ~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~   93 (282)
T cd07831          14 EVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGR   93 (282)
T ss_pred             eEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCccHHHHHHhc
Confidence            389999999999999999876433333345567999999885 99999999999987  899999999999999988776


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      ...+++..+..++.|++.||++||+.|++|+||+|+||+++. +.++|+|||.+........ .....++..|+|||.+.
T Consensus        94 ~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~  171 (282)
T cd07831          94 KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-YTEYISTRWYRAPECLL  171 (282)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-cCCCCCCcccCChhHhh
Confidence            677999999999999999999999999999999999999999 9999999999876643322 22335678899999876


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      ....++.++|+||+|+++|+|++|..| |.+.+..+....+....+.+.........................+......
T Consensus       172 ~~~~~~~~~Di~slGv~l~el~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (282)
T cd07831         172 TDGYYGPKMDIWAVGCVFFEILSLFPL-FPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPN  250 (282)
T ss_pred             cCCCCCcchhHHHHHHHHHHHHcCCcC-CCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHccc
Confidence            555468999999999999999976554 7877777777777665554443211000000000000000011122233446


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      ++..+.++|.+||+.+|.+|||++++++||||
T Consensus       251 ~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         251 ASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            79999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5.4e-44  Score=291.41  Aligned_cols=250  Identities=21%  Similarity=0.313  Sum_probs=194.6

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCccc-HHHHHHhc-
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSL-   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~-l~~~~~~~-   77 (282)
                      ||+|.++.+|+.||+|++...  ........+..|++++++++||||+++++++.++...++||||++|+ +.+.+... 
T Consensus         9 Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~   88 (277)
T cd05607           9 VCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVG   88 (277)
T ss_pred             EEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhcc
Confidence            899999999999999998752  12222345667999999999999999999999999999999999865 44444332 


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      ...+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.
T Consensus        89 ~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~  167 (277)
T cd05607          89 ERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTNGYMAPEILK  167 (277)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCCCccCHHHHc
Confidence            2358999999999999999999999999999999999999999999999999987664322 223346788999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|+||+|+++|++++|..| |...........+.......                        ........
T Consensus       168 ~~~-~~~~~DvwslGv~l~el~~g~~p-~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~  221 (277)
T cd05607         168 EEP-YSYPVDWFAMGCSIYEMVAGRTP-FKDHKEKVAKEELKRRTLED------------------------EVKFEHQN  221 (277)
T ss_pred             cCC-CCCchhHHHHHHHHHHHHhCCCC-CCCCcchhhHHHHHHHhhcc------------------------cccccccc
Confidence            776 79999999999999999998888 44322211111111111000                        00011135


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCccCCccchhh
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSA----EDAMSHIYFSDLNVAIKS  278 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~----~~ll~h~~~~~~~~~~~~  278 (282)
                      +++++.++|++||+.||.+||++    ++++.||||+.+++....
T Consensus       222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~  266 (277)
T cd05607         222 FTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLE  266 (277)
T ss_pred             CCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHh
Confidence            78999999999999999999999    678899999998765443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.3e-44  Score=302.36  Aligned_cols=266  Identities=32%  Similarity=0.554  Sum_probs=204.0

Q ss_pred             CeeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC------CeEEEEEecCcccHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE------KKLTLVFEHCDQDLKKY   73 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~------~~~~iv~e~~~g~l~~~   73 (282)
                      .||+|.+..+++.||||++.. .........+.+|+.+++.++||||+++++++...      ..+|+||||+++++...
T Consensus        39 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~  118 (364)
T cd07875          39 IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV  118 (364)
T ss_pred             EEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCCCHHHH
Confidence            489999999999999999876 33344456788999999999999999999987643      36799999999988877


Q ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccCh
Q psy6044          74 FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP  153 (282)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aP  153 (282)
                      +.   ..+++..+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||++...+... ......++..|+||
T Consensus       119 ~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~-~~~~~~~t~~y~aP  194 (364)
T cd07875         119 IQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAP  194 (364)
T ss_pred             HH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC-cccCCcccCCcCCH
Confidence            64   358899999999999999999999999999999999999999999999999997654322 22344678899999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCC--------CCCCCC----
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNL--------LPDFKP----  221 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~----  221 (282)
                      |.+.+.. ++.++|+|||||++|+|++|+.| |.+.+..+....+....+.+.++.+.....        ......    
T Consensus       195 E~~~~~~-~~~~~DiwSlG~il~ell~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (364)
T cd07875         195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVL-FPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFE  272 (364)
T ss_pred             HHHhCCC-CCchhhHHhHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChH
Confidence            9997766 79999999999999999988777 777777777777766655543322111100        000000    


Q ss_pred             -CCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         222 -FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       222 -~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                       .................+..+++||.+||+.||.+|||+.++|+||||...
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         273 KLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             hhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence             000000000111223356789999999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3e-44  Score=305.37  Aligned_cols=247  Identities=23%  Similarity=0.323  Sum_probs=194.0

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|+++.+++.||+|++...  ........+.+|+.+++.++||||+++++++.+...+++||||++|+.+..+....+
T Consensus        17 Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~   96 (381)
T cd05626          17 VCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME   96 (381)
T ss_pred             EEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcC
Confidence            899999999999999999862  233345678899999999999999999999999999999999998755544444467


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--------------------
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--------------------  139 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--------------------  139 (282)
                      .+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++........                    
T Consensus        97 ~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (381)
T cd05626          97 VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL  176 (381)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccc
Confidence            899999999999999999999999999999999999999999999999998753210000                    


Q ss_pred             ---------------------------ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChH
Q psy6044         140 ---------------------------CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD  192 (282)
Q Consensus       140 ---------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~  192 (282)
                                                 ......|++.|+|||.+.+.. ++.++|||||||++|+|++|..| |...+..
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~P-f~~~~~~  254 (381)
T cd05626         177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVGVILFEMLVGQPP-FLAPTPT  254 (381)
T ss_pred             cccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-CCCccceeehhhHHHHHHhCCCC-CcCCCHH
Confidence                                       001235789999999997765 78999999999999999998888 5554444


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhc--ccCCCCCCCHHHHhcCCCcc
Q psy6044         193 DQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLL--VCNPVQRMSAEDAMSHIYFS  270 (282)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l--~~dp~~Rps~~~ll~h~~~~  270 (282)
                      +....+........                         ......+++++.+||.+|+  ..+|..|++++++++||||+
T Consensus       255 ~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~  309 (381)
T cd05626         255 ETQLKVINWENTLH-------------------------IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFS  309 (381)
T ss_pred             HHHHHHHccccccC-------------------------CCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccC
Confidence            44433332111000                         0011247899999999965  45556699999999999999


Q ss_pred             CCccc
Q psy6044         271 DLNVA  275 (282)
Q Consensus       271 ~~~~~  275 (282)
                      ++++.
T Consensus       310 ~~~~~  314 (381)
T cd05626         310 EVDFS  314 (381)
T ss_pred             CCChh
Confidence            87653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-44  Score=304.38  Aligned_cols=270  Identities=33%  Similarity=0.544  Sum_probs=206.2

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC------CeEEEEEecCcccHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSE------KKLTLVFEHCDQDLKKY   73 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~------~~~~iv~e~~~g~l~~~   73 (282)
                      .||+|.+..+++.||+|++... ........+.+|+.++++++||||+++++++...      ...+++++++++++...
T Consensus        30 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  109 (343)
T cd07878          30 SVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNI  109 (343)
T ss_pred             EEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecCCCCHHHH
Confidence            3899999999999999998752 2222345677899999999999999999988643      45799999998877665


Q ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccCh
Q psy6044          74 FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP  153 (282)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aP  153 (282)
                      +.  ...+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++......   .....++..|+||
T Consensus       110 ~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~t~~y~aP  184 (343)
T cd07878         110 VK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE---MTGYVATRWYRAP  184 (343)
T ss_pred             Hh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC---cCCccccccccCc
Confidence            43  467999999999999999999999999999999999999999999999999998766432   2334678899999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCC--CCCCCCCCCCCCCc
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLP--DFKPFPMYHPSMSF  231 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  231 (282)
                      |.+.+...++.++||||||+++|+|++|..| |...+..+....+....+.+............  ..............
T Consensus       185 E~~~~~~~~~~~~DiwslG~il~el~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (343)
T cd07878         185 EIMLNWMHYNQTVDIWSVGCIMAELLKGKAL-FPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDL  263 (343)
T ss_pred             hHhcCCccCCchhhhHhHHHHHHHHHHCCCC-CCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhH
Confidence            9997755578999999999999999988776 67766666666666655544332221110000  00000001111122


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      .......++.+.+||.+||+.||.+|||+.++++||||.....+.
T Consensus       264 ~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~  308 (343)
T cd07878         264 KKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE  308 (343)
T ss_pred             HHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence            233345678899999999999999999999999999999875543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8.3e-45  Score=303.42  Aligned_cols=248  Identities=25%  Similarity=0.327  Sum_probs=200.3

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      ||+|+++.+|+.||+|++...  ........+.+|+.+++.++||||+++++++.+....++||||++| ++.+.+....
T Consensus        17 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   96 (330)
T cd05601          17 VQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYE   96 (330)
T ss_pred             EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhc
Confidence            899999999999999999872  2333456788899999999999999999999999999999999975 5555555544


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~  157 (282)
                      ..+++..+..++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++........ ......+++.|+|||.+.
T Consensus        97 ~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~  176 (330)
T cd05601          97 DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT  176 (330)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhc
Confidence            7899999999999999999999999999999999999999999999999999976643322 122345788999999986


Q ss_pred             C-----CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         158 G-----AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       158 ~-----~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      .     ...++.++||||||+++|+|++|..| |...+.......+.......                        .. 
T Consensus       177 ~~~~~~~~~~~~~~DiwslG~il~el~~g~~P-f~~~~~~~~~~~i~~~~~~~------------------------~~-  230 (330)
T cd05601         177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP-FHEGTSAKTYNNIMNFQRFL------------------------KF-  230 (330)
T ss_pred             cccccccCCCCCcceeecccceeeeeccCCCC-CCCCCHHHHHHHHHcCCCcc------------------------CC-
Confidence            3     33368899999999999999998888 55555555555444321000                        00 


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      .....+++.+.+||..||. +|.+|||++++++||||+.+++..
T Consensus       231 ~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~  273 (330)
T cd05601         231 PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNN  273 (330)
T ss_pred             CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHH
Confidence            0113478999999999998 999999999999999999876543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0667|consensus

Probab=100.00  E-value=9.7e-45  Score=306.27  Aligned_cols=264  Identities=31%  Similarity=0.479  Sum_probs=213.8

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCC-C-----CCccceeeeeeeCCeEEEEEecCcccHHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK-H-----KNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h-----~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~   75 (282)
                      |-+|.|.+|++.||||+++...  ........|+.+|..++ |     -|+|+++++|...++.+||+|.+..+|.+++.
T Consensus       202 Vvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~~NLYellK  279 (586)
T KOG0667|consen  202 VVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLSTNLYELLK  279 (586)
T ss_pred             eEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhhhhHHHHHH
Confidence            7799999999999999998633  23456778999999996 3     67999999999999999999999999999998


Q ss_pred             hcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC--CcEEEEecCCccccCCCccccccccccccccC
Q psy6044          76 SLN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN--GELKLADFGLARAFGIPVKCYSAEVVTLWYRP  152 (282)
Q Consensus        76 ~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~a  152 (282)
                      .++ ..++...++.++.||+.||..||+.||+|+||||+|||+...  ..+||+|||++...+...-   ....+..|+|
T Consensus       280 ~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy---tYiQSRfYRA  356 (586)
T KOG0667|consen  280 NNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY---TYIQSRFYRA  356 (586)
T ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcce---eeeecccccc
Confidence            865 349999999999999999999999999999999999999643  4799999999987653322   4566888999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCC----CCC----------
Q psy6044         153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNL----LPD----------  218 (282)
Q Consensus       153 PE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~----------  218 (282)
                      ||++.+.. |+.+.|||||||++.||++| .|+|++.+..+.+..|.+.++.|+....+....    ...          
T Consensus       357 PEVILGlp-Y~~~IDmWSLGCIlAEL~tG-~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~  434 (586)
T KOG0667|consen  357 PEVILGLP-YDTAIDMWSLGCILAELFTG-EPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVE  434 (586)
T ss_pred             chhhccCC-CCCccceeehhhhHHhHhcC-ccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeee
Confidence            99999988 79999999999999999976 999999999999999999999887643332100    000          


Q ss_pred             CC-----------C-----CCC--CC-CCCCccccCc-cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         219 FK-----------P-----FPM--YH-PSMSFSQVAP-KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       219 ~~-----------~-----~~~--~~-~~~~~~~~~~-~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      ..           .     ...  .. ...++..... .....+.+||++||..||.+|+|+.++|+||||...
T Consensus       435 ~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  435 TSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGT  508 (586)
T ss_pred             ecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccccc
Confidence            00           0     000  00 1112222222 455677899999999999999999999999999954

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-43  Score=290.48  Aligned_cols=268  Identities=56%  Similarity=1.021  Sum_probs=217.9

Q ss_pred             CeeeeeeCCCCceEEEeeeecCC-CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVG-NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      .||+|++..+++.+|+|++.... .......+..|+.+++.++|+|++++++++.+....++|+|++++++.+.+.....
T Consensus        14 ~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~i~~~~~   93 (282)
T cd07829          14 VVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPG   93 (282)
T ss_pred             eEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCcCHHHHHHhhcc
Confidence            38999999999999999998733 34445678899999999999999999999999999999999999988888777556


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...............+..|+|||.+.+.
T Consensus        94 ~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  173 (282)
T cd07829          94 PLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGS  173 (282)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCC
Confidence            89999999999999999999999999999999999999999999999999987765444334444557789999998776


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      ..++.++|+||||++++++++|. ++|...+..+....+....+.+.+..++........................+..+
T Consensus       174 ~~~~~~~Dv~slG~~l~~l~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (282)
T cd07829         174 KHYSTAVDIWSVGCIFAEMITGK-PLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLD  252 (282)
T ss_pred             cCCCccccHHHHHHHHHHHHhCC-CCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhccccc
Confidence            45799999999999999999874 55888877788888887777776665554433322111111111112223334568


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      ..+.++|++||..||++||+++++++||||
T Consensus       253 ~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         253 PEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             HHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.2e-43  Score=294.96  Aligned_cols=266  Identities=36%  Similarity=0.657  Sum_probs=196.7

Q ss_pred             CeeeeeeC--CCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeee--CCeEEEEEecCcccHHHHHHh
Q psy6044           1 MFTSGVDR--TPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQDLKKYFDS   76 (282)
Q Consensus         1 ~vy~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~--~~~~~iv~e~~~g~l~~~~~~   76 (282)
                      .||+|+++  .+++.||+|.+...   .....+.+|+.+++.++||||+++++++..  +...++++||+++++.+.+..
T Consensus        16 ~Vy~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~   92 (317)
T cd07868          16 HVYKAKRKDGKDDRDYALKQIEGT---GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKF   92 (317)
T ss_pred             EEEEEEEccCCCCceEEEEEECCC---CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCCHHHHHHh
Confidence            48999965  47899999988642   223567899999999999999999999864  467899999999988777643


Q ss_pred             c--------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE----cCCCcEEEEecCCccccCCCc---ccc
Q psy6044          77 L--------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI----NKNGELKLADFGLARAFGIPV---KCY  141 (282)
Q Consensus        77 ~--------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~----~~~~~~~l~df~~~~~~~~~~---~~~  141 (282)
                      .        ...+++..+..++.||+.||.|||+.|++|+||||+||++    +.++.++|+|||++.......   ...
T Consensus        93 ~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~  172 (317)
T cd07868          93 HRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL  172 (317)
T ss_pred             cccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCcccccc
Confidence            2        1248999999999999999999999999999999999999    456789999999997654322   122


Q ss_pred             ccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC--------hHHHHHHHHHHhCCCCCCCCCCC
Q psy6044         142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSD--------VDDQLKRIFKLLGTPTEDTWPGM  213 (282)
Q Consensus       142 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~  213 (282)
                      ....+++.|+|||.+.+...++.++|+||+||++|+|++|..|+.....        ..+....+...++.+....++..
T Consensus       173 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (317)
T cd07868         173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDI  252 (317)
T ss_pred             CCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHH
Confidence            3456688999999997765579999999999999999988777432221        23455566666665555444432


Q ss_pred             CCCCCCCCC-------CC--CCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         214 NLLPDFKPF-------PM--YHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       214 ~~~~~~~~~-------~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      .........       ..  ..............+..+.+||++||+.||.+|||++|+|+||||
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         253 KKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             hhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            221111000       00  000000111122356778999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.6e-44  Score=306.07  Aligned_cols=246  Identities=23%  Similarity=0.340  Sum_probs=194.8

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|+++.+++.||+|++...  ........+.+|+.++++++||||+++++.+.++..+|+||||++|+.+..+....+
T Consensus        17 Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~   96 (382)
T cd05625          17 VCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG   96 (382)
T ss_pred             EEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC
Confidence            899999999999999999762  223334678889999999999999999999999999999999998654444444467


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc---------------------
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---------------------  138 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~---------------------  138 (282)
                      .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......                     
T Consensus        97 ~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (382)
T cd05625          97 IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE  176 (382)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccccccccccccccccccc
Confidence            79999999999999999999999999999999999999999999999999874321000                     


Q ss_pred             --------------------------cccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChH
Q psy6044         139 --------------------------KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD  192 (282)
Q Consensus       139 --------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~  192 (282)
                                                .......|++.|+|||.+.+.. ++.++|+|||||++|+|++|..| |...+..
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvil~elltG~~P-f~~~~~~  254 (382)
T cd05625         177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEMLVGQPP-FLAQTPL  254 (382)
T ss_pred             ccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-CCCeeeEEechHHHHHHHhCCCC-CCCCCHH
Confidence                                      0011235788999999997766 79999999999999999998877 5555555


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCc
Q psy6044         193 DQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS---AEDAMSHIYF  269 (282)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~h~~~  269 (282)
                      +....+........                         ......+++++.++|.+|+ .+|.+|++   ++++++||||
T Consensus       255 ~~~~~i~~~~~~~~-------------------------~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f  308 (382)
T cd05625         255 ETQMKVINWQTSLH-------------------------IPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFF  308 (382)
T ss_pred             HHHHHHHccCCCcC-------------------------CCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCc
Confidence            44444433111100                         0011347899999999987 59999997   9999999999


Q ss_pred             cCCccc
Q psy6044         270 SDLNVA  275 (282)
Q Consensus       270 ~~~~~~  275 (282)
                      +.++..
T Consensus       309 ~~~~~~  314 (382)
T cd05625         309 KTIDFS  314 (382)
T ss_pred             CCcChH
Confidence            988654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0666|consensus

Probab=100.00  E-value=3.7e-45  Score=283.32  Aligned_cols=274  Identities=41%  Similarity=0.727  Sum_probs=224.0

Q ss_pred             CeeeeeeCCCCc----eEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeee-CCeEEEEEecCcccHHHHH
Q psy6044           1 MFTSGVDRTPNT----ALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHS-EKKLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~~~~----~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~-~~~~~iv~e~~~g~l~~~~   74 (282)
                      .||+|..++++.    .+|||.+.. ....+.....-+|+.+++.++|||++.+..++.+ +..+++++||++.+|+..+
T Consensus        39 ~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEhDL~~II  118 (438)
T KOG0666|consen   39 KVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEHDLWHII  118 (438)
T ss_pred             eeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhhhHHHHH
Confidence            389997666544    789999987 4455667788899999999999999999999987 7899999999999999987


Q ss_pred             HhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC----CcEEEEecCCccccCCCcccc---cc
Q psy6044          75 DSLN----GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN----GELKLADFGLARAFGIPVKCY---SA  143 (282)
Q Consensus        75 ~~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~----~~~~l~df~~~~~~~~~~~~~---~~  143 (282)
                      ..-.    ..++...+..+++||+.|+.|||++.+.||||||.||++..+    |.+||+|+|+++....+....   ..
T Consensus       119 ~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~  198 (438)
T KOG0666|consen  119 KFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDP  198 (438)
T ss_pred             HHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCc
Confidence            5432    348999999999999999999999999999999999999887    999999999998876554333   33


Q ss_pred             ccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCC---------ChHHHHHHHHHHhCCCCCCCCCCCC
Q psy6044         144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGS---------DVDDQLKRIFKLLGTPTEDTWPGMN  214 (282)
Q Consensus       144 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~  214 (282)
                      .+.|.+|+|||++.+...|+.+.|+||+||++.||+ +-.|.|.+.         -..+.+.+|.+.++.|..+.|+...
T Consensus       199 VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElL-tl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lk  277 (438)
T KOG0666|consen  199 VVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELL-TLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLK  277 (438)
T ss_pred             eEEEEEecChHHhcccccccchhhhHHHHHHHHHHH-ccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhh
Confidence            455899999999999988999999999999999999 566767553         2457889999999999999999987


Q ss_pred             CCCCCCC----CCC--CCC--CCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         215 LLPDFKP----FPM--YHP--SMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       215 ~~~~~~~----~~~--~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      .+++...    +..  +.+  -..+-+....-++...+|+.+||+.||.+|+|++++|+|+||..-+-+
T Consensus       278 k~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lp  346 (438)
T KOG0666|consen  278 KMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLP  346 (438)
T ss_pred             hCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCCCC
Confidence            7777622    110  000  011112223356668899999999999999999999999999976443

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.6e-44  Score=299.17  Aligned_cols=245  Identities=21%  Similarity=0.297  Sum_probs=193.1

Q ss_pred             eeeeee---CCCCceEEEeeeecC---CCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHH
Q psy6044           2 FTSGVD---RTPNTALAIKGTHLV---GNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         2 vy~a~~---~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~   74 (282)
                      ||+|++   ..+|+.||+|++...   ........+..|+.+++.+ .||+|+++++++..++..++||||++|+.+...
T Consensus        16 Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~   95 (332)
T cd05614          16 VFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTH   95 (332)
T ss_pred             EEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHH
Confidence            787775   358999999999762   2233345678899999999 589999999999999999999999986444444


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccCh
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPP  153 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aP  153 (282)
                      ......+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... .......|++.|+||
T Consensus        96 l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aP  175 (332)
T cd05614          96 LYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP  175 (332)
T ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCH
Confidence            4446779999999999999999999999999999999999999999999999999987653222 122234678999999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCC---ChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGS---DVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMS  230 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
                      |.+.+...++.++||||||+++|+|++|..|+....   ........+..                             .
T Consensus       176 E~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-----------------------------~  226 (332)
T cd05614         176 EIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-----------------------------C  226 (332)
T ss_pred             HHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-----------------------------C
Confidence            999776557889999999999999999988843221   11222222211                             0


Q ss_pred             ccccCccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCccc
Q psy6044         231 FSQVAPKLTAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~  275 (282)
                      ...++..+++.+.++|.+||+.||++||     +++++++||||++.++.
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  276 (332)
T cd05614         227 DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWE  276 (332)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence            1122345789999999999999999999     88999999999987543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0197|consensus

Probab=100.00  E-value=3.3e-44  Score=296.80  Aligned_cols=232  Identities=26%  Similarity=0.404  Sum_probs=201.2

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHh-cCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDS-LNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~-~~~   79 (282)
                      ||.|... ....||+|.+...  .-..+.|++|+++|++|+|++||+++++|..+..++|||||++ |+|++++.. ..+
T Consensus       222 V~~g~~~-~~~~vavk~ik~~--~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~  298 (468)
T KOG0197|consen  222 VWLGKWN-GSTKVAVKTIKEG--SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGG  298 (468)
T ss_pred             EEEEEEc-CCCcccceEEecc--ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCC
Confidence            7777763 3558999998753  3345788999999999999999999999999999999999996 788888886 456


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~  158 (282)
                      .+.....+.++.|||+|++||++++++||||...||||+++..+||+|||+++..+.+.- ...+.--+..|.|||.+..
T Consensus       299 ~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~  378 (468)
T KOG0197|consen  299 LLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNY  378 (468)
T ss_pred             ccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhh
Confidence            799999999999999999999999999999999999999999999999999996553322 2222333678999999988


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.+|||||||+++||++|.+..++++.+..+.++.+.++.+.+.+                            ...
T Consensus       379 ~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P----------------------------~~C  429 (468)
T KOG0197|consen  379 GK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP----------------------------EGC  429 (468)
T ss_pred             CC-cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC----------------------------CCC
Confidence            87 7999999999999999999999999999999999999988766543                            447


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      |+.+.+++..||+.+|++|||++.+..
T Consensus       430 P~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  430 PDEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             CHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence            899999999999999999999997765

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=6.8e-44  Score=300.77  Aligned_cols=266  Identities=33%  Similarity=0.574  Sum_probs=201.8

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC------CeEEEEEecCcccHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSE------KKLTLVFEHCDQDLKKY   73 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~------~~~~iv~e~~~g~l~~~   73 (282)
                      .||+|.+..+++.||+|++... ........+.+|+.+++.++||||+++++++...      ...++||||+++++...
T Consensus        32 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~  111 (355)
T cd07874          32 IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQV  111 (355)
T ss_pred             EEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcccHHHH
Confidence            3899999999999999998762 3333456778899999999999999999988643      35799999999988776


Q ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccCh
Q psy6044          74 FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP  153 (282)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aP  153 (282)
                      +.   ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...+.. .......++..|+||
T Consensus       112 ~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aP  187 (355)
T cd07874         112 IQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAP  187 (355)
T ss_pred             Hh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc-cccCCccccCCccCH
Confidence            64   35889999999999999999999999999999999999999999999999999765433 222344678899999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCC--------CCCCCCC--CC
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN--------LLPDFKP--FP  223 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~--~~  223 (282)
                      |.+.+.. ++.++|+||||+++|+|++|..| |.+.+..+.........+.+..+.+....        .......  ++
T Consensus       188 E~~~~~~-~~~~~DiwslG~il~el~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (355)
T cd07874         188 EVILGMG-YKENVDIWSVGCIMGEMVRHKIL-FPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFP  265 (355)
T ss_pred             HHHcCCC-CCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccch
Confidence            9997766 69999999999999999988777 66666666666555555443322111100        0000000  00


Q ss_pred             C---CCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         224 M---YHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       224 ~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      .   ..............+..+.+||.+||+.||++|||+.++|+||||...
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         266 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             hhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence            0   000000111223457789999999999999999999999999999744

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.1e-44  Score=306.03  Aligned_cols=248  Identities=24%  Similarity=0.357  Sum_probs=196.0

Q ss_pred             CeeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      .||+|+++.+|+.||+|++...  ........+.+|+.+++.++||||+++++.+.+++.+++||||++|+.+..+....
T Consensus        16 ~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~   95 (376)
T cd05598          16 EVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL   95 (376)
T ss_pred             EEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc
Confidence            3899999999999999998762  22233466788999999999999999999999999999999999865555444546


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC---------------------
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP---------------------  137 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~---------------------  137 (282)
                      +.+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++......                     
T Consensus        96 ~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (376)
T cd05598          96 GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE  175 (376)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccc
Confidence            78999999999999999999999999999999999999999999999999987432100                     


Q ss_pred             ----------------------ccccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHH
Q psy6044         138 ----------------------VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL  195 (282)
Q Consensus       138 ----------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~  195 (282)
                                            ........|++.|+|||.+.+.. ++.++|||||||++|+|++|..| |......+..
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyell~G~~P-f~~~~~~~~~  253 (376)
T cd05598         176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEMLVGQPP-FLADTPAETQ  253 (376)
T ss_pred             cccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-CCcceeeeeccceeeehhhCCCC-CCCCCHHHHH
Confidence                                  00011235788999999997766 69999999999999999998888 5555555544


Q ss_pred             HHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCCccCC
Q psy6044         196 KRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM---SAEDAMSHIYFSDL  272 (282)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~h~~~~~~  272 (282)
                      ..+........                         ......+++.+.++|.+|+ .+|.+|+   |+.++++||||+.+
T Consensus       254 ~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         254 LKVINWETTLH-------------------------IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             HHHhccCcccc-------------------------CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            44322110000                         0011347889999999977 5999999   99999999999987


Q ss_pred             ccch
Q psy6044         273 NVAI  276 (282)
Q Consensus       273 ~~~~  276 (282)
                      +...
T Consensus       308 ~~~~  311 (376)
T cd05598         308 DFAS  311 (376)
T ss_pred             CHHH
Confidence            6543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.9e-43  Score=294.73  Aligned_cols=273  Identities=39%  Similarity=0.672  Sum_probs=218.1

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCC-------------CCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEG-------------VPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD   67 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~-------------~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   67 (282)
                      .||+|.++.+|+.||+|++.......             ....+.+|+.+++.++||||+++++++...+..++++||++
T Consensus        24 ~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  103 (335)
T PTZ00024         24 KVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA  103 (335)
T ss_pred             eEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc
Confidence            48999999999999999987632211             11247789999999999999999999999999999999999


Q ss_pred             ccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCC-----------
Q psy6044          68 QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGI-----------  136 (282)
Q Consensus        68 g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~-----------  136 (282)
                      |++.+.+.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....           
T Consensus       104 ~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  182 (335)
T PTZ00024        104 SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE  182 (335)
T ss_pred             cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeecccccccccccccc
Confidence            988877754 56799999999999999999999999999999999999999999999999998876541           


Q ss_pred             ---CccccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCC
Q psy6044         137 ---PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGM  213 (282)
Q Consensus       137 ---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  213 (282)
                         .........++..|+|||.+.+...++.++|+||||+++|++++|..| |.+.+..+....+....+.+....|+..
T Consensus       183 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p-~~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (335)
T PTZ00024        183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL-FPGENEIDQLGRIFELLGTPNEDNWPQA  261 (335)
T ss_pred             cccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCchhhCcch
Confidence               111222334567899999987665578999999999999999986555 7888888888888888877776666544


Q ss_pred             CCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         214 NLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      .......+..... ...........+..+.++|.+||+.+|.+|||+++++.||||+....++
T Consensus       262 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~~  323 (335)
T PTZ00024        262 KKLPLYTEFTPRK-PKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPC  323 (335)
T ss_pred             hhcccccccCcCC-cccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCCC
Confidence            3332222222111 1233344556789999999999999999999999999999999775543

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.4e-44  Score=291.97  Aligned_cols=268  Identities=33%  Similarity=0.582  Sum_probs=207.4

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      .||+|.++.+|+.||+|++... ........+.+|+++++.++||||+++++++..++..++|+||+++++++.+.....
T Consensus        16 ~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~   95 (286)
T cd07846          16 MVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN   95 (286)
T ss_pred             EEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccC
Confidence            3899999999999999998762 223345678899999999999999999999999999999999999988888777666


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .+++..+..++.||+.||+|||+.|++|+|++|+||+++.++.++|+|||.+..............++..|+|||.+.+.
T Consensus        96 ~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  175 (286)
T cd07846          96 GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGD  175 (286)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccc
Confidence            79999999999999999999999999999999999999999999999999987665443433445567889999998765


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCC--CCCCCCCCCCCCCCccccCcc
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLL--PDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      ..++.++|+||||++++++++|..| |......+....+..................  ......+............+.
T Consensus       176 ~~~~~~~Dv~slG~~l~el~~g~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (286)
T cd07846         176 TKYGRAVDIWAVGCLVTEMLTGEPL-FPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPK  254 (286)
T ss_pred             cccCchHhHHHHHHHHHHHHcCCCC-CCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCC
Confidence            5568899999999999999988654 6666655655555554443221110000000  000001111111122233456


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      ++..+.+++.+||+.+|.+|||+.++++||||
T Consensus       255 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         255 LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            88999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-44  Score=305.40  Aligned_cols=247  Identities=23%  Similarity=0.323  Sum_probs=195.1

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|.++.+|+.||||++...  ........+.+|+++++.++||||+++++++.++...|+||||++|+.+..+....+
T Consensus        17 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~   96 (377)
T cd05629          17 VRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD   96 (377)
T ss_pred             EEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcC
Confidence            899999999999999998762  223334567889999999999999999999999999999999997654444444467


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc------------c--------
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV------------K--------  139 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~------------~--------  139 (282)
                      .+++..+..++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++.......            .        
T Consensus        97 ~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (377)
T cd05629          97 TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR  176 (377)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccc
Confidence            89999999999999999999999999999999999999999999999999885321100            0        


Q ss_pred             ---------------------------ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChH
Q psy6044         140 ---------------------------CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD  192 (282)
Q Consensus       140 ---------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~  192 (282)
                                                 ......|++.|+|||.+.+.. ++.++|+|||||++|+|++|..| |......
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltG~~P-f~~~~~~  254 (377)
T cd05629         177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQECDWWSLGAIMFECLIGWPP-FCSENSH  254 (377)
T ss_pred             cccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC-CCCceeeEecchhhhhhhcCCCC-CCCCCHH
Confidence                                       000135788999999997766 79999999999999999988777 6655555


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCC---CCHHHHhcCCCc
Q psy6044         193 DQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQR---MSAEDAMSHIYF  269 (282)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R---ps~~~ll~h~~~  269 (282)
                      +....+.......                        ... -...++.++.+||.+||. +|.+|   +|+.++++||||
T Consensus       255 ~~~~~i~~~~~~~------------------------~~p-~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~  308 (377)
T cd05629         255 ETYRKIINWRETL------------------------YFP-DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFF  308 (377)
T ss_pred             HHHHHHHccCCcc------------------------CCC-CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCc
Confidence            5555444311100                        000 012478899999999998 77776   599999999999


Q ss_pred             cCCccch
Q psy6044         270 SDLNVAI  276 (282)
Q Consensus       270 ~~~~~~~  276 (282)
                      +++++..
T Consensus       309 ~~~~~~~  315 (377)
T cd05629         309 RGVDWDT  315 (377)
T ss_pred             CCCCHHH
Confidence            9876543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0580|consensus

Probab=100.00  E-value=4.5e-45  Score=272.97  Aligned_cols=238  Identities=29%  Similarity=0.461  Sum_probs=210.2

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHhc-
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSL-   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~-   77 (282)
                      ||.|+.++++..||+|++-+  .......+.+.+|+++...|+||||++++++|.++..+|+++||.+ |+++..+... 
T Consensus        38 vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~  117 (281)
T KOG0580|consen   38 VYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGR  117 (281)
T ss_pred             EeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcc
Confidence            89999999999999999998  3456678899999999999999999999999999999999999996 6777776643 


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      ...+++...+.++.|++.||.|+|..+++||||||+|++++..+.++++|||.+....  .......+||..|.+||-..
T Consensus       118 ~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--~~kR~tlcgt~dyl~pEmv~  195 (281)
T KOG0580|consen  118 MKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SNKRKTLCGTLDYLPPEMVE  195 (281)
T ss_pred             cccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--CCCceeeecccccCCHhhcC
Confidence            4569999999999999999999999999999999999999999999999999987654  22334457899999999998


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++...|+|++|++.||++.|..| |......+..+++.+..-                             .++..
T Consensus       196 ~~~-hd~~Vd~w~lgvl~yeflvg~pp-Fes~~~~etYkrI~k~~~-----------------------------~~p~~  244 (281)
T KOG0580|consen  196 GRG-HDKFVDLWSLGVLCYEFLVGLPP-FESQSHSETYKRIRKVDL-----------------------------KFPST  244 (281)
T ss_pred             CCC-ccchhhHHHHHHHHHHHHhcCCc-hhhhhhHHHHHHHHHccc-----------------------------cCCcc
Confidence            887 69999999999999999977666 777778888888887432                             24467


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      ++..+.++|.+||..+|.+|.+..|++.|||+...
T Consensus       245 is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  245 ISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             cChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence            99999999999999999999999999999998754

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-44  Score=291.19  Aligned_cols=248  Identities=22%  Similarity=0.326  Sum_probs=198.0

Q ss_pred             CeeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHH-HHHHhc
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLK-KYFDSL   77 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~-~~~~~~   77 (282)
                      .||+|.+..+++.||+|++...  ........+.+|+.+++.++||||+++++.+..+...++||||++|+.+ +.+...
T Consensus        15 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~   94 (285)
T cd05605          15 EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNM   94 (285)
T ss_pred             EEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhc
Confidence            3899999999999999998762  2222345577899999999999999999999999999999999986544 444332


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhh
Q psy6044          78 -NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        78 -~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~  156 (282)
                       ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+
T Consensus        95 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~  173 (285)
T cd05605          95 GNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TIRGRVGTVGYMAPEVV  173 (285)
T ss_pred             CcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-ccccccCCCCccCcHHh
Confidence             3469999999999999999999999999999999999999999999999999987654222 22334678899999999


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       157 ~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      .+.. ++.++|+||+|+++|++++|..| |.+.........+......                         .....+.
T Consensus       174 ~~~~-~~~~~Diws~G~~l~el~~g~~p-f~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~  226 (285)
T cd05605         174 KNER-YTFSPDWWGLGCLIYEMIEGKSP-FRQRKEKVKREEVERRVKE-------------------------DQEEYSE  226 (285)
T ss_pred             cCCC-CCccccchhHHHHHHHHHHCCCC-CCCCchhhHHHHHHHHhhh-------------------------cccccCc
Confidence            7665 68999999999999999998887 5554443333333222111                         1112334


Q ss_pred             cCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCccch
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~  276 (282)
                      .++..+.+||.+||+.||.+||     +++++++||||...+..-
T Consensus       227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~  271 (285)
T cd05605         227 KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKR  271 (285)
T ss_pred             ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHH
Confidence            5889999999999999999999     999999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0589|consensus

Probab=100.00  E-value=8.6e-45  Score=299.09  Aligned_cols=240  Identities=27%  Similarity=0.398  Sum_probs=211.1

Q ss_pred             eeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCe-EEEEEecCccc-HHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKK-LTLVFEHCDQD-LKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~-~~iv~e~~~g~-l~~~~~~~~   78 (282)
                      ++..+++.++..|++|.++. ...........+|+.+++++.||||+.+.+.|..++. .+|||+||+|+ +.+.+...+
T Consensus        20 a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k   99 (426)
T KOG0589|consen   20 ALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQK   99 (426)
T ss_pred             hhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHh
Confidence            46778889999999999998 5555566789999999999999999999999998887 99999999875 444454444


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          79 -GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 -~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                       .-++++.+..|+.|++.|+.|||+.+|.|||||+.|||++.++.++|+|||+++.++..........||+.|++||.+.
T Consensus       100 ~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~  179 (426)
T KOG0589|consen  100 GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILS  179 (426)
T ss_pred             hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhC
Confidence             4599999999999999999999999999999999999999999999999999999987765566678999999999998


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. |+.++|||||||++|||++-+.+ |...+.......+.....                            ..++..
T Consensus       180 d~p-Yn~KSDiWsLGC~~yEm~~lk~a-F~a~~m~~Li~ki~~~~~----------------------------~Plp~~  229 (426)
T KOG0589|consen  180 DIP-YNEKSDIWSLGCCLYEMCTLKPA-FKASNMSELILKINRGLY----------------------------SPLPSM  229 (426)
T ss_pred             CCC-CCccCcchhhcchHHHHHhcccc-cCccchHHHHHHHhhccC----------------------------CCCCcc
Confidence            877 79999999999999999965555 999999999999888642                            234566


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD  271 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  271 (282)
                      ++.+++.+|+.||..+|..||++.++|.+|.+..
T Consensus       230 ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  230 YSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             ccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence            8999999999999999999999999999998773

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-43  Score=302.93  Aligned_cols=261  Identities=25%  Similarity=0.315  Sum_probs=197.8

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEI   81 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~   81 (282)
                      ||+|.+..+++.||||...       ...+.+|+.++++++|+||+++++++......++|+|++.+++...+......+
T Consensus       185 Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~l  257 (461)
T PHA03211        185 VFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRPL  257 (461)
T ss_pred             EEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccCCCHHHHHHhcCCCC
Confidence            8999999999999999532       245678999999999999999999999999999999999999999887766789


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--ccccccccccccChhhhcCC
Q psy6044          82 DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--CYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        82 ~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~  159 (282)
                      ++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........  ......|+..|+|||.+.+.
T Consensus       258 ~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~  337 (461)
T PHA03211        258 GLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGD  337 (461)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCC
Confidence            9999999999999999999999999999999999999999999999999876532211  11234578999999999776


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCh------HHHHHHHHHHhCCCCCCCCCCC--CCCCCC-----CCCCCCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDV------DDQLKRIFKLLGTPTEDTWPGM--NLLPDF-----KPFPMYH  226 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-----~~~~~~~  226 (282)
                      . ++.++|||||||++|++++|..++|.....      ...+..+.........+.....  .....+     .......
T Consensus       338 ~-~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  416 (461)
T PHA03211        338 P-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAY  416 (461)
T ss_pred             C-CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCcc
Confidence            6 799999999999999999998887765321      2233333333222111111000  000000     0000000


Q ss_pred             CCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q psy6044         227 PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD  271 (282)
Q Consensus       227 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  271 (282)
                      ....+.. ...++..+.+||.+||+.||++|||+.|+|+||||++
T Consensus       417 ~~~~~~~-~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        417 TRPAWTR-YYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCcchhh-hccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            0001111 1246778999999999999999999999999999975

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.1e-43  Score=294.99  Aligned_cols=269  Identities=23%  Similarity=0.368  Sum_probs=196.3

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||+|.++.+|..+|+|.+...........+.+|++++++++||||+++++++.+++..++||||++|+.+..+....+.
T Consensus        20 ~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~   99 (333)
T cd06650          20 VVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR   99 (333)
T ss_pred             EEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCC
Confidence            38999999999999999987643333456788999999999999999999999999999999999987555544444677


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSR-NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      +++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......  .....++..|+|||.+.+.
T Consensus       100 ~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~  177 (333)
T cd06650         100 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGT  177 (333)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc--cccCCCCccccCHHHhcCC
Confidence            99999999999999999999985 79999999999999999999999999987553221  1234568899999999776


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCC-------------
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYH-------------  226 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------  226 (282)
                      . ++.++|+|||||++|++++|..| |......+....+............................             
T Consensus       178 ~-~~~~~DvwslG~il~~l~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (333)
T cd06650         178 H-YSVQSDIWSMGLSLVEMAIGRYP-IPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELL  255 (333)
T ss_pred             C-CCcHHHHHHHHHHHHHHHHCCCC-CCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHH
Confidence            5 68999999999999999999888 44433322222111100000000000000000000000000             


Q ss_pred             ---CCCCcccc-CccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         227 ---PSMSFSQV-APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       227 ---~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                         ........ ...++.++.+||.+||+.||++|||+++++.||||+...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         256 DYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             HHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence               00000111 123678999999999999999999999999999998764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-43  Score=289.56  Aligned_cols=268  Identities=47%  Similarity=0.797  Sum_probs=216.0

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      .||+|.+..+|+.+++|.+... ........+.+|+.++++++||||+++++++..+...++++||+++++.+.+.....
T Consensus        14 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~l~~~~~   93 (283)
T cd05118          14 VVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQR   93 (283)
T ss_pred             eEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCCCHHHHHHhhcc
Confidence            3899999999999999998763 233445678899999999999999999999999999999999999999888877667


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+.
T Consensus        94 ~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~  173 (283)
T cd05118          94 GLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGD  173 (283)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcC
Confidence            89999999999999999999999999999999999999999999999999987765443233344567789999998776


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCC-CCCCCCCCCCccccCccC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFK-PFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  238 (282)
                      ..++.++|+||+|+++|++++|+.| |...+..+....+....+.+....++......... ...............+.+
T Consensus       174 ~~~~~~~Di~slG~~l~~l~tg~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (283)
T cd05118         174 KGYSTPVDIWSVGCIFAELLSRRPL-FPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNA  252 (283)
T ss_pred             CCCCchhHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhh
Confidence            4579999999999999999988655 77777777777777766665554444332211110 000111111223344568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      +..+.++|.+||+.||.+||++++++.||||
T Consensus       253 ~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         253 SPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             CHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            9999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.7e-44  Score=302.18  Aligned_cols=248  Identities=20%  Similarity=0.313  Sum_probs=198.5

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|.++.+|+.||+|++..  .........+..|+.++..++||+|+++++.+.+.+.+++||||++|+.+..+....+
T Consensus        17 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~   96 (360)
T cd05627          17 VRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD   96 (360)
T ss_pred             EEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcC
Confidence            89999999999999999986  2233345677889999999999999999999999999999999998755555555467


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--------------------
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--------------------  139 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--------------------  139 (282)
                      .+++..+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||++........                    
T Consensus        97 ~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (360)
T cd05627          97 TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM  176 (360)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCccccccccc
Confidence            899999999999999999999999999999999999999999999999998865421100                    


Q ss_pred             ---------------ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCC
Q psy6044         140 ---------------CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT  204 (282)
Q Consensus       140 ---------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~  204 (282)
                                     ......|++.|+|||.+.+.. ++.++|+|||||++|+|++|..| |.+.+..+....+......
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyel~tG~~P-f~~~~~~~~~~~i~~~~~~  254 (360)
T cd05627         177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPP-FCSETPQETYRKVMNWKET  254 (360)
T ss_pred             ccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccccceeeecccCCCC-CCCCCHHHHHHHHHcCCCc
Confidence                           011235789999999997766 79999999999999999988777 6666665555554431100


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCCccCCccchh
Q psy6044         205 PTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM---SAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~h~~~~~~~~~~~  277 (282)
                      .                        ..+ ....+++.++++|.+|+. ||.+|+   +++++++||||+++++...
T Consensus       255 ~------------------------~~p-~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~~  304 (360)
T cd05627         255 L------------------------VFP-PEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWGHI  304 (360)
T ss_pred             e------------------------ecC-CCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHHHH
Confidence            0                        000 012378899999999874 999999   5899999999999876543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.5e-43  Score=289.60  Aligned_cols=268  Identities=38%  Similarity=0.674  Sum_probs=204.7

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC--------eEEEEEecCcccHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK--------KLTLVFEHCDQDLK   71 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~--------~~~iv~e~~~g~l~   71 (282)
                      .||+|.+..+|+.||+|.+... ........+.+|+.++++++||||+++++++....        ..++|+||+++++.
T Consensus        27 ~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~  106 (310)
T cd07865          27 EVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLA  106 (310)
T ss_pred             EEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCcCHH
Confidence            3899999999999999998763 23333445678999999999999999999987653        45999999999988


Q ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc----ccccccc
Q psy6044          72 KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC----YSAEVVT  147 (282)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~  147 (282)
                      +.+......+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........    .....++
T Consensus       107 ~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~  186 (310)
T cd07865         107 GLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT  186 (310)
T ss_pred             HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccC
Confidence            888776668999999999999999999999999999999999999999999999999998765432211    1223456


Q ss_pred             ccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHP  227 (282)
Q Consensus       148 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (282)
                      ..|+|||.+.+...++.++|+||+|+++|++++|..| |.+.+.......+....+..+.+.++................
T Consensus       187 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (310)
T cd07865         187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPI-MQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQG  265 (310)
T ss_pred             ccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCc
Confidence            7899999987665568899999999999999987655 777776666666666666555555444322222211110000


Q ss_pred             C--CCcccc-CccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         228 S--MSFSQV-APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       228 ~--~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      .  ...... ....++.+.++|.+||..||.+|||++++++||||
T Consensus       266 ~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         266 QKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             cchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            0  000000 11246788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-43  Score=287.11  Aligned_cols=268  Identities=34%  Similarity=0.615  Sum_probs=210.0

Q ss_pred             CeeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      .||+|.++.+++.||+|++.. .........+.+|++++++++|+||+++++++..++..++++||++++++..+.....
T Consensus        16 ~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~   95 (288)
T cd07833          16 VVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPG   95 (288)
T ss_pred             eEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCC
Confidence            389999999999999999886 3344456788999999999999999999999999999999999999999888777677


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~  158 (282)
                      .+++..++.++.||+.||.+||+.|++|+|++|+||+++.++.++|+|||.+........ ......++..|+|||.+..
T Consensus        96 ~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~  175 (288)
T cd07833          96 GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVG  175 (288)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcC
Confidence            799999999999999999999999999999999999999999999999999877654432 3334456788999999987


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCC--CCCCCCCCCcc-ccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP--FPMYHPSMSFS-QVA  235 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~  235 (282)
                      ...++.++|+||||+++|++++|..| |......+....+....+..+...............  +.......... ..+
T Consensus       176 ~~~~~~~~Dv~slG~~l~~l~~g~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (288)
T cd07833         176 DTNYGKPVDVWAIGCIMAELLDGEPL-FPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYP  254 (288)
T ss_pred             CCCcCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcC
Confidence            74479999999999999999987655 666666666665555554433322211111111111  00000000111 123


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      ..++..+.+||++||+.+|.+|||+++++.||||
T Consensus       255 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         255 GKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             CccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            3458999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.8e-43  Score=293.78  Aligned_cols=273  Identities=16%  Similarity=0.173  Sum_probs=193.0

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCccc-HHHHHHhc-C
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSL-N   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~-l~~~~~~~-~   78 (282)
                      ||+|.++.+|+.||+|++... ........+.+|+.+++.++||||+++++++..++..++|+||++++ +.+.+... .
T Consensus        16 v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~   95 (327)
T cd08227          16 VNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFM   95 (327)
T ss_pred             EEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhcc
Confidence            899999999999999998763 22333456778999999999999999999999999999999999865 44444332 3


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-------cccccccccccc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-------CYSAEVVTLWYR  151 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~~~  151 (282)
                      ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++.+++.||+..........       ......++..|+
T Consensus        96 ~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~  175 (327)
T cd08227          96 DGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWL  175 (327)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceeccc
Confidence            4589999999999999999999999999999999999999999999999986543321110       011123456799


Q ss_pred             ChhhhcCC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCC-C------CCCCCCCC-------CCC
Q psy6044         152 PPDVLFGA-KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT-P------TEDTWPGM-------NLL  216 (282)
Q Consensus       152 aPE~~~~~-~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~-~------~~~~~~~~-------~~~  216 (282)
                      |||.+.+. ..++.++|+|||||++|++++|..|+ .................. .      +.+.....       ...
T Consensus       176 aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T cd08227         176 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF-KDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGL  254 (327)
T ss_pred             ChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCC-CCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCC
Confidence            99998653 34789999999999999999988884 443332222221111000 0      00000000       000


Q ss_pred             CCCCC---CCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         217 PDFKP---FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       217 ~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      .....   ................+++.+.+||++||+.||++|||++++++||||+++...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~~  316 (327)
T cd08227         255 GESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRR  316 (327)
T ss_pred             CcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcchh
Confidence            00000   000000011112334578899999999999999999999999999999987543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1e-42  Score=287.40  Aligned_cols=267  Identities=37%  Similarity=0.658  Sum_probs=210.8

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC----------eEEEEEecCcccH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK----------KLTLVFEHCDQDL   70 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~----------~~~iv~e~~~g~l   70 (282)
                      ||+|.++.+|+.||+|.++.. ........+.+|+++++.++|||++++++++.+..          .+++++||+++++
T Consensus        23 v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l  102 (302)
T cd07864          23 VYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDL  102 (302)
T ss_pred             EEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCccH
Confidence            899999999999999999873 33334456778999999999999999999987654          7999999999988


Q ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-cccccccccc
Q psy6044          71 KKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLW  149 (282)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~  149 (282)
                      ...+......+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+........ ......++..
T Consensus       103 ~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  182 (302)
T cd07864         103 MGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW  182 (302)
T ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccC
Confidence            888776556799999999999999999999999999999999999999999999999999876543321 1122344667


Q ss_pred             ccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCC-CCCCC
Q psy6044         150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFP-MYHPS  228 (282)
Q Consensus       150 ~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  228 (282)
                      |+|||.+.+...++.++|+||+|++++++++|..| |...+..+....+....+.+.+..++............ .....
T Consensus       183 y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (302)
T cd07864         183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPI-FQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYR  261 (302)
T ss_pred             ccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccc
Confidence            99999887655568999999999999999987655 77777777777777777666665555433322221110 01111


Q ss_pred             CCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         229 MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       229 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      .........++..+.++|..||+.||.+|||++++++||||
T Consensus       262 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         262 RRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             cchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            12222334578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=8.2e-43  Score=289.10  Aligned_cols=268  Identities=39%  Similarity=0.678  Sum_probs=210.0

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC--------CeEEEEEecCcccHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSE--------KKLTLVFEHCDQDLK   71 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~--------~~~~iv~e~~~g~l~   71 (282)
                      .||+|.++.+++.+|+|++... ........+.+|+++++.++||||+++++++.+.        ..+++|+||+.+++.
T Consensus        23 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~~l~  102 (311)
T cd07866          23 EVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLS  102 (311)
T ss_pred             EEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCcCHH
Confidence            3899999999999999998763 3333345678899999999999999999987543        357999999999988


Q ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc-----------
Q psy6044          72 KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC-----------  140 (282)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-----------  140 (282)
                      ..+......+++..+..++.|+++||.+||++|++|+||+|+||+++.++.++|+|||.+.........           
T Consensus       103 ~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  182 (311)
T cd07866         103 GLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK  182 (311)
T ss_pred             HHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccc
Confidence            888766678999999999999999999999999999999999999999999999999988765432211           


Q ss_pred             cccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCC
Q psy6044         141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFK  220 (282)
Q Consensus       141 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (282)
                      .....+++.|+|||.+.+...++.++|+||||+++|+|++|..| |.+.+.......+....+.+.+..++.........
T Consensus       183 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (311)
T cd07866         183 YTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPI-LQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCE  261 (311)
T ss_pred             cccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCChhhchhhhhccccc
Confidence            11224467799999987665578999999999999999987655 77777777777777776666655555443333322


Q ss_pred             C-CCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         221 P-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       221 ~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      . ......+.........+++.+.++|.+||+.||.+|||+.++++||||
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         262 GVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             ccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            1 111111112222334567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=8.4e-43  Score=289.87  Aligned_cols=266  Identities=36%  Similarity=0.657  Sum_probs=196.4

Q ss_pred             CeeeeeeCC--CCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeee--CCeEEEEEecCcccHHHHHHh
Q psy6044           1 MFTSGVDRT--PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQDLKKYFDS   76 (282)
Q Consensus         1 ~vy~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~--~~~~~iv~e~~~g~l~~~~~~   76 (282)
                      .||+|+++.  ++..||+|.+...   .....+.+|+.+++.++||||+++++++..  +...++++||+++++.+.+..
T Consensus        16 ~Vy~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~   92 (317)
T cd07867          16 HVYKAKRKDGKDEKEYALKQIEGT---GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKF   92 (317)
T ss_pred             eEEEEEecCCCccceEEEEEecCC---CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCcHHHHHHh
Confidence            389999654  6789999988642   223467899999999999999999998853  568899999999988877643


Q ss_pred             c--------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE----cCCCcEEEEecCCccccCCCcc---cc
Q psy6044          77 L--------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI----NKNGELKLADFGLARAFGIPVK---CY  141 (282)
Q Consensus        77 ~--------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~----~~~~~~~l~df~~~~~~~~~~~---~~  141 (282)
                      .        ...+++..+..++.||+.||.+||+.|++|+||||+||++    +.++.++|+|||++........   ..
T Consensus        93 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~  172 (317)
T cd07867          93 HRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL  172 (317)
T ss_pred             hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCccccccc
Confidence            2        1248899999999999999999999999999999999999    4567899999999976643321   22


Q ss_pred             ccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC--------hHHHHHHHHHHhCCCCCCCCCCC
Q psy6044         142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSD--------VDDQLKRIFKLLGTPTEDTWPGM  213 (282)
Q Consensus       142 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~  213 (282)
                      ....++..|+|||.+.+...++.++|+||+|+++|+|+||..|+.....        .......+...++.+....|...
T Consensus       173 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (317)
T cd07867         173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDI  252 (317)
T ss_pred             CcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhh
Confidence            3345688899999997765579999999999999999998777432221        12344555565665555555443


Q ss_pred             CCCCCCCCCCC------C---CCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         214 NLLPDFKPFPM------Y---HPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       214 ~~~~~~~~~~~------~---~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      .....+.....      .   .............+..+.++|.+||+.||.+|||++|+|+||||
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         253 RKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            22222111000      0   00001111223456788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5e-43  Score=282.47  Aligned_cols=238  Identities=24%  Similarity=0.387  Sum_probs=197.4

Q ss_pred             eeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc-C
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL-N   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~-~   78 (282)
                      ||+|.++.+|+.|++|.+.. .........+.+|+.+++.++|||++++++++.+.+..++|+||++| ++.+.+... .
T Consensus        16 v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~   95 (256)
T cd08529          16 VFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRG   95 (256)
T ss_pred             EEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcC
Confidence            79999999999999999876 33444567888999999999999999999999999999999999976 555555443 3


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............++..|+|||...+
T Consensus        96 ~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  175 (256)
T cd08529          96 RPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED  175 (256)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcC
Confidence            56899999999999999999999999999999999999999999999999998776544333334456788999999977


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||||++++++++|..| |...+..+....+....                            ...++..+
T Consensus       176 ~~-~~~~~Di~slG~il~~l~~g~~p-~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~  225 (256)
T cd08529         176 KP-YNEKSDVWALGVVLYECCTGKHP-FDANNQGALILKIIRGV----------------------------FPPVSQMY  225 (256)
T ss_pred             CC-CCCccchHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHcCC----------------------------CCCCcccc
Confidence            66 68999999999999999998887 55555555444433311                            11122357


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      +..+.+++.+||+.+|++||++.++++|||+
T Consensus       226 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         226 SQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence            8899999999999999999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.3e-43  Score=295.41  Aligned_cols=275  Identities=39%  Similarity=0.637  Sum_probs=211.1

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC-----CeEEEEEecCcccHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSE-----KKLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~-----~~~~iv~e~~~g~l~~~~   74 (282)
                      .||+|.+..+|+.||||.+... ........+.+|+.+++.++||||+++++++...     ...++++||+++++.+.+
T Consensus        20 ~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~   99 (337)
T cd07858          20 IVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQII   99 (337)
T ss_pred             EEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCCCCHHHHH
Confidence            3899999999999999998762 2333455678899999999999999999988654     358999999999887776


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChh
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPD  154 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE  154 (282)
                      .. .+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++..............++..|+|||
T Consensus       100 ~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE  178 (337)
T cd07858         100 RS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPE  178 (337)
T ss_pred             hc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChH
Confidence            55 57899999999999999999999999999999999999999999999999999876643322233345678899999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCC--CCCCCCCCCCCCcc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPD--FKPFPMYHPSMSFS  232 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  232 (282)
                      .+.....++.++|+||||+++|++++|..| |.+.+.......+....+.+....+........  ..............
T Consensus       179 ~~~~~~~~~~~~DiwslG~il~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (337)
T cd07858         179 LLLNCSEYTTAIDVWSVGCIFAELLGRKPL-FPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFA  257 (337)
T ss_pred             HHhcCCCCCCcccHHHHHHHHHHHHcCCCC-CCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHH
Confidence            987644478999999999999999977655 777776666666666665544433311100000  00000111111223


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccchh
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  277 (282)
                      ...+.+++.+.++|++||+.||++|||++++++||||+.+.....
T Consensus       258 ~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~  302 (337)
T cd07858         258 RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSD  302 (337)
T ss_pred             HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCccc
Confidence            344568999999999999999999999999999999998755443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2e-43  Score=298.56  Aligned_cols=245  Identities=22%  Similarity=0.305  Sum_probs=194.9

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|+++.+++.+|+|++..  .........+.+|+.+++.++||||+++++++.++...|+||||++|+.+..+.. ..
T Consensus        59 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~-~~  137 (370)
T cd05621          59 VQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS-NY  137 (370)
T ss_pred             EEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHH-hc
Confidence            89999999999999999976  2223334567889999999999999999999999999999999998654444444 34


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~  158 (282)
                      .+++..+..++.||+.||++||++||+|+||||+||+++.++.++|+|||++........ ......|++.|+|||.+..
T Consensus       138 ~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~  217 (370)
T cd05621         138 DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS  217 (370)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhc
Confidence            689999999999999999999999999999999999999999999999999876643221 2234567999999999865


Q ss_pred             CC---CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         159 AK---LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       159 ~~---~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      ..   .++.++|+||+||++|+|++|..| |...+.......+........   ++                      ..
T Consensus       218 ~~~~~~~~~~~DiwSlG~ilyell~G~~P-f~~~~~~~~~~~i~~~~~~~~---~p----------------------~~  271 (370)
T cd05621         218 QGGDGYYGRECDWWSVGVFLFEMLVGDTP-FYADSLVGTYSKIMDHKNSLN---FP----------------------ED  271 (370)
T ss_pred             cCCCCCCCcccCEEeehHHHHHHHhCCCC-CCCCCHHHHHHHHHhCCcccC---CC----------------------Cc
Confidence            42   367899999999999999998888 555555555555544211110   00                      01


Q ss_pred             ccCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCCc
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQ--RMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~h~~~~~~~  273 (282)
                      ..++..++++|..||..++.+  |+|+.++++||||+...
T Consensus       272 ~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~  311 (370)
T cd05621         272 VEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ  311 (370)
T ss_pred             ccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence            247899999999999865543  88999999999999754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.4e-43  Score=296.41  Aligned_cols=276  Identities=34%  Similarity=0.606  Sum_probs=213.6

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeee----CCeEEEEEecCcccHHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHS----EKKLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~----~~~~~iv~e~~~g~l~~~~~   75 (282)
                      .||+|.++.+|+.||+|++... ........+.+|+.++++++||||+++++++..    ....++|+||+.|++.+.+.
T Consensus        20 ~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~   99 (334)
T cd07855          20 VVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIH   99 (334)
T ss_pred             EEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhhhhHHHHhc
Confidence            4899999999999999998763 233445677889999999999999999998763    35789999999987766655


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc----ccccccccccc
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC----YSAEVVTLWYR  151 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~~  151 (282)
                      . ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........    .....++..|+
T Consensus       100 ~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~  178 (334)
T cd07855         100 S-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR  178 (334)
T ss_pred             c-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCccccccccccccc
Confidence            4 567999999999999999999999999999999999999999999999999998765432211    12235678899


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCC--CCCCCCCCCCC
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPD--FKPFPMYHPSM  229 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  229 (282)
                      |||.+.+...++.++|+||+|+++|+|++|..| |...+.......+....+.++...+.......-  ...........
T Consensus       179 ~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~p-f~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (334)
T cd07855         179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQL-FPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPV  257 (334)
T ss_pred             ChHHhcCCcccccccchHHHHHHHHHHHcCCCc-cCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCC
Confidence            999986655578999999999999999976665 777777777777777766665444322111000  00000111112


Q ss_pred             CccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccchhh
Q psy6044         230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKS  278 (282)
Q Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~  278 (282)
                      .+.......++++.++|++||+.+|.+|||+++++.||||++.+.+...
T Consensus       258 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~  306 (334)
T cd07855         258 PWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDE  306 (334)
T ss_pred             CHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCccc
Confidence            2334445679999999999999999999999999999999988766544

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0611|consensus

Probab=100.00  E-value=2.7e-44  Score=287.89  Aligned_cols=243  Identities=26%  Similarity=0.498  Sum_probs=207.9

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      |-+|++..+|+.||||.+++  ..+....-.+.+|+++|..|+||||+.+|++|++...+.|||||..| .|++++.. .
T Consensus        69 Vk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSe-r  147 (668)
T KOG0611|consen   69 VKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISE-R  147 (668)
T ss_pred             eeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHH-h
Confidence            55788889999999999998  34444566789999999999999999999999999999999999975 66666655 7


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +.+++.++..++.||.+|+.|+|.++++|+|||.+||+++.++++||+|||++...... ......+|++-|.+||+..+
T Consensus       148 ~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~-kfLqTFCGSPLYASPEIvNG  226 (668)
T KOG0611|consen  148 GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK-KFLQTFCGSPLYASPEIVNG  226 (668)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc-cHHHHhcCCcccCCccccCC
Confidence            89999999999999999999999999999999999999999999999999999877543 33445688999999999988


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      ..+-++..|.||||+++|.|+.|..| |++.+......++..+-                              ...+.-
T Consensus       227 ~PY~GPEVDsWsLGvLLYtLVyGtMP-FDG~Dhk~lvrQIs~Ga------------------------------YrEP~~  275 (668)
T KOG0611|consen  227 TPYKGPEVDSWSLGVLLYTLVYGTMP-FDGRDHKRLVRQISRGA------------------------------YREPET  275 (668)
T ss_pred             CCCCCCccchhhHHHHHHHHhhcccc-cCCchHHHHHHHhhccc------------------------------ccCCCC
Confidence            88778999999999999999988888 88888777776665421                              112345


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc-CCccchh
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS-DLNVAIK  277 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~-~~~~~~~  277 (282)
                      +.+..-||++||..||.+|.|+++|-.|=|+. +.++.+.
T Consensus       276 PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy~~~V~  315 (668)
T KOG0611|consen  276 PSDASGLIRWMLMVNPERRATIEDIASHWWVNWGYNMPVI  315 (668)
T ss_pred             CchHHHHHHHHHhcCcccchhHHHHhhhheeecccccccc
Confidence            67788999999999999999999999999986 4454443

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-43  Score=295.53  Aligned_cols=274  Identities=38%  Similarity=0.638  Sum_probs=218.9

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC-----eEEEEEecCcccHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK-----KLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~-----~~~iv~e~~~g~l~~~~   74 (282)
                      .||+|++..+|+.||+|++... ......+.+.+|+.+++.++||||+++++++....     ..|+++||+++++.+.+
T Consensus        15 ~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l   94 (330)
T cd07834          15 VVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVI   94 (330)
T ss_pred             EEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchhhhHHHHH
Confidence            3899999999999999998873 23445678999999999999999999999988775     88999999998777766


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc---ccccccccccccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---KCYSAEVVTLWYR  151 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~  151 (282)
                      .. ...+++..++.++.||+.||++||+.|++|+||+|.||+++.++.++|+|||.+.......   .......++..|+
T Consensus        95 ~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~  173 (330)
T cd07834          95 KS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR  173 (330)
T ss_pred             hC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcC
Confidence            54 5589999999999999999999999999999999999999999999999999998765432   1233345678899


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCC--CCCCCCCCCCCCCCC
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN--LLPDFKPFPMYHPSM  229 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  229 (282)
                      |||.+.+...++.++|+||+|+++|++++|..| |.+.+..+....+....+.+....+....  ....+-.........
T Consensus       174 aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (330)
T cd07834         174 APELLLSSSRYTKAIDIWSVGCIFAELLTRKPL-FPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKK  252 (330)
T ss_pred             CceeeecccCCCcchhHHHHHHHHHHHHcCCCC-cCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcc
Confidence            999997774579999999999999999977655 88888888888888877766654443111  111110011111222


Q ss_pred             CccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      ......+.++..+.++|.+||+.+|.+|||+++++.||||+++..+.
T Consensus       253 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~  299 (330)
T cd07834         253 PLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE  299 (330)
T ss_pred             hhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccc
Confidence            33444556899999999999999999999999999999999887653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-43  Score=284.07  Aligned_cols=239  Identities=25%  Similarity=0.417  Sum_probs=193.1

Q ss_pred             eeeeeeCCCCceEEEeeeecCCC-C---CCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhc
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGN-E---GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~-~---~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~   77 (282)
                      ||+|.+..+++.+|+|.+..... .   .....+.+|++++++++||||+++++++.++...++++||++|+.+......
T Consensus        18 vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~   97 (263)
T cd06625          18 VYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA   97 (263)
T ss_pred             EEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHH
Confidence            79999999999999999876321 1   1234678899999999999999999999999999999999987555544444


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccc---ccccccccccChh
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY---SAEVVTLWYRPPD  154 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~~aPE  154 (282)
                      .+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..........   ....++..|+|||
T Consensus        98 ~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE  177 (263)
T cd06625          98 YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE  177 (263)
T ss_pred             hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcc
Confidence            6779999999999999999999999999999999999999999999999999987653221111   2234577899999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      .+.+.. ++.++|+||+|+++|++++|..| |...+..+.........                           ....+
T Consensus       178 ~~~~~~-~~~~~Di~slG~il~el~~g~~p-~~~~~~~~~~~~~~~~~---------------------------~~~~~  228 (263)
T cd06625         178 VISGEG-YGRKADVWSVGCTVVEMLTEKPP-WAEFEAMAAIFKIATQP---------------------------TNPQL  228 (263)
T ss_pred             eeccCC-CCchhhhHHHHHHHHHHHhCCCC-ccccchHHHHHHHhccC---------------------------CCCCC
Confidence            998776 68999999999999999998887 44444333333222110                           11123


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      +..++..+.++|++||..+|.+|||+.++++||||
T Consensus       229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         229 PSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             CccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            45688999999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-43  Score=294.70  Aligned_cols=272  Identities=35%  Similarity=0.631  Sum_probs=208.6

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC-----CeEEEEEecCcccHHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE-----KKLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~-----~~~~iv~e~~~g~l~~~~~   75 (282)
                      .||+|.+..+|+.||+|++...........+.+|+.+++.++||||+++++++...     ...++++||+++++...+.
T Consensus        20 ~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~   99 (336)
T cd07849          20 MVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIK   99 (336)
T ss_pred             EEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcccCHHHHHh
Confidence            48999999999999999987533344456788899999999999999999987644     3589999999998877664


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc---ccccccccccccC
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK---CYSAEVVTLWYRP  152 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~a  152 (282)
                        ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++........   ......++..|+|
T Consensus       100 --~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  177 (336)
T cd07849         100 --TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA  177 (336)
T ss_pred             --cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccC
Confidence              46799999999999999999999999999999999999999999999999999876543221   1122356788999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCC--CCCCCCCCCCCC
Q psy6044         153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPD--FKPFPMYHPSMS  230 (282)
Q Consensus       153 PE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  230 (282)
                      ||.+.+...++.++|+||+|+++|+|++|..| |.+.+.......+...++.+..+.+........  ............
T Consensus       178 PE~~~~~~~~~~~~DvwslGvil~el~~G~~~-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (336)
T cd07849         178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPL-FPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVP  256 (336)
T ss_pred             hHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCccc
Confidence            99876655578999999999999999988666 666666666666666666554433322111000  000000111112


Q ss_pred             ccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      .....+.+++.+.++|.+||+.||++|||+.++++||||+....+
T Consensus       257 ~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         257 WNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             HHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence            233345678999999999999999999999999999999987544

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-43  Score=284.03  Aligned_cols=244  Identities=24%  Similarity=0.353  Sum_probs=199.7

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||+|++..+|+.||+|.+...........+.+|+.+++.++|||++++++++.++...++|+||++|+.+..+... ..
T Consensus        16 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~   94 (274)
T cd06609          16 EVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GK   94 (274)
T ss_pred             EEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhh-cC
Confidence            38999999999999999988654344456788999999999999999999999999999999999987544444442 38


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..+..++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+..
T Consensus        95 ~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~  174 (274)
T cd06609          95 LDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG  174 (274)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccccCCccccChhhhccCC
Confidence            89999999999999999999999999999999999999999999999999987765434344456678899999997776


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc-CC
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK-LT  239 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  239 (282)
                       ++.++|+||||+++|++++|..| |...+.......+....                            ....... ++
T Consensus       175 -~~~~sDv~slG~il~~l~tg~~p-~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~  224 (274)
T cd06609         175 -YDEKADIWSLGITAIELAKGEPP-LSDLHPMRVLFLIPKNN----------------------------PPSLEGNKFS  224 (274)
T ss_pred             -CCchhhHHHHHHHHHHHHhCCCC-cccCchHHHHHHhhhcC----------------------------CCCCcccccC
Confidence             79999999999999999988777 55544433333332210                            0011122 78


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      +.+.+++.+||..+|.+|||++++++||||++....
T Consensus       225 ~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         225 KPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             HHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence            899999999999999999999999999999976443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=8.1e-43  Score=286.39  Aligned_cols=241  Identities=22%  Similarity=0.364  Sum_probs=199.9

Q ss_pred             CeeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL   77 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~   77 (282)
                      .||+|.+..+++.+|+|++...  ........+.+|++++++++||||+++++++.+.+..++|+||++| ++.+.+.. 
T Consensus        16 ~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-   94 (290)
T cd05580          16 RVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK-   94 (290)
T ss_pred             EEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHH-
Confidence            3899999999999999998762  2333456788999999999999999999999999999999999965 55555444 


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      .+.+++..+..++.|++.||.+||+.|++|+||+|.||+++.++.++|+|||.+......   .....+++.|+|||.+.
T Consensus        95 ~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~  171 (290)
T cd05580          95 SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TYTLCGTPEYLAPEIIL  171 (290)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CCCCCCCccccChhhhc
Confidence            678999999999999999999999999999999999999999999999999998776533   22335678899999987


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. .+.++|+||||+++|+|++|..| |...+..+..+.+...                             ...++..
T Consensus       172 ~~~-~~~~~Di~slG~il~~l~~g~~p-~~~~~~~~~~~~~~~~-----------------------------~~~~~~~  220 (290)
T cd05580         172 SKG-YGKAVDWWALGILIYEMLAGYPP-FFDDNPIQIYEKILEG-----------------------------KVRFPSF  220 (290)
T ss_pred             CCC-CCccccHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHhcC-----------------------------CccCCcc
Confidence            665 68999999999999999998877 5555544444444321                             1123345


Q ss_pred             CCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCccch
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~  276 (282)
                      +++.++++|.+||..||.+|+     +++++++||||+.+.+..
T Consensus       221 ~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~  264 (290)
T cd05580         221 FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIA  264 (290)
T ss_pred             CCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHH
Confidence            789999999999999999999     999999999999987543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.3e-43  Score=282.57  Aligned_cols=244  Identities=24%  Similarity=0.362  Sum_probs=198.1

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|.+..+++.+|+|++...  ........+.+|+.+++.++||||+++++.+.+....++++||++|+.+..+.....
T Consensus         9 v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   88 (262)
T cd05572           9 VELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG   88 (262)
T ss_pred             EEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcC
Confidence            899999999999999999862  223345678999999999999999999999999999999999998655554544456


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|++||.+...
T Consensus        89 ~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~  167 (262)
T cd05572          89 LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEYVAPEIILNK  167 (262)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCccChhHhcCC
Confidence            78999999999999999999999999999999999999999999999999988765432 12233567889999998766


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCC-hHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSD-VDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      . ++.++|+||+|+++|++++|..|+..... ..+....+....                           .....+...
T Consensus       168 ~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~  219 (262)
T cd05572         168 G-YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN---------------------------GKLEFPNYI  219 (262)
T ss_pred             C-CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC---------------------------CCCCCCccc
Confidence            5 68999999999999999998888544332 333333332111                           111123345


Q ss_pred             CHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCcc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMS-----AEDAMSHIYFSDLNV  274 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps-----~~~ll~h~~~~~~~~  274 (282)
                      ++.+.++|.+||..||.+|||     ++++++||||++.++
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence            889999999999999999999     999999999998754

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=284.98  Aligned_cols=267  Identities=41%  Similarity=0.720  Sum_probs=212.8

Q ss_pred             eeeeeeCCCCceEEEeeeecCC-CCCCCccHHHHHHHHhhCCCCCccceeeeeeeC--CeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG-NEGVPSSALREICLLKELKHKNIVRLYDVLHSE--KKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~--~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||+|.+..+|+.+|+|++.... .......+.+|+.+++.++|||++++++++.+.  +..++|+||+++++.+.+....
T Consensus        15 vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~   94 (287)
T cd07840          15 VYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPE   94 (287)
T ss_pred             EEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccccHHHHHhccC
Confidence            8999999999999999998743 334456788999999999999999999999988  8999999999998888777655


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~  157 (282)
                      ..+++..++.++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.
T Consensus        95 ~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  174 (287)
T cd07840          95 VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLL  174 (287)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeE
Confidence            6899999999999999999999999999999999999999999999999999877654321 123335577899999876


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCC-CCCCCCccccCc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM-YHPSMSFSQVAP  236 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  236 (282)
                      +...++.++|+||||+++|++++|..| |...+..+....+....+.+....++............. ............
T Consensus       175 ~~~~~~~~~Dv~slG~~l~el~t~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (287)
T cd07840         175 GATRYGPEVDMWSVGCILAELFLGKPI-FQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFK  253 (287)
T ss_pred             ccccCChHHHHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhc
Confidence            655578999999999999999988666 677777777777777777666666554333211111100 111111112223


Q ss_pred             c-CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         237 K-LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       237 ~-~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      . +++.+.+++++||+.+|.+|||++++++||||
T Consensus       254 ~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         254 HLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            3 48999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-43  Score=290.76  Aligned_cols=249  Identities=21%  Similarity=0.316  Sum_probs=195.8

Q ss_pred             CeeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL   77 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~   77 (282)
                      .||+|+++.+++.||+|++..  .........+.+|..++..++|+||+++++++.+++.+|+|+||++| ++.+.+...
T Consensus        16 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~   95 (331)
T cd05597          16 EVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKF   95 (331)
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHh
Confidence            389999999999999999976  22333445688899999999999999999999999999999999975 555555544


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccChhhh
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~  156 (282)
                      ...+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+........ ......+++.|+|||.+
T Consensus        96 ~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~  175 (331)
T cd05597          96 EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEIL  175 (331)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHH
Confidence            56799999999999999999999999999999999999999999999999999866543222 12224578999999998


Q ss_pred             cC----CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         157 FG----AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       157 ~~----~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      ..    ...++.++|+||+||++|+|++|..| |......+....+.......                        ...
T Consensus       176 ~~~~~~~~~~~~~~DiwslG~~l~el~~g~~P-f~~~~~~~~~~~i~~~~~~~------------------------~~~  230 (331)
T cd05597         176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGETP-FYAESLVETYGKIMNHKEHF------------------------QFP  230 (331)
T ss_pred             hhccccccCCCCcceeehhhhHHHHHhhCCCC-CCCCCHHHHHHHHHcCCCcc------------------------cCC
Confidence            63    23368899999999999999998888 55555444444443211000                        111


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCCcc
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQ--RMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~h~~~~~~~~  274 (282)
                      .....+++.++++|++||..++++  |++++++++||||.++++
T Consensus       231 ~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~  274 (331)
T cd05597         231 PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW  274 (331)
T ss_pred             CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence            122347899999999998764443  789999999999998754

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2e-42  Score=279.22  Aligned_cols=238  Identities=24%  Similarity=0.406  Sum_probs=193.6

Q ss_pred             eeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeee-CCeEEEEEecCcc-cHHHHHHhc-
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHS-EKKLTLVFEHCDQ-DLKKYFDSL-   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~-~~~~~iv~e~~~g-~l~~~~~~~-   77 (282)
                      ||+|.++.+++.||+|.+.. .......+.+.+|++++++++|+|++++++.+.. +...++++||++| ++.+.+... 
T Consensus        16 v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~   95 (257)
T cd08223          16 VSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQK   95 (257)
T ss_pred             EEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhc
Confidence            79999999999999999876 2333445678899999999999999999998764 4578999999986 555555443 


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      ...+++.+++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............+++.|+|||...
T Consensus        96 ~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  175 (257)
T cd08223          96 GKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFS  175 (257)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhc
Confidence            34589999999999999999999999999999999999999999999999999876644333333445678899999987


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|+||+|++++++++|..| |...+.......+....                            ....+..
T Consensus       176 ~~~-~~~~~Dv~slG~il~~l~~g~~~-~~~~~~~~~~~~~~~~~----------------------------~~~~~~~  225 (257)
T cd08223         176 NKP-YNYKSDVWALGCCVYEMATLKHA-FNAKDMNSLVYRIIEGK----------------------------LPPMPKD  225 (257)
T ss_pred             CCC-CCchhhhHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHHhcC----------------------------CCCCccc
Confidence            766 68999999999999999988877 55555444444333311                            1112345


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      +++.+.+++.+||+.||.+|||+.++++||||
T Consensus       226 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         226 YSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             cCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            78999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.6e-42  Score=281.34  Aligned_cols=242  Identities=24%  Similarity=0.333  Sum_probs=192.6

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++.+...+..++++||++++.+..+....+.
T Consensus        24 ~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~  102 (267)
T cd06645          24 DVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP  102 (267)
T ss_pred             EEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCC
Confidence            389999999999999999876432 2234677899999999999999999999999999999999987555555555778


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc--C
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF--G  158 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~  158 (282)
                      +++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.  .
T Consensus       103 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  182 (267)
T cd06645         103 LSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER  182 (267)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhcccc
Confidence            99999999999999999999999999999999999999999999999999876654433334456788999999974  2


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      ...++.++|+||||+++|++++|..|++.......... ....  .....                     .. .....+
T Consensus       183 ~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~-~~~~--~~~~~---------------------~~-~~~~~~  237 (267)
T cd06645         183 KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-MTKS--NFQPP---------------------KL-KDKMKW  237 (267)
T ss_pred             CCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh-hhcc--CCCCC---------------------cc-cccCCC
Confidence            23368899999999999999998888655443322221 1111  00000                     00 011246


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIY  268 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~  268 (282)
                      +..+.++|++||..+|++|||++++++|||
T Consensus       238 ~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         238 SNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             CHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=8.1e-43  Score=295.12  Aligned_cols=246  Identities=21%  Similarity=0.299  Sum_probs=195.4

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|+++.+++.+|+|++..  .........+.+|+.+++.++||||+++++++.++...++||||++|+.+..+.. ..
T Consensus        59 Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~-~~  137 (371)
T cd05622          59 VQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS-NY  137 (371)
T ss_pred             EEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHH-hc
Confidence            89999999999999999875  2223334567789999999999999999999999999999999998755554444 35


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~  158 (282)
                      .+++..+..++.||+.||.+||++||+|+||||+||+++.++.++|+|||++........ ......|++.|+|||.+..
T Consensus       138 ~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~  217 (371)
T cd05622         138 DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS  217 (371)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhc
Confidence            689999999999999999999999999999999999999999999999999876643221 2234467899999999865


Q ss_pred             CC---CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         159 AK---LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       159 ~~---~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      ..   .++.++|+|||||++|+|++|..| |...+.......+.......                        .. ...
T Consensus       218 ~~~~~~~~~~~DiwSlGvilyell~G~~P-f~~~~~~~~~~~i~~~~~~~------------------------~~-~~~  271 (371)
T cd05622         218 QGGDGYYGRECDWWSVGVFLYEMLVGDTP-FYADSLVGTYSKIMNHKNSL------------------------TF-PDD  271 (371)
T ss_pred             cCCCccCCCccceeehhHHHHHHHhCCCC-CCCCCHHHHHHHHHcCCCcc------------------------cC-CCc
Confidence            42   268899999999999999998877 66666555555554321110                        00 012


Q ss_pred             ccCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCCcc
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQ--RMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~h~~~~~~~~  274 (282)
                      ..++..+.++|..||..++.+  |++++++++||||++..+
T Consensus       272 ~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~  312 (371)
T cd05622         272 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  312 (371)
T ss_pred             CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence            358999999999999844433  789999999999998643

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2e-42  Score=284.75  Aligned_cols=242  Identities=26%  Similarity=0.364  Sum_probs=197.5

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEI   81 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~   81 (282)
                      ||+|.+..+|+.|++|.+..... .....+.+|+.+++.++|||++++++++......++|+||++|+.+..+.. ...+
T Consensus        35 vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~l  112 (296)
T cd06655          35 VFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVT-ETCM  112 (296)
T ss_pred             EEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHH-hcCC
Confidence            79999999999999999876332 234678899999999999999999999999999999999998766666555 3568


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCCC
Q psy6044          82 DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKL  161 (282)
Q Consensus        82 ~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  161 (282)
                      ++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+.. 
T Consensus       113 ~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-  191 (296)
T cd06655         113 DEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-  191 (296)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCC-
Confidence            9999999999999999999999999999999999999999999999998876543333333345678899999987665 


Q ss_pred             CCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHH
Q psy6044         162 YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAK  241 (282)
Q Consensus       162 ~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (282)
                      ++.++|+||||+++|++++|..| |...+..+....+... ..                         .....+..+++.
T Consensus       192 ~~~~~Dv~slGvil~~lltg~~p-f~~~~~~~~~~~~~~~-~~-------------------------~~~~~~~~~~~~  244 (296)
T cd06655         192 YGPKVDIWSLGIMAIEMVEGEPP-YLNENPLRALYLIATN-GT-------------------------PELQNPEKLSPI  244 (296)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhc-CC-------------------------cccCCcccCCHH
Confidence            68999999999999999998877 4444443333332221 00                         001122457889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         242 GRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       242 l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      +.++|++||..||.+|||+.+++.||||+...
T Consensus       245 ~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         245 FRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             HHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence            99999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-43  Score=287.00  Aligned_cols=244  Identities=34%  Similarity=0.548  Sum_probs=194.2

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCC-CCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEG-VPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      ||+|++..+++.||+|++....... ......+|+.++++++||||+++++++.+....++++|++++ ++.+.+. ...
T Consensus        15 v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~-~~~   93 (260)
T PF00069_consen   15 VYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQ-KNK   93 (260)
T ss_dssp             EEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHH-HHS
T ss_pred             EEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccccccccccc-ccc
Confidence            8999999999999999998732222 222345599999999999999999999999999999999998 5655555 467


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............++..|.|||.....
T Consensus        94 ~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  173 (260)
T PF00069_consen   94 PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQG  173 (260)
T ss_dssp             SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            89999999999999999999999999999999999999999999999999997654344555566778899999999733


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      ...+.++|+||+|+++++|++|..| |......+....+............                      ......+
T Consensus       174 ~~~~~~~Di~slG~il~~l~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~  230 (260)
T PF00069_consen  174 KKYTRKSDIWSLGIILYELLTGKLP-FEESNSDDQLEIIEKILKRPLPSSS----------------------QQSREKS  230 (260)
T ss_dssp             SSBSTHHHHHHHHHHHHHHHHSSSS-STTSSHHHHHHHHHHHHHTHHHHHT----------------------TSHTTSH
T ss_pred             ccccccccccccccccccccccccc-cccccchhhhhhhhhcccccccccc----------------------cccchhH
Confidence            4479999999999999999998888 4554333333333322211100000                      0001123


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      +.+.++|+.||+.||++|||+.++++||||
T Consensus       231 ~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  231 EELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            899999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.2e-42  Score=284.61  Aligned_cols=246  Identities=23%  Similarity=0.359  Sum_probs=195.0

Q ss_pred             eeeeeeCCCCceEEEeeeecCC--CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCccc-HHHHHHhc-
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG--NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSL-   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~-l~~~~~~~-   77 (282)
                      ||+|.+..+++.||+|.+....  .......+..|+.++++++|++++++++.+.+++..++|+||++|+ +.+.+... 
T Consensus        16 v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~   95 (285)
T cd05630          16 VCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG   95 (285)
T ss_pred             EEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhc
Confidence            8999999999999999987622  2222345778999999999999999999999999999999999865 44444332 


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.
T Consensus        96 ~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~g~~~y~aPE~~~  174 (285)
T cd05630          96 EAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTVGYMAPEVVK  174 (285)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-cccCCCCCccccChHHHc
Confidence            2358999999999999999999999999999999999999999999999999987654222 223346788999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCh--HHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDV--DDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      +.. ++.++|+||+|+++|++++|..|+......  .+.........                            ....+
T Consensus       175 ~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~----------------------------~~~~~  225 (285)
T cd05630         175 NER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----------------------------QEEYS  225 (285)
T ss_pred             CCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh----------------------------hhhcC
Confidence            766 799999999999999999988885433221  11111111110                            01123


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCccchh
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMS-----AEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~h~~~~~~~~~~~  277 (282)
                      ..+++++.+|+++||+.||.+|||     ++++++||||+.++....
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~  272 (285)
T cd05630         226 EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRL  272 (285)
T ss_pred             ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHH
Confidence            457889999999999999999999     899999999998866543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.7e-42  Score=283.02  Aligned_cols=247  Identities=21%  Similarity=0.320  Sum_probs=195.2

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||+|.+..+++.||+|.+...........+.+|++++++++||||+++++.+..++..++++||++|+.++..    ..
T Consensus        16 ~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~----~~   91 (279)
T cd06619          16 TVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RK   91 (279)
T ss_pred             EEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh----hc
Confidence            38999999999999999987643333345688999999999999999999999999999999999998766543    35


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......  .....++..|+|||.+.+..
T Consensus        92 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~  169 (279)
T cd06619          92 IPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTYVGTNAYMAPERISGEQ  169 (279)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--ccCCCCChhhcCceeecCCC
Confidence            7889999999999999999999999999999999999999999999999987654322  23346688999999997766


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHH--HHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQ--LKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                       ++.++|+||||+++|++++|..|+.........  ..............                       ......+
T Consensus       170 -~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~  225 (279)
T cd06619         170 -YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP-----------------------VLPVGQF  225 (279)
T ss_pred             -CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCC-----------------------CCCCCcC
Confidence             699999999999999999988885432211110  11111111110000                       0011347


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccchh
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  277 (282)
                      ++++.++|.+||+.||.+||+++++++||||+..+..-.
T Consensus       226 ~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~~  264 (279)
T cd06619         226 SEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA  264 (279)
T ss_pred             CHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCccH
Confidence            889999999999999999999999999999997754433

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-42  Score=303.04  Aligned_cols=240  Identities=26%  Similarity=0.374  Sum_probs=195.2

Q ss_pred             eeeeeeCCC-CceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHh---
Q psy6044           2 FTSGVDRTP-NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDS---   76 (282)
Q Consensus         2 vy~a~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~---   76 (282)
                      ||+|.+..+ ++.||+|.+.... ......+..|+.+++.++||||+++++++..++..|+||||++| +|.+.+..   
T Consensus        83 vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~  161 (478)
T PTZ00267         83 AFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLK  161 (478)
T ss_pred             EEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHh
Confidence            799998888 7889998765422 22335677899999999999999999999999999999999976 55444432   


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--ccccccccccccChh
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--CYSAEVVTLWYRPPD  154 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE  154 (282)
                      ....+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........  ......|++.|+|||
T Consensus       162 ~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE  241 (478)
T PTZ00267        162 EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE  241 (478)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHh
Confidence            245689999999999999999999999999999999999999999999999999976643221  123345789999999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      .+.+.. ++.++|||||||++|+|++|..| |...+..+....+.....                            ...
T Consensus       242 ~~~~~~-~~~~~Dv~slG~~l~el~tg~~P-f~~~~~~~~~~~~~~~~~----------------------------~~~  291 (478)
T PTZ00267        242 LWERKR-YSKKADMWSLGVILYELLTLHRP-FKGPSQREIMQQVLYGKY----------------------------DPF  291 (478)
T ss_pred             HhCCCC-CCcHHhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhCCC----------------------------CCC
Confidence            997765 79999999999999999998887 566665555555443211                            112


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      +..++..+.++|.+||+.||++|||+++++.|+|++.+
T Consensus       292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             CccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            34578899999999999999999999999999999765

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-42  Score=282.41  Aligned_cols=247  Identities=28%  Similarity=0.372  Sum_probs=197.8

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHH-HhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYF-DSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~-~~~~~   79 (282)
                      .||+|.+..+++.+|+|.+.... ......+..|++++++++|||++++++.+..+...++||||++|+.+..+ .....
T Consensus        20 ~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~   98 (280)
T cd06611          20 KVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELER   98 (280)
T ss_pred             eEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcC
Confidence            38999999999999999987532 22345688899999999999999999999999999999999987555544 44456


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC-
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG-  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-  158 (282)
                      .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.. 
T Consensus        99 ~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~  178 (280)
T cd06611          99 GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE  178 (280)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhc
Confidence            7999999999999999999999999999999999999999999999999988665443333334456888999999742 


Q ss_pred             ---CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         159 ---AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       159 ---~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                         ...++.++|+||||+++|++++|..| |...+.......+.....                          .....+
T Consensus       179 ~~~~~~~~~~sDi~slG~il~~l~~g~~p-~~~~~~~~~~~~~~~~~~--------------------------~~~~~~  231 (280)
T cd06611         179 TFKDNPYDYKADIWSLGITLIELAQMEPP-HHELNPMRVLLKILKSEP--------------------------PTLDQP  231 (280)
T ss_pred             ccCCCCCCccccHHHHHHHHHHHHhCCCC-cccCCHHHHHHHHhcCCC--------------------------CCcCCc
Confidence               23367899999999999999988777 555554444333322100                          001122


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ..++..+.++|..||+.+|.+|||++++++||||++....
T Consensus       232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  271 (280)
T cd06611         232 SKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDN  271 (280)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccchh
Confidence            4578899999999999999999999999999999987443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.3e-42  Score=293.01  Aligned_cols=267  Identities=22%  Similarity=0.329  Sum_probs=201.2

Q ss_pred             eeeeeeC--CCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDR--TPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|...  .++..||+|.+...      ....+|+.++++++||||+++++++......+++||++.+++...+. ..+
T Consensus       108 Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~-~~~  180 (392)
T PHA03207        108 VFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVD-RSG  180 (392)
T ss_pred             EEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcCCCHHHHHH-hcC
Confidence            7888754  46788999987532      34568999999999999999999999999999999999999888873 367


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc--cccccccccccccChhhhc
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--KCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~  157 (282)
                      .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......  .......++..|+|||.+.
T Consensus       181 ~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~  260 (392)
T PHA03207        181 PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLA  260 (392)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhc
Confidence            89999999999999999999999999999999999999999999999999987654322  1222346789999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC--hHHHHHHHHHHhCCCCCCCCCCCCC--CCCCCCCCCC-CCCCCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSD--VDDQLKRIFKLLGTPTEDTWPGMNL--LPDFKPFPMY-HPSMSFS  232 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~  232 (282)
                      ... ++.++|+|||||++|+|++|+.|++....  ....+..+.+..+..+.+.......  ...+..+... .......
T Consensus       261 ~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (392)
T PHA03207        261 LDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIP  339 (392)
T ss_pred             CCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCcccc
Confidence            766 78999999999999999999999765432  3445555555554433222111000  0000000000 0000011


Q ss_pred             c--cCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         233 Q--VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       233 ~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      .  ....++.++.++|++||..||++|||+.++|.||||+..+...
T Consensus       340 ~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~  385 (392)
T PHA03207        340 PVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINL  385 (392)
T ss_pred             chhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhh
Confidence            1  1124678899999999999999999999999999999865543

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.6e-42  Score=280.84  Aligned_cols=244  Identities=27%  Similarity=0.433  Sum_probs=198.0

Q ss_pred             eeeeeeCCCCceEEEeeeecCC--CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG--NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|.+..+|+.+++|++....  .......+.+|++++++++||||+++++.+......++++||++|+.+..+....+
T Consensus         9 vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   88 (265)
T cd05579           9 VFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG   88 (265)
T ss_pred             EEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC
Confidence            8999999999999999987632  22345678889999999999999999999999999999999998755554444456


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--------cccccccccccc
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--------CYSAEVVTLWYR  151 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~~  151 (282)
                      .+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++........        ......++..|+
T Consensus        89 ~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (265)
T cd05579          89 SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI  168 (265)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCcccc
Confidence            899999999999999999999999999999999999999999999999998865432211        223345577899


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSF  231 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
                      +||...... .+.++|+||||++++++++|..| |......+....+.......                          
T Consensus       169 ~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p-~~~~~~~~~~~~~~~~~~~~--------------------------  220 (265)
T cd05579         169 APEVILGQG-HSKTVDWWSLGCILYEFLVGIPP-FHGETPEEIFQNILNGKIEW--------------------------  220 (265)
T ss_pred             CHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHhcCCcCC--------------------------
Confidence            999987766 68999999999999999988777 56555555554443311000                          


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCCCCH---HHHhcCCCccCCcc
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSA---EDAMSHIYFSDLNV  274 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~---~~ll~h~~~~~~~~  274 (282)
                      .. ...++..+.+++++||+.+|.+|||+   .++++||||+++++
T Consensus       221 ~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         221 PE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             Cc-cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence            00 01258999999999999999999999   99999999998864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.1e-42  Score=281.88  Aligned_cols=244  Identities=25%  Similarity=0.451  Sum_probs=195.3

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~   80 (282)
                      ||+|.++.+++.+|+|.+...........+.+|++++++++||||+++++.+..++..++++|+++| ++.+.+......
T Consensus        17 v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~   96 (265)
T cd06605          17 VSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGR   96 (265)
T ss_pred             EEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCC
Confidence            7999999999999999988754444556788999999999999999999999999999999999995 555555443478


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      +++..+..++.|++.||.+||+ .|++|+||+|+||+++.++.++|+|||.+.........  ...++..|+|||.+.+.
T Consensus        97 ~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~y~~PE~~~~~  174 (265)
T cd06605          97 IPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQGN  174 (265)
T ss_pred             CCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh--cccCChhccCHHHHcCC
Confidence            9999999999999999999999 99999999999999999999999999988665422221  14567889999999776


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc-C
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK-L  238 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  238 (282)
                      . ++.++|+||||++++++++|..|+.......+.............                        ....+.. +
T Consensus       175 ~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~  229 (265)
T cd06605         175 D-YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP------------------------PPRLPSGKF  229 (265)
T ss_pred             C-CCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC------------------------CCCCChhhc
Confidence            5 799999999999999999988886544221121111111111100                        0111122 7


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      ++.+.++|..||..||.+|||+.+++.||||+..
T Consensus       230 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         230 SPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             CHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            8899999999999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.6e-42  Score=284.10  Aligned_cols=243  Identities=26%  Similarity=0.342  Sum_probs=194.9

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||+|.+..+++.|++|.+...... ....+.+|+.+++.++|||++++++.+..+...++|+||++|+.+..+.. ...
T Consensus        35 ~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~  112 (296)
T cd06654          35 TVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETC  112 (296)
T ss_pred             EEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHH-hcC
Confidence            3899999999999999998763332 24678899999999999999999999999999999999998654444444 356


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++.++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+..
T Consensus       113 ~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  192 (296)
T cd06654         113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA  192 (296)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCC
Confidence            89999999999999999999999999999999999999999999999998876543333333446678899999987765


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                       ++.++|+||||+++|++++|..|+ .............. ...                         .....+..++.
T Consensus       193 -~~~~~Dv~s~Gvil~~l~~g~~pf-~~~~~~~~~~~~~~-~~~-------------------------~~~~~~~~~~~  244 (296)
T cd06654         193 -YGPKVDIWSLGIMAIEMIEGEPPY-LNENPLRALYLIAT-NGT-------------------------PELQNPEKLSA  244 (296)
T ss_pred             -CCccchHHHHHHHHHHHHhCCCCC-CCCCHHHhHHHHhc-CCC-------------------------CCCCCccccCH
Confidence             689999999999999999988885 44333322221111 000                         00011245788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      .+.++|.+||..||.+|||++++++||||+..+
T Consensus       245 ~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  277 (296)
T cd06654         245 IFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (296)
T ss_pred             HHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence            999999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.9e-42  Score=282.04  Aligned_cols=248  Identities=24%  Similarity=0.324  Sum_probs=197.2

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHH-HHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKY-FDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~-~~~~~~~   80 (282)
                      ||+|.+..+++.+++|.+.... ......+.+|+.+++.++|||++++++.+..++..++||||++|+.+.. +.+....
T Consensus        28 vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~  106 (292)
T cd06644          28 VYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG  106 (292)
T ss_pred             EEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCC
Confidence            8999999999999999987532 2234668889999999999999999999999999999999998765554 4444567


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC--
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG--  158 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--  158 (282)
                      +++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+  
T Consensus       107 l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  186 (292)
T cd06644         107 LTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET  186 (292)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccceecCCccccCceeecccc
Confidence            999999999999999999999999999999999999999999999999988665433333334456788999998842  


Q ss_pred             --CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         159 --AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       159 --~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                        ...++.++|+||||+++|+|++|..| |...+.......+...   ..                       .....+.
T Consensus       187 ~~~~~~~~~~Dv~slG~il~el~~g~~p-~~~~~~~~~~~~~~~~---~~-----------------------~~~~~~~  239 (292)
T cd06644         187 MKDTPYDYKADIWSLGITLIEMAQIEPP-HHELNPMRVLLKIAKS---EP-----------------------PTLSQPS  239 (292)
T ss_pred             ccCCCCCchhhhHhHHHHHHHHhcCCCC-CccccHHHHHHHHhcC---CC-----------------------ccCCCCc
Confidence              23367899999999999999988777 5444433333222211   00                       0001124


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccchh
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  277 (282)
                      .++.++.++|++||+.||.+||+++++++||||+.+++.-.
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~  280 (292)
T cd06644         240 KWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRP  280 (292)
T ss_pred             ccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccchh
Confidence            57889999999999999999999999999999998876543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.7e-42  Score=281.53  Aligned_cols=243  Identities=23%  Similarity=0.328  Sum_probs=197.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEI   81 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~   81 (282)
                      ||+|.+..+++.||+|++...........+.+|+.+++.++||||+++++++.++...++|+||++|+.+..+.. ...+
T Consensus        20 vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~-~~~l   98 (277)
T cd06640          20 VFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR-AGPF   98 (277)
T ss_pred             EEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHh-cCCC
Confidence            799999999999999998764433445678899999999999999999999999999999999998754444444 4578


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCCC
Q psy6044          82 DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKL  161 (282)
Q Consensus        82 ~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  161 (282)
                      ++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+.. 
T Consensus        99 ~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-  177 (277)
T cd06640          99 DEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA-  177 (277)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCC-
Confidence            9999999999999999999999999999999999999999999999999876654333333345677899999987665 


Q ss_pred             CCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHH
Q psy6044         162 YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAK  241 (282)
Q Consensus       162 ~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (282)
                      .+.++|+||||+++|++++|..| |...........+...                            ........++..
T Consensus       178 ~~~~~Dv~slG~il~el~tg~~p-~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~  228 (277)
T cd06640         178 YDSKADIWSLGITAIELAKGEPP-NSDMHPMRVLFLIPKN----------------------------NPPTLTGEFSKP  228 (277)
T ss_pred             CccHHHHHHHHHHHHHHHHCCCC-CCCcChHhHhhhhhcC----------------------------CCCCCchhhhHH
Confidence            68999999999999999988877 5444433322221110                            111223457888


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         242 GRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       242 l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      +.+++.+||+.+|.+||++++++.|+||...+..
T Consensus       229 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  262 (277)
T cd06640         229 FKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK  262 (277)
T ss_pred             HHHHHHHHcccCcccCcCHHHHHhChHhhhcchh
Confidence            9999999999999999999999999999887653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.2e-42  Score=281.08  Aligned_cols=243  Identities=23%  Similarity=0.322  Sum_probs=195.5

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHH-HhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYF-DSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~-~~~~~~   80 (282)
                      ||+|.+..++..+++|.+.... ......+.+|+++++.++|||++++++++...+..++|+||++|+.+..+ ......
T Consensus        21 v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~   99 (282)
T cd06643          21 VYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP   99 (282)
T ss_pred             EEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCC
Confidence            7999999999999999986532 22345678899999999999999999999999999999999987666554 444567


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc---
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF---  157 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---  157 (282)
                      +++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.   
T Consensus       100 l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  179 (282)
T cd06643         100 LTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET  179 (282)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccccccccccCHhhccccC
Confidence            99999999999999999999999999999999999999999999999999876543333333445688899999984   


Q ss_pred             -CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         158 -GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       158 -~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                       ....++.++|+||+|+++|++++|+.| |...+..+....+......                          ....+.
T Consensus       180 ~~~~~~~~~~Dv~slGvil~el~~g~~p-~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~  232 (282)
T cd06643         180 SKDRPYDYKADVWSLGITLIEMAQIEPP-HHELNPMRVLLKIAKSEPP--------------------------TLAQPS  232 (282)
T ss_pred             CCCCCCCccchhhhHHHHHHHHccCCCC-ccccCHHHHHHHHhhcCCC--------------------------CCCCcc
Confidence             223367899999999999999987766 6555544444443321110                          001223


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      .++..+.++|++||+.||.+|||+.++++||||+..
T Consensus       233 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         233 RWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            478899999999999999999999999999999854

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.7e-42  Score=278.58  Aligned_cols=238  Identities=24%  Similarity=0.477  Sum_probs=192.3

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCC--------CCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEG--------VPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKY   73 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~   73 (282)
                      ||+|.+..+++.+|+|.+.......        ....+.+|+.++++++||||+++++++..+...++++||++|..+..
T Consensus        16 v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   95 (267)
T cd06628          16 VYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAA   95 (267)
T ss_pred             EEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHH
Confidence            7999999999999999887632211        12457789999999999999999999999999999999998755555


Q ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc------cccccccc
Q psy6044          74 FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK------CYSAEVVT  147 (282)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~------~~~~~~~~  147 (282)
                      +....+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........      ......++
T Consensus        96 ~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~  175 (267)
T cd06628          96 LLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS  175 (267)
T ss_pred             HHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCC
Confidence            555567899999999999999999999999999999999999999999999999999876642211      11122457


Q ss_pred             ccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHP  227 (282)
Q Consensus       148 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (282)
                      ..|+|||.+.+.. ++.++|+||+|+++|++++|..| |...+.......+...                          
T Consensus       176 ~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p-~~~~~~~~~~~~~~~~--------------------------  227 (267)
T cd06628         176 VFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHP-FPDCTQLQAIFKIGEN--------------------------  227 (267)
T ss_pred             cCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCC-CCCccHHHHHHHHhcc--------------------------
Confidence            7899999987765 68999999999999999998888 5544433333322221                          


Q ss_pred             CCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         228 SMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       228 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                        .....+..++..+.++|++||+.||.+||++.++++||||
T Consensus       228 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         228 --ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             --CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence              1112334578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.2e-42  Score=286.01  Aligned_cols=274  Identities=18%  Similarity=0.202  Sum_probs=196.5

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhc--
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL--   77 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~--   77 (282)
                      +||+++++.+|+.||+|++... ........+.+|+.+++.++||||+++++++.+++..++++||++++.+..+...  
T Consensus        15 ~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~   94 (314)
T cd08216          15 IVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHF   94 (314)
T ss_pred             eEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhc
Confidence            4788899899999999999873 3444567899999999999999999999999999999999999986544444432  


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-------ccccccccccc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-------CYSAEVVTLWY  150 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~~  150 (282)
                      ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+||+.+........       ......++..|
T Consensus        95 ~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  174 (314)
T cd08216          95 PEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW  174 (314)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccc
Confidence            34689999999999999999999999999999999999999999999999998765432111       11223346679


Q ss_pred             cChhhhcCC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCC-CCCCCC--CCCCCCCC-CCCC
Q psy6044         151 RPPDVLFGA-KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTE-DTWPGM--NLLPDFKP-FPMY  225 (282)
Q Consensus       151 ~aPE~~~~~-~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~-~~~~  225 (282)
                      +|||.+... ..++.++|+||+|++++++++|..|+...................... ...+..  ........ ....
T Consensus       175 ~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (314)
T cd08216         175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPN  254 (314)
T ss_pred             cCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccc
Confidence            999998653 336889999999999999999888854433333332222111100000 000000  00000000 0000


Q ss_pred             CCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         226 HPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       226 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      ............++.++.+|+.+||..||.+|||++++++||||+.+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~  303 (314)
T cd08216         255 NRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKR  303 (314)
T ss_pred             hhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcc
Confidence            0000111223346788999999999999999999999999999998863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-42  Score=277.86  Aligned_cols=241  Identities=25%  Similarity=0.349  Sum_probs=193.5

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC-CC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN-GE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~-~~   80 (282)
                      ||+|.+..+++.+++|++...... ....+.+|+.++++++||||+++++++.+...++++|||++|+.+..+.... ..
T Consensus        19 v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~   97 (262)
T cd06613          19 VYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP   97 (262)
T ss_pred             EEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccC
Confidence            799999999999999999864333 4578899999999999999999999999999999999999876555554434 78


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC-
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA-  159 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-  159 (282)
                      +++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+... 
T Consensus        98 l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~  177 (262)
T cd06613          98 LSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVER  177 (262)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccc
Confidence            9999999999999999999999999999999999999999999999999987665433233344567789999998655 


Q ss_pred             -CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         160 -KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       160 -~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                       ..++.++|+||+|+++|+|++|..|+. ..+..............+                        ........+
T Consensus       178 ~~~~~~~~Di~slG~~l~~~~tg~~p~~-~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~  232 (262)
T cd06613         178 KGGYDGKCDIWALGITAIELAELQPPMF-DLHPMRALFLISKSNFPP------------------------PKLKDKEKW  232 (262)
T ss_pred             cCCcCchhhhHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhccCCC------------------------ccccchhhh
Confidence             136889999999999999999888754 443333332222210000                        000112346


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIY  268 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~  268 (282)
                      +.++.+++++||..+|.+|||+.+++.|+|
T Consensus       233 ~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         233 SPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             hHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.8e-42  Score=284.38  Aligned_cols=246  Identities=22%  Similarity=0.397  Sum_probs=199.3

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||+|.+..++..||||.+.... ......+.+|+.+++.++|||++++++.+...+..++|+||++|+.+..+.. .+.
T Consensus        37 ~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~  114 (292)
T cd06658          37 IVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT-HTR  114 (292)
T ss_pred             EEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHh-cCC
Confidence            38999999999999999886532 2234568899999999999999999999999999999999998876666554 457


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+..
T Consensus       115 l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  194 (292)
T cd06658         115 MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP  194 (292)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCC
Confidence            89999999999999999999999999999999999999999999999999876543333333445688899999987665


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                       ++.++|+||+|+++|++++|..|+ ...+.......+.......                          ......++.
T Consensus       195 -~~~~~Dv~slGvil~el~~g~~p~-~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~  246 (292)
T cd06658         195 -YGTEVDIWSLGIMVIEMIDGEPPY-FNEPPLQAMRRIRDNLPPR--------------------------VKDSHKVSS  246 (292)
T ss_pred             -CCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhcCCCc--------------------------cccccccCH
Confidence             689999999999999999988884 4444444433333221110                          001124788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      .+.+++.+||..||.+|||++++++||||+....+.
T Consensus       247 ~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         247 VLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence            899999999999999999999999999999775543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=8.9e-43  Score=284.34  Aligned_cols=243  Identities=24%  Similarity=0.334  Sum_probs=196.4

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||+|.+..+|+.||+|.+...........+.+|+.+++.++||||+++++++..++..++|+||++|+.+..+.. ...
T Consensus        19 ~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~   97 (277)
T cd06642          19 EVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGP   97 (277)
T ss_pred             eEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhh-cCC
Confidence            4899999999999999998764433445678899999999999999999999999999999999998755554444 467


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+..
T Consensus        98 ~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  177 (277)
T cd06642          98 LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA  177 (277)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCC
Confidence            89999999999999999999999999999999999999999999999999876653332222335677899999997766


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                       ++.++|+||||+++|++++|..| +...........+...                            .........+.
T Consensus       178 -~~~~~Dv~slG~il~el~tg~~p-~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~  227 (277)
T cd06642         178 -YDFKADIWSLGITAIELAKGEPP-NSDLHPMRVLFLIPKN----------------------------SPPTLEGQYSK  227 (277)
T ss_pred             -CchhhhHHHHHHHHHHHHhCCCC-CcccchhhHHhhhhcC----------------------------CCCCCCcccCH
Confidence             68999999999999999988777 4443333222211110                            01112334788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      .+.++|.+||+.+|.+|||+.++++||||+....
T Consensus       228 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06642         228 PFKEFVEACLNKDPRFRPTAKELLKHKFITRYTK  261 (277)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhh
Confidence            8999999999999999999999999999986543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=5.6e-42  Score=279.79  Aligned_cols=247  Identities=23%  Similarity=0.336  Sum_probs=191.9

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCC--CCCCccHHHHHHHHhh---CCCCCccceeeeeeeCCeEEEEEecCcccHHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGN--EGVPSSALREICLLKE---LKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~---l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~   75 (282)
                      .||+|.+..+|+.+|+|.+.....  ........+|..+++.   .+||+++.+++.+..++..++||||++|+.+..+.
T Consensus         9 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i   88 (279)
T cd05633           9 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   88 (279)
T ss_pred             EEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHH
Confidence            389999999999999999876321  2222334455544444   47999999999999999999999999876565555


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhh
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDV  155 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~  155 (282)
                      ...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........  ....++..|+|||.
T Consensus        89 ~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~y~aPE~  166 (279)
T cd05633          89 SQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPEV  166 (279)
T ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--cCcCCCcCccCHHH
Confidence            5567899999999999999999999999999999999999999999999999999865543222  23457889999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC-hHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSD-VDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      ......++.++|+||+|+++|++++|..|+..... ..........   .                         .....
T Consensus       167 ~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---~-------------------------~~~~~  218 (279)
T cd05633         167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---T-------------------------VNVEL  218 (279)
T ss_pred             hcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh---c-------------------------CCcCC
Confidence            86544478999999999999999998888543222 1111111110   0                         01123


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCccchh
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~  277 (282)
                      +..++..+.++|++||+.||.+||     |++++++||||++++....
T Consensus       219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~  266 (279)
T cd05633         219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQV  266 (279)
T ss_pred             ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHH
Confidence            345889999999999999999999     6999999999999875443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-42  Score=284.76  Aligned_cols=267  Identities=40%  Similarity=0.727  Sum_probs=200.7

Q ss_pred             eeeeeeCC--CCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC--CeEEEEEecCcccHHHHHH
Q psy6044           2 FTSGVDRT--PNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSE--KKLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~--~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~--~~~~iv~e~~~g~l~~~~~   75 (282)
                      ||+|.++.  +++.||+|.+...  ........+.+|+.+++.++||||+++++++.+.  ..+++|+||+++++.+.+.
T Consensus        16 v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~   95 (316)
T cd07842          16 VYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIK   95 (316)
T ss_pred             EEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCcCHHHHHH
Confidence            89999988  8999999998872  2334456788999999999999999999999988  8899999999988877664


Q ss_pred             hc----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC----CCcEEEEecCCccccCCCcc---ccccc
Q psy6044          76 SL----NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK----NGELKLADFGLARAFGIPVK---CYSAE  144 (282)
Q Consensus        76 ~~----~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~----~~~~~l~df~~~~~~~~~~~---~~~~~  144 (282)
                      ..    ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.    ++.++|+|||.+........   .....
T Consensus        96 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  175 (316)
T cd07842          96 FHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV  175 (316)
T ss_pred             hhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCc
Confidence            32    236899999999999999999999999999999999999999    89999999999876543322   12233


Q ss_pred             cccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCh---------HHHHHHHHHHhCCCCCCCCCCCCC
Q psy6044         145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDV---------DDQLKRIFKLLGTPTEDTWPGMNL  215 (282)
Q Consensus       145 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~  215 (282)
                      .++..|+|||.+.+...++.++|+||||++++++++|..| |.....         .+.+..+...+..+....+.....
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  254 (316)
T cd07842         176 VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI-FKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKK  254 (316)
T ss_pred             cccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCC-CcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhh
Confidence            5577899999987765578999999999999999988766 443322         234445555555444333322111


Q ss_pred             CCCCCCC------CCCCCCC--CccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         216 LPDFKPF------PMYHPSM--SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       216 ~~~~~~~------~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      ..++...      .......  .........+..+.+++.+||+.||++|||+.++++||||
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         255 MPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             cccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            1111110      0000000  0001112678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.4e-42  Score=278.80  Aligned_cols=243  Identities=26%  Similarity=0.438  Sum_probs=200.1

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEI   81 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~   81 (282)
                      ||+|.+..+|+.|++|++...........+.+|+..+..++|+|++++++++..++..++++||++|+.+..+......+
T Consensus        17 v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l   96 (264)
T cd06623          17 VYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKI   96 (264)
T ss_pred             EEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCCC
Confidence            79999999999999999887433345678999999999999999999999999999999999999965555555445789


Q ss_pred             CHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          82 DLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        82 ~~~~~~~~~~qi~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      ++..++.++.|++.|+.+||+ .|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+....
T Consensus        97 ~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~  176 (264)
T cd06623          97 PEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGES  176 (264)
T ss_pred             CHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCC
Confidence            999999999999999999999 9999999999999999999999999999887654443333445678899999987765


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCC--ChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc-
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGS--DVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK-  237 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  237 (282)
                       ++.++|+||||+++|++++|..|+....  ...+....+...                            ........ 
T Consensus       177 -~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~  227 (264)
T cd06623         177 -YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG----------------------------PPPSLPAEE  227 (264)
T ss_pred             -CCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC----------------------------CCCCCCccc
Confidence             6899999999999999999888843332  333333333211                            11112233 


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      ++..+.++|..||+.+|++|||+.++++||||+..+
T Consensus       228 ~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         228 FSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence            789999999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.6e-42  Score=284.82  Aligned_cols=271  Identities=24%  Similarity=0.374  Sum_probs=197.3

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||+|.+..+|..+|+|.+...........+.+|++++++++||||+++++++.+++.+++++||++|+.+..+....+.
T Consensus        16 ~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~   95 (308)
T cd06615          16 VVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR   95 (308)
T ss_pred             EEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCC
Confidence            38999999999999999987643333445688999999999999999999999999999999999987555555555678


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      +++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.+.+.
T Consensus        96 ~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~  173 (308)
T cd06615          96 IPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGT  173 (308)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc--cccCCCCcCccChhHhcCC
Confidence            9999999999999999999997 599999999999999999999999999886553221  2234567889999998766


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCC-C--CCCCCCCCCC-----CCCCCCCc
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPG-M--NLLPDFKPFP-----MYHPSMSF  231 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~-----~~~~~~~~  231 (282)
                      . ++.++|+||||+++|++++|..|+ ...+.......+.............. .  ..........     ........
T Consensus       174 ~-~~~~~DiwslG~~l~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (308)
T cd06615         174 H-YTVQSDIWSLGLSLVEMAIGRYPI-PPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPP  251 (308)
T ss_pred             C-CCccchHHHHHHHHHHHHhCCCCC-CCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCC
Confidence            5 689999999999999999998884 44333332222211100000000000 0  0000000000     00000000


Q ss_pred             cccC-ccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         232 SQVA-PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       232 ~~~~-~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ...+ ..++.++.+|+.+||..||.+|||++++++||||.+...+
T Consensus       252 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  296 (308)
T cd06615         252 PKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE  296 (308)
T ss_pred             ccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence            0111 2378899999999999999999999999999999987555

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=6.6e-42  Score=275.95  Aligned_cols=237  Identities=24%  Similarity=0.415  Sum_probs=192.5

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHH-HHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKK-YFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~-~~~~~~~~   80 (282)
                      ||+|+++.+++.+++|.+.....   ...+.+|+.+++.++||||+++++.+.++...++++|+++|+.+. .+......
T Consensus        19 v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~   95 (256)
T cd06612          19 VYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT   95 (256)
T ss_pred             EEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccC
Confidence            79999999999999999875322   578999999999999999999999999999999999999875444 44444567


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+..
T Consensus        96 l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~  175 (256)
T cd06612          96 LTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIG  175 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCC
Confidence            89999999999999999999999999999999999999999999999999887654433333345678899999987765


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                       ++.++|+||+|+++|++++|..| +...........+..   .. .                      .....+..++.
T Consensus       176 -~~~~~Di~s~G~il~~l~~g~~p-~~~~~~~~~~~~~~~---~~-~----------------------~~~~~~~~~~~  227 (256)
T cd06612         176 -YNNKADIWSLGITAIEMAEGKPP-YSDIHPMRAIFMIPN---KP-P----------------------PTLSDPEKWSP  227 (256)
T ss_pred             -CCchhhHHHHHHHHHHHHhCCCC-CCCcchhhhhhhhcc---CC-C----------------------CCCCchhhcCH
Confidence             68999999999999999988777 444333222211111   00 0                      01112245788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      .+.++|.+||+.||.+|||+++++.||||
T Consensus       228 ~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         228 EFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0604|consensus

Probab=100.00  E-value=1.3e-43  Score=273.33  Aligned_cols=238  Identities=29%  Similarity=0.414  Sum_probs=197.4

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeC----CeEEEEEecCccc-HHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSE----KKLTLVFEHCDQD-LKKYFD   75 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~----~~~~iv~e~~~g~-l~~~~~   75 (282)
                      |..+.++.||+.+|+|++..      ....++|+++.-.. .|||||.++++|++.    ..+.+|||.++|+ |++.+.
T Consensus        78 V~~C~~k~T~ekfALKvL~D------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq  151 (400)
T KOG0604|consen   78 VVQCVHKRTQEKFALKVLLD------SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQ  151 (400)
T ss_pred             eEEEEeccchhhhHHHHHhc------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHH
Confidence            56688999999999999863      45677899887776 699999999998864    4688999999864 555554


Q ss_pred             hc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC---CCcEEEEecCCccccCCCcccccccccccccc
Q psy6044          76 SL-NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK---NGELKLADFGLARAFGIPVKCYSAEVVTLWYR  151 (282)
Q Consensus        76 ~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  151 (282)
                      .. ...++|.++..|++||..|+.|||+.+|.||||||+|+++..   +..+||+|||+++....... ....+.|+.|.
T Consensus       152 ~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~-L~TPc~TPyYv  230 (400)
T KOG0604|consen  152 DRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGD-LMTPCFTPYYV  230 (400)
T ss_pred             HcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCcc-ccCCccccccc
Confidence            43 234999999999999999999999999999999999999964   55799999999987764433 33446699999


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC---hHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSD---VDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPS  228 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
                      |||++...+ |+...|+||+|+++|-|++|..||+....   ......+|..+.-.++.+.|                  
T Consensus       231 aPevlg~eK-ydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEW------------------  291 (400)
T KOG0604|consen  231 APEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEW------------------  291 (400)
T ss_pred             CHHHhCchh-cCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhH------------------
Confidence            999996666 79999999999999999988888777654   33456667666666665555                  


Q ss_pred             CCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         229 MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       229 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                             ..+|++.+++|+.+|..+|.+|.|++++++|||+.+.
T Consensus       292 -------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  292 -------SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             -------hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence                   4699999999999999999999999999999999865

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-42  Score=284.24  Aligned_cols=247  Identities=26%  Similarity=0.421  Sum_probs=197.3

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCC--CCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc-
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNE--GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL-   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~-   77 (282)
                      ||+|.+..+++.||+|.+......  .....+..|+++++.++||||+++++.+.+....++|+||+.| ++.+.+... 
T Consensus        17 vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   96 (316)
T cd05574          17 VFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQP   96 (316)
T ss_pred             EEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCC
Confidence            899999999999999999863222  2456788999999999999999999999999999999999976 555544432 


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc------------------
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK------------------  139 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~------------------  139 (282)
                      ...+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+........                  
T Consensus        97 ~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (316)
T cd05574          97 GKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI  176 (316)
T ss_pred             CCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccccccccccccccccccc
Confidence            25689999999999999999999999999999999999999999999999998765432111                  


Q ss_pred             -----------ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy6044         140 -----------CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTED  208 (282)
Q Consensus       140 -----------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  208 (282)
                                 ......++..|+|||.+.+.. ++.++|+||||+++|++++|..| |...+.......+......    
T Consensus       177 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~p-f~~~~~~~~~~~~~~~~~~----  250 (316)
T cd05574         177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTP-FKGSNRDETFSNILKKEVT----  250 (316)
T ss_pred             chhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCCC-CCCCchHHHHHHHhcCCcc----
Confidence                       011234577899999997766 68999999999999999998888 5555554444333221000    


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCC----HHHHhcCCCccCCccchh
Q psy6044         209 TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS----AEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~~~  277 (282)
                                            .. ....++..+.++|.+||..||++|||    ++++++||||++.++...
T Consensus       251 ----------------------~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~  300 (316)
T cd05574         251 ----------------------FP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALI  300 (316)
T ss_pred             ----------------------CC-CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhc
Confidence                                  00 01127899999999999999999999    999999999999876544

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.9e-42  Score=280.12  Aligned_cols=247  Identities=24%  Similarity=0.359  Sum_probs=197.7

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHH-HHHhc-
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKK-YFDSL-   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~-~~~~~-   77 (282)
                      ||+|.+..+|+.+|+|.+...  ........+.+|+++++.++|+|++++++.+..++..++++||++|..+. .+... 
T Consensus        16 vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   95 (285)
T cd05632          16 VCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMG   95 (285)
T ss_pred             EEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhc
Confidence            799999999999999998762  12223355788999999999999999999999999999999999875444 44332 


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.
T Consensus        96 ~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~g~~~~~aPE~~~  174 (285)
T cd05632          96 NPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SIRGRVGTVGYMAPEVLN  174 (285)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-cccCCCCCcCccChHHhc
Confidence            3469999999999999999999999999999999999999999999999999886654222 223346789999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|+||+|+++|++++|..| |...........+........                         ......
T Consensus       175 ~~~-~~~~~Di~slG~~l~~l~~g~~P-~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~  227 (285)
T cd05632         175 NQR-YTLSPDYWGLGCLIYEMIEGQSP-FRGRKEKVKREEVDRRVLETE-------------------------EVYSAK  227 (285)
T ss_pred             CCC-CCcccchHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHhhhccc-------------------------cccCcc
Confidence            665 78999999999999999998887 555444433333332211111                         112345


Q ss_pred             CCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCccch
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMS-----AEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps-----~~~ll~h~~~~~~~~~~  276 (282)
                      +++.+.+|+..||+.||++|||     +.++++|+||++.+..-
T Consensus       228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~  271 (285)
T cd05632         228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKR  271 (285)
T ss_pred             CCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHH
Confidence            7889999999999999999999     88999999999986553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=5e-42  Score=279.89  Aligned_cols=248  Identities=24%  Similarity=0.333  Sum_probs=195.7

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      ||+|.+..+|+.||+|.+...  ........+..|++++++++|||++++++++...+..++|+||++| ++.+.+....
T Consensus         9 vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   88 (277)
T cd05577           9 VCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVG   88 (277)
T ss_pred             EEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcC
Confidence            899999999999999998762  2233345677899999999999999999999999999999999986 4544544422


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          79 -GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 -~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                       ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.
T Consensus        89 ~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~~PE~~~  167 (277)
T cd05577          89 EPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTPGYMAPEVLQ  167 (277)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCCCCcCCHHHhc
Confidence             26999999999999999999999999999999999999999999999999988765432 2223345577899999987


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|+||+|+++|++++|..|+ ...........+......                         .....+..
T Consensus       168 ~~~-~~~~~Di~slG~il~~l~~g~~p~-~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~  220 (277)
T cd05577         168 GEV-YDFSVDWFALGCTLYEMIAGRSPF-RQRKEKVEKEELKRRTLE-------------------------MAVEYPDK  220 (277)
T ss_pred             CCC-CCchhhhHHHHHHHHHHhhCCCCC-CCCcccccHHHHHhcccc-------------------------ccccCCcc
Confidence            766 789999999999999999988884 433221111111111000                         11123345


Q ss_pred             CCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCccchh
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~  277 (282)
                      +++.+.++|++||+.||.+||     ++.++++||||+.+++...
T Consensus       221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~  265 (277)
T cd05577         221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRL  265 (277)
T ss_pred             CCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhh
Confidence            789999999999999999999     8889999999999887543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.4e-42  Score=283.52  Aligned_cols=244  Identities=26%  Similarity=0.346  Sum_probs=195.1

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||+|.+..+|+.||+|.+...... ....+.+|+.+++.++|||++++++++..+...++|+||++|..+..+.. ...
T Consensus        34 ~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~  111 (297)
T cd06656          34 TVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETC  111 (297)
T ss_pred             EEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHH-hCC
Confidence            3899999999999999998763322 34668889999999999999999999999999999999998755555444 356


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+..
T Consensus       112 ~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  191 (297)
T cd06656         112 MDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA  191 (297)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCC
Confidence            89999999999999999999999999999999999999999999999999876544333333445678899999997765


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                       ++.++|+||+|+++|++++|..|+. ..+........... ..                         .....+..++.
T Consensus       192 -~~~~~Di~slGvil~~l~tg~~pf~-~~~~~~~~~~~~~~-~~-------------------------~~~~~~~~~~~  243 (297)
T cd06656         192 -YGPKVDIWSLGIMAIEMVEGEPPYL-NENPLRALYLIATN-GT-------------------------PELQNPERLSA  243 (297)
T ss_pred             -CCcHHHHHHHHHHHHHHHhCCCCCC-CCCcchheeeeccC-CC-------------------------CCCCCccccCH
Confidence             6899999999999999999888853 33221111111000 00                         01112345788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      .+.+++.+||..||.+|||++++++||||+..+.
T Consensus       244 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (297)
T cd06656         244 VFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP  277 (297)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence            8999999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.8e-42  Score=278.55  Aligned_cols=242  Identities=26%  Similarity=0.338  Sum_probs=190.4

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||+|+++.+|+.||+|++..... .....+.+|+.++++++||||+++++++...+..++|+||++++.+..+....+.
T Consensus        24 ~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~  102 (267)
T cd06646          24 DVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGP  102 (267)
T ss_pred             EEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCC
Confidence            389999999999999999875322 2235678899999999999999999999999999999999987655555444678


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC--
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG--  158 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--  158 (282)
                      +++..+..++.|++.||.+||+.|++|+|++|+||+++.++.++|+|||.+..............++..|+|||.+..  
T Consensus       103 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~  182 (267)
T cd06646         103 LSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEK  182 (267)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCccccCccccCHhHccccc
Confidence            999999999999999999999999999999999999999999999999998766433332333456788999998742  


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      ...++.++|+||+|+++|++++|+.|++..... +....+......+                        ........+
T Consensus       183 ~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~------------------------~~~~~~~~~  237 (267)
T cd06646         183 NGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-RALFLMSKSNFQP------------------------PKLKDKTKW  237 (267)
T ss_pred             CCCCcchhhHHHHHHHHHHHHhCCCCccccchh-hhheeeecCCCCC------------------------CCCcccccc
Confidence            233678999999999999999998885443321 1111110000000                        000112347


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIY  268 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~  268 (282)
                      +..+.++|++||+.+|++|||++++++|+|
T Consensus       238 ~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         238 SSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             CHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            889999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.3e-42  Score=287.80  Aligned_cols=250  Identities=21%  Similarity=0.313  Sum_probs=197.6

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      ||+|+++.+++.+|+|++..  .........+..|+.++..++|++|+++++++.++...++||||++| ++.+.+.+..
T Consensus        17 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~   96 (332)
T cd05623          17 VAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE   96 (332)
T ss_pred             EEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhc
Confidence            89999999999999999975  22333345578899999999999999999999999999999999975 6666665556


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~  157 (282)
                      ..+++..+..++.||+.||.+||++|++|+||||+||+++.++.++|+|||++........ ......|++.|+|||.+.
T Consensus        97 ~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~  176 (332)
T cd05623          97 DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ  176 (332)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHh
Confidence            7899999999999999999999999999999999999999999999999999865432221 222346789999999986


Q ss_pred             C----CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         158 G----AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       158 ~----~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      .    ...++.++|+||||+++|+|++|+.| |...+..+....+.......                        ....
T Consensus       177 ~~~~~~~~~~~~~DvwSlGvil~ell~g~~P-f~~~~~~~~~~~i~~~~~~~------------------------~~p~  231 (332)
T cd05623         177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETP-FYAESLVETYGKIMNHKERF------------------------QFPA  231 (332)
T ss_pred             ccccCCCCCCCcCCEEeeHHHHHHHhcCCCC-CCCCCHHHHHHHHhCCCccc------------------------cCCC
Confidence            3    33468899999999999999998888 55555555555443211000                        1112


Q ss_pred             cCccCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCCccch
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQ--RMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~h~~~~~~~~~~  276 (282)
                      ....+++++.++|++||..++.+  |++++++++||||+++++..
T Consensus       232 ~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~  276 (332)
T cd05623         232 QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDN  276 (332)
T ss_pred             ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHH
Confidence            22457899999999999665444  68999999999999987543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-42  Score=279.36  Aligned_cols=243  Identities=24%  Similarity=0.372  Sum_probs=196.3

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCC---CCCccceeeeeeeCCeEEEEEecCcccHHHHHHhc
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK---HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL   77 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~---h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~   77 (282)
                      .||+|.+..+|+.||+|.+...........+.+|+.++++++   |||++++++++......++++||++|+.+..+.. 
T Consensus        16 ~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-   94 (277)
T cd06917          16 AVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK-   94 (277)
T ss_pred             eEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHH-
Confidence            389999999999999999876444444567888999999996   9999999999999999999999998755555554 


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      .+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.
T Consensus        95 ~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  174 (277)
T cd06917          95 AGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT  174 (277)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhc
Confidence            35799999999999999999999999999999999999999999999999999877654443334445678899999987


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC-c
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA-P  236 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  236 (282)
                      +...++.++|+||||+++|++++|..| |...........+...                            ....+. .
T Consensus       175 ~~~~~~~~~Dv~slG~~l~~ll~g~~p-~~~~~~~~~~~~~~~~----------------------------~~~~~~~~  225 (277)
T cd06917         175 EGKYYDTKADIWSLGITIYEMATGNPP-YSDVDAFRAMMLIPKS----------------------------KPPRLEDN  225 (277)
T ss_pred             cCCccccchhHHHHHHHHHHHHhCCCC-CCCCChhhhhhccccC----------------------------CCCCCCcc
Confidence            665578999999999999999998777 5544332222111000                            000111 1


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      .++.++.+++.+||+.||.+|||+.+++.|+||++..
T Consensus       226 ~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         226 GYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             cCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence            2778999999999999999999999999999998765

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.5e-42  Score=299.80  Aligned_cols=264  Identities=21%  Similarity=0.298  Sum_probs=196.4

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCC------CCccceeeeeeeC-CeEEEEEecCcccHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKH------KNIVRLYDVLHSE-KKLTLVFEHCDQDLKKY   73 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h------~~i~~~~~~~~~~-~~~~iv~e~~~g~l~~~   73 (282)
                      .||+|.+..+++.||||+++...  ........|+.+++.++|      .+++++++++..+ ..+++|++++++++++.
T Consensus       144 ~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~g~~l~~~  221 (467)
T PTZ00284        144 KVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDW  221 (467)
T ss_pred             EEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEeccCCCHHHH
Confidence            38999999999999999987522  123445667777777755      4588888888765 57999999998888888


Q ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCC----------------cEEEEecCCccccCC
Q psy6044          74 FDSLNGEIDLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNG----------------ELKLADFGLARAFGI  136 (282)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~dl~~~nil~~~~~----------------~~~l~df~~~~~~~~  136 (282)
                      +.. .+.+++..+..++.||+.||.|||+ .||+|+||||+||+++.++                .+||+|||.+.... 
T Consensus       222 l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-  299 (467)
T PTZ00284        222 IMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER-  299 (467)
T ss_pred             HHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCc-
Confidence            766 5789999999999999999999998 5999999999999998765                49999999875432 


Q ss_pred             CccccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCC
Q psy6044         137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLL  216 (282)
Q Consensus       137 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  216 (282)
                        .......+++.|+|||++.+.. ++.++|||||||++|+|++|+.| |.+.+..+.+..+...++.++..+.......
T Consensus       300 --~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~p-f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~  375 (467)
T PTZ00284        300 --HSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLL-YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTE  375 (467)
T ss_pred             --cccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHcCCCCHHHHhhccch
Confidence              2223456789999999998776 79999999999999999987766 7777777777777777766554322110000


Q ss_pred             ------CCCCCCCCCCCCCCcc------cc-CccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         217 ------PDFKPFPMYHPSMSFS------QV-APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       217 ------~~~~~~~~~~~~~~~~------~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                            .....+..........      .. ....++.+.+||.+||+.||++|||++|+|+||||.+.
T Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~  444 (467)
T PTZ00284        376 EARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY  444 (467)
T ss_pred             hHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence                  0000000000000000      00 01125678899999999999999999999999999975

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.2e-41  Score=286.73  Aligned_cols=265  Identities=33%  Similarity=0.589  Sum_probs=201.1

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC------CeEEEEEecCcccHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSE------KKLTLVFEHCDQDLKKY   73 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~------~~~~iv~e~~~g~l~~~   73 (282)
                      .||+|++..+|+.||+|.+... ........+.+|+.++++++||||+++++++..+      ...|+|+||+++++.+.
T Consensus        31 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~  110 (353)
T cd07850          31 IVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQV  110 (353)
T ss_pred             EEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCCCHHHH
Confidence            3899999999999999998752 2333345677899999999999999999998644      35799999999988887


Q ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccCh
Q psy6044          74 FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP  153 (282)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aP  153 (282)
                      +..   .+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+...+.... .....++..|+||
T Consensus       111 ~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~y~aP  186 (353)
T cd07850         111 IQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAP  186 (353)
T ss_pred             Hhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC-CCCCcccccccCH
Confidence            654   289999999999999999999999999999999999999999999999999977653322 2334567889999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCC--------CCCCCC--CC-
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN--------LLPDFK--PF-  222 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~--~~-  222 (282)
                      |.+.+.. ++.++|+||||+++|+|++|+.| |...+..+....+...++.+..+......        ......  .+ 
T Consensus       187 E~~~~~~-~~~~~DvwslG~~l~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (353)
T cd07850         187 EVILGMG-YKENVDIWSVGCIMGEMIRGTVL-FPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFE  264 (353)
T ss_pred             HHHhCCC-CCCchhhHhHHHHHHHHHHCCCC-CCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchh
Confidence            9997766 79999999999999999988777 66666666666666655554332111100        000000  00 


Q ss_pred             ---CCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q psy6044         223 ---PMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD  271 (282)
Q Consensus       223 ---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  271 (282)
                         +...-...........++.+.++|.+||+.||++|||+.++|+||||+.
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         265 ELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             hhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence               0000000111112345778899999999999999999999999999973

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.1e-42  Score=280.39  Aligned_cols=231  Identities=16%  Similarity=0.232  Sum_probs=186.0

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCC--CCccHHHHHHHHhhCCCCCccceeeeeee----CCeEEEEEecCcccHHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEG--VPSSALREICLLKELKHKNIVRLYDVLHS----EKKLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~l~h~~i~~~~~~~~~----~~~~~iv~e~~~g~l~~~~~   75 (282)
                      ||+|..  +|+.||||.+.......  ..+.+.+|+.++++++||||+++++++.+    ...+++|+||++|+.+..+.
T Consensus        36 v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l  113 (283)
T PHA02988         36 IYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL  113 (283)
T ss_pred             EEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHH
Confidence            788886  78999999987632211  23567799999999999999999999877    35789999999976555555


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChh
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPD  154 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE  154 (282)
                      .....+++.....++.+++.||.+||+ .+++|+||+|+||+++.++.++|+|||++.......   ....++..|+|||
T Consensus       114 ~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~y~aPE  190 (283)
T PHA02988        114 DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---FKNVNFMVYFSYK  190 (283)
T ss_pred             hhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---ccccCcccccCHH
Confidence            556789999999999999999999998 499999999999999999999999999987654321   2335678899999


Q ss_pred             hhcCC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         155 VLFGA-KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       155 ~~~~~-~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      .+.+. ..++.++||||||+++|++++|..| |.+.+..+....+......+                           .
T Consensus       191 ~~~~~~~~~~~k~Di~SlGvil~el~~g~~P-f~~~~~~~~~~~i~~~~~~~---------------------------~  242 (283)
T PHA02988        191 MLNDIFSEYTIKDDIYSLGVVLWEIFTGKIP-FENLTTKEIYDLIINKNNSL---------------------------K  242 (283)
T ss_pred             HhhhccccccchhhhhHHHHHHHHHHHCCCC-CCCCCHHHHHHHHHhcCCCC---------------------------C
Confidence            98652 3479999999999999999998887 66666665555543321110                           1


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      .+...++.+.+++.+||+.||.+|||+.++++
T Consensus       243 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        243 LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            22347889999999999999999999999986

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=8.1e-42  Score=281.23  Aligned_cols=245  Identities=22%  Similarity=0.417  Sum_probs=198.8

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||+|.+..+++.||+|++..... .....+.+|+.+++.++|||++++++++..++..++++||++|+.+..+.. ...
T Consensus        36 ~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~-~~~  113 (297)
T cd06659          36 IVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QTR  113 (297)
T ss_pred             eEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHh-hcC
Confidence            489999999999999999876322 234668899999999999999999999999999999999998765555554 457


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+..
T Consensus       114 ~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  193 (297)
T cd06659         114 LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTP  193 (297)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCC
Confidence            89999999999999999999999999999999999999999999999999876544333333456688899999997766


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                       ++.++|+||||+++|++++|..|++. ....+....+...    ..                      ........++.
T Consensus       194 -~~~~~Dv~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~----~~----------------------~~~~~~~~~~~  245 (297)
T cd06659         194 -YGTEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDS----PP----------------------PKLKNAHKISP  245 (297)
T ss_pred             -CCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcc----CC----------------------CCccccCCCCH
Confidence             68999999999999999998888554 3433333332211    00                      01111234788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      .+.++|++||+.+|.+|||++++++||||.+...+
T Consensus       246 ~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~  280 (297)
T cd06659         246 VLRDFLERMLTREPQERATAQELLDHPFLLQTGLP  280 (297)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCc
Confidence            89999999999999999999999999999977543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-42  Score=276.77  Aligned_cols=244  Identities=26%  Similarity=0.360  Sum_probs=192.9

Q ss_pred             CeeeeeeCCCCceEEEeeeecCC--CCCCCccHHHHHHH-HhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhc
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVG--NEGVPSSALREICL-LKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL   77 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~-~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~   77 (282)
                      .||+|.+..+|+.||+|++....  .......+..|..+ ....+|||++++++++...+.+++|+||++|+.+..+...
T Consensus        11 ~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   90 (260)
T cd05611          11 SVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKT   90 (260)
T ss_pred             eEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHH
Confidence            38999999999999999987521  11122334445444 4455899999999999999999999999987666666555


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      .+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....    .....++..|++||.+.
T Consensus        91 ~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~~~y~~pe~~~  166 (260)
T cd05611          91 LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVGTPDYLAPETIL  166 (260)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCCCcCccChhhhc
Confidence            67899999999999999999999999999999999999999999999999998865432    12234577899999987


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|+||+|+++|++++|..| |...+.......+.......                         .......
T Consensus       167 ~~~-~~~~~Dv~slG~il~~l~~g~~p-~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~  219 (260)
T cd05611         167 GVG-DDKMSDWWSLGCVIFEFLFGYPP-FHAETPDAVFDNILSRRINW-------------------------PEEVKEF  219 (260)
T ss_pred             CCC-CcchhhhHHHHHHHHHHHHCCCC-CCCCCHHHHHHHHHhcccCC-------------------------CCccccc
Confidence            776 68999999999999999988877 66665555554443321110                         0111235


Q ss_pred             CCHHHHHHHHHhcccCCCCCC---CHHHHhcCCCccCCccc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRM---SAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rp---s~~~ll~h~~~~~~~~~  275 (282)
                      +++.+.++|.+||+.||.+||   +++|++.||||++++++
T Consensus       220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~  260 (260)
T cd05611         220 CSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD  260 (260)
T ss_pred             CCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence            789999999999999999999   55799999999998763

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.1e-42  Score=280.68  Aligned_cols=247  Identities=21%  Similarity=0.370  Sum_probs=196.7

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC--
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~--   78 (282)
                      .||+|.+..+|..||+|.+...........+.+|+.++++++||||+++++.+..++..++|+||++|..+..+....  
T Consensus        16 ~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~   95 (286)
T cd06622          16 SVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVA   95 (286)
T ss_pred             EEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccc
Confidence            389999999999999998875433333467889999999999999999999999999999999999876555554432  


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhh
Q psy6044          79 -GEIDLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        79 -~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~  156 (282)
                       ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+........  ....++..|+|||.+
T Consensus        96 ~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~y~aPE~~  173 (286)
T cd06622          96 TEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA--KTNIGCQSYMAPERI  173 (286)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc--ccCCCccCccCcchh
Confidence             378999999999999999999997 5999999999999999999999999999876542222  223467789999998


Q ss_pred             cCCC-----CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q psy6044         157 FGAK-----LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSF  231 (282)
Q Consensus       157 ~~~~-----~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
                      .+..     .++.++|+||+|+++|++++|..| |...........+......                         ..
T Consensus       174 ~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~p-f~~~~~~~~~~~~~~~~~~-------------------------~~  227 (286)
T cd06622         174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP-YPPETYANIFAQLSAIVDG-------------------------DP  227 (286)
T ss_pred             cCCCCCccCCCCcccchHhHHHHHHHHHhCCCC-CCCcchhhHHHHHHHHhhc-------------------------CC
Confidence            5432     257899999999999999998888 5444333333333222111                         11


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ..++..+++++.++|.+||+.+|.+||+++++++||||...+..
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         228 PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence            12334589999999999999999999999999999999877544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.3e-42  Score=278.13  Aligned_cols=238  Identities=24%  Similarity=0.365  Sum_probs=195.3

Q ss_pred             CeeeeeeCCCCceEEEeeeecCC--CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVG--NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      .||+|.+..+++.||+|++....  .....+.+.+|++++++++||||+++++++.++...++|+||++|+.+.......
T Consensus        15 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   94 (258)
T cd05578          15 KVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK   94 (258)
T ss_pred             eEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc
Confidence            38999999999999999998622  2245678899999999999999999999999999999999999876555555545


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      ..+++..+..++.||++||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+..
T Consensus        95 ~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~  173 (258)
T cd05578          95 VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTSTSGTPGYMAPEVLCR  173 (258)
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cccccCCChhhcCHHHHcc
Confidence            789999999999999999999999999999999999999999999999999987664332 2233456778999999977


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC--hHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSD--VDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      .. ++.++|+||+|+++|++++|..|+.....  ..+..+....                             .....+.
T Consensus       174 ~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~  223 (258)
T cd05578         174 QG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-----------------------------ADVLYPA  223 (258)
T ss_pred             cC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-----------------------------ccccCcc
Confidence            66 69999999999999999999888443332  2222221111                             1112334


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCH--HHHhcCCCc
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSA--EDAMSHIYF  269 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~--~~ll~h~~~  269 (282)
                      ..+..+.++|.+||+.||.+||++  +++++||||
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         224 TWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             cCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            578999999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.4e-42  Score=276.13  Aligned_cols=238  Identities=24%  Similarity=0.445  Sum_probs=195.3

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC-
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~-   78 (282)
                      ||++++..+|+.||+|.+... ........+.+|+.++++++||||+++++++...+..++|+||+.| ++.+.+.... 
T Consensus        16 ~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~   95 (256)
T cd08218          16 AILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRG   95 (256)
T ss_pred             EEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccC
Confidence            789999999999999998762 2333446788999999999999999999999999999999999975 6666555432 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+..............++..|+|||...+
T Consensus        96 ~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~  175 (256)
T cd08218          96 VLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN  175 (256)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCC
Confidence            35899999999999999999999999999999999999999999999999998766543333333456778999999877


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. .+.++|+||||++++++++|..| +...+..+....+....                            ....+..+
T Consensus       176 ~~-~~~~~Dv~slG~i~~~l~~g~~~-~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~  225 (256)
T cd08218         176 RP-YNNKSDIWALGCVLYEMCTLKHA-FEAGNMKNLVLKIIRGS----------------------------YPPVSSHY  225 (256)
T ss_pred             CC-CCCccchhHHHHHHHHHHcCCCC-ccCCCHHHHHHHHhcCC----------------------------CCCCcccC
Confidence            66 68999999999999999998887 44444444444433211                            11123457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      +..+.++|.+||+.+|.+||++.++++||||
T Consensus       226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         226 SYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             CHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            8899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0669|consensus

Probab=100.00  E-value=2.9e-43  Score=265.61  Aligned_cols=275  Identities=36%  Similarity=0.654  Sum_probs=230.8

Q ss_pred             eeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC--------CeEEEEEecCcccHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE--------KKLTLVFEHCDQDLKK   72 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~--------~~~~iv~e~~~g~l~~   72 (282)
                      ||+|+.+++|+.||+|+.-. ...++.....++|+.++..++|+|++.++++|...        ..+|+|+++|..++..
T Consensus        33 VFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~cehDLaG  112 (376)
T KOG0669|consen   33 VFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEHDLAG  112 (376)
T ss_pred             HHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhhhHHH
Confidence            78999999999999998776 45666778899999999999999999999987642        3589999999999998


Q ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC----ccccccccccc
Q psy6044          73 YFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP----VKCYSAEVVTL  148 (282)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~~~  148 (282)
                      .+......++..++..+.+++.+||.|+|...|.|||+|+.|++++.+|.++|+|||+++.++..    ...++..+.|.
T Consensus       113 lLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTL  192 (376)
T KOG0669|consen  113 LLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTL  192 (376)
T ss_pred             HhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeee
Confidence            88877788999999999999999999999999999999999999999999999999999665422    23345556699


Q ss_pred             cccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCC-CC
Q psy6044         149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY-HP  227 (282)
Q Consensus       149 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  227 (282)
                      +|++||.+.+...++++.|+|+-||++.+|+ .+.|.+.+.+....+..+....+....+.||....++-+...... ..
T Consensus       193 wYrppEllLG~r~yg~~iDiWgAgCimaeMw-trspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~  271 (376)
T KOG0669|consen  193 WYRPPELLLGDREYGPPIDIWGAGCIMAEMW-TRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLP  271 (376)
T ss_pred             ecCCHHHhhcccccCCcchhHhHHHHHHHHH-ccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCC
Confidence            9999999999888999999999999999999 567889999999999999999999999999987665554433221 11


Q ss_pred             CCCcccc-----CccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccchh
Q psy6044         228 SMSFSQV-----APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       228 ~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  277 (282)
                      ......+     +-.-+++..+++..||..||.+|+++.++++|.||..-++++.
T Consensus       272 ~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~pqa  326 (376)
T KOG0669|consen  272 KGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMPQA  326 (376)
T ss_pred             cchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcchh
Confidence            1111111     1123567889999999999999999999999999998777643

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=278.63  Aligned_cols=267  Identities=34%  Similarity=0.562  Sum_probs=209.8

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCC-CCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC-
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN-   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~-   78 (282)
                      .||+|.+..+++.|+||++.............+|+..+++++ |||++++++++.++...++|+||++|++.+.+.... 
T Consensus        14 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~   93 (283)
T cd07830          14 SVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKG   93 (283)
T ss_pred             EEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecCCCCHHHHHHhccc
Confidence            389999999999999999876433223345567999999998 999999999999999999999999889888887654 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+..
T Consensus        94 ~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~  172 (283)
T cd07830          94 KPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-PYTDYVSTRWYRAPEILLR  172 (283)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-CcCCCCCcccccCceeeec
Confidence            478999999999999999999999999999999999999999999999999987664322 2233456778999998866


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCC-CCCCCCCCCCCCccccCcc
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPD-FKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  237 (282)
                      ...++.++|+||||++++++++|+.| |......+....+...++.+....+........ ...................
T Consensus       173 ~~~~~~~~Di~s~G~~l~el~~g~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (283)
T cd07830         173 STSYSSPVDIWALGCIMAELYTLRPL-FPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPN  251 (283)
T ss_pred             CcCcCCccchhhHHHHHHHHHhCCCc-cCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHccc
Confidence            55578999999999999999988655 777777777777777776665544433221111 1111111111122233334


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      .+..+.++|++||+.||.+|||+++++.||||
T Consensus       252 ~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         252 ASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             CCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            57899999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.9e-42  Score=298.87  Aligned_cols=241  Identities=22%  Similarity=0.390  Sum_probs=195.3

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC--------eEEEEEecCcc-cHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK--------KLTLVFEHCDQ-DLK   71 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~--------~~~iv~e~~~g-~l~   71 (282)
                      ||+|++..+|+.||||++... ........+.+|+.++..++|+|++++++.+....        .+++|+||+++ ++.
T Consensus        48 Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~  127 (496)
T PTZ00283         48 VLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLR  127 (496)
T ss_pred             EEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHH
Confidence            899999999999999998763 23334556788999999999999999988775332        47899999985 565


Q ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc--cccccccc
Q psy6044          72 KYFDSL---NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--KCYSAEVV  146 (282)
Q Consensus        72 ~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~  146 (282)
                      +.+...   ...+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......  .......|
T Consensus       128 ~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~G  207 (496)
T PTZ00283        128 QEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG  207 (496)
T ss_pred             HHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccC
Confidence            555432   3468999999999999999999999999999999999999999999999999987654221  12233467


Q ss_pred             cccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYH  226 (282)
Q Consensus       147 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (282)
                      ++.|+|||.+.+.. ++.++||||||+++|+|++|..| |...+..+....+....                        
T Consensus       208 t~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~P-f~~~~~~~~~~~~~~~~------------------------  261 (496)
T PTZ00283        208 TPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRP-FDGENMEEVMHKTLAGR------------------------  261 (496)
T ss_pred             CcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCC-CCCCCHHHHHHHHhcCC------------------------
Confidence            89999999997766 79999999999999999998877 66666666555543321                        


Q ss_pred             CCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         227 PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       227 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                          ....+..+++.+.+++..||+.||.+|||+.++++|||++..
T Consensus       262 ----~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        262 ----YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence                112345688999999999999999999999999999998754

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.4e-41  Score=276.94  Aligned_cols=245  Identities=24%  Similarity=0.445  Sum_probs=197.4

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||+|.+..+++.+++|++..... .....+.+|+.+++.++|||++++++++...+..++++||++|..+..+... +.
T Consensus        34 ~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~  111 (285)
T cd06648          34 IVCIATDKSTGRQVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-TR  111 (285)
T ss_pred             EEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-CC
Confidence            379999999999999998865322 2245688999999999999999999999999999999999987555555443 67


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+..............++..|+|||...+..
T Consensus       112 ~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  191 (285)
T cd06648         112 MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLP  191 (285)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCC
Confidence            89999999999999999999999999999999999999999999999998776544333333445788899999987665


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                       ++.++|+||+|+++|++++|+.|++ ..+..+....+....  ++                        .......++.
T Consensus       192 -~~~~~Dv~slGv~l~ell~g~~p~~-~~~~~~~~~~~~~~~--~~------------------------~~~~~~~~~~  243 (285)
T cd06648         192 -YGTEVDIWSLGIMVIEMVDGEPPYF-NEPPLQAMKRIRDNL--PP------------------------KLKNLHKVSP  243 (285)
T ss_pred             -CCCcccHHHHHHHHHHHHhCCCCCc-CCCHHHHHHHHHhcC--CC------------------------CCcccccCCH
Confidence             6899999999999999999888854 444444443333210  00                        0001123788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      .+.+++.+||+.+|.+|||+.++++||||++.+..
T Consensus       244 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  278 (285)
T cd06648         244 RLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP  278 (285)
T ss_pred             HHHHHHHHHcccChhhCcCHHHHccCcccccCCCc
Confidence            99999999999999999999999999999987653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.2e-41  Score=278.59  Aligned_cols=247  Identities=24%  Similarity=0.349  Sum_probs=192.3

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHH-HhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHh---
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICL-LKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS---   76 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~-~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~---   76 (282)
                      .||+|.++.+|+.||+|++...........+..|... ++.++|||++++++++..+...++++||++|++.+.+..   
T Consensus        16 ~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~   95 (283)
T cd06617          16 VVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYD   95 (283)
T ss_pred             EEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhcccHHHHHHHhcc
Confidence            3899999999999999998764332233455566664 666799999999999999999999999999987666544   


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhh
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSR-NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDV  155 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~  155 (282)
                      ....+++..++.++.||+.||.+||++ +++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.
T Consensus        96 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~  174 (283)
T cd06617          96 KGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-AKTIDAGCKPYMAPER  174 (283)
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-ccccccCCccccChhh
Confidence            235689999999999999999999997 99999999999999999999999999987654322 1222356778999998


Q ss_pred             hcCC---CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         156 LFGA---KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       156 ~~~~---~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      +.+.   ..++.++|+||+|+++|++++|..|+.......+...........                           .
T Consensus       175 ~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~  227 (283)
T cd06617         175 INPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP---------------------------Q  227 (283)
T ss_pred             cCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCC---------------------------C
Confidence            8542   236889999999999999999888854333333333332221000                           0


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      .....+|..+.++|.+||..+|.+|||+.++++||||+..+..
T Consensus       228 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  270 (283)
T cd06617         228 LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK  270 (283)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence            0012378999999999999999999999999999999986533

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.4e-41  Score=272.76  Aligned_cols=238  Identities=24%  Similarity=0.423  Sum_probs=197.7

Q ss_pred             eeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc-C
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL-N   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~-~   78 (282)
                      ||.+++..+++.+++|.+.. .........+.+|+.++++++|+||+++++++.+.+..++++||++| ++.+.+... .
T Consensus        16 v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~   95 (256)
T cd08221          16 ATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG   95 (256)
T ss_pred             EEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccc
Confidence            68899999999999999876 33444556788999999999999999999999999999999999986 555555443 3


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............+++.|.|||...+
T Consensus        96 ~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~  175 (256)
T cd08221          96 QLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG  175 (256)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCC
Confidence            56899999999999999999999999999999999999999999999999998776544433344567889999999877


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||+|++++++++|..| |...+..+....+....                            .......+
T Consensus       176 ~~-~~~~~Dv~slG~i~~~l~~g~~~-~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~  225 (256)
T cd08221         176 VK-YNFKSDIWALGCVLYELLTLKRT-FDATNPLNLVVKIVQGN----------------------------YTPVVSVY  225 (256)
T ss_pred             CC-CCCcchhHHHHHHHHHHHHCCCC-CCCCCHHHHHHHHHcCC----------------------------CCCCcccc
Confidence            66 68999999999999999998877 56655555555443311                            11112457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      +..+.++|.+||..+|.+|||++++++|||+
T Consensus       226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         226 SSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence            8899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0577|consensus

Probab=100.00  E-value=1.9e-43  Score=294.58  Aligned_cols=241  Identities=24%  Similarity=0.334  Sum_probs=207.2

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||.|+|..+.+.||||++..  .+....+.++++|+..+++++|||++.+.++|..+.+.|+|||||-|+-.+.+.-...
T Consensus        42 VYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClGSAsDlleVhkK  121 (948)
T KOG0577|consen   42 VYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKK  121 (948)
T ss_pred             eEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhccHHHHHHHHhc
Confidence            89999999999999999987  4445567899999999999999999999999999999999999999987777777678


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc--
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF--  157 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--  157 (282)
                      ++.+.+|..|..+.+.||+|||+.+.+|+|||..||++++.|.+||+|||++..+...    ...+|||.|+|||++.  
T Consensus       122 plqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----nsFvGTPywMAPEVILAM  197 (948)
T KOG0577|consen  122 PLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----NSFVGTPYWMAPEVILAM  197 (948)
T ss_pred             cchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch----hcccCCccccchhHheec
Confidence            9999999999999999999999999999999999999999999999999999876533    3458899999999984  


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      ....|+.++||||||++..|+...+.|+|+............+.-...                            -..+
T Consensus       198 DEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtL----------------------------qs~e  249 (948)
T KOG0577|consen  198 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL----------------------------QSNE  249 (948)
T ss_pred             cccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCC----------------------------CCch
Confidence            334489999999999999999988888787766655554333311111                            1245


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      .|..+++|+..||++-|.+|||.+++|.|+|...-+.
T Consensus       250 WS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp  286 (948)
T KOG0577|consen  250 WSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERP  286 (948)
T ss_pred             hHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence            7899999999999999999999999999999875543

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.5e-41  Score=279.49  Aligned_cols=247  Identities=23%  Similarity=0.334  Sum_probs=197.4

Q ss_pred             eeeeeeCCCCceEEEeeeecCC--CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG--NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|.++.+++.|++|.+....  .......+.+|+++++.++||||+++++.+..++..++|+||++|+.+..+....+
T Consensus        17 v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~   96 (305)
T cd05609          17 VYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG   96 (305)
T ss_pred             EEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcC
Confidence            8999999999999999987632  22334577889999999999999999999999999999999998765655555567


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc---------------cccccc
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---------------KCYSAE  144 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~---------------~~~~~~  144 (282)
                      .+++..+..++.|++.||.+||+.|++|+||+|.||+++.++.++|+|||.+.......               ......
T Consensus        97 ~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (305)
T cd05609          97 ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV  176 (305)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCC
Confidence            89999999999999999999999999999999999999999999999999875311000               000112


Q ss_pred             cccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM  224 (282)
Q Consensus       145 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (282)
                      .++..|+|||.+.... ++.++|+||||+++|++++|..| |.+.+..+............+                  
T Consensus       177 ~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~el~~g~~p-f~~~~~~~~~~~~~~~~~~~~------------------  236 (305)
T cd05609         177 CGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVP-FFGDTPEELFGQVISDDIEWP------------------  236 (305)
T ss_pred             ccCccccCchhccCCC-CCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhcccCCC------------------
Confidence            4567899999987665 69999999999999999998888 445555555554443211110                  


Q ss_pred             CCCCCCccccCccCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCccCCccch
Q psy6044         225 YHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS---AEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       225 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~~~~  276 (282)
                              .....++..+.++|++||+.||.+|||   +.++++||||...+...
T Consensus       237 --------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~  283 (305)
T cd05609         237 --------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG  283 (305)
T ss_pred             --------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence                    111247889999999999999999997   79999999998876554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=9.4e-42  Score=286.21  Aligned_cols=271  Identities=36%  Similarity=0.618  Sum_probs=200.0

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC--------------CeEEEEEecC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE--------------KKLTLVFEHC   66 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~--------------~~~~iv~e~~   66 (282)
                      .||+|.++.+|+.||+|.+..... .....+.+|+.++++++||||+++++++...              ...++|+||+
T Consensus        20 ~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~   98 (342)
T cd07854          20 LVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM   98 (342)
T ss_pred             EEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeecc
Confidence            389999999999999999876332 3456788999999999999999999876654              3579999999


Q ss_pred             cccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-CCcEEEEecCCccccCCCcc---ccc
Q psy6044          67 DQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVK---CYS  142 (282)
Q Consensus        67 ~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~-~~~~~l~df~~~~~~~~~~~---~~~  142 (282)
                      ++++.+.+.  .+.+++..++.++.||+.||.+||+.|++|+||+|+||+++. ++.++|+|||.+........   ...
T Consensus        99 ~~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  176 (342)
T cd07854          99 ETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS  176 (342)
T ss_pred             cccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccc
Confidence            988776654  357899999999999999999999999999999999999974 55789999999876532211   112


Q ss_pred             cccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCC-CCCCCCCC
Q psy6044         143 AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGM-NLLPDFKP  221 (282)
Q Consensus       143 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  221 (282)
                      ...++..|+|||.+.....++.++|+||||+++|++++|+.| |......+....+............... +.......
T Consensus       177 ~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (342)
T cd07854         177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPL-FAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVR  255 (342)
T ss_pred             cccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhh
Confidence            234577899999876655578999999999999999988887 5555554444444433222211111100 00000000


Q ss_pred             CCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         222 FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ........+.......++.++.+||++||+.||.+|||+++++.||||+....+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~  309 (342)
T cd07854         256 NDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP  309 (342)
T ss_pred             hcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence            011112223334445688999999999999999999999999999999976544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.2e-42  Score=288.44  Aligned_cols=267  Identities=34%  Similarity=0.588  Sum_probs=206.2

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCe------EEEEEecCcccHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKK------LTLVFEHCDQDLKKYF   74 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~------~~iv~e~~~g~l~~~~   74 (282)
                      ||+|++..+++.||+|++... ........+.+|+.+++.++|||++++++++.....      .++|+||+++++.+.+
T Consensus        31 vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~  110 (343)
T cd07851          31 VCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIV  110 (343)
T ss_pred             EEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecCCCCHHHHH
Confidence            899999999999999988752 223334567789999999999999999998876554      8999999988877766


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChh
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPD  154 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE  154 (282)
                      ..  ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......   .....++..|+|||
T Consensus       111 ~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE  185 (343)
T cd07851         111 KC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPE  185 (343)
T ss_pred             hc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc---ccCCcccccccCHH
Confidence            54  57999999999999999999999999999999999999999999999999998876533   23335677899999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCC---CCCCCCCCc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPF---PMYHPSMSF  231 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  231 (282)
                      ...+...++.++|+||||+++|++++|..| |.+....+....+....+.+++..+..... .....+   .........
T Consensus       186 ~~~~~~~~~~~~DvwslGv~l~elltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  263 (343)
T cd07851         186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTL-FPGSDHIDQLKRIMNLVGTPDEELLQKISS-ESARNYIQSLPQMPKKDF  263 (343)
T ss_pred             HHhCCCCCCchHhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCCHHHHhhccc-hhHHHHHHhccccCCCCH
Confidence            987654578999999999999999988776 666666666666666655444332221110 000000   000111122


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ......+++.+.++|++||+.||.+|||+.++++||||++....
T Consensus       264 ~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         264 KEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             HHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence            23334568999999999999999999999999999999977544

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=7.6e-42  Score=285.45  Aligned_cols=250  Identities=21%  Similarity=0.308  Sum_probs=197.1

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      ||+|+++.+++.||+|++..  .........+..|..++..++|++|+++++++.+++..|+||||++| ++.+.+....
T Consensus        17 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~   96 (331)
T cd05624          17 VAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFE   96 (331)
T ss_pred             EEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhc
Confidence            89999999999999999876  22233345578899999999999999999999999999999999976 5555555545


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc-cccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC-YSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~  157 (282)
                      ..+++..+..++.|++.||.+||++||+|+||||+||+++.++.++|+|||++......... .....|++.|+|||.+.
T Consensus        97 ~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~  176 (331)
T cd05624          97 DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ  176 (331)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHh
Confidence            78999999999999999999999999999999999999999999999999998766433221 12345789999999986


Q ss_pred             CC----CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         158 GA----KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       158 ~~----~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      ..    ..++.++|+||+|+++|+|++|..| |...+..+....+.......                        ....
T Consensus       177 ~~~~~~~~~~~~~DiwSlGvil~ell~g~~P-f~~~~~~~~~~~i~~~~~~~------------------------~~p~  231 (331)
T cd05624         177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETP-FYAESLVETYGKIMNHEERF------------------------QFPS  231 (331)
T ss_pred             ccccCCCCCCCcccEEeeehhhhhhhhCCCC-ccCCCHHHHHHHHHcCCCcc------------------------cCCC
Confidence            42    2368899999999999999998888 55555555444443211000                        1111


Q ss_pred             cCccCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCCccch
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQ--RMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~h~~~~~~~~~~  276 (282)
                      ....+++.+.++|.+||..++++  |++++++++||||+++++..
T Consensus       232 ~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~  276 (331)
T cd05624         232 HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWEN  276 (331)
T ss_pred             ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHH
Confidence            22357899999999999876654  56999999999999886543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.1e-41  Score=274.94  Aligned_cols=241  Identities=24%  Similarity=0.404  Sum_probs=189.5

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      .||+|.+..++..|++|.+...... ....+.+|+.+++.++|+||+++++++..++..++++||++| ++.+.+.....
T Consensus        23 ~v~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~  101 (268)
T cd06624          23 IVYAARDLSTQVRIAIKEIPERDSR-YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWG  101 (268)
T ss_pred             EEEEeEecCCCcEEEEEEecCCCHH-HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcc
Confidence            3899999999999999987653222 345788999999999999999999999999999999999986 55555544335


Q ss_pred             CC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-CCcEEEEecCCccccCCCccccccccccccccChhhh
Q psy6044          80 EI--DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        80 ~~--~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~  156 (282)
                      .+  ++..+..++.||+.||++||+.|++|+||+|+||+++. ++.++|+|||.+..............++..|+|||.+
T Consensus       102 ~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~  181 (268)
T cd06624         102 PLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVI  181 (268)
T ss_pred             cCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhh
Confidence            55  88899999999999999999999999999999999976 6799999999987654333333334567889999998


Q ss_pred             cCC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         157 FGA-KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       157 ~~~-~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      ... ..++.++|+||+|+++|++++|..|+............... ..                          ....++
T Consensus       182 ~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~-~~--------------------------~~~~~~  234 (268)
T cd06624         182 DKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM-FK--------------------------IHPEIP  234 (268)
T ss_pred             ccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhh-hc--------------------------cCCCCC
Confidence            553 23688999999999999999988775433222221111100 00                          112234


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      ..+++.+.+++++||+.+|.+|||+.+++.||||
T Consensus       235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             cccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            5678999999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-41  Score=285.35  Aligned_cols=268  Identities=35%  Similarity=0.576  Sum_probs=202.2

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC------CeEEEEEecCcccHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSE------KKLTLVFEHCDQDLKKY   73 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~------~~~~iv~e~~~g~l~~~   73 (282)
                      .||+|.+..+|+.||+|++... ........+.+|+.+++.++||||+++++++...      ...++|+||+.+++...
T Consensus        30 ~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~  109 (342)
T cd07879          30 SVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI  109 (342)
T ss_pred             EEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccccCHHHH
Confidence            3899999999999999998762 2333445688999999999999999999998754      35699999998765554


Q ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccCh
Q psy6044          74 FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP  153 (282)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aP  153 (282)
                      .   ...+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+......   .....++..|+||
T Consensus       110 ~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~---~~~~~~~~~y~aP  183 (342)
T cd07879         110 M---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAP  183 (342)
T ss_pred             H---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC---CCCceeeecccCh
Confidence            3   346899999999999999999999999999999999999999999999999998765422   2233557789999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCC--CCCCCCCCCCCCCc
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLP--DFKPFPMYHPSMSF  231 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  231 (282)
                      |.+.+...++.++|+||||+++|++++|+.| |.+.+.......+....+.+.+...+......  ..............
T Consensus       184 E~~~~~~~~~~~~Dv~slGvil~el~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (342)
T cd07879         184 EVILNWMHYNQTVDIWSVGCIMAEMLTGKTL-FKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDF  262 (342)
T ss_pred             hhhcCccccCchHHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchH
Confidence            9987654478999999999999999998777 66666555566555554433222111110000  00000001111122


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ....+..++.+.+||.+||+.||.+|||+++++.||||+.++..
T Consensus       263 ~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         263 STLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             HHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence            23334578899999999999999999999999999999998653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-41  Score=275.05  Aligned_cols=264  Identities=46%  Similarity=0.826  Sum_probs=203.8

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhC---CCCCccceeeeeeeCCe-----EEEEEecCcccHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKEL---KHKNIVRLYDVLHSEKK-----LTLVFEHCDQDLK   71 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l---~h~~i~~~~~~~~~~~~-----~~iv~e~~~g~l~   71 (282)
                      .||+|.++.+|+.||+|++... ........+.+|+.+++++   +|||++++++++.....     .++++|++++++.
T Consensus        14 ~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~~l~   93 (287)
T cd07838          14 TVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLA   93 (287)
T ss_pred             EEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcccCHH
Confidence            3899999999999999999862 2333345566788777666   69999999999988776     9999999999887


Q ss_pred             HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccc
Q psy6044          72 KYFDSLN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWY  150 (282)
Q Consensus        72 ~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  150 (282)
                      +.+.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........ .....++..|
T Consensus        94 ~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~  172 (287)
T cd07838          94 TYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWY  172 (287)
T ss_pred             HHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCcc-cccccccccc
Confidence            7766543 3589999999999999999999999999999999999999999999999999877653322 2233457789


Q ss_pred             cChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMS  230 (282)
Q Consensus       151 ~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
                      +|||.+.+.. ++.++|+||+|+++|+|++| .|+|......+....+......+....++....... ..+ .......
T Consensus       173 ~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~  248 (287)
T cd07838         173 RAPEVLLQSS-YATPVDMWSVGCIFAELFRR-RPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR-SSF-PSYTPRS  248 (287)
T ss_pred             cChHHhccCC-CCCcchhhhHHHHHHHHHhC-CCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch-hhc-ccccccc
Confidence            9999997766 68999999999999999977 555888777777777776655443333322110000 000 0111112


Q ss_pred             ccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      .....+.+++.+.++|.+||+.||.+||++++++.||||
T Consensus       249 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         249 FKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             hhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            233344678899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.3e-41  Score=274.42  Aligned_cols=244  Identities=23%  Similarity=0.329  Sum_probs=193.9

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC---
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN---   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~---   78 (282)
                      ||+|.+..++..+++|++...........+.+|+++++.++|+|++++++.+...+..++++|+++|+.+..+....   
T Consensus        17 v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~   96 (267)
T cd06610          17 VYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPR   96 (267)
T ss_pred             EEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhccc
Confidence            79999999999999999876443335678899999999999999999999999999999999999875555444332   


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc----cccccccccccChh
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC----YSAEVVTLWYRPPD  154 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~~aPE  154 (282)
                      ..+++..+..++.|++.||++||+.|++|+||+|+||++++++.++|+|||.+.........    .....++..|+|||
T Consensus        97 ~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe  176 (267)
T cd06610          97 GGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE  176 (267)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChH
Confidence            46899999999999999999999999999999999999999999999999998766433221    12234677899999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      .+.....++.++|+||||++++++++|..| |...+...........   .+.. .                   .....
T Consensus       177 ~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p-~~~~~~~~~~~~~~~~---~~~~-~-------------------~~~~~  232 (267)
T cd06610         177 VMEQVHGYDFKADIWSFGITAIELATGAAP-YSKYPPMKVLMLTLQN---DPPS-L-------------------ETGAD  232 (267)
T ss_pred             HHccccCcCcccchHhHhHHHHHHHhCCCC-ccccChhhhHHHHhcC---CCCC-c-------------------CCccc
Confidence            987764479999999999999999998888 4444433333322221   1000 0                   00001


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      ...+++.+.+++.+||..||.+|||++++++||||
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            23578999999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.6e-41  Score=274.10  Aligned_cols=238  Identities=27%  Similarity=0.414  Sum_probs=187.0

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeC------CeEEEEEecCcc-cHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSE------KKLTLVFEHCDQ-DLKKY   73 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~------~~~~iv~e~~~g-~l~~~   73 (282)
                      ||+|.+..+++.||+|++....  .....+..|+.+++++ +|||++++++++...      ...++++||+++ ++.+.
T Consensus        22 vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~   99 (272)
T cd06637          22 VYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL   99 (272)
T ss_pred             EEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHH
Confidence            8999999999999999987532  2345788899999998 799999999998753      468999999986 55554


Q ss_pred             HHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccC
Q psy6044          74 FDSL-NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRP  152 (282)
Q Consensus        74 ~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~a  152 (282)
                      +... ...+++..+..++.|++.||+|||+++++|+|++|+||+++.++.++|+|||++..............++..|+|
T Consensus       100 l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~a  179 (272)
T cd06637         100 IKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA  179 (272)
T ss_pred             HHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccC
Confidence            4442 346899999999999999999999999999999999999999999999999998765433333344566888999


Q ss_pred             hhhhcC----CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         153 PDVLFG----AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPS  228 (282)
Q Consensus       153 PE~~~~----~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
                      ||.+..    ...++.++|+||+|+++|++++|+.|+. .............   ..                       
T Consensus       180 PE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~-~~~~~~~~~~~~~---~~-----------------------  232 (272)
T cd06637         180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC-DMHPMRALFLIPR---NP-----------------------  232 (272)
T ss_pred             HhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcc-ccCHHHHHHHHhc---CC-----------------------
Confidence            999853    2236889999999999999999988853 3332222221111   00                       


Q ss_pred             CCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         229 MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       229 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                       ........++..+.+|+.+||..||.+|||+.+++.||||
T Consensus       233 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         233 -APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             -CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence             0001123467899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.7e-41  Score=271.27  Aligned_cols=240  Identities=24%  Similarity=0.399  Sum_probs=194.7

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCC----CCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHh
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGN----EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS   76 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~   76 (282)
                      .||+|.+..+++.|++|.+.....    ....+.+.+|+.+++.++||||+++++++.+....++++||++|..+..+..
T Consensus        15 ~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   94 (258)
T cd06632          15 SVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLK   94 (258)
T ss_pred             eEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHH
Confidence            389999998999999999876321    2234568899999999999999999999999999999999998755555555


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhh
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~  156 (282)
                      ..+.+++..+..++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|++||.+
T Consensus        95 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~~~~~~~~~y~~pe~~  173 (258)
T cd06632          95 KYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FAKSFKGSPYWMAPEVI  173 (258)
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-cccccCCCcceeCHHHh
Confidence            56679999999999999999999999999999999999999999999999999887654332 22334567889999998


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       157 ~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      .....++.++|+||||+++|++++|..| |......+.........                           ....++.
T Consensus       174 ~~~~~~~~~~D~~slG~~l~~l~~g~~p-f~~~~~~~~~~~~~~~~---------------------------~~~~~~~  225 (258)
T cd06632         174 AQQGGYGLAADIWSLGCTVLEMATGKPP-WSQLEGVAAVFKIGRSK---------------------------ELPPIPD  225 (258)
T ss_pred             cCCCCCCchhhhHHHHHHHHHHHhCCCC-cccCcHHHHHHHHHhcc---------------------------cCCCcCC
Confidence            6554468999999999999999988877 54444333332222110                           1122345


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      .+++.+.+++++||+.+|.+|||+.+++.|||+
T Consensus       226 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         226 HLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             CcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            578999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.9e-41  Score=278.59  Aligned_cols=240  Identities=25%  Similarity=0.362  Sum_probs=195.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCCC--CCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGN--EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|++..+|+.|++|++.....  ......+.+|+.+++.++|||++++++++.+....|+|+||+.|++++.+.....
T Consensus        37 v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~  116 (313)
T cd06633          37 VYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKK  116 (313)
T ss_pred             EEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCC
Confidence            89999999999999999876322  2233567889999999999999999999999999999999999999888877677


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC-
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG-  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-  158 (282)
                      .+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....    .....++..|+|||.+.. 
T Consensus       117 ~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~  192 (313)
T cd06633         117 PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----ANSFVGTPYWMAPEVILAM  192 (313)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----CCCccccccccChhhcccc
Confidence            899999999999999999999999999999999999999999999999998864332    123456788999999842 


Q ss_pred             -CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         159 -AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       159 -~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                       ...++.++|+||||+++|++++|..|++... .......+...  ..+                         ......
T Consensus       193 ~~~~~~~~sDv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~--~~~-------------------------~~~~~~  244 (313)
T cd06633         193 DEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQN--DSP-------------------------TLQSNE  244 (313)
T ss_pred             CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhc--CCC-------------------------CCCccc
Confidence             2336889999999999999999888855443 33333322221  000                         001234


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      ++..+.+|+.+||+.+|.+||++.+++.||||+..+
T Consensus       245 ~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         245 WTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            677899999999999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.2e-41  Score=276.13  Aligned_cols=243  Identities=23%  Similarity=0.343  Sum_probs=197.0

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||+|.+..+++.+|+|.+...........+.+|+.++++++||||+++++++..+...++|+||++|+.+..+.. ...
T Consensus        19 ~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~-~~~   97 (277)
T cd06641          19 EVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGP   97 (277)
T ss_pred             EEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHh-cCC
Confidence            3899999999999999988754333345678899999999999999999999999999999999998755555544 457


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+..
T Consensus        98 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~  177 (277)
T cd06641          98 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA  177 (277)
T ss_pred             CCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccCCccccChhhhccCC
Confidence            89999999999999999999999999999999999999999999999998876543332233345677899999987665


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                       .+.++|+||+|+++|++++|..| +...........+...                            ........++.
T Consensus       178 -~~~~~Dv~slG~~l~~l~~g~~p-~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~  227 (277)
T cd06641         178 -YDSKADIWSLGITAIELAKGEPP-HSELHPMKVLFLIPKN----------------------------NPPTLEGNYSK  227 (277)
T ss_pred             -CCchhhHHHHHHHHHHHHcCCCC-CCccchHHHHHHHhcC----------------------------CCCCCCcccCH
Confidence             68899999999999999988777 5554443333332111                            01112345788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      .+.++|.+||+.+|.+||++.++++||||.+...
T Consensus       228 ~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~  261 (277)
T cd06641         228 PLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK  261 (277)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhh
Confidence            9999999999999999999999999999986543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=8.9e-42  Score=285.95  Aligned_cols=271  Identities=35%  Similarity=0.625  Sum_probs=204.4

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeC--CeEEEEEecCcccHHHHHHh
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSE--KKLTLVFEHCDQDLKKYFDS   76 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~--~~~~iv~e~~~g~l~~~~~~   76 (282)
                      .||+|.+..+|+.+|+|++... ........+.+|+.+++++ +||||+++++++...  ...++|+||+++++...+..
T Consensus        22 ~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~  101 (337)
T cd07852          22 IVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRA  101 (337)
T ss_pred             eEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccccCHHHHHhc
Confidence            3899999999999999988652 2223345677899999999 999999999998653  46899999999988777654


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-----ccccccccccccc
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-----KCYSAEVVTLWYR  151 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~~  151 (282)
                        ..+++..+..++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+.......     .......++..|+
T Consensus       102 --~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~  179 (337)
T cd07852         102 --NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYR  179 (337)
T ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhccccccccc
Confidence              378899999999999999999999999999999999999999999999999887654322     1222345678899


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCC--CCCCCCCCCCCCCC
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNL--LPDFKPFPMYHPSM  229 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  229 (282)
                      |||.+.+...++.++|+||||+++|++++|..| |.+....+....+....+.+....+.....  ....-.........
T Consensus       180 aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (337)
T cd07852         180 APEILLGSTRYTKGVDMWSVGCILGEMLLGKPL-FPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRK  258 (337)
T ss_pred             CceeeeccccccccchHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhccccccc
Confidence            999886655578999999999999999988766 676666666666655554433221111000  00000000000111


Q ss_pred             CccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      ......+.++.++.++|.+||+.||.+|||+.++++||||++...
T Consensus       259 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~  303 (337)
T cd07852         259 PLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN  303 (337)
T ss_pred             chhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence            222333458899999999999999999999999999999998744

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.8e-41  Score=272.56  Aligned_cols=240  Identities=26%  Similarity=0.419  Sum_probs=187.7

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCC-C---CCCccHHHHHHHHhhCCCCCccceeeeeee--CCeEEEEEecCcccHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGN-E---GVPSSALREICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~-~---~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~--~~~~~iv~e~~~g~l~~~~   74 (282)
                      .||+|.+..+|..|++|.+..... .   .....+.+|+.++++++||||+++++++.+  ....++++||+++..+...
T Consensus        17 ~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~   96 (266)
T cd06651          17 RVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQ   96 (266)
T ss_pred             EEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHH
Confidence            389999999999999999876321 1   123457889999999999999999999875  3678999999987544444


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc---ccccccccccccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---KCYSAEVVTLWYR  151 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~  151 (282)
                      ......+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.......   .......++..|+
T Consensus        97 l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~  176 (266)
T cd06651          97 LKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM  176 (266)
T ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCcccccc
Confidence            4445678999999999999999999999999999999999999999999999999987553211   1112234677899


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSF  231 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
                      |||.+.+.. ++.++|+||+|+++|++++|+.| |..............   ..                        ..
T Consensus       177 aPE~~~~~~-~~~~~Dv~slG~i~~el~~g~~p-f~~~~~~~~~~~~~~---~~------------------------~~  227 (266)
T cd06651         177 SPEVISGEG-YGRKADVWSLGCTVVEMLTEKPP-WAEYEAMAAIFKIAT---QP------------------------TN  227 (266)
T ss_pred             CHHHhCCCC-CCchhhhHHHHHHHHHHHHCCCC-ccccchHHHHHHHhc---CC------------------------CC
Confidence            999997765 68999999999999999998877 554433333322211   10                        11


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS  270 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  270 (282)
                      ..++..+++.+.+++ .||..+|++|||++++++||||+
T Consensus       228 ~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         228 PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            123345788899999 57778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.8e-41  Score=274.79  Aligned_cols=245  Identities=23%  Similarity=0.330  Sum_probs=191.2

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCC--CCCCccHHHHHH---HHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGN--EGVPSSALREIC---LLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~---~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~   75 (282)
                      .||+|.+..+|+.||+|.+.....  ......+..|..   .++...||+|+++++++......++|+||++|+.+..+.
T Consensus         9 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l   88 (278)
T cd05606           9 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL   88 (278)
T ss_pred             EEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHH
Confidence            389999999999999999876221  111122344443   344457999999999999999999999999876666666


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhh
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDV  155 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~  155 (282)
                      ...+.+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++.++|+|||.+........  ....++..|+|||.
T Consensus        89 ~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~y~aPE~  166 (278)
T cd05606          89 SQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPEV  166 (278)
T ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--cCcCCCcCCcCcHH
Confidence            5577899999999999999999999999999999999999999999999999999876543222  23467889999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC--hHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSD--VDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      +.+...++.++|+||+|+++|++++|..|+.....  ..+.......                             ....
T Consensus       167 ~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~  217 (278)
T cd05606         167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-----------------------------MAVE  217 (278)
T ss_pred             hcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc-----------------------------cCCC
Confidence            97654478999999999999999998888433321  1111111110                             1112


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCccch
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~  276 (282)
                      .+..++..+.+++++||..+|.+||     ++.++++||||+..++..
T Consensus       218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~  265 (278)
T cd05606         218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM  265 (278)
T ss_pred             CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence            3345789999999999999999999     999999999999986543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4e-41  Score=271.55  Aligned_cols=238  Identities=28%  Similarity=0.497  Sum_probs=193.3

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC-
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~-   78 (282)
                      ||+|.++.+|..+|+|.+... ......+.+.+|+.+++.++|+|++++++.+..+...++|+||++| ++.+.+.... 
T Consensus        16 v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~   95 (257)
T cd08225          16 IYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRG   95 (257)
T ss_pred             EEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccC
Confidence            899999999999999998772 2333456788999999999999999999999999999999999976 5555554433 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc-EEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE-LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||.+..............++..|+|||...
T Consensus        96 ~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~  175 (257)
T cd08225          96 VLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQ  175 (257)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHc
Confidence            24799999999999999999999999999999999999988864 69999999877654433333445688899999987


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|+||||++++++++|..| |...+..+........                            ......+.
T Consensus       176 ~~~-~~~~~Dv~slG~il~~l~~g~~p-~~~~~~~~~~~~~~~~----------------------------~~~~~~~~  225 (257)
T cd08225         176 NRP-YNNKTDIWSLGCVLYELCTLKHP-FEGNNLHQLVLKICQG----------------------------YFAPISPN  225 (257)
T ss_pred             CCC-CCchhhHHHHHHHHHHHHhCCCC-CCCccHHHHHHHHhcc----------------------------cCCCCCCC
Confidence            665 68999999999999999988887 5544444433332221                            11122345


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      ++..+.++|.+||..+|++|||+.+++.||||
T Consensus       226 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         226 FSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            78899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.1e-41  Score=273.92  Aligned_cols=244  Identities=28%  Similarity=0.461  Sum_probs=193.7

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCC-----CCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNE-----GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~   75 (282)
                      .||+|.+..+|+.+|+|++......     .....+.+|+.++++++||||+++++++.+.+..++|+||++|..+..+.
T Consensus        15 ~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l   94 (268)
T cd06630          15 SCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLL   94 (268)
T ss_pred             EEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHH
Confidence            3899999999999999998753211     12457889999999999999999999999999999999999976666555


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC-cEEEEecCCccccCCCccc----cccccccccc
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG-ELKLADFGLARAFGIPVKC----YSAEVVTLWY  150 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~-~~~l~df~~~~~~~~~~~~----~~~~~~~~~~  150 (282)
                      ...+.+++..+..++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.+.........    .....++..|
T Consensus        95 ~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~  174 (268)
T cd06630          95 SKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAF  174 (268)
T ss_pred             HHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccce
Confidence            5567899999999999999999999999999999999999998776 5999999998766533211    1223457789


Q ss_pred             cChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMS  230 (282)
Q Consensus       151 ~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
                      +|||.+.+.. ++.++|+||+|++++++++|..| |...........+.......                        .
T Consensus       175 ~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p-~~~~~~~~~~~~~~~~~~~~------------------------~  228 (268)
T cd06630         175 MAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKPP-WNAEKHSNHLALIFKIASAT------------------------T  228 (268)
T ss_pred             eCHhHhccCC-CCcccchHHHHHHHHHHHhCCCC-CCCCCCcchHHHHHHHhccC------------------------C
Confidence            9999987655 68999999999999999998877 44333222222222211000                        1


Q ss_pred             ccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q psy6044         231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS  270 (282)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  270 (282)
                      ....+..+++.+.+++.+||..+|.+|||+.++++||||+
T Consensus       229 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            1223456889999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=6.7e-41  Score=271.54  Aligned_cols=239  Identities=25%  Similarity=0.365  Sum_probs=190.9

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCC-----CCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHh
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNE-----GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS   76 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~   76 (282)
                      ||+|.+ .+|+.+|+|.+......     .....+.+|+++++.++|+||+++++++.++...++++||++|..+..+..
T Consensus        16 v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   94 (265)
T cd06631          16 VYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILN   94 (265)
T ss_pred             EEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHH
Confidence            789887 57999999988753221     112457889999999999999999999999999999999998866666655


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC------ccccccccccccc
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP------VKCYSAEVVTLWY  150 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~------~~~~~~~~~~~~~  150 (282)
                      ..+.+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+......      ........++..|
T Consensus        95 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (265)
T cd06631          95 RFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW  174 (265)
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccc
Confidence            5678899999999999999999999999999999999999999999999999988654211      1112233567889


Q ss_pred             cChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMS  230 (282)
Q Consensus       151 ~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
                      +|||.+.+.. ++.++|+||||+++|++++|..|+ ...+.......+.....                          .
T Consensus       175 ~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~-~~~~~~~~~~~~~~~~~--------------------------~  226 (265)
T cd06631         175 MAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPL-ASMDRLAAMFYIGAHRG--------------------------L  226 (265)
T ss_pred             cChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCcc-ccCChHHHHHHhhhccC--------------------------C
Confidence            9999987766 689999999999999999988884 44333332222222110                          1


Q ss_pred             ccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      ....+..++..+.++|++||+.+|.+|||+.++++||||
T Consensus       227 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         227 MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            122345688999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.2e-41  Score=273.15  Aligned_cols=239  Identities=28%  Similarity=0.476  Sum_probs=194.5

Q ss_pred             CeeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeee--CCeEEEEEecCcc-cHHHHHHh
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQ-DLKKYFDS   76 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~--~~~~~iv~e~~~g-~l~~~~~~   76 (282)
                      .||+|.+..+|+.+|+|.+.. .......+.+..|+.+++.++|||++++++++..  ....++++||+++ ++.+.+..
T Consensus        15 ~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~   94 (265)
T cd08217          15 TVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQK   94 (265)
T ss_pred             EEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHH
Confidence            389999999999999999876 2333345678889999999999999999998764  4578999999986 45555443


Q ss_pred             c---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccc
Q psy6044          77 L---NGEIDLDIVKSFMYQLLRGLAFCH-----SRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL  148 (282)
Q Consensus        77 ~---~~~~~~~~~~~~~~qi~~~l~~lh-----~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~  148 (282)
                      .   ...+++..++.++.||+.||.+||     +.+++|+||+|+||+++.++.++|+|||.+..............++.
T Consensus        95 ~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~  174 (265)
T cd08217          95 CKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTP  174 (265)
T ss_pred             HhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCC
Confidence            2   467999999999999999999999     89999999999999999999999999999987764443233446788


Q ss_pred             cccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPS  228 (282)
Q Consensus       149 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
                      .|+|||.+.+.. ++.++|+||||++++++++|..| |...+..+....+...                           
T Consensus       175 ~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p-~~~~~~~~~~~~~~~~---------------------------  225 (265)
T cd08217         175 YYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPP-FTARNQLQLASKIKEG---------------------------  225 (265)
T ss_pred             CccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCc-ccCcCHHHHHHHHhcC---------------------------
Confidence            899999997766 68999999999999999988877 6655544444433221                           


Q ss_pred             CCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         229 MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       229 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                       .....+..++..+.+++.+||+.+|.+|||++++++|||+
T Consensus       226 -~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         226 -KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             -CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence             1112334578999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4e-41  Score=270.90  Aligned_cols=236  Identities=22%  Similarity=0.315  Sum_probs=187.7

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      .||+|+++.+|+.+|+|.+...........+.+|++++++++||||+++++++......++|+||++| ++.+.+.....
T Consensus        10 ~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~   89 (252)
T cd05084          10 EVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGP   89 (252)
T ss_pred             cEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCC
Confidence            48999999999999999876543334456789999999999999999999999999999999999976 55555544445


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccc--ccccccccccChhhhc
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY--SAEVVTLWYRPPDVLF  157 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~  157 (282)
                      .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..........  .....+..|+|||.+.
T Consensus        90 ~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  169 (252)
T cd05084          90 RLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALN  169 (252)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhc
Confidence            68999999999999999999999999999999999999999999999999987544221111  1112235699999987


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|+||||+++|++++++.+++......+....+.....                            ...+..
T Consensus       170 ~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~  220 (252)
T cd05084         170 YGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR----------------------------LPCPEL  220 (252)
T ss_pred             CCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC----------------------------CCCccc
Confidence            666 689999999999999999856655766555544443332110                            012234


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ++..+.+++.+||+.+|++|||+.++++
T Consensus       221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         221 CPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            6889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.8e-41  Score=281.57  Aligned_cols=278  Identities=38%  Similarity=0.619  Sum_probs=210.1

Q ss_pred             CeeeeeeCCC--CceEEEeeeecC-CCCCCCccHHHHHHHHhhC-CCCCccceeeeeee----CCeEEEEEecCcccHHH
Q psy6044           1 MFTSGVDRTP--NTALAIKGTHLV-GNEGVPSSALREICLLKEL-KHKNIVRLYDVLHS----EKKLTLVFEHCDQDLKK   72 (282)
Q Consensus         1 ~vy~a~~~~~--~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~----~~~~~iv~e~~~g~l~~   72 (282)
                      .||+|.+..+  +..||+|++... ........+.+|+.+++++ .||||+++++....    ....+++++++++++.+
T Consensus        15 ~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~~~L~~   94 (332)
T cd07857          15 IVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQ   94 (332)
T ss_pred             EEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEecccCCHHH
Confidence            3899999888  999999998752 2223345678899999999 59999999987543    25688999999988877


Q ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc----ccccccccc
Q psy6044          73 YFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK----CYSAEVVTL  148 (282)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~  148 (282)
                      .+.. ...+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+........    ......++.
T Consensus        95 ~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~  173 (332)
T cd07857          95 IIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR  173 (332)
T ss_pred             HHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCc
Confidence            7654 67799999999999999999999999999999999999999999999999999876542211    122335688


Q ss_pred             cccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCC---CCCCCC
Q psy6044         149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDF---KPFPMY  225 (282)
Q Consensus       149 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  225 (282)
                      .|+|||...+...++.++|+||+|+++|++++|. ++|...+.......+...++.++.+.+.........   .... .
T Consensus       174 ~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  251 (332)
T cd07857         174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK-PVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLP-N  251 (332)
T ss_pred             cccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCC-cCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhcc-c
Confidence            8999999876555799999999999999999665 557777777777777777766554332211110000   0000 0


Q ss_pred             CCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccchhhhhc
Q psy6044         226 HPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKSERC  281 (282)
Q Consensus       226 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~  281 (282)
                      ..........+..+..+.+|+.+||+.||++|||+.+++.||||+....+.....|
T Consensus       252 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~  307 (332)
T cd07857         252 IPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVC  307 (332)
T ss_pred             cCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccc
Confidence            01112222334568899999999999999999999999999999877665544444

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.8e-41  Score=279.46  Aligned_cols=240  Identities=25%  Similarity=0.354  Sum_probs=194.7

Q ss_pred             eeeeeeCCCCceEEEeeeecCC--CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG--NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|.+..+|+.||+|++....  .......+.+|+.+++.++|||++++++++.++...++|+||++|++.+.+.....
T Consensus        31 vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~  110 (307)
T cd06607          31 VYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKK  110 (307)
T ss_pred             EEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhCCCHHHHHHHccc
Confidence            8999999999999999987522  22233568899999999999999999999999999999999999999888876667


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC-
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG-  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-  158 (282)
                      .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......    ....++..|+|||.+.+ 
T Consensus       111 ~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~  186 (307)
T cd06607         111 PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA----NSFVGTPYWMAPEVILAM  186 (307)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC----CCccCCccccCceeeecc
Confidence            8999999999999999999999999999999999999999999999999988654322    22355778999998742 


Q ss_pred             -CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         159 -AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       159 -~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                       ...++.++|+||||+++|++++|..|+ ...+.......+...  .++                         ......
T Consensus       187 ~~~~~~~~sDv~s~G~il~el~tg~~p~-~~~~~~~~~~~~~~~--~~~-------------------------~~~~~~  238 (307)
T cd06607         187 DEGQYDGKVDVWSLGITCIELAERKPPL-FNMNAMSALYHIAQN--DSP-------------------------TLSSND  238 (307)
T ss_pred             CCCCCCcccchHHHHHHHHHHHcCCCCC-CCccHHHHHHHHhcC--CCC-------------------------CCCchh
Confidence             233688999999999999999988774 444433332222110  000                         000123


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      ++..+.++|.+||+.||.+|||+.+++.||||....
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         239 WSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             hCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            678899999999999999999999999999998654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=6.1e-41  Score=270.31  Aligned_cols=238  Identities=26%  Similarity=0.433  Sum_probs=193.7

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      .||+|.+..+++.+|+|.+... ........+.+|++++++++|||++++++.+...+..++|+||++| ++.+.+....
T Consensus        15 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   94 (256)
T cd08220          15 IVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRC   94 (256)
T ss_pred             EEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhc
Confidence            3799999999999999999863 3334456788999999999999999999999999999999999986 5555554432


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC-cEEEEecCCccccCCCccccccccccccccChhhh
Q psy6044          79 -GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG-ELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        79 -~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~  156 (282)
                       ..+++..+..++.+++.||.+||++|++|+||+|.||+++.++ .++|+|||.+........ .....++..|+|||.+
T Consensus        95 ~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~y~aPE~~  173 (256)
T cd08220          95 NSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-AYTVVGTPCYISPELC  173 (256)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-ccccccCCcccCchhc
Confidence             3589999999999999999999999999999999999998654 579999999987653322 2234567889999998


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       157 ~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      .... ++.++|+||+|+++|++++|..| |...+.......+...                            ....++.
T Consensus       174 ~~~~-~~~~~Dv~slG~~l~~l~~~~~~-~~~~~~~~~~~~~~~~----------------------------~~~~~~~  223 (256)
T cd08220         174 EGKP-YNQKSDIWALGCVLYELASLKRA-FEAANLPALVLKIMSG----------------------------TFAPISD  223 (256)
T ss_pred             cCCC-CCcccchHHHHHHHHHHHhCCCC-cccCchHHHHHHHHhc----------------------------CCCCCCC
Confidence            7665 68999999999999999998877 5555554444433321                            1112234


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      .++..+.+++..||+.||.+|||+.++++||||
T Consensus       224 ~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         224 RYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             CcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence            578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.5e-41  Score=305.41  Aligned_cols=245  Identities=28%  Similarity=0.448  Sum_probs=192.8

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeee--CCeEEEEEecCcc-cHHHHHHh
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQ-DLKKYFDS   76 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~--~~~~~iv~e~~~g-~l~~~~~~   76 (282)
                      .||+|.++.++..+|+|++... ........+..|+.++++++||||++++++|..  ...+||||||+++ +|...+..
T Consensus        28 tVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k  107 (1021)
T PTZ00266         28 EVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQK  107 (1021)
T ss_pred             EEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHH
Confidence            3899999999999999998762 333345678899999999999999999998854  4679999999985 55555543


Q ss_pred             c---CCCCCHHHHHHHHHHHHHHHHHHHhC-------CccccCCCCCcEEEcC-----------------CCcEEEEecC
Q psy6044          77 L---NGEIDLDIVKSFMYQLLRGLAFCHSR-------NVLHRDLKPQNLLINK-----------------NGELKLADFG  129 (282)
Q Consensus        77 ~---~~~~~~~~~~~~~~qi~~~l~~lh~~-------~i~H~dl~~~nil~~~-----------------~~~~~l~df~  129 (282)
                      .   .+.+++..++.|+.||+.||.|||+.       +|+|+||||+|||++.                 .+.++|+|||
T Consensus       108 ~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFG  187 (1021)
T PTZ00266        108 CYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG  187 (1021)
T ss_pred             HhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCC
Confidence            2   35799999999999999999999984       4999999999999964                 2358999999


Q ss_pred             CccccCCCccccccccccccccChhhhcCC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy6044         130 LARAFGIPVKCYSAEVVTLWYRPPDVLFGA-KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTED  208 (282)
Q Consensus       130 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  208 (282)
                      ++....... ......+++.|+|||.+... ..++.++|||||||++|+|++|..||............+...    +. 
T Consensus       188 lAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~----p~-  261 (1021)
T PTZ00266        188 LSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG----PD-  261 (1021)
T ss_pred             ccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcC----CC-
Confidence            997664332 22334678999999998543 346899999999999999999988854444444333332221    00 


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         209 TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                                              ......+.++.+||..||..+|.+|||+.++|.|||++.+..+
T Consensus       262 ------------------------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p  304 (1021)
T PTZ00266        262 ------------------------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP  304 (1021)
T ss_pred             ------------------------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence                                    0113468899999999999999999999999999999987654

>KOG4279|consensus

Probab=100.00  E-value=1.3e-42  Score=294.40  Aligned_cols=244  Identities=24%  Similarity=0.395  Sum_probs=208.0

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhc-CC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL-NG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~-~~   79 (282)
                      +||.|+|+.+...+|||.+....++ ..+.+..|+.+.++++|.|||++.|.+.+++.+-|.||.++|+.++.+.+. =|
T Consensus       590 ~VYA~RD~~tqvrIaIKEIpekdsr-~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWG  668 (1226)
T KOG4279|consen  590 TVYAARDMDTQVRIAIKEIPEKDSR-EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWG  668 (1226)
T ss_pred             EEEeeccccceeEEEeeecccccch-hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccC
Confidence            5999999999999999998764433 458899999999999999999999999999999999999998766666554 36


Q ss_pred             CC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc-CCCcEEEEecCCccccCCCccccccccccccccChhhh
Q psy6044          80 EI--DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        80 ~~--~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~  156 (282)
                      ++  .|+.+..+.+||++||.|||++.|+|||||.+|++++ -.|.+||+|||-++++..-++......||..|+|||++
T Consensus       669 PlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvI  748 (1226)
T KOG4279|consen  669 PLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVI  748 (1226)
T ss_pred             CCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhh
Confidence            77  8999999999999999999999999999999999996 47999999999999887667777777889999999999


Q ss_pred             c-CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         157 F-GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       157 ~-~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      . +...|+.++|||||||++.||.||+.||.........+.+.---                  +         ..+.++
T Consensus       749 DqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmy------------------K---------vHP~iP  801 (1226)
T KOG4279|consen  749 DQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMY------------------K---------VHPPIP  801 (1226)
T ss_pred             ccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcce------------------e---------cCCCCc
Confidence            4 34558999999999999999999888866555554433322110                  0         334567


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      ..+|.++++||.+|+.+||.+||++.++|+.||++.-
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence            7799999999999999999999999999999999865

>KOG0574|consensus

Probab=100.00  E-value=2.8e-43  Score=272.26  Aligned_cols=245  Identities=22%  Similarity=0.359  Sum_probs=207.4

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~~~~   80 (282)
                      ||+|.++.+|+.+|||.+..   +...+.+.+|+.++++.++|++|++|+.+-....+|||||||+ |+..+.+..++.+
T Consensus        49 V~KAIH~EsG~v~AIK~VPV---~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~  125 (502)
T KOG0574|consen   49 VHKAIHRESGHVLAIKKVPV---DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKP  125 (502)
T ss_pred             HHHHHHhccCcEEEEEecCc---cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCC
Confidence            78999999999999998764   3456889999999999999999999999999999999999997 6777777777889


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      ++++++..+++.-+.||+|||...-+|+|||..||+++.+|..||.|||.+-.+...........||+.|+|||++..-.
T Consensus       126 L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIG  205 (502)
T KOG0574|consen  126 LSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIG  205 (502)
T ss_pred             ccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhc
Confidence            99999999999999999999999999999999999999999999999999988876666667788999999999998777


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                       |..++||||||++..||..|+.| +.+-.+...+..+                          ...+..--..+...|.
T Consensus       206 -Y~~~ADIWSLGITaIEMAEG~PP-YsDIHPMRAIFMI--------------------------PT~PPPTF~KPE~WS~  257 (502)
T KOG0574|consen  206 -YDTKADIWSLGITAIEMAEGRPP-YSDIHPMRAIFMI--------------------------PTKPPPTFKKPEEWSS  257 (502)
T ss_pred             -cchhhhHhhhcchhhhhhcCCCC-cccccccceeEec--------------------------cCCCCCCCCChHhhhh
Confidence             79999999999999999966555 5544332211111                          0111111122345889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccchh
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  277 (282)
                      ++.+||++||.++|++|-|+.++++|||+++-+.+..
T Consensus       258 ~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I  294 (502)
T KOG0574|consen  258 EFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCDI  294 (502)
T ss_pred             HHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccH
Confidence            9999999999999999999999999999998766543

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=8.6e-41  Score=274.43  Aligned_cols=244  Identities=21%  Similarity=0.398  Sum_probs=197.4

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||+|.++.+|+.||+|++.... ......+.+|+.+++.++|+|++++++.+...+..++++||++++.+..+.. .+.
T Consensus        35 ~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~  112 (292)
T cd06657          35 IVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTR  112 (292)
T ss_pred             EEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHh-cCC
Confidence            38999999999999999876422 2234568889999999999999999999999999999999998866666554 457


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..+..++.|++.|+++||+.|++|+||+|.||+++.++.++|+|||.+..............++..|++||.+....
T Consensus       113 ~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~  192 (292)
T cd06657         113 MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP  192 (292)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCccccCHHHhcCCC
Confidence            89999999999999999999999999999999999999999999999998876543333333345678899999886655


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                       ++.++|+||+|+++|++++|..| |......+....+......                         . ......++.
T Consensus       193 -~~~~~Dv~slGvil~el~tg~~p-~~~~~~~~~~~~~~~~~~~-------------------------~-~~~~~~~~~  244 (292)
T cd06657         193 -YGPEVDIWSLGIMVIEMVDGEPP-YFNEPPLKAMKMIRDNLPP-------------------------K-LKNLHKVSP  244 (292)
T ss_pred             -CCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhhCCc-------------------------c-cCCcccCCH
Confidence             68999999999999999998887 5444444443333322110                         0 001234788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      .+.+++.+||+.||.+||++.++++||||.....
T Consensus       245 ~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         245 SLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             HHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence            8999999999999999999999999999997753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-40  Score=271.37  Aligned_cols=244  Identities=25%  Similarity=0.399  Sum_probs=189.9

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCC---------CCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEG---------VPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKK   72 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~---------~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~   72 (282)
                      ||+|.+..+|+.+|+|.+.......         ..+.+..|+.+++.++|||++++++++...+..++|+||++|+.+.
T Consensus        17 vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   96 (272)
T cd06629          17 VYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIG   96 (272)
T ss_pred             EEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHH
Confidence            8999999999999999886521111         1235778999999999999999999999999999999999875555


Q ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--ccccccccccc
Q psy6044          73 YFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--CYSAEVVTLWY  150 (282)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~  150 (282)
                      ......+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........  ......++..|
T Consensus        97 ~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y  176 (272)
T cd06629          97 SCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW  176 (272)
T ss_pred             HHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccc
Confidence            5555467899999999999999999999999999999999999999999999999999876542211  11223457789


Q ss_pred             cChhhhcCCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         151 RPPDVLFGAK-LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSM  229 (282)
Q Consensus       151 ~aPE~~~~~~-~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
                      +|||.+.... .++.++|+||||++++++++|..| |......+...........   ..                    
T Consensus       177 ~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p-~~~~~~~~~~~~~~~~~~~---~~--------------------  232 (272)
T cd06629         177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEEAIAAMFKLGNKRSA---PP--------------------  232 (272)
T ss_pred             cCHHHhccccCCCCccchhHHHHHHHHHHHhCCCC-CcCcchHHHHHHhhccccC---Cc--------------------
Confidence            9999986543 368899999999999999998877 4443333222221110000   00                    


Q ss_pred             CccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      ........++..+.++|.+||..+|.+|||++++++||||
T Consensus       233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         233 IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             CCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            0112234578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0983|consensus

Probab=100.00  E-value=5.7e-42  Score=261.42  Aligned_cols=246  Identities=18%  Similarity=0.297  Sum_probs=205.2

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      .||+++.+.+|...|||......+.+..+.++..+.++..- ++|+||+++++|..+..++|-||.+..-.-..+....+
T Consensus       107 ~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~C~ekLlkrik~  186 (391)
T KOG0983|consen  107 QVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMSTCAEKLLKRIKG  186 (391)
T ss_pred             ceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHHHHHHHHHHhcC
Confidence            48999999999999999999866666678888888887766 58999999999999999999999887655555556578


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSR-NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +++|..+-++...++.||.||.++ |++|+|+||+||++|..|++||+|||.+-.+... ...+...|.+.|+|||.+..
T Consensus       187 piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-kAhtrsAGC~~YMaPERidp  265 (391)
T KOG0983|consen  187 PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-KAHTRSAGCAAYMAPERIDP  265 (391)
T ss_pred             CchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc-cccccccCCccccCccccCC
Confidence            899999999999999999999965 8999999999999999999999999999877533 33344567888999999854


Q ss_pred             C--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         159 A--KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       159 ~--~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      .  ..|..++||||||+.++||.||+.|+-....+-+.+..+.+.  .|+.                       +. -..
T Consensus       266 ~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~--ePP~-----------------------L~-~~~  319 (391)
T KOG0983|consen  266 PDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE--EPPL-----------------------LP-GHM  319 (391)
T ss_pred             CCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--CCCC-----------------------CC-ccc
Confidence            4  347899999999999999999999966666667777776652  1110                       00 112


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      .+|+.+++|+..||..|+.+||...++|+|||+....
T Consensus       320 gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  320 GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             CcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence            3899999999999999999999999999999998653

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=9e-41  Score=278.55  Aligned_cols=270  Identities=34%  Similarity=0.579  Sum_probs=205.9

Q ss_pred             CeeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeee-CCeEEEEEecCcccHHHHHHhcC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHS-EKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~-~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      .||+|.++.+|+.||+|++.. .........+..|+.+++.++||||+++++++.. ....++++||+++++...+.  .
T Consensus        25 ~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~~~~L~~~~~--~  102 (328)
T cd07856          25 LVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLT--S  102 (328)
T ss_pred             EEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehhccCHHHHHh--c
Confidence            389999999999999998876 3333445678899999999999999999999875 56789999999887766554  3


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+......   .....++..|+|||.+.+
T Consensus       103 ~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~  179 (328)
T cd07856         103 RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---MTGYVSTRYYRAPEIMLT  179 (328)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC---cCCCcccccccCceeeec
Confidence            56889999999999999999999999999999999999999999999999998765422   123355778999998866


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCC--CCCCCCCCCCccccCc
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFK--PFPMYHPSMSFSQVAP  236 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  236 (282)
                      ...++.++|+||||+++|++++|..| |...........+.+.++.++.+...........+  ............+..+
T Consensus       180 ~~~~~~~~Dv~slG~il~el~tg~~~-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (328)
T cd07856         180 WQKYDVEVDIWSAGCIFAEMLEGKPL-FPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFK  258 (328)
T ss_pred             cCCcCcHHHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcC
Confidence            44579999999999999999988665 77766666666666665554433222110000000  0000011112223345


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      .++..+.++|++||+.+|++|||+++++.||||+....+.
T Consensus       259 ~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~  298 (328)
T cd07856         259 NADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT  298 (328)
T ss_pred             CCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCc
Confidence            6789999999999999999999999999999998765553

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-41  Score=272.16  Aligned_cols=239  Identities=25%  Similarity=0.376  Sum_probs=188.2

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCC------eEEEEEecCcccHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEK------KLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~------~~~iv~e~~~g~l~~~~   74 (282)
                      ||+|.++.+++.+++|++.....  ..+.+.+|+.+++++ +|+||+++++++....      .+++|+||++++.+..+
T Consensus        22 v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~   99 (275)
T cd06608          22 VYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDL   99 (275)
T ss_pred             EEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHH
Confidence            79999999999999999876332  236788999999999 7999999999997644      58999999987544443


Q ss_pred             Hhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccc
Q psy6044          75 DSL----NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWY  150 (282)
Q Consensus        75 ~~~----~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  150 (282)
                      ...    +..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............++..|
T Consensus       100 ~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y  179 (275)
T cd06608         100 VKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYW  179 (275)
T ss_pred             HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccc
Confidence            322    3579999999999999999999999999999999999999999999999999987665444444445678889


Q ss_pred             cChhhhcCC----CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         151 RPPDVLFGA----KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYH  226 (282)
Q Consensus       151 ~aPE~~~~~----~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (282)
                      +|||.+...    ..++.++|+||||+++|++++|..|+ ...........+...   ...                   
T Consensus       180 ~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~-~~~~~~~~~~~~~~~---~~~-------------------  236 (275)
T cd06608         180 MAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL-CDMHPMRALFKIPRN---PPP-------------------  236 (275)
T ss_pred             cCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCc-cccchHHHHHHhhcc---CCC-------------------
Confidence            999987432    23678999999999999999888774 443333333322211   000                   


Q ss_pred             CCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         227 PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       227 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                          .......++..+.++|.+||..||++|||+.++++|||+
T Consensus       237 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         237 ----TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             ----CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                001123478899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-41  Score=268.19  Aligned_cols=236  Identities=27%  Similarity=0.433  Sum_probs=194.7

Q ss_pred             eeeeeeCCCCceEEEeeeecCC--CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG--NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      ||+|.+..+++.+|+|++....  .......+..|+.++++++|||++++++.+..+...++++|++++ ++.+.+.. .
T Consensus         9 v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~-~   87 (250)
T cd05123           9 VLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSK-E   87 (250)
T ss_pred             EEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHh-c
Confidence            7999999999999999988632  222455788999999999999999999999999999999999965 55555544 5


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+..............++..|++||...+
T Consensus        88 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~  167 (250)
T cd05123          88 GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG  167 (250)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCC
Confidence            67999999999999999999999999999999999999999999999999998776543223344456778999999877


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. .+.++|+||||+++|++++|..| |...+.......+...                             ....+...
T Consensus       168 ~~-~~~~~D~~slG~~~~~l~~g~~p-~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~  216 (250)
T cd05123         168 KG-YGKAVDWWSLGVLLYEMLTGKPP-FYAEDRKEIYEKILKD-----------------------------PLRFPEFL  216 (250)
T ss_pred             CC-CCchhhHHHHHHHHHHHHHCCCC-CCCCCHHHHHHHHhcC-----------------------------CCCCCCCC
Confidence            66 68999999999999999998887 5555544444433320                             11123346


Q ss_pred             CHHHHHHHHHhcccCCCCCCCH---HHHhcCCCc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSA---EDAMSHIYF  269 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~---~~ll~h~~~  269 (282)
                      +..+.+++++||..||.+|||+   +++++||||
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            8899999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG4236|consensus

Probab=100.00  E-value=9.6e-43  Score=287.05  Aligned_cols=246  Identities=27%  Similarity=0.424  Sum_probs=212.9

Q ss_pred             CeeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhc-C
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL-N   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~-~   78 (282)
                      +||.|+++++|+.||||++.+ .........++.|+.+++++.||.|+.+.-.|+..+.+++|||-+.|+.++.+... .
T Consensus       579 ~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEk  658 (888)
T KOG4236|consen  579 TVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEK  658 (888)
T ss_pred             eeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhc
Confidence            599999999999999999999 55555568899999999999999999999999999999999999999999988765 5


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC---CcEEEEecCCccccCCCccccccccccccccChhh
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN---GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDV  155 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~  155 (282)
                      +.+++..-..++.||+.||+|||.++|+|+||||+||++.+.   .++||+|||+++.++... -.....||+.|+|||+
T Consensus       659 gRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-FRrsVVGTPAYLaPEV  737 (888)
T KOG4236|consen  659 GRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-FRRSVVGTPAYLAPEV  737 (888)
T ss_pred             ccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh-hhhhhcCCccccCHHH
Confidence            779999999999999999999999999999999999999654   479999999999998543 3455689999999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      +.+.. |...-|+||+|+++|--++|..||..+.+..+.++   +.-...++..|                         
T Consensus       738 LrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQ---NAaFMyPp~PW-------------------------  788 (888)
T KOG4236|consen  738 LRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQ---NAAFMYPPNPW-------------------------  788 (888)
T ss_pred             Hhhcc-ccccccceeeeEEEEEEecccccCCCccchhHHhh---ccccccCCCch-------------------------
Confidence            98887 79999999999999999999999655544444443   33333333333                         


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      ..+++.+.+||..+|+..-++|-|.+..|.|||+++...|.
T Consensus       789 ~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~  829 (888)
T KOG4236|consen  789 SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWL  829 (888)
T ss_pred             hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHH
Confidence            45899999999999999999999999999999999987663

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-40  Score=267.78  Aligned_cols=238  Identities=29%  Similarity=0.452  Sum_probs=196.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCC-CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG-NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      ||+|.+..+++.|++|.+.... .......+.+|++++++++|||++++++++.+++..++++|+++|..+..+....+.
T Consensus        16 v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~   95 (254)
T cd06627          16 VYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP   95 (254)
T ss_pred             EEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccC
Confidence            7999999999999999998732 223456789999999999999999999999999999999999987655555555678


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..++.++.|++.||.+||+.|++|+||+|.||+++.++.++|+|||.+..............++..|+|||......
T Consensus        96 l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~  175 (254)
T cd06627          96 FPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG  175 (254)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCC
Confidence            99999999999999999999999999999999999999999999999999987765444334456678899999987666


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                       .+.++|+|++|++++++++|..|+. ..............                            .....+..+++
T Consensus       176 -~~~~~Dv~~lG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~  225 (254)
T cd06627         176 -ASTASDIWSLGCTVIELLTGNPPYY-DLNPMAALFRIVQD----------------------------DHPPLPEGISP  225 (254)
T ss_pred             -CCcchhHHHHHHHHHHHHhCCCCCC-CccHHHHHHHHhcc----------------------------CCCCCCCCCCH
Confidence             6899999999999999998887744 33333222222110                            11123345789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      .+.+++.+||+.+|++|||+.+++.||||
T Consensus       226 ~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         226 ELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.3e-40  Score=268.34  Aligned_cols=236  Identities=27%  Similarity=0.448  Sum_probs=193.9

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc-CC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL-NG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~-~~   79 (282)
                      ||+|.++.+++.+|+|.++........+.+.+|+.+++.++|||++++++.+..++.+++++||++| ++.+.+... ..
T Consensus        16 v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~   95 (255)
T cd08219          16 ALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGK   95 (255)
T ss_pred             EEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCC
Confidence            7999999999999999987644444567788999999999999999999999999999999999975 566655442 34


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .++++.+..++.|++.||.+||+.|++|+||+|+||+++.++.++++|||.+..............++..|+|||.+.+.
T Consensus        96 ~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  175 (255)
T cd08219          96 LFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENM  175 (255)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccC
Confidence            58999999999999999999999999999999999999999999999999987665443333345567889999998776


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      . ++.++|+||+|+++|+|++|..| |...+.......+....                            ....+..++
T Consensus       176 ~-~~~~~Dv~slG~i~~~l~~g~~p-~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~  225 (255)
T cd08219         176 P-YNNKSDIWSLGCILYELCTLKHP-FQANSWKNLILKVCQGS----------------------------YKPLPSHYS  225 (255)
T ss_pred             C-cCchhhhhhhchhheehhhccCC-CCCCCHHHHHHHHhcCC----------------------------CCCCCcccC
Confidence            6 68999999999999999998888 55555444444333211                            111234578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCC
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSHI  267 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h~  267 (282)
                      ..+.++|.+||+.||.+|||+.+++.-.
T Consensus       226 ~~~~~li~~~l~~~P~~Rp~~~~il~~~  253 (255)
T cd08219         226 YELRSLIKQMFKRNPRSRPSATTILSRG  253 (255)
T ss_pred             HHHHHHHHHHHhCCcccCCCHHHHhhcc
Confidence            8899999999999999999999998743

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.1e-40  Score=273.36  Aligned_cols=241  Identities=29%  Similarity=0.438  Sum_probs=194.7

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~   80 (282)
                      ||+|.+..++..+++|++.....  ....+.+|+++++.++|+|++++++++..+...++++||++| ++.+.+......
T Consensus        35 v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~  112 (286)
T cd06614          35 VYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR  112 (286)
T ss_pred             EEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccC
Confidence            79999998999999999976332  456788999999999999999999999999999999999995 555555443338


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............++..|++||.+.+..
T Consensus       113 l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~  192 (286)
T cd06614         113 MNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKD  192 (286)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCC
Confidence            99999999999999999999999999999999999999999999999998866543333223334577899999987665


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                       ++.++|+||||+++|++++|..| +...........+... ..+                         .......++.
T Consensus       193 -~~~~~Dv~slGvil~~l~~g~~p-~~~~~~~~~~~~~~~~-~~~-------------------------~~~~~~~~~~  244 (286)
T cd06614         193 -YGPKVDIWSLGIMCIEMAEGEPP-YLREPPLRALFLITTK-GIP-------------------------PLKNPEKWSP  244 (286)
T ss_pred             -CCCccccHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhc-CCC-------------------------CCcchhhCCH
Confidence             68999999999999999988877 4444443333332221 000                         0011133788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      .+.++|.+||+.+|.+|||+.++++|+||++.
T Consensus       245 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         245 EFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence            99999999999999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.8e-40  Score=268.71  Aligned_cols=243  Identities=27%  Similarity=0.448  Sum_probs=192.9

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCC-CCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGN-EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      .||+|.+..+++.|++|.+..... ......+..|+.+++.++|+||+++++.+.+.+.+++|+||+++..+..+.....
T Consensus        15 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   94 (264)
T cd06626          15 KVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR   94 (264)
T ss_pred             EEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcC
Confidence            379999999999999999887322 2356788999999999999999999999999999999999998766666655566


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccc----cccccccccChhh
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS----AEVVTLWYRPPDV  155 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~----~~~~~~~~~aPE~  155 (282)
                      .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...........    ...++..|+|||.
T Consensus        95 ~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~  174 (264)
T cd06626          95 ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV  174 (264)
T ss_pred             CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhh
Confidence            789999999999999999999999999999999999999999999999999877653322211    2345778999999


Q ss_pred             hcCCC--CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         156 LFGAK--LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       156 ~~~~~--~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      +....  ..+.++|+||||++++++++|+.|+............+..  ...+                       ... 
T Consensus       175 ~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~-----------------------~~~-  228 (264)
T cd06626         175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA--GHKP-----------------------PIP-  228 (264)
T ss_pred             ccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc--CCCC-----------------------CCC-
Confidence            86543  2588999999999999999988884333222222222111  1100                       000 


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      ....+++.+.++|.+||+.+|.+|||+.+++.|||+
T Consensus       229 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         229 DSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             cccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            012358889999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0579|consensus

Probab=100.00  E-value=4.2e-42  Score=288.80  Aligned_cols=246  Identities=26%  Similarity=0.374  Sum_probs=208.0

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHH-HHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKK-YFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~-~~~~~~~~   80 (282)
                      ||+|.++.++...|-|++... .......++-|++++...+||+|+++++.|.-++.++|+.|+|+|+-.+ .+......
T Consensus        48 VyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~  126 (1187)
T KOG0579|consen   48 VYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRV  126 (1187)
T ss_pred             hhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccc
Confidence            899999999999999988763 3445788999999999999999999999999999999999999876554 45666788


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc---
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF---  157 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---  157 (282)
                      +.+.++..+++|++.||.|||+++|+|+|||..||+++-+|.++|+|||.+..............||+.|+|||+..   
T Consensus       127 LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET  206 (1187)
T KOG0579|consen  127 LTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCET  206 (1187)
T ss_pred             cchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeecc
Confidence            99999999999999999999999999999999999999999999999999987766666667789999999999973   


Q ss_pred             -CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         158 -GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       158 -~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                       ...+|+.++||||||+++.+|.-+..| -...+...++-.+.+.  .|+                        -.--+.
T Consensus       207 ~KD~PYDykaDiWSlGITLIEMAqiEPP-HhelnpMRVllKiaKS--ePP------------------------TLlqPS  259 (1187)
T KOG0579|consen  207 FKDQPYDYKADIWSLGITLIEMAQIEPP-HHELNPMRVLLKIAKS--EPP------------------------TLLQPS  259 (1187)
T ss_pred             ccCCCchhhhhHHhhhhHHHHHhccCCC-ccccchHHHHHHHhhc--CCC------------------------cccCcc
Confidence             335689999999999999999955444 5555555555554441  111                        111245


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      +.+..+.+|++.||.+||..||++.++++|||+++++..
T Consensus       260 ~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  260 HWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN  298 (1187)
T ss_pred             hhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence            688999999999999999999999999999999987654

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.2e-40  Score=272.10  Aligned_cols=240  Identities=23%  Similarity=0.347  Sum_probs=186.4

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeC-----CeEEEEEecCcccHHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSE-----KKLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~-----~~~~iv~e~~~g~l~~~~~   75 (282)
                      ||+|.+..+++.+|+|++...  ......+..|+.+++++ +|||++++++++...     +..++|+||++|+.+..+.
T Consensus        38 vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~  115 (291)
T cd06639          38 VYKVTNKKDGSLAAVKILDPI--SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV  115 (291)
T ss_pred             EEEEEECCCCCEEEEEEeccc--ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHH
Confidence            899999999999999998642  12235677899999998 899999999998754     3689999999874444332


Q ss_pred             h----cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccccccccccccc
Q psy6044          76 S----LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYR  151 (282)
Q Consensus        76 ~----~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  151 (282)
                      .    ....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............++..|+
T Consensus       116 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~  195 (291)
T cd06639         116 KGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWM  195 (291)
T ss_pred             HHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCcccc
Confidence            2    345789999999999999999999999999999999999999999999999999876553333333345678899


Q ss_pred             ChhhhcCCC----CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         152 PPDVLFGAK----LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHP  227 (282)
Q Consensus       152 aPE~~~~~~----~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (282)
                      |||.+....    .++.++|+||+|+++|++++|..|+ ...........+...   ...                    
T Consensus       196 aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~-~~~~~~~~~~~~~~~---~~~--------------------  251 (291)
T cd06639         196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL-FDMHPVKTLFKIPRN---PPP--------------------  251 (291)
T ss_pred             ChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCC-CCCcHHHHHHHHhcC---CCC--------------------
Confidence            999975432    2578999999999999999987774 444433333222211   000                    


Q ss_pred             CCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q psy6044         228 SMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS  270 (282)
Q Consensus       228 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  270 (282)
                         ....+..++..+.++|.+||+.+|.+|||+.++++||||+
T Consensus       252 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         252 ---TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             ---CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence               0011234677899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.9e-41  Score=281.76  Aligned_cols=275  Identities=18%  Similarity=0.238  Sum_probs=192.5

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc-C
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL-N   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~-~   78 (282)
                      ||+|.+..+|+.||+|++... ......+.+.+|+.+++.++||||+++++++......++|+||+.+ ++.+.+... .
T Consensus        16 v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~   95 (328)
T cd08226          16 VYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFP   95 (328)
T ss_pred             EEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcc
Confidence            899999999999999998763 2233346788899999999999999999999999999999999986 555444432 2


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccc-------cccccccccc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY-------SAEVVTLWYR  151 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-------~~~~~~~~~~  151 (282)
                      ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++++||+............       ....++..|+
T Consensus        96 ~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~  175 (328)
T cd08226          96 EGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWL  175 (328)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCcc
Confidence            358999999999999999999999999999999999999999999999997543321111000       0112345699


Q ss_pred             ChhhhcCC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCC--CCCC-----C--------C
Q psy6044         152 PPDVLFGA-KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDT--WPGM-----N--------L  215 (282)
Q Consensus       152 aPE~~~~~-~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-----~--------~  215 (282)
                      |||.+.+. ..++.++|+||+|+++|++++|..| |...................+...  .+..     +        .
T Consensus       176 aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (328)
T cd08226         176 SPELLRQDLYGYNVKSDIYSVGITACELATGRVP-FQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGI  254 (328)
T ss_pred             ChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhccc
Confidence            99998654 3368999999999999999988777 555443333222221111000000  0000     0        0


Q ss_pred             CCCCCC--CC-CCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccchh
Q psy6044         216 LPDFKP--FP-MYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       216 ~~~~~~--~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  277 (282)
                      .+....  .. ..............+++.+.+||++||+.||.+|||++++++||||+++.....
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~~~  319 (328)
T cd08226         255 GESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQTQ  319 (328)
T ss_pred             ccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHhcc
Confidence            000000  00 000000011122347788999999999999999999999999999998865443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=7.9e-41  Score=274.36  Aligned_cols=248  Identities=19%  Similarity=0.343  Sum_probs=192.6

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCC-CCCccceeeeeeeCCeEEEEEecCcccHHHHHH----
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFD----   75 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~----   75 (282)
                      .||++.+..+|+.+|+|.+...........+.+|+.++.++. ||||+++++++..++..++++|++++++.+...    
T Consensus        19 ~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~~l~~l~~~~~~   98 (288)
T cd06616          19 TVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYE   98 (288)
T ss_pred             EEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccCCHHHHHHHHHH
Confidence            389999999999999999876333344567888999999995 999999999999999999999999876544322    


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChh
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSR-NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPD  154 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE  154 (282)
                      .....+++..+..++.|++.||+|||+. |++|+||+|+||+++.++.++|+|||++......... ....++..|+|||
T Consensus        99 ~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~y~aPE  177 (288)
T cd06616          99 VLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK-TRDAGCRPYMAPE  177 (288)
T ss_pred             hhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc-ccccCccCccCHH
Confidence            2246799999999999999999999975 9999999999999999999999999998765432221 2235677899999


Q ss_pred             hhcCC--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         155 VLFGA--KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       155 ~~~~~--~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      .+.+.  ..++.++|+||+|+++|++++|+.| |....  .....+.......++.                     ...
T Consensus       178 ~~~~~~~~~~~~~~Di~slG~il~el~~g~~p-~~~~~--~~~~~~~~~~~~~~~~---------------------~~~  233 (288)
T cd06616         178 RIDPSARDGYDVRSDVWSLGITLYEVATGKFP-YPKWN--SVFDQLTQVVKGDPPI---------------------LSN  233 (288)
T ss_pred             HhccccccCCcchhhhhHHHHHHHHHHhCCCC-chhcc--hHHHHHhhhcCCCCCc---------------------CCC
Confidence            98766  3478999999999999999998888 44332  1222222211111000                     001


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      .....++..+.+||.+||+.||.+|||+++++.||||+...
T Consensus       234 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            11234789999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.4e-40  Score=268.24  Aligned_cols=238  Identities=28%  Similarity=0.491  Sum_probs=197.1

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc--
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL--   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~--   77 (282)
                      ||+|.+..++..+++|++... ........+.+|+++++.++|||++++++.+......++++|+++| ++.+.+...  
T Consensus        16 v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~   95 (258)
T cd08215          16 VYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKK   95 (258)
T ss_pred             EEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhc
Confidence            799999999999999999873 2334456788999999999999999999999999999999999986 555555543  


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhh
Q psy6044          78 -NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        78 -~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~  156 (282)
                       ...+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............+++.|+|||..
T Consensus        96 ~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~  175 (258)
T cd08215          96 EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC  175 (258)
T ss_pred             cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHh
Confidence             3679999999999999999999999999999999999999999999999999987765443233334567889999998


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       157 ~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      .... ++.++|+||+|++++++++|..| |...+..+........                            .....+.
T Consensus       176 ~~~~-~~~~~Dv~slG~~~~~l~~g~~p-~~~~~~~~~~~~~~~~----------------------------~~~~~~~  225 (258)
T cd08215         176 QNKP-YNYKSDIWSLGCVLYELCTLKHP-FEGENLLELALKILKG----------------------------QYPPIPS  225 (258)
T ss_pred             ccCC-CCccccHHHHHHHHHHHHcCCCC-CCCCcHHHHHHHHhcC----------------------------CCCCCCC
Confidence            7666 68999999999999999987777 6555544444443221                            1112234


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      .++..+.++++.||..+|.+|||+.++++||||
T Consensus       226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         226 QYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.1e-40  Score=272.67  Aligned_cols=238  Identities=27%  Similarity=0.397  Sum_probs=185.2

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeee------CCeEEEEEecCcc-cHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHS------EKKLTLVFEHCDQ-DLKKY   73 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~------~~~~~iv~e~~~g-~l~~~   73 (282)
                      ||+|.+..+++.+|+|++....  .....+..|+.+++++ +|||++++++++..      ...++++|||+++ ++.+.
T Consensus        32 v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~  109 (282)
T cd06636          32 VYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDL  109 (282)
T ss_pred             EEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHH
Confidence            8999999999999999986532  2235678899999998 79999999999853      4678999999986 45554


Q ss_pred             HHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccC
Q psy6044          74 FDSL-NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRP  152 (282)
Q Consensus        74 ~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~a  152 (282)
                      +... ...+++..+..++.||+.||.|||+.|++|+|++|+||+++.++.++|+|||.+..............++..|+|
T Consensus       110 ~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~a  189 (282)
T cd06636         110 VKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA  189 (282)
T ss_pred             HHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccC
Confidence            4432 345889999999999999999999999999999999999999999999999998765433222333456788999


Q ss_pred             hhhhcC----CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         153 PDVLFG----AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPS  228 (282)
Q Consensus       153 PE~~~~----~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
                      ||.+..    ...++.++|+||||+++|++++|..|+ ...........+..   ..                       
T Consensus       190 PE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~-~~~~~~~~~~~~~~---~~-----------------------  242 (282)
T cd06636         190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL-CDMHPMRALFLIPR---NP-----------------------  242 (282)
T ss_pred             HhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCc-cccCHHhhhhhHhh---CC-----------------------
Confidence            998752    233678999999999999999988774 43333222221111   00                       


Q ss_pred             CCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         229 MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       229 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                       ........++..+.+||++||+.||.+|||+.++++||||
T Consensus       243 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         243 -PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             -CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence             0011123578899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.4e-40  Score=274.12  Aligned_cols=241  Identities=25%  Similarity=0.365  Sum_probs=196.5

Q ss_pred             eeeeeeCCCCceEEEeeeecCC--CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG--NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|++..+|..+|+|++....  .......+.+|+.+++.++|||++++++++.++...++|+||++|++++.+.....
T Consensus        41 v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~  120 (317)
T cd06635          41 VYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKK  120 (317)
T ss_pred             EEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCCCHHHHHHHhcC
Confidence            7999999999999999987532  22234568889999999999999999999999999999999999998888776677


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC-
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG-  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-  158 (282)
                      .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......    ....++..|+|||.+.. 
T Consensus       121 ~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~  196 (317)
T cd06635         121 PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----NSFVGTPYWMAPEVILAM  196 (317)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----ccccCCccccChhhhhcC
Confidence            8999999999999999999999999999999999999999999999999987654322    23356778999999742 


Q ss_pred             -CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         159 -AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       159 -~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                       ...++.++|+||||+++|++++|+.|++.. ........+.......                           .....
T Consensus       197 ~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~~---------------------------~~~~~  248 (317)
T cd06635         197 DEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPT---------------------------LQSNE  248 (317)
T ss_pred             CCCCCCccccHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHhccCCC---------------------------CCCcc
Confidence             233688999999999999999998885544 3333333333311100                           01134


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      +++.+.+++.+||+.+|.+|||+.++++|+|+.....
T Consensus       249 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         249 WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             ccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence            6788999999999999999999999999999976544

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=8.2e-41  Score=273.00  Aligned_cols=236  Identities=28%  Similarity=0.495  Sum_probs=193.8

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCC-CCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~   77 (282)
                      ||+|.++.+|+.||+|++...  ........+..|+.++++++ ||||+++++++..++..+++||+++| ++.+.+ ..
T Consensus        17 vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l-~~   95 (280)
T cd05581          17 VVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI-RK   95 (280)
T ss_pred             EEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHH-HH
Confidence            899999999999999998762  22333467888999999998 99999999999999999999999965 555544 44


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc------------------
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK------------------  139 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~------------------  139 (282)
                      .+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........                  
T Consensus        96 ~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (280)
T cd05581          96 YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN  175 (280)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCcccccccccc
Confidence            66899999999999999999999999999999999999999999999999999876643321                  


Q ss_pred             --ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCC
Q psy6044         140 --CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLP  217 (282)
Q Consensus       140 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  217 (282)
                        ......++..|+|||...... ++.++|+||||++++++++|..| |...+.......+...                
T Consensus       176 ~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p-~~~~~~~~~~~~~~~~----------------  237 (280)
T cd05581         176 RRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPP-FRGSNEYLTFQKILKL----------------  237 (280)
T ss_pred             ccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCC-CCCccHHHHHHHHHhc----------------
Confidence              112234567899999987765 68999999999999999988777 6655544444443321                


Q ss_pred             CCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCc
Q psy6044         218 DFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA----EDAMSHIYF  269 (282)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~----~~ll~h~~~  269 (282)
                                   ....+..+++.+.+||.+||+.+|.+|||+    +++++||||
T Consensus       238 -------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         238 -------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             -------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence                         112334568999999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.6e-41  Score=280.86  Aligned_cols=236  Identities=21%  Similarity=0.386  Sum_probs=179.4

Q ss_pred             Ceeeeee-----CCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeC-CeEEEEEecCcc-cHHH
Q psy6044           1 MFTSGVD-----RTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSE-KKLTLVFEHCDQ-DLKK   72 (282)
Q Consensus         1 ~vy~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~-~~~~iv~e~~~g-~l~~   72 (282)
                      .||+|.+     ..+++.||+|++...........+.+|+.++..+ +||||+++++++... ..++++|||++| ++.+
T Consensus        22 ~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~  101 (338)
T cd05102          22 KVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSN  101 (338)
T ss_pred             eEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHH
Confidence            3788874     3456789999987543333456789999999999 899999999988764 468999999986 5555


Q ss_pred             HHHhc-------------------------------------------------------------CCCCCHHHHHHHHH
Q psy6044          73 YFDSL-------------------------------------------------------------NGEIDLDIVKSFMY   91 (282)
Q Consensus        73 ~~~~~-------------------------------------------------------------~~~~~~~~~~~~~~   91 (282)
                      ++...                                                             ...+++..+..++.
T Consensus       102 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  181 (338)
T cd05102         102 FLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSF  181 (338)
T ss_pred             HHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHH
Confidence            44332                                                             12377888999999


Q ss_pred             HHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--ccccccccccccChhhhcCCCCCCchhhHH
Q psy6044          92 QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--CYSAEVVTLWYRPPDVLFGAKLYTTSIDMW  169 (282)
Q Consensus        92 qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~  169 (282)
                      ||+.||.|||++||+|+||||+||+++.++.++|+|||++........  ......++..|+|||.+.+.. ++.++|||
T Consensus       182 qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiw  260 (338)
T cd05102         182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKV-YTTQSDVW  260 (338)
T ss_pred             HHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCC-CCcccCHH
Confidence            999999999999999999999999999999999999999876532211  112223457799999997766 69999999


Q ss_pred             HHHHHHHHHHhcCCCCCCCCChHH-HHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHH
Q psy6044         170 SAGCIFAELANAGRPLFPGSDVDD-QLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQR  248 (282)
Q Consensus       170 slG~ll~~ll~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  248 (282)
                      |||+++|++++.+.++|.+....+ ....+....                            ....+...++.+.+++.+
T Consensus       261 slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~  312 (338)
T cd05102         261 SFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT----------------------------RMRAPENATPEIYRIMLA  312 (338)
T ss_pred             HHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC----------------------------CCCCCCCCCHHHHHHHHH
Confidence            999999999974444466544333 222222110                            011224578899999999


Q ss_pred             hcccCCCCCCCHHHHhc
Q psy6044         249 LLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       249 ~l~~dp~~Rps~~~ll~  265 (282)
                      ||+.||.+|||+.++++
T Consensus       313 cl~~dp~~RPs~~el~~  329 (338)
T cd05102         313 CWQGDPKERPTFSALVE  329 (338)
T ss_pred             HccCChhhCcCHHHHHH
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.3e-40  Score=271.04  Aligned_cols=243  Identities=24%  Similarity=0.399  Sum_probs=193.8

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEI   81 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~   81 (282)
                      ||+|.+..+|+.||+|++...........+.+|+++++.++||||+++++.+...+..++|+||++|+.+..+....+.+
T Consensus        21 v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~  100 (284)
T cd06620          21 VSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPI  100 (284)
T ss_pred             EEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCC
Confidence            89999999999999999876544455678899999999999999999999999999999999999876666666556789


Q ss_pred             CHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          82 DLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        82 ~~~~~~~~~~qi~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      ++..+..++.+++.||.|||+ .|++|+||+|+||+++.++.++|+|||++........  ....++..|+|||.+.+..
T Consensus       101 ~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~--~~~~~~~~~~aPE~~~~~~  178 (284)
T cd06620         101 PVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA--DTFVGTSTYMSPERIQGGK  178 (284)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc--CccccCcccCCHHHHccCC
Confidence            999999999999999999997 5899999999999999999999999998765432221  2335688899999987665


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChH-------HHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVD-------DQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                       ++.++|+||+|+++|++++|..|+.......       ..............                         ..
T Consensus       179 -~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~  232 (284)
T cd06620         179 -YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP-------------------------PR  232 (284)
T ss_pred             -CCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC-------------------------CC
Confidence             6899999999999999999888844332211       11111111110000                         00


Q ss_pred             cC-ccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         234 VA-PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       234 ~~-~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      ++ ..++..+.+|+.+||+.||.+|||++++++|+||..-
T Consensus       233 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         233 LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            11 1267889999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.4e-41  Score=273.09  Aligned_cols=235  Identities=27%  Similarity=0.426  Sum_probs=186.5

Q ss_pred             eeeeeeC----CCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHh
Q psy6044           2 FTSGVDR----TPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDS   76 (282)
Q Consensus         2 vy~a~~~----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~   76 (282)
                      ||+|...    ..+..|+||.+.........+.+.+|++.+++++||||+++++++...+..++|+||++ |++.+.+..
T Consensus        15 v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~   94 (259)
T PF07714_consen   15 VYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKS   94 (259)
T ss_dssp             EEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHH
T ss_pred             EEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccccccccccccccc
Confidence            6777766    56789999999653333346789999999999999999999999998888999999998 567777776


Q ss_pred             c-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC--ccccccccccccccCh
Q psy6044          77 L-NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VKCYSAEVVTLWYRPP  153 (282)
Q Consensus        77 ~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~aP  153 (282)
                      . ...+++..+..++.||+.||.|||+++++|++|+++||+++.++.+||+|||.+......  ............|+||
T Consensus        95 ~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aP  174 (259)
T PF07714_consen   95 KNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAP  174 (259)
T ss_dssp             TCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-H
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            5 467999999999999999999999999999999999999999999999999999876321  2222333456789999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      |.+.... ++.++||||||+++||+++++..++...+..+....+.....                            ..
T Consensus       175 E~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~----------------------------~~  225 (259)
T PF07714_consen  175 EVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR----------------------------LP  225 (259)
T ss_dssp             HHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE----------------------------TT
T ss_pred             ccccccc-cccccccccccccccccccccccccccccccccccccccccc----------------------------ce
Confidence            9997776 699999999999999999965555777777777776644221                            12


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      .+..++..+.++|..||+.||.+|||+.++++
T Consensus       226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             eccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            33458999999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.8e-40  Score=269.32  Aligned_cols=237  Identities=25%  Similarity=0.390  Sum_probs=188.8

Q ss_pred             CeeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCccc-HHHHHH--
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFD--   75 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~-l~~~~~--   75 (282)
                      .||+|+++.+|+.||||.+..  .........+.+|+.+++.++||||+++++++.+.+..++++||++++ +.+.+.  
T Consensus        17 ~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~   96 (267)
T cd08228          17 EVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYF   96 (267)
T ss_pred             eEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHh
Confidence            489999999999999998875  223333456788999999999999999999999999999999999864 443332  


Q ss_pred             -hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChh
Q psy6044          76 -SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPD  154 (282)
Q Consensus        76 -~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE  154 (282)
                       .....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+..............++..|+|||
T Consensus        97 ~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE  176 (267)
T cd08228          97 KKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE  176 (267)
T ss_pred             hhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChh
Confidence             2245589999999999999999999999999999999999999999999999998876654333333345678899999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChH-HHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD-DQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      .+.+.. ++.++|+||+|+++|++++|+.|++...... +....+.. ... +                         ..
T Consensus       177 ~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~-~-------------------------~~  228 (267)
T cd08228         177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ-CDY-P-------------------------PL  228 (267)
T ss_pred             hhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc-CCC-C-------------------------CC
Confidence            997766 6899999999999999999999976554332 22222211 110 0                         00


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ....++..+.+++.+||..+|.+|||+.++++
T Consensus       229 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         229 PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence            12347788999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4e-40  Score=267.03  Aligned_cols=239  Identities=26%  Similarity=0.445  Sum_probs=187.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCC----CCCccHHHHHHHHhhCCCCCccceeeeeeeC--CeEEEEEecCcccHHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNE----GVPSSALREICLLKELKHKNIVRLYDVLHSE--KKLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~--~~~~iv~e~~~g~l~~~~~   75 (282)
                      ||+|.+..+|..||+|.+......    .....+.+|+.+++.++||||+++++++.++  ..+++++||++|+.+..+.
T Consensus        18 v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l   97 (265)
T cd06652          18 VYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL   97 (265)
T ss_pred             EEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHH
Confidence            899999999999999998752211    1234677899999999999999999998764  5788999999875554444


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc---cccccccccccccC
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---KCYSAEVVTLWYRP  152 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~a  152 (282)
                      .....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......   .......++..|+|
T Consensus        98 ~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  177 (265)
T cd06652          98 KSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS  177 (265)
T ss_pred             HHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccC
Confidence            445678999999999999999999999999999999999999999999999999887653211   11222346778999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       153 PE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      ||.+.+.. ++.++|+||||+++|++++|+.| |.............   ..+                        ...
T Consensus       178 PE~~~~~~-~~~~~Dv~slG~il~el~~g~~p-~~~~~~~~~~~~~~---~~~------------------------~~~  228 (265)
T cd06652         178 PEVISGEG-YGRKADIWSVGCTVVEMLTEKPP-WAEFEAMAAIFKIA---TQP------------------------TNP  228 (265)
T ss_pred             hhhhcCCC-CCcchhHHHHHHHHHHHhhCCCC-CCccchHHHHHHHh---cCC------------------------CCC
Confidence            99997765 68999999999999999998887 44443333322221   111                        011


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS  270 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  270 (282)
                      ..+..++..+.++|++|+. +|++|||++++++|||+.
T Consensus       229 ~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         229 VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            2334578889999999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.6e-41  Score=280.42  Aligned_cols=268  Identities=34%  Similarity=0.597  Sum_probs=201.3

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC------eEEEEEecCcccHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK------KLTLVFEHCDQDLKKY   73 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~------~~~iv~e~~~g~l~~~   73 (282)
                      .||+|.+..+|..||+|++... ........+.+|+.+++.++||||+++++++..+.      ..++|+|++++++...
T Consensus        30 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~  109 (343)
T cd07880          30 TVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKL  109 (343)
T ss_pred             EEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecCCCCHHHH
Confidence            3899999999999999998652 22333456789999999999999999999987653      4689999997766655


Q ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccCh
Q psy6044          74 FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP  153 (282)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aP  153 (282)
                      +.  ...+++..+..++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+.......   ....++..|++|
T Consensus       110 ~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~y~aP  184 (343)
T cd07880         110 MK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM---TGYVVTRWYRAP  184 (343)
T ss_pred             Hh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccCc---cccccCCcccCH
Confidence            44  3679999999999999999999999999999999999999999999999999987654322   223457789999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCC--C-CCCCCCCCCCCC
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLP--D-FKPFPMYHPSMS  230 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~  230 (282)
                      |.+.+...++.++|+||+|+++|++++|..| |...+.......+.......+.+.........  . ....+ ......
T Consensus       185 E~~~~~~~~~~~~Di~slG~ll~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  262 (343)
T cd07880         185 EVILNWMHYTQTVDIWSVGCIMAEMLTGKPL-FKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLP-RFRKKD  262 (343)
T ss_pred             HHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhcc-ccCcch
Confidence            9987644478999999999999999988777 66555555555554433332221111100000  0 00000 011112


Q ss_pred             ccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      .......+++.+.++|.+||+.||.+|||+.+++.||||+.....
T Consensus       263 ~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         263 FRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             HHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence            233445688899999999999999999999999999999987543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.6e-40  Score=266.81  Aligned_cols=240  Identities=28%  Similarity=0.471  Sum_probs=195.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCC-CCCCCccHHHHHHHHhhCCCCCccceeeeeeeC--CeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG-NEGVPSSALREICLLKELKHKNIVRLYDVLHSE--KKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~--~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||+|.+..+++.+++|++.... .....+.+.+|+.++++++||||+++++.+.+.  ...++++|+++|..+..+....
T Consensus        16 v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~   95 (260)
T cd06606          16 VYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF   95 (260)
T ss_pred             EEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHc
Confidence            7999999999999999987632 233467889999999999999999999999988  8999999999765555555545


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--ccccccccccccChhhh
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--CYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~  156 (282)
                      ..+++..++.++.|++.||.+||+.|++|+|++|+||+++.++.++|+|||.+........  ......++..|.|||.+
T Consensus        96 ~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~  175 (260)
T cd06606          96 GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI  175 (260)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhh
Confidence            6899999999999999999999999999999999999999999999999999887764432  12334567889999999


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       157 ~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      .... .+.++|+||||++++++++|..|+....+.......+..                           ......++.
T Consensus       176 ~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~  227 (260)
T cd06606         176 RGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS---------------------------SGEPPEIPE  227 (260)
T ss_pred             cCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc---------------------------cCCCcCCCc
Confidence            7766 699999999999999999988884333322222221111                           002223445


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      ..+..+.++|.+||..||.+||++.+++.||||
T Consensus       228 ~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         228 HLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             ccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.3e-40  Score=270.53  Aligned_cols=248  Identities=24%  Similarity=0.419  Sum_probs=190.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC--CeEEEEEecCcc-cHHHHHH---
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE--KKLTLVFEHCDQ-DLKKYFD---   75 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~--~~~~iv~e~~~g-~l~~~~~---   75 (282)
                      ||+|.+..+++.+|+|.+...........+.+|++++++++||||+++++++.+.  +.+++|+||++| ++.+.+.   
T Consensus        17 v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   96 (287)
T cd06621          17 VTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVK   96 (287)
T ss_pred             EEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHH
Confidence            8999999999999999988644444557789999999999999999999988653  478999999986 4444332   


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhh
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDV  155 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~  155 (282)
                      .....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+........  ....++..|+|||.
T Consensus        97 ~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~y~~pE~  174 (287)
T cd06621          97 KRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA--GTFTGTSFYMAPER  174 (287)
T ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc--ccccCCccccCHHH
Confidence            2345689999999999999999999999999999999999999999999999999866543222  22345778999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCC----ChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGS----DVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSF  231 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
                      +.+.. ++.++|+||||+++|++++|..|+....    ...+....+..   .... ..+                  ..
T Consensus       175 ~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~-~~~------------------~~  231 (287)
T cd06621         175 IQGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---MPNP-ELK------------------DE  231 (287)
T ss_pred             hcCCC-CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc---CCch-hhc------------------cC
Confidence            87666 6899999999999999999888854331    22222222111   0000 000                  00


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      .......++.+.+||.+||+.+|.+|||+.+++.||||++..-
T Consensus       232 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  274 (287)
T cd06621         232 PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK  274 (287)
T ss_pred             CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence            0001235788999999999999999999999999999986643

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.3e-40  Score=273.06  Aligned_cols=241  Identities=24%  Similarity=0.334  Sum_probs=195.4

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|+++.+++.+|+|.+...  ........+.+|+++++.++|+|++++++++..+...++|+||+.|++.+.+.....
T Consensus        31 v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~  110 (308)
T cd06634          31 VYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK  110 (308)
T ss_pred             EEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccCCCHHHHHHHcCC
Confidence            899999999999999998752  222334567889999999999999999999999999999999999988887776667


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC-
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG-  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-  158 (282)
                      .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......    ....++..|+|||.+.. 
T Consensus       111 ~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~  186 (308)
T cd06634         111 PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NXFVGTPYWMAPEVILAM  186 (308)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc----ccccCCccccCHHHHhhc
Confidence            7999999999999999999999999999999999999999999999999988655422    22355778999999752 


Q ss_pred             -CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         159 -AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       159 -~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                       ...++.++|+||||+++|++++|..|++.. +..+....+......                           ......
T Consensus       187 ~~~~~~~~~Di~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~---------------------------~~~~~~  238 (308)
T cd06634         187 DEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESP---------------------------ALQSGH  238 (308)
T ss_pred             ccCCCCcccchHHHHHHHHHHHcCCCCCccc-cHHHHHHHHhhcCCC---------------------------CcCccc
Confidence             233688999999999999999988885443 333322222221100                           001235


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      ++..+.++|++||..+|.+||+++++++|||+.....
T Consensus       239 ~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~  275 (308)
T cd06634         239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  275 (308)
T ss_pred             ccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence            7888999999999999999999999999999987644

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.8e-40  Score=266.73  Aligned_cols=231  Identities=21%  Similarity=0.349  Sum_probs=181.0

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      ||++.++.+|..+|+|.+.......      .|+.....+ +|||++++++.+..++..++|+||++| ++.+.+.. ..
T Consensus        32 v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~-~~  104 (267)
T PHA03390         32 VSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK-EG  104 (267)
T ss_pred             EEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHh-cC
Confidence            7999999999999999987532111      133333322 799999999999999999999999976 55555444 56


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC-cEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG-ELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+.......    ...++..|+|||.+.+
T Consensus       105 ~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~y~aPE~~~~  180 (267)
T PHA03390        105 KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS----CYDGTLDYFSPEKIKG  180 (267)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc----cCCCCCcccChhhhcC
Confidence            899999999999999999999999999999999999999998 99999999887654322    2346788999999977


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHH-HHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQ-LKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      .. ++.++|+||+|+++|++++|..|+. .....+. .........                          .....+..
T Consensus       181 ~~-~~~~~DvwslG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~  232 (267)
T PHA03390        181 HN-YDVSFDWWAVGVLTYELLTGKHPFK-EDEDEELDLESLLKRQQ--------------------------KKLPFIKN  232 (267)
T ss_pred             CC-CCchhhHHHHHHHHHHHHHCCCCCC-CCCcchhhHHHHHHhhc--------------------------ccCCcccc
Confidence            66 6899999999999999999988854 3332221 122211110                          01112235


Q ss_pred             CCHHHHHHHHHhcccCCCCCCC-HHHHhcCCCccC
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMS-AEDAMSHIYFSD  271 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps-~~~ll~h~~~~~  271 (282)
                      .++.+.+||.+||+.||.+||+ ++++|+||||++
T Consensus       233 ~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        233 VSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             cCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            8999999999999999999996 699999999975

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-40  Score=267.08  Aligned_cols=237  Identities=24%  Similarity=0.354  Sum_probs=195.9

Q ss_pred             CeeeeeeCCC---CceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHh
Q psy6044           1 MFTSGVDRTP---NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDS   76 (282)
Q Consensus         1 ~vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~   76 (282)
                      .||+|.+...   +..+++|.+...........+.+|+.+++.++|+|++++++++.+...+++++||++| ++.+.+..
T Consensus        10 ~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   89 (262)
T cd00192          10 EVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRK   89 (262)
T ss_pred             EEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhh
Confidence            3899998876   9999999998744333467889999999999999999999999999999999999965 55555555


Q ss_pred             c--------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc--cccccccc
Q psy6044          77 L--------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--KCYSAEVV  146 (282)
Q Consensus        77 ~--------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~  146 (282)
                      .        ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .......+
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  169 (262)
T cd00192          90 SRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKL  169 (262)
T ss_pred             ccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCc
Confidence            3        3779999999999999999999999999999999999999999999999999998765432  22233455


Q ss_pred             cccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYH  226 (282)
Q Consensus       147 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (282)
                      +..|+|||.+.... ++.++|+||+|+++|++++++.++|......+....+....                        
T Consensus       170 ~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~------------------------  224 (262)
T cd00192         170 PIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY------------------------  224 (262)
T ss_pred             CccccCHHHhccCC-cchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------------------
Confidence            77899999987765 69999999999999999986566687777666665554311                        


Q ss_pred             CCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         227 PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       227 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                          ....+..+++++.+++.+||..+|.+|||+.+++++
T Consensus       225 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         225 ----RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             ----CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                112234568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.1e-40  Score=268.79  Aligned_cols=235  Identities=16%  Similarity=0.188  Sum_probs=185.5

Q ss_pred             eeeeeeC---CCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHh-c
Q psy6044           2 FTSGVDR---TPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS-L   77 (282)
Q Consensus         2 vy~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~-~   77 (282)
                      ||+|..+   ..+..||+|.+...........+.+|+.++++++||||+++++++..++..++||||++|+.++.+.. .
T Consensus        21 V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  100 (266)
T cd05064          21 LCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKH  100 (266)
T ss_pred             EEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhC
Confidence            7888764   45779999998864433444678899999999999999999999999999999999998766655444 3


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccChhhh
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~  156 (282)
                      .+.+++..++.++.||+.||++||++|++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+
T Consensus       101 ~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~  180 (266)
T cd05064         101 EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAI  180 (266)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHH
Confidence            46789999999999999999999999999999999999999999999999998755432211 11112335679999998


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       157 ~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      .+.. ++.++||||||+++|++++.+.++|......+....+.....                            ...+.
T Consensus       181 ~~~~-~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~  231 (266)
T cd05064         181 QYHH-FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR----------------------------LPAPR  231 (266)
T ss_pred             hhCC-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC----------------------------CCCCC
Confidence            7665 799999999999999988644444666666555554432111                            01234


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      .++..+.+++..||+.+|.+|||+++|++
T Consensus       232 ~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         232 NCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             CCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            57889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2e-40  Score=271.22  Aligned_cols=236  Identities=24%  Similarity=0.358  Sum_probs=188.0

Q ss_pred             CeeeeeeCCCC-----ceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHH
Q psy6044           1 MFTSGVDRTPN-----TALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~   74 (282)
                      .||+|.+...+     ..||+|.+...........+.+|+.+++.++||||+++++++.+....++++||+++ ++.+.+
T Consensus        20 ~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l   99 (283)
T cd05048          20 KVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFL   99 (283)
T ss_pred             cEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHH
Confidence            48899876655     789999887543333445688999999999999999999999999999999999975 555555


Q ss_pred             HhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-
Q psy6044          75 DSLN---------------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-  138 (282)
Q Consensus        75 ~~~~---------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-  138 (282)
                      ....               ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus       100 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~  179 (283)
T cd05048         100 VRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY  179 (283)
T ss_pred             HhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeecccccc
Confidence            4321               457889999999999999999999999999999999999999999999999987653221 


Q ss_pred             -cccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCC
Q psy6044         139 -KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLL  216 (282)
Q Consensus       139 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  216 (282)
                       .......+++.|+|||.+.+.. ++.++|+||||+++|++++ |..| |.+....+....+....              
T Consensus       180 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p-~~~~~~~~~~~~i~~~~--------------  243 (283)
T cd05048         180 YRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQP-YYGFSNQEVIEMIRSRQ--------------  243 (283)
T ss_pred             ccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCC-CCCCCHHHHHHHHHcCC--------------
Confidence             1122334467899999987766 6999999999999999998 6556 55656555555443321              


Q ss_pred             CCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         217 PDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                                    ....+..+++.+.+|+++||+.||.+|||+.+++++
T Consensus       244 --------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         244 --------------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             --------------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                          112335689999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4e-40  Score=270.19  Aligned_cols=244  Identities=22%  Similarity=0.346  Sum_probs=190.4

Q ss_pred             eeeeeeCC-----CCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHH
Q psy6044           2 FTSGVDRT-----PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~   75 (282)
                      ||+|.++.     .+..||+|.+...........+.+|+.+++.++||||+++++++.+....++||||++| ++.+.+.
T Consensus        22 Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~  101 (288)
T cd05061          22 VYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLR  101 (288)
T ss_pred             EEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHH
Confidence            78887542     35689999876533333344678899999999999999999999999999999999975 5555554


Q ss_pred             hcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc--cccc
Q psy6044          76 SLN---------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC--YSAE  144 (282)
Q Consensus        76 ~~~---------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~  144 (282)
                      ...         ...+...+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.........  ....
T Consensus       102 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~  181 (288)
T cd05061         102 SLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKG  181 (288)
T ss_pred             HhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCC
Confidence            321         23567788999999999999999999999999999999999999999999988754322111  1112


Q ss_pred             cccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM  224 (282)
Q Consensus       145 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (282)
                      .++..|+|||.+.+.. ++.++|+||||+++|++++++.++|.+....+....+....                      
T Consensus       182 ~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~----------------------  238 (288)
T cd05061         182 LLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG----------------------  238 (288)
T ss_pred             cccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------------------
Confidence            3356799999987666 68999999999999999986666677777666555443211                      


Q ss_pred             CCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc------CCCccCCcc
Q psy6044         225 YHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS------HIYFSDLNV  274 (282)
Q Consensus       225 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~------h~~~~~~~~  274 (282)
                            ....+...++.+.+++.+||+.||.+|||+.++++      ||||.++++
T Consensus       239 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~  288 (288)
T cd05061         239 ------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF  288 (288)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence                  01122346789999999999999999999999987      999998864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-40  Score=278.62  Aligned_cols=268  Identities=34%  Similarity=0.565  Sum_probs=200.1

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC------CeEEEEEecCcccHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSE------KKLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~------~~~~iv~e~~~g~l~~~~   74 (282)
                      ||+|.+..+|+.||+|++... ........+.+|+.++++++||||+++++++...      ...+++++++++++.+.+
T Consensus        33 v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~~~~L~~~~  112 (345)
T cd07877          33 VCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV  112 (345)
T ss_pred             EEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhcccCHHHHH
Confidence            799999999999999998762 2222345678899999999999999999988643      357899999877776554


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChh
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPD  154 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE  154 (282)
                      .  ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+......   .....++..|+|||
T Consensus       113 ~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE  187 (345)
T cd07877         113 K--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPE  187 (345)
T ss_pred             h--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccccc---ccccccCCCccCHH
Confidence            3  346999999999999999999999999999999999999999999999999998765422   22345678899999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCC--CCCCCCCCCCCCcc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPD--FKPFPMYHPSMSFS  232 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  232 (282)
                      .+.+...++.++|+||+|+++|++++|..| |...+.......+......++............  +.............
T Consensus       188 ~~~~~~~~~~~~DvwslG~il~el~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (345)
T cd07877         188 IMLNWMHYNQTVDIWSVGCIMAELLTGRTL-FPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA  266 (345)
T ss_pred             HHhCccCCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchh
Confidence            987655578999999999999999988776 666655555555555544433322211110000  00000000011111


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ......++.+.++|..||+.||.+|||+.++++||||++...+
T Consensus       267 ~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~  309 (345)
T cd07877         267 NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  309 (345)
T ss_pred             hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence            2223468899999999999999999999999999999976443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.4e-40  Score=271.65  Aligned_cols=246  Identities=19%  Similarity=0.294  Sum_probs=193.2

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      .||+|.+..+|+.||||.+...........+..|+.++... .||||+++++++.+....++++||+++.+...+.....
T Consensus        30 ~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~l~~~~~~  109 (296)
T cd06618          30 QVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQG  109 (296)
T ss_pred             EEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCcCHHHHHHHhcC
Confidence            38999999999999999997643333345566777766666 59999999999999999999999999877777766667


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      .+++..+..++.|++.|++|||+ .|++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+
T Consensus       110 ~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~  188 (296)
T cd06618         110 PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA-KTRSAGCAAYMAPERIDP  188 (296)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc-ccCCCCCccccCHhhcCC
Confidence            89999999999999999999997 5999999999999999999999999999876543222 122345678999999864


Q ss_pred             C---CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         159 A---KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       159 ~---~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      .   ..++.++|+||||+++|++++|+.|+.......+..........  +                       .. ...
T Consensus       189 ~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~-----------------------~~-~~~  242 (296)
T cd06618         189 PDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP--P-----------------------SL-PPN  242 (296)
T ss_pred             CCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC--C-----------------------CC-CCC
Confidence            4   23678999999999999999988885433333333333322100  0                       00 001


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      ..++..+.+|+.+||+.||.+|||++++++||||+..+
T Consensus       243 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         243 EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence            14788999999999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.7e-40  Score=272.94  Aligned_cols=243  Identities=26%  Similarity=0.349  Sum_probs=193.4

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||+|.+..++..||+|.+..... ...+.+.+|+.+++.++|||++++++++...+..++|+||++|+.+..+.. ...
T Consensus        34 ~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~  111 (293)
T cd06647          34 TVYTAIDVATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETC  111 (293)
T ss_pred             EEEEEEEcCCCCEEEEEEeccccc-hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHh-hcC
Confidence            389999999999999999865322 234678899999999999999999999999999999999998755554444 346


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+..............++..|++||.+....
T Consensus       112 l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~  191 (293)
T cd06647         112 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA  191 (293)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhccCC
Confidence            88999999999999999999999999999999999999999999999998766543333333345678899999987665


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                       ++.++|+||||+++|++++|..| |...+..+....+..  ...                        ........++.
T Consensus       192 -~~~~~Dv~slG~ll~~ll~g~~p-f~~~~~~~~~~~~~~--~~~------------------------~~~~~~~~~~~  243 (293)
T cd06647         192 -YGPKVDIWSLGIMAIEMVEGEPP-YLNENPLRALYLIAT--NGT------------------------PELQNPEKLSA  243 (293)
T ss_pred             -CCchhhHHHHHHHHHHHHhCCCC-CCCCChhhheeehhc--CCC------------------------CCCCCccccCH
Confidence             68999999999999999988877 444333222111110  000                        00111234788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      .+.++|++||..+|.+||++.+++.|+||+..+
T Consensus       244 ~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         244 IFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            899999999999999999999999999999765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0586|consensus

Probab=100.00  E-value=1.7e-41  Score=284.29  Aligned_cols=242  Identities=26%  Similarity=0.430  Sum_probs=207.7

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      |..|++..+|..||||.+.+. .+......+.+|+++|..++||||++++.+...+..+|+||||+.|+.+..+....+.
T Consensus        72 V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr  151 (596)
T KOG0586|consen   72 VKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGR  151 (596)
T ss_pred             EEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhccc
Confidence            778999999999999999983 3444456689999999999999999999999999999999999987655555555888


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      ..+..+..++.|+.+|++|||+++|+|+|||.+|++++.+.+++|+|||++..+. ........+|++.|.|||++.+..
T Consensus       152 ~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-~~~~lqt~cgsppyAaPEl~~g~~  230 (596)
T KOG0586|consen  152 MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD-YGLMLQTFCGSPPYAAPELFNGKK  230 (596)
T ss_pred             chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec-ccccccccCCCCCccChHhhcCcc
Confidence            8889999999999999999999999999999999999999999999999999887 444455678899999999999998


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                      +.+++.|+|++|+++|.++.|..| |++.+..+.......                             ..-.++-.++.
T Consensus       231 y~gpe~D~Wslgvvly~LV~GsLP-FDG~~lk~Lr~rvl~-----------------------------gk~rIp~~ms~  280 (596)
T KOG0586|consen  231 YDGPEVDIWSLGVVLYALVEGSLP-FDGQNLKELRPRVLR-----------------------------GKYRIPFYMSC  280 (596)
T ss_pred             cCCcceehhhhhhhheeeeecccc-cCCcccccccchhee-----------------------------eeecccceeec
Confidence            889999999999999999999888 666655444333222                             12224455889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      ++.++|+++|.++|.+|++.++++.|.|......
T Consensus       281 dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~  314 (596)
T KOG0586|consen  281 DCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE  314 (596)
T ss_pred             hhHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence            9999999999999999999999999999875543

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.2e-40  Score=270.50  Aligned_cols=240  Identities=22%  Similarity=0.351  Sum_probs=184.6

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeee-----eCCeEEEEEecCcccHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLH-----SEKKLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~-----~~~~~~iv~e~~~g~l~~~~   74 (282)
                      .||+|.++.+++.+|+|++....  .....+..|+.+++.+ +||||+++++++.     ..+..++||||++|+.+..+
T Consensus        33 ~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~  110 (286)
T cd06638          33 KVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDL  110 (286)
T ss_pred             EEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHH
Confidence            38999999999999999876421  2235677899999999 7999999999874     44679999999987544433


Q ss_pred             -H---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccc
Q psy6044          75 -D---SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWY  150 (282)
Q Consensus        75 -~---~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  150 (282)
                       .   .....+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+..............++..|
T Consensus       111 l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y  190 (286)
T cd06638         111 VKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFW  190 (286)
T ss_pred             HHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcc
Confidence             2   224568999999999999999999999999999999999999999999999999987664333233334578889


Q ss_pred             cChhhhcCC----CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         151 RPPDVLFGA----KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYH  226 (282)
Q Consensus       151 ~aPE~~~~~----~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (282)
                      +|||.+...    ..++.++|+||+|+++|++++|+.|+.... ...........   ..                    
T Consensus       191 ~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~-~~~~~~~~~~~---~~--------------------  246 (286)
T cd06638         191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH-PMRALFKIPRN---PP--------------------  246 (286)
T ss_pred             cChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc-hhHHHhhcccc---CC--------------------
Confidence            999987532    236889999999999999999888854432 22211111110   00                    


Q ss_pred             CCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         227 PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       227 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                         .....+..++..+.++|.+||+.||.+|||+.++++|+||
T Consensus       247 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         247 ---PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ---CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence               0001123467889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=8e-40  Score=264.95  Aligned_cols=234  Identities=23%  Similarity=0.336  Sum_probs=187.8

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc-C
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL-N   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~-~   78 (282)
                      .||+|.++++++.||+|.+...  ......+.+|+++++.++||||+++++++..+...++++||+++ ++.+.+... .
T Consensus        21 ~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~   98 (263)
T cd05052          21 EVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR   98 (263)
T ss_pred             eEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCC
Confidence            3899999999999999987642  22245788999999999999999999999999999999999975 555555443 2


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccc-ccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY-SAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~  157 (282)
                      ..+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.......... .....+..|+|||.+.
T Consensus        99 ~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  178 (263)
T cd05052          99 QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA  178 (263)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhc
Confidence            458999999999999999999999999999999999999999999999999987665332211 1122355799999987


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|+||||+++|+|++++.+++.+....+....+.....                            ...+..
T Consensus       179 ~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~  229 (263)
T cd05052         179 YNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR----------------------------MERPEG  229 (263)
T ss_pred             cCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC----------------------------CCCCCC
Confidence            666 689999999999999999845555777666655554432110                            112345


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ++..+.++|.+||+.||.+|||+.++++
T Consensus       230 ~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         230 CPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             CCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            7899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0690|consensus

Probab=100.00  E-value=8.9e-42  Score=266.38  Aligned_cols=245  Identities=23%  Similarity=0.347  Sum_probs=211.9

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      |-+++.+.+|+.||+|++++  .-..+....-+.|-.+++..+||.+..+.-.|+.+..+++||||++|+.+....+...
T Consensus       184 VIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer  263 (516)
T KOG0690|consen  184 VILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRER  263 (516)
T ss_pred             EEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhh
Confidence            56788999999999999998  2333445677889999999999999999999999999999999999877766666677


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .+++.....+-..|++||.|||+++|+++|+|.+|.+++.+|.+||.|||++..--.........+||+.|+|||++...
T Consensus       264 ~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDn  343 (516)
T KOG0690|consen  264 VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDN  343 (516)
T ss_pred             cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhccc
Confidence            89999999999999999999999999999999999999999999999999998765566666778999999999999888


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      . |+.+.|-|.+|+++|||++|+.||++ .+.......+...-                             -.++..++
T Consensus       344 D-YgraVDWWG~GVVMYEMmCGRLPFyn-~dh~kLFeLIl~ed-----------------------------~kFPr~ls  392 (516)
T KOG0690|consen  344 D-YGRAVDWWGVGVVMYEMMCGRLPFYN-KDHEKLFELILMED-----------------------------LKFPRTLS  392 (516)
T ss_pred             c-ccceeehhhhhHHHHHHHhccCcccc-cchhHHHHHHHhhh-----------------------------ccCCccCC
Confidence            7 79999999999999999999999554 44444444444321                             12456799


Q ss_pred             HHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCccchh
Q psy6044         240 AKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~  277 (282)
                      ++++.|+..+|.+||++|.     .+.+|.+|+||.++++...
T Consensus       393 ~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~  435 (516)
T KOG0690|consen  393 PEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEAT  435 (516)
T ss_pred             HHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHH
Confidence            9999999999999999998     6899999999999998754

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.1e-39  Score=262.02  Aligned_cols=237  Identities=29%  Similarity=0.465  Sum_probs=191.5

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCccc-HHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~-l~~~~~~~~~~   80 (282)
                      ||+|.+..+|+.+++|++..... .....+.+|+.+++.++|||++++++++..+...++++||++|. +.+.+......
T Consensus        16 v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~   94 (253)
T cd05122          16 VYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT   94 (253)
T ss_pred             EEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCC
Confidence            79999999999999999976333 34568899999999999999999999999999999999999964 44444443368


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+....
T Consensus        95 ~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~  173 (253)
T cd05122          95 LTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKP  173 (253)
T ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-ccceecCCcccCHHHHcCCC
Confidence            99999999999999999999999999999999999999999999999999877654332 23345678899999997766


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                       .+.++|+||||++++++++|..| +...+..........  ...+.                        ......++.
T Consensus       174 -~~~~~Dv~slG~il~~l~~g~~p-~~~~~~~~~~~~~~~--~~~~~------------------------~~~~~~~~~  225 (253)
T cd05122         174 -YDYKADIWSLGITAIELAEGKPP-YSELPPMKALFKIAT--NGPPG------------------------LRNPEKWSD  225 (253)
T ss_pred             -CCccccHHHHHHHHHHHHhCCCC-CCCCchHHHHHHHHh--cCCCC------------------------cCcccccCH
Confidence             68999999999999999988877 444433333322221  10000                        000112488


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCC
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIY  268 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~  268 (282)
                      .+.++|..||+.||++|||+.++++|||
T Consensus       226 ~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         226 EFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            9999999999999999999999999999

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=6.4e-40  Score=264.32  Aligned_cols=236  Identities=24%  Similarity=0.396  Sum_probs=193.8

Q ss_pred             eeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCccc-HHHHHHhc--
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSL--   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~-l~~~~~~~--   77 (282)
                      ||+|.++.+|+.+++|.+.. .........+.+|+.+++.++|+||+++++++.+....++|+||++|. +...+...  
T Consensus        16 v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~   95 (256)
T cd08530          16 VYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKK   95 (256)
T ss_pred             EEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHh
Confidence            79999999999999999886 323344567789999999999999999999999999999999999764 44444331  


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhh
Q psy6044          78 -NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        78 -~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~  156 (282)
                       ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+......  ......++..|++||.+
T Consensus        96 ~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~  173 (256)
T cd08530          96 KRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEVW  173 (256)
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--CcccccCCccccCHHHH
Confidence             356899999999999999999999999999999999999999999999999998776543  22234567889999999


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       157 ~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      .+.. ++.++|+||+|++++++++|..| |...+..+........                            .....+.
T Consensus       174 ~~~~-~~~~~D~~slG~~~~~l~~g~~p-~~~~~~~~~~~~~~~~----------------------------~~~~~~~  223 (256)
T cd08530         174 KGRP-YSYKSDIWSLGCLLYEMATFAPP-FEARSMQDLRYKVQRG----------------------------KYPPIPP  223 (256)
T ss_pred             CCCC-CCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHhcC----------------------------CCCCCch
Confidence            7765 68999999999999999987776 6666655444433221                            1112234


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      .++.++.+++.+||+.+|.+|||+.++++||++
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         224 IYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             hhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            578899999999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0607|consensus

Probab=100.00  E-value=4.8e-41  Score=261.48  Aligned_cols=246  Identities=22%  Similarity=0.359  Sum_probs=201.4

Q ss_pred             eeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCCC
Q psy6044           3 TSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE   80 (282)
Q Consensus         3 y~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~   80 (282)
                      --|....+|..||||++.+. .......+.+|++++.+. .|+||+.++++|+++..+|+|||-+.| .++..+.+ ...
T Consensus        95 qtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~-~~~  172 (463)
T KOG0607|consen   95 QTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQK-RKH  172 (463)
T ss_pred             eeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHH-hhh
Confidence            34667789999999999885 444578899999999999 699999999999999999999999975 56666555 678


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC---cEEEEecCCccccCCC-------ccccccccccccc
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG---ELKLADFGLARAFGIP-------VKCYSAEVVTLWY  150 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~---~~~l~df~~~~~~~~~-------~~~~~~~~~~~~~  150 (282)
                      +++.++..+.+.|+.||.+||.+||.|+|+||+||+..+..   -+||+||.+...+...       .+.....+|+-.|
T Consensus       173 F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEf  252 (463)
T KOG0607|consen  173 FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEF  252 (463)
T ss_pred             ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhh
Confidence            99999999999999999999999999999999999996554   4899999887665322       2333445667789


Q ss_pred             cChhhhc----CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC--------------hHHHHHHHHHHhCCCCCCCCCC
Q psy6044         151 RPPDVLF----GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSD--------------VDDQLKRIFKLLGTPTEDTWPG  212 (282)
Q Consensus       151 ~aPE~~~----~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~  212 (282)
                      ||||+..    ....|+.+.|.||||+++|-|++|..||-..-.              .......|.++.-.+++..|  
T Consensus       253 MAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdW--  330 (463)
T KOG0607|consen  253 MAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDW--  330 (463)
T ss_pred             cchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhh--
Confidence            9999862    334589999999999999999988888533211              23456667666666555555  


Q ss_pred             CCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         213 MNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                                             .++|.+.+++|+.+|..|+.+|.++.++++|||++.+..+
T Consensus       331 -----------------------ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  331 -----------------------AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             -----------------------HHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence                                   5699999999999999999999999999999999987544

>KOG0596|consensus

Probab=100.00  E-value=7.1e-41  Score=276.99  Aligned_cols=246  Identities=25%  Similarity=0.392  Sum_probs=192.2

Q ss_pred             eeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+++..+ .+.||+|++.. ..+.....-+..|+..|.+| .|.+|++++++-..++.+|+|||+-+-+|...+.+...
T Consensus       377 V~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~DL~kiL~k~~~  455 (677)
T KOG0596|consen  377 VFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGDIDLNKILKKKKS  455 (677)
T ss_pred             eeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecccccHHHHHHhccC
Confidence            78888744 45566665555 77778889999999999999 68999999999999999999999999999999888666


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--ccccccccccccChhhhc
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--CYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~  157 (282)
                      ..+.-.+..+..||+.|+.++|+.||+|.||||.|+++ -.|.+||+|||.+..+...+.  .....+||+.|++||.+.
T Consensus       456 ~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~  534 (677)
T KOG0596|consen  456 IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALT  534 (677)
T ss_pred             CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHh
Confidence            66656899999999999999999999999999999998 678999999999988764432  334468899999999985


Q ss_pred             CCC----------CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         158 GAK----------LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHP  227 (282)
Q Consensus       158 ~~~----------~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (282)
                      ...          ..+.++|||||||++|+|+.|+.| |....  ...+++........                     
T Consensus       535 ~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktP-f~~~~--n~~aKl~aI~~P~~---------------------  590 (677)
T KOG0596|consen  535 DMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTP-FGQII--NQIAKLHAITDPNH---------------------  590 (677)
T ss_pred             hccccccCCCcceeecCccchhhhhhHHHHHHhcCCc-hHHHH--HHHHHHHhhcCCCc---------------------
Confidence            332          156899999999999999977777 43322  12222222111101                     


Q ss_pred             CCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         228 SMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       228 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ..+.++++..  .++.++++.||..||++|||+.++|+|||++-...+
T Consensus       591 ~Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~  636 (677)
T KOG0596|consen  591 EIEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIP  636 (677)
T ss_pred             cccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhcCccccccccc
Confidence            1122222222  238999999999999999999999999999975544

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.2e-39  Score=263.15  Aligned_cols=234  Identities=19%  Similarity=0.269  Sum_probs=183.6

Q ss_pred             eeeee--eCCCCceEEEeeeecCC-CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGV--DRTPNTALAIKGTHLVG-NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~--~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||+|.  ...++..+|+|++.... .....+.+..|+.+++.++||||+++++++.. ...++|+||++++.+..+....
T Consensus        11 v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~   89 (257)
T cd05116          11 VKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELGPLNKFLQKN   89 (257)
T ss_pred             eEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHHHhc
Confidence            78885  45678999999987532 22335678899999999999999999998864 4678999999865444444446


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc---cccccccccccChhh
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC---YSAEVVTLWYRPPDV  155 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~aPE~  155 (282)
                      ..+++..+..++.|++.||++||++|++|+||+|.||+++.++.++|+|||.+.........   .....++..|+|||.
T Consensus        90 ~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  169 (257)
T cd05116          90 KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC  169 (257)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhH
Confidence            77999999999999999999999999999999999999999999999999998766433221   112223468999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      +.... ++.++|+||||+++|++++.+.++|......+....+....                            ....+
T Consensus       170 ~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~----------------------------~~~~~  220 (257)
T cd05116         170 MNYYK-FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE----------------------------RMECP  220 (257)
T ss_pred             hccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC----------------------------CCCCC
Confidence            86555 68999999999999999984444477666655555543311                            11123


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ...++++.++|.+||+.||.+|||+.+|..
T Consensus       221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         221 QRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             CCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence            457899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.7e-40  Score=262.81  Aligned_cols=223  Identities=26%  Similarity=0.318  Sum_probs=177.8

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~   80 (282)
                      ||+|+++.+|+.||+|++....      ....|...+....||||+++++++.+....++++||++| ++.+.+.. ...
T Consensus         9 v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~   81 (237)
T cd05576           9 VLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK-FLN   81 (237)
T ss_pred             EEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH-hcC
Confidence            8999999999999999987532      223455555566799999999999999999999999986 55555544 567


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++++|||.+.......   ....++..|+|||......
T Consensus        82 l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~  158 (237)
T cd05576          82 IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENMYCAPEVGGISE  158 (237)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCccccCCcccCCCC
Confidence            9999999999999999999999999999999999999999999999999876654321   2233466799999886555


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                       ++.++|+||+|+++|++++|..++.......          ..                        .....++..+++
T Consensus       159 -~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------~~------------------------~~~~~~~~~~~~  203 (237)
T cd05576         159 -ETEACDWWSLGAILFELLTGKTLVECHPSGI----------NT------------------------HTTLNIPEWVSE  203 (237)
T ss_pred             -CCchhhHHHHHHHHHHHHHCcchhhcCchhc----------cc------------------------ccccCCcccCCH
Confidence             6899999999999999999876632111000          00                        000123455889


Q ss_pred             HHHHHHHHhcccCCCCCCCH-----HHHhcCCCc
Q psy6044         241 KGRDLLQRLLVCNPVQRMSA-----EDAMSHIYF  269 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~-----~~ll~h~~~  269 (282)
                      .+.++|.+||+.||.+|||+     +++++||||
T Consensus       204 ~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         204 EARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             HHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            99999999999999999986     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.1e-39  Score=264.66  Aligned_cols=237  Identities=25%  Similarity=0.393  Sum_probs=187.0

Q ss_pred             CeeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHh-
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDS-   76 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~-   76 (282)
                      .||+|.+..+|+.+|||.+...  ........+.+|+.+++.++||||+++++++..++..++++||++| ++.+.+.. 
T Consensus        17 ~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~   96 (267)
T cd08229          17 EVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHF   96 (267)
T ss_pred             EEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHh
Confidence            3899999999999999988752  2222345788999999999999999999999999999999999986 44444432 


Q ss_pred             --cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChh
Q psy6044          77 --LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPD  154 (282)
Q Consensus        77 --~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE  154 (282)
                        ....+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+..............++..|+|||
T Consensus        97 ~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape  176 (267)
T cd08229          97 KKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE  176 (267)
T ss_pred             hccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHH
Confidence              235689999999999999999999999999999999999999999999999998876654333333345678899999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChH-HHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD-DQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      ...+.. ++.++|+||||+++|++++|..|++...... +....+....  .                         ...
T Consensus       177 ~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~-------------------------~~~  228 (267)
T cd08229         177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--Y-------------------------PPL  228 (267)
T ss_pred             HhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC--C-------------------------CCC
Confidence            997766 6899999999999999999998865433222 2222211100  0                         000


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ....+++.+.+++.+||+.||.+|||+.++++
T Consensus       229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         229 PSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             CcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence            12347889999999999999999999998775

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.7e-39  Score=268.47  Aligned_cols=234  Identities=21%  Similarity=0.307  Sum_probs=177.6

Q ss_pred             CCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC----------
Q psy6044          10 PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN----------   78 (282)
Q Consensus        10 ~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~----------   78 (282)
                      ++..||+|.+...........+.+|+.++++++||||+++++++.+.+..++|+||+++ ++.+.+....          
T Consensus        45 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~  124 (304)
T cd05096          45 RPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND  124 (304)
T ss_pred             cceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhcccccccccccc
Confidence            45589999987643333456788999999999999999999999999999999999976 5555443311          


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc--cccccccccc
Q psy6044          79 --------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--KCYSAEVVTL  148 (282)
Q Consensus        79 --------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~  148 (282)
                              ..+++..+..++.||+.||.+||+.|++|+||||+||+++.++.++|+|||.+.......  .......++.
T Consensus       125 ~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~  204 (304)
T cd05096         125 AVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPI  204 (304)
T ss_pred             ccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCc
Confidence                    236788899999999999999999999999999999999999999999999987653221  1112223467


Q ss_pred             cccChhhhcCCCCCCchhhHHHHHHHHHHHHhcC-CCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHP  227 (282)
Q Consensus       149 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (282)
                      .|+|||.+.... ++.++|+||||+++|+|+++. ..+|......+................                  
T Consensus       205 ~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------  265 (304)
T cd05096         205 RWMAWECILMGK-FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQV------------------  265 (304)
T ss_pred             cccCHHHHhcCC-CCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccc------------------
Confidence            899999987665 799999999999999998642 334666665555554433221111000                  


Q ss_pred             CCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         228 SMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       228 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                         ....++..+..+.+++.+||+.||++|||+.+|.+
T Consensus       266 ---~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         266 ---YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             ---cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence               01122457889999999999999999999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG2345|consensus

Probab=100.00  E-value=4.4e-41  Score=252.89  Aligned_cols=239  Identities=22%  Similarity=0.305  Sum_probs=184.5

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC-----eEEEEEecCc-ccHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK-----KLTLVFEHCD-QDLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~-----~~~iv~e~~~-g~l~~~~   74 (282)
                      +||.+.+..+++.||+|++.... .+..+..++|++..++++|||++++++....+.     ..||+++|+. |++++.+
T Consensus        36 fv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i  114 (302)
T KOG2345|consen   36 FVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEI  114 (302)
T ss_pred             eeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHH
Confidence            58889999999999999998854 344688999999999999999999998876544     4999999995 7788887


Q ss_pred             HhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccc--------
Q psy6044          75 DSLN---GEIDLDIVKSFMYQLLRGLAFCHSRN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY--------  141 (282)
Q Consensus        75 ~~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--------  141 (282)
                      ....   ..+++.+++.|+.+|++||++||+..  +.|+||||.||++++++.+++.|||+++...-.....        
T Consensus       115 ~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe  194 (302)
T KOG2345|consen  115 ERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQE  194 (302)
T ss_pred             HHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHH
Confidence            6553   35999999999999999999999998  9999999999999999999999999998764222211        


Q ss_pred             -ccccccccccChhhhcC--CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCC
Q psy6044         142 -SAEVVTLWYRPPDVLFG--AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPD  218 (282)
Q Consensus       142 -~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (282)
                       ....+|..|+|||.+.-  ....+.++|||||||++|+|+.|..||-......+.++                      
T Consensus       195 ~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla----------------------  252 (302)
T KOG2345|consen  195 WAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA----------------------  252 (302)
T ss_pred             HHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE----------------------
Confidence             12344778999999842  23368999999999999999999888511110000000                      


Q ss_pred             CCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         219 FKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                         +..-.....++.. ..+|+.+.++|++||+.||.+||++.+++.+
T Consensus       253 ---LAv~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  253 ---LAVQNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             ---EeeeccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence               0000000011111 2399999999999999999999999999864

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.4e-39  Score=265.78  Aligned_cols=235  Identities=23%  Similarity=0.375  Sum_probs=185.3

Q ss_pred             CeeeeeeC-----CCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCccc-HHHHH
Q psy6044           1 MFTSGVDR-----TPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYF   74 (282)
Q Consensus         1 ~vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~-l~~~~   74 (282)
                      .||+|.+.     .+++.||+|.+...........+.+|+++++.++||||+++++++......++++||++|+ +.+.+
T Consensus        20 ~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i   99 (280)
T cd05049          20 KVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFL   99 (280)
T ss_pred             eEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHH
Confidence            37888764     3468999999876444434578899999999999999999999999999999999999864 44444


Q ss_pred             Hhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc--c
Q psy6044          75 DSL-------------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--K  139 (282)
Q Consensus        75 ~~~-------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~--~  139 (282)
                      ...             ...+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .
T Consensus       100 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~  179 (280)
T cd05049         100 RSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR  179 (280)
T ss_pred             HhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCccee
Confidence            332             1347889999999999999999999999999999999999999999999999987543221  1


Q ss_pred             ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCC
Q psy6044         140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPD  218 (282)
Q Consensus       140 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (282)
                      ......++..|+|||.+.+.. ++.++|+||||+++|++++ |..| |......+....+....                
T Consensus       180 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p-~~~~~~~~~~~~~~~~~----------------  241 (280)
T cd05049         180 VGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQP-WYGLSNEEVIECITQGR----------------  241 (280)
T ss_pred             cCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCC-CCCCCHHHHHHHHHcCC----------------
Confidence            112233467899999997766 6999999999999999998 6666 55555555444443211                


Q ss_pred             CCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         219 FKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                  ....+..++..+.+++++||..||.+|||+.++++
T Consensus       242 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         242 ------------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             ------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                        11122357899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.3e-39  Score=276.01  Aligned_cols=236  Identities=23%  Similarity=0.355  Sum_probs=182.2

Q ss_pred             eeeeee-----CCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHHHH
Q psy6044           2 FTSGVD-----RTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         2 vy~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~   74 (282)
                      ||+|++     ..++..||+|++.........+.+.+|+.+++.+ +||||+++++++......++||||++| ++.+.+
T Consensus        51 V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l  130 (375)
T cd05104          51 VVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFL  130 (375)
T ss_pred             EEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHH
Confidence            777753     4567899999987543334456788999999999 899999999999999999999999975 565555


Q ss_pred             HhcC--------------------------------------------------------------------------CC
Q psy6044          75 DSLN--------------------------------------------------------------------------GE   80 (282)
Q Consensus        75 ~~~~--------------------------------------------------------------------------~~   80 (282)
                      ....                                                                          ..
T Consensus       131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (375)
T cd05104         131 RRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELA  210 (375)
T ss_pred             HhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCC
Confidence            4321                                                                          24


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc--cccccccccccChhhhcC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC--YSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~  158 (282)
                      +++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.........  .....++..|+|||.+.+
T Consensus       211 l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  290 (375)
T cd05104         211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN  290 (375)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcC
Confidence            788899999999999999999999999999999999999999999999998765432211  111233567999999977


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHH-HHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDD-QLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      .. ++.++|+||||+++|++++++.++|....... ..+.+.....                            ...+..
T Consensus       291 ~~-~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~  341 (375)
T cd05104         291 CV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR----------------------------MLSPEC  341 (375)
T ss_pred             CC-CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc----------------------------CCCCCC
Confidence            66 69999999999999999985555566554333 3332222110                            011233


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      .+.++.++|.+||+.||++|||+.++++.
T Consensus       342 ~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         342 APSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            57889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.3e-39  Score=265.69  Aligned_cols=237  Identities=19%  Similarity=0.285  Sum_probs=186.7

Q ss_pred             CeeeeeeCC-----CCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHH
Q psy6044           1 MFTSGVDRT-----PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~   74 (282)
                      .||+|.+..     ++..|++|.+...........+..|+.+++.++|+||+++++++.+....++++||++| ++.+.+
T Consensus        21 ~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i  100 (277)
T cd05036          21 EVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFL  100 (277)
T ss_pred             cEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHH
Confidence            389999877     78999999887544333446789999999999999999999999998899999999975 555555


Q ss_pred             HhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC---cEEEEecCCccccCCCcc--cccc
Q psy6044          75 DSLN------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG---ELKLADFGLARAFGIPVK--CYSA  143 (282)
Q Consensus        75 ~~~~------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~---~~~l~df~~~~~~~~~~~--~~~~  143 (282)
                      ....      ..+++..+..++.||+.||.+||+.|++|+||+|+||+++.++   .++|+|||.+........  ....
T Consensus       101 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  180 (277)
T cd05036         101 RENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR  180 (277)
T ss_pred             HHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCC
Confidence            4432      2489999999999999999999999999999999999998655   589999999876532211  1111


Q ss_pred             ccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCC
Q psy6044         144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFP  223 (282)
Q Consensus       144 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (282)
                      ...+..|+|||.+.+.. ++.++|||||||++|++++++.++|...+..+....+....                     
T Consensus       181 ~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~---------------------  238 (277)
T cd05036         181 AMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG---------------------  238 (277)
T ss_pred             CCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC---------------------
Confidence            22245799999997766 79999999999999999975555577766665554433211                     


Q ss_pred             CCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         224 MYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                             ....+..++..+.+++.+||+.+|.+|||+.++++|
T Consensus       239 -------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         239 -------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             -------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                   011234578899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.6e-39  Score=265.14  Aligned_cols=237  Identities=22%  Similarity=0.346  Sum_probs=183.2

Q ss_pred             CeeeeeeC-----CCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHH
Q psy6044           1 MFTSGVDR-----TPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~   74 (282)
                      .||+|.++     .++..||+|++...........+.+|+.+++.++||||+++++++......++|+||+++ ++.+.+
T Consensus        21 ~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~  100 (277)
T cd05062          21 MVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL  100 (277)
T ss_pred             eEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHH
Confidence            37888754     346789999886532222345688999999999999999999999999999999999986 454444


Q ss_pred             HhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc--ccc
Q psy6044          75 DSLN---------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC--YSA  143 (282)
Q Consensus        75 ~~~~---------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~  143 (282)
                      ....         ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........  ...
T Consensus       101 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  180 (277)
T cd05062         101 RSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK  180 (277)
T ss_pred             HHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCC
Confidence            3321         23577888999999999999999999999999999999999999999999998655322111  112


Q ss_pred             ccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCC
Q psy6044         144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFP  223 (282)
Q Consensus       144 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (282)
                      ..++..|+|||.+.+.. ++.++|+||||+++|++++++.++|......+....+....                     
T Consensus       181 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~---------------------  238 (277)
T cd05062         181 GLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG---------------------  238 (277)
T ss_pred             CccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC---------------------
Confidence            23366799999987665 69999999999999999986565577766665555443311                     


Q ss_pred             CCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         224 MYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                             ....+...+..+.+++.+||+.||++|||+.+++++
T Consensus       239 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         239 -------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             -------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                   111223467889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.7e-40  Score=288.33  Aligned_cols=244  Identities=25%  Similarity=0.345  Sum_probs=179.6

Q ss_pred             CccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC
Q psy6044          28 PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN----GEIDLDIVKSFMYQLLRGLAFCHSR  103 (282)
Q Consensus        28 ~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lh~~  103 (282)
                      ...+.+|+.++++++||||+++++++......|++++++.++++.++....    .......+..++.||+.||.|||++
T Consensus       207 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~  286 (501)
T PHA03210        207 AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK  286 (501)
T ss_pred             HHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence            345778999999999999999999999999999999999999888775432    2244667888999999999999999


Q ss_pred             CccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcC
Q psy6044         104 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG  182 (282)
Q Consensus       104 ~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~  182 (282)
                      ||+|+||||+||+++.++.++|+|||++..+..... ......|+..|+|||.+.+.. ++.++|||||||++|+|++++
T Consensus       287 gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~  365 (501)
T PHA03210        287 KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHD  365 (501)
T ss_pred             CeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCC
Confidence            999999999999999999999999999977653322 222346789999999997766 799999999999999999998


Q ss_pred             CCCCCCCC--hHHHHHHHHHHhCCCCCCCCCCC-CCCCCC-CCCCCCCCCCCccc--cCccCCHHHHHHHHHhcccCCCC
Q psy6044         183 RPLFPGSD--VDDQLKRIFKLLGTPTEDTWPGM-NLLPDF-KPFPMYHPSMSFSQ--VAPKLTAKGRDLLQRLLVCNPVQ  256 (282)
Q Consensus       183 ~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~  256 (282)
                      .+++....  ....+..+.........+ ++.. ....++ ..............  ....++.++.++|.+||+.||++
T Consensus       366 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~  444 (501)
T PHA03210        366 FCPIGDGGGKPGKQLLKIIDSLSVCDEE-FPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHL  444 (501)
T ss_pred             CCCccCCCCCHHHHHHHHHHhcccChhh-cCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCccc
Confidence            77665432  333444444433322211 1110 000000 00000000000000  11236778899999999999999


Q ss_pred             CCCHHHHhcCCCccCCc
Q psy6044         257 RMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       257 Rps~~~ll~h~~~~~~~  273 (282)
                      |||+.|+|+||||....
T Consensus       445 Rpsa~elL~hp~f~~~~  461 (501)
T PHA03210        445 RPGAAELLALPLFSAEE  461 (501)
T ss_pred             CcCHHHHhhChhhhcCC
Confidence            99999999999998764

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-39  Score=259.49  Aligned_cols=234  Identities=19%  Similarity=0.277  Sum_probs=186.7

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      .||+|.++ ++..+|+|.+...  ......+.+|++++++++||||+++++++......++|+||++| ++.+.+.....
T Consensus        19 ~v~~~~~~-~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~   95 (256)
T cd05059          19 VVHLGKWR-GKIDVAIKMIREG--AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG   95 (256)
T ss_pred             eEEEeEec-CCccEEEEEeccC--CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc
Confidence            48999875 5778999987642  22335688999999999999999999999999999999999976 56666655456


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~  158 (282)
                      .+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+
T Consensus        96 ~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~  175 (256)
T cd05059          96 KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDY  175 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhcc
Confidence            789999999999999999999999999999999999999999999999998876542211 1111223457999999977


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||||+++|++++++.++|...+..+....+.....                            ...+...
T Consensus       176 ~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~  226 (256)
T cd05059         176 SR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR----------------------------LYRPKLA  226 (256)
T ss_pred             CC-CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc----------------------------CCCCCCC
Confidence            66 689999999999999999866666777666655554433211                            1122347


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      ++.+.+++.+||..+|++|||+.++++.
T Consensus       227 ~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            8999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-39  Score=261.72  Aligned_cols=236  Identities=20%  Similarity=0.326  Sum_probs=188.1

Q ss_pred             CeeeeeeCCC---CceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHh
Q psy6044           1 MFTSGVDRTP---NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDS   76 (282)
Q Consensus         1 ~vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~   76 (282)
                      .||+|+.+.+   ...||+|.+...........+.+|+.++++++||||+++++++...+..++++||+++ ++.+.+..
T Consensus        19 ~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~   98 (266)
T cd05033          19 EVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRE   98 (266)
T ss_pred             eEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHh
Confidence            3899988654   5689999887644444456788899999999999999999999999999999999986 55555555


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc--cccccccccccChh
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC--YSAEVVTLWYRPPD  154 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE  154 (282)
                      ..+.+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.........  .....++..|+|||
T Consensus        99 ~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe  178 (266)
T cd05033          99 NDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE  178 (266)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChh
Confidence            4567999999999999999999999999999999999999999999999999999876422111  11223356799999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      .+.... ++.++|+||||+++|++++ |..| |......+....+......                            .
T Consensus       179 ~~~~~~-~~~~~Dv~slG~~l~~l~~~g~~p-~~~~~~~~~~~~~~~~~~~----------------------------~  228 (266)
T cd05033         179 AIAYRK-FTSASDVWSFGIVMWEVMSYGERP-YWDMSNQDVIKAVEDGYRL----------------------------P  228 (266)
T ss_pred             hhccCC-CccccchHHHHHHHHHHHccCCCC-CCCCCHHHHHHHHHcCCCC----------------------------C
Confidence            987666 6999999999999999997 5555 6555555555544332111                            1


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      .+...++.+.+++..||+.+|++||++.+++++
T Consensus       229 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         229 PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            123478899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG4721|consensus

Probab=100.00  E-value=4.4e-41  Score=279.37  Aligned_cols=226  Identities=21%  Similarity=0.313  Sum_probs=184.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEI   81 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~   81 (282)
                      ||+|+.  -++-||||+++        +.-..+++-|++|+||||+.+.++|.....++||||||..+-+....+....+
T Consensus       140 VF~Grl--~netVAVKKV~--------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~i  209 (904)
T KOG4721|consen  140 VFLGRL--HNETVAVKKVR--------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPI  209 (904)
T ss_pred             eeeeec--cCceehhHHHh--------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCcc
Confidence            677774  47899999775        34446888999999999999999999999999999999754444445557889


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCCC
Q psy6044          82 DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKL  161 (282)
Q Consensus        82 ~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  161 (282)
                      .......|.++|+.|+.|||..+|+|+|||..||+++.+..+||+|||-++..+.. .......||..|+|||++.+.. 
T Consensus       210 tp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaGTVaWMAPEvIrneP-  287 (904)
T KOG4721|consen  210 TPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSFAGTVAWMAPEVIRNEP-  287 (904)
T ss_pred             CHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhhhhhHhhhCHHHhhcCC-
Confidence            99999999999999999999999999999999999999999999999999877644 4445568899999999997766 


Q ss_pred             CCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHH
Q psy6044         162 YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAK  241 (282)
Q Consensus       162 ~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (282)
                      .+.|.|||||||++|||+||.-|+ .+-+....+    =+.+.                       .......+...++.
T Consensus       288 csEKVDIwSfGVVLWEmLT~EiPY-kdVdssAII----wGVGs-----------------------NsL~LpvPstcP~G  339 (904)
T KOG4721|consen  288 CSEKVDIWSFGVVLWEMLTGEIPY-KDVDSSAII----WGVGS-----------------------NSLHLPVPSTCPDG  339 (904)
T ss_pred             cccccceehhHHHHHHHHhcCCCc-cccchheeE----EeccC-----------------------CcccccCcccCchH
Confidence            799999999999999999999994 332211110    00000                       00122345678999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCC
Q psy6044         242 GRDLLQRLLVCNPVQRMSAEDAMSHI  267 (282)
Q Consensus       242 l~~li~~~l~~dp~~Rps~~~ll~h~  267 (282)
                      ++-||+.||+..|..|||+.+||.|-
T Consensus       340 fklL~Kqcw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  340 FKLLLKQCWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             HHHHHHHHHhcCCCCCccHHHHHHHH
Confidence            99999999999999999999999984

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.9e-39  Score=260.03  Aligned_cols=235  Identities=23%  Similarity=0.311  Sum_probs=183.1

Q ss_pred             CeeeeeeC--CCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc
Q psy6044           1 MFTSGVDR--TPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL   77 (282)
Q Consensus         1 ~vy~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~   77 (282)
                      .||+|..+  .++..||+|++.........+.+.+|+.++++++||||+++++++.. ...++|+||++| ++.+.+...
T Consensus        10 ~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~   88 (257)
T cd05115          10 CVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGK   88 (257)
T ss_pred             cEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhC
Confidence            37888764  45667999998764434445668899999999999999999998864 568999999976 555555444


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc---cccccccccccChh
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC---YSAEVVTLWYRPPD  154 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~aPE  154 (282)
                      ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.........   .....++..|+|||
T Consensus        89 ~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE  168 (257)
T cd05115          89 KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE  168 (257)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHH
Confidence            567999999999999999999999999999999999999999999999999998755432211   11122246799999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      .+.... ++.++|+||||+++|++++.+.++|......+....+.....                            ...
T Consensus       169 ~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~  219 (257)
T cd05115         169 CINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR----------------------------LDC  219 (257)
T ss_pred             HHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC----------------------------CCC
Confidence            987655 689999999999999999734444766666555444433211                            112


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      +...++++.++|..||..||++||++.++.+
T Consensus       220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            3457899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG1026|consensus

Probab=100.00  E-value=1.7e-40  Score=287.88  Aligned_cols=227  Identities=26%  Similarity=0.375  Sum_probs=196.6

Q ss_pred             CCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHhcCC---------
Q psy6044          10 PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNG---------   79 (282)
Q Consensus        10 ~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~~~---------   79 (282)
                      +...||||.++...+.....+|.+|+++++.++|||||+++|+|.+.+.+++|+||+. |+|-+++....+         
T Consensus       515 ~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~  594 (774)
T KOG1026|consen  515 DEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQ  594 (774)
T ss_pred             cceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCC
Confidence            5678999999886666677899999999999999999999999999999999999996 788777755422         


Q ss_pred             ----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCC--CccccccccccccccCh
Q psy6044          80 ----EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGI--PVKCYSAEVVTLWYRPP  153 (282)
Q Consensus        80 ----~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~~~aP  153 (282)
                          +++..+.+.++.||+.|+.||-++.++|+||-.+|++|.++-.+||+|||+++.+=.  ..........+.+||||
T Consensus       595 ~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMpp  674 (774)
T KOG1026|consen  595 DTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPP  674 (774)
T ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCH
Confidence                277889999999999999999999999999999999999999999999999987521  12222233447899999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      |.+.-.+ ++.+|||||+||++||+++.+.-++.+..+++.++.+..+                            ..-+
T Consensus       675 EsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g----------------------------~lL~  725 (774)
T KOG1026|consen  675 ESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG----------------------------QLLS  725 (774)
T ss_pred             HHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC----------------------------Cccc
Confidence            9998887 7999999999999999998877779999999999998775                            3345


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      .+...+.++.+|+..||+.+|++|||++||-.
T Consensus       726 ~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~  757 (774)
T KOG1026|consen  726 CPENCPTEVYSLMLECWNENPKRRPSFKEIHS  757 (774)
T ss_pred             CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            56779999999999999999999999999853

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.4e-39  Score=275.64  Aligned_cols=236  Identities=22%  Similarity=0.334  Sum_probs=180.4

Q ss_pred             CeeeeeeCC-----CCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHHH
Q psy6044           1 MFTSGVDRT-----PNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY   73 (282)
Q Consensus         1 ~vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~   73 (282)
                      .||+|++..     ++..||+|++...........+.+|+.+++.+ +|+||+++++++......++||||++| ++.+.
T Consensus        53 ~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~  132 (374)
T cd05106          53 KVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNF  132 (374)
T ss_pred             cEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHH
Confidence            478888544     44689999997643333456788999999999 899999999999999999999999975 55555


Q ss_pred             HHhcC---------------------------------------------------------------------CCCCHH
Q psy6044          74 FDSLN---------------------------------------------------------------------GEIDLD   84 (282)
Q Consensus        74 ~~~~~---------------------------------------------------------------------~~~~~~   84 (282)
                      +....                                                                     ..+++.
T Consensus       133 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  212 (374)
T cd05106         133 LRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLD  212 (374)
T ss_pred             HHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHH
Confidence            43211                                                                     247888


Q ss_pred             HHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--ccccccccccccChhhhcCCCCC
Q psy6044          85 IVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--CYSAEVVTLWYRPPDVLFGAKLY  162 (282)
Q Consensus        85 ~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~  162 (282)
                      .+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........  ......++..|+|||.+.... +
T Consensus       213 ~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~  291 (374)
T cd05106         213 DLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCV-Y  291 (374)
T ss_pred             HHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCC-C
Confidence            9999999999999999999999999999999999999999999999876542211  111122356799999987665 7


Q ss_pred             CchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHH
Q psy6044         163 TTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAK  241 (282)
Q Consensus       163 ~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (282)
                      +.++|+||||+++|+|++ |..| |..................                           ...+...+++
T Consensus       292 ~~~~DvwSlGvil~ellt~G~~P-f~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~  343 (374)
T cd05106         292 TVQSDVWSYGILLWEIFSLGKSP-YPGILVNSKFYKMVKRGYQ---------------------------MSRPDFAPPE  343 (374)
T ss_pred             CccccHHHHHHHHHHHHhCCCCC-CccccccHHHHHHHHcccC---------------------------ccCCCCCCHH
Confidence            999999999999999997 6555 5554433322222221100                           0112336889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         242 GRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       242 l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      +.+++.+||+.||.+|||+.++++
T Consensus       344 l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         344 IYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6e-39  Score=260.26  Aligned_cols=236  Identities=25%  Similarity=0.432  Sum_probs=187.9

Q ss_pred             CeeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHh-
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDS-   76 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~-   76 (282)
                      .||+|.+..+|+.||+|.+..  .........+.+|++++++++|+|++++++++..++..++++||++| ++...+.. 
T Consensus        17 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   96 (267)
T cd08224          17 VVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHF   96 (267)
T ss_pred             EEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHh
Confidence            389999999999999999875  22333356788999999999999999999999999999999999986 55554433 


Q ss_pred             --cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChh
Q psy6044          77 --LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPD  154 (282)
Q Consensus        77 --~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE  154 (282)
                        ....+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............++..|.|||
T Consensus        97 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE  176 (267)
T cd08224          97 KKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE  176 (267)
T ss_pred             cccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHH
Confidence              234589999999999999999999999999999999999999999999999998876543333233345677899999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCh-HHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDV-DDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      .+.+.. ++.++|+||||+++|++++|..|+...... .+....+....                            ...
T Consensus       177 ~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~  227 (267)
T cd08224         177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD----------------------------YPP  227 (267)
T ss_pred             HhccCC-CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC----------------------------CCC
Confidence            987666 689999999999999999998885443322 22222222110                            011


Q ss_pred             cC-ccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         234 VA-PKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       234 ~~-~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      .+ ..++..+.++|.+||+.+|.+|||+.+|++
T Consensus       228 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         228 LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            11 257889999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.2e-39  Score=264.20  Aligned_cols=236  Identities=21%  Similarity=0.282  Sum_probs=187.1

Q ss_pred             CeeeeeeCC-----CCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHH
Q psy6044           1 MFTSGVDRT-----PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         1 ~vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~   75 (282)
                      .||+|.+..     ++..||+|++...........+..|+.++..++||||+++++++......++++||+++..+..+.
T Consensus        20 ~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l   99 (283)
T cd05091          20 KVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFL   99 (283)
T ss_pred             eEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHH
Confidence            388998654     368899999876433333456788999999999999999999999999999999999865444433


Q ss_pred             hc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc
Q psy6044          76 SL----------------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK  139 (282)
Q Consensus        76 ~~----------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~  139 (282)
                      ..                ...+++..+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||++........
T Consensus       100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  179 (283)
T cd05091         100 VMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY  179 (283)
T ss_pred             HhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchh
Confidence            21                23478889999999999999999999999999999999999999999999998876532211


Q ss_pred             --ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCC
Q psy6044         140 --CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLP  217 (282)
Q Consensus       140 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  217 (282)
                        ......+++.|+|||.+.... ++.++|+||||+++|+|++++.++|.+....+....+....               
T Consensus       180 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~---------------  243 (283)
T cd05091         180 YKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ---------------  243 (283)
T ss_pred             eeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC---------------
Confidence              112233467899999987666 68999999999999999986666677776666655554421               


Q ss_pred             CCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         218 DFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                   ....+...+..+.+++..||+.+|.+||++.+|+.
T Consensus       244 -------------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~  278 (283)
T cd05091         244 -------------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS  278 (283)
T ss_pred             -------------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence                         11123457899999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG4645|consensus

Probab=100.00  E-value=8.4e-42  Score=305.75  Aligned_cols=250  Identities=27%  Similarity=0.404  Sum_probs=214.7

Q ss_pred             eeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      ||-|.+..+|+..|+|-++. .......+.+.+|..++..++|||+++++++-.+.+.++|.||||.|+.+..+...++.
T Consensus      1251 VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri 1330 (1509)
T KOG4645|consen 1251 VYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRI 1330 (1509)
T ss_pred             eEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcch
Confidence            89999999999999999998 55677889999999999999999999999999999999999999998888888887788


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc----ccccccccccccChhhh
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK----CYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~aPE~~  156 (282)
                      .++.....+..|+++|++|||+.||+|+||||.||+++.+|.+|++|||.+..+..+..    ......||+-|+|||++
T Consensus      1331 ~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvi 1410 (1509)
T KOG4645|consen 1331 EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVI 1410 (1509)
T ss_pred             hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhh
Confidence            88999999999999999999999999999999999999999999999999988765542    22345789999999999


Q ss_pred             cCCC--CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         157 FGAK--LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       157 ~~~~--~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      .+..  ....+.|||||||++.||+||++| |...+....+.--+.-.                           ..+++
T Consensus      1411 t~t~~kG~~~A~DiWslGCVVlEM~tGkrP-W~~~dne~aIMy~V~~g---------------------------h~Pq~ 1462 (1509)
T KOG4645|consen 1411 TGTKGKGHGGAADIWSLGCVVLEMATGKRP-WAELDNEWAIMYHVAAG---------------------------HKPQI 1462 (1509)
T ss_pred             cccccCCCCcchhhhcccceEEEeecCCCc-hhhccchhHHHhHHhcc---------------------------CCCCC
Confidence            6553  357899999999999999999999 66555444332222211                           33445


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccchhhh
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKSE  279 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~  279 (282)
                      |..+|++-++||..||..||++|.++.||++|.|=+...+.+..+
T Consensus      1463 P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~~s~~ 1507 (1509)
T KOG4645|consen 1463 PERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDEDSSE 1507 (1509)
T ss_pred             chhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccccchhh
Confidence            666999999999999999999999999999999999887776554

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=7.8e-39  Score=258.14  Aligned_cols=233  Identities=21%  Similarity=0.327  Sum_probs=185.1

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      .||+|..+ ++..+|+|.+...  ......+.+|+++++.++||||+++++++......+++|||++| ++.+.+....+
T Consensus        19 ~vy~~~~~-~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~   95 (256)
T cd05114          19 VVHLGKWR-AQIKVAIKAINEG--AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQG   95 (256)
T ss_pred             eEEEEEec-cCceEEEEecccC--CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCcc
Confidence            48898874 4678999987642  22345788999999999999999999999999999999999975 56665555456


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~  158 (282)
                      .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+..
T Consensus        96 ~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  175 (256)
T cd05114          96 KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF  175 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhccc
Confidence            78999999999999999999999999999999999999999999999999887653221 11122234567999999876


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||||+++|++++++.++|...+..+....+......                            ..+...
T Consensus       176 ~~-~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~----------------------------~~~~~~  226 (256)
T cd05114         176 SK-YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL----------------------------YRPKLA  226 (256)
T ss_pred             Cc-cchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC----------------------------CCCCCC
Confidence            65 6899999999999999998455557776666655555432110                            112236


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      +..+.+++.+||..+|.+|||++++++
T Consensus       227 ~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         227 SMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.1e-39  Score=264.16  Aligned_cols=234  Identities=23%  Similarity=0.332  Sum_probs=184.0

Q ss_pred             eeeeee-----CCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHH
Q psy6044           2 FTSGVD-----RTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFD   75 (282)
Q Consensus         2 vy~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~   75 (282)
                      ||++.+     ..++..+|+|.+.... ......+.+|+.++++++||||+++++++...+..++++||+++ ++.+.+.
T Consensus        21 v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~   99 (288)
T cd05093          21 VFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLR   99 (288)
T ss_pred             EEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHH
Confidence            677774     3456789999886532 22345788999999999999999999999999999999999985 5555444


Q ss_pred             hcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--cc
Q psy6044          76 SLN------------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--CY  141 (282)
Q Consensus        76 ~~~------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~  141 (282)
                      ...            ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+........  ..
T Consensus       100 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~  179 (288)
T cd05093         100 AHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVG  179 (288)
T ss_pred             HcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecC
Confidence            321            2489999999999999999999999999999999999999999999999999876532211  11


Q ss_pred             ccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCC
Q psy6044         142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP  221 (282)
Q Consensus       142 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (282)
                      ....++..|+|||.+.+.. ++.++|+||||+++|+|++++.++|......+....+.....                  
T Consensus       180 ~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~------------------  240 (288)
T cd05093         180 GHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV------------------  240 (288)
T ss_pred             CCCCccccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc------------------
Confidence            2223356799999987665 689999999999999999855555777666665555443211                  


Q ss_pred             CCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         222 FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                ...+..++..+.+++.+||+.||.+|||+.+++.
T Consensus       241 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         241 ----------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                      1112347889999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=6e-39  Score=259.53  Aligned_cols=234  Identities=21%  Similarity=0.312  Sum_probs=190.3

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc-C
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL-N   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~-~   78 (282)
                      .||+|.++. +..+++|++..... .....+..|+.+++.++||||+++++++......++|+||+++ ++.+.+... .
T Consensus        21 ~vy~~~~~~-~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~   98 (261)
T cd05148          21 EVWEGLWKN-RVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEG   98 (261)
T ss_pred             cEEEeEecC-CCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCC
Confidence            389999977 99999999876322 2345788999999999999999999999999999999999986 666655443 3


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      ..+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............++..|++||....
T Consensus        99 ~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~  178 (261)
T cd05148          99 QVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH  178 (261)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHcc
Confidence            45899999999999999999999999999999999999999999999999998776543333333344667999999876


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||||+++|++++++.++|......+....+......                            ..+...
T Consensus       179 ~~-~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~  229 (261)
T cd05148         179 GT-FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM----------------------------PCPAKC  229 (261)
T ss_pred             CC-CCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC----------------------------CCCCCC
Confidence            65 6899999999999999998555557776666666555432111                            122457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ++.+.+++.+||+.||.+|||+.++++
T Consensus       230 ~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         230 PQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             CHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0986|consensus

Probab=100.00  E-value=7.1e-41  Score=271.17  Aligned_cols=243  Identities=24%  Similarity=0.379  Sum_probs=207.1

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||-+..+.||+-||.|++.+  ..........+.|..++.+++.+.||.+--.|+....+++|+..++|+-+.+.+.+-+
T Consensus       201 V~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g  280 (591)
T KOG0986|consen  201 VCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHG  280 (591)
T ss_pred             eeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccC
Confidence            67888899999999999987  3445556789999999999999999999999999999999999999876666555444


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          80 --EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        80 --~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                        .+++..+..++.+|+.||.+||.++|++||+||+||++|+.|.++|+|+|++..+..... .....||..|+|||++.
T Consensus       281 ~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~-~~~rvGT~GYMAPEvl~  359 (591)
T KOG0986|consen  281 NPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP-IRGRVGTVGYMAPEVLQ  359 (591)
T ss_pred             CCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCc-cccccCcccccCHHHHc
Confidence              699999999999999999999999999999999999999999999999999998875444 34458999999999998


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC---hHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSD---VDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      +.. |+...|-|||||++|+|+.|..||-....   .++.-..+.+                             ...+.
T Consensus       360 ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~-----------------------------~~~ey  409 (591)
T KOG0986|consen  360 NEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE-----------------------------DPEEY  409 (591)
T ss_pred             CCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc-----------------------------chhhc
Confidence            888 89999999999999999988888533322   2233333332                             23344


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCccc
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~  275 (282)
                      +..+|++++++.+.+|..||++|.     ++.++-+||||+++++.
T Consensus       410 ~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~  455 (591)
T KOG0986|consen  410 SDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR  455 (591)
T ss_pred             ccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence            567999999999999999999998     66799999999999874

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7.7e-39  Score=257.25  Aligned_cols=235  Identities=23%  Similarity=0.334  Sum_probs=185.8

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      .||+|.. .++..+|+|.+...........+.+|+++++.++||||+++++++......++|+||++| ++.+.+.....
T Consensus        10 ~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~   88 (250)
T cd05085          10 EVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKD   88 (250)
T ss_pred             eEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCC
Confidence            4899986 468999999887643333345688999999999999999999999999999999999975 55555555456


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccc-ccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY-SAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~  158 (282)
                      .+++..+..++.|++.||.++|+.|++|+||+|+||+++.++.++|+|||.+.......... ....++..|+|||.+..
T Consensus        89 ~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  168 (250)
T cd05085          89 ELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY  168 (250)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhcc
Confidence            68999999999999999999999999999999999999999999999999886543222111 11223467999999876


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||||+++|++++.+.++|...........+.....                            ...+..+
T Consensus       169 ~~-~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~  219 (250)
T cd05085         169 GR-YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR----------------------------MSCPQKC  219 (250)
T ss_pred             CC-CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC----------------------------CCCCCCC
Confidence            65 689999999999999999844444766665555444432110                            0122347


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      +..+.+++.+|++.+|++|||+.++++
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-39  Score=259.34  Aligned_cols=234  Identities=24%  Similarity=0.311  Sum_probs=184.0

Q ss_pred             CeeeeeeCCCC---ceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHh
Q psy6044           1 MFTSGVDRTPN---TALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDS   76 (282)
Q Consensus         1 ~vy~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~   76 (282)
                      .||+|....++   ..+|+|.+.........+.+..|+.+++.++|||++++++++.. ...++++||+++ ++.+.+..
T Consensus        10 ~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~   88 (257)
T cd05060          10 SVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKK   88 (257)
T ss_pred             eEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCCCcHHHHHHh
Confidence            37888766655   89999998763332345678899999999999999999998764 468999999975 55555544


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccc---cccccccccCh
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS---AEVVTLWYRPP  153 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~---~~~~~~~~~aP  153 (282)
                       ...+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+...........   ...++..|+||
T Consensus        89 -~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aP  167 (257)
T cd05060          89 -RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAP  167 (257)
T ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCH
Confidence             56899999999999999999999999999999999999999999999999999876643322111   11223569999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      |.+.+.. ++.++|+||||+++|++++++.++|...+..+....+....                            ...
T Consensus       168 E~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~  218 (257)
T cd05060         168 ECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE----------------------------RLP  218 (257)
T ss_pred             HHhcCCC-CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC----------------------------cCC
Confidence            9987666 69999999999999999984555577666655544443211                            011


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      .+..++..+.++|.+||+.+|.+|||+.++++
T Consensus       219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            23457889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-39  Score=259.72  Aligned_cols=239  Identities=25%  Similarity=0.402  Sum_probs=188.8

Q ss_pred             CeeeeeeCCCCceEEEeeeecCC----CCCCCccHHHHHHHHhhCCCCCccceeeeeeeC--CeEEEEEecCcccHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVG----NEGVPSSALREICLLKELKHKNIVRLYDVLHSE--KKLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~--~~~~iv~e~~~g~l~~~~   74 (282)
                      .||+|.+..+|+.||+|.+....    .......+.+|++++++++||||+++++++.+.  ..+++++||++|..+...
T Consensus        17 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~   96 (264)
T cd06653          17 EVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQ   96 (264)
T ss_pred             EEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHH
Confidence            38999999999999999886421    122345788899999999999999999998764  568999999987555444


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc---ccccccccccccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---KCYSAEVVTLWYR  151 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~  151 (282)
                      ....+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......   .......++..|+
T Consensus        97 ~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~  176 (264)
T cd06653          97 LKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM  176 (264)
T ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCccccc
Confidence            4445678999999999999999999999999999999999999999999999999987653211   1112235678899


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSF  231 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
                      |||.+.+.. ++.++|+||||++++++++|..| |......+....+.   ..+                        ..
T Consensus       177 aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p-~~~~~~~~~~~~~~---~~~------------------------~~  227 (264)
T cd06653         177 SPEVISGEG-YGRKADVWSVACTVVEMLTEKPP-WAEYEAMAAIFKIA---TQP------------------------TK  227 (264)
T ss_pred             CHhhhcCCC-CCccccHHHHHHHHHHHHhCCCC-CCccCHHHHHHHHH---cCC------------------------CC
Confidence            999997766 68999999999999999998777 55444333332221   111                        11


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      ..++..+++.+.++|..||. +|..|||+.++++|||.
T Consensus       228 ~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         228 PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            22445688999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-39  Score=257.70  Aligned_cols=234  Identities=23%  Similarity=0.344  Sum_probs=187.5

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~   80 (282)
                      ||+|.+.. ++.||+|.+...........+.+|++++++++||||+++++++.+....++|+||++| ++.+.+......
T Consensus        11 v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~   89 (251)
T cd05041          11 VYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNR   89 (251)
T ss_pred             EEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCC
Confidence            89999877 9999999887633333456788999999999999999999999999999999999976 455555454567


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccc--ccccccccccChhhhcC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY--SAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~  158 (282)
                      +++..+..++.+++.||.+||++|++|+||+|+||+++.++.++|+|||.+..........  .....+..|+|||.+.+
T Consensus        90 ~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  169 (251)
T cd05041          90 LTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY  169 (251)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhcc
Confidence            8999999999999999999999999999999999999999999999999987654221111  11222456999999876


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||||+++|++++++.++|...........+.....                            ...+...
T Consensus       170 ~~-~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~  220 (251)
T cd05041         170 GR-YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR----------------------------MPAPQLC  220 (251)
T ss_pred             CC-CCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC----------------------------CCCCccC
Confidence            65 699999999999999999966666776665554444322110                            0112346


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      +..+.+++.+||+.+|.+|||+.++++
T Consensus       221 ~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         221 PEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=7.8e-39  Score=258.24  Aligned_cols=236  Identities=25%  Similarity=0.380  Sum_probs=191.9

Q ss_pred             CeeeeeeCCCC----ceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHH
Q psy6044           1 MFTSGVDRTPN----TALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFD   75 (282)
Q Consensus         1 ~vy~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~   75 (282)
                      .||+|.+..++    ..+|+|++...........+..|+.+++.++|+||+++++++.+++..++++|+++| ++.+.+.
T Consensus        14 ~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~   93 (258)
T smart00219       14 EVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLR   93 (258)
T ss_pred             ceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHH
Confidence            48999988776    999999987644333567889999999999999999999999999999999999986 5555544


Q ss_pred             hcCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccc-cccccccccCh
Q psy6044          76 SLNGE-IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS-AEVVTLWYRPP  153 (282)
Q Consensus        76 ~~~~~-~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~aP  153 (282)
                      ..... +++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+........... ...++..|+||
T Consensus        94 ~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~P  173 (258)
T smart00219       94 KNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAP  173 (258)
T ss_pred             hhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccCh
Confidence            43333 99999999999999999999999999999999999999999999999999876653311111 12356789999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      |...... ++.++|+||+|++++++++++.++|...+..+..+.+.....                            ..
T Consensus       174 e~~~~~~-~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~  224 (258)
T smart00219      174 ESLKDGK-FTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR----------------------------LP  224 (258)
T ss_pred             HHhccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC----------------------------CC
Confidence            9986555 699999999999999999867777877776666665543211                            11


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      .+..++.++.+++.+||+.||++|||+.++++
T Consensus       225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      225 KPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence            22347899999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6.1e-39  Score=262.52  Aligned_cols=237  Identities=22%  Similarity=0.335  Sum_probs=184.7

Q ss_pred             Ceeeeee----CCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHH
Q psy6044           1 MFTSGVD----RTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFD   75 (282)
Q Consensus         1 ~vy~a~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~   75 (282)
                      .||+|..    ..++..+++|.+...........+.+|+.+++.++||||+++++++......++++||+++ ++.+.+.
T Consensus        20 ~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   99 (283)
T cd05090          20 KIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLI   99 (283)
T ss_pred             ceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHH
Confidence            3788874    4567899999987533333345788899999999999999999999999999999999986 5555543


Q ss_pred             hc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-
Q psy6044          76 SL----------------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-  138 (282)
Q Consensus        76 ~~----------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-  138 (282)
                      ..                ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... 
T Consensus       100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  179 (283)
T cd05090         100 MRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADY  179 (283)
T ss_pred             hcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcc
Confidence            21                1247889999999999999999999999999999999999999999999999997653221 


Q ss_pred             -cccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCC
Q psy6044         139 -KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLP  217 (282)
Q Consensus       139 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  217 (282)
                       .......++..|+|||.+.+.. ++.++|+||||+++|+|++++.++|.+....+....+....               
T Consensus       180 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~---------------  243 (283)
T cd05090         180 YRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ---------------  243 (283)
T ss_pred             eecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC---------------
Confidence             1112223356799999987665 69999999999999999984555566655555544443311               


Q ss_pred             CCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         218 DFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                                   ....+..+++.+.+++.+||+.||++||++.+++++
T Consensus       244 -------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         244 -------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             -------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence                         111223578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0584|consensus

Probab=100.00  E-value=1.6e-40  Score=278.88  Aligned_cols=240  Identities=21%  Similarity=0.385  Sum_probs=199.5

Q ss_pred             eeeeeeCCCCceEEEeeeec---CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC--eEEEEEecCcccHHHHHHh
Q psy6044           2 FTSGVDRTPNTALAIKGTHL---VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK--KLTLVFEHCDQDLKKYFDS   76 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~---~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~--~~~iv~e~~~g~l~~~~~~   76 (282)
                      ||+|.|..+|-.||=-.+..   .+.....+.+..|+.+++.|+||||+++++++.+..  .+.+|+|.+..+.|..+.+
T Consensus        56 VYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~k  135 (632)
T KOG0584|consen   56 VYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRK  135 (632)
T ss_pred             eeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHH
Confidence            89999999999988544443   455555689999999999999999999999998764  5889999997555555555


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEcC-CCcEEEEecCCccccCCCccccccccccccccCh
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRN--VLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP  153 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~dl~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aP  153 (282)
                      ..+.++...+..|++||+.||.|||++.  |+|||||-+|||++. -|.+||+|+|+++.......  ....|||.||||
T Consensus       136 k~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a--ksvIGTPEFMAP  213 (632)
T KOG0584|consen  136 KHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA--KSVIGTPEFMAP  213 (632)
T ss_pred             HhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc--ceeccCccccCh
Confidence            5889999999999999999999999985  999999999999975 59999999999988754333  336899999999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      |.+..  .|....||||||++++||.|+..|+-...+......+...+..+.                        .   
T Consensus       214 EmYEE--~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~------------------------s---  264 (632)
T KOG0584|consen  214 EMYEE--NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPA------------------------A---  264 (632)
T ss_pred             HHHhh--hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHH------------------------H---
Confidence            99963  379999999999999999999999777777777777766543211                        1   


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      +..--.+++++||.+||.. .++|||+.++|.||||..-+
T Consensus       265 l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~  303 (632)
T KOG0584|consen  265 LSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDG  303 (632)
T ss_pred             hhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcccc
Confidence            1122468899999999999 99999999999999999753

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=8.4e-39  Score=262.62  Aligned_cols=249  Identities=21%  Similarity=0.301  Sum_probs=191.8

Q ss_pred             eeeeeeC---CCCceEEEeeeecC---CCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHH
Q psy6044           2 FTSGVDR---TPNTALAIKGTHLV---GNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         2 vy~a~~~---~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~   74 (282)
                      ||.|.+.   .+|+.||+|++...   ......+.+.+|+.+++++ +|+||+++++++..+...++|+||++|..+...
T Consensus        16 v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   95 (290)
T cd05613          16 VFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTH   95 (290)
T ss_pred             EEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHH
Confidence            7888874   47999999998762   1222345678899999999 689999999999999999999999986444444


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccCh
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPP  153 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aP  153 (282)
                      ......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... .......++..|+||
T Consensus        96 l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aP  175 (290)
T cd05613          96 LSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP  175 (290)
T ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCCh
Confidence            4446778999999999999999999999999999999999999999999999999887654321 112233467889999


Q ss_pred             hhhcCC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         154 DVLFGA-KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       154 E~~~~~-~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      |.+... ..++.++|+||||+++|++++|..|+ ...........+......                         ...
T Consensus       176 E~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~-~~~~~~~~~~~~~~~~~~-------------------------~~~  229 (290)
T cd05613         176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF-TVDGEKNSQAEISRRILK-------------------------SEP  229 (290)
T ss_pred             hhccCCCCCCCccccHHHHHHHHHHHhcCCCCC-CcCCccccHHHHHHHhhc-------------------------cCC
Confidence            998653 23578999999999999999988874 332221111111111100                         001


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCccch
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~  276 (282)
                      ..+..+++.+.+++++||+.||.+||     ++++++.||||+..+++.
T Consensus       230 ~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~  278 (290)
T cd05613         230 PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDD  278 (290)
T ss_pred             CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHH
Confidence            12345788999999999999999997     899999999999998655

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.6e-38  Score=256.24  Aligned_cols=234  Identities=20%  Similarity=0.301  Sum_probs=184.1

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      .||+|.... +..+|+|.+....  .....+.+|+.++++++||||+++++++......++++||+.+ ++.+.+.....
T Consensus        19 ~vy~~~~~~-~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~   95 (256)
T cd05113          19 VVKYGKWRG-QYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK   95 (256)
T ss_pred             eEEEEEecC-CCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCC
Confidence            378887644 5569999876422  2235688999999999999999999999999999999999976 55555555445


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~  158 (282)
                      .+++..++.++.||+.||++||+.|++|+||+|.||+++.++.++|+|||.+........ ......++..|+|||...+
T Consensus        96 ~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~  175 (256)
T cd05113          96 RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLY  175 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhc
Confidence            789999999999999999999999999999999999999999999999998876543221 1112234567999999976


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||||+++|++++.+.++|......+....+......                            ..+...
T Consensus       176 ~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~  226 (256)
T cd05113         176 SK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL----------------------------YRPHLA  226 (256)
T ss_pred             Cc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC----------------------------CCCCCC
Confidence            66 6899999999999999998344447666655555554332111                            112236


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      +..+.+++.+||+.||.+|||+.+++++
T Consensus       227 ~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         227 SEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence            7899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0193|consensus

Probab=100.00  E-value=1.6e-40  Score=277.74  Aligned_cols=235  Identities=18%  Similarity=0.266  Sum_probs=187.8

Q ss_pred             eeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCccc-HHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~-l~~~~~~~~~   79 (282)
                      ||+|+.   -..||||+++. ....+..+.|.+|+.++++.+|.||+-+.|++..++. .||+.+|+|+ |+..++....
T Consensus       408 V~Rg~w---hGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~et  483 (678)
T KOG0193|consen  408 VYRGRW---HGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQET  483 (678)
T ss_pred             eeeccc---ccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhh
Confidence            788887   45799999998 4455568899999999999999999999999998887 9999999985 5555555567


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC--ccccccccccccccChhhhc
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~  157 (282)
                      +++....+.|+.||+.|+.|||.++|+|+|||..||++.++++|+|+|||+++.-+.-  ........+...|+|||++.
T Consensus       484 kfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIR  563 (678)
T KOG0193|consen  484 KFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIR  563 (678)
T ss_pred             hhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHh
Confidence            7999999999999999999999999999999999999999999999999998654321  12223345577899999995


Q ss_pred             CC--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         158 GA--KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       158 ~~--~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      ..  .+|++.+||||||+++|||++|..|+ .....+..+-..-.+...                        .......
T Consensus       564 mqd~nPfS~qSDVYaFGiV~YELltg~lPy-si~~~dqIifmVGrG~l~------------------------pd~s~~~  618 (678)
T KOG0193|consen  564 MQDDNPFSFQSDVYAFGIVWYELLTGELPY-SIQNRDQIIFMVGRGYLM------------------------PDLSKIR  618 (678)
T ss_pred             hcccCCCCcccchhhhhHHHHHHHhCcCCc-CCCChhheEEEecccccC------------------------ccchhhh
Confidence            43  56899999999999999999999994 433332222211111111                        1233344


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ...+.++++|+..||..++++||++.+||.
T Consensus       619 s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  619 SNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             ccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            567889999999999999999999999987

>KOG0603|consensus

Probab=100.00  E-value=1.3e-39  Score=274.24  Aligned_cols=227  Identities=26%  Similarity=0.365  Sum_probs=183.9

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      |-++.++.+++..++|++...     .....+|+.++... +||||+++++++.+....|+|||.+.|..+-........
T Consensus       338 ~~~~~~~~t~~~~~vkii~~~-----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~  412 (612)
T KOG0603|consen  338 VKYCESSPTDQEPAVKIISKR-----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPE  412 (612)
T ss_pred             eeeeeccccccchhheecccc-----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcch
Confidence            456778889999999998764     22333566554444 899999999999999999999999987655544443444


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE-cCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI-NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~-~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .. ..+..|+.+|+.|+.|||++|++||||||+||++ +..++++|+|||.+......   ......|..|.|||+....
T Consensus       413 ~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---~~tp~~t~~y~APEvl~~~  488 (612)
T KOG0603|consen  413 FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---CDTPALTLQYVAPEVLAIQ  488 (612)
T ss_pred             hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---hcccchhhcccChhhhccC
Confidence            44 7888899999999999999999999999999999 68999999999999876544   2233557889999999866


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      . ++.++|+||||+++|+|++|..|+-......+....+..    +                           .+...+|
T Consensus       489 ~-yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~----~---------------------------~~s~~vS  536 (612)
T KOG0603|consen  489 E-YTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQM----P---------------------------KFSECVS  536 (612)
T ss_pred             C-CCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcC----C---------------------------ccccccC
Confidence            5 799999999999999999999986555555444444322    1                           1225699


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      .++++||+.||+.||.+||++.+++.||||
T Consensus       537 ~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  537 DEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            999999999999999999999999999999

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.4e-39  Score=264.62  Aligned_cols=237  Identities=25%  Similarity=0.372  Sum_probs=185.1

Q ss_pred             CeeeeeeCCC-----CceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHHH
Q psy6044           1 MFTSGVDRTP-----NTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY   73 (282)
Q Consensus         1 ~vy~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~   73 (282)
                      .||+|..+..     ...+|+|.+...........+.+|+.+++++ +||||+++++++..++.+++++||+++ ++...
T Consensus        27 ~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~  106 (293)
T cd05053          27 QVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDF  106 (293)
T ss_pred             cEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHH
Confidence            3788887643     4789999887643333345688999999999 899999999999999999999999975 55555


Q ss_pred             HHh---------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc
Q psy6044          74 FDS---------------LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  138 (282)
Q Consensus        74 ~~~---------------~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~  138 (282)
                      +..               ....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus       107 l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  186 (293)
T cd05053         107 LRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHID  186 (293)
T ss_pred             HHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCcccccccccccc
Confidence            432               13458999999999999999999999999999999999999999999999999987664322


Q ss_pred             c--ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCC
Q psy6044         139 K--CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLL  216 (282)
Q Consensus       139 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  216 (282)
                      .  ......++..|+|||.+.+.. ++.++|+||||+++|++++.+.++|......+....+.....             
T Consensus       187 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-------------  252 (293)
T cd05053         187 YYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYR-------------  252 (293)
T ss_pred             ceeccCCCCCCccccCHHHhccCC-cCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc-------------
Confidence            1  111223356799999986665 689999999999999999744444776666655554432110             


Q ss_pred             CCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         217 PDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                                     ...+...+..+.+|+.+||..||++|||+.+++++
T Consensus       253 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         253 ---------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence                           11223468899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG1035|consensus

Probab=100.00  E-value=7.1e-40  Score=292.01  Aligned_cols=241  Identities=26%  Similarity=0.393  Sum_probs=195.1

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeee--------------------------
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHS--------------------------   55 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~--------------------------   55 (282)
                      ||+++++-+|+.||||++....+......+.+|+.++.+|+|||||+++..+.+                          
T Consensus       495 VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~  574 (1351)
T KOG1035|consen  495 VVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSESRSQSASKYN  574 (1351)
T ss_pred             EEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchhhhcccCCCcc
Confidence            899999999999999999986577778899999999999999999999763221                          


Q ss_pred             --------------------------------------------------------------------------------
Q psy6044          56 --------------------------------------------------------------------------------   55 (282)
Q Consensus        56 --------------------------------------------------------------------------------   55 (282)
                                                                                                      
T Consensus       575 ~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~  654 (1351)
T KOG1035|consen  575 GVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPK  654 (1351)
T ss_pred             cceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCcchhhhhhccc
Confidence                                                                                            


Q ss_pred             -----C--------CeEEEEEecCcccHHHHHHhcCCCC-CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC
Q psy6044          56 -----E--------KKLTLVFEHCDQDLKKYFDSLNGEI-DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG  121 (282)
Q Consensus        56 -----~--------~~~~iv~e~~~g~l~~~~~~~~~~~-~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~  121 (282)
                           +        ..+||-||||+.+++..+...+... ..+..|+++.+|++||+|+|++|++||||||.|||+++++
T Consensus       655 ~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~  734 (1351)
T KOG1035|consen  655 TENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRN  734 (1351)
T ss_pred             cCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCC
Confidence                 0        2468999999999999888755544 5888999999999999999999999999999999999999


Q ss_pred             cEEEEecCCcccc------------------CCCccccccccccccccChhhhcCCC--CCCchhhHHHHHHHHHHHHhc
Q psy6044         122 ELKLADFGLARAF------------------GIPVKCYSAEVVTLWYRPPDVLFGAK--LYTTSIDMWSAGCIFAELANA  181 (282)
Q Consensus       122 ~~~l~df~~~~~~------------------~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~ll~~  181 (282)
                      .+||+|||+++..                  +.+....+..+||--|+|||++.+..  .|+.|+|+||||++++||+  
T Consensus       735 ~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~--  812 (1351)
T KOG1035|consen  735 SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML--  812 (1351)
T ss_pred             CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh--
Confidence            9999999999772                  12223556678899999999997765  6899999999999999999  


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHH
Q psy6044         182 GRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAE  261 (282)
Q Consensus       182 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  261 (282)
                       .||-..+.....+..+.++..+.+                         ..+...--+.-..+|++||+.||.+||||.
T Consensus       813 -yPF~TsMERa~iL~~LR~g~iP~~-------------------------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~  866 (1351)
T KOG1035|consen  813 -YPFGTSMERASILTNLRKGSIPEP-------------------------ADFFDPEHPEEASLIRWLLSHDPSKRPTAT  866 (1351)
T ss_pred             -ccCCchHHHHHHHHhcccCCCCCC-------------------------cccccccchHHHHHHHHHhcCCCccCCCHH
Confidence             455455555555555543221111                         111222334457899999999999999999


Q ss_pred             HHhcCCCcc
Q psy6044         262 DAMSHIYFS  270 (282)
Q Consensus       262 ~ll~h~~~~  270 (282)
                      |+|++.||-
T Consensus       867 eLL~s~llp  875 (1351)
T KOG1035|consen  867 ELLNSELLP  875 (1351)
T ss_pred             HHhhccCCC
Confidence            999999997

>KOG0612|consensus

Probab=100.00  E-value=4.9e-40  Score=291.10  Aligned_cols=246  Identities=23%  Similarity=0.330  Sum_probs=207.1

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      |.+.+++.+++.||+|++++  .........|..|-.+|..-+.+=|+.++-.|++++++|+||||++| +++..+.+ .
T Consensus        91 V~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk-~  169 (1317)
T KOG0612|consen   91 VALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSK-F  169 (1317)
T ss_pred             eEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhh-c
Confidence            67889999999999999998  34455678899999999999999999999999999999999999975 66666666 4


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~  157 (282)
                      +.+++..++.++..|+.||..+|+.|++||||||+||+++..|.+||+|||.+-.+.... -.....+|||.|.|||++.
T Consensus       170 ~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLq  249 (1317)
T KOG0612|consen  170 DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQ  249 (1317)
T ss_pred             CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHH
Confidence            489999999999999999999999999999999999999999999999999998887443 3445578999999999984


Q ss_pred             CC----CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         158 GA----KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       158 ~~----~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      ..    ..|+..+|-||+|+++|||+.|..||+ .....+.+.+|+......                        +++ 
T Consensus       250 s~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY-adslveTY~KIm~hk~~l------------------------~FP-  303 (1317)
T KOG0612|consen  250 SQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY-ADSLVETYGKIMNHKESL------------------------SFP-  303 (1317)
T ss_pred             hhcCCccccCCccchhhhHHHHHHHHcCCCcch-HHHHHHHHHHHhchhhhc------------------------CCC-
Confidence            32    347999999999999999999999954 445556666666541110                        111 


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCccCCccc
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMS---AEDAMSHIYFSDLNVA  275 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~~~  275 (282)
                      -...+|+.+++||++++. +|..|.+   ++++-.||||.+++|.
T Consensus       304 ~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~  347 (1317)
T KOG0612|consen  304 DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWD  347 (1317)
T ss_pred             cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChh
Confidence            013499999999998876 5889998   9999999999999984

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.4e-38  Score=259.95  Aligned_cols=235  Identities=18%  Similarity=0.243  Sum_probs=185.5

Q ss_pred             CeeeeeeCCCCce----EEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHH
Q psy6044           1 MFTSGVDRTPNTA----LAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFD   75 (282)
Q Consensus         1 ~vy~a~~~~~~~~----vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~   75 (282)
                      .||+|.+..+|+.    ||+|++...........+.+|+.+++.+.||||+++++++... ..++++|+++ |++.+.+.
T Consensus        22 ~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~  100 (279)
T cd05109          22 TVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVR  100 (279)
T ss_pred             eEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHh
Confidence            4899998777774    7999887644444456788999999999999999999998754 4678999997 56776666


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc--cccccccccccCh
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC--YSAEVVTLWYRPP  153 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aP  153 (282)
                      ...+.+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++.........  .....++..|+||
T Consensus       101 ~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~P  180 (279)
T cd05109         101 ENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL  180 (279)
T ss_pred             hccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCH
Confidence            55567999999999999999999999999999999999999999999999999998766432221  1122335679999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      |...+.. ++.++|+||||+++|++++.+.++|...........+.....                            ..
T Consensus       181 E~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~  231 (279)
T cd05109         181 ESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER----------------------------LP  231 (279)
T ss_pred             HHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc----------------------------CC
Confidence            9997666 689999999999999999855555776655554443322110                            01


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      .+...+..+.+++.+||+.||++|||+.++++
T Consensus       232 ~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         232 QPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            12347889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG1989|consensus

Probab=100.00  E-value=6.7e-40  Score=285.16  Aligned_cols=233  Identities=25%  Similarity=0.389  Sum_probs=184.1

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCC-CCCccceeee-eee---C---CeEEEEEecCc-ccHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK-HKNIVRLYDV-LHS---E---KKLTLVFEHCD-QDLK   71 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~-~~~---~---~~~~iv~e~~~-g~l~   71 (282)
                      +||+|.+...|..||+|++-.. ++.....+.+|+.+|++|+ |+|||.+++. ...   +   -.+.|+||||. |++.
T Consensus        52 ~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lv  130 (738)
T KOG1989|consen   52 QVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLV  130 (738)
T ss_pred             EEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHH
Confidence            4999999998899999998776 6666788999999999996 9999999993 221   1   35789999998 6899


Q ss_pred             HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccc-------
Q psy6044          72 KYFDSL-NGEIDLDIVKSFMYQLLRGLAFCHSRN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY-------  141 (282)
Q Consensus        72 ~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-------  141 (282)
                      +++..+ ...|++.++++|+.++++|+++||..+  |+|||||-+|||++.+|..||||||+++-........       
T Consensus       131 d~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve  210 (738)
T KOG1989|consen  131 DFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVE  210 (738)
T ss_pred             HHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHH
Confidence            988754 345999999999999999999999998  9999999999999999999999999986543221100       


Q ss_pred             --ccccccccccChhhh--cCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCC
Q psy6044         142 --SAEVVTLWYRPPDVL--FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLP  217 (282)
Q Consensus       142 --~~~~~~~~~~aPE~~--~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  217 (282)
                        -....|+.|+|||.+  ....+.+.|+|||||||+||.|+....| |........    ..+.-              
T Consensus       211 ~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~P-Fe~sg~laI----lng~Y--------------  271 (738)
T KOG1989|consen  211 EEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTP-FEESGKLAI----LNGNY--------------  271 (738)
T ss_pred             HHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCC-cCcCcceeE----Eeccc--------------
Confidence              011237899999987  3334469999999999999999988888 544421111    11000              


Q ss_pred             CCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         218 DFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                                  .++. .+.++..+.+||+.||+.||.+||++-|++.+
T Consensus       272 ------------~~P~-~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  272 ------------SFPP-FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             ------------cCCC-CccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence                        1111 14689999999999999999999999999874

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.1e-38  Score=265.06  Aligned_cols=236  Identities=19%  Similarity=0.285  Sum_probs=185.5

Q ss_pred             CeeeeeeCCCCce----EEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHH
Q psy6044           1 MFTSGVDRTPNTA----LAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFD   75 (282)
Q Consensus         1 ~vy~a~~~~~~~~----vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~   75 (282)
                      .||+|.+..+|+.    ||+|.+...........+.+|+.+++.++||||+++++++..+ ..++++||++ |++.+.+.
T Consensus        22 ~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~  100 (316)
T cd05108          22 TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVR  100 (316)
T ss_pred             eEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHH
Confidence            3899988766664    8999887544444456788999999999999999999998765 4678899886 56777776


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccc--ccccccccccCh
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY--SAEVVTLWYRPP  153 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~aP  153 (282)
                      .....+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+..........  .....+..|++|
T Consensus       101 ~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ap  180 (316)
T cd05108         101 EHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL  180 (316)
T ss_pred             hccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecCh
Confidence            656678999999999999999999999999999999999999999999999999998765332221  112235679999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      |.+.... ++.++|+||||+++|++++.+.++|.+....+..........                            ..
T Consensus       181 E~~~~~~-~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~  231 (316)
T cd05108         181 ESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER----------------------------LP  231 (316)
T ss_pred             HHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCC----------------------------CC
Confidence            9997766 699999999999999999744554776655554333222110                            01


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      .+...+..+.+++..||..||.+|||+.+++.+
T Consensus       232 ~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         232 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            123467889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-38  Score=260.41  Aligned_cols=236  Identities=23%  Similarity=0.348  Sum_probs=185.3

Q ss_pred             CeeeeeeCCC-----CceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHH
Q psy6044           1 MFTSGVDRTP-----NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~   74 (282)
                      .||+|.++..     +..||+|.+...........+.+|+.+++.++||||+++++++......++|+||+++ ++.+.+
T Consensus        21 ~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l  100 (277)
T cd05032          21 MVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL  100 (277)
T ss_pred             eEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHH
Confidence            3788887644     4899999986533333345688999999999999999999999999999999999975 555554


Q ss_pred             Hhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc--ccccc
Q psy6044          75 DSL---------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--KCYSA  143 (282)
Q Consensus        75 ~~~---------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~  143 (282)
                      ...         ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......  .....
T Consensus       101 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~  180 (277)
T cd05032         101 RSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK  180 (277)
T ss_pred             HhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCC
Confidence            332         1236888999999999999999999999999999999999999999999999987653221  11122


Q ss_pred             ccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCC
Q psy6044         144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFP  223 (282)
Q Consensus       144 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (282)
                      ..++..|+|||.+.... ++.++|+||||+++|++++++.++|...+..+....+...                      
T Consensus       181 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~----------------------  237 (277)
T cd05032         181 GLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG----------------------  237 (277)
T ss_pred             CCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC----------------------
Confidence            34467899999987666 6899999999999999998455557776666655544321                      


Q ss_pred             CCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         224 MYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                            .....+...+..+.+++.+||+.+|++|||+.++++
T Consensus       238 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         238 ------GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                  011123346889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.6e-38  Score=260.95  Aligned_cols=235  Identities=23%  Similarity=0.400  Sum_probs=182.2

Q ss_pred             eeeeee-----CCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHHHH
Q psy6044           2 FTSGVD-----RTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         2 vy~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~   74 (282)
                      ||+|.+     ..++..+|+|.+...........+.+|+.+++++ +||||+++++++...+..++++||+++ ++.+.+
T Consensus        51 V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i  130 (302)
T cd05055          51 VVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL  130 (302)
T ss_pred             EEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHH
Confidence            677764     4467789999887643333446788999999999 899999999999999999999999985 555555


Q ss_pred             HhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--cccccccccccc
Q psy6044          75 DSLN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--CYSAEVVTLWYR  151 (282)
Q Consensus        75 ~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~  151 (282)
                      .... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||.+........  ......++..|+
T Consensus       131 ~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~  210 (302)
T cd05055         131 RRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM  210 (302)
T ss_pred             HhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccC
Confidence            4433 2389999999999999999999999999999999999999999999999999876543221  111223467799


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMS  230 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
                      |||.+.... ++.++|+||+|+++|++++ |..| |......+...........                          
T Consensus       211 aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p-~~~~~~~~~~~~~~~~~~~--------------------------  262 (302)
T cd05055         211 APESIFNCV-YTFESDVWSYGILLWEIFSLGSNP-YPGMPVDSKFYKLIKEGYR--------------------------  262 (302)
T ss_pred             CHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCC-cCCCCchHHHHHHHHcCCc--------------------------
Confidence            999987766 6899999999999999998 5555 5555444333332221100                          


Q ss_pred             ccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                       ...+...++.+.+++.+||+.+|++|||+.++++
T Consensus       263 -~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         263 -MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence             0112346889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6.9e-39  Score=264.59  Aligned_cols=235  Identities=20%  Similarity=0.292  Sum_probs=180.2

Q ss_pred             CeeeeeeCCCCce--EEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHh
Q psy6044           1 MFTSGVDRTPNTA--LAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDS   76 (282)
Q Consensus         1 ~vy~a~~~~~~~~--vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~   76 (282)
                      .||+|.++.+|..  +++|.+...........+.+|+.++.++ +||||+++++++..++.+++|+||++| ++.+.+..
T Consensus        22 ~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  101 (303)
T cd05088          22 QVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK  101 (303)
T ss_pred             eEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHh
Confidence            4899998888765  4666655432333345678899999999 899999999999999999999999975 55555543


Q ss_pred             cC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccc
Q psy6044          77 LN---------------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY  141 (282)
Q Consensus        77 ~~---------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  141 (282)
                      ..               ..+++..++.++.||+.||++||++|++|+||+|+||+++.++.++|+|||++...... ...
T Consensus       102 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~  180 (303)
T cd05088         102 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKK  180 (303)
T ss_pred             cccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccCcccchh-hhc
Confidence            21               25789999999999999999999999999999999999999999999999988643211 111


Q ss_pred             ccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCC
Q psy6044         142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFK  220 (282)
Q Consensus       142 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (282)
                      .....+..|+|||.+.... ++.++|+||||+++|+++| |..| |...+..+....+....                  
T Consensus       181 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p-~~~~~~~~~~~~~~~~~------------------  240 (303)
T cd05088         181 TMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTP-YCGMTCAELYEKLPQGY------------------  240 (303)
T ss_pred             ccCCCcccccCHHHHhccC-CcccccchhhhhHHHHHHhcCCCC-cccCChHHHHHHHhcCC------------------
Confidence            1122356799999886655 6899999999999999998 5555 65555554443332110                  


Q ss_pred             CCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         221 PFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                                ....+...++.+.+++.+||+.+|.+|||+++++.+
T Consensus       241 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         241 ----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             ----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                      001123467889999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.1e-38  Score=257.85  Aligned_cols=238  Identities=23%  Similarity=0.375  Sum_probs=187.0

Q ss_pred             CeeeeeeCCCCceEEEeeeecCC----CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHH-HH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVG----NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKY-FD   75 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~-~~   75 (282)
                      .||+|.+..++..+++|++....    .......+..|+.+++.++||||+++++++.+....++++||+++..+.. +.
T Consensus        15 ~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~   94 (260)
T cd08222          15 TVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLE   94 (260)
T ss_pred             eEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHH
Confidence            38999998888888888776521    22223456678999999999999999999999999999999998644443 32


Q ss_pred             h---cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccC
Q psy6044          76 S---LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRP  152 (282)
Q Consensus        76 ~---~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~a  152 (282)
                      .   ....+++..++.++.|++.||.+||+.|++|+||+|+||+++. +.++|+|||.+..............++..|+|
T Consensus        95 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~  173 (260)
T cd08222          95 ELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMS  173 (260)
T ss_pred             HHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCcccccCCCCCcCccC
Confidence            2   2456999999999999999999999999999999999999964 67999999988766433333333456778999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       153 PE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      ||.+.... ++.++|+||+|+++|++++|..| |...........+...                            ...
T Consensus       174 pe~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~-~~~~~~~~~~~~~~~~----------------------------~~~  223 (260)
T cd08222         174 PEALKHQG-YDSKSDIWSLGCILYEMCCLAHA-FEGQNFLSVVLRIVEG----------------------------PTP  223 (260)
T ss_pred             HHHHccCC-CCchhhHHHHHHHHHHHHhCCCC-CCCccHHHHHHHHHcC----------------------------CCC
Confidence            99986655 68899999999999999988887 5544444433333221                            111


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      ..+..++.++.++|.+||+.||.+||++.++++||||
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         224 SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            1234578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0671|consensus

Probab=100.00  E-value=1.1e-40  Score=264.80  Aligned_cols=263  Identities=27%  Similarity=0.414  Sum_probs=203.2

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCC--CC----ccceeeeeeeCCeEEEEEecCcccHHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKH--KN----IVRLYDVLHSEKKLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h--~~----i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~   75 (282)
                      |-.+.|..++..||||+++.+...  .+..+-|+++++++.+  |+    ++.+.++|.-.++.+||+|.++.++.+++.
T Consensus       105 V~ec~D~~~~~~vAlKIik~V~kY--reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfellG~S~~dFlk  182 (415)
T KOG0671|consen  105 VVECWDRETKEHVALKIIKNVDKY--REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELLGLSTFDFLK  182 (415)
T ss_pred             eEEEeecCCCceehHHHHHHHHHH--hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEeccChhHHHHhc
Confidence            567788889999999999875433  4678889999999932  22    677888899999999999999999999988


Q ss_pred             hcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC--------------------CCcEEEEecCCcccc
Q psy6044          76 SLN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK--------------------NGELKLADFGLARAF  134 (282)
Q Consensus        76 ~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~--------------------~~~~~l~df~~~~~~  134 (282)
                      .++ .+++...+..+.+|+++++++||+.+++|.||||+||++.+                    +..++++|||+++..
T Consensus       183 ~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~  262 (415)
T KOG0671|consen  183 ENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFD  262 (415)
T ss_pred             cCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCccee
Confidence            754 46999999999999999999999999999999999999842                    335999999999765


Q ss_pred             CCCccccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCC-
Q psy6044         135 GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGM-  213 (282)
Q Consensus       135 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  213 (282)
                      .   ...+..+.|.+|+|||++.+-. ++.++||||+||+++|+++|..- |...++.|.+..+...+++.|....... 
T Consensus       263 ~---e~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~L-FqtHen~EHLaMMerIlGp~P~~mi~r~~  337 (415)
T KOG0671|consen  263 H---EHHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETL-FQTHENLEHLAMMERILGPIPSRMIKKTR  337 (415)
T ss_pred             c---cCcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeecccee-cccCCcHHHHHHHHHhhCCCcHHHhhhhh
Confidence            4   2234556799999999998887 89999999999999999988776 6666677877777777776654332221 


Q ss_pred             ---------------CCCCCCCCCCCCCCCCCccccCc---cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         214 ---------------NLLPDFKPFPMYHPSMSFSQVAP---KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       214 ---------------~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                                     +...+.+.  .............   .....+.+||++||..||.+|+|+.|+|.||||+...
T Consensus       338 ~~Kyf~~~rldw~e~~~~~~~k~--v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  338 KEKYFRRGRLDWPEVSSKGKSKY--VFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT  413 (415)
T ss_pred             hHhhhhcccccCccccccccchh--hhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence                           11000000  0001111111111   1334578999999999999999999999999999764

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.4e-38  Score=256.16  Aligned_cols=235  Identities=21%  Similarity=0.284  Sum_probs=183.3

Q ss_pred             eeeeeeCC---CCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeee-eCCeEEEEEecCcc-cHHHHHHh
Q psy6044           2 FTSGVDRT---PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLH-SEKKLTLVFEHCDQ-DLKKYFDS   76 (282)
Q Consensus         2 vy~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~-~~~~~~iv~e~~~g-~l~~~~~~   76 (282)
                      ||+|.+..   ++..+|+|.+...........+.+|+.+++.++|||++++++++. .++..++++||+.+ ++.+.+..
T Consensus        11 v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~   90 (262)
T cd05058          11 VYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRS   90 (262)
T ss_pred             EEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHh
Confidence            78888643   456899998765333333567888999999999999999999765 45678999999975 66666555


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc----cccccccccccccC
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV----KCYSAEVVTLWYRP  152 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~~a  152 (282)
                      .....++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+.......    .......++..|+|
T Consensus        91 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~a  170 (262)
T cd05058          91 ETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA  170 (262)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccC
Confidence            45567888889999999999999999999999999999999999999999999987553211    11112234567999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       153 PE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      ||.+.... ++.++||||||+++|++++|+.|+|......+....+.....                            .
T Consensus       171 PE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------~  221 (262)
T cd05058         171 LESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR----------------------------L  221 (262)
T ss_pred             hhHhccCc-cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC----------------------------C
Confidence            99987665 699999999999999999988888887766555444322110                            0


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ..+...++.+.+++..||..+|++||++.++++
T Consensus       222 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         222 LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            011236788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.1e-38  Score=259.98  Aligned_cols=246  Identities=20%  Similarity=0.311  Sum_probs=190.0

Q ss_pred             eeeeeeC---CCCceEEEeeeecC---CCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHH
Q psy6044           2 FTSGVDR---TPNTALAIKGTHLV---GNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         2 vy~a~~~---~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~   74 (282)
                      ||+|.+.   .+++.||+|++...   ........+..|+.++.++ +||||+++++.+......++|+||++|+.+...
T Consensus        16 vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   95 (288)
T cd05583          16 VFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTH   95 (288)
T ss_pred             EEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHH
Confidence            7887753   57899999998752   2233446678899999999 699999999999999999999999986444444


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccCh
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPP  153 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aP  153 (282)
                      ......+++..+..++.|++.||.+||+.|++|+||+|.||+++.++.++|+|||.+........ ......++..|++|
T Consensus        96 ~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aP  175 (288)
T cd05583          96 LYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP  175 (288)
T ss_pred             HhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCH
Confidence            33356789999999999999999999999999999999999999999999999998866532221 11223467889999


Q ss_pred             hhhcCCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCC---hHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         154 DVLFGAK-LYTTSIDMWSAGCIFAELANAGRPLFPGSD---VDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSM  229 (282)
Q Consensus       154 E~~~~~~-~~~~~~Di~slG~ll~~ll~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
                      |...+.. ..+.++|+||||+++|++++|..|+.....   ..+....+...                            
T Consensus       176 E~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~----------------------------  227 (288)
T cd05583         176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS----------------------------  227 (288)
T ss_pred             HHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc----------------------------
Confidence            9986543 257899999999999999998888432221   12222222111                            


Q ss_pred             CccccCccCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCccCCccch
Q psy6044         230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMS---AEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~~~~  276 (282)
                       ....+..++..+.++|.+||+.||++|||   +.++|+||||+.+.++.
T Consensus       228 -~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~  276 (288)
T cd05583         228 -KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDD  276 (288)
T ss_pred             -CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHH
Confidence             11123457889999999999999999998   56789999999998754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-38  Score=254.79  Aligned_cols=229  Identities=22%  Similarity=0.330  Sum_probs=184.7

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC-
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~-   78 (282)
                      .||+|..  .|+.||+|.+.....  ..+.+.+|+.+++.++|+|++++++++.+....++|+|++++ ++.+.+.... 
T Consensus        21 ~v~~~~~--~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~   96 (256)
T cd05039          21 DVMLGDY--RGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGR   96 (256)
T ss_pred             eEEEEEe--cCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCC
Confidence            3788886  489999999876432  456789999999999999999999999999999999999985 6666554433 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........   ....+..|+|||.+..
T Consensus        97 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~ape~~~~  173 (256)
T cd05039          97 AVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---SGKLPVKWTAPEALRE  173 (256)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc---cCCCcccccCchhhcC
Confidence            2689999999999999999999999999999999999999999999999999877642222   2233567999999876


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||||++++++++.+.++|......+....+....                            ....+..+
T Consensus       174 ~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~  224 (256)
T cd05039         174 KK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY----------------------------RMEAPEGC  224 (256)
T ss_pred             Cc-CCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC----------------------------CCCCccCC
Confidence            65 68999999999999999974454477666665544443211                            01122347


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ++.+.++|++||..+|.+|||+++++.
T Consensus       225 ~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         225 PPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.1e-38  Score=257.18  Aligned_cols=235  Identities=22%  Similarity=0.326  Sum_probs=185.0

Q ss_pred             CeeeeeeCCCCc---eEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHh
Q psy6044           1 MFTSGVDRTPNT---ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDS   76 (282)
Q Consensus         1 ~vy~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~   76 (282)
                      .||+|.++.++.   .+|+|.+...........+.+|+.++++++||||+++++++..++..++|+||++| ++.+.+..
T Consensus        19 ~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~   98 (267)
T cd05066          19 EVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK   98 (267)
T ss_pred             ceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHh
Confidence            489998865544   79999886533333356788999999999999999999999999999999999986 55555555


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccc---ccccccccccCh
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY---SAEVVTLWYRPP  153 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~~aP  153 (282)
                      ..+.+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+..........   ....++..|++|
T Consensus        99 ~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~p  178 (267)
T cd05066          99 HDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP  178 (267)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCH
Confidence            45678999999999999999999999999999999999999999999999999987664322111   111224579999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      |.+.+.. ++.++|+||||+++|++++ |..| |......+....+.+....                            
T Consensus       179 e~~~~~~-~~~~~Dv~slG~~l~ell~~g~~p-~~~~~~~~~~~~~~~~~~~----------------------------  228 (267)
T cd05066         179 EAIAYRK-FTSASDVWSYGIVMWEVMSYGERP-YWEMSNQDVIKAIEEGYRL----------------------------  228 (267)
T ss_pred             hHhccCc-cCchhhhHHHHHHHHHHhcCCCCC-cccCCHHHHHHHHhCCCcC----------------------------
Confidence            9997766 6999999999999999886 6666 5555545444444332110                            


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ..+..+++.+.+++.+||+.+|.+|||+.++++
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         229 PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            112346889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.2e-38  Score=257.75  Aligned_cols=237  Identities=21%  Similarity=0.304  Sum_probs=183.3

Q ss_pred             CeeeeeeCCCCc--eEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC------CeEEEEEecCcc-cH
Q psy6044           1 MFTSGVDRTPNT--ALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSE------KKLTLVFEHCDQ-DL   70 (282)
Q Consensus         1 ~vy~a~~~~~~~--~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~------~~~~iv~e~~~g-~l   70 (282)
                      .||+|.+..++.  .+|+|.+... ........+..|+.+++.++||||+++++++...      ...++++||+++ ++
T Consensus        14 ~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l   93 (272)
T cd05075          14 SVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDL   93 (272)
T ss_pred             eEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcH
Confidence            489999877776  6999988763 2333356788899999999999999999976432      357899999975 55


Q ss_pred             HHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc--ccc
Q psy6044          71 KKYFDS-----LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC--YSA  143 (282)
Q Consensus        71 ~~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~  143 (282)
                      ...+..     ....+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+..+......  ...
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  173 (272)
T cd05075          94 HSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRI  173 (272)
T ss_pred             HHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCc
Confidence            444422     1234899999999999999999999999999999999999999999999999998876432211  112


Q ss_pred             ccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCC
Q psy6044         144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFP  223 (282)
Q Consensus       144 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (282)
                      ..++..|++||...... ++.++|+||||+++|++++++.++|......+....+.....                    
T Consensus       174 ~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--------------------  232 (272)
T cd05075         174 AKMPVKWIAIESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR--------------------  232 (272)
T ss_pred             ccCCcccCCHHHccCCC-cChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC--------------------
Confidence            23456799999987766 699999999999999999866666777666555544433110                    


Q ss_pred             CCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         224 MYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                              ...+..++..+.++|.+||+.||.+|||+.++++.
T Consensus       233 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         233 --------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             --------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                    01123577889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG1095|consensus

Probab=100.00  E-value=4.6e-39  Score=288.23  Aligned_cols=236  Identities=22%  Similarity=0.328  Sum_probs=203.6

Q ss_pred             CeeeeeeCCCCc-----eEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHH
Q psy6044           1 MFTSGVDRTPNT-----ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~   74 (282)
                      .||.|.-.....     .||||.+....+......|++|+.+|+.++||||++++|++-+....+|++||+. |+|+.++
T Consensus       707 ~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sfl  786 (1025)
T KOG1095|consen  707 EVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFL  786 (1025)
T ss_pred             ceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHH
Confidence            488888665443     4999999887777888999999999999999999999999999999999999996 6888888


Q ss_pred             Hhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCC-Cc-cccccccc
Q psy6044          75 DSL------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGI-PV-KCYSAEVV  146 (282)
Q Consensus        75 ~~~------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~-~~-~~~~~~~~  146 (282)
                      .+.      ...++....+.++.+|+.|..||++++++||||..+|+|++....+||+|||+++.+-. +. ........
T Consensus       787 r~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~l  866 (1025)
T KOG1095|consen  787 RESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAML  866 (1025)
T ss_pred             HhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCcccc
Confidence            887      55699999999999999999999999999999999999999999999999999985522 11 11111233


Q ss_pred             cccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYH  226 (282)
Q Consensus       147 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (282)
                      +..|+|||.+.... ++.++||||||+++||++|.+.++|++.++.+.+....++.+.++                    
T Consensus       867 PvkWm~PEsl~d~i-FtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~--------------------  925 (1025)
T KOG1095|consen  867 PVKWMPPESLKDGI-FTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDP--------------------  925 (1025)
T ss_pred             ceecCCHHHHhhcc-cccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCC--------------------
Confidence            57899999998866 899999999999999999999999999999999887666543332                    


Q ss_pred             CCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         227 PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       227 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                              +..+++.+.+++..||+.+|++||++..|++
T Consensus       926 --------P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  926 --------PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             --------CCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence                    3457888999999999999999999999998

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.2e-38  Score=260.22  Aligned_cols=234  Identities=23%  Similarity=0.335  Sum_probs=181.0

Q ss_pred             eeeeeeC-----CCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHH
Q psy6044           2 FTSGVDR-----TPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFD   75 (282)
Q Consensus         2 vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~   75 (282)
                      ||+|.+.     .++..+++|.+.... ....+.+.+|++++++++||||+++++++......++||||++| ++.+.+.
T Consensus        21 vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~   99 (291)
T cd05094          21 VFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLR   99 (291)
T ss_pred             EEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHH
Confidence            7888743     356678888875422 12235688999999999999999999999999999999999976 5555443


Q ss_pred             hc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-
Q psy6044          76 SL---------------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-  139 (282)
Q Consensus        76 ~~---------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-  139 (282)
                      ..               .+.+++..++.++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+........ 
T Consensus       100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~  179 (291)
T cd05094         100 AHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY  179 (291)
T ss_pred             hcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCcee
Confidence            32               13488999999999999999999999999999999999999999999999999876543211 


Q ss_pred             -ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCC
Q psy6044         140 -CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPD  218 (282)
Q Consensus       140 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (282)
                       ......++..|+|||.+.+.. ++.++|+||||+++|+|++++.++|......+....+....                
T Consensus       180 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~----------------  242 (291)
T cd05094         180 RVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR----------------  242 (291)
T ss_pred             ecCCCCCcceeecChHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCC----------------
Confidence             112234467899999987766 68999999999999999983444465555555444432211                


Q ss_pred             CCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         219 FKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                  ........+..+.+++.+||+.||++|||+.++++
T Consensus       243 ------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         243 ------------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             ------------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence                        11112346788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-38  Score=254.12  Aligned_cols=233  Identities=23%  Similarity=0.353  Sum_probs=184.6

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC-
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~-   78 (282)
                      .||+|.+. +++.||+|.+....  .....+.+|+.++++++||||+++++++...+..++++|+++| ++.+.+.... 
T Consensus        21 ~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~   97 (261)
T cd05068          21 EVWEGLWN-NTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAG   97 (261)
T ss_pred             cEEEEEec-CCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCC
Confidence            48999874 46789999886422  2346688999999999999999999999999999999999964 5666554433 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc-cccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC-YSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~  157 (282)
                      ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......... ......+..|+|||...
T Consensus        98 ~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  177 (261)
T cd05068          98 RALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAAL  177 (261)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccc
Confidence            36899999999999999999999999999999999999999999999999998776532211 11112235799999887


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|+||||+++|++++++.++|.+.+.......+......                            ..+..
T Consensus       178 ~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~  228 (261)
T cd05068         178 YNR-FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM----------------------------PCPPG  228 (261)
T ss_pred             cCC-CCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------------------------CCCCc
Confidence            665 6899999999999999999555557776666555544332110                            11234


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      .+..+.+++.+||+.+|.+||++.++++
T Consensus       229 ~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         229 CPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             CCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            6789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.2e-38  Score=255.58  Aligned_cols=235  Identities=24%  Similarity=0.356  Sum_probs=185.1

Q ss_pred             CeeeeeeCCCCc---eEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCccc-HHHHHHh
Q psy6044           1 MFTSGVDRTPNT---ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDS   76 (282)
Q Consensus         1 ~vy~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~-l~~~~~~   76 (282)
                      .||+|+++.+++   .+|+|.+...........+..|+++++.++|||++++++++.+....++|+||++++ +.+.+..
T Consensus        20 ~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~   99 (268)
T cd05063          20 EVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD   99 (268)
T ss_pred             cEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHh
Confidence            389999877665   799998865433334567889999999999999999999999999999999999864 4445444


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccc---ccccccccccCh
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY---SAEVVTLWYRPP  153 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~~aP  153 (282)
                      ..+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..........   .....+..|+||
T Consensus       100 ~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~P  179 (268)
T cd05063         100 HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP  179 (268)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCH
Confidence            45679999999999999999999999999999999999999999999999999987654221111   111224569999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      |.+.... ++.++|+||||+++|++++ |..| |......+....+......+                           
T Consensus       180 E~~~~~~-~~~~~Dv~slG~il~ell~~g~~p-~~~~~~~~~~~~i~~~~~~~---------------------------  230 (268)
T cd05063         180 EAIAYRK-FTSASDVWSFGIVMWEVMSFGERP-YWDMSNHEVMKAINDGFRLP---------------------------  230 (268)
T ss_pred             HHhhcCC-cChHhHHHHHHHHHHHHHhCCCCC-CCcCCHHHHHHHHhcCCCCC---------------------------
Confidence            9987665 6899999999999999997 6666 55555555554443321110                           


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                       .....+..+.+++.+||+.+|.+||++.++++
T Consensus       231 -~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         231 -APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             -CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence             11246788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.8e-38  Score=256.85  Aligned_cols=221  Identities=17%  Similarity=0.242  Sum_probs=172.3

Q ss_pred             CceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHh-cCCCCCHHHHHHH
Q psy6044          11 NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS-LNGEIDLDIVKSF   89 (282)
Q Consensus        11 ~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~-~~~~~~~~~~~~~   89 (282)
                      ...+++|.+.... ......+.+|+.+++.++||||+++++++..+...++++||++++.++.+.. ....+++..+..+
T Consensus        32 ~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i  110 (262)
T cd05077          32 EIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKV  110 (262)
T ss_pred             ceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHH
Confidence            3468888876532 2334578889999999999999999999999999999999998766555544 3567999999999


Q ss_pred             HHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc-------EEEEecCCccccCCCccccccccccccccChhhhcCCCCC
Q psy6044          90 MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE-------LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLY  162 (282)
Q Consensus        90 ~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~-------~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  162 (282)
                      +.||+.||+|||++|++|+||+|+||+++.++.       ++++|||.+......    ....++..|+|||.+.....+
T Consensus       111 ~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~  186 (262)
T cd05077         111 AKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR----QECVERIPWIAPECVEDSKNL  186 (262)
T ss_pred             HHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc----ccccccccccChhhhcCCCCC
Confidence            999999999999999999999999999987664       899999988654322    223457789999998755557


Q ss_pred             CchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHH
Q psy6044         163 TTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKG  242 (282)
Q Consensus       163 ~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  242 (282)
                      +.++||||||+++|++++++.+++......+... .....                             .......+..+
T Consensus       187 ~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~-----------------------------~~~~~~~~~~~  236 (262)
T cd05077         187 SIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQ-----------------------------CMLVTPSCKEL  236 (262)
T ss_pred             CchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcC-----------------------------ccCCCCChHHH
Confidence            9999999999999999866666566654433322 11100                             00112245788


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         243 RDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       243 ~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      .++|.+||+.||.+||++.+|+++
T Consensus       237 ~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         237 ADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHh
Confidence            999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0696|consensus

Probab=100.00  E-value=1.2e-39  Score=261.85  Aligned_cols=246  Identities=21%  Similarity=0.315  Sum_probs=212.9

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      |-+|..+.+.+.||||++++  .-.....+--+.|-.++... +-|.++.++.+|+.-..+|+||||+.|+-+.+..+.-
T Consensus       365 VlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~  444 (683)
T KOG0696|consen  365 VLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV  444 (683)
T ss_pred             eeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHh
Confidence            56788889999999999998  23344456677788888777 5789999999999999999999999988777777778


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +++.|..+..++..|+.||-+||++||+++|||.+||+++.+|.+||.|||.+..--.........+||+.|+|||++.-
T Consensus       445 GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~Y  524 (683)
T KOG0696|consen  445 GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAY  524 (683)
T ss_pred             cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEe
Confidence            99999999999999999999999999999999999999999999999999999765444455556788999999999865


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. |+...|-||+|+++|||+.| +|+|++.+.++..+.+.+.                             ....+..+
T Consensus       525 qP-YgksvDWWa~GVLLyEmlaG-QpPFdGeDE~elF~aI~eh-----------------------------nvsyPKsl  573 (683)
T KOG0696|consen  525 QP-YGKSVDWWAFGVLLYEMLAG-QPPFDGEDEDELFQAIMEH-----------------------------NVSYPKSL  573 (683)
T ss_pred             cc-cccchhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHHc-----------------------------cCcCcccc
Confidence            55 89999999999999999955 5559999999999999883                             34456789


Q ss_pred             CHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCccchhh
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMS-----AEDAMSHIYFSDLNVAIKS  278 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps-----~~~ll~h~~~~~~~~~~~~  278 (282)
                      |.++.++++..|.+.|.+|..     -.+|-+||||+.|+++-..
T Consensus       574 SkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E  618 (683)
T KOG0696|consen  574 SKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLE  618 (683)
T ss_pred             cHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHh
Confidence            999999999999999999984     3689999999999886543

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-38  Score=257.22  Aligned_cols=234  Identities=21%  Similarity=0.301  Sum_probs=181.0

Q ss_pred             CeeeeeeCCCCc--eEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHh
Q psy6044           1 MFTSGVDRTPNT--ALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDS   76 (282)
Q Consensus         1 ~vy~a~~~~~~~--~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~   76 (282)
                      .||+|.++.+|.  .+++|.+...........+.+|++++.++ .||||+++++++...+..+++|||+++ ++.+.+..
T Consensus        10 ~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~   89 (270)
T cd05047          10 QVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK   89 (270)
T ss_pred             eEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHh
Confidence            489999988876  46888776433333446788899999999 899999999999999999999999975 56555543


Q ss_pred             cC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccc
Q psy6044          77 LN---------------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY  141 (282)
Q Consensus        77 ~~---------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  141 (282)
                      ..               ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        90 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~-~~  168 (270)
T cd05047          90 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KK  168 (270)
T ss_pred             ccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchhh-hc
Confidence            21               247899999999999999999999999999999999999999999999999875332111 11


Q ss_pred             ccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCC
Q psy6044         142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFK  220 (282)
Q Consensus       142 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (282)
                      .....+..|+|||.+.... ++.++|+||||+++|++++ |..| |.+.+..+....+....                  
T Consensus       169 ~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~el~~~g~~p-f~~~~~~~~~~~~~~~~------------------  228 (270)
T cd05047         169 TMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTP-YCGMTCAELYEKLPQGY------------------  228 (270)
T ss_pred             cCCCCccccCChHHHccCC-CCchhhHHHHHHHHHHHHcCCCCC-ccccCHHHHHHHHhCCC------------------
Confidence            1122245699999986655 6899999999999999997 5555 66655555444432210                  


Q ss_pred             CCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         221 PFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                ....+...+.++.+++.+||+.||.+|||+.+++.
T Consensus       229 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         229 ----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             ----------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                      00112346788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-38  Score=257.99  Aligned_cols=237  Identities=19%  Similarity=0.265  Sum_probs=183.5

Q ss_pred             CeeeeeeCC---CCceEEEeeeecCC-CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCe------EEEEEecCcc-c
Q psy6044           1 MFTSGVDRT---PNTALAIKGTHLVG-NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKK------LTLVFEHCDQ-D   69 (282)
Q Consensus         1 ~vy~a~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~------~~iv~e~~~g-~   69 (282)
                      .||+|....   ++..||+|.+.... .......+.+|+..++.++||||+++++++.....      .++++||+++ +
T Consensus        14 ~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~   93 (273)
T cd05035          14 SVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGD   93 (273)
T ss_pred             eEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCC
Confidence            378888765   34889999987632 22234578899999999999999999998865543      7999999986 4


Q ss_pred             HHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc--cc
Q psy6044          70 LKKYFDSL-----NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC--YS  142 (282)
Q Consensus        70 l~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~  142 (282)
                      +...+...     ...+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.+.........  ..
T Consensus        94 l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  173 (273)
T cd05035          94 LHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGR  173 (273)
T ss_pred             HHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeeccccccccccc
Confidence            44444221     235899999999999999999999999999999999999999999999999998765422211  11


Q ss_pred             cccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCC
Q psy6044         143 AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPF  222 (282)
Q Consensus       143 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (282)
                      ....+..|+|||.+.... ++.++|+||||+++|++++++.++|.+....+....+....                    
T Consensus       174 ~~~~~~~~~~pe~~~~~~-~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--------------------  232 (273)
T cd05035         174 IAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN--------------------  232 (273)
T ss_pred             cccCCccccCHhhcccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------------------
Confidence            122356799999986655 68999999999999999986666677777666555443311                    


Q ss_pred             CCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         223 PMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                              ....+..++..+.+++.+||+.||.+|||+.+++++
T Consensus       233 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         233 --------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             --------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                    111234578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.9e-38  Score=253.62  Aligned_cols=235  Identities=21%  Similarity=0.319  Sum_probs=186.5

Q ss_pred             CeeeeeeCC-CC--ceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHh
Q psy6044           1 MFTSGVDRT-PN--TALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDS   76 (282)
Q Consensus         1 ~vy~a~~~~-~~--~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~   76 (282)
                      .||+|.+.. .+  ..||+|.+.........+.+.+|+.++++++||||+++++.+.. ...++++||+++ ++.+.+..
T Consensus        10 ~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~   88 (257)
T cd05040          10 VVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRK   88 (257)
T ss_pred             cEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHh
Confidence            489998765 33  36999998774332445678899999999999999999999988 899999999974 66666655


Q ss_pred             cC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc---cccccccccccC
Q psy6044          77 LN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC---YSAEVVTLWYRP  152 (282)
Q Consensus        77 ~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~a  152 (282)
                      .. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........   .....++..|+|
T Consensus        89 ~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~  168 (257)
T cd05040          89 DALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCA  168 (257)
T ss_pred             cccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecC
Confidence            44 46899999999999999999999999999999999999999999999999998776432111   112334667999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q psy6044         153 PDVLFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSF  231 (282)
Q Consensus       153 PE~~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
                      ||.+.... ++.++|+||||+++|+|++ |..| |...+..+....+.....                           .
T Consensus       169 pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p-~~~~~~~~~~~~~~~~~~---------------------------~  219 (257)
T cd05040         169 PESLRTRT-FSHASDVWMFGVTLWEMFTYGEEP-WAGLSGSQILKKIDKEGE---------------------------R  219 (257)
T ss_pred             HHHhcccC-cCchhhhHHHHHHHHHHHhCCCCC-CCCCCHHHHHHHHHhcCC---------------------------c
Confidence            99987666 6899999999999999998 5555 766666665555443110                           0


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ...+...+..+.+++..||+.+|++|||+.++++
T Consensus       220 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         220 LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence            0112346789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.7e-38  Score=260.42  Aligned_cols=235  Identities=20%  Similarity=0.296  Sum_probs=182.5

Q ss_pred             CeeeeeeCCCCc--eEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHh
Q psy6044           1 MFTSGVDRTPNT--ALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDS   76 (282)
Q Consensus         1 ~vy~a~~~~~~~--~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~   76 (282)
                      .||+|.++.++.  .+++|.+.........+.+.+|+.++.++ +||||+++++++......++++||+++ ++.+.+..
T Consensus        17 ~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   96 (297)
T cd05089          17 QVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRK   96 (297)
T ss_pred             eEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHh
Confidence            389999887775  46888776433333346788999999999 799999999999999999999999975 56665543


Q ss_pred             cC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccc
Q psy6044          77 LN---------------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY  141 (282)
Q Consensus        77 ~~---------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  141 (282)
                      ..               ..+++..++.++.|++.||++||+.|++|+||||+||+++.++.++|+|||++........ .
T Consensus        97 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~  175 (297)
T cd05089          97 SRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK-K  175 (297)
T ss_pred             ccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCccccceec-c
Confidence            21               2488999999999999999999999999999999999999999999999998864321111 1


Q ss_pred             ccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCC
Q psy6044         142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFK  220 (282)
Q Consensus       142 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (282)
                      .....+..|+|||...... ++.++|+||||+++|+|++ |..| |......+....+.....                 
T Consensus       176 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~p-f~~~~~~~~~~~~~~~~~-----------------  236 (297)
T cd05089         176 TMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTP-YCGMTCAELYEKLPQGYR-----------------  236 (297)
T ss_pred             CCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCC-CCCCCHHHHHHHHhcCCC-----------------
Confidence            1122245699999987665 6899999999999999997 5555 766666655544332111                 


Q ss_pred             CCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         221 PFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                                 ...+..++..+.+|+.+||+.+|.+|||++++++.
T Consensus       237 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         237 -----------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                       11224578999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2e-38  Score=265.17  Aligned_cols=237  Identities=24%  Similarity=0.371  Sum_probs=178.8

Q ss_pred             CeeeeeeC-----CCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeee-CCeEEEEEecCcccHH-H
Q psy6044           1 MFTSGVDR-----TPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHS-EKKLTLVFEHCDQDLK-K   72 (282)
Q Consensus         1 ~vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~-~~~~~iv~e~~~g~l~-~   72 (282)
                      .||+|.+.     .+++.||+|++.........+.+.+|+.+++++ +|+||+++++++.. +..+++++||++|+.+ +
T Consensus        22 ~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~  101 (337)
T cd05054          22 KVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSN  101 (337)
T ss_pred             eEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHH
Confidence            47888643     346899999987533333345678899999999 89999999998764 4678999999986444 4


Q ss_pred             HHHhc------------------------------------------------------------CCCCCHHHHHHHHHH
Q psy6044          73 YFDSL------------------------------------------------------------NGEIDLDIVKSFMYQ   92 (282)
Q Consensus        73 ~~~~~------------------------------------------------------------~~~~~~~~~~~~~~q   92 (282)
                      .+...                                                            ...+++..+..++.|
T Consensus       102 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q  181 (337)
T cd05054         102 YLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQ  181 (337)
T ss_pred             HHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHH
Confidence            43321                                                            125789999999999


Q ss_pred             HHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--ccccccccccccChhhhcCCCCCCchhhHHH
Q psy6044          93 LLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWS  170 (282)
Q Consensus        93 i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s  170 (282)
                      |+.||+|||++||+|+||||.||+++.++.++|+|||++..+.....  ......++..|+|||.+.+.. ++.++|+||
T Consensus       182 i~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~S  260 (337)
T cd05054         182 VARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKV-YTTQSDVWS  260 (337)
T ss_pred             HHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCC-CCccccHHH
Confidence            99999999999999999999999999999999999999976532211  112233456799999987766 799999999


Q ss_pred             HHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHh
Q psy6044         171 AGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRL  249 (282)
Q Consensus       171 lG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  249 (282)
                      |||++|++++ |..| |.+....+..........                           ....+...++++.+++.+|
T Consensus       261 lGv~l~el~t~g~~p-~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~l~~~c  312 (337)
T cd05054         261 FGVLLWEIFSLGASP-YPGVQIDEEFCRRLKEGT---------------------------RMRAPEYATPEIYSIMLDC  312 (337)
T ss_pred             HHHHHHHHHHcCCCC-CCCCCccHHHHHHHhccC---------------------------CCCCCccCCHHHHHHHHHH
Confidence            9999999998 5555 655433332222221100                           0011234678999999999


Q ss_pred             cccCCCCCCCHHHHhcC
Q psy6044         250 LVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       250 l~~dp~~Rps~~~ll~h  266 (282)
                      |+.+|++|||++++++|
T Consensus       313 l~~~p~~RPs~~ell~~  329 (337)
T cd05054         313 WHNNPEDRPTFSELVEI  329 (337)
T ss_pred             ccCChhhCcCHHHHHHH
Confidence            99999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.3e-38  Score=254.02  Aligned_cols=233  Identities=23%  Similarity=0.339  Sum_probs=185.4

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc-C
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL-N   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~-~   78 (282)
                      .||+|.+. ++..||+|.+...  ....+.+.+|+.+++.++|+||+++++++...+..++++||++| ++.+.+... .
T Consensus        21 ~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~   97 (261)
T cd05072          21 EVWMGYYN-NSTKVAVKTLKPG--TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEG   97 (261)
T ss_pred             eEEEEEec-CCceEEEEEccCC--chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcC
Confidence            38999864 5678999987642  22346788999999999999999999999999999999999975 666655443 3


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~  157 (282)
                      ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||...
T Consensus        98 ~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  177 (261)
T cd05072          98 GKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN  177 (261)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhc
Confidence            5689999999999999999999999999999999999999999999999999976643221 112223456799999987


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      ... ++.++|+||||+++|++++++.++|......+....+......                            .....
T Consensus       178 ~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~  228 (261)
T cd05072         178 FGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM----------------------------PRMEN  228 (261)
T ss_pred             cCC-CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC----------------------------CCCCC
Confidence            665 6899999999999999998455557776666655554332110                            11234


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ++..+.+++.+||+.+|++|||++++++
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         229 CPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            7889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.2e-38  Score=259.18  Aligned_cols=233  Identities=18%  Similarity=0.290  Sum_probs=179.3

Q ss_pred             CceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC----------C
Q psy6044          11 NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN----------G   79 (282)
Q Consensus        11 ~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~----------~   79 (282)
                      +..||+|.+...........+.+|++++++++||||+++++++..+...++++|++++ ++.+.+....          .
T Consensus        46 ~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~  125 (296)
T cd05051          46 PVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK  125 (296)
T ss_pred             ceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCC
Confidence            4678999987643334456788899999999999999999999999999999999986 4555444322          1


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc--cccccccccccccChhhhc
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--KCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~  157 (282)
                      .+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.......  .......++..|+|||.+.
T Consensus       126 ~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  205 (296)
T cd05051         126 SLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL  205 (296)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhh
Confidence            68999999999999999999999999999999999999999999999999987553221  1112233466899999987


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhc-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANA-GRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      ... ++.++|+||||+++|+++++ +.+++...+..+...............                     .....+.
T Consensus       206 ~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~  263 (296)
T cd05051         206 LGK-FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQ---------------------IYLPRPP  263 (296)
T ss_pred             cCC-CCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcccccccc---------------------ccCCCcc
Confidence            765 69999999999999999973 344466666666555544322111100                     0011223


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      .++.++.+++.+||+.||.+|||+.++++
T Consensus       264 ~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         264 NCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             CCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            46789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.3e-38  Score=258.40  Aligned_cols=236  Identities=21%  Similarity=0.337  Sum_probs=182.4

Q ss_pred             CeeeeeeCC-----CCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHH
Q psy6044           1 MFTSGVDRT-----PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~   74 (282)
                      .||+|.+..     ....+++|.+...........+.+|+.+++.++||||+++++.+..+...++++||+++ ++.+.+
T Consensus        15 ~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   94 (290)
T cd05045          15 KVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFL   94 (290)
T ss_pred             ceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHH
Confidence            378888653     33578888876533333346788999999999999999999999999999999999985 444443


Q ss_pred             Hhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCc
Q psy6044          75 DSL-----------------------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA  131 (282)
Q Consensus        75 ~~~-----------------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~  131 (282)
                      ...                       ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~  174 (290)
T cd05045          95 RESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLS  174 (290)
T ss_pred             HhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEecccccc
Confidence            321                       124788999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCcc--ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy6044         132 RAFGIPVK--CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDT  209 (282)
Q Consensus       132 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  209 (282)
                      ........  ......++..|+|||...+.. ++.++|+||||+++++|++++.++|.+....+..+........     
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----  248 (290)
T cd05045         175 RDVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRM-----  248 (290)
T ss_pred             ccccCccchhcccCCCCCccccCHHHHccCC-cchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC-----
Confidence            75532211  112223456799999987665 6999999999999999998445557776666555443321110     


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         210 WPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                             ..+..++.++.+++..||+.+|.+||++.++++
T Consensus       249 -----------------------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         249 -----------------------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                                   112347889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.7e-38  Score=258.55  Aligned_cols=236  Identities=23%  Similarity=0.320  Sum_probs=183.2

Q ss_pred             CeeeeeeC-----CCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHH
Q psy6044           1 MFTSGVDR-----TPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~   74 (282)
                      .||+|.+.     .++..||+|.+...........+.+|+.+++.++||||+++++++.+....++++||+++ ++.+.+
T Consensus        20 ~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   99 (288)
T cd05050          20 RVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL   99 (288)
T ss_pred             cEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHH
Confidence            37888874     378899999987643333346788999999999999999999999999999999999985 565555


Q ss_pred             HhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccc
Q psy6044          75 DSLN---------------------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARA  133 (282)
Q Consensus        75 ~~~~---------------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~  133 (282)
                      ....                     ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus       100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  179 (288)
T cd05050         100 RHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN  179 (288)
T ss_pred             HHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECcccccee
Confidence            4321                     2478889999999999999999999999999999999999999999999999875


Q ss_pred             cCCCcc--ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCC
Q psy6044         134 FGIPVK--CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWP  211 (282)
Q Consensus       134 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  211 (282)
                      ......  .......+..|+|||.+.+.. ++.++|+||||+++|+|++.+..+|.+....+....+....         
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~---------  249 (288)
T cd05050         180 IYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGN---------  249 (288)
T ss_pred             cccCccccccCCCccChhhcCHHHHhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---------
Confidence            532211  111223356799999987666 79999999999999999974443355555555544433211         


Q ss_pred             CCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         212 GMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                         ....+...+..+.+||.+||+.||.+|||+.|+++
T Consensus       250 -------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         250 -------------------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             -------------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                               01122346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-38  Score=256.66  Aligned_cols=231  Identities=18%  Similarity=0.236  Sum_probs=182.0

Q ss_pred             CeeeeeeCCCCce-------EEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCccc-HHH
Q psy6044           1 MFTSGVDRTPNTA-------LAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKK   72 (282)
Q Consensus         1 ~vy~a~~~~~~~~-------vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~-l~~   72 (282)
                      .||+|.++.++..       +++|.+.... ....+.+..|+.+++.++|||++++++++..+...++||||++++ +..
T Consensus        10 ~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~   88 (258)
T cd05078          10 KIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDT   88 (258)
T ss_pred             hheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHH
Confidence            4899988765544       8888775422 223456788999999999999999999999999999999999865 545


Q ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc--------EEEEecCCccccCCCccccccc
Q psy6044          73 YFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE--------LKLADFGLARAFGIPVKCYSAE  144 (282)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~--------~~l~df~~~~~~~~~~~~~~~~  144 (282)
                      .+......+++..+..++.||+.||+|||+.|++|+||||+||+++.++.        ++++|||.+......    ...
T Consensus        89 ~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~----~~~  164 (258)
T cd05078          89 YLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK----EIL  164 (258)
T ss_pred             HHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCCc----hhc
Confidence            55444456899999999999999999999999999999999999987765        699999988655321    223


Q ss_pred             cccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM  224 (282)
Q Consensus       145 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (282)
                      .++..|+|||.+.+...++.++|+||||+++|++++|+.+++...+..........                        
T Consensus       165 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~------------------------  220 (258)
T cd05078         165 LERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED------------------------  220 (258)
T ss_pred             cccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc------------------------
Confidence            45778999999977555789999999999999999987776766655543332211                        


Q ss_pred             CCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         225 YHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       225 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                            ....+...+.++.+++.+||+.||.+|||++++++.
T Consensus       221 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         221 ------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             ------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                  011223456789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.3e-38  Score=268.49  Aligned_cols=235  Identities=25%  Similarity=0.368  Sum_probs=180.2

Q ss_pred             CeeeeeeCCC-----CceEEEeeeecCCCCCCCccHHHHHHHHhhCC-CCCccceeeeeeeCCeEEEEEecCcc-cHHHH
Q psy6044           1 MFTSGVDRTP-----NTALAIKGTHLVGNEGVPSSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY   73 (282)
Q Consensus         1 ~vy~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~   73 (282)
                      .||+|.+...     +..||||++.........+.+++|+++++++. ||||+++++++.+....++||||++| ++.+.
T Consensus        52 ~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~  131 (400)
T cd05105          52 KVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNY  131 (400)
T ss_pred             eEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHH
Confidence            3788886433     45799999876444444567899999999995 99999999999999999999999975 55544


Q ss_pred             HHhc----------------------------------------------------------------------------
Q psy6044          74 FDSL----------------------------------------------------------------------------   77 (282)
Q Consensus        74 ~~~~----------------------------------------------------------------------------   77 (282)
                      +..+                                                                            
T Consensus       132 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  211 (400)
T cd05105         132 LHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRP  211 (400)
T ss_pred             HHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCccccc
Confidence            4331                                                                            


Q ss_pred             -------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc
Q psy6044          78 -------------------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  138 (282)
Q Consensus        78 -------------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~  138 (282)
                                         ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus       212 ~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~  291 (400)
T cd05105         212 ASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDS  291 (400)
T ss_pred             ccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccc
Confidence                               1237788889999999999999999999999999999999999999999999987653221


Q ss_pred             c--ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCCh-HHHHHHHHHHhCCCCCCCCCCCC
Q psy6044         139 K--CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDV-DDQLKRIFKLLGTPTEDTWPGMN  214 (282)
Q Consensus       139 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  214 (282)
                      .  ......++..|+|||.+.+.. ++.++||||||+++|++++ |+.| |..... ......+.....           
T Consensus       292 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt~g~~P-~~~~~~~~~~~~~~~~~~~-----------  358 (400)
T cd05105         292 NYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTP-YPGMIVDSTFYNKIKSGYR-----------  358 (400)
T ss_pred             cccccCCcCCCcceEChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCC-CcccchhHHHHHHHhcCCC-----------
Confidence            1  112223467799999987765 6999999999999999997 6666 554333 233222222100           


Q ss_pred             CCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         215 LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                       ...+..++..+.+++.+||+.||++|||+.++.+
T Consensus       359 -----------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         359 -----------------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             -----------------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence                             0112357889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.8e-38  Score=255.37  Aligned_cols=235  Identities=20%  Similarity=0.318  Sum_probs=184.7

Q ss_pred             CeeeeeeCCCCc---eEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCccc-HHHHHHh
Q psy6044           1 MFTSGVDRTPNT---ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDS   76 (282)
Q Consensus         1 ~vy~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~-l~~~~~~   76 (282)
                      .||+|.++.+|+   .||+|.+...........+..|+.+++.++||||+++++++.++...++|+||++|+ +.+.+..
T Consensus        19 ~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   98 (269)
T cd05065          19 EVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQ   98 (269)
T ss_pred             eEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhh
Confidence            389999887765   699999876433434567889999999999999999999999999999999999875 4444444


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc--cccc---ccccccc
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC--YSAE---VVTLWYR  151 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~---~~~~~~~  151 (282)
                      ..+.+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.........  ....   ..+..|+
T Consensus        99 ~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~  178 (269)
T cd05065          99 NDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT  178 (269)
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeec
Confidence            4567899999999999999999999999999999999999999999999999988655322111  1111   1134699


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMS  230 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
                      |||.+.... ++.++|+||+|+++|++++ |..| |......+....+......                          
T Consensus       179 ~PE~~~~~~-~~~~~DvwslG~~l~e~l~~g~~p-~~~~~~~~~~~~i~~~~~~--------------------------  230 (269)
T cd05065         179 APEAIAYRK-FTSASDVWSYGIVMWEVMSYGERP-YWDMSNQDVINAIEQDYRL--------------------------  230 (269)
T ss_pred             CHhHhccCc-ccchhhhhhhHHHHHHHhcCCCCC-CCCCCHHHHHHHHHcCCcC--------------------------
Confidence            999997666 6899999999999999886 5555 5555555554444321110                          


Q ss_pred             ccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                        ..+..++..+.+++.+||..+|.+||++.+++.
T Consensus       231 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         231 --PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             --CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence              012346788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6.7e-38  Score=254.52  Aligned_cols=240  Identities=22%  Similarity=0.302  Sum_probs=179.6

Q ss_pred             eeeeeeC--CCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDR--TPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      ||+|...  .....+++|.+...........+.+|+..++.++||||+++++.+......++||||+++ ++.+.+....
T Consensus        11 v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~   90 (269)
T cd05042          11 VLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNR   90 (269)
T ss_pred             EEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhcc
Confidence            7888543  345678888776533333345678999999999999999999999999999999999986 5555544422


Q ss_pred             C----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc--cccccccccccccC
Q psy6044          79 G----EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--KCYSAEVVTLWYRP  152 (282)
Q Consensus        79 ~----~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~a  152 (282)
                      .    ..++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.......  .......++..|+|
T Consensus        91 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a  170 (269)
T cd05042          91 GMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLA  170 (269)
T ss_pred             ccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccC
Confidence            2    24678889999999999999999999999999999999999999999999886532211  11122234567999


Q ss_pred             hhhhcC------CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         153 PDVLFG------AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYH  226 (282)
Q Consensus       153 PE~~~~------~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (282)
                      ||....      ...++.++|+||||+++|++++++.++|......+.............                    
T Consensus       171 PE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~--------------------  230 (269)
T cd05042         171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL--------------------  230 (269)
T ss_pred             HHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccC--------------------
Confidence            999743      223688999999999999999866666777666655544433211110                    


Q ss_pred             CCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         227 PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       227 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                         ........++..+.+++..|+ .||.+|||++++++
T Consensus       231 ---~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         231 ---PKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ---CCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence               111233458888999999998 59999999999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.1e-37  Score=252.36  Aligned_cols=232  Identities=25%  Similarity=0.360  Sum_probs=182.5

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc-C
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL-N   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~-~   78 (282)
                      .||+|.+..+ ..||+|.+....  .....+.+|+++++.++||||+++++.+.+ ...++|+||+++ ++.+.+... .
T Consensus        21 ~v~~~~~~~~-~~valK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~   96 (262)
T cd05071          21 EVWMGTWNGT-TRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMG   96 (262)
T ss_pred             cEEEEEecCC-ceEEEEecccCc--cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccc
Confidence            3899988665 459999987522  123568899999999999999999998754 557999999986 666665543 3


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc-cccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC-YSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~  157 (282)
                      ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||...
T Consensus        97 ~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  176 (262)
T cd05071          97 KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL  176 (262)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhc
Confidence            45899999999999999999999999999999999999999999999999998765432221 11223456799999887


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      ... ++.++|+||||+++|++++++.++|......+....+.....                            ......
T Consensus       177 ~~~-~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~  227 (262)
T cd05071         177 YGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR----------------------------MPCPPE  227 (262)
T ss_pred             cCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC----------------------------CCCccc
Confidence            666 699999999999999999966666877666655544332110                            011235


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ++..+.+++.+|++.||.+|||+.++++
T Consensus       228 ~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         228 CPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             cCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            7889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.5e-38  Score=260.29  Aligned_cols=235  Identities=24%  Similarity=0.365  Sum_probs=184.0

Q ss_pred             eeeeeeCC-------CCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHH
Q psy6044           2 FTSGVDRT-------PNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKK   72 (282)
Q Consensus         2 vy~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~   72 (282)
                      ||+|++..       ++..+|+|.+...........+..|+.+++.+ +||||+++++++......++|+||+++ ++.+
T Consensus        34 V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  113 (307)
T cd05098          34 VVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE  113 (307)
T ss_pred             EEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHH
Confidence            78887543       34579999887543333345688899999999 799999999999999999999999985 6666


Q ss_pred             HHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC
Q psy6044          73 YFDSLN---------------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP  137 (282)
Q Consensus        73 ~~~~~~---------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~  137 (282)
                      .+....               ..+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus       114 ~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~  193 (307)
T cd05098         114 YLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI  193 (307)
T ss_pred             HHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCccccccccc
Confidence            654422               24788999999999999999999999999999999999999999999999998765422


Q ss_pred             cc--ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCC
Q psy6044         138 VK--CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNL  215 (282)
Q Consensus       138 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  215 (282)
                      ..  ......++..|+|||.+.+.. ++.++|+||||+++|+|++++.++|......+....+....             
T Consensus       194 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-------------  259 (307)
T cd05098         194 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH-------------  259 (307)
T ss_pred             chhhccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCC-------------
Confidence            11  111122346799999987766 68999999999999999985666677766655554443211             


Q ss_pred             CCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         216 LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                     ....+...+.++.+++.+||+.+|.+|||+.++++
T Consensus       260 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~  294 (307)
T cd05098         260 ---------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  294 (307)
T ss_pred             ---------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence                           01123457889999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.3e-38  Score=283.34  Aligned_cols=236  Identities=20%  Similarity=0.276  Sum_probs=179.9

Q ss_pred             CeeeeeeCCCCceEEEeeeecCC--CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHH-HHHHhc
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVG--NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLK-KYFDSL   77 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~-~~~~~~   77 (282)
                      .||+|.+..+|+.||+|++....  .....+.+.+|+.+++.++||||+++++++.+++..+++|||++|+.+ +.+...
T Consensus        17 ~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~   96 (932)
T PRK13184         17 EVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSV   96 (932)
T ss_pred             EEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHh
Confidence            38999999999999999987632  222345688999999999999999999999999999999999987544 443321


Q ss_pred             ----------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC----------
Q psy6044          78 ----------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP----------  137 (282)
Q Consensus        78 ----------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~----------  137 (282)
                                ....+...+..++.||+.||++||+.|++||||||+||+++.++.++|+|||.+......          
T Consensus        97 ~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~  176 (932)
T PRK13184         97 WQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD  176 (932)
T ss_pred             hhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccc
Confidence                      123566778899999999999999999999999999999999999999999998765211          


Q ss_pred             --------ccccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy6044         138 --------VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDT  209 (282)
Q Consensus       138 --------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  209 (282)
                              ........|++.|+|||.+.+.. ++.++|+||+||++|+|++|..| |...........  .....+.   
T Consensus       177 ~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~P-F~~~~~~ki~~~--~~i~~P~---  249 (932)
T PRK13184        177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFP-YRRKKGRKISYR--DVILSPI---  249 (932)
T ss_pred             cccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCC-CCCcchhhhhhh--hhccChh---
Confidence                    01111235789999999997766 69999999999999999999888 444332221111  1000000   


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHh
Q psy6044         210 WPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAM  264 (282)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  264 (282)
                                          .. .-...+++.+.+++.+||+.||++|++..+.+
T Consensus       250 --------------------~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL  283 (932)
T PRK13184        250 --------------------EV-APYREIPPFLSQIAMKALAVDPAERYSSVQEL  283 (932)
T ss_pred             --------------------hc-cccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence                                00 00135788999999999999999998765544

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=7.5e-38  Score=259.75  Aligned_cols=236  Identities=25%  Similarity=0.372  Sum_probs=183.5

Q ss_pred             CeeeeeeC-------CCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHH
Q psy6044           1 MFTSGVDR-------TPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLK   71 (282)
Q Consensus         1 ~vy~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~   71 (282)
                      .||+|++.       ..+..+|+|.+...........+..|+.+++++ +||||+++++++..+...++++||+++ ++.
T Consensus        27 ~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~  106 (314)
T cd05099          27 QVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR  106 (314)
T ss_pred             cEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHH
Confidence            37888753       245679999887533333345688899999999 699999999999999999999999986 555


Q ss_pred             HHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCC
Q psy6044          72 KYFDSLN---------------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGI  136 (282)
Q Consensus        72 ~~~~~~~---------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~  136 (282)
                      +++....               ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus       107 ~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  186 (314)
T cd05099         107 EFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHD  186 (314)
T ss_pred             HHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccc
Confidence            5554321               3488899999999999999999999999999999999999999999999999976542


Q ss_pred             Ccc--ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCC
Q psy6044         137 PVK--CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN  214 (282)
Q Consensus       137 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  214 (282)
                      ...  ......++..|+|||.+.+.. ++.++|+||||+++|++++++.++|......+....+.....           
T Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-----------  254 (314)
T cd05099         187 IDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR-----------  254 (314)
T ss_pred             cccccccccCCCCccccCHHHHccCC-cCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence            211  111122345799999987765 689999999999999999855555777766665555433110           


Q ss_pred             CCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         215 LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                       ...+..++..+.+++.+||+.||++|||+.++++
T Consensus       255 -----------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         255 -----------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                             1122457889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=6.5e-38  Score=256.05  Aligned_cols=234  Identities=24%  Similarity=0.358  Sum_probs=182.8

Q ss_pred             eeeeee-----CCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHH
Q psy6044           2 FTSGVD-----RTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFD   75 (282)
Q Consensus         2 vy~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~   75 (282)
                      ||+|..     ..++..+|+|.+.... ......+.+|+++++.++|+||+++++++......++++||+++ ++.+.+.
T Consensus        21 v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~   99 (280)
T cd05092          21 VFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLR   99 (280)
T ss_pred             EEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHH
Confidence            777753     3467789999876432 23346788999999999999999999999999999999999975 5555544


Q ss_pred             hcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--
Q psy6044          76 SLN--------------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--  139 (282)
Q Consensus        76 ~~~--------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--  139 (282)
                      ...              ..+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+........  
T Consensus       100 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  179 (280)
T cd05092         100 SHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR  179 (280)
T ss_pred             hcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceee
Confidence            322              2478999999999999999999999999999999999999999999999999865532211  


Q ss_pred             ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCC
Q psy6044         140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDF  219 (282)
Q Consensus       140 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (282)
                      ......+++.|+|||.+.+.. ++.++|+||||+++|++++++.++|......+....+.....                
T Consensus       180 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------  242 (280)
T cd05092         180 VGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRE----------------  242 (280)
T ss_pred             cCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCcc----------------
Confidence            111223356799999987766 699999999999999999855655766666555544433211                


Q ss_pred             CCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         220 KPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                  ...+..+++.+.++|.+||+.||.+||++.++++
T Consensus       243 ------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         243 ------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                        1122357889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.4e-37  Score=251.42  Aligned_cols=231  Identities=24%  Similarity=0.364  Sum_probs=181.7

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc-CC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL-NG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~-~~   79 (282)
                      ||+|.+. ++..+|+|.+.....  ..+.+.+|+.++++++|||++++++++.. ...+++|||+++ ++.+.+... ..
T Consensus        22 v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~   97 (260)
T cd05070          22 VWMGTWN-GNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGR   97 (260)
T ss_pred             EEEEEec-CCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhcCCC
Confidence            7999875 567799998875222  24578899999999999999999998854 568899999976 555555442 34


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~  158 (282)
                      .+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||....
T Consensus        98 ~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  177 (260)
T cd05070          98 ALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY  177 (260)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhc
Confidence            589999999999999999999999999999999999999999999999999876543221 1112233557999999876


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||||+++|++++++.++|.+.+..+....+.....                            ...+...
T Consensus       178 ~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~  228 (260)
T cd05070         178 GR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR----------------------------MPCPQDC  228 (260)
T ss_pred             CC-CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----------------------------CCCCCcC
Confidence            65 689999999999999999856666777666655555432110                            0122457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      +..+.+++.+||..+|.+|||+.++.+
T Consensus       229 ~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         229 PISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             CHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-37  Score=251.34  Aligned_cols=233  Identities=26%  Similarity=0.372  Sum_probs=185.4

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC-
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~-   78 (282)
                      .||+|.+. +++.+|+|.+...  ......+.+|+.++++++|||++++++++......++++|++++ ++.+.+.... 
T Consensus        21 ~v~~~~~~-~~~~~~vK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~   97 (261)
T cd05034          21 EVWMGTWN-GTTKVAVKTLKPG--TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEG   97 (261)
T ss_pred             EEEEEEEc-CCceEEEEEecCC--ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhcccc
Confidence            38999975 4688999988742  22346789999999999999999999999998999999999976 5555554433 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~  157 (282)
                      ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+........ .......+..|+|||.+.
T Consensus        98 ~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  177 (261)
T cd05034          98 KKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAAN  177 (261)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhc
Confidence            4689999999999999999999999999999999999999999999999999876643211 111222346799999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|+||+|++++++++++.++|.+.+.......+......                            ..+..
T Consensus       178 ~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~  228 (261)
T cd05034         178 YGR-FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM----------------------------PRPPN  228 (261)
T ss_pred             cCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------------------------CCCCC
Confidence            665 6899999999999999998455557777666666655432111                            11233


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      .+..+.+++.+||+.+|.+||+++++++
T Consensus       229 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         229 CPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            5788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7e-38  Score=258.80  Aligned_cols=236  Identities=23%  Similarity=0.363  Sum_probs=185.5

Q ss_pred             CeeeeeeC-------CCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHH
Q psy6044           1 MFTSGVDR-------TPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLK   71 (282)
Q Consensus         1 ~vy~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~   71 (282)
                      .||+|++.       .++..||+|.+...........+.+|+.+++.+ +||||+++++++......++++||+++ ++.
T Consensus        30 ~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~  109 (304)
T cd05101          30 QVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR  109 (304)
T ss_pred             eEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHH
Confidence            37888642       245689999887543333456788999999999 899999999999999999999999976 555


Q ss_pred             HHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCC
Q psy6044          72 KYFDSLN---------------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGI  136 (282)
Q Consensus        72 ~~~~~~~---------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~  136 (282)
                      +++....               ..++...+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||.+.....
T Consensus       110 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~  189 (304)
T cd05101         110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNN  189 (304)
T ss_pred             HHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceeccc
Confidence            5554421               2477888999999999999999999999999999999999999999999999876643


Q ss_pred             Cccc--cccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCC
Q psy6044         137 PVKC--YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN  214 (282)
Q Consensus       137 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  214 (282)
                      ....  .....++..|+|||.+.+.. ++.++|+||||+++|++++++.+++.+.+..+....+.....           
T Consensus       190 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-----------  257 (304)
T cd05101         190 IDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR-----------  257 (304)
T ss_pred             ccccccccCCCCCceeeCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc-----------
Confidence            2211  12223356799999997765 689999999999999999855555777776666555432110           


Q ss_pred             CCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         215 LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                       ...+...+..+.+++.+||+.+|.+|||+.++++
T Consensus       258 -----------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~  291 (304)
T cd05101         258 -----------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE  291 (304)
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                             0112357889999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.1e-37  Score=248.97  Aligned_cols=239  Identities=37%  Similarity=0.577  Sum_probs=193.2

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~   80 (282)
                      ||+|.+..+|+.+|+|++.........+.+.+|+..+++++|+|++++++.+......++++|++++ ++.+.+.. ...
T Consensus         5 v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~-~~~   83 (244)
T smart00220        5 VYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK-RGR   83 (244)
T ss_pred             EEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh-ccC
Confidence            7999999999999999988643332257899999999999999999999999999999999999988 55555444 444


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..++.++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|++||......
T Consensus        84 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~  162 (244)
T smart00220       84 LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEVLLGKG  162 (244)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHHHccCC
Confidence            8999999999999999999999999999999999999999999999999998765432 233445677899999997655


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                       ++.++|+|++|++++++++|..|+............+.......                          ......++.
T Consensus       163 -~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~  215 (244)
T smart00220      163 -YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF--------------------------PPPEWKISP  215 (244)
T ss_pred             -CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC--------------------------ccccccCCH
Confidence             68899999999999999998877433244433333332211100                          001111778


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      .+.+++.+||..+|.+||++.++++||||
T Consensus       216 ~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      216 EAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             HHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence            99999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=5.4e-38  Score=255.03  Aligned_cols=235  Identities=21%  Similarity=0.336  Sum_probs=183.8

Q ss_pred             CeeeeeeCCCC------ceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHH
Q psy6044           1 MFTSGVDRTPN------TALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY   73 (282)
Q Consensus         1 ~vy~a~~~~~~------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~   73 (282)
                      .||+|.++..+      ..+|+|.+...........+.+|+.+++.++||||+++++++..+...++++||++| ++.+.
T Consensus        10 ~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~   89 (269)
T cd05044          10 EVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSY   89 (269)
T ss_pred             eEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHH
Confidence            37888876544      789999887643334456788999999999999999999999999999999999975 56655


Q ss_pred             HHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC-----cEEEEecCCccccCCCc--cc
Q psy6044          74 FDSL------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG-----ELKLADFGLARAFGIPV--KC  140 (282)
Q Consensus        74 ~~~~------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~-----~~~l~df~~~~~~~~~~--~~  140 (282)
                      +...      ...+++..+..++.|++.||+|||+.+++|+||+|+||+++.++     .++|+|||.+.......  ..
T Consensus        90 l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~  169 (269)
T cd05044          90 LRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRK  169 (269)
T ss_pred             HHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccccccccccccc
Confidence            5432      23478899999999999999999999999999999999999887     89999999986553221  11


Q ss_pred             cccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCC
Q psy6044         141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDF  219 (282)
Q Consensus       141 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (282)
                      .....++..|+|||.+.+.. ++.++|+||||+++|++++ |..| |...+..+....+....                 
T Consensus       170 ~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p-~~~~~~~~~~~~~~~~~-----------------  230 (269)
T cd05044         170 EGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQP-YPALNNQEVLQHVTAGG-----------------  230 (269)
T ss_pred             CcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCC-CcccCHHHHHHHHhcCC-----------------
Confidence            11223456799999997766 6999999999999999998 5555 66665555444332210                 


Q ss_pred             CCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         220 KPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                 ....+..+++.+.++|.+||..+|.+|||+.++++
T Consensus       231 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         231 -----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             -----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                       01122457889999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.2e-38  Score=254.89  Aligned_cols=220  Identities=16%  Similarity=0.212  Sum_probs=170.2

Q ss_pred             ceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHh-cCCCCCHHHHHHHH
Q psy6044          12 TALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS-LNGEIDLDIVKSFM   90 (282)
Q Consensus        12 ~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~-~~~~~~~~~~~~~~   90 (282)
                      ..|++|++..... .....+.+|+.+++.++||||+++++++..+...++||||++|+.++.+.. ..+.+++..+..++
T Consensus        45 ~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~  123 (274)
T cd05076          45 LRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVA  123 (274)
T ss_pred             eeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHH
Confidence            4688888764221 223567889999999999999999999999999999999998766665554 35678999999999


Q ss_pred             HHHHHHHHHHHhCCccccCCCCCcEEEcCCC-------cEEEEecCCccccCCCccccccccccccccChhhhcCCCCCC
Q psy6044          91 YQLLRGLAFCHSRNVLHRDLKPQNLLINKNG-------ELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYT  163 (282)
Q Consensus        91 ~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~-------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  163 (282)
                      .||+.||+|||++|++|+||||+||+++..+       .++++|||.+......    ....++..|+|||.+.+...++
T Consensus       124 ~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~  199 (274)
T cd05076         124 QQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLS  199 (274)
T ss_pred             HHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCC
Confidence            9999999999999999999999999997643       4899999987543221    1224567799999987655579


Q ss_pred             chhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHH
Q psy6044         164 TSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGR  243 (282)
Q Consensus       164 ~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  243 (282)
                      .++|+||||+++|++++++.++|......+.........                              ..+...++.+.
T Consensus       200 ~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~  249 (274)
T cd05076         200 TAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKH------------------------------RLPEPSCKELA  249 (274)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhcc------------------------------CCCCCCChHHH
Confidence            999999999999999755555566555444332221110                              01123456789


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcC
Q psy6044         244 DLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       244 ~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      ++|.+||+.+|.+|||+.+++++
T Consensus       250 ~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         250 TLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHHHHcccChhhCcCHHHHHHh
Confidence            99999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.1e-38  Score=256.36  Aligned_cols=239  Identities=20%  Similarity=0.341  Sum_probs=180.7

Q ss_pred             eeeee----eCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC--CeEEEEEecCccc-HHHHH
Q psy6044           2 FTSGV----DRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE--KKLTLVFEHCDQD-LKKYF   74 (282)
Q Consensus         2 vy~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~--~~~~iv~e~~~g~-l~~~~   74 (282)
                      ||+|+    .+.++..||+|.+...........+.+|+.+++.++|||++++++++...  ...++|+||++|. +.+.+
T Consensus        20 v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l   99 (284)
T cd05079          20 VELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL   99 (284)
T ss_pred             EEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHH
Confidence            67776    45689999999987644444456789999999999999999999998875  6789999999765 44444


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc---cccccccccccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK---CYSAEVVTLWYR  151 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~  151 (282)
                      ......+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+........   ......++..|+
T Consensus       100 ~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~  179 (284)
T cd05079         100 PRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY  179 (284)
T ss_pred             HhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCcccc
Confidence            44345689999999999999999999999999999999999999999999999999876543221   112234456799


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChH----------HHHHHHHHHhCCCCCCCCCCCCCCCCCCC
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD----------DQLKRIFKLLGTPTEDTWPGMNLLPDFKP  221 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (282)
                      |||.+.+.. ++.++|+||||+++|++++++.|........          .............                
T Consensus       180 apE~~~~~~-~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------  242 (284)
T cd05079         180 APECLIQSK-FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG----------------  242 (284)
T ss_pred             CHHHhccCC-CCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC----------------
Confidence            999987665 6899999999999999998766533221100          0000000000000                


Q ss_pred             CCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         222 FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                              .....+..++..+.+|+.+||+.||.+|||+.++++
T Consensus       243 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  278 (284)
T cd05079         243 --------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE  278 (284)
T ss_pred             --------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                    011123457899999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1e-37  Score=251.91  Aligned_cols=228  Identities=18%  Similarity=0.240  Sum_probs=177.9

Q ss_pred             CeeeeeeCCCC----------ceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccH
Q psy6044           1 MFTSGVDRTPN----------TALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDL   70 (282)
Q Consensus         1 ~vy~a~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l   70 (282)
                      .||+|.++.++          ..+++|.+......  ...+.+|+.+++.++||||+++++++.. ...++|+||++++.
T Consensus        10 ~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~   86 (259)
T cd05037          10 NIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGP   86 (259)
T ss_pred             eEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCc
Confidence            38999998777          35777876543222  5788899999999999999999999888 77899999998755


Q ss_pred             HHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC-------cEEEEecCCccccCCCccccc
Q psy6044          71 KKYFDSLNG-EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG-------ELKLADFGLARAFGIPVKCYS  142 (282)
Q Consensus        71 ~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~-------~~~l~df~~~~~~~~~~~~~~  142 (282)
                      +..+..... .+++..+..++.||+.||+|||++|++|+||+|+||+++.++       .++|+|||.+.....    ..
T Consensus        87 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~  162 (259)
T cd05037          87 LDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS----RE  162 (259)
T ss_pred             HHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccccc----cc
Confidence            555544334 789999999999999999999999999999999999999887       799999999876543    12


Q ss_pred             cccccccccChhhhcCC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCC
Q psy6044         143 AEVVTLWYRPPDVLFGA-KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP  221 (282)
Q Consensus       143 ~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (282)
                      ...++..|+|||.+... ..++.++|+||||+++|++++++.+++......+....... ..                  
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~------------------  223 (259)
T cd05037         163 ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-QH------------------  223 (259)
T ss_pred             ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-CC------------------
Confidence            23446679999998766 34789999999999999999876665666543332222211 00                  


Q ss_pred             CCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         222 FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                 ..+......+.++|.+||..+|.+|||+.++++
T Consensus       224 -----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         224 -----------RLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             -----------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                       001112378899999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-37  Score=253.80  Aligned_cols=235  Identities=20%  Similarity=0.296  Sum_probs=185.8

Q ss_pred             CeeeeeeCCCCc----eEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHH
Q psy6044           1 MFTSGVDRTPNT----ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFD   75 (282)
Q Consensus         1 ~vy~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~   75 (282)
                      .||+|.++.+|+    .+|+|.............+.+|+.+++.++|||++++++++.. ...++++||+++ ++.+.+.
T Consensus        22 ~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~  100 (279)
T cd05057          22 TVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVR  100 (279)
T ss_pred             cEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHH
Confidence            379999877765    5899987664433345678899999999999999999999887 788999999975 6666666


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccc--cccccccccCh
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS--AEVVTLWYRPP  153 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~--~~~~~~~~~aP  153 (282)
                      .....+++..+..++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+...........  ...++..|+||
T Consensus       101 ~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~P  180 (279)
T cd05057         101 NHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL  180 (279)
T ss_pred             hccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCH
Confidence            6566799999999999999999999999999999999999999999999999999876643222111  12224579999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      |.+.... ++.++|+||||+++|++++.+.++|......+..+.+.....                            ..
T Consensus       181 E~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~  231 (279)
T cd05057         181 ESILHRI-YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER----------------------------LP  231 (279)
T ss_pred             HHhhcCC-cCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC----------------------------CC
Confidence            9986655 689999999999999999834444777666665554433111                            11


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      .+...+..+.+++.+||..||.+|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         232 QPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            22346788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.9e-38  Score=255.64  Aligned_cols=246  Identities=19%  Similarity=0.231  Sum_probs=178.1

Q ss_pred             eeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC--CeEEEEEecCcccHHHHHHhcCCCC
Q psy6044           4 SGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE--KKLTLVFEHCDQDLKKYFDSLNGEI   81 (282)
Q Consensus         4 ~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~--~~~~iv~e~~~g~l~~~~~~~~~~~   81 (282)
                      .+....++..||+|.+...........+.+|+++++.++||||+++++++...  ...+++|||++++.+..+.. ...+
T Consensus        26 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~l  104 (283)
T cd05080          26 DPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLP-KHKL  104 (283)
T ss_pred             ccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHH-HcCC
Confidence            34455789999999987643333456788999999999999999999987653  46899999998755554444 3469


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc---cccccccccccChhhhcC
Q psy6044          82 DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC---YSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        82 ~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~  158 (282)
                      ++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.........   .....++..|+|||...+
T Consensus       105 ~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~  184 (283)
T cd05080         105 NLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE  184 (283)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcc
Confidence            99999999999999999999999999999999999999999999999998765432111   111233566999999876


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||||+++|+|++|..|+........   ......   .. .......    ...   .........+...
T Consensus       185 ~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~---~~~~~~---~~-~~~~~~~----~~~---~~~~~~~~~~~~~  249 (283)
T cd05080         185 NK-FSYASDVWSFGVTLYELLTHCDSKQSPPKKFE---EMIGPK---QG-QMTVVRL----IEL---LERGMRLPCPKNC  249 (283)
T ss_pred             cC-CCcccccHHHHHHHHHHHhCCCCCCCCcchhh---hhhccc---cc-ccchhhh----hhh---hhcCCCCCCCCCC
Confidence            65 68999999999999999999888432221110   000000   00 0000000    000   0000011234567


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      +..+.+++..||+.||++|||++++++
T Consensus       250 ~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         250 PQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             CHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0194|consensus

Probab=100.00  E-value=5.2e-39  Score=269.68  Aligned_cols=235  Identities=26%  Similarity=0.395  Sum_probs=194.5

Q ss_pred             eeeeeeCCCCc---e-EEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHH
Q psy6044           2 FTSGVDRTPNT---A-LAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         2 vy~a~~~~~~~---~-vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~   74 (282)
                      ||+|+.+..+.   . ||+|....  .........+++|++++++++||||++++|+...+..+++|||+|+| +|.+++
T Consensus       173 V~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L  252 (474)
T KOG0194|consen  173 VFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYL  252 (474)
T ss_pred             EEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHH
Confidence            77887665422   3 89998885  34455678899999999999999999999999999999999999976 666777


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChh
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPD  154 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE  154 (282)
                      .+..+.++..+...++.+.+.||+|||+++++||||-.+|++++.++.+||+|||++..-..........-.+..|+|||
T Consensus       253 ~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPE  332 (474)
T KOG0194|consen  253 KKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPE  332 (474)
T ss_pred             HhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChh
Confidence            66555799999999999999999999999999999999999999999999999999865432211111223467899999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH-HhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK-LLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      .+.... ++.++||||||+++||+++.+..++.+....+..+.+.. ..+.+                            
T Consensus       333 tl~~~~-~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~----------------------------  383 (474)
T KOG0194|consen  333 TLNTGI-FSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP----------------------------  383 (474)
T ss_pred             hhccCc-cccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC----------------------------
Confidence            998875 899999999999999999865656999999988888844 33322                            


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      .+...+..+..++..|+..||++|||+.++.+
T Consensus       384 ~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  384 IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             CCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            22357888999999999999999999999876

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.8e-37  Score=249.62  Aligned_cols=232  Identities=24%  Similarity=0.357  Sum_probs=181.7

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC-
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~-   78 (282)
                      .||+|.+..+ ..+|+|.+...  ......+.+|+.+++.++|||++++++++.. ...+++|||+++ ++.+.+.... 
T Consensus        21 ~v~~~~~~~~-~~~~lK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~   96 (260)
T cd05069          21 EVWMGTWNGT-TKVAIKTLKPG--TMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDG   96 (260)
T ss_pred             eEEEEEEcCC-ceEEEEEcccC--CccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhCCC
Confidence            3799987655 46999987542  2234578899999999999999999998854 567899999985 6777665533 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~  157 (282)
                      ..+++..+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|||.+....... .......++..|+|||...
T Consensus        97 ~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~  176 (260)
T cd05069          97 KYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL  176 (260)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhc
Confidence            348999999999999999999999999999999999999999999999999987654322 1112223456799999887


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|+||||+++|++++++.++|.+....+....+.....                            ...+..
T Consensus       177 ~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~  227 (260)
T cd05069         177 YGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR----------------------------MPCPQG  227 (260)
T ss_pred             cCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------------------------CCCCcc
Confidence            666 689999999999999999955555777666655554433110                            012235


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      .+..+.+++++||..||.+||+++++++
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         228 CPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            7889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG0668|consensus

Probab=100.00  E-value=2.3e-39  Score=241.39  Aligned_cols=270  Identities=32%  Similarity=0.565  Sum_probs=212.1

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCC-CCCccceeeeeeeC--CeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK-HKNIVRLYDVLHSE--KKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~--~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||.|++..+++.++||+++-+    ..+.+.+|+.+++.|+ ||||+++++++.++  ..+.+|+||++..-...+   -
T Consensus        54 VFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~l---y  126 (338)
T KOG0668|consen   54 VFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQL---Y  126 (338)
T ss_pred             HhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHH---h
Confidence            688899999999999998753    2467899999999996 99999999999865  578999999987543333   3


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC-CcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      ..++.-.+..++.+++.||.|+|++||.|+|+||.|++++.. ..++|+|||++.... +.........+..|-.||.+.
T Consensus       127 ~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH-p~~eYnVRVASRyfKGPELLV  205 (338)
T KOG0668|consen  127 PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV  205 (338)
T ss_pred             hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC-CCceeeeeeehhhcCCchhee
Confidence            467888899999999999999999999999999999999865 579999999997654 334445556677889999998


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCC---CCCCCCCCCCCCCCCCCCcccc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPG---MNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      .-+.|...-|+|||||++..|+..+.|||.+.++.+.+.++.+.++...-..+-.   ...-+.+.......+...+..+
T Consensus       206 dy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~F  285 (338)
T KOG0668|consen  206 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRF  285 (338)
T ss_pred             echhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHh
Confidence            8887999999999999999999999999999999999999998887642111000   0111111111111222222222


Q ss_pred             -----CccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccchhhh
Q psy6044         235 -----APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKSE  279 (282)
Q Consensus       235 -----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~  279 (282)
                           ..-+++++.+|+.++|..|..+|+|++|++.||||..+.....+.
T Consensus       286 i~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~~~~  335 (338)
T KOG0668|consen  286 INSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAESSR  335 (338)
T ss_pred             CCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHhhcc
Confidence                 123679999999999999999999999999999999886655443

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.6e-37  Score=252.31  Aligned_cols=235  Identities=18%  Similarity=0.239  Sum_probs=179.5

Q ss_pred             CeeeeeeCCCCce----EEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHH
Q psy6044           1 MFTSGVDRTPNTA----LAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFD   75 (282)
Q Consensus         1 ~vy~a~~~~~~~~----vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~   75 (282)
                      .||+|....+|+.    +++|.+...........+..|+..++.++||||+++++++.. ...++++||++ |++.+.+.
T Consensus        22 ~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~  100 (279)
T cd05111          22 TVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVR  100 (279)
T ss_pred             ceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHH
Confidence            4899998887775    566665432222233567778888899999999999998764 45778899987 57777766


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--ccccccccccccCh
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--CYSAEVVTLWYRPP  153 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aP  153 (282)
                      ...+.+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+........  ......++..|++|
T Consensus       101 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~p  180 (279)
T cd05111         101 QHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMAL  180 (279)
T ss_pred             hcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCH
Confidence            6567899999999999999999999999999999999999999999999999999876532211  12223446679999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      |.+.... ++.++|+||||+++|++++.+.++|.+.........+.+....                            .
T Consensus       181 E~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~  231 (279)
T cd05111         181 ESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERL----------------------------A  231 (279)
T ss_pred             HHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC----------------------------C
Confidence            9997665 6999999999999999998444447666555444333221100                            0


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      .+...+.++.+++.+||..||.+|||+.++++
T Consensus       232 ~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         232 QPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            11235678899999999999999999999977

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG1187|consensus

Probab=100.00  E-value=9.1e-38  Score=260.09  Aligned_cols=246  Identities=24%  Similarity=0.310  Sum_probs=181.2

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC-eEEEEEecCc-ccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK-KLTLVFEHCD-QDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~-~~~iv~e~~~-g~l~~~~~~~~~   79 (282)
                      ||+|...+ |..||||++....... ...|.+|+.++.+++|||+++++|||.+.+ ...+|+||++ |+|.+.+.....
T Consensus        91 VYkG~l~~-~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~  168 (361)
T KOG1187|consen   91 VYKGVLSD-GTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKG  168 (361)
T ss_pred             EEEEEECC-CCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCC
Confidence            89999854 5999999877643332 456999999999999999999999999998 5999999997 677677666555


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccc-cccccccChh
Q psy6044          80 -EIDLDIVKSFMYQLLRGLAFCHSRN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE-VVTLWYRPPD  154 (282)
Q Consensus        80 -~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~-~~~~~~~aPE  154 (282)
                       .++|....+|+.++|.||+|||+..   |+|+||||.||++|.+...||+|||++............. .||..|++||
T Consensus       169 ~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PE  248 (361)
T KOG1187|consen  169 EPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPE  248 (361)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChh
Confidence             8999999999999999999999854   9999999999999999999999999996544311111112 6789999999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCC--ChHHHHHHHHHHhCCCC-CCCCCCCCCCCCCCCCCCCCCCCCc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGS--DVDDQLKRIFKLLGTPT-EDTWPGMNLLPDFKPFPMYHPSMSF  231 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
                      ...... .+.++||||||+++.|++||+.+.....  ................. .+..+               +....
T Consensus       249 y~~~g~-lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD---------------~~l~~  312 (361)
T KOG1187|consen  249 YASTGK-LTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD---------------PRLKE  312 (361)
T ss_pred             hhccCC-cCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC---------------CCccC
Confidence            997765 6999999999999999999997754332  11112222111111110 00000               00000


Q ss_pred             cccCc-cCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         232 SQVAP-KLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       232 ~~~~~-~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ..... ..-..+..+...|++.+|++||++.++++
T Consensus       313 ~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  313 GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            01110 12233668889999999999999999754

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.7e-37  Score=249.15  Aligned_cols=228  Identities=21%  Similarity=0.320  Sum_probs=179.7

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeee-eCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLH-SEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~-~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      .||+|..  .|..+|+|.....   ...+.+.+|+.++++++|+|++++++++. .++..++++||+++ ++.+.+....
T Consensus        21 ~v~~~~~--~~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   95 (256)
T cd05082          21 DVMLGDY--RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG   95 (256)
T ss_pred             eEEEEEE--cCCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcC
Confidence            3788865  4888999987542   23457889999999999999999999754 55689999999985 6666655433


Q ss_pred             C-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          79 G-EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      . .+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.......   .....+..|+|||.+.
T Consensus        96 ~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~y~aPE~~~  172 (256)
T cd05082          96 RSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALR  172 (256)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC---CCCccceeecCHHHHc
Confidence            3 48899999999999999999999999999999999999999999999999987654322   1223356799999987


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      ... ++.++|+||||+++|++++.+.++|......+....+....                            .......
T Consensus       173 ~~~-~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~  223 (256)
T cd05082         173 EKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------------------------KMDAPDG  223 (256)
T ss_pred             cCC-CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----------------------------CCCCCCC
Confidence            665 68999999999999999984444466666555544443211                            0112245


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      +++.+.+++.+||+.+|.+|||+.++++
T Consensus       224 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         224 CPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            7899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0665|consensus

Probab=100.00  E-value=5.7e-39  Score=249.68  Aligned_cols=264  Identities=33%  Similarity=0.544  Sum_probs=211.5

Q ss_pred             CeeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC------CeEEEEEecCcccHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE------KKLTLVFEHCDQDLKKY   73 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~------~~~~iv~e~~~g~l~~~   73 (282)
                      +|-.|-|...+++||+|+... .......+...+|..++..++|+||++++.+|.-.      ...|+|||++.+++-..
T Consensus        31 ~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~v  110 (369)
T KOG0665|consen   31 IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQV  110 (369)
T ss_pred             eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhhHHHHH
Confidence            356677888999999999877 44455678888999999999999999999999743      46899999999988777


Q ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccCh
Q psy6044          74 FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP  153 (282)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aP  153 (282)
                      ..   -.++=..+..++.|++.|+++||+.||+||||||+||++..+..+||.|||++...+.. ...+..+.+..|.||
T Consensus       111 i~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~-~~mtpyVvtRyyrap  186 (369)
T KOG0665|consen  111 IL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD-FMMTPYVVTRYYRAP  186 (369)
T ss_pred             HH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc-cccCchhheeeccCc
Confidence            65   46777889999999999999999999999999999999999999999999999876544 456677778899999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCC-----C--------CCCC
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNL-----L--------PDFK  220 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~--------~~~~  220 (282)
                      |++.+.. +....||||+||++.||++| ..+|++.+..+...++...++.+.+..+..+..     .        .++.
T Consensus       187 evil~~~-~ke~vdiwSvGci~gEli~~-~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~  264 (369)
T KOG0665|consen  187 EVILGMG-YKENVDIWSVGCIMGELILG-TVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFS  264 (369)
T ss_pred             hheeccC-CcccchhhhhhhHHHHHhhc-eEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchh
Confidence            9998888 79999999999999999955 555899999999999999999886644433210     0        0011


Q ss_pred             CCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q psy6044         221 PFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS  270 (282)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  270 (282)
                      .+.....-....+..+.-+..+++++.+||..||++|.|++++|+|||++
T Consensus       265 ~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  265 ELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             hhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence            11111111111111223456678999999999999999999999999997

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.8e-37  Score=249.60  Aligned_cols=231  Identities=23%  Similarity=0.367  Sum_probs=182.2

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc-CC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL-NG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~-~~   79 (282)
                      ||+|.++ +++.||+|.+....  .....+.+|+.++++++|||++++++++. ....++++|++.+ ++.+.+... ..
T Consensus        22 v~~~~~~-~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~   97 (260)
T cd05067          22 VWMGYYN-GHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGI   97 (260)
T ss_pred             EEeeecC-CCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCC
Confidence            8999864 57889999887522  23467889999999999999999999875 4568999999975 666655443 34


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC-ccccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP-VKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      .+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+...... ........++..|+|||.+..
T Consensus        98 ~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~  177 (260)
T cd05067          98 KLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY  177 (260)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhcc
Confidence            6899999999999999999999999999999999999999999999999998765422 112222334567999999876


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||||+++|++++++.++|.+.+..+....+......                            ..+...
T Consensus       178 ~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~  228 (260)
T cd05067         178 GT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM----------------------------PRPDNC  228 (260)
T ss_pred             CC-cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC----------------------------CCCCCC
Confidence            65 6899999999999999998445557766666555544332111                            122346


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      +.++.+++.+||+.+|++|||++++++
T Consensus       229 ~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         229 PEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.8e-37  Score=252.72  Aligned_cols=236  Identities=21%  Similarity=0.314  Sum_probs=184.1

Q ss_pred             eeeeeeCC-----CCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHH
Q psy6044           2 FTSGVDRT-----PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~   75 (282)
                      ||+|+.+.     +.+.+++|.+...........+.+|++++++++||||+++++++.+....++|+||+++ ++.+.+.
T Consensus        21 v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~  100 (275)
T cd05046          21 VFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLR  100 (275)
T ss_pred             EEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHH
Confidence            78888654     45789999876533333456789999999999999999999999999999999999986 5545444


Q ss_pred             hcCC---------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC-cccccccc
Q psy6044          76 SLNG---------EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP-VKCYSAEV  145 (282)
Q Consensus        76 ~~~~---------~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~  145 (282)
                      . ..         .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++++|||.+...... ........
T Consensus       101 ~-~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  179 (275)
T cd05046         101 A-TKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL  179 (275)
T ss_pred             h-cccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCce
Confidence            3 33         6899999999999999999999999999999999999999999999999987643211 11222334


Q ss_pred             ccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY  225 (282)
Q Consensus       146 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (282)
                      ++..|+|||.+.+.. .+.++|+||||+++|++++++.++|..................                     
T Consensus       180 ~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~---------------------  237 (275)
T cd05046         180 IPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE---------------------  237 (275)
T ss_pred             eEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcC---------------------
Confidence            466799999987666 6899999999999999998555557665555544443221100                     


Q ss_pred             CCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         226 HPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       226 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                            ......++..+.+++.+||+.+|.+|||+.+++..
T Consensus       238 ------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         238 ------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence                  01123578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.6e-37  Score=247.78  Aligned_cols=234  Identities=21%  Similarity=0.316  Sum_probs=184.3

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHH-HHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKK-YFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~-~~~~~~~   79 (282)
                      .||+|.+. ++..+|+|.+...  ......+.+|++++++++|||++++++++......++++||++|+.+. .+....+
T Consensus        19 ~v~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~   95 (256)
T cd05112          19 LVWLGYWL-EKRKVAIKTIREG--AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG   95 (256)
T ss_pred             eEEEEEEe-CCCeEEEEECCCC--CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCcc
Confidence            37899875 4778999987642  122357889999999999999999999999999999999999865444 4444456


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~  158 (282)
                      .++++.++.++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+
T Consensus        96 ~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~  175 (256)
T cd05112          96 KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF  175 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhcc
Confidence            789999999999999999999999999999999999999999999999998875542211 1112233567999999876


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||||+++|++++.+.++|......+....+......                            ..+...
T Consensus       176 ~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~  226 (256)
T cd05112         176 SK-YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL----------------------------YKPRLA  226 (256)
T ss_pred             CC-cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCC----------------------------CCCCCC
Confidence            65 6899999999999999998455557766666555554321110                            112336


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      +..+.+|+.+||+.+|.+|||+.++++.
T Consensus       227 ~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         227 SQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             CHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence            7899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-37  Score=254.90  Aligned_cols=243  Identities=19%  Similarity=0.256  Sum_probs=181.7

Q ss_pred             CeeeeeeCCC--------------CceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecC
Q psy6044           1 MFTSGVDRTP--------------NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC   66 (282)
Q Consensus         1 ~vy~a~~~~~--------------~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~   66 (282)
                      .||+|.+..+              ...||+|.+...........+.+|++++++++|||++++++++...+..++||||+
T Consensus        20 ~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   99 (295)
T cd05097          20 EVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYM   99 (295)
T ss_pred             eEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecC
Confidence            3777776543              23589998875433333456889999999999999999999999999999999999


Q ss_pred             cc-cHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCcccc
Q psy6044          67 DQ-DLKKYFDSLN-----------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF  134 (282)
Q Consensus        67 ~g-~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~  134 (282)
                      +| ++.+.+....           ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus       100 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~  179 (295)
T cd05097         100 ENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL  179 (295)
T ss_pred             CCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEeccccccccc
Confidence            86 4444443211           23688899999999999999999999999999999999999999999999998754


Q ss_pred             CCCcc--ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhc-CCCCCCCCChHHHHHHHHHHhCCCCCCCCC
Q psy6044         135 GIPVK--CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANA-GRPLFPGSDVDDQLKRIFKLLGTPTEDTWP  211 (282)
Q Consensus       135 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  211 (282)
                      .....  ......++..|+|||...... ++.++|+||||+++|+++++ +.++|......+...............   
T Consensus       180 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---  255 (295)
T cd05097         180 YSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQ---  255 (295)
T ss_pred             ccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhcccc---
Confidence            32211  112223356799999987666 69999999999999999973 334466666555554443321110000   


Q ss_pred             CCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         212 GMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                        .....+...++.+.+|+++||+.||.+|||+.++++
T Consensus       256 ------------------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         256 ------------------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             ------------------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                              001122347889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.8e-37  Score=249.38  Aligned_cols=240  Identities=19%  Similarity=0.246  Sum_probs=180.4

Q ss_pred             eeeeeeCCC--CceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc-
Q psy6044           2 FTSGVDRTP--NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL-   77 (282)
Q Consensus         2 vy~a~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~-   77 (282)
                      ||+|....+  ...+++|.+...........+.+|+.+++.++||||+++++.+......++||||+++ ++.+.+... 
T Consensus        11 v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   90 (268)
T cd05086          11 VLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQ   90 (268)
T ss_pred             EEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhh
Confidence            788875433  3456677666543334456899999999999999999999999999999999999986 555555432 


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC--ccccccccccccccCh
Q psy6044          78 --NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VKCYSAEVVTLWYRPP  153 (282)
Q Consensus        78 --~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~aP  153 (282)
                        ....++..+..++.||+.||+|||+.+++|+||+|+||+++.++.++|+|||.+......  ........++..|+||
T Consensus        91 ~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  170 (268)
T cd05086          91 WHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAP  170 (268)
T ss_pred             cccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCc
Confidence              234677788899999999999999999999999999999999999999999987543211  1112234557789999


Q ss_pred             hhhcCC------CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         154 DVLFGA------KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHP  227 (282)
Q Consensus       154 E~~~~~------~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (282)
                      |.+...      ..++.++|+||||+++|+|++++.++|......+....+........                     
T Consensus       171 E~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~---------------------  229 (268)
T cd05086         171 ELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL---------------------  229 (268)
T ss_pred             hhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccccc---------------------
Confidence            987432      22478999999999999999887777877666665555433211100                     


Q ss_pred             CCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         228 SMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       228 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                        ....+...+++.+.+++..|+ .+|.+|||++++++
T Consensus       230 --~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         230 --FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             --CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence              111223457889999999999 67999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2e-37  Score=259.32  Aligned_cols=236  Identities=23%  Similarity=0.356  Sum_probs=184.0

Q ss_pred             eeeeeeCC-------CCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHH
Q psy6044           2 FTSGVDRT-------PNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKK   72 (282)
Q Consensus         2 vy~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~   72 (282)
                      ||+|.+..       .+..||+|.+...........+.+|+++++++ +||||+++++++..+...++++||+++ ++.+
T Consensus        28 v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~  107 (334)
T cd05100          28 VVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLRE  107 (334)
T ss_pred             EEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHH
Confidence            78887543       23478999877544444456788999999999 899999999999999999999999976 5555


Q ss_pred             HHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC
Q psy6044          73 YFDSLN---------------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP  137 (282)
Q Consensus        73 ~~~~~~---------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~  137 (282)
                      .+....               ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus       108 ~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  187 (334)
T cd05100         108 YLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNI  187 (334)
T ss_pred             HHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccc
Confidence            554321               24788889999999999999999999999999999999999999999999998765422


Q ss_pred             ccc--cccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCC
Q psy6044         138 VKC--YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNL  215 (282)
Q Consensus       138 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  215 (282)
                      ...  .....++..|+|||.+.+.. ++.++|+||||+++|+|++++.++|...+..+....+....             
T Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-------------  253 (334)
T cd05100         188 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGH-------------  253 (334)
T ss_pred             cccccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            111  11122345799999997766 68999999999999999985555577776666555443211             


Q ss_pred             CCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         216 LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                                     ....+...+..+.+++.+||+.+|.+|||+.+++++
T Consensus       254 ---------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         254 ---------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence                           011223567899999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.2e-37  Score=251.60  Aligned_cols=234  Identities=24%  Similarity=0.373  Sum_probs=182.4

Q ss_pred             eeeeeeCCC---CceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc
Q psy6044           2 FTSGVDRTP---NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL   77 (282)
Q Consensus         2 vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~   77 (282)
                      ||+|.+...   ...|++|...........+.+.+|+.+++.++||||+++++++.++ ..++|+||+++ ++.+.+...
T Consensus        22 v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~  100 (270)
T cd05056          22 VYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWIVMELAPLGELRSYLQVN  100 (270)
T ss_pred             EEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEEEEEcCCCCcHHHHHHhC
Confidence            789987544   4579999887644333456788999999999999999999998764 56899999975 566655554


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc-cccccccccccChhhh
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC-YSAEVVTLWYRPPDVL  156 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~aPE~~  156 (282)
                      ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......... .....++..|+|||.+
T Consensus       101 ~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~  180 (270)
T cd05056         101 KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESI  180 (270)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhh
Confidence            556899999999999999999999999999999999999999999999999998765433211 1122234579999988


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       157 ~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      .... ++.++|+||||+++|++++.+.++|......+....+.....                            ...+.
T Consensus       181 ~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~----------------------------~~~~~  231 (270)
T cd05056         181 NFRR-FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER----------------------------LPMPP  231 (270)
T ss_pred             ccCC-CCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc----------------------------CCCCC
Confidence            6655 689999999999999999734444766665555544432110                            11234


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ..+..+.++|.+|+..+|.+|||+.+++.
T Consensus       232 ~~~~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         232 NCPPTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            57889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.6e-37  Score=262.02  Aligned_cols=236  Identities=22%  Similarity=0.342  Sum_probs=182.1

Q ss_pred             eeeeee-----CCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCC-CCCccceeeeeeeCCeEEEEEecCcc-cHHHHH
Q psy6044           2 FTSGVD-----RTPNTALAIKGTHLVGNEGVPSSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         2 vy~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~   74 (282)
                      ||+|++     ..++..||+|++.........+.+.+|+.++.++. ||||+++++++..+...++|+||++| ++.+.+
T Consensus        53 Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l  132 (401)
T cd05107          53 VVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYL  132 (401)
T ss_pred             EEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHH
Confidence            888985     34567899999986444444457889999999997 99999999999999999999999975 565555


Q ss_pred             HhcC----------------------------------------------------------------------------
Q psy6044          75 DSLN----------------------------------------------------------------------------   78 (282)
Q Consensus        75 ~~~~----------------------------------------------------------------------------   78 (282)
                      ....                                                                            
T Consensus       133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  212 (401)
T cd05107         133 HRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESP  212 (401)
T ss_pred             HhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCc
Confidence            4321                                                                            


Q ss_pred             ---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC
Q psy6044          79 ---------------------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP  137 (282)
Q Consensus        79 ---------------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~  137 (282)
                                           ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~  292 (401)
T cd05107         213 YDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD  292 (401)
T ss_pred             hhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccc
Confidence                                 13567788899999999999999999999999999999999999999999998754321


Q ss_pred             c--cccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCC
Q psy6044         138 V--KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN  214 (282)
Q Consensus       138 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  214 (282)
                      .  .......++..|+|||.+.... ++.++|+||||+++|++++ |+.| |......+...........          
T Consensus       293 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~e~l~~g~~P-~~~~~~~~~~~~~~~~~~~----------  360 (401)
T cd05107         293 SNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTP-YPELPMNEQFYNAIKRGYR----------  360 (401)
T ss_pred             cccccCCCcCCCCceeChHHhcCCC-CCcHhHHHHHHHHHHHHHHcCCCC-CCCCCchHHHHHHHHcCCC----------
Confidence            1  1112234567899999997765 6899999999999999998 5555 6554444433322221000          


Q ss_pred             CCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         215 LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                                       ...+..++..+.+++.+||..+|.+||++++|++.
T Consensus       361 -----------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         361 -----------------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                             01234578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.3e-37  Score=254.60  Aligned_cols=234  Identities=21%  Similarity=0.294  Sum_probs=181.2

Q ss_pred             CeeeeeeCCCCc----eEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHH
Q psy6044           1 MFTSGVDRTPNT----ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFD   75 (282)
Q Consensus         1 ~vy~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~   75 (282)
                      .||+|.+..+|+    .+|+|.+...........+.+|+.+++.++||||+++++++... ..++++||++ |++.+.+.
T Consensus        22 ~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~  100 (303)
T cd05110          22 TVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVH  100 (303)
T ss_pred             cEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHH
Confidence            489999888877    46888776533333334678899999999999999999998765 4678999997 56777666


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc--cccccccccccCh
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC--YSAEVVTLWYRPP  153 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aP  153 (282)
                      .....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.........  .....++..|+||
T Consensus       101 ~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~P  180 (303)
T cd05110         101 EHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL  180 (303)
T ss_pred             hcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCH
Confidence            65557899999999999999999999999999999999999999999999999999766433221  1122335679999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      |.+.+.. ++.++|+||||+++|++++ |+.| |.+....+....+..... +                           
T Consensus       181 E~~~~~~-~~~~~DiwslG~~l~el~t~g~~p-~~~~~~~~~~~~~~~~~~-~---------------------------  230 (303)
T cd05110         181 ECIHYRK-FTHQSDVWSYGVTIWELMTFGGKP-YDGIPTREIPDLLEKGER-L---------------------------  230 (303)
T ss_pred             HHhccCC-CChHHHHHHHHHHHHHHHhCCCCC-CCCCCHHHHHHHHHCCCC-C---------------------------
Confidence            9987665 6999999999999999997 5555 665554444333321100 0                           


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ..+...+..+.+++..||..+|++||+++++++
T Consensus       231 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~  263 (303)
T cd05110         231 PQPPICTIDVYMVMVKCWMIDADSRPKFKELAA  263 (303)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            012336788999999999999999999999887

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.4e-37  Score=248.78  Aligned_cols=240  Identities=20%  Similarity=0.244  Sum_probs=177.6

Q ss_pred             CeeeeeeC--CCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc
Q psy6044           1 MFTSGVDR--TPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL   77 (282)
Q Consensus         1 ~vy~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~   77 (282)
                      .||+|...  .++..+|+|.+...........+.+|+.++++++||||+++++++.+....++||||++| ++.+.+...
T Consensus        10 ~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~   89 (269)
T cd05087          10 KVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSC   89 (269)
T ss_pred             eEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHh
Confidence            48998753  456789999887643333345788899999999999999999999999999999999985 554554332


Q ss_pred             C----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--cccccccccccc
Q psy6044          78 N----GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--CYSAEVVTLWYR  151 (282)
Q Consensus        78 ~----~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~  151 (282)
                      .    ...++..+..++.|++.|+.|||+.|++|+||||+||+++.++.++|+|||.+........  ......++..|+
T Consensus        90 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~  169 (269)
T cd05087          90 RKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI  169 (269)
T ss_pred             hhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCccccc
Confidence            1    2456778889999999999999999999999999999999999999999998865432211  112234567799


Q ss_pred             ChhhhcCCC------CCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         152 PPDVLFGAK------LYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM  224 (282)
Q Consensus       152 aPE~~~~~~------~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (282)
                      |||.+....      .++.++|+||||+++|++++ |..| |......+.............                  
T Consensus       170 aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p-~~~~~~~~~~~~~~~~~~~~~------------------  230 (269)
T cd05087         170 APELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP-YRHLSDEQVLTYTVREQQLKL------------------  230 (269)
T ss_pred             CHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCC-CCCCChHHHHHHHhhcccCCC------------------
Confidence            999985321      24789999999999999996 5555 666555544333222110000                  


Q ss_pred             CCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         225 YHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       225 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                           .........++.+.+++..|+ .+|.+|||+++|+.
T Consensus       231 -----~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         231 -----PKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             -----CCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                 111122346788899999998 68999999999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.5e-37  Score=251.11  Aligned_cols=235  Identities=18%  Similarity=0.238  Sum_probs=182.9

Q ss_pred             CeeeeeeCC----CCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeee-CCeEEEEEecCcc-cHHHHH
Q psy6044           1 MFTSGVDRT----PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHS-EKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~-~~~~~iv~e~~~g-~l~~~~   74 (282)
                      .||+|.+..    ++..|++|.+...........+.+|+.+++.++||||+++++++.. +...+++++|+++ ++.+.+
T Consensus        21 ~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l  100 (280)
T cd05043          21 RIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL  100 (280)
T ss_pred             eEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHH
Confidence            489999876    3688999988754444445678899999999999999999998765 4678999999975 555555


Q ss_pred             HhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc--ccccc
Q psy6044          75 DSLN-------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC--YSAEV  145 (282)
Q Consensus        75 ~~~~-------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~  145 (282)
                      ....       ..+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++..+......  .....
T Consensus       101 ~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~  180 (280)
T cd05043         101 QQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN  180 (280)
T ss_pred             HhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCC
Confidence            4422       45899999999999999999999999999999999999999999999999998765322111  11223


Q ss_pred             ccccccChhhhcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM  224 (282)
Q Consensus       146 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (282)
                      ++..|+|||.+.+.. ++.++||||||+++|++++ |..| |...+..+....+......                    
T Consensus       181 ~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p-~~~~~~~~~~~~~~~~~~~--------------------  238 (280)
T cd05043         181 RPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTP-YVEIDPFEMAAYLKDGYRL--------------------  238 (280)
T ss_pred             cchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCC-cCcCCHHHHHHHHHcCCCC--------------------
Confidence            356799999997666 6999999999999999998 5555 6665555544433321100                    


Q ss_pred             CCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         225 YHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       225 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                              .....+++.+.+++.+||..||++|||+.++++
T Consensus       239 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         239 --------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             --------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                    012346788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=6.1e-37  Score=257.09  Aligned_cols=237  Identities=23%  Similarity=0.382  Sum_probs=177.6

Q ss_pred             Ceeeeee-----CCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeC-CeEEEEEecCcc-cHHH
Q psy6044           1 MFTSGVD-----RTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSE-KKLTLVFEHCDQ-DLKK   72 (282)
Q Consensus         1 ~vy~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~-~~~~iv~e~~~g-~l~~   72 (282)
                      .||+|.+     ..+++.||||++...........+.+|+.++.++ +||||+++++++... ...++++||++| ++.+
T Consensus        22 ~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~  101 (343)
T cd05103          22 QVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSN  101 (343)
T ss_pred             eEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHH
Confidence            4888874     3568899999987643333456788999999999 689999999987654 568999999986 4544


Q ss_pred             HHHhcC------------------------------------------------------------------CCCCHHHH
Q psy6044          73 YFDSLN------------------------------------------------------------------GEIDLDIV   86 (282)
Q Consensus        73 ~~~~~~------------------------------------------------------------------~~~~~~~~   86 (282)
                      .+....                                                                  ..+++..+
T Consensus       102 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (343)
T cd05103         102 YLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDL  181 (343)
T ss_pred             HHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHH
Confidence            443311                                                                  23677888


Q ss_pred             HHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--ccccccccccccChhhhcCCCCCCc
Q psy6044          87 KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--CYSAEVVTLWYRPPDVLFGAKLYTT  164 (282)
Q Consensus        87 ~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~  164 (282)
                      ..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+........  ......++..|+|||.+.+.. ++.
T Consensus       182 ~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~  260 (343)
T cd05103         182 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTI  260 (343)
T ss_pred             HHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCC-CCc
Confidence            89999999999999999999999999999999999999999999876532211  111223356799999987665 699


Q ss_pred             hhhHHHHHHHHHHHHhcCCCCCCCCChH-HHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHH
Q psy6044         165 SIDMWSAGCIFAELANAGRPLFPGSDVD-DQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGR  243 (282)
Q Consensus       165 ~~Di~slG~ll~~ll~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  243 (282)
                      ++|+||||+++|++++++.++|...... +....+.....                            ...+...++.+.
T Consensus       261 ~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~  312 (343)
T cd05103         261 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR----------------------------MRAPDYTTPEMY  312 (343)
T ss_pred             hhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC----------------------------CCCCCCCCHHHH
Confidence            9999999999999997444446554332 22222222110                            011223678899


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcC
Q psy6044         244 DLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       244 ~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      +++..||+.||.+|||+.++++|
T Consensus       313 ~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         313 QTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1e-36  Score=250.95  Aligned_cols=233  Identities=21%  Similarity=0.308  Sum_probs=175.2

Q ss_pred             CCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC----------
Q psy6044          10 PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN----------   78 (282)
Q Consensus        10 ~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~----------   78 (282)
                      ++..+|+|.+...........+.+|+++++.++|+||+++++++..+...++++||+++ ++.+.+....          
T Consensus        45 ~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~  124 (296)
T cd05095          45 QPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV  124 (296)
T ss_pred             ceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccc
Confidence            45679999987543333456788999999999999999999999999999999999975 5555554322          


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--ccccccccccccChhhh
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--CYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~  156 (282)
                      ..+++..+..++.|++.||++||+.|++|+||||+||+++.++.++|+|||.+..+.....  .......+..|++||..
T Consensus       125 ~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~  204 (296)
T cd05095         125 VTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESI  204 (296)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHH
Confidence            2367789999999999999999999999999999999999999999999999876532211  11112235679999987


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHh--cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         157 FGAKLYTTSIDMWSAGCIFAELAN--AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       157 ~~~~~~~~~~Di~slG~ll~~ll~--~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      .... ++.++|+||||+++|++++  +..| |......+...............                     .....
T Consensus       205 ~~~~-~~~~~DiwSlG~~l~el~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~  261 (296)
T cd05095         205 LLGK-FTTASDVWAFGVTLWEILTLCKEQP-YSQLSDEQVIENTGEFFRDQGRQ---------------------VYLPK  261 (296)
T ss_pred             hcCC-ccchhhhhHHHHHHHHHHHhCCCCC-ccccChHHHHHHHHHHHhhcccc---------------------ccCCC
Confidence            6665 7999999999999999998  4444 55555544443322211100000                     00011


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      +...++.+.+|+.+||+.||.+|||+.++++
T Consensus       262 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         262 PALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            2346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=8e-37  Score=275.17  Aligned_cols=132  Identities=28%  Similarity=0.385  Sum_probs=115.4

Q ss_pred             CeeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      .||+|.+..+++.||||++...  ........+..|+.++..++||||+++++++.....+|+||||+.|+.+..+....
T Consensus        19 ~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~   98 (669)
T cd05610          19 KVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY   98 (669)
T ss_pred             EEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhc
Confidence            3899999999999999999762  22223467888999999999999999999999999999999999765444444446


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCcc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR  132 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~  132 (282)
                      +.+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.
T Consensus        99 ~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          99 GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            778999999999999999999999999999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.3e-36  Score=246.98  Aligned_cols=236  Identities=20%  Similarity=0.388  Sum_probs=184.8

Q ss_pred             CeeeeeeCC-CCceEEEeeeecCC---------CCCCCccHHHHHHHHhh-CCCCCccceeeeeeeCCeEEEEEecCcc-
Q psy6044           1 MFTSGVDRT-PNTALAIKGTHLVG---------NEGVPSSALREICLLKE-LKHKNIVRLYDVLHSEKKLTLVFEHCDQ-   68 (282)
Q Consensus         1 ~vy~a~~~~-~~~~vaiK~~~~~~---------~~~~~~~~~~e~~~~~~-l~h~~i~~~~~~~~~~~~~~iv~e~~~g-   68 (282)
                      .||+|.++. +++.+|+|.+....         .......+..|+.++.+ ++||||+++++++..++..++++||++| 
T Consensus        15 ~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   94 (269)
T cd08528          15 CVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGA   94 (269)
T ss_pred             eEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCC
Confidence            389999888 78999999987521         11123446678887765 6999999999999999999999999986 


Q ss_pred             cHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccc
Q psy6044          69 DLKKYFD---SLNGEIDLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE  144 (282)
Q Consensus        69 ~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  144 (282)
                      ++.+.+.   .....+++..++.++.|++.||.+||+ .|++|+||+|.||+++.++.++|+|||.+....... .....
T Consensus        95 ~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~  173 (269)
T cd08528          95 PLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES-KLTSV  173 (269)
T ss_pred             cHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeeccccc-ccccc
Confidence            4444432   234569999999999999999999996 789999999999999999999999999987765432 33445


Q ss_pred             cccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM  224 (282)
Q Consensus       145 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (282)
                      .++..|++||.+.+.. ++.++|+||||+++|++++|..| |...........+......+.                  
T Consensus       174 ~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p-~~~~~~~~~~~~~~~~~~~~~------------------  233 (269)
T cd08528         174 VGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPP-FYSTNMLSLATKIVEAVYEPL------------------  233 (269)
T ss_pred             cCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCc-ccccCHHHHHHHHhhccCCcC------------------
Confidence            6688899999997766 69999999999999999998777 555544444444333211110                  


Q ss_pred             CCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         225 YHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       225 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                               ....+++.+.++|.+||+.||.+|||+.++..+
T Consensus       234 ---------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         234 ---------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ---------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                     012468899999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0695|consensus

Probab=100.00  E-value=6.2e-38  Score=246.16  Aligned_cols=246  Identities=22%  Similarity=0.340  Sum_probs=208.7

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      |-.++.++|.+.||+|++++  ....+..+-...|..+..+- +||.++-++.+|+.+..+++|.||++|+-+.+..+.+
T Consensus       266 vl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrq  345 (593)
T KOG0695|consen  266 VLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ  345 (593)
T ss_pred             hhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhh
Confidence            45678889999999999998  55666677778888888887 7999999999999999999999999987666666668


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      .+++++.+..+...|+.||.|||++||+++|+|.+|++++..|.+||.|+|.++.--.+....+..+||+.|.|||++.+
T Consensus       346 rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrg  425 (593)
T KOG0695|consen  346 RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG  425 (593)
T ss_pred             hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcc
Confidence            89999999999999999999999999999999999999999999999999999876666666677889999999999998


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCC------CCCChHHHHHH-HHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLF------PGSDVDDQLKR-IFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSF  231 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~------~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
                      .. |+...|-|+||++++||+.|+.||-      +..+.++++.+ +.+.                             .
T Consensus       426 ee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek-----------------------------q  475 (593)
T KOG0695|consen  426 EE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK-----------------------------Q  475 (593)
T ss_pred             cc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh-----------------------------c
Confidence            88 7999999999999999999988852      12333444433 3331                             1


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCCC------CHHHHhcCCCccCCccchh
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQRM------SAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~~ll~h~~~~~~~~~~~  277 (282)
                      -.++..+|-....+++..|++||++|.      .+.++-.|+||+.++++.-
T Consensus       476 iriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~l  527 (593)
T KOG0695|consen  476 IRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLL  527 (593)
T ss_pred             ccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHH
Confidence            224455777778899999999999998      5789999999999987653

>KOG0196|consensus

Probab=100.00  E-value=1.8e-38  Score=271.90  Aligned_cols=234  Identities=23%  Similarity=0.333  Sum_probs=204.3

Q ss_pred             eeeeeeCCCC---ceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHhc
Q psy6044           2 FTSGVDRTPN---TALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSL   77 (282)
Q Consensus         2 vy~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~   77 (282)
                      |++|+.+..|   ..||||.++....++...+|+.|+.+|-+++||||+++.+++...+.+.||+||++ |.|-.++..+
T Consensus       645 Vc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~  724 (996)
T KOG0196|consen  645 VCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQN  724 (996)
T ss_pred             eecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhc
Confidence            6788877766   58999999988788888999999999999999999999999999999999999996 6666777777


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccc---cccccChh
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV---TLWYRPPD  154 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~---~~~~~aPE  154 (282)
                      .+.+..-++..+++.|+.|++||-++|++||||...|||++.+-.+|++|||+++.+....+......|   +.+|.|||
T Consensus       725 DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPE  804 (996)
T KOG0196|consen  725 DGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPE  804 (996)
T ss_pred             CCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChh
Confidence            888999999999999999999999999999999999999999999999999999877544322222122   57899999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      .+...+ ++.+||+||+|+++||.++ |.+| +=+.++++.++.+.++.+.|++.                         
T Consensus       805 AIa~RK-FTsASDVWSyGIVmWEVmSyGERP-YWdmSNQdVIkaIe~gyRLPpPm-------------------------  857 (996)
T KOG0196|consen  805 AIAYRK-FTSASDVWSYGIVMWEVMSYGERP-YWDMSNQDVIKAIEQGYRLPPPM-------------------------  857 (996)
T ss_pred             Hhhhcc-cCchhhccccceEEEEecccCCCc-ccccchHHHHHHHHhccCCCCCC-------------------------
Confidence            998777 7999999999999999886 4556 55677789999999998887754                         


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                         +.+..|.+|+..||++|-..||.+.||+.
T Consensus       858 ---DCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  858 ---DCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             ---CCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence               47889999999999999999999999986

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.5e-36  Score=244.11  Aligned_cols=232  Identities=22%  Similarity=0.325  Sum_probs=181.5

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc-C
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL-N   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~-~   78 (282)
                      .||+|.+. .+..+|+|.+...  ....+.+.+|+.+++.++|+||+++++++.. ...++++||+++ ++.+.+... .
T Consensus        21 ~vy~~~~~-~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~   96 (260)
T cd05073          21 EVWMATYN-KHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG   96 (260)
T ss_pred             EEEEEEec-CCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCc
Confidence            38999864 5667999987642  2234678899999999999999999999887 778999999975 666666542 3


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~  157 (282)
                      ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.
T Consensus        97 ~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  176 (260)
T cd05073          97 SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN  176 (260)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhc
Confidence            457889999999999999999999999999999999999999999999999887653221 1112223456799999987


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      ... ++.++|+||||+++|++++++.++|...+..+....+.....                            ......
T Consensus       177 ~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~  227 (260)
T cd05073         177 FGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR----------------------------MPRPEN  227 (260)
T ss_pred             cCC-cCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC----------------------------CCCccc
Confidence            665 688999999999999999855555777665555544332110                            012245


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      .+..+.+++.+||+.+|++||++.++++
T Consensus       228 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         228 CPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             CCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            7889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.4e-36  Score=247.28  Aligned_cols=248  Identities=21%  Similarity=0.297  Sum_probs=177.4

Q ss_pred             eeeee----eCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeee--CCeEEEEEecCcc-cHHHHH
Q psy6044           2 FTSGV----DRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         2 vy~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~--~~~~~iv~e~~~g-~l~~~~   74 (282)
                      ||+|.    +..++..||+|.+.... ......+.+|++++++++||||+++++++..  ...+++|+||++| ++.+.+
T Consensus        20 v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   98 (284)
T cd05081          20 VELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL   98 (284)
T ss_pred             EEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHH
Confidence            67776    55689999999986532 2224578899999999999999999998754  3578999999975 666666


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc---ccccccccccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC---YSAEVVTLWYR  151 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~  151 (282)
                      ......+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.........   .....++..|+
T Consensus        99 ~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~  178 (284)
T cd05081          99 QKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY  178 (284)
T ss_pred             HhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEee
Confidence            554567999999999999999999999999999999999999999999999999998765432211   11112244589


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCC-CCCCCCCCCCCCCCCCCC
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPG-MNLLPDFKPFPMYHPSMS  230 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  230 (282)
                      |||.+.+.. ++.++|+||||+++++++++..+.... . ......+..... . ...... .....          ...
T Consensus       179 aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~-~-~~~~~~~~~~~~-~-~~~~~~~~~~~~----------~~~  243 (284)
T cd05081         179 APESLTESK-FSVASDVWSFGVVLYELFTYSDKSCSP-P-AEFMRMMGNDKQ-G-QMIVYHLIELLK----------NNG  243 (284)
T ss_pred             CHHHhccCC-cChHHHHHHHHHHHHHHhhcCCcCCCc-c-hhhhhhcccccc-c-ccchHHHHHHHh----------cCC
Confidence            999987665 689999999999999999876653221 1 111110000000 0 000000 00000          000


Q ss_pred             ccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      .......++..+.+++.+||..+|++|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         244 RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            01123457889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.6e-36  Score=243.15  Aligned_cols=226  Identities=23%  Similarity=0.371  Sum_probs=179.3

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC-C
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-G   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~-~   79 (282)
                      ||+|.  .+++.||+|.+...   .....+.+|+.+++.++|||++++++++..+. .++++||++| ++.+.+.... .
T Consensus        22 v~~~~--~~~~~~~iK~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~   95 (254)
T cd05083          22 VLQGE--YTGQKVAVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRA   95 (254)
T ss_pred             eEecc--cCCCceEEEeecCc---chHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCCCCCHHHHHHhcCcC
Confidence            67765  47889999988642   12357889999999999999999999987654 7999999985 6666655433 3


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......   ......+..|+|||.+.+.
T Consensus        96 ~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~y~~pe~~~~~  172 (254)
T cd05083          96 LVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---VDNSKLPVKWTAPEALKHK  172 (254)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---CCCCCCCceecCHHHhccC
Confidence            5899999999999999999999999999999999999999999999999988754322   1122335679999998766


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      . ++.++|+||||+++|++++++.++|...+..+....+.....                            ......++
T Consensus       173 ~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~  223 (254)
T cd05083         173 K-FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR----------------------------MEPPEGCP  223 (254)
T ss_pred             C-cCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC----------------------------CCCCCcCC
Confidence            5 689999999999999999855666777766655544432110                            01123478


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      +.+.+++.+||+.+|.+|||++++++
T Consensus       224 ~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         224 ADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            89999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.5e-36  Score=248.33  Aligned_cols=239  Identities=25%  Similarity=0.371  Sum_probs=182.5

Q ss_pred             eeeeeeC----CCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeee--CCeEEEEEecCcc-cHHHHH
Q psy6044           2 FTSGVDR----TPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         2 vy~a~~~----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~--~~~~~iv~e~~~g-~l~~~~   74 (282)
                      ||+|+..    .+++.+|+|++...........+.+|+.+++.++||||+++++++..  ....++++||++| ++.+.+
T Consensus        20 v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   99 (284)
T cd05038          20 VELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL   99 (284)
T ss_pred             EEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHH
Confidence            7888853    45899999998764332345678999999999999999999999887  5689999999975 666666


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc---ccccccccccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC---YSAEVVTLWYR  151 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~  151 (282)
                      ......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........   .....++..|.
T Consensus       100 ~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~  179 (284)
T cd05038         100 QRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY  179 (284)
T ss_pred             HhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCccccc
Confidence            554556999999999999999999999999999999999999999999999999999876522211   11123345699


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHH----------HHHHHHHHhCCCCCCCCCCCCCCCCCCC
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDD----------QLKRIFKLLGTPTEDTWPGMNLLPDFKP  221 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (282)
                      +||...+.. ++.++|+||||++++++++|..|+........          ....+........               
T Consensus       180 ~Pe~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------  243 (284)
T cd05038         180 APECLRTSK-FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE---------------  243 (284)
T ss_pred             CcHHHccCC-CCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCC---------------
Confidence            999987665 68999999999999999999888543322110          0111111111000               


Q ss_pred             CCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         222 FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                               ....+...+..+.+++.+||+.+|.+|||+.++++
T Consensus       244 ---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         244 ---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             ---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                     00112346788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.6e-36  Score=245.67  Aligned_cols=236  Identities=20%  Similarity=0.277  Sum_probs=179.8

Q ss_pred             CeeeeeeC---CCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC------eEEEEEecCcc-c
Q psy6044           1 MFTSGVDR---TPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK------KLTLVFEHCDQ-D   69 (282)
Q Consensus         1 ~vy~a~~~---~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~------~~~iv~e~~~g-~   69 (282)
                      .||+|..+   .+++.+|||++.. .......+.+.+|+++++.++||||+++++++....      ..+++++|+.+ +
T Consensus        14 ~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (273)
T cd05074          14 SVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGD   93 (273)
T ss_pred             CEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCc
Confidence            37888754   4689999999876 223334566889999999999999999999886532      34788999975 4


Q ss_pred             HHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--ccc
Q psy6044          70 LKKYFDSL-----NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--CYS  142 (282)
Q Consensus        70 l~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~  142 (282)
                      +...+...     ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........  ...
T Consensus        94 l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  173 (273)
T cd05074          94 LHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGC  173 (273)
T ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCC
Confidence            44443221     12478999999999999999999999999999999999999999999999999876542211  111


Q ss_pred             cccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCC
Q psy6044         143 AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPF  222 (282)
Q Consensus       143 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (282)
                      ...++..|++||.+.... ++.++|+||||+++|++++++.++|...+..+....+.....                   
T Consensus       174 ~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-------------------  233 (273)
T cd05074         174 ASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR-------------------  233 (273)
T ss_pred             CccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc-------------------
Confidence            223356789999987665 689999999999999999866666777666554444332100                   


Q ss_pred             CCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         223 PMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                               .......+..+.+++.+||+.+|.+|||+.++++
T Consensus       234 ---------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         234 ---------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                     0111346789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0614|consensus

Probab=100.00  E-value=1.9e-38  Score=260.40  Aligned_cols=236  Identities=25%  Similarity=0.399  Sum_probs=205.4

Q ss_pred             CceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCCCHHHHHH
Q psy6044          11 NTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKS   88 (282)
Q Consensus        11 ~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~   88 (282)
                      ...+|+|++++  .-+....+.+..|-++|...++|.|+++|..|.++.++|++||.|-|+.+-.+.+..+.+++.....
T Consensus       445 ~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF  524 (732)
T KOG0614|consen  445 KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARF  524 (732)
T ss_pred             chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhh
Confidence            33588888887  3344445678889999999999999999999999999999999997655555555589999999999


Q ss_pred             HHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCCCCCchhhH
Q psy6044          89 FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDM  168 (282)
Q Consensus        89 ~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  168 (282)
                      ++..+++|+.|||++||+++||||+|.+++.+|-+||.|||+++.++.... .-..+||+.|.|||++.+.. ...+.|.
T Consensus       525 ~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K-TwTFcGTpEYVAPEIILnKG-HD~avDy  602 (732)
T KOG0614|consen  525 YVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK-TWTFCGTPEYVAPEIILNKG-HDRAVDY  602 (732)
T ss_pred             hHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc-eeeecCCcccccchhhhccC-cchhhHH
Confidence            999999999999999999999999999999999999999999999875443 34568899999999998887 6999999


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHH
Q psy6044         169 WSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQR  248 (282)
Q Consensus       169 ~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  248 (282)
                      ||||+++|||++|..| |.+.++....+.+.++..                           .-++|..++....++|++
T Consensus       603 WaLGIli~ELL~G~pP-Fs~~dpmktYn~ILkGid---------------------------~i~~Pr~I~k~a~~Lik~  654 (732)
T KOG0614|consen  603 WALGILIYELLTGSPP-FSGVDPMKTYNLILKGID---------------------------KIEFPRRITKTATDLIKK  654 (732)
T ss_pred             HHHHHHHHHHHcCCCC-CCCCchHHHHHHHHhhhh---------------------------hhhcccccchhHHHHHHH
Confidence            9999999999976555 999999999999988653                           334567799999999999


Q ss_pred             hcccCCCCCCC-----HHHHhcCCCccCCccch
Q psy6044         249 LLVCNPVQRMS-----AEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       249 ~l~~dp~~Rps-----~~~ll~h~~~~~~~~~~  276 (282)
                      +...+|.+|..     +.+|-.|.||.+.+++-
T Consensus       655 LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweg  687 (732)
T KOG0614|consen  655 LCRDNPTERLGYQKGGINDIKKHRWFEGFDWEG  687 (732)
T ss_pred             HHhcCcHhhhccccCChHHHHhhhhhhcCChhh
Confidence            99999999995     89999999999998764

>KOG4278|consensus

Probab=100.00  E-value=3.5e-37  Score=258.85  Aligned_cols=233  Identities=22%  Similarity=0.331  Sum_probs=202.8

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~~~~   80 (282)
                      ||.|..++-.--||||.++.  +.-..+.|+.|+.+|+.+.|||+|++.++|..+..+|||+||+. |+|++++..++..
T Consensus       283 VYeGvWKkyslTvAVKtLKE--DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~  360 (1157)
T KOG4278|consen  283 VYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRS  360 (1157)
T ss_pred             eeeeeeeccceeeehhhhhh--cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchh
Confidence            79999999999999998864  33446899999999999999999999999999999999999984 8999999998765


Q ss_pred             -CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccChhhhcC
Q psy6044          81 -IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        81 -~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~  158 (282)
                       ++.-..+.++.||.+|+.||..++++|+||...|.++.++..+|+.|||+++.+.... ....+.--...|.|||.+.-
T Consensus       361 ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAy  440 (1157)
T KOG4278|consen  361 EVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY  440 (1157)
T ss_pred             hcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccc
Confidence             7777788999999999999999999999999999999999999999999999986543 22222233677999999977


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      +. ++.++|||+||+++||+.|.++.++++-+.......+.++.+...                            +..+
T Consensus       441 Nt-FSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~----------------------------PeGC  491 (1157)
T KOG4278|consen  441 NT-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDG----------------------------PEGC  491 (1157)
T ss_pred             cc-cccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccC----------------------------CCCC
Confidence            66 799999999999999999999999999998888888877655432                            3457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ++.+.+|++.||+++|.+||++.++-+
T Consensus       492 PpkVYeLMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  492 PPKVYELMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             CHHHHHHHHHHhcCCcccCccHHHHHH
Confidence            899999999999999999999998744

>KOG0664|consensus

Probab=100.00  E-value=1.4e-39  Score=248.66  Aligned_cols=274  Identities=35%  Similarity=0.549  Sum_probs=220.4

Q ss_pred             CeeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC-----eEEEEEecCcccHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK-----KLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~-----~~~iv~e~~~g~l~~~~   74 (282)
                      +||...|.++|+.||+|++.. .++-...+.+.+|++++..++|.|++...++.+-..     .+|+++|.+..++-..+
T Consensus        68 VVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQSDLHKII  147 (449)
T KOG0664|consen   68 VVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQSDLHKII  147 (449)
T ss_pred             EEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHhhhhhee
Confidence            689999999999999999988 444556788999999999999999999998876543     46788888877766655


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccC-CCccccccccccccccCh
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG-IPVKCYSAEVVTLWYRPP  153 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~~aP  153 (282)
                      .. ...++.+.+.-++.||+.||+|||+.||.|+||||.|.+++++-.+||+|||+++... .....++....|..|+||
T Consensus       148 VS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAP  226 (449)
T KOG0664|consen  148 VS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAP  226 (449)
T ss_pred             cc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccH
Confidence            44 6779999999999999999999999999999999999999999999999999997653 234566666778999999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc-
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS-  232 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  232 (282)
                      |++.+..-|+.+.||||+||++.|++ |++.+|...+..+.++.+.+.++.+.-+.+..-..-.....+.......+.. 
T Consensus       227 EiLMGaRhYs~AvDiWSVGCIFaELL-gRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~v  305 (449)
T KOG0664|consen  227 ELLMGARRYTGAVDIWSVGCIFAELL-QRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQR  305 (449)
T ss_pred             HHhhcchhhcCccceehhhHHHHHHH-hhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccc
Confidence            99999988999999999999999999 9999999999999999999999998765544321111111111111111111 


Q ss_pred             --cc--CccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         233 --QV--APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       233 --~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                        .+  +.+-..+...++..|+.+||.+|.+.++.+.|+++...+.-.
T Consensus       306 LYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~r~  353 (449)
T KOG0664|consen  306 LYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRLRF  353 (449)
T ss_pred             eeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccceee
Confidence              11  123455677899999999999999999999999998775433

>KOG4257|consensus

Probab=100.00  E-value=6.8e-37  Score=256.85  Aligned_cols=234  Identities=22%  Similarity=0.346  Sum_probs=194.4

Q ss_pred             eeeeee----CCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHh
Q psy6044           2 FTSGVD----RTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDS   76 (282)
Q Consensus         2 vy~a~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~   76 (282)
                      ||+|.-    ++..-.||||.++.....+..+.|+.|+.+|++++||||++++|+|.+. ..|||||.++ |.+.+++..
T Consensus       405 Vy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~  483 (974)
T KOG4257|consen  405 VYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQ  483 (974)
T ss_pred             eeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHh
Confidence            566663    3345578999998866666789999999999999999999999999766 4899999997 778888888


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc-cccccccccccChhh
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC-YSAEVVTLWYRPPDV  155 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~aPE~  155 (282)
                      +...++......++.||+.||+|||+.+++||||...||++.+..-+||+|||+++-+....-- .+....+..|+|||.
T Consensus       484 nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPES  563 (974)
T KOG4257|consen  484 NKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPES  563 (974)
T ss_pred             ccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccc
Confidence            7788999999999999999999999999999999999999999999999999999887644221 112223567999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      +.-.. ++.+||+|.||+++||++.-+.-+|.+-.+.+.+-.+.++-                            ....+
T Consensus       564 INfRr-FTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGe----------------------------RlP~P  614 (974)
T KOG4257|consen  564 INFRR-FTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGE----------------------------RLPCP  614 (974)
T ss_pred             cchhc-ccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCC----------------------------CCCCC
Confidence            96666 79999999999999999866655577777777666655543                            23356


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      +.+++.+..++.+||..+|.+||++.+|..
T Consensus       615 ~nCPp~LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  615 PNCPPALYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             CCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence            678999999999999999999999988764

>KOG4250|consensus

Probab=100.00  E-value=4.2e-37  Score=261.61  Aligned_cols=190  Identities=27%  Similarity=0.397  Sum_probs=162.1

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC------eEEEEEecCcccHHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK------KLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~------~~~iv~e~~~g~l~~~~~   75 (282)
                      ||+|+++.+|+.||||.++....-...+...+|++++++++|||||+++++-++..      ...++||||.|+.+....
T Consensus        29 V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L  108 (732)
T KOG4250|consen   29 VYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVL  108 (732)
T ss_pred             eeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHh
Confidence            89999999999999999998555556788999999999999999999999876543      568999999865555444


Q ss_pred             hcC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc--CCCc--EEEEecCCccccCCCccccccccccc
Q psy6044          76 SLN---GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN--KNGE--LKLADFGLARAFGIPVKCYSAEVVTL  148 (282)
Q Consensus        76 ~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~--~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~  148 (282)
                      +..   ..+++.+++.++.++..|+.|||++||+||||||.||++.  .+|+  -||+|||.++.+.... ......||+
T Consensus       109 ~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s-~~~S~vGT~  187 (732)
T KOG4250|consen  109 NSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS-LFTSLVGTE  187 (732)
T ss_pred             cCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC-eeeeecCch
Confidence            432   3499999999999999999999999999999999999984  3343  5999999999987554 566778999


Q ss_pred             cccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChH
Q psy6044         149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD  192 (282)
Q Consensus       149 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~  192 (282)
                      .|++||.+....+|+...|.|||||++|++.||..||.+..++.
T Consensus       188 ~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk  231 (732)
T KOG4250|consen  188 EYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK  231 (732)
T ss_pred             hhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc
Confidence            99999999865668999999999999999999999986655543

>KOG1006|consensus

Probab=100.00  E-value=8.5e-38  Score=237.61  Aligned_cols=247  Identities=19%  Similarity=0.294  Sum_probs=196.1

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHH----h
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFD----S   76 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~----~   76 (282)
                      |++-.++.+|+..|||+++....+..-..++.|.+...+- ++||||+++|..-.++..||-||.++-++-..+.    .
T Consensus        80 V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~SlDklYk~vy~v  159 (361)
T KOG1006|consen   80 VNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDISLDKLYKRVYSV  159 (361)
T ss_pred             hhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhhhHHHHHHHHHHH
Confidence            6677889999999999999866555667788888866655 7899999999999999999999999865544332    2


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhh
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDV  155 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~  155 (282)
                      .+..++|+.+-.+....+.||.||.+ .+|+|||+||+||+++..|.+||+|||.+-.+..+ ...+...|...|+|||.
T Consensus       160 q~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-iAkT~daGCrpYmAPER  238 (361)
T KOG1006|consen  160 QKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-IAKTVDAGCRPYMAPER  238 (361)
T ss_pred             HhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH-HHhhhccCCccccChhc
Confidence            24569999999999999999999995 58999999999999999999999999999776533 33445577788999999


Q ss_pred             hcCCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         156 LFGAKL-YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       156 ~~~~~~-~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      +..... |..+||+||||+++||+.||..| +.+.+.  ...++.......++..                    ....-
T Consensus       239 i~p~~~gyDiRSDvWSLGITL~EvAtG~fP-yr~w~s--vfeql~~Vv~gdpp~l--------------------~~~~~  295 (361)
T KOG1006|consen  239 IDPSDKGYDIRSDVWSLGITLYEVATGNFP-YRKWDS--VFEQLCQVVIGDPPIL--------------------LFDKE  295 (361)
T ss_pred             cCCccCCcchhhhhhhhcceEeeeecCCCC-cchHHH--HHHHHHHHHcCCCCee--------------------cCccc
Confidence            976654 88999999999999999999988 444433  3333333322211111                    11112


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      .-+++..++.||..||.+|-.+||...+++.+||++..
T Consensus       296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY  333 (361)
T ss_pred             ccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence            23589999999999999999999999999999999855

>KOG1027|consensus

Probab=100.00  E-value=3e-37  Score=266.23  Aligned_cols=236  Identities=29%  Similarity=0.388  Sum_probs=185.5

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      +||+|.-  .|+.||||++-.    +..+...+|+..++.- +||||+++++.-++....||..|.|..+|-+.+.....
T Consensus       525 ~Vf~G~y--e~R~VAVKrll~----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~dlie~~~~  598 (903)
T KOG1027|consen  525 VVFRGVY--EGREVAVKRLLE----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQDLIESSGL  598 (903)
T ss_pred             EEEEEee--CCceehHHHHhh----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhHHHHHhcccc
Confidence            5888885  688999998763    2345788999999988 79999999999999999999999999999888876311


Q ss_pred             C---CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC---C--CcEEEEecCCccccCCCc---cccccccccc
Q psy6044          80 E---IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK---N--GELKLADFGLARAFGIPV---KCYSAEVVTL  148 (282)
Q Consensus        80 ~---~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~---~--~~~~l~df~~~~~~~~~~---~~~~~~~~~~  148 (282)
                      .   ......+.+..|++.||++||+.+|+||||||.||+++.   +  .+++|+|||+++......   .......||.
T Consensus       599 d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~  678 (903)
T KOG1027|consen  599 DVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTS  678 (903)
T ss_pred             chhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcc
Confidence            1   111345788999999999999999999999999999976   3  468999999999885432   3345567899


Q ss_pred             cccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPS  228 (282)
Q Consensus       149 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
                      +|.|||.+..... +.+.||||+||++|..++|+..+|.+.-..+  .+|..+.-                         
T Consensus       679 GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~-------------------------  730 (903)
T KOG1027|consen  679 GWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNY-------------------------  730 (903)
T ss_pred             cccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCcc-------------------------
Confidence            9999999988874 7899999999999999999887787654322  11211100                         


Q ss_pred             CCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q psy6044         229 MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD  271 (282)
Q Consensus       229 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  271 (282)
                       ....+.+....++.+||.+|++++|..||++.++|.||||=+
T Consensus       731 -~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~  772 (903)
T KOG1027|consen  731 -TLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD  772 (903)
T ss_pred             -ceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence             111111222227899999999999999999999999999843

>KOG0199|consensus

Probab=100.00  E-value=3.2e-36  Score=255.57  Aligned_cols=239  Identities=21%  Similarity=0.323  Sum_probs=200.5

Q ss_pred             CeeeeeeCCC---CceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHh
Q psy6044           1 MFTSGVDRTP---NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDS   76 (282)
Q Consensus         1 ~vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~   76 (282)
                      +|++|..+..   --.||||++.........+.|++|+..|.+++|||++++||++.+ ....+|+|.++ |+|++.+.+
T Consensus       125 vV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrk  203 (1039)
T KOG0199|consen  125 VVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRK  203 (1039)
T ss_pred             eEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhh
Confidence            4777776543   347999999875544478999999999999999999999999988 66889999998 678888777


Q ss_pred             -cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccc---cccccccC
Q psy6044          77 -LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTLWYRP  152 (282)
Q Consensus        77 -~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~---~~~~~~~a  152 (282)
                       ....+.......++.||+.|+.||.+++++|+||...|+++-....+||+|||+.+.++.....+...   -....|.|
T Consensus       204 a~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCa  283 (1039)
T KOG0199|consen  204 AKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCA  283 (1039)
T ss_pred             ccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccC
Confidence             35668999999999999999999999999999999999999999999999999999887554433221   11456999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       153 PE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      ||.+.... ++.++|+|++|+++|||+|++..+|.+......++.+-++                            ...
T Consensus       284 PEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~----------------------------erL  334 (1039)
T KOG0199|consen  284 PESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG----------------------------ERL  334 (1039)
T ss_pred             HhHhcccc-ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc----------------------------ccC
Confidence            99998887 7999999999999999999999889999988888877543                            222


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      .-++..++++.++++.||..+|++|||+..|.+.-++
T Consensus       335 pRPk~csedIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             CCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence            3345689999999999999999999999999754443

>KOG1290|consensus

Probab=100.00  E-value=5e-36  Score=244.96  Aligned_cols=268  Identities=28%  Similarity=0.424  Sum_probs=203.3

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCC-----C---CCccceeeeeeeC----CeEEEEEecCccc
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK-----H---KNIVRLYDVLHSE----KKLTLVFEHCDQD   69 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-----h---~~i~~~~~~~~~~----~~~~iv~e~~~g~   69 (282)
                      ||+|.|..+.+.||+|+.+..+  ...+..+.|+.++++++     |   .+||++++.|...    .++++|+|+++.+
T Consensus        94 VWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdn  171 (590)
T KOG1290|consen   94 VWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDN  171 (590)
T ss_pred             eEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhhhhH
Confidence            8999999999999999988633  34678899999999983     2   4699999999853    5899999999999


Q ss_pred             HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCC--------------------------
Q psy6044          70 LKKYFDSLN-GEIDLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNG--------------------------  121 (282)
Q Consensus        70 l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~dl~~~nil~~~~~--------------------------  121 (282)
                      ||..+...+ ..++...+..|+.||+.||.|||. .||+|.||||+|||+-.+.                          
T Consensus       172 LLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~  251 (590)
T KOG1290|consen  172 LLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVS  251 (590)
T ss_pred             HHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCccccc
Confidence            999998876 459999999999999999999996 5999999999999984110                          


Q ss_pred             --------------------------------------------------------------------------------
Q psy6044         122 --------------------------------------------------------------------------------  121 (282)
Q Consensus       122 --------------------------------------------------------------------------------  121 (282)
                                                                                                      
T Consensus       252 t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~  331 (590)
T KOG1290|consen  252 TRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNR  331 (590)
T ss_pred             ccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCC
Confidence                                                                                            


Q ss_pred             ------------------------------------------------------------cEEEEecCCccccCCCcccc
Q psy6044         122 ------------------------------------------------------------ELKLADFGLARAFGIPVKCY  141 (282)
Q Consensus       122 ------------------------------------------------------------~~~l~df~~~~~~~~~~~~~  141 (282)
                                                                                  ++||+|||.+....   ..+
T Consensus       332 ~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~---khF  408 (590)
T KOG1290|consen  332 ENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVH---KHF  408 (590)
T ss_pred             ccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhh---hhh
Confidence                                                                        14444444444322   233


Q ss_pred             ccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCC-----CChHHHHHHHHHHhCCCCCCCCCCCCC-
Q psy6044         142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG-----SDVDDQLKRIFKLLGTPTEDTWPGMNL-  215 (282)
Q Consensus       142 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~-  215 (282)
                      +..+.|..|+|||++.+.. |+..+||||++|++|||.||..-|-+.     ..+++.++.+++.++..|......... 
T Consensus       409 T~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~S  487 (590)
T KOG1290|consen  409 TEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYS  487 (590)
T ss_pred             chhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcch
Confidence            4445567899999999998 799999999999999999988775332     347789999999998876533222211 


Q ss_pred             ---------CCCCCCCCC---CCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         216 ---------LPDFKPFPM---YHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       216 ---------~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                               +..+..+..   ...-...-+.+.....++.+|+.-||+.+|++||||.++|+|||+..+...
T Consensus       488 RdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  488 RDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             HhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence                     111111111   111112223344466778899999999999999999999999999987664

>KOG0587|consensus

Probab=100.00  E-value=9.1e-36  Score=258.34  Aligned_cols=242  Identities=25%  Similarity=0.367  Sum_probs=196.3

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeee-----CCeEEEEEecCcccHHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHS-----EKKLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~-----~~~~~iv~e~~~g~l~~~~~   75 (282)
                      ||+++++.+|+..|+|+....  .+.-..+.-|.++++.. .|||++.+++++..     +..+|+|||+|.|+....+.
T Consensus        35 v~k~k~~~~~~~aa~kI~~~~--~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLV  112 (953)
T KOG0587|consen   35 VYKGRHVKTGQLAAIKIMDPT--EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLV  112 (953)
T ss_pred             EEEEeeeecCceeeeEeecCC--ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHH
Confidence            799999999999999988753  33346777888999888 79999999999873     46899999999865544444


Q ss_pred             hc--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccCh
Q psy6044          76 SL--NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP  153 (282)
Q Consensus        76 ~~--~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aP  153 (282)
                      ++  +..+.|..+..|++.++.||.+||...++|+|+|-.||+++.++.+||+|||.+.............+||+.|+||
T Consensus       113 Kn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAP  192 (953)
T KOG0587|consen  113 KNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAP  192 (953)
T ss_pred             hhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccc
Confidence            33  4569999999999999999999999999999999999999999999999999999888777777778999999999


Q ss_pred             hhhcCCC----CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         154 DVLFGAK----LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSM  229 (282)
Q Consensus       154 E~~~~~~----~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
                      |++...+    .|+..+|+||||++..||-.|..|+++.........    .-+.|+                       
T Consensus       193 EViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~----IpRNPP-----------------------  245 (953)
T KOG0587|consen  193 EVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPP-----------------------  245 (953)
T ss_pred             eeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc----CCCCCC-----------------------
Confidence            9985432    267899999999999999977766554433222111    111111                       


Q ss_pred             CccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      .-..-+...+..+.+||..||.+|-.+||+..++|+|||++..
T Consensus       246 PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  246 PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             ccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence            1122245688999999999999999999999999999999944

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.9e-34  Score=233.75  Aligned_cols=239  Identities=17%  Similarity=0.175  Sum_probs=171.8

Q ss_pred             CeeeeeeCCC---CceEEEeeeecCCCCCC----------CccHHHHHHHHhhCCCCCccceeeeeeeCC----eEEEEE
Q psy6044           1 MFTSGVDRTP---NTALAIKGTHLVGNEGV----------PSSALREICLLKELKHKNIVRLYDVLHSEK----KLTLVF   63 (282)
Q Consensus         1 ~vy~a~~~~~---~~~vaiK~~~~~~~~~~----------~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~----~~~iv~   63 (282)
                      .||+|.+..+   +..+|+|+.........          ......+...+..++|++++++++++....    ..++++
T Consensus        27 ~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~  106 (294)
T PHA02882         27 CVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILL  106 (294)
T ss_pred             eEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEE
Confidence            4899998887   77888886544221110          011223334556678999999999766543    457888


Q ss_pred             ecCcccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-----
Q psy6044          64 EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-----  138 (282)
Q Consensus        64 e~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-----  138 (282)
                      +++..++.+.+.. ....++..+..++.|++.||.+||+.+++||||||+||+++.++.++|+|||++.......     
T Consensus       107 ~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~  185 (294)
T PHA02882        107 EKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEY  185 (294)
T ss_pred             ehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCccccc
Confidence            8887776665544 3456788899999999999999999999999999999999999999999999987653211     


Q ss_pred             --cccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCC-ChHHHHHHHHHHh-CCCCCCCCCCCC
Q psy6044         139 --KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGS-DVDDQLKRIFKLL-GTPTEDTWPGMN  214 (282)
Q Consensus       139 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~  214 (282)
                        .......+++.|+|||...+.. ++.++||||||+++|++++|..| |.+. ............. ......      
T Consensus       186 ~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P-~~~~~~~~~~~~~~~~~~~~~~~~~------  257 (294)
T PHA02882        186 SKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLP-WKGFGHNGNLIHAAKCDFIKRLHEG------  257 (294)
T ss_pred             ccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCC-CCccccchHHHHHhHHHHHHHhhhh------
Confidence              1112235789999999987766 79999999999999999998777 5544 3333222211111 000000      


Q ss_pred             CCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         215 LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                       .......++.+.++++.|+..+|.+||++.++++
T Consensus       258 -----------------~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        258 -----------------KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             -----------------hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                             0012345788999999999999999999999875

>KOG0670|consensus

Probab=100.00  E-value=2e-36  Score=249.23  Aligned_cols=264  Identities=27%  Similarity=0.486  Sum_probs=207.8

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCC------CCccceeeeeeeCCeEEEEEecCcccHHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKH------KNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h------~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~   75 (282)
                      |.+|+|..-|..||||++..  ++-.-+.-+.|+++|++|+.      -|+++++..|...+++++|+|.+..+|.+.+.
T Consensus       448 Vvra~D~~r~~~vAiKIIRn--NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~LslNLRevLK  525 (752)
T KOG0670|consen  448 VVRARDQARGQEVAIKIIRN--NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLSLNLREVLK  525 (752)
T ss_pred             eeeccccCCCCeeEEEEeec--chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhhchHHHHHH
Confidence            66889999999999999985  22334566789999999953      57899999999999999999999999988887


Q ss_pred             hcCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC-CcEEEEecCCccccCCCccccccccccccccC
Q psy6044          76 SLNG--EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRP  152 (282)
Q Consensus        76 ~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~a  152 (282)
                      +.+.  .+....+..++.|++.||..|...|++|.||||+|||++.. ..+||||||.+...+.+..  +.+..+..|.|
T Consensus       526 KyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei--tPYLVSRFYRa  603 (752)
T KOG0670|consen  526 KYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASENEI--TPYLVSRFYRA  603 (752)
T ss_pred             HhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccccccccc--cHHHHHHhccC
Confidence            7644  48889999999999999999999999999999999999876 4579999999987764322  33455778999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCC-------------
Q psy6044         153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDF-------------  219 (282)
Q Consensus       153 PE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------  219 (282)
                      ||++.+.. |+...|+||+||++||++||+-- |++.++...+...+...+..+........+...-             
T Consensus       604 PEIiLG~~-yd~~iD~WSvgctLYElYtGkIl-FpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D  681 (752)
T KOG0670|consen  604 PEIILGLP-YDYPIDTWSVGCTLYELYTGKIL-FPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVD  681 (752)
T ss_pred             cceeecCc-ccCCccceeeceeeEEeecccee-cCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEecc
Confidence            99999887 79999999999999999977665 9999999999999999888876555443222110             


Q ss_pred             --------CCCCCCCCCCCc----------cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q psy6044         220 --------KPFPMYHPSMSF----------SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD  271 (282)
Q Consensus       220 --------~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  271 (282)
                              ..+....+-..+          +.-....-..+.+|+.+||..||++|.|..++|.||||+.
T Consensus       682 ~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  682 KVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             ccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence                    000000010000          0001123356779999999999999999999999999974

>KOG1094|consensus

Probab=100.00  E-value=2.4e-35  Score=245.75  Aligned_cols=232  Identities=23%  Similarity=0.312  Sum_probs=192.6

Q ss_pred             CceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHhcCCC-CCHHHHHH
Q psy6044          11 NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGE-IDLDIVKS   88 (282)
Q Consensus        11 ~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~~~~-~~~~~~~~   88 (282)
                      +..||+|.++..........|.+|+++|.+++||||+.++++|..++.+++|+||+. |++..++.+...+ +.-.....
T Consensus       562 ~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vs  641 (807)
T KOG1094|consen  562 PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVS  641 (807)
T ss_pred             ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHH
Confidence            689999999886555567899999999999999999999999999999999999996 7888887775434 35566778


Q ss_pred             HHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCcccc--CCCccccccccccccccChhhhcCCCCCCchh
Q psy6044          89 FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSI  166 (282)
Q Consensus        89 ~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~--~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  166 (282)
                      ++.||++|++||.+.+++|||+.+.|++++.++++||+|||.++.+  +...........+.+|+|+|.+...+ ++.++
T Consensus       642 i~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgk-FttaS  720 (807)
T KOG1094|consen  642 ICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGK-FTTAS  720 (807)
T ss_pred             HHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhcc-ccchh
Confidence            9999999999999999999999999999999999999999998754  22333344445578999999998887 79999


Q ss_pred             hHHHHHHHHHHHH--hcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHH
Q psy6044         167 DMWSAGCIFAELA--NAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRD  244 (282)
Q Consensus       167 Di~slG~ll~~ll--~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  244 (282)
                      |+|+||+++||++  +..+| |...++++...+....+.......                     ....+.-++..+.+
T Consensus       721 DvWafgvTlwE~~~~C~e~P-y~~lt~e~vven~~~~~~~~~~~~---------------------~l~~P~~cp~~lye  778 (807)
T KOG1094|consen  721 DVWAFGVTLWEVFMLCREQP-YSQLTDEQVVENAGEFFRDQGRQV---------------------VLSRPPACPQGLYE  778 (807)
T ss_pred             hhhhhHHHHHHHHHHHhhCc-hhhhhHHHHHHhhhhhcCCCCcce---------------------eccCCCcCcHHHHH
Confidence            9999999999975  45566 788888887777766655443322                     22234568899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhc
Q psy6044         245 LLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       245 li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ++..||..+.++|||++++-.
T Consensus       779 lml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  779 LMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             HHHHHhchhhhcCCCHHHHHH
Confidence            999999999999999999854

>KOG1151|consensus

Probab=100.00  E-value=1.5e-35  Score=240.34  Aligned_cols=245  Identities=25%  Similarity=0.418  Sum_probs=197.1

Q ss_pred             eeeeeeCCCCceEEEeeeecC--C----CCCCCccHHHHHHHHhhCCCCCccceeeeeeeC-CeEEEEEecCcccHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--G----NEGVPSSALREICLLKELKHKNIVRLYDVLHSE-KKLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~----~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~-~~~~iv~e~~~g~l~~~~   74 (282)
                      ||+|.|....+.||+|+-...  .    .+...+...+|..+.+.|+||.||++|+++.-+ ..++-|.|||+|+-++++
T Consensus       479 VyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFY  558 (775)
T KOG1151|consen  479 VYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFY  558 (775)
T ss_pred             HHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHH
Confidence            799999999999999986652  1    222345578899999999999999999999854 578899999999999999


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEcC---CCcEEEEecCCccccCCCcc-------ccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRN--VLHRDLKPQNLLINK---NGELKLADFGLARAFGIPVK-------CYS  142 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~dl~~~nil~~~---~~~~~l~df~~~~~~~~~~~-------~~~  142 (282)
                      .+....+++.++..|+.||+.||.||.+..  |+|.||||.||++..   -|.+||.|||++..+.....       ..+
T Consensus       559 LKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTS  638 (775)
T KOG1151|consen  559 LKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTS  638 (775)
T ss_pred             HHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeec
Confidence            998899999999999999999999999874  999999999999943   47899999999999864432       233


Q ss_pred             cccccccccChhhhcCC---CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCC
Q psy6044         143 AEVVTLWYRPPDVLFGA---KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDF  219 (282)
Q Consensus       143 ~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (282)
                      ...||.+|++||.+.-.   ...+.+.||||+|+++|.++.|+.||-.+....+.++.-.-.. . ....+         
T Consensus       639 QgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk-A-tEVqF---------  707 (775)
T KOG1151|consen  639 QGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK-A-TEVQF---------  707 (775)
T ss_pred             ccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc-c-eeccC---------
Confidence            45678999999998432   3368899999999999999999999655555555544311100 0 00000         


Q ss_pred             CCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q psy6044         220 KPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS  270 (282)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  270 (282)
                                   ...+.++++.+.||++||..--++|....++..||+|.
T Consensus       708 -------------P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll  745 (775)
T KOG1151|consen  708 -------------PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL  745 (775)
T ss_pred             -------------CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence                         11245899999999999999999999999999999986

>KOG0608|consensus

Probab=100.00  E-value=4.8e-35  Score=246.24  Aligned_cols=248  Identities=24%  Similarity=0.365  Sum_probs=194.3

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      |.+++...|...||+|.+++  +-..........|..+|..-+++-||++|-.|++...+|+||+|++| ++...+++ -
T Consensus       645 V~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIr-m  723 (1034)
T KOG0608|consen  645 VCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR-M  723 (1034)
T ss_pred             eEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHH-h
Confidence            56777778899999999988  33444456677899999999999999999999999999999999986 55565555 6


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC---------------------
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP---------------------  137 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~---------------------  137 (282)
                      +.+.|+.+..++..+..|+++.|.+|++|+||||+|||+|.+|.+||.|||+++-+-+.                     
T Consensus       724 gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~  803 (1034)
T KOG0608|consen  724 GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSP  803 (1034)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCch
Confidence            88999999999999999999999999999999999999999999999999998655100                     


Q ss_pred             ---------------------ccccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q psy6044         138 ---------------------VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK  196 (282)
Q Consensus       138 ---------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~  196 (282)
                                           .......+||+.|+|||++.... ++..+|-||.|+++|||+.|+.| |...+..+...
T Consensus       804 e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws~gvil~em~~g~~p-f~~~tp~~tq~  881 (1034)
T KOG0608|consen  804 EWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWSVGVILYEMLVGQPP-FLADTPGETQY  881 (1034)
T ss_pred             hhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhHhhHHHHHHhhCCCC-ccCCCCCccee
Confidence                                 00111245688999999998777 69999999999999999988777 55544444333


Q ss_pred             HHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCCccCCc
Q psy6044         197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM---SAEDAMSHIYFSDLN  273 (282)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~h~~~~~~~  273 (282)
                      ++.++.....                         -.....+|+++.++|.++. .++..|+   .++++-.||||+.|+
T Consensus       882 kv~nw~~~l~-------------------------~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgID  935 (1034)
T KOG0608|consen  882 KVINWRNFLH-------------------------IPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGID  935 (1034)
T ss_pred             eeeehhhccc-------------------------cccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccc
Confidence            3332211100                         0112458999999997654 4577887   577899999999998


Q ss_pred             cchhh
Q psy6044         274 VAIKS  278 (282)
Q Consensus       274 ~~~~~  278 (282)
                      +...+
T Consensus       936 fsslR  940 (1034)
T KOG0608|consen  936 FSSLR  940 (1034)
T ss_pred             hHhhh
Confidence            87633

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.2e-33  Score=248.96  Aligned_cols=259  Identities=20%  Similarity=0.245  Sum_probs=159.2

Q ss_pred             CeeeeeeCCC----CceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeee------eeeCCeEEEEEecCccc-
Q psy6044           1 MFTSGVDRTP----NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDV------LHSEKKLTLVFEHCDQD-   69 (282)
Q Consensus         1 ~vy~a~~~~~----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~------~~~~~~~~iv~e~~~g~-   69 (282)
                      .||+|++..+    +..||+|++....   .......+  .++...+.++..+...      .......++|+||++++ 
T Consensus       147 ~VYka~~~~~~~~~~~~vAvK~~~~~~---~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gs  221 (566)
T PLN03225        147 VVYKASLVNKQSKKEGKYVLKKATEYG---AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGEST  221 (566)
T ss_pred             EEEEEEEcCCccccCcEEEEEEecccc---hhHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEEEEEecCCCc
Confidence            3899999999    9999999875321   11111111  1222222333332222      23456799999999865 


Q ss_pred             HHHHHHhcCCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-CCcEEEEecC
Q psy6044          70 LKKYFDSLNGE-------------------IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK-NGELKLADFG  129 (282)
Q Consensus        70 l~~~~~~~~~~-------------------~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~-~~~~~l~df~  129 (282)
                      +.+.+......                   .....+..++.||+.||.|||++||+|+||||+||+++. ++.++|+|||
T Consensus       222 L~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFG  301 (566)
T PLN03225        222 LADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLG  301 (566)
T ss_pred             HHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCC
Confidence            44444332111                   123456789999999999999999999999999999985 5799999999


Q ss_pred             CccccCCCc-cccccccccccccChhhhcCCC---------------------CCCchhhHHHHHHHHHHHHhcCCCCCC
Q psy6044         130 LARAFGIPV-KCYSAEVVTLWYRPPDVLFGAK---------------------LYTTSIDMWSAGCIFAELANAGRPLFP  187 (282)
Q Consensus       130 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~---------------------~~~~~~Di~slG~ll~~ll~~~~p~~~  187 (282)
                      ++..+.... .......+++.|+|||.+....                     .++.++||||+||++|+|+++..+   
T Consensus       302 lA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~---  378 (566)
T PLN03225        302 AAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLR---  378 (566)
T ss_pred             CccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCC---
Confidence            997653221 1223346688999999763221                     123466999999999999975443   


Q ss_pred             CCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q psy6044         188 GSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHI  267 (282)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~  267 (282)
                      .................... .|...  ....   . ........++....+....+||.+||+.||++|||+.++|+||
T Consensus       379 ~~~~~~~~~~~l~~~~~~~~-~~~~~--~~~~---~-~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hp  451 (566)
T PLN03225        379 SDSNLIQFNRQLKRNDYDLV-AWRKL--VEPR---A-SPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHP  451 (566)
T ss_pred             CchHHHHHHHHHHhcCCcHH-HHHHh--hccc---c-chhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCc
Confidence            22222222222221111000 00000  0000   0 0000000112223445667999999999999999999999999


Q ss_pred             CccCCcc
Q psy6044         268 YFSDLNV  274 (282)
Q Consensus       268 ~~~~~~~  274 (282)
                      ||++.+.
T Consensus       452 ff~~~~~  458 (566)
T PLN03225        452 YFDREGL  458 (566)
T ss_pred             CcCCCCc
Confidence            9997654

>KOG0200|consensus

Probab=100.00  E-value=2.7e-33  Score=248.94  Aligned_cols=226  Identities=26%  Similarity=0.392  Sum_probs=189.7

Q ss_pred             CceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHhcC----------
Q psy6044          11 NTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLN----------   78 (282)
Q Consensus        11 ~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~~----------   78 (282)
                      ...||||.+.........+.+..|+++++.+ .|+||+.+.+++...+.+++|.||+. |++++++.++.          
T Consensus       328 ~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~  407 (609)
T KOG0200|consen  328 YVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGV  407 (609)
T ss_pred             eEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCC
Confidence            5689999998855556778999999999999 79999999999999999999999996 78888888766          


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc---ccccccccccc
Q psy6044          79 -----GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK---CYSAEVVTLWY  150 (282)
Q Consensus        79 -----~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~  150 (282)
                           ..++......++.||+.|++||++.+++||||-.+||++..+..+||+|||+++.......   ..+....+..|
T Consensus       408 ~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kW  487 (609)
T KOG0200|consen  408 FPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKW  487 (609)
T ss_pred             CccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceee
Confidence                 3488999999999999999999999999999999999999999999999999986432211   11111135669


Q ss_pred             cChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC-hHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSD-VDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSM  229 (282)
Q Consensus       151 ~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
                      +|||.+.... ++.++||||+|+++||++|.+.+++++.. ..+..+.+..+.+.                         
T Consensus       488 mApEsl~~~~-ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~-------------------------  541 (609)
T KOG0200|consen  488 MAPESLFDRV-FTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRM-------------------------  541 (609)
T ss_pred             cCHHHhccCc-ccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCC-------------------------
Confidence            9999998855 89999999999999999998888888755 56665555554322                         


Q ss_pred             CccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                         +.|...++++.++++.||+.+|++||++.++.+
T Consensus       542 ---~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  542 ---EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             ---CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence               234567999999999999999999999999887

>KOG0576|consensus

Probab=100.00  E-value=4.7e-35  Score=247.25  Aligned_cols=245  Identities=24%  Similarity=0.332  Sum_probs=206.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEI   81 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~   81 (282)
                      ||+|+|+.+++..|+|+++..... ...-+.+|+-+++..+||||+.+++.+......+|.||||+|+.++......+++
T Consensus        31 vyKaRd~~s~elaavkvVkLep~d-d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~Tgpl  109 (829)
T KOG0576|consen   31 VYKARDKRSGELAAVKVVKLEPGD-DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPL  109 (829)
T ss_pred             hhhhcccccCchhhheeeeccCCc-cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccc
Confidence            799999999999999999885444 3577888999999999999999999999999999999999998888888889999


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc--CC
Q psy6044          82 DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF--GA  159 (282)
Q Consensus        82 ~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~  159 (282)
                      ++.++..+.+..+.||+|||++|-+|||||-.||++++.|.+++.|||.+-.++..........|++.|+|||+..  ..
T Consensus       110 selqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverk  189 (829)
T KOG0576|consen  110 SELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERK  189 (829)
T ss_pred             hhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhc
Confidence            9999999999999999999999999999999999999999999999999988887777777889999999999862  22


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      .-|...+|+|++|+...|+-..+.|.|........ ..+.+....++.                        ..-....+
T Consensus       190 ggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l-~LmTkS~~qpp~------------------------lkDk~kws  244 (829)
T KOG0576|consen  190 GGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL-FLMTKSGFQPPT------------------------LKDKTKWS  244 (829)
T ss_pred             ccccccccccccccchhhhhhcCCcccccchHHHH-HHhhccCCCCCc------------------------ccCCccch
Confidence            23789999999999999999666665554443332 222222211111                        11234578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      +.+.+|++.+|.++|++|||++.+|.|||...-
T Consensus       245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            899999999999999999999999999998754

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.2e-32  Score=259.74  Aligned_cols=239  Identities=20%  Similarity=0.232  Sum_probs=170.9

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||+|+++.+|..||+|.+....     .....|++.+++++||||+++++++.++...++||||++|+.+..+..   .
T Consensus       705 ~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~---~  776 (968)
T PLN00113        705 ASYKGKSIKNGMQFVVKEINDVN-----SIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR---N  776 (968)
T ss_pred             eEEEEEECCCCcEEEEEEccCCc-----cccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh---c
Confidence            38999999999999999886422     123457899999999999999999999999999999998655555543   4


Q ss_pred             CCHHHHHHHHHHHHHHHHHHH---hCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCH---SRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      +++..+..++.|++.|++|||   +.+++|+|+||+||+++.++..++. ++........    ....++..|+|||.+.
T Consensus       777 l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----~~~~~t~~y~aPE~~~  851 (968)
T PLN00113        777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFISSAYVAPETRE  851 (968)
T ss_pred             CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----CCccccccccCccccc
Confidence            889999999999999999999   6699999999999999988887765 4443322111    1235678899999987


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH-HhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK-LLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      +.. ++.++||||||+++||+++|+.|+............... .........+-        .+..    . .......
T Consensus       852 ~~~-~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~----~-~~~~~~~  917 (968)
T PLN00113        852 TKD-ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWI--------DPSI----R-GDVSVNQ  917 (968)
T ss_pred             CCC-CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhee--------Cccc----c-CCCCccH
Confidence            766 799999999999999999999885332221111111111 11000000000        0000    0 0001111


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      ....++.+++.+||+.||++|||+.++++.
T Consensus       918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        918 NEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             HHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            233467789999999999999999999873

>KOG1167|consensus

Probab=100.00  E-value=5.4e-33  Score=223.75  Aligned_cols=267  Identities=28%  Similarity=0.462  Sum_probs=201.9

Q ss_pred             CeeeeeeCC---CCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHh
Q psy6044           1 MFTSGVDRT---PNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS   76 (282)
Q Consensus         1 ~vy~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~   76 (282)
                      +||+|.+..   ..+.||+|.+...   +....+..|++++..+ -+.||+++.+++..+....+|+||++..-...+..
T Consensus        51 sv~~a~~~~~~~~~~~valk~i~~t---s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~  127 (418)
T KOG1167|consen   51 SVYKATDIEQDTKRRYVALKAIYRT---SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR  127 (418)
T ss_pred             hhhhhhHhhhccccceEeeeecccc---cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHh
Confidence            478888877   7999999988753   3456799999999999 68999999999999999999999998754444433


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC-CcEEEEecCCccccC-----------------C--
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAFG-----------------I--  136 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~-~~~~l~df~~~~~~~-----------------~--  136 (282)
                         .++..++..+++.++.||+++|..||+|+|+||.|++++.. ++-.|+|||++....                 .  
T Consensus       128 ---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~  204 (418)
T KOG1167|consen  128 ---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAM  204 (418)
T ss_pred             ---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccc
Confidence               56789999999999999999999999999999999999754 678999999986210                 0  


Q ss_pred             -------------------------CccccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCh
Q psy6044         137 -------------------------PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDV  191 (282)
Q Consensus       137 -------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~  191 (282)
                                               .........||++|+|||++.....-+.+.||||.|+++..++++..|||...++
T Consensus       205 g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd  284 (418)
T KOG1167|consen  205 GKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDD  284 (418)
T ss_pred             cCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccc
Confidence                                     0011122456889999999977655689999999999999999999999999888


Q ss_pred             HHHHHHHHHHhCCCC--------CC--CCCCCC------CCCCCCCCC---CCCCC---CCccccCccCCHHHHHHHHHh
Q psy6044         192 DDQLKRIFKLLGTPT--------ED--TWPGMN------LLPDFKPFP---MYHPS---MSFSQVAPKLTAKGRDLLQRL  249 (282)
Q Consensus       192 ~~~~~~~~~~~~~~~--------~~--~~~~~~------~~~~~~~~~---~~~~~---~~~~~~~~~~~~~l~~li~~~  249 (282)
                      .+.+..+...++...        +.  .|...+      ....+....   ....+   .........++..+.+|+.+|
T Consensus       285 ~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~  364 (418)
T KOG1167|consen  285 ADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKC  364 (418)
T ss_pred             cchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHH
Confidence            887777766555321        11  111111      111111111   00101   112223345677999999999


Q ss_pred             cccCCCCCCCHHHHhcCCCccCCc
Q psy6044         250 LVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       250 l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      |+.||.+|.|++++|.||||...+
T Consensus       365 le~np~kRitAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  365 LELNPQKRITAEDALKHPFFDEAD  388 (418)
T ss_pred             ccCChhhcccHHHHhcCcCCcchh
Confidence            999999999999999999999654

>KOG1025|consensus

Probab=100.00  E-value=1e-32  Score=238.04  Aligned_cols=234  Identities=22%  Similarity=0.279  Sum_probs=200.1

Q ss_pred             eeeeeeCCC----CceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHh
Q psy6044           2 FTSGVDRTP----NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDS   76 (282)
Q Consensus         2 vy~a~~~~~----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~   76 (282)
                      ||+|...=.    +-+||||++......+....+++|+.+|.+++|||++++++++..+. +-||++|++ |.|++++..
T Consensus       712 V~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~  790 (1177)
T KOG1025|consen  712 VYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVRE  790 (1177)
T ss_pred             EEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHH
Confidence            677764433    44789999888777777899999999999999999999999998776 889999998 688888888


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccc--cccccChh
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV--TLWYRPPD  154 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~--~~~~~aPE  154 (282)
                      ....+.....+.|..||+.|+.|||+++++||||-.+|+++.+-..+|+.|||++.........+....+  .+.|+|-|
T Consensus       791 hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale  870 (1177)
T KOG1025|consen  791 HRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALE  870 (1177)
T ss_pred             hhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHH
Confidence            7888999999999999999999999999999999999999999999999999999888766555544433  56799999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      .+.... ++.++|||||||++||++|-+.-++.+...++.-..+..+.+.                            ..
T Consensus       871 ~i~~~~-~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRL----------------------------sq  921 (1177)
T KOG1025|consen  871 SIRIRK-YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERL----------------------------SQ  921 (1177)
T ss_pred             HhhccC-CCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccC----------------------------CC
Confidence            987777 7999999999999999998777668888877777766664332                            23


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ++..+.++..++.+||..|+..||+++++..
T Consensus       922 PpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  922 PPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             CCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence            4568899999999999999999999999865

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.6e-31  Score=230.32  Aligned_cols=243  Identities=21%  Similarity=0.339  Sum_probs=162.5

Q ss_pred             CCCceEEEeeeecCCC-------------CCCCccHHHHHHHHhhCCCCCc-----cceeeeeee--------CCeEEEE
Q psy6044           9 TPNTALAIKGTHLVGN-------------EGVPSSALREICLLKELKHKNI-----VRLYDVLHS--------EKKLTLV   62 (282)
Q Consensus         9 ~~~~~vaiK~~~~~~~-------------~~~~~~~~~e~~~~~~l~h~~i-----~~~~~~~~~--------~~~~~iv   62 (282)
                      ..++.||||++.....             ....+....|+.++.+++|.++     +++++++..        .+..++|
T Consensus       184 ~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV  263 (507)
T PLN03224        184 QKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLV  263 (507)
T ss_pred             ccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEE
Confidence            3567899999875221             1123345567777888866554     666776653        3568999


Q ss_pred             EecCcc-cHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q psy6044          63 FEHCDQ-DLKKYFDSLN-----------------------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN  118 (282)
Q Consensus        63 ~e~~~g-~l~~~~~~~~-----------------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~  118 (282)
                      +||+++ ++.+.+....                       ..+++..+..++.|++.||.|||+.+++|+||||+||+++
T Consensus       264 ~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~  343 (507)
T PLN03224        264 WKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT  343 (507)
T ss_pred             EEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC
Confidence            999986 4444443211                       1245678889999999999999999999999999999999


Q ss_pred             CCCcEEEEecCCccccCCCcc-ccccccccccccChhhhcCCCC---------------------CCchhhHHHHHHHHH
Q psy6044         119 KNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDVLFGAKL---------------------YTTSIDMWSAGCIFA  176 (282)
Q Consensus       119 ~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~---------------------~~~~~Di~slG~ll~  176 (282)
                      .++.++|+|||++..+..... .......++.|+|||.+.....                     ...+.|+||+||+++
T Consensus       344 ~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~  423 (507)
T PLN03224        344 VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLM  423 (507)
T ss_pred             CCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHH
Confidence            999999999999866532211 1112233788999999753321                     113479999999999


Q ss_pred             HHHhcCCCCCCCCChHH-HHH---HHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhccc
Q psy6044         177 ELANAGRPLFPGSDVDD-QLK---RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVC  252 (282)
Q Consensus       177 ~ll~~~~p~~~~~~~~~-~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  252 (282)
                      +|+++..+++.....-. ...   .............                   ... ......++...+|+.+||..
T Consensus       424 em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~-------------------~~~-~~~d~~s~~~~dLi~~LL~~  483 (507)
T PLN03224        424 QMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK-------------------YDF-SLLDRNKEAGWDLACKLITK  483 (507)
T ss_pred             HHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC-------------------CCc-ccccccChHHHHHHHHHhcc
Confidence            99988764454321111 000   0000000000000                   011 12345789999999999998


Q ss_pred             CC---CCCCCHHHHhcCCCccC
Q psy6044         253 NP---VQRMSAEDAMSHIYFSD  271 (282)
Q Consensus       253 dp---~~Rps~~~ll~h~~~~~  271 (282)
                      +|   .+|+|++|+|+||||..
T Consensus       484 ~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        484 RDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             CCCCcccCCCHHHHhCCCCcCC
Confidence            76   68999999999999964

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=6.9e-31  Score=205.02  Aligned_cols=205  Identities=36%  Similarity=0.617  Sum_probs=174.1

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~   80 (282)
                      ||++.+..+|+.+++|++...........+.+|+..++.++|++++++++++......++++|+++| ++.+.+......
T Consensus         9 v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~   88 (215)
T cd00180           9 VYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGK   88 (215)
T ss_pred             EEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCC
Confidence            7999998889999999988643322346799999999999999999999999999999999999995 555554443357


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-CCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      +++..++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+||+.+..............+...|.+||.....
T Consensus        89 ~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~  168 (215)
T cd00180          89 LSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGK  168 (215)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhccc
Confidence            899999999999999999999999999999999999999 8999999999987765443223334557789999999776


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      ...+.++|+|++|++++++                                                             
T Consensus       169 ~~~~~~~D~~~lg~~~~~l-------------------------------------------------------------  187 (215)
T cd00180         169 GYYSEKSDIWSLGVILYEL-------------------------------------------------------------  187 (215)
T ss_pred             CCCCchhhhHHHHHHHHHH-------------------------------------------------------------
Confidence            3468999999999999999                                                             


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCC
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSHI  267 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h~  267 (282)
                      ..+.+++..|++.||.+||++.++++|+
T Consensus       188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence            2246899999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0984|consensus

Probab=99.98  E-value=7.3e-32  Score=198.24  Aligned_cols=197  Identities=25%  Similarity=0.377  Sum_probs=161.4

Q ss_pred             eeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHH---HhcC
Q psy6044           3 TSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYF---DSLN   78 (282)
Q Consensus         3 y~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~---~~~~   78 (282)
                      =+-++..+|...|+|.++..-+...-+..++|+.+..+. .+|.++++++....+..++|-||.++.++-.++   ...+
T Consensus        63 ekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~tSldkfy~~v~~~g  142 (282)
T KOG0984|consen   63 EKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDTSLDKFYRKVLKKG  142 (282)
T ss_pred             hheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhhhHHHHHHHHHhcC
Confidence            345678899999999999844444556778888877665 799999999999999999999999987655543   4446


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSR-NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      +.++|..+-+++..++.||.|||++ .++|||+||+||+++.+|++|++|||.+-.+..+. ..+...|...|+|||.+.
T Consensus       143 ~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi-Akt~daGCkpYmaPEri~  221 (282)
T KOG0984|consen  143 GTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI-AKTMDAGCKPYMAPERIN  221 (282)
T ss_pred             CcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhh-HHHHhcCCCccCChhhcC
Confidence            7899999999999999999999976 89999999999999999999999999987665332 233356778899999984


Q ss_pred             CC---CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q psy6044         158 GA---KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK  200 (282)
Q Consensus       158 ~~---~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~  200 (282)
                      ..   ..|+.++||||||+.+.||.+++.|+-...+.-+.+.++.+
T Consensus       222 ~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  222 PELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             cccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            32   24899999999999999999999996666666666666555

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=6.4e-32  Score=248.79  Aligned_cols=202  Identities=15%  Similarity=0.198  Sum_probs=144.8

Q ss_pred             hhCCC-CCccceeeee-------eeCCeEEEEEecCcccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy6044          39 KELKH-KNIVRLYDVL-------HSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDL  110 (282)
Q Consensus        39 ~~l~h-~~i~~~~~~~-------~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl  110 (282)
                      +.++| +||.++++++       .....++.++|+++++|.+.+......+++..+..++.||+.||.|||++||+|+||
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl  106 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV  106 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            34556 6888888877       233568888999999988888765567999999999999999999999999999999


Q ss_pred             CCCcEEEcCCCcEE-------------------EEecCCccccCCCc----------------cccccccccccccChhh
Q psy6044         111 KPQNLLINKNGELK-------------------LADFGLARAFGIPV----------------KCYSAEVVTLWYRPPDV  155 (282)
Q Consensus       111 ~~~nil~~~~~~~~-------------------l~df~~~~~~~~~~----------------~~~~~~~~~~~~~aPE~  155 (282)
                      ||+||+++..+.++                   ++|||++.......                .......+++.|+|||.
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            99999996655555                   55555443211000                00011346788999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      +.+.. ++.++|||||||++|||+++..| +...  ......+.....  ++.                          .
T Consensus       187 ~~~~~-~~~~sDVwSlGviL~ELl~~~~~-~~~~--~~~~~~~~~~~~--~~~--------------------------~  234 (793)
T PLN00181        187 DNGSS-SNCASDVYRLGVLLFELFCPVSS-REEK--SRTMSSLRHRVL--PPQ--------------------------I  234 (793)
T ss_pred             hccCC-CCchhhhhhHHHHHHHHhhCCCc-hhhH--HHHHHHHHHhhc--Chh--------------------------h
Confidence            87766 69999999999999999976554 3221  112222211110  000                          0


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      ....+...+++.+||++||.+|||+.++++||||...
T Consensus       235 ~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        235 LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence            0123456789999999999999999999999999864

>KOG3653|consensus

Probab=99.97  E-value=4.1e-31  Score=215.63  Aligned_cols=230  Identities=23%  Similarity=0.266  Sum_probs=170.5

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC--CCCCccceeeeeeeCC----eEEEEEecCc-ccHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL--KHKNIVRLYDVLHSEK----KLTLVFEHCD-QDLKKYF   74 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l--~h~~i~~~~~~~~~~~----~~~iv~e~~~-g~l~~~~   74 (282)
                      ||+|..  +++.||||++..    ...+.+..|.++++..  +|+||++++++-....    .++||++|.+ |+|-+++
T Consensus       226 V~KaqL--~~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL  299 (534)
T KOG3653|consen  226 VWKAQL--DNRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYL  299 (534)
T ss_pred             eehhhc--cCceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHH
Confidence            788885  569999999875    2346777888888776  8999999999866443    7899999996 6777766


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHh---------CCccccCCCCCcEEEcCCCcEEEEecCCccccCCC--cccccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHS---------RNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VKCYSA  143 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~---------~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~  143 (282)
                      ..  ..+++....+++..++.||+|||+         ..|+|||||+.||++.+|+++.|+|||++.++...  ......
T Consensus       300 ~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~  377 (534)
T KOG3653|consen  300 KA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHG  377 (534)
T ss_pred             Hh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhh
Confidence            64  678999999999999999999996         24999999999999999999999999999877422  223334


Q ss_pred             ccccccccChhhhcCCCCCC-----chhhHHHHHHHHHHHHhcCCCCCCCC----------------ChHHHHHHHHHHh
Q psy6044         144 EVVTLWYRPPDVLFGAKLYT-----TSIDMWSAGCIFAELANAGRPLFPGS----------------DVDDQLKRIFKLL  202 (282)
Q Consensus       144 ~~~~~~~~aPE~~~~~~~~~-----~~~Di~slG~ll~~ll~~~~p~~~~~----------------~~~~~~~~~~~~~  202 (282)
                      .+||.+|||||++.+...+.     .+.||||+|.++||+++...-.+++.                +.++.........
T Consensus       378 qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK  457 (534)
T KOG3653|consen  378 QVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKK  457 (534)
T ss_pred             hhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhc
Confidence            78899999999997765444     47899999999999997655433211                1112111111111


Q ss_pred             CCC-CCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHH
Q psy6044         203 GTP-TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAED  262 (282)
Q Consensus       203 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  262 (282)
                      ..| -+..|.                       ....-..+++.+..||+.||+.|.|+.=
T Consensus       458 ~RP~~p~~W~-----------------------~h~~~~~l~et~EeCWDhDaeARLTA~C  495 (534)
T KOG3653|consen  458 QRPKIPDAWR-----------------------KHAGMAVLCETIEECWDHDAEARLTAGC  495 (534)
T ss_pred             cCCCChhhhh-----------------------cCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence            111 011110                       0124467889999999999999999863

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=6.1e-30  Score=194.66  Aligned_cols=168  Identities=19%  Similarity=0.217  Sum_probs=129.6

Q ss_pred             ccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccccccccc
Q psy6044          68 QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT  147 (282)
Q Consensus        68 g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  147 (282)
                      |+|.+.+...+..+++..++.++.|++.||.|||+++      ||+||+++.++.+++  ||.+.......     ..++
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----~~g~   67 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----SRVD   67 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc-----CCCc
Confidence            5677777665667999999999999999999999998      999999999999999  99887654322     2568


Q ss_pred             ccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHP  227 (282)
Q Consensus       148 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (282)
                      +.|+|||.+.+.. ++.++||||||+++|+|++|..|+............+...........                  
T Consensus        68 ~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------  128 (176)
T smart00750       68 PYFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD------------------  128 (176)
T ss_pred             ccccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc------------------
Confidence            8999999997776 799999999999999999999886544443444444443322111000                  


Q ss_pred             CCCccccCccCCH--HHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q psy6044         228 SMSFSQVAPKLTA--KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD  271 (282)
Q Consensus       228 ~~~~~~~~~~~~~--~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  271 (282)
                          ......++.  .+.++|.+||..||.+|||+.++++|+|+..
T Consensus       129 ----~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      129 ----RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             ----cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence                001122333  6899999999999999999999999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG2052|consensus

Probab=99.97  E-value=1.4e-29  Score=205.35  Aligned_cols=170  Identities=25%  Similarity=0.316  Sum_probs=137.7

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC--CCCCccceeeeeeeC----CeEEEEEecCc-ccHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL--KHKNIVRLYDVLHSE----KKLTLVFEHCD-QDLKKYF   74 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l--~h~~i~~~~~~~~~~----~~~~iv~e~~~-g~l~~~~   74 (282)
                      ||+|+.  -|+.||||++..    ...+...+|.++++..  +|+||+.+++.=..+    ..+|+|++|.+ |+|.+++
T Consensus       227 VwrG~w--rGe~VAVKiF~s----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL  300 (513)
T KOG2052|consen  227 VWRGRW--RGEDVAVKIFSS----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYL  300 (513)
T ss_pred             eeeccc--cCCceEEEEecc----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHH
Confidence            677775  489999999864    2346677888888765  999999999875433    36899999997 6777777


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHh-----CC---ccccCCCCCcEEEcCCCcEEEEecCCccccCCC----ccccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHS-----RN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIP----VKCYS  142 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~-----~~---i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~----~~~~~  142 (282)
                      ..  ..++.+...+++..++.||++||.     +|   |.|||||+.||++.+++.+.|+|+|++......    .....
T Consensus       301 ~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N  378 (513)
T KOG2052|consen  301 NR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPN  378 (513)
T ss_pred             hh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCC
Confidence            65  789999999999999999999994     33   999999999999999999999999999766433    12335


Q ss_pred             cccccccccChhhhcCCCC-----CCchhhHHHHHHHHHHHH
Q psy6044         143 AEVVTLWYRPPDVLFGAKL-----YTTSIDMWSAGCIFAELA  179 (282)
Q Consensus       143 ~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~ll~~ll  179 (282)
                      ..+||.+|+|||++.....     .-..+||||||.++||+.
T Consensus       379 ~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEia  420 (513)
T KOG2052|consen  379 PRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIA  420 (513)
T ss_pred             CccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHH
Confidence            5688999999999954421     124789999999999986

>KOG1152|consensus

Probab=99.97  E-value=2.6e-30  Score=215.58  Aligned_cols=184  Identities=25%  Similarity=0.388  Sum_probs=157.8

Q ss_pred             CeeeeeeCCCCceEEEeeeecCC-------CCCCCccHHHHHHHHhhCC---CCCccceeeeeeeCCeEEEEEecCc-c-
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVG-------NEGVPSSALREICLLKELK---HKNIVRLYDVLHSEKKLTLVFEHCD-Q-   68 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~---h~~i~~~~~~~~~~~~~~iv~e~~~-g-   68 (282)
                      .|+.|.++++...|+||.+.+..       .....-.+-.|+++|..++   |+||++++++|++++++||+||--+ | 
T Consensus       576 kV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gI  655 (772)
T KOG1152|consen  576 KVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGI  655 (772)
T ss_pred             eEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCc
Confidence            38999999999999999998721       2223445667999999997   9999999999999999999999874 5 


Q ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccc
Q psy6044          69 DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL  148 (282)
Q Consensus        69 ~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~  148 (282)
                      +|.++ ......++|.++..|++|++.|+++||++||+|||||-+|++++.+|-+||+|||++.-.+.  .......||.
T Consensus       656 DLFd~-IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ks--gpfd~f~gtv  732 (772)
T KOG1152|consen  656 DLFDF-IEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKS--GPFDVFVGTV  732 (772)
T ss_pred             chhhh-hhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhcC--CCcceeeeec
Confidence            45554 45578899999999999999999999999999999999999999999999999999876542  2234457899


Q ss_pred             cccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Q psy6044         149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFP  187 (282)
Q Consensus       149 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~  187 (282)
                      .|.|||++.+..+.+..-|||++|+++|.++....|+++
T Consensus       733 ~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  733 DYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             cccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            999999999999889999999999999999977778653

>KOG1024|consensus

Probab=99.96  E-value=5.2e-29  Score=199.32  Aligned_cols=227  Identities=17%  Similarity=0.217  Sum_probs=184.9

Q ss_pred             CCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC-CeEEEEEecCc-ccHHHHHHhcCC-------C
Q psy6044          10 PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE-KKLTLVFEHCD-QDLKKYFDSLNG-------E   80 (282)
Q Consensus        10 ~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~-~~~~iv~e~~~-g~l~~~~~~~~~-------~   80 (282)
                      +.+.|.+|.++...++-....++.|.-++.-+.|||++.+.++..++ ...++++.+.+ |++..++..+.+       .
T Consensus       313 ~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqt  392 (563)
T KOG1024|consen  313 DCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQT  392 (563)
T ss_pred             hHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccc
Confidence            45567777776655555567889999999999999999999988765 57888888887 677777664432       2


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC-ccccc-cccccccccChhhhcC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP-VKCYS-AEVVTLWYRPPDVLFG  158 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~-~~~~~-~~~~~~~~~aPE~~~~  158 (282)
                      ++-.+...++.|++.|++|||+.|++|.||...|.++++.-++||+|-.+++.+-.. ....+ ..-.+..|++||.+.+
T Consensus       393 vtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n  472 (563)
T KOG1024|consen  393 VTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN  472 (563)
T ss_pred             hhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhh
Confidence            667778899999999999999999999999999999999999999999988765311 11111 1122567999999988


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. |+.++|+||||+++|||+|-+.-++..-++.|...-+.++.+...+.                            +.
T Consensus       473 ~~-yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~----------------------------NC  523 (563)
T KOG1024|consen  473 SH-YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPF----------------------------NC  523 (563)
T ss_pred             hh-hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCC----------------------------CC
Confidence            87 79999999999999999987777799999999888888876654433                            47


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ++++..++..||..+|++||+++|+..
T Consensus       524 PDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  524 PDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             cHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            899999999999999999999999875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=3.5e-28  Score=191.93  Aligned_cols=197  Identities=35%  Similarity=0.537  Sum_probs=160.2

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~   80 (282)
                      ||+|.+..+++.+++|.+.........+.+.+|++.++.++|+|++++++.+......++++|++++ ++.+.+.. ...
T Consensus        15 v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~   93 (225)
T smart00221       15 VYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRK-KGG   93 (225)
T ss_pred             EEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHh-ccc
Confidence            7999999999999999988633222457888999999999999999999999999999999999998 55555544 444


Q ss_pred             -CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccChhhhcC
Q psy6044          81 -IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        81 -~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~  158 (282)
                       +++..+..++.+++.++.+||+.+++|+|++|.||+++.++.++|+|||.+....... .......++..|++||....
T Consensus        94 ~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~  173 (225)
T smart00221       94 KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLG  173 (225)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcC
Confidence             8999999999999999999999999999999999999999999999999987765432 11223355678999999843


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCC-CChH-HHHHHHHH
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPG-SDVD-DQLKRIFK  200 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~-~~~~-~~~~~~~~  200 (282)
                      ...++.++|+|+||++++++++|+.|+ .. .... ...+.+..
T Consensus       174 ~~~~~~~~Dv~~lG~~~~~l~~g~~pf-~~~~~~~~~~~~~~~~  216 (225)
T smart00221      174 GKGYGEAVDIWSLGVILYELLWGPEPF-SGEGEFTSLLSDVWSF  216 (225)
T ss_pred             CCCCCchhhHHHHHHHHHHHHHCCCCc-cccchhHHHHHHHHhc
Confidence            334678999999999999999987774 44 3333 45555544

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0590|consensus

Probab=99.95  E-value=1e-28  Score=217.32  Aligned_cols=225  Identities=27%  Similarity=0.410  Sum_probs=175.5

Q ss_pred             HHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy6044          31 ALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDL  110 (282)
Q Consensus        31 ~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl  110 (282)
                      +..|+-+-..+.|||++.....+.+.....-.||||++++...+.. .+.+...++..+++|++.|++|+|+.|+.|+|+
T Consensus       368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~Giahrdl  446 (601)
T KOG0590|consen  368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPYDLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDL  446 (601)
T ss_pred             hhhheeecccccCCchhhhHHHHhhcccchhhhhcccHHHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccC
Confidence            5556666777899999888888777666666699999966655554 568999999999999999999999999999999


Q ss_pred             CCCcEEEcCCCcEEEEecCCccccCCC--c--cccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCC
Q psy6044         111 KPQNLLINKNGELKLADFGLARAFGIP--V--KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF  186 (282)
Q Consensus       111 ~~~nil~~~~~~~~l~df~~~~~~~~~--~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~  186 (282)
                      |++|+++..+|.+||+|||.+......  .  ....+..|+..|+|||.+.+........||||.|+++..|.+|+.| |
T Consensus       447 K~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~-W  525 (601)
T KOG0590|consen  447 KLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFP-W  525 (601)
T ss_pred             ccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCc-c
Confidence            999999999999999999998665322  2  3455667788999999999988778899999999999999999777 5


Q ss_pred             CCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         187 PGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      ......+........                    ........+...+...++...+.+|.+||++||.+|.|+++|++.
T Consensus       526 k~a~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  526 KVAKKSDNSFKTNNY--------------------SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             ccccccccchhhhcc--------------------ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            544333222100000                    000011112333445688888999999999999999999999999


Q ss_pred             CCccCCccchh
Q psy6044         267 IYFSDLNVAIK  277 (282)
Q Consensus       267 ~~~~~~~~~~~  277 (282)
                      +||+.+.+|..
T Consensus       586 ~W~~~i~~c~v  596 (601)
T KOG0590|consen  586 EWIRSIECCHV  596 (601)
T ss_pred             hHhhhcceEEe
Confidence            99999998754

>KOG1345|consensus

Probab=99.95  E-value=9.1e-28  Score=183.67  Aligned_cols=239  Identities=24%  Similarity=0.335  Sum_probs=174.9

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeee-eeeCCeEEEEEecCc-ccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDV-LHSEKKLTLVFEHCD-QDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~-~~~~~~~~iv~e~~~-g~l~~~~~~~~   78 (282)
                      +-+|.++.++..+++|.+....  .....|.+|..---.| .|.||+.-|++ |+..+.+++++||++ |+|.+....  
T Consensus        40 IlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~--  115 (378)
T KOG1345|consen   40 ILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA--  115 (378)
T ss_pred             EEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc--
Confidence            4578999999999999887533  3457788888766566 58999987775 777889999999998 566665443  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC--CCcEEEEecCCccccCCCccccccccccccccChhhh
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK--NGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~  156 (282)
                      ..+.|.....++.|+++||.|+|+.+++|||||.+||++..  .-++||+|||.+...+........   ...|.+||..
T Consensus       116 ~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~~~~---~~~y~~pe~~  192 (378)
T KOG1345|consen  116 AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKYLEY---VNNYHAPELC  192 (378)
T ss_pred             ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceehhhhh---hcccCCcHHH
Confidence            55889999999999999999999999999999999999953  348999999999877644332221   4457888876


Q ss_pred             cCC----CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHH-HHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q psy6044         157 FGA----KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDD-QLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSF  231 (282)
Q Consensus       157 ~~~----~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
                      ...    -...+.+|+|+||+++|.++||..| |......+ ...+..........                      ..
T Consensus       193 ~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~P-WQka~~~d~~Y~~~~~w~~rk~~----------------------~~  249 (378)
T KOG1345|consen  193 DTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFP-WQKASIMDKPYWEWEQWLKRKNP----------------------AL  249 (378)
T ss_pred             hhccccceEecccccchheeeeeeeeecCCCc-chhhhccCchHHHHHHHhcccCc----------------------cC
Confidence            322    1256899999999999999988887 66544332 22222222211110                      12


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCC---CCHHHHhcCCCcc
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQR---MSAEDAMSHIYFS  270 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~R---ps~~~ll~h~~~~  270 (282)
                      +.....+|+.+..+.++-|..+|++|   -+++....-.|.+
T Consensus       250 P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  250 PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence            22335589999999999999999999   4555555555543

>KOG1240|consensus

Probab=99.92  E-value=1.8e-25  Score=199.00  Aligned_cols=222  Identities=25%  Similarity=0.327  Sum_probs=168.2

Q ss_pred             CCCceEEEeeeecCCCCCCCccHHHHHHHH--hhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCCCHHHH
Q psy6044           9 TPNTALAIKGTHLVGNEGVPSSALREICLL--KELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIV   86 (282)
Q Consensus         9 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~--~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~   86 (282)
                      .....|+||++-+..+.-....+.++++-.  ...++||.+++.-+...+..-|+|-+|...+|.+.+.. .+-+..-+.
T Consensus        44 ~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkhnLyDRlST-RPFL~~iEK  122 (1431)
T KOG1240|consen   44 DREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKHNLYDRLST-RPFLVLIEK  122 (1431)
T ss_pred             CCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhhhhhhhhcc-chHHHHHHH
Confidence            344559999999855444555555544433  34489999999998888888999999999999998776 455788888


Q ss_pred             HHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc---ccc----ccccccccChhhhcCC
Q psy6044          87 KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC---YSA----EVVTLWYRPPDVLFGA  159 (282)
Q Consensus        87 ~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~----~~~~~~~~aPE~~~~~  159 (282)
                      +.|+.|++.||..+|..|++|||||.+||++++-+.+.|.||...+..--+..+   ++.    ......|.|||.+...
T Consensus       123 kWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~  202 (1431)
T KOG1240|consen  123 KWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSA  202 (1431)
T ss_pred             HHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhcc
Confidence            999999999999999999999999999999999999999999987554111111   111    1113569999998542


Q ss_pred             ---------CC-CCchhhHHHHHHHHHHHHhcCCCCCCCCChHH-------HHHHHHHHhCCCCCCCCCCCCCCCCCCCC
Q psy6044         160 ---------KL-YTTSIDMWSAGCIFAELANAGRPLFPGSDVDD-------QLKRIFKLLGTPTEDTWPGMNLLPDFKPF  222 (282)
Q Consensus       160 ---------~~-~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (282)
                               .+ ++++.||||+||++.|+++-+.|+|.-..--.       ..+...+                      
T Consensus       203 ~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le----------------------  260 (1431)
T KOG1240|consen  203 LGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLE----------------------  260 (1431)
T ss_pred             ccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHH----------------------
Confidence                     12 67899999999999999999999886432111       1111111                      


Q ss_pred             CCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         223 PMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                                   .--+..++++|..|++.||++|.|+++.|+-
T Consensus       261 -------------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  261 -------------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             -------------hCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence                         1134577999999999999999999999874

>KOG0195|consensus

Probab=99.92  E-value=6e-25  Score=168.66  Aligned_cols=225  Identities=16%  Similarity=0.207  Sum_probs=175.8

Q ss_pred             eeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHhcCC-
Q psy6044           3 TSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNG-   79 (282)
Q Consensus         3 y~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~~~-   79 (282)
                      |+|+.  +|..++.|+++. .........|..|.-.++-+.||||+.+++.|..+..+.++..|++ |+++..+....+ 
T Consensus       207 wrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~v  284 (448)
T KOG0195|consen  207 WRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSV  284 (448)
T ss_pred             ccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccE
Confidence            55654  577888898887 5556667889999999999999999999999999999999999998 566666555332 


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEcCCCcEEEE--ecCCccccCCCccccccccccccccChhh
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRN--VLHRDLKPQNLLINKNGELKLA--DFGLARAFGIPVKCYSAEVVTLWYRPPDV  155 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~~aPE~  155 (282)
                      -++-.++.+++.+++.|++|||+..  |.-..+.+..++++++-+.+|+  |--++...       .+....+.|++||.
T Consensus       285 vvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe-------~gr~y~pawmspea  357 (448)
T KOG0195|consen  285 VVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE-------VGRAYSPAWMSPEA  357 (448)
T ss_pred             EEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec-------cccccCcccCCHHH
Confidence            2678889999999999999999875  5566799999999998766654  43332211       12234788999999


Q ss_pred             hcCCCC--CCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         156 LFGAKL--YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       156 ~~~~~~--~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      ++....  .-.++|+|||++++||+.|...||-+-...+..++...++++                            ..
T Consensus       358 lqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglr----------------------------v~  409 (448)
T KOG0195|consen  358 LQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLR----------------------------VH  409 (448)
T ss_pred             HhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccc----------------------------cc
Confidence            965532  346899999999999999998885555555556665555433                            35


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHh
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAM  264 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  264 (282)
                      +++.++..+..++.-|++.||.+||.+..++
T Consensus       410 ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             CCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            6788999999999999999999999988765

>KOG0603|consensus

Probab=99.91  E-value=3.6e-25  Score=187.45  Aligned_cols=235  Identities=23%  Similarity=0.282  Sum_probs=192.7

Q ss_pred             eeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCC-CCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      |.++.....|..+|+|+..+ ....+.......|..++...+ ||.+++++..++.+...+++.++..|+.+........
T Consensus        13 vrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~   92 (612)
T KOG0603|consen   13 VRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEV   92 (612)
T ss_pred             HHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCC
Confidence            34455667899999999988 222222236667888888886 9999999999999999999999998865555555466


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .+.+.....+...++-++.++|+.|++|+|+|++||+++.+|.+++.|||.++..-.....    +|+..|+|||+..+ 
T Consensus        93 ~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----cgt~eymApEI~~g-  167 (612)
T KOG0603|consen   93 MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----CGTYEYRAPEIING-  167 (612)
T ss_pred             chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc----ccchhhhhhHhhhc-
Confidence            7888889999999999999999999999999999999999999999999999765433222    77999999999973 


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                        ....+|.||+|++++++++|..|+..     +....|.+                             .-...+...+
T Consensus       168 --h~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~-----------------------------~~~~~p~~l~  211 (612)
T KOG0603|consen  168 --HLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILK-----------------------------AELEMPRELS  211 (612)
T ss_pred             --cCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhh-----------------------------hccCCchhhh
Confidence              57899999999999999999999554     66666655                             2223456688


Q ss_pred             HHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCccchh
Q psy6044         240 AKGRDLLQRLLVCNPVQRMS-----AEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps-----~~~ll~h~~~~~~~~~~~  277 (282)
                      ..+++++..++..+|..|..     +.++.+|+||+.+++...
T Consensus       212 ~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l  254 (612)
T KOG0603|consen  212 AEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNEL  254 (612)
T ss_pred             HHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhH
Confidence            99999999999999999994     479999999999988743

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.90  E-value=1.9e-21  Score=162.18  Aligned_cols=248  Identities=31%  Similarity=0.450  Sum_probs=189.4

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCC--CCccHHHHHHHHhhCCCC-CccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEG--VPSSALREICLLKELKHK-NIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~l~h~-~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||++.+.   ..+++|.+.......  ....+.+|+..++.+.|+ +++++.+.+......+++++++.|..+..+....
T Consensus        16 v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~   92 (384)
T COG0515          16 VYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKI   92 (384)
T ss_pred             EEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhc
Confidence            6777775   788999988733333  467899999999999988 7999999998888889999999876555555544


Q ss_pred             C---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC-cEEEEecCCccccCCCcc------ccccccccc
Q psy6044          79 G---EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG-ELKLADFGLARAFGIPVK------CYSAEVVTL  148 (282)
Q Consensus        79 ~---~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~-~~~l~df~~~~~~~~~~~------~~~~~~~~~  148 (282)
                      .   .++......++.|++.++.++|+.|++|+|+||+||+++..+ .+++.|||.+........      ......++.
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~  172 (384)
T COG0515          93 GRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP  172 (384)
T ss_pred             ccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccccccccccccccc
Confidence            3   799999999999999999999999999999999999999988 799999999875543322      235567789


Q ss_pred             cccChhhhcCC--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCh----HHHHHHHHHHhCC-CCCCCCCCCCCCCCCCC
Q psy6044         149 WYRPPDVLFGA--KLYTTSIDMWSAGCIFAELANAGRPLFPGSDV----DDQLKRIFKLLGT-PTEDTWPGMNLLPDFKP  221 (282)
Q Consensus       149 ~~~aPE~~~~~--~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~----~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  221 (282)
                      .|.+||.....  .......|+|++|+++++++++..| +.....    ......+...... ......           
T Consensus       173 ~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------  240 (384)
T COG0515         173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP-FEGEKNSSATSQTLKIILELPTPSLASPLS-----------  240 (384)
T ss_pred             ccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCC-CCCCCccccHHHHHHHHHhcCCcccccccC-----------
Confidence            99999999873  3479999999999999999988888 555443    3333333332211 000000           


Q ss_pred             CCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         222 FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                                ..........+.+++..++..+|..|.+..+...++|......
T Consensus       241 ----------~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~  283 (384)
T COG0515         241 ----------PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKL  283 (384)
T ss_pred             ----------ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccc
Confidence                      0000223467889999999999999999999998876665433

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.90  E-value=6.5e-23  Score=163.34  Aligned_cols=220  Identities=22%  Similarity=0.318  Sum_probs=139.7

Q ss_pred             CeeeeeeCCCCceEEEeeeecCC--CCCCCccHHHHHHHHhhCC----------CCCccceeeeeee------------C
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVG--NEGVPSSALREICLLKELK----------HKNIVRLYDVLHS------------E   56 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~----------h~~i~~~~~~~~~------------~   56 (282)
                      +||.++|..||+.+|+|+.....  .....+.+.+|.-....+.          |-.++..++...-            .
T Consensus        27 ~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~~  106 (288)
T PF14531_consen   27 IVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPGQ  106 (288)
T ss_dssp             EEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEECETT
T ss_pred             EEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceecCCCC
Confidence            58999999999999999998833  2223445555555555532          2233333443321            1


Q ss_pred             C-----eEEEEEecCcccHHHHHHh---cCCC---CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEE
Q psy6044          57 K-----KLTLVFEHCDQDLKKYFDS---LNGE---IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL  125 (282)
Q Consensus        57 ~-----~~~iv~e~~~g~l~~~~~~---~~~~---~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l  125 (282)
                      +     ..+++|+-+.+++......   ....   +.......+..|++..+++||+.|++|+||+|+|++++.+|.+.|
T Consensus       107 ~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~L  186 (288)
T PF14531_consen  107 SIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFL  186 (288)
T ss_dssp             EEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE
T ss_pred             ccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEE
Confidence            1     2367888888877665432   1211   333444566799999999999999999999999999999999999


Q ss_pred             EecCCccccCCCccccccccccccccChhhhcCC-------CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHH
Q psy6044         126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA-------KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRI  198 (282)
Q Consensus       126 ~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~  198 (282)
                      +||+.....+.....   ...+..|.+||.....       -.++.+.|.|+||+++|.++++..| |+.........  
T Consensus       187 g~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP-f~~~~~~~~~~--  260 (288)
T PF14531_consen  187 GDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP-FGLSSPEADPE--  260 (288)
T ss_dssp             --GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S-TCCCGGGSTSG--
T ss_pred             cChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC-CCCCCcccccc--
Confidence            999988776643332   2335678999987432       2368899999999999999999888 44332211000  


Q ss_pred             HHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCC
Q psy6044         199 FKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQR  257 (282)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R  257 (282)
                                                    ..+..+. ++++.++.||+.+|+.||.+|
T Consensus       261 ------------------------------~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  261 ------------------------------WDFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             ------------------------------GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ------------------------------ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence                                          0233444 799999999999999999988

>KOG1164|consensus

Probab=99.89  E-value=5.1e-21  Score=158.94  Aligned_cols=237  Identities=21%  Similarity=0.171  Sum_probs=178.6

Q ss_pred             eeeeeeCCCC-ceEEEeeeecCCCCCCCccHHHHHHHHhhCC----CCCccceeeee-eeCCeEEEEEecCcccHHHHHH
Q psy6044           2 FTSGVDRTPN-TALAIKGTHLVGNEGVPSSALREICLLKELK----HKNIVRLYDVL-HSEKKLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~----h~~i~~~~~~~-~~~~~~~iv~e~~~g~l~~~~~   75 (282)
                      ||.+.+..++ ..+|+|........... .+..|..++..+.    .+++..+++.. ..+...|+||+.++.+|.+...
T Consensus        34 V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~G~sL~dl~~  112 (322)
T KOG1164|consen   34 VYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLLGPSLEDLRK  112 (322)
T ss_pred             EEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEeccCccHHHHHH
Confidence            7999987775 68999988764333322 7778999999886    36899999999 5778899999999999998876


Q ss_pred             hcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC-----CcEEEEecCCcc--ccCCCc--------c
Q psy6044          76 SLN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-----GELKLADFGLAR--AFGIPV--------K  139 (282)
Q Consensus        76 ~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~-----~~~~l~df~~~~--~~~~~~--------~  139 (282)
                      ... +.++...+..++.|++.+|+++|+.|++||||||.|+.+...     ..+.|.|||++.  ......        .
T Consensus       113 ~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~  192 (322)
T KOG1164|consen  113 RNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRP  192 (322)
T ss_pred             hCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCC
Confidence            554 789999999999999999999999999999999999999765     469999999998  321111        1


Q ss_pred             ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCC
Q psy6044         140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDF  219 (282)
Q Consensus       140 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (282)
                      ......||..|.++....+.. .+.+.|+||++.++.++..|..| |......................           
T Consensus       193 ~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LP-W~~~~~~~~~~~~~~~~~~~~~~-----------  259 (322)
T KOG1164|consen  193 QKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLP-WEALEMTDLKSKFEKDPRKLLTD-----------  259 (322)
T ss_pred             CccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCC-CccccccchHHHHHHHhhhhccc-----------
Confidence            122345899999999988877 59999999999999999977777 65544332232222211110000           


Q ss_pred             CCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         220 KPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                   ......+..+.++...+-..+...+|....+..
T Consensus       260 -------------~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~  292 (322)
T KOG1164|consen  260 -------------RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE  292 (322)
T ss_pred             -------------cccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence                         012235577778888888889999998777654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.87  E-value=9.1e-22  Score=150.52  Aligned_cols=130  Identities=18%  Similarity=0.105  Sum_probs=99.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCC-CC-------CccH-----------------HHHHHHHhhCCCCCccceeeeeeeC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNE-GV-------PSSA-----------------LREICLLKELKHKNIVRLYDVLHSE   56 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~-~~-------~~~~-----------------~~e~~~~~~l~h~~i~~~~~~~~~~   56 (282)
                      ||+|.+. +|+.||||+++..... ..       ...+                 ..|++.+.++.++++.....+....
T Consensus        13 Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p~~~~~~~   91 (190)
T cd05147          13 VYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCPEPILLKS   91 (190)
T ss_pred             EEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCcEEEecC
Confidence            8999997 8999999999863211 11       1122                 3499999999888775443332222


Q ss_pred             CeEEEEEecCcccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCcEEEcCCCcEEEEecCCccccC
Q psy6044          57 KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFC-HSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG  135 (282)
Q Consensus        57 ~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l-h~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~  135 (282)
                        .++||||++|+.+.......+.+++..+..++.|++.+|.++ |+.|++|+||||+||+++ ++.++|+|||++....
T Consensus        92 --~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147          92 --HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             --CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEEccccccCC
Confidence              389999999865443322356799999999999999999999 799999999999999998 5789999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG4158|consensus

Probab=99.87  E-value=2.9e-21  Score=155.77  Aligned_cols=190  Identities=24%  Similarity=0.336  Sum_probs=138.1

Q ss_pred             CCCCccceeeeeee---------------------------CCeEEEEEecCcccHHHHHHhcCCCCCHHHHHHHHHHHH
Q psy6044          42 KHKNIVRLYDVLHS---------------------------EKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLL   94 (282)
Q Consensus        42 ~h~~i~~~~~~~~~---------------------------~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~   94 (282)
                      +||||+++..+|.+                           +.++|+||..++.++..++-.  ...+.....-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~--~~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT--RHRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc--CCCchHHHHHHHHHHH
Confidence            59999999887754                           357899999999999998875  4455667777899999


Q ss_pred             HHHHHHHhCCccccCCCCCcEEEc--CC--CcEEEEecCCccccCCC------ccccccccccccccChhhhcCCCC---
Q psy6044          95 RGLAFCHSRNVLHRDLKPQNLLIN--KN--GELKLADFGLARAFGIP------VKCYSAEVVTLWYRPPDVLFGAKL---  161 (282)
Q Consensus        95 ~~l~~lh~~~i~H~dl~~~nil~~--~~--~~~~l~df~~~~~~~~~------~~~~~~~~~~~~~~aPE~~~~~~~---  161 (282)
                      +|+.|||.+|+.|+|+|++||++.  +|  ..+.++|||++-.-...      .......-|.-..+|||+.....-   
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            999999999999999999999983  33  35789999987443211      111122233455799999843321   


Q ss_pred             --CCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         162 --YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       162 --~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                        .-.++|.|+.|.+.||++....||+......-......                            +.+.+..+..++
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq----------------------------e~qLPalp~~vp  483 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ----------------------------ESQLPALPSRVP  483 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh----------------------------hhhCCCCcccCC
Confidence              23699999999999999966667655211110000000                            114455667799


Q ss_pred             HHHHHHHHHhcccCCCCCCCHH
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAE  261 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~  261 (282)
                      +.+++++..+|+.||++|+|..
T Consensus       484 p~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  484 PVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             hHHHHHHHHHhcCCccccCCcc
Confidence            9999999999999999999865

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.6e-21  Score=161.84  Aligned_cols=146  Identities=26%  Similarity=0.229  Sum_probs=109.1

Q ss_pred             CeeeeeeCC-CCceEEEeeeecCC----CCCCCccHHHHHHHHhhCCCCCccc-eeeeeeeCCeEEEEEecCcccHHHHH
Q psy6044           1 MFTSGVDRT-PNTALAIKGTHLVG----NEGVPSSALREICLLKELKHKNIVR-LYDVLHSEKKLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~-~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~~i~~-~~~~~~~~~~~~iv~e~~~g~l~~~~   74 (282)
                      .||+|.++. +|+.+|||++....    .......+.+|++++++++|+|+++ +++    .+..|+||||++|..+...
T Consensus        33 ~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L~~~  108 (365)
T PRK09188         33 TVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGKDGLVRGWTEGVPLHLA  108 (365)
T ss_pred             EEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCcEEEEEccCCCCHHHh
Confidence            389999876 78888999875321    1122456889999999999999985 443    2457999999998766532


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCcEEEcCCCcEEEEecCCccccCCCcccc--------cccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDL-KPQNLLINKNGELKLADFGLARAFGIPVKCY--------SAEV  145 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl-~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--------~~~~  145 (282)
                      .    ...   ...++.|++.||.+||++||+|+|| ||+||+++.++.++|+|||++..........        ....
T Consensus       109 ~----~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~  181 (365)
T PRK09188        109 R----PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLL  181 (365)
T ss_pred             C----ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhh
Confidence            1    111   1467899999999999999999999 9999999999999999999998664322111        1223


Q ss_pred             ccccccChhhhc
Q psy6044         146 VTLWYRPPDVLF  157 (282)
Q Consensus       146 ~~~~~~aPE~~~  157 (282)
                      ++..|.+||.+.
T Consensus       182 ~~~~~~~pe~~~  193 (365)
T PRK09188        182 KHKRTYAPDALT  193 (365)
T ss_pred             ccCccCCcccCC
Confidence            456688888874

>KOG1163|consensus

Probab=99.86  E-value=1.4e-20  Score=142.19  Aligned_cols=233  Identities=20%  Similarity=0.222  Sum_probs=180.5

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCC-CCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKH-KNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      +|.|....+|+.||||+-....   .-..+..|..+++.+++ ..|+.+..+..+..+-.+||+..+.++.+.+.-+...
T Consensus        31 Iy~~~~i~~ge~VAiK~Es~~a---~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLLGPsLEdLfnfC~R~  107 (341)
T KOG1163|consen   31 IYLGISITSGEEVAIKLESSKA---KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLLGPSLEDLFNFCSRR  107 (341)
T ss_pred             eeeeeeccCCceEEEEeecccC---CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeeccCccHHHHHHHHhhh
Confidence            6899999999999999876422   23567889999999964 8899999999999999999999999999999888899


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc---CCCcEEEEecCCccccCCC-------ccccccccccccc
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN---KNGELKLADFGLARAFGIP-------VKCYSAEVVTLWY  150 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~---~~~~~~l~df~~~~~~~~~-------~~~~~~~~~~~~~  150 (282)
                      ++..+++-++-|++.-++|+|.++++|+||||+|+++.   ...++.++|||++...-..       ........||.+|
T Consensus       108 ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRY  187 (341)
T KOG1163|consen  108 FTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARY  187 (341)
T ss_pred             hhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeee
Confidence            99999999999999999999999999999999999995   3467999999999776322       2223445678888


Q ss_pred             cChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMS  230 (282)
Q Consensus       151 ~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
                      .+-....+.. .+.+.|+=|+|.++..+..|..| |.+.......+...+....                     ..+.+
T Consensus       188 ASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LP-WQglka~tk~QKyEkI~Ek---------------------K~s~~  244 (341)
T KOG1163|consen  188 ASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLP-WQGLKAATKKQKYEKISEK---------------------KMSTP  244 (341)
T ss_pred             hhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCc-ccccchhhHHHHHHHHHHh---------------------hcCCC
Confidence            8877776666 48899999999999888867777 7775544433332221111                     11114


Q ss_pred             ccccCccCCHHHHHHHHHhcccCCCCCCCH
Q psy6044         231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSA  260 (282)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  260 (282)
                      +......+|.++.-.+.-|=..-=++-|..
T Consensus       245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             HHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence            455567788888888877766666665643

>KOG1023|consensus

Probab=99.86  E-value=4.5e-21  Score=162.25  Aligned_cols=206  Identities=25%  Similarity=0.335  Sum_probs=153.6

Q ss_pred             HhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-cccCCCCCcE
Q psy6044          38 LKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNV-LHRDLKPQNL  115 (282)
Q Consensus        38 ~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i-~H~dl~~~ni  115 (282)
                      ++.+.|.|+.++++.+.+++..++|.+||. |++.+.+......++.-....++++|+.|+.|+|+-.| +|+.+++.|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            367899999999999999999999999997 67777776656779999999999999999999998765 8999999999


Q ss_pred             EEcCCCcEEEEecCCccccCC--CccccccccccccccChhhhcCCCC------CCchhhHHHHHHHHHHHHhcCCCCCC
Q psy6044         116 LINKNGELKLADFGLARAFGI--PVKCYSAEVVTLWYRPPDVLFGAKL------YTTSIDMWSAGCIFAELANAGRPLFP  187 (282)
Q Consensus       116 l~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~~~aPE~~~~~~~------~~~~~Di~slG~ll~~ll~~~~p~~~  187 (282)
                      +++..+.+||.|||+......  .............|.|||.+.....      .+.+.|+||+|++++|+++...|+..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            999999999999999876632  1111111122456999999966411      36789999999999999988888544


Q ss_pred             CCCh---HHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHh
Q psy6044         188 GSDV---DDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAM  264 (282)
Q Consensus       188 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  264 (282)
                      ....   .+....+.+..   .....|                  ..... ....+++..+++.||..+|.+||+++++-
T Consensus       161 ~~~~~~~~eii~~~~~~~---~~~~rP------------------~i~~~-~e~~~~l~~l~~~cw~e~P~~rPs~~~i~  218 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGG---SNPFRP------------------SIELL-NELPPELLLLVARCWEEIPEKRPSIEQIR  218 (484)
T ss_pred             ccccCChHHHHHHHHhcC---CCCcCc------------------chhhh-hhcchHHHHHHHHhcccChhhCccHHHHH
Confidence            3222   23333333301   100110                  00000 13555889999999999999999999876


Q ss_pred             c
Q psy6044         265 S  265 (282)
Q Consensus       265 ~  265 (282)
                      .
T Consensus       219 ~  219 (484)
T KOG1023|consen  219 S  219 (484)
T ss_pred             h
Confidence            5

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.84  E-value=1.8e-20  Score=143.93  Aligned_cols=129  Identities=17%  Similarity=0.108  Sum_probs=101.2

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCC-CC------------------------CccHHHHHHHHhhCCCCCccceeeeeeeC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNE-GV------------------------PSSALREICLLKELKHKNIVRLYDVLHSE   56 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~-~~------------------------~~~~~~e~~~~~~l~h~~i~~~~~~~~~~   56 (282)
                      ||+|.+. +|+.||||+++..... ..                        ......|...+.++.++++.....+....
T Consensus        13 Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~   91 (190)
T cd05145          13 VYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVPEPILLKK   91 (190)
T ss_pred             EEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCceEEEecC
Confidence            8999987 8999999999873211 00                        01124688999999999886555444333


Q ss_pred             CeEEEEEecCccc-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEecCCcccc
Q psy6044          57 KKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGLARAF  134 (282)
Q Consensus        57 ~~~~iv~e~~~g~-l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~  134 (282)
                        .++||||++|. +...... ...++...+..++.|++.++.++|+ .|++|+||||.||+++ ++.++|+|||++...
T Consensus        92 --~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~  167 (190)
T cd05145          92 --NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVEL  167 (190)
T ss_pred             --CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceec
Confidence              48999999986 3333222 4678889999999999999999999 9999999999999998 899999999999765


Q ss_pred             C
Q psy6044         135 G  135 (282)
Q Consensus       135 ~  135 (282)
                      .
T Consensus       168 ~  168 (190)
T cd05145         168 D  168 (190)
T ss_pred             C
Confidence            4

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1165|consensus

Probab=99.84  E-value=1.1e-19  Score=143.38  Aligned_cols=195  Identities=21%  Similarity=0.311  Sum_probs=162.0

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      +++.|++.-++++||||.-..   .+....+..|...++.| ..++|+..+-+..+..+..+|+|.++.+|.+.+.-++.
T Consensus        43 ~lf~G~Nl~nne~VAIKfEPr---kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLLGPSLEDLFD~CgR  119 (449)
T KOG1165|consen   43 VLFLGKNLYNNEPVAIKFEPR---KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLLGPSLEDLFDLCGR  119 (449)
T ss_pred             eeecccccccCceEEEEeccc---cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhhCcCHHHHHHHhcC
Confidence            467888889999999997653   33457788999999999 57999999999988889999999999999999999999


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC-----CcEEEEecCCccccCCC-------cccccccccc
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-----GELKLADFGLARAFGIP-------VKCYSAEVVT  147 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~-----~~~~l~df~~~~~~~~~-------~~~~~~~~~~  147 (282)
                      .++...+.-++.|++.-++++|++.++.|||||+|+++..-     ..+.++|||.++..-.+       ........||
T Consensus       120 ~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGT  199 (449)
T KOG1165|consen  120 RFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGT  199 (449)
T ss_pred             cccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccc
Confidence            99999999999999999999999999999999999999643     35899999999776332       2233445678


Q ss_pred             ccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC---hHHHHHHHHH
Q psy6044         148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSD---VDDQLKRIFK  200 (282)
Q Consensus       148 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~---~~~~~~~~~~  200 (282)
                      -+||+-....+.+ -+.+.|+=|||-+++.++-|..| |.+..   ..+..++|-+
T Consensus       200 ARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLP-WQGLKA~tnK~kYeKIGe  253 (449)
T KOG1165|consen  200 ARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLP-WQGLKADTNKEKYEKIGE  253 (449)
T ss_pred             eeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCc-cccccCcchHHHHHHhcc
Confidence            8999988877887 49999999999999999977777 77643   4444444433

>KOG0606|consensus

Probab=99.84  E-value=8.1e-21  Score=169.25  Aligned_cols=208  Identities=26%  Similarity=0.381  Sum_probs=152.9

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEI   81 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~   81 (282)
                      ||..+|+.+.+.+|+| +++.      ..+++  +++....+|.++                    |+....+. +-+++
T Consensus        99 vylvrh~~trqrfa~k-iNkq------~lilR--nilt~a~npfvv--------------------gDc~tllk-~~g~l  148 (1205)
T KOG0606|consen   99 VYLVRHKETRQRFAMK-INKQ------NLILR--NILTFAGNPFVV--------------------GDCATLLK-NIGPL  148 (1205)
T ss_pred             eeeeeccccccchhhc-cccc------chhhh--ccccccCCccee--------------------chhhhhcc-cCCCC
Confidence            7888888888888884 3321      01111  022222333333                    44444333 24556


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC---------------ccccccccc
Q psy6044          82 DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP---------------VKCYSAEVV  146 (282)
Q Consensus        82 ~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~---------------~~~~~~~~~  146 (282)
                      +.+.        +.+++|||+.||+|+|+||+|.+++.-|.+|+.|||++......               .......++
T Consensus       149 Pvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcg  220 (1205)
T KOG0606|consen  149 PVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCG  220 (1205)
T ss_pred             cchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccC
Confidence            5544        66899999999999999999999999999999999998654211               111223467


Q ss_pred             cccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYH  226 (282)
Q Consensus       147 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (282)
                      ++.|.|||++.... |+...|-|++|+++|+.+.|..| |.+.+.++.+.........-+++                  
T Consensus       221 TPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvp-ffGdtpeelfg~visd~i~wpE~------------------  280 (1205)
T KOG0606|consen  221 TPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVP-FFGDTPEELFGQVISDDIEWPEE------------------  280 (1205)
T ss_pred             CccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeee-ccCCCHHHHHhhhhhhhcccccc------------------
Confidence            99999999997776 79999999999999999988888 66777788777766654433332                  


Q ss_pred             CCCCccccCccCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCCccCCccc
Q psy6044         227 PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM---SAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       227 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~h~~~~~~~~~  275 (282)
                              -..++++++++|..+|+.+|..|.   .+-++-+|+||+.+++.
T Consensus       281 --------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  281 --------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             --------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence                    234889999999999999999998   66788889999999875

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.83  E-value=1.6e-20  Score=145.43  Aligned_cols=153  Identities=13%  Similarity=0.106  Sum_probs=112.1

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCC--CCcc------HHHHHHHHhhCCCCCccceeeeeeeC--------CeEEEEEec
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEG--VPSS------ALREICLLKELKHKNIVRLYDVLHSE--------KKLTLVFEH   65 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~--~~~~------~~~e~~~~~~l~h~~i~~~~~~~~~~--------~~~~iv~e~   65 (282)
                      ||++.+  ++..+|+|+++......  ....      +.+|+..+.++.||+|..+.+++...        +..+++|||
T Consensus        47 v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEy  124 (232)
T PRK10359         47 VSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEY  124 (232)
T ss_pred             EEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEE
Confidence            666544  57789999997632221  1112      57899999999999999999886643        357899999


Q ss_pred             CcccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccccccc
Q psy6044          66 CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEV  145 (282)
Q Consensus        66 ~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  145 (282)
                      ++|..+..+.    .+++    ....+++.++..+|+.|++|+|++|.||+++.+| ++|+|||.........       
T Consensus       125 i~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~-------  188 (232)
T PRK10359        125 IEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRK-------  188 (232)
T ss_pred             ECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccccchh-------
Confidence            9996555442    2333    2456999999999999999999999999999988 9999999876542111       


Q ss_pred             ccccccChh-hhcCCCCCCchhhHHHHHHHHHHHH
Q psy6044         146 VTLWYRPPD-VLFGAKLYTTSIDMWSAGCIFAELA  179 (282)
Q Consensus       146 ~~~~~~aPE-~~~~~~~~~~~~Di~slG~ll~~ll  179 (282)
                            |-+ ...... +..++|+|+||+++..+.
T Consensus       189 ------a~d~~vler~-y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        189 ------AKDRIDLERH-YGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             ------hHHHHHHHhH-hcccccccceeEeehHHH
Confidence                  111 222223 568999999999987665

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=3.8e-19  Score=134.99  Aligned_cols=169  Identities=15%  Similarity=-0.004  Sum_probs=122.5

Q ss_pred             CCceEEEeeeecCCCCC---CCccHHHHHHHHhhCC-CCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCCCHHH
Q psy6044          10 PNTALAIKGTHLVGNEG---VPSSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDI   85 (282)
Q Consensus        10 ~~~~vaiK~~~~~~~~~---~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~   85 (282)
                      .+..++.+.+.......   ....+.+|+++++++. ++++++++++    +..+++|||+.|..+.....      .. 
T Consensus        24 ~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~------~~-   92 (218)
T PRK12274         24 GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPP------RG-   92 (218)
T ss_pred             CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhh------hh-
Confidence            67778877666533211   1125789999999995 5889999886    34699999999976653221      11 


Q ss_pred             HHHHHHHHHHHHHHHHhCCccccCC-CCCcEEEcCCCcEEEEecCCccccCCCccc-----c--------cccccccccc
Q psy6044          86 VKSFMYQLLRGLAFCHSRNVLHRDL-KPQNLLINKNGELKLADFGLARAFGIPVKC-----Y--------SAEVVTLWYR  151 (282)
Q Consensus        86 ~~~~~~qi~~~l~~lh~~~i~H~dl-~~~nil~~~~~~~~l~df~~~~~~~~~~~~-----~--------~~~~~~~~~~  151 (282)
                      ...++.|++.+|.++|+.|++|+|| ||.||+++.++.++|+|||++.........     .        .....++.++
T Consensus        93 ~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l  172 (218)
T PRK12274         93 DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAAL  172 (218)
T ss_pred             hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence            1357889999999999999999999 799999999999999999999865433210     0        0112356677


Q ss_pred             ChhhhcCCCCCC-chhhHHHHHHHHHHHHhcCCCCCCCC
Q psy6044         152 PPDVLFGAKLYT-TSIDMWSAGCIFAELANAGRPLFPGS  189 (282)
Q Consensus       152 aPE~~~~~~~~~-~~~Di~slG~ll~~ll~~~~p~~~~~  189 (282)
                      .|+...-....+ ...+-++.|+-+|.++|++.+.|.+.
T Consensus       173 ~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        173 TPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             CHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            777653332123 67788899999999999999877654

>KOG1033|consensus

Probab=99.81  E-value=1e-20  Score=157.61  Aligned_cols=177  Identities=24%  Similarity=0.379  Sum_probs=132.2

Q ss_pred             eEEEEEecCcccHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCcccc
Q psy6044          58 KLTLVFEHCDQDLKKYFDSLN---GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF  134 (282)
Q Consensus        58 ~~~iv~e~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~  134 (282)
                      ++||.|++|.-+.+..+....   ...+......++.|++.|+.|   +|.+|+|++|.||++..+..++|+|||+.+..
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            589999999876666666432   347888899999999999999   99999999999999999999999999999877


Q ss_pred             CCCc------cccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCC
Q psy6044         135 GIPV------KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTE  207 (282)
Q Consensus       135 ~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~  207 (282)
                      ....      ...+...++.+|++||.+.+.. |+.++||||||++++|+++ -...    .........+..+      
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~----~er~~t~~d~r~g------  475 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQ----FERIATLTDIRDG------  475 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccH----HHHHHhhhhhhcC------
Confidence            5332      2455678899999999998888 7999999999999999995 1222    1111111222111      


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q psy6044         208 DTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS  270 (282)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  270 (282)
                                            .++.....--+.-..|+.+|+.+.|.+||++.+.--|.|.+
T Consensus       476 ----------------------~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  476 ----------------------IIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             ----------------------CCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence                                  11101111123335899999999999999888887787753

>smart00090 RIO RIO-like kinase

Probab=99.75  E-value=6.8e-18  Score=133.47  Aligned_cols=130  Identities=15%  Similarity=0.063  Sum_probs=98.4

Q ss_pred             Ceeeee-eCCCCceEEEeeeecCCCCC-C----------------------CccHHHHHHHHhhCCCC--Cccceeeeee
Q psy6044           1 MFTSGV-DRTPNTALAIKGTHLVGNEG-V----------------------PSSALREICLLKELKHK--NIVRLYDVLH   54 (282)
Q Consensus         1 ~vy~a~-~~~~~~~vaiK~~~~~~~~~-~----------------------~~~~~~e~~~~~~l~h~--~i~~~~~~~~   54 (282)
                      .||+|. +..+|+.||+|+++...... .                      ...+..|+..+.++.+.  .++++++.  
T Consensus        43 ~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p~~~~~--  120 (237)
T smart00090       43 NVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPKPIAW--  120 (237)
T ss_pred             eEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeEe--
Confidence            389999 77899999999998632110 0                      01245799999999753  34444442  


Q ss_pred             eCCeEEEEEecCcccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCcEEEcCCCcEEEEecCCccc
Q psy6044          55 SEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN-VLHRDLKPQNLLINKNGELKLADFGLARA  133 (282)
Q Consensus        55 ~~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~-i~H~dl~~~nil~~~~~~~~l~df~~~~~  133 (282)
                       . ..++||||++|..+..............+..++.|++.++.+||+.| ++|+|++|+||+++ ++.++|+|||.+..
T Consensus       121 -~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~  197 (237)
T smart00090      121 -R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             -c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence             2 34899999999655443323455677778899999999999999999 99999999999998 88999999998765


Q ss_pred             cC
Q psy6044         134 FG  135 (282)
Q Consensus       134 ~~  135 (282)
                      .+
T Consensus       198 ~~  199 (237)
T smart00090      198 LD  199 (237)
T ss_pred             cC
Confidence            43

>PRK10345 hypothetical protein; Provisional

Probab=99.75  E-value=2.5e-17  Score=127.26  Aligned_cols=122  Identities=19%  Similarity=0.233  Sum_probs=92.1

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-----CCCCccceeeeeeeCC---eEE-EEEecCc--c-c
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-----KHKNIVRLYDVLHSEK---KLT-LVFEHCD--Q-D   69 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-----~h~~i~~~~~~~~~~~---~~~-iv~e~~~--g-~   69 (282)
                      ||.  +..++.. +||++..... ...+.+.+|+..++.+     +||||++++++++++.   .++ +|+||.+  + +
T Consensus        18 Vy~--hp~~~~k-~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~t   93 (210)
T PRK10345         18 CYA--HPEDAQR-CIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSIT   93 (210)
T ss_pred             EEE--CCCCcCe-EEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchh
Confidence            664  6666666 6998876322 2346799999999999     5799999999999874   434 7899944  4 5


Q ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHhCCccccCCCCCcEEEcC----CCcEEEEecCCc
Q psy6044          70 LKKYFDSLNGEIDLDIVKSFMYQLLRGL-AFCHSRNVLHRDLKPQNLLINK----NGELKLADFGLA  131 (282)
Q Consensus        70 l~~~~~~~~~~~~~~~~~~~~~qi~~~l-~~lh~~~i~H~dl~~~nil~~~----~~~~~l~df~~~  131 (282)
                      |.+.+.+  +.+++.  ..++.+++.++ +|||+.+|+|+||||+||+++.    ++.++|+|++.+
T Consensus        94 L~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         94 LTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             HHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            5555533  456666  35678888777 9999999999999999999974    347999995433

>KOG0601|consensus

Probab=99.73  E-value=7.3e-18  Score=143.11  Aligned_cols=240  Identities=19%  Similarity=0.181  Sum_probs=189.3

Q ss_pred             eeeeee--CCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhc
Q psy6044           2 FTSGVD--RTPNTALAIKGTHL-VGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL   77 (282)
Q Consensus         2 vy~a~~--~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~   77 (282)
                      ||.++.  +.++..+|+|.-.. .........-.+|+...+.+ .|++.++.+..+......|+-+|+|+..+.++....
T Consensus       132 ~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~~sl~~~~~~~  211 (524)
T KOG0601|consen  132 VFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCGESLQSYCHTP  211 (524)
T ss_pred             eecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeeccccchhHHhhhcc
Confidence            566777  88999999998666 33333445556677777777 689999999999999999999999999999988886


Q ss_pred             CCCCCHHHHHHHHHHHHH----HHHHHHhCCccccCCCCCcEEEcCC-CcEEEEecCCccccCCCccccccc-----ccc
Q psy6044          78 NGEIDLDIVKSFMYQLLR----GLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVKCYSAE-----VVT  147 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~----~l~~lh~~~i~H~dl~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~-----~~~  147 (282)
                      ...++...++..+.+...    ||.++|+.+++|.|++|.||+...+ ..++++|||+...++.........     .+.
T Consensus       212 ~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~  291 (524)
T KOG0601|consen  212 CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGD  291 (524)
T ss_pred             cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCC
Confidence            677999999999999999    9999999999999999999999999 889999999998887554333222     567


Q ss_pred             ccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHP  227 (282)
Q Consensus       148 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (282)
                      ..|++||...+.  ++...|+|++|.+..+..++...+-.+........  ....                         
T Consensus       292 ~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~--r~~~-------------------------  342 (524)
T KOG0601|consen  292 CIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL--RQGY-------------------------  342 (524)
T ss_pred             ceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCcccc--cccc-------------------------
Confidence            789999999665  58999999999999998877776544421110000  0000                         


Q ss_pred             CCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         228 SMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       228 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                        -..++....+..+...+..|++.+|..|+++..++.|+++..-
T Consensus       343 --ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  343 --IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             --CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence              1122334567777889999999999999999999999998743

>KOG1166|consensus

Probab=99.72  E-value=4.4e-17  Score=147.62  Aligned_cols=175  Identities=20%  Similarity=0.216  Sum_probs=137.1

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCC---CCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHhc
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK---HKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSL   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~---h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~   77 (282)
                      ||+|.+.+ |+.||+|+-.-..    .-.|--=.+++.+|+   -+.|+.+...+.-.+..++|+||.+ |++++... .
T Consensus       714 vy~a~~~~-~~~~alK~e~P~~----~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N-~  787 (974)
T KOG1166|consen  714 VYVATHSN-GKLVALKVEKPPN----PWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLIN-T  787 (974)
T ss_pred             EEEeecCC-CcEEEEEeecCCC----ceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhc-c
Confidence            89999977 9999999865321    112222234455554   3556777777777778899999998 67777665 4


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-------CCcEEEEecCCccccC--CCccccccccccc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK-------NGELKLADFGLARAFG--IPVKCYSAEVVTL  148 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~-------~~~~~l~df~~~~~~~--~~~~~~~~~~~~~  148 (282)
                      .+.+++..+..++.|++..+.+||..||+||||||+|+++..       +.-++|+|||.+..+.  .........+.+-
T Consensus       788 ~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td  867 (974)
T KOG1166|consen  788 NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTD  867 (974)
T ss_pred             CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccc
Confidence            777999999999999999999999999999999999999953       3358999999998774  2234455667788


Q ss_pred             cccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCC
Q psy6044         149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR  183 (282)
Q Consensus       149 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~  183 (282)
                      .+-.+|...+.. ++.+.|.|.|+.+++-|+.|+.
T Consensus       868 ~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  868 LFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHHH
Confidence            888999887766 9999999999999999998754

>KOG1266|consensus

Probab=99.71  E-value=4.4e-18  Score=134.33  Aligned_cols=238  Identities=15%  Similarity=0.160  Sum_probs=155.8

Q ss_pred             eeeeeeCCCCceEEEeeeec---CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC-----CeEEEEEecCc-ccHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHL---VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE-----KKLTLVFEHCD-QDLKK   72 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~---~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~-----~~~~iv~e~~~-g~l~~   72 (282)
                      ||.|.+...|..|+=-.+..   ............-...+-++.|.||++++.++.+.     ....+++||+. |++..
T Consensus        82 v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~  161 (458)
T KOG1266|consen   82 VYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQ  161 (458)
T ss_pred             HHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHH
Confidence            56666666666655433332   11111112222233445566899999999998764     35789999996 55444


Q ss_pred             HH---HhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEcCCCcEEEEecCCccccC----CCcccccc
Q psy6044          73 YF---DSLNGEIDLDIVKSFMYQLLRGLAFCHSRN--VLHRDLKPQNLLINKNGELKLADFGLARAFG----IPVKCYSA  143 (282)
Q Consensus        73 ~~---~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~l~df~~~~~~~----~~~~~~~~  143 (282)
                      ++   ..+...+......+|+.||+.||.|||+..  |+|+++..+.|++..+|-++++--.......    ........
T Consensus       162 fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~  241 (458)
T KOG1266|consen  162 FLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSV  241 (458)
T ss_pred             HHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhc
Confidence            44   333456888999999999999999999874  9999999999999999999986432221110    01111222


Q ss_pred             ccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCC
Q psy6044         144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFP  223 (282)
Q Consensus       144 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (282)
                      ..+-++|.+||.-...+ .+.++|||++|++..+|..+.--.-++....+....+........                 
T Consensus       242 ~~~~~g~~a~~sg~~tn-~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le-----------------  303 (458)
T KOG1266|consen  242 NTSLPGFSAPESGTTTN-TTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE-----------------  303 (458)
T ss_pred             cccCCccccCCcCcccc-cccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc-----------------
Confidence            34456788888765555 578999999999999998666543333332222222222111100                 


Q ss_pred             CCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         224 MYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                                     ..--++++.+|++..|..||++.+++.||-+-++
T Consensus       304 ---------------n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV  337 (458)
T KOG1266|consen  304 ---------------NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV  337 (458)
T ss_pred             ---------------CccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence                           1112468999999999999999999999987654

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=2.6e-16  Score=123.13  Aligned_cols=125  Identities=19%  Similarity=0.201  Sum_probs=100.1

Q ss_pred             eeeeeeCCCCceEEEeeeecCC-CCC------CCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG-NEG------VPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~-~~~------~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~   74 (282)
                      ||+|..  +|..+++|+..... ...      ....+.+|+.++..+.|+++.....++......+++|||++|..+..+
T Consensus        12 vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~   89 (211)
T PRK14879         12 IYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDL   89 (211)
T ss_pred             EEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHH
Confidence            799986  67889999765421 111      113467899999999999998888787777888999999988555544


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARA  133 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~  133 (282)
                      .....   . ....++.+++.+|.++|+.|++|+|++|.||+++ ++.++|+|||.+..
T Consensus        90 ~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         90 INSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             HHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            43222   2 7788999999999999999999999999999998 88999999998864

>KOG1243|consensus

Probab=99.69  E-value=8.3e-16  Score=132.21  Aligned_cols=167  Identities=24%  Similarity=0.325  Sum_probs=129.3

Q ss_pred             eeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc--cHHHHHHhcCCCC
Q psy6044           4 SGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ--DLKKYFDSLNGEI   81 (282)
Q Consensus         4 ~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g--~l~~~~~~~~~~~   81 (282)
                      .|..+.++.+|.|.+...... .......+.++.++.++||||+++++.++.++..|||+|.+..  ..+..+       
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~Pl~~~lk~l-------  101 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRPLETVLKEL-------  101 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccccHHHHHHHh-------
Confidence            367788999999999887554 5567788999999999999999999999999999999999853  333322       


Q ss_pred             CHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          82 DLDIVKSFMYQLLRGLAFCH-SRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        82 ~~~~~~~~~~qi~~~l~~lh-~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      ....+..-++||+.||.+|| +.+++|+++.-+.|+++..|..+|++|..+...............-..|..|+......
T Consensus       102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc
Confidence            25666777899999999998 56899999999999999999999999988765543322111111123356666543322


Q ss_pred             CCCchhhHHHHHHHHHHHHhc
Q psy6044         161 LYTTSIDMWSAGCIFAELANA  181 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~  181 (282)
                         -..|.|.||+++++++.|
T Consensus       182 ---~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 ---WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ---cchhhhhHHHHHHHHhCc
Confidence               356999999999999966

>KOG0590|consensus

Probab=99.67  E-value=4.1e-18  Score=150.62  Aligned_cols=236  Identities=24%  Similarity=0.333  Sum_probs=177.5

Q ss_pred             CCceEEEeeeecCC-CCCCCccHHHHHHHHhhCC-CCCccceeeeeeeCCeEEEEEecCcccHHHHHH-hcCC-CCCHHH
Q psy6044          10 PNTALAIKGTHLVG-NEGVPSSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFD-SLNG-EIDLDI   85 (282)
Q Consensus        10 ~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~-~~~~-~~~~~~   85 (282)
                      +...+|.|.+.... ..........|..+-..+. |+|++.+++...+.+..+++.++..|+.+.... .... ..+...
T Consensus        45 ~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~  124 (601)
T KOG0590|consen   45 PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSS  124 (601)
T ss_pred             CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcc
Confidence            34455666555432 2333444455777777776 999999999999999999999998875554444 4343 677888


Q ss_pred             HHHHHHHHHHHHHHHH-hCCccccCCCCCcEEEcCCC-cEEEEecCCccccCC---Cccccccccc-cccccChhhhcCC
Q psy6044          86 VKSFMYQLLRGLAFCH-SRNVLHRDLKPQNLLINKNG-ELKLADFGLARAFGI---PVKCYSAEVV-TLWYRPPDVLFGA  159 (282)
Q Consensus        86 ~~~~~~qi~~~l~~lh-~~~i~H~dl~~~nil~~~~~-~~~l~df~~~~~~~~---~~~~~~~~~~-~~~~~aPE~~~~~  159 (282)
                      ...++.|+..++.|+| ..++.|+|++|+|.+++.++ .+++.|||+++....   .........| ++.|.|||...+.
T Consensus       125 ~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~  204 (601)
T KOG0590|consen  125 ASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGK  204 (601)
T ss_pred             hhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccch
Confidence            8999999999999999 99999999999999999999 999999999987654   2233344566 8899999999886


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHH-HHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDD-QLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      ....+..|+||.|+++..+++|..| +......+ .........                         ..........+
T Consensus       205 ~~~~~~~d~~S~g~~l~~~~~g~~p-~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~  258 (601)
T KOG0590|consen  205 AYRGPSVDVWSLGIVLSAMLTGELP-WDFPSRKDGRYSSWKSNK-------------------------GRFTQLPWNSI  258 (601)
T ss_pred             hhcCCCcccccccccccccccCCCC-ccccccccccceeecccc-------------------------cccccCccccC
Confidence            5568999999999999999999998 43333222 100000000                         00011223457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD  271 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  271 (282)
                      +....+++.+++..+|..|.+.+++-.++|+..
T Consensus       259 ~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  259 SDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ChhhhhcccccccCCchhccccccccccccccc
Confidence            888899999999999999999999999999998

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.67  E-value=5.4e-16  Score=120.18  Aligned_cols=122  Identities=18%  Similarity=0.176  Sum_probs=94.5

Q ss_pred             eeeeeeCCCCceEEEeeeecCC-CCCC------CccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG-NEGV------PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~-~~~~------~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~   74 (282)
                      ||+|.  .+|..+++|+..... ....      ...+.+|+++++.+.|+++.....++..+...+++|||++|..+...
T Consensus        10 vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~   87 (199)
T TIGR03724        10 IYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDV   87 (199)
T ss_pred             EEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHH
Confidence            89998  467899999865421 1111      24466899999999888766665566666777999999988655544


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARA  133 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~  133 (282)
                      ......       .++.+++.+|.++|+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus        88 ~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        88 IEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             HhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            432211       7899999999999999999999999999998 89999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.65  E-value=1.5e-15  Score=117.59  Aligned_cols=123  Identities=17%  Similarity=0.192  Sum_probs=92.9

Q ss_pred             eeeeeeCCCCceEEEeeeecCC-CCC--------------------CCccHHHHHHHHhhCCCCC--ccceeeeeeeCCe
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG-NEG--------------------VPSSALREICLLKELKHKN--IVRLYDVLHSEKK   58 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~-~~~--------------------~~~~~~~e~~~~~~l~h~~--i~~~~~~~~~~~~   58 (282)
                      ||+|... +|+.||||+++... ...                    .......|...+..+.+++  ++..++    ...
T Consensus        31 Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~~----~~~  105 (198)
T cd05144          31 VYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPID----WNR  105 (198)
T ss_pred             EEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCceee----cCC
Confidence            8999874 79999999977522 000                    0112567888888887764  444443    234


Q ss_pred             EEEEEecCcccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccC
Q psy6044          59 LTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG  135 (282)
Q Consensus        59 ~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~  135 (282)
                      .+++|||++|..+..+..      ......++.+++.++.++|+.|++|+||+|.||+++.++.++|+|||.+....
T Consensus       106 ~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         106 HAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             ceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            589999999866554322      13456788999999999999999999999999999999999999999986554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG3741|consensus

Probab=99.65  E-value=1.4e-14  Score=121.39  Aligned_cols=209  Identities=16%  Similarity=0.196  Sum_probs=160.9

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeee----CCeEEEEEecCcc--cHHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHS----EKKLTLVFEHCDQ--DLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~----~~~~~iv~e~~~g--~l~~~~~   75 (282)
                      .|+|....+|..|++|+++...... ......-++.++++.|+|++++.+++..    +..+++|++|+++  +|++.+.
T Consensus       292 tyk~~s~~DG~~YvLkRlhg~r~~~-~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F  370 (655)
T KOG3741|consen  292 TYKATSNVDGNAYVLKRLHGDRDQS-TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYF  370 (655)
T ss_pred             eEeeeeccCCceeeeeeeccccccC-cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHc
Confidence            4899999999999999996533332 3345567899999999999999999883    4678999999985  6777654


Q ss_pred             hc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccc
Q psy6044          76 SL--------------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY  141 (282)
Q Consensus        76 ~~--------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  141 (282)
                      ..              +...+|+.+|.++.|+..||.++|+.|+...-|.|.+|+++.+.+++|+..|....+..+.   
T Consensus       371 ~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~---  447 (655)
T KOG3741|consen  371 ANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP---  447 (655)
T ss_pred             cCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC---
Confidence            32              2237899999999999999999999999999999999999999999999888775543221   


Q ss_pred             ccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCC
Q psy6044         142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP  221 (282)
Q Consensus       142 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (282)
                               .  |.+.    -..+-|.=.||.+++.|.||...-+...........                        
T Consensus       448 ---------~--~~le----~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~------------------------  488 (655)
T KOG3741|consen  448 ---------T--EPLE----SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT------------------------  488 (655)
T ss_pred             ---------C--cchh----HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHH------------------------
Confidence                     0  1111    145789999999999999886654444333333111                        


Q ss_pred             CCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         222 FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                 .+...+|.+++++|..+...++++ -++.+++.
T Consensus       489 -----------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp  520 (655)
T KOG3741|consen  489 -----------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLP  520 (655)
T ss_pred             -----------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHH
Confidence                       122468999999999999999987 68888776

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.62  E-value=9e-15  Score=115.94  Aligned_cols=125  Identities=17%  Similarity=0.173  Sum_probs=91.3

Q ss_pred             eeeeeeCCCCceEEEeeeecCC------C------CCCCccHHHHHHHHhhCCCCCc--cceeeeeeeC-C---eEEEEE
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG------N------EGVPSSALREICLLKELKHKNI--VRLYDVLHSE-K---KLTLVF   63 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~------~------~~~~~~~~~e~~~~~~l~h~~i--~~~~~~~~~~-~---~~~iv~   63 (282)
                      ||.+..  .+..++||.+....      .      ......+.+|+.++..+.|+++  ++.+++.... .   ..++|+
T Consensus        48 v~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~  125 (239)
T PRK01723         48 TWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILI  125 (239)
T ss_pred             EEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEE
Confidence            344443  37789999885411      1      1223567889999999988775  6667664432 2   235999


Q ss_pred             ecCcc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccc
Q psy6044          64 EHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARA  133 (282)
Q Consensus        64 e~~~g-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~  133 (282)
                      |+++| ..+..+.. ...+++..    +.+|+.+|.+||+.||+|+||+|.||+++.++.++|+|||.+..
T Consensus       126 e~l~G~~~L~~~l~-~~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        126 ERIEGARDLVALLQ-EAPLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             EecCCCCCHHHHHh-cCCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            99986 44444443 34566543    57899999999999999999999999999999999999998764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.61  E-value=8.1e-15  Score=112.44  Aligned_cols=122  Identities=18%  Similarity=0.148  Sum_probs=87.7

Q ss_pred             eeeeeeCCCCceEEEeeeecCCC-CCCCccH----------------------HHHHHHHhhCCCCC--ccceeeeeeeC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGN-EGVPSSA----------------------LREICLLKELKHKN--IVRLYDVLHSE   56 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~~----------------------~~e~~~~~~l~h~~--i~~~~~~~~~~   56 (282)
                      ||+|.+. +|+.||||++..... .......                      ..|...+..+.+..  +++++++    
T Consensus        13 Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~----   87 (187)
T cd05119          13 VYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKPIDL----   87 (187)
T ss_pred             EEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCceEec----
Confidence            8999986 899999999876221 1111111                      34555565654332  4444443    


Q ss_pred             CeEEEEEecCcc-----cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEecCC
Q psy6044          57 KKLTLVFEHCDQ-----DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGL  130 (282)
Q Consensus        57 ~~~~iv~e~~~g-----~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~l~df~~  130 (282)
                      ...++++||++|     ..+.....     . ..+..++.+++.++.++|+ .|++|+||+|+||+++ ++.++++|||.
T Consensus        88 ~~~~lv~e~~~g~~~~~~~l~~~~~-----~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~  160 (187)
T cd05119          88 NRHVLVMEFIGGDGIPAPRLKDVRL-----L-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQ  160 (187)
T ss_pred             CCCEEEEEEeCCCCccChhhhhhhh-----c-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECcc
Confidence            235899999998     33332211     1 6678899999999999999 9999999999999999 99999999999


Q ss_pred             ccccC
Q psy6044         131 ARAFG  135 (282)
Q Consensus       131 ~~~~~  135 (282)
                      +....
T Consensus       161 a~~~~  165 (187)
T cd05119         161 AVEID  165 (187)
T ss_pred             ccccc
Confidence            87554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.59  E-value=1.2e-14  Score=128.74  Aligned_cols=122  Identities=19%  Similarity=0.129  Sum_probs=93.8

Q ss_pred             eeeeeeCCCCceEEEeeeec-CCCCC------CCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-VGNEG------VPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~~~~~------~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~   74 (282)
                      ||+|....  ..+++|+... .....      ....+.+|+++++.++|++++....+..+....++||||++|..+...
T Consensus       349 Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~  426 (535)
T PRK09605        349 IKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDV  426 (535)
T ss_pred             EEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHH
Confidence            78887643  3444544322 11111      124578899999999999999888777777778999999988655544


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCcccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF  134 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~  134 (282)
                      ..        ....++.+++.+|.+||+.|++|+|+||+||++ .++.++|+|||.+...
T Consensus       427 l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        427 LE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             HH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            32        356789999999999999999999999999999 6789999999998643

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.55  E-value=3.3e-14  Score=105.04  Aligned_cols=119  Identities=18%  Similarity=0.158  Sum_probs=99.0

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCC--CCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKH--KNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h--~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||++.+.+  ..+++|.......   ...+..|+..++.+.+  .++++++.+....+..++++||++|..+..+     
T Consensus        14 v~~~~~~~--~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-----   83 (155)
T cd05120          14 VYLLGTKD--EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-----   83 (155)
T ss_pred             eEEEEecC--CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-----
Confidence            78888643  7899998764322   4578899999999976  5899999988888889999999988644432     


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCcEEEcCCCcEEEEecCCcc
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSR---NVLHRDLKPQNLLINKNGELKLADFGLAR  132 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~l~df~~~~  132 (282)
                        +......++.+++.+++.+|..   +++|+|++|.||+++..+.++++||+.+.
T Consensus        84 --~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          84 --SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             --CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence              5566778899999999999985   69999999999999998999999999775

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.50  E-value=2.8e-13  Score=102.93  Aligned_cols=128  Identities=19%  Similarity=0.145  Sum_probs=91.8

Q ss_pred             eeeeeeCC------CCceEEEeeeecCC------------CCC---------CCccHH----HHHHHHhhCCC--CCccc
Q psy6044           2 FTSGVDRT------PNTALAIKGTHLVG------------NEG---------VPSSAL----REICLLKELKH--KNIVR   48 (282)
Q Consensus         2 vy~a~~~~------~~~~vaiK~~~~~~------------~~~---------~~~~~~----~e~~~~~~l~h--~~i~~   48 (282)
                      ||.|....      .+..+|||+.+...            +..         ....+.    +|+..|+++..  -++++
T Consensus        13 V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl~~~Gv~vP~   92 (197)
T cd05146          13 VLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRMQKAGIPCPE   92 (197)
T ss_pred             EEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCe
Confidence            78887654      36899999988621            100         011223    78888888843  55666


Q ss_pred             eeeeeeeCCeEEEEEecCcccHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCcEEEcCCCcEEEE
Q psy6044          49 LYDVLHSEKKLTLVFEHCDQDLK-KYFDSLNGEIDLDIVKSFMYQLLRGLAFC-HSRNVLHRDLKPQNLLINKNGELKLA  126 (282)
Q Consensus        49 ~~~~~~~~~~~~iv~e~~~g~l~-~~~~~~~~~~~~~~~~~~~~qi~~~l~~l-h~~~i~H~dl~~~nil~~~~~~~~l~  126 (282)
                      .+++    ..-+||||+++|+.+ ....+ +..+++..+..+..+++.++..+ |+.|++|||+++.||++. ++.+.|+
T Consensus        93 pi~~----~~~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~-~~~v~iI  166 (197)
T cd05146          93 VVVL----KKHVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH-DGKVWFI  166 (197)
T ss_pred             EEEe----cCCEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE-CCcEEEE
Confidence            6664    445899999987422 11122 23456667778889999999998 899999999999999996 5789999


Q ss_pred             ecCCccccC
Q psy6044         127 DFGLARAFG  135 (282)
Q Consensus       127 df~~~~~~~  135 (282)
                      |||.+....
T Consensus       167 DF~qav~~~  175 (197)
T cd05146         167 DVSQSVEPT  175 (197)
T ss_pred             ECCCceeCC
Confidence            999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0606|consensus

Probab=99.48  E-value=2.3e-14  Score=128.79  Aligned_cols=211  Identities=25%  Similarity=0.361  Sum_probs=160.0

Q ss_pred             CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC
Q psy6044          42 KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG  121 (282)
Q Consensus        42 ~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~  121 (282)
                      .+|.+++...-+..-...+++++|++|+-+....++.+..+++.....+..+..++.+||+..+.|+|++|.|.+...++
T Consensus       862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g  941 (1205)
T KOG0606|consen  862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG  941 (1205)
T ss_pred             CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccC
Confidence            34555554444444567899999997643333334456778888888888999999999999999999999999999999


Q ss_pred             cEEEEecCCccccCC-------------------------------CccccccccccccccChhhhcCCCCCCchhhHHH
Q psy6044         122 ELKLADFGLARAFGI-------------------------------PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWS  170 (282)
Q Consensus       122 ~~~l~df~~~~~~~~-------------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s  170 (282)
                      ..++.+|+.....+-                               +........+++.|.+||...+.. .....|.|+
T Consensus       942 h~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~ 1020 (1205)
T KOG0606|consen  942 HRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWS 1020 (1205)
T ss_pred             CcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhh
Confidence            999999874322210                               001122235578899999998887 589999999


Q ss_pred             HHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhc
Q psy6044         171 AGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLL  250 (282)
Q Consensus       171 lG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  250 (282)
                      +|+++++.++|..| |+........+.+....                          ..+...+...+...++++...+
T Consensus      1021 ~g~~l~e~l~g~pp-~na~tpq~~f~ni~~~~--------------------------~~~p~g~~~~s~~aq~~~~~ll 1073 (1205)
T KOG0606|consen 1021 SGVCLFEVLTGIPP-FNAETPQQIFENILNRD--------------------------IPWPEGPEEGSYEAQDLINRLL 1073 (1205)
T ss_pred             hhhhhhhhhcCCCC-CCCcchhhhhhccccCC--------------------------CCCCCCccccChhhhhhhhhhh
Confidence            99999999976665 78777777665554422                          2444455668889999999999


Q ss_pred             ccCCCCCCCHH---HHhcCCCccCCccchhhhh
Q psy6044         251 VCNPVQRMSAE---DAMSHIYFSDLNVAIKSER  280 (282)
Q Consensus       251 ~~dp~~Rps~~---~ll~h~~~~~~~~~~~~~~  280 (282)
                      ..+|.+|..+.   ++-.|+||+.++++..+..
T Consensus      1074 ~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q 1106 (1205)
T KOG0606|consen 1074 TEEPTQRLGAKGAAEVKGHPFFQDVDWENLALQ 1106 (1205)
T ss_pred             ccCchhccCcccccccccCCccCCCCccccccc
Confidence            99999999888   8888999999998765543

>KOG2137|consensus

Probab=99.37  E-value=2.1e-13  Score=118.10  Aligned_cols=158  Identities=25%  Similarity=0.380  Sum_probs=119.8

Q ss_pred             HHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc----ccc-----cccccccccChhhhcCC
Q psy6044          90 MYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK----CYS-----AEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        90 ~~qi~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~----~~~-----~~~~~~~~~aPE~~~~~  159 (282)
                      +.+.+.|+.++|. .+++|++|.|++|.++.++.+||++|+++.....+..    ...     .......|.|||.+.+.
T Consensus       105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            3445589999995 5899999999999999999999999998866543221    000     01114569999999775


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      . .+.++|+||+|+++|.+..++.+.+...........-......                         ........++
T Consensus       185 ~-~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~-------------------------~~~~~s~~~p  238 (700)
T KOG2137|consen  185 T-NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNA-------------------------GAFGYSNNLP  238 (700)
T ss_pred             c-ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccc-------------------------ccccccccCc
Confidence            5 6899999999999999998888877766544443332221111                         1222336789


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      +++++=+.+++..++.-||++..++..|||.+..
T Consensus       239 ~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~  272 (700)
T KOG2137|consen  239 SELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG  272 (700)
T ss_pred             HHHHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence            9999999999999999999999999999999764

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.34  E-value=7.4e-12  Score=94.39  Aligned_cols=116  Identities=18%  Similarity=0.064  Sum_probs=84.3

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCC-ccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKN-IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~-i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      ||++..  .|+.|++|.......  .......|+.+++.+.+.+ +++++....  ...++|||+++|..+...     .
T Consensus        14 vy~~~~--~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~-----~   82 (170)
T cd05151          14 NYRVEV--ANKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTE-----D   82 (170)
T ss_pred             eEEEEE--CCeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccccc-----c
Confidence            677775  378899998754321  2345688999999986544 445555433  234899999998644321     1


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCc-----cccCCCCCcEEEcCCCcEEEEecCCcc
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNV-----LHRDLKPQNLLINKNGELKLADFGLAR  132 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i-----~H~dl~~~nil~~~~~~~~l~df~~~~  132 (282)
                         ......+.+++.+|+.||+.++     +|+|++|.||+++ ++.++++||+.+.
T Consensus        83 ---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          83 ---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence               1123456899999999999885     9999999999998 6789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.33  E-value=1e-11  Score=106.87  Aligned_cols=76  Identities=25%  Similarity=0.360  Sum_probs=56.8

Q ss_pred             CeEEEEEecCcccHHHHHHhc-CCCCCHHHHHHHHHHHHH-HHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCcccc
Q psy6044          57 KKLTLVFEHCDQDLKKYFDSL-NGEIDLDIVKSFMYQLLR-GLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF  134 (282)
Q Consensus        57 ~~~~iv~e~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~-~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~  134 (282)
                      ...++||||++|..+..+... ....+   ...++..++. .+..+|..|++|+|++|.||+++.+++++++|||.+..+
T Consensus       231 ~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       231 SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL  307 (437)
T ss_pred             CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence            446899999998655444321 11222   2345555555 467889999999999999999999999999999998776


Q ss_pred             C
Q psy6044         135 G  135 (282)
Q Consensus       135 ~  135 (282)
                      +
T Consensus       308 ~  308 (437)
T TIGR01982       308 S  308 (437)
T ss_pred             C
Confidence            5

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601|consensus

Probab=99.31  E-value=1.3e-12  Score=111.39  Aligned_cols=228  Identities=19%  Similarity=0.131  Sum_probs=163.7

Q ss_pred             CCCceEEEeeeec-CCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCCCHHHH
Q psy6044           9 TPNTALAIKGTHL-VGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIV   86 (282)
Q Consensus         9 ~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~   86 (282)
                      .++..|++|.+.. ..........+.|+.+...+ .|.+++.+...+......|+-.|||.|...+........+++...
T Consensus       289 ~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~  368 (524)
T KOG0601|consen  289 EGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPR  368 (524)
T ss_pred             CCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchh
Confidence            5677888887776 33333334456677777666 689999999999888888899999987655555544556889999


Q ss_pred             HHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC-CcEEEEecCCccccCCCcccccccccccccc-ChhhhcCCCCCCc
Q psy6044          87 KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYR-PPDVLFGAKLYTT  164 (282)
Q Consensus        87 ~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~-aPE~~~~~~~~~~  164 (282)
                      +.+..|++.++.++|+..++|+|++|+||++..+ +..+++||+..+.+....   ......-++. .+|++.....+..
T Consensus       369 ~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~  445 (524)
T KOG0601|consen  369 LRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS---GVFHHIDRLYPIAEILLEDYPHLS  445 (524)
T ss_pred             hhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceec---ccccccccccccchhhcccccccc
Confidence            9999999999999999999999999999999886 788999999887543211   1112233344 3566655555899


Q ss_pred             hhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHH
Q psy6044         165 SIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRD  244 (282)
Q Consensus       165 ~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  244 (282)
                      +.|+++||.-+.+..++..-...........    .                             ..-.........+..
T Consensus       446 ~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~----~-----------------------------~~~p~~~~~~~~~q~  492 (524)
T KOG0601|consen  446 KADIFSLGLSVDEAITGSPLSESGVQSLTIR----S-----------------------------GDTPNLPGLKLQLQV  492 (524)
T ss_pred             ccccccccccccccccCcccCcccccceeee----c-----------------------------ccccCCCchHHhhhh
Confidence            9999999999999996544322222111100    0                             101111234467788


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         245 LLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       245 li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      +.+.++..++..||++.++..|.-|...
T Consensus       493 ~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  493 LLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             hhhhhcCCccccchhhhhhcccchhhhh
Confidence            9999999999999999999998766543

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.24  E-value=5.9e-12  Score=109.80  Aligned_cols=127  Identities=14%  Similarity=0.182  Sum_probs=81.7

Q ss_pred             eeeeeeCCCCceEEEeeeecCC----------------------CC-CC----------------CccHHHHHHHHhhCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG----------------------NE-GV----------------PSSALREICLLKELK   42 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~----------------------~~-~~----------------~~~~~~e~~~~~~l~   42 (282)
                      ||+|+.+.+|+.||||+.+..-                      .. ..                .-++.+|+..+.++.
T Consensus       135 Vh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N~~~~~  214 (537)
T PRK04750        135 VHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREAANASQLR  214 (537)
T ss_pred             EEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHHHHHHHHH
Confidence            8999998889999999997421                      00 00                012444554444442


Q ss_pred             ----CCCccceeeeeee-CCeEEEEEecCcccHHHHHH--hcCC----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy6044          43 ----HKNIVRLYDVLHS-EKKLTLVFEHCDQDLKKYFD--SLNG----EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLK  111 (282)
Q Consensus        43 ----h~~i~~~~~~~~~-~~~~~iv~e~~~g~l~~~~~--~~~~----~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~  111 (282)
                          +...+.+-.++.+ ....++||||++|.-++.+.  ...+    .+.+..+..++.|++       ..|++|+|+|
T Consensus       215 ~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~GffHaDpH  287 (537)
T PRK04750        215 RNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFFHADMH  287 (537)
T ss_pred             HHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCeeeCCCC
Confidence                3333333333322 34457999999986554332  1122    244445555555554       5899999999


Q ss_pred             CCcEEEcCCC----cEEEEecCCccccC
Q psy6044         112 PQNLLINKNG----ELKLADFGLARAFG  135 (282)
Q Consensus       112 ~~nil~~~~~----~~~l~df~~~~~~~  135 (282)
                      |.||+++.++    +++++|||....++
T Consensus       288 PGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        288 PGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             hHHeEEecCCCCCCeEEEEecceEEECC
Confidence            9999999888    99999999987764

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.23  E-value=1.3e-10  Score=88.08  Aligned_cols=126  Identities=19%  Similarity=0.247  Sum_probs=82.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCC------------CCC-------------CCccHHHHHHHHhhCCCC--Cccceeeeee
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG------------NEG-------------VPSSALREICLLKELKHK--NIVRLYDVLH   54 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~------------~~~-------------~~~~~~~e~~~~~~l~h~--~i~~~~~~~~   54 (282)
                      ||.|.. .+|..+|+|+.+...            ...             ......+|++.|.++..-  ++++.+++. 
T Consensus         2 Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    2 VYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             EEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            788988 568899999987621            000             011256799999999765  567776542 


Q ss_pred             eCCeEEEEEecCc--ccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HHhCCccccCCCCCcEEEcCCCcEEEEecCCc
Q psy6044          55 SEKKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAF-CHSRNVLHRDLKPQNLLINKNGELKLADFGLA  131 (282)
Q Consensus        55 ~~~~~~iv~e~~~--g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~-lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~  131 (282)
                       .  .+|||||++  |..+..+...  .++.+....++.+++..+.. +|..|++|||+++.||+++.+ .+.++|||.+
T Consensus        80 -~--~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qa  153 (188)
T PF01163_consen   80 -R--NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQA  153 (188)
T ss_dssp             -T--TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTE
T ss_pred             -C--CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcc
Confidence             2  379999999  7555554442  22244556677888885555 679999999999999999877 9999999988


Q ss_pred             cccC
Q psy6044         132 RAFG  135 (282)
Q Consensus       132 ~~~~  135 (282)
                      ....
T Consensus       154 v~~~  157 (188)
T PF01163_consen  154 VDSS  157 (188)
T ss_dssp             EETT
T ss_pred             eecC
Confidence            6543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.22  E-value=1.6e-10  Score=92.75  Aligned_cols=124  Identities=15%  Similarity=0.132  Sum_probs=89.4

Q ss_pred             CCCceEEEeeeecCCCCC---------C-CccHHHHHHHHhhCCCCCc--cceeeeeee-----CCeEEEEEecCccc--
Q psy6044           9 TPNTALAIKGTHLVGNEG---------V-PSSALREICLLKELKHKNI--VRLYDVLHS-----EKKLTLVFEHCDQD--   69 (282)
Q Consensus         9 ~~~~~vaiK~~~~~~~~~---------~-~~~~~~e~~~~~~l~h~~i--~~~~~~~~~-----~~~~~iv~e~~~g~--   69 (282)
                      -.|+.|.||.........         . ...+.+|...+.++..-+|  ++.+++.+.     ...-++|+|+++|.  
T Consensus        43 ~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~s  122 (268)
T PRK15123         43 LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTIS  122 (268)
T ss_pred             ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCcc
Confidence            357899999764422110         0 1137899999988854444  344555543     23578999999984  


Q ss_pred             HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-------CCcEEEEecCCcc
Q psy6044          70 LKKYFDSL-NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK-------NGELKLADFGLAR  132 (282)
Q Consensus        70 l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~-------~~~~~l~df~~~~  132 (282)
                      +.+.+... ....+......++.+++..+..||+.|++|+|+++.||+++.       ++.+.++||+.+.
T Consensus       123 L~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        123 LEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             HHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            44444321 345667788899999999999999999999999999999975       4689999999775

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.22  E-value=9.1e-11  Score=86.55  Aligned_cols=97  Identities=18%  Similarity=0.200  Sum_probs=77.3

Q ss_pred             ccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q psy6044          29 SSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHR  108 (282)
Q Consensus        29 ~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~  108 (282)
                      ..-.+|+.++.+..--.|....-+..+.....|+|||++|.++.......       ...++..+-.-+.-||..||+||
T Consensus        44 ~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHG  116 (204)
T COG3642          44 ERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHG  116 (204)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecC
Confidence            34567899999887666666666666777889999999998888555433       24566777777889999999999


Q ss_pred             CCCCCcEEEcCCCcEEEEecCCccc
Q psy6044         109 DLKPQNLLINKNGELKLADFGLARA  133 (282)
Q Consensus       109 dl~~~nil~~~~~~~~l~df~~~~~  133 (282)
                      |+.++||++..++ +.++|||++..
T Consensus       117 DLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642         117 DLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CCccceEEEeCCc-EEEEECCcccc
Confidence            9999999996554 99999999863

>KOG3087|consensus

Probab=99.21  E-value=2e-10  Score=84.47  Aligned_cols=126  Identities=19%  Similarity=0.185  Sum_probs=92.9

Q ss_pred             CCCceEEEeeeec-CCC------CCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc--cHHHHHHhcCC
Q psy6044           9 TPNTALAIKGTHL-VGN------EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ--DLKKYFDSLNG   79 (282)
Q Consensus         9 ~~~~~vaiK~~~~-~~~------~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g--~l~~~~~~~~~   79 (282)
                      -+|+..+||.-.. ...      .-......+|+..+.++.--.|.-..-++.+.+.-.|+|||++|  .+.+++.....
T Consensus        28 ~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~  107 (229)
T KOG3087|consen   28 FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTME  107 (229)
T ss_pred             cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHcc
Confidence            4788888875332 111      11345567788888888666666666677788888999999999  66666655433


Q ss_pred             CCCHH-HHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC---cEEEEecCCcccc
Q psy6044          80 EIDLD-IVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG---ELKLADFGLARAF  134 (282)
Q Consensus        80 ~~~~~-~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~---~~~l~df~~~~~~  134 (282)
                      .-.++ ....++..|-+.+.-||..+|+||||..+||++.+++   .+.++|||++...
T Consensus       108 ~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen  108 DESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             CcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            33333 3478899999999999999999999999999996554   4589999998643

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.17  E-value=3.1e-10  Score=89.33  Aligned_cols=129  Identities=16%  Similarity=0.129  Sum_probs=94.5

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCC--CCccceeeeeeeC---CeEEEEEecCcccHHHHHHh
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKH--KNIVRLYDVLHSE---KKLTLVFEHCDQDLKKYFDS   76 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h--~~i~~~~~~~~~~---~~~~iv~e~~~g~l~~~~~~   76 (282)
                      ||++...+ |+.+++|.............+..|+++++.+.+  ..+++++.+....   +..++|+|+++|..+.....
T Consensus        14 ~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~   92 (223)
T cd05154          14 TYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLL   92 (223)
T ss_pred             EEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCC
Confidence            67777633 689999987653332345688999999999965  4467777776654   36789999999865543322


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------------------
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHS------------------------------------------------------  102 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~------------------------------------------------------  102 (282)
                       ...++++....++.+++.+|..||+                                                      
T Consensus        93 -~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (223)
T cd05154          93 -RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPAD  171 (223)
T ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCC
Confidence             1356667777777777777777773                                                      


Q ss_pred             --CCccccCCCCCcEEEcC--CCcEEEEecCCcc
Q psy6044         103 --RNVLHRDLKPQNLLINK--NGELKLADFGLAR  132 (282)
Q Consensus       103 --~~i~H~dl~~~nil~~~--~~~~~l~df~~~~  132 (282)
                        ..++|+|++|.||+++.  ++.+.|+||+.+.
T Consensus       172 ~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         172 SRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             CCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence              23689999999999988  5678999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.03  E-value=1.5e-08  Score=83.98  Aligned_cols=190  Identities=14%  Similarity=0.127  Sum_probs=126.4

Q ss_pred             eEEEEEecCccc--HHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCC
Q psy6044          58 KLTLVFEHCDQD--LKKYFDSL-----NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGL  130 (282)
Q Consensus        58 ~~~iv~e~~~g~--l~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~  130 (282)
                      .+.++|..++|.  ....+...     .....+....+....++.+.+.||..|.+-||+.++|+++++++.+.|.|-..
T Consensus        84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence            377888888763  22222111     12378899999999999999999999999999999999999999999998765


Q ss_pred             ccccCCCccccccccccccccChhhhc-----CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCh-----HHHHHHHHH
Q psy6044         131 ARAFGIPVKCYSAEVVTLWYRPPDVLF-----GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDV-----DDQLKRIFK  200 (282)
Q Consensus       131 ~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~-----~~~~~~~~~  200 (282)
                      .... .+........+...|.+||...     +.. -+..+|.|.||+++++++.|+..+|.+-..     ......|..
T Consensus       164 fqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~-r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~  241 (637)
T COG4248         164 FQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFE-RTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH  241 (637)
T ss_pred             eeec-cCCceEecccCccccCCHHHhccccccccC-CCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence            5443 3445566678889999999864     223 367899999999999999986666665321     011112222


Q ss_pred             HhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccC--CCCCCCHHH
Q psy6044         201 LLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCN--PVQRMSAED  262 (282)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d--p~~Rps~~~  262 (282)
                      +.....+.      ....   ....    ....-..-++++++.+..+|+...  +.-|||++.
T Consensus       242 g~f~ya~~------~~~g---~~p~----P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         242 GRFAYASD------QRRG---LKPP----PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             ceeeechh------ccCC---CCCC----CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            11111000      0000   0001    111112337788899998898764  568999876

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.03  E-value=6.7e-09  Score=80.67  Aligned_cols=124  Identities=19%  Similarity=0.112  Sum_probs=90.3

Q ss_pred             CCceEEEeeeecCCCC------CCCccHHHHHHHHhhCCCC--CccceeeeeeeC----CeEEEEEecCccc-HHHHHHh
Q psy6044          10 PNTALAIKGTHLVGNE------GVPSSALREICLLKELKHK--NIVRLYDVLHSE----KKLTLVFEHCDQD-LKKYFDS   76 (282)
Q Consensus        10 ~~~~vaiK~~~~~~~~------~~~~~~~~e~~~~~~l~h~--~i~~~~~~~~~~----~~~~iv~e~~~g~-l~~~~~~   76 (282)
                      .++.+-+|........      -......+|...+..+..-  .+++.+++.+..    ...++|+|+++|. .+..+..
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~  110 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ  110 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence            4556666654431111      2345688888888888543  345566665542    2468999999873 4444444


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC---cEEEEecCCccc
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG---ELKLADFGLARA  133 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~---~~~l~df~~~~~  133 (282)
                      .....+......++.+++..++-||+.|++|+|+++.||+++.++   .+.++||+.+..
T Consensus       111 ~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  111 QWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             hhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            333477788889999999999999999999999999999999887   899999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.96  E-value=8.3e-09  Score=80.90  Aligned_cols=124  Identities=18%  Similarity=0.227  Sum_probs=92.1

Q ss_pred             eeeeeeCCCCceEEEeeeecC-C---------C-----------CCCCccHHHHHHHHhhCCCC--CccceeeeeeeCCe
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-G---------N-----------EGVPSSALREICLLKELKHK--NIVRLYDVLHSEKK   58 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~---------~-----------~~~~~~~~~e~~~~~~l~h~--~i~~~~~~~~~~~~   58 (282)
                      ||.|.+. .|.++|||.=+.. .         +           .-......+|.+.|.+|...  .+++.++    .+.
T Consensus       107 VY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~~----~nR  181 (304)
T COG0478         107 VYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPIA----WNR  181 (304)
T ss_pred             EEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCccc----ccc
Confidence            7888885 6999999965431 0         0           01123467799999998654  6777776    356


Q ss_pred             EEEEEecCcccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccC
Q psy6044          59 LTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG  135 (282)
Q Consensus        59 ~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~  135 (282)
                      -.+|||+++|-.+...     +++.+....++..|+.-+...-..|++|||+++-||+++++|.+.++||..+...+
T Consensus       182 HaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~~~  253 (304)
T COG0478         182 HAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAVPIS  253 (304)
T ss_pred             ceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCcccccCC
Confidence            6899999999655432     23455666677777777777779999999999999999999999999998775443

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.71  E-value=1.2e-07  Score=72.79  Aligned_cols=121  Identities=15%  Similarity=0.165  Sum_probs=73.3

Q ss_pred             eeeeeCCCCceEEEeeeecCCCCCC--------CccHHHHHHHHhhCCC---CCccceeeeee-----eCCeEEEEEecC
Q psy6044           3 TSGVDRTPNTALAIKGTHLVGNEGV--------PSSALREICLLKELKH---KNIVRLYDVLH-----SEKKLTLVFEHC   66 (282)
Q Consensus         3 y~a~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~e~~~~~~l~h---~~i~~~~~~~~-----~~~~~~iv~e~~   66 (282)
                      |.|.-.-+|+.+++|..+.......        -....+++.....++.   .....++.+.+     -....++++||+
T Consensus        46 ~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYI  125 (229)
T PF06176_consen   46 YVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYI  125 (229)
T ss_pred             EEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEe
Confidence            3445455788899998765221100        0112333443444432   22223222222     224556899999


Q ss_pred             cccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCcc
Q psy6044          67 DQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR  132 (282)
Q Consensus        67 ~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~  132 (282)
                      +|..+..+.    .+++    .+...+.+++.-+|+.|+.|||.+|.|++++.+ .++++|++...
T Consensus       126 eG~~l~d~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k~  182 (229)
T PF06176_consen  126 EGVELNDIE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGKR  182 (229)
T ss_pred             cCeecccch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECcccc
Confidence            995444322    1222    244667788999999999999999999999754 59999997654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK09902 hypothetical protein; Provisional

Probab=98.68  E-value=5e-07  Score=69.18  Aligned_cols=122  Identities=15%  Similarity=0.190  Sum_probs=87.9

Q ss_pred             CceEEEeeeecC--C--C-CCCCccHHHHHHHHhhCCCCC--ccceeeeee-e----CCeEEEEEecCcc--cHHHHHHh
Q psy6044          11 NTALAIKGTHLV--G--N-EGVPSSALREICLLKELKHKN--IVRLYDVLH-S----EKKLTLVFEHCDQ--DLKKYFDS   76 (282)
Q Consensus        11 ~~~vaiK~~~~~--~--~-~~~~~~~~~e~~~~~~l~h~~--i~~~~~~~~-~----~~~~~iv~e~~~g--~l~~~~~~   76 (282)
                      |+.+-+|.-...  .  . .--...+.+|...++++..-+  +++.. ++. .    ...-+||+|-++|  ++.+.+..
T Consensus        41 g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~  119 (216)
T PRK09902         41 GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQ  119 (216)
T ss_pred             CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhc
Confidence            446777766531  1  1 224578999999999995322  44444 222 1    1356899998885  45444433


Q ss_pred             c-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc--EEEEecCCccc
Q psy6044          77 L-NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE--LKLADFGLARA  133 (282)
Q Consensus        77 ~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~~l~df~~~~~  133 (282)
                      . -.+.+......++.+++.+++-||+.|+.|+|+.+.||+++.++.  +.++||..+..
T Consensus       120 ~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        120 HAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             CCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            2 234678888899999999999999999999999999999987777  99999987653

>KOG1035|consensus

Probab=98.61  E-value=2.8e-07  Score=85.28  Aligned_cols=200  Identities=19%  Similarity=0.227  Sum_probs=134.7

Q ss_pred             HHHHHHHHhhCCCCCccceeeeeeeCCeE----EEEEecCcccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q psy6044          31 ALREICLLKELKHKNIVRLYDVLHSEKKL----TLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVL  106 (282)
Q Consensus        31 ~~~e~~~~~~l~h~~i~~~~~~~~~~~~~----~iv~e~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~  106 (282)
                      ...|.+.+..+.|+|+..++.+-.+....    .+..++|.+..+......-+.++.+..+.+..+...||+++|+....
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~  308 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE  308 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence            34567778888999999999987655433    34566777655555555578899999999999999999999998655


Q ss_pred             ccCCCCC---cEEEcCCCcEEEE--ecCCccccCCCccccccccccccccChhhhcCCC-CCCchhhHHHHHHHHHHHHh
Q psy6044         107 HRDLKPQ---NLLINKNGELKLA--DFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK-LYTTSIDMWSAGCIFAELAN  180 (282)
Q Consensus       107 H~dl~~~---nil~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~ll~  180 (282)
                      |.-+..+   +.-.+.++....+  ||+.+........... ...+..+.+||...... ......|+|++|.+...+..
T Consensus       309 ~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~-~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~  387 (1351)
T KOG1035|consen  309 HVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS-DLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQ  387 (1351)
T ss_pred             eeEEecccccccccCccceeecchhhhcccccCCCcccchh-hcCccccccccccccccchhhhhhHHHHHHHHHhhhhh
Confidence            5555444   3333445556665  8887766653322222 23345567777764443 12445799999999999987


Q ss_pred             cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCH
Q psy6044         181 AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA  260 (282)
Q Consensus       181 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  260 (282)
                      +..+.-........+                                       .........+...+|+.-++++|+++
T Consensus       388 ~~~i~~~~~~~~~~l---------------------------------------~~~~~~~~~d~~~~~~~~~~~~Rl~~  428 (1351)
T KOG1035|consen  388 GEDISEKSAVPVSLL---------------------------------------DVLSTSELLDALPKCLDEDSEERLSA  428 (1351)
T ss_pred             cCcccccccchhhhh---------------------------------------ccccchhhhhhhhhhcchhhhhccch
Confidence            766531111111100                                       01111256788899999999999999


Q ss_pred             HHHhcCCCcc
Q psy6044         261 EDAMSHIYFS  270 (282)
Q Consensus       261 ~~ll~h~~~~  270 (282)
                      .+++.|+|.+
T Consensus       429 ~~ll~~~f~~  438 (1351)
T KOG1035|consen  429 LELLTHPFLR  438 (1351)
T ss_pred             hhhhhchhcc
Confidence            9999999987

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.59  E-value=3.1e-07  Score=71.45  Aligned_cols=127  Identities=17%  Similarity=0.110  Sum_probs=83.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCC-C--------------Ccc--------HHHHHHHHhhCC--CCCccceeeeeeeC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEG-V--------------PSS--------ALREICLLKELK--HKNIVRLYDVLHSE   56 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~-~--------------~~~--------~~~e~~~~~~l~--h~~i~~~~~~~~~~   56 (282)
                      ||+|.. .++..+|+|++......- .              ...        ..+|+..|+++.  +-.+++.+++.   
T Consensus        64 Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~---  139 (268)
T COG1718          64 VYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR---  139 (268)
T ss_pred             EEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec---
Confidence            788876 679999999998632110 0              001        233555555552  23334444432   


Q ss_pred             CeEEEEEecCcccHHHH-HHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEecCCcccc
Q psy6044          57 KKLTLVFEHCDQDLKKY-FDSLNGEIDLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGLARAF  134 (282)
Q Consensus        57 ~~~~iv~e~~~g~l~~~-~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~  134 (282)
                       ...+|||+++..-.-. ..+ .-.+...+...+..+++..+.-|-. .|++|+||+.-||++. ++.+.++|++.+...
T Consensus       140 -~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         140 -NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             -CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECcccccc
Confidence             3479999997541110 000 1223344677888899999888887 8999999999999998 889999999988755


Q ss_pred             C
Q psy6044         135 G  135 (282)
Q Consensus       135 ~  135 (282)
                      .
T Consensus       217 ~  217 (268)
T COG1718         217 D  217 (268)
T ss_pred             C
Confidence            4

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.47  E-value=2.8e-06  Score=67.93  Aligned_cols=65  Identities=14%  Similarity=-0.059  Sum_probs=46.7

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCC-CCCccceeeeeeeCCeEEEEEecCcccHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQDLKK   72 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~   72 (282)
                      ||+...  .+..+++|......    .....+|+.+++.+. +--+++++++...++..++|||+++|..+.
T Consensus        15 v~~~~~--~~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150          15 VYRLDG--KNPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             EEEEcC--CCCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            567654  34688888765432    346778999998883 445677888777767789999999985444

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.35  E-value=7.6e-06  Score=64.47  Aligned_cols=118  Identities=15%  Similarity=0.110  Sum_probs=71.1

Q ss_pred             CceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCC--ccceeeeeeeCCeEEEEEecCcccH-HHH--------------
Q psy6044          11 NTALAIKGTHLVGNEGVPSSALREICLLKELKHKN--IVRLYDVLHSEKKLTLVFEHCDQDL-KKY--------------   73 (282)
Q Consensus        11 ~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~--i~~~~~~~~~~~~~~iv~e~~~g~l-~~~--------------   73 (282)
                      |..+++|.....   .......+|.++++.+..-.  +++.+++...++...+|||+++|.. ...              
T Consensus        22 ~~~~VlR~~~~~---~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~   98 (226)
T TIGR02172        22 TGKWMLKLYNPG---FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAK   98 (226)
T ss_pred             CCCEEEEeCCCC---CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHH
Confidence            556778876532   23355789999999986433  5778888888888899999999841 110              


Q ss_pred             --------HHhcCC-CCCHHH-HHHHHHHH----------HHH-HHHHH----hCCccccCCCCCcEEEcCCCcEEEEec
Q psy6044          74 --------FDSLNG-EIDLDI-VKSFMYQL----------LRG-LAFCH----SRNVLHRDLKPQNLLINKNGELKLADF  128 (282)
Q Consensus        74 --------~~~~~~-~~~~~~-~~~~~~qi----------~~~-l~~lh----~~~i~H~dl~~~nil~~~~~~~~l~df  128 (282)
                              ++.... ..+... ...+..++          ... ..+|.    ...++|+|+.|.||+++.++ +.++||
T Consensus        99 ~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDw  177 (226)
T TIGR02172        99 IFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDL  177 (226)
T ss_pred             HHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEec
Confidence                    111000 011000 01111111          111 11121    12478999999999999888 999999


Q ss_pred             CCcc
Q psy6044         129 GLAR  132 (282)
Q Consensus       129 ~~~~  132 (282)
                      +.+.
T Consensus       178 e~a~  181 (226)
T TIGR02172       178 GDFG  181 (226)
T ss_pred             hhcC
Confidence            8764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.31  E-value=7.2e-06  Score=71.72  Aligned_cols=78  Identities=21%  Similarity=0.328  Sum_probs=51.8

Q ss_pred             CCeEEEEEecCcccHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCcccc
Q psy6044          56 EKKLTLVFEHCDQDLKKYFDS-LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF  134 (282)
Q Consensus        56 ~~~~~iv~e~~~g~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~  134 (282)
                      .+.-.++|||++|--.+.... .....+...+.....++.  +..+-..|+.|.|.+|.||+++.+|++.+.|||....+
T Consensus       238 t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         238 TTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             cCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence            345589999999843333321 123344333332222221  23333489999999999999999999999999998766


Q ss_pred             C
Q psy6044         135 G  135 (282)
Q Consensus       135 ~  135 (282)
                      +
T Consensus       316 ~  316 (517)
T COG0661         316 D  316 (517)
T ss_pred             C
Confidence            5

>KOG1235|consensus

Probab=98.16  E-value=3e-05  Score=67.85  Aligned_cols=76  Identities=21%  Similarity=0.244  Sum_probs=51.6

Q ss_pred             CeEEEEEecCcc---cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC----CCcEEEEecC
Q psy6044          57 KKLTLVFEHCDQ---DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK----NGELKLADFG  129 (282)
Q Consensus        57 ~~~~iv~e~~~g---~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~----~~~~~l~df~  129 (282)
                      ..-.++|||++|   +-++.+.+  ..++...+..-+.+...  .-+=..|++|+|-+|.||+++.    ++.+.+.|||
T Consensus       275 t~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhG  350 (538)
T KOG1235|consen  275 TKRVLTMEYVDGIKINDLDAIDK--RGISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHG  350 (538)
T ss_pred             cceEEEEEecCCccCCCHHHHHH--cCCCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccc
Confidence            345899999998   34444444  34555544433333222  2233568999999999999984    6789999999


Q ss_pred             CccccCC
Q psy6044         130 LARAFGI  136 (282)
Q Consensus       130 ~~~~~~~  136 (282)
                      +...++.
T Consensus       351 l~~~is~  357 (538)
T KOG1235|consen  351 LYAVISH  357 (538)
T ss_pred             ccccccH
Confidence            9876653

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.11  E-value=2.1e-05  Score=62.24  Aligned_cols=64  Identities=13%  Similarity=0.020  Sum_probs=41.5

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCC--Cccceeeeee---eCCeEEEEEecCcccH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHK--NIVRLYDVLH---SEKKLTLVFEHCDQDL   70 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~--~i~~~~~~~~---~~~~~~iv~e~~~g~l   70 (282)
                      ||+.....  ..+++|.....   .....+..|..+++.+...  .+++++....   .....++++++++|..
T Consensus        13 ~~~v~~~~--~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~   81 (239)
T PF01636_consen   13 VYRVTTDD--GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRP   81 (239)
T ss_dssp             EEEEEETT--SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEE
T ss_pred             EEEEEECC--cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecccc
Confidence            56666533  59999986532   2346777899999888433  3566666443   3346899999998853

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=98.10  E-value=3.9e-05  Score=71.93  Aligned_cols=58  Identities=12%  Similarity=0.142  Sum_probs=40.8

Q ss_pred             ceEEEeeeecCCCCCCCccHHHHHHHHhhCC-CCCc--cceeeeeeeC---CeEEEEEecCccc
Q psy6044          12 TALAIKGTHLVGNEGVPSSALREICLLKELK-HKNI--VRLYDVLHSE---KKLTLVFEHCDQD   69 (282)
Q Consensus        12 ~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i--~~~~~~~~~~---~~~~iv~e~~~g~   69 (282)
                      ..+++|+............+.+|+.+++.+. |+++  ++++.++.+.   +..|+|||+++|.
T Consensus        66 ~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~  129 (822)
T PLN02876         66 KRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGR  129 (822)
T ss_pred             eeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCc
Confidence            4677776544222222356889999999995 6665  7777777664   4689999999885

>KOG0576|consensus

Probab=98.10  E-value=2.2e-06  Score=74.91  Aligned_cols=212  Identities=19%  Similarity=0.092  Sum_probs=135.4

Q ss_pred             ccHHHHHHHHhhCCCCC-ccceeeeeeeCCeEEEEEecCccc--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy6044          29 SSALREICLLKELKHKN-IVRLYDVLHSEKKLTLVFEHCDQD--LKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNV  105 (282)
Q Consensus        29 ~~~~~e~~~~~~l~h~~-i~~~~~~~~~~~~~~iv~e~~~g~--l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i  105 (282)
                      ....-+++++.+.+||| .+..++-++-+...++.++++.++  ...........+..-+.......-+.+++++|+.--
T Consensus       278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~  357 (829)
T KOG0576|consen  278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYK  357 (829)
T ss_pred             hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccc
Confidence            34556889999999999 777777777788899999999764  222221111223344444555566778889998766


Q ss_pred             cccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCC
Q psy6044         106 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL  185 (282)
Q Consensus       106 ~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~  185 (282)
                      +|+|    ||+. .++..+..+|+....+.... ......+++.++|||....+. +....|.|++|.-..++--| .|+
T Consensus       358 ~~~d----~~l~-s~~~~~~~~~~v~~~L~~~~-~~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~-~pP  429 (829)
T KOG0576|consen  358 VHRD----NILG-SEEEVKLLDFAVPPQLTRTM-KPRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPG-LPP  429 (829)
T ss_pred             cCcc----cccc-cccccccccccCCcccCccc-ccccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCC-CCC
Confidence            7776    6655 44778999999887766443 234456789999999887776 68999999999876666633 332


Q ss_pred             CCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHH-HHHHHhcccCCCCCCCHHHHh
Q psy6044         186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGR-DLLQRLLVCNPVQRMSAEDAM  264 (282)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~li~~~l~~dp~~Rps~~~ll  264 (282)
                      -..                |+.....-.+          ..+...... ....++... ++...|+..-|..|+....++
T Consensus       430 r~~----------------P~~~~~~~g~----------~p~s~~L~~-~~aw~~~~~~~~~~~~~~g~P~~pkv~mgac  482 (829)
T KOG0576|consen  430 RSS----------------PPAVLPMIGN----------GPNSPMLTD-KSAWSPVFHRDFPAPCLNGLPPTPKVHMGAC  482 (829)
T ss_pred             CCC----------------CccccCCCCC----------CCCccccch-hhhcCcccccCCcccccCCCCCCCcchhhHH
Confidence            222                1000000000          000000000 001111112 477889999999999999999


Q ss_pred             cCCCccCCccc
Q psy6044         265 SHIYFSDLNVA  275 (282)
Q Consensus       265 ~h~~~~~~~~~  275 (282)
                      -|.+|...+.-
T Consensus       483 fsKvfngCpl~  493 (829)
T KOG0576|consen  483 FSKVFNGCPLR  493 (829)
T ss_pred             HHHHhccCccc
Confidence            99999987653

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.88  E-value=6.6e-05  Score=57.27  Aligned_cols=97  Identities=22%  Similarity=0.151  Sum_probs=76.6

Q ss_pred             HHHHHHhhCCC-CCccceeeeeeeCCeEEEEEecCcc-cHHHH---HHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q psy6044          33 REICLLKELKH-KNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY---FDSLNGEIDLDIVKSFMYQLLRGLAFCHS---RN  104 (282)
Q Consensus        33 ~e~~~~~~l~h-~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~---~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~  104 (282)
                      .|.-+++.+.+ +++++++|+|-    -+++.||.+. .+...   +.. -...++..+.+++.++++.+.+|+.   ..
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            57888888865 69999999883    2678888874 33321   111 1346899999999999999999997   45


Q ss_pred             ccccCCCCCcEEEcCCCcEEEEecCCcccc
Q psy6044         105 VLHRDLKPQNLLINKNGELKLADFGLARAF  134 (282)
Q Consensus       105 i~H~dl~~~nil~~~~~~~~l~df~~~~~~  134 (282)
                      +.-.|++++|+-++++++++++|.......
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888999999999999999999999876544

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.81  E-value=0.00058  Score=52.45  Aligned_cols=116  Identities=22%  Similarity=0.301  Sum_probs=79.9

Q ss_pred             CceEEEeeeecCC---------------CCCCCccHHHHHHHHhhCC------CCCccceeeeeeeCCeEEEEEecCc--
Q psy6044          11 NTALAIKGTHLVG---------------NEGVPSSALREICLLKELK------HKNIVRLYDVLHSEKKLTLVFEHCD--   67 (282)
Q Consensus        11 ~~~vaiK~~~~~~---------------~~~~~~~~~~e~~~~~~l~------h~~i~~~~~~~~~~~~~~iv~e~~~--   67 (282)
                      ....+||+.....               .....+...+|+.-+..+.      +.+|.+++|+.+++.-..+|+|.+.  
T Consensus        23 dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~  102 (199)
T PF10707_consen   23 DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDA  102 (199)
T ss_pred             CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECC
Confidence            4567788877633               1223566777887777776      7899999999999999999999873  


Q ss_pred             -cc---HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC----cEEEEe-cCCc
Q psy6044          68 -QD---LKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG----ELKLAD-FGLA  131 (282)
Q Consensus        68 -g~---l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~----~~~l~d-f~~~  131 (282)
                       |.   .+..+.. .+.+++ ....   .+-+-..+|-+.+|+.+|++|.||++...+    .+.|+| ||..
T Consensus       103 dG~~s~TL~~~l~-~~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  103 DGNISPTLEDYLK-EGGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             CCCcCccHHHHHH-cCCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEeCCCCc
Confidence             32   3333333 345655 3333   334445677888999999999999996432    577776 4544

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.73  E-value=0.0003  Score=56.63  Aligned_cols=124  Identities=22%  Similarity=0.232  Sum_probs=68.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCc-cceeeeeeeCCeEEEEEecCcccHHHH-------
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNI-VRLYDVLHSEKKLTLVFEHCDQDLKKY-------   73 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i-~~~~~~~~~~~~~~iv~e~~~g~l~~~-------   73 (282)
                      +|+..  .+|+.+++|........ ..-...+|..+++.+....+ ++++...  .  -++|+||++|..+..       
T Consensus        12 ~y~~~--~~~~~~vlR~~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~~~~~~~~   84 (256)
T TIGR02721        12 SWRIE--HPGISFVWRPQSPVCKA-LGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITLDQFVALD   84 (256)
T ss_pred             eEEEE--eCCccEEEeeCCccccc-ccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccccccccCch
Confidence            45554  45778888865432111 11246789999999854333 4444433  2  368999998843321       


Q ss_pred             -----------HHhcCC---CCCH-HHHHHHHHHH---------HHHHHHHHh--------CCccccCCCCCcEEEcCCC
Q psy6044          74 -----------FDSLNG---EIDL-DIVKSFMYQL---------LRGLAFCHS--------RNVLHRDLKPQNLLINKNG  121 (282)
Q Consensus        74 -----------~~~~~~---~~~~-~~~~~~~~qi---------~~~l~~lh~--------~~i~H~dl~~~nil~~~~~  121 (282)
                                 ++....   +++. ..+..+..++         ...+..+..        ..++|+|+.|.||+++.++
T Consensus        85 ~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~  164 (256)
T TIGR02721        85 LLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG  164 (256)
T ss_pred             hHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCCC
Confidence                       111110   1111 1122222122         111222221        2489999999999998877


Q ss_pred             cEEEEecCCccc
Q psy6044         122 ELKLADFGLARA  133 (282)
Q Consensus       122 ~~~l~df~~~~~  133 (282)
                       +.++||+.+..
T Consensus       165 -~~lIDwE~a~~  175 (256)
T TIGR02721       165 -LKLIDWEYASD  175 (256)
T ss_pred             -CEEEeccccCc
Confidence             78999987753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.71  E-value=0.00054  Score=50.86  Aligned_cols=116  Identities=16%  Similarity=0.124  Sum_probs=77.6

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCcc-ceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIV-RLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~-~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      +||++..  .|..+|+|+-..+   +-...+..|++++..+...++- +++.+-.    .++.|||+.|..+...... +
T Consensus        37 ~Vyl~~~--~~~~~a~Kvrr~d---s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L~~~~~~-~  106 (201)
T COG2112          37 VVYLGEW--RGGEVALKVRRRD---SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPLGKLEIG-G  106 (201)
T ss_pred             EEEEeec--cCceEEEEEecCC---cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcchhhhhhc-c
Confidence            4777775  4568899976543   3346788999999999766653 3444322    2455999999544433221 1


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCC-CCcEEEcCCCcEEEEecCCcc
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLK-PQNLLINKNGELKLADFGLAR  132 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~-~~nil~~~~~~~~l~df~~~~  132 (282)
                        +.    +-+..+++..--|-..||-|+.++ |...++..++.+.|+||..++
T Consensus       107 --~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112         107 --DR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             --cH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence              22    334455566556778899999985 566666677799999999886

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.56  E-value=0.0003  Score=55.88  Aligned_cols=30  Identities=33%  Similarity=0.468  Sum_probs=25.1

Q ss_pred             CCccccCCCCCcEEEcCCCcEEEEecCCcc
Q psy6044         103 RNVLHRDLKPQNLLINKNGELKLADFGLAR  132 (282)
Q Consensus       103 ~~i~H~dl~~~nil~~~~~~~~l~df~~~~  132 (282)
                      .+++|+|+++.||+++.++..-|+||+.+.
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            348999999999999876656799999764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1093|consensus

Probab=97.55  E-value=0.00016  Score=62.38  Aligned_cols=174  Identities=20%  Similarity=0.253  Sum_probs=110.4

Q ss_pred             CccHHHHHHHHhhCCCCCccceeeeeeeC-CeEEEEEecCcccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q psy6044          28 PSSALREICLLKELKHKNIVRLYDVLHSE-KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVL  106 (282)
Q Consensus        28 ~~~~~~e~~~~~~l~h~~i~~~~~~~~~~-~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~  106 (282)
                      ...++.-.++++.+.|+|...++++-... ....+|+|++..++.+.....+  +......                  .
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~--l~~~s~~------------------~   85 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN--LKDESLL------------------A   85 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcc--cchhhhc------------------c
Confidence            35677778889999999999999887643 5688999999999888776533  2111111                  2


Q ss_pred             ccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCC
Q psy6044         107 HRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF  186 (282)
Q Consensus       107 H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~  186 (282)
                      |+ +-+.|++.       ..| .+.+    .            +  |-      +-.+++|||++|.++.++..|..- +
T Consensus        86 ~~-~~~~~~~~-------~td-~~~t----~------------~--~~------~~~pKsdVwsl~~i~~el~L~~~l-~  131 (725)
T KOG1093|consen   86 HG-VLHLNIIY-------ITD-HFLT----K------------Y--PS------PIGPKSDVWSLGFIILELYLGISL-E  131 (725)
T ss_pred             cc-cceehhhh-------ccc-cccc----c------------C--CC------CCCcchhhhhHHHHHHHHHHhhHH-H
Confidence            22 11222222       222 0000    0            0  00      013599999999999999855443 6


Q ss_pred             CCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         187 PGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      ......+....+.+....+.....-.                 -...+....+.....+..+|+...|..||...++.++
T Consensus       132 ~~~~~s~~l~~i~k~~~~d~~~~~~a-----------------~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~  194 (725)
T KOG1093|consen  132 AELTESEYLEILLKYYTDDQELLSTA-----------------MEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKR  194 (725)
T ss_pred             HHHHHHHHHHHHHHhccCchhHHHHH-----------------HHHHHHHhhhHhHHHHhccCCccccccccchhHHhcC
Confidence            66666676666666443322211100                 0012223467777899999999999999999999999


Q ss_pred             CCccCC
Q psy6044         267 IYFSDL  272 (282)
Q Consensus       267 ~~~~~~  272 (282)
                      +-|..+
T Consensus       195 ~i~~ev  200 (725)
T KOG1093|consen  195 CSFTEV  200 (725)
T ss_pred             ccHHHH
Confidence            988755

>KOG2270|consensus

Probab=97.53  E-value=0.00095  Score=55.46  Aligned_cols=130  Identities=20%  Similarity=0.181  Sum_probs=85.5

Q ss_pred             eeeeeeCCCCceEEEeeeecC---C--CCC-----------C----Ccc-----HHHHHHHHhhCCCCCccceeeeeeeC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV---G--NEG-----------V----PSS-----ALREICLLKELKHKNIVRLYDVLHSE   56 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~---~--~~~-----------~----~~~-----~~~e~~~~~~l~h~~i~~~~~~~~~~   56 (282)
                      ||-|.. .+|..+|||++.-.   .  .+.           .    ...     ...|+.-|.++....|+..--....+
T Consensus       160 VYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~PePIlLk~  238 (520)
T KOG2270|consen  160 VYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPCPEPILLKN  238 (520)
T ss_pred             eEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCCCCceeeec
Confidence            677776 56888999998751   1  000           0    000     34466667776655544332222222


Q ss_pred             CeEEEEEecCcccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCcEEEcCCCcEEEEecCCccccC
Q psy6044          57 KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH-SRNVLHRDLKPQNLLINKNGELKLADFGLARAFG  135 (282)
Q Consensus        57 ~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh-~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~  135 (282)
                        -.|||++++++-...-.-.+..++...+..+-.+++.-+.-|- ..+++|.||+=-|+++ .+|.+.++|.+.+....
T Consensus       239 --hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  239 --HVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKLYIIDVSQSVEHD  315 (520)
T ss_pred             --ceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEEEEEEccccccCC
Confidence              3799999975322221112456788888888888887777765 5699999999999998 67899999998876554

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.51  E-value=0.0012  Score=54.36  Aligned_cols=125  Identities=16%  Similarity=0.062  Sum_probs=70.8

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCC--ccceeee------eeeCCeEEEEEecCcccHHH-
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKN--IVRLYDV------LHSEKKLTLVFEHCDQDLKK-   72 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~--i~~~~~~------~~~~~~~~iv~e~~~g~l~~-   72 (282)
                      +|+...  ++..+++|+...    ........|+.+++.+...+  +++++..      ...++..++++++++|.... 
T Consensus        30 ~y~v~~--~~~~~vLr~~~~----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~  103 (296)
T cd05153          30 NYFVTT--DSGRYVLTLFEK----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTR  103 (296)
T ss_pred             eEEEEe--CCCcEEEEEcCC----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCC
Confidence            455442  345788887653    22355667888888874322  4444332      23345678999999874321 


Q ss_pred             --------------HHHhcCCCCC--------HHHHHH------------HHHHHHHHHHHHHh-------CCccccCCC
Q psy6044          73 --------------YFDSLNGEID--------LDIVKS------------FMYQLLRGLAFCHS-------RNVLHRDLK  111 (282)
Q Consensus        73 --------------~~~~~~~~~~--------~~~~~~------------~~~qi~~~l~~lh~-------~~i~H~dl~  111 (282)
                                    .++.....+.        ......            ....+..++..+.+       .+++|+|++
T Consensus       104 ~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~  183 (296)
T cd05153         104 PTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLF  183 (296)
T ss_pred             CCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcC
Confidence                          1111111000        010000            11112233444443       469999999


Q ss_pred             CCcEEEcCCCcEEEEecCCcc
Q psy6044         112 PQNLLINKNGELKLADFGLAR  132 (282)
Q Consensus       112 ~~nil~~~~~~~~l~df~~~~  132 (282)
                      |.|++++.++.+.|+||+.+.
T Consensus       184 ~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         184 RDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             cccEEEeCCceEEEeehhhhc
Confidence            999999987777899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.47  E-value=0.0029  Score=50.18  Aligned_cols=29  Identities=28%  Similarity=0.465  Sum_probs=25.7

Q ss_pred             CccccCCCCCcEEEcC-CCcEEEEecCCcc
Q psy6044         104 NVLHRDLKPQNLLINK-NGELKLADFGLAR  132 (282)
Q Consensus       104 ~i~H~dl~~~nil~~~-~~~~~l~df~~~~  132 (282)
                      +++|+|+.+.||+++. ++.+.++||..+.
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            5999999999999997 5789999998764

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.42  E-value=0.0022  Score=53.12  Aligned_cols=30  Identities=37%  Similarity=0.564  Sum_probs=26.9

Q ss_pred             CCccccCCCCCcEEEcCCCcEEEEecCCcc
Q psy6044         103 RNVLHRDLKPQNLLINKNGELKLADFGLAR  132 (282)
Q Consensus       103 ~~i~H~dl~~~nil~~~~~~~~l~df~~~~  132 (282)
                      .+++|+|+++.|++++.++...|+||+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            679999999999999988877899998774

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.38  E-value=0.0017  Score=53.53  Aligned_cols=119  Identities=18%  Similarity=0.154  Sum_probs=73.5

Q ss_pred             CceEEEeeeecCCCCCCCccHHHHHHHHhhCCC--CCccceeeeeeeCC--eEEEEEecCcccHHHHHHhcCCCCCHHHH
Q psy6044          11 NTALAIKGTHLVGNEGVPSSALREICLLKELKH--KNIVRLYDVLHSEK--KLTLVFEHCDQDLKKYFDSLNGEIDLDIV   86 (282)
Q Consensus        11 ~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h--~~i~~~~~~~~~~~--~~~iv~e~~~g~l~~~~~~~~~~~~~~~~   86 (282)
                      ++.+++..-.............+|+.+++.+.-  .-+...+++|.++.  ..|.||+++.|.....     .-.+...-
T Consensus        48 ~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~-----~~~~~~~~  122 (321)
T COG3173          48 GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWS-----ALPPESLG  122 (321)
T ss_pred             CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccC-----cCCcccch
Confidence            777777722123333445667788888888743  33445566666555  7899999999831110     00000000


Q ss_pred             HHHH-HHHHHHHHHHHh----------------------------------------------------------CCccc
Q psy6044          87 KSFM-YQLLRGLAFCHS----------------------------------------------------------RNVLH  107 (282)
Q Consensus        87 ~~~~-~qi~~~l~~lh~----------------------------------------------------------~~i~H  107 (282)
                      ..++ ..++..|+.||+                                                          ..++|
T Consensus       123 ~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvH  202 (321)
T COG3173         123 RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVH  202 (321)
T ss_pred             HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeee
Confidence            1111 244444444443                                                          23799


Q ss_pred             cCCCCCcEEEcCCCcEEEEecCCcccc
Q psy6044         108 RDLKPQNLLINKNGELKLADFGLARAF  134 (282)
Q Consensus       108 ~dl~~~nil~~~~~~~~l~df~~~~~~  134 (282)
                      ||+++.|++++.++-+-++||+.+..-
T Consensus       203 GD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         203 GDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             CCcccCCEEEeCCCeeEEEeccccccC
Confidence            999999999999988999999988643

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.24  E-value=0.01  Score=50.72  Aligned_cols=66  Identities=17%  Similarity=0.106  Sum_probs=43.9

Q ss_pred             CeeeeeeCCCCceEEEeeeecC----CC--CCCCccHHHHHHHHhhCC---CCCccceeeeeeeCCeEEEEEecCcc
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV----GN--EGVPSSALREICLLKELK---HKNIVRLYDVLHSEKKLTLVFEHCDQ   68 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~----~~--~~~~~~~~~e~~~~~~l~---h~~i~~~~~~~~~~~~~~iv~e~~~g   68 (282)
                      .||+..+...++.++||.-...    ..  .-.......|.+.++.+.   ..++++++.+  ++...++|||++++
T Consensus        41 ~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lVME~L~~  115 (401)
T PRK09550         41 LVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTVMEDLSD  115 (401)
T ss_pred             EEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEEEecCCC
Confidence            3788888544468999985421    01  123456778888888862   2457777776  34557899999875

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.18  E-value=0.013  Score=48.59  Aligned_cols=29  Identities=28%  Similarity=0.519  Sum_probs=25.2

Q ss_pred             CCccccCCCCCcEEEcCCCcEEEEecCCcc
Q psy6044         103 RNVLHRDLKPQNLLINKNGELKLADFGLAR  132 (282)
Q Consensus       103 ~~i~H~dl~~~nil~~~~~~~~l~df~~~~  132 (282)
                      .+++|||+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57899999999999987 678999998653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.15  E-value=0.0078  Score=46.12  Aligned_cols=110  Identities=21%  Similarity=0.203  Sum_probs=74.7

Q ss_pred             eeeeeeCCCCceEEEeeeec---CCCC-----------------CCCccHHHHHHHHhhCC---CCCc--cceeeeeeeC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL---VGNE-----------------GVPSSALREICLLKELK---HKNI--VRLYDVLHSE   56 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~---~~~~-----------------~~~~~~~~e~~~~~~l~---h~~i--~~~~~~~~~~   56 (282)
                      ||++.-  .|+.||+|.+..   ....                 .....|..|-....+|+   +.++  ++++|+..-.
T Consensus        54 V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~  131 (207)
T PF13095_consen   54 VFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLT  131 (207)
T ss_pred             EEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceEEEeeEEEEEc
Confidence            566664  688999999443   1100                 23456778888888774   3455  9999987311


Q ss_pred             ------------------CeEEEEEecCcccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q psy6044          57 ------------------KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN  118 (282)
Q Consensus        57 ------------------~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~  118 (282)
                                        ....||-||++...         .+..    .-+.+|.+-+..+|..||+-+|+++.|..  
T Consensus       132 ~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~--  196 (207)
T PF13095_consen  132 EDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILHKLGIVPRDVKPRNYR--  196 (207)
T ss_pred             hHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHHHCCeeeccCcccccc--
Confidence                              12457788776532         2222    23566777788999999999999999987  


Q ss_pred             CCCcEEEEecCCc
Q psy6044         119 KNGELKLADFGLA  131 (282)
Q Consensus       119 ~~~~~~l~df~~~  131 (282)
                         .-+|+|||.+
T Consensus       197 ---~G~lvDfs~~  206 (207)
T PF13095_consen  197 ---GGKLVDFSSS  206 (207)
T ss_pred             ---CCEEEecccC
Confidence               4589999864

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.14  E-value=0.0037  Score=51.63  Aligned_cols=29  Identities=34%  Similarity=0.465  Sum_probs=25.7

Q ss_pred             CccccCCCCCcEEEcCC----CcEEEEecCCcc
Q psy6044         104 NVLHRDLKPQNLLINKN----GELKLADFGLAR  132 (282)
Q Consensus       104 ~i~H~dl~~~nil~~~~----~~~~l~df~~~~  132 (282)
                      +++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            58999999999999875    889999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.13  E-value=0.019  Score=47.84  Aligned_cols=30  Identities=33%  Similarity=0.432  Sum_probs=25.8

Q ss_pred             CCccccCCCCCcEEEcCCCcEEEEecCCcc
Q psy6044         103 RNVLHRDLKPQNLLINKNGELKLADFGLAR  132 (282)
Q Consensus       103 ~~i~H~dl~~~nil~~~~~~~~l~df~~~~  132 (282)
                      .+++|+|++|.||+++.+...-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            479999999999999866556899998874

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=97.07  E-value=0.0066  Score=50.53  Aligned_cols=106  Identities=20%  Similarity=0.221  Sum_probs=71.7

Q ss_pred             eCCeEEEEEecCcccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEcCCCcEEEEecCCccc
Q psy6044          55 SEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSR-NVLHRDLKPQNLLINKNGELKLADFGLARA  133 (282)
Q Consensus        55 ~~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~l~df~~~~~  133 (282)
                      +..+.|+++++-.+.+..     ...-..+++..++++.+..+.-+... .+-|+|+..+||+++ +|++.|+||.+++.
T Consensus       297 e~~y~yl~~kdhgt~is~-----ik~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         297 ETLYLYLHFKDHGTPISI-----IKADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             CceEEEEEEecCCceeee-----eecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence            345678888877665433     22345788889999988877777654 588999999999999 99999999999874


Q ss_pred             cCCCccccccccccccccChhhhcCCCCCCchhhHHHHHH
Q psy6044         134 FGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC  173 (282)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~  173 (282)
                      -.......     ....--|-.+.+..  +.+-+||-+--
T Consensus       371 ~~~q~~is-----y~rldhp~lF~G~d--d~QFeIYrlMr  403 (488)
T COG5072         371 SYSQGIIS-----YNRLDHPDLFNGVD--DYQFEIYRLMR  403 (488)
T ss_pred             ccCCceee-----ccccCchhhhcCcc--ceeeeHHHHHH
Confidence            33222211     12234455555443  56777776433

>KOG1826|consensus

Probab=96.94  E-value=0.00041  Score=67.12  Aligned_cols=213  Identities=15%  Similarity=-0.019  Sum_probs=136.6

Q ss_pred             HHHHHHHHhhCCCCCccceeeeeee--CCeEEEEEecCc-ccHHHHHHhcCCC---CCHHHHHHHHHHHHHHHHHHHhCC
Q psy6044          31 ALREICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCD-QDLKKYFDSLNGE---IDLDIVKSFMYQLLRGLAFCHSRN  104 (282)
Q Consensus        31 ~~~e~~~~~~l~h~~i~~~~~~~~~--~~~~~iv~e~~~-g~l~~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lh~~~  104 (282)
                      .+.|..-.+...|+++.....-...  +..-+..++++. |.+.+.+.+...+   ++...+.....+.+.+..-+|++.
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            3444444555678888776665443  335688899986 5666666654332   445555554555466777766532


Q ss_pred             -----ccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHH
Q psy6044         105 -----VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELA  179 (282)
Q Consensus       105 -----i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll  179 (282)
                           -+|.++++-|.++..+-.++++++|+.+.........+...+++.|+.|++...-. ++.++|+|..|+.+|...
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik-~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIK-FTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHh-hhhHHHHHHHHHHHHHHh
Confidence                 67999999999999999999999999984443444444456677788888875555 577899999999999988


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCC
Q psy6044         180 NAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS  259 (282)
Q Consensus       180 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  259 (282)
                      .|..++      ....+...++.....                       ....++.-.|.+.-.....+|-..-..||.
T Consensus      1435 ~~n~~f------i~flq~~Lkgiidn~-----------------------tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~ 1485 (2724)
T KOG1826|consen 1435 DGNAYF------IFFLQPALKGIIDNH-----------------------TFFSIEKLKPGDANVEALHRLLWKYMERPG 1485 (2724)
T ss_pred             cccHHH------HHHHHHHHcCccccc-----------------------ccccccccCCCcccHHHHHHHHHHhhhcch
Confidence            554442      233333333221110                       111222223444455566666777778999


Q ss_pred             HHHHhcCCCccCCc
Q psy6044         260 AEDAMSHIYFSDLN  273 (282)
Q Consensus       260 ~~~ll~h~~~~~~~  273 (282)
                      -...+..+.+....
T Consensus      1486 q~isls~d~~a~~~ 1499 (2724)
T KOG1826|consen 1486 QYISLSRDHFAVGL 1499 (2724)
T ss_pred             hhhhcccccccccc
Confidence            88888877776443

>PLN02236 choline kinase

Probab=96.84  E-value=0.0098  Score=50.12  Aligned_cols=29  Identities=24%  Similarity=0.504  Sum_probs=25.4

Q ss_pred             CccccCCCCCcEEEcC-CCcEEEEecCCcc
Q psy6044         104 NVLHRDLKPQNLLINK-NGELKLADFGLAR  132 (282)
Q Consensus       104 ~i~H~dl~~~nil~~~-~~~~~l~df~~~~  132 (282)
                      .++|+|+++.||+++. ++.+.++||..+.
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            5899999999999976 4689999998774

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.83  E-value=0.027  Score=47.32  Aligned_cols=65  Identities=15%  Similarity=0.057  Sum_probs=42.6

Q ss_pred             CeeeeeeCCCCceEEEeeeec---C---CCCCCCccHHHHHHHHhhCC--CC-CccceeeeeeeCCeEEEEEecCc
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL---V---GNEGVPSSALREICLLKELK--HK-NIVRLYDVLHSEKKLTLVFEHCD   67 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~---~---~~~~~~~~~~~e~~~~~~l~--h~-~i~~~~~~~~~~~~~~iv~e~~~   67 (282)
                      +||++.+...++.|+||.-..   .   ...-......-|...|+...  .| .+++++.+  ++....+|||+++
T Consensus        10 ~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vMEdL~   83 (370)
T TIGR01767        10 LVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVMEDLS   83 (370)
T ss_pred             EEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehHhhCc
Confidence            489999854447899998664   1   12334566777888887763  34 45555443  4555678999885

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.77  E-value=0.014  Score=48.99  Aligned_cols=29  Identities=34%  Similarity=0.580  Sum_probs=25.2

Q ss_pred             ccccCCCCCcEEEcC-CCcEEEEecCCccc
Q psy6044         105 VLHRDLKPQNLLINK-NGELKLADFGLARA  133 (282)
Q Consensus       105 i~H~dl~~~nil~~~-~~~~~l~df~~~~~  133 (282)
                      ++|+|+.+.||++++ ++.++++||+.+..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            799999999999975 57899999988743

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.59  E-value=0.055  Score=44.88  Aligned_cols=29  Identities=17%  Similarity=0.240  Sum_probs=26.7

Q ss_pred             CccccCCCCCcEEEcCCCcEEEEecCCcc
Q psy6044         104 NVLHRDLKPQNLLINKNGELKLADFGLAR  132 (282)
Q Consensus       104 ~i~H~dl~~~nil~~~~~~~~l~df~~~~  132 (282)
                      +++|+|+.++|++++.++.+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            69999999999999999999999998764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.47  E-value=0.012  Score=47.87  Aligned_cols=29  Identities=31%  Similarity=0.588  Sum_probs=24.4

Q ss_pred             CccccCCCCCcEEEcCCCc-EEEEecCCcc
Q psy6044         104 NVLHRDLKPQNLLINKNGE-LKLADFGLAR  132 (282)
Q Consensus       104 ~i~H~dl~~~nil~~~~~~-~~l~df~~~~  132 (282)
                      .++|+|+++.||+++.++. .-|+||+.+.
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            3899999999999987565 4699999775

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.47  E-value=0.014  Score=45.29  Aligned_cols=103  Identities=22%  Similarity=0.245  Sum_probs=64.8

Q ss_pred             ceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCCCHHHHHHHHH
Q psy6044          12 TALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY   91 (282)
Q Consensus        12 ~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~~~~   91 (282)
                      .+..+|+++...-.-....+..+..++.++.  .|+++..=  +...+.++.|+|..-         .....    .++.
T Consensus        86 G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~---------~i~~~----N~i~  148 (308)
T PF07387_consen   86 GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI---------KINFS----NFIT  148 (308)
T ss_pred             chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc---------ccchh----HHHH
Confidence            4556666655322212345667777777653  46666632  344678999998431         01111    1122


Q ss_pred             HHHHHHHHHHh--CCccccCCCCCcEEEcCCCcEEEEecCCc
Q psy6044          92 QLLRGLAFCHS--RNVLHRDLKPQNLLINKNGELKLADFGLA  131 (282)
Q Consensus        92 qi~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~~l~df~~~  131 (282)
                      .=+.+|..+|+  .+..|||..|+|||-+..|.+||.|=+..
T Consensus       149 agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  149 AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence            22456778884  46999999999999999999999986543

The function of this family is unknown.

>KOG2268|consensus

Probab=96.39  E-value=0.0053  Score=50.35  Aligned_cols=95  Identities=16%  Similarity=0.234  Sum_probs=63.9

Q ss_pred             HHHHHHHHhhCCC--CCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q psy6044          31 ALREICLLKELKH--KNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHR  108 (282)
Q Consensus        31 ~~~e~~~~~~l~h--~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~  108 (282)
                      ..+|...|+.|..  =-+++.++    .+.-++|||++.|-.+-....   -.+   ...+...+..-+.-|...|++||
T Consensus       157 a~kEfafmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~---v~d---~~~ly~~lm~~Iv~la~~GlIHg  226 (465)
T KOG2268|consen  157 ATKEFAFMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRH---VED---PPTLYDDLMGLIVRLANHGLIHG  226 (465)
T ss_pred             HHHHHHHHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeee---cCC---hHHHHHHHHHHHHHHHHcCceec
Confidence            4557777777733  22444444    345678999998743332221   112   22344455555667888999999


Q ss_pred             CCCCCcEEEcCCCcEEEEecCCccccC
Q psy6044         109 DLKPQNLLINKNGELKLADFGLARAFG  135 (282)
Q Consensus       109 dl~~~nil~~~~~~~~l~df~~~~~~~  135 (282)
                      |+.--||+++.++.+.++||......+
T Consensus       227 DFNEFNimv~dd~~i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  227 DFNEFNIMVKDDDKIVVIDFPQMVSTS  253 (465)
T ss_pred             ccchheeEEecCCCEEEeechHhhccC
Confidence            999999999999999999998765544

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.32  E-value=0.087  Score=45.17  Aligned_cols=63  Identities=14%  Similarity=0.084  Sum_probs=42.0

Q ss_pred             eeeeeeCCCCceEEEeeeec-C--CCC---CCCccHHHHHHHHhhCC---CCCccceeeeeeeCCeEEEEEecCcc
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-V--GNE---GVPSSALREICLLKELK---HKNIVRLYDVLHSEKKLTLVFEHCDQ   68 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~--~~~---~~~~~~~~e~~~~~~l~---h~~i~~~~~~~~~~~~~~iv~e~~~g   68 (282)
                      ||+..+  .++.++||.-.. .  ...   ........|+..|+.+.   -..+++++.++.+.  .+++||++++
T Consensus        48 VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vlvME~L~~  119 (418)
T PLN02756         48 VYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALIGMRYLEP  119 (418)
T ss_pred             EEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEEEEeecCC
Confidence            677775  355799998763 1  111   24556666777777663   24788888887744  4788999976

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.25  E-value=0.042  Score=46.80  Aligned_cols=65  Identities=12%  Similarity=-0.014  Sum_probs=42.6

Q ss_pred             CeeeeeeCCCCceEEEeeeec-C----CCCCCCccHHHHHHHHhhCC--CC-CccceeeeeeeCCeEEEEEecCc
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL-V----GNEGVPSSALREICLLKELK--HK-NIVRLYDVLHSEKKLTLVFEHCD   67 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~-~----~~~~~~~~~~~e~~~~~~l~--h~-~i~~~~~~~~~~~~~~iv~e~~~   67 (282)
                      .||++.+...++.|+||.-.. .    ...-..++..-|.+.|+...  .| ++++++.+  ++....+|||+++
T Consensus        44 ~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vMEdL~  116 (409)
T PRK12396         44 YVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVMEDLS  116 (409)
T ss_pred             EEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHHHhCc
Confidence            489998854467899997664 1    12334566777888888763  34 45555554  4455678888875

>PTZ00384 choline kinase; Provisional

Probab=95.87  E-value=0.11  Score=44.45  Aligned_cols=29  Identities=31%  Similarity=0.281  Sum_probs=24.2

Q ss_pred             CCccccCCCCCcEEEcCCCcEEEEecCCcc
Q psy6044         103 RNVLHRDLKPQNLLINKNGELKLADFGLAR  132 (282)
Q Consensus       103 ~~i~H~dl~~~nil~~~~~~~~l~df~~~~  132 (282)
                      ...+|.|+.+.||+.+ ++.+.++||..+.
T Consensus       227 ~VfCHNDL~~gNIL~~-~~~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDF-NQGIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEec-CCCEEEEEecccc
Confidence            4579999999999875 4569999998774

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.62  E-value=0.19  Score=41.16  Aligned_cols=56  Identities=16%  Similarity=0.046  Sum_probs=37.7

Q ss_pred             CCCceEEEeeeecCCCCCCCccHHHHHHHHhhCC---CCCccceeeeeeeCCeEEEEEecCcc
Q psy6044           9 TPNTALAIKGTHLVGNEGVPSSALREICLLKELK---HKNIVRLYDVLHSEKKLTLVFEHCDQ   68 (282)
Q Consensus         9 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~---h~~i~~~~~~~~~~~~~~iv~e~~~g   68 (282)
                      .+++.+.+|+-.    ......+..|++-++.|.   .-.+++++++...+...++|+||++.
T Consensus        38 ~~~~~~FvK~~~----~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   38 TDGGSYFVKVNS----ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             TTS-EEEEEEEE----GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             CCCccEEEEecC----hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            678899999866    223567889999998883   45578889888877777999999863

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK06148 hypothetical protein; Provisional

Probab=95.53  E-value=0.15  Score=49.32  Aligned_cols=31  Identities=32%  Similarity=0.567  Sum_probs=26.0

Q ss_pred             CCccccCCCCCcEEEcCCC--cEE-EEecCCccc
Q psy6044         103 RNVLHRDLKPQNLLINKNG--ELK-LADFGLARA  133 (282)
Q Consensus       103 ~~i~H~dl~~~nil~~~~~--~~~-l~df~~~~~  133 (282)
                      .+++|+|+.+.||+++.++  ++. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4699999999999998775  554 999998754

>PRK10271 thiK thiamine kinase; Provisional

Probab=94.68  E-value=0.032  Score=42.32  Aligned_cols=29  Identities=34%  Similarity=0.479  Sum_probs=25.2

Q ss_pred             ccccCCCCCcEEEcCCCcEEEEecCCcccc
Q psy6044         105 VLHRDLKPQNLLINKNGELKLADFGLARAF  134 (282)
Q Consensus       105 i~H~dl~~~nil~~~~~~~~l~df~~~~~~  134 (282)
                      .+|+|+.|.|++++.++ ++++||+.+...
T Consensus        79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g  107 (188)
T PRK10271         79 PLHMDVHAGNLVHSASG-LRLIDWEYAGDG  107 (188)
T ss_pred             eecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence            68999999999998777 999999988543

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=94.59  E-value=0.073  Score=43.15  Aligned_cols=44  Identities=34%  Similarity=0.447  Sum_probs=32.8

Q ss_pred             HHHHHHHHHHHHhC--CccccCCCCCcEEEcCCCcEEEEecCCccc
Q psy6044          90 MYQLLRGLAFCHSR--NVLHRDLKPQNLLINKNGELKLADFGLARA  133 (282)
Q Consensus        90 ~~qi~~~l~~lh~~--~i~H~dl~~~nil~~~~~~~~l~df~~~~~  133 (282)
                      +..+-.++.-.+..  -.+|+|+.|.|++.++.+.++|+||..+..
T Consensus       138 ~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         138 LKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            33333444444433  489999999999999999999999987753

>PTZ00296 choline kinase; Provisional

Probab=94.56  E-value=0.43  Score=41.71  Aligned_cols=28  Identities=29%  Similarity=0.473  Sum_probs=23.3

Q ss_pred             CccccCCCCCcEEEcCCCcEEEEecCCcc
Q psy6044         104 NVLHRDLKPQNLLINKNGELKLADFGLAR  132 (282)
Q Consensus       104 ~i~H~dl~~~nil~~~~~~~~l~df~~~~  132 (282)
                      .++|.|+.+.||+.+.+ .++++||..+.
T Consensus       285 VfCHNDl~~~NiL~~~~-~l~LIDfEYAg  312 (442)
T PTZ00296        285 VFCHNDLQENNIINTNK-CLRLIDFEYSG  312 (442)
T ss_pred             eEEeCCCCccceeecCC-CEEEEeecccc
Confidence            48999999999987544 49999998764

>PRK10593 hypothetical protein; Provisional

Probab=94.37  E-value=0.39  Score=39.62  Aligned_cols=83  Identities=16%  Similarity=0.071  Sum_probs=55.6

Q ss_pred             eEEEeeeecCCCCCCCccHHHHHHHHhhCCC---CCccceeeeeee---CCeEEEEEecCcccHHHHHHhcCCCCCHHHH
Q psy6044          13 ALAIKGTHLVGNEGVPSSALREICLLKELKH---KNIVRLYDVLHS---EKKLTLVFEHCDQDLKKYFDSLNGEIDLDIV   86 (282)
Q Consensus        13 ~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h---~~i~~~~~~~~~---~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~   86 (282)
                      .+++|..+.   ......+..|+..++.+..   -.++++++++..   .+..++|||+++|..+..     ...+....
T Consensus        39 ~~~~k~~~~---~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~~~-----~~~~~~~~  110 (297)
T PRK10593         39 NPMPLMARS---FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSVEA-----PARTPERW  110 (297)
T ss_pred             CEEEEEecc---cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEecCC-----CCCCHHHH
Confidence            466676332   1123588999999999843   468888887754   366899999999854432     11234445


Q ss_pred             HHHHHHHHHHHHHHHhC
Q psy6044          87 KSFMYQLLRGLAFCHSR  103 (282)
Q Consensus        87 ~~~~~qi~~~l~~lh~~  103 (282)
                      ..+..+++.+|+.||+.
T Consensus       111 ~~l~~~l~~~La~LH~~  127 (297)
T PRK10593        111 EQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             HHHHHHHHHHHHHHhCC
Confidence            56667778888888864

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=93.98  E-value=0.034  Score=43.30  Aligned_cols=29  Identities=55%  Similarity=0.842  Sum_probs=20.8

Q ss_pred             CccccCCCCCcEEE-cCCCcEEEEecCCcc
Q psy6044         104 NVLHRDLKPQNLLI-NKNGELKLADFGLAR  132 (282)
Q Consensus       104 ~i~H~dl~~~nil~-~~~~~~~l~df~~~~  132 (282)
                      .++|+|+.+.||++ +.++.++++||..+.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            48999999999999 889999999998774

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=93.91  E-value=0.48  Score=37.29  Aligned_cols=53  Identities=19%  Similarity=0.059  Sum_probs=39.7

Q ss_pred             CceEEEeeeecCCCCCCCccHHHHHHHHhhCC---CCCccceeeeeeeCCeEEEEEecCc
Q psy6044          11 NTALAIKGTHLVGNEGVPSSALREICLLKELK---HKNIVRLYDVLHSEKKLTLVFEHCD   67 (282)
Q Consensus        11 ~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~---h~~i~~~~~~~~~~~~~~iv~e~~~   67 (282)
                      ..++.+|+-    .......+..|+.-++.+.   .-.+.+++.+-.+..+.|+|+||++
T Consensus        39 ~~~~FvK~n----~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~   94 (286)
T COG3001          39 TDPFFVKCN----QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLP   94 (286)
T ss_pred             CcceEEEec----chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeecc
Confidence            456777753    3334567888888777773   3568888888889999999999986

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	282
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-123
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-123
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		9e-84
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-83
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-83
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-83
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-82
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		6e-82
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-81
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-81
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-81
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		7e-81
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-81
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		7e-81
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-81
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		7e-81
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-81
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-81
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-81
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-80
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-80
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-80
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-80
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-80
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-80
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-80
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-80
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-80
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-80
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-80
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-80
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-80
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-80
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-80
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-80
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-80
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-80
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-79
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-79
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-79
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-79
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-79
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-77
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-77
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		9e-69
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-56
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-56
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-56
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-54
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-52
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-51
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-51
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-49
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-44
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-43
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-43
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-43
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-43
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-42
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-42
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-41
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-41
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-41
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-41
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-41
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-41
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-41
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-41
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-41
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-40
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-40
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-40
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-40
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-40
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-40
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-40
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-40
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-40
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-40
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-40
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-40
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-40
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-40
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-40
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-40
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-40
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-40
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-40
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-40
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-40
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-39
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-39
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-39
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-39
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-39
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-39
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-39
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		8e-39
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-39
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		9e-39
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-38
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-38
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-38
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-38
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-38
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-38
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-38
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-38
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-38
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-38
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-38
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-38
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-38
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-38
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-38
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-38
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-38
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-38
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-38
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-38
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-38
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-38
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-38
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-38
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-38
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-38
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-38
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-38
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-38
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-38
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-38
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-38
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-38
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-38
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-38
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-38
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-38
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-38
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-38
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-38
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-38
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-38
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-38
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-38
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-38
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-38
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-38
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-38
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-38
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-38
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-38
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-37
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-37
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-37
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-37
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-37
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-37
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-37
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-37
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-37
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-37
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		7e-37
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-37
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		8e-37
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-37
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-36
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-36
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-36
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-36
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-36
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-36
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-36
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-36
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-36
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-36
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-36
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-36
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-36
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-35
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-35
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		4e-35
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-35
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-35
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-35
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-35
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-34
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-34
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-34
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-34
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-34
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-34
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		5e-34
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		5e-34
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		5e-34
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		5e-34
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		5e-34
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		6e-34
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		6e-34
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		6e-34
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-34
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		9e-34
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-33
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-33
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-33
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-33
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-33
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-33
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-33
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-33
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-33
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-32
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-32
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-32
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-32
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		6e-32
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		6e-32
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-30
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-30
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		3e-30
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-30
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-29
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-29
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-29
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-29
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-29
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-29
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-29
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-29
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-29
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-29
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-29
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-29
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-29
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-29
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		2e-29
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-29
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-29
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-29
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-29
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-29
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-29
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-29
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-29
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-28
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		9e-26
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-25
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-25
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-25
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-25
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-25
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-25
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-25
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-25
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		8e-25
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-25
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		9e-25
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-24
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-24
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-24
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-24
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-24
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-24
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-24
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-24
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-24
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-24
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-24
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-24
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-24
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-24
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-24
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-24
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-24
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-24
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-24
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-24
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-23
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-23
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-23
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-21
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-21
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-21
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		8e-21
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-21
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-21
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		9e-21
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		9e-21
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		9e-21
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		9e-21
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-20
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-20
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		5e-20
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-20
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-20
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-19
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-19
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-19
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-19
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-19
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-19
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-19
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-19
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-19
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-19
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-19
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-19
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-19
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-19
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-19
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-18
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-18
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-18
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-18
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-18
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-18
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-18
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-18
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-18
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-18
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-18
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-18
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-18
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-18
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-18
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-18
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-18
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-18
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-18
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-18
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-18
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-18
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		8e-18
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		9e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		9e-18
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		9e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		9e-18
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-17
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-17
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-17
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-17
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-17
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-17
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-17
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-17
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-17
3soa_A	444	Full-Length Human Camkii Length = 444		2e-17
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-17
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-17
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-17
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-17
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-17
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		8e-17
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-17
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		8e-17
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		8e-17
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		8e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		8e-17
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-17
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-17
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-17
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		8e-17
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-17
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-17
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		8e-17
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-17
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-17
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-17
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-17
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		9e-17
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		9e-17
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		9e-17
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		9e-17
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-17
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		9e-17
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		9e-17
3kk8_A	284	Camkii Substrate Complex A Length = 284		9e-17
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		9e-17
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-16
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-16
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-16
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-16
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-16
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-16
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-16
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-16
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-16
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-16
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-16
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-16
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-16
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-16
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-16
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-16
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-16
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-15
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-15
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-15
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-15
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-15
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-15
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-15
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-15
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-15
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-15
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-15
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-15
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-15
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-15
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-15
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-15
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-15
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-15
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		7e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-15
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-14
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-14
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-14
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-14
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-14
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-14
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-14
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-14
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-14
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-14
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-14
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-14
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-14
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-14
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-14
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-14
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-14
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-14
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-14
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-14
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-14
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-14
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-14
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-14
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-14
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		6e-14
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-14
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-14
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-14
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		7e-14
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		8e-14
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		9e-14
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-13
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-13
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-13
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-13
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-13
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-13
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-13
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-13
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-13
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-13
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		3e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-13
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-13
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		3e-13
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-13
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-13
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-13
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		5e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-13
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-13
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		6e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		6e-13
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		6e-13
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-13
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		6e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-13
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		6e-13
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		6e-13
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		6e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-13
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		6e-13
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-13
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		6e-13
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-13
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		6e-13
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		6e-13
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		7e-13
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		7e-13
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		7e-13
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		7e-13
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		7e-13
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-13
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-13
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-13
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		7e-13
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-13
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		7e-13
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		8e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-13
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-12
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-12
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-12
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-12
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-12
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-12
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-12
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-12
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-12
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-12
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-12
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-12
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-12
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-12
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-12
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-12
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-12
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-12
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-12
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-12
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-12
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-12
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-12
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-12
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-12
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-12
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-12
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-12
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-12
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-12
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-12
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-12
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-12
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-12
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-12
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-12
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-12
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-12
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-12
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-12
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-12
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-12
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-12
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-12
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-12
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-12
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-12
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		6e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		6e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		8e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		8e-12
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		8e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		8e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		8e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		8e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		8e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		8e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		8e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		8e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		9e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		9e-12
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		9e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		9e-12
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		9e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		9e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-11
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-11
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-11
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-11
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-11
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		5e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-11
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-11
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		6e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		8e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		9e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		9e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		9e-11
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		9e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		9e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-10
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-10
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-10
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-10
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-10
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-10
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		5e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-10
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-10
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-10
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-10
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-10
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-10
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-10
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		6e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-10
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		7e-10
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-10
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		8e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-10
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		9e-10
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		9e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-09
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-09
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-09
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-09
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-09
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-09
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-09
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-09
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		4e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-09
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		6e-09
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		7e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		7e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		8e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		8e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		9e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		9e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		9e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		9e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		9e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		9e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		9e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		9e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-08
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-08
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-08
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-08
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-08
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-08
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-08
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-08

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  437 bits (1123), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 209/267 (78%), Positives = 235/267 (88%), Gaps = 1/267 (0%)
Query: 7   DRTPNTALAIKGTHLVGN-EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           +R  +  +A+K   L  + EGVPSSALREICLLKELKHKNIVRL+DVLHS+KKLTLVFE 
Sbjct: 23  NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82
Query: 66  CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
           CDQDLKKYFDS NG++D +IVKSF++QLL+GL FCHSRNVLHRDLKPQNLLIN+NGELKL
Sbjct: 83  CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKL 142
Query: 126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
           A+FGLARAFGIPV+CYSAEVVTLWYRPPDVLFGAKLY+TSIDMWSAGCIFAELANAGRPL
Sbjct: 143 ANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
Query: 186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
           FPG+DVDDQLKRIF+LLGTPTE+ WP M  LPD+KP+PMY  + S   V PKL A GRDL
Sbjct: 203 FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDL 262
Query: 246 LQRLLVCNPVQRMSAEDAMSHIYFSDL 272
           LQ LL CNPVQR+SAE+A+ H YFSD 
Sbjct: 263 LQNLLKCNPVQRISAEEALQHPYFSDF 289

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  437 bits (1123), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 209/267 (78%), Positives = 234/267 (87%), Gaps = 1/267 (0%)
Query: 7   DRTPNTALAIKGTHLVGN-EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           +R  +  +A+K   L  + EGVPSSALREICLLKELKHKNIVRL+DVLHS+KKLTLVFE 
Sbjct: 23  NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82
Query: 66  CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
           CDQDLKKYFDS NG++D +IVKSF++QLL+GL FCHSRNVLHRDLKPQNLLIN+NGELKL
Sbjct: 83  CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKL 142
Query: 126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
           ADFGLARAFGIPV+CYSAEVVTLWYRPPDVLFGAKLY+TSIDMWSAGCIFAELANA RPL
Sbjct: 143 ADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPL 202
Query: 186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
           FPG+DVDDQLKRIF+LLGTPTE+ WP M  LPD+KP+PMY  + S   V PKL A GRDL
Sbjct: 203 FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDL 262
Query: 246 LQRLLVCNPVQRMSAEDAMSHIYFSDL 272
           LQ LL CNPVQR+SAE+A+ H YFSD 
Sbjct: 263 LQNLLKCNPVQRISAEEALQHPYFSDF 289

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  306 bits (784), Expect = 9e-84,   Method: Compositional matrix adjust.
 Identities = 153/274 (55%), Positives = 192/274 (70%), Gaps = 4/274 (1%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
           G  +  +  +A+K   L   EG P +A+RE+ LLK+LKH NIV L+D++H+EK LTLVFE
Sbjct: 21  GKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80
Query: 65  HCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELK 124
           + D+DLK+Y D     I++  VK F++QLLRGLA+CH + VLHRDLKPQNLLIN+ GELK
Sbjct: 81  YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELK 140
Query: 125 LADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRP 184
           LADFGLARA  IP K Y  EVVTLWYRPPD+L G+  Y+T IDMW  GCIF E+A  GRP
Sbjct: 141 LADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMA-TGRP 199
Query: 185 LFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP--FPMYHPSMSFSQVAPKLTAKG 242
           LFPGS V++QL  IF++LGTPTE+TWPG+    +FK   +P Y      S  AP+L + G
Sbjct: 200 LFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSH-APRLDSDG 258
Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI 276
            DLL +LL      R+SAEDAM H +F  L   I
Sbjct: 259 ADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI 292

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  305 bits (782), Expect = 1e-83,   Method: Compositional matrix adjust.
 Identities = 145/251 (57%), Positives = 184/251 (73%), Gaps = 3/251 (1%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL 83
           +EG+PS+ +REI +LKELKH NIV+LYDV+H++K+L LVFEH DQDLKK  D   G ++ 
Sbjct: 40  DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLES 99
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
              KSF+ QLL G+A+CH R VLHRDLKPQNLLIN+ GELK+ADFGLARAFGIPV+ Y+ 
Sbjct: 100 VTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
           EVVTLWYR PDVL G+K Y+T+ID+WS GCIFAE+ N G PLFPG    DQL RIF++LG
Sbjct: 160 EVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGVSEADQLMRIFRILG 218
Query: 204 TPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAED 262
           TP    WP +  LP + P F +Y P + +      L   G DLL ++L  +P QR++A+ 
Sbjct: 219 TPNSKNWPNVTELPKYDPNFTVYEP-LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ 277
Query: 263 AMSHIYFSDLN 273
           A+ H YF + N
Sbjct: 278 ALEHAYFKENN 288

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  305 bits (782), Expect = 1e-83,   Method: Compositional matrix adjust.
 Identities = 145/251 (57%), Positives = 184/251 (73%), Gaps = 3/251 (1%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL 83
           +EG+PS+ +REI +LKELKH NIV+LYDV+H++K+L LVFEH DQDLKK  D   G ++ 
Sbjct: 40  DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLES 99
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
              KSF+ QLL G+A+CH R VLHRDLKPQNLLIN+ GELK+ADFGLARAFGIPV+ Y+ 
Sbjct: 100 VTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
           EVVTLWYR PDVL G+K Y+T+ID+WS GCIFAE+ N G PLFPG    DQL RIF++LG
Sbjct: 160 EVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GAPLFPGVSEADQLMRIFRILG 218
Query: 204 TPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAED 262
           TP    WP +  LP + P F +Y P + +      L   G DLL ++L  +P QR++A+ 
Sbjct: 219 TPNSKNWPNVTELPKYDPNFTVYEP-LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ 277
Query: 263 AMSHIYFSDLN 273
           A+ H YF + N
Sbjct: 278 ALEHAYFKENN 288

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  305 bits (781), Expect = 2e-83,   Method: Compositional matrix adjust.
 Identities = 144/251 (57%), Positives = 184/251 (73%), Gaps = 3/251 (1%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL 83
           +EG+PS+ +REI +LKELKH NIV+LYDV+H++K+L LVFEH DQDLKK  D   G ++ 
Sbjct: 40  DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLES 99
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
              KSF+ QLL G+A+CH R VLHRDLKPQNLLIN+ GELK+ADFGLARAFGIPV+ Y+ 
Sbjct: 100 VTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
           E+VTLWYR PDVL G+K Y+T+ID+WS GCIFAE+ N G PLFPG    DQL RIF++LG
Sbjct: 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGVSEADQLMRIFRILG 218
Query: 204 TPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAED 262
           TP    WP +  LP + P F +Y P + +      L   G DLL ++L  +P QR++A+ 
Sbjct: 219 TPNSKNWPNVTELPKYDPNFTVYEP-LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ 277
Query: 263 AMSHIYFSDLN 273
           A+ H YF + N
Sbjct: 278 ALEHAYFKENN 288

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  302 bits (773), Expect = 2e-82,   Method: Compositional matrix adjust.
 Identities = 150/260 (57%), Positives = 190/260 (73%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFEH DQDLKK+ D+  L G I
Sbjct: 45  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTG-I 103
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 104 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 163
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
             EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 164 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 222
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 223 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 281
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 282 KAALAHPFFQDVTKPVPHLR 301

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  300 bits (768), Expect = 6e-82,   Method: Compositional matrix adjust.
 Identities = 149/277 (53%), Positives = 190/277 (68%), Gaps = 11/277 (3%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
           G+++T    +A+K   L   EG PS+A+REI L+KELKH+NIVRLYDV+H+E KLTLVFE
Sbjct: 24  GLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83
Query: 65  HCDQDLKKYFDSLN-----GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK 119
             D DLKKY DS         ++L++VK F +QLL+GLAFCH   +LHRDLKPQNLLINK
Sbjct: 84  FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINK 143
Query: 120 NGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELA 179
            G+LKL DFGLARAFGIPV  +S+EVVTLWYR PDVL G++ Y+TSID+WS GCI AE+ 
Sbjct: 144 RGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI 203
Query: 180 NAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV----- 234
             G+PLFPG++ ++QLK IF ++GTP E  WP +  LP + P     P     QV     
Sbjct: 204 -TGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT 262
Query: 235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD 271
              L     D L  LL  NP  R+SA+ A+ H +F++
Sbjct: 263 KEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  299 bits (765), Expect = 1e-81,   Method: Compositional matrix adjust.
 Identities = 148/260 (56%), Positives = 189/260 (72%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFEH  QDLK + D+  L G I
Sbjct: 41  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTG-I 99
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 100 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
           + EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 218
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 219 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 278 KAALAHPFFQDVTKPVPHLR 297

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  297 bits (760), Expect = 5e-81,   Method: Compositional matrix adjust.
 Identities = 147/253 (58%), Positives = 187/253 (73%), Gaps = 6/253 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 42  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 100
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 101 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 160
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
           + EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 161 THEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 219
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 220 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 261 EDAMSHIYFSDLN 273
           + A++H +F D+ 
Sbjct: 279 KAALAHPFFQDVT 291

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  296 bits (759), Expect = 6e-81,   Method: Compositional matrix adjust.
 Identities = 148/260 (56%), Positives = 189/260 (72%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 49  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 107
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 108 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 167
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
           + EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 168 THEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 226
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 227 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 285
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 286 KAALAHPFFQDVTKPVPHLR 305

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  296 bits (759), Expect = 7e-81,   Method: Compositional matrix adjust.
 Identities = 148/262 (56%), Positives = 190/262 (72%), Gaps = 6/262 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 46  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 104
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 105 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 164
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
           + EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 165 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 223
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 224 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 282
Query: 261 EDAMSHIYFSDLNVAIKSERCQ 282
           + A++H +F D+   +   R +
Sbjct: 283 KAALAHPFFQDVTKPVPHLRLE 304

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  296 bits (759), Expect = 7e-81,   Method: Compositional matrix adjust.
 Identities = 148/260 (56%), Positives = 189/260 (72%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 42  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 100
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 101 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 160
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
           + EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 161 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 219
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 220 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 279 KAALAHPFFQDVTKPVPHLR 298

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  296 bits (759), Expect = 7e-81,   Method: Compositional matrix adjust.
 Identities = 148/260 (56%), Positives = 189/260 (72%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 42  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 100
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 101 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 160
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
           + EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 161 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 219
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 220 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 279 KAALAHPFFQDVTKPVPHLR 298

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  296 bits (759), Expect = 7e-81,   Method: Compositional matrix adjust.
 Identities = 148/260 (56%), Positives = 189/260 (72%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 41  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 99
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 100 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
           + EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 218
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 219 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 278 KAALAHPFFQDVTKPVPHLR 297

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  296 bits (759), Expect = 7e-81,   Method: Compositional matrix adjust.
 Identities = 148/260 (56%), Positives = 189/260 (72%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 41  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 99
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 100 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
           + EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 218
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 219 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 278 KAALAHPFFQDVTKPVPHLR 297

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  296 bits (759), Expect = 7e-81,   Method: Compositional matrix adjust.
 Identities = 148/260 (56%), Positives = 189/260 (72%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 43  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 101
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 102 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 161
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
           + EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 162 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 220
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 221 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 279
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 280 KAALAHPFFQDVTKPVPHLR 299

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  296 bits (758), Expect = 8e-81,   Method: Compositional matrix adjust.
 Identities = 148/260 (56%), Positives = 189/260 (72%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 42  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 100
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 101 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 160
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
           + EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 161 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 219
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 220 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 279 KAALAHPFFQDVTKPVPHLR 298

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  296 bits (758), Expect = 8e-81,   Method: Compositional matrix adjust.
 Identities = 148/260 (56%), Positives = 189/260 (72%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 41  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 99
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 100 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
           + EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 218
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 219 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 278 KAALAHPFFQDVTKPVPHLR 297

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  296 bits (757), Expect = 1e-80,   Method: Compositional matrix adjust.
 Identities = 148/260 (56%), Positives = 189/260 (72%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 49  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 107
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 108 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 167
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
           + EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 168 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 226
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 227 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 285
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 286 KAALAHPFFQDVTKPVPHLR 305

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  295 bits (756), Expect = 1e-80,   Method: Compositional matrix adjust.
 Identities = 148/260 (56%), Positives = 188/260 (72%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 42  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 100
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 101 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 160
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
             EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 161 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 219
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 220 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 279 KAALAHPFFQDVTKPVPHLR 298

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  295 bits (756), Expect = 1e-80,   Method: Compositional matrix adjust.
 Identities = 148/260 (56%), Positives = 188/260 (72%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 44  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 102
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 103 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 162
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
             EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 163 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 221
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 222 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 280
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 281 KAALAHPFFQDVTKPVPHLR 300

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  295 bits (756), Expect = 1e-80,   Method: Compositional matrix adjust.
 Identities = 148/260 (56%), Positives = 188/260 (72%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 41  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 99
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 100 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
             EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 160 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 218
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 219 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 278 KAALAHPFFQDVTKPVPHLR 297

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  295 bits (756), Expect = 1e-80,   Method: Compositional matrix adjust.
 Identities = 148/260 (56%), Positives = 188/260 (72%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 46  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 104
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 105 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 164
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
             EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 165 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 223
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 224 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 282
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 283 KAALAHPFFQDVTKPVPHLR 302

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  295 bits (756), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 147/253 (58%), Positives = 186/253 (73%), Gaps = 6/253 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 42  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 100
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 101 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 160
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
             EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 161 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 219
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 220 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 261 EDAMSHIYFSDLN 273
           + A++H +F D+ 
Sbjct: 279 KAALAHPFFQDVT 291

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  295 bits (756), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 148/260 (56%), Positives = 188/260 (72%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 43  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 101
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 102 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 161
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
             EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 162 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 220
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 221 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 279
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 280 KAALAHPFFQDVTKPVPHLR 299

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  295 bits (756), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 147/253 (58%), Positives = 186/253 (73%), Gaps = 6/253 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 41  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 99
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 100 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
             EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 160 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 218
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 219 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
Query: 261 EDAMSHIYFSDLN 273
           + A++H +F D+ 
Sbjct: 278 KAALAHPFFQDVT 290

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  295 bits (756), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 147/260 (56%), Positives = 189/260 (72%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 42  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 100
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GL+FCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 101 PLPLIKSYLFQLLQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 160
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
           + EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 161 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 219
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 220 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 279 KAALAHPFFQDVTKPVPHLR 298

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  295 bits (756), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 148/260 (56%), Positives = 188/260 (72%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 42  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 100
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 101 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 160
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
             EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 161 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 219
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 220 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 279 KAALAHPFFQDVTKPVPHLR 298

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  295 bits (756), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 148/260 (56%), Positives = 188/260 (72%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 45  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 103
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 104 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 163
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
             EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 164 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 222
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 223 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 281
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 282 KAALAHPFFQDVTKPVPHLR 301

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  295 bits (755), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 148/260 (56%), Positives = 188/260 (72%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 45  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 103
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 104 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 163
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
             EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 164 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 222
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 223 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 281
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 282 KAALAHPFFQDVTKPVPHLR 301

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  295 bits (755), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 148/260 (56%), Positives = 188/260 (72%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 44  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 102
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 103 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 162
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
             EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 163 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 221
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 222 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 280
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 281 KAALAHPFFQDVTKPVPHLR 300

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  295 bits (755), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 147/253 (58%), Positives = 186/253 (73%), Gaps = 6/253 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 43  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 101
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 102 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 161
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
             EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 162 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 220
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 221 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 279
Query: 261 EDAMSHIYFSDLN 273
           + A++H +F D+ 
Sbjct: 280 KAALAHPFFQDVT 292

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  295 bits (754), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 147/251 (58%), Positives = 185/251 (73%), Gaps = 6/251 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 42  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 100
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 101 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 160
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
             EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 161 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 219
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 220 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 261 EDAMSHIYFSD 271
           + A++H +F D
Sbjct: 279 KAALAHPFFQD 289

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  294 bits (752), Expect = 4e-80,   Method: Compositional matrix adjust.
 Identities = 147/260 (56%), Positives = 188/260 (72%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 44  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 102
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKP+NLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 103 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTY 162
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
             EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 163 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 221
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 222 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 280
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 281 KAALAHPFFQDVTKPVPHLR 300

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  294 bits (752), Expect = 4e-80,   Method: Compositional matrix adjust.
 Identities = 147/260 (56%), Positives = 188/260 (72%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLKK+ D+  L G I
Sbjct: 43  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-I 101
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKP+NLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 102 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTY 161
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
             EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 162 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 220
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 221 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 279
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 280 KAALAHPFFQDVTKPVPHLR 299

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  293 bits (751), Expect = 6e-80,   Method: Compositional matrix adjust.
 Identities = 147/260 (56%), Positives = 187/260 (71%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLK + D+  L G I
Sbjct: 45  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTG-I 103
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 104 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 163
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
             EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 164 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 222
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 223 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 281
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 282 KAALAHPFFQDVTKPVPHLR 301

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  292 bits (748), Expect = 1e-79,   Method: Compositional matrix adjust.
 Identities = 145/253 (57%), Positives = 185/253 (73%), Gaps = 6/253 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE    DLKK+ D+  L G I
Sbjct: 43  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTG-I 101
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKP+NLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 102 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTY 161
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
             EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 162 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 220
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 221 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 279
Query: 261 EDAMSHIYFSDLN 273
           + A++H +F D+ 
Sbjct: 280 KAALAHPFFQDVT 292

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  292 bits (747), Expect = 2e-79,   Method: Compositional matrix adjust.
 Identities = 146/260 (56%), Positives = 187/260 (71%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE    DLKK+ D+  L G I
Sbjct: 45  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTG-I 103
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKP+NLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 104 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTY 163
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
             EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 164 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 222
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 223 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 281
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 282 KAALAHPFFQDVTKPVPHLR 301

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  291 bits (746), Expect = 2e-79,   Method: Compositional matrix adjust.
 Identities = 146/260 (56%), Positives = 187/260 (71%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE   QDLK + D+  L G I
Sbjct: 42  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTG-I 100
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKP+NLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 101 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTY 160
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
             EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 161 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 219
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 220 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 279 KAALAHPFFQDVTKPVPHLR 298

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  291 bits (745), Expect = 3e-79,   Method: Compositional matrix adjust.
 Identities = 146/260 (56%), Positives = 186/260 (71%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE    DLK + D+  L G I
Sbjct: 44  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTG-I 102
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 103 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 162
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
             EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 163 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 221
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 222 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 280
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 281 KAALAHPFFQDVTKPVPHLR 300

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  291 bits (745), Expect = 3e-79,   Method: Compositional matrix adjust.
 Identities = 146/260 (56%), Positives = 186/260 (71%), Gaps = 6/260 (2%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS--LNGEI 81
            EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVFE    DLK + D+  L G I
Sbjct: 45  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTG-I 103
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G +KLADFGLARAFG+PV+ Y
Sbjct: 104 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 163
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
             EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    R LFPG    DQL RIF+ 
Sbjct: 164 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRT 222
Query: 202 LGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP E  WPG+  +PD+KP FP +     FS+V P L   GR LL ++L  +P +R+SA
Sbjct: 223 LGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 281
Query: 261 EDAMSHIYFSDLNVAIKSER 280
           + A++H +F D+   +   R
Sbjct: 282 KAALAHPFFQDVTKPVPHLR 301

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  285 bits (729), Expect = 2e-77,   Method: Compositional matrix adjust.
 Identities = 143/255 (56%), Positives = 181/255 (70%), Gaps = 4/255 (1%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL 83
           +EG+PS+A+REI LLKEL H NIV L DV+HSE+ LTLVFE  ++DLKK  D     +  
Sbjct: 59  DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQD 118
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
             +K ++YQLLRG+A CH   +LHRDLKPQNLLIN +G LKLADFGLARAFGIPV+ Y+ 
Sbjct: 119 SQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
           EVVTLWYR PDVL G+K Y+TS+D+WS GCIFAE+   G+PLFPG   DDQL +IF +LG
Sbjct: 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMI-TGKPLFPGVTDDDQLPKIFSILG 237
Query: 204 TPTEDTWPGMNLLPDFK--PFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAE 261
           TP    WP +  LP +K   F ++     +S + P    +G DLL  +L  +P +R+SA 
Sbjct: 238 TPNPREWPQVQELPLWKQRTFQVFEKK-PWSSIIPGFCQEGIDLLSNMLCFDPNKRISAR 296
Query: 262 DAMSHIYFSDLNVAI 276
           DAM+H YF DL+  I
Sbjct: 297 DAMNHPYFKDLDPQI 311

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  285 bits (729), Expect = 2e-77,   Method: Compositional matrix adjust.
 Identities = 143/255 (56%), Positives = 181/255 (70%), Gaps = 4/255 (1%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL 83
           +EG+PS+A+REI LLKEL H NIV L DV+HSE+ LTLVFE  ++DLKK  D     +  
Sbjct: 59  DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQD 118
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
             +K ++YQLLRG+A CH   +LHRDLKPQNLLIN +G LKLADFGLARAFGIPV+ Y+ 
Sbjct: 119 SQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
           EVVTLWYR PDVL G+K Y+TS+D+WS GCIFAE+   G+PLFPG   DDQL +IF +LG
Sbjct: 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMI-TGKPLFPGVTDDDQLPKIFSILG 237
Query: 204 TPTEDTWPGMNLLPDFK--PFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAE 261
           TP    WP +  LP +K   F ++     +S + P    +G DLL  +L  +P +R+SA 
Sbjct: 238 TPNPREWPQVQELPLWKQRTFQVFEKK-PWSSIIPGFCQEGIDLLSNMLCFDPNKRISAR 296
Query: 262 DAMSHIYFSDLNVAI 276
           DAM+H YF DL+  I
Sbjct: 297 DAMNHPYFKDLDPQI 311

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  256 bits (654), Expect = 9e-69,   Method: Compositional matrix adjust.
 Identities = 130/273 (47%), Positives = 186/273 (68%), Gaps = 9/273 (3%)
Query: 5   GVDRTPNTALAIKGTHLVGNE-GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF 63
            +D   N  +AIK   L   E GVP +A+RE+ LLKEL+H+NI+ L  V+H   +L L+F
Sbjct: 53  AIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112
Query: 64  EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN----- 118
           E+ + DLKKY D  N ++ + ++KSF+YQL+ G+ FCHSR  LHRDLKPQNLL++     
Sbjct: 113 EYAENDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDAS 171
Query: 119 KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
           +   LK+ DFGLARAFGIP++ ++ E++TLWYRPP++L G++ Y+TS+D+WS  CI+AE+
Sbjct: 172 ETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEM 231
Query: 179 ANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFK-PFPMYHPSMSFSQVAPK 237
                PLFPG    DQL +IF++LG P + TWPG+  LPD+K  FP +        +   
Sbjct: 232 L-MKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGAL 290
Query: 238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
           L  +G DLL  +L  +PV+R+SA++A+ H YFS
Sbjct: 291 LDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS 323

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  214 bits (544), Expect = 6e-56,   Method: Compositional matrix adjust.
 Identities = 121/272 (44%), Positives = 162/272 (59%), Gaps = 24/272 (8%)
Query: 22  VGNEGVPSSALREICLLKELK---HKNIVRLYDV-----LHSEKKLTLVFEHCDQDLKKY 73
            G EG+P S +RE+ +L+ L+   H N+VRL+DV        E KLTLVFEH DQDL  Y
Sbjct: 49  TGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY 108
Query: 74  FDSL-NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR 132
            D +    +  + +K  M+QLLRGL F HS  V+HRDLKPQN+L+  +G++KLADFGLAR
Sbjct: 109 LDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
Query: 133 AFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD 192
            +   +   S  VVTLWYR P+VL  +  Y T +D+WS GCIFAE+    +PLF GS   
Sbjct: 169 IYSFQMALTSV-VVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRR-KPLFRGSSDV 225
Query: 193 DQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYH--PSMSFSQVAPKLTAKGRDLLQRLL 250
           DQL +I  ++G P E+ WP    LP       +H   +    +    +   G+DLL + L
Sbjct: 226 DQLGKILDVIGLPGEEDWPRDVALPR----QAFHSKSAQPIEKFVTDIDELGKDLLLKCL 281
Query: 251 VCNPVQRMSAEDAMSHIYFSDLNVAIKSERCQ 282
             NP +R+SA  A+SH YF DL      ERC+
Sbjct: 282 TFNPAKRISAYSALSHPYFQDL------ERCK 307

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  214 bits (544), Expect = 6e-56,   Method: Compositional matrix adjust.
 Identities = 121/272 (44%), Positives = 162/272 (59%), Gaps = 24/272 (8%)
Query: 22  VGNEGVPSSALREICLLKELK---HKNIVRLYDV-----LHSEKKLTLVFEHCDQDLKKY 73
            G EG+P S +RE+ +L+ L+   H N+VRL+DV        E KLTLVFEH DQDL  Y
Sbjct: 49  TGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY 108
Query: 74  FDSL-NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR 132
            D +    +  + +K  M+QLLRGL F HS  V+HRDLKPQN+L+  +G++KLADFGLAR
Sbjct: 109 LDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
Query: 133 AFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD 192
            +   +   S  VVTLWYR P+VL  +  Y T +D+WS GCIFAE+    +PLF GS   
Sbjct: 169 IYSFQMALTSV-VVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRR-KPLFRGSSDV 225
Query: 193 DQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYH--PSMSFSQVAPKLTAKGRDLLQRLL 250
           DQL +I  ++G P E+ WP    LP       +H   +    +    +   G+DLL + L
Sbjct: 226 DQLGKILDVIGLPGEEDWPRDVALPR----QAFHSKSAQPIEKFVTDIDELGKDLLLKCL 281
Query: 251 VCNPVQRMSAEDAMSHIYFSDLNVAIKSERCQ 282
             NP +R+SA  A+SH YF DL      ERC+
Sbjct: 282 TFNPAKRISAYSALSHPYFQDL------ERCK 307

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  213 bits (542), Expect = 8e-56,   Method: Compositional matrix adjust.
 Identities = 118/272 (43%), Positives = 160/272 (58%), Gaps = 12/272 (4%)
Query: 7   DRTPNTALAIK----GTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLV 62
           D+  N  +AIK    G      +G+  +ALREI LL+EL H NI+ L D    +  ++LV
Sbjct: 31  DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV 90
Query: 63  FEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           F+  + DL+      +  +    +K++M   L+GL + H   +LHRDLKP NLL+++NG 
Sbjct: 91  FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV 150
Query: 123 LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
           LKLADFGLA++FG P + Y  +VVT WYR P++LFGA++Y   +DMW+ GCI AEL    
Sbjct: 151 LKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL-LR 209
Query: 183 RPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPD---FKPFPMYHPSMSFSQVAPKLT 239
            P  PG    DQL RIF+ LGTPTE+ WP M  LPD   FK FP       FS     L 
Sbjct: 210 VPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLL 269
Query: 240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD 271
               DL+Q L + NP  R++A  A+   YFS+
Sbjct: 270 ----DLIQGLFLFNPCARITATQALKMKYFSN 297

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  209 bits (531), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 116/259 (44%), Positives = 156/259 (60%), Gaps = 18/259 (6%)
Query: 23  GNEGVPSSALREICLLKELK---HKNIVRLYDV-----LHSEKKLTLVFEHCDQDLKKYF 74
           G EG+P S +RE+ +L+ L+   H N+VRL+DV        E KLTLVFEH DQDL  Y 
Sbjct: 50  GEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL 109
Query: 75  DSL-NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARA 133
           D +    +  + +K  M+QLLRGL F HS  V+HRDLKPQN+L+  +G++KLADFGLAR 
Sbjct: 110 DKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169
Query: 134 FGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDD 193
           +   +   S  VVTLWYR P+VL  +  Y T +D+WS GCIFAE+    +PLF GS   D
Sbjct: 170 YSFQMALTSV-VVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRR-KPLFRGSSDVD 226
Query: 194 QLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYH--PSMSFSQVAPKLTAKGRDLLQRLLV 251
           QL +I  ++G P E+ WP    LP       +H   +    +    +   G+DLL + L 
Sbjct: 227 QLGKILDVIGLPGEEDWPRDVALPR----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLT 282
Query: 252 CNPVQRMSAEDAMSHIYFS 270
            NP +R+SA  A+SH YF 
Sbjct: 283 FNPAKRISAYSALSHPYFQ 301

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  201 bits (511), Expect = 4e-52,   Method: Compositional matrix adjust.
 Identities = 115/256 (44%), Positives = 151/256 (58%), Gaps = 14/256 (5%)
Query: 23  GNEGVPSSALREICLLKELK---HKNIVRLYDVLHS-----EKKLTLVFEHCDQDLKKYF 74
           G EG+P S +RE+ LL+ L+   H N+VRL DV  +     E K+TLVFEH DQDL+ Y 
Sbjct: 42  GEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYL 101
Query: 75  DSLNGE-IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARA 133
           D      +  + +K  M Q LRGL F H+  ++HRDLKP+N+L+   G +KLADFGLAR 
Sbjct: 102 DKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI 161
Query: 134 FGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDD 193
           +   +  +   VVTLWYR P+VL  +  Y T +DMWS GCIFAE+    +PLF G+   D
Sbjct: 162 YSYQMALFPV-VVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRR-KPLFCGNSEAD 218
Query: 194 QLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCN 253
           QL +IF L+G P ED WP    LP    FP   P      V P++   G  LL  +L  N
Sbjct: 219 QLGKIFDLIGLPPEDDWPRDVSLPR-GAFPPRGPR-PVQSVVPEMEESGAQLLLEMLTFN 276
Query: 254 PVQRMSAEDAMSHIYF 269
           P +R+SA  A+ H Y 
Sbjct: 277 PHKRISAFRALQHSYL 292

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  199 bits (507), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 115/256 (44%), Positives = 151/256 (58%), Gaps = 14/256 (5%)
Query: 23  GNEGVPSSALREICLLKELK---HKNIVRLYDVLHS-----EKKLTLVFEHCDQDLKKYF 74
           G EG+P S +RE+ LL+ L+   H N+VRL DV  +     E K+TLVFEH DQDL+ Y 
Sbjct: 42  GEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYL 101
Query: 75  DSLNGE-IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARA 133
           D      +  + +K  M Q LRGL F H+  ++HRDLKP+N+L+   G +KLADFGLAR 
Sbjct: 102 DKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI 161
Query: 134 FGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDD 193
           +   +   +  VVTLWYR P+VL  +  Y T +DMWS GCIFAE+    +PLF G+   D
Sbjct: 162 YSYQM-ALAPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRR-KPLFCGNSEAD 218
Query: 194 QLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCN 253
           QL +IF L+G P ED WP    LP    FP   P      V P++   G  LL  +L  N
Sbjct: 219 QLGKIFDLIGLPPEDDWPRDVSLPR-GAFPPRGPR-PVQSVVPEMEESGAQLLLEMLTFN 276
Query: 254 PVQRMSAEDAMSHIYF 269
           P +R+SA  A+ H Y 
Sbjct: 277 PHKRISAFRALQHSYL 292

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  199 bits (505), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 115/256 (44%), Positives = 150/256 (58%), Gaps = 14/256 (5%)
Query: 23  GNEGVPSSALREICLLKELK---HKNIVRLYDVLHS-----EKKLTLVFEHCDQDLKKYF 74
           G EG+P S +RE+ LL+ L+   H N+VRL DV  +     E K+TLVFEH DQDL+ Y 
Sbjct: 42  GEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYL 101
Query: 75  DSLNGE-IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARA 133
           D      +  + +K  M Q LRGL F H+  ++HRDLKP+N+L+   G +KLADFGLAR 
Sbjct: 102 DKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI 161
Query: 134 FGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDD 193
           +   +      VVTLWYR P+VL  +  Y T +DMWS GCIFAE+    +PLF G+   D
Sbjct: 162 YSYQM-ALDPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRR-KPLFCGNSEAD 218
Query: 194 QLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCN 253
           QL +IF L+G P ED WP    LP    FP   P      V P++   G  LL  +L  N
Sbjct: 219 QLGKIFDLIGLPPEDDWPRDVSLPR-GAFPPRGPR-PVQSVVPEMEESGAQLLLEMLTFN 276
Query: 254 PVQRMSAEDAMSHIYF 269
           P +R+SA  A+ H Y 
Sbjct: 277 PHKRISAFRALQHSYL 292

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  192 bits (489), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 112/252 (44%), Positives = 148/252 (58%), Gaps = 14/252 (5%)
Query: 27  VPSSALREICLLKELK---HKNIVRLYDVLHS-----EKKLTLVFEHCDQDLKKYFDSLN 78
           +P S +RE+ LL+ L+   H N+VRL DV  +     E K+TLVFEH DQDL+ Y D   
Sbjct: 54  LPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAP 113
Query: 79  GE-IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
              +  + +K  M Q LRGL F H+  ++HRDLKP+N+L+   G +KLADFGLAR +   
Sbjct: 114 PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 173
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
           +   +  VVTLWYR P+VL  +  Y T +DMWS GCIFAE+    +PLF G+   DQL +
Sbjct: 174 M-ALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRR-KPLFCGNSEADQLGK 230
Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQR 257
           IF L+G P ED WP    LP    FP   P      V P++   G  LL  +L  NP +R
Sbjct: 231 IFDLIGLPPEDDWPRDVSLPR-GAFPPRGPR-PVQSVVPEMEESGAQLLLEMLTFNPHKR 288
Query: 258 MSAEDAMSHIYF 269
           +SA  A+ H Y 
Sbjct: 289 ISAFRALQHSYL 300

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  174 bits (441), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 104/284 (36%), Positives = 162/284 (57%), Gaps = 21/284 (7%)
Query: 1   MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE---- 56
           M +S  D    T +AIK      ++      LREI +L   +H+N++ + D+L +     
Sbjct: 58  MVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEA 117
Query: 57  -KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            + + +V +  + DL K   S   ++  D +  F+YQ+LRGL + HS NVLHRDLKP NL
Sbjct: 118 MRDVYIVQDLMETDLYKLLKS--QQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 175
Query: 116 LINKNGELKLADFGLARAFGIPVKCYSA----EVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           LIN   +LK+ DFGLAR    P   ++      V T WYR P+++  +K YT SID+WS 
Sbjct: 176 LINTTCDLKICDFGLAR-IADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSV 234
Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP--FPMYHPS- 228
           GCI AE+  + RP+FPG    DQL  I  +LG+P+++    +N + + K   +    PS 
Sbjct: 235 GCILAEML-SNRPIFPGKHYLDQLNHILGILGSPSQE---DLNCIINMKARNYLQSLPSK 290
Query: 229 --MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
             ++++++ PK  +K  DLL R+L  NP +R++ E+A++H Y  
Sbjct: 291 TKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLE 334

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  172 bits (435), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 98/262 (37%), Positives = 147/262 (56%), Gaps = 20/262 (7%)
Query: 25  EGVPSSALREICLLKELKHKNIVRLYDVLHSEKK--------LTLVFEHCDQDLKKYFDS 76
           EG P +ALREI +L+ LKH+N+V L ++  ++          + LVF+ C+ DL     +
Sbjct: 58  EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN 117
Query: 77  LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGI 136
           +  +  L  +K  M  LL GL + H   +LHRD+K  N+LI ++G LKLADFGLARAF +
Sbjct: 118 VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 177
Query: 137 PVKC----YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD 192
                   Y   VVTLWYRPP++L G + Y   ID+W AGCI AE+     P+  G+   
Sbjct: 178 AKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQ 236
Query: 193 DQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGR-----DLLQ 247
            QL  I +L G+ T + WP ++    ++   +        +V  +L A  R     DL+ 
Sbjct: 237 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQK--RKVKDRLKAYVRDPYALDLID 294
Query: 248 RLLVCNPVQRMSAEDAMSHIYF 269
           +LLV +P QR+ ++DA++H +F
Sbjct: 295 KLLVLDPAQRIDSDDALNHDFF 316

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  171 bits (434), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 98/262 (37%), Positives = 147/262 (56%), Gaps = 20/262 (7%)
Query: 25  EGVPSSALREICLLKELKHKNIVRLYDVLHSEKK--------LTLVFEHCDQDLKKYFDS 76
           EG P +ALREI +L+ LKH+N+V L ++  ++          + LVF+ C+ DL     +
Sbjct: 58  EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSN 117
Query: 77  LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGI 136
           +  +  L  +K  M  LL GL + H   +LHRD+K  N+LI ++G LKLADFGLARAF +
Sbjct: 118 VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 177
Query: 137 PVKC----YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD 192
                   Y   VVTLWYRPP++L G + Y   ID+W AGCI AE+     P+  G+   
Sbjct: 178 AKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQ 236
Query: 193 DQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGR-----DLLQ 247
            QL  I +L G+ T + WP ++    ++   +        +V  +L A  R     DL+ 
Sbjct: 237 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQK--RKVKDRLKAYVRDPYALDLID 294
Query: 248 RLLVCNPVQRMSAEDAMSHIYF 269
           +LLV +P QR+ ++DA++H +F
Sbjct: 295 KLLVLDPAQRIDSDDALNHDFF 316

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  171 bits (434), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 98/262 (37%), Positives = 147/262 (56%), Gaps = 20/262 (7%)
Query: 25  EGVPSSALREICLLKELKHKNIVRLYDVLHSEKK--------LTLVFEHCDQDLKKYFDS 76
           EG P +ALREI +L+ LKH+N+V L ++  ++          + LVF+ C+ DL     +
Sbjct: 57  EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN 116
Query: 77  LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGI 136
           +  +  L  +K  M  LL GL + H   +LHRD+K  N+LI ++G LKLADFGLARAF +
Sbjct: 117 VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 176
Query: 137 PVKC----YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD 192
                   Y   VVTLWYRPP++L G + Y   ID+W AGCI AE+     P+  G+   
Sbjct: 177 AKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQ 235
Query: 193 DQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGR-----DLLQ 247
            QL  I +L G+ T + WP ++    ++   +        +V  +L A  R     DL+ 
Sbjct: 236 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQK--RKVKDRLKAYVRDPYALDLID 293
Query: 248 RLLVCNPVQRMSAEDAMSHIYF 269
           +LLV +P QR+ ++DA++H +F
Sbjct: 294 KLLVLDPAQRIDSDDALNHDFF 315

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  171 bits (434), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 98/262 (37%), Positives = 147/262 (56%), Gaps = 20/262 (7%)
Query: 25  EGVPSSALREICLLKELKHKNIVRLYDVLHSEKK--------LTLVFEHCDQDLKKYFDS 76
           EG P +ALREI +L+ LKH+N+V L ++  ++          + LVF+ C+ DL     +
Sbjct: 58  EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN 117
Query: 77  LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGI 136
           +  +  L  +K  M  LL GL + H   +LHRD+K  N+LI ++G LKLADFGLARAF +
Sbjct: 118 VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 177
Query: 137 PVKC----YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD 192
                   Y   VVTLWYRPP++L G + Y   ID+W AGCI AE+     P+  G+   
Sbjct: 178 AKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQ 236
Query: 193 DQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGR-----DLLQ 247
            QL  I +L G+ T + WP ++    ++   +        +V  +L A  R     DL+ 
Sbjct: 237 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQK--RKVKDRLKAYVRDPYALDLID 294
Query: 248 RLLVCNPVQRMSAEDAMSHIYF 269
           +LLV +P QR+ ++DA++H +F
Sbjct: 295 KLLVLDPAQRIDSDDALNHDFF 316

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  169 bits (427), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 94/253 (37%), Positives = 139/253 (54%), Gaps = 21/253 (8%)
Query: 31  ALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFM 90
           ALREI +LK+LKH N+V L +V   +++L LVFE+CD  +    D     +   +VKS  
Sbjct: 49  ALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSIT 108
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWY 150
           +Q L+ + FCH  N +HRD+KP+N+LI K+  +KL DFG AR    P   Y  EV T WY
Sbjct: 109 WQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWY 168
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT------ 204
           R P++L G   Y   +D+W+ GC+FAEL  +G PL+PG    DQL  I K LG       
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELL-SGVPLWPGKSDVDQLYLIRKTLGDLIPRHQ 227
Query: 205 ---PTEDTWPGMNL--LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
               T   + G+ +    D +P  +  P++S+  +          LL+  L  +P +R++
Sbjct: 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALG---------LLKGCLHMDPTERLT 278
Query: 260 AEDAMSHIYFSDL 272
            E  + H YF ++
Sbjct: 279 CEQLLHHPYFENI 291

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  167 bits (424), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 102/281 (36%), Positives = 155/281 (55%), Gaps = 15/281 (5%)
Query: 1   MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE---- 56
           M  S  D      +AIK      ++      LREI +L   +H+NI+ + D++ +     
Sbjct: 40  MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDIIRAPTIEQ 99
Query: 57  -KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            K + +V +  + DL K   +    +  D +  F+YQ+LRGL + HS NVLHRDLKP NL
Sbjct: 100 MKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 157
Query: 116 LINKNGELKLADFGLARAFGIPVKCYSA----EVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           L+N   +LK+ DFGLAR    P   ++      V T WYR P+++  +K YT SID+WS 
Sbjct: 158 LLNTTSDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 216
Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT-EDTWPGMNLLPDFKPFPMYHPS-M 229
           GCI AE+  + RP+FPG    DQL  I  +LG+P+ ED   G+NL        + H + +
Sbjct: 217 GCILAEML-SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKARNYLLSLPHKNKV 275
Query: 230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++++ P   +K  DLL ++L  NP +R+  E A++H Y +
Sbjct: 276 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLA 316

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  165 bits (417), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 87/246 (35%), Positives = 134/246 (54%), Gaps = 3/246 (1%)
Query: 27  VPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIV 86
           V   A+REI LLK+L+H+N+V L +V   +K+  LVFE  D  +    +     +D  +V
Sbjct: 67  VKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVV 126
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           + +++Q++ G+ FCHS N++HRD+KP+N+L++++G +KL DFG AR    P + Y  EV 
Sbjct: 127 QKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA 186
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P++L G   Y  ++D+W+ GC+  E+   G PLFPG    DQL  I   LG   
Sbjct: 187 TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMF-MGEPLFPGDSDIDQLYHIMMCLGNLI 245
Query: 207 EDTWPGMNLLPDFKP--FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAM 264
                  N  P F     P         +  PKL+    DL ++ L  +P +R    + +
Sbjct: 246 PRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305
Query: 265 SHIYFS 270
            H +F 
Sbjct: 306 HHDFFQ 311

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  164 bits (415), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 153/281 (54%), Gaps = 15/281 (5%)
Query: 1   MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE---- 56
           M  S  D      +AIK      ++      LREI +L   +H+NI+ + D++ +     
Sbjct: 38  MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 97
Query: 57  -KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            K + +V +  + DL K   +    +  D +  F+YQ+LRGL + HS NVLHRDLKP NL
Sbjct: 98  MKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 155
Query: 116 LINKNGELKLADFGLARAFGIPVKCYSA----EVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           L+N   +LK+ DFGLAR    P   ++      V T WYR P+++  +K YT SID+WS 
Sbjct: 156 LLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 214
Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT-EDTWPGMNLLPDFKPFPMYHPS-M 229
           GCI AE+  + RP+FPG    DQL  I  +LG+P+ ED    +NL        + H + +
Sbjct: 215 GCILAEML-SNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNKV 273
Query: 230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++++ P   +K  DLL ++L  NP +R+  E A++H Y  
Sbjct: 274 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  164 bits (415), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 104/285 (36%), Positives = 158/285 (55%), Gaps = 40/285 (14%)
Query: 22  VGNEGVPSSALREICLLKELKHKNIVRLYDVL--HSEKKLTLVFEHCDQDLK---KYFDS 76
           +   G+  SA REI LL+ELKH N++ L  V   H+++K+ L+F++ + DL    K+  +
Sbjct: 56  IEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRA 115
Query: 77  LNG-----EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI----NKNGELKLAD 127
                   ++   +VKS +YQ+L G+ + H+  VLHRDLKP N+L+     + G +K+AD
Sbjct: 116 SKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175
Query: 128 FGLARAFGIPVKCYS---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRP 184
            G AR F  P+K  +     VVT WYR P++L GA+ YT +ID+W+ GCIFAEL  +  P
Sbjct: 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EP 234
Query: 185 LFPGSDVD---------DQLKRIFKLLGTPTEDTWPGMNLLP-------DFKPFPMYHPS 228
           +F     D         DQL RIF ++G P +  W  +  +P       DF+     + S
Sbjct: 235 IFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCS 294
Query: 229 ----MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
               M   +V P   +K   LLQ+LL  +P++R+++E AM   YF
Sbjct: 295 LIKYMEKHKVKP--DSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 337

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  164 bits (415), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 153/281 (54%), Gaps = 15/281 (5%)
Query: 1   MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE---- 56
           M  S  D      +AIK      ++      LREI +L   +H+NI+ + D++ +     
Sbjct: 38  MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 97
Query: 57  -KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            K + +V +  + DL K   +    +  D +  F+YQ+LRGL + HS NVLHRDLKP NL
Sbjct: 98  MKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 155
Query: 116 LINKNGELKLADFGLARAFGIPVKCYSA----EVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           L+N   +LK+ DFGLAR    P   ++      V T WYR P+++  +K YT SID+WS 
Sbjct: 156 LLNTTXDLKIXDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 214
Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT-EDTWPGMNLLPDFKPFPMYHPS-M 229
           GCI AE+  + RP+FPG    DQL  I  +LG+P+ ED    +NL        + H + +
Sbjct: 215 GCILAEML-SNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNKV 273
Query: 230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++++ P   +K  DLL ++L  NP +R+  E A++H Y  
Sbjct: 274 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  164 bits (414), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 153/281 (54%), Gaps = 15/281 (5%)
Query: 1   MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE---- 56
           M  S  D      +AIK      ++      LREI +L   +H+NI+ + D++ +     
Sbjct: 38  MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 97
Query: 57  -KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            K + +V +  + DL K   +    +  D +  F+YQ+LRGL + HS NVLHRDLKP NL
Sbjct: 98  MKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 155
Query: 116 LINKNGELKLADFGLARAFGIPVKCYSA----EVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           L+N   +LK+ DFGLAR    P   ++      V T WYR P+++  +K YT SID+WS 
Sbjct: 156 LLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 214
Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT-EDTWPGMNLLPDFKPFPMYHPS-M 229
           GCI AE+  + RP+FPG    DQL  I  +LG+P+ ED    +NL        + H + +
Sbjct: 215 GCILAEML-SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 273
Query: 230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++++ P   +K  DLL ++L  NP +R+  E A++H Y  
Sbjct: 274 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  164 bits (414), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 153/281 (54%), Gaps = 15/281 (5%)
Query: 1   MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE---- 56
           M  S  D      +AIK      ++      LREI +L   +H+NI+ + D++ +     
Sbjct: 42  MVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101
Query: 57  -KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            K + +V +  + DL K   +    +  D +  F+YQ+LRGL + HS NVLHRDLKP NL
Sbjct: 102 MKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 159
Query: 116 LINKNGELKLADFGLARAFGIPVKCYSA----EVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           L+N   +LK+ DFGLAR    P   ++      V T WYR P+++  +K YT SID+WS 
Sbjct: 160 LLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 218
Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT-EDTWPGMNLLPDFKPFPMYHPS-M 229
           GCI AE+  + RP+FPG    DQL  I  +LG+P+ ED    +NL        + H + +
Sbjct: 219 GCILAEML-SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 277
Query: 230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++++ P   +K  DLL ++L  NP +R+  E A++H Y  
Sbjct: 278 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  163 bits (413), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 154/281 (54%), Gaps = 15/281 (5%)
Query: 1   MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE---- 56
           M  S  D      +AIK      ++      LREI +L   +H+NI+ + D++ +     
Sbjct: 40  MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDIIRAPTIEQ 99
Query: 57  -KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            K + +V +  + DL K   +    +  D +  F+YQ+LRGL + HS NVLHRDLKP NL
Sbjct: 100 MKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 157
Query: 116 LINKNGELKLADFGLARAFGIPVKCYSA----EVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           L+N   +LK+ DFGLAR    P   ++      V T WYR P+++  +K YT SID+WS 
Sbjct: 158 LLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 216
Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT-EDTWPGMNLLPDFKPFPMYHPS-M 229
           GCI AE+  + RP+FPG    DQL  I  +LG+P+ ED    +NL        + H + +
Sbjct: 217 GCILAEML-SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 275
Query: 230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++++ P   +K  DLL ++L  NP +R+  E A++H Y +
Sbjct: 276 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLA 316

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  163 bits (413), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 153/281 (54%), Gaps = 15/281 (5%)
Query: 1   MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE---- 56
           M  S  D      +AIK      ++      LREI +L   +H+NI+ + D++ +     
Sbjct: 38  MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 97
Query: 57  -KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            K + +V +  + DL K   +    +  D +  F+YQ+LRGL + HS NVLHRDLKP NL
Sbjct: 98  MKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 155
Query: 116 LINKNGELKLADFGLARAFGIPVKCYSA----EVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           L+N   +LK+ DFGLAR    P   ++      V T WYR P+++  +K YT SID+WS 
Sbjct: 156 LLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 214
Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT-EDTWPGMNLLPDFKPFPMYHPS-M 229
           GCI AE+  + RP+FPG    DQL  I  +LG+P+ ED    +NL        + H + +
Sbjct: 215 GCILAEML-SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 273
Query: 230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++++ P   +K  DLL ++L  NP +R+  E A++H Y  
Sbjct: 274 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  163 bits (413), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 153/281 (54%), Gaps = 15/281 (5%)
Query: 1   MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE---- 56
           M  S  D      +AIK      ++      LREI +L   +H+NI+ + D++ +     
Sbjct: 40  MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 99
Query: 57  -KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            K + +V +  + DL K   +    +  D +  F+YQ+LRGL + HS NVLHRDLKP NL
Sbjct: 100 MKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 157
Query: 116 LINKNGELKLADFGLARAFGIPVKCYSA----EVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           L+N   +LK+ DFGLAR    P   ++      V T WYR P+++  +K YT SID+WS 
Sbjct: 158 LLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 216
Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT-EDTWPGMNLLPDFKPFPMYHPS-M 229
           GCI AE+  + RP+FPG    DQL  I  +LG+P+ ED    +NL        + H + +
Sbjct: 217 GCILAEML-SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 275
Query: 230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++++ P   +K  DLL ++L  NP +R+  E A++H Y  
Sbjct: 276 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 316

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 153/281 (54%), Gaps = 15/281 (5%)
Query: 1   MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE---- 56
           M  S  D      +AIK      ++      LREI +L   +H+NI+ + D++ +     
Sbjct: 58  MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 117
Query: 57  -KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            K + +V +  + DL K   +    +  D +  F+YQ+LRGL + HS NVLHRDLKP NL
Sbjct: 118 MKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 175
Query: 116 LINKNGELKLADFGLARAFGIPVKCYSA----EVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           L+N   +LK+ DFGLAR    P   ++      V T WYR P+++  +K YT SID+WS 
Sbjct: 176 LLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 234
Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT-EDTWPGMNLLPDFKPFPMYHPS-M 229
           GCI AE+  + RP+FPG    DQL  I  +LG+P+ ED    +NL        + H + +
Sbjct: 235 GCILAEML-SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 293
Query: 230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++++ P   +K  DLL ++L  NP +R+  E A++H Y  
Sbjct: 294 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 334

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 153/281 (54%), Gaps = 15/281 (5%)
Query: 1   MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE---- 56
           M  S  D      +AIK      ++      LREI +L   +H+NI+ + D++ +     
Sbjct: 42  MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101
Query: 57  -KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            K + +V +  + DL K   +    +  D +  F+YQ+LRGL + HS NVLHRDLKP NL
Sbjct: 102 MKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 159
Query: 116 LINKNGELKLADFGLARAFGIPVKCYSA----EVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           L+N   +LK+ DFGLAR    P   ++      V T WYR P+++  +K YT SID+WS 
Sbjct: 160 LLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 218
Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT-EDTWPGMNLLPDFKPFPMYHPS-M 229
           GCI AE+  + RP+FPG    DQL  I  +LG+P+ ED    +NL        + H + +
Sbjct: 219 GCILAEML-SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 277
Query: 230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++++ P   +K  DLL ++L  NP +R+  E A++H Y  
Sbjct: 278 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 153/281 (54%), Gaps = 15/281 (5%)
Query: 1   MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE---- 56
           M  S  D      +AIK      ++      LREI +L   +H+NI+ + D++ +     
Sbjct: 42  MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101
Query: 57  -KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            K + +V +  + DL K   +    +  D +  F+YQ+LRGL + HS NVLHRDLKP NL
Sbjct: 102 MKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 159
Query: 116 LINKNGELKLADFGLARAFGIPVKCYSA----EVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           L+N   +LK+ DFGLAR    P   ++      V T WYR P+++  +K YT SID+WS 
Sbjct: 160 LLNTTCDLKICDFGLARV-ADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSV 218
Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT-EDTWPGMNLLPDFKPFPMYHPS-M 229
           GCI AE+  + RP+FPG    DQL  I  +LG+P+ ED    +NL        + H + +
Sbjct: 219 GCILAEML-SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 277
Query: 230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++++ P   +K  DLL ++L  NP +R+  E A++H Y  
Sbjct: 278 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 153/281 (54%), Gaps = 15/281 (5%)
Query: 1   MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE---- 56
           M  S  D      +AIK      ++      LREI +L   +H+NI+ + D++ +     
Sbjct: 43  MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 102
Query: 57  -KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            K + +V +  + DL K   +    +  D +  F+YQ+LRGL + HS NVLHRDLKP NL
Sbjct: 103 MKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 160
Query: 116 LINKNGELKLADFGLARAFGIPVKCYSA----EVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           L+N   +LK+ DFGLAR    P   ++      V T WYR P+++  +K YT SID+WS 
Sbjct: 161 LLNTTCDLKICDFGLARV-ADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSV 219
Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT-EDTWPGMNLLPDFKPFPMYHPS-M 229
           GCI AE+  + RP+FPG    DQL  I  +LG+P+ ED    +NL        + H + +
Sbjct: 220 GCILAEML-SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 278
Query: 230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++++ P   +K  DLL ++L  NP +R+  E A++H Y  
Sbjct: 279 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 319

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 153/281 (54%), Gaps = 15/281 (5%)
Query: 1   MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE---- 56
           M  S  D      +AIK      ++      LREI +L   +H+NI+ + D++ +     
Sbjct: 46  MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 105
Query: 57  -KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            K + +V +  + DL K   +    +  D +  F+YQ+LRGL + HS NVLHRDLKP NL
Sbjct: 106 MKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 163
Query: 116 LINKNGELKLADFGLARAFGIPVKCYSA----EVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           L+N   +LK+ DFGLAR    P   ++      V T WYR P+++  +K YT SID+WS 
Sbjct: 164 LLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 222
Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT-EDTWPGMNLLPDFKPFPMYHPS-M 229
           GCI AE+  + RP+FPG    DQL  I  +LG+P+ ED    +NL        + H + +
Sbjct: 223 GCILAEML-SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 281
Query: 230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++++ P   +K  DLL ++L  NP +R+  E A++H Y  
Sbjct: 282 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 322

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 153/281 (54%), Gaps = 15/281 (5%)
Query: 1   MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE---- 56
           M  S  D      +AIK      ++      LREI +L   +H+NI+ + D++ +     
Sbjct: 38  MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 97
Query: 57  -KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            K + +V +  + DL K   +    +  D +  F+YQ+LRGL + HS NVLHRDLKP NL
Sbjct: 98  MKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 155
Query: 116 LINKNGELKLADFGLARAFGIPVKCYSA----EVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           L+N   +LK+ DFGLAR    P   ++      V T WYR P+++  +K YT SID+WS 
Sbjct: 156 LLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 214
Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT-EDTWPGMNLLPDFKPFPMYHPS-M 229
           GCI AE+  + RP+FPG    DQL  I  +LG+P+ ED    +NL        + H + +
Sbjct: 215 GCILAEML-SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 273
Query: 230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++++ P   +K  DLL ++L  NP +R+  E A++H Y  
Sbjct: 274 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 153/281 (54%), Gaps = 15/281 (5%)
Query: 1   MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE---- 56
           M  S  D      +AIK      ++      LREI +L   +H+NI+ + D++ +     
Sbjct: 36  MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 95
Query: 57  -KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            K + +V +  + DL K   +    +  D +  F+YQ+LRGL + HS NVLHRDLKP NL
Sbjct: 96  MKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 153
Query: 116 LINKNGELKLADFGLARAFGIPVKCYSA----EVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           L+N   +LK+ DFGLAR    P   ++      V T WYR P+++  +K YT SID+WS 
Sbjct: 154 LLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 212
Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT-EDTWPGMNLLPDFKPFPMYHPS-M 229
           GCI AE+  + RP+FPG    DQL  I  +LG+P+ ED    +NL        + H + +
Sbjct: 213 GCILAEML-SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 271
Query: 230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++++ P   +K  DLL ++L  NP +R+  E A++H Y  
Sbjct: 272 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 312

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 102/281 (36%), Positives = 151/281 (53%), Gaps = 15/281 (5%)
Query: 1   MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE---- 56
           M  S  D      +AIK      ++      LREI +L   +H+NI+ + D++ +     
Sbjct: 58  MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 117
Query: 57  -KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            K + LV      DL K   +    +  D +  F+YQ+LRGL + HS NVLHRDLKP NL
Sbjct: 118 MKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 175
Query: 116 LINKNGELKLADFGLARAFGIPVKCYSA----EVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           L+N   +LK+ DFGLAR    P   ++      V T WYR P+++  +K YT SID+WS 
Sbjct: 176 LLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 234
Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT-EDTWPGMNLLPDFKPFPMYHPS-M 229
           GCI AE+  + RP+FPG    DQL  I  +LG+P+ ED    +NL        + H + +
Sbjct: 235 GCILAEML-SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 293
Query: 230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++++ P   +K  DLL ++L  NP +R+  E A++H Y  
Sbjct: 294 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 334

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 97/259 (37%), Positives = 142/259 (54%), Gaps = 23/259 (8%)
Query: 31  ALREICLLKELKHKNIVRLYDVLHSE-----KKLTLVFEHCDQDLKKYFDSLNGEIDLDI 85
            LREI +LK  KH+NI+ ++++   +      ++ ++ E    DL +   +    +  D 
Sbjct: 56  TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST--QMLSDDH 113
Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-------GIPV 138
           ++ F+YQ LR +   H  NV+HRDLKP NLLIN N +LK+ DFGLAR           P 
Sbjct: 114 IQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 139 KCYSA---EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL 195
              S     V T WYR P+V+  +  Y+ ++D+WS GCI AEL    RP+FPG D   QL
Sbjct: 174 GQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF-LRRPIFPGRDYRHQL 232
Query: 196 KRIFKLLGTPTEDTWPGMNLLPD----FKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLV 251
             IF ++GTP  D        P      K  PMY P+    ++ P++  KG DLLQR+LV
Sbjct: 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMY-PAAPLEKMFPRVNPKGIDLLQRMLV 291
Query: 252 CNPVQRMSAEDAMSHIYFS 270
            +P +R++A++A+ H Y  
Sbjct: 292 FDPAKRITAKEALEHPYLQ 310

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 153/281 (54%), Gaps = 15/281 (5%)
Query: 1   MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE---- 56
           M  S  D      +AIK      ++      LREI +L   +H+NI+ + D++ +     
Sbjct: 43  MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 102
Query: 57  -KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            K + +V +  + DL K   +    +  D +  F+YQ+LRGL + HS NVLHRDLKP NL
Sbjct: 103 MKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 160
Query: 116 LINKNGELKLADFGLARAFGIPVKCYSA----EVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           L+N   +LK+ DFGLAR    P   ++      V T WYR P+++  +K YT SID+WS 
Sbjct: 161 LLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 219
Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT-EDTWPGMNLLPDFKPFPMYHPS-M 229
           GCI AE+  + RP+FPG    DQL  I  +LG+P+ ED    +NL        + H + +
Sbjct: 220 GCILAEML-SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 278
Query: 230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++++ P   +K  DLL ++L  NP +R+  E A++H Y  
Sbjct: 279 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 319

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 153/281 (54%), Gaps = 15/281 (5%)
Query: 1   MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE---- 56
           M  S  D      +AIK      ++      LREI +L   +H+NI+ + D++ +     
Sbjct: 44  MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 103
Query: 57  -KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            K + +V +  + DL K   +    +  D +  F+YQ+LRGL + HS NVLHRDLKP NL
Sbjct: 104 MKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 161
Query: 116 LINKNGELKLADFGLARAFGIPVKCYSA----EVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           L+N   +LK+ DFGLAR    P   ++      V T WYR P+++  +K YT SID+WS 
Sbjct: 162 LLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 220
Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT-EDTWPGMNLLPDFKPFPMYHPS-M 229
           GCI AE+  + RP+FPG    DQL  I  +LG+P+ ED    +NL        + H + +
Sbjct: 221 GCILAEML-SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 279
Query: 230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++++ P   +K  DLL ++L  NP +R+  E A++H Y  
Sbjct: 280 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 320

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 153/281 (54%), Gaps = 15/281 (5%)
Query: 1   MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE---- 56
           M  S  D      +AIK      ++      LREI +L   +H+NI+ + D++ +     
Sbjct: 35  MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 94
Query: 57  -KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            K + +V +  + DL K   +    +  D +  F+YQ+LRGL + HS NVLHRDLKP NL
Sbjct: 95  MKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 152
Query: 116 LINKNGELKLADFGLARAFGIPVKCYSA----EVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           L+N   +LK+ DFGLAR    P   ++      V T WYR P+++  +K YT SID+WS 
Sbjct: 153 LLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 211
Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT-EDTWPGMNLLPDFKPFPMYHPS-M 229
           GCI AE+  + RP+FPG    DQL  I  +LG+P+ ED    +NL        + H + +
Sbjct: 212 GCILAEML-SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 270
Query: 230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++++ P   +K  DLL ++L  NP +R+  E A++H Y  
Sbjct: 271 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 311

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 153/281 (54%), Gaps = 15/281 (5%)
Query: 1   MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE---- 56
           M  S  D      +AIK      ++      LREI +L   +H+NI+ + D++ +     
Sbjct: 42  MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101
Query: 57  -KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            K + +V +  + DL K   +    +  D +  F+YQ+LRGL + HS NVLHRDLKP NL
Sbjct: 102 MKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 159
Query: 116 LINKNGELKLADFGLARAFGIPVKCYSA----EVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           L+N   +LK+ DFGLAR    P   ++      V T WYR P+++  +K YT SID+WS 
Sbjct: 160 LLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 218
Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT-EDTWPGMNLLPDFKPFPMYHPS-M 229
           GCI AE+  + RP+FPG    DQL  I  +LG+P+ ED    +NL        + H + +
Sbjct: 219 GCILAEML-SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 277
Query: 230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++++ P   +K  DLL ++L  NP +R+  E A++H Y  
Sbjct: 278 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 96/259 (37%), Positives = 141/259 (54%), Gaps = 23/259 (8%)
Query: 31  ALREICLLKELKHKNIVRLYDVLHSE-----KKLTLVFEHCDQDLKKYFDSLNGEIDLDI 85
            LREI +LK  KH+NI+ ++++   +      ++ ++ E    DL +   +    +  D 
Sbjct: 56  TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST--QMLSDDH 113
Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE- 144
           ++ F+YQ LR +   H  NV+HRDLKP NLLIN N +LK+ DFGLAR         S   
Sbjct: 114 IQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 145 ---------VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL 195
                    V T WYR P+V+  +  Y+ ++D+WS GCI AEL    RP+FPG D   QL
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF-LRRPIFPGRDYRHQL 232
Query: 196 KRIFKLLGTPTEDTWPGMNLLPD----FKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLV 251
             IF ++GTP  D        P      K  PMY P+    ++ P++  KG DLLQR+LV
Sbjct: 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMY-PAAPLEKMFPRVNPKGIDLLQRMLV 291
Query: 252 CNPVQRMSAEDAMSHIYFS 270
            +P +R++A++A+ H Y  
Sbjct: 292 FDPAKRITAKEALEHPYLQ 310

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 96/259 (37%), Positives = 141/259 (54%), Gaps = 23/259 (8%)
Query: 31  ALREICLLKELKHKNIVRLYDVLHSE-----KKLTLVFEHCDQDLKKYFDSLNGEIDLDI 85
            LREI +LK  KH+NI+ ++++   +      ++ ++ E    DL +   +    +  D 
Sbjct: 56  TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST--QMLSDDH 113
Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE- 144
           ++ F+YQ LR +   H  NV+HRDLKP NLLIN N +LK+ DFGLAR         S   
Sbjct: 114 IQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 145 ---------VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL 195
                    V T WYR P+V+  +  Y+ ++D+WS GCI AEL    RP+FPG D   QL
Sbjct: 174 GQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF-LRRPIFPGRDYRHQL 232
Query: 196 KRIFKLLGTPTEDTWPGMNLLPD----FKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLV 251
             IF ++GTP  D        P      K  PMY P+    ++ P++  KG DLLQR+LV
Sbjct: 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMY-PAAPLEKMFPRVNPKGIDLLQRMLV 291
Query: 252 CNPVQRMSAEDAMSHIYFS 270
            +P +R++A++A+ H Y  
Sbjct: 292 FDPAKRITAKEALEHPYLQ 310

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  162 bits (409), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 152/281 (54%), Gaps = 15/281 (5%)
Query: 1   MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE---- 56
           M  S  D      +AIK      ++      LREI +L   +H+NI+ + D++ +     
Sbjct: 36  MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 95
Query: 57  -KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            K + +V +  + DL K   +    +  D +  F+YQ+LRGL + HS NVLHRDLKP NL
Sbjct: 96  MKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 153
Query: 116 LINKNGELKLADFGLARAFGIPVKCYSA----EVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           L+N   +LK+ DFGLAR    P   ++      V T WYR P+++  +K YT SID+WS 
Sbjct: 154 LLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 212
Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP-TEDTWPGMNLLPDFKPFPMYHPS-M 229
           GCI AE+  + RP+FPG    DQL  I  +LG+P  ED    +NL        + H + +
Sbjct: 213 GCILAEML-SNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKARNYLLSLPHKNKV 271
Query: 230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++++ P   +K  DLL ++L  NP +R+  E A++H Y  
Sbjct: 272 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 312

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 96/250 (38%), Positives = 138/250 (55%), Gaps = 22/250 (8%)
Query: 33  REICLLKELKHKNIVRLYDV------LHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK LKH+N++ L DV      +    ++ LV      DL     S    +  + V
Sbjct: 76  RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKS--QALSDEHV 133
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQLLRGL + HS  ++HRDLKP N+ +N++ EL++ DFGLAR     +  Y   V 
Sbjct: 134 QFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGY---VA 190
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   G+ LFPGSD  DQLKRI +++GTP+
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQ-GKALFPGSDYIDQLKRIMEVVGTPS 249
Query: 207 EDTWPGMN------LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
            +    ++       +    P P    S  F    P       DLL R+LV +  QR+SA
Sbjct: 250 PEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAI----DLLGRMLVLDSDQRVSA 305
Query: 261 EDAMSHIYFS 270
            +A++H YFS
Sbjct: 306 AEALAHAYFS 315

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 152/281 (54%), Gaps = 15/281 (5%)
Query: 1   MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE---- 56
           M  S  D      +AIK      ++      LREI +L   +H+NI+ + D++ +     
Sbjct: 42  MVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101
Query: 57  -KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            K + +V +  + DL K        +  D +  F+YQ+LRGL + HS NVLHRDLKP NL
Sbjct: 102 MKDVYIVQDLMETDLYKLLKC--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 159
Query: 116 LINKNGELKLADFGLARAFGIPVKCYSA----EVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           L+N   +LK+ DFGLAR    P   ++      V T WYR P+++  +K YT SID+WS 
Sbjct: 160 LLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 218
Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT-EDTWPGMNLLPDFKPFPMYHPS-M 229
           GCI AE+  + RP+FPG    DQL  I  +LG+P+ ED    +NL        + H + +
Sbjct: 219 GCILAEML-SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 277
Query: 230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++++ P   +K  DLL ++L  NP +R+  E A++H Y  
Sbjct: 278 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 100/281 (35%), Positives = 153/281 (54%), Gaps = 15/281 (5%)
Query: 1   MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE---- 56
           M  S  D      +AI+      ++      LREI +L   +H+NI+ + D++ +     
Sbjct: 42  MVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101
Query: 57  -KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            K + +V +  + DL K   +    +  D +  F+YQ+LRGL + HS NVLHRDLKP NL
Sbjct: 102 MKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 159
Query: 116 LINKNGELKLADFGLARAFGIPVKCYSA----EVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           L+N   +LK+ DFGLAR    P   ++      V T WYR P+++  +K YT SID+WS 
Sbjct: 160 LLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 218
Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT-EDTWPGMNLLPDFKPFPMYHPS-M 229
           GCI AE+  + RP+FPG    DQL  I  +LG+P+ ED    +NL        + H + +
Sbjct: 219 GCILAEML-SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 277
Query: 230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++++ P   +K  DLL ++L  NP +R+  E A++H Y  
Sbjct: 278 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  161 bits (408), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 106/287 (36%), Positives = 161/287 (56%), Gaps = 25/287 (8%)
Query: 4   SGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLH-SEKKLT-- 60
           S VD   +  +AIK   L   + V   ALREI +++ L H NIV+++++L  S  +LT  
Sbjct: 29  SAVDNDCDKRVAIKKIVLTDPQSV-KHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87
Query: 61  -----------LVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRD 109
                      +V E+ + DL    +   G +  +  + FMYQLLRGL + HS NVLHRD
Sbjct: 88  VGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRD 145
Query: 110 LKPQNLLIN-KNGELKLADFGLARAFGIPVKCY----SAEVVTLWYRPPDVLFGAKLYTT 164
           LKP NL IN ++  LK+ DFGLAR    P   +    S  +VT WYR P +L     YT 
Sbjct: 146 LKPANLFINTEDLVLKIGDFGLARIMD-PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTK 204
Query: 165 SIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG-TPTEDTWPGMNLLPDFKPFP 223
           +IDMW+AGCIFAE+   G+ LF G+   +Q++ I + +     ED    ++++P +    
Sbjct: 205 AIDMWAAGCIFAEML-TGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRND 263
Query: 224 MYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
           M  P    +Q+ P ++ +  D L+++L  +P+ R++AE+A+SH Y S
Sbjct: 264 MTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS 310

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  161 bits (407), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 99/256 (38%), Positives = 151/256 (58%), Gaps = 18/256 (7%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKK----LTLVFEHCDQDL---KKYFDSLNGEIDL 83
           RE+ +++ +KH N+V L    +S  +KK    L LV E+  + +    +++  L   + +
Sbjct: 81  RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPM 140
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYS 142
            ++K +MYQLLR LA+ HS  + HRD+KPQNLL++  +G LKL DFG A+   I  +   
Sbjct: 141 LLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-IAGEPNV 199
Query: 143 AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
           + + + +YR P+++FGA  YTT+ID+WS GC+ AEL   G+PLFPG    DQL  I K+L
Sbjct: 200 SXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ-GQPLFPGESGIDQLVEIIKVL 258
Query: 203 GTPTEDTWPGMNLLPDF--KPFPMYHPSMSFSQV-APKLTAKGRDLLQRLLVCNPVQRMS 259
           GTP+ +    MN  P++    FP   P   FS+V  P+      DL+ RLL   P  R++
Sbjct: 259 GTPSREQIKTMN--PNYMEHKFPQIRPH-PFSKVFRPRTPPDAIDLISRLLEYTPSARLT 315
Query: 260 AEDAMSHIYFSDLNVA 275
           A +A+ H +F +L   
Sbjct: 316 AIEALCHPFFDELRTG 331

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 97/252 (38%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVL--------HSEKKLTLVFEHCDQDLKKYFDSLNGEIDLD 84
           RE+ LLK LKH+N++ L DV          SE  L       D +      +L+ E    
Sbjct: 76  RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEH--- 132
Query: 85  IVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE 144
            V+  +YQLLRGL + HS  ++HRDLKP N+ +N++ EL++ DFGLAR     +  Y   
Sbjct: 133 -VQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGY--- 188
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
           V T WYR P+++     Y  ++D+WS GCI AEL   G+ LFPGSD  DQLKRI +++GT
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQ-GKALFPGSDYIDQLKRIMEVVGT 247
Query: 205 PTEDTWPGMN------LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
           P+ +    ++       +    P P    S  F    P       DLL R+LV +  QR+
Sbjct: 248 PSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAI----DLLGRMLVLDSDQRV 303
Query: 259 SAEDAMSHIYFS 270
           SA +A++H YFS
Sbjct: 304 SAAEALAHAYFS 315

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 94/250 (37%), Positives = 138/250 (55%), Gaps = 22/250 (8%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 127
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++  A  Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GTP 
Sbjct: 185 TRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGTPG 243
Query: 207 ED------TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
            +      +    N +          P M+F+ V         DLL+++LV +  +R++A
Sbjct: 244 AELLKKISSESARNYIQSLTQM----PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 261 EDAMSHIYFS 270
             A++H YF+
Sbjct: 300 AQALAHAYFA 309

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  158 bits (399), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 97/252 (38%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVL--------HSEKKLTLVFEHCDQDLKKYFDSLNGEIDLD 84
           RE+ LLK LKH+N++ L DV          SE  L       D +      +L+ E    
Sbjct: 68  RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEH--- 124
Query: 85  IVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE 144
            V+  +YQLLRGL + HS  ++HRDLKP N+ +N++ EL++ DFGLAR     +  Y   
Sbjct: 125 -VQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGY--- 180
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
           V T WYR P+++     Y  ++D+WS GCI AEL   G+ LFPGSD  DQLKRI +++GT
Sbjct: 181 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQ-GKALFPGSDYIDQLKRIMEVVGT 239
Query: 205 PTEDTWPGMN------LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
           P+ +    ++       +    P P    S  F    P       DLL R+LV +  QR+
Sbjct: 240 PSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAI----DLLGRMLVLDSDQRV 295
Query: 259 SAEDAMSHIYFS 270
           SA +A++H YFS
Sbjct: 296 SAAEALAHAYFS 307

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 93/250 (37%), Positives = 137/250 (54%), Gaps = 22/250 (8%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 76  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 133
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 134 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGY---VA 190
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GTP 
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGTPG 249
Query: 207 ED------TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
            +      +    N +          P M+F+ V         DLL+++LV +  +R++A
Sbjct: 250 AELLKKISSESARNYIQSLTQM----PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 305
Query: 261 EDAMSHIYFS 270
             A++H YF+
Sbjct: 306 AQALAHAYFA 315

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL     S   ++  D V
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKS--QKLTDDHV 127
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGL R     +  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGY---VA 184
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 241
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 242 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 297
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 298 TAAQALAHAYFA 309

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  157 bits (397), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 72  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 129
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 130 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGY---VA 186
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 243
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 244 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 299
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 300 TAAQALAHAYFA 311

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  157 bits (397), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX--QKLTDDHV 127
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VA 184
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 241
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 242 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 297
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 298 TAAQALAHAYFA 309

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 134
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 135 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY---VA 191
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLILRLVGT-- 248
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 249 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 304
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 305 TAAQALAHAYFA 316

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  157 bits (396), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 81  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 138
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 139 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VA 195
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 196 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 252
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 253 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 308
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 309 TAAQALAHAYFA 320

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  156 bits (395), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 134
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 135 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY---VA 191
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLILRLVGT-- 248
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 249 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 304
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 305 TAAQALAHAYFA 316

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 95/277 (34%), Positives = 148/277 (53%), Gaps = 18/277 (6%)
Query: 4   SGVDRTPNTALAIKG-THLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT-- 60
           S +D+     +AIK  +    +E     A RE+ LLK ++H+N++ L DV      L   
Sbjct: 60  SAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119
Query: 61  ----LVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLL 116
               LV      DL+K    +  E   + ++  +YQ+L+GL + HS  V+HRDLKP NL 
Sbjct: 120 YDFYLVMPFMQTDLQKI---MGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLA 176
Query: 117 INKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFA 176
           +N++ ELK+ DFGLAR     +  Y   VVT WYR P+V+     Y  ++D+WS GCI A
Sbjct: 177 VNEDCELKILDFGLARHADAEMTGY---VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 233
Query: 177 ELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN---LLPDFKPFPMYHPSMSFSQ 233
           E+   G+ LF G D  DQL +I K+ G P  +    +N        +  P   P   F+Q
Sbjct: 234 EMLT-GKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQ-TPRKDFTQ 291
Query: 234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
           + P+ + +  DLL+++L  +  +R++A  A++H +F 
Sbjct: 292 LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 75  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 132
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 133 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VA 189
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 246
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 247 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 302
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 303 TAAQALAHAYFA 314

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 134
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 135 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY---VA 191
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLILRLVGT-- 248
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 249 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 304
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 305 TAAQALAHAYFA 316

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  156 bits (394), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 75  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 132
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 133 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VA 189
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 246
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 247 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 302
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 303 TAAQALAHAYFA 314

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  156 bits (394), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 93/250 (37%), Positives = 137/250 (54%), Gaps = 22/250 (8%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--AKLTDDHV 123
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 124 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 180
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GTP 
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLILRLVGTPG 239
Query: 207 ED------TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
            +      +    N +          P M+F+ V         DLL+++LV +  +R++A
Sbjct: 240 AELLKKISSESARNYIQSLAQM----PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
Query: 261 EDAMSHIYFS 270
             A++H YF+
Sbjct: 296 AQALAHAYFA 305

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  156 bits (394), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX--QKLTDDHV 127
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 241
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 242 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 297
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 298 TAAQALAHAYFA 309

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  156 bits (394), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 82  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 139
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 140 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 196
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 253
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 254 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 309
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 310 TAAQALAHAYFA 321

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  156 bits (394), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 82  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 139
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 140 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 196
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 253
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 254 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 309
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 310 TAAQALAHAYFA 321

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  156 bits (394), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 82  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 139
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 140 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 196
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 253
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 254 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 309
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 310 TAAQALAHAYFA 321

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 93  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 150
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 151 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGY---VA 207
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 208 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 264
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 265 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 320
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 321 TAAQALAHAYFA 332

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 72  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 129
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 130 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 186
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 243
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 244 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 299
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 300 TAAQALAHAYFA 311

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 93/250 (37%), Positives = 137/250 (54%), Gaps = 22/250 (8%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 93  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 150
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 151 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 207
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GTP 
Sbjct: 208 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGTPG 266
Query: 207 ED------TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
            +      +    N +          P M+F+ V         DLL+++LV +  +R++A
Sbjct: 267 AELLKKISSESARNYIQSLTQM----PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 322
Query: 261 EDAMSHIYFS 270
             A++H YF+
Sbjct: 323 AQALAHAYFA 332

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 72  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 129
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 130 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 186
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 243
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 244 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 299
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 300 TAAQALAHAYFA 311

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 93/250 (37%), Positives = 137/250 (54%), Gaps = 22/250 (8%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 76  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 133
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 134 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 190
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GTP 
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGTPG 249
Query: 207 ED------TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
            +      +    N +          P M+F+ V         DLL+++LV +  +R++A
Sbjct: 250 AELLKKISSESARNYIQSLTQM----PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 305
Query: 261 EDAMSHIYFS 270
             A++H YF+
Sbjct: 306 AQALAHAYFA 315

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 127
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 241
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 242 ----PGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 297
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 298 TAAQALAHAYFA 309

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 127
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 241
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 242 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 297
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 298 TAAQALAHAYFA 309

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 127
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 241
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 242 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 297
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 298 TAAQALAHAYFA 309

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 93/250 (37%), Positives = 137/250 (54%), Gaps = 22/250 (8%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 90  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 147
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 148 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 204
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GTP 
Sbjct: 205 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGTPG 263
Query: 207 ED------TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
            +      +    N +          P M+F+ V         DLL+++LV +  +R++A
Sbjct: 264 AELLKKISSESARNYIQSLAQM----PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 319
Query: 261 EDAMSHIYFS 270
             A++H YF+
Sbjct: 320 AQALAHAYFA 329

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 80  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 137
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 138 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 194
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 195 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 251
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 252 ----PGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 307
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 308 TAAQALAHAYFA 319

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 127
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 241
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 242 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 297
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 298 TAAQALAHAYFA 309

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 93/250 (37%), Positives = 137/250 (54%), Gaps = 22/250 (8%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 67  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 124
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 125 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 181
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GTP 
Sbjct: 182 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGTPG 240
Query: 207 ED------TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
            +      +    N +          P M+F+ V         DLL+++LV +  +R++A
Sbjct: 241 AELLKKISSESARNYIQSLTQM----PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 296
Query: 261 EDAMSHIYFS 270
             A++H YF+
Sbjct: 297 AQALAHAYFA 306

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 93/250 (37%), Positives = 137/250 (54%), Gaps = 22/250 (8%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 75  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 132
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 133 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 189
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GTP 
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGTPG 248
Query: 207 ED------TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
            +      +    N +          P M+F+ V         DLL+++LV +  +R++A
Sbjct: 249 AELLKKISSESARNYIQSLTQM----PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 304
Query: 261 EDAMSHIYFS 270
             A++H YF+
Sbjct: 305 AQALAHAYFA 314

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 127
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 241
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 242 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 297
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 298 TAAQALAHAYFA 309

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 134
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 135 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 191
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 248
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 249 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 304
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 305 TAAQALAHAYFA 316

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 93/250 (37%), Positives = 137/250 (54%), Gaps = 22/250 (8%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 89  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 146
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 147 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 203
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GTP 
Sbjct: 204 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGTPG 262
Query: 207 ED------TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
            +      +    N +          P M+F+ V         DLL+++LV +  +R++A
Sbjct: 263 AELLKKISSESARNYIQSLAQM----PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 318
Query: 261 EDAMSHIYFS 270
             A++H YF+
Sbjct: 319 AQALAHAYFA 328

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 81  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 138
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 139 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 195
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 196 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 252
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 253 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 308
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 309 TAAQALAHAYFA 320

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 75  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 132
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 133 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 189
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 246
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 247 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 302
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 303 TAAQALAHAYFA 314

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 127
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 241
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 242 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 297
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 298 TAAQALAHAYFA 309

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 69  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 126
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 127 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 183
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 184 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 240
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 241 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 296
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 297 TAAQALAHAYFA 308

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 93/250 (37%), Positives = 137/250 (54%), Gaps = 22/250 (8%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 76  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 133
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 134 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 190
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GTP 
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGTPG 249
Query: 207 ED------TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
            +      +    N +          P M+F+ V         DLL+++LV +  +R++A
Sbjct: 250 AELLKKISSESARNYIQSLAQM----PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 305
Query: 261 EDAMSHIYFS 270
             A++H YF+
Sbjct: 306 AQALAHAYFA 315

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 127
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 241
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 242 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 297
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 298 TAAQALAHAYFA 309

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 93/250 (37%), Positives = 137/250 (54%), Gaps = 22/250 (8%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 89  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 146
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 147 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 203
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GTP 
Sbjct: 204 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGTPG 262
Query: 207 ED------TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
            +      +    N +          P M+F+ V         DLL+++LV +  +R++A
Sbjct: 263 AELLKKISSESARNYIQSLTQM----PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 318
Query: 261 EDAMSHIYFS 270
             A++H YF+
Sbjct: 319 AQALAHAYFA 328

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 93/250 (37%), Positives = 137/250 (54%), Gaps = 22/250 (8%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 90  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 147
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 148 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 204
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GTP 
Sbjct: 205 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGTPG 263
Query: 207 ED------TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
            +      +    N +          P M+F+ V         DLL+++LV +  +R++A
Sbjct: 264 AELLKKISSESARNYIQSLTQM----PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 319
Query: 261 EDAMSHIYFS 270
             A++H YF+
Sbjct: 320 AQALAHAYFA 329

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 68  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 125
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 126 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 182
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 183 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 239
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 240 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 295
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 296 TAAQALAHAYFA 307

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 93/250 (37%), Positives = 137/250 (54%), Gaps = 22/250 (8%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 76  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 133
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 134 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 190
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GTP 
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGTPG 249
Query: 207 ED------TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
            +      +    N +          P M+F+ V         DLL+++LV +  +R++A
Sbjct: 250 AELLKKISSESARNYIQSLTQM----PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 305
Query: 261 EDAMSHIYFS 270
             A++H YF+
Sbjct: 306 AQALAHAYFA 315

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 127
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 241
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 242 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 297
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 298 TAAQALAHAYFA 309

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/258 (36%), Positives = 137/258 (53%), Gaps = 28/258 (10%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSE------KKLTLVFEHCDQDLKKYFDSLNGEIDLDI 85
           LRE+ +LK  KH NI+ + D+L         K + +V +  + DL +   S +  + L+ 
Sbjct: 101 LRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHS-SQPLTLEH 159
Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY---- 141
           V+ F+YQLLRGL + HS  V+HRDLKP NLL+N+N ELK+ DFG+AR        +    
Sbjct: 160 VRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFM 219
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
           +  V T WYR P+++     YT +ID+WS GCIF E+  A R LFPG +   QL+ I  +
Sbjct: 220 TEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML-ARRQLFPGKNYVHQLQLIMMV 278
Query: 202 LGTPT---------EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVC 252
           LGTP+         E     +  LP  +P P       +  V P    +   LL R+L  
Sbjct: 279 LGTPSPAVIQAVGAERVRAYIQSLPPRQPVP-------WETVYPGADRQALSLLGRMLRF 331
Query: 253 NPVQRMSAEDAMSHIYFS 270
            P  R+SA  A+ H + +
Sbjct: 332 EPSARISAAAALRHPFLA 349

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 72  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 129
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 130 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 186
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 243
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 244 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 299
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 300 TAAQALAHAYFA 311

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 67  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 124
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 125 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 181
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 182 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 238
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 239 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 294
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 295 TAAQALAHAYFA 306

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 93/250 (37%), Positives = 137/250 (54%), Gaps = 22/250 (8%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 123
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 124 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 180
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GTP 
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGTPG 239
Query: 207 ED------TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
            +      +    N +          P M+F+ V         DLL+++LV +  +R++A
Sbjct: 240 AELLKKISSESARNYIQSLTQM----PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
Query: 261 EDAMSHIYFS 270
             A++H YF+
Sbjct: 296 AQALAHAYFA 305

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 93/250 (37%), Positives = 137/250 (54%), Gaps = 22/250 (8%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 123
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 124 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 180
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GTP 
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGTPG 239
Query: 207 ED------TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
            +      +    N +          P M+F+ V         DLL+++LV +  +R++A
Sbjct: 240 AELLKKISSESARNYIQSLAQM----PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
Query: 261 EDAMSHIYFS 270
             A++H YF+
Sbjct: 296 AQALAHAYFA 305

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 95/258 (36%), Positives = 137/258 (53%), Gaps = 28/258 (10%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSE------KKLTLVFEHCDQDLKKYFDSLNGEIDLDI 85
           LRE+ +LK  KH NI+ + D+L         K + +V +  + DL +   S +  + L+ 
Sbjct: 102 LRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHS-SQPLTLEH 160
Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY---- 141
           V+ F+YQLLRGL + HS  V+HRDLKP NLL+N+N ELK+ DFG+AR        +    
Sbjct: 161 VRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFM 220
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
           +  V T WYR P+++     YT +ID+WS GCIF E+  A R LFPG +   QL+ I  +
Sbjct: 221 TEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML-ARRQLFPGKNYVHQLQLIMMV 279
Query: 202 LGTPT---------EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVC 252
           LGTP+         E     +  LP  +P P       +  V P    +   LL R+L  
Sbjct: 280 LGTPSPAVIQAVGAERVRAYIQSLPPRQPVP-------WETVYPGADRQALSLLGRMLRF 332
Query: 253 NPVQRMSAEDAMSHIYFS 270
            P  R+SA  A+ H + +
Sbjct: 333 EPSARISAAAALRHPFLA 350

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  154 bits (390), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 94/277 (33%), Positives = 148/277 (53%), Gaps = 18/277 (6%)
Query: 4   SGVDRTPNTALAIKG-THLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT-- 60
           S +D+     +AIK  +    +E     A RE+ LLK ++H+N++ L DV      L   
Sbjct: 42  SAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101
Query: 61  ----LVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLL 116
               LV      DL+K    +  +   + ++  +YQ+L+GL + HS  V+HRDLKP NL 
Sbjct: 102 YDFYLVMPFMQTDLQKI---MGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLA 158
Query: 117 INKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFA 176
           +N++ ELK+ DFGLAR     +  Y   VVT WYR P+V+     Y  ++D+WS GCI A
Sbjct: 159 VNEDCELKILDFGLARHADAEMTGY---VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 215
Query: 177 ELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN---LLPDFKPFPMYHPSMSFSQ 233
           E+   G+ LF G D  DQL +I K+ G P  +    +N        +  P   P   F+Q
Sbjct: 216 EMLT-GKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQ-TPRKDFTQ 273
Query: 234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
           + P+ + +  DLL+++L  +  +R++A  A++H +F 
Sbjct: 274 LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  154 bits (390), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 94/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 127
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ D+GLAR     +  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGY---VA 184
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 241
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 242 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 297
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 298 TAAQALAHAYFA 309

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  154 bits (390), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 98/286 (34%), Positives = 153/286 (53%), Gaps = 29/286 (10%)
Query: 4   SGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT-- 60
           S VD      +AIK  +    +E     A RE+ LLK ++H+N++ L DV   ++ L   
Sbjct: 43  SAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102
Query: 61  ----LVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLL 116
               LV      DL K     + ++  D ++  +YQ+L+GL + H+  ++HRDLKP NL 
Sbjct: 103 TDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA 160
Query: 117 INKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFA 176
           +N++ ELK+ DFGLAR     +      VVT WYR P+V+     YT ++D+WS GCI A
Sbjct: 161 VNEDCELKILDFGLARQADSEM---XGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 217
Query: 177 ELANAGRPLFPGSDVDDQLKRIFKLLGTP---------TEDTWPGMNLLPDFKPFPMYHP 227
           E+   G+ LF GSD  DQLK I K+ GTP         +++    M  LP+ +       
Sbjct: 218 EMIT-GKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELE------- 269
Query: 228 SMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN 273
              F+ +    +    +LL+++LV +  QR++A +A++H YF  L+
Sbjct: 270 KKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  154 bits (389), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 94/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 127
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +   +  V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGXVA 184
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 241
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 242 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 297
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 298 TAAQALAHAYFA 309

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  154 bits (389), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 94/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 127
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  +   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF---VA 184
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 241
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 242 ----PGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 297
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 298 TAAQALAHAYFA 309

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  154 bits (389), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 94/252 (37%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 127
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  +   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF---VA 184
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 241
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 242 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 297
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 298 TAAQALAHAYFA 309

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  154 bits (389), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 108/329 (32%), Positives = 158/329 (48%), Gaps = 66/329 (20%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVP-SSALREICLLKELKHKNIVRLYDVLHSEK-----K 58
             D+     +AIK  + +  + +     LREI +L  LK   I+RLYD++  +      +
Sbjct: 45  AYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104
Query: 59  LTLVFEHCDQDLKKYFDS---LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
           L +V E  D DLKK F +   L  E     +K+ +Y LL G  F H   ++HRDLKP N 
Sbjct: 105 LYIVLEIADSDLKKLFKTPIFLTEEH----IKTILYNLLLGENFIHESGIIHRDLKPANC 160
Query: 116 LINKNGELKLADFGLARAFGIP----------------------VKCYSAEVVTLWYRPP 153
           L+N++  +K+ DFGLAR                            K  ++ VVT WYR P
Sbjct: 161 LLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAP 220
Query: 154 DVLFGAKLYTTSIDMWSAGCIFAELANAGR----------PLFPGSDV------------ 191
           +++   + YT SID+WS GCIFAEL N  +          PLFPGS              
Sbjct: 221 ELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKV 280
Query: 192 -----DDQLKRIFKLLGTPTEDTWPGMN---LLPDFKPFPMYHPSMSFSQVAPKLTAKGR 243
                 DQL  IF ++GTPTED    +N   ++   K FP   P ++  Q  P ++  G 
Sbjct: 281 HEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP-INLKQKYPSISDDGI 339
Query: 244 DLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
           +LL+ +L  NP +R++ + A+ H Y  D+
Sbjct: 340 NLLESMLKFNPNKRITIDQALDHPYLKDV 368

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  154 bits (388), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 92/250 (36%), Positives = 137/250 (54%), Gaps = 22/250 (8%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 123
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  +   V 
Sbjct: 124 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF---VA 180
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GTP 
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGTPG 239
Query: 207 ED------TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
            +      +    N +          P M+F+ V         DLL+++LV +  +R++A
Sbjct: 240 AELLKKISSESARNYIQSLAQM----PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
Query: 261 EDAMSHIYFS 270
             A++H YF+
Sbjct: 296 AQALAHAYFA 305

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  153 bits (387), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 92/250 (36%), Positives = 136/250 (54%), Gaps = 22/250 (8%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 90  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 147
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +      V 
Sbjct: 148 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---XGXVA 204
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GTP 
Sbjct: 205 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGTPG 263
Query: 207 ED------TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
            +      +    N +          P M+F+ V         DLL+++LV +  +R++A
Sbjct: 264 AELLKKISSESARNYIQSLAQM----PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 319
Query: 261 EDAMSHIYFS 270
             A++H YF+
Sbjct: 320 AQALAHAYFA 329

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  153 bits (386), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 94/252 (37%), Positives = 136/252 (53%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 127
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+  FGLAR     +  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGY---VA 184
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 241
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 242 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 297
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 298 TAAQALAHAYFA 309

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  152 bits (385), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 94/252 (37%), Positives = 136/252 (53%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 127
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ D GLAR     +  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGY---VA 184
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 241
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 242 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 297
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 298 TAAQALAHAYFA 309

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 94/253 (37%), Positives = 137/253 (54%), Gaps = 28/253 (11%)
Query: 33  REICLLKELKHKNIVRLYDV------LHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV      L     + LV      DL         ++  D V
Sbjct: 99  RELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 156
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 157 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 213
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  +QL++I +L GTP 
Sbjct: 214 TRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELL-TGRTLFPGTDHINQLQQIMRLTGTPP 272
Query: 207 EDTWPGM---------NLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQR 257
                 M         N LP         P  +F+ V         DLL+++LV +  +R
Sbjct: 273 ASVISRMPSHEARNYINSLPQM-------PKRNFADVFIGANPLAVDLLEKMLVLDTDKR 325
Query: 258 MSAEDAMSHIYFS 270
           ++A +A++H YFS
Sbjct: 326 ITASEALAHPYFS 338

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  152 bits (384), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 94/252 (37%), Positives = 136/252 (53%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 127
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ D GLAR     +  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGY---VA 184
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 241
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 242 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 297
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 298 TAAQALAHAYFA 309

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  152 bits (384), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 94/252 (37%), Positives = 136/252 (53%), Gaps = 26/252 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 127
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ D GLAR     +  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGY---VA 184
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GT  
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGT-- 241
Query: 207 EDTWPGMNLLPDFKPFPMYH--------PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               PG  LL         +        P M+F+ V         DLL+++LV +  +R+
Sbjct: 242 ----PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 297
Query: 259 SAEDAMSHIYFS 270
           +A  A++H YF+
Sbjct: 298 TAAQALAHAYFA 309

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  152 bits (384), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 92/250 (36%), Positives = 136/250 (54%), Gaps = 22/250 (8%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLDIV 86
           RE+ LLK +KH+N++ L DV    + L       LV      DL         ++  D V
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 127
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           +  +YQ+LRGL + HS +++HRDLKP NL +N++ ELK+ DF LAR     +  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGY---VA 184
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T WYR P+++     Y  ++D+WS GCI AEL   GR LFPG+D  DQLK I +L+GTP 
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGTPG 243
Query: 207 ED------TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
            +      +    N +          P M+F+ V         DLL+++LV +  +R++A
Sbjct: 244 AELLKKISSESARNYIQSLTQM----PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 261 EDAMSHIYFS 270
             A++H YF+
Sbjct: 300 AQALAHAYFA 309

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  150 bits (380), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 100/264 (37%), Positives = 147/264 (55%), Gaps = 21/264 (7%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKK----LTLVFEHCDQDL---KKYFDSLNGEIDL 83
           RE+ ++++L H NIVRL    +S  EKK    L LV ++  + +    +++      + +
Sbjct: 90  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 149
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAF--GIPVKC 140
             VK +MYQL R LA+ HS  + HRD+KPQNLL++ +   LKL DFG A+    G P   
Sbjct: 150 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 209
Query: 141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           Y   + + +YR P+++FGA  YT+SID+WSAGC+ AEL   G+P+FPG    DQL  I K
Sbjct: 210 Y---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIK 265
Query: 201 LLGTPTEDTWPGMNL-LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
           +LGTPT +    MN    +FK FP            P+   +   L  RLL   P  R++
Sbjct: 266 VLGTPTREQIREMNPNYTEFK-FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 324
Query: 260 AEDAMSHIYFSDL---NVAIKSER 280
             +A +H +F +L   NV + + R
Sbjct: 325 PLEACAHSFFDELRDPNVKLPNGR 348

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  150 bits (380), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 100/264 (37%), Positives = 147/264 (55%), Gaps = 21/264 (7%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKK----LTLVFEHCDQDL---KKYFDSLNGEIDL 83
           RE+ ++++L H NIVRL    +S  EKK    L LV ++  + +    +++      + +
Sbjct: 96  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 155
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAF--GIPVKC 140
             VK +MYQL R LA+ HS  + HRD+KPQNLL++ +   LKL DFG A+    G P   
Sbjct: 156 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215
Query: 141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           Y   + + +YR P+++FGA  YT+SID+WSAGC+ AEL   G+P+FPG    DQL  I K
Sbjct: 216 Y---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIK 271
Query: 201 LLGTPTEDTWPGMNL-LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
           +LGTPT +    MN    +FK FP            P+   +   L  RLL   P  R++
Sbjct: 272 VLGTPTREQIREMNPNYTEFK-FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 330
Query: 260 AEDAMSHIYFSDL---NVAIKSER 280
             +A +H +F +L   NV + + R
Sbjct: 331 PLEACAHSFFDELRDPNVKLPNGR 354

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  150 bits (380), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 100/267 (37%), Positives = 149/267 (55%), Gaps = 27/267 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKK----LTLVFEHCDQDL---KKYFDSLNGEIDL 83
           RE+ ++++L H NIVRL    +S  EKK    L LV ++  + +    +++      + +
Sbjct: 67  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 126
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAF--GIPVKC 140
             VK +MYQL R LA+ HS  + HRD+KPQNLL++ +   LKL DFG A+    G P   
Sbjct: 127 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 186
Query: 141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           Y   + + +YR P+++FGA  YT+SID+WSAGC+ AEL   G+P+FPG    DQL  I K
Sbjct: 187 Y---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIK 242
Query: 201 LLGTPTEDTWPGMNLLPDFKPFPM----YHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
           +LGTPT +    MN  P++  F       HP     +  P+   +   L  RLL   P  
Sbjct: 243 VLGTPTREQIREMN--PNYTEFKFPQIKAHPWTKVFR--PRTPPEAIALCSRLLEYTPTA 298
Query: 257 RMSAEDAMSHIYFSDL---NVAIKSER 280
           R++  +A +H +F +L   NV + + R
Sbjct: 299 RLTPLEACAHSFFDELRDPNVKLPNGR 325

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  150 bits (380), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 100/264 (37%), Positives = 147/264 (55%), Gaps = 21/264 (7%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKK----LTLVFEHCDQDL---KKYFDSLNGEIDL 83
           RE+ ++++L H NIVRL    +S  EKK    L LV ++  + +    +++      + +
Sbjct: 141 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 200
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAF--GIPVKC 140
             VK +MYQL R LA+ HS  + HRD+KPQNLL++ +   LKL DFG A+    G P   
Sbjct: 201 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 260
Query: 141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           Y   + + +YR P+++FGA  YT+SID+WSAGC+ AEL   G+P+FPG    DQL  I K
Sbjct: 261 Y---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIK 316
Query: 201 LLGTPTEDTWPGMNL-LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
           +LGTPT +    MN    +FK FP            P+   +   L  RLL   P  R++
Sbjct: 317 VLGTPTREQIREMNPNYTEFK-FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 375
Query: 260 AEDAMSHIYFSDL---NVAIKSER 280
             +A +H +F +L   NV + + R
Sbjct: 376 PLEACAHSFFDELRDPNVKLPNGR 399

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  150 bits (379), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 100/264 (37%), Positives = 147/264 (55%), Gaps = 21/264 (7%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKK----LTLVFEHCDQDL---KKYFDSLNGEIDL 83
           RE+ ++++L H NIVRL    +S  EKK    L LV ++  + +    +++      + +
Sbjct: 100 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 159
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAF--GIPVKC 140
             VK +MYQL R LA+ HS  + HRD+KPQNLL++ +   LKL DFG A+    G P   
Sbjct: 160 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 219
Query: 141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           Y   + + +YR P+++FGA  YT+SID+WSAGC+ AEL   G+P+FPG    DQL  I K
Sbjct: 220 Y---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIK 275
Query: 201 LLGTPTEDTWPGMNL-LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
           +LGTPT +    MN    +FK FP            P+   +   L  RLL   P  R++
Sbjct: 276 VLGTPTREQIREMNPNYTEFK-FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 334
Query: 260 AEDAMSHIYFSDL---NVAIKSER 280
             +A +H +F +L   NV + + R
Sbjct: 335 PLEACAHSFFDELRDPNVKLPNGR 358

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  150 bits (379), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 100/267 (37%), Positives = 149/267 (55%), Gaps = 27/267 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKK----LTLVFEHCDQDL---KKYFDSLNGEIDL 83
           RE+ ++++L H NIVRL    +S  EKK    L LV ++  + +    +++      + +
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAF--GIPVKC 140
             VK +MYQL R LA+ HS  + HRD+KPQNLL++ +   LKL DFG A+    G P   
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           Y   + + +YR P+++FGA  YT+SID+WSAGC+ AEL   G+P+FPG    DQL  I K
Sbjct: 182 Y---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIK 237
Query: 201 LLGTPTEDTWPGMNLLPDFKPFPM----YHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
           +LGTPT +    MN  P++  F       HP     +  P+   +   L  RLL   P  
Sbjct: 238 VLGTPTREQIREMN--PNYTEFAFPQIKAHPWTKVFR--PRTPPEAIALCSRLLEYTPTA 293
Query: 257 RMSAEDAMSHIYFSDL---NVAIKSER 280
           R++  +A +H +F +L   NV + + R
Sbjct: 294 RLTPLEACAHSFFDELRDPNVKLPNGR 320

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  150 bits (379), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 100/264 (37%), Positives = 147/264 (55%), Gaps = 21/264 (7%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKK----LTLVFEHCDQDL---KKYFDSLNGEIDL 83
           RE+ ++++L H NIVRL    +S  EKK    L LV ++  + +    +++      + +
Sbjct: 98  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 157
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAF--GIPVKC 140
             VK +MYQL R LA+ HS  + HRD+KPQNLL++ +   LKL DFG A+    G P   
Sbjct: 158 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 217
Query: 141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           Y   + + +YR P+++FGA  YT+SID+WSAGC+ AEL   G+P+FPG    DQL  I K
Sbjct: 218 Y---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIK 273
Query: 201 LLGTPTEDTWPGMNL-LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
           +LGTPT +    MN    +FK FP            P+   +   L  RLL   P  R++
Sbjct: 274 VLGTPTREQIREMNPNYTEFK-FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 332
Query: 260 AEDAMSHIYFSDL---NVAIKSER 280
             +A +H +F +L   NV + + R
Sbjct: 333 PLEACAHSFFDELRDPNVKLPNGR 356

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  150 bits (379), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 100/264 (37%), Positives = 147/264 (55%), Gaps = 21/264 (7%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKK----LTLVFEHCDQDL---KKYFDSLNGEIDL 83
           RE+ ++++L H NIVRL    +S  EKK    L LV ++  + +    +++      + +
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAF--GIPVKC 140
             VK +MYQL R LA+ HS  + HRD+KPQNLL++ +   LKL DFG A+    G P   
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           Y   + + +YR P+++FGA  YT+SID+WSAGC+ AEL   G+P+FPG    DQL  I K
Sbjct: 182 Y---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIK 237
Query: 201 LLGTPTEDTWPGMNL-LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
           +LGTPT +    MN    +FK FP            P+   +   L  RLL   P  R++
Sbjct: 238 VLGTPTREQIREMNPNYTEFK-FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296
Query: 260 AEDAMSHIYFSDL---NVAIKSER 280
             +A +H +F +L   NV + + R
Sbjct: 297 PLEACAHSFFDELRDPNVKLPNGR 320

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 100/264 (37%), Positives = 147/264 (55%), Gaps = 21/264 (7%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKK----LTLVFEHCDQDL---KKYFDSLNGEIDL 83
           RE+ ++++L H NIVRL    +S  EKK    L LV ++  + +    +++      + +
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAF--GIPVKC 140
             VK +MYQL R LA+ HS  + HRD+KPQNLL++ +   LKL DFG A+    G P   
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           Y   + + +YR P+++FGA  YT+SID+WSAGC+ AEL   G+P+FPG    DQL  I K
Sbjct: 182 Y---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIK 237
Query: 201 LLGTPTEDTWPGMNL-LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
           +LGTPT +    MN    +FK FP            P+   +   L  RLL   P  R++
Sbjct: 238 VLGTPTREQIREMNPNYTEFK-FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296
Query: 260 AEDAMSHIYFSDL---NVAIKSER 280
             +A +H +F +L   NV + + R
Sbjct: 297 PLEACAHSFFDELRDPNVKLPNGR 320

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 100/264 (37%), Positives = 147/264 (55%), Gaps = 21/264 (7%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKK----LTLVFEHCDQDL---KKYFDSLNGEIDL 83
           RE+ ++++L H NIVRL    +S  EKK    L LV ++  + +    +++      + +
Sbjct: 75  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 134
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAF--GIPVKC 140
             VK +MYQL R LA+ HS  + HRD+KPQNLL++ +   LKL DFG A+    G P   
Sbjct: 135 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 194
Query: 141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           Y   + + +YR P+++FGA  YT+SID+WSAGC+ AEL   G+P+FPG    DQL  I K
Sbjct: 195 Y---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIK 250
Query: 201 LLGTPTEDTWPGMNL-LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
           +LGTPT +    MN    +FK FP            P+   +   L  RLL   P  R++
Sbjct: 251 VLGTPTREQIREMNPNYTEFK-FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 309
Query: 260 AEDAMSHIYFSDL---NVAIKSER 280
             +A +H +F +L   NV + + R
Sbjct: 310 PLEACAHSFFDELRDPNVKLPNGR 333

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  149 bits (375), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 96/253 (37%), Positives = 142/253 (56%), Gaps = 18/253 (7%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKK----LTLVFEHCDQDL---KKYFDSLNGEIDL 83
           RE+ ++++L H NIVRL    +S  EKK    L LV ++  + +    +++      + +
Sbjct: 96  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 155
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAF--GIPVKC 140
             VK +MYQL R LA+ HS  + HRD+KPQNLL++ +   LKL DFG A+    G P   
Sbjct: 156 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--- 212
Query: 141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
             + + + +YR P+++FGA  YT+SID+WSAGC+ AEL   G+P+FPG    DQL  I K
Sbjct: 213 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIK 271
Query: 201 LLGTPTEDTWPGMNL-LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
           +LGTPT +    MN    +FK FP            P+   +   L  RLL   P  R++
Sbjct: 272 VLGTPTREQIREMNPNYTEFK-FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 330
Query: 260 AEDAMSHIYFSDL 272
             +A +H +F +L
Sbjct: 331 PLEACAHSFFDEL 343

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  148 bits (374), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 96/253 (37%), Positives = 142/253 (56%), Gaps = 18/253 (7%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKK----LTLVFEHCDQDL---KKYFDSLNGEIDL 83
           RE+ ++++L H NIVRL    +S  EKK    L LV ++  + +    +++      + +
Sbjct: 74  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 133
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAF--GIPVKC 140
             VK +MYQL R LA+ HS  + HRD+KPQNLL++ +   LKL DFG A+    G P   
Sbjct: 134 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--- 190
Query: 141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
             + + + +YR P+++FGA  YT+SID+WSAGC+ AEL   G+P+FPG    DQL  I K
Sbjct: 191 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIK 249
Query: 201 LLGTPTEDTWPGMNL-LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
           +LGTPT +    MN    +FK FP            P+   +   L  RLL   P  R++
Sbjct: 250 VLGTPTREQIREMNPNYTEFK-FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 308
Query: 260 AEDAMSHIYFSDL 272
             +A +H +F +L
Sbjct: 309 PLEACAHSFFDEL 321

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  148 bits (374), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 99/264 (37%), Positives = 147/264 (55%), Gaps = 21/264 (7%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKK----LTLVFEHCDQDL---KKYFDSLNGEIDL 83
           RE+ ++++L H NIVRL    +S  EKK    L LV ++  + +    +++      + +
Sbjct: 70  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 129
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAF--GIPVKC 140
             VK +MYQL R LA+ HS  + HRD+KPQNLL++ +   LKL DFG A+    G P   
Sbjct: 130 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--- 186
Query: 141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
             + + + +YR P+++FGA  YT+SID+WSAGC+ AEL   G+P+FPG    DQL  I K
Sbjct: 187 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIK 245
Query: 201 LLGTPTEDTWPGMNL-LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
           +LGTPT +    MN    +FK FP            P+   +   L  RLL   P  R++
Sbjct: 246 VLGTPTREQIREMNPNYTEFK-FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 304
Query: 260 AEDAMSHIYFSDL---NVAIKSER 280
             +A +H +F +L   NV + + R
Sbjct: 305 PLEACAHSFFDELRDPNVKLPNGR 328

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  148 bits (374), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 99/264 (37%), Positives = 147/264 (55%), Gaps = 21/264 (7%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKK----LTLVFEHCDQDL---KKYFDSLNGEIDL 83
           RE+ ++++L H NIVRL    +S  EKK    L LV ++  + +    +++      + +
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAF--GIPVKC 140
             VK +MYQL R LA+ HS  + HRD+KPQNLL++ +   LKL DFG A+    G P   
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--- 178
Query: 141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
             + + + +YR P+++FGA  YT+SID+WSAGC+ AEL   G+P+FPG    DQL  I K
Sbjct: 179 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIK 237
Query: 201 LLGTPTEDTWPGMNL-LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
           +LGTPT +    MN    +FK FP            P+   +   L  RLL   P  R++
Sbjct: 238 VLGTPTREQIREMNPNYTEFK-FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296
Query: 260 AEDAMSHIYFSDL---NVAIKSER 280
             +A +H +F +L   NV + + R
Sbjct: 297 PLEACAHSFFDELRDPNVKLPNGR 320

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  148 bits (373), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 99/264 (37%), Positives = 147/264 (55%), Gaps = 21/264 (7%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKK----LTLVFEHCDQDL---KKYFDSLNGEIDL 83
           RE+ ++++L H NIVRL    +S  EKK    L LV ++  + +    +++      + +
Sbjct: 74  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 133
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAF--GIPVKC 140
             VK +MYQL R LA+ HS  + HRD+KPQNLL++ +   LKL DFG A+    G P   
Sbjct: 134 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--- 190
Query: 141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
             + + + +YR P+++FGA  YT+SID+WSAGC+ AEL   G+P+FPG    DQL  I K
Sbjct: 191 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIK 249
Query: 201 LLGTPTEDTWPGMNL-LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
           +LGTPT +    MN    +FK FP            P+   +   L  RLL   P  R++
Sbjct: 250 VLGTPTREQIREMNPNYTEFK-FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 308
Query: 260 AEDAMSHIYFSDL---NVAIKSER 280
             +A +H +F +L   NV + + R
Sbjct: 309 PLEACAHSFFDELRDPNVKLPNGR 332

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  148 bits (373), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 99/264 (37%), Positives = 147/264 (55%), Gaps = 21/264 (7%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKK----LTLVFEHCDQDL---KKYFDSLNGEIDL 83
           RE+ ++++L H NIVRL    +S  EKK    L LV ++  + +    +++      + +
Sbjct: 81  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 140
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAF--GIPVKC 140
             VK +MYQL R LA+ HS  + HRD+KPQNLL++ +   LKL DFG A+    G P   
Sbjct: 141 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--- 197
Query: 141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
             + + + +YR P+++FGA  YT+SID+WSAGC+ AEL   G+P+FPG    DQL  I K
Sbjct: 198 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIK 256
Query: 201 LLGTPTEDTWPGMNL-LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
           +LGTPT +    MN    +FK FP            P+   +   L  RLL   P  R++
Sbjct: 257 VLGTPTREQIREMNPNYTEFK-FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 315
Query: 260 AEDAMSHIYFSDL---NVAIKSER 280
             +A +H +F +L   NV + + R
Sbjct: 316 PLEACAHSFFDELRDPNVKLPNGR 339

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  148 bits (373), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 99/264 (37%), Positives = 147/264 (55%), Gaps = 21/264 (7%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKK----LTLVFEHCDQDL---KKYFDSLNGEIDL 83
           RE+ ++++L H NIVRL    +S  EKK    L LV ++  + +    +++      + +
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAF--GIPVKC 140
             VK +MYQL R LA+ HS  + HRD+KPQNLL++ +   LKL DFG A+    G P   
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--- 178
Query: 141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
             + + + +YR P+++FGA  YT+SID+WSAGC+ AEL   G+P+FPG    DQL  I K
Sbjct: 179 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIK 237
Query: 201 LLGTPTEDTWPGMNL-LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
           +LGTPT +    MN    +FK FP            P+   +   L  RLL   P  R++
Sbjct: 238 VLGTPTREQIREMNPNYTEFK-FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296
Query: 260 AEDAMSHIYFSDL---NVAIKSER 280
             +A +H +F +L   NV + + R
Sbjct: 297 PLEACAHSFFDELRDPNVKLPNGR 320

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  148 bits (373), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 99/264 (37%), Positives = 147/264 (55%), Gaps = 21/264 (7%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKK----LTLVFEHCDQDL---KKYFDSLNGEIDL 83
           RE+ ++++L H NIVRL    +S  EKK    L LV ++  + +    +++      + +
Sbjct: 66  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 125
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAF--GIPVKC 140
             VK +MYQL R LA+ HS  + HRD+KPQNLL++ +   LKL DFG A+    G P   
Sbjct: 126 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--- 182
Query: 141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
             + + + +YR P+++FGA  YT+SID+WSAGC+ AEL   G+P+FPG    DQL  I K
Sbjct: 183 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIK 241
Query: 201 LLGTPTEDTWPGMNL-LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
           +LGTPT +    MN    +FK FP            P+   +   L  RLL   P  R++
Sbjct: 242 VLGTPTREQIREMNPNYTEFK-FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 300
Query: 260 AEDAMSHIYFSDL---NVAIKSER 280
             +A +H +F +L   NV + + R
Sbjct: 301 PLEACAHSFFDELRDPNVKLPNGR 324

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  148 bits (373), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 99/264 (37%), Positives = 147/264 (55%), Gaps = 21/264 (7%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKK----LTLVFEHCDQDL---KKYFDSLNGEIDL 83
           RE+ ++++L H NIVRL    +S  EKK    L LV ++  + +    +++      + +
Sbjct: 63  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 122
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAF--GIPVKC 140
             VK +MYQL R LA+ HS  + HRD+KPQNLL++ +   LKL DFG A+    G P   
Sbjct: 123 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--- 179
Query: 141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
             + + + +YR P+++FGA  YT+SID+WSAGC+ AEL   G+P+FPG    DQL  I K
Sbjct: 180 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIK 238
Query: 201 LLGTPTEDTWPGMNL-LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
           +LGTPT +    MN    +FK FP            P+   +   L  RLL   P  R++
Sbjct: 239 VLGTPTREQIREMNPNYTEFK-FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 297
Query: 260 AEDAMSHIYFSDL---NVAIKSER 280
             +A +H +F +L   NV + + R
Sbjct: 298 PLEACAHSFFDELRDPNVKLPNGR 321

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  148 bits (373), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 99/264 (37%), Positives = 147/264 (55%), Gaps = 21/264 (7%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKK----LTLVFEHCDQDL---KKYFDSLNGEIDL 83
           RE+ ++++L H NIVRL    +S  EKK    L LV ++  + +    +++      + +
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAF--GIPVKC 140
             VK +MYQL R LA+ HS  + HRD+KPQNLL++ +   LKL DFG A+    G P   
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--- 178
Query: 141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
             + + + +YR P+++FGA  YT+SID+WSAGC+ AEL   G+P+FPG    DQL  I K
Sbjct: 179 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIK 237
Query: 201 LLGTPTEDTWPGMNL-LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
           +LGTPT +    MN    +FK FP            P+   +   L  RLL   P  R++
Sbjct: 238 VLGTPTREQIREMNPNYTEFK-FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296
Query: 260 AEDAMSHIYFSDL---NVAIKSER 280
             +A +H +F +L   NV + + R
Sbjct: 297 PLEACAHSFFDELRDPNVKLPNGR 320

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  147 bits (372), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 99/267 (37%), Positives = 148/267 (55%), Gaps = 27/267 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKK----LTLVFEHCDQDL---KKYFDSLNGEIDL 83
           RE+ ++++L H NIVRL    +S  EKK    L LV ++    +    +++      + +
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPV 121
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAF--GIPVKC 140
             VK +MYQL R LA+ HS  + HRD+KPQNLL++ +   LKL DFG A+    G P   
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--- 178
Query: 141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
             + + + +YR P+++FGA  YT+SID+WSAGC+ AEL   G+P+FPG    DQL  I K
Sbjct: 179 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIK 237
Query: 201 LLGTPTEDTWPGMNLLPDFKPFPM----YHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
           +LGTPT +    MN  P++  F       HP     +  P+   +   L  RLL   P  
Sbjct: 238 VLGTPTREQIREMN--PNYTEFAFPQIKAHPWTKVFR--PRTPPEAIALCSRLLEYTPTA 293
Query: 257 RMSAEDAMSHIYFSDL---NVAIKSER 280
           R++  +A +H +F +L   NV + + R
Sbjct: 294 RLTPLEACAHSFFDELRDPNVKLPNGR 320

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 103/309 (33%), Positives = 150/309 (48%), Gaps = 67/309 (21%)
Query: 32  LREICLLKELKHKNIVRLYDVL---HSEK--KLTLVFEHCDQDLKKYFDSLNGEIDLDIV 86
           LREI +L  L H ++V++ D++     EK  +L +V E  D D KK F +     +L I 
Sbjct: 100 LREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHI- 158
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS---- 142
           K+ +Y LL G+ + HS  +LHRDLKP N L+N++  +K+ DFGLAR    P    S    
Sbjct: 159 KTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218
Query: 143 -----------------------AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELA 179
                                    VVT WYR P+++   + YT +ID+WS GCIFAEL 
Sbjct: 219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278
Query: 180 N---------AGR-PLFPGSDV--------------------DDQLKRIFKLLGTPTEDT 209
           N         A R PLFPGS                       DQL  IF +LGTP+E+ 
Sbjct: 279 NMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEED 338
Query: 210 WPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRD---LLQRLLVCNPVQRMSAEDAMSH 266
              +    D K +    P    + +A +  A   D   LL+R+LV NP +R++  + ++H
Sbjct: 339 IEALE-KEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397
Query: 267 IYFSDLNVA 275
            +F ++ +A
Sbjct: 398 PFFKEVRIA 406

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  145 bits (366), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 90/266 (33%), Positives = 140/266 (52%), Gaps = 25/266 (9%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       LV E  D +L +    +
Sbjct: 63  NQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQ---VI 119
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 120 QMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS 179
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  E+    + LFPG D  DQ  +
Sbjct: 180 F-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNK 236
Query: 198 IFKLLGTP----TEDTWPGMNLLPDFKP------FPMYHPSMSF---SQVAPKLTAKGRD 244
           + + LGTP     +   P +    + +P      FP   P   F   S+      ++ RD
Sbjct: 237 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 296
Query: 245 LLQRLLVCNPVQRMSAEDAMSHIYFS 270
           LL ++LV +P +R+S +DA+ H Y +
Sbjct: 297 LLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  144 bits (364), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 95/295 (32%), Positives = 147/295 (49%), Gaps = 46/295 (15%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHS-------------------------------- 55
           P    RE+ ++K L H NI++L D  ++                                
Sbjct: 44  PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSV 103
Query: 56  ------EKKLTLVFEHCDQDLKKYFDSL---NGEIDLDIVKSFMYQLLRGLAFCHSRNVL 106
                  K L ++ E+    L K   S       I ++++  ++YQL R + F HS  + 
Sbjct: 104 IVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGIC 163
Query: 107 HRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTS 165
           HRD+KPQNLL+N K+  LKL DFG A+   IP +   A + + +YR P+++ GA  YT S
Sbjct: 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKL-IPSEPSVAXICSRFYRAPELMLGATEYTPS 222
Query: 166 IDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY 225
           ID+WS GC+F EL   G+PLF G    DQL RI +++GTPT++    MN       FP  
Sbjct: 223 IDLWSIGCVFGELI-LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTL 281
Query: 226 HPSMSFSQVAPKLTAK-GRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKSE 279
             +  + ++ P+ T     DLL+++L   P  R++  +AM+H +F  L  + +SE
Sbjct: 282 K-AKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESE 335

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  144 bits (363), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 90/266 (33%), Positives = 140/266 (52%), Gaps = 25/266 (9%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       LV E  D +L +    +
Sbjct: 63  NQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQV---I 119
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS 179
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  E+    + LFPG D  DQ  +
Sbjct: 180 F-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNK 236
Query: 198 IFKLLGTP----TEDTWPGMNLLPDFKP------FPMYHPSMSF---SQVAPKLTAKGRD 244
           + + LGTP     +   P +    + +P      FP   P   F   S+      ++ RD
Sbjct: 237 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 296
Query: 245 LLQRLLVCNPVQRMSAEDAMSHIYFS 270
           LL ++LV +P +R+S +DA+ H Y +
Sbjct: 297 LLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  144 bits (363), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 105/329 (31%), Positives = 157/329 (47%), Gaps = 63/329 (19%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVP-SSALREICLLKELKHKNIVRLYDVLHSEK-----K 58
             D+  N  +AIK  + +  + +     LREI +L  LK   I+RL+D++  E      +
Sbjct: 47  AYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDLIIPEDLLKFDE 106
Query: 59  LTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN 118
           L +V E  D DLKK F +     +   VK+ +Y LL G  F H   ++HRDLKP N L+N
Sbjct: 107 LYIVLEIADSDLKKLFKTPIFLTEQH-VKTILYNLLLGEKFIHESGIIHRDLKPANCLLN 165
Query: 119 KNGELKLADFGLARAFG----IPV---------------------KCYSAEVVTLWYRPP 153
           ++  +K+ DFGLAR       I +                     K  ++ VVT WYR P
Sbjct: 166 QDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAP 225
Query: 154 DVLFGAKLYTTSIDMWSAGCIFAELANAGR----------PLFPGSDV------------ 191
           +++   + YT SID+WS GCIFAEL N  +          PLFPGS              
Sbjct: 226 ELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFPLFPGSSCFPLSPDHNSKKV 285
Query: 192 -----DDQLKRIFKLLGTPTEDTWPGMN---LLPDFKPFPMYHPSMSFSQVAPKLTAKGR 243
                 DQL  IF ++GTP E+    +    ++   K FP     +  S+    ++ +G 
Sbjct: 286 HEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKYIKLFPT-RDGIDLSKKYSSISKEGI 344
Query: 244 DLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
           DLL+ +L  N  +R++ + A+SH Y  D+
Sbjct: 345 DLLESMLRFNAQKRITIDKALSHPYLKDV 373

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  144 bits (362), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 90/266 (33%), Positives = 140/266 (52%), Gaps = 25/266 (9%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       LV E  D +L +    +
Sbjct: 56  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQ---VI 112
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 113 QMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS 172
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  E+    + LFPG D  DQ  +
Sbjct: 173 F-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNK 229
Query: 198 IFKLLGTP----TEDTWPGMNLLPDFKP------FPMYHPSMSF---SQVAPKLTAKGRD 244
           + + LGTP     +   P +    + +P      FP   P   F   S+      ++ RD
Sbjct: 230 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 289
Query: 245 LLQRLLVCNPVQRMSAEDAMSHIYFS 270
           LL ++LV +P +R+S +DA+ H Y +
Sbjct: 290 LLSKMLVIDPAKRISVDDALQHPYIN 315

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  144 bits (362), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 90/266 (33%), Positives = 140/266 (52%), Gaps = 25/266 (9%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       LV E  D +L +    +
Sbjct: 63  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQ---VI 119
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 120 QMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS 179
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  E+    + LFPG D  DQ  +
Sbjct: 180 F-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNK 236
Query: 198 IFKLLGTP----TEDTWPGMNLLPDFKP------FPMYHPSMSF---SQVAPKLTAKGRD 244
           + + LGTP     +   P +    + +P      FP   P   F   S+      ++ RD
Sbjct: 237 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 296
Query: 245 LLQRLLVCNPVQRMSAEDAMSHIYFS 270
           LL ++LV +P +R+S +DA+ H Y +
Sbjct: 297 LLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 90/266 (33%), Positives = 140/266 (52%), Gaps = 25/266 (9%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       LV E  D +L +    +
Sbjct: 63  NQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV---I 119
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS 179
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  E+    + LFPG D  DQ  +
Sbjct: 180 F-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNK 236
Query: 198 IFKLLGTP----TEDTWPGMNLLPDFKP------FPMYHPSMSF---SQVAPKLTAKGRD 244
           + + LGTP     +   P +    + +P      FP   P   F   S+      ++ RD
Sbjct: 237 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 296
Query: 245 LLQRLLVCNPVQRMSAEDAMSHIYFS 270
           LL ++LV +P +R+S +DA+ H Y +
Sbjct: 297 LLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 87/268 (32%), Positives = 141/268 (52%), Gaps = 29/268 (10%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       +V E  D +L +    +
Sbjct: 63  NQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQV---I 119
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 120 QMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS 179
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  E+   G  LFPG+D  DQ  +
Sbjct: 180 F-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNK 236
Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHP---SMSFSQVAPKL------------TAKG 242
           + + LGTP+ +      L P  + +    P     SF ++ P +             ++ 
Sbjct: 237 VIEQLGTPSPEFMK--KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQA 294
Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
           RDLL ++LV +  +R+S ++A+ H Y +
Sbjct: 295 RDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  142 bits (358), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 87/268 (32%), Positives = 141/268 (52%), Gaps = 29/268 (10%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       +V E  D +L +    +
Sbjct: 63  NQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQV---I 119
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS 179
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  E+   G  LFPG+D  DQ  +
Sbjct: 180 F-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNK 236
Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHP---SMSFSQVAPKL------------TAKG 242
           + + LGTP+ +      L P  + +    P     SF ++ P +             ++ 
Sbjct: 237 VIEQLGTPSPEFMK--KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQA 294
Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
           RDLL ++LV +  +R+S ++A+ H Y +
Sbjct: 295 RDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  141 bits (355), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 87/268 (32%), Positives = 141/268 (52%), Gaps = 29/268 (10%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       +V E  D +L +    +
Sbjct: 63  NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQV---I 119
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS 179
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  E+   G  LFPG+D  DQ  +
Sbjct: 180 F-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNK 236
Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHP---SMSFSQVAPKL------------TAKG 242
           + + LGTP+ +      L P  + +    P     SF ++ P +             ++ 
Sbjct: 237 VIEQLGTPSPEFMK--KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQA 294
Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
           RDLL ++LV +  +R+S ++A+ H Y +
Sbjct: 295 RDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  141 bits (355), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 144/269 (53%), Gaps = 31/269 (11%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ LLK + HKNI+ L +V   +K L       LV E  D +L +    +
Sbjct: 61  NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV---I 117
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
           + E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR     
Sbjct: 118 HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTN 177
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  EL   G  +F G+D  DQ  +
Sbjct: 178 F-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVK-GSVIFQGTDHIDQWNK 234
Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPF----PMYHPSMSFSQVAPKL------------TAK 241
           + + LGTP+ +    +   P  + +    P Y P ++F ++ P              T++
Sbjct: 235 VIEQLGTPSAEFMAALQ--PTVRNYVENRPAY-PGIAFEELFPDWIFPSESERDKIKTSQ 291
Query: 242 GRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            RDLL ++LV +P +R+S ++A+ H Y +
Sbjct: 292 ARDLLSKMLVIDPDKRISVDEALRHPYIT 320

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  141 bits (355), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 90/266 (33%), Positives = 140/266 (52%), Gaps = 25/266 (9%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       LV E  D +L +    +
Sbjct: 101 NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV---I 157
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 158 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  E+    + LFPG D  DQ  +
Sbjct: 218 F-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNK 274
Query: 198 IFKLLGTPTED----TWPGMNLLPDFKP------FPMYHPSMSF---SQVAPKLTAKGRD 244
           + + LGTP  +      P +    + +P      FP   P   F   S+      ++ RD
Sbjct: 275 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 334
Query: 245 LLQRLLVCNPVQRMSAEDAMSHIYFS 270
           LL ++LV +P +R+S +DA+ H Y +
Sbjct: 335 LLSKMLVIDPAKRISVDDALQHPYIN 360

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  141 bits (355), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 90/266 (33%), Positives = 140/266 (52%), Gaps = 25/266 (9%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       LV E  D +L +    +
Sbjct: 64  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV---I 120
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 121 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  E+    + LFPG D  DQ  +
Sbjct: 181 F-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNK 237
Query: 198 IFKLLGTP----TEDTWPGMNLLPDFKP------FPMYHPSMSF---SQVAPKLTAKGRD 244
           + + LGTP     +   P +    + +P      FP   P   F   S+      ++ RD
Sbjct: 238 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 297
Query: 245 LLQRLLVCNPVQRMSAEDAMSHIYFS 270
           LL ++LV +P +R+S +DA+ H Y +
Sbjct: 298 LLSKMLVIDPAKRISVDDALQHPYIN 323

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  140 bits (354), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 90/266 (33%), Positives = 140/266 (52%), Gaps = 25/266 (9%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       LV E  D +L +    +
Sbjct: 62  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV---I 118
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 119 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 178
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  E+    + LFPG D  DQ  +
Sbjct: 179 F-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNK 235
Query: 198 IFKLLGTP----TEDTWPGMNLLPDFKP------FPMYHPSMSF---SQVAPKLTAKGRD 244
           + + LGTP     +   P +    + +P      FP   P   F   S+      ++ RD
Sbjct: 236 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 295
Query: 245 LLQRLLVCNPVQRMSAEDAMSHIYFS 270
           LL ++LV +P +R+S +DA+ H Y +
Sbjct: 296 LLSKMLVIDPAKRISVDDALQHPYIN 321

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  140 bits (354), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 90/266 (33%), Positives = 140/266 (52%), Gaps = 25/266 (9%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       LV E  D +L +    +
Sbjct: 63  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV---I 119
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  E+    + LFPG D  DQ  +
Sbjct: 180 F-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNK 236
Query: 198 IFKLLGTP----TEDTWPGMNLLPDFKP------FPMYHPSMSF---SQVAPKLTAKGRD 244
           + + LGTP     +   P +    + +P      FP   P   F   S+      ++ RD
Sbjct: 237 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 296
Query: 245 LLQRLLVCNPVQRMSAEDAMSHIYFS 270
           LL ++LV +P +R+S +DA+ H Y +
Sbjct: 297 LLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  140 bits (354), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 90/266 (33%), Positives = 140/266 (52%), Gaps = 25/266 (9%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       LV E  D +L +    +
Sbjct: 63  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV---I 119
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  E+    + LFPG D  DQ  +
Sbjct: 180 F-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNK 236
Query: 198 IFKLLGTP----TEDTWPGMNLLPDFKP------FPMYHPSMSF---SQVAPKLTAKGRD 244
           + + LGTP     +   P +    + +P      FP   P   F   S+      ++ RD
Sbjct: 237 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 296
Query: 245 LLQRLLVCNPVQRMSAEDAMSHIYFS 270
           LL ++LV +P +R+S +DA+ H Y +
Sbjct: 297 LLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  140 bits (354), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 90/266 (33%), Positives = 140/266 (52%), Gaps = 25/266 (9%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       LV E  D +L +    +
Sbjct: 101 NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV---I 157
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 158 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  E+    + LFPG D  DQ  +
Sbjct: 218 F-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNK 274
Query: 198 IFKLLGTPTED----TWPGMNLLPDFKP------FPMYHPSMSF---SQVAPKLTAKGRD 244
           + + LGTP  +      P +    + +P      FP   P   F   S+      ++ RD
Sbjct: 275 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 334
Query: 245 LLQRLLVCNPVQRMSAEDAMSHIYFS 270
           LL ++LV +P +R+S +DA+ H Y +
Sbjct: 335 LLSKMLVIDPAKRISVDDALQHPYIN 360

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  140 bits (354), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 90/266 (33%), Positives = 140/266 (52%), Gaps = 25/266 (9%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       LV E  D +L +    +
Sbjct: 64  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV---I 120
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 121 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  E+    + LFPG D  DQ  +
Sbjct: 181 F-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNK 237
Query: 198 IFKLLGTP----TEDTWPGMNLLPDFKP------FPMYHPSMSF---SQVAPKLTAKGRD 244
           + + LGTP     +   P +    + +P      FP   P   F   S+      ++ RD
Sbjct: 238 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 297
Query: 245 LLQRLLVCNPVQRMSAEDAMSHIYFS 270
           LL ++LV +P +R+S +DA+ H Y +
Sbjct: 298 LLSKMLVIDPAKRISVDDALQHPYIN 323

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  140 bits (354), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 90/266 (33%), Positives = 140/266 (52%), Gaps = 25/266 (9%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       LV E  D +L +    +
Sbjct: 56  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ---VI 112
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 113 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  E+    + LFPG D  DQ  +
Sbjct: 173 F-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNK 229
Query: 198 IFKLLGTPTED----TWPGMNLLPDFKP------FPMYHPSMSF---SQVAPKLTAKGRD 244
           + + LGTP  +      P +    + +P      FP   P   F   S+      ++ RD
Sbjct: 230 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 289
Query: 245 LLQRLLVCNPVQRMSAEDAMSHIYFS 270
           LL ++LV +P +R+S +DA+ H Y +
Sbjct: 290 LLSKMLVIDPAKRISVDDALQHPYIN 315

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  140 bits (354), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 90/266 (33%), Positives = 140/266 (52%), Gaps = 25/266 (9%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       LV E  D +L +    +
Sbjct: 57  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ---VI 113
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 114 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 173
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  E+    + LFPG D  DQ  +
Sbjct: 174 F-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNK 230
Query: 198 IFKLLGTP----TEDTWPGMNLLPDFKP------FPMYHPSMSF---SQVAPKLTAKGRD 244
           + + LGTP     +   P +    + +P      FP   P   F   S+      ++ RD
Sbjct: 231 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 290
Query: 245 LLQRLLVCNPVQRMSAEDAMSHIYFS 270
           LL ++LV +P +R+S +DA+ H Y +
Sbjct: 291 LLSKMLVIDPAKRISVDDALQHPYIN 316

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  140 bits (354), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 90/266 (33%), Positives = 140/266 (52%), Gaps = 25/266 (9%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       LV E  D +L +    +
Sbjct: 57  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ---VI 113
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 114 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 173
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  E+    + LFPG D  DQ  +
Sbjct: 174 F-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNK 230
Query: 198 IFKLLGTPTED----TWPGMNLLPDFKP------FPMYHPSMSF---SQVAPKLTAKGRD 244
           + + LGTP  +      P +    + +P      FP   P   F   S+      ++ RD
Sbjct: 231 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 290
Query: 245 LLQRLLVCNPVQRMSAEDAMSHIYFS 270
           LL ++LV +P +R+S +DA+ H Y +
Sbjct: 291 LLSKMLVIDPAKRISVDDALQHPYIN 316

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  140 bits (352), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 88/268 (32%), Positives = 141/268 (52%), Gaps = 29/268 (10%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       +V E  D +L +    +
Sbjct: 63  NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV---I 119
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               + EVVT +YR P+V+ G   Y  ++D+WS GCI  E+   G  LFPG+D  DQ  +
Sbjct: 180 F-MMTPEVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGV-LFPGTDHIDQWNK 236
Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHP---SMSFSQVAPKL------------TAKG 242
           + + LGTP  +      L P  + +    P     SF ++ P +             ++ 
Sbjct: 237 VIEQLGTPCPEFMK--KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQA 294
Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
           RDLL ++LV +  +R+S ++A+ H Y +
Sbjct: 295 RDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 86/268 (32%), Positives = 140/268 (52%), Gaps = 29/268 (10%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       +V E  D +L +    +
Sbjct: 63  NQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQV---I 119
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 120 QMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS 179
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS G I  E+   G  LFPG+D  DQ  +
Sbjct: 180 F-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGVIMGEMIKGG-VLFPGTDHIDQWNK 236
Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHP---SMSFSQVAPKL------------TAKG 242
           + + LGTP+ +      L P  + +    P     SF ++ P +             ++ 
Sbjct: 237 VIEQLGTPSPEFMK--KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQA 294
Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
           RDLL ++LV +  +R+S ++A+ H Y +
Sbjct: 295 RDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/268 (32%), Positives = 141/268 (52%), Gaps = 29/268 (10%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       +V E  D +L +    +
Sbjct: 63  NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQV---I 119
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  E+   G  LFPG+D  DQ  +
Sbjct: 180 F-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNK 236
Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHP---SMSFSQVAPKL------------TAKG 242
           + + LGTP+ +      L P  + +    P     SF ++ P +             ++ 
Sbjct: 237 VIEQLGTPSPEFMK--KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQA 294
Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
           RDLL ++LV +  +R+S ++A+ H Y +
Sbjct: 295 RDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 86/268 (32%), Positives = 140/268 (52%), Gaps = 29/268 (10%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       +V E  D +L +    +
Sbjct: 63  NQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQV---I 119
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 120 QMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS 179
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS G I  E+   G  LFPG+D  DQ  +
Sbjct: 180 F-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGVIMGEMIKGG-VLFPGTDHIDQWNK 236
Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHP---SMSFSQVAPKL------------TAKG 242
           + + LGTP+ +      L P  + +    P     SF ++ P +             ++ 
Sbjct: 237 VIEQLGTPSPEFMK--KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQA 294
Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
           RDLL ++LV +  +R+S ++A+ H Y +
Sbjct: 295 RDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  139 bits (349), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 143/269 (53%), Gaps = 31/269 (11%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ LLK + HKNI+ L +V   +K L       LV E  D +L +    +
Sbjct: 63  NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV---I 119
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
           + E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR     
Sbjct: 120 HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 179
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  EL   G  +F G+D  DQ  +
Sbjct: 180 F-MMTPYVVTRYYRAPEVILGMG-YAANVDIWSVGCIMGELVK-GCVIFQGTDHIDQWNK 236
Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPF----PMYHPSMSFSQVAPKL------------TAK 241
           + + LGTP+ +    +   P  + +    P Y P + F ++ P              T++
Sbjct: 237 VIEQLGTPSAEFMAALQ--PTVRNYVENRPKY-PGIKFEELFPDWIFPSESERDKIKTSQ 293
Query: 242 GRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            RDLL ++LV +P +R+S ++A+ H Y +
Sbjct: 294 ARDLLSKMLVIDPDKRISVDEALRHPYIT 322

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  138 bits (348), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 87/268 (32%), Positives = 141/268 (52%), Gaps = 29/268 (10%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       +V E  D +L +    +
Sbjct: 63  NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV---I 119
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  E+   G  LFPG+D  DQ  +
Sbjct: 180 F-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNK 236
Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHP---SMSFSQVAPKL------------TAKG 242
           + + LGTP+ +      L P  + +    P     SF ++ P +             ++ 
Sbjct: 237 VIEQLGTPSPEFMK--KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQA 294
Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
           RDLL ++LV +  +R+S ++A+ H Y +
Sbjct: 295 RDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  137 bits (346), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 97/310 (31%), Positives = 151/310 (48%), Gaps = 48/310 (15%)
Query: 5   GVDRTPNTALAIKGT-HLVGNEGVPSSALREICLLKELK-HKNIVRLYDVLHSE--KKLT 60
            +DR     +A+K       N        REI +L EL  H+NIV L +VL ++  + + 
Sbjct: 28  SIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87
Query: 61  LVFEHCDQDLKKYFDSLNGEIDLDIVKSFM-YQLLRGLAFCHSRNVLHRDLKPQNLLINK 119
           LVF++ + DL      +   I   + K ++ YQL++ + + HS  +LHRD+KP N+L+N 
Sbjct: 88  LVFDYMETDLHAV---IRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNA 144
Query: 120 NGELKLADFGLARAF--------GIPVK-------------CYSAEVVTLWYRPPDVLFG 158
              +K+ADFGL+R+F         IP+                +  V T WYR P++L G
Sbjct: 145 ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG 204
Query: 159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN---- 214
           +  YT  IDMWS GCI  E+   G+P+FPGS   +QL+RI  ++  P+ +    +     
Sbjct: 205 STKYTKGIDMWSLGCILGEIL-CGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFA 263
Query: 215 --LLPDFKPFPMYHPSMS----------FSQVAPKL--TAKGRDLLQRLLVCNPVQRMSA 260
             ++   K       S              ++ PK     +  DLL +LL  NP +R+SA
Sbjct: 264 KTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323
Query: 261 EDAMSHIYFS 270
            DA+ H + S
Sbjct: 324 NDALKHPFVS 333

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  137 bits (346), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 87/268 (32%), Positives = 140/268 (52%), Gaps = 29/268 (10%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       +V E  D +L +    +
Sbjct: 63  NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV---I 119
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  E+   G  LFPG+D  DQ  +
Sbjct: 180 F-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNK 236
Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHP---SMSFSQVAPKL------------TAKG 242
           + + LGTP  +      L P  + +    P     SF ++ P +             ++ 
Sbjct: 237 VIEQLGTPCPEFMK--KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQA 294
Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
           RDLL ++LV +  +R+S ++A+ H Y +
Sbjct: 295 RDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  137 bits (345), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 87/268 (32%), Positives = 140/268 (52%), Gaps = 29/268 (10%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       +V E  D +L +    +
Sbjct: 64  NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV---I 120
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 121 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  E+   G  LFPG+D  DQ  +
Sbjct: 181 F-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNK 237
Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHP---SMSFSQVAPKL------------TAKG 242
           + + LGTP  +      L P  + +    P     SF ++ P +             ++ 
Sbjct: 238 VIEQLGTPCPEFMK--KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQA 295
Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
           RDLL ++LV +  +R+S ++A+ H Y +
Sbjct: 296 RDLLSKMLVIDASKRISVDEALQHPYIN 323

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  137 bits (345), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 87/268 (32%), Positives = 139/268 (51%), Gaps = 29/268 (10%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       +V E  D +L +    +
Sbjct: 63  NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV---I 119
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
                 EVVT +YR P+V+ G   Y  ++D+WS GCI  E+    + LFPG D  DQ  +
Sbjct: 180 F-MMEPEVVTRYYRAPEVILGMG-YKENVDLWSVGCIMGEMV-CHKILFPGRDYIDQWNK 236
Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHP---SMSFSQVAPKL------------TAKG 242
           + + LGTP  +      L P  + +    P     SF ++ P +             ++ 
Sbjct: 237 VIEQLGTPCPEFMK--KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQA 294
Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
           RDLL ++LV +  +R+S ++A+ H Y +
Sbjct: 295 RDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  136 bits (342), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 87/268 (32%), Positives = 139/268 (51%), Gaps = 29/268 (10%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       +V E  D +L +    +
Sbjct: 65  NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV---I 121
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 122 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 181
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
                  VVT +YR P+V+ G   Y  ++D+WS GCI  E+   G  LFPG+D  DQ  +
Sbjct: 182 FMMVPF-VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNK 238
Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHP---SMSFSQVAPKL------------TAKG 242
           + + LGTP  +      L P  + +    P     SF ++ P +             ++ 
Sbjct: 239 VIEQLGTPCPEFMK--KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQA 296
Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
           RDLL ++LV +  +R+S ++A+ H Y +
Sbjct: 297 RDLLSKMLVIDASKRISVDEALQHPYIN 324

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 88/270 (32%), Positives = 139/270 (51%), Gaps = 33/270 (12%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       +V E  D +L +    +
Sbjct: 63  NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV---I 119
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
                 EVVT +YR P+V+ G   Y  ++D+WS GCI  E+    + LFPG D  DQ  +
Sbjct: 180 F-MMEPEVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMV-CHKILFPGRDYIDQWNK 236
Query: 198 IFKLLGTPTEDTWPGM--NLLPDFKPFPMYHP---SMSFSQVAPKL------------TA 240
           + + LGTP     P     L P  + +    P     SF ++ P +             +
Sbjct: 237 VIEQLGTPC----PAFMKKLQPTVRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKAS 292
Query: 241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
           + RDLL ++LV +  +R+S ++A+ H Y +
Sbjct: 293 QARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 86/268 (32%), Positives = 139/268 (51%), Gaps = 29/268 (10%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       +V E  D +L +    +
Sbjct: 68  NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV---I 124
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 125 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 184
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  E+    + LFPG D  DQ  +
Sbjct: 185 F-MMTPYVVTRYYRAPEVILGMG-YKENVDLWSVGCIMGEMV-CHKILFPGRDYIDQWNK 241
Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHP---SMSFSQVAPKL------------TAKG 242
           + + LGTP  +      L P  + +    P     SF ++ P +             ++ 
Sbjct: 242 VIEQLGTPCPEFMK--KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQA 299
Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
           RDLL ++LV +  +R+S ++A+ H Y +
Sbjct: 300 RDLLSKMLVIDASKRISVDEALQHPYIN 327

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  135 bits (339), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 86/268 (32%), Positives = 139/268 (51%), Gaps = 29/268 (10%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSL 77
           N+     A RE+ L+K + HKNI+ L +V   +K L       +V E  D +L +    +
Sbjct: 57  NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ---VI 113
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
             E+D + +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G  
Sbjct: 114 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 173
Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
               +  VVT +YR P+V+ G   Y  ++D+WS GCI  E+    + LFPG D  DQ  +
Sbjct: 174 F-MMTPYVVTRYYRAPEVILGMG-YKENVDLWSVGCIMGEMV-CHKILFPGRDYIDQWNK 230
Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHP---SMSFSQVAPKL------------TAKG 242
           + + LGTP  +      L P  + +    P     SF ++ P +             ++ 
Sbjct: 231 VIEQLGTPCPEFMK--KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQA 288
Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
           RDLL ++LV +  +R+S ++A+ H Y +
Sbjct: 289 RDLLSKMLVIDASKRISVDEALQHPYIN 316

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  134 bits (337), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 92/278 (33%), Positives = 139/278 (50%), Gaps = 14/278 (5%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDV-LHSEK----KL 59
            + R  NT    +  +++ +  +    LREI LL    H NI+ L D+ +H E+    KL
Sbjct: 50  AIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKL 109
Query: 60  TLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK 119
            LV E    DL +        I    ++ FMY +L GL   H   V+HRDL P N+L+  
Sbjct: 110 YLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD 169
Query: 120 NGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELA 179
           N ++ + DF LAR         +  V   WYR P+++   K +T  +DMWSAGC+ AE+ 
Sbjct: 170 NNDITICDFNLARE-DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228
Query: 180 NAGRPLFPGSDVDDQLKRIFKLLGTP-TEDTWPGMNLLPDFKPFPMYH----PSMSFSQV 234
           N  + LF GS   +QL +I +++GTP  ED    M   P  + +        P+ +++ V
Sbjct: 229 NR-KALFRGSTFYNQLNKIVEVVGTPKIEDVV--MFSSPSARDYLRNSLSNVPARAWTAV 285
Query: 235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
            P       DL+ ++L  NP +R+S E A+ H YF  L
Sbjct: 286 VPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  134 bits (337), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 92/278 (33%), Positives = 139/278 (50%), Gaps = 14/278 (5%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDV-LHSEK----KL 59
            + R  NT    +  +++ +  +    LREI LL    H NI+ L D+ +H E+    KL
Sbjct: 50  AIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKL 109
Query: 60  TLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK 119
            LV E    DL +        I    ++ FMY +L GL   H   V+HRDL P N+L+  
Sbjct: 110 YLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD 169
Query: 120 NGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELA 179
           N ++ + DF LAR         +  V   WYR P+++   K +T  +DMWSAGC+ AE+ 
Sbjct: 170 NNDITICDFNLARE-DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228
Query: 180 NAGRPLFPGSDVDDQLKRIFKLLGTP-TEDTWPGMNLLPDFKPFPMYH----PSMSFSQV 234
           N  + LF GS   +QL +I +++GTP  ED    M   P  + +        P+ +++ V
Sbjct: 229 NR-KALFRGSTFYNQLNKIVEVVGTPKIEDVV--MFSSPSARDYLRNSLSNVPARAWTAV 285
Query: 235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
            P       DL+ ++L  NP +R+S E A+ H YF  L
Sbjct: 286 VPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  129 bits (325), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 86/252 (34%), Positives = 139/252 (55%), Gaps = 22/252 (8%)
Query: 33  REICLLKELKHK-NIVRLYDVLHSEKKLT--LVFEHCDQ-DLKKYFDSLNGEIDLDIVKS 88
           REI +L+ L+   NI+ L D++      T  LVFEH +  D K+ + +L    D DI + 
Sbjct: 80  REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT---DYDI-RF 135
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVT 147
           +MY++L+ L +CHS  ++HRD+KP N++I+ ++ +L+L D+GLA  F  P + Y+  V +
Sbjct: 136 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVAS 194
Query: 148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTE 207
            +++ P++L   ++Y  S+DMWS GC+ A +     P F G D  DQL RI K+LG  TE
Sbjct: 195 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TE 252
Query: 208 DTWP-----GMNLLPDFKPFPMYHPSMSFSQVAPK-----LTAKGRDLLQRLLVCNPVQR 257
           D +       + L P F      H    + +         ++ +  D L +LL  +   R
Sbjct: 253 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 312
Query: 258 MSAEDAMSHIYF 269
           ++A +AM H YF
Sbjct: 313 LTAREAMEHPYF 324

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/239 (34%), Positives = 135/239 (56%), Gaps = 21/239 (8%)
Query: 45  NIVRLYDVLHS--EKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           NI++L D +     K   LVFE+ +  D K+ +  L    D DI + +MY+LL+ L +CH
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILT---DFDI-RFYMYELLKALDYCH 149
Query: 102 SRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           S+ ++HRD+KP N++I+ +  +L+L D+GLA  F  P + Y+  V + +++ P++L   +
Sbjct: 150 SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAE-FYHPAQEYNVRVASRYFKGPELLVDYQ 208
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWP-----GMNL 215
           +Y  S+DMWS GC+ A +     P F G D  DQL RI K+LG  TE+ +       ++L
Sbjct: 209 MYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLG--TEELYGYLKKYHIDL 266
Query: 216 LPDFKPFPMYHPSMSF-----SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
            P F      H    +     S+    ++ +  DLL +LL  +  QR++A++AM H YF
Sbjct: 267 DPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 82/237 (34%), Positives = 133/237 (56%), Gaps = 17/237 (7%)
Query: 45  NIVRLYDVLHS--EKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           NI++L D +     K   LVFE+ +  D K+ +  L    D DI + +MY+LL+ L +CH
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILT---DFDI-RFYMYELLKALDYCH 154
Query: 102 SRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           S+ ++HRD+KP N++I+ +  +L+L D+GLA  F  P + Y+  V + +++ P++L   +
Sbjct: 155 SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAE-FYHPAQEYNVRVASRYFKGPELLVDYQ 213
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTW---PGMNLLP 217
           +Y  S+DMWS GC+ A +     P F G D  DQL RI K+LGT     +     ++L P
Sbjct: 214 MYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDP 273
Query: 218 DFKPFPMYHPSMSF-----SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
            F      H    +     S+    ++ +  DLL +LL  +  QR++A++AM H YF
Sbjct: 274 HFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  127 bits (320), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 151/288 (52%), Gaps = 26/288 (9%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHS-------EK 57
           G +++   ++AIK   ++ +    +  L+ +  L  L H NIV+L    ++       + 
Sbjct: 42  GKEKSTGMSVAIK--KVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99
Query: 58  KLTLVFEHCDQDL----KKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH--SRNVLHRDLK 111
            L +V E+    L    + Y+        + ++K F++QL+R +   H  S NV HRD+K
Sbjct: 100 YLNVVMEYVPDTLHRCCRNYYRRQVAPPPI-LIKVFLFQLIRSIGCLHLPSVNVCHRDIK 158
Query: 112 PQNLLINK-NGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWS 170
           P N+L+N+ +G LKL DFG A+    P +   A + + +YR P+++FG + YTT++D+WS
Sbjct: 159 PHNVLVNEADGTLKLCDFGSAKKLS-PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWS 217
Query: 171 AGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHP--- 227
            GCIFAE+   G P+F G +   QL  I ++LG P+ +    +N  P      +Y+    
Sbjct: 218 VGCIFAEMM-LGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN--PSHTDVDLYNSKGI 274
Query: 228 --SMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN 273
             S  FS  + K   +  DLL  LL   P +RM   +A+ H YF +L+
Sbjct: 275 PWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 82/239 (34%), Positives = 131/239 (54%), Gaps = 21/239 (8%)
Query: 45  NIVRLYDVLHSEKKLT--LVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           NI+ L D++      T  LVFEH +  D K+ + +L    D DI + +MY++L+ L +CH
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT---DYDI-RFYMYEILKALDYCH 148
Query: 102 SRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           S  ++HRD+KP N+LI+ ++ +L+L D+GLA  F  P + Y+  V + +++ P++L   +
Sbjct: 149 SMGIMHRDVKPHNVLIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWP-----GMNL 215
           +Y  S+DMWS GC+ A +     P F G D  DQL RI K+LG  TED +       + L
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYIDKYNIEL 265
Query: 216 LPDFKPFPMYHPSMSFSQVAPK-----LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
            P F      H    + +         ++ +  D L +LL  +   R++A +AM H YF
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 82/246 (33%), Positives = 138/246 (56%), Gaps = 17/246 (6%)
Query: 45  NIVRLYDVLHSE--KKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           NIV+L D++  +  K  +L+FE+ +  D K  + +L    D DI + ++Y+LL+ L +CH
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLT---DYDI-RYYIYELLKALDYCH 143
Query: 102 SRNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           S+ ++HRD+KP N++I+    +L+L D+GLA  F  P K Y+  V + +++ P++L   +
Sbjct: 144 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPG---MNLLP 217
            Y  S+DMWS GC+FA +     P F G D  DQL +I K+LGT   + +     + L P
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 262
Query: 218 DFKPFPMYH---PSMSFSQVAPK--LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
             +     H   P + F     +  ++ +  D L +LL  +  +R++A +AM+H YF  +
Sbjct: 263 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQV 322
Query: 273 NVAIKS 278
             A  S
Sbjct: 323 RAAENS 328

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 82/246 (33%), Positives = 138/246 (56%), Gaps = 17/246 (6%)
Query: 45  NIVRLYDVLHSE--KKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           NIV+L D++  +  K  +L+FE+ +  D K  + +L    D DI + ++Y+LL+ L +CH
Sbjct: 89  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLT---DYDI-RYYIYELLKALDYCH 144
Query: 102 SRNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           S+ ++HRD+KP N++I+    +L+L D+GLA  F  P K Y+  V + +++ P++L   +
Sbjct: 145 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 203
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPG---MNLLP 217
            Y  S+DMWS GC+FA +     P F G D  DQL +I K+LGT   + +     + L P
Sbjct: 204 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 263
Query: 218 DFKPFPMYH---PSMSFSQVAPK--LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
             +     H   P + F     +  ++ +  D L +LL  +  +R++A +AM+H YF  +
Sbjct: 264 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQV 323
Query: 273 NVAIKS 278
             A  S
Sbjct: 324 RAAENS 329

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 82/246 (33%), Positives = 138/246 (56%), Gaps = 17/246 (6%)
Query: 45  NIVRLYDVLHSE--KKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           NIV+L D++  +  K  +L+FE+ +  D K  + +L    D DI + ++Y+LL+ L +CH
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLT---DYDI-RYYIYELLKALDYCH 142
Query: 102 SRNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           S+ ++HRD+KP N++I+    +L+L D+GLA  F  P K Y+  V + +++ P++L   +
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPG---MNLLP 217
            Y  S+DMWS GC+FA +     P F G D  DQL +I K+LGT   + +     + L P
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 218 DFKPFPMYH---PSMSFSQVAPK--LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
             +     H   P + F     +  ++ +  D L +LL  +  +R++A +AM+H YF  +
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQV 321
Query: 273 NVAIKS 278
             A  S
Sbjct: 322 RAAENS 327

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 82/246 (33%), Positives = 138/246 (56%), Gaps = 17/246 (6%)
Query: 45  NIVRLYDVLHSE--KKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           NIV+L D++  +  K  +L+FE+ +  D K  + +L    D DI + ++Y+LL+ L +CH
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLT---DYDI-RYYIYELLKALDYCH 142
Query: 102 SRNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           S+ ++HRD+KP N++I+    +L+L D+GLA  F  P K Y+  V + +++ P++L   +
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPG---MNLLP 217
            Y  S+DMWS GC+FA +     P F G D  DQL +I K+LGT   + +     + L P
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 218 DFKPFPMYH---PSMSFSQVAPK--LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
             +     H   P + F     +  ++ +  D L +LL  +  +R++A +AM+H YF  +
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQV 321
Query: 273 NVAIKS 278
             A  S
Sbjct: 322 RAAENS 327

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 131/239 (54%), Gaps = 21/239 (8%)
Query: 45  NIVRLYDVLHSEKKLT--LVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           NI+ L D++      T  LVFEH +  D K+ + +L    D DI + +MY++L+ L +CH
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT---DYDI-RFYMYEILKALDYCH 148
Query: 102 SRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           S  ++HRD+KP N++I+ ++ +L+L D+GLA  F  P + Y+  V + +++ P++L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWP-----GMNL 215
           +Y  S+DMWS GC+ A +     P F G D  DQL RI K+LG  TED +       + L
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYIDKYNIEL 265
Query: 216 LPDFKPFPMYHPSMSFSQVAPK-----LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
            P F      H    + +         ++ +  D L +LL  +   R++A +AM H YF
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 82/246 (33%), Positives = 138/246 (56%), Gaps = 17/246 (6%)
Query: 45  NIVRLYDVLHSE--KKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           NIV+L D++  +  K  +L+FE+ +  D K  + +L    D DI + ++Y+LL+ L +CH
Sbjct: 108 NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLT---DYDI-RYYIYELLKALDYCH 163
Query: 102 SRNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           S+ ++HRD+KP N++I+    +L+L D+GLA  F  P K Y+  V + +++ P++L   +
Sbjct: 164 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 222
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPG---MNLLP 217
            Y  S+DMWS GC+FA +     P F G D  DQL +I K+LGT   + +     + L P
Sbjct: 223 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKYRIELDP 282
Query: 218 DFKPFPMYH---PSMSFSQVAPK--LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
             +     H   P + F     +  ++ +  D L +LL  +  +R++A +AM+H YF  +
Sbjct: 283 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQV 342
Query: 273 NVAIKS 278
             A  S
Sbjct: 343 RAAENS 348

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 131/239 (54%), Gaps = 21/239 (8%)
Query: 45  NIVRLYDVLHSEKKLT--LVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           NI+ L D++      T  LVFEH +  D K+ + +L    D DI + +MY++L+ L +CH
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT---DYDI-RFYMYEILKALDYCH 148
Query: 102 SRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           S  ++HRD+KP N++I+ ++ +L+L D+GLA  F  P + Y+  V + +++ P++L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWP-----GMNL 215
           +Y  S+DMWS GC+ A +     P F G D  DQL RI K+LG  TED +       + L
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYIDKYNIEL 265
Query: 216 LPDFKPFPMYHPSMSFSQVAPK-----LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
            P F      H    + +         ++ +  D L +LL  +   R++A +AM H YF
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 131/239 (54%), Gaps = 21/239 (8%)
Query: 45  NIVRLYDVLHSEKKLT--LVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           NI+ L D++      T  LVFEH +  D K+ + +L    D DI + +MY++L+ L +CH
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT---DYDI-RFYMYEILKALDYCH 148
Query: 102 SRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           S  ++HRD+KP N++I+ ++ +L+L D+GLA  F  P + Y+  V + +++ P++L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWP-----GMNL 215
           +Y  S+DMWS GC+ A +     P F G D  DQL RI K+LG  TED +       + L
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYIDKYNIEL 265
Query: 216 LPDFKPFPMYHPSMSFSQVAPK-----LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
            P F      H    + +         ++ +  D L +LL  +   R++A +AM H YF
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 82/246 (33%), Positives = 138/246 (56%), Gaps = 17/246 (6%)
Query: 45  NIVRLYDVLHSE--KKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           NIV+L D++  +  K  +L+FE+ +  D K  + +L    D DI + ++Y+LL+ L +CH
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLT---DYDI-RYYIYELLKALDYCH 142
Query: 102 SRNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           S+ ++HRD+KP N++I+    +L+L D+GLA  F  P K Y+  V + +++ P++L   +
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPG---MNLLP 217
            Y  S+DMWS GC+FA +     P F G D  DQL +I K+LGT   + +     + L P
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 218 DFKPFPMYH---PSMSFSQVAPK--LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
             +     H   P + F     +  ++ +  D L +LL  +  +R++A +AM+H YF  +
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQV 321
Query: 273 NVAIKS 278
             A  S
Sbjct: 322 RAAENS 327

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 131/239 (54%), Gaps = 21/239 (8%)
Query: 45  NIVRLYDVLHSEKKLT--LVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           NI+ L D++      T  LVFEH +  D K+ + +L    D DI + +MY++L+ L +CH
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT---DYDI-RFYMYEILKALDYCH 147
Query: 102 SRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           S  ++HRD+KP N++I+ ++ +L+L D+GLA  F  P + Y+  V + +++ P++L   +
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWP-----GMNL 215
           +Y  S+DMWS GC+ A +     P F G D  DQL RI K+LG  TED +       + L
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYIDKYNIEL 264
Query: 216 LPDFKPFPMYHPSMSFSQVAPK-----LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
            P F      H    + +         ++ +  D L +LL  +   R++A +AM H YF
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 131/239 (54%), Gaps = 21/239 (8%)
Query: 45  NIVRLYDVLHSEKKLT--LVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           NI+ L D++      T  LVFEH +  D K+ + +L    D DI + +MY++L+ L +CH
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT---DYDI-RFYMYEILKALDYCH 148
Query: 102 SRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           S  ++HRD+KP N++I+ ++ +L+L D+GLA  F  P + Y+  V + +++ P++L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWP-----GMNL 215
           +Y  S+DMWS GC+ A +     P F G D  DQL RI K+LG  TED +       + L
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYIDKYNIEL 265
Query: 216 LPDFKPFPMYHPSMSFSQVAPK-----LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
            P F      H    + +         ++ +  D L +LL  +   R++A +AM H YF
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 82/246 (33%), Positives = 138/246 (56%), Gaps = 17/246 (6%)
Query: 45  NIVRLYDVLHSE--KKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           NIV+L D++  +  K  +L+FE+ +  D K  + +L    D DI + ++Y+LL+ L +CH
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLT---DYDI-RYYIYELLKALDYCH 143
Query: 102 SRNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           S+ ++HRD+KP N++I+    +L+L D+GLA  F  P K Y+  V + +++ P++L   +
Sbjct: 144 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPG---MNLLP 217
            Y  S+DMWS GC+FA +     P F G D  DQL +I K+LGT   + +     + L P
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 262
Query: 218 DFKPFPMYH---PSMSFSQVAPK--LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
             +     H   P + F     +  ++ +  D L +LL  +  +R++A +AM+H YF  +
Sbjct: 263 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQV 322
Query: 273 NVAIKS 278
             A  S
Sbjct: 323 RAAENS 328

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 131/239 (54%), Gaps = 21/239 (8%)
Query: 45  NIVRLYDVLHSEKKLT--LVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           NI+ L D++      T  LVFEH +  D K+ + +L    D DI + +MY++L+ L +CH
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT---DYDI-RFYMYEILKALDYCH 148
Query: 102 SRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           S  ++HRD+KP N++I+ ++ +L+L D+GLA  F  P + Y+  V + +++ P++L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWP-----GMNL 215
           +Y  S+DMWS GC+ A +     P F G D  DQL RI K+LG  TED +       + L
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYIDKYNIEL 265
Query: 216 LPDFKPFPMYHPSMSFSQVAPK-----LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
            P F      H    + +         ++ +  D L +LL  +   R++A +AM H YF
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 131/239 (54%), Gaps = 21/239 (8%)
Query: 45  NIVRLYDVLHSEKKLT--LVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           NI+ L D++      T  LVFEH +  D K+ + +L    D DI + +MY++L+ L +CH
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT---DYDI-RFYMYEILKALDYCH 148
Query: 102 SRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           S  ++HRD+KP N++I+ ++ +L+L D+GLA  F  P + Y+  V + +++ P++L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWP-----GMNL 215
           +Y  S+DMWS GC+ A +     P F G D  DQL RI K+LG  TED +       + L
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYIDKYNIEL 265
Query: 216 LPDFKPFPMYHPSMSFSQVAPK-----LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
            P F      H    + +         ++ +  D L +LL  +   R++A +AM H YF
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 131/239 (54%), Gaps = 21/239 (8%)
Query: 45  NIVRLYDVLHSEKKLT--LVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           NI+ L D++      T  LVFEH +  D K+ + +L    D DI + +MY++L+ L +CH
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT---DYDI-RFYMYEILKALDYCH 148
Query: 102 SRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           S  ++HRD+KP N++I+ ++ +L+L D+GLA  F  P + Y+  V + +++ P++L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWP-----GMNL 215
           +Y  S+DMWS GC+ A +     P F G D  DQL RI K+LG  TED +       + L
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYIDKYNIEL 265
Query: 216 LPDFKPFPMYHPSMSFSQVAPK-----LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
            P F      H    + +         ++ +  D L +LL  +   R++A +AM H YF
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 131/239 (54%), Gaps = 21/239 (8%)
Query: 45  NIVRLYDVLHSEKKLT--LVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           NI+ L D++      T  LVFEH +  D K+ + +L    D DI + +MY++L+ L +CH
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT---DYDI-RFYMYEILKALDYCH 147
Query: 102 SRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           S  ++HRD+KP N++I+ ++ +L+L D+GLA  F  P + Y+  V + +++ P++L   +
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWP-----GMNL 215
           +Y  S+DMWS GC+ A +     P F G D  DQL RI K+LG  TED +       + L
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYIDKYNIEL 264
Query: 216 LPDFKPFPMYHPSMSFSQVAPK-----LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
            P F      H    + +         ++ +  D L +LL  +   R++A +AM H YF
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 131/239 (54%), Gaps = 21/239 (8%)
Query: 45  NIVRLYDVLHSEKKLT--LVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           NI+ L D++      T  LVFEH +  D K+ + +L    D DI + +MY++L+ L +CH
Sbjct: 98  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT---DYDI-RFYMYEILKALDYCH 153
Query: 102 SRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           S  ++HRD+KP N++I+ ++ +L+L D+GLA  F  P + Y+  V + +++ P++L   +
Sbjct: 154 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQ 212
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWP-----GMNL 215
           +Y  S+DMWS GC+ A +     P F G D  DQL RI K+LG  TED +       + L
Sbjct: 213 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYIDKYNIEL 270
Query: 216 LPDFKPFPMYHPSMSFSQVAPK-----LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
            P F      H    + +         ++ +  D L +LL  +   R++A +AM H YF
Sbjct: 271 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 329

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/251 (33%), Positives = 137/251 (54%), Gaps = 22/251 (8%)
Query: 45  NIVRLYDVLHSEKKLT--LVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           NI+ L D++      T  LVFEH +  D K+ + +L    D DI + +MY++L+ L +CH
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT---DYDI-RFYMYEILKALDYCH 148
Query: 102 SRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           S  ++HRD+KP N++I+ ++ +L+L D+GLA  F  P + Y+  V + +++ P++L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWP-----GMNL 215
           +Y  S+DMWS GC+ A +     P F G D  DQL RI K+LG  TED +       + L
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYIDKYNIEL 265
Query: 216 LPDFKPFPMYHPSMSFSQVAPK-----LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            P F      H    + +         ++ +  D L +LL  +   R++A +AM H YF 
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 325
Query: 271 DLNVAIKSERC 281
            + V  +S+ C
Sbjct: 326 PV-VKEQSQPC 335

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 81/243 (33%), Positives = 137/243 (56%), Gaps = 17/243 (6%)
Query: 45  NIVRLYDVLHSE--KKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           NIV+L D++  +  K  +L+FE+ +  D K  + +L    D DI + ++Y+LL+ L +CH
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLT---DYDI-RYYIYELLKALDYCH 142
Query: 102 SRNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           S+ ++HRD+KP N++I+    +L+L D+GLA  F  P K Y+  V + +++ P++L   +
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPG---MNLLP 217
            Y  S+DMWS GC+FA +     P F G D  DQL +I K+LGT   + +     + L P
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 218 DFKPFPMYH---PSMSFSQVAPK--LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
             +     H   P + F     +  ++ +  D L +LL  +  +R++A +AM+H YF  +
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQV 321
Query: 273 NVA 275
             A
Sbjct: 322 RAA 324

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 131/239 (54%), Gaps = 21/239 (8%)
Query: 45  NIVRLYDVLHSEKKLT--LVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           NI+ L D++      T  LVFEH +  D K+ + +L    D DI + +MY++L+ L +CH
Sbjct: 91  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT---DYDI-RFYMYEILKALDYCH 146
Query: 102 SRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           S  ++HRD+KP N++I+ ++ +L+L D+GLA  F  P + Y+  V + +++ P++L   +
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWP-----GMNL 215
           +Y  S+DMWS GC+ A +     P F G D  DQL RI K+LG  TED +       + L
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYIDKYNIEL 263
Query: 216 LPDFKPFPMYHPSMSFSQVAPK-----LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
            P F      H    + +         ++ +  D L +LL  +   R++A +AM H YF
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  125 bits (314), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 81/243 (33%), Positives = 137/243 (56%), Gaps = 17/243 (6%)
Query: 45  NIVRLYDVLHSE--KKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           NIV+L D++  +  K  +L+FE+ +  D K  + +L    D DI + ++Y+LL+ L +CH
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLT---DYDI-RYYIYELLKALDYCH 142
Query: 102 SRNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           S+ ++HRD+KP N++I+    +L+L D+GLA  F  P K Y+  V + +++ P++L   +
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPG---MNLLP 217
            Y  S+DMWS GC+FA +     P F G D  DQL +I K+LGT   + +     + L P
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 218 DFKPFPMYH---PSMSFSQVAPK--LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
             +     H   P + F     +  ++ +  D L +LL  +  +R++A +AM+H YF  +
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQV 321
Query: 273 NVA 275
             A
Sbjct: 322 RAA 324

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  125 bits (314), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 81/243 (33%), Positives = 137/243 (56%), Gaps = 17/243 (6%)
Query: 45  NIVRLYDVLHSE--KKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           NIV+L D++  +  K  +L+FE+ +  D K  + +L    D DI + ++Y+LL+ L +CH
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLT---DYDI-RYYIYELLKALDYCH 142
Query: 102 SRNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           S+ ++HRD+KP N++I+    +L+L D+GLA  F  P K Y+  V + +++ P++L   +
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPG---MNLLP 217
            Y  S+DMWS GC+FA +     P F G D  DQL +I K+LGT   + +     + L P
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 218 DFKPFPMYH---PSMSFSQVAPK--LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
             +     H   P + F     +  ++ +  D L +LL  +  +R++A +AM+H YF  +
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQV 321
Query: 273 NVA 275
             A
Sbjct: 322 RAA 324

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 130/239 (54%), Gaps = 21/239 (8%)
Query: 45  NIVRLYDVLHSEKKLT--LVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           NI+ L D++      T  LVFEH +  D K+   +L    D DI + +MY++L+ L +CH
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLRQTLT---DYDI-RFYMYEILKALDYCH 148
Query: 102 SRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
           S  ++HRD+KP N++I+ ++ +L+L D+GLA  F  P + Y+  V + +++ P++L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWP-----GMNL 215
           +Y  S+DMWS GC+ A +     P F G D  DQL RI K+LG  TED +       + L
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG--TEDLYDYIDKYNIEL 265
Query: 216 LPDFKPFPMYHPSMSFSQVAPK-----LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
            P F      H    + +         ++ +  D L +LL  +   R++A +AM H YF
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  114 bits (284), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 75/247 (30%), Positives = 118/247 (47%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 50  GVEHQLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAP--LGTVYRELQKLSKFDE 107
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P    +A
Sbjct: 108 QRTATYITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRAA 165
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   D  KRI ++  
Sbjct: 166 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQDTYKRISRVEF 223
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 224 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 254
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 255 LEHPWIT 261

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 120/246 (48%), Gaps = 35/246 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLD 84
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+  + ++ K    L+ + D  
Sbjct: 55  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLS-KFDEQ 113
Query: 85  IVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE 144
              +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P    +  
Sbjct: 114 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTL 171
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
             TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  T
Sbjct: 172 CGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEFT 229
Query: 205 PTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAM 264
                       PDF                  +T   RDL+ RLL  NP QR    + +
Sbjct: 230 -----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREVL 260
Query: 265 SHIYFS 270
            H + +
Sbjct: 261 EHPWIT 266

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 118/247 (47%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 53  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 110
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P    +A
Sbjct: 111 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRAA 168
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 169 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 226
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 227 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 257
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 258 LEHPWIT 264

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 119/246 (48%), Gaps = 35/246 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLD 84
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+  + ++ K    L+ + D  
Sbjct: 55  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLS-KFDEQ 113
Query: 85  IVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE 144
              +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P       
Sbjct: 114 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRXXL 171
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
             TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  T
Sbjct: 172 XGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEFT 229
Query: 205 PTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAM 264
                       PDF                  +T   RDL+ RLL  NP QR    + +
Sbjct: 230 -----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREVL 260
Query: 265 SHIYFS 270
            H + +
Sbjct: 261 EHPWIT 266

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 118/247 (47%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 50  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 107
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P    +A
Sbjct: 108 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRAA 165
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 166 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 223
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 224 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 254
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 255 LEHPWIT 261

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 76  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 133
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P    + 
Sbjct: 134 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTT 191
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 192 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 249
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 250 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 280
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 281 LEHPWIT 287

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  110 bits (276), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 67  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 124
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P    + 
Sbjct: 125 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTT 182
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 183 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 240
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 241 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 271
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 272 LEHPWIT 278

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  110 bits (276), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 53  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 110
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P    + 
Sbjct: 111 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTT 168
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 169 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 226
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 227 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 257
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 258 LEHPWIT 264

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  110 bits (276), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 55  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 112
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P    + 
Sbjct: 113 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTT 170
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 171 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 228
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 229 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 259
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 260 LEHPWIT 266

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  110 bits (275), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 50  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 107
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P    + 
Sbjct: 108 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTT 165
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 166 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 223
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 224 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 254
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 255 LEHPWIT 261

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  110 bits (275), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 49  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 106
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P    + 
Sbjct: 107 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTT 164
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 165 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 222
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 223 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 253
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 254 LEHPWIT 260

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  110 bits (275), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 50  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 107
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P    + 
Sbjct: 108 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTE 165
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 166 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 223
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 224 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 254
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 255 LEHPWIT 261

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 54  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 111
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P    + 
Sbjct: 112 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTT 169
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 170 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 227
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 228 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 258
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 259 LEHPWIT 265

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 53  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 110
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P    + 
Sbjct: 111 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTT 168
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 169 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 226
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 227 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 257
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 258 LEHPWIT 264

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 47  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 104
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P    + 
Sbjct: 105 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTT 162
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 163 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 220
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 221 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 251
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 252 LEHPWIT 258

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 50  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 107
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P    + 
Sbjct: 108 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTX 165
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 166 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 223
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 224 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 254
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 255 LEHPWIT 261

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 51  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 108
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P    + 
Sbjct: 109 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SCHAPSSRRTT 166
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 167 LSGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 224
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 225 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 255
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 256 LEHPWIT 262

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 55  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 112
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P    + 
Sbjct: 113 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTD 170
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 171 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 228
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 229 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 259
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 260 LEHPWIT 266

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 50  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 107
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P    + 
Sbjct: 108 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTD 165
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 166 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 223
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 224 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 254
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 255 LEHPWIT 261

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 116/247 (46%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 76  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 133
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P      
Sbjct: 134 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRDD 191
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 192 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 249
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 250 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 280
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 281 LEHPWIT 287

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 50  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 107
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P    + 
Sbjct: 108 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTD 165
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 166 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 223
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 224 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 254
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 255 LEHPWIT 261

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 116/247 (46%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 51  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 108
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P      
Sbjct: 109 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRDT 166
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 167 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 224
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 225 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 255
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 256 LEHPWIT 262

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 51  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 108
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P    + 
Sbjct: 109 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTD 166
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 167 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 224
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 225 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 255
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 256 LEHPWIT 262

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 115/247 (46%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 55  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 112
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P    + 
Sbjct: 113 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTT 170
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+ + G + +   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 171 LCGTLDYLPPEXIEG-RXHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 228
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 229 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPXLREV 259
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 260 LEHPWIT 266

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 116/247 (46%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 52  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 109
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P      
Sbjct: 110 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRXX 167
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 168 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 225
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 226 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 256
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 257 LEHPWIT 263

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 116/247 (46%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 53  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 110
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P      
Sbjct: 111 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRXX 168
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 169 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 226
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 227 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 257
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 258 LEHPWIT 264

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 114/243 (46%), Gaps = 37/243 (15%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L      D 
Sbjct: 54  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSRFDE 111
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+  NGELK+ADFG   +   P    + 
Sbjct: 112 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGW--SVHAPSSRRTT 169
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G P F      +  +RI ++  
Sbjct: 170 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGMPPFEAHTYQETYRRISRVEF 227
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  N  QR++  + 
Sbjct: 228 T-----------FPDF------------------VTEGARDLISRLLKHNASQRLTLAEV 258
Query: 264 MSH 266
           + H
Sbjct: 259 LEH 261

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 116/247 (46%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 50  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 107
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P      
Sbjct: 108 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRXX 165
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 166 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 223
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 224 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 254
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 255 LEHPWIT 261

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 117/247 (47%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 52  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 109
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+A+FG   +   P    + 
Sbjct: 110 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGW--SVHAPSSRRTT 167
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 168 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 225
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 226 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 256
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 257 LEHPWIT 263

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 117/247 (47%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 53  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 110
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+A+FG   +   P    + 
Sbjct: 111 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGW--SVHAPSSRRTT 168
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 169 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 226
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 227 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 257
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 258 LEHPWIT 264

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 116/247 (46%), Gaps = 37/247 (14%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L    + D 
Sbjct: 53  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSKFDE 110
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG   +   P      
Sbjct: 111 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRDD 168
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI ++  
Sbjct: 169 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF 226
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  NP QR    + 
Sbjct: 227 T-----------FPDF------------------VTEGARDLISRLLKHNPSQRPMLREV 257
Query: 264 MSHIYFS 270
           + H + +
Sbjct: 258 LEHPWIT 264

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 113/243 (46%), Gaps = 37/243 (15%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN--GEIDL 83
           GV     RE+ +   L+H NI+RLY   H   ++ L+ E+    L   +  L      D 
Sbjct: 54  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--LGTVYRELQKLSRFDE 111
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
               +++ +L   L++CHS+ V+HRD+KP+NLL+  NGELK+ADFG   +   P      
Sbjct: 112 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGW--SVHAPSSRRDT 169
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
              TL Y PP+++ G +++   +D+WS G +  E    G P F      +  +RI ++  
Sbjct: 170 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGMPPFEAHTYQETYRRISRVEF 227
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
           T            PDF                  +T   RDL+ RLL  N  QR++  + 
Sbjct: 228 T-----------FPDF------------------VTEGARDLISRLLKHNASQRLTLAEV 258
Query: 264 MSH 266
           + H
Sbjct: 259 LEH 261

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 118/255 (46%), Gaps = 35/255 (13%)
Query: 13  ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLK 71
           AL +     +  EGV     REI +   L+H NI+R+Y+  H  K++ L+ E   + +L 
Sbjct: 44  ALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELY 103
Query: 72  KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA 131
           K     +G  D     +FM +L   L +CH R V+HRD+KP+NLL+   GELK+ADFG  
Sbjct: 104 KELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW- 161
Query: 132 RAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDV 191
            +   P         TL Y PP+++ G K +   +D+W AG +  E    G P F     
Sbjct: 162 -SVHAPSLRRRXMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFL-VGMPPFDSPSH 218
Query: 192 DDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLV 251
            +  +RI              +N+   F PF               L+   +DL+ +LL 
Sbjct: 219 TETHRRI--------------VNVDLKFPPF---------------LSDGSKDLISKLLR 249
Query: 252 CNPVQRMSAEDAMSH 266
            +P QR+  +  M H
Sbjct: 250 YHPPQRLPLKGVMEH 264

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 118/255 (46%), Gaps = 35/255 (13%)
Query: 13  ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLK 71
           AL +     +  EGV     REI +   L+H NI+R+Y+  H  K++ L+ E   + +L 
Sbjct: 43  ALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELY 102
Query: 72  KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA 131
           K     +G  D     +FM +L   L +CH R V+HRD+KP+NLL+   GELK+ADFG  
Sbjct: 103 KELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW- 160
Query: 132 RAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDV 191
            +   P         TL Y PP+++ G K +   +D+W AG +  E    G P F     
Sbjct: 161 -SVHAPSLRRRXMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFL-VGMPPFDSPSH 217
Query: 192 DDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLV 251
            +  +RI              +N+   F PF               L+   +DL+ +LL 
Sbjct: 218 TETHRRI--------------VNVDLKFPPF---------------LSDGSKDLISKLLR 248
Query: 252 CNPVQRMSAEDAMSH 266
            +P QR+  +  M H
Sbjct: 249 YHPPQRLPLKGVMEH 263

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 98.2 bits (243), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 127/260 (48%), Gaps = 38/260 (14%)
Query: 13  ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE-HCDQDLK 71
           A+ +     V  +    S LRE+ LLK+L H NI++LY+    +    LV E +   +L 
Sbjct: 61  AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL- 119
Query: 72  KYFDSLNGEIDLDIVKS--FMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLA 126
             FD +        V +   + Q+L G+ + H   ++HRDLKP+NLL+   +K+  +++ 
Sbjct: 120 --FDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRII 177
Query: 127 DFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           DFGL+  F    K    ++ T +Y  P+VL G   Y    D+WS G I   L  +G P F
Sbjct: 178 DFGLSTHFEASKKM-KDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILL-SGCPPF 233
Query: 187 PGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLL 246
            G++  D LK++ K  G  T +       LP +K                K++   +DL+
Sbjct: 234 NGANEYDILKKVEK--GKYTFE-------LPQWK----------------KVSESAKDLI 268
Query: 247 QRLLVCNPVQRMSAEDAMSH 266
           +++L   P  R+SA DA+ H
Sbjct: 269 RKMLTYVPSMRISARDALDH 288

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 115/239 (48%), Gaps = 43/239 (17%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL--NGEIDLDIVKSF 89
            RE+ ++K L H NIV+L++V+ +EK L L+ E+      + FD L  +G +     +S 
Sbjct: 59  FREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG--EVFDYLVAHGRMKEKEARSK 116
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK----CYSAEV 145
             Q++  + +CH + ++HRDLK +NLL++ +  +K+ADFG +  F +  K    C S   
Sbjct: 117 FRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPP- 175
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
               Y  P++  G K     +D+WS G I   L +   P F G ++ +  +R+ +     
Sbjct: 176 ----YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP-FDGQNLKELRERVLR----- 225
Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAM 264
                 G   +P +                  ++    +LL+R LV NP++R + E  M
Sbjct: 226 ------GKYRIPFY------------------MSTDCENLLKRFLVLNPIKRGTLEQIM 260

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 97.4 bits (241), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 78/258 (30%), Positives = 127/258 (49%), Gaps = 34/258 (13%)
Query: 13  ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE-HCDQDLK 71
           A+ +     V  +    S LRE+ LLK+L H NI++LY+    +    LV E +   +L 
Sbjct: 55  AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELF 114
Query: 72  KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADF 128
               S     ++D  +  + Q+L G+ + H   ++HRDLKP+NLL+   +K+  +++ DF
Sbjct: 115 DEIISRKRFSEVDAAR-IIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDF 173
Query: 129 GLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
           GL+  F    K    ++ T +Y  P+VL G   Y    D+WS G I   L  +G P F G
Sbjct: 174 GLSTHFEASKKM-KDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILL-SGCPPFNG 229
Query: 189 SDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQR 248
           ++  D LK++ K  G  T +       LP +K                K++   +DL+++
Sbjct: 230 ANEYDILKKVEK--GKYTFE-------LPQWK----------------KVSESAKDLIRK 264
Query: 249 LLVCNPVQRMSAEDAMSH 266
           +L   P  R+SA DA+ H
Sbjct: 265 MLTYVPSMRISARDALDH 282

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 97.4 bits (241), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 76/241 (31%), Positives = 122/241 (50%), Gaps = 34/241 (14%)
Query: 30  SALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE-HCDQDLKKYFDSLNGEIDLDIVKS 88
           S LRE+ LLK+L H NI++LY+    +    LV E +   +L     S     ++D  + 
Sbjct: 95  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR- 153
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVKCYSAEV 145
            + Q+L G+ + H   ++HRDLKP+NLL+   +K+  +++ DFGL+  F    K    ++
Sbjct: 154 IIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM-KDKI 212
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
            T +Y  P+VL G   Y    D+WS G I   L  +G P F G++  D LK++ K  G  
Sbjct: 213 GTAYYIAPEVLHGT--YDEKCDVWSTGVILYILL-SGCPPFNGANEYDILKKVEK--GKY 267
Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS 265
           T +       LP +K                K++   +DL++++L   P  R+SA DA+ 
Sbjct: 268 TFE-------LPQWK----------------KVSESAKDLIRKMLTYVPSMRISARDALD 304
Query: 266 H 266
           H
Sbjct: 305 H 305

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 97.4 bits (241), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 120/255 (47%), Gaps = 33/255 (12%)
Query: 26  GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLNGEIDLD 84
           G+      E+ +  +LKH +I+ LY+       + LV E C + ++ +Y  +       +
Sbjct: 53  GMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSEN 112
Query: 85  IVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE 144
             + FM+Q++ G+ + HS  +LHRDL   NLL+ +N  +K+ADFGLA    +P + +   
Sbjct: 113 EARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL 172
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
             T  Y  P++   +  +    D+WS GC+F  L   GRP F    V + L ++      
Sbjct: 173 CGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLL-IGRPPFDTDTVKNTLNKV------ 224
Query: 205 PTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAM 264
                     +L D++      PS         L+ + +DL+ +LL  NP  R+S    +
Sbjct: 225 ----------VLADYEM-----PSF--------LSIEAKDLIHQLLRRNPADRLSLSSVL 261
Query: 265 SHIYFSDLNVAIKSE 279
            H + S  N + KS+
Sbjct: 262 DHPFMSR-NSSTKSK 275

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 114/235 (48%), Gaps = 35/235 (14%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL--NGEIDLDIVKSF 89
            RE+ ++K L H NIV+L++V+ +EK L L+ E+      + FD L  +G +     +S 
Sbjct: 62  FREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG--EVFDYLVAHGRMKEKEARSK 119
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW 149
             Q++  + +CH + ++HRDLK +NLL++ +  +K+ADFG +  F +  K   A      
Sbjct: 120 FRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL-DAFCGAPP 178
Query: 150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDT 209
           Y  P++  G K     +D+WS G I   L +   P F G ++ +  +R+ +         
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP-FDGQNLKELRERVLR--------- 228
Query: 210 WPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAM 264
             G   +P +                  ++    +LL+R LV NP++R + E  M
Sbjct: 229 --GKYRIPFY------------------MSTDCENLLKRFLVLNPIKRGTLEQIM 263

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 97.1 bits (240), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 120/262 (45%), Gaps = 40/262 (15%)
Query: 12  TALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLK 71
            AL I    ++    +     REI  L+ L+H +I++LYDV+ S+ ++ +V E+   +L 
Sbjct: 36  VALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELF 95
Query: 72  KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA 131
            Y    +   + +  + F  Q++  + +CH   ++HRDLKP+NLL++++  +K+ADFGL+
Sbjct: 96  DYIVQRDKMSEQE-ARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLS 154
Query: 132 RAFG----IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFP 187
                   +   C S       Y  P+V+ G       +D+WS G I   +     P   
Sbjct: 155 NIMTDGNFLKTSCGSPN-----YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF-- 207
Query: 188 GSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQ 247
               D+ +  +FK +         G+  LP F                  L+     L++
Sbjct: 208 ---DDESIPVLFKNISN-------GVYTLPKF------------------LSPGAAGLIK 239
Query: 248 RLLVCNPVQRMSAEDAMSHIYF 269
           R+L+ NP+ R+S  + M   +F
Sbjct: 240 RMLIVNPLNRISIHEIMQDDWF 261

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 97.1 bits (240), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 120/262 (45%), Gaps = 40/262 (15%)
Query: 12  TALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLK 71
            AL I    ++    +     REI  L+ L+H +I++LYDV+ S+ ++ +V E+   +L 
Sbjct: 41  VALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELF 100
Query: 72  KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA 131
            Y    +   + +  + F  Q++  + +CH   ++HRDLKP+NLL++++  +K+ADFGL+
Sbjct: 101 DYIVQRDKMSEQE-ARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLS 159
Query: 132 RAFG----IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFP 187
                   +   C S       Y  P+V+ G       +D+WS G I   +     P   
Sbjct: 160 NIMTDGNFLKTSCGSPN-----YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF-- 212
Query: 188 GSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQ 247
               D+ +  +FK +         G+  LP F                  L+     L++
Sbjct: 213 ---DDESIPVLFKNISN-------GVYTLPKF------------------LSPGAAGLIK 244
Query: 248 RLLVCNPVQRMSAEDAMSHIYF 269
           R+L+ NP+ R+S  + M   +F
Sbjct: 245 RMLIVNPLNRISIHEIMQDDWF 266

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 97.1 bits (240), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 76/241 (31%), Positives = 122/241 (50%), Gaps = 34/241 (14%)
Query: 30  SALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE-HCDQDLKKYFDSLNGEIDLDIVKS 88
           S LRE+ LLK+L H NI++LY+    +    LV E +   +L     S     ++D  + 
Sbjct: 96  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR- 154
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVKCYSAEV 145
            + Q+L G+ + H   ++HRDLKP+NLL+   +K+  +++ DFGL+  F    K    ++
Sbjct: 155 IIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM-KDKI 213
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
            T +Y  P+VL G   Y    D+WS G I   L  +G P F G++  D LK++ K  G  
Sbjct: 214 GTAYYIAPEVLHGT--YDEKCDVWSTGVILYILL-SGCPPFNGANEYDILKKVEK--GKY 268
Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS 265
           T +       LP +K                K++   +DL++++L   P  R+SA DA+ 
Sbjct: 269 TFE-------LPQWK----------------KVSESAKDLIRKMLTYVPSMRISARDALD 305
Query: 266 H 266
           H
Sbjct: 306 H 306

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 97.1 bits (240), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 120/262 (45%), Gaps = 40/262 (15%)
Query: 12  TALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLK 71
            AL I    ++    +     REI  L+ L+H +I++LYDV+ S+ ++ +V E+   +L 
Sbjct: 32  VALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELF 91
Query: 72  KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA 131
            Y    +   + +  + F  Q++  + +CH   ++HRDLKP+NLL++++  +K+ADFGL+
Sbjct: 92  DYIVQRDKMSEQE-ARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLS 150
Query: 132 RAFG----IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFP 187
                   +   C S       Y  P+V+ G       +D+WS G I   +     P   
Sbjct: 151 NIMTDGNFLKTSCGSPN-----YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF-- 203
Query: 188 GSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQ 247
               D+ +  +FK +         G+  LP F                  L+     L++
Sbjct: 204 ---DDESIPVLFKNISN-------GVYTLPKF------------------LSPGAAGLIK 235
Query: 248 RLLVCNPVQRMSAEDAMSHIYF 269
           R+L+ NP+ R+S  + M   +F
Sbjct: 236 RMLIVNPLNRISIHEIMQDDWF 257

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 120/262 (45%), Gaps = 40/262 (15%)
Query: 12  TALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLK 71
            AL I    ++    +     REI  L+ L+H +I++LYDV+ S+ ++ +V E+   +L 
Sbjct: 42  VALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELF 101
Query: 72  KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA 131
            Y    +   + +  + F  Q++  + +CH   ++HRDLKP+NLL++++  +K+ADFGL+
Sbjct: 102 DYIVQRDKMSEQE-ARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLS 160
Query: 132 RAFG----IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFP 187
                   +   C S       Y  P+V+ G       +D+WS G I   +     P   
Sbjct: 161 NIMTDGNFLKTSCGSPN-----YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF-- 213
Query: 188 GSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQ 247
               D+ +  +FK +         G+  LP F                  L+     L++
Sbjct: 214 ---DDESIPVLFKNISN-------GVYTLPKF------------------LSPGAAGLIK 245
Query: 248 RLLVCNPVQRMSAEDAMSHIYF 269
           R+L+ NP+ R+S  + M   +F
Sbjct: 246 RMLIVNPLNRISIHEIMQDDWF 267

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 94.7 bits (234), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 125/260 (48%), Gaps = 38/260 (14%)
Query: 13  ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE-HCDQDLK 71
           A+ +     V  +    S LRE+ LLK+L H NI +LY+    +    LV E +   +L 
Sbjct: 55  AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGEL- 113
Query: 72  KYFDSLNGEIDLDIVKS--FMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLA 126
             FD +        V +   + Q+L G+ + H   ++HRDLKP+NLL+   +K+  +++ 
Sbjct: 114 --FDEIISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRII 171
Query: 127 DFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           DFGL+  F    K    ++ T +Y  P+VL G   Y    D+WS G I   L  +G P F
Sbjct: 172 DFGLSTHFEASKKX-KDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILL-SGCPPF 227
Query: 187 PGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLL 246
            G++  D LK++ K  G  T +       LP +K                K++   +DL+
Sbjct: 228 NGANEYDILKKVEK--GKYTFE-------LPQWK----------------KVSESAKDLI 262
Query: 247 QRLLVCNPVQRMSAEDAMSH 266
           ++ L   P  R+SA DA+ H
Sbjct: 263 RKXLTYVPSXRISARDALDH 282

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 94.7 bits (234), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 106/214 (49%), Gaps = 29/214 (13%)
Query: 30  SALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYF--DSLNGEI 81
            A  EI +L+ L+ ++     +V+H  +  T      + FE    +L +    +   G  
Sbjct: 139 QAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-F 197
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVK 139
            L +V+ F + +L+ L   H   ++H DLKP+N+L+ + G   +K+ DFG +        
Sbjct: 198 SLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-------- 249
Query: 140 CYSAEVV-----TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQ 194
           CY  + V     + +YR P+V+ GA+ Y   IDMWS GCI AEL   G PL PG D  DQ
Sbjct: 250 CYEHQRVYTXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELL-TGYPLLPGEDEGDQ 307
Query: 195 LKRIFKLLGTPTEDTWPGMNLLPDF---KPFPMY 225
           L  + +LLG P++          +F   K +P Y
Sbjct: 308 LACMIELLGMPSQKLLDASKRAKNFVSXKGYPRY 341

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 106/214 (49%), Gaps = 29/214 (13%)
Query: 30  SALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYF--DSLNGEI 81
            A  EI +L+ L+ ++     +V+H  +  T      + FE    +L +    +   G  
Sbjct: 139 QAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-F 197
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVK 139
            L +V+ F + +L+ L   H   ++H DLKP+N+L+ + G   +K+ DFG +        
Sbjct: 198 SLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-------- 249
Query: 140 CYSAEVV-----TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQ 194
           CY  + V     + +YR P+V+ GA+ Y   IDMWS GCI AEL   G PL PG D  DQ
Sbjct: 250 CYEHQRVYTXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELL-TGYPLLPGEDEGDQ 307
Query: 195 LKRIFKLLGTPTEDTWPGMNLLPDF---KPFPMY 225
           L  + +LLG P++          +F   K +P Y
Sbjct: 308 LACMIELLGMPSQKLLDASKRAKNFVSXKGYPRY 341

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 123/245 (50%), Gaps = 40/245 (16%)
Query: 33  REICLLKELKHKNIVRLYDVLHSE--KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFM 90
           +EI LL+ L+HKN+++L DVL++E  +K+ +V E+C   +++  DS+  E    + ++  
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHG 113
Query: 91  Y--QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARA---FGIPVKCYSAEV 145
           Y  QL+ GL + HS+ ++H+D+KP NLL+   G LK++  G+A A   F     C +++ 
Sbjct: 114 YFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ- 172
Query: 146 VTLWYRPPDVLFGAKLYTT-SIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
            +  ++PP++  G   ++   +D+WSAG     +     P F G    D + ++F+ +G 
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP-FEG----DNIYKLFENIGK 227
Query: 205 PTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAM 264
                  G   +P                  P L+    DLL+ +L   P +R S     
Sbjct: 228 -------GSYAIP--------------GDCGPPLS----DLLKGMLEYEPAKRFSIRQIR 262
Query: 265 SHIYF 269
            H +F
Sbjct: 263 QHSWF 267

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 105/214 (49%), Gaps = 29/214 (13%)
Query: 30  SALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYF--DSLNGEI 81
            A  EI +L+ L+ ++     +V+H  +  T      + FE    +L +    +   G  
Sbjct: 139 QAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-F 197
Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVK 139
            L +V+ F + +L+ L   H   ++H DLKP+N+L+ + G   +K+ DFG +        
Sbjct: 198 SLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-------- 249
Query: 140 CYSAEVV-----TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQ 194
           CY  + V     + +YR P+V+ GA+ Y   IDMWS GCI AEL   G PL PG D  DQ
Sbjct: 250 CYEHQRVYXXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELL-TGYPLLPGEDEGDQ 307
Query: 195 LKRIFKLLGTPTEDTWPGMNLLPDF---KPFPMY 225
           L  + +LLG P +          +F   K +P Y
Sbjct: 308 LACMIELLGMPXQKLLDASKRAKNFVSXKGYPRY 341

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 122/263 (46%), Gaps = 40/263 (15%)
Query: 12  TALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLK 71
            AL      L+    +     REI  LK L+H +I++LYDV+ +   + +V E+   +L 
Sbjct: 37  VALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELF 96
Query: 72  KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA 131
            Y       +  D  + F  Q++  + +CH   ++HRDLKP+NLL++ N  +K+ADFGL+
Sbjct: 97  DYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS 155
Query: 132 RAFG----IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFP 187
                   +   C S       Y  P+V+ G       +D+WS G +   +   GR  F 
Sbjct: 156 NIMTDGNFLKTSCGSPN-----YAAPEVINGKLYAGPEVDVWSCGIVLYVML-VGRLPFD 209
Query: 188 GSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQ 247
               D+ +  +FK + +        + ++PDF                  L+   + L++
Sbjct: 210 ----DEFIPNLFKKVNS-------CVYVMPDF------------------LSPGAQSLIR 240
Query: 248 RLLVCNPVQRMSAEDAMSHIYFS 270
           R++V +P+QR++ ++     +F+
Sbjct: 241 RMIVADPMQRITIQEIRRDPWFN 263

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 135/275 (49%), Gaps = 43/275 (15%)
Query: 7   DRTPNTALAIKGTHLVGNEGVPSSA----LREICLLKELKHKNIVRLYDVLHSEKKLTLV 62
           D+  +   AIK   ++    V +S+    L E+ +LK L H NI++LYD    ++   LV
Sbjct: 58  DKVTHVERAIK---IIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114
Query: 63  FEHCDQDLKKYFDSLNGEIDLDIVKS--FMYQLLRGLAFCHSRNVLHRDLKPQNLLI--- 117
            E C +   + FD +   +  + V +   + Q+L G+ + H  N++HRDLKP+NLL+   
Sbjct: 115 ME-CYKG-GELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESK 172
Query: 118 NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAE 177
            K+  +K+ DFGL+  F    K     + T +Y  P+VL   K Y    D+WS G I   
Sbjct: 173 EKDALIKIVDFGLSAVFENQKKM-KERLGTAYYIAPEVL--RKKYDEKCDVWSIGVILFI 229
Query: 178 LANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK 237
           L  AG P F G    + L+++ K  G  T D+       P++K                 
Sbjct: 230 LL-AGYPPFGGQTDQEILRKVEK--GKYTFDS-------PEWK----------------N 263
Query: 238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
           ++   +DL++++L  +  +R+SA+ A+ H +  ++
Sbjct: 264 VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/251 (30%), Positives = 108/251 (43%), Gaps = 52/251 (20%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKS---- 88
           +EI ++K L H NI+RLY+       + LV E C            GE+   +V      
Sbjct: 55  QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCT----------GGELFERVVHKRVFR 104
Query: 89  ------FMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVK 139
                  M  +L  +A+CH  NV HRDLKP+N L    + +  LKL DFGLA  F  P K
Sbjct: 105 ESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGK 163
Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF 199
               +V T +Y  P VL G  LY    D WSAG +   L     P    +D +  LK   
Sbjct: 164 MMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE 221
Query: 200 KLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
                P +D W  +N+ P                       +   L++RLL  +P QR++
Sbjct: 222 GTFTFPEKD-W--LNVSP-----------------------QAESLIRRLLTKSPKQRIT 255
Query: 260 AEDAMSHIYFS 270
           +  A+ H +F 
Sbjct: 256 SLQALEHEWFE 266

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/251 (30%), Positives = 108/251 (43%), Gaps = 52/251 (20%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKS---- 88
           +EI ++K L H NI+RLY+       + LV E C            GE+   +V      
Sbjct: 72  QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCT----------GGELFERVVHKRVFR 121
Query: 89  ------FMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVK 139
                  M  +L  +A+CH  NV HRDLKP+N L    + +  LKL DFGLA  F  P K
Sbjct: 122 ESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGK 180
Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF 199
               +V T +Y  P VL G  LY    D WSAG +   L     P    +D +  LK   
Sbjct: 181 MMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE 238
Query: 200 KLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
                P +D W  +N+ P                       +   L++RLL  +P QR++
Sbjct: 239 GTFTFPEKD-W--LNVSP-----------------------QAESLIRRLLTKSPKQRIT 272
Query: 260 AEDAMSHIYFS 270
           +  A+ H +F 
Sbjct: 273 SLQALEHEWFE 283

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 125/274 (45%), Gaps = 53/274 (19%)
Query: 7   DRTPNTALAIKGTHLVGNEGVPSSA-LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           DR      A+K  +    +   +S  LRE+ LLK+L H NI++L+++L       +V E 
Sbjct: 43  DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102
Query: 66  CDQDLKKYFDSLNGEIDLDIVKS----------FMYQLLRGLAFCHSRNVLHRDLKPQNL 115
                        GE+  +I+K            + Q+  G+ + H  N++HRDLKP+N+
Sbjct: 103 Y----------TGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENI 152
Query: 116 LI---NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAG 172
           L+    K+ ++K+ DFGL+  F    K     + T +Y  P+VL G   Y    D+WSAG
Sbjct: 153 LLESKEKDCDIKIIDFGLSTCFQQNTKM-KDRIGTAYYIAPEVLRGT--YDEKCDVWSAG 209
Query: 173 CIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS 232
            I   L  +G P F G +  D LKR+         +T      LP ++            
Sbjct: 210 VILYILL-SGTPPFYGKNEYDILKRV---------ETGKYAFDLPQWRT----------- 248
Query: 233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                ++   +DL++++L  +P  R++A   + H
Sbjct: 249 -----ISDDAKDLIRKMLTFHPSLRITATQCLEH 277

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 125/274 (45%), Gaps = 53/274 (19%)
Query: 7   DRTPNTALAIKGTHLVGNEGVPSSA-LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           DR      A+K  +    +   +S  LRE+ LLK+L H NI++L+++L       +V E 
Sbjct: 43  DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102
Query: 66  CDQDLKKYFDSLNGEIDLDIVKS----------FMYQLLRGLAFCHSRNVLHRDLKPQNL 115
                        GE+  +I+K            + Q+  G+ + H  N++HRDLKP+N+
Sbjct: 103 ----------YTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENI 152
Query: 116 LI---NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAG 172
           L+    K+ ++K+ DFGL+  F    K     + T +Y  P+VL G   Y    D+WSAG
Sbjct: 153 LLESKEKDCDIKIIDFGLSTCFQQNTKM-KDRIGTAYYIAPEVLRGT--YDEKCDVWSAG 209
Query: 173 CIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS 232
            I   L  +G P F G +  D LKR+         +T      LP ++            
Sbjct: 210 VILYILL-SGTPPFYGKNEYDILKRV---------ETGKYAFDLPQWRT----------- 248
Query: 233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                ++   +DL++++L  +P  R++A   + H
Sbjct: 249 -----ISDDAKDLIRKMLTFHPSLRITATQCLEH 277

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 125/274 (45%), Gaps = 53/274 (19%)
Query: 7   DRTPNTALAIKGTHLVGNEGVPSSA-LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           DR      A+K  +    +   +S  LRE+ LLK+L H NI++L+++L       +V E 
Sbjct: 43  DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102
Query: 66  CDQDLKKYFDSLNGEIDLDIVKS----------FMYQLLRGLAFCHSRNVLHRDLKPQNL 115
                        GE+  +I+K            + Q+  G+ + H  N++HRDLKP+N+
Sbjct: 103 ----------YTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENI 152
Query: 116 LI---NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAG 172
           L+    K+ ++K+ DFGL+  F    K     + T +Y  P+VL G   Y    D+WSAG
Sbjct: 153 LLESKEKDCDIKIIDFGLSTCFQQNTKM-KDRIGTAYYIAPEVLRGT--YDEKCDVWSAG 209
Query: 173 CIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS 232
            I   L  +G P F G +  D LKR+         +T      LP ++            
Sbjct: 210 VILYILL-SGTPPFYGKNEYDILKRV---------ETGKYAFDLPQWRT----------- 248
Query: 233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                ++   +DL++++L  +P  R++A   + H
Sbjct: 249 -----ISDDAKDLIRKMLTFHPSLRITATQCLEH 277

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 94/175 (53%), Gaps = 14/175 (8%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL--NGEIDLDIVKSF 89
            RE+ ++K L H NIV+L++V+ +EK L LV E+      + FD L  +G +     ++ 
Sbjct: 62  FREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAK 119
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK----CYSAEV 145
             Q++  + +CH + ++HRDLK +NLL++ +  +K+ADFG +  F +  K    C S   
Sbjct: 120 FRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPP- 178
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
               Y  P++  G K     +D+WS G I   L +   P F G ++ +  +R+ +
Sbjct: 179 ----YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP-FDGQNLKELRERVLR 228

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 113/239 (47%), Gaps = 43/239 (17%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL--NGEIDLDIVKSF 89
            RE+ ++K L H NIV+L++V+ +EK L LV E+      + FD L  +G +     ++ 
Sbjct: 61  FREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAK 118
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK----CYSAEV 145
             Q++  + +CH + ++HRDLK +NLL++ +  +K+ADFG +  F    K    C S   
Sbjct: 119 FRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPP- 177
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
               Y  P++  G K     +D+WS G I   L +   P F G ++ +  +R+ +     
Sbjct: 178 ----YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP-FDGQNLKELRERVLR----- 227
Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAM 264
                 G   +P +                  ++    +LL++ L+ NP +R + E  M
Sbjct: 228 ------GKYRIPFY------------------MSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 112/235 (47%), Gaps = 35/235 (14%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL--NGEIDLDIVKSF 89
            RE+ ++K L H NIV+L++V+ +EK L LV E+      + FD L  +G +     ++ 
Sbjct: 61  FREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAK 118
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW 149
             Q++  + +CH + ++HRDLK +NLL++ +  +K+ADFG +  F    K   A      
Sbjct: 119 FRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL-DAFCGAPP 177
Query: 150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDT 209
           Y  P++  G K     +D+WS G I   L +   P F G ++ +  +R+ +         
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP-FDGQNLKELRERVLR--------- 227
Query: 210 WPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAM 264
             G   +P +                  ++    +LL++ L+ NP +R + E  M
Sbjct: 228 --GKYRIPFY------------------MSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 113/239 (47%), Gaps = 43/239 (17%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL--NGEIDLDIVKSF 89
            RE+ ++K L H NIV+L++V+ +EK L LV E+      + FD L  +G +     ++ 
Sbjct: 61  FREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAK 118
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK----CYSAEV 145
             Q++  + +CH + ++HRDLK +NLL++ +  +K+ADFG +  F    K    C S   
Sbjct: 119 FRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPP- 177
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
               Y  P++  G K     +D+WS G I   L +   P F G ++ +  +R+ +     
Sbjct: 178 ----YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP-FDGQNLKELRERVLR----- 227
Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAM 264
                 G   +P +                  ++    +LL++ L+ NP +R + E  M
Sbjct: 228 ------GKYRIPFY------------------MSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 113/239 (47%), Gaps = 43/239 (17%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL--NGEIDLDIVKSF 89
            RE+ ++K L H NIV+L++V+ +EK L LV E+      + FD L  +G +     ++ 
Sbjct: 61  FREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAK 118
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK----CYSAEV 145
             Q++  + +CH + ++HRDLK +NLL++ +  +K+ADFG +  F    K    C S   
Sbjct: 119 FRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPP- 177
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
               Y  P++  G K     +D+WS G I   L +   P F G ++ +  +R+ +     
Sbjct: 178 ----YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP-FDGQNLKELRERVLR----- 227
Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAM 264
                 G   +P +                  ++    +LL++ L+ NP +R + E  M
Sbjct: 228 ------GKYRIPFY------------------MSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 113/239 (47%), Gaps = 43/239 (17%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL--NGEIDLDIVKSF 89
            RE+ ++K L H NIV+L++V+ +EK L LV E+      + FD L  +G +     ++ 
Sbjct: 61  FREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAK 118
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK----CYSAEV 145
             Q++  + +CH + ++HRDLK +NLL++ +  +K+ADFG +  F    K    C S   
Sbjct: 119 FRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPP- 177
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
               Y  P++  G K     +D+WS G I   L +   P F G ++ +  +R+ +     
Sbjct: 178 ----YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP-FDGQNLKELRERVLR----- 227
Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAM 264
                 G   +P +                  ++    +LL++ L+ NP +R + E  M
Sbjct: 228 ------GKYRIPFY------------------MSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 120/243 (49%), Gaps = 42/243 (17%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN-----GEIDLDIV 86
           L E+ +LK+L H NI++LY+    ++   LV E       + FD +       E+D  ++
Sbjct: 69  LDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGG--ELFDEIILRQKFSEVDAAVI 126
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVKCYSA 143
              M Q+L G  + H  N++HRDLKP+NLL+   +++  +K+ DFGL+  F +  K    
Sbjct: 127 ---MKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM-KE 182
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
            + T +Y  P+VL   K Y    D+WS G I   L   G P F G    + LKR+ K  G
Sbjct: 183 RLGTAYYIAPEVL--RKKYDEKCDVWSCGVILYILL-CGYPPFGGQTDQEILKRVEK--G 237
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
             + D        PD+                 +++ + + L++ +L   P +R+SAE+A
Sbjct: 238 KFSFDP-------PDW----------------TQVSDEAKQLVKLMLTYEPSKRISAEEA 274
Query: 264 MSH 266
           ++H
Sbjct: 275 LNH 277

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 113/239 (47%), Gaps = 43/239 (17%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL--NGEIDLDIVKSF 89
            RE+ ++K L H NIV+L++V+ +EK L LV E+      + FD L  +G +     ++ 
Sbjct: 54  FREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGWMKEKEARAK 111
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK----CYSAEV 145
             Q++  + +CH + ++HRDLK +NLL++ +  +K+ADFG +  F    K    C S   
Sbjct: 112 FRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPP- 170
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
               Y  P++  G K     +D+WS G I   L +   P F G ++ +  +R+ +     
Sbjct: 171 ----YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP-FDGQNLKELRERVLR----- 220
Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAM 264
                 G   +P +                  ++    +LL++ L+ NP +R + E  M
Sbjct: 221 ------GKYRIPFY------------------MSTDCENLLKKFLILNPSKRGTLEQIM 255

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 120/243 (49%), Gaps = 42/243 (17%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN-----GEIDLDIV 86
           L E+ +LK+L H NI++LY+    ++   LV E       + FD +       E+D  ++
Sbjct: 52  LDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGG--ELFDEIILRQKFSEVDAAVI 109
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVKCYSA 143
              M Q+L G  + H  N++HRDLKP+NLL+   +++  +K+ DFGL+  F +  K    
Sbjct: 110 ---MKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM-KE 165
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
            + T +Y  P+VL   K Y    D+WS G I   L   G P F G    + LKR+ K  G
Sbjct: 166 RLGTAYYIAPEVL--RKKYDEKCDVWSCGVILYILL-CGYPPFGGQTDQEILKRVEK--G 220
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
             + D        PD+                 +++ + + L++ +L   P +R+SAE+A
Sbjct: 221 KFSFDP-------PDW----------------TQVSDEAKQLVKLMLTYEPSKRISAEEA 257
Query: 264 MSH 266
           ++H
Sbjct: 258 LNH 260

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 81/159 (50%), Gaps = 3/159 (1%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEI-DLDIVKSFM 90
           RE+ +L  +KH NIV+  +       L +V ++C+  DL K  ++  G +   D +  + 
Sbjct: 72  REVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF 131
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWY 150
            Q+   L   H R +LHRD+K QN+ + K+G ++L DFG+AR     V+   A + T +Y
Sbjct: 132 VQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYY 191
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGS 189
             P++    K Y    D+W+ GC+  EL         GS
Sbjct: 192 LSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS 229

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 78/162 (48%), Gaps = 5/162 (3%)
Query: 29  SSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLK---KYFDSLNGEIDLD 84
           +  ++EI LLK+L H N+++ Y     + +L +V E  D  DL    K+F      I   
Sbjct: 77  ADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPER 136
Query: 85  IVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE 144
            V  +  QL   L   HSR V+HRD+KP N+ I   G +KL D GL R F        + 
Sbjct: 137 TVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 196
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           V T +Y  P+ +     Y    D+WS GC+  E+A    P +
Sbjct: 197 VGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFY 237

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 6/190 (3%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            V+R    A+A+K   +      P +  +EIC+ K L H+N+V+ Y          L  E
Sbjct: 26  AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85
Query: 65  HCDQDLKKYFDSLNGEIDLDI--VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           +C     + FD +  +I +     + F +QL+ G+ + H   + HRD+KP+NLL+++   
Sbjct: 86  YCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 143
Query: 123 LKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           LK++DFGLA  F      +  +    TL Y  P++L   + +   +D+WS G +   +  
Sbjct: 144 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203
Query: 181 AGRPLFPGSD 190
              P    SD
Sbjct: 204 GELPWDQPSD 213

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 6/190 (3%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            V+R    A+A+K   +      P +  +EIC+ K L H+N+V+ Y          L  E
Sbjct: 24  AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83
Query: 65  HCDQDLKKYFDSLNGEIDLDI--VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           +C     + FD +  +I +     + F +QL+ G+ + H   + HRD+KP+NLL+++   
Sbjct: 84  YCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 141
Query: 123 LKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           LK++DFGLA  F      +  +    TL Y  P++L   + +   +D+WS G +   +  
Sbjct: 142 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 201
Query: 181 AGRPLFPGSD 190
              P    SD
Sbjct: 202 GELPWDQPSD 211

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 6/190 (3%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            V+R    A+A+K   +      P +  +EIC+ K L H+N+V+ Y          L  E
Sbjct: 25  AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 84
Query: 65  HCDQDLKKYFDSLNGEIDLDI--VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           +C     + FD +  +I +     + F +QL+ G+ + H   + HRD+KP+NLL+++   
Sbjct: 85  YCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 142
Query: 123 LKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           LK++DFGLA  F      +  +    TL Y  P++L   + +   +D+WS G +   +  
Sbjct: 143 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 202
Query: 181 AGRPLFPGSD 190
              P    SD
Sbjct: 203 GELPWDQPSD 212

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 6/190 (3%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            V+R    A+A+K   +      P +  +EIC+ K L H+N+V+ Y          L  E
Sbjct: 25  AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 84
Query: 65  HCDQDLKKYFDSLNGEIDLDI--VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           +C     + FD +  +I +     + F +QL+ G+ + H   + HRD+KP+NLL+++   
Sbjct: 85  YCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 142
Query: 123 LKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           LK++DFGLA  F      +  +    TL Y  P++L   + +   +D+WS G +   +  
Sbjct: 143 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 202
Query: 181 AGRPLFPGSD 190
              P    SD
Sbjct: 203 GELPWDQPSD 212

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 6/190 (3%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            V+R    A+A+K   +      P +  +EIC+ K L H+N+V+ Y          L  E
Sbjct: 26  AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85
Query: 65  HCDQDLKKYFDSLNGEIDLDI--VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           +C     + FD +  +I +     + F +QL+ G+ + H   + HRD+KP+NLL+++   
Sbjct: 86  YCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 143
Query: 123 LKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           LK++DFGLA  F      +  +    TL Y  P++L   + +   +D+WS G +   +  
Sbjct: 144 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203
Query: 181 AGRPLFPGSD 190
              P    SD
Sbjct: 204 GELPWDQPSD 213

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 6/190 (3%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            V+R    A+A+K   +      P +  +EIC+ K L H+N+V+ Y          L  E
Sbjct: 26  AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85
Query: 65  HCDQDLKKYFDSLNGEIDLDI--VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           +C     + FD +  +I +     + F +QL+ G+ + H   + HRD+KP+NLL+++   
Sbjct: 86  YCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 143
Query: 123 LKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           LK++DFGLA  F      +  +    TL Y  P++L   + +   +D+WS G +   +  
Sbjct: 144 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203
Query: 181 AGRPLFPGSD 190
              P    SD
Sbjct: 204 GELPWDQPSD 213

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 6/190 (3%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            V+R    A+A+K   +      P +  +EIC+ K L H+N+V+ Y          L  E
Sbjct: 26  AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85
Query: 65  HCDQDLKKYFDSLNGEIDLDI--VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           +C     + FD +  +I +     + F +QL+ G+ + H   + HRD+KP+NLL+++   
Sbjct: 86  YCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 143
Query: 123 LKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           LK++DFGLA  F      +  +    TL Y  P++L   + +   +D+WS G +   +  
Sbjct: 144 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203
Query: 181 AGRPLFPGSD 190
              P    SD
Sbjct: 204 GELPWDQPSD 213

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 6/190 (3%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            V+R    A+A+K   +      P +  +EIC+ K L H+N+V+ Y          L  E
Sbjct: 25  AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 84
Query: 65  HCDQDLKKYFDSLNGEIDLDI--VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           +C     + FD +  +I +     + F +QL+ G+ + H   + HRD+KP+NLL+++   
Sbjct: 85  YCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 142
Query: 123 LKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           LK++DFGLA  F      +  +    TL Y  P++L   + +   +D+WS G +   +  
Sbjct: 143 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 202
Query: 181 AGRPLFPGSD 190
              P    SD
Sbjct: 203 GELPWDQPSD 212

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 6/190 (3%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            V+R    A+A+K   +      P +  +EIC+ K L H+N+V+ Y          L  E
Sbjct: 25  AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 84
Query: 65  HCDQDLKKYFDSLNGEIDLDI--VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           +C     + FD +  +I +     + F +QL+ G+ + H   + HRD+KP+NLL+++   
Sbjct: 85  YCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 142
Query: 123 LKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           LK++DFGLA  F      +  +    TL Y  P++L   + +   +D+WS G +   +  
Sbjct: 143 LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 202
Query: 181 AGRPLFPGSD 190
              P    SD
Sbjct: 203 GELPWDQPSD 212

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 6/190 (3%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            V+R    A+A+K   +      P +  +EIC+ K L H+N+V+ Y          L  E
Sbjct: 26  AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85
Query: 65  HCDQDLKKYFDSLNGEIDLDI--VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           +C     + FD +  +I +     + F +QL+ G+ + H   + HRD+KP+NLL+++   
Sbjct: 86  YCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 143
Query: 123 LKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           LK++DFGLA  F      +  +    TL Y  P++L   + +   +D+WS G +   +  
Sbjct: 144 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203
Query: 181 AGRPLFPGSD 190
              P    SD
Sbjct: 204 GELPWDQPSD 213

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 6/190 (3%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            V+R    A+A+K   +      P +  +EIC+ K L H+N+V+ Y          L  E
Sbjct: 25  AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 84
Query: 65  HCDQDLKKYFDSLNGEIDLDI--VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           +C     + FD +  +I +     + F +QL+ G+ + H   + HRD+KP+NLL+++   
Sbjct: 85  YCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 142
Query: 123 LKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           LK++DFGLA  F      +  +    TL Y  P++L   + +   +D+WS G +   +  
Sbjct: 143 LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 202
Query: 181 AGRPLFPGSD 190
              P    SD
Sbjct: 203 GELPWDQPSD 212

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 90/171 (52%), Gaps = 6/171 (3%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL--NGEIDLDIVKSF 89
            RE+ + K L H NIV+L++V+ +EK L LV E+      + FD L  +G       ++ 
Sbjct: 61  FREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGG--EVFDYLVAHGRXKEKEARAK 118
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW 149
             Q++  + +CH + ++HRDLK +NLL++ +  +K+ADFG +  F    K   A      
Sbjct: 119 FRQIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKL-DAFCGAPP 177
Query: 150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           Y  P++  G K     +D+WS G I   L +   P F G ++ +  +R+ +
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP-FDGQNLKELRERVLR 227

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 6/190 (3%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            V+R    A+A+K   +      P +  +EIC+ K L H+N+V+ Y          L  E
Sbjct: 25  AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 84
Query: 65  HCDQDLKKYFDSLNGEIDLDI--VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           +C     + FD +  +I +     + F +QL+ G+ + H   + HRD+KP+NLL+++   
Sbjct: 85  YCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 142
Query: 123 LKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           LK++DFGLA  F      +  +    TL Y  P++L   + +   +D+WS G +   +  
Sbjct: 143 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 202
Query: 181 AGRPLFPGSD 190
              P    SD
Sbjct: 203 GELPWDQPSD 212

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 6/190 (3%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            V+R    A+A+K   +      P +  +EIC+ K L H+N+V+ Y          L  E
Sbjct: 25  AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 84
Query: 65  HCDQDLKKYFDSLNGEIDLDI--VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           +C     + FD +  +I +     + F +QL+ G+ + H   + HRD+KP+NLL+++   
Sbjct: 85  YCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 142
Query: 123 LKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           LK++DFGLA  F      +  +    TL Y  P++L   + +   +D+WS G +   +  
Sbjct: 143 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 202
Query: 181 AGRPLFPGSD 190
              P    SD
Sbjct: 203 GELPWDQPSD 212

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 6/190 (3%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            V+R    A+A+K   +      P +  +EIC+ K L H+N+V+ Y          L  E
Sbjct: 25  AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 84
Query: 65  HCDQDLKKYFDSLNGEIDLDI--VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           +C     + FD +  +I +     + F +QL+ G+ + H   + HRD+KP+NLL+++   
Sbjct: 85  YCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 142
Query: 123 LKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           LK++DFGLA  F      +  +    TL Y  P++L   + +   +D+WS G +   +  
Sbjct: 143 LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 202
Query: 181 AGRPLFPGSD 190
              P    SD
Sbjct: 203 GELPWDQPSD 212

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 96/183 (52%), Gaps = 14/183 (7%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEID----L 83
           P + L+E  ++K+L+H+ +V+LY V+ SE+ + +V E+  +      D L GE+     L
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVIEYMSKG--SLLDFLKGEMGKYLRL 113
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVKCY 141
             +     Q+  G+A+    N +HRDL+  N+L+ +N   K+ADFGLAR           
Sbjct: 114 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQ 173
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKRI 198
            A+    W  P   L+G   +T   D+WS G +  EL   GR  +PG    +V DQ++R 
Sbjct: 174 GAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 231
Query: 199 FKL 201
           +++
Sbjct: 232 YRM 234

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 99/185 (53%), Gaps = 18/185 (9%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEID----L 83
           P + L+E  ++K+L+H+ +V+LY V+ SE+ + +V E+  +      D L GE+     L
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVIEYMSKG--SLLDFLKGEMGKYLRL 113
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS- 142
             +     Q+  G+A+    N +HRDL+  N+L+ +N   K+ADFGLAR   I    Y+ 
Sbjct: 114 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTA 171
Query: 143 ---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLK 196
              A+    W  P   L+G   +T   D+WS G +  EL   GR  +PG    +V DQ++
Sbjct: 172 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 197 RIFKL 201
           R +++
Sbjct: 230 RGYRM 234

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 6/190 (3%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            V+R    A+A+K   +      P +  +EIC+ K L H+N+V+ Y          L  E
Sbjct: 26  AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85
Query: 65  HCDQDLKKYFDSLNGEIDLDI--VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           +C     + FD +  +I +     + F +QL+ G+ + H   + HRD+KP+NLL+++   
Sbjct: 86  YCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 143
Query: 123 LKLADFGLARAF--GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           LK++DFGLA  F      +  +    TL Y  P++L   + +   +D+WS G +   +  
Sbjct: 144 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203
Query: 181 AGRPLFPGSD 190
              P    SD
Sbjct: 204 GELPWDQPSD 213

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 6/190 (3%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            V+R    A+A+K   +      P +  +EIC+ K L H+N+V+ Y          L  E
Sbjct: 25  AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 84
Query: 65  HCDQDLKKYFDSLNGEIDLDI--VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           +C     + FD +  +I +     + F +QL+ G+ + H   + HRD+KP+NLL+++   
Sbjct: 85  YCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 142
Query: 123 LKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           LK++DFGLA  F      +  +    TL Y  P++L   + +   +D+WS G +   +  
Sbjct: 143 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 202
Query: 181 AGRPLFPGSD 190
              P    SD
Sbjct: 203 GELPWDQPSD 212

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 6/190 (3%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            V+R    A+A+K   +      P +  +EIC+ K L H+N+V+ Y          L  E
Sbjct: 25  AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 84
Query: 65  HCDQDLKKYFDSLNGEIDLDI--VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           +C     + FD +  +I +     + F +QL+ G+ + H   + HRD+KP+NLL+++   
Sbjct: 85  YCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 142
Query: 123 LKLADFGLARAF--GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           LK++DFGLA  F      +  +    TL Y  P++L   + +   +D+WS G +   +  
Sbjct: 143 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 202
Query: 181 AGRPLFPGSD 190
              P    SD
Sbjct: 203 GELPWDQPSD 212

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 96/183 (52%), Gaps = 14/183 (7%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE----IDL 83
           P + L+E  ++K+L+H+ +V+LY V+ SE+ + +V E+  +      D L GE    + L
Sbjct: 47  PEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIXIVTEYMSKG--SLLDFLKGETGKYLRL 103
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVKCY 141
             +     Q+  G+A+    N +HRDL+  N+L+ +N   K+ADFGLAR           
Sbjct: 104 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQ 163
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKRI 198
            A+    W  P   L+G   +T   D+WS G +  EL   GR  +PG    +V DQ++R 
Sbjct: 164 GAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 221
Query: 199 FKL 201
           +++
Sbjct: 222 YRM 224

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 111/250 (44%), Gaps = 50/250 (20%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY- 91
           RE  + + LKH NIVRL+D +  E    LVF     DL        GE+  DIV    Y 
Sbjct: 52  REARICRLLKHPNIVRLHDSISEEGFHYLVF-----DL-----VTGGELFEDIVAREYYS 101
Query: 92  ---------QLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVK 139
                    Q+L  +  CH   ++HRDLKP+NLL+   +K   +KLADFGLA       +
Sbjct: 102 EADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ 161
Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF 199
            +     T  Y  P+VL     Y   +DMW+ G I   L   G P F     D+   R++
Sbjct: 162 AWFGFAGTPGYLSPEVL-RKDPYGKPVDMWACGVILYILL-VGYPPF----WDEDQHRLY 215
Query: 200 KLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
           + +     D                  PS  +  V P    + +DL+ ++L  NP +R++
Sbjct: 216 QQIKAGAYD-----------------FPSPEWDTVTP----EAKDLINKMLTINPAKRIT 254
Query: 260 AEDAMSHIYF 269
           A +A+ H + 
Sbjct: 255 ASEALKHPWI 264

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 99/185 (53%), Gaps = 18/185 (9%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEID----L 83
           P + L+E  ++K+L+H+ +V+LY V+ SE+ + +V E+  +      D L GE+     L
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVMEYMSKGC--LLDFLKGEMGKYLRL 113
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS- 142
             +     Q+  G+A+    N +HRDL+  N+L+ +N   K+ADFGLAR   I    Y+ 
Sbjct: 114 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTA 171
Query: 143 ---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLK 196
              A+    W  P   L+G   +T   D+WS G +  EL   GR  +PG    +V DQ++
Sbjct: 172 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 197 RIFKL 201
           R +++
Sbjct: 230 RGYRM 234

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 59/156 (37%), Positives = 78/156 (50%), Gaps = 12/156 (7%)
Query: 34  EICLLKELKHKNIVRLYDVL--HSEKKLTLVFEHCDQ-DLKKYFDSLNGE---IDLDIVK 87
           E+ LL+ELKH NIVR YD +   +   L +V E+C+  DL         E   +D + V 
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 88  SFMYQLLRGLAFCHSRN-----VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS 142
             M QL   L  CH R+     VLHRDLKP N+ ++    +KL DFGLAR          
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 174
Query: 143 AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
           A V T +Y  P+ +     Y    D+WS GC+  EL
Sbjct: 175 AFVGTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYEL 209

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 87.0 bits (214), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 100/185 (54%), Gaps = 18/185 (9%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE----IDL 83
           P + L+E  ++K+L+H+ +V+LY V+ SE+ + +V E+ ++      D L GE    + L
Sbjct: 54  PEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMNKG--SLLDFLKGETGKYLRL 110
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS- 142
             +     Q+  G+A+    N +HRDL+  N+L+ +N   K+ADFGLAR   I    Y+ 
Sbjct: 111 PQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTA 168
Query: 143 ---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLK 196
              A+    W  P   L+G   +T   D+WS G +  EL   GR  +PG    +V DQ++
Sbjct: 169 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 226
Query: 197 RIFKL 201
           R +++
Sbjct: 227 RGYRM 231

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 110/251 (43%), Gaps = 50/251 (19%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY- 91
           RE  + + LKH NIVRL+D +  E    L+F     DL        GE+  DIV    Y 
Sbjct: 70  REARICRLLKHPNIVRLHDSISEEGHHYLIF-----DL-----VTGGELFEDIVAREYYS 119
Query: 92  ---------QLLRGLAFCHSRNVLHRDLKPQNLLIN---KNGELKLADFGLARAFGIPVK 139
                    Q+L  +  CH   V+HRDLKP+NLL+    K   +KLADFGLA       +
Sbjct: 120 EADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 179
Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF 199
            +     T  Y  P+VL     Y   +D+W+ G I   L     P +     D+   R++
Sbjct: 180 AWFGFAGTPGYLSPEVL-RKDPYGKPVDLWACGVILYILLVGYPPFW-----DEDQHRLY 233
Query: 200 KLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
           + +     D                  PS  +  V P    + +DL+ ++L  NP +R++
Sbjct: 234 QQIKAGAYD-----------------FPSPEWDTVTP----EAKDLINKMLTINPSKRIT 272
Query: 260 AEDAMSHIYFS 270
           A +A+ H + S
Sbjct: 273 AAEALKHPWIS 283

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 99/185 (53%), Gaps = 18/185 (9%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEID----L 83
           P + L+E  ++K+L+H+ +V+LY V+ SE+ + +V E+  +      D L GE+     L
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKG--SLLDFLKGEMGKYLRL 113
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS- 142
             +     Q+  G+A+    N +HRDL+  N+L+ +N   K+ADFGLAR   I    Y+ 
Sbjct: 114 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTA 171
Query: 143 ---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLK 196
              A+    W  P   L+G   +T   D+WS G +  EL   GR  +PG    +V DQ++
Sbjct: 172 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 197 RIFKL 201
           R +++
Sbjct: 230 RGYRM 234

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 99/185 (53%), Gaps = 18/185 (9%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE----IDL 83
           P + L+E  ++K+L+H+ +V+LY V+ SE+ + +V E+  +      D L GE    + L
Sbjct: 306 PEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKG--SLLDFLKGETGKYLRL 362
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS- 142
             +     Q+  G+A+    N +HRDL+  N+L+ +N   K+ADFGLAR   I    Y+ 
Sbjct: 363 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTA 420
Query: 143 ---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLK 196
              A+    W  P   L+G   +T   D+WS G +  EL   GR  +PG    +V DQ++
Sbjct: 421 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
Query: 197 RIFKL 201
           R +++
Sbjct: 479 RGYRM 483

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 99/185 (53%), Gaps = 18/185 (9%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEID----L 83
           P + L+E  ++K+L+H+ +V+LY V+ SE+ + +V E+  +      D L GE+     L
Sbjct: 46  PEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKG--SLLDFLKGEMGKYLRL 102
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS- 142
             +     Q+  G+A+    N +HRDL+  N+L+ +N   K+ADFGLAR   I    Y+ 
Sbjct: 103 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTA 160
Query: 143 ---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLK 196
              A+    W  P   L+G   +T   D+WS G +  EL   GR  +PG    +V DQ++
Sbjct: 161 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 218
Query: 197 RIFKL 201
           R +++
Sbjct: 219 RGYRM 223

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 99/185 (53%), Gaps = 18/185 (9%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE----IDL 83
           P + L+E  ++K+L+H+ +V+LY V+ SE+ + +V E+  +      D L GE    + L
Sbjct: 50  PEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKG--SLLDFLKGETGKYLRL 106
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS- 142
             +     Q+  G+A+    N +HRDL+  N+L+ +N   K+ADFGLAR   I    Y+ 
Sbjct: 107 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTA 164
Query: 143 ---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLK 196
              A+    W  P   L+G   +T   D+WS G +  EL   GR  +PG    +V DQ++
Sbjct: 165 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 222
Query: 197 RIFKL 201
           R +++
Sbjct: 223 RGYRM 227

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 109/247 (44%), Gaps = 50/247 (20%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY- 91
           RE  + + LKH NIVRL+D +  E    LVF     DL        GE+  DIV    Y 
Sbjct: 52  REARICRLLKHPNIVRLHDSISEEGFHYLVF-----DL-----VTGGELFEDIVAREYYS 101
Query: 92  ---------QLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVK 139
                    Q+L  +  CH   ++HRDLKP+NLL+   +K   +KLADFGLA       +
Sbjct: 102 EADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ 161
Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF 199
            +     T  Y  P+VL     Y   +DMW+ G I   L     P +     D+   R++
Sbjct: 162 AWFGFAGTPGYLSPEVL-RKDPYGKPVDMWACGVILYILLVGYPPFW-----DEDQHRLY 215
Query: 200 KLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
           + +     D                  PS  +  V P    + +DL+ ++L  NP +R++
Sbjct: 216 QQIKAGAYD-----------------FPSPEWDTVTP----EAKDLINKMLTINPAKRIT 254
Query: 260 AEDAMSH 266
           A +A+ H
Sbjct: 255 ASEALKH 261

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 99/185 (53%), Gaps = 18/185 (9%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEID----L 83
           P + L+E  ++K+L+H+ +V+LY V+ SE+ + +V E+  +      D L GE+     L
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVCEYMSKG--SLLDFLKGEMGKYLRL 113
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS- 142
             +     Q+  G+A+    N +HRDL+  N+L+ +N   K+ADFGLAR   I    Y+ 
Sbjct: 114 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTA 171
Query: 143 ---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLK 196
              A+    W  P   L+G   +T   D+WS G +  EL   GR  +PG    +V DQ++
Sbjct: 172 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 197 RIFKL 201
           R +++
Sbjct: 230 RGYRM 234

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 99/185 (53%), Gaps = 18/185 (9%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE----IDL 83
           P + L+E  ++K+L+H+ +V+LY V+ SE+ + +V E+  +      D L GE    + L
Sbjct: 223 PEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKG--SLLDFLKGETGKYLRL 279
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS- 142
             +     Q+  G+A+    N +HRDL+  N+L+ +N   K+ADFGLAR   I    Y+ 
Sbjct: 280 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTA 337
Query: 143 ---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLK 196
              A+    W  P   L+G   +T   D+WS G +  EL   GR  +PG    +V DQ++
Sbjct: 338 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
Query: 197 RIFKL 201
           R +++
Sbjct: 396 RGYRM 400

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/181 (34%), Positives = 91/181 (50%), Gaps = 11/181 (6%)
Query: 25  EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLD 84
           E        EI LLK L H NI++L+DV   +K   LV E  +    + F+ +      D
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGG--ELFEQIINRHKFD 144
Query: 85  I--VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI-NKNG--ELKLADFGLARAFGIPVK 139
                + M Q+L G+ + H  N++HRD+KP+N+L+ NKN    +K+ DFGL+  F    K
Sbjct: 145 ECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF 199
                + T +Y  P+VL   K Y    D+WS G I   L   G P F G +  D +K++ 
Sbjct: 205 L-RDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILL-CGYPPFGGQNDQDIIKKVE 260
Query: 200 K 200
           K
Sbjct: 261 K 261

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 99/185 (53%), Gaps = 18/185 (9%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEID----L 83
           P + L+E  ++K+L+H+ +V+LY V+ SE+ + +V E+  +      D L GE+     L
Sbjct: 48  PEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKG--SLLDFLKGEMGKYLRL 104
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS- 142
             +     Q+  G+A+    N +HRDL+  N+L+ +N   K+ADFGLAR   I    Y+ 
Sbjct: 105 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTA 162
Query: 143 ---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLK 196
              A+    W  P   L+G   +T   D+WS G +  EL   GR  +PG    +V DQ++
Sbjct: 163 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 220
Query: 197 RIFKL 201
           R +++
Sbjct: 221 RGYRM 225

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 99/185 (53%), Gaps = 18/185 (9%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE----IDL 83
           P + L+E  ++K+L+H+ +V+LY V+ SE+ + +V E+  +      D L GE    + L
Sbjct: 223 PEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKG--SLLDFLKGETGKYLRL 279
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS- 142
             +     Q+  G+A+    N +HRDL+  N+L+ +N   K+ADFGLAR   I    Y+ 
Sbjct: 280 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTA 337
Query: 143 ---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLK 196
              A+    W  P   L+G   +T   D+WS G +  EL   GR  +PG    +V DQ++
Sbjct: 338 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
Query: 197 RIFKL 201
           R +++
Sbjct: 396 RGYRM 400

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 99/185 (53%), Gaps = 18/185 (9%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEID----L 83
           P + L+E  ++K+L+H+ +V+LY V+ SE+ + +V E+  +      D L GE+     L
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGC--LLDFLKGEMGKYLRL 113
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS- 142
             +     Q+  G+A+    N +HRDL+  N+L+ +N   K+ADFGLAR   I    Y+ 
Sbjct: 114 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTA 171
Query: 143 ---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLK 196
              A+    W  P   L+G   +T   D+WS G +  EL   GR  +PG    +V DQ++
Sbjct: 172 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 197 RIFKL 201
           R +++
Sbjct: 230 RGYRM 234

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 97/183 (53%), Gaps = 14/183 (7%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE----IDL 83
           P + L+E  ++K+L+H+ +V+LY V+ SE+ + +V E+ ++      D L GE    + L
Sbjct: 54  PEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMNKG--SLLDFLKGETGKYLRL 110
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVKCY 141
             +     Q+  G+A+    N +HRDL+  N+L+ +N   K+ADFGLAR           
Sbjct: 111 PQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQ 170
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKRI 198
            A+    W  P   L+G   +T   D+WS G +  EL   GR  +PG    +V DQ++R 
Sbjct: 171 GAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 228
Query: 199 FKL 201
           +++
Sbjct: 229 YRM 231

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 99/185 (53%), Gaps = 18/185 (9%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE----IDL 83
           P + L+E  ++K+L+H+ +V+LY V+ SE+ + +V E+  +      D L GE    + L
Sbjct: 223 PEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVGEYMSKG--SLLDFLKGETGKYLRL 279
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS- 142
             +     Q+  G+A+    N +HRDL+  N+L+ +N   K+ADFGLAR   I    Y+ 
Sbjct: 280 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTA 337
Query: 143 ---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLK 196
              A+    W  P   L+G   +T   D+WS G +  EL   GR  +PG    +V DQ++
Sbjct: 338 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
Query: 197 RIFKL 201
           R +++
Sbjct: 396 RGYRM 400

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/185 (31%), Positives = 99/185 (53%), Gaps = 18/185 (9%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEID----L 83
           P + L+E  ++K+++H+ +V+LY V+ SE+ + +V E+  +      D L GE+     L
Sbjct: 57  PEAFLQEAQVMKKIRHEKLVQLYAVV-SEEPIYIVTEYMSKG--SLLDFLKGEMGKYLRL 113
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS- 142
             +     Q+  G+A+    N +HRDL+  N+L+ +N   K+ADFGLAR   I    Y+ 
Sbjct: 114 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTA 171
Query: 143 ---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLK 196
              A+    W  P   L+G   +T   D+WS G +  EL   GR  +PG    +V DQ++
Sbjct: 172 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 197 RIFKL 201
           R +++
Sbjct: 230 RGYRM 234

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 98/185 (52%), Gaps = 18/185 (9%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEID----L 83
           P + L+E  ++K+L+H+ +V+LY V+ SE+ + +V E+  +      D L GE+     L
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKG--SLLDFLKGEMGKYLRL 113
Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS- 142
             +     Q+  G+A+    N +HRDL   N+L+ +N   K+ADFGLAR   I    Y+ 
Sbjct: 114 PQLVDMAAQIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARL--IEDNEYTA 171
Query: 143 ---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLK 196
              A+    W  P   L+G   +T   D+WS G +  EL   GR  +PG    +V DQ++
Sbjct: 172 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 197 RIFKL 201
           R +++
Sbjct: 230 RGYRM 234

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 118/256 (46%), Gaps = 35/256 (13%)
Query: 12  TALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DL 70
            AL +     +  EGV     REI +   L H NI+RLY+  +  +++ L+ E+  + +L
Sbjct: 51  VALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGEL 110
Query: 71  KKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGL 130
            K     +   D     + M +L   L +CH + V+HRD+KP+NLL+   GELK+ADFG 
Sbjct: 111 YKELQK-SCTFDEQRTATIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGW 169
Query: 131 ARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSD 190
             +   P         TL Y PP+++ G +++   +D+W  G +  EL   G P F  + 
Sbjct: 170 --SVHAPSLRRKTMCGTLDYLPPEMIEG-RMHNEKVDLWCIGVLCYELL-VGNPPFESAS 225
Query: 191 VDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLL 250
            ++  +RI K+                D K FP   P+              +DL+ +LL
Sbjct: 226 HNETYRRIVKV----------------DLK-FPASVPT------------GAQDLISKLL 256
Query: 251 VCNPVQRMSAEDAMSH 266
             NP +R+      +H
Sbjct: 257 RHNPSERLPLAQVSAH 272

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 91/190 (47%), Gaps = 6/190 (3%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            V+R    A+A+K   +      P +  +EIC+   L H+N+V+ Y          L  E
Sbjct: 26  AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHRREGNIQYLFLE 85
Query: 65  HCDQDLKKYFDSLNGEIDLDI--VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           +C     + FD +  +I +     + F +QL+ G+ + H   + HRD+KP+NLL+++   
Sbjct: 86  YCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 143
Query: 123 LKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           LK++DFGLA  F      +  +    TL Y  P++L   + +   +D+WS G +   +  
Sbjct: 144 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203
Query: 181 AGRPLFPGSD 190
              P    SD
Sbjct: 204 GELPWDQPSD 213

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 111/251 (44%), Gaps = 50/251 (19%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY- 91
           RE  + + LKH NIVRL+D +  E    L+F     DL        GE+  DIV    Y 
Sbjct: 59  REARICRLLKHPNIVRLHDSISEEGHHYLIF-----DL-----VTGGELFEDIVAREYYS 108
Query: 92  ---------QLLRGLAFCHSRNVLHRDLKPQNLLIN---KNGELKLADFGLARAFGIPVK 139
                    Q+L  +  CH   V+HR+LKP+NLL+    K   +KLADFGLA       +
Sbjct: 109 EADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168
Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF 199
            +     T  Y  P+VL     Y   +D+W+ G I   L   G P F     D+   R++
Sbjct: 169 AWFGFAGTPGYLSPEVL-RKDPYGKPVDLWACGVILYILL-VGYPPF----WDEDQHRLY 222
Query: 200 KLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
           + +     D                  PS  +  V P    + +DL+ ++L  NP +R++
Sbjct: 223 QQIKAGAYD-----------------FPSPEWDTVTP----EAKDLINKMLTINPSKRIT 261
Query: 260 AEDAMSHIYFS 270
           A +A+ H + S
Sbjct: 262 AAEALKHPWIS 272

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/156 (37%), Positives = 77/156 (49%), Gaps = 12/156 (7%)
Query: 34  EICLLKELKHKNIVRLYDVL--HSEKKLTLVFEHCDQ-DLKKYFDSLNGE---IDLDIVK 87
           E+ LL+ELKH NIVR YD +   +   L +V E+C+  DL         E   +D + V 
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 88  SFMYQLLRGLAFCHSRN-----VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS 142
             M QL   L  CH R+     VLHRDLKP N+ ++    +KL DFGLAR          
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 174
Query: 143 AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
             V T +Y  P+ +     Y    D+WS GC+  EL
Sbjct: 175 TFVGTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYEL 209

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 106/202 (52%), Gaps = 20/202 (9%)
Query: 11  NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDL 70
            T +AIK T   GN   P + L+E  ++K+L+H+ +V+LY V+ SE+ + +V E+  +  
Sbjct: 209 TTRVAIK-TLKPGNMS-PEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKG- 264
Query: 71  KKYFDSLNGEID----LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLA 126
               D L GE+     L  +     Q+  G+A+    N +HRDL+  N+L+ +N   K+A
Sbjct: 265 -SLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVA 323
Query: 127 DFGLARAFGIPVKCYS----AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
           DFGL R   I    Y+    A+    W  P   L+G   +T   D+WS G +  EL   G
Sbjct: 324 DFGLGRL--IEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKG 379
Query: 183 RPLFPG---SDVDDQLKRIFKL 201
           R  +PG    +V DQ++R +++
Sbjct: 380 RVPYPGMVNREVLDQVERGYRM 401

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 110/245 (44%), Gaps = 51/245 (20%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY- 91
           RE  + ++L+H NIVRL+D +  E    LVF+              GE+  DIV    Y 
Sbjct: 54  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLV----------TGGELFEDIVAREFYS 103
Query: 92  ---------QLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVK 139
                    Q+L  +A+CHS  ++HR+LKP+NLL+    K   +KLADFGLA       +
Sbjct: 104 EADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSE 162
Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF 199
            +     T  Y  P+VL     Y+  +D+W+ G I   L   G P F     D+   R++
Sbjct: 163 AWHGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVILYILL-VGYPPF----WDEDQHRLY 216
Query: 200 KLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
             +     D                 +PS  +  V P    + + L+  +L  NP +R++
Sbjct: 217 AQIKAGAYD-----------------YPSPEWDTVTP----EAKSLIDSMLTVNPKKRIT 255
Query: 260 AEDAM 264
           A+ A+
Sbjct: 256 ADQAL 260

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 111/243 (45%), Gaps = 43/243 (17%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL--NGEIDLDIVKSFM 90
           REI  LK  +H +I++LY V+ +   + +V E+      + FD +  NG +D    +   
Sbjct: 65  REIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGG--ELFDYICKNGRLDEKESRRLF 122
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG----IPVKCYSAEVV 146
            Q+L G+ +CH   V+HRDLKP+N+L++ +   K+ADFGL+        +   C S    
Sbjct: 123 QQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPN-- 180
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
              Y  P+V+ G       +D+WS+G I   L     P       DD +  +FK +    
Sbjct: 181 ---YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF-----DDDHVPTLFKKICD-- 230
Query: 207 EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                G+   P +              + P + +    LL+ +L  +P++R + +D   H
Sbjct: 231 -----GIFYTPQY--------------LNPSVIS----LLKHMLQVDPMKRATIKDIREH 267
Query: 267 IYF 269
            +F
Sbjct: 268 EWF 270

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 113/246 (45%), Gaps = 36/246 (14%)
Query: 20  HLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLN 78
           H++    VP    RE  ++  L H   V+LY     ++KL     +  + +L KY   + 
Sbjct: 66  HIIKENKVPY-VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 123
Query: 79  GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 138
           G  D    + +  +++  L + H + ++HRDLKP+N+L+N++  +++ DFG A+      
Sbjct: 124 GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 183
Query: 139 KCYSAE--VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K   A   V T  Y  P++L   K    S D+W+ GCI  +L  AG P F   +     +
Sbjct: 184 KQARANSFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLV-AGLPPFRAGNEYLIFQ 241
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
           +I KL     E  +P        K FP                 K RDL+++LLV +  +
Sbjct: 242 KIIKL-----EYDFPE-------KFFP-----------------KARDLVEKLLVLDATK 272
Query: 257 RMSAED 262
           R+  E+
Sbjct: 273 RLGCEE 278

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 99/185 (53%), Gaps = 16/185 (8%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIV 86
           P + L E  L+K+L+H+ +VRLY V+ +++ + ++ E+ +   L  +  + +G I L I 
Sbjct: 62  PDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSG-IKLTIN 119
Query: 87  K--SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS-- 142
           K      Q+  G+AF   RN +HRDL+  N+L++     K+ADFGLAR   I    Y+  
Sbjct: 120 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEYTAR 177
Query: 143 --AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKR 197
             A+    W  P  + +G   +T   D+WS G +  E+   GR  +PG    +V   L+R
Sbjct: 178 EGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 235
Query: 198 IFKLL 202
            ++++
Sbjct: 236 GYRMV 240

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 110/245 (44%), Gaps = 51/245 (20%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY- 91
           RE  + ++L+H NIVRL+D +  E    LVF+              GE+  DIV    Y 
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLV----------TGGELFEDIVAREFYS 126
Query: 92  ---------QLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVK 139
                    Q+L  +A+CHS  ++HR+LKP+NLL+    K   +KLADFGLA       +
Sbjct: 127 EADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSE 185
Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF 199
            +     T  Y  P+VL     Y+  +D+W+ G I   L   G P F     D+   R++
Sbjct: 186 AWHGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVILYILL-VGYPPF----WDEDQHRLY 239
Query: 200 KLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
             +     D                 +PS  +  V P    + + L+  +L  NP +R++
Sbjct: 240 AQIKAGAYD-----------------YPSPEWDTVTP----EAKSLIDSMLTVNPKKRIT 278
Query: 260 AEDAM 264
           A+ A+
Sbjct: 279 ADQAL 283

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 112/246 (45%), Gaps = 36/246 (14%)
Query: 20  HLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLN 78
           H++    VP    RE  ++  L H   V+LY     ++KL     +  + +L KY   + 
Sbjct: 69  HIIKENKVPY-VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 126
Query: 79  GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 138
           G  D    + +  +++  L + H + ++HRDLKP+N+L+N++  +++ DFG A+      
Sbjct: 127 GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186
Query: 139 KCYSAE--VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K   A   V T  Y  P++L   K    S D+W+ GCI  +L  AG P F   +      
Sbjct: 187 KQARANXFVGTAQYVSPELL-TEKSAXKSSDLWALGCIIYQLV-AGLPPFRAGNEGLIFA 244
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
           +I KL     E  +P        K FP                 K RDL+++LLV +  +
Sbjct: 245 KIIKL-----EYDFPE-------KFFP-----------------KARDLVEKLLVLDATK 275
Query: 257 RMSAED 262
           R+  E+
Sbjct: 276 RLGCEE 281

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 113/246 (45%), Gaps = 36/246 (14%)
Query: 20  HLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLN 78
           H++    VP    RE  ++  L H   V+LY     ++KL     +  + +L KY   + 
Sbjct: 69  HIIKENKVPY-VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 126
Query: 79  GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 138
           G  D    + +  +++  L + H + ++HRDLKP+N+L+N++  +++ DFG A+      
Sbjct: 127 GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186
Query: 139 KCYSAE--VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K   A   V T  Y  P++L   K    S D+W+ GCI  +L  AG P F   +     +
Sbjct: 187 KQARANXFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLV-AGLPPFRAGNEYLIFQ 244
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
           +I KL     E  +P        K FP                 K RDL+++LLV +  +
Sbjct: 245 KIIKL-----EYDFPE-------KFFP-----------------KARDLVEKLLVLDATK 275
Query: 257 RMSAED 262
           R+  E+
Sbjct: 276 RLGCEE 281

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 118/265 (44%), Gaps = 38/265 (14%)
Query: 14  LAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-----Q 68
           +A K  HL     + +  +RE+ +L E     IV  Y   +S+ ++++  EH D     Q
Sbjct: 34  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 93
Query: 69  DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN-VLHRDLKPQNLLINKNGELKLAD 127
            LKK      G I   I+      +++GL +   ++ ++HRD+KP N+L+N  GE+KL D
Sbjct: 94  VLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCD 148
Query: 128 FGLARAFGIPVKCYSAEVV-TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           FG++   G  +   +   V T  Y  P+ L G   Y+   D+WS G    E+A    P+ 
Sbjct: 149 FGVS---GQLIDSMANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIP 204
Query: 187 PGSDVDDQLK--RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRD 244
           P    +D      IF+LL     +  P +             PS  FS        + +D
Sbjct: 205 PPDAKEDSRPPMAIFELLDYIVNEPPPKL-------------PSGVFS-------LEFQD 244
Query: 245 LLQRLLVCNPVQRMSAEDAMSHIYF 269
            + + L+ NP +R   +  M H + 
Sbjct: 245 FVNKCLIKNPAERADLKQLMVHAFI 269

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 7   DRTPNTALAIKGTHLVGNE-GVPSSALREICLLKELKHKNIVRLYDVLHSEKK------L 59
           DR     +AIK   ++ N+    + A  E+ LL+ +   +    Y ++H ++       L
Sbjct: 75  DRVEQEWVAIK---IIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131
Query: 60  TLVFEHCDQDLKKYFDSLNGE-IDLDIVKSFMYQLLRGLAFCHS--RNVLHRDLKPQNLL 116
            LVFE    +L     + N   + L++ + F  Q+   L F  +   +++H DLKP+N+L
Sbjct: 132 CLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENIL 191
Query: 117 I--NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCI 174
           +   K   +K+ DFG +   G  +      + + +YR P+VL G   Y  +IDMWS GCI
Sbjct: 192 LCNPKRSAIKIVDFGSSCQLGQRI---YQXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCI 247
Query: 175 FAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
             E+ + G PLF G++  DQ+ +I ++LG P
Sbjct: 248 LVEM-HTGEPLFSGANEVDQMNKIVEVLGIP 277

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 90/182 (49%), Gaps = 10/182 (5%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVK 87
           P + L E  L+K+L+H+ +VRLY V+  E    +     +  L  +  + +G I L I K
Sbjct: 52  PDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINK 110
Query: 88  --SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVKCYSA 143
                 Q+  G+AF   RN +HRDL+  N+L++     K+ADFGLAR            A
Sbjct: 111 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGA 170
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKRIFK 200
           +    W  P  + +G   +T   D+WS G +  E+   GR  +PG    +V   L+R ++
Sbjct: 171 KFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR 228
Query: 201 LL 202
           ++
Sbjct: 229 MV 230

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 58/156 (37%), Positives = 77/156 (49%), Gaps = 12/156 (7%)
Query: 34  EICLLKELKHKNIVRLYDVL--HSEKKLTLVFEHCDQ-DLKKYFDSLNGE---IDLDIVK 87
           E+ LL+ELKH NIVR YD +   +   L +V E+C+  DL         E   +D + V 
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 88  SFMYQLLRGLAFCHSRN-----VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS 142
             M QL   L  CH R+     VLHRDLKP N+ ++    +KL DFGLAR          
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAK 174
Query: 143 AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
             V T +Y  P+ +     Y    D+WS GC+  EL
Sbjct: 175 EFVGTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYEL 209

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 91/190 (47%), Gaps = 6/190 (3%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            V+R    A+A+K   +      P +  +EI + K L H+N+V+ Y          L  E
Sbjct: 26  AVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLE 85
Query: 65  HCDQDLKKYFDSLNGEIDLDI--VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           +C     + FD +  +I +     + F +QL+ G+ + H   + HRD+KP+NLL+++   
Sbjct: 86  YCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 143
Query: 123 LKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           LK++DFGLA  F      +  +    TL Y  P++L   + +   +D+WS G +   +  
Sbjct: 144 LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203
Query: 181 AGRPLFPGSD 190
              P    SD
Sbjct: 204 GELPWDQPSD 213

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 113/246 (45%), Gaps = 36/246 (14%)
Query: 20  HLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLN 78
           H++    VP    RE  ++  L H   V+LY     ++KL     +  + +L KY   + 
Sbjct: 66  HIIKENKVPY-VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 123
Query: 79  GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 138
           G  D    + +  +++  L + H + ++HRDLKP+N+L+N++  +++ DFG A+      
Sbjct: 124 GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 183
Query: 139 KCYSAE--VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K   A   V T  Y  P++L   K    S D+W+ GCI  +L  AG P F   +     +
Sbjct: 184 KQARANXFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLV-AGLPPFRAGNEYLIFQ 241
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
           +I KL     E  +P        K FP                 K RDL+++LLV +  +
Sbjct: 242 KIIKL-----EYDFPE-------KFFP-----------------KARDLVEKLLVLDATK 272
Query: 257 RMSAED 262
           R+  E+
Sbjct: 273 RLGCEE 278

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 113/246 (45%), Gaps = 36/246 (14%)
Query: 20  HLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLN 78
           H++    VP    RE  ++  L H   V+LY     ++KL     +  + +L KY   + 
Sbjct: 67  HIIKENKVPY-VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 124
Query: 79  GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 138
           G  D    + +  +++  L + H + ++HRDLKP+N+L+N++  +++ DFG A+      
Sbjct: 125 GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 184
Query: 139 KCYSAE--VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K   A   V T  Y  P++L   K    S D+W+ GCI  +L  AG P F   +     +
Sbjct: 185 KQARANAFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLV-AGLPPFRAGNEYLIFQ 242
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
           +I KL     E  +P        K FP                 K RDL+++LLV +  +
Sbjct: 243 KIIKL-----EYDFPE-------KFFP-----------------KARDLVEKLLVLDATK 273
Query: 257 RMSAED 262
           R+  E+
Sbjct: 274 RLGCEE 279

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 113/246 (45%), Gaps = 36/246 (14%)
Query: 20  HLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLN 78
           H++    VP    RE  ++  L H   V+LY     ++KL     +  + +L KY   + 
Sbjct: 67  HIIKENKVPY-VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 124
Query: 79  GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 138
           G  D    + +  +++  L + H + ++HRDLKP+N+L+N++  +++ DFG A+      
Sbjct: 125 GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 184
Query: 139 KCYSAE--VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K   A   V T  Y  P++L   K    S D+W+ GCI  +L  AG P F   +     +
Sbjct: 185 KQARANXFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLV-AGLPPFRAGNEYLIFQ 242
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
           +I KL     E  +P        K FP                 K RDL+++LLV +  +
Sbjct: 243 KIIKL-----EYDFPE-------KFFP-----------------KARDLVEKLLVLDATK 273
Query: 257 RMSAED 262
           R+  E+
Sbjct: 274 RLGCEE 279

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 113/246 (45%), Gaps = 36/246 (14%)
Query: 20  HLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLN 78
           H++    VP    RE  ++  L H   V+LY     ++KL     +  + +L KY   + 
Sbjct: 67  HIIKENKVPY-VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 124
Query: 79  GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 138
           G  D    + +  +++  L + H + ++HRDLKP+N+L+N++  +++ DFG A+      
Sbjct: 125 GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 184
Query: 139 KCYSAE--VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K   A   V T  Y  P++L   K    S D+W+ GCI  +L  AG P F   +     +
Sbjct: 185 KQARANXFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLV-AGLPPFRAGNEYLIFQ 242
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
           +I KL     E  +P        K FP                 K RDL+++LLV +  +
Sbjct: 243 KIIKL-----EYDFPE-------KFFP-----------------KARDLVEKLLVLDATK 273
Query: 257 RMSAED 262
           R+  E+
Sbjct: 274 RLGCEE 279

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 96/183 (52%), Gaps = 12/183 (6%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIV 86
           P + L E  L+K+L+H+ +VRLY V+ +++ + ++ E+ +   L  +  + +G I L I 
Sbjct: 58  PDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSG-IKLTIN 115
Query: 87  K--SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVKCYS 142
           K      Q+  G+AF   RN +HRDL+  N+L++     K+ADFGLAR            
Sbjct: 116 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 175
Query: 143 AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKRIF 199
           A+    W  P  + +G   +T   D+WS G +  E+   GR  +PG    +V   L+R +
Sbjct: 176 AKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY 233
Query: 200 KLL 202
           +++
Sbjct: 234 RMV 236

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 109/247 (44%), Gaps = 50/247 (20%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY- 91
           RE  + + LKH NIVRL+D +  E    LVF     DL        GE+  DIV    Y 
Sbjct: 52  REARICRLLKHSNIVRLHDSISEEGFHYLVF-----DL-----VTGGELFEDIVAREYYS 101
Query: 92  ---------QLLRGLAFCHSRNVLHRDLKPQNLLIN---KNGELKLADFGLARAFGIPVK 139
                    Q+L  +  CH   V+HRDLKP+NLL+    K   +KLADFGLA       +
Sbjct: 102 EADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQ 161
Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF 199
            +     T  Y  P+VL   + Y   +D+W+ G I   L     P +     D+   +++
Sbjct: 162 AWFGFAGTPGYLSPEVL-RKEAYGKPVDIWACGVILYILLVGYPPFW-----DEDQHKLY 215
Query: 200 KLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
           + +     D                  PS  +  V P    + ++L+ ++L  NP +R++
Sbjct: 216 QQIKAGAYD-----------------FPSPEWDTVTP----EAKNLINQMLTINPAKRIT 254
Query: 260 AEDAMSH 266
           A +A+ H
Sbjct: 255 AHEALKH 261

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 111/245 (45%), Gaps = 51/245 (20%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY- 91
           RE  + ++L+H NIVRL+D +  E    LVF     DL        GE+  DIV    Y 
Sbjct: 53  REARICRKLQHPNIVRLHDSIQEESFHYLVF-----DL-----VTGGELFEDIVAREFYS 102
Query: 92  ---------QLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVK 139
                    Q+L  +A+CHS  ++HR+LKP+NLL+    K   +KLADFGLA       +
Sbjct: 103 EADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSE 161
Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF 199
            +     T  Y  P+VL     Y+  +D+W+ G I   L   G P F     D+   R++
Sbjct: 162 AWHGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVILYILL-VGYPPF----WDEDQHRLY 215
Query: 200 KLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
             +     D                 +PS  +  V P    + + L+  +L  NP +R++
Sbjct: 216 AQIKAGAYD-----------------YPSPEWDTVTP----EAKSLIDSMLTVNPKKRIT 254
Query: 260 AEDAM 264
           A+ A+
Sbjct: 255 ADQAL 259

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 113/246 (45%), Gaps = 36/246 (14%)
Query: 20  HLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLN 78
           H++    VP    RE  ++  L H   V+LY     ++KL     +  + +L KY   + 
Sbjct: 70  HIIKENKVPY-VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 127
Query: 79  GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 138
           G  D    + +  +++  L + H + ++HRDLKP+N+L+N++  +++ DFG A+      
Sbjct: 128 GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 187
Query: 139 KCYSAE--VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K   A   V T  Y  P++L   K    S D+W+ GCI  +L  AG P F   +     +
Sbjct: 188 KQARANSFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLV-AGLPPFRAGNEYLIFQ 245
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
           +I KL     E  +P        K FP                 K RDL+++LLV +  +
Sbjct: 246 KIIKL-----EYDFPE-------KFFP-----------------KARDLVEKLLVLDATK 276
Query: 257 RMSAED 262
           R+  E+
Sbjct: 277 RLGCEE 282

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 113/246 (45%), Gaps = 36/246 (14%)
Query: 20  HLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLN 78
           H++    VP    RE  ++  L H   V+LY     ++KL     +  + +L KY   + 
Sbjct: 67  HIIKENKVPY-VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 124
Query: 79  GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 138
           G  D    + +  +++  L + H + ++HRDLKP+N+L+N++  +++ DFG A+      
Sbjct: 125 GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 184
Query: 139 KCYSAE--VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K   A   V T  Y  P++L   K    S D+W+ GCI  +L  AG P F   +     +
Sbjct: 185 KQARANXFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLV-AGLPPFRAGNEYLIFQ 242
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
           +I KL     E  +P        K FP                 K RDL+++LLV +  +
Sbjct: 243 KIIKL-----EYDFPE-------KFFP-----------------KARDLVEKLLVLDATK 273
Query: 257 RMSAED 262
           R+  E+
Sbjct: 274 RLGCEE 279

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 91/190 (47%), Gaps = 6/190 (3%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            V+R    A+A+K   +      P +  +EI + K L H+N+V+ Y          L  E
Sbjct: 25  AVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLE 84
Query: 65  HCDQDLKKYFDSLNGEIDLDI--VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           +C     + FD +  +I +     + F +QL+ G+ + H   + HRD+KP+NLL+++   
Sbjct: 85  YCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 142
Query: 123 LKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           LK++DFGLA  F      +  +    TL Y  P++L   + +   +D+WS G +   +  
Sbjct: 143 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 202
Query: 181 AGRPLFPGSD 190
              P    SD
Sbjct: 203 GELPWDQPSD 212

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 113/246 (45%), Gaps = 36/246 (14%)
Query: 20  HLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLN 78
           H++    VP    RE  ++  L H   V+LY     ++KL     +  + +L KY   + 
Sbjct: 69  HIIKENKVPY-VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 126
Query: 79  GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 138
           G  D    + +  +++  L + H + ++HRDLKP+N+L+N++  +++ DFG A+      
Sbjct: 127 GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186
Query: 139 KCYSAE--VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K   A   V T  Y  P++L   K    S D+W+ GCI  +L  AG P F   +     +
Sbjct: 187 KQARANXFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLV-AGLPPFRAGNEYLIFQ 244
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
           +I KL     E  +P        K FP                 K RDL+++LLV +  +
Sbjct: 245 KIIKL-----EYDFPE-------KFFP-----------------KARDLVEKLLVLDATK 275
Query: 257 RMSAED 262
           R+  E+
Sbjct: 276 RLGCEE 281

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 112/246 (45%), Gaps = 36/246 (14%)
Query: 20  HLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLN 78
           H++    VP    RE  ++  L H   V+LY     ++KL     +     L KY   + 
Sbjct: 69  HIIKENKVPY-VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKI- 126
Query: 79  GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 138
           G  D    + +  +++  L + H + ++HRDLKP+N+L+N++  +++ DFG A+      
Sbjct: 127 GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186
Query: 139 KCYSAE--VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K   A   V T  Y  P++L   K  + S D+W+ GCI  +L  AG P F   +     +
Sbjct: 187 KQARANSFVGTAQYVSPELL-TEKSASKSSDLWALGCIIYQLV-AGLPPFRAGNEYLIFQ 244
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
           +I KL     E  +P        K FP                 K RDL+++LLV +  +
Sbjct: 245 KIIKL-----EYDFPE-------KFFP-----------------KARDLVEKLLVLDATK 275
Query: 257 RMSAED 262
           R+  E+
Sbjct: 276 RLGCEE 281

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 113/246 (45%), Gaps = 36/246 (14%)
Query: 20  HLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLN 78
           H++    VP    RE  ++  L H   V+LY     ++KL     +  + +L KY   + 
Sbjct: 70  HIIKENKVPY-VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 127
Query: 79  GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 138
           G  D    + +  +++  L + H + ++HRDLKP+N+L+N++  +++ DFG A+      
Sbjct: 128 GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 187
Query: 139 KCYSAE--VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K   A   V T  Y  P++L   K    S D+W+ GCI  +L  AG P F   +     +
Sbjct: 188 KQARANXFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLV-AGLPPFRAGNEYLIFQ 245
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
           +I KL     E  +P        K FP                 K RDL+++LLV +  +
Sbjct: 246 KIIKL-----EYDFPE-------KFFP-----------------KARDLVEKLLVLDATK 276
Query: 257 RMSAED 262
           R+  E+
Sbjct: 277 RLGCEE 282

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 112/246 (45%), Gaps = 36/246 (14%)
Query: 20  HLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLN 78
           H++    VP    RE  ++  L H   V+LY     ++KL     +  + +L KY   + 
Sbjct: 69  HIIKENKVPY-VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 126
Query: 79  GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 138
           G  D    + +  +++  L + H + ++HRDLKP+N+L+N++  +++ DFG A+      
Sbjct: 127 GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186
Query: 139 KCYSAE--VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K   A   V T  Y  P++L   K    S D+W+ GCI  +L  AG P F   +      
Sbjct: 187 KQARANXFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLV-AGLPPFRAGNEGLIFA 244
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
           +I KL     E  +P        K FP                 K RDL+++LLV +  +
Sbjct: 245 KIIKL-----EYDFPE-------KFFP-----------------KARDLVEKLLVLDATK 275
Query: 257 RMSAED 262
           R+  E+
Sbjct: 276 RLGCEE 281

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 93/184 (50%), Gaps = 14/184 (7%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVK 87
           P + L E  L+K+L+H+ +VRLY V+  E    +     +  L  +  + +G I L I K
Sbjct: 58  PDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINK 116
Query: 88  --SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS--- 142
                 Q+  G+AF   RN +HRDL+  N+L++     K+ADFGLAR   I    Y+   
Sbjct: 117 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEYTARE 174
Query: 143 -AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKRI 198
            A+    W  P  + +G   +T   D+WS G +  E+   GR  +PG    +V   L+R 
Sbjct: 175 GAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 232
Query: 199 FKLL 202
           ++++
Sbjct: 233 YRMV 236

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 91/190 (47%), Gaps = 6/190 (3%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            V+R    A+A+K   +      P +  +EI + K L H+N+V+ Y          L  E
Sbjct: 25  AVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLE 84
Query: 65  HCDQDLKKYFDSLNGEIDLDI--VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           +C     + FD +  +I +     + F +QL+ G+ + H   + HRD+KP+NLL+++   
Sbjct: 85  YCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 142
Query: 123 LKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           LK++DFGLA  F      +  +    TL Y  P++L   + +   +D+WS G +   +  
Sbjct: 143 LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 202
Query: 181 AGRPLFPGSD 190
              P    SD
Sbjct: 203 GELPWDQPSD 212

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 111/245 (45%), Gaps = 51/245 (20%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY- 91
           RE  + ++L+H NIVRL+D +  E    LVF     DL        GE+  DIV    Y 
Sbjct: 54  REARICRKLQHPNIVRLHDSIQEESFHYLVF-----DL-----VTGGELFEDIVAREFYS 103
Query: 92  ---------QLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVK 139
                    Q+L  +A+CHS  ++HR+LKP+NLL+    K   +KLADFGLA       +
Sbjct: 104 EADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSE 162
Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF 199
            +     T  Y  P+VL     Y+  +D+W+ G I   L   G P F     D+   R++
Sbjct: 163 AWHGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVILYILL-VGYPPF----WDEDQHRLY 216
Query: 200 KLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
             +     D                 +PS  +  V P    + + L+  +L  NP +R++
Sbjct: 217 AQIKAGAYD-----------------YPSPEWDTVTP----EAKSLIDSMLTVNPKKRIT 255
Query: 260 AEDAM 264
           A+ A+
Sbjct: 256 ADQAL 260

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 99/185 (53%), Gaps = 16/185 (8%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIV 86
           P + L E  L+K+L+H+ +VRLY V+ +++ + ++ E+ +   L  +  + +G I L I 
Sbjct: 57  PDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSG-IKLTIN 114
Query: 87  K--SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS-- 142
           K      Q+  G+AF   RN +HRDL+  N+L++     K+ADFGLAR   I    Y+  
Sbjct: 115 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEYTAR 172
Query: 143 --AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKR 197
             A+    W  P  + +G   +T   D+WS G +  E+   GR  +PG    +V   L+R
Sbjct: 173 EGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 230
Query: 198 IFKLL 202
            ++++
Sbjct: 231 GYRMV 235

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 113/246 (45%), Gaps = 36/246 (14%)
Query: 20  HLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLN 78
           H++    VP    RE  ++  L H   V+LY     ++KL     +  + +L KY   + 
Sbjct: 44  HIIKENKVPY-VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 101
Query: 79  GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 138
           G  D    + +  +++  L + H + ++HRDLKP+N+L+N++  +++ DFG A+      
Sbjct: 102 GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 161
Query: 139 KCYSAE--VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K   A   V T  Y  P++L   K    S D+W+ GCI  +L  AG P F   +     +
Sbjct: 162 KQARANXFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLV-AGLPPFRAGNEYLIFQ 219
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
           +I KL     E  +P        K FP                 K RDL+++LLV +  +
Sbjct: 220 KIIKL-----EYDFPE-------KFFP-----------------KARDLVEKLLVLDATK 250
Query: 257 RMSAED 262
           R+  E+
Sbjct: 251 RLGCEE 256

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 117/264 (44%), Gaps = 40/264 (15%)
Query: 13  ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD----- 67
            +A K  HL     + +  +RE+ +L E     IV  Y   +S+ ++++  EH D     
Sbjct: 52  VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 111
Query: 68  QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN-VLHRDLKPQNLLINKNGELKLA 126
           Q LKK      G I   I+      +++GL +   ++ ++HRD+KP N+L+N  GE+KL 
Sbjct: 112 QVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC 166
Query: 127 DFGLARAFGIPVKCYSAEVV-TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
           DFG++   G  +   +   V T  Y  P+ L G   Y+   D+WS G    E+A    P+
Sbjct: 167 DFGVS---GQLIDSMANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPI 222
Query: 186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
             GS        IF+LL     +  P +             PS  FS        + +D 
Sbjct: 223 GSGSGS----MAIFELLDYIVNEPPPKL-------------PSGVFS-------LEFQDF 258
Query: 246 LQRLLVCNPVQRMSAEDAMSHIYF 269
           + + L+ NP +R   +  M H + 
Sbjct: 259 VNKCLIKNPAERADLKQLMVHAFI 282

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 90/182 (49%), Gaps = 10/182 (5%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVK 87
           P + L E  L+K+L+H+ +VRLY V+  E    +     +  L  +  + +G I L I K
Sbjct: 61  PDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINK 119
Query: 88  --SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVKCYSA 143
                 Q+  G+AF   RN +HRDL+  N+L++     K+ADFGLAR            A
Sbjct: 120 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 179
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKRIFK 200
           +    W  P  + +G   +T   D+WS G +  E+   GR  +PG    +V   L+R ++
Sbjct: 180 KFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR 237
Query: 201 LL 202
           ++
Sbjct: 238 MV 239

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 90/182 (49%), Gaps = 10/182 (5%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVK 87
           P + L E  L+K+L+H+ +VRLY V+  E    +     +  L  +  + +G I L I K
Sbjct: 60  PDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINK 118
Query: 88  --SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVKCYSA 143
                 Q+  G+AF   RN +HRDL+  N+L++     K+ADFGLAR            A
Sbjct: 119 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 178
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKRIFK 200
           +    W  P  + +G   +T   D+WS G +  E+   GR  +PG    +V   L+R ++
Sbjct: 179 KFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR 236
Query: 201 LL 202
           ++
Sbjct: 237 MV 238

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 122/267 (45%), Gaps = 33/267 (12%)
Query: 7   DRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC 66
           D+  N  +A+K  ++   E +  +  REI   + L+H NIVR  +V+ +   L +V E+ 
Sbjct: 40  DKQANELVAVK--YIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 97
Query: 67  DQDLKKYFDSL--NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN--GE 122
                + F+ +   G    D  + F  QL+ G+++ H+  V HRDLK +N L++ +    
Sbjct: 98  SGG--ELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPR 155
Query: 123 LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
           LK+ADFG ++A  +  +  SA V T  Y  P+VL   +      D+WS G     +    
Sbjct: 156 LKIADFGYSKASVLHSQPKSA-VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGA 214
Query: 183 RPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKG 242
            P     +  +  K I ++L             +PD            +  ++P+     
Sbjct: 215 YPFEDPEEPKNFRKTIHRILNV--------QYAIPD------------YVHISPEC---- 250
Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYF 269
           R L+ R+ V +P +R+S  +  +H +F
Sbjct: 251 RHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 93/184 (50%), Gaps = 14/184 (7%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVK 87
           P + L E  L+K+L+H+ +VRLY V+  E    +     +  L  +  + +G I L I K
Sbjct: 47  PDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINK 105
Query: 88  --SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS--- 142
                 Q+  G+AF   RN +HRDL+  N+L++     K+ADFGLAR   I    Y+   
Sbjct: 106 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEYTARE 163
Query: 143 -AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKRI 198
            A+    W  P  + +G   +T   D+WS G +  E+   GR  +PG    +V   L+R 
Sbjct: 164 GAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 221
Query: 199 FKLL 202
           ++++
Sbjct: 222 YRMV 225

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 113/246 (45%), Gaps = 36/246 (14%)
Query: 20  HLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLN 78
           H++    VP    RE  ++  L H   V+LY     ++KL     +  + +L KY   + 
Sbjct: 69  HIIKENKVPY-VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 126
Query: 79  GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 138
           G  D    + +  +++  L + H + ++HRDLKP+N+L+N++  +++ DFG A+      
Sbjct: 127 GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186
Query: 139 KCYSAE--VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K   A   V T  Y  P++L   K    S D+W+ GCI  +L  AG P F   +     +
Sbjct: 187 KQARANXFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLV-AGLPPFRAGNEYLIFQ 244
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
           +I KL     E  +P        K FP                 K RDL+++LLV +  +
Sbjct: 245 KIIKL-----EYDFPE-------KFFP-----------------KARDLVEKLLVLDATK 275
Query: 257 RMSAED 262
           R+  E+
Sbjct: 276 RLGCEE 281

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 113/246 (45%), Gaps = 36/246 (14%)
Query: 20  HLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLN 78
           H++    VP    RE  ++  L H   V+LY     ++KL     +  + +L KY   + 
Sbjct: 45  HIIKENKVPY-VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 102
Query: 79  GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 138
           G  D    + +  +++  L + H + ++HRDLKP+N+L+N++  +++ DFG A+      
Sbjct: 103 GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162
Query: 139 KCYSAE--VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K   A   V T  Y  P++L   K    S D+W+ GCI  +L  AG P F   +     +
Sbjct: 163 KQARANXFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLV-AGLPPFRAGNEYLIFQ 220
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
           +I KL     E  +P        K FP                 K RDL+++LLV +  +
Sbjct: 221 KIIKL-----EYDFPE-------KFFP-----------------KARDLVEKLLVLDATK 251
Query: 257 RMSAED 262
           R+  E+
Sbjct: 252 RLGCEE 257

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 113/246 (45%), Gaps = 36/246 (14%)
Query: 20  HLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLN 78
           H++    VP    RE  ++  L H   V+LY     ++KL     +  + +L KY   + 
Sbjct: 51  HIIKENKVPY-VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 108
Query: 79  GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 138
           G  D    + +  +++  L + H + ++HRDLKP+N+L+N++  +++ DFG A+      
Sbjct: 109 GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 168
Query: 139 KCYSAE--VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K   A   V T  Y  P++L   K    S D+W+ GCI  +L  AG P F   +     +
Sbjct: 169 KQARANXFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLV-AGLPPFRAGNEYLIFQ 226
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
           +I KL     E  +P        K FP                 K RDL+++LLV +  +
Sbjct: 227 KIIKL-----EYDFPE-------KFFP-----------------KARDLVEKLLVLDATK 257
Query: 257 RMSAED 262
           R+  E+
Sbjct: 258 RLGCEE 263

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 90/182 (49%), Gaps = 10/182 (5%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVK 87
           P + L E  L+K+L+H+ +VRLY V+  E    +     +  L  +  + +G I L I K
Sbjct: 52  PDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINK 110
Query: 88  --SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVKCYSA 143
                 Q+  G+AF   RN +HRDL+  N+L++     K+ADFGLAR            A
Sbjct: 111 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 170
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKRIFK 200
           +    W  P  + +G   +T   D+WS G +  E+   GR  +PG    +V   L+R ++
Sbjct: 171 KFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR 228
Query: 201 LL 202
           ++
Sbjct: 229 MV 230

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 113/246 (45%), Gaps = 36/246 (14%)
Query: 20  HLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLN 78
           H++    VP    RE  ++  L H   V+LY     ++KL     +  + +L KY   + 
Sbjct: 46  HIIKENKVPY-VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 103
Query: 79  GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 138
           G  D    + +  +++  L + H + ++HRDLKP+N+L+N++  +++ DFG A+      
Sbjct: 104 GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 163
Query: 139 KCYSAE--VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K   A   V T  Y  P++L   K    S D+W+ GCI  +L  AG P F   +     +
Sbjct: 164 KQARANXFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLV-AGLPPFRAGNEYLIFQ 221
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
           +I KL     E  +P        K FP                 K RDL+++LLV +  +
Sbjct: 222 KIIKL-----EYDFPE-------KFFP-----------------KARDLVEKLLVLDATK 252
Query: 257 RMSAED 262
           R+  E+
Sbjct: 253 RLGCEE 258

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 7   DRTPNTALAIKGTHLVGNE-GVPSSALREICLLKELKHKNIVRLYDVLHSEKK------L 59
           DR     +AIK   ++ N+    + A  E+ LL+ +   +    Y ++H ++       L
Sbjct: 56  DRVEQEWVAIK---IIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 112
Query: 60  TLVFEHCDQDLKKYFDSLNGE-IDLDIVKSFMYQLLRGLAFCHS--RNVLHRDLKPQNLL 116
            LVFE    +L     + N   + L++ + F  Q+   L F  +   +++H DLKP+N+L
Sbjct: 113 CLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENIL 172
Query: 117 I--NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCI 174
           +   K   +K+ DFG +   G  +      + + +YR P+VL G   Y  +IDMWS GCI
Sbjct: 173 LCNPKRSAIKIVDFGSSCQLGQRI---YQXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCI 228
Query: 175 FAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
             E+ + G PLF G++  DQ+ +I ++LG P
Sbjct: 229 LVEM-HTGEPLFSGANEVDQMNKIVEVLGIP 258

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 113/246 (45%), Gaps = 36/246 (14%)
Query: 20  HLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLN 78
           H++    VP    RE  ++  L H   V+LY     ++KL     +  + +L KY   + 
Sbjct: 47  HIIKENKVPY-VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 104
Query: 79  GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 138
           G  D    + +  +++  L + H + ++HRDLKP+N+L+N++  +++ DFG A+      
Sbjct: 105 GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 164
Query: 139 KCYSAE--VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K   A   V T  Y  P++L   K    S D+W+ GCI  +L  AG P F   +     +
Sbjct: 165 KQARANXFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLV-AGLPPFRAGNEYLIFQ 222
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
           +I KL     E  +P        K FP                 K RDL+++LLV +  +
Sbjct: 223 KIIKL-----EYDFPE-------KFFP-----------------KARDLVEKLLVLDATK 253
Query: 257 RMSAED 262
           R+  E+
Sbjct: 254 RLGCEE 259

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 7   DRTPNTALAIKGTHLVGNE-GVPSSALREICLLKELKHKNIVRLYDVLHSEKK------L 59
           DR     +AIK   ++ N+    + A  E+ LL+ +   +    Y ++H ++       L
Sbjct: 75  DRVEQEWVAIK---IIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131
Query: 60  TLVFEHCDQDLKKYFDSLNGE-IDLDIVKSFMYQLLRGLAFCHS--RNVLHRDLKPQNLL 116
            LVFE    +L     + N   + L++ + F  Q+   L F  +   +++H DLKP+N+L
Sbjct: 132 CLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENIL 191
Query: 117 I--NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCI 174
           +   K   +K+ DFG +   G  +      + + +YR P+VL G   Y  +IDMWS GCI
Sbjct: 192 LCNPKRXAIKIVDFGSSCQLGQRI---YQXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCI 247
Query: 175 FAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
             E+ + G PLF G++  DQ+ +I ++LG P
Sbjct: 248 LVEM-HTGEPLFSGANEVDQMNKIVEVLGIP 277

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 93/184 (50%), Gaps = 14/184 (7%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVK 87
           P + L E  L+K+L+H+ +VRLY V+  E    +     +  L  +  + +G I L I K
Sbjct: 52  PDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINK 110
Query: 88  --SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS--- 142
                 Q+  G+AF   RN +HRDL+  N+L++     K+ADFGLAR   I    Y+   
Sbjct: 111 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEYTARE 168
Query: 143 -AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKRI 198
            A+    W  P  + +G   +T   D+WS G +  E+   GR  +PG    +V   L+R 
Sbjct: 169 GAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226
Query: 199 FKLL 202
           ++++
Sbjct: 227 YRMV 230

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 90/182 (49%), Gaps = 10/182 (5%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVK 87
           P + L E  L+K+L+H+ +VRLY V+  E    +     +  L  +  + +G I L I K
Sbjct: 54  PDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINK 112
Query: 88  --SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVKCYSA 143
                 Q+  G+AF   RN +HRDL+  N+L++     K+ADFGLAR            A
Sbjct: 113 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 172
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKRIFK 200
           +    W  P  + +G   +T   D+WS G +  E+   GR  +PG    +V   L+R ++
Sbjct: 173 KFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR 230
Query: 201 LL 202
           ++
Sbjct: 231 MV 232

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 90/182 (49%), Gaps = 10/182 (5%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVK 87
           P + L E  L+K+L+H+ +VRLY V+  E    +     +  L  +  + +G I L I K
Sbjct: 53  PDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINK 111
Query: 88  --SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVKCYSA 143
                 Q+  G+AF   RN +HRDL+  N+L++     K+ADFGLAR            A
Sbjct: 112 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 171
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKRIFK 200
           +    W  P  + +G   +T   D+WS G +  E+   GR  +PG    +V   L+R ++
Sbjct: 172 KFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR 229
Query: 201 LL 202
           ++
Sbjct: 230 MV 231

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 112/246 (45%), Gaps = 36/246 (14%)
Query: 20  HLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLN 78
           H++    VP    RE  ++  L H   V+LY     ++KL     +  + +L KY   + 
Sbjct: 72  HIIKENKVPY-VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 129
Query: 79  GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 138
           G  D    + +  +++  L + H + ++HRDLKP+N+L+N++  +++ DFG A+      
Sbjct: 130 GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 189
Query: 139 KCYSAE--VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K   A   V T  Y  P++L   K    S D+W+ GCI  +L  AG P F   +     +
Sbjct: 190 KQARANXFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLV-AGLPPFRAGNEYLIFQ 247
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
           +I KL     E  +P          FP                 K RDL+++LLV +  +
Sbjct: 248 KIIKL-----EYDFPAAF-------FP-----------------KARDLVEKLLVLDATK 278
Query: 257 RMSAED 262
           R+  E+
Sbjct: 279 RLGCEE 284

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 113/246 (45%), Gaps = 36/246 (14%)
Query: 20  HLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLN 78
           H++    VP    RE  ++  L H   V+LY     ++KL     +  + +L KY   + 
Sbjct: 74  HIIKENKVPY-VTRERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKI- 131
Query: 79  GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 138
           G  D    + +  +++  L + H + ++HRDLKP+N+L+N++  +++ DFG A+      
Sbjct: 132 GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 191
Query: 139 KCYSAE--VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K   A   V T  Y  P++L   K    S D+W+ GCI  +L  AG P F   +     +
Sbjct: 192 KQARANXFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLV-AGLPPFRAGNEYLIFQ 249
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
           +I KL     E  +P        K FP                 K RDL+++LLV +  +
Sbjct: 250 KIIKL-----EYDFPE-------KFFP-----------------KARDLVEKLLVLDATK 280
Query: 257 RMSAED 262
           R+  E+
Sbjct: 281 RLGCEE 286

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 90/182 (49%), Gaps = 10/182 (5%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVK 87
           P + L E  L+K+L+H+ +VRLY V+  E    +     +  L  +  + +G I L I K
Sbjct: 52  PDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINK 110
Query: 88  --SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVKCYSA 143
                 Q+  G+AF   RN +HRDL+  N+L++     K+ADFGLAR            A
Sbjct: 111 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 170
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKRIFK 200
           +    W  P  + +G   +T   D+WS G +  E+   GR  +PG    +V   L+R ++
Sbjct: 171 KFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR 228
Query: 201 LL 202
           ++
Sbjct: 229 MV 230

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 122/267 (45%), Gaps = 33/267 (12%)
Query: 7   DRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC 66
           D+  N  +A+K  ++   E + ++  REI   + L+H NIVR  +V+ +   L +V E+ 
Sbjct: 40  DKQSNELVAVK--YIERGEKIAANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 97
Query: 67  DQDLKKYFDSL--NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN--GE 122
                + F+ +   G    D  + F  QL+ G+++CH+  V HRDLK +N L++ +    
Sbjct: 98  SG--GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 155
Query: 123 LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
           LK+ DFG +++  +  +  S  V T  Y  P+VL   +      D+WS G     +    
Sbjct: 156 LKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGA 214
Query: 183 RPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKG 242
            P     +  +  K I ++L             +PD            +  ++P+     
Sbjct: 215 YPFEDPEEPKNFRKTIHRILNV--------QYAIPD------------YVHISPEC---- 250
Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYF 269
           R L+ R+ V +P +R+S  +  +H +F
Sbjct: 251 RHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 84/158 (53%), Gaps = 5/158 (3%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMY 91
           RE+    +L H+NIV + DV   +    LV E+ +   L +Y +S +G + +D   +F  
Sbjct: 60  REVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTN 118
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q+L G+   H   ++HRD+KPQN+LI+ N  LK+ DFG+A+A        +  V+ T+ Y
Sbjct: 119 QILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQY 178
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
             P+   G +      D++S G +  E+   G P F G
Sbjct: 179 FSPEQAKG-EATDECTDIYSIGIVLYEML-VGEPPFNG 214

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 99/185 (53%), Gaps = 16/185 (8%)
Query: 28  PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIV 86
           P + L E  L+K+L+H+ +VRLY V+ +++ + ++ E+ +   L  +  + +G I L I 
Sbjct: 48  PDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSG-IKLTIN 105
Query: 87  K--SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS-- 142
           K      Q+  G+AF   RN +HR+L+  N+L++     K+ADFGLAR   I    Y+  
Sbjct: 106 KLLDMAAQIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARL--IEDNEYTAR 163
Query: 143 --AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKR 197
             A+    W  P  + +G   +T   D+WS G +  E+   GR  +PG    +V   L+R
Sbjct: 164 EGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 221
Query: 198 IFKLL 202
            ++++
Sbjct: 222 GYRMV 226

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 117/263 (44%), Gaps = 44/263 (16%)
Query: 14  LAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-----Q 68
           +A K  HL     + +  +RE+ +L E     IV  Y   +S+ ++++  EH D     Q
Sbjct: 37  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 96
Query: 69  DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN-VLHRDLKPQNLLINKNGELKLAD 127
            LKK      G I   I+      +++GL +   ++ ++HRD+KP N+L+N  GE+KL D
Sbjct: 97  VLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCD 151
Query: 128 FGLARAFGIPVKCYSAEVV-TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           FG++   G  +   + E V T  Y  P+ L G   Y+   D+WS G    E+A    P  
Sbjct: 152 FGVS---GQLIDEMANEFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPRP 207
Query: 187 PGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLL 246
           P +        IF+LL     +  P +             PS  FS        + +D +
Sbjct: 208 PMA--------IFELLDYIVNEPPPKL-------------PSAVFS-------LEFQDFV 239
Query: 247 QRLLVCNPVQRMSAEDAMSHIYF 269
            + L+ NP +R   +  M H + 
Sbjct: 240 NKCLIKNPAERADLKQLMVHAFI 262

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 8   RTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD 67
           R     +A K  HL     + +  +RE+ +L E     IV  Y   +S+ ++++  EH D
Sbjct: 38  RPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 97
Query: 68  QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN-VLHRDLKPQNLLINKNGELKLA 126
                        I  +I+      +LRGLA+   ++ ++HRD+KP N+L+N  GE+KL 
Sbjct: 98  GGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLC 157
Query: 127 DFGLARAFGIPVKCYSAEVV-TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
           DFG++   G  +   +   V T  Y  P+ L G   Y+   D+WS G    ELA  GR  
Sbjct: 158 DFGVS---GQLIDSMANSFVGTRSYMAPERLQGTH-YSVQSDIWSMGLSLVELA-VGRYP 212
Query: 186 FPGSDVDDQLKRIFKLLGTPTEDTWPG 212
            P  D     K +  + G P  D   G
Sbjct: 213 IPPPDA----KELEAIFGRPVVDGEEG 235

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 121/267 (45%), Gaps = 33/267 (12%)
Query: 7   DRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC 66
           D+  N  +A+K  ++   E +  +  REI   + L+H NIVR  +V+ +   L +V E+ 
Sbjct: 39  DKQSNELVAVK--YIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 96
Query: 67  DQDLKKYFDSL--NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN--GE 122
                + F+ +   G    D  + F  QL+ G+++CH+  V HRDLK +N L++ +    
Sbjct: 97  SG--GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 154
Query: 123 LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
           LK+ DFG +++  +  +  S  V T  Y  P+VL   +      D+WS G     +    
Sbjct: 155 LKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGA 213
Query: 183 RPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKG 242
            P     +  +  K I ++L             +PD            +  ++P+     
Sbjct: 214 YPFEDPEEPKNFRKTIHRILNV--------QYAIPD------------YVHISPEC---- 249
Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYF 269
           R L+ R+ V +P +R+S  +  +H +F
Sbjct: 250 RHLISRIFVADPAKRISIPEIRNHEWF 276

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 11  NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD- 69
           NT +AIK   L      P S L E  ++K+LKH  +V+LY V+ SE+ + +V E+ ++  
Sbjct: 33  NTKVAIK--TLKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVV-SEEPIYIVTEYMNKGS 89
Query: 70  -LKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADF 128
            L    D     + L  +     Q+  G+A+    N +HRDL+  N+L+      K+ADF
Sbjct: 90  LLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADF 149
Query: 129 GLARAF--GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           GLAR            A+    W  P   L+G   +T   D+WS G +  EL   GR  +
Sbjct: 150 GLARLIEDNEXTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRVPY 207
Query: 187 PG---SDVDDQLKRIFKL 201
           PG    +V +Q++R +++
Sbjct: 208 PGMNNREVLEQVERGYRM 225

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 111/237 (46%), Gaps = 31/237 (13%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQL 93
           E+ ++++ +H N+V +Y      ++L ++ E           S    ++ + + +    +
Sbjct: 92  EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAV 150
Query: 94  LRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP 153
           L+ LA+ H++ V+HRD+K  ++L+  +G +KL+DFG        V      V T ++  P
Sbjct: 151 LQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAP 210
Query: 154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGM 213
           +V+    LY T +D+WS G +  E+ +   P F  S V                     M
Sbjct: 211 EVI-SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-------------------AM 250
Query: 214 NLLPDFKPFPMYHPSMSFS-QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
             L D  P     P +  S +V+P L    RD L+R+LV +P +R +A++ + H + 
Sbjct: 251 KRLRDSPP-----PKLKNSHKVSPVL----RDFLERMLVRDPQERATAQELLDHPFL 298

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 122/277 (44%), Gaps = 30/277 (10%)
Query: 14  LAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-----Q 68
           +A K  HL     + +  +RE+ +L E     IV  Y   +S+ ++++  EH D     Q
Sbjct: 61  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 69  DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN-VLHRDLKPQNLLINKNGELKLAD 127
            LKK      G I   I+      +++GL +   ++ ++HRD+KP N+L+N  GE+KL D
Sbjct: 121 VLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCD 175
Query: 128 FGLARAFGIPVKCYSAEVV-TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           FG++   G  +   +   V T  Y  P+ L G   Y+   D+WS G    E+A    P+ 
Sbjct: 176 FGVS---GQLIDSMANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIP 231
Query: 187 PGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM-YHPSMSF--------SQVAPK 237
           P    + +L    ++ G   E              F M   P M+         ++  PK
Sbjct: 232 PPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPK 291
Query: 238 LTA-----KGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
           L +     + +D + + L+ NP +R   +  M H + 
Sbjct: 292 LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 112/243 (46%), Gaps = 37/243 (15%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE---IDLDIVKSF 89
           EI +LK L H NI+++++V      + +V E C+  +L +   S       +    V   
Sbjct: 70  EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL 129
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINK---NGELKLADFGLARAFGIPVKCYSAEVV 146
           M Q++  LA+ HS++V+H+DLKP+N+L      +  +K+ DFGLA  F       +A   
Sbjct: 130 MKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGT 189
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
            L Y  P+V    +  T   D+WSAG +   L     P F G+ +++  ++         
Sbjct: 190 AL-YMAPEVF--KRDVTFKCDIWSAGVVMYFLLTGCLP-FTGTSLEEVQQKA-------- 237
Query: 207 EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
             T+   N   + +P                LT +  DLL+++L  +P +R SA   + H
Sbjct: 238 --TYKEPNYAVECRP----------------LTPQAVDLLKQMLTKDPERRPSAAQVLHH 279
Query: 267 IYF 269
            +F
Sbjct: 280 EWF 282

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 122/277 (44%), Gaps = 30/277 (10%)
Query: 14  LAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-----Q 68
           +A K  HL     + +  +RE+ +L E     IV  Y   +S+ ++++  EH D     Q
Sbjct: 34  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 93
Query: 69  DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN-VLHRDLKPQNLLINKNGELKLAD 127
            LKK      G I   I+      +++GL +   ++ ++HRD+KP N+L+N  GE+KL D
Sbjct: 94  VLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCD 148
Query: 128 FGLARAFGIPVKCYSAEVV-TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           FG++   G  +   +   V T  Y  P+ L G   Y+   D+WS G    E+A    P+ 
Sbjct: 149 FGVS---GQLIDSMANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIP 204
Query: 187 PGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM-YHPSMSF--------SQVAPK 237
           P    + +L    ++ G   E              + M   P M+         ++  PK
Sbjct: 205 PPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPK 264
Query: 238 LTA-----KGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
           L +     + +D + + L+ NP +R   +  M H + 
Sbjct: 265 LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 122/277 (44%), Gaps = 30/277 (10%)
Query: 14  LAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-----Q 68
           +A K  HL     + +  +RE+ +L E     IV  Y   +S+ ++++  EH D     Q
Sbjct: 96  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 155
Query: 69  DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN-VLHRDLKPQNLLINKNGELKLAD 127
            LKK      G I   I+      +++GL +   ++ ++HRD+KP N+L+N  GE+KL D
Sbjct: 156 VLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCD 210
Query: 128 FGLARAFGIPVKCYSAEVV-TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           FG++   G  +   +   V T  Y  P+ L G   Y+   D+WS G    E+A    P+ 
Sbjct: 211 FGVS---GQLIDSMANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIP 266
Query: 187 PGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM-YHPSMSF--------SQVAPK 237
           P    + +L    ++ G   E              + M   P M+         ++  PK
Sbjct: 267 PPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPK 326
Query: 238 LTA-----KGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
           L +     + +D + + L+ NP +R   +  M H + 
Sbjct: 327 LPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 363

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 122/277 (44%), Gaps = 30/277 (10%)
Query: 14  LAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-----Q 68
           +A K  HL     + +  +RE+ +L E     IV  Y   +S+ ++++  EH D     Q
Sbjct: 34  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 93
Query: 69  DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN-VLHRDLKPQNLLINKNGELKLAD 127
            LKK      G I   I+      +++GL +   ++ ++HRD+KP N+L+N  GE+KL D
Sbjct: 94  VLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCD 148
Query: 128 FGLARAFGIPVKCYSAEVV-TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           FG++   G  +   +   V T  Y  P+ L G   Y+   D+WS G    E+A    P+ 
Sbjct: 149 FGVS---GQLIDSMANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIP 204
Query: 187 PGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM-YHPSMSF--------SQVAPK 237
           P    + +L    ++ G   E              + M   P M+         ++  PK
Sbjct: 205 PPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPK 264
Query: 238 LTA-----KGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
           L +     + +D + + L+ NP +R   +  M H + 
Sbjct: 265 LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 122/278 (43%), Gaps = 30/278 (10%)
Query: 13  ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD----- 67
            +A K  HL     + +  +RE+ +L E     IV  Y   +S+ ++++  EH D     
Sbjct: 33  VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 92
Query: 68  QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN-VLHRDLKPQNLLINKNGELKLA 126
           Q LKK      G I   I+      +++GL +   ++ ++HRD+KP N+L+N  GE+KL 
Sbjct: 93  QVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC 147
Query: 127 DFGLARAFGIPVKCYSAEVV-TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
           DFG++   G  +   +   V T  Y  P+ L G   Y+   D+WS G    E+A    P+
Sbjct: 148 DFGVS---GQLIDSMANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPI 203
Query: 186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM-YHPSMSF--------SQVAP 236
            P    + +L    ++ G   E              + M   P M+         ++  P
Sbjct: 204 PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPP 263
Query: 237 KLTA-----KGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
           KL +     + +D + + L+ NP +R   +  M H + 
Sbjct: 264 KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 122/278 (43%), Gaps = 30/278 (10%)
Query: 13  ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD----- 67
            +A K  HL     + +  +RE+ +L E     IV  Y   +S+ ++++  EH D     
Sbjct: 33  VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 92
Query: 68  QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN-VLHRDLKPQNLLINKNGELKLA 126
           Q LKK      G I   I+      +++GL +   ++ ++HRD+KP N+L+N  GE+KL 
Sbjct: 93  QVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC 147
Query: 127 DFGLARAFGIPVKCYSAEVV-TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
           DFG++   G  +   +   V T  Y  P+ L G   Y+   D+WS G    E+A    P+
Sbjct: 148 DFGVS---GQLIDSMANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPI 203
Query: 186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM-YHPSMSF--------SQVAP 236
            P    + +L    ++ G   E              + M   P M+         ++  P
Sbjct: 204 PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPP 263
Query: 237 KLTA-----KGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
           KL +     + +D + + L+ NP +R   +  M H + 
Sbjct: 264 KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 6/192 (3%)
Query: 10  PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-Q 68
           P  A+AIK      ++ V    L+E   +++  H +IV+L  V+ +E  + ++ E C   
Sbjct: 37  PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLG 95
Query: 69  DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADF 128
           +L+ +       +DL  +  + YQL   LA+  S+  +HRD+  +N+L++ N  +KL DF
Sbjct: 96  ELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 155
Query: 129 GLARAF--GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           GL+R        K    ++   W  P  + F  + +T++ D+W  G    E+   G   F
Sbjct: 156 GLSRYMEDSTXXKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPF 213
Query: 187 PGSDVDDQLKRI 198
            G   +D + RI
Sbjct: 214 QGVKNNDVIGRI 225

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 95/179 (53%), Gaps = 13/179 (7%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDS-LNGEIDLDIVKSF 89
           L E  L+K L+H  +VRLY V+  E+ + ++ E+  +  L  +  S   G++ L  +  F
Sbjct: 56  LEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF 115
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS----AEV 145
             Q+  G+A+   +N +HRDL+  N+L++++   K+ADFGLAR   I    Y+    A+ 
Sbjct: 116 SAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARV--IEDNEYTAREGAKF 173
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKRIFKL 201
              W  P  + FG   +T   D+WS G +  E+   G+  +PG   +DV   L + +++
Sbjct: 174 PIKWTAPEAINFGC--FTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRM 230

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 116/290 (40%), Gaps = 73/290 (25%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-----QDLKKYFDSLNGEIDLDIVKS 88
           E+ L+K+L H NI RLY+V   E+ + LV E C        L  + D   G+  +D+VK+
Sbjct: 78  EVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKT 137
Query: 89  -----------------------------------FMYQLLRGLAFCHSRNVLHRDLKPQ 113
                                               M Q+   L + H++ + HRD+KP+
Sbjct: 138 QICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPE 197
Query: 114 NLLI--NKNGELKLADFGLARAF----GIPVKCYSAEVVTLWYRPPDVLFGA-KLYTTSI 166
           N L   NK+ E+KL DFGL++ F           + +  T ++  P+VL    + Y    
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 167 DMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYH 226
           D WSAG +   L     P FPG +  D + ++                     K     +
Sbjct: 258 DAWSAGVLLHLLLMGAVP-FPGVNDADTISQVLN-------------------KKLCFEN 297
Query: 227 PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI 276
           P+ +       L+   RDLL  LL  N  +R  A  A+ H + S  +  I
Sbjct: 298 PNYNV------LSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKI 341

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 6/192 (3%)
Query: 10  PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-Q 68
           P  A+AIK      ++ V    L+E   +++  H +IV+L  V+ +E  + ++ E C   
Sbjct: 37  PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLG 95
Query: 69  DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADF 128
           +L+ +       +DL  +  + YQL   LA+  S+  +HRD+  +N+L++ N  +KL DF
Sbjct: 96  ELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 155
Query: 129 GLARAF--GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           GL+R        K    ++   W  P  + F  + +T++ D+W  G    E+   G   F
Sbjct: 156 GLSRYMEDSTYYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPF 213
Query: 187 PGSDVDDQLKRI 198
            G   +D + RI
Sbjct: 214 QGVKNNDVIGRI 225

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 6/192 (3%)
Query: 10  PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-Q 68
           P  A+AIK      ++ V    L+E   +++  H +IV+L  V+ +E  + ++ E C   
Sbjct: 65  PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLG 123
Query: 69  DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADF 128
           +L+ +       +DL  +  + YQL   LA+  S+  +HRD+  +N+L++ N  +KL DF
Sbjct: 124 ELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 183
Query: 129 GLARAF--GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           GL+R        K    ++   W  P  + F  + +T++ D+W  G    E+   G   F
Sbjct: 184 GLSRYMEDSTYYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPF 241
Query: 187 PGSDVDDQLKRI 198
            G   +D + RI
Sbjct: 242 QGVKNNDVIGRI 253

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 116/259 (44%), Gaps = 35/259 (13%)
Query: 21  LVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD--QDLKKYFDSLN 78
           +  +E    +  +EI  +  L+H  +V L+D    + ++ +++E     +  +K  D  N
Sbjct: 191 MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN 250
Query: 79  GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN--KNGELKLADFGLARAFGI 136
            ++  D    +M Q+ +GL   H  N +H DLKP+N++    ++ ELKL DFGL  A   
Sbjct: 251 -KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT-AHLD 308
Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKL-YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL 195
           P +       T  +  P+V  G  + Y T  DMWS G +   L +   P   G + DD+ 
Sbjct: 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYT--DMWSVGVLSYILLSGLSPF--GGENDDET 364
Query: 196 KRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPV 255
            R  K      +D+                    +FS +    +  G+D +++LL+ +P 
Sbjct: 365 LRNVKSCDWNMDDS--------------------AFSGI----SEDGKDFIRKLLLADPN 400
Query: 256 QRMSAEDAMSHIYFSDLNV 274
            RM+   A+ H + +  N 
Sbjct: 401 TRMTIHQALEHPWLTPGNA 419

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 116/259 (44%), Gaps = 35/259 (13%)
Query: 21  LVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD--QDLKKYFDSLN 78
           +  +E    +  +EI  +  L+H  +V L+D    + ++ +++E     +  +K  D  N
Sbjct: 85  MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN 144
Query: 79  GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN--KNGELKLADFGLARAFGI 136
            ++  D    +M Q+ +GL   H  N +H DLKP+N++    ++ ELKL DFGL  A   
Sbjct: 145 -KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT-AHLD 202
Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKL-YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL 195
           P +       T  +  P+V  G  + Y T  DMWS G +   L +   P   G + DD+ 
Sbjct: 203 PKQSVKVTTGTAEFAAPEVAEGKPVGYYT--DMWSVGVLSYILLSGLSPF--GGENDDET 258
Query: 196 KRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPV 255
            R  K      +D+                    +FS ++      G+D +++LL+ +P 
Sbjct: 259 LRNVKSCDWNMDDS--------------------AFSGIS----EDGKDFIRKLLLADPN 294
Query: 256 QRMSAEDAMSHIYFSDLNV 274
            RM+   A+ H + +  N 
Sbjct: 295 TRMTIHQALEHPWLTPGNA 313

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 6/192 (3%)
Query: 10  PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-Q 68
           P  A+AIK      ++ V    L+E   +++  H +IV+L  V+ +E  + ++ E C   
Sbjct: 42  PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLG 100
Query: 69  DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADF 128
           +L+ +       +DL  +  + YQL   LA+  S+  +HRD+  +N+L++ N  +KL DF
Sbjct: 101 ELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 160
Query: 129 GLARAF--GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           GL+R        K    ++   W  P  + F  + +T++ D+W  G    E+   G   F
Sbjct: 161 GLSRYMEDSTYYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPF 218
Query: 187 PGSDVDDQLKRI 198
            G   +D + RI
Sbjct: 219 QGVKNNDVIGRI 230

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 116/248 (46%), Gaps = 39/248 (15%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-----DLKKYFDSLNGEIDLDIVK 87
           RE  +   LKH +IV L +   S+  L +VFE  D      ++ K  D+  G +  + V 
Sbjct: 75  REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADA--GFVYSEAVA 132
Query: 88  S-FMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVKCYSA 143
           S +M Q+L  L +CH  N++HRD+KP+N+L+     +  +KL DFG+A   G        
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGG 192
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
            V T  +  P+V+   + Y   +D+W  G I   L +   P +   +      R+F+ + 
Sbjct: 193 RVGTPHFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTKE------RLFEGI- 244
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
                      +   +K  P     +S S          +DL++R+L+ +P +R++  +A
Sbjct: 245 -----------IKGKYKMNPRQWSHISES---------AKDLVRRMLMLDPAERITVYEA 284
Query: 264 MSHIYFSD 271
           ++H +  +
Sbjct: 285 LNHPWLKE 292

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 6/192 (3%)
Query: 10  PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-Q 68
           P  A+AIK      ++ V    L+E   +++  H +IV+L  V+ +E  + ++ E C   
Sbjct: 39  PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLG 97
Query: 69  DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADF 128
           +L+ +       +DL  +  + YQL   LA+  S+  +HRD+  +N+L++ N  +KL DF
Sbjct: 98  ELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 157
Query: 129 GLARAF--GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           GL+R        K    ++   W  P  + F  + +T++ D+W  G    E+   G   F
Sbjct: 158 GLSRYMEDSTYYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPF 215
Query: 187 PGSDVDDQLKRI 198
            G   +D + RI
Sbjct: 216 QGVKNNDVIGRI 227

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 6/192 (3%)
Query: 10  PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-Q 68
           P  A+AIK      ++ V    L+E   +++  H +IV+L  V+ +E  + ++ E C   
Sbjct: 37  PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLG 95
Query: 69  DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADF 128
           +L+ +       +DL  +  + YQL   LA+  S+  +HRD+  +N+L++ N  +KL DF
Sbjct: 96  ELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 155
Query: 129 GLARAF--GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           GL+R        K    ++   W  P  + F  + +T++ D+W  G    E+   G   F
Sbjct: 156 GLSRYMEDSTYYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPF 213
Query: 187 PGSDVDDQLKRI 198
            G   +D + RI
Sbjct: 214 QGVKNNDVIGRI 225

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 6/192 (3%)
Query: 10  PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-Q 68
           P  A+AIK      ++ V    L+E   +++  H +IV+L  V+ +E  + ++ E C   
Sbjct: 34  PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLG 92
Query: 69  DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADF 128
           +L+ +       +DL  +  + YQL   LA+  S+  +HRD+  +N+L++ N  +KL DF
Sbjct: 93  ELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 152
Query: 129 GLARAF--GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           GL+R        K    ++   W  P  + F  + +T++ D+W  G    E+   G   F
Sbjct: 153 GLSRYMEDSTYYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPF 210
Query: 187 PGSDVDDQLKRI 198
            G   +D + RI
Sbjct: 211 QGVKNNDVIGRI 222

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 6/192 (3%)
Query: 10  PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-Q 68
           P  A+AIK      ++ V    L+E   +++  H +IV+L  V+ +E  + ++ E C   
Sbjct: 40  PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLG 98
Query: 69  DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADF 128
           +L+ +       +DL  +  + YQL   LA+  S+  +HRD+  +N+L++ N  +KL DF
Sbjct: 99  ELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 158
Query: 129 GLARAF--GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           GL+R        K    ++   W  P  + F  + +T++ D+W  G    E+   G   F
Sbjct: 159 GLSRYMEDSTYYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPF 216
Query: 187 PGSDVDDQLKRI 198
            G   +D + RI
Sbjct: 217 QGVKNNDVIGRI 228

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 94/193 (48%), Gaps = 6/193 (3%)
Query: 9   TPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD- 67
            P  A+AIK      ++ V    L+E   +++  H +IV+L  V+ +E  + ++ E C  
Sbjct: 416 NPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTL 474
Query: 68  QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLAD 127
            +L+ +       +DL  +  + YQL   LA+  S+  +HRD+  +N+L++ N  +KL D
Sbjct: 475 GELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGD 534
Query: 128 FGLARAF--GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
           FGL+R        K    ++   W  P  + F  + +T++ D+W  G    E+   G   
Sbjct: 535 FGLSRYMEDSTYYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKP 592
Query: 186 FPGSDVDDQLKRI 198
           F G   +D + RI
Sbjct: 593 FQGVKNNDVIGRI 605

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 120/267 (44%), Gaps = 33/267 (12%)
Query: 7   DRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC 66
           D+  N  +A+K  ++   E +  +  REI   + L+H NIVR  +V+ +   L +V E+ 
Sbjct: 40  DKQSNELVAVK--YIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 97
Query: 67  DQDLKKYFDSL--NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN--GE 122
                + F+ +   G    D  + F  QL+ G+++CH+  V HRDLK +N L++ +    
Sbjct: 98  SG--GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 155
Query: 123 LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
           LK+  FG +++  +  +  S  V T  Y  P+VL   +      D+WS G     +    
Sbjct: 156 LKICAFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGA 214
Query: 183 RPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKG 242
            P     +  +  K I ++L             +PD            +  ++P+     
Sbjct: 215 YPFEDPEEPKNFRKTIHRILNV--------QYAIPD------------YVHISPEC---- 250
Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYF 269
           R L+ R+ V +P +R+S  +  +H +F
Sbjct: 251 RHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 109/247 (44%), Gaps = 50/247 (20%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY- 91
           RE  + + LKH NIVRL+D +  E    LVF     DL        GE+  DIV    Y 
Sbjct: 79  REARICRLLKHPNIVRLHDSISEEGFHYLVF-----DL-----VTGGELFEDIVAREYYS 128
Query: 92  ---------QLLRGLAFCHSRNVLHRDLKPQNLLIN---KNGELKLADFGLARAFGIPVK 139
                    Q+L  +   H  +++HRDLKP+NLL+    K   +KLADFGLA       +
Sbjct: 129 EADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQ 188
Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF 199
            +     T  Y  P+VL     Y   +D+W+ G I   L   G P F     D+   +++
Sbjct: 189 AWFGFAGTPGYLSPEVL-RKDPYGKPVDIWACGVILYILL-VGYPPF----WDEDQHKLY 242
Query: 200 KLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
           + +     D                  PS  +  V P    + ++L+ ++L  NP +R++
Sbjct: 243 QQIKAGAYD-----------------FPSPEWDTVTP----EAKNLINQMLTINPAKRIT 281
Query: 260 AEDAMSH 266
           A+ A+ H
Sbjct: 282 ADQALKH 288

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 94/179 (52%), Gaps = 13/179 (7%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDS-LNGEIDLDIVKSF 89
           L E  L+K L+H  +VRLY V+  E+ + ++ E   +  L  +  S   G++ L  +  F
Sbjct: 55  LEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDF 114
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS----AEV 145
             Q+  G+A+   +N +HRDL+  N+L++++   K+ADFGLAR   I    Y+    A+ 
Sbjct: 115 SAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARV--IEDNEYTAREGAKF 172
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKRIFKL 201
              W  P  + FG   +T   ++WS G +  E+   G+  +PG   +DV   L + +++
Sbjct: 173 PIKWTAPEAINFGC--FTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRM 229

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 113/244 (46%), Gaps = 37/244 (15%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE----IDLDIVKSF 89
           EI ++ +L H N+++LYD   S+  + LV E+ D    + FD +  E     +LD +  F
Sbjct: 136 EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG--ELFDRIIDESYNLTELDTI-LF 192
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLL-INKNG-ELKLADFGLARAFGIPVKCYSAEVVT 147
           M Q+  G+   H   +LH DLKP+N+L +N++  ++K+ DFGLAR +  P +       T
Sbjct: 193 MKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-PREKLKVNFGT 251
Query: 148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTE 207
             +  P+V+      +   DMWS G I   L +   P F G +  + L  I         
Sbjct: 252 PEFLAPEVV-NYDFVSFPTDMWSVGVIAYMLLSGLSP-FLGDNDAETLNNILAC------ 303
Query: 208 DTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHI 267
             W     L D              +    ++ + ++ + +LL+     R+SA +A+ H 
Sbjct: 304 -RWD----LED--------------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHP 344
Query: 268 YFSD 271
           + SD
Sbjct: 345 WLSD 348

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 5/159 (3%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLNGEI--DLDIVKSF 89
            EI L K LKHKNIV+          + +  E      L     S  G +  +   +  +
Sbjct: 68  EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 127
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVKCYSAEVVTL 148
             Q+L GL + H   ++HRD+K  N+LIN  +G LK++DFG ++       C      TL
Sbjct: 128 TKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTL 187
Query: 149 WYRPPDVL-FGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
            Y  P+++  G + Y  + D+WS GC   E+A    P +
Sbjct: 188 QYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 83/144 (57%), Gaps = 5/144 (3%)
Query: 33  REICLLKELKHKNIVRLYDVLH--SEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFM 90
           +EI +LK+L H N+V+L +VL   +E  L +VFE  +Q       +L   +  D  + + 
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-PLSEDQARFYF 143
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWY 150
             L++G+ + H + ++HRD+KP NLL+ ++G +K+ADFG++  F       S  V T  +
Sbjct: 144 QDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAF 203
Query: 151 RPPDVLFGA-KLYT-TSIDMWSAG 172
             P+ L    K+++  ++D+W+ G
Sbjct: 204 MAPESLSETRKIFSGKALDVWAMG 227

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 118/250 (47%), Gaps = 46/250 (18%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLNGEIDL--DIVKSFM 90
           E  +L ++ H  +V+L+    +E KL L+ +     DL   F  L+ E+    + VK ++
Sbjct: 80  ERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYL 136
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR-AFGIPVKCYSAEVVTLW 149
            +L  GL   HS  +++RDLKP+N+L+++ G +KL DFGL++ A     K YS    T+ 
Sbjct: 137 AELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSF-CGTVE 195
Query: 150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL-LGTPTED 208
           Y  P+V+   + ++ S D WS G +  E+     P F G D  + +  I K  LG     
Sbjct: 196 YMAPEVV-NRQGHSHSADWWSYGVLMFEMLTGSLP-FQGKDRKETMTLILKAKLG----- 248
Query: 209 TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM-----SAEDA 263
                  +P F                  L+ + + LL+ L   NP  R+      AE+ 
Sbjct: 249 -------MPQF------------------LSTEAQSLLRALFKRNPANRLGSGPDGAEEI 283
Query: 264 MSHIYFSDLN 273
             H+++S ++
Sbjct: 284 KRHVFYSTID 293

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 5/159 (3%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLNGEI--DLDIVKSF 89
            EI L K LKHKNIV+          + +  E      L     S  G +  +   +  +
Sbjct: 54  EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 113
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVKCYSAEVVTL 148
             Q+L GL + H   ++HRD+K  N+LIN  +G LK++DFG ++       C      TL
Sbjct: 114 TKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTL 173
Query: 149 WYRPPDVL-FGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
            Y  P+++  G + Y  + D+WS GC   E+A    P +
Sbjct: 174 QYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 212

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 10  PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-Q 68
           P  A+AIK      ++ V    L+E   +++  H +IV+L  V+ +E  + ++ E C   
Sbjct: 37  PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLG 95
Query: 69  DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADF 128
           +L+ +       +DL  +  + YQL   LA+  S+  +HRD+  +N+L++    +KL DF
Sbjct: 96  ELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDF 155
Query: 129 GLARAF--GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           GL+R        K    ++   W  P  + F  + +T++ D+W  G    E+   G   F
Sbjct: 156 GLSRYMEDSTYYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPF 213
Query: 187 PGSDVDDQLKRI 198
            G   +D + RI
Sbjct: 214 QGVKNNDVIGRI 225

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 119/267 (44%), Gaps = 33/267 (12%)
Query: 7   DRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC 66
           D+  N  +A+K  ++   E +  +  REI   + L+H NIVR  +V+ +   L +V E+ 
Sbjct: 40  DKQSNELVAVK--YIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 97
Query: 67  DQDLKKYFDSL--NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN--GE 122
                + F+ +   G    D  + F  QL+ G+++CH+  V HRDLK +N L++ +    
Sbjct: 98  SG--GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 155
Query: 123 LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
           LK+  FG +++  +  +     V T  Y  P+VL   +      D+WS G     +    
Sbjct: 156 LKICAFGYSKSSVLHSQPKDT-VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGA 214
Query: 183 RPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKG 242
            P     +  +  K I ++L             +PD            +  ++P+     
Sbjct: 215 YPFEDPEEPKNFRKTIHRILNV--------QYAIPD------------YVHISPEC---- 250
Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYF 269
           R L+ R+ V +P +R+S  +  +H +F
Sbjct: 251 RHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 31/222 (13%)
Query: 5   GVDR-TPN--TALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLT 60
           G+D+  PN  T +A+K       E   S  + E+ ++K + KHKNI+ L      +  L 
Sbjct: 51  GLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 110
Query: 61  LVFEHCDQ-DLKKYFD-------------SLNGEIDL---DIVKSFMYQLLRGLAFCHSR 103
           ++ E+  + +L++Y               S N E  L   D+V S  YQ+ RG+ +  S+
Sbjct: 111 VIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV-SCAYQVARGMEYLASK 169
Query: 104 NVLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
             +HRDL  +N+L+ ++  +K+ADFGLAR         K  +  +   W   P+ LF  +
Sbjct: 170 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWM-APEALFD-R 227
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
           +YT   D+WS G +  E+   G   +PG  V++    +FKLL
Sbjct: 228 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----LFKLL 265

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 10  PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-Q 68
           P  A+AIK      ++ V    L+E   +++  H +IV+L  V+ +E  + ++ E C   
Sbjct: 417 PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLG 475
Query: 69  DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADF 128
           +L+ +       +DL  +  + YQL   LA+  S+  +HRD+  +N+L++    +KL DF
Sbjct: 476 ELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDF 535
Query: 129 GLARAF--GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           GL+R        K    ++   W  P  + F  + +T++ D+W  G    E+   G   F
Sbjct: 536 GLSRYMEDSTYYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPF 593
Query: 187 PGSDVDDQLKRI 198
            G   +D + RI
Sbjct: 594 QGVKNNDVIGRI 605

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 116/250 (46%), Gaps = 46/250 (18%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLNGEIDL--DIVKSFM 90
           E  +L E+ H  IV+L+    +E KL L+ +     DL   F  L+ E+    + VK ++
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYL 132
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR-AFGIPVKCYSAEVVTLW 149
            +L   L   HS  +++RDLKP+N+L+++ G +KL DFGL++ +     K YS    T+ 
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF-CGTVE 191
Query: 150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL-LGTPTED 208
           Y  P+V+   + +T S D WS G +  E+     P F G D  + +  I K  LG     
Sbjct: 192 YMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKETMTMILKAKLG----- 244
Query: 209 TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA-----EDA 263
                  +P F                  L+ + + LL+ L   NP  R+ A     E+ 
Sbjct: 245 -------MPQF------------------LSPEAQSLLRMLFKRNPANRLGAGPDGVEEI 279
Query: 264 MSHIYFSDLN 273
             H +FS ++
Sbjct: 280 KRHSFFSTID 289

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 29/221 (13%)
Query: 5   GVDR-TPNTAL--AIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLT 60
           G+D+  P  A+  A+K       E   S  + E+ ++K + KHKNI+ L      +  L 
Sbjct: 58  GIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 117
Query: 61  LVFEHCDQ-DLKKYFDS-----LNGEIDLDIVK----------SFMYQLLRGLAFCHSRN 104
           ++ E+  + +L++Y  +     +    D++ V           S  YQL RG+ +  S+ 
Sbjct: 118 VIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 177
Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAFG---IPVKCYSAEVVTLWYRPPDVLFGAKL 161
            +HRDL  +N+L+ +N  +K+ADFGLAR         K  +  +   W   P+ LF  ++
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWM-APEALFD-RV 235
Query: 162 YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
           YT   D+WS G +  E+   G   +PG  V++    +FKLL
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----LFKLL 272

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 113/251 (45%), Gaps = 36/251 (14%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLD--IVKSFMY 91
           EI +LK+L H  I+++ +   +E    +V E  +    + FD + G   L     K + Y
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGG--ELFDKVVGNKRLKEATCKLYFY 121
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVKCYSAEVVTL 148
           Q+L  + + H   ++HRDLKP+N+L++   E   +K+ DFG ++  G           T 
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTP 180
Query: 149 WYRPPDVL--FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
            Y  P+VL   G   Y  ++D WS G I   +  +G P F        LK          
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPFSEHRTQVSLK---------D 230
Query: 207 EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
           + T    N +P               +V  +++ K  DL+++LLV +P  R + E+A+ H
Sbjct: 231 QITSGKYNFIP---------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275
Query: 267 IYFSDLNVAIK 277
            +  D ++  K
Sbjct: 276 PWLQDEDMKRK 286

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 106/243 (43%), Gaps = 43/243 (17%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL--NGEIDLDIVKSFM 90
           REI  LK  +H +I++LY V+ +     +V E+      + FD +  +G ++    +   
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGG--ELFDYICKHGRVEEMEARRLF 117
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG----IPVKCYSAEVV 146
            Q+L  + +CH   V+HRDLKP+N+L++ +   K+ADFGL+        +   C S    
Sbjct: 118 QQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN-- 175
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
              Y  P+V+ G       +D+WS G I   L     P       D+ +  +FK +    
Sbjct: 176 ---YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF-----DDEHVPTLFKKIRG-- 225
Query: 207 EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                G+  +P++                  L      LL  +L  +P++R + +D   H
Sbjct: 226 -----GVFYIPEY------------------LNRSVATLLMHMLQVDPLKRATIKDIREH 262
Query: 267 IYF 269
            +F
Sbjct: 263 EWF 265

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 113/251 (45%), Gaps = 36/251 (14%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLD--IVKSFMY 91
           EI +LK+L H  I+++ +   +E    +V E  +    + FD + G   L     K + Y
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGG--ELFDKVVGNKRLKEATCKLYFY 121
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVKCYSAEVVTL 148
           Q+L  + + H   ++HRDLKP+N+L++   E   +K+ DFG ++  G           T 
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTP 180
Query: 149 WYRPPDVL--FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
            Y  P+VL   G   Y  ++D WS G I   +  +G P F        LK          
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPFSEHRTQVSLK---------D 230
Query: 207 EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
           + T    N +P               +V  +++ K  DL+++LLV +P  R + E+A+ H
Sbjct: 231 QITSGKYNFIP---------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275
Query: 267 IYFSDLNVAIK 277
            +  D ++  K
Sbjct: 276 PWLQDEDMKRK 286

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 113/251 (45%), Gaps = 36/251 (14%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLD--IVKSFMY 91
           EI +LK+L H  I+++ +   +E    +V E  +    + FD + G   L     K + Y
Sbjct: 71  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGG--ELFDKVVGNKRLKEATCKLYFY 127
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVKCYSAEVVTL 148
           Q+L  + + H   ++HRDLKP+N+L++   E   +K+ DFG ++  G           T 
Sbjct: 128 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTP 186
Query: 149 WYRPPDVL--FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
            Y  P+VL   G   Y  ++D WS G I   +  +G P F        LK          
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPFSEHRTQVSLK---------D 236
Query: 207 EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
           + T    N +P               +V  +++ K  DL+++LLV +P  R + E+A+ H
Sbjct: 237 QITSGKYNFIP---------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 281
Query: 267 IYFSDLNVAIK 277
            +  D ++  K
Sbjct: 282 PWLQDEDMKRK 292

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 31/222 (13%)
Query: 5   GVDR-TPN--TALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLT 60
           G+D+  PN  T +A+K       E   S  + E+ ++K + KHKNI+ L      +  L 
Sbjct: 44  GLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 103
Query: 61  LVFEHCDQ-DLKKYFD-------------SLNGEIDL---DIVKSFMYQLLRGLAFCHSR 103
           ++ E+  + +L++Y               S N E  L   D+V S  YQ+ RG+ +  S+
Sbjct: 104 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV-SCAYQVARGMEYLASK 162
Query: 104 NVLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
             +HRDL  +N+L+ ++  +K+ADFGLAR         K  +  +   W   P+ LF  +
Sbjct: 163 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-R 220
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
           +YT   D+WS G +  E+   G   +PG  V++    +FKLL
Sbjct: 221 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----LFKLL 258

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 113/251 (45%), Gaps = 36/251 (14%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLD--IVKSFMY 91
           EI +LK+L H  I+++ +   +E    +V E  +    + FD + G   L     K + Y
Sbjct: 64  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGG--ELFDKVVGNKRLKEATCKLYFY 120
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVKCYSAEVVTL 148
           Q+L  + + H   ++HRDLKP+N+L++   E   +K+ DFG ++  G           T 
Sbjct: 121 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTP 179
Query: 149 WYRPPDVL--FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
            Y  P+VL   G   Y  ++D WS G I   +  +G P F        LK          
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPFSEHRTQVSLK---------D 229
Query: 207 EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
           + T    N +P               +V  +++ K  DL+++LLV +P  R + E+A+ H
Sbjct: 230 QITSGKYNFIP---------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 274
Query: 267 IYFSDLNVAIK 277
            +  D ++  K
Sbjct: 275 PWLQDEDMKRK 285

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 115/247 (46%), Gaps = 46/247 (18%)
Query: 37  LLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLNGEIDL--DIVKSFMYQL 93
           +L E+ H  IV+L+    +E KL L+ +     DL   F  L+ E+    + VK ++ +L
Sbjct: 80  ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYLAEL 136
Query: 94  LRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR-AFGIPVKCYSAEVVTLWYRP 152
              L   HS  +++RDLKP+N+L+++ G +KL DFGL++ +     K YS    T+ Y  
Sbjct: 137 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF-CGTVEYMA 195
Query: 153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL-LGTPTEDTWP 211
           P+V+   + +T S D WS G +  E+     P F G D  + +  I K  LG        
Sbjct: 196 PEVV-NRRGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKETMTMILKAKLG-------- 245
Query: 212 GMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA-----EDAMSH 266
               +P F                  L+ + + LL+ L   NP  R+ A     E+   H
Sbjct: 246 ----MPQF------------------LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 283
Query: 267 IYFSDLN 273
            +FS ++
Sbjct: 284 SFFSTID 290

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 113/251 (45%), Gaps = 36/251 (14%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLD--IVKSFMY 91
           EI +LK+L H  I+++ +   +E    +V E  +    + FD + G   L     K + Y
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGG--ELFDKVVGNKRLKEATCKLYFY 121
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVKCYSAEVVTL 148
           Q+L  + + H   ++HRDLKP+N+L++   E   +K+ DFG ++  G           T 
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTP 180
Query: 149 WYRPPDVL--FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
            Y  P+VL   G   Y  ++D WS G I   +  +G P F        LK          
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPFSEHRTQVSLK---------D 230
Query: 207 EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
           + T    N +P               +V  +++ K  DL+++LLV +P  R + E+A+ H
Sbjct: 231 QITSGKYNFIP---------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275
Query: 267 IYFSDLNVAIK 277
            +  D ++  K
Sbjct: 276 PWLQDEDMKRK 286

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 77/159 (48%), Gaps = 13/159 (8%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEID-LDIVKSFM 90
           L E  ++K L+H  +V+L+ V+  E    +        L  +  S  G    L  +  F 
Sbjct: 225 LAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 284
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG-IPVKCYSAEVVTLW 149
            Q+  G+AF   RN +HRDL+  N+L++ +   K+ADFGLAR     P+K         W
Sbjct: 285 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPIK---------W 335
Query: 150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
             P  + FG+  +T   D+WS G +  E+   GR  +PG
Sbjct: 336 TAPEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPG 372

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 31/222 (13%)
Query: 5   GVDR-TPN--TALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLT 60
           G+D+  PN  T +A+K       E   S  + E+ ++K + KHKNI+ L      +  L 
Sbjct: 51  GLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 110
Query: 61  LVFEHCDQ-DLKKYFD-------------SLNGEIDL---DIVKSFMYQLLRGLAFCHSR 103
           ++ E+  + +L++Y               S N E  L   D+V S  YQ+ RG+ +  S+
Sbjct: 111 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV-SCAYQVARGMEYLASK 169
Query: 104 NVLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
             +HRDL  +N+L+ ++  +K+ADFGLAR         K  +  +   W   P+ LF  +
Sbjct: 170 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-R 227
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
           +YT   D+WS G +  E+   G   +PG  V++    +FKLL
Sbjct: 228 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----LFKLL 265

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 5   GVDR-TPNTAL--AIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLT 60
           G+D+  P  A+  A+K       E   S  + E+ ++K + KHKNI+ L      +  L 
Sbjct: 58  GIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 117
Query: 61  LVFEHCDQ-DLKKYFDSLNG---EIDLDIVK------------SFMYQLLRGLAFCHSRN 104
           ++ E+  + +L++Y  +      E   DI +            S  YQL RG+ +  S+ 
Sbjct: 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 177
Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAFG---IPVKCYSAEVVTLWYRPPDVLFGAKL 161
            +HRDL  +N+L+ +N  +K+ADFGLAR         K  +  +   W   P+ LF  ++
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWM-APEALFD-RV 235
Query: 162 YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
           YT   D+WS G +  E+   G   +PG  V++    +FKLL
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----LFKLL 272

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 31/222 (13%)
Query: 5   GVDR-TPN--TALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLT 60
           G+D+  PN  T +A+K       E   S  + E+ ++K + KHKNI+ L      +  L 
Sbjct: 92  GLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 151
Query: 61  LVFEHCDQ-DLKKYFD-------------SLNGEIDL---DIVKSFMYQLLRGLAFCHSR 103
           ++ E+  + +L++Y               S N E  L   D+V S  YQ+ RG+ +  S+
Sbjct: 152 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV-SCAYQVARGMEYLASK 210
Query: 104 NVLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
             +HRDL  +N+L+ ++  +K+ADFGLAR         K  +  +   W   P+ LF  +
Sbjct: 211 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-R 268
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
           +YT   D+WS G +  E+   G   +PG  V++    +FKLL
Sbjct: 269 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----LFKLL 306

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 31/222 (13%)
Query: 5   GVDR-TPN--TALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLT 60
           G+D+  PN  T +A+K       E   S  + E+ ++K + KHKNI+ L      +  L 
Sbjct: 40  GLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 99
Query: 61  LVFEHCDQ-DLKKYFD-------------SLNGEIDL---DIVKSFMYQLLRGLAFCHSR 103
           ++ E+  + +L++Y               S N E  L   D+V S  YQ+ RG+ +  S+
Sbjct: 100 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV-SCAYQVARGMEYLASK 158
Query: 104 NVLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
             +HRDL  +N+L+ ++  +K+ADFGLAR         K  +  +   W   P+ LF  +
Sbjct: 159 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-R 216
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
           +YT   D+WS G +  E+   G   +PG  V++    +FKLL
Sbjct: 217 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----LFKLL 254

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 31/222 (13%)
Query: 5   GVDR-TPN--TALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLT 60
           G+D+  PN  T +A+K       E   S  + E+ ++K + KHKNI+ L      +  L 
Sbjct: 51  GLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 110
Query: 61  LVFEHCDQ-DLKKYFD-------------SLNGEIDL---DIVKSFMYQLLRGLAFCHSR 103
           ++ E+  + +L++Y               S N E  L   D+V S  YQ+ RG+ +  S+
Sbjct: 111 VIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV-SCAYQVARGMEYLASK 169
Query: 104 NVLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
             +HRDL  +N+L+ ++  +K+ADFGLAR         K  +  +   W   P+ LF  +
Sbjct: 170 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-R 227
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
           +YT   D+WS G +  E+   G   +PG  V++    +FKLL
Sbjct: 228 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----LFKLL 265

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 31/222 (13%)
Query: 5   GVDR-TPN--TALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLT 60
           G+D+  PN  T +A+K       E   S  + E+ ++K + KHKNI+ L      +  L 
Sbjct: 51  GLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 110
Query: 61  LVFEHCDQ-DLKKYFD-------------SLNGEIDL---DIVKSFMYQLLRGLAFCHSR 103
           ++ E+  + +L++Y               S N E  L   D+V S  YQ+ RG+ +  S+
Sbjct: 111 VIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV-SCAYQVARGMEYLASK 169
Query: 104 NVLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
             +HRDL  +N+L+ ++  +K+ADFGLAR         K  +  +   W   P+ LF  +
Sbjct: 170 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-R 227
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
           +YT   D+WS G +  E+   G   +PG  V++    +FKLL
Sbjct: 228 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----LFKLL 265

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 114/254 (44%), Gaps = 37/254 (14%)
Query: 25  EGVPSSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL 83
           E V  +  RE  +L+++  H +I+ L D   S   + LVF+   +   + FD L  ++ L
Sbjct: 140 EEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG--ELFDYLTEKVAL 197
Query: 84  DI--VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
                +S M  LL  ++F H+ N++HRDLKP+N+L++ N +++L+DFG +     P +  
Sbjct: 198 SEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE-PGEKL 256
Query: 142 SAEVVTLWYRPPDVLFGA-----KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
                T  Y  P++L  +       Y   +D+W+ G I   L  AG P F        L+
Sbjct: 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL-AGSPPFWHRRQILMLR 315
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
            I +     +   W                            ++  +DL+ RLL  +P  
Sbjct: 316 MIMEGQYQFSSPEWDDR-------------------------SSTVKDLISRLLQVDPEA 350
Query: 257 RMSAEDAMSHIYFS 270
           R++AE A+ H +F 
Sbjct: 351 RLTAEQALQHPFFE 364

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 113/251 (45%), Gaps = 36/251 (14%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLD--IVKSFMY 91
           EI +LK+L H  I+++ +   +E    +V E  +    + FD + G   L     K + Y
Sbjct: 204 EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGG--ELFDKVVGNKRLKEATCKLYFY 260
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVKCYSAEVVTL 148
           Q+L  + + H   ++HRDLKP+N+L++   E   +K+ DFG ++  G           T 
Sbjct: 261 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTP 319
Query: 149 WYRPPDVL--FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
            Y  P+VL   G   Y  ++D WS G I   +  +G P F        LK          
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPFSEHRTQVSLK---------D 369
Query: 207 EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
           + T    N +P               +V  +++ K  DL+++LLV +P  R + E+A+ H
Sbjct: 370 QITSGKYNFIP---------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 414
Query: 267 IYFSDLNVAIK 277
            +  D ++  K
Sbjct: 415 PWLQDEDMKRK 425

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 31/222 (13%)
Query: 5   GVDR-TPN--TALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLT 60
           G+D+  PN  T +A+K       E   S  + E+ ++K + KHKNI+ L      +  L 
Sbjct: 43  GLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 102
Query: 61  LVFEHCDQ-DLKKYFD-------------SLNGEIDL---DIVKSFMYQLLRGLAFCHSR 103
           ++ E+  + +L++Y               S N E  L   D+V S  YQ+ RG+ +  S+
Sbjct: 103 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV-SCAYQVARGMEYLASK 161
Query: 104 NVLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
             +HRDL  +N+L+ ++  +K+ADFGLAR         K  +  +   W   P+ LF  +
Sbjct: 162 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-R 219
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
           +YT   D+WS G +  E+   G   +PG  V++    +FKLL
Sbjct: 220 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----LFKLL 257

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 5   GVDR-TPNTAL--AIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLT 60
           G+D+  P  A+  A+K       E   S  + E+ ++K + KHKNI+ L      +  L 
Sbjct: 104 GIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 163
Query: 61  LVFEHCDQ-DLKKYFDSLNG---EIDLDIVK------------SFMYQLLRGLAFCHSRN 104
           ++ E+  + +L++Y  +      E   DI +            S  YQL RG+ +  S+ 
Sbjct: 164 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 223
Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAFG---IPVKCYSAEVVTLWYRPPDVLFGAKL 161
            +HRDL  +N+L+ +N  +K+ADFGLAR         K  +  +   W   P+ LF  ++
Sbjct: 224 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM-APEALFD-RV 281
Query: 162 YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
           YT   D+WS G +  E+   G   +PG  V++    +FKLL
Sbjct: 282 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----LFKLL 318

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 113/251 (45%), Gaps = 36/251 (14%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLD--IVKSFMY 91
           EI +LK+L H  I+++ +   +E    +V E  +    + FD + G   L     K + Y
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGG--ELFDKVVGNKRLKEATCKLYFY 246
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVKCYSAEVVTL 148
           Q+L  + + H   ++HRDLKP+N+L++   E   +K+ DFG ++  G           T 
Sbjct: 247 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTP 305
Query: 149 WYRPPDVL--FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
            Y  P+VL   G   Y  ++D WS G I   +  +G P F        LK          
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPFSEHRTQVSLK---------D 355
Query: 207 EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
           + T    N +P               +V  +++ K  DL+++LLV +P  R + E+A+ H
Sbjct: 356 QITSGKYNFIP---------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400
Query: 267 IYFSDLNVAIK 277
            +  D ++  K
Sbjct: 401 PWLQDEDMKRK 411

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 31/222 (13%)
Query: 5   GVDR-TPN--TALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLT 60
           G+D+  PN  T +A+K       E   S  + E+ ++K + KHKNI+ L      +  L 
Sbjct: 36  GLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 95
Query: 61  LVFEHCDQ-DLKKYFD-------------SLNGEIDL---DIVKSFMYQLLRGLAFCHSR 103
           ++ E+  + +L++Y               S N E  L   D+V S  YQ+ RG+ +  S+
Sbjct: 96  VIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV-SCAYQVARGMEYLASK 154
Query: 104 NVLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVKCYSAEVVTLWYRPPDVLFGAK 160
             +HRDL  +N+L+ ++  +K+ADFGLAR         K  +  +   W   P+ LF  +
Sbjct: 155 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-R 212
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
           +YT   D+WS G +  E+   G   +PG  V++    +FKLL
Sbjct: 213 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----LFKLL 250

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 116/250 (46%), Gaps = 46/250 (18%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLNGEIDL--DIVKSFM 90
           E  +L E+ H  IV+L+    +E KL L+ +     DL   F  L+ E+    + VK ++
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYL 132
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR-AFGIPVKCYSAEVVTLW 149
            +L   L   HS  +++RDLKP+N+L+++ G +KL DFGL++ +     K YS    T+ 
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF-CGTVE 191
Query: 150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL-LGTPTED 208
           Y  P+V+   + +T S D WS G +  E+     P F G D  + +  I K  LG     
Sbjct: 192 YMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKETMTMILKAKLG----- 244
Query: 209 TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA-----EDA 263
                  +P F                  L+ + + LL+ L   NP  R+ A     E+ 
Sbjct: 245 -------MPQF------------------LSPEAQSLLRMLFKRNPANRLGAGPDGVEEI 279
Query: 264 MSHIYFSDLN 273
             H +FS ++
Sbjct: 280 KRHSFFSTID 289

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 115/245 (46%), Gaps = 36/245 (14%)
Query: 32  LREICLLKELKH-KNIVRLYDVLHSEKKLTLVFEHC--DQDLKKYFDSLNGEIDLDIVKS 88
           L EI +L+  K    ++ L++V  +  ++ L+ E+    +        L   +  + V  
Sbjct: 76  LHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIR 135
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN---GELKLADFGLARAFGIPVKCYSAEV 145
            + Q+L G+ + H  N++H DLKPQN+L++     G++K+ DFG++R  G    C   E+
Sbjct: 136 LIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA--CELREI 193
Query: 146 V-TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
           + T  Y  P++L    + TT+ DMW+ G I   L     P F G D  +    I ++   
Sbjct: 194 MGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSP-FVGEDNQETYLNISQVNVD 251
Query: 205 PTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAM 264
            +E+T+                   S SQ+A        D +Q LLV NP +R +AE  +
Sbjct: 252 YSEETFS------------------SVSQLAT-------DFIQSLLVKNPEKRPTAEICL 286
Query: 265 SHIYF 269
           SH + 
Sbjct: 287 SHSWL 291

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 5   GVDR-TPNTAL--AIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLT 60
           G+D+  P  A+  A+K       E   S  + E+ ++K + KHKNI+ L      +  L 
Sbjct: 45  GIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 104
Query: 61  LVFEHCDQ-DLKKYFDSLNG---EIDLDIVK------------SFMYQLLRGLAFCHSRN 104
           ++ E+  + +L++Y  +      E   DI +            S  YQL RG+ +  S+ 
Sbjct: 105 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 164
Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAFG---IPVKCYSAEVVTLWYRPPDVLFGAKL 161
            +HRDL  +N+L+ +N  +K+ADFGLAR         K  +  +   W   P+ LF  ++
Sbjct: 165 CIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM-APEALFD-RV 222
Query: 162 YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
           YT   D+WS G +  E+   G   +PG  V++    +FKLL
Sbjct: 223 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----LFKLL 259

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 5   GVDR-TPNTAL--AIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLT 60
           G+D+  P  A+  A+K       E   S  + E+ ++K + KHKNI+ L      +  L 
Sbjct: 58  GIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLY 117
Query: 61  LVFEHCDQ-DLKKYFDSLNG---EIDLDIVK------------SFMYQLLRGLAFCHSRN 104
           ++ E+  + +L++Y  +      E   DI +            S  YQL RG+ +  S+ 
Sbjct: 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 177
Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAFG---IPVKCYSAEVVTLWYRPPDVLFGAKL 161
            +HRDL  +N+L+ +N  +K+ADFGLAR         K  +  +   W   P+ LF  ++
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM-APEALFD-RV 235
Query: 162 YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
           YT   D+WS G +  E+   G   +PG  V++    +FKLL
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----LFKLL 272

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 5   GVDR-TPNTAL--AIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLT 60
           G+D+  P  A+  A+K       E   S  + E+ ++K + KHKNI+ L      +  L 
Sbjct: 47  GIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 106
Query: 61  LVFEHCDQ-DLKKYFDSLNG---EIDLDIVK------------SFMYQLLRGLAFCHSRN 104
           ++ E+  + +L++Y  +      E   DI +            S  YQL RG+ +  S+ 
Sbjct: 107 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 166
Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAFG---IPVKCYSAEVVTLWYRPPDVLFGAKL 161
            +HRDL  +N+L+ +N  +K+ADFGLAR         K  +  +   W   P+ LF  ++
Sbjct: 167 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM-APEALFD-RV 224
Query: 162 YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
           YT   D+WS G +  E+   G   +PG  V++    +FKLL
Sbjct: 225 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----LFKLL 261

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 121/261 (46%), Gaps = 39/261 (14%)
Query: 29  SSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN-GEIDLDIV 86
           S A RE+ LL+E  +H N++R +      +   +  E C   L++Y +  +   + L+ +
Sbjct: 62  SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPI 121
Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELK--LADFGLARAFGIPVKCY 141
            + + Q   GLA  HS N++HRDLKP N+LI   N +G++K  ++DFGL +   +    +
Sbjct: 122 -TLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF 180
Query: 142 SAEV----VTLWYRPPDVLFGAKLYTT-SIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           S          W  P  +    K   T ++D++SAGC+F  + + G   F G  +  Q  
Sbjct: 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF-GKSLQRQAN 239
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
               LLG  + D                 HP      +A       R+L+++++  +P +
Sbjct: 240 ---ILLGACSLDCL---------------HPEKHEDVIA-------RELIEKMIAMDPQK 274
Query: 257 RMSAEDAMSHIYFSDLNVAIK 277
           R SA+  + H +F  L   ++
Sbjct: 275 RPSAKHVLKHPFFWSLEKQLQ 295

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 5   GVDR-TPNTAL--AIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLT 60
           G+D+  P  A+  A+K       E   S  + E+ ++K + KHKNI+ L      +  L 
Sbjct: 50  GIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 109
Query: 61  LVFEHCDQ-DLKKYFDSLNG---EIDLDIVK------------SFMYQLLRGLAFCHSRN 104
           ++ E+  + +L++Y  +      E   DI +            S  YQL RG+ +  S+ 
Sbjct: 110 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 169
Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAFG---IPVKCYSAEVVTLWYRPPDVLFGAKL 161
            +HRDL  +N+L+ +N  +K+ADFGLAR         K  +  +   W   P+ LF  ++
Sbjct: 170 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM-APEALFD-RV 227
Query: 162 YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
           YT   D+WS G +  E+   G   +PG  V++    +FKLL
Sbjct: 228 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----LFKLL 264

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 5   GVDR-TPNTAL--AIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLT 60
           G+D+  P  A+  A+K       E   S  + E+ ++K + KHKNI+ L      +  L 
Sbjct: 58  GIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 117
Query: 61  LVFEHCDQ-DLKKYFDSLNG---EIDLDIVK------------SFMYQLLRGLAFCHSRN 104
           ++ E+  + +L++Y  +      E   DI +            S  YQL RG+ +  S+ 
Sbjct: 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 177
Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAFG---IPVKCYSAEVVTLWYRPPDVLFGAKL 161
            +HRDL  +N+L+ +N  +K+ADFGLAR         K  +  +   W   P+ LF  ++
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM-APEALFD-RV 235
Query: 162 YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
           YT   D+WS G +  E+   G   +PG  V++    +FKLL
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----LFKLL 272

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 124/274 (45%), Gaps = 45/274 (16%)
Query: 7   DRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF--- 63
           D+     +AIK       EG   S   EI +L ++KH NIV L D+  S   L L+    
Sbjct: 39  DKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 98
Query: 64  ---EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLL---I 117
              E  D+ ++K F +   E D       ++Q+L  + + H   ++HRDLKP+NLL   +
Sbjct: 99  SGGELFDRIVEKGFYT---ERD---ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL 152
Query: 118 NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAE 177
           +++ ++ ++DFGL++    P    S    T  Y  P+VL   K Y+ ++D WS G I A 
Sbjct: 153 DEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVL-AQKPYSKAVDCWSIGVI-AY 209
Query: 178 LANAGRPLFPGSDVDDQLKRIF-KLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP 236
           +   G P F     D+   ++F ++L    E   P  + + D                  
Sbjct: 210 ILLCGYPPF----YDENDAKLFEQILKAEYEFDSPYWDDISD------------------ 247
Query: 237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
                 +D ++ L+  +P +R + E A+ H + +
Sbjct: 248 ----SAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 5   GVDR-TPNTAL--AIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLT 60
           G+D+  P  A+  A+K       E   S  + E+ ++K + KHKNI+ L      +  L 
Sbjct: 58  GIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLY 117
Query: 61  LVFEHCDQ-DLKKYFDSLNG---EIDLDIVK------------SFMYQLLRGLAFCHSRN 104
           ++ E+  + +L++Y  +      E   DI +            S  YQL RG+ +  S+ 
Sbjct: 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 177
Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAFG---IPVKCYSAEVVTLWYRPPDVLFGAKL 161
            +HRDL  +N+L+ +N  +K+ADFGLAR         K  +  +   W   P+ LF  ++
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM-APEALFD-RV 235
Query: 162 YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
           YT   D+WS G +  E+   G   +PG  V++    +FKLL
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----LFKLL 272

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 120/273 (43%), Gaps = 43/273 (15%)
Query: 7   DRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF--- 63
           D+     +AIK       EG   S   EI +L ++KH NIV L D+  S   L L+    
Sbjct: 39  DKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 98
Query: 64  ---EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLL---I 117
              E  D+ ++K F +   E D       ++Q+L  + + H   ++HRDLKP+NLL   +
Sbjct: 99  SGGELFDRIVEKGFYT---ERD---ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL 152
Query: 118 NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAE 177
           +++ ++ ++DFGL++    P    S    T  Y  P+VL   K Y+ ++D WS G I   
Sbjct: 153 DEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVL-AQKPYSKAVDCWSIGVIAYI 210
Query: 178 LANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK 237
           L     P +  +D     K   ++L    E   P  + + D                   
Sbjct: 211 LLCGYPPFYDENDA----KLFEQILKAEYEFDSPYWDDISD------------------- 247
Query: 238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
                +D ++ L+  +P +R + E A+ H + +
Sbjct: 248 ---SAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 120/273 (43%), Gaps = 43/273 (15%)
Query: 7   DRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF--- 63
           D+     +AIK       EG   S   EI +L ++KH NIV L D+  S   L L+    
Sbjct: 39  DKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 98
Query: 64  ---EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLL---I 117
              E  D+ ++K F +   E D       ++Q+L  + + H   ++HRDLKP+NLL   +
Sbjct: 99  SGGELFDRIVEKGFYT---ERD---ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL 152
Query: 118 NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAE 177
           +++ ++ ++DFGL++    P    S    T  Y  P+VL   K Y+ ++D WS G I   
Sbjct: 153 DEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVL-AQKPYSKAVDCWSIGVIAYI 210
Query: 178 LANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK 237
           L     P +  +D     K   ++L    E   P  + + D                   
Sbjct: 211 LLCGYPPFYDENDA----KLFEQILKAEYEFDSPYWDDISD------------------- 247
Query: 238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
                +D ++ L+  +P +R + E A+ H + +
Sbjct: 248 ---SAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 106/243 (43%), Gaps = 43/243 (17%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL--NGEIDLDIVKSFM 90
           REI  LK  +H +I++LY V+ +     +V E+      + FD +  +G ++    +   
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGG--ELFDYICKHGRVEEMEARRLF 117
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG----IPVKCYSAEVV 146
            Q+L  + +CH   V+HRDLKP+N+L++ +   K+ADFGL+        +   C S    
Sbjct: 118 QQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPN-- 175
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
              Y  P+V+ G       +D+WS G I   L     P       D+ +  +FK +    
Sbjct: 176 ---YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF-----DDEHVPTLFKKIRG-- 225
Query: 207 EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                G+  +P++                  L      LL  +L  +P++R + +D   H
Sbjct: 226 -----GVFYIPEY------------------LNRSVATLLMHMLQVDPLKRATIKDIREH 262
Query: 267 IYF 269
            +F
Sbjct: 263 EWF 265

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 126/273 (46%), Gaps = 43/273 (15%)
Query: 7   DRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF--- 63
           D+     +AIK       EG   S   EI +L ++KH NIV L D+  S   L L+    
Sbjct: 39  DKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 98
Query: 64  ---EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLL---I 117
              E  D+ ++K F +   E D       ++Q+L  + + H   ++HRDLKP+NLL   +
Sbjct: 99  SGGELFDRIVEKGFYT---ERD---ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL 152
Query: 118 NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAE 177
           +++ ++ ++DFGL++    P    S    T  Y  P+VL   K Y+ ++D WS G I A 
Sbjct: 153 DEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVL-AQKPYSKAVDCWSIGVI-AY 209
Query: 178 LANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK 237
           +   G P F     D+   ++F+ +            L  +++    Y   +S S     
Sbjct: 210 ILLCGYPPF----YDENDAKLFEQI------------LKAEYEFDSPYWDDISDS----- 248
Query: 238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
                +D ++ L+  +P +R + E A+ H + +
Sbjct: 249 ----AKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 116/261 (44%), Gaps = 34/261 (13%)
Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY 73
           A+K   ++ ++ V  + + +  L    +H  +  ++    +++ L  V E+ +  DL  +
Sbjct: 49  ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYH 108
Query: 74  FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARA 133
             S + + DL     +  +++ GL F HS+ +++RDLK  N+L++K+G +K+ADFG+ + 
Sbjct: 109 IQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167
Query: 134 FGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDD 193
             +     +    T  Y  P++L G K Y  S+D WS G +  E+     P F G D ++
Sbjct: 168 NMLGDAKTNXFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSP-FHGQDEEE 225
Query: 194 QLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCN 253
               I   +  P    W                           L  + +DLL +L V  
Sbjct: 226 LFHSI--RMDNPFYPRW---------------------------LEKEAKDLLVKLFVRE 256
Query: 254 PVQRMSAE-DAMSHIYFSDLN 273
           P +R+    D   H  F ++N
Sbjct: 257 PEKRLGVRGDIRQHPLFREIN 277

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 116/261 (44%), Gaps = 34/261 (13%)
Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY 73
           A+K   ++ ++ V  + + +  L    +H  +  ++    +++ L  V E+ +  DL  +
Sbjct: 50  ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYH 109
Query: 74  FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARA 133
             S + + DL     +  +++ GL F HS+ +++RDLK  N+L++K+G +K+ADFG+ + 
Sbjct: 110 IQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 168
Query: 134 FGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDD 193
             +     +    T  Y  P++L G K Y  S+D WS G +  E+     P F G D ++
Sbjct: 169 NMLGDAKTNEFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSP-FHGQDEEE 226
Query: 194 QLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCN 253
               I   +  P    W                           L  + +DLL +L V  
Sbjct: 227 LFHSI--RMDNPFYPRW---------------------------LEKEAKDLLVKLFVRE 257
Query: 254 PVQRMSAE-DAMSHIYFSDLN 273
           P +R+    D   H  F ++N
Sbjct: 258 PEKRLGVRGDIRQHPLFREIN 278

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 12/178 (6%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEID-LDIVKSFM 90
           L E  ++K L+H  +V+L+ V+  E    +        L  +  S  G    L  +  F 
Sbjct: 58  LAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 117
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS----AEVV 146
            Q+  G+AF   RN +HRDL+  N+L++ +   K+ADFGLAR   I    Y+    A+  
Sbjct: 118 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFP 175
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKRIFKL 201
             W  P  + FG+  +T   D+WS G +  E+   GR  +PG    +V   L+R +++
Sbjct: 176 IKWTAPEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM 231

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 5   GVDR-TPNTAL--AIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLT 60
           G+D+  P  A+  A+K       E   S  + E+ ++K + KHKNI+ L      +  L 
Sbjct: 58  GIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 117
Query: 61  LVFEHCDQ-DLKKYFDSLNG---EIDLDIVK------------SFMYQLLRGLAFCHSRN 104
           ++ E+  + +L++Y  +      E   DI +            S  YQL RG+ +  S+ 
Sbjct: 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 177
Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAFG---IPVKCYSAEVVTLWYRPPDVLFGAKL 161
            +HRDL  +N+L+ +N  +++ADFGLAR         K  +  +   W   P+ LF  ++
Sbjct: 178 CIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWM-APEALFD-RV 235
Query: 162 YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
           YT   D+WS G +  E+   G   +PG  V++    +FKLL
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----LFKLL 272

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 79/162 (48%), Gaps = 9/162 (5%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEID-LDIVKSFM 90
           L E  ++K L+H  +V+L+ V+  E    +        L  +  S  G    L  +  F 
Sbjct: 231 LAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 290
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS----AEVV 146
            Q+  G+AF   RN +HRDL+  N+L++ +   K+ADFGLAR   I    Y+    A+  
Sbjct: 291 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFP 348
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
             W  P  + FG+  +T   D+WS G +  E+   GR  +PG
Sbjct: 349 IKWTAPEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPG 388

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 116/250 (46%), Gaps = 56/250 (22%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL--DIVKSFM 90
           RE+ +LKE++H N++ L++V  ++  + L+ E       + FD L  +  L  +    F+
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGG--ELFDFLAEKESLTEEEATEFL 120
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQN-LLINKN---GELKLADFGLARA----------FGI 136
            Q+L G+ + HS  + H DLKP+N +L+++N     +K+ DFGLA            FG 
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           P +  + E+V   Y P  +           DMWS G I   L +   P            
Sbjct: 181 P-EFVAPEIVN--YEPLGL---------EADMWSIGVITYILLSGASP------------ 216
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
                LG   ++T   ++ + +++    Y  + S         A  +D ++RLLV +P +
Sbjct: 217 ----FLGDTKQETLANVSAV-NYEFEDEYFSNTS---------ALAKDFIRRLLVKDPKK 262
Query: 257 RMSAEDAMSH 266
           RM+ +D++ H
Sbjct: 263 RMTIQDSLQH 272

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 108/230 (46%), Gaps = 47/230 (20%)
Query: 5   GVDR-TPNTAL--AIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLT 60
           G+D+  P  A+  A+K       E   S  + E+ ++K + KHKNI+ L      +  L 
Sbjct: 58  GIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 117
Query: 61  LVFEHCDQ-DLKKYFDSLNG---EIDLDIVK------------SFMYQLLRGLAFCHSRN 104
           ++ E+  + +L++Y  +      E   DI +            S  YQL RG+ +  S+ 
Sbjct: 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 177
Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAFG------------IPVKCYSAEVVTLWYRP 152
            +HRDL  +N+L+ +N  +K+ADFGLAR               +PVK          +  
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVK----------WMA 227
Query: 153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
           P+ LF  ++YT   D+WS G +  E+   G   +PG  V++    +FKLL
Sbjct: 228 PEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----LFKLL 272

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 116/250 (46%), Gaps = 56/250 (22%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL--DIVKSFM 90
           RE+ +LKE++H N++ L++V  ++  + L+ E       + FD L  +  L  +    F+
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGG--ELFDFLAEKESLTEEEATEFL 120
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQN-LLINKN---GELKLADFGLARA----------FGI 136
            Q+L G+ + HS  + H DLKP+N +L+++N     +K+ DFGLA            FG 
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           P +  + E+V   Y P  +           DMWS G I   L +   P            
Sbjct: 181 P-EFVAPEIVN--YEPLGL---------EADMWSIGVITYILLSGASP------------ 216
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
                LG   ++T   ++ + +++    Y  + S         A  +D ++RLLV +P +
Sbjct: 217 ----FLGDTKQETLANVSAV-NYEFEDEYFSNTS---------ALAKDFIRRLLVKDPKK 262
Query: 257 RMSAEDAMSH 266
           RM+ +D++ H
Sbjct: 263 RMTIQDSLQH 272

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 116/250 (46%), Gaps = 56/250 (22%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL--DIVKSFM 90
           RE+ +LKE++H N++ L++V  ++  + L+ E       + FD L  +  L  +    F+
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGG--ELFDFLAEKESLTEEEATEFL 120
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQN-LLINKN---GELKLADFGLARA----------FGI 136
            Q+L G+ + HS  + H DLKP+N +L+++N     +K+ DFGLA            FG 
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           P +  + E+V   Y P  +           DMWS G I   L +   P            
Sbjct: 181 P-EFVAPEIVN--YEPLGL---------EADMWSIGVITYILLSGASP------------ 216
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
                LG   ++T   ++ + +++    Y  + S         A  +D ++RLLV +P +
Sbjct: 217 ----FLGDTKQETLANVSAV-NYEFEDEYFSNTS---------ALAKDFIRRLLVKDPKK 262
Query: 257 RMSAEDAMSH 266
           RM+ +D++ H
Sbjct: 263 RMTIQDSLQH 272

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 116/250 (46%), Gaps = 56/250 (22%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL--DIVKSFM 90
           RE+ +LKE++H N++ L++V  ++  + L+ E       + FD L  +  L  +    F+
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGG--ELFDFLAEKESLTEEEATEFL 119
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQN-LLINKN---GELKLADFGLARA----------FGI 136
            Q+L G+ + HS  + H DLKP+N +L+++N     +K+ DFGLA            FG 
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 179
Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           P +  + E+V   Y P  +           DMWS G I   L +   P            
Sbjct: 180 P-EFVAPEIVN--YEPLGL---------EADMWSIGVITYILLSGASP------------ 215
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
                LG   ++T   ++ + +++    Y  + S         A  +D ++RLLV +P +
Sbjct: 216 ----FLGDTKQETLANVSAV-NYEFEDEYFSNTS---------ALAKDFIRRLLVKDPKK 261
Query: 257 RMSAEDAMSH 266
           RM+ +D++ H
Sbjct: 262 RMTIQDSLQH 271

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 116/250 (46%), Gaps = 56/250 (22%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL--DIVKSFM 90
           RE+ +LKE++H N++ L++V  ++  + L+ E       + FD L  +  L  +    F+
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGG--ELFDFLAEKESLTEEEATEFL 119
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQN-LLINKN---GELKLADFGLARA----------FGI 136
            Q+L G+ + HS  + H DLKP+N +L+++N     +K+ DFGLA            FG 
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 179
Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           P +  + E+V   Y P  +           DMWS G I   L +   P            
Sbjct: 180 P-EFVAPEIVN--YEPLGL---------EADMWSIGVITYILLSGASP------------ 215
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
                LG   ++T   ++ + +++    Y  + S         A  +D ++RLLV +P +
Sbjct: 216 ----FLGDTKQETLANVSAV-NYEFEDEYFSNTS---------ALAKDFIRRLLVKDPKK 261
Query: 257 RMSAEDAMSH 266
           RM+ +D++ H
Sbjct: 262 RMTIQDSLQH 271

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 116/250 (46%), Gaps = 56/250 (22%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL--DIVKSFM 90
           RE+ +LKE++H N++ L++V  ++  + L+ E       + FD L  +  L  +    F+
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGG--ELFDFLAEKESLTEEEATEFL 120
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQN-LLINKN---GELKLADFGLARA----------FGI 136
            Q+L G+ + HS  + H DLKP+N +L+++N     +K+ DFGLA            FG 
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           P +  + E+V   Y P  +           DMWS G I   L +   P            
Sbjct: 181 P-EFVAPEIVN--YEPLGL---------EADMWSIGVITYILLSGASP------------ 216
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
                LG   ++T   ++ + +++    Y  + S         A  +D ++RLLV +P +
Sbjct: 217 ----FLGDTKQETLANVSAV-NYEFEDEYFSNTS---------ALAKDFIRRLLVKDPKK 262
Query: 257 RMSAEDAMSH 266
           RM+ +D++ H
Sbjct: 263 RMTIQDSLQH 272

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 116/250 (46%), Gaps = 56/250 (22%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL--DIVKSFM 90
           RE+ +LKE++H N++ L++V  ++  + L+ E       + FD L  +  L  +    F+
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGG--ELFDFLAEKESLTEEEATEFL 120
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQN-LLINKN---GELKLADFGLARA----------FGI 136
            Q+L G+ + HS  + H DLKP+N +L+++N     +K+ DFGLA            FG 
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           P +  + E+V   Y P  +           DMWS G I   L +   P            
Sbjct: 181 P-EFVAPEIVN--YEPLGL---------EADMWSIGVITYILLSGASP------------ 216
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
                LG   ++T   ++ + +++    Y  + S         A  +D ++RLLV +P +
Sbjct: 217 ----FLGDTKQETLANVSAV-NYEFEDEYFSNTS---------ALAKDFIRRLLVKDPKK 262
Query: 257 RMSAEDAMSH 266
           RM+ +D++ H
Sbjct: 263 RMTIQDSLQH 272

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 116/250 (46%), Gaps = 56/250 (22%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL--DIVKSFM 90
           RE+ +LKE++H N++ L++V  ++  + L+ E       + FD L  +  L  +    F+
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGG--ELFDFLAEKESLTEEEATEFL 120
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQN-LLINKN---GELKLADFGLARA----------FGI 136
            Q+L G+ + HS  + H DLKP+N +L+++N     +K+ DFGLA            FG 
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           P +  + E+V   Y P  +           DMWS G I   L +   P            
Sbjct: 181 P-EFVAPEIVN--YEPLGL---------EADMWSIGVITYILLSGASP------------ 216
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
                LG   ++T   ++ + +++    Y  + S         A  +D ++RLLV +P +
Sbjct: 217 ----FLGDTKQETLANVSAV-NYEFEDEYFSNTS---------ALAKDFIRRLLVKDPKK 262
Query: 257 RMSAEDAMSH 266
           RM+ +D++ H
Sbjct: 263 RMTIQDSLQH 272

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/265 (24%), Positives = 112/265 (42%), Gaps = 40/265 (15%)
Query: 16  IKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFD 75
           +K   +V N    +    E  +L+E+KH  IV L     +  KL L+ E+      + F 
Sbjct: 53  LKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGG--ELFM 110
Query: 76  SLNGEIDL--DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARA 133
            L  E     D    ++ ++   L   H + +++RDLKP+N+++N  G +KL DFGL + 
Sbjct: 111 QLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170
Query: 134 FGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDD 193
                        T+ Y  P++L  +  +  ++D WS G +  ++   G P F G +   
Sbjct: 171 SIHDGTVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLT-GAPPFTGENRKK 228
Query: 194 QLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCN 253
            + +I K            +NL                    P LT + RDLL++LL  N
Sbjct: 229 TIDKILKC----------KLNL-------------------PPYLTQEARDLLKKLLKRN 259
Query: 254 PVQRMS-----AEDAMSHIYFSDLN 273
              R+      A +  +H +F  +N
Sbjct: 260 AASRLGAGPGDAGEVQAHPFFRHIN 284

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 116/250 (46%), Gaps = 56/250 (22%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL--DIVKSFM 90
           RE+ +LKE++H N++ L++V  ++  + L+ E       + FD L  +  L  +    F+
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGG--ELFDFLAEKESLTEEEATEFL 120
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQN-LLINKN---GELKLADFGLARA----------FGI 136
            Q+L G+ + HS  + H DLKP+N +L+++N     +K+ DFGLA            FG 
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           P +  + E+V   Y P  +           DMWS G I   L +   P            
Sbjct: 181 P-EFVAPEIVN--YEPLGL---------EADMWSIGVITYILLSGASP------------ 216
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
                LG   ++T   ++ + +++    Y  + S         A  +D ++RLLV +P +
Sbjct: 217 ----FLGDTKQETLANVSAV-NYEFEDEYFSNTS---------ALAKDFIRRLLVKDPKK 262
Query: 257 RMSAEDAMSH 266
           RM+ +D++ H
Sbjct: 263 RMTIQDSLQH 272

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 116/250 (46%), Gaps = 56/250 (22%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL--DIVKSFM 90
           RE+ +LKE++H N++ L++V  ++  + L+ E       + FD L  +  L  +    F+
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGG--ELFDFLAEKESLTEEEATEFL 120
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQN-LLINKN---GELKLADFGLARA----------FGI 136
            Q+L G+ + HS  + H DLKP+N +L+++N     +K+ DFGLA            FG 
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           P +  + E+V   Y P  +           DMWS G I   L +   P            
Sbjct: 181 P-EFVAPEIVN--YEPLGL---------EADMWSIGVITYILLSGASP------------ 216
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
                LG   ++T   ++ + +++    Y  + S         A  +D ++RLLV +P +
Sbjct: 217 ----FLGDTKQETLANVSAV-NYEFEDEYFSNTS---------ALAKDFIRRLLVKDPKK 262
Query: 257 RMSAEDAMSH 266
           RM+ +D++ H
Sbjct: 263 RMTIQDSLQH 272

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 116/250 (46%), Gaps = 56/250 (22%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL--DIVKSFM 90
           RE+ +LKE++H N++ L++V  ++  + L+ E       + FD L  +  L  +    F+
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGG--ELFDFLAEKESLTEEEATEFL 120
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQN-LLINKN---GELKLADFGLARA----------FGI 136
            Q+L G+ + HS  + H DLKP+N +L+++N     +K+ DFGLA            FG 
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           P +  + E+V   Y P  +           DMWS G I   L +   P            
Sbjct: 181 P-EFVAPEIVN--YEPLGL---------EADMWSIGVITYILLSGASP------------ 216
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
                LG   ++T   ++ + +++    Y  + S         A  +D ++RLLV +P +
Sbjct: 217 ----FLGDTKQETLANVSAV-NYEFEDEYFSNTS---------ALAKDFIRRLLVKDPKK 262
Query: 257 RMSAEDAMSH 266
           RM+ +D++ H
Sbjct: 263 RMTIQDSLQH 272

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 112/251 (44%), Gaps = 58/251 (23%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL--DIVKSFM 90
           RE+ +L+E++H NI+ L+D+  ++  + L+ E       + FD L  +  L  D    F+
Sbjct: 57  REVNILREIRHPNIITLHDIFENKTDVVLILELVSGG--ELFDFLAEKESLTEDEATQFL 114
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQN-LLINK---NGELKLADFGLARA----------FGI 136
            Q+L G+ + HS+ + H DLKP+N +L++K   N  +KL DFG+A            FG 
Sbjct: 115 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGT 174
Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           P +  + E+V   Y P  +           DMWS G I   L +   P            
Sbjct: 175 P-EFVAPEIVN--YEPLGL---------EADMWSIGVITYILLSGASP------------ 210
Query: 197 RIFKLLGTPTEDTWPGMNLLP-DFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPV 255
                LG   ++T   ++ +  DF             +     +   +D ++RLLV +P 
Sbjct: 211 ----FLGETKQETLTNISAVNYDFD-----------EEYFSNTSELAKDFIRRLLVKDPK 255
Query: 256 QRMSAEDAMSH 266
           +RM+   ++ H
Sbjct: 256 RRMTIAQSLEH 266

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/265 (24%), Positives = 112/265 (42%), Gaps = 40/265 (15%)
Query: 16  IKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFD 75
           +K   +V N    +    E  +L+E+KH  IV L     +  KL L+ E+      + F 
Sbjct: 53  LKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGG--ELFM 110
Query: 76  SLNGEIDL--DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARA 133
            L  E     D    ++ ++   L   H + +++RDLKP+N+++N  G +KL DFGL + 
Sbjct: 111 QLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170
Query: 134 FGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDD 193
                        T+ Y  P++L  +  +  ++D WS G +  ++   G P F G +   
Sbjct: 171 SIHDGTVTHXFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLT-GAPPFTGENRKK 228
Query: 194 QLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCN 253
            + +I K            +NL                    P LT + RDLL++LL  N
Sbjct: 229 TIDKILKC----------KLNL-------------------PPYLTQEARDLLKKLLKRN 259
Query: 254 PVQRMS-----AEDAMSHIYFSDLN 273
              R+      A +  +H +F  +N
Sbjct: 260 AASRLGAGPGDAGEVQAHPFFRHIN 284

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 6/157 (3%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY 91
           ++E+  L++L+H N ++       E    LV E+C        +     +    + +  +
Sbjct: 102 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH 161
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYR 151
             L+GLA+ HS N++HRD+K  N+L+++ G +KL DFG A     P   +   V T ++ 
Sbjct: 162 GALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-PANXF---VGTPYWM 217
Query: 152 PPDVLFG--AKLYTTSIDMWSAGCIFAELANAGRPLF 186
            P+V+       Y   +D+WS G    ELA    PLF
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 254

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 116/250 (46%), Gaps = 56/250 (22%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL--DIVKSFM 90
           RE+ +LKE++H N++ L++V  ++  + L+ E       + FD L  +  L  +    F+
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGG--ELFDFLAEKESLTEEEATEFL 120
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQN-LLINKN---GELKLADFGLARA----------FGI 136
            Q+L G+ + HS  + H DLKP+N +L+++N     +K+ DFGLA            FG 
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           P +  + E+V   Y P  +           DMWS G I   L +   P            
Sbjct: 181 P-EFVAPEIVN--YEPLGL---------EADMWSIGVITYILLSGASP------------ 216
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
                LG   ++T   ++ + +++    Y  + S         A  +D ++RLLV +P +
Sbjct: 217 ----FLGDTKQETLANVSAV-NYEFEDEYFSNTS---------ALAKDFIRRLLVKDPKK 262
Query: 257 RMSAEDAMSH 266
           RM+ +D++ H
Sbjct: 263 RMTIQDSLQH 272

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 112/257 (43%), Gaps = 43/257 (16%)
Query: 29  SSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDI-- 85
            + L+E+ +L+++  H NI++L D   +     LVF+   +   + FD L  ++ L    
Sbjct: 68  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG--ELFDYLTEKVTLSEKE 125
Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEV 145
            +  M  LL  +   H  N++HRDLKP+N+L++ +  +KL DFG +     P +   +  
Sbjct: 126 TRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLRSVC 184
Query: 146 VTLWYRPPDVLFGA-----KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
            T  Y  P+++  +       Y   +DMWS G I   L  AG P F        L+ I  
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL-AGSPPFWHRKQMLMLRMIMS 243
Query: 201 ---LLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQR 257
                G+P  D +                            +   +DL+ R LV  P +R
Sbjct: 244 GNYQFGSPEWDDY----------------------------SDTVKDLVSRFLVVQPQKR 275
Query: 258 MSAEDAMSHIYFSDLNV 274
            +AE+A++H +F    V
Sbjct: 276 YTAEEALAHPFFQQYVV 292

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 115/250 (46%), Gaps = 56/250 (22%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL--DIVKSFM 90
           RE+ +LKE++H N++ L++V  ++  + L+ E       + FD L  +  L  +    F+
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGG--ELFDFLAEKESLTEEEATEFL 120
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQN-LLINKN---GELKLADFGLARA----------FGI 136
            Q+L G+ + HS  + H DLKP+N +L+++N     +K+ DFGLA            FG 
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           P    + E+V   Y P  +           DMWS G I   L +   P            
Sbjct: 181 PA-FVAPEIVN--YEPLGL---------EADMWSIGVITYILLSGASP------------ 216
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
                LG   ++T   ++ + +++    Y  + S         A  +D ++RLLV +P +
Sbjct: 217 ----FLGDTKQETLANVSAV-NYEFEDEYFSNTS---------ALAKDFIRRLLVKDPKK 262
Query: 257 RMSAEDAMSH 266
           RM+ +D++ H
Sbjct: 263 RMTIQDSLQH 272

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 112/265 (42%), Gaps = 29/265 (10%)
Query: 7   DRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC 66
           D+     +A+K  ++     +  +  REI   + L+H NIVR  +V+ +   L ++ E+ 
Sbjct: 41  DKLTKELVAVK--YIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98
Query: 67  DQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN--GELK 124
                       G    D  + F  QLL G+++CHS  + HRDLK +N L++ +    LK
Sbjct: 99  SGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLK 158
Query: 125 LADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRP 184
           + DFG +++  +  +  S  V T  Y  P+VL   +      D+WS G     +     P
Sbjct: 159 ICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
Query: 185 LFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRD 244
                +  D  K I ++L             +PD                  +++ +   
Sbjct: 218 FEDPEEPRDYRKTIQRILSVKYS--------IPD----------------DIRISPECCH 253
Query: 245 LLQRLLVCNPVQRMSAEDAMSHIYF 269
           L+ R+ V +P  R+S  +  +H +F
Sbjct: 254 LISRIFVADPATRISIPEIKTHSWF 278

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 111/251 (44%), Gaps = 58/251 (23%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL--DIVKSFM 90
           RE+ +L+E++H NI+ L+D+  ++  + L+ E       + FD L  +  L  D    F+
Sbjct: 64  REVNILREIRHPNIITLHDIFENKTDVVLILELVSGG--ELFDFLAEKESLTEDEATQFL 121
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQN-LLINK---NGELKLADFGLARA----------FGI 136
            Q+L G+ + HS+ + H DLKP+N +L++K   N  +KL DFG+A            FG 
Sbjct: 122 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGT 181
Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           P +  + E+V   Y P  +           DMWS G I   L +   P            
Sbjct: 182 P-EFVAPEIVN--YEPLGL---------EADMWSIGVITYILLSGASP------------ 217
Query: 197 RIFKLLGTPTEDTWPGMNLLP-DFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPV 255
                LG   ++T   ++ +  DF             +     +   +D ++RLLV +P 
Sbjct: 218 ----FLGETKQETLTNISAVNYDFD-----------EEYFSNTSELAKDFIRRLLVKDPK 262
Query: 256 QRMSAEDAMSH 266
           +RM    ++ H
Sbjct: 263 RRMXIAQSLEH 273

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 86/181 (47%), Gaps = 4/181 (2%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
           G+D      +AIK   L   E       +EI +L +     + + Y     + KL ++ E
Sbjct: 46  GIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 105
Query: 65  HCDQDLKKYFDSLN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL 123
           +         D L  G +D   + + + ++L+GL + HS   +HRD+K  N+L++++GE+
Sbjct: 106 YLGGG--SALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEV 163
Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           KLADFG+A          +  V T ++  P+V+     Y +  D+WS G    ELA    
Sbjct: 164 KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELARGEP 222
Query: 184 P 184
           P
Sbjct: 223 P 223

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 6/157 (3%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY 91
           ++E+  L++L+H N ++       E    LV E+C        +     +    + +  +
Sbjct: 63  IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH 122
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYR 151
             L+GLA+ HS N++HRD+K  N+L+++ G +KL DFG A     P   +   V T ++ 
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-PANXF---VGTPYWM 178
Query: 152 PPDVLFGAK--LYTTSIDMWSAGCIFAELANAGRPLF 186
            P+V+       Y   +D+WS G    ELA    PLF
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 111/251 (44%), Gaps = 58/251 (23%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL--DIVKSFM 90
           RE+ +L+E++H NI+ L+D+  ++  + L+ E       + FD L  +  L  D    F+
Sbjct: 78  REVNILREIRHPNIITLHDIFENKTDVVLILELVSGG--ELFDFLAEKESLTEDEATQFL 135
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQN-LLINK---NGELKLADFGLARA----------FGI 136
            Q+L G+ + HS+ + H DLKP+N +L++K   N  +KL DFG+A            FG 
Sbjct: 136 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGT 195
Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           P +  + E+V   Y P  +           DMWS G I   L +   P            
Sbjct: 196 P-EFVAPEIVN--YEPLGL---------EADMWSIGVITYILLSGASP------------ 231
Query: 197 RIFKLLGTPTEDTWPGMNLLP-DFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPV 255
                LG   ++T   ++ +  DF             +     +   +D ++RLLV +P 
Sbjct: 232 ----FLGETKQETLTNISAVNYDFD-----------EEYFSNTSELAKDFIRRLLVKDPK 276
Query: 256 QRMSAEDAMSH 266
           +RM    ++ H
Sbjct: 277 RRMXIAQSLEH 287

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 113/248 (45%), Gaps = 39/248 (15%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-----DLKKYFDSLNGEIDLDIVK 87
           RE  +   LKH +IV L +   S+  L +VFE  D      ++ K  D+  G +  + V 
Sbjct: 77  REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADA--GFVYSEAVA 134
Query: 88  S-FMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVKCYSA 143
           S +M Q+L  L +CH  N++HRD+KP  +L+     +  +KL  FG+A   G        
Sbjct: 135 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 194
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
            V T  +  P+V+   + Y   +D+W  G I   L +   P +   +      R+F+ + 
Sbjct: 195 RVGTPHFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTKE------RLFEGI- 246
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
                      +   +K  P     +S S          +DL++R+L+ +P +R++  +A
Sbjct: 247 -----------IKGKYKMNPRQWSHISES---------AKDLVRRMLMLDPAERITVYEA 286
Query: 264 MSHIYFSD 271
           ++H +  +
Sbjct: 287 LNHPWLKE 294

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           L+E  ++KE+KH N+V+L  V   E    +V E+    +L  Y    N E    +V  +M
Sbjct: 76  LKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYM 135
Query: 91  -YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYSAEVVTL 148
             Q+   + +   +N +HRDL  +N L+ +N  +K+ADFGL+R   G     ++     +
Sbjct: 136 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPI 195
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
            +  P+ L     ++   D+W+ G +  E+A  G   +PG D    L +++ LL
Sbjct: 196 KWTAPESL-AYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYDLL 244

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 86/181 (47%), Gaps = 4/181 (2%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
           G+D      +AIK   L   E       +EI +L +     + + Y     + KL ++ E
Sbjct: 26  GIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 85
Query: 65  HCDQDLKKYFDSLN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL 123
           +         D L  G +D   + + + ++L+GL + HS   +HRD+K  N+L++++GE+
Sbjct: 86  YLGGG--SALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEV 143
Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           KLADFG+A          +  V T ++  P+V+     Y +  D+WS G    ELA    
Sbjct: 144 KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELARGEP 202
Query: 184 P 184
           P
Sbjct: 203 P 203

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 29/221 (13%)
Query: 5   GVDR-TPNTAL--AIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLT 60
           G+D+  P  A+  A+K       E   S  + E+ ++K + KHKNI+ L      +  L 
Sbjct: 58  GIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 117
Query: 61  LVFEHCDQ-DLKKYFDSLNG---EIDLDIVK------------SFMYQLLRGLAFCHSRN 104
           ++  +  + +L++Y  +      E   DI +            S  YQL RG+ +  S+ 
Sbjct: 118 VIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 177
Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAFG---IPVKCYSAEVVTLWYRPPDVLFGAKL 161
            +HRDL  +N+L+ +N  +K+ADFGLAR         K  +  +   W   P+ LF  ++
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM-APEALFD-RV 235
Query: 162 YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
           YT   D+WS G +  E+   G   +PG  V++    +FKLL
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----LFKLL 272

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 111/257 (43%), Gaps = 43/257 (16%)
Query: 29  SSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDI-- 85
            + L+E+ +L+++  H NI++L D   +     LVF+   +   + FD L  ++ L    
Sbjct: 68  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG--ELFDYLTEKVTLSEKE 125
Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEV 145
            +  M  LL  +   H  N++HRDLKP+N+L++ +  +KL DFG +     P +      
Sbjct: 126 TRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLREVC 184
Query: 146 VTLWYRPPDVLFGAKL-----YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
            T  Y  P+++  +       Y   +DMWS G I   L  AG P F        L+ I  
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL-AGSPPFWHRKQMLMLRMIMS 243
Query: 201 ---LLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQR 257
                G+P  D +                            +   +DL+ R LV  P +R
Sbjct: 244 GNYQFGSPEWDDY----------------------------SDTVKDLVSRFLVVQPQKR 275
Query: 258 MSAEDAMSHIYFSDLNV 274
            +AE+A++H +F    V
Sbjct: 276 YTAEEALAHPFFQQYVV 292

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 86/181 (47%), Gaps = 4/181 (2%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
           G+D      +AIK   L   E       +EI +L +     + + Y     + KL ++ E
Sbjct: 41  GIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100
Query: 65  HCDQDLKKYFDSLN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL 123
           +         D L  G +D   + + + ++L+GL + HS   +HRD+K  N+L++++GE+
Sbjct: 101 YLGGG--SALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEV 158
Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           KLADFG+A          +  V T ++  P+V+     Y +  D+WS G    ELA    
Sbjct: 159 KLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELARGEP 217
Query: 184 P 184
           P
Sbjct: 218 P 218

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 86/181 (47%), Gaps = 4/181 (2%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
           G+D      +AIK   L   E       +EI +L +     + + Y     + KL ++ E
Sbjct: 26  GIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 85
Query: 65  HCDQDLKKYFDSLN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL 123
           +         D L  G +D   + + + ++L+GL + HS   +HRD+K  N+L++++GE+
Sbjct: 86  YLGGG--SALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEV 143
Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           KLADFG+A          +  V T ++  P+V+     Y +  D+WS G    ELA    
Sbjct: 144 KLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELARGEP 202
Query: 184 P 184
           P
Sbjct: 203 P 203

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 116/250 (46%), Gaps = 56/250 (22%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL--DIVKSFM 90
           RE+ +LKE++H N++ L++V  ++  + L+ E       + FD L  +  L  +    F+
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILIGELVAGG--ELFDFLAEKESLTEEEATEFL 120
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQN-LLINKN---GELKLADFGLARA----------FGI 136
            Q+L G+ + HS  + H DLKP+N +L+++N     +K+ DFGLA            FG 
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           P +  + E+V   Y P  +           DMWS G I   L +   P            
Sbjct: 181 P-EFVAPEIVN--YEPLGL---------EADMWSIGVITYILLSGASP------------ 216
Query: 197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
                LG   ++T   ++ + +++    Y  + S         A  +D ++RLLV +P +
Sbjct: 217 ----FLGDTKQETLANVSAV-NYEFEDEYFSNTS---------ALAKDFIRRLLVKDPKK 262
Query: 257 RMSAEDAMSH 266
           RM+ +D++ H
Sbjct: 263 RMTIQDSLQH 272

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 113/248 (45%), Gaps = 39/248 (15%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-----DLKKYFDSLNGEIDLDIVK 87
           RE  +   LKH +IV L +   S+  L +VFE  D      ++ K  D+  G +  + V 
Sbjct: 75  REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADA--GFVYSEAVA 132
Query: 88  S-FMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVKCYSA 143
           S +M Q+L  L +CH  N++HRD+KP  +L+     +  +KL  FG+A   G        
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 192
Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
            V T  +  P+V+   + Y   +D+W  G I   L +   P +   +      R+F+ + 
Sbjct: 193 RVGTPHFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTKE------RLFEGI- 244
Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
                      +   +K  P     +S S          +DL++R+L+ +P +R++  +A
Sbjct: 245 -----------IKGKYKMNPRQWSHISES---------AKDLVRRMLMLDPAERITVYEA 284
Query: 264 MSHIYFSD 271
           ++H +  +
Sbjct: 285 LNHPWLKE 292

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 110/253 (43%), Gaps = 43/253 (16%)
Query: 29  SSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDI-- 85
            + L+E+ +L+++  H NI++L D   +     LVF+   +   + FD L  ++ L    
Sbjct: 55  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG--ELFDYLTEKVTLSEKE 112
Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEV 145
            +  M  LL  +   H  N++HRDLKP+N+L++ +  +KL DFG +     P +      
Sbjct: 113 TRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLREVC 171
Query: 146 VTLWYRPPDVLFGAKL-----YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
            T  Y  P+++  +       Y   +DMWS G I   L  AG P F        L+ I  
Sbjct: 172 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL-AGSPPFWHRKQMLMLRMIMS 230
Query: 201 ---LLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQR 257
                G+P  D +                            +   +DL+ R LV  P +R
Sbjct: 231 GNYQFGSPEWDDY----------------------------SDTVKDLVSRFLVVQPQKR 262
Query: 258 MSAEDAMSHIYFS 270
            +AE+A++H +F 
Sbjct: 263 YTAEEALAHPFFQ 275

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/237 (22%), Positives = 110/237 (46%), Gaps = 29/237 (12%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQL 93
           E+ ++++ +H+N+V +Y+      +L +V E  +        + +  ++ + + +    +
Sbjct: 198 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAV 256
Query: 94  LRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP 153
           L+ L+  H++ V+HRD+K  ++L+  +G +KL+DFG        V      V T ++  P
Sbjct: 257 LQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP 316
Query: 154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGM 213
           + L     Y   +D+WS G +  E+ +   P F     ++   +  K++           
Sbjct: 317 E-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYF-----NEPPLKAMKMIRD--------- 361
Query: 214 NLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
           NL P  K         +  +V+P L    +  L RLLV +P QR +A + + H + +
Sbjct: 362 NLPPRLK---------NLHKVSPSL----KGFLDRLLVRDPAQRATAAELLKHPFLA 405

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 29/221 (13%)
Query: 5   GVDR-TPNTAL--AIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLT 60
           G+D+  P  A+  A+K       E   S  + E+ ++K + KHKNI+ L      +  L 
Sbjct: 58  GIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 117
Query: 61  LVFEHCDQ-DLKKYFDSLNG---EIDLDIVK------------SFMYQLLRGLAFCHSRN 104
           ++  +  + +L++Y  +      E   DI +            S  YQL RG+ +  S+ 
Sbjct: 118 VIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 177
Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAFG---IPVKCYSAEVVTLWYRPPDVLFGAKL 161
            +HRDL  +N+L+ +N  +K+ADFGLAR         K  +  +   W   P+ LF  ++
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM-APEALFD-RV 235
Query: 162 YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
           YT   D+WS G +  E+   G   +PG  V++    +FKLL
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----LFKLL 272

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-GEIDLDIVKSF 89
           L+E  ++KE+KH N+V+L  V   E    ++ E     +L  Y    N  E++  ++   
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYSAEVVTL 148
             Q+   + +   +N +HRDL  +N L+ +N  +K+ADFGL+R   G     ++     +
Sbjct: 122 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 181
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
            +  P+ L   K    S D+W+ G +  E+A  G   +PG D    L ++++LL
Sbjct: 182 KWTAPESLAYNKFSIKS-DVWAFGVLLWEIATYGMSPYPGID----LSQVYELL 230

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/237 (22%), Positives = 110/237 (46%), Gaps = 29/237 (12%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQL 93
           E+ ++++ +H+N+V +Y+      +L +V E  +        + +  ++ + + +    +
Sbjct: 121 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAV 179
Query: 94  LRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP 153
           L+ L+  H++ V+HRD+K  ++L+  +G +KL+DFG        V      V T ++  P
Sbjct: 180 LQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP 239
Query: 154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGM 213
           + L     Y   +D+WS G +  E+ +   P F     ++   +  K++           
Sbjct: 240 E-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYF-----NEPPLKAMKMIRD--------- 284
Query: 214 NLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
           NL P  K         +  +V+P L    +  L RLLV +P QR +A + + H + +
Sbjct: 285 NLPPRLK---------NLHKVSPSL----KGFLDRLLVRDPAQRATAAELLKHPFLA 328

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-GEIDLDIVKSF 89
           L+E  ++KE+KH N+V+L  V   E    ++ E     +L  Y    N  E++  ++   
Sbjct: 58  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYM 117
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYSAEVVTL 148
             Q+   + +   +N +HRDL  +N L+ +N  +K+ADFGL+R   G     ++     +
Sbjct: 118 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 177
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
            +  P+ L   K    S D+W+ G +  E+A  G   +PG D    L ++++LL
Sbjct: 178 KWTAPESLAYNKFSIKS-DVWAFGVLLWEIATYGMSPYPGID----LSQVYELL 226

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 84/178 (47%), Gaps = 28/178 (15%)
Query: 29  SSALREICLLKELKHKNIVRLYDV----------LHSEKKLTLVF---EHCD-QDLKKYF 74
           S+ L E+ LL  L H+ +VR Y            + + KK + +F   E+C+ + L    
Sbjct: 47  STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLI 106
Query: 75  DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA--- 131
            S N     D       Q+L  L++ HS+ ++HRDLKP N+ I+++  +K+ DFGLA   
Sbjct: 107 HSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166
Query: 132 -RAFGI----------PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
            R+  I               ++ + T  Y   +VL G   Y   IDM+S G IF E+
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/238 (22%), Positives = 108/238 (45%), Gaps = 31/238 (13%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQL 93
           E+ ++++ +H+N+V +Y+      +L +V E  +        + +  ++ + + +    +
Sbjct: 71  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAV 129
Query: 94  LRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP 153
           L+ L+  H++ V+HRD+K  ++L+  +G +KL+DFG        V      V T ++  P
Sbjct: 130 LQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP 189
Query: 154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGM 213
           + L     Y   +D+WS G +  E+ +   P F                    E     M
Sbjct: 190 E-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYF-------------------NEPPLKAM 229
Query: 214 NLLPDFKPFPMYHPSM-SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++ D  P     P + +  +V+P L    +  L RLLV +P QR +A + + H + +
Sbjct: 230 KMIRDNLP-----PRLKNLHKVSPSL----KGFLDRLLVRDPAQRATAAELLKHPFLA 278

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/238 (22%), Positives = 108/238 (45%), Gaps = 31/238 (13%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQL 93
           E+ ++++ +H+N+V +Y+      +L +V E  +        + +  ++ + + +    +
Sbjct: 78  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAV 136
Query: 94  LRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP 153
           L+ L+  H++ V+HRD+K  ++L+  +G +KL+DFG        V      V T ++  P
Sbjct: 137 LQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP 196
Query: 154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGM 213
           + L     Y   +D+WS G +  E+ +   P F                    E     M
Sbjct: 197 E-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYF-------------------NEPPLKAM 236
Query: 214 NLLPDFKPFPMYHPSM-SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++ D  P     P + +  +V+P L    +  L RLLV +P QR +A + + H + +
Sbjct: 237 KMIRDNLP-----PRLKNLHKVSPSL----KGFLDRLLVRDPAQRATAAELLKHPFLA 285

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 83/178 (46%), Gaps = 28/178 (15%)
Query: 29  SSALREICLLKELKHKNIVRLYDV----------LHSEKKLTLVF---EHCDQ-DLKKYF 74
           S+ L E+ LL  L H+ +VR Y            + + KK + +F   E+C+   L    
Sbjct: 47  STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI 106
Query: 75  DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA--- 131
            S N     D       Q+L  L++ HS+ ++HRDLKP N+ I+++  +K+ DFGLA   
Sbjct: 107 HSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166
Query: 132 -RAFGI----------PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
            R+  I               ++ + T  Y   +VL G   Y   IDM+S G IF E+
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/238 (22%), Positives = 108/238 (45%), Gaps = 31/238 (13%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQL 93
           E+ ++++ +H+N+V +Y+      +L +V E  +        + +  ++ + + +    +
Sbjct: 67  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAV 125
Query: 94  LRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP 153
           L+ L+  H++ V+HRD+K  ++L+  +G +KL+DFG        V      V T ++  P
Sbjct: 126 LQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP 185
Query: 154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGM 213
           + L     Y   +D+WS G +  E+ +   P F                    E     M
Sbjct: 186 E-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYF-------------------NEPPLKAM 225
Query: 214 NLLPDFKPFPMYHPSM-SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++ D  P     P + +  +V+P L    +  L RLLV +P QR +A + + H + +
Sbjct: 226 KMIRDNLP-----PRLKNLHKVSPSL----KGFLDRLLVRDPAQRATAAELLKHPFLA 274

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/238 (22%), Positives = 108/238 (45%), Gaps = 31/238 (13%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQL 93
           E+ ++++ +H+N+V +Y+      +L +V E  +        + +  ++ + + +    +
Sbjct: 76  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAV 134
Query: 94  LRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP 153
           L+ L+  H++ V+HRD+K  ++L+  +G +KL+DFG        V      V T ++  P
Sbjct: 135 LQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP 194
Query: 154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGM 213
           + L     Y   +D+WS G +  E+ +   P F                    E     M
Sbjct: 195 E-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYF-------------------NEPPLKAM 234
Query: 214 NLLPDFKPFPMYHPSM-SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
            ++ D  P     P + +  +V+P L    +  L RLLV +P QR +A + + H + +
Sbjct: 235 KMIRDNLP-----PRLKNLHKVSPSL----KGFLDRLLVRDPAQRATAAELLKHPFLA 283

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-GEIDLDIVKSF 89
           L+E  ++KE+KH N+V+L  V   E    ++ E     +L  Y    N  E++  ++   
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYSAEVVTL 148
             Q+   + +   +N +HRDL  +N L+ +N  +K+ADFGL+R   G     ++     +
Sbjct: 122 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 181
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
            +  P+ L   K    S D+W+ G +  E+A  G   +PG D    L ++++LL
Sbjct: 182 KWTAPESLAYNKFSIKS-DVWAFGVLLWEIATYGMSPYPGID----LSQVYELL 230

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 115/259 (44%), Gaps = 49/259 (18%)
Query: 29  SSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF------EHCDQDLKKYFDSLNGEID 82
           SS   EI +LK++KH+NIV L D+  S     LV       E  D+ L++    +  E D
Sbjct: 51  SSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER---GVYTEKD 107
Query: 83  LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVK 139
             +V   + Q+L  + + H   ++HRDLKP+NLL     +N ++ + DFGL++     + 
Sbjct: 108 ASLV---IQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI- 163
Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD--DQLKR 197
             S    T  Y  P+VL   K Y+ ++D WS G I   L     P +  ++    +++K 
Sbjct: 164 -MSTACGTPGYVAPEVL-AQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE 221
Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQR 257
            +    +P  D                             ++   +D +  LL  +P +R
Sbjct: 222 GYYEFESPFWD----------------------------DISESAKDFICHLLEKDPNER 253
Query: 258 MSAEDAMSHIYFSDLNVAI 276
            + E A+SH +  D N A+
Sbjct: 254 YTCEKALSHPWI-DGNTAL 271

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-GEIDLDIVKSF 89
           L+E  ++KE+KH N+V+L  V   E    ++ E     +L  Y    N  E++  ++   
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYSAEVVTL 148
             Q+   + +   +N +HRDL  +N L+ +N  +K+ADFGL+R   G     ++     +
Sbjct: 122 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 181
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
            +  P+ L   K    S D+W+ G +  E+A  G   +PG D    L ++++LL
Sbjct: 182 KWTAPESLAYNKFSIKS-DVWAFGVLLWEIATYGMSPYPGID----LSQVYELL 230

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-GEIDLDIVKSF 89
           L+E  ++KE+KH N+V+L  V   E    ++ E     +L  Y    N  E++  ++   
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYSAEVVTL 148
             Q+   + +   +N +HRDL  +N L+ +N  +K+ADFGL+R   G     ++     +
Sbjct: 122 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 181
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
            +  P+ L   K    S D+W+ G +  E+A  G   +PG D    L ++++LL
Sbjct: 182 KWTAPESLAYNKFSIKS-DVWAFGVLLWEIATYGMSPYPGID----LSQVYELL 230

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-GEIDLDIVKSF 89
           L+E  ++KE+KH N+V+L  V   E    ++ E     +L  Y    N  E++  ++   
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 120
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYSAEVVTL 148
             Q+   + +   +N +HRDL  +N L+ +N  +K+ADFGL+R   G     ++     +
Sbjct: 121 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
            +  P+ L   K    S D+W+ G +  E+A  G   +PG D    L ++++LL
Sbjct: 181 KWTAPESLAYNKFSIKS-DVWAFGVLLWEIATYGMSPYPGID----LSQVYELL 229

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 130/306 (42%), Gaps = 59/306 (19%)
Query: 21  LVGNEGVPSSALR-EICLLKELKHKN------IVRLYDVLHSEKKLTLVFEHCDQDLKKY 73
           ++ N G    A R EI +LK++K K+       V + D  +    + + FE   ++  ++
Sbjct: 52  IIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEF 111
Query: 74  FDSLNGE-IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLL-IN------------- 118
               N +   L  V+   YQL   L F H   + H DLKP+N+L +N             
Sbjct: 112 LKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC 171
Query: 119 -----KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
                KN  +++ADFG A       + ++  V T  YRPP+V+     +    D+WS GC
Sbjct: 172 EEKSVKNTSIRVADFGSA---TFDHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGC 227
Query: 174 IFAELANAGRPLFPGSDVDDQLKRIFKLLG-TPT--------------------EDTWPG 212
           I  E    G  LF   +  + L  + K+LG  P+                    E++  G
Sbjct: 228 ILFEYYR-GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDG 286
Query: 213 MNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
             +  + KP   Y    S   V      +  DL++R+L  +P QR++  +A+ H +F+ L
Sbjct: 287 RYVKENCKPLKSYMLQDSLEHV------QLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340
Query: 273 NVAIKS 278
               +S
Sbjct: 341 TPEERS 346

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 130/306 (42%), Gaps = 59/306 (19%)
Query: 21  LVGNEGVPSSALR-EICLLKELKHKN------IVRLYDVLHSEKKLTLVFEHCDQDLKKY 73
           ++ N G    A R EI +LK++K K+       V + D  +    + + FE   ++  ++
Sbjct: 61  IIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEF 120
Query: 74  FDSLNGE-IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLL-IN------------- 118
               N +   L  V+   YQL   L F H   + H DLKP+N+L +N             
Sbjct: 121 LKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC 180
Query: 119 -----KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
                KN  +++ADFG A       + ++  V T  YRPP+V+     +    D+WS GC
Sbjct: 181 EEKSVKNTSIRVADFGSA---TFDHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGC 236
Query: 174 IFAELANAGRPLFPGSDVDDQLKRIFKLLG-TPT--------------------EDTWPG 212
           I  E    G  LF   +  + L  + K+LG  P+                    E++  G
Sbjct: 237 ILFEYYR-GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDG 295
Query: 213 MNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
             +  + KP   Y    S   V      +  DL++R+L  +P QR++  +A+ H +F+ L
Sbjct: 296 RYVKENCKPLKSYMLQDSLEHV------QLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 349
Query: 273 NVAIKS 278
               +S
Sbjct: 350 TPEERS 355

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 82/161 (50%), Gaps = 8/161 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSFM 90
           L E  ++ +  H NI+RL  V+   K + ++ E+ +   L K+    +GE  +  +   +
Sbjct: 94  LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 153
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYS---AEVV 146
             +  G+ +  + N +HRDL  +N+L+N N   K++DFGL+R     P   Y+    ++ 
Sbjct: 154 RGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 213
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPLF 186
             W  P  + +  + +T++ D+WS G +  E+   G RP +
Sbjct: 214 IRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYW 252

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 22  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +     G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 82  DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNXGVLHRDIKDEN 140
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 141 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 198
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 199 LLYDMVCGDIPF 210

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 130/306 (42%), Gaps = 59/306 (19%)
Query: 21  LVGNEGVPSSALR-EICLLKELKHKN------IVRLYDVLHSEKKLTLVFEHCDQDLKKY 73
           ++ N G    A R EI +LK++K K+       V + D  +    + + FE   ++  ++
Sbjct: 84  IIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEF 143
Query: 74  FDSLNGE-IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLL-IN------------- 118
               N +   L  V+   YQL   L F H   + H DLKP+N+L +N             
Sbjct: 144 LKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC 203
Query: 119 -----KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
                KN  +++ADFG A       + ++  V T  YRPP+V+     +    D+WS GC
Sbjct: 204 EEKSVKNTSIRVADFGSA---TFDHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGC 259
Query: 174 IFAELANAGRPLFPGSDVDDQLKRIFKLLG-TPT--------------------EDTWPG 212
           I  E    G  LF   +  + L  + K+LG  P+                    E++  G
Sbjct: 260 ILFEYYR-GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDG 318
Query: 213 MNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
             +  + KP   Y    S   V      +  DL++R+L  +P QR++  +A+ H +F+ L
Sbjct: 319 RYVKENCKPLKSYMLQDSLEHV------QLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 372
Query: 273 NVAIKS 278
               +S
Sbjct: 373 TPEERS 378

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 106/246 (43%), Gaps = 42/246 (17%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC------DQDLKKYFDSLNGEIDLDIVK 87
           EI +L  L H NI++L ++  +  +++LV E        D+ ++K + S     D     
Sbjct: 98  EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA---- 153
Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK---NGELKLADFGLARAFGIPVKCYSAE 144
             + Q+L  +A+ H   ++HRDLKP+NLL      +  LK+ADFGL++     V   +  
Sbjct: 154 --VKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV- 210
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
             T  Y  P++L G   Y   +DMWS G I   L     P +         +RI      
Sbjct: 211 CGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY 269
Query: 205 PTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAM 264
                W  ++L                           +DL+++L+V +P +R++   A+
Sbjct: 270 FISPWWDEVSL-------------------------NAKDLVRKLIVLDPKKRLTTFQAL 304
Query: 265 SHIYFS 270
            H + +
Sbjct: 305 QHPWVT 310

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 86/174 (49%), Gaps = 8/174 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-GEIDLDIVKSF 89
           L+E  ++KE+KH N+V+L  V   E    ++ E     +L  Y    N  E+   ++   
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYSAEVVTL 148
             Q+   + +   +N +HRDL  +N L+ +N  +K+ADFGL+R   G     ++     +
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
            +  P+ L   K    S D+W+ G +  E+A  G   +PG D    L ++++LL
Sbjct: 177 KWTAPESLAYNKFSIKS-DVWAFGVLLWEIATYGMSPYPGID----LSQVYELL 225

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-GEIDLDIVKSF 89
           L+E  ++KE+KH N+V+L  V   E    ++ E     +L  Y    N  E++  ++   
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 116
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYSAEVVTL 148
             Q+   + +   +N +HRDL  +N L+ +N  +K+ADFGL+R   G     ++     +
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
            +  P+ L   K    S D+W+ G +  E+A  G   +PG D    L ++++LL
Sbjct: 177 KWTAPESLAYNKFSIKS-DVWAFGVLLWEIATYGMSPYPGID----LSQVYELL 225

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 126/253 (49%), Gaps = 24/253 (9%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD----LKKYFDSLNGE----IDLDI 85
           E+ ++ ++K++  +    ++ +  ++ +++E+ + D      +YF  L+      I + +
Sbjct: 93  ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 86  VKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE 144
           +K  +  +L   ++ H+ +N+ HRD+KP N+L++KNG +KL+DFG +    +  K     
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEY--MVDKKIKGS 210
Query: 145 VVTLWYRPPDVLFGAKLYT-TSIDMWSAG-CIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
             T  + PP+       Y    +D+WS G C++    N    + P S +   L  +F  +
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN----VVPFS-LKISLVELFNNI 265
Query: 203 GTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAED 262
            T   + +P   L  +   +P+ +   + S     L+ +  D L+  L  NP +R+++ED
Sbjct: 266 RTKNIE-YP---LDRNHFLYPLTNKKSTCSNNF--LSNEDIDFLKLFLRKNPAERITSED 319
Query: 263 AMSHIYFSDLNVA 275
           A+ H + +D N+ 
Sbjct: 320 ALKHEWLADTNIE 332

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-GEIDLDIVKSF 89
           L+E  ++KE+KH N+V+L  V   E    ++ E     +L  Y    N  E++  ++   
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 116
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYSAEVVTL 148
             Q+   + +   +N +HRDL  +N L+ +N  +K+ADFGL+R   G     ++     +
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
            +  P+ L   K    S D+W+ G +  E+A  G   +PG D    L ++++LL
Sbjct: 177 KWTAPESLAYNKFSIKS-DVWAFGVLLWEIATYGMSPYPGID----LSQVYELL 225

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 86/174 (49%), Gaps = 8/174 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-GEIDLDIVKSF 89
           L+E  ++KE+KH N+V+L  V   E    ++ E     +L  Y    N  E+   ++   
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYSAEVVTL 148
             Q+   + +   +N +HRDL  +N L+ +N  +K+ADFGL+R   G     ++     +
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
            +  P+ L   K    S D+W+ G +  E+A  G   +PG D    L ++++LL
Sbjct: 177 KWTAPESLAYNKFSIKS-DVWAFGVLLWEIATYGMSPYPGID----LSQVYELL 225

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-GEIDLDIVKSF 89
           L+E  ++KE+KH N+V+L  V   E    ++ E     +L  Y    N  E++  ++   
Sbjct: 59  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 118
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYSAEVVTL 148
             Q+   + +   +N +HRDL  +N L+ +N  +K+ADFGL+R   G     ++     +
Sbjct: 119 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 178
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
            +  P+ L   K    S D+W+ G +  E+A  G   +PG D    L ++++LL
Sbjct: 179 KWTAPESLAYNKFSIKS-DVWAFGVLLWEIATYGMSPYPGID----LSQVYELL 227

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-GEIDLDIVKSF 89
           L+E  ++KE+KH N+V+L  V   E    ++ E     +L  Y    N  E++  ++   
Sbjct: 59  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 118
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYSAEVVTL 148
             Q+   + +   +N +HRDL  +N L+ +N  +K+ADFGL+R   G     ++     +
Sbjct: 119 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 178
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
            +  P+ L   K    S D+W+ G +  E+A  G   +PG D    L ++++LL
Sbjct: 179 KWTAPESLAYNKFSIKS-DVWAFGVLLWEIATYGMSPYPGID----LSQVYELL 227

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-GEIDLDIVKSF 89
           L+E  ++KE+KH N+V+L  V   E    ++ E     +L  Y    N  E++  ++   
Sbjct: 70  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 129
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYSAEVVTL 148
             Q+   + +   +N +HRDL  +N L+ +N  +K+ADFGL+R   G     ++     +
Sbjct: 130 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 189
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
            +  P+ L   K    S D+W+ G +  E+A  G   +PG D    L ++++LL
Sbjct: 190 KWTAPESLAYNKFSIKS-DVWAFGVLLWEIATYGMSPYPGID----LSQVYELL 238

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 26  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 85
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +  +  G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 86  DSFVLILERMEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 144
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 145 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 202
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 203 LLYDMVCGDIPF 214

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 114/252 (45%), Gaps = 37/252 (14%)
Query: 25  EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL--NGEID 82
           +G  SS   EI +L+++KH+NIV L D+  S   L LV +       + FD +   G   
Sbjct: 61  KGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGG--ELFDRIVEKGFYT 118
Query: 83  LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVK 139
                + + Q+L  + + H   ++HRDLKP+NLL    ++  ++ ++DFGL++  G    
Sbjct: 119 EKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEG-KGD 177
Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF 199
             S    T  Y  P+VL   K Y+ ++D WS G I A +   G P F     D+   ++F
Sbjct: 178 VMSTACGTPGYVAPEVL-AQKPYSKAVDCWSIGVI-AYILLCGYPPF----YDENDSKLF 231
Query: 200 -KLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
            ++L    E   P  + + D                        +D ++ L+  +P +R 
Sbjct: 232 EQILKAEYEFDSPYWDDISD----------------------SAKDFIRNLMEKDPNKRY 269
Query: 259 SAEDAMSHIYFS 270
           + E A  H + +
Sbjct: 270 TCEQAARHPWIA 281

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 87/178 (48%), Gaps = 16/178 (8%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-GEIDLDIVKSF 89
           L+E  ++KE+KH N+V+L  V   E    ++ E     +L  Y    N  E++  ++   
Sbjct: 58  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 117
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR-----AFGIPVKCYSAE 144
             Q+   + +   +N +HRDL  +N L+ +N  +K+ADFGL+R      +  P     A+
Sbjct: 118 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPA---GAK 174
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
               W  P  + +    ++   D+W+ G +  E+A  G   +PG D    L ++++LL
Sbjct: 175 FPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYELL 226

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 86/174 (49%), Gaps = 8/174 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-GEIDLDIVKSF 89
           L+E  ++KE+KH N+V+L  V   E    ++ E     +L  Y    N  E+   ++   
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 121
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYSAEVVTL 148
             Q+   + +   +N +HRDL  +N L+ +N  +K+ADFGL+R   G     ++     +
Sbjct: 122 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 181
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
            +  P+ L   K    S D+W+ G +  E+A  G   +PG D    L ++++LL
Sbjct: 182 KWTAPESLAYNKFSIKS-DVWAFGVLLWEIATYGMSPYPGID----LSQVYELL 230

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 8/200 (4%)
Query: 4   SGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF 63
           SG  R  NT +A+K         + +  L+E  +LK+  H NIVRL  V   ++ + +V 
Sbjct: 132 SGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191
Query: 64  EHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           E     D   +  +    + +  +   +     G+ +  S+  +HRDL  +N L+ +   
Sbjct: 192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV 251
Query: 123 LKLADFGLARAFGIPVKCYSA---EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELA 179
           LK++DFG++R     V   S    +V   W  P  + +G   Y++  D+WS G +  E  
Sbjct: 252 LKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGR--YSSESDVWSFGILLWETF 309
Query: 180 NAGRPLFPGSDVDDQLKRIF 199
           + G   +P  ++ +Q  R F
Sbjct: 310 SLGASPYP--NLSNQQTREF 327

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 87/178 (48%), Gaps = 16/178 (8%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-GEIDLDIVKSF 89
           L+E  ++KE+KH N+V+L  V   E    ++ E     +L  Y    N  E++  ++   
Sbjct: 59  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 118
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR-----AFGIPVKCYSAE 144
             Q+   + +   +N +HRDL  +N L+ +N  +K+ADFGL+R      +  P     A+
Sbjct: 119 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPA---GAK 175
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
               W  P  + +    ++   D+W+ G +  E+A  G   +PG D    L ++++LL
Sbjct: 176 FPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYELL 227

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 27  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 86
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +  +  G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 87  DSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 145
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 146 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 203
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 204 LLYDMVCGDIPF 215

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 86/174 (49%), Gaps = 8/174 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-GEIDLDIVKSF 89
           L+E  ++KE+KH N+V+L  V   E    ++ E     +L  Y    N  E+   ++   
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYSAEVVTL 148
             Q+   + +   +N +HRDL  +N L+ +N  +K+ADFGL+R   G     ++     +
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
            +  P+ L   K    S D+W+ G +  E+A  G   +PG D    L ++++LL
Sbjct: 177 KWTAPESLAYNKFSIKS-DVWAFGVLLWEIATYGMSPYPGID----LSQVYELL 225

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 54/237 (22%), Positives = 108/237 (45%), Gaps = 31/237 (13%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMY 91
           +EI +L   +H+NI+ L++   S ++L ++FE     D+ +  ++   E++   + S+++
Sbjct: 50  KEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH 109
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLL--INKNGELKLADFGLARAFGIPVKCYSAEVVTLW 149
           Q+   L F HS N+ H D++P+N++    ++  +K+ +FG AR    P   +        
Sbjct: 110 QVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNFRLLFTAPE 168
Query: 150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDT 209
           Y  P+V     + +T+ DMWS G +   L +   P    ++    ++ I     T  E+ 
Sbjct: 169 YYAPEV-HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENIMNAEYTFDEEA 226
Query: 210 WPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
           +                          +++ +  D + RLLV     RM+A +A+ H
Sbjct: 227 F-------------------------KEISIEAMDFVDRLLVKERKSRMTASEALQH 258

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 105/236 (44%), Gaps = 29/236 (12%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           ++EI ++++    ++V+ Y        L +V E+C    +       N  +  D + + +
Sbjct: 72  IKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATIL 131
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWY 150
              L+GL + H    +HRD+K  N+L+N  G  KLADFG+A      +   +  + T ++
Sbjct: 132 QSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFW 191
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTW 210
             P+V+     Y    D+WS G    E+A  G+P  P +D+   ++ IF +   P     
Sbjct: 192 MAPEVIQEIG-YNCVADIWSLGITAIEMAE-GKP--PYADIHP-MRAIFMIPTNPP---- 242
Query: 211 PGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                 P F+   ++  + +             D +++ LV +P QR +A   + H
Sbjct: 243 ------PTFRKPELWSDNFT-------------DFVKQCLVKSPEQRATATQLLQH 279

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 26  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 85
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +  +  G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 86  DSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 144
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 145 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 202
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 203 LLYDMVCGDIPF 214

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 86/174 (49%), Gaps = 8/174 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-GEIDLDIVKSF 89
           L+E  ++KE+KH N+V+L  V   E    ++ E     +L  Y    N  E+   ++   
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYSAEVVTL 148
             Q+   + +   +N +HRDL  +N L+ +N  +K+ADFGL+R   G     ++     +
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
            +  P+ L   K    S D+W+ G +  E+A  G   +PG D    L ++++LL
Sbjct: 177 KWTAPESLAYNKFSIKS-DVWAFGVLLWEIATYGMSPYPGID----LSQVYELL 225

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 27  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 86
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +     G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 87  DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 145
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 146 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 203
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 204 LLYDMVCGDIPF 215

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 38/117 (32%), Positives = 68/117 (58%), Gaps = 3/117 (2%)
Query: 81  IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR-AFGIPVK 139
           I ++ + S+ +Q+ RG+ F  SR  +HRDL  +N+L+++N  +K+ DFGLAR  +  P  
Sbjct: 196 ITMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDY 255
Query: 140 CYSAEV-VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL 195
               +  + L +  P+ +F  K+Y+T  D+WS G +  E+ + G   +PG  +D+  
Sbjct: 256 VRKGDTRLPLKWMAPESIFD-KIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDF 311

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 27  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 86
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +  +  G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 87  DSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 145
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 146 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 203
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 204 LLYDMVCGDIPF 215

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 88/188 (46%), Gaps = 7/188 (3%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
           G+D      +AIK   L   E       +EI +L +     + + Y       KL ++ E
Sbjct: 42  GIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSYLKGSKLWIIME 101
Query: 65  HCDQDLKKYFDSLN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL 123
           +         D L  G  D   + + + ++L+GL + HS   +HRD+K  N+L+++ G++
Sbjct: 102 YLGGG--SALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDV 159
Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           KLADFG+A          +  V T ++  P+V+     Y +  D+WS G    ELA  G 
Sbjct: 160 KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYDSKADIWSLGITAIELAK-GE 217
Query: 184 PLFPGSDV 191
           P  P SD+
Sbjct: 218 P--PNSDM 223

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 42  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 101
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +  +  G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 102 DSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 160
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 161 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 218
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 219 LLYDMVCGDIPF 230

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 41  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 100
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +  +  G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 101 DSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 159
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 160 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 217
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 218 LLYDMVCGDIPF 229

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 22  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +     G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 82  DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 140
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 141 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 198
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 199 LLYDMVCGDIPF 210

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 8/200 (4%)
Query: 4   SGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF 63
           SG  R  NT +A+K         + +  L+E  +LK+  H NIVRL  V   ++ + +V 
Sbjct: 132 SGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191
Query: 64  EHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           E     D   +  +    + +  +   +     G+ +  S+  +HRDL  +N L+ +   
Sbjct: 192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV 251
Query: 123 LKLADFGLARAFGIPVKCYSA---EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELA 179
           LK++DFG++R     V   S    +V   W  P  + +G   Y++  D+WS G +  E  
Sbjct: 252 LKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR--YSSESDVWSFGILLWETF 309
Query: 180 NAGRPLFPGSDVDDQLKRIF 199
           + G   +P  ++ +Q  R F
Sbjct: 310 SLGASPYP--NLSNQQTREF 327

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 25  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 84
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +  +  G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 85  DSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 143
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 144 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 201
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 202 LLYDMVCGDIPF 213

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 55  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 114
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +     G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 115 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 173
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 174 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 231
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 232 LLYDMVCGDIPF 243

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 42  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 101
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +  +  G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 102 DSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 160
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 161 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 218
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 219 LLYDMVCGDIPF 230

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 55  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 114
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +     G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 115 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 173
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 174 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 231
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 232 LLYDMVCGDIPF 243

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 22  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +     G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 82  DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 140
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 141 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 198
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 199 LLYDMVCGDIPF 210

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 61  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +     G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 121 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 179
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 180 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 237
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 238 LLYDMVCGDIPF 249

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 41  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 100
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +  +  G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 101 DSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 159
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 160 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 217
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 218 LLYDMVCGDIPF 229

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 49  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 108
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +     G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 109 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 167
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 168 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 225
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 226 LLYDMVCGDIPF 237

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 54  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 113
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +     G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 114 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 172
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 173 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 230
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 231 LLYDMVCGDIPF 242

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 42  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 101
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +  +  G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 102 DSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 160
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 161 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 218
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 219 LLYDMVCGDIPF 230

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 69  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 128
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +     G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 129 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 187
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 188 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 245
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 246 LLYDMVCGDIPF 257

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 55  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 114
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +     G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 115 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 173
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 174 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 231
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 232 LLYDMVCGDIPF 243

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 54  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 113
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +     G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 114 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 172
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 173 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 230
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 231 LLYDMVCGDIPF 242

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 55  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 114
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +     G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 115 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 173
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 174 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 231
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 232 LLYDMVCGDIPF 243

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 54  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 113
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +     G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 114 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 172
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 173 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 230
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 231 LLYDMVCGDIPF 242

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 69  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 128
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +     G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 129 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 187
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 188 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 245
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 246 LLYDMVCGDIPF 257

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 54  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 113
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +     G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 114 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 172
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 173 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 230
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 231 LLYDMVCGDIPF 242

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 4   SGVDRTPNTALAIKGTH--LVGNEGVPSSALR---EICLLKELKH--KNIVRLYDVLHSE 56
           SG+  + N  +AIK      + + G   +  R   E+ LLK++      ++RL D     
Sbjct: 74  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 133
Query: 57  KKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
               L+ E  +  QDL  +     G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N
Sbjct: 134 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 192
Query: 115 LLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +LI+ N GELKL DFG        V  Y+    T  Y PP+ +   + +  S  +WS G 
Sbjct: 193 ILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 250
Query: 174 IFAELANAGRPL 185
           +  ++     P 
Sbjct: 251 LLYDMVCGDIPF 262

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-GEIDLDIVKSF 89
           L+E  ++KE+KH N+V+L  V   E    ++ E     +L  Y    N  E++  ++   
Sbjct: 303 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 362
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYSAEVVTL 148
             Q+   + +   +N +HR+L  +N L+ +N  +K+ADFGL+R   G     ++     +
Sbjct: 363 ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 422
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
            +  P+ L   K    S D+W+ G +  E+A  G   +PG D    L ++++LL
Sbjct: 423 KWTAPESLAYNKFSIKS-DVWAFGVLLWEIATYGMSPYPGID----LSQVYELL 471

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 106/243 (43%), Gaps = 55/243 (22%)
Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLR----GLAFCH 101
           I+ +Y+ +H  K+  L+   C  +  + F  +    D    +    +++R     + F H
Sbjct: 87  ILDVYENMHHGKRCLLIIMEC-MEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 102 SRNVLHRDLKPQNLLIN---KNGELKLADFGLARAF---GIPVKCYSAEVVTLWYRPPDV 155
           S N+ HRD+KP+NLL     K+  LKL DFG A+      +   CY     T +Y  P+V
Sbjct: 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY-----TPYYVAPEV 200
Query: 156 LFGAKLYTTSIDMWSAGCIFAEL--------ANAGRPLFPGSDVDDQLKRIFKLLGTPTE 207
           L G + Y  S DMWS G I   L        +N G+ + PG      +KR  +L      
Sbjct: 201 L-GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG------MKRRIRL------ 247
Query: 208 DTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHI 267
               G    P+        P  S      +++   + L++ LL  +P +R++    M+H 
Sbjct: 248 ----GQYGFPN--------PEWS------EVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289
Query: 268 YFS 270
           + +
Sbjct: 290 WIN 292

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/235 (22%), Positives = 103/235 (43%), Gaps = 33/235 (14%)
Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNV 105
           +V L+    +E KL L+ ++ +        S         V+ ++ +++  L   H   +
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI 180
Query: 106 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWYRPPDVLFGAKL-YT 163
           ++RD+K +N+L++ NG + L DFGL++ F       + +   T+ Y  PD++ G    + 
Sbjct: 181 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHD 240
Query: 164 TSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFP 223
            ++D WS G +  EL     P              F + G           +L    P+P
Sbjct: 241 KAVDWWSLGVLMYELLTGASP--------------FTVDGEKNSQAEISRRILKSEPPYP 286
Query: 224 MYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS-----AEDAMSHIYFSDLN 273
                        +++A  +DL+QRLL+ +P +R+      A++   H++F  +N
Sbjct: 287 Q------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 4/162 (2%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-GEIDLDIVKSF 89
           L+E  ++KE+KH N+V+L  V   E    ++ E     +L  Y    N  E+   ++   
Sbjct: 55  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYM 114
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYSAEVVTL 148
             Q+   + +   +N +HRDL  +N L+ +N  +K+ADFGL+R   G     ++     +
Sbjct: 115 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 174
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSD 190
            +  P+ L   K    S D+W+ G +  E+A  G   +PG D
Sbjct: 175 KWTAPESLAYNKFSIKS-DVWAFGVLLWEIATYGMSPYPGID 215

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 86/174 (49%), Gaps = 8/174 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-GEIDLDIVKSF 89
           L+E  ++KE+KH N+V+L  V   E    ++ E     +L  Y    N  E+   ++   
Sbjct: 264 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 323
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYSAEVVTL 148
             Q+   + +   +N +HR+L  +N L+ +N  +K+ADFGL+R   G     ++     +
Sbjct: 324 ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 383
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
            +  P+ L   K    S D+W+ G +  E+A  G   +PG D    L ++++LL
Sbjct: 384 KWTAPESLAYNKFSIKS-DVWAFGVLLWEIATYGMSPYPGID----LSQVYELL 432

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 32/220 (14%)
Query: 5   GVDRTPNT-ALAIKGTHLVGNEGVPSSALREICLLKELK-------HKNIVRLYDVLHSE 56
           G+D+T     +A+K    +  EG   S  R   L+ ELK       H N+V L       
Sbjct: 50  GIDKTATXRTVAVK----MLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKP 103
Query: 57  KK-LTLVFEHCD-QDLKKYFDSLNGEI--DLDIVKSFM---------YQLLRGLAFCHSR 103
              L ++ E C   +L  Y  S   E     D+ K F+         +Q+ +G+ F  SR
Sbjct: 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASR 163
Query: 104 NVLHRDLKPQNLLINKNGELKLADFGLAR-AFGIP--VKCYSAEVVTLWYRPPDVLFGAK 160
             +HRDL  +N+L+++   +K+ DFGLAR  +  P  V+   A +   W  P  +    +
Sbjct: 164 KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--DR 221
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           +YT   D+WS G +  E+ + G   +PG  +D++  R  K
Sbjct: 222 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLK 261

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 80/166 (48%), Gaps = 14/166 (8%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQ-DLKKYFDSLNGEIDLDI- 85
           EI ++K+L H N+V   +V    +KL       L  E+C+  DL+KY +       L   
Sbjct: 63  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 122
Query: 86  -VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL---KLADFGLARAFGIPVKCY 141
            +++ +  +   L + H   ++HRDLKP+N+++    +    K+ D G A+       C 
Sbjct: 123 PIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC- 181
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFP 187
           +  V TL Y  P++L   K YT ++D WS G +  E     RP  P
Sbjct: 182 TEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 80/166 (48%), Gaps = 14/166 (8%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQ-DLKKYFDSLNGEIDLDI- 85
           EI ++K+L H N+V   +V    +KL       L  E+C+  DL+KY +       L   
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 86  -VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL---KLADFGLARAFGIPVKCY 141
            +++ +  +   L + H   ++HRDLKP+N+++    +    K+ D G A+       C 
Sbjct: 122 PIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC- 180
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFP 187
           +  V TL Y  P++L   K YT ++D WS G +  E     RP  P
Sbjct: 181 TEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 106/243 (43%), Gaps = 55/243 (22%)
Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLR----GLAFCH 101
           I+ +Y+ +H  K+  L+   C  +  + F  +    D    +    +++R     + F H
Sbjct: 68  ILDVYENMHHGKRCLLIIMEC-MEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 126
Query: 102 SRNVLHRDLKPQNLLIN---KNGELKLADFGLARAF---GIPVKCYSAEVVTLWYRPPDV 155
           S N+ HRD+KP+NLL     K+  LKL DFG A+      +   CY     T +Y  P+V
Sbjct: 127 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY-----TPYYVAPEV 181
Query: 156 LFGAKLYTTSIDMWSAGCIFAEL--------ANAGRPLFPGSDVDDQLKRIFKLLGTPTE 207
           L G + Y  S DMWS G I   L        +N G+ + PG      +KR  +L      
Sbjct: 182 L-GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG------MKRRIRL------ 228
Query: 208 DTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHI 267
               G    P+        P  S      +++   + L++ LL  +P +R++    M+H 
Sbjct: 229 ----GQYGFPN--------PEWS------EVSEDAKQLIRLLLKTDPTERLTITQFMNHP 270
Query: 268 YFS 270
           + +
Sbjct: 271 WIN 273

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/237 (23%), Positives = 109/237 (45%), Gaps = 31/237 (13%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQL 93
           E+ ++++  H N+V +Y       +L +V E  +        + +  ++ + + +    +
Sbjct: 92  EVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSV 150
Query: 94  LRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP 153
           LR L++ H++ V+HRD+K  ++L+  +G +KL+DFG        V      V T ++  P
Sbjct: 151 LRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAP 210
Query: 154 DVLFGAKL-YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPG 212
           +V+  ++L Y T +D+WS G +  E+ +   P F    +   ++RI         D+ P 
Sbjct: 211 EVI--SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-QAMRRI--------RDSLP- 258
Query: 213 MNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
               P  K                K+++  R  L  +LV  P QR +A++ + H + 
Sbjct: 259 ----PRVKDL-------------HKVSSVLRGFLDLMLVREPSQRATAQELLGHPFL 298

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 89/186 (47%), Gaps = 8/186 (4%)
Query: 13  ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLK 71
           ++AIK   +   E      L E  ++ +  H NI+RL  V+   K + +V E+ +   L 
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 72  KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA 131
            +    + +  +  +   +  +  G+ +      +HRDL  +N+LIN N   K++DFGLA
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLA 194
Query: 132 RAF-GIPVKCYS---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPLF 186
           R     P   Y+    ++   W  P  + +  + +T++ D+WS G +  E+ + G RP +
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 187 PGSDVD 192
             S+ D
Sbjct: 253 EMSNQD 258

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/244 (23%), Positives = 105/244 (43%), Gaps = 39/244 (15%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQL 93
           E  +L  + H  I+R++      +++ ++ ++ +          +      + K +  ++
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 115
Query: 94  LRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP 153
              L + HS+++++RDLKP+N+L++KNG +K+ DFG A+   +P   Y     T  Y  P
Sbjct: 116 CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTYXL-CGTPDYIAP 172
Query: 154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGM 213
           +V+   K Y  SID WS G +  E+     P +      + +K   K+L           
Sbjct: 173 EVV-STKPYNKSIDWWSFGILIYEMLAGYTPFYDS----NTMKTYEKILNAELR------ 221
Query: 214 NLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIY 268
                F PF                    +DLL RL+  +  QR+       ED  +H +
Sbjct: 222 -----FPPF---------------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261
Query: 269 FSDL 272
           F ++
Sbjct: 262 FKEV 265

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 81/169 (47%), Gaps = 14/169 (8%)
Query: 24  NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLNGEID 82
           +E    + L+E+ +++ L+H N+++   VL+ +K+L  + E+     L+    S++ +  
Sbjct: 47  DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYP 106
Query: 83  LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA----------- 131
                SF   +  G+A+ HS N++HRDL   N L+ +N  + +ADFGLA           
Sbjct: 107 WSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166
Query: 132 --RAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
             R+   P +     VV   Y     +   + Y   +D++S G +  E+
Sbjct: 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEI 215

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 112/253 (44%), Gaps = 48/253 (18%)
Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQ-DLKK 72
           A+K  + + + G  S  L E  ++K+  H N++ L  + L SE    +V  +    DL+ 
Sbjct: 63  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 122
Query: 73  YFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR 132
           +  +      +  +  F  Q+ +G+ F  S+  +HRDL  +N ++++   +K+ADFGLAR
Sbjct: 123 FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182
Query: 133 --------------AFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
                            +PVK  + E +             + +TT  D+WS G +  EL
Sbjct: 183 DMLDKEFDSVHNKTGAKLPVKWMALESLQ-----------TQKFTTKSDVWSFGVLLWEL 231
Query: 179 ANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY-------HPSM-- 229
              G P +P  DV+     ++ L G           L P++ P P+Y       HP    
Sbjct: 232 MTRGAPPYP--DVNTFDITVYLLQGRRL--------LQPEYCPDPLYEVMLKCWHPKAEM 281
Query: 230 --SFSQVAPKLTA 240
             SFS++  +++A
Sbjct: 282 RPSFSELVSRISA 294

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 112/253 (44%), Gaps = 48/253 (18%)
Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQ-DLKK 72
           A+K  + + + G  S  L E  ++K+  H N++ L  + L SE    +V  +    DL+ 
Sbjct: 121 AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 180
Query: 73  YFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR 132
           +  +      +  +  F  Q+ +G+ F  S+  +HRDL  +N ++++   +K+ADFGLAR
Sbjct: 181 FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240
Query: 133 --------------AFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
                            +PVK  + E +             + +TT  D+WS G +  EL
Sbjct: 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQ-----------TQKFTTKSDVWSFGVLLWEL 289
Query: 179 ANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY-------HPSM-- 229
              G P +P  DV+     ++ L G           L P++ P P+Y       HP    
Sbjct: 290 MTRGAPPYP--DVNTFDITVYLLQGRRL--------LQPEYCPDPLYEVMLKCWHPKAEM 339
Query: 230 --SFSQVAPKLTA 240
             SFS++  +++A
Sbjct: 340 RPSFSELVSRISA 352

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 112/253 (44%), Gaps = 48/253 (18%)
Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQ-DLKK 72
           A+K  + + + G  S  L E  ++K+  H N++ L  + L SE    +V  +    DL+ 
Sbjct: 62  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 121
Query: 73  YFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR 132
           +  +      +  +  F  Q+ +G+ F  S+  +HRDL  +N ++++   +K+ADFGLAR
Sbjct: 122 FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181
Query: 133 --------------AFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
                            +PVK  + E +             + +TT  D+WS G +  EL
Sbjct: 182 DMYDKEFDSVHNKTGAKLPVKWMALESLQ-----------TQKFTTKSDVWSFGVLLWEL 230
Query: 179 ANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY-------HPSM-- 229
              G P +P  DV+     ++ L G           L P++ P P+Y       HP    
Sbjct: 231 MTRGAPPYP--DVNTFDITVYLLQGRRL--------LQPEYCPDPLYEVMLKCWHPKAEM 280
Query: 230 --SFSQVAPKLTA 240
             SFS++  +++A
Sbjct: 281 RPSFSELVSRISA 293

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 10/219 (4%)
Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
           G+D      +AIK   L   E       +EI +L +     I R +       KL ++ E
Sbjct: 38  GIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSYLKSTKLWIIME 97
Query: 65  HCDQDLKKYFDSLN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL 123
           +         D L  G ++   + + + ++L+GL + HS   +HRD+K  N+L+++ G++
Sbjct: 98  YLGGG--SALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDV 155
Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           KLADFG+A          +  V T ++  P+V+     Y    D+WS G    ELA  G 
Sbjct: 156 KLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAYDFKADIWSLGITAIELAK-GE 213
Query: 184 PLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPF 222
           P  P SD+     R+  L+   +  T  G +  P FK F
Sbjct: 214 P--PNSDLHPM--RVLFLIPKNSPPTLEGQHSKP-FKEF 247

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 112/253 (44%), Gaps = 48/253 (18%)
Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQ-DLKK 72
           A+K  + + + G  S  L E  ++K+  H N++ L  + L SE    +V  +    DL+ 
Sbjct: 62  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 121
Query: 73  YFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR 132
           +  +      +  +  F  Q+ +G+ F  S+  +HRDL  +N ++++   +K+ADFGLAR
Sbjct: 122 FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181
Query: 133 --------------AFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
                            +PVK  + E +             + +TT  D+WS G +  EL
Sbjct: 182 DMYDKEFDSVHNKTGAKLPVKWMALESLQ-----------TQKFTTKSDVWSFGVLLWEL 230
Query: 179 ANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY-------HPSM-- 229
              G P +P  DV+     ++ L G           L P++ P P+Y       HP    
Sbjct: 231 MTRGAPPYP--DVNTFDITVYLLQGRRL--------LQPEYCPDPLYEVMLKCWHPKAEM 280
Query: 230 --SFSQVAPKLTA 240
             SFS++  +++A
Sbjct: 281 RPSFSELVSRISA 293

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 112/253 (44%), Gaps = 48/253 (18%)
Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQ-DLKK 72
           A+K  + + + G  S  L E  ++K+  H N++ L  + L SE    +V  +    DL+ 
Sbjct: 63  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 122
Query: 73  YFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR 132
           +  +      +  +  F  Q+ +G+ F  S+  +HRDL  +N ++++   +K+ADFGLAR
Sbjct: 123 FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182
Query: 133 --------------AFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
                            +PVK  + E +             + +TT  D+WS G +  EL
Sbjct: 183 DMYDKEFDSVHNKTGAKLPVKWMALESLQ-----------TQKFTTKSDVWSFGVLLWEL 231
Query: 179 ANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY-------HPSM-- 229
              G P +P  DV+     ++ L G           L P++ P P+Y       HP    
Sbjct: 232 MTRGAPPYP--DVNTFDITVYLLQGRRL--------LQPEYCPDPLYEVMLKCWHPKAEM 281
Query: 230 --SFSQVAPKLTA 240
             SFS++  +++A
Sbjct: 282 RPSFSELVSRISA 294

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 8/157 (5%)
Query: 34  EICLLKELKH--KNIVRLYDVLHSEKKLTLVFEHCD--QDLKKYFDSLNGEIDLDIVKSF 89
           E+ LLK++      ++RL D         L+ E  +  QDL  +     G +  ++ +SF
Sbjct: 104 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSF 162
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVKCYSAEVVTL 148
            +Q+L  +  CH+  VLHRD+K +N+LI+ N GELKL DFG        V  Y+    T 
Sbjct: 163 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTR 220
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
            Y PP+ +   + +  S  +WS G +  ++     P 
Sbjct: 221 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 112/253 (44%), Gaps = 48/253 (18%)
Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQ-DLKK 72
           A+K  + + + G  S  L E  ++K+  H N++ L  + L SE    +V  +    DL+ 
Sbjct: 60  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 119
Query: 73  YFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR 132
           +  +      +  +  F  Q+ +G+ F  S+  +HRDL  +N ++++   +K+ADFGLAR
Sbjct: 120 FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179
Query: 133 --------------AFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
                            +PVK  + E +             + +TT  D+WS G +  EL
Sbjct: 180 DMYDKEFDSVHNKTGAKLPVKWMALESLQ-----------TQKFTTKSDVWSFGVLLWEL 228
Query: 179 ANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY-------HPSM-- 229
              G P +P  DV+     ++ L G           L P++ P P+Y       HP    
Sbjct: 229 MTRGAPPYP--DVNTFDITVYLLQGRRL--------LQPEYCPDPLYEVMLKCWHPKAEM 278
Query: 230 --SFSQVAPKLTA 240
             SFS++  +++A
Sbjct: 279 RPSFSELVSRISA 291

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 2/167 (1%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQL 93
           EI + K L + ++V  +     +  + +V E C +            +     + FM Q 
Sbjct: 92  EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQT 151
Query: 94  LRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP 153
           ++G+ + H+  V+HRDLK  NL +N + ++K+ DFGLA       +       T  Y  P
Sbjct: 152 IQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAP 211
Query: 154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           +VL   K ++  +D+WS GCI   L   G+P F  S + +   RI K
Sbjct: 212 EVLC-KKGHSFEVDIWSLGCILYTLL-VGKPPFETSCLKETYIRIKK 256

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 85/186 (45%), Gaps = 34/186 (18%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDS--------------- 76
           RE  LL  L+H++IV+ Y V      L +VFE+    DL K+  +               
Sbjct: 66  REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 77  LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGI 136
             GE+ L  +     Q+  G+ +  S++ +HRDL  +N L+  N  +K+ DFG++R    
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR---- 181
Query: 137 PVKCYSAEVVTL---------WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR-PLF 186
               YS +   +         W  P  +++  + +TT  D+WS G I  E+   G+ P F
Sbjct: 182 --DVYSTDYYRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVILWEIFTYGKQPWF 237
Query: 187 PGSDVD 192
             S+ +
Sbjct: 238 QLSNTE 243

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 112/253 (44%), Gaps = 48/253 (18%)
Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQ-DLKK 72
           A+K  + + + G  S  L E  ++K+  H N++ L  + L SE    +V  +    DL+ 
Sbjct: 67  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 126
Query: 73  YFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR 132
           +  +      +  +  F  Q+ +G+ F  S+  +HRDL  +N ++++   +K+ADFGLAR
Sbjct: 127 FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 186
Query: 133 --------------AFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
                            +PVK  + E +             + +TT  D+WS G +  EL
Sbjct: 187 DMYDKEFDSVHNKTGAKLPVKWMALESLQ-----------TQKFTTKSDVWSFGVLLWEL 235
Query: 179 ANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY-------HPSM-- 229
              G P +P  DV+     ++ L G           L P++ P P+Y       HP    
Sbjct: 236 MTRGAPPYP--DVNTFDITVYLLQGRRL--------LQPEYCPDPLYEVMLKCWHPKAEM 285
Query: 230 --SFSQVAPKLTA 240
             SFS++  +++A
Sbjct: 286 RPSFSELVSRISA 298

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 90/186 (48%), Gaps = 13/186 (6%)
Query: 6   VDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFE 64
           V +  N A A+K    + ++ + ++  +EI  LK  + H NIV+L++V H +    LV E
Sbjct: 31  VHKKSNQAFAVK----IISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVME 86
Query: 65  HCDQDLKKYFDSLNGEIDLDIVKS--FMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NK 119
             +    + F+ +  +      ++   M +L+  ++  H   V+HRDLKP+NLL    N 
Sbjct: 87  LLNGG--ELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEND 144
Query: 120 NGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELA 179
           N E+K+ DFG AR      +       TL Y  P++L     Y  S D+WS G I   + 
Sbjct: 145 NLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL-NQNGYDESCDLWSLGVILYTML 203
Query: 180 NAGRPL 185
           +   P 
Sbjct: 204 SGQVPF 209

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 4/162 (2%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-GEIDLDIVKSF 89
           L+E  ++KE+KH N+V+L  V   E    ++ E     +L  Y    N  E+   ++   
Sbjct: 55  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 114
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYSAEVVTL 148
             Q+   + +   +N +HRDL  +N L+ +N  +K+ADFGL+R   G     ++     +
Sbjct: 115 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 174
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSD 190
            +  P+ L   K    S D+W+ G +  E+A  G   +PG D
Sbjct: 175 KWTAPESLAYNKFSIKS-DVWAFGVLLWEIATYGMSPYPGID 215

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 71/145 (48%), Gaps = 22/145 (15%)
Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT 147
           SF YQ+ +G+AF  S+N +HRDL  +N+L+      K+ DFGLAR     +K  S  VV 
Sbjct: 165 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR----DIKNDSNYVVK 220
Query: 148 ------LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
                 + +  P+ +F   +YT   D+WS G    EL + G   +PG  VD +  ++ K 
Sbjct: 221 GNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK- 278
Query: 202 LGTPTEDTWPGMNLL-PDFKPFPMY 225
                     G  +L P+  P  MY
Sbjct: 279 ---------EGFRMLSPEHAPAEMY 294

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 4/162 (2%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-GEIDLDIVKSF 89
           L+E  ++KE+KH N+V+L  V   E    ++ E     +L  Y    N  E+   ++   
Sbjct: 55  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 114
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYSAEVVTL 148
             Q+   + +   +N +HRDL  +N L+ +N  +K+ADFGL+R   G     ++     +
Sbjct: 115 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI 174
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSD 190
            +  P+ L   K    S D+W+ G +  E+A  G   +PG D
Sbjct: 175 KWTAPESLAYNKFSIKS-DVWAFGVLLWEIATYGMSPYPGID 215

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 2/167 (1%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQL 93
           EI + K L + ++V  +     +  + +V E C +            +     + FM Q 
Sbjct: 92  EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQT 151
Query: 94  LRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP 153
           ++G+ + H+  V+HRDLK  NL +N + ++K+ DFGLA       +       T  Y  P
Sbjct: 152 IQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAP 211
Query: 154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           +VL   K ++  +D+WS GCI   L   G+P F  S + +   RI K
Sbjct: 212 EVLC-KKGHSFEVDIWSLGCILYTLL-VGKPPFETSCLKETYIRIKK 256

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 71/145 (48%), Gaps = 22/145 (15%)
Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT 147
           SF YQ+ +G+AF  S+N +HRDL  +N+L+      K+ DFGLAR     +K  S  VV 
Sbjct: 172 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARH----IKNDSNYVVK 227
Query: 148 ------LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
                 + +  P+ +F   +YT   D+WS G    EL + G   +PG  VD +  ++ K 
Sbjct: 228 GNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK- 285
Query: 202 LGTPTEDTWPGMNLL-PDFKPFPMY 225
                     G  +L P+  P  MY
Sbjct: 286 ---------EGFRMLSPEHAPAEMY 301

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 71/145 (48%), Gaps = 22/145 (15%)
Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT 147
           SF YQ+ +G+AF  S+N +HRDL  +N+L+      K+ DFGLAR     +K  S  VV 
Sbjct: 167 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR----DIKNDSNYVVK 222
Query: 148 ------LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
                 + +  P+ +F   +YT   D+WS G    EL + G   +PG  VD +  ++ K 
Sbjct: 223 GNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK- 280
Query: 202 LGTPTEDTWPGMNLL-PDFKPFPMY 225
                     G  +L P+  P  MY
Sbjct: 281 ---------EGFRMLSPEHAPAEMY 296

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 112/251 (44%), Gaps = 58/251 (23%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL--DIVKSFM 90
           RE+ +L+++ H N++ L+DV  +   + L+ E       + FD L  +  L  +   SF+
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGG--ELFDFLAQKESLSEEEATSFI 121
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQN-LLINKN---GELKLADFGLARA----------FGI 136
            Q+L G+ + H++ + H DLKP+N +L++KN     +KL DFGLA            FG 
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           P +  + E+V   Y P  +           DMWS G I   L +   P            
Sbjct: 182 P-EFVAPEIVN--YEPLGL---------EADMWSIGVITYILLSGASP------------ 217
Query: 197 RIFKLLGTPTEDTWPGMNLLP-DFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPV 255
                LG   ++T   +  +  DF           FSQ     +   +D +++LLV    
Sbjct: 218 ----FLGDTKQETLANITAVSYDF-------DEEFFSQT----SELAKDFIRKLLVKETR 262
Query: 256 QRMSAEDAMSH 266
           +R++ ++A+ H
Sbjct: 263 KRLTIQEALRH 273

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 71/145 (48%), Gaps = 22/145 (15%)
Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT 147
           SF YQ+ +G+AF  S+N +HRDL  +N+L+      K+ DFGLAR     +K  S  VV 
Sbjct: 149 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR----DIKNDSNYVVK 204
Query: 148 ------LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
                 + +  P+ +F   +YT   D+WS G    EL + G   +PG  VD +  ++ K 
Sbjct: 205 GNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK- 262
Query: 202 LGTPTEDTWPGMNLL-PDFKPFPMY 225
                     G  +L P+  P  MY
Sbjct: 263 ---------EGFRMLSPEHAPAEMY 278

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 80/155 (51%), Gaps = 11/155 (7%)
Query: 49  LYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHR 108
           L   L S++   + ++   +DL K F      + L+ +  + +Q+ +G+ F  SR  +HR
Sbjct: 121 LSTYLRSKRNEFVPYKEAPEDLYKDF------LTLEHLICYSFQVAKGMEFLASRKCIHR 174
Query: 109 DLKPQNLLINKNGELKLADFGLAR-AFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTS 165
           DL  +N+L+++   +K+ DFGLAR  +  P  V+   A +   W  P  +    ++YT  
Sbjct: 175 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQ 232
Query: 166 IDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
            D+WS G +  E+ + G   +PG  +D++  R  K
Sbjct: 233 SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 267

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 71/145 (48%), Gaps = 22/145 (15%)
Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT 147
           SF YQ+ +G+AF  S+N +HRDL  +N+L+      K+ DFGLAR     +K  S  VV 
Sbjct: 172 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR----DIKNDSNYVVK 227
Query: 148 ------LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
                 + +  P+ +F   +YT   D+WS G    EL + G   +PG  VD +  ++ K 
Sbjct: 228 GNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK- 285
Query: 202 LGTPTEDTWPGMNLL-PDFKPFPMY 225
                     G  +L P+  P  MY
Sbjct: 286 ---------EGFRMLSPEHAPAEMY 301

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 110/251 (43%), Gaps = 58/251 (23%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL--DIVKSFM 90
           RE+ +L+++ H N++ L+DV  +   + L+ E       + FD L  +  L  +   SF+
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGG--ELFDFLAQKESLSEEEATSFI 121
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQN-LLINKN---GELKLADFGLARA----------FGI 136
            Q+L G+ + H++ + H DLKP+N +L++KN     +KL DFGLA            FG 
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           P +  + E+V   Y P  +           DMWS G I   L +   P            
Sbjct: 182 P-EFVAPEIVN--YEPLGL---------EADMWSIGVITYILLSGASP------------ 217
Query: 197 RIFKLLGTPTEDTWPGMNLLP-DFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPV 255
                LG   ++T   +  +  DF      H S              +D +++LLV    
Sbjct: 218 ----FLGDTKQETLANITSVSYDFDEEFFSHTS-----------ELAKDFIRKLLVKETR 262
Query: 256 QRMSAEDAMSH 266
           +R++ ++A+ H
Sbjct: 263 KRLTIQEALRH 273

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 114/255 (44%), Gaps = 58/255 (22%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL--DIVKSFM 90
           RE+ +L+++ H N++ L+DV  +   + L+ E       + FD L  +  L  +   SF+
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGG--ELFDFLAQKESLSEEEATSFI 121
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQN-LLINKN---GELKLADFGLARA----------FGI 136
            Q+L G+ + H++ + H DLKP+N +L++KN     +KL DFGLA            FG 
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           P +  + E+V   Y P  +           DMWS G I   L +   P            
Sbjct: 182 P-EFVAPEIVN--YEPLGL---------EADMWSIGVITYILLSGASP------------ 217
Query: 197 RIFKLLGTPTEDTWPGMNLLP-DFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPV 255
                LG   ++T   +  +  DF           FSQ     +   +D +++LLV    
Sbjct: 218 ----FLGDTKQETLANITAVSYDF-------DEEFFSQT----SELAKDFIRKLLVKETR 262
Query: 256 QRMSAEDAMSHIYFS 270
           +R++ ++A+ H + +
Sbjct: 263 KRLTIQEALRHPWIT 277

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 113/253 (44%), Gaps = 48/253 (18%)
Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQ-DLKK 72
           A+K  + + + G  S  L E  ++K+  H N++ L  + L SE    +V  +    DL+ 
Sbjct: 61  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 120
Query: 73  YFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR 132
           +  +      +  +  F  Q+ +G+ +  S+  +HRDL  +N ++++   +K+ADFGLAR
Sbjct: 121 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180
Query: 133 AFGIPVKCYSAEVVTLWYRPPDVLFGAKL--------------YTTSIDMWSAGCIFAEL 178
                   Y  E  ++  +      GAKL              +TT  D+WS G +  EL
Sbjct: 181 DM------YDKEXXSVHNKT-----GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 229
Query: 179 ANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY-------HPSM-- 229
              G P +P  DV+     ++ L G           L P++ P P+Y       HP    
Sbjct: 230 MTRGAPPYP--DVNTFDITVYLLQGRRL--------LQPEYCPDPLYEVMLKCWHPKAEM 279
Query: 230 --SFSQVAPKLTA 240
             SFS++  +++A
Sbjct: 280 RPSFSELVSRISA 292

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 19/186 (10%)
Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKH-KNIVRLYDVLHS------EKKLTLVFEHCD 67
           AIK   + G+E       +EI +LK+  H +NI   Y           + +L LV E C 
Sbjct: 53  AIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCG 110
Query: 68  ----QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL 123
                DL K  ++    +  + +     ++LRGL+  H   V+HRD+K QN+L+ +N E+
Sbjct: 111 AGSVTDLIK--NTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEV 168
Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK----LYTTSIDMWSAGCIFAELA 179
           KL DFG++      V   +  + T ++  P+V+   +     Y    D+WS G    E+A
Sbjct: 169 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228
Query: 180 NAGRPL 185
               PL
Sbjct: 229 EGAPPL 234

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 30/224 (13%)
Query: 5   GVDRTP-NTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLV 62
           G+ +T  +  +A+K      +     + + E+ ++ +L  H+NIV L         + L+
Sbjct: 68  GISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 127
Query: 63  FEHC-DQDLKKYFDS-----------------LNGEIDLDIVK-----SFMYQLLRGLAF 99
           FE+C   DL  Y  S                 L  E DL+++       F YQ+ +G+ F
Sbjct: 128 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 187
Query: 100 CHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVKCYSAEVVTLWYRPPDVL 156
              ++ +HRDL  +N+L+     +K+ DFGLAR        V   +A +   W  P  + 
Sbjct: 188 LEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 247
Query: 157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
            G  +YT   D+WS G +  E+ + G   +PG  VD    ++ +
Sbjct: 248 EG--IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ 289

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 32/220 (14%)
Query: 5   GVDRTPNT-ALAIKGTHLVGNEGVPSSALREICLLKELK-------HKNIVRLYDVLHSE 56
           G+D+T     +A+K    +  EG   S  R   L+ ELK       H N+V L       
Sbjct: 50  GIDKTATXRTVAVK----MLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKP 103
Query: 57  KK-LTLVFEHCD-QDLKKYFDSLNGEI--DLDIVKSFM---------YQLLRGLAFCHSR 103
              L ++ E C   +L  Y  S   E     D+ K F+         +Q+ +G+ F  SR
Sbjct: 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASR 163
Query: 104 NVLHRDLKPQNLLINKNGELKLADFGLAR-AFGIP--VKCYSAEVVTLWYRPPDVLFGAK 160
             +HRDL  +N+L+++   +K+ DFGLAR  +  P  V+   A +   W  P  +    +
Sbjct: 164 KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--DR 221
Query: 161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           +YT   D+WS G +  E+ + G   +PG  +D++  R  K
Sbjct: 222 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 261

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 110/251 (43%), Gaps = 58/251 (23%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL--DIVKSFM 90
           RE+ +L+++ H N++ L+DV  +   + L+ E       + FD L  +  L  +   SF+
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGG--ELFDFLAQKESLSEEEATSFI 121
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQN-LLINKN---GELKLADFGLARA----------FGI 136
            Q+L G+ + H++ + H DLKP+N +L++KN     +KL DFGLA            FG 
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           P +  + E+V   Y P  +           DMWS G I   L +   P            
Sbjct: 182 P-EFVAPEIVN--YEPLGL---------EADMWSIGVITYILLSGASP------------ 217
Query: 197 RIFKLLGTPTEDTWPGMNLLP-DFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPV 255
                LG   ++T   +  +  DF      H S              +D +++LLV    
Sbjct: 218 ----FLGDTKQETLANITSVSYDFDEEFFSHTS-----------ELAKDFIRKLLVKETR 262
Query: 256 QRMSAEDAMSH 266
           +R++ ++A+ H
Sbjct: 263 KRLTIQEALRH 273

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 113/253 (44%), Gaps = 48/253 (18%)
Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQ-DLKK 72
           A+K  + + + G  S  L E  ++K+  H N++ L  + L SE    +V  +    DL+ 
Sbjct: 80  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 139
Query: 73  YFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR 132
           +  +      +  +  F  Q+ +G+ +  S+  +HRDL  +N ++++   +K+ADFGLAR
Sbjct: 140 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 199
Query: 133 AFGIPVKCYSAEVVTLWYRPPDVLFGAKL--------------YTTSIDMWSAGCIFAEL 178
                   Y  E  ++  +      GAKL              +TT  D+WS G +  EL
Sbjct: 200 DM------YDKEYYSVHNKT-----GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 248
Query: 179 ANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY-------HPSM-- 229
              G P +P  DV+     ++ L G           L P++ P P+Y       HP    
Sbjct: 249 MTRGAPPYP--DVNTFDITVYLLQGRRL--------LQPEYCPDPLYEVMLKCWHPKAEM 298
Query: 230 --SFSQVAPKLTA 240
             SFS++  +++A
Sbjct: 299 RPSFSELVSRISA 311

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 104/244 (42%), Gaps = 39/244 (15%)
Query: 36  CLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY--QL 93
            LLK +KH  +V L+    +  KL  V ++ +    + F  L  E      ++  Y  ++
Sbjct: 91  VLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG--ELFYHLQRERCFLEPRARFYAAEI 148
Query: 94  LRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP 153
              L + HS N+++RDLKP+N+L++  G + L DFGL +         S    T  Y  P
Sbjct: 149 ASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAP 208
Query: 154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGM 213
           +VL   + Y  ++D W  G +  E+   G P F   +  +    I               
Sbjct: 209 EVLH-KQPYDRTVDWWCLGAVLYEML-YGLPPFYSRNTAEMYDNILN------------- 253
Query: 214 NLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAM----SHIYF 269
                 KP           Q+ P +T   R LL+ LL  +  +R+ A+D      SH++F
Sbjct: 254 ------KPL----------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297
Query: 270 SDLN 273
           S +N
Sbjct: 298 SLIN 301

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 106/248 (42%), Gaps = 38/248 (15%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDI----VKSF 89
           EI +L    H  IV+L    + + KL ++ E C        D++  E+D  +    ++  
Sbjct: 58  EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGA---VDAIMLELDRGLTEPQIQVV 114
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW 149
             Q+L  L F HS+ ++HRDLK  N+L+   G+++LADFG++      ++   + + T +
Sbjct: 115 CRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY 174
Query: 150 YRPPDVLFGAKL----YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
           +  P+V+    +    Y    D+WS G    E+A    P         +L  +  LL   
Sbjct: 175 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP-------HHELNPMRVLLKIA 227
Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS 265
             D            P  +  PS        K + + RD L+  L  NP  R SA   + 
Sbjct: 228 KSD------------PPTLLTPS--------KWSVEFRDFLKIALDKNPETRPSAAQLLE 267
Query: 266 HIYFSDLN 273
           H + S + 
Sbjct: 268 HPFVSSIT 275

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 89/186 (47%), Gaps = 8/186 (4%)
Query: 13  ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLK 71
           ++AIK   +   E      L E  ++ +  H NI+RL  V+   K + +V E+ +   L 
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 72  KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA 131
            +    + +  +  +   +  +  G+ +      +HRDL  +N+LIN N   K++DFGL+
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 132 RAF-GIPVKCYS---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPLF 186
           R     P   Y+    ++   W  P  + +  + +T++ D+WS G +  E+ + G RP +
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 187 PGSDVD 192
             S+ D
Sbjct: 253 EMSNQD 258

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 113/253 (44%), Gaps = 48/253 (18%)
Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQ-DLKK 72
           A+K  + + + G  S  L E  ++K+  H N++ L  + L SE    +V  +    DL+ 
Sbjct: 62  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 121
Query: 73  YFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR 132
           +  +      +  +  F  Q+ +G+ +  S+  +HRDL  +N ++++   +K+ADFGLAR
Sbjct: 122 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181
Query: 133 AFGIPVKCYSAEVVTLWYRPPDVLFGAKL--------------YTTSIDMWSAGCIFAEL 178
                   Y  E  ++  +      GAKL              +TT  D+WS G +  EL
Sbjct: 182 DM------YDKEYYSVHNKT-----GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 230
Query: 179 ANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY-------HPSM-- 229
              G P +P  DV+     ++ L G           L P++ P P+Y       HP    
Sbjct: 231 MTRGAPPYP--DVNTFDITVYLLQGRRL--------LQPEYCPDPLYEVMLKCWHPKAEM 280
Query: 230 --SFSQVAPKLTA 240
             SFS++  +++A
Sbjct: 281 RPSFSELVSRISA 293

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 2/167 (1%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQL 93
           EI + K L + ++V  +     +  + +V E C +            +     + FM Q 
Sbjct: 92  EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQT 151
Query: 94  LRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP 153
           ++G+ + H+  V+HRDLK  NL +N + ++K+ DFGLA       +       T  Y  P
Sbjct: 152 IQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAP 211
Query: 154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           +VL   K ++  +D+WS GCI   L   G+P F  S + +   RI K
Sbjct: 212 EVLC-KKGHSFEVDIWSLGCILYTLL-VGKPPFETSCLKETYIRIKK 256

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 89/186 (47%), Gaps = 8/186 (4%)
Query: 13  ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLK 71
           ++AIK   +   E      L E  ++ +  H NI+RL  V+   K + +V E+ +   L 
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 72  KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA 131
            +    + +  +  +   +  +  G+ +      +HRDL  +N+LIN N   K++DFGL+
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 132 RAF-GIPVKCYS---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPLF 186
           R     P   Y+    ++   W  P  + +  + +T++ D+WS G +  E+ + G RP +
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 187 PGSDVD 192
             S+ D
Sbjct: 253 EMSNQD 258

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 89/186 (47%), Gaps = 8/186 (4%)
Query: 13  ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLK 71
           ++AIK   +   E      L E  ++ +  H NI+RL  V+   K + +V E+ +   L 
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 72  KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA 131
            +    + +  +  +   +  +  G+ +      +HRDL  +N+LIN N   K++DFGL+
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 132 RAF-GIPVKCYS---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPLF 186
           R     P   Y+    ++   W  P  + +  + +T++ D+WS G +  E+ + G RP +
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 187 PGSDVD 192
             S+ D
Sbjct: 253 EMSNQD 258

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 89/186 (47%), Gaps = 8/186 (4%)
Query: 13  ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLK 71
           ++AIK   +   E      L E  ++ +  H NI+RL  V+   K + +V E+ +   L 
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 72  KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA 131
            +    + +  +  +   +  +  G+ +      +HRDL  +N+LIN N   K++DFGL+
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 132 RAF-GIPVKCYS---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPLF 186
           R     P   Y+    ++   W  P  + +  + +T++ D+WS G +  E+ + G RP +
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 187 PGSDVD 192
             S+ D
Sbjct: 253 EMSNQD 258

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 112/253 (44%), Gaps = 48/253 (18%)
Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQ-DLKK 72
           A+K  + + + G  S  L E  ++K+  H N++ L  + L SE    +V  +    DL+ 
Sbjct: 54  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 113
Query: 73  YFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR 132
           +  +      +  +  F  Q+ +G+ +  S+  +HRDL  +N ++++   +K+ADFGLAR
Sbjct: 114 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 173
Query: 133 --------------AFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
                            +PVK  + E +             + +TT  D+WS G +  EL
Sbjct: 174 DMYDKEYYSVHNKTGAKLPVKWMALESLQ-----------TQKFTTKSDVWSFGVLLWEL 222
Query: 179 ANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY-------HPSM-- 229
              G P +P  DV+     ++ L G           L P++ P P+Y       HP    
Sbjct: 223 MTRGAPPYP--DVNTFDITVYLLQGRRL--------LQPEYCPDPLYEVMLKCWHPKAEM 272
Query: 230 --SFSQVAPKLTA 240
             SFS++  +++A
Sbjct: 273 RPSFSELVSRISA 285

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 89/186 (47%), Gaps = 8/186 (4%)
Query: 13  ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLK 71
           ++AIK   +   E      L E  ++ +  H NI+RL  V+   K + +V E+ +   L 
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 72  KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA 131
            +    + +  +  +   +  +  G+ +      +HRDL  +N+LIN N   K++DFGL+
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 132 RAF-GIPVKCYS---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPLF 186
           R     P   Y+    ++   W  P  + +  + +T++ D+WS G +  E+ + G RP +
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 187 PGSDVD 192
             S+ D
Sbjct: 253 EMSNQD 258

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 113/253 (44%), Gaps = 48/253 (18%)
Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQ-DLKK 72
           A+K  + + + G  S  L E  ++K+  H N++ L  + L SE    +V  +    DL+ 
Sbjct: 81  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 140
Query: 73  YFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR 132
           +  +      +  +  F  Q+ +G+ +  S+  +HRDL  +N ++++   +K+ADFGLAR
Sbjct: 141 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 200
Query: 133 AFGIPVKCYSAEVVTLWYRPPDVLFGAKL--------------YTTSIDMWSAGCIFAEL 178
                   Y  E  ++  +      GAKL              +TT  D+WS G +  EL
Sbjct: 201 DM------YDKEYYSVHNKT-----GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 249
Query: 179 ANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY-------HPSM-- 229
              G P +P  DV+     ++ L G           L P++ P P+Y       HP    
Sbjct: 250 MTRGAPPYP--DVNTFDITVYLLQGRRL--------LQPEYCPDPLYEVMLKCWHPKAEM 299
Query: 230 --SFSQVAPKLTA 240
             SFS++  +++A
Sbjct: 300 RPSFSELVSRISA 312

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 106/248 (42%), Gaps = 38/248 (15%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDI----VKSF 89
           EI +L    H  IV+L    + + KL ++ E C        D++  E+D  +    ++  
Sbjct: 66  EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGA---VDAIMLELDRGLTEPQIQVV 122
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW 149
             Q+L  L F HS+ ++HRDLK  N+L+   G+++LADFG++      ++   + + T +
Sbjct: 123 CRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY 182
Query: 150 YRPPDVLFGAKL----YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
           +  P+V+    +    Y    D+WS G    E+A    P         +L  +  LL   
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP-------HHELNPMRVLLKIA 235
Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS 265
             D            P  +  PS        K + + RD L+  L  NP  R SA   + 
Sbjct: 236 KSD------------PPTLLTPS--------KWSVEFRDFLKIALDKNPETRPSAAQLLE 275
Query: 266 HIYFSDLN 273
           H + S + 
Sbjct: 276 HPFVSSIT 283

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 77/158 (48%), Gaps = 6/158 (3%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVK--S 88
           LRE+ ++K L+H NIV     +     L++V E+  +  L +          LD  +  S
Sbjct: 82  LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLS 141
Query: 89  FMYQLLRGLAFCHSRN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
             Y + +G+ + H+RN  ++HRDLK  NLL++K   +K+ DFGL+R              
Sbjct: 142 MAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAG 201
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRP 184
           T  +  P+VL        S D++S G I  ELA   +P
Sbjct: 202 TPEWMAPEVLRDEPSNEKS-DVYSFGVILWELATLQQP 238

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 89/186 (47%), Gaps = 8/186 (4%)
Query: 13  ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLK 71
           ++AIK   +   E      L E  ++ +  H NI+RL  V+   K + +V E+ +   L 
Sbjct: 73  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 132
Query: 72  KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA 131
            +    + +  +  +   +  +  G+ +      +HRDL  +N+LIN N   K++DFGL+
Sbjct: 133 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS 192
Query: 132 RAF-GIPVKCYS---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPLF 186
           R     P   Y+    ++   W  P  + +  + +T++ D+WS G +  E+ + G RP +
Sbjct: 193 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYW 250
Query: 187 PGSDVD 192
             S+ D
Sbjct: 251 EMSNQD 256

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 110/251 (43%), Gaps = 58/251 (23%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL--DIVKSFM 90
           RE+ +L+++ H N++ L+DV  +   + L+ E       + FD L  +  L  +   SF+
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGG--ELFDFLAQKESLSEEEATSFI 121
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQN-LLINKN---GELKLADFGLARA----------FGI 136
            Q+L G+ + H++ + H DLKP+N +L++KN     +KL DFGLA            FG 
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           P +  + E+V   Y P  +           DMWS G I   L +   P            
Sbjct: 182 P-EFVAPEIVN--YEPLGL---------EADMWSIGVITYILLSGASP------------ 217
Query: 197 RIFKLLGTPTEDTWPGMNLLP-DFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPV 255
                LG   ++T   +  +  DF      H S              +D +++LLV    
Sbjct: 218 ----FLGDTKQETLANITSVSYDFDEEFFSHTS-----------ELAKDFIRKLLVKETR 262
Query: 256 QRMSAEDAMSH 266
           +R++ ++A+ H
Sbjct: 263 KRLTIQEALRH 273

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 113/253 (44%), Gaps = 48/253 (18%)
Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQ-DLKK 72
           A+K  + + + G  S  L E  ++K+  H N++ L  + L SE    +V  +    DL+ 
Sbjct: 59  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 118
Query: 73  YFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR 132
           +  +      +  +  F  Q+ +G+ +  S+  +HRDL  +N ++++   +K+ADFGLAR
Sbjct: 119 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 133 AFGIPVKCYSAEVVTLWYRPPDVLFGAKL--------------YTTSIDMWSAGCIFAEL 178
                   Y  E  ++  +      GAKL              +TT  D+WS G +  EL
Sbjct: 179 DM------YDKEYYSVHNKT-----GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 227
Query: 179 ANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY-------HPSM-- 229
              G P +P  DV+     ++ L G           L P++ P P+Y       HP    
Sbjct: 228 MTRGAPPYP--DVNTFDITVYLLQGRRL--------LQPEYCPDPLYEVMLKCWHPKAEM 277
Query: 230 --SFSQVAPKLTA 240
             SFS++  +++A
Sbjct: 278 RPSFSELVSRISA 290

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 2/167 (1%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQL 93
           EI + K L + ++V  +     +  + +V E C +            +     + FM Q 
Sbjct: 76  EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQT 135
Query: 94  LRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP 153
           ++G+ + H+  V+HRDLK  NL +N + ++K+ DFGLA       +       T  Y  P
Sbjct: 136 IQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAP 195
Query: 154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           +VL   K ++  +D+WS GCI   L   G+P F  S + +   RI K
Sbjct: 196 EVL-CKKGHSFEVDIWSLGCILYTLL-VGKPPFETSCLKETYIRIKK 240

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 113/253 (44%), Gaps = 48/253 (18%)
Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQ-DLKK 72
           A+K  + + + G  S  L E  ++K+  H N++ L  + L SE    +V  +    DL+ 
Sbjct: 61  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 120
Query: 73  YFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR 132
           +  +      +  +  F  Q+ +G+ +  S+  +HRDL  +N ++++   +K+ADFGLAR
Sbjct: 121 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180
Query: 133 AFGIPVKCYSAEVVTLWYRPPDVLFGAKL--------------YTTSIDMWSAGCIFAEL 178
                   Y  E  ++  +      GAKL              +TT  D+WS G +  EL
Sbjct: 181 DM------YDKEYYSVHNKT-----GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 229
Query: 179 ANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY-------HPSM-- 229
              G P +P  DV+     ++ L G           L P++ P P+Y       HP    
Sbjct: 230 MTRGAPPYP--DVNTFDITVYLLQGRRL--------LQPEYCPDPLYEVMLKCWHPKAEM 279
Query: 230 --SFSQVAPKLTA 240
             SFS++  +++A
Sbjct: 280 RPSFSELVSRISA 292

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 113/253 (44%), Gaps = 48/253 (18%)
Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQ-DLKK 72
           A+K  + + + G  S  L E  ++K+  H N++ L  + L SE    +V  +    DL+ 
Sbjct: 62  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 121
Query: 73  YFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR 132
           +  +      +  +  F  Q+ +G+ +  S+  +HRDL  +N ++++   +K+ADFGLAR
Sbjct: 122 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181
Query: 133 AFGIPVKCYSAEVVTLWYRPPDVLFGAKL--------------YTTSIDMWSAGCIFAEL 178
                   Y  E  ++  +      GAKL              +TT  D+WS G +  EL
Sbjct: 182 DM------YDKEYYSVHNKT-----GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 230
Query: 179 ANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY-------HPSM-- 229
              G P +P  DV+     ++ L G           L P++ P P+Y       HP    
Sbjct: 231 MTRGAPPYP--DVNTFDITVYLLQGRRL--------LQPEYCPDPLYEVMLKCWHPKAEM 280
Query: 230 --SFSQVAPKLTA 240
             SFS++  +++A
Sbjct: 281 RPSFSELVSRISA 293

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 76/153 (49%), Gaps = 9/153 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSF 89
           REI +LK L+H NIV+   V +S   + L L+ E+     L+ Y       ID   +  +
Sbjct: 61  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 120
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS----AEV 145
             Q+ +G+ +  ++  +HR+L  +N+L+     +K+ DFGL +      + Y      E 
Sbjct: 121 TSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES 180
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              WY  P+ L  +K ++ + D+WS G +  EL
Sbjct: 181 PIFWY-APESLTESK-FSVASDVWSFGVVLYEL 211

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 40/232 (17%)
Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLA----FCH 101
           IV +Y+ L++ +K  L+   C  D  + F  +    D    +    ++++ +     + H
Sbjct: 90  IVDVYENLYAGRKCLLIVMEC-LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 148
Query: 102 SRNVLHRDLKPQNLLINK---NGELKLADFGLARAF----GIPVKCYSAEVVTLWYRPPD 154
           S N+ HRD+KP+NLL      N  LKL DFG A+       +   CY     T +Y  P+
Sbjct: 149 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-----TPYYVAPE 203
Query: 155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN 214
           VL G + Y  S DMWS G I   L     P +    +                   PGM 
Sbjct: 204 VL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------------PGMK 246
Query: 215 LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                  +    P+  +S+V+ ++    + L++ LL   P QRM+  + M+H
Sbjct: 247 TRIRMGQYEF--PNPEWSEVSEEV----KMLIRNLLKTEPTQRMTITEFMNH 292

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 89/186 (47%), Gaps = 8/186 (4%)
Query: 13  ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLK 71
           ++AIK   +   E      L E  ++ +  H NI+RL  V+   K + +V E+ +   L 
Sbjct: 46  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 105
Query: 72  KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA 131
            +    + +  +  +   +  +  G+ +      +HRDL  +N+LIN N   K++DFGL+
Sbjct: 106 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS 165
Query: 132 RAF-GIPVKCYS---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPLF 186
           R     P   Y+    ++   W  P  + +  + +T++ D+WS G +  E+ + G RP +
Sbjct: 166 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYW 223
Query: 187 PGSDVD 192
             S+ D
Sbjct: 224 EMSNQD 229

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 89/186 (47%), Gaps = 8/186 (4%)
Query: 13  ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLK 71
           ++AIK   +   E      L E  ++ +  H NI+RL  V+   K + +V E+ +   L 
Sbjct: 63  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 122
Query: 72  KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA 131
            +    + +  +  +   +  +  G+ +      +HRDL  +N+LIN N   K++DFGL+
Sbjct: 123 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS 182
Query: 132 RAF-GIPVKCYS---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPLF 186
           R     P   Y+    ++   W  P  + +  + +T++ D+WS G +  E+ + G RP +
Sbjct: 183 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYW 240
Query: 187 PGSDVD 192
             S+ D
Sbjct: 241 EMSNQD 246

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 114/255 (44%), Gaps = 58/255 (22%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDL--DIVKSFM 90
           RE+ +L+++ H NI+ L+DV  +   + L+ E       + FD L  +  L  +   SF+
Sbjct: 64  REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGG--ELFDFLAQKESLSEEEATSFI 121
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQN-LLINKN---GELKLADFGLARA----------FGI 136
            Q+L G+ + H++ + H DLKP+N +L++KN     +KL DFGLA            FG 
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           P +  + E+V   Y P  +           DMWS G I   L +   P            
Sbjct: 182 P-EFVAPEIVN--YEPLGL---------EADMWSIGVITYILLSGASP------------ 217
Query: 197 RIFKLLGTPTEDTWPGMNLLP-DFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPV 255
                LG   ++T   +  +  DF           FSQ +       +D +++LLV    
Sbjct: 218 ----FLGDTKQETLANITAVSYDF-------DEEFFSQTSE----LAKDFIRKLLVKETR 262
Query: 256 QRMSAEDAMSHIYFS 270
           +R++ ++A+ H + +
Sbjct: 263 KRLTIQEALRHPWIT 277

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 76/153 (49%), Gaps = 9/153 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSF 89
           REI +LK L+H NIV+   V +S   + L L+ E+     L+ Y       ID   +  +
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS----AEV 145
             Q+ +G+ +  ++  +HRDL  +N+L+     +K+ DFGL +      + +      E 
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              WY  P+ L  +K ++ + D+WS G +  EL
Sbjct: 180 PIFWY-APESLTESK-FSVASDVWSFGVVLYEL 210

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 113/253 (44%), Gaps = 48/253 (18%)
Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQ-DLKK 72
           A+K  + + + G  S  L E  ++K+  H N++ L  + L SE    +V  +    DL+ 
Sbjct: 60  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 119
Query: 73  YFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR 132
           +  +      +  +  F  Q+ +G+ +  S+  +HRDL  +N ++++   +K+ADFGLAR
Sbjct: 120 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179
Query: 133 AFGIPVKCYSAEVVTLWYRPPDVLFGAKL--------------YTTSIDMWSAGCIFAEL 178
                   Y  E  ++  +      GAKL              +TT  D+WS G +  EL
Sbjct: 180 DM------YDKEYYSVHNKT-----GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 228
Query: 179 ANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY-------HPSM-- 229
              G P +P  DV+     ++ L G           L P++ P P+Y       HP    
Sbjct: 229 MTRGAPPYP--DVNTFDITVYLLQGRRL--------LQPEYCPDPLYEVMLKCWHPKAEM 278
Query: 230 --SFSQVAPKLTA 240
             SFS++  +++A
Sbjct: 279 RPSFSELVSRISA 291

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 113/253 (44%), Gaps = 48/253 (18%)
Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQ-DLKK 72
           A+K  + + + G  S  L E  ++K+  H N++ L  + L SE    +V  +    DL+ 
Sbjct: 57  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 116
Query: 73  YFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR 132
           +  +      +  +  F  Q+ +G+ +  S+  +HRDL  +N ++++   +K+ADFGLAR
Sbjct: 117 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
Query: 133 AFGIPVKCYSAEVVTLWYRPPDVLFGAKL--------------YTTSIDMWSAGCIFAEL 178
                   Y  E  ++  +      GAKL              +TT  D+WS G +  EL
Sbjct: 177 DM------YDKEYYSVHNKT-----GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 225
Query: 179 ANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY-------HPSM-- 229
              G P +P  DV+     ++ L G           L P++ P P+Y       HP    
Sbjct: 226 MTRGAPPYP--DVNTFDITVYLLQGRRL--------LQPEYCPDPLYEVMLKCWHPKAEM 275
Query: 230 --SFSQVAPKLTA 240
             SFS++  +++A
Sbjct: 276 RPSFSELVSRISA 288

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 88/186 (47%), Gaps = 8/186 (4%)
Query: 13  ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLK 71
           ++AIK   +   E      L E  ++ +  H NI+RL  V+   K + +V E+ +   L 
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 72  KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA 131
            +    + +  +  +   +  +  G+ +      +HRDL  +N+LIN N   K++DFGL 
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194
Query: 132 RAF-GIPVKCYS---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPLF 186
           R     P   Y+    ++   W  P  + +  + +T++ D+WS G +  E+ + G RP +
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 187 PGSDVD 192
             S+ D
Sbjct: 253 EMSNQD 258

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 40/232 (17%)
Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLA----FCH 101
           IV +Y+ L++ +K  L+   C  D  + F  +    D    +    ++++ +     + H
Sbjct: 76  IVDVYENLYAGRKCLLIVMEC-LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 102 SRNVLHRDLKPQNLLINK---NGELKLADFGLARAF----GIPVKCYSAEVVTLWYRPPD 154
           S N+ HRD+KP+NLL      N  LKL DFG A+       +   CY     T +Y  P+
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-----TPYYVAPE 189
Query: 155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN 214
           VL G + Y  S DMWS G I   L     P +    +                   PGM 
Sbjct: 190 VL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------------PGMK 232
Query: 215 LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                  +    P+  +S+V+ ++    + L++ LL   P QRM+  + M+H
Sbjct: 233 TRIRMGQYEF--PNPEWSEVSEEV----KMLIRNLLKTEPTQRMTITEFMNH 278

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT----LVFEHCDQDLKKYFDSLNGEIDLDIVKS 88
           RE      L H  IV +YD   +E        +V E+ D    +      G +       
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE 120
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVKCYSAEV 145
            +    + L F H   ++HRD+KP N+LI+    +K+ DFG+ARA    G  V   +A +
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVI 180
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
            T  Y  P+   G  +   S D++S GC+  E+   G P F G
Sbjct: 181 GTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLT-GEPPFTG 221

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 40/232 (17%)
Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLA----FCH 101
           IV +Y+ L++ +K  L+   C  D  + F  +    D    +    ++++ +     + H
Sbjct: 82  IVDVYENLYAGRKCLLIVMEC-LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 140
Query: 102 SRNVLHRDLKPQNLLINK---NGELKLADFGLARAF----GIPVKCYSAEVVTLWYRPPD 154
           S N+ HRD+KP+NLL      N  LKL DFG A+       +   CY     T +Y  P+
Sbjct: 141 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-----TPYYVAPE 195
Query: 155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN 214
           VL G + Y  S DMWS G I   L     P +    +                   PGM 
Sbjct: 196 VL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------------PGMK 238
Query: 215 LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                  +   +P  S      +++ + + L++ LL   P QRM+  + M+H
Sbjct: 239 TRIRMGQYEFPNPEWS------EVSEEVKMLIRNLLKTEPTQRMTITEFMNH 284

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 40/232 (17%)
Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLA----FCH 101
           IV +Y+ L++ +K  L+   C  D  + F  +    D    +    ++++ +     + H
Sbjct: 81  IVDVYENLYAGRKCLLIVMEC-LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 139
Query: 102 SRNVLHRDLKPQNLLINK---NGELKLADFGLARAF----GIPVKCYSAEVVTLWYRPPD 154
           S N+ HRD+KP+NLL      N  LKL DFG A+       +   CY     T +Y  P+
Sbjct: 140 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-----TPYYVAPE 194
Query: 155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN 214
           VL G + Y  S DMWS G I   L     P +    +                   PGM 
Sbjct: 195 VL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------------PGMK 237
Query: 215 LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                  +   +P  S      +++ + + L++ LL   P QRM+  + M+H
Sbjct: 238 TRIRMGQYEFPNPEWS------EVSEEVKMLIRNLLKTEPTQRMTITEFMNH 283

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 11/159 (6%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY-- 91
           EI +L    H NIV+L D  + E  L ++ E C        D++  E++  + +S +   
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFC---AGGAVDAVMLELERPLTESQIQVV 140
Query: 92  --QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW 149
             Q L  L + H   ++HRDLK  N+L   +G++KLADFG++      ++   + + T +
Sbjct: 141 CKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPY 200
Query: 150 YRPPDVLF----GAKLYTTSIDMWSAGCIFAELANAGRP 184
           +  P+V+       + Y    D+WS G    E+A    P
Sbjct: 201 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 40/232 (17%)
Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLA----FCH 101
           IV +Y+ L++ +K  L+   C  D  + F  +    D    +    ++++ +     + H
Sbjct: 120 IVDVYENLYAGRKCLLIVMEC-LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 178
Query: 102 SRNVLHRDLKPQNLLINK---NGELKLADFGLARAF----GIPVKCYSAEVVTLWYRPPD 154
           S N+ HRD+KP+NLL      N  LKL DFG A+       +   CY     T +Y  P+
Sbjct: 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-----TPYYVAPE 233
Query: 155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN 214
           VL G + Y  S DMWS G I   L     P +    +                   PGM 
Sbjct: 234 VL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------------PGMK 276
Query: 215 LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                  +    P+  +S+V+ ++    + L++ LL   P QRM+  + M+H
Sbjct: 277 TRIRMGQYEF--PNPEWSEVSEEV----KMLIRNLLKTEPTQRMTITEFMNH 322

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 40/232 (17%)
Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLA----FCH 101
           IV +Y+ L++ +K  L+   C  D  + F  +    D    +    ++++ +     + H
Sbjct: 75  IVDVYENLYAGRKCLLIVMEC-LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 133
Query: 102 SRNVLHRDLKPQNLLINK---NGELKLADFGLARAF----GIPVKCYSAEVVTLWYRPPD 154
           S N+ HRD+KP+NLL      N  LKL DFG A+       +   CY     T +Y  P+
Sbjct: 134 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-----TPYYVAPE 188
Query: 155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN 214
           VL G + Y  S DMWS G I   L     P +    +                   PGM 
Sbjct: 189 VL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------------PGMK 231
Query: 215 LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                  +    P+  +S+V+ ++    + L++ LL   P QRM+  + M+H
Sbjct: 232 TRIRMGQYEF--PNPEWSEVSEEV----KMLIRNLLKTEPTQRMTITEFMNH 277

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 40/232 (17%)
Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLA----FCH 101
           IV +Y+ L++ +K  L+   C  D  + F  +    D    +    ++++ +     + H
Sbjct: 80  IVDVYENLYAGRKCLLIVMEC-LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 138
Query: 102 SRNVLHRDLKPQNLLINK---NGELKLADFGLARAF----GIPVKCYSAEVVTLWYRPPD 154
           S N+ HRD+KP+NLL      N  LKL DFG A+       +   CY     T +Y  P+
Sbjct: 139 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-----TPYYVAPE 193
Query: 155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN 214
           VL G + Y  S DMWS G I   L     P +    +                   PGM 
Sbjct: 194 VL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------------PGMK 236
Query: 215 LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                  +   +P  S      +++ + + L++ LL   P QRM+  + M+H
Sbjct: 237 TRIRMGQYEFPNPEWS------EVSEEVKMLIRNLLKTEPTQRMTITEFMNH 282

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 40/232 (17%)
Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLA----FCH 101
           IV +Y+ L++ +K  L+   C  D  + F  +    D    +    ++++ +     + H
Sbjct: 76  IVDVYENLYAGRKCLLIVMEC-LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 102 SRNVLHRDLKPQNLLINK---NGELKLADFGLARAF----GIPVKCYSAEVVTLWYRPPD 154
           S N+ HRD+KP+NLL      N  LKL DFG A+       +   CY     T +Y  P+
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-----TPYYVAPE 189
Query: 155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN 214
           VL G + Y  S DMWS G I   L     P +    +                   PGM 
Sbjct: 190 VL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------------PGMK 232
Query: 215 LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                  +    P+  +S+V+ ++    + L++ LL   P QRM+  + M+H
Sbjct: 233 TRIRMGQYEF--PNPEWSEVSEEV----KMLIRNLLKTEPTQRMTITEFMNH 278

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 40/232 (17%)
Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLA----FCH 101
           IV +Y+ L++ +K  L+   C  D  + F  +    D    +    ++++ +     + H
Sbjct: 74  IVDVYENLYAGRKCLLIVMEC-LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 132
Query: 102 SRNVLHRDLKPQNLLINK---NGELKLADFGLARAF----GIPVKCYSAEVVTLWYRPPD 154
           S N+ HRD+KP+NLL      N  LKL DFG A+       +   CY     T +Y  P+
Sbjct: 133 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-----TPYYVAPE 187
Query: 155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN 214
           VL G + Y  S DMWS G I   L     P +    +                   PGM 
Sbjct: 188 VL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------------PGMK 230
Query: 215 LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                  +    P+  +S+V+ ++    + L++ LL   P QRM+  + M+H
Sbjct: 231 TRIRMGQYEF--PNPEWSEVSEEV----KMLIRNLLKTEPTQRMTITEFMNH 276

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 40/232 (17%)
Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLA----FCH 101
           IV +Y+ L++ +K  L+   C  D  + F  +    D    +    ++++ +     + H
Sbjct: 126 IVDVYENLYAGRKCLLIVMEC-LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 184
Query: 102 SRNVLHRDLKPQNLLINK---NGELKLADFGLARAF----GIPVKCYSAEVVTLWYRPPD 154
           S N+ HRD+KP+NLL      N  LKL DFG A+       +   CY     T +Y  P+
Sbjct: 185 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-----TPYYVAPE 239
Query: 155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN 214
           VL G + Y  S DMWS G I   L     P +    +                   PGM 
Sbjct: 240 VL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------------PGMK 282
Query: 215 LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                  +    P+  +S+V+ ++    + L++ LL   P QRM+  + M+H
Sbjct: 283 TRIRMGQYEF--PNPEWSEVSEEV----KMLIRNLLKTEPTQRMTITEFMNH 328

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 39/205 (19%)
Query: 10  PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ- 68
           P T +A+K      +  + +   RE  L+ E  + NIV+L  V    K + L+FE+    
Sbjct: 76  PFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYG 135
Query: 69  DLKKYFDSLNGEIDLDIVKS-----------------------FMYQLLRGLAFCHSRNV 105
           DL ++  S++      +  S                          Q+  G+A+   R  
Sbjct: 136 DLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF 195
Query: 106 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA--------EVVTLWYRPPDVLF 157
           +HRDL  +N L+ +N  +K+ADFGL+R        YSA        + + + + PP+ +F
Sbjct: 196 VHRDLATRNCLVGENMVVKIADFGLSR------NIYSADYYKADGNDAIPIRWMPPESIF 249
Query: 158 GAKLYTTSIDMWSAGCIFAELANAG 182
             + YTT  D+W+ G +  E+ + G
Sbjct: 250 YNR-YTTESDVWAYGVVLWEIFSYG 273

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 6/158 (3%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVK--S 88
           LRE+ ++K L+H NIV     +     L++V E+  +  L +          LD  +  S
Sbjct: 82  LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLS 141
Query: 89  FMYQLLRGLAFCHSRN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
             Y + +G+ + H+RN  ++HR+LK  NLL++K   +K+ DFGL+R          +   
Sbjct: 142 MAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAG 201
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRP 184
           T  +  P+VL        S D++S G I  ELA   +P
Sbjct: 202 TPEWMAPEVLRDEPSNEKS-DVYSFGVILWELATLQQP 238

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 34/222 (15%)
Query: 5   GVDRTPNT-ALAIKGTHLVGNEGVPSSALREICLLKELK-------HKNIVRLYDVLHSE 56
           G+D+T     +A+K    +  EG   S  R   L+ ELK       H N+V L       
Sbjct: 52  GIDKTATXRTVAVK----MLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKP 105
Query: 57  KK-LTLVFEHCD-QDLKKYFDSLNGEI----DLDIVKSFM---------YQLLRGLAFCH 101
              L ++ E C   +L  Y  S   E       D+ K F+         +Q+ +G+ F  
Sbjct: 106 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLA 165
Query: 102 SRNVLHRDLKPQNLLINKNGELKLADFGLARAFGI---PVKCYSAEVVTLWYRPPDVLFG 158
           SR  +HRDL  +N+L+++   +K+ DFGLAR        V+   A +   W  P  +   
Sbjct: 166 SRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIF-- 223
Query: 159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
            ++YT   D+WS G +  E+ + G   +PG  +D++  R  K
Sbjct: 224 DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 78/150 (52%), Gaps = 12/150 (8%)
Query: 55  SEKKLTLVFEH-CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQ 113
            EK L+ V E    +DL K F      + L+ +  + +Q+ +G+ F  SR  +HRDL  +
Sbjct: 169 EEKSLSDVEEEEAPEDLYKDF------LTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 222
Query: 114 NLLINKNGELKLADFGLAR-AFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWS 170
           N+L+++   +K+ DFGLAR  +  P  V+   A +   W  P  +    ++YT   D+WS
Sbjct: 223 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWS 280
Query: 171 AGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
            G +  E+ + G   +PG  +D++  R  K
Sbjct: 281 FGVLLWEIFSLGASPYPGVKIDEEFCRRLK 310

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 78/150 (52%), Gaps = 12/150 (8%)
Query: 55  SEKKLTLVFEH-CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQ 113
            EK L+ V E    +DL K F      + L+ +  + +Q+ +G+ F  SR  +HRDL  +
Sbjct: 176 EEKSLSDVEEEEAPEDLYKDF------LTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 229
Query: 114 NLLINKNGELKLADFGLAR-AFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWS 170
           N+L+++   +K+ DFGLAR  +  P  V+   A +   W  P  +    ++YT   D+WS
Sbjct: 230 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWS 287
Query: 171 AGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
            G +  E+ + G   +PG  +D++  R  K
Sbjct: 288 FGVLLWEIFSLGASPYPGVKIDEEFCRRLK 317

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 11/159 (6%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY-- 91
           EI +L    H NIV+L D  + E  L ++ E C        D++  E++  + +S +   
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFC---AGGAVDAVMLELERPLTESQIQVV 140
Query: 92  --QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW 149
             Q L  L + H   ++HRDLK  N+L   +G++KLADFG++      ++   + + T +
Sbjct: 141 CKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPY 200
Query: 150 YRPPDVLF----GAKLYTTSIDMWSAGCIFAELANAGRP 184
           +  P+V+       + Y    D+WS G    E+A    P
Sbjct: 201 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 73/167 (43%), Gaps = 9/167 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT----LVFEHCDQDLKKYFDSLNGEIDLDIVKS 88
           RE      L H  IV +YD   +E        +V E+ D    +      G +       
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE 120
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVKCYSAEV 145
            +    + L F H   ++HRD+KP N++I+    +K+ DFG+ARA    G  V   +A +
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD 192
            T  Y  P+   G  +   S D++S GC+  E+   G P F G   D
Sbjct: 181 GTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLT-GEPPFTGDSPD 225

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 78/150 (52%), Gaps = 12/150 (8%)
Query: 55  SEKKLTLVFEH-CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQ 113
            EK L+ V E    +DL K F      + L+ +  + +Q+ +G+ F  SR  +HRDL  +
Sbjct: 174 EEKSLSDVEEEEAPEDLYKDF------LTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 227
Query: 114 NLLINKNGELKLADFGLAR-AFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWS 170
           N+L+++   +K+ DFGLAR  +  P  V+   A +   W  P  +    ++YT   D+WS
Sbjct: 228 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWS 285
Query: 171 AGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
            G +  E+ + G   +PG  +D++  R  K
Sbjct: 286 FGVLLWEIFSLGASPYPGVKIDEEFCRRLK 315

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 101/224 (45%), Gaps = 36/224 (16%)
Query: 5   GVDRTPNT-ALAIKGTHLVGNEGVPSSALREICLLKELK-------HKNIVRLYDVLHSE 56
           G+D+T     +A+K    +  EG   S  R   L+ ELK       H N+V L       
Sbjct: 87  GIDKTATCRTVAVK----MLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKP 140
Query: 57  KK-LTLVFEHCD-QDLKKYFDSLNGEI------DLDIVKSFM---------YQLLRGLAF 99
              L ++ E C   +L  Y  S   E         D+ K F+         +Q+ +G+ F
Sbjct: 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 200
Query: 100 CHSRNVLHRDLKPQNLLINKNGELKLADFGLAR-AFGIP--VKCYSAEVVTLWYRPPDVL 156
             SR  +HRDL  +N+L+++   +K+ DFGLAR  +  P  V+   A +   W  P  + 
Sbjct: 201 LASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 260
Query: 157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
              ++YT   D+WS G +  E+ + G   +PG  +D++  R  K
Sbjct: 261 --DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 302

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 88/186 (47%), Gaps = 8/186 (4%)
Query: 13  ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLK 71
           ++AIK   +   E      L E  ++ +  H NI+RL  V+   K + +V E  +   L 
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD 134
Query: 72  KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA 131
            +    + +  +  +   +  +  G+ +      +HRDL  +N+LIN N   K++DFGL+
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 132 RAF-GIPVKCYS---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPLF 186
           R     P   Y+    ++   W  P  + +  + +T++ D+WS G +  E+ + G RP +
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 187 PGSDVD 192
             S+ D
Sbjct: 253 EMSNQD 258

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 78/150 (52%), Gaps = 12/150 (8%)
Query: 55  SEKKLTLVFEH-CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQ 113
            EK L+ V E    +DL K F      + L+ +  + +Q+ +G+ F  SR  +HRDL  +
Sbjct: 167 EEKSLSDVEEEEAPEDLYKDF------LTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 220
Query: 114 NLLINKNGELKLADFGLAR-AFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWS 170
           N+L+++   +K+ DFGLAR  +  P  V+   A +   W  P  +    ++YT   D+WS
Sbjct: 221 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWS 278
Query: 171 AGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
            G +  E+ + G   +PG  +D++  R  K
Sbjct: 279 FGVLLWEIFSLGASPYPGVKIDEEFCRRLK 308

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 111/258 (43%), Gaps = 43/258 (16%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE---IDLDIVKSFM 90
           EI ++ +L H  ++ L+D    + ++ L+ E       + FD +  E   +    V ++M
Sbjct: 98  EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG--ELFDRIAAEDYKMSEAEVINYM 155
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLL--INKNGELKLADFGLARAFGIPVKCYSAEVVTL 148
            Q   GL   H  +++H D+KP+N++    K   +K+ DFGLA     P +       T 
Sbjct: 156 RQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATA 214
Query: 149 WYRPPDVL--FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
            +  P+++       YT   DMW+ G +   L +   P F G D  + L+ + +      
Sbjct: 215 EFAAPEIVDREPVGFYT---DMWAIGVLGYVLLSGLSP-FAGEDDLETLQNVKRCDWEFD 270
Query: 207 EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
           ED                     +FS V+P    + +D ++ LL   P +R++  DA+ H
Sbjct: 271 ED---------------------AFSSVSP----EAKDFIKNLLQKEPRKRLTVHDALEH 305
Query: 267 IYF----SDLNVAIKSER 280
            +     S+L   I S R
Sbjct: 306 PWLKGDHSNLTSRIPSSR 323

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 2/167 (1%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQL 93
           EI + + L H+++V  +        + +V E C +            +     + ++ Q+
Sbjct: 71  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 130
Query: 94  LRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP 153
           + G  + H   V+HRDLK  NL +N++ E+K+ DFGLA       +       T  Y  P
Sbjct: 131 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 190
Query: 154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           +VL   K ++  +D+WS GCI   L   G+P F  S + +   RI K
Sbjct: 191 EVL-SKKGHSFEVDVWSIGCIMYTLL-VGKPPFETSCLKETYLRIKK 235

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 8/181 (4%)
Query: 8   RTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD 67
           R     +AIK       +      +RE  ++ +L +  IVRL  V  +E  L LV E   
Sbjct: 34  RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAG 92
Query: 68  QD-LKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLA 126
              L K+      EI +  V   ++Q+  G+ +   +N +HRDL  +N+L+      K++
Sbjct: 93  GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKIS 152
Query: 127 DFGLARAFGIPVKCYSAEVVT----LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
           DFGL++A G     Y+A         WY P  + F  + +++  D+WS G    E  + G
Sbjct: 153 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYG 210
Query: 183 R 183
           +
Sbjct: 211 Q 211

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 80/155 (51%), Gaps = 11/155 (7%)
Query: 49  LYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHR 108
           L   L S++   + ++   +DL K F      + L+ +  + +Q+ +G+ F  SR  +HR
Sbjct: 110 LSTYLRSKRNEFVPYKVAPEDLYKDF------LTLEHLICYSFQVAKGMEFLASRKCIHR 163
Query: 109 DLKPQNLLINKNGELKLADFGLAR-AFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTS 165
           DL  +N+L+++   +K+ DFGLAR  +  P  V+   A +   W  P  +    ++YT  
Sbjct: 164 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQ 221
Query: 166 IDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
            D+WS G +  E+ + G   +PG  +D++  R  K
Sbjct: 222 SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 256

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 2/167 (1%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQL 93
           EI + + L H+++V  +        + +V E C +            +     + ++ Q+
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 126
Query: 94  LRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP 153
           + G  + H   V+HRDLK  NL +N++ E+K+ DFGLA       +       T  Y  P
Sbjct: 127 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 186
Query: 154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           +VL   K ++  +D+WS GCI   L   G+P F  S + +   RI K
Sbjct: 187 EVL-SKKGHSFEVDVWSIGCIMYTLL-VGKPPFETSCLKETYLRIKK 231

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 80/155 (51%), Gaps = 11/155 (7%)
Query: 49  LYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHR 108
           L   L S++   + ++   +DL K F      + L+ +  + +Q+ +G+ F  SR  +HR
Sbjct: 110 LSTYLRSKRNEFVPYKVAPEDLYKDF------LTLEHLICYSFQVAKGMEFLASRKCIHR 163
Query: 109 DLKPQNLLINKNGELKLADFGLAR-AFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTS 165
           DL  +N+L+++   +K+ DFGLAR  +  P  V+   A +   W  P  +    ++YT  
Sbjct: 164 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQ 221
Query: 166 IDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
            D+WS G +  E+ + G   +PG  +D++  R  K
Sbjct: 222 SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 256

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 79/151 (52%), Gaps = 11/151 (7%)
Query: 53  LHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKP 112
           L S++   + ++   +DL K F      + L+ +  + +Q+ +G+ F  SR  +HRDL  
Sbjct: 123 LRSKRNEFVPYKVAPEDLYKDF------LTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 176
Query: 113 QNLLINKNGELKLADFGLAR-AFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMW 169
           +N+L+++   +K+ DFGLAR  +  P  V+   A +   W  P  +    ++YT   D+W
Sbjct: 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVW 234
Query: 170 SAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           S G +  E+ + G   +PG  +D++  R  K
Sbjct: 235 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 2/167 (1%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQL 93
           EI + + L H+++V  +        + +V E C +            +     + ++ Q+
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 126
Query: 94  LRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP 153
           + G  + H   V+HRDLK  NL +N++ E+K+ DFGLA       +       T  Y  P
Sbjct: 127 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 186
Query: 154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           +VL   K ++  +D+WS GCI   L   G+P F  S + +   RI K
Sbjct: 187 EVL-SKKGHSFEVDVWSIGCIMYTLL-VGKPPFETSCLKETYLRIKK 231

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 2/167 (1%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQL 93
           EI + + L H+++V  +        + +V E C +            +     + ++ Q+
Sbjct: 65  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 124
Query: 94  LRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP 153
           + G  + H   V+HRDLK  NL +N++ E+K+ DFGLA       +       T  Y  P
Sbjct: 125 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 184
Query: 154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           +VL   K ++  +D+WS GCI   L   G+P F  S + +   RI K
Sbjct: 185 EVL-SKKGHSFEVDVWSIGCIMYTLL-VGKPPFETSCLKETYLRIKK 229

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 80/155 (51%), Gaps = 11/155 (7%)
Query: 49  LYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHR 108
           L   L S++   + ++   +DL K F      + L+ +  + +Q+ +G+ F  SR  +HR
Sbjct: 119 LSTYLRSKRNEFVPYKVAPEDLYKDF------LTLEHLICYSFQVAKGMEFLASRKCIHR 172
Query: 109 DLKPQNLLINKNGELKLADFGLAR-AFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTS 165
           DL  +N+L+++   +K+ DFGLAR  +  P  V+   A +   W  P  +    ++YT  
Sbjct: 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIF--DRVYTIQ 230
Query: 166 IDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
            D+WS G +  E+ + G   +PG  +D++  R  K
Sbjct: 231 SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 2/167 (1%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQL 93
           EI + + L H+++V  +        + +V E C +            +     + ++ Q+
Sbjct: 89  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 148
Query: 94  LRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP 153
           + G  + H   V+HRDLK  NL +N++ E+K+ DFGLA       +       T  Y  P
Sbjct: 149 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 208
Query: 154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           +VL   K ++  +D+WS GCI   L   G+P F  S + +   RI K
Sbjct: 209 EVL-SKKGHSFEVDVWSIGCIMYTLL-VGKPPFETSCLKETYLRIKK 253

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 35/223 (15%)
Query: 5   GVDRTPNT-ALAIKGTHLVGNEGVPSSALREICLLKELK-------HKNIVRLYDVLHSE 56
           G+D+T     +A+K    +  EG   S  R   L+ ELK       H N+V L       
Sbjct: 51  GIDKTATCRTVAVK----MLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKP 104
Query: 57  KK-LTLVFEHCD-QDLKKYFDSLNGEI-----DLDIVKSFM---------YQLLRGLAFC 100
              L ++ E C   +L  Y  S   E        D+ K F+         +Q+ +G+ F 
Sbjct: 105 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFL 164
Query: 101 HSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGI---PVKCYSAEVVTLWYRPPDVLF 157
            SR  +HRDL  +N+L+++   +K+ DFGLAR        V+   A +   W  P  +  
Sbjct: 165 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIF- 223
Query: 158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
             ++YT   D+WS G +  E+ + G   +PG  +D++  R  K
Sbjct: 224 -DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 88/185 (47%), Gaps = 8/185 (4%)
Query: 14  LAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKK 72
           +AIK   +   E      L E  ++ +  H NI+ L  V+   K + +V E+ +   L  
Sbjct: 53  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDT 112
Query: 73  YFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR 132
           +    +G+  +  +   +  +  G+ +      +HRDL  +N+LIN N   K++DFGL+R
Sbjct: 113 FLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSR 172
Query: 133 AF-GIPVKCYS---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPLFP 187
                P   Y+    ++   W  P  + F  + +T++ D+WS G +  E+ + G RP + 
Sbjct: 173 VLEDDPEAAYTTRGGKIPIRWTAPEAIAF--RKFTSASDVWSYGIVMWEVVSYGERPYWE 230
Query: 188 GSDVD 192
            ++ D
Sbjct: 231 MTNQD 235

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 2/167 (1%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQL 93
           EI + + L H+++V  +        + +V E C +            +     + ++ Q+
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 150
Query: 94  LRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP 153
           + G  + H   V+HRDLK  NL +N++ E+K+ DFGLA       +       T  Y  P
Sbjct: 151 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 210
Query: 154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           +VL   K ++  +D+WS GCI   L   G+P F  S + +   RI K
Sbjct: 211 EVL-SKKGHSFEVDVWSIGCIMYTLL-VGKPPFETSCLKETYLRIKK 255

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 9/153 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSF 89
           REI +LK L+H NIV+   V +S   + L L+ E+     L+ Y       ID   +  +
Sbjct: 91  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 150
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS----AEV 145
             Q+ +G+ +  ++  +HRDL  +N+L+     +K+ DFGL +      +        E 
Sbjct: 151 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 210
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              WY  P+ L  +K ++ + D+WS G +  EL
Sbjct: 211 PIFWY-APESLTESK-FSVASDVWSFGVVLYEL 241

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 78/155 (50%), Gaps = 11/155 (7%)
Query: 49  LYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHR 108
           L   L S++   + ++   +DL K F      + L+ +  + +Q+ +G+ F  SR  +HR
Sbjct: 110 LSTYLRSKRNEFVPYKVAPEDLYKDF------LTLEHLICYSFQVAKGMEFLASRKCIHR 163
Query: 109 DLKPQNLLINKNGELKLADFGLARAFGI---PVKCYSAEVVTLWYRPPDVLFGAKLYTTS 165
           DL  +N+L+++   +K+ DFGLAR        V+   A +   W  P  +    ++YT  
Sbjct: 164 DLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIF--DRVYTIQ 221
Query: 166 IDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
            D+WS G +  E+ + G   +PG  +D++  R  K
Sbjct: 222 SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 256

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 78/155 (50%), Gaps = 11/155 (7%)
Query: 49  LYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHR 108
           L   L S++   + ++   +DL K F      + L+ +  + +Q+ +G+ F  SR  +HR
Sbjct: 110 LSTYLRSKRNEFVPYKVAPEDLYKDF------LTLEHLICYSFQVAKGMEFLASRKCIHR 163
Query: 109 DLKPQNLLINKNGELKLADFGLARAFGI---PVKCYSAEVVTLWYRPPDVLFGAKLYTTS 165
           DL  +N+L+++   +K+ DFGLAR        V+   A +   W  P  +    ++YT  
Sbjct: 164 DLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIF--DRVYTIQ 221
Query: 166 IDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
            D+WS G +  E+ + G   +PG  +D++  R  K
Sbjct: 222 SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 256

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT----LVFEHCDQDLKKYFDSLNGEIDLDIVKS 88
           RE      L H  IV +YD   +E        +V E+ D    +      G +       
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE 120
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVKCYSAEV 145
            +    + L F H   ++HRD+KP N++I+    +K+ DFG+ARA    G  V   +A +
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
            T  Y  P+   G  +   S D++S GC+  E+   G P F G
Sbjct: 181 GTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLT-GEPPFTG 221

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 104/239 (43%), Gaps = 31/239 (12%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE-IDLDIVKSFM 90
           + EI +++E K+ NIV   D      +L +V E+         D +    +D   + +  
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVC 122
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWY 150
            + L+ L F HS  V+HRD+K  N+L+  +G +KL DFG            S  V T ++
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYW 182
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTW 210
             P+V+   K Y   +D+WS G +  E+   G P +    +++   R   L+ T      
Sbjct: 183 MAPEVVT-RKAYGPKVDIWSLGIMAIEMIE-GEPPY----LNENPLRALYLIAT------ 230
Query: 211 PGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
              N  P+              Q   KL+A  RD L R L  +  +R SA++ + H + 
Sbjct: 231 ---NGTPEL-------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 88/186 (47%), Gaps = 8/186 (4%)
Query: 13  ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLK 71
           ++AIK   +   E      L E  ++ +  H NI+RL  V+   K + +V E  +   L 
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD 134
Query: 72  KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA 131
            +    + +  +  +   +  +  G+ +      +HRDL  +N+LIN N   K++DFGL+
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 132 RAF-GIPVKCYS---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPLF 186
           R     P   Y+    ++   W  P  + +  + +T++ D+WS G +  E+ + G RP +
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 187 PGSDVD 192
             S+ D
Sbjct: 253 EMSNQD 258

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 9/153 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSF 89
           REI +LK L+H NIV+   V +S   + L L+ E+     L+ Y       ID   +  +
Sbjct: 64  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 123
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS----AEV 145
             Q+ +G+ +  ++  +HRDL  +N+L+     +K+ DFGL +      +        E 
Sbjct: 124 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 183
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              WY  P+ L  +K ++ + D+WS G +  EL
Sbjct: 184 PIFWY-APESLTESK-FSVASDVWSFGVVLYEL 214

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 11/159 (6%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY-- 91
           EI +L    H NIV+L D  + E  L ++ E C        D++  E++  + +S +   
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFC---AGGAVDAVMLELERPLTESQIQVV 140
Query: 92  --QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW 149
             Q L  L + H   ++HRDLK  N+L   +G++KLADFG++      ++     + T +
Sbjct: 141 CKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPY 200
Query: 150 YRPPDVLF----GAKLYTTSIDMWSAGCIFAELANAGRP 184
           +  P+V+       + Y    D+WS G    E+A    P
Sbjct: 201 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 101/235 (42%), Gaps = 40/235 (17%)
Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLA----FCH 101
           IV +Y+ L++ +K  L+   C  D  + F  +    D    +    ++++ +     + H
Sbjct: 74  IVDVYENLYAGRKCLLIVMEC-LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 132
Query: 102 SRNVLHRDLKPQNLLINK---NGELKLADFGLARAF----GIPVKCYSAEVVTLWYRPPD 154
           S N+ HRD+KP+NLL      N  LKL DFG A+       +   CY     T +Y  P+
Sbjct: 133 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCY-----TPYYVAPE 187
Query: 155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN 214
           VL G + Y  S DMWS G I   L     P +    +                   PGM 
Sbjct: 188 VL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------------PGMK 230
Query: 215 LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
                  +    P+  +S+V+ ++    + L++ LL   P QRM+  + M+H + 
Sbjct: 231 TRIRMGQYEF--PNPEWSEVSEEV----KMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 9/153 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSF 89
           REI +LK L+H NIV+   V +S   + L L+ E+     L+ Y       ID   +  +
Sbjct: 78  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 137
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS----AEV 145
             Q+ +G+ +  ++  +HRDL  +N+L+     +K+ DFGL +      +        E 
Sbjct: 138 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 197
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              WY  P+ L  +K ++ + D+WS G +  EL
Sbjct: 198 PIFWY-APESLTESK-FSVASDVWSFGVVLYEL 228

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 9/153 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSF 89
           REI +LK L+H NIV+   V +S   + L L+ E+     L+ Y       ID   +  +
Sbjct: 59  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 118
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS----AEV 145
             Q+ +G+ +  ++  +HRDL  +N+L+     +K+ DFGL +      +        E 
Sbjct: 119 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 178
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              WY  P+ L  +K ++ + D+WS G +  EL
Sbjct: 179 PIFWY-APESLTESK-FSVASDVWSFGVVLYEL 209

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 87/184 (47%), Gaps = 13/184 (7%)
Query: 14  LAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ----D 69
           +AIK  +L   +      L+EI  + +  H NIV  Y     + +L LV +        D
Sbjct: 43  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 102
Query: 70  LKKYF----DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
           + K+     +  +G +D   + + + ++L GL + H    +HRD+K  N+L+ ++G +++
Sbjct: 103 IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQI 162
Query: 126 ADFGLAR--AFGIPV---KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           ADFG++   A G  +   K     V T  +  P+V+   + Y    D+WS G    ELA 
Sbjct: 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELAT 222
Query: 181 AGRP 184
              P
Sbjct: 223 GAAP 226

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 9/153 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSF 89
           REI +LK L+H NIV+   V +S   + L L+ E+     L+ Y       ID   +  +
Sbjct: 63  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 122
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS----AEV 145
             Q+ +G+ +  ++  +HRDL  +N+L+     +K+ DFGL +      +        E 
Sbjct: 123 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              WY  P+ L  +K ++ + D+WS G +  EL
Sbjct: 183 PIFWY-APESLTESK-FSVASDVWSFGVVLYEL 213

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 9/153 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSF 89
           REI +LK L+H NIV+   V +S   + L L+ E+     L+ Y       ID   +  +
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS----AEV 145
             Q+ +G+ +  ++  +HRDL  +N+L+     +K+ DFGL +      +        E 
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 179
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              WY  P+ L  +K ++ + D+WS G +  EL
Sbjct: 180 PIFWY-APESLTESK-FSVASDVWSFGVVLYEL 210

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 78/155 (50%), Gaps = 11/155 (7%)
Query: 49  LYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHR 108
           L   L S++   + ++   +DL K F      + L+ +  + +Q+ +G+ F  SR  +HR
Sbjct: 119 LSTYLRSKRNEFVPYKVAPEDLYKDF------LTLEHLICYSFQVAKGMEFLASRKCIHR 172
Query: 109 DLKPQNLLINKNGELKLADFGLARAFGI---PVKCYSAEVVTLWYRPPDVLFGAKLYTTS 165
           DL  +N+L+++   +K+ DFGLAR        V+   A +   W  P  +    ++YT  
Sbjct: 173 DLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIF--DRVYTIQ 230
Query: 166 IDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
            D+WS G +  E+ + G   +PG  +D++  R  K
Sbjct: 231 SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT----LVFEHCDQDLKKYFDSLNGEIDLDIVKS 88
           RE      L H  IV +YD   +E        +V E+ D    +      G +       
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE 120
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVKCYSAEV 145
            +    + L F H   ++HRD+KP N++I+    +K+ DFG+ARA    G  V   +A +
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
            T  Y  P+   G  +   S D++S GC+  E+   G P F G
Sbjct: 181 GTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLT-GEPPFTG 221

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 9/153 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSF 89
           REI +LK L+H NIV+   V +S   + L L+ E+     L+ Y       ID   +  +
Sbjct: 67  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 126
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS----AEV 145
             Q+ +G+ +  ++  +HRDL  +N+L+     +K+ DFGL +      +        E 
Sbjct: 127 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 186
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              WY  P+ L  +K ++ + D+WS G +  EL
Sbjct: 187 PIFWY-APESLTESK-FSVASDVWSFGVVLYEL 217

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 87/184 (47%), Gaps = 13/184 (7%)
Query: 14  LAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ----D 69
           +AIK  +L   +      L+EI  + +  H NIV  Y     + +L LV +        D
Sbjct: 38  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 97
Query: 70  LKKYF----DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
           + K+     +  +G +D   + + + ++L GL + H    +HRD+K  N+L+ ++G +++
Sbjct: 98  IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQI 157
Query: 126 ADFGLAR--AFGIPV---KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           ADFG++   A G  +   K     V T  +  P+V+   + Y    D+WS G    ELA 
Sbjct: 158 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELAT 217
Query: 181 AGRP 184
              P
Sbjct: 218 GAAP 221

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 104/239 (43%), Gaps = 31/239 (12%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE-IDLDIVKSFM 90
           + EI +++E K+ NIV   D      +L +V E+         D +    +D   + +  
Sbjct: 66  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVC 123
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWY 150
            + L+ L F HS  V+HRD+K  N+L+  +G +KL DFG            S  V T ++
Sbjct: 124 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYW 183
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTW 210
             P+V+   K Y   +D+WS G +  E+   G P +    +++   R   L+ T      
Sbjct: 184 MAPEVV-TRKAYGPKVDIWSLGIMAIEMIE-GEPPY----LNENPLRALYLIAT------ 231
Query: 211 PGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
              N  P+              Q   KL+A  RD L R L  +  +R SA++ + H + 
Sbjct: 232 ---NGTPEL-------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 9/153 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSF 89
           REI +LK L+H NIV+   V +S   + L L+ E+     L+ Y       ID   +  +
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS----AEV 145
             Q+ +G+ +  ++  +HRDL  +N+L+     +K+ DFGL +      +        E 
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 179
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              WY  P+ L  +K ++ + D+WS G +  EL
Sbjct: 180 PIFWY-APESLTESK-FSVASDVWSFGVVLYEL 210

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 88/186 (47%), Gaps = 8/186 (4%)
Query: 13  ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLK 71
           ++AIK   +   E      L E  ++ +  H NI+RL  V+   K + +V E  +   L 
Sbjct: 46  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD 105
Query: 72  KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA 131
            +    + +  +  +   +  +  G+ +      +HRDL  +N+LIN N   K++DFGL+
Sbjct: 106 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS 165
Query: 132 RAF-GIPVKCYS---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPLF 186
           R     P   Y+    ++   W  P  + +  + +T++ D+WS G +  E+ + G RP +
Sbjct: 166 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYW 223
Query: 187 PGSDVD 192
             S+ D
Sbjct: 224 EMSNQD 229

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 104/239 (43%), Gaps = 31/239 (12%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE-IDLDIVKSFM 90
           + EI +++E K+ NIV   D      +L +V E+         D +    +D   + +  
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVC 122
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWY 150
            + L+ L F HS  V+HRD+K  N+L+  +G +KL DFG            S  V T ++
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTW 210
             P+V+   K Y   +D+WS G +  E+   G P +    +++   R   L+ T      
Sbjct: 183 MAPEVVT-RKAYGPKVDIWSLGIMAIEMIE-GEPPY----LNENPLRALYLIAT------ 230
Query: 211 PGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
              N  P+              Q   KL+A  RD L R L  +  +R SA++ + H + 
Sbjct: 231 ---NGTPEL-------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 9/153 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSF 89
           REI +LK L+H NIV+   V +S   + L L+ E+     L+ Y       ID   +  +
Sbjct: 58  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 117
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS----AEV 145
             Q+ +G+ +  ++  +HRDL  +N+L+     +K+ DFGL +      +        E 
Sbjct: 118 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 177
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              WY  P+ L  +K ++ + D+WS G +  EL
Sbjct: 178 PIFWY-APESLTESK-FSVASDVWSFGVVLYEL 208

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 9/153 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSF 89
           REI +LK L+H NIV+   V +S   + L L+ E+     L+ Y       ID   +  +
Sbjct: 65  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 124
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS----AEV 145
             Q+ +G+ +  ++  +HRDL  +N+L+     +K+ DFGL +      +        E 
Sbjct: 125 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 184
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              WY  P+ L  +K ++ + D+WS G +  EL
Sbjct: 185 PIFWY-APESLTESK-FSVASDVWSFGVVLYEL 215

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 9/153 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSF 89
           REI +LK L+H NIV+   V +S   + L L+ E+     L+ Y       ID   +  +
Sbjct: 78  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 137
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS----AEV 145
             Q+ +G+ +  ++  +HRDL  +N+L+     +K+ DFGL +      +        E 
Sbjct: 138 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 197
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              WY  P+ L  +K ++ + D+WS G +  EL
Sbjct: 198 PIFWY-APESLTESK-FSVASDVWSFGVVLYEL 228

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 108/240 (45%), Gaps = 33/240 (13%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE-IDLDIVKSFM 90
           + EI +++E K+ NIV   D      +L +V E+         D +    +D   + +  
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVC 122
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLW 149
            + L+ L F HS  V+HRD+K  N+L+  +G +KL DFG       P +   +E+V T +
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSEMVGTPY 181
Query: 150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDT 209
           +  P+V+   K Y   +D+WS G +  E+   G P +    +++   R   L+ T     
Sbjct: 182 WMAPEVVT-RKAYGPKVDIWSLGIMAIEMIE-GEPPY----LNENPLRALYLIAT----- 230
Query: 210 WPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
               N  P+              Q   KL+A  RD L R L  +  +R SA++ + H + 
Sbjct: 231 ----NGTPEL-------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 9/153 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHSE--KKLTLVFEHC-DQDLKKYFDSLNGEIDLDIVKSF 89
           +EI +L+ L H+NIV+   +   +    + L+ E      LK+Y      +I+L     +
Sbjct: 72  KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY 131
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA----EV 145
             Q+ +G+ +  SR  +HRDL  +N+L+    ++K+ DFGL +A     +  +     + 
Sbjct: 132 AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDS 191
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              WY  P+ L  +K Y  S D+WS G    EL
Sbjct: 192 PVFWY-APECLMQSKFYIAS-DVWSFGVTLHEL 222

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 92/182 (50%), Gaps = 26/182 (14%)
Query: 31  ALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN-GEIDLDIVK- 87
           AL EI LL E   H N++R Y    +++ L +  E C+ +L+   +S N  + +L + K 
Sbjct: 73  ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKE 132
Query: 88  ----SFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN-------------KNGELKLADFGL 130
               S + Q+  G+A  HS  ++HRDLKPQN+L++             +N  + ++DFGL
Sbjct: 133 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 192
Query: 131 ARAFGIPVKCYSAEVV----TLWYRPPDVLFGA--KLYTTSIDMWSAGCIFAELANAGRP 184
            +        +   +     T  +R P++L  +  +  T SID++S GC+F  + + G+ 
Sbjct: 193 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH 252
Query: 185 LF 186
            F
Sbjct: 253 PF 254

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 76/153 (49%), Gaps = 9/153 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSF 89
           REI +LK L+H NIV+   V +S   + L L+ E+     L+ Y  +    ID   +  +
Sbjct: 63  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQY 122
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS----AEV 145
             Q+ +G+ +  ++  +HRDL  +N+L+     +K+ DFGL +      +        E 
Sbjct: 123 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              WY  P+ L  +K ++ + D+WS G +  EL
Sbjct: 183 PIFWY-APESLTESK-FSVASDVWSFGVVLYEL 213

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 92/182 (50%), Gaps = 26/182 (14%)
Query: 31  ALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN-GEIDLDIVK- 87
           AL EI LL E   H N++R Y    +++ L +  E C+ +L+   +S N  + +L + K 
Sbjct: 73  ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKE 132
Query: 88  ----SFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN-------------KNGELKLADFGL 130
               S + Q+  G+A  HS  ++HRDLKPQN+L++             +N  + ++DFGL
Sbjct: 133 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 192
Query: 131 ARAFGIPVKCYSAEVV----TLWYRPPDVLFGA--KLYTTSIDMWSAGCIFAELANAGRP 184
            +        +   +     T  +R P++L  +  +  T SID++S GC+F  + + G+ 
Sbjct: 193 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH 252
Query: 185 LF 186
            F
Sbjct: 253 PF 254

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 9/153 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSF 89
           REI +LK L+H NIV+   V +S   + L L+ E+     L+ Y       ID   +  +
Sbjct: 66  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 125
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS----AEV 145
             Q+ +G+ +  ++  +HRDL  +N+L+     +K+ DFGL +      +        E 
Sbjct: 126 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 185
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              WY  P+ L  +K ++ + D+WS G +  EL
Sbjct: 186 PIFWY-APESLTESK-FSVASDVWSFGVVLYEL 216

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 9/153 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHSE--KKLTLVFEHC-DQDLKKYFDSLNGEIDLDIVKSF 89
           +EI +L+ L H+NIV+   +   +    + L+ E      LK+Y      +I+L     +
Sbjct: 60  KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY 119
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA----EV 145
             Q+ +G+ +  SR  +HRDL  +N+L+    ++K+ DFGL +A     +  +     + 
Sbjct: 120 AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDS 179
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              WY  P+ L  +K Y  S D+WS G    EL
Sbjct: 180 PVFWY-APECLMQSKFYIAS-DVWSFGVTLHEL 210

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT----LVFEHCDQDLKKYFDSLNGEIDLDIVKS 88
           RE      L H  IV +YD   +E        +V E+ D    +      G +       
Sbjct: 78  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE 137
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVKCYSAEV 145
            +    + L F H   ++HRD+KP N++I+    +K+ DFG+ARA    G  V   +A +
Sbjct: 138 VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 197
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
            T  Y  P+   G  +   S D++S GC+  E+   G P F G
Sbjct: 198 GTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLT-GEPPFTG 238

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 92/186 (49%), Gaps = 30/186 (16%)
Query: 31  ALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN-GEIDLDIVK- 87
           AL EI LL E   H N++R Y    +++ L +  E C+ +L+   +S N  + +L + K 
Sbjct: 55  ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKE 114
Query: 88  ----SFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN-------------KNGELKLADFGL 130
               S + Q+  G+A  HS  ++HRDLKPQN+L++             +N  + ++DFGL
Sbjct: 115 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 131 ARAFGIPVKCYSAEVV----TLWYRPPDVLFGA------KLYTTSIDMWSAGCIFAELAN 180
            +        +   +     T  +R P++L  +      +  T SID++S GC+F  + +
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
Query: 181 AGRPLF 186
            G+  F
Sbjct: 235 KGKHPF 240

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 9/153 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSF 89
           REI +LK L+H NIV+   V +S   + L L+ E      L++Y       ID   +  +
Sbjct: 63  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQY 122
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS----AEV 145
             Q+ +G+ +  ++  +HRDL  +N+L+     +K+ DFGL +      +        E 
Sbjct: 123 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              WY  P+ L  +K ++ + D+WS G +  EL
Sbjct: 183 PIFWY-APESLTESK-FSVASDVWSFGVVLYEL 213

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 74/153 (48%), Gaps = 2/153 (1%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKY-FDSLNGEIDLDIVKSFMYQ 92
           EI +L  ++H NI+++ D+  ++    LV E     L  + F   +  +D  +      Q
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 93  LLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRP 152
           L+  + +   ++++HRD+K +N++I ++  +KL DFG A A+    K +     T+ Y  
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA-AYLERGKLFYTFCGTIEYCA 197
Query: 153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
           P+VL G       ++MWS G     L     P 
Sbjct: 198 PEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 8/157 (5%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSFM 90
           +RE  ++ +L +  IVRL  V  +E  L LV E      L K+      EI +  V   +
Sbjct: 384 MREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 442
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT--- 147
           +Q+  G+ +   +N +HR+L  +N+L+      K++DFGL++A G     Y+A       
Sbjct: 443 HQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 502
Query: 148 -LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
             WY P  + F  + +++  D+WS G    E  + G+
Sbjct: 503 LKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQ 537

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 79/177 (44%), Gaps = 28/177 (15%)
Query: 29  SSALREICLLKELKHKNIVRLY-------------DVLHSEKKLTLVFEHCD-QDLKKYF 74
           S+ L E+ LL  L H+ +VR Y               +  +  L +  E+C+ + L    
Sbjct: 47  STILSEVXLLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLI 106
Query: 75  DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA--- 131
            S N     D       Q+L  L++ HS+ ++HR+LKP N+ I+++  +K+ DFGLA   
Sbjct: 107 HSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNV 166
Query: 132 -RAFGI----------PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAE 177
            R+  I               ++ + T  Y   +VL G   Y   ID +S G IF E
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 98/233 (42%), Gaps = 49/233 (21%)
Query: 83  LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK-------------------NGEL 123
           LD ++   YQ+ + + F HS  + H DLKP+N+L  +                   N ++
Sbjct: 117 LDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           K+ DFG A       + +S  V T  YR P+V+  A  ++   D+WS GCI  E    G 
Sbjct: 177 KVVDFGSA---TYDDEHHSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYY-LGF 231
Query: 184 PLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGR 243
            +FP  D  + L  + ++LG       P   +    K    +H  + + + +       R
Sbjct: 232 TVFPTHDSKEHLAMMERILG-----PLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSR 286
Query: 244 --------------------DLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI 276
                               DL+Q++L  +P +R++  +A+ H +F  L  +I
Sbjct: 287 ACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI 339

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 104/239 (43%), Gaps = 31/239 (12%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE-IDLDIVKSFM 90
           + EI +++E K+ NIV   D      +L +V E+         D +    +D   + +  
Sbjct: 66  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVC 123
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWY 150
            + L+ L F HS  V+HR++K  N+L+  +G +KL DFG            S  V T ++
Sbjct: 124 RECLQALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 183
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTW 210
             P+V+   K Y   +D+WS G +  E+   G P +    +++   R   L+ T      
Sbjct: 184 MAPEVV-TRKAYGPKVDIWSLGIMAIEMIE-GEPPY----LNENPLRALYLIAT------ 231
Query: 211 PGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
              N  P+              Q   KL+A  RD L R L  +  +R SA++ + H + 
Sbjct: 232 ---NGTPEL-------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 89/188 (47%), Gaps = 8/188 (4%)
Query: 11  NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD- 69
           + A+AIK   +   E      L E  ++ +  H N+V L  V+   K + +V E  +   
Sbjct: 71  DVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGA 130
Query: 70  LKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFG 129
           L  +    +G+  +  +   +  +  G+ +      +HRDL  +N+L+N N   K++DFG
Sbjct: 131 LDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFG 190
Query: 130 LARAF-GIPVKCYS---AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RP 184
           L+R     P   Y+    ++   W  P  + +  + +T++ D+WS G +  E+ + G RP
Sbjct: 191 LSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERP 248
Query: 185 LFPGSDVD 192
            +  S+ D
Sbjct: 249 YWDMSNQD 256

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 92/186 (49%), Gaps = 30/186 (16%)
Query: 31  ALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN-GEIDLDIVK- 87
           AL EI LL E   H N++R Y    +++ L +  E C+ +L+   +S N  + +L + K 
Sbjct: 55  ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKE 114
Query: 88  ----SFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN-------------KNGELKLADFGL 130
               S + Q+  G+A  HS  ++HRDLKPQN+L++             +N  + ++DFGL
Sbjct: 115 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 131 ARAFGIPVKCYSAEVV----TLWYRPPDVLFGA------KLYTTSIDMWSAGCIFAELAN 180
            +        +   +     T  +R P++L  +      +  T SID++S GC+F  + +
Sbjct: 175 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
Query: 181 AGRPLF 186
            G+  F
Sbjct: 235 KGKHPF 240

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 72/140 (51%), Gaps = 2/140 (1%)
Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNV 105
           IV +    H+  KL+ + +  +     Y  S +G      ++ +  +++ GL   H+R V
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 313
Query: 106 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTS 165
           ++RDLKP N+L++++G ++++D GLA  F    K   A V T  Y  P+VL     Y +S
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 166 IDMWSAGCIFAELANAGRPL 185
            D +S GC+  +L     P 
Sbjct: 372 ADWFSLGCMLFKLLRGHSPF 391

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 72/140 (51%), Gaps = 2/140 (1%)
Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNV 105
           IV +    H+  KL+ + +  +     Y  S +G      ++ +  +++ GL   H+R V
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 313
Query: 106 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTS 165
           ++RDLKP N+L++++G ++++D GLA  F    K   A V T  Y  P+VL     Y +S
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 166 IDMWSAGCIFAELANAGRPL 185
            D +S GC+  +L     P 
Sbjct: 372 ADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 72/140 (51%), Gaps = 2/140 (1%)
Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNV 105
           IV +    H+  KL+ + +  +     Y  S +G      ++ +  +++ GL   H+R V
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 313
Query: 106 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTS 165
           ++RDLKP N+L++++G ++++D GLA  F    K   A V T  Y  P+VL     Y +S
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 166 IDMWSAGCIFAELANAGRPL 185
            D +S GC+  +L     P 
Sbjct: 372 ADWFSLGCMLFKLLRGHSPF 391

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 72/140 (51%), Gaps = 2/140 (1%)
Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNV 105
           IV +    H+  KL+ + +  +     Y  S +G      ++ +  +++ GL   H+R V
Sbjct: 253 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 312
Query: 106 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTS 165
           ++RDLKP N+L++++G ++++D GLA  F    K   A V T  Y  P+VL     Y +S
Sbjct: 313 VYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPHASVGTHGYMAPEVLQKGVAYDSS 370
Query: 166 IDMWSAGCIFAELANAGRPL 185
            D +S GC+  +L     P 
Sbjct: 371 ADWFSLGCMLFKLLRGHSPF 390

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 82/173 (47%), Gaps = 30/173 (17%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDS--------LNGEIDL 83
           RE  LL  L+H++IV+ Y V      L +VFE+    DL K+  +          G    
Sbjct: 64  REAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPT 123
Query: 84  DIVKSFMY----QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK 139
           ++ +S M     Q+  G+ +  S++ +HRDL  +N L+ +N  +K+ DFG++R       
Sbjct: 124 ELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR------D 177
Query: 140 CYSAEVVTL---------WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
            YS +   +         W  P  +++  + +TT  D+WS G +  E+   G+
Sbjct: 178 VYSTDYYRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGK 228

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 83/185 (44%), Gaps = 26/185 (14%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSFM 90
           + E  ++ +L H  +V+LY V   +  + LVFE  +   L  Y  +  G    + +    
Sbjct: 50  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 109
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR-----------AFGIPVK 139
             +  G+A+    +V+HRDL  +N L+ +N  +K++DFG+ R               PVK
Sbjct: 110 LDVCEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK 169
Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLK 196
             S EV           F    Y++  D+WS G +  E+ + G+  +     S+V + + 
Sbjct: 170 WASPEV-----------FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 218
Query: 197 RIFKL 201
             F+L
Sbjct: 219 TGFRL 223

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 101/260 (38%), Gaps = 59/260 (22%)
Query: 71  KKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFG 129
           + + D LN  +    V+ +M  L + L   H   ++HRD+KP N L N+   +  L DFG
Sbjct: 105 ESFLDILNS-LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFG 163
Query: 130 LARAF--------------GIPVKC--------------YSAEVVTLWYRPPDVLFGAKL 161
           LA+                    +C               +    T  +R P+VL     
Sbjct: 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPN 223
Query: 162 YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG---TPTEDTWPGMNLL-- 216
            TT+IDMWSAG IF  L +   P +  SD    L +I  + G   T       G ++L  
Sbjct: 224 QTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCS 283
Query: 217 -----PDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRL-----------------LVCNP 254
                 D +        M  S   PKLT+  +     L                 L  NP
Sbjct: 284 KEVPAQDLRKLCERLRGMDSS--TPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNP 341
Query: 255 VQRMSAEDAMSHIYFSDLNV 274
             R++AE+A+ H +F D+++
Sbjct: 342 ASRITAEEALLHPFFKDMSL 361

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 107/252 (42%), Gaps = 45/252 (17%)
Query: 32  LREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN-----GEIDLDI 85
           + E+ ++  L +H+NIV L         + ++ E+C      Y D LN      E DLD 
Sbjct: 89  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYC-----CYGDLLNFLRRKAEADLDK 143
Query: 86  VKS----------FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF- 134
                        F  Q+ +G+AF  S+N +HRD+  +N+L+      K+ DFGLAR   
Sbjct: 144 EDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 203
Query: 135 ---GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDV 191
                 VK  +A +   W  P  +     +YT   D+WS G +  E+ + G   +PG  V
Sbjct: 204 NDSNYIVKG-NARLPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 260
Query: 192 DDQLKRIFKLLGTPTEDTWPGMNLL-PDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLL 250
           + +  ++ K           G  +  P F P  +Y    S  Q    L    R   Q+  
Sbjct: 261 NSKFYKLVK----------DGYQMAQPAFAPKNIY----SIMQACWALEPTHRPTFQQ-- 304
Query: 251 VCNPVQRMSAED 262
           +C+ +Q  + ED
Sbjct: 305 ICSFLQEQAQED 316

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 83/169 (49%), Gaps = 10/169 (5%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN-GEIDLDIVKSFM 90
           L E  ++ + +H NI+RL  V+ +   + ++ E  +      F  LN G+  +  +   +
Sbjct: 65  LSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGML 124
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF----GIPVKCYS--AE 144
             +  G+ +    + +HRDL  +N+L+N N   K++DFGL+R        P +  S   +
Sbjct: 125 RGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGK 184
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPLFPGSDVD 192
           +   W  P  + F  + +T++ D WS G +  E+ + G RP +  S+ D
Sbjct: 185 IPIRWTAPEAIAF--RKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQD 231

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 113/270 (41%), Gaps = 45/270 (16%)
Query: 14  LAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKK 72
           +A+K      +     + + E+ ++  L +H+NIV L         + ++ E+C      
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYC-----C 133
Query: 73  YFDSLN-----GEIDLDIVKS----------FMYQLLRGLAFCHSRNVLHRDLKPQNLLI 117
           Y D LN      E DLD              F  Q+ +G+AF  S+N +HRD+  +N+L+
Sbjct: 134 YGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 193
Query: 118 NKNGELKLADFGLARAF----GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
                 K+ DFGLAR         VK  +A +   W  P  +     +YT   D+WS G 
Sbjct: 194 TNGHVAKIGDFGLARDIMNDSNYIVKG-NARLPVKWMAPESIF--DCVYTVQSDVWSYGI 250
Query: 174 IFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLL-PDFKPFPMYHPSMSFS 232
           +  E+ + G   +PG  V+ +  ++ K           G  +  P F P  +Y    S  
Sbjct: 251 LLWEIFSLGLNPYPGILVNSKFYKLVK----------DGYQMAQPAFAPKNIY----SIM 296
Query: 233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAED 262
           Q    L    R   Q+  +C+ +Q  + ED
Sbjct: 297 QACWALEPTHRPTFQQ--ICSFLQEQAQED 324

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 71/163 (43%), Gaps = 9/163 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLT----LVFEHCDQDLKKYFDSLNGEIDLDIVKS 88
           RE      L H  IV +Y    +E        +V E+ D    +      G +       
Sbjct: 61  REAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE 120
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVKCYSAEV 145
            +    + L F H   ++HRD+KP N++I+    +K+ DFG+ARA    G  V   +A +
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
            T  Y  P+   G  +   S D++S GC+  E+   G P F G
Sbjct: 181 GTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLT-GEPPFTG 221

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 49/233 (21%)
Query: 83  LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK-------------------NGEL 123
           LD ++   YQ+ + + F HS  + H DLKP+N+L  +                   N ++
Sbjct: 117 LDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           K+ DFG A       + +S  V    YR P+V+  A  ++   D+WS GCI  E    G 
Sbjct: 177 KVVDFGSA---TYDDEHHSTLVXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYY-LGF 231
Query: 184 PLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGR 243
            +FP  D  + L  + ++LG       P   +    K    +H  + + + +       R
Sbjct: 232 TVFPTHDSKEHLAMMERILG-----PLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSR 286
Query: 244 --------------------DLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI 276
                               DL+Q++L  +P +R++  +A+ H +F  L  +I
Sbjct: 287 ACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI 339

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 9/153 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSF 89
           REI +LK L    IV+   V +    + L LV E+     L+ +       +D   +  +
Sbjct: 60  REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY 119
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY----SAEV 145
             Q+ +G+ +  SR  +HRDL  +N+L+     +K+ADFGLA+   +    Y      + 
Sbjct: 120 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 179
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              WY P  +     +++   D+WS G +  EL
Sbjct: 180 PIFWYAPESL--SDNIFSRQSDVWSFGVVLYEL 210

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/247 (22%), Positives = 107/247 (43%), Gaps = 31/247 (12%)
Query: 30  SALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSF 89
           +  +E+ +++ L+H  +V L+     E+ + +V +       +Y    N     + VK F
Sbjct: 61  NVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF 120
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW 149
           + +L+  L +  ++ ++HRD+KP N+L++++G + + DF +A       +  +    T  
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI-TTMAGTKP 179
Query: 150 YRPPDVLFGAK--LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTE 207
           Y  P++    K   Y+ ++D WS G    EL    RP    S    +             
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK------------- 226
Query: 208 DTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA-EDAMSH 266
                  ++  F+   + +PS    ++          LL++LL  NP QR S   D  + 
Sbjct: 227 ------EIVHTFETTVVTYPSAWSQEMV--------SLLKKLLEPNPDQRFSQLSDVQNF 272
Query: 267 IYFSDLN 273
            Y +D+N
Sbjct: 273 PYMNDIN 279

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 9/153 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSF 89
           REI +LK L    IV+   V +    + L LV E+     L+ +       +D   +  +
Sbjct: 73  REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY 132
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY----SAEV 145
             Q+ +G+ +  SR  +HRDL  +N+L+     +K+ADFGLA+   +    Y      + 
Sbjct: 133 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              WY P  +     +++   D+WS G +  EL
Sbjct: 193 PIFWYAPESL--SDNIFSRQSDVWSFGVVLYEL 223

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 89/189 (47%), Gaps = 21/189 (11%)
Query: 22  VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKK-LTLVFEHCDQ-DLKKYFDSLNG 79
           + N+    + L E  ++ +L+H N+V+L  V+  EK  L +V E+  +  L  Y  S   
Sbjct: 224 IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR 283
Query: 80  EI-DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG--- 135
            +   D +  F   +   + +    N +HRDL  +N+L++++   K++DFGL +      
Sbjct: 284 SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343
Query: 136 ----IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDV 191
               +PVK  + E +             K ++T  D+WS G +  E+ + GR  +P   +
Sbjct: 344 DTGKLPVKWTAPEALR-----------EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 392
Query: 192 DDQLKRIFK 200
            D + R+ K
Sbjct: 393 KDVVPRVEK 401

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 110/251 (43%), Gaps = 37/251 (14%)
Query: 31  ALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFM 90
           AL E  +L+++  + +V L     ++  L LV    +    K+     G+      ++  
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290
Query: 91  Y--QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVT 147
           Y  ++  GL   H   +++RDLKP+N+L++ +G ++++D GL  A  +P  +     V T
Sbjct: 291 YAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL--AVHVPEGQTIKGRVGT 348
Query: 148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTE 207
           + Y  P+V+   + YT S D W+ GC+  E+     P         Q K+  K      E
Sbjct: 349 VGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPF-------QQRKKKIK-----RE 395
Query: 208 DTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM-----SAED 262
           +    +  +P+              + + + + + R L  +LL  +P +R+     SA +
Sbjct: 396 EVERLVKEVPE--------------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSARE 441
Query: 263 AMSHIYFSDLN 273
              H  F  LN
Sbjct: 442 VKEHPLFKKLN 452

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 78/170 (45%), Gaps = 18/170 (10%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSFMY 91
           +E  L   LKH NI+ L  V   E  L LV E      L +        I  DI+ ++  
Sbjct: 55  QEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAV 112
Query: 92  QLLRGLAFCHSRN---VLHRDLKPQNLLI---NKNGE-----LKLADFGLARAFGIPVKC 140
           Q+ RG+ + H      ++HRDLK  N+LI    +NG+     LK+ DFGLAR +    K 
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK- 171
Query: 141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSD 190
            SA     W  P   +  A +++   D+WS G +  EL     P F G D
Sbjct: 172 MSAAGAYAWMAPE--VIRASMFSKGSDVWSYGVLLWELLTGEVP-FRGID 218

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 9/153 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSF 89
           REI +LK L    IV+   V +    + L LV E+     L+ +       +D   +  +
Sbjct: 61  REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY 120
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY----SAEV 145
             Q+ +G+ +  SR  +HRDL  +N+L+     +K+ADFGLA+   +    Y      + 
Sbjct: 121 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 180
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              WY P  +     +++   D+WS G +  EL
Sbjct: 181 PIFWYAPESL--SDNIFSRQSDVWSFGVVLYEL 211

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 119/292 (40%), Gaps = 61/292 (20%)
Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYF 74
           AIK   L   E      +RE+  L +L+H  IVR ++    EK  T   +     +  Y 
Sbjct: 34  AIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW-LEKNTTEKLQPSSPKVYLYI 92
Query: 75  -----------DSLNG-----EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN 118
                      D +NG     E +  +      Q+   + F HS+ ++HRDLKP N+   
Sbjct: 93  QMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT 152
Query: 119 KNGELKLADFGLARAFG---------IPVKCY---SAEVVTLWYRPPDVLFGAKLYTTSI 166
            +  +K+ DFGL  A            P+  Y   + +V T  Y  P+ + G   Y+  +
Sbjct: 153 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKV 211
Query: 167 DMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYH 226
           D++S G I  EL      L+P S    Q++R+  L            NL   F P     
Sbjct: 212 DIFSLGLILFEL------LYPFS---TQMERVRTLTDV--------RNL--KFPPL---- 248
Query: 227 PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKS 278
               F+Q  P        ++Q +L  +P++R  A + + +  F DL+   K+
Sbjct: 249 ----FTQKYPCEYV----MVQDMLSPSPMERPEAINIIENAVFEDLDFPGKT 292

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 89/189 (47%), Gaps = 21/189 (11%)
Query: 22  VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKK-LTLVFEHCDQ-DLKKYFDSLNG 79
           + N+    + L E  ++ +L+H N+V+L  V+  EK  L +V E+  +  L  Y  S   
Sbjct: 37  IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR 96
Query: 80  EI-DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG--- 135
            +   D +  F   +   + +    N +HRDL  +N+L++++   K++DFGL +      
Sbjct: 97  SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156
Query: 136 ----IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDV 191
               +PVK  + E +             K ++T  D+WS G +  E+ + GR  +P   +
Sbjct: 157 DTGKLPVKWTAPEALR-----------EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205
Query: 192 DDQLKRIFK 200
            D + R+ K
Sbjct: 206 KDVVPRVEK 214

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/253 (22%), Positives = 113/253 (44%), Gaps = 42/253 (16%)
Query: 29  SSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKS 88
           +  + E  +L+  +H  +  L     +  +L  V E+ +     +  S       +  + 
Sbjct: 50  AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF 109
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVKCYSAEV 145
           +  +++  L + HSR+V++RD+K +NL+++K+G +K+ DFGL +   + G  +K +    
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG-- 167
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
            T  Y  P+VL     Y  ++D W  G +  E+     P +     +   +R+F+L+   
Sbjct: 168 -TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY-----NQDHERLFELI--- 217
Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS-----A 260
                    L+ + + FP              L+ + + LL  LL  +P QR+      A
Sbjct: 218 ---------LMEEIR-FPR------------TLSPEAKSLLAGLLKKDPKQRLGGGPSDA 255
Query: 261 EDAMSHIYFSDLN 273
           ++ M H +F  +N
Sbjct: 256 KEVMEHRFFLSIN 268

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 104/239 (43%), Gaps = 20/239 (8%)
Query: 6   VDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           V   P T +AIK  +   +       L E  ++KE    ++VRL  V+   +   ++ E 
Sbjct: 35  VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 94
Query: 66  CDQ-DLKKYFDSLNGEID---------LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
             + DLK Y  SL  E++         L  +     ++  G+A+ ++   +HRDL  +N 
Sbjct: 95  MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 154
Query: 116 LINKNGELKLADFGLARAF---GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAG 172
           ++ ++  +K+ DFG+ R         K     +   W  P  +  G  ++TT  D+WS G
Sbjct: 155 MVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFG 212
Query: 173 CIFAELANAGRPLFPGSDVDDQLKRIFK--LLGTPTEDTWPGMNLLPDFKPFPMYHPSM 229
            +  E+A      + G   +  L+ + +  LL  P  D  P M LL   +    Y+P M
Sbjct: 213 VVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP--DNCPDM-LLELMRMCWQYNPKM 268

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 110/251 (43%), Gaps = 37/251 (14%)
Query: 31  ALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFM 90
           AL E  +L+++  + +V L     ++  L LV    +    K+     G+      ++  
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290
Query: 91  Y--QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVT 147
           Y  ++  GL   H   +++RDLKP+N+L++ +G ++++D GL  A  +P  +     V T
Sbjct: 291 YAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL--AVHVPEGQTIKGRVGT 348
Query: 148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTE 207
           + Y  P+V+   + YT S D W+ GC+  E+     P         Q K+  K      E
Sbjct: 349 VGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPF-------QQRKKKIK-----RE 395
Query: 208 DTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM-----SAED 262
           +    +  +P+              + + + + + R L  +LL  +P +R+     SA +
Sbjct: 396 EVERLVKEVPE--------------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSARE 441
Query: 263 AMSHIYFSDLN 273
              H  F  LN
Sbjct: 442 VKEHPLFKKLN 452

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 89/189 (47%), Gaps = 21/189 (11%)
Query: 22  VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKK-LTLVFEHCDQ-DLKKYFDSLNG 79
           + N+    + L E  ++ +L+H N+V+L  V+  EK  L +V E+  +  L  Y  S   
Sbjct: 52  IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR 111
Query: 80  EI-DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG--- 135
            +   D +  F   +   + +    N +HRDL  +N+L++++   K++DFGL +      
Sbjct: 112 SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171
Query: 136 ----IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDV 191
               +PVK  + E +             K ++T  D+WS G +  E+ + GR  +P   +
Sbjct: 172 DTGKLPVKWTAPEALR-----------EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 220
Query: 192 DDQLKRIFK 200
            D + R+ K
Sbjct: 221 KDVVPRVEK 229

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 26/185 (14%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSFM 90
           + E  ++ +L H  +V+LY V   +  + LVFE  +   L  Y  +  G    + +    
Sbjct: 50  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 109
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR-----------AFGIPVK 139
             +  G+A+     V+HRDL  +N L+ +N  +K++DFG+ R               PVK
Sbjct: 110 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK 169
Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLK 196
             S EV           F    Y++  D+WS G +  E+ + G+  +     S+V + + 
Sbjct: 170 WASPEV-----------FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 218
Query: 197 RIFKL 201
             F+L
Sbjct: 219 TGFRL 223

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 90/189 (47%), Gaps = 21/189 (11%)
Query: 22  VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKK-LTLVFEHCDQ-DLKKYFDSLNG 79
           + N+    + L E  ++ +L+H N+V+L  V+  EK  L +V E+  +  L  Y  S   
Sbjct: 43  IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR 102
Query: 80  EI-DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG--- 135
            +   D +  F   +   + +    N +HRDL  +N+L++++   K++DFGL +      
Sbjct: 103 SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 162
Query: 136 ----IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDV 191
               +PVK          +  P+ L  A  ++T  D+WS G +  E+ + GR  +P   +
Sbjct: 163 DTGKLPVK----------WTAPEALREAA-FSTKSDVWSFGILLWEIYSFGRVPYPRIPL 211
Query: 192 DDQLKRIFK 200
            D + R+ K
Sbjct: 212 KDVVPRVEK 220

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 22/170 (12%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF--------------DSL 77
           RE  LL  L+H++IVR + V    + L +VFE+    DL ++               D  
Sbjct: 92  REAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
            G + L  + +   Q+  G+ +    + +HRDL  +N L+ +   +K+ DFG++R     
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-YS 210
Query: 138 VKCYSAEVVTL----WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
              Y     T+    W  P  +L+  + +TT  D+WS G +  E+   G+
Sbjct: 211 TDYYRVGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGK 258

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 26/185 (14%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSFM 90
           + E  ++ +L H  +V+LY V   +  + LVFE  +   L  Y  +  G    + +    
Sbjct: 70  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 129
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR-----------AFGIPVK 139
             +  G+A+     V+HRDL  +N L+ +N  +K++DFG+ R               PVK
Sbjct: 130 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK 189
Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLK 196
             S EV           F    Y++  D+WS G +  E+ + G+  +     S+V + + 
Sbjct: 190 WASPEV-----------FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 238
Query: 197 RIFKL 201
             F+L
Sbjct: 239 TGFRL 243

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/253 (22%), Positives = 113/253 (44%), Gaps = 42/253 (16%)
Query: 29  SSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKS 88
           +  + E  +L+  +H  +  L     +  +L  V E+ +     +  S       +  + 
Sbjct: 53  AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF 112
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVKCYSAEV 145
           +  +++  L + HSR+V++RD+K +NL+++K+G +K+ DFGL +   + G  +K +    
Sbjct: 113 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG-- 170
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
            T  Y  P+VL     Y  ++D W  G +  E+     P +     +   +R+F+L+   
Sbjct: 171 -TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY-----NQDHERLFELI--- 220
Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS-----A 260
                    L+ + + FP              L+ + + LL  LL  +P QR+      A
Sbjct: 221 ---------LMEEIR-FPR------------TLSPEAKSLLAGLLKKDPKQRLGGGPSDA 258
Query: 261 EDAMSHIYFSDLN 273
           ++ M H +F  +N
Sbjct: 259 KEVMEHRFFLSIN 271

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 26/185 (14%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSFM 90
           + E  ++ +L H  +V+LY V   +  + LVFE  +   L  Y  +  G    + +    
Sbjct: 53  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 112
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR-----------AFGIPVK 139
             +  G+A+     V+HRDL  +N L+ +N  +K++DFG+ R               PVK
Sbjct: 113 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK 172
Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLK 196
             S EV           F    Y++  D+WS G +  E+ + G+  +     S+V + + 
Sbjct: 173 WASPEV-----------FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 221
Query: 197 RIFKL 201
             F+L
Sbjct: 222 TGFRL 226

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/253 (22%), Positives = 113/253 (44%), Gaps = 42/253 (16%)
Query: 29  SSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKS 88
           +  + E  +L+  +H  +  L     +  +L  V E+ +     +  S       +  + 
Sbjct: 50  AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF 109
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVKCYSAEV 145
           +  +++  L + HSR+V++RD+K +NL+++K+G +K+ DFGL +   + G  +K +    
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG-- 167
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
            T  Y  P+VL     Y  ++D W  G +  E+     P +     +   +R+F+L+   
Sbjct: 168 -TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY-----NQDHERLFELI--- 217
Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS-----A 260
                    L+ + + FP              L+ + + LL  LL  +P QR+      A
Sbjct: 218 ---------LMEEIR-FPR------------TLSPEAKSLLAGLLKKDPKQRLGGGPSDA 255
Query: 261 EDAMSHIYFSDLN 273
           ++ M H +F  +N
Sbjct: 256 KEVMEHRFFLSIN 268

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 82/169 (48%), Gaps = 10/169 (5%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN-GEIDLDIVKSFM 90
           L E  ++ + +H NI+RL  V+ +   + ++ E  +      F  LN G+  +  +   +
Sbjct: 63  LSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGML 122
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF----GIPVKCYS--AE 144
             +  G+ +    + +HRDL  +N+L+N N   K++DFGL+R        P    S   +
Sbjct: 123 RGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGK 182
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPLFPGSDVD 192
           +   W  P  + F  + +T++ D WS G +  E+ + G RP +  S+ D
Sbjct: 183 IPIRWTAPEAIAF--RKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQD 229

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 26/185 (14%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSFM 90
           + E  ++ +L H  +V+LY V   +  + LVFE  +   L  Y  +  G    + +    
Sbjct: 48  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 107
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR-----------AFGIPVK 139
             +  G+A+     V+HRDL  +N L+ +N  +K++DFG+ R               PVK
Sbjct: 108 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK 167
Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLK 196
             S EV           F    Y++  D+WS G +  E+ + G+  +     S+V + + 
Sbjct: 168 WASPEV-----------FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 216
Query: 197 RIFKL 201
             F+L
Sbjct: 217 TGFRL 221

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 103/237 (43%), Gaps = 38/237 (16%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF-----DSLNGEIDLD-IV 86
           E  L   L+H N+V L  V+  ++ L+++F +C   DL ++       S  G  D D  V
Sbjct: 62  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 87  KS---------FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
           KS          + Q+  G+ +  S +V+H+DL  +N+L+     +K++D GL R     
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----- 176
Query: 138 VKCYSAEVVTL---------WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
            + Y+A+   L         W  P  +++G   ++   D+WS G +  E+ + G   + G
Sbjct: 177 -EVYAADYYKLLGNSLLPIRWMAPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPYCG 233
Query: 189 SDVDDQLKRIFKLLGTPTED---TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKG 242
               D ++ I      P  D    W    ++  +  FP   P   F  +  +L A G
Sbjct: 234 YSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRP--RFKDIHSRLRAWG 288

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 103/237 (43%), Gaps = 38/237 (16%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF-----DSLNGEIDLD-IV 86
           E  L   L+H N+V L  V+  ++ L+++F +C   DL ++       S  G  D D  V
Sbjct: 79  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 138
Query: 87  KS---------FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
           KS          + Q+  G+ +  S +V+H+DL  +N+L+     +K++D GL R     
Sbjct: 139 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----- 193
Query: 138 VKCYSAEVVTL---------WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
            + Y+A+   L         W  P  +++G   ++   D+WS G +  E+ + G   + G
Sbjct: 194 -EVYAADYYKLLGNSLLPIRWMAPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPYCG 250
Query: 189 SDVDDQLKRIFKLLGTPTED---TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKG 242
               D ++ I      P  D    W    ++  +  FP   P   F  +  +L A G
Sbjct: 251 YSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRP--RFKDIHSRLRAWG 305

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 77/158 (48%), Gaps = 8/158 (5%)
Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNV 105
           + +L+    +  +L  V E+ +     Y     G+        +  ++  GL F H R +
Sbjct: 82  LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGI 141
Query: 106 LHRDLKPQNLLINKNGELKLADFGLARAF---GIPVKCYSAEVVTLWYRPPDVLFGAKLY 162
           ++RDLK  N++++  G +K+ADFG+ +     G+  + +     T  Y  P+++   + Y
Sbjct: 142 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCG---TPDYIAPEII-AYQPY 197
Query: 163 TTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
             S+D W+ G +  E+  AG+P F G D D+  + I +
Sbjct: 198 GKSVDWWAYGVLLYEML-AGQPPFDGEDEDELFQSIME 234

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 28/198 (14%)
Query: 6   VDRTPN-TALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKL--TLV 62
           +D+  N    AIK    +       + LRE  L++ L H N++ L  ++   + L   L+
Sbjct: 43  IDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102
Query: 63  FEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
              C  DL ++  S      +  + SF  Q+ RG+ +   +  +HRDL  +N +++++  
Sbjct: 103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT 162
Query: 123 LKLADFGLARAF--------------GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDM 168
           +K+ADFGLAR                 +PVK  + E +   YR          +TT  D+
Sbjct: 163 VKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT-YR----------FTTKSDV 211
Query: 169 WSAGCIFAELANAGRPLF 186
           WS G +  EL   G P +
Sbjct: 212 WSFGVLLWELLTRGAPPY 229

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 34/202 (16%)
Query: 21  LVGNEGVPSSAL-REICLLKELK-HKNIVRLYDVLH--------SEKKLTLVFEHCDQDL 70
           L+ NE   + A+ +E+C +K+L  H NIV+               + +  L+ E C   L
Sbjct: 61  LLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQL 120
Query: 71  KKYFDSLN--GEIDLDIVKSFMYQLLRGLAFCHSRN--VLHRDLKPQNLLINKNGELKLA 126
            ++   +   G +  D V    YQ  R +   H +   ++HRDLK +NLL++  G +KL 
Sbjct: 121 VEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC 180
Query: 127 DFGLARAFG-IPVKCYSAEV-----------VTLWYRPPDVLFGAKLYTT-----SIDMW 169
           DFG A      P   +SA+             T  YR P+++    LY+        D+W
Sbjct: 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII---DLYSNFPIGEKQDIW 237
Query: 170 SAGCIFAELANAGRPLFPGSDV 191
           + GCI   L     P   G+ +
Sbjct: 238 ALGCILYLLCFRQHPFEDGAKL 259

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 11/157 (7%)
Query: 29  SSALREICLLKELKHKNIVRLYDVL--HSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDI 85
           S   +EI +L+ L H++I++         EK L LV E+     L+ Y    +  I L  
Sbjct: 61  SGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQ 118
Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY---- 141
           +  F  Q+  G+A+ HS++ +HR+L  +N+L++ +  +K+ DFGLA+A     + Y    
Sbjct: 119 LLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 178
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
             +    WY  P+ L   K Y  S D+WS G    EL
Sbjct: 179 DGDSPVFWY-APECLKEYKFYYAS-DVWSFGVTLYEL 213

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 22/170 (12%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF--------------DSL 77
           RE  LL  L+H++IVR + V    + L +VFE+    DL ++               D  
Sbjct: 63  REAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 122
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
            G + L  + +   Q+  G+ +    + +HRDL  +N L+ +   +K+ DFG++R     
Sbjct: 123 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-YS 181
Query: 138 VKCYSAEVVTL----WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
              Y     T+    W  P  +L+  + +TT  D+WS G +  E+   G+
Sbjct: 182 TDYYRVGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGK 229

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/253 (22%), Positives = 113/253 (44%), Gaps = 42/253 (16%)
Query: 29  SSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKS 88
           +  + E  +L+  +H  +  L     +  +L  V E+ +     +  S       +  + 
Sbjct: 50  AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF 109
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVKCYSAEV 145
           +  +++  L + HSR+V++RD+K +NL+++K+G +K+ DFGL +   + G  +K +    
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG-- 167
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
            T  Y  P+VL     Y  ++D W  G +  E+     P +     +   +R+F+L+   
Sbjct: 168 -TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY-----NQDHERLFELI--- 217
Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS-----A 260
                    L+ + + FP              L+ + + LL  LL  +P QR+      A
Sbjct: 218 ---------LMEEIR-FPR------------TLSPEAKSLLAGLLKKDPKQRLGGGPSDA 255
Query: 261 EDAMSHIYFSDLN 273
           ++ M H +F  +N
Sbjct: 256 KEVMEHRFFLSIN 268

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 82/167 (49%), Gaps = 8/167 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           L E  ++ +  H NI+ L  V+   K + ++ E+ +   L  +    +G   +  +   +
Sbjct: 78  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGML 137
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYS---AEVV 146
             +  G+ +    + +HRDL  +N+L+N N   K++DFG++R     P   Y+    ++ 
Sbjct: 138 RGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP 197
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPLFPGSDVD 192
             W  P  + +  + +T++ D+WS G +  E+ + G RP +  S+ D
Sbjct: 198 IRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 242

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 22/170 (12%)
Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF--------------DSL 77
           RE  LL  L+H++IVR + V    + L +VFE+    DL ++               D  
Sbjct: 69  REAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 128
Query: 78  NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 137
            G + L  + +   Q+  G+ +    + +HRDL  +N L+ +   +K+ DFG++R     
Sbjct: 129 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-YS 187
Query: 138 VKCYSAEVVTL----WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
              Y     T+    W  P  +L+  + +TT  D+WS G +  E+   G+
Sbjct: 188 TDYYRVGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGK 235

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/253 (22%), Positives = 113/253 (44%), Gaps = 42/253 (16%)
Query: 29  SSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKS 88
           +  + E  +L+  +H  +  L     +  +L  V E+ +     +  S       +  + 
Sbjct: 50  AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF 109
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVKCYSAEV 145
           +  +++  L + HSR+V++RD+K +NL+++K+G +K+ DFGL +   + G  +K +    
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG-- 167
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
            T  Y  P+VL     Y  ++D W  G +  E+     P +     +   +R+F+L+   
Sbjct: 168 -TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY-----NQDHERLFELI--- 217
Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS-----A 260
                    L+ + + FP              L+ + + LL  LL  +P QR+      A
Sbjct: 218 ---------LMEEIR-FPR------------TLSPEAKSLLAGLLKKDPKQRLGGGPSDA 255
Query: 261 EDAMSHIYFSDLN 273
           ++ M H +F  +N
Sbjct: 256 KEVMEHRFFLSIN 268

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/253 (22%), Positives = 113/253 (44%), Gaps = 42/253 (16%)
Query: 29  SSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKS 88
           +  + E  +L+  +H  +  L     +  +L  V E+ +     +  S       +  + 
Sbjct: 55  AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF 114
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVKCYSAEV 145
           +  +++  L + HSR+V++RD+K +NL+++K+G +K+ DFGL +   + G  +K +    
Sbjct: 115 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG-- 172
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
            T  Y  P+VL     Y  ++D W  G +  E+     P +     +   +R+F+L+   
Sbjct: 173 -TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY-----NQDHERLFELI--- 222
Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS-----A 260
                    L+ + + FP              L+ + + LL  LL  +P QR+      A
Sbjct: 223 ---------LMEEIR-FPR------------TLSPEAKSLLAGLLKKDPKQRLGGGPSDA 260
Query: 261 EDAMSHIYFSDLN 273
           ++ M H +F  +N
Sbjct: 261 KEVMEHRFFLSIN 273

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 85/177 (48%), Gaps = 20/177 (11%)
Query: 31  ALREICLLKELKHKNIVRL--------YDVLHSEKK--------LTLVFEHCDQD-LKKY 73
           A RE+  L +L H NIV          YD   S K         L +  E CD+  L+++
Sbjct: 51  AEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQW 110
Query: 74  FDSLNGE-IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR 132
            +   GE +D  +      Q+ +G+ + HS+ +++RDLKP N+ +    ++K+ DFGL  
Sbjct: 111 IEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT 170
Query: 133 AFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGS 189
           +     K   ++  TL Y  P+ +  ++ Y   +D+++ G I AEL +     F  S
Sbjct: 171 SLKNDGKRXRSK-GTLRYMSPEQI-SSQDYGKEVDLYALGLILAELLHVCDTAFETS 225

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/253 (22%), Positives = 113/253 (44%), Gaps = 42/253 (16%)
Query: 29  SSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKS 88
           +  + E  +L+  +H  +  L     +  +L  V E+ +     +  S       +  + 
Sbjct: 50  AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF 109
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVKCYSAEV 145
           +  +++  L + HSR+V++RD+K +NL+++K+G +K+ DFGL +   + G  +K +    
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG-- 167
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
            T  Y  P+VL     Y  ++D W  G +  E+     P +     +   +R+F+L+   
Sbjct: 168 -TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY-----NQDHERLFELI--- 217
Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS-----A 260
                    L+ + + FP              L+ + + LL  LL  +P QR+      A
Sbjct: 218 ---------LMEEIR-FPR------------TLSPEAKSLLAGLLKKDPKQRLGGGPSDA 255
Query: 261 EDAMSHIYFSDLN 273
           ++ M H +F  +N
Sbjct: 256 KEVMEHRFFLSIN 268

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 82/167 (49%), Gaps = 8/167 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           L E  ++ +  H NI+ L  V+   K + ++ E+ +   L  +    +G   +  +   +
Sbjct: 57  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGML 116
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYS---AEVV 146
             +  G+ +    + +HRDL  +N+L+N N   K++DFG++R     P   Y+    ++ 
Sbjct: 117 RGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP 176
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPLFPGSDVD 192
             W  P  + +  + +T++ D+WS G +  E+ + G RP +  S+ D
Sbjct: 177 IRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 221

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 82/167 (49%), Gaps = 8/167 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           L E  ++ +  H NI+ L  V+   K + ++ E+ +   L  +    +G   +  +   +
Sbjct: 63  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGML 122
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYS---AEVV 146
             +  G+ +    + +HRDL  +N+L+N N   K++DFG++R     P   Y+    ++ 
Sbjct: 123 RGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP 182
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPLFPGSDVD 192
             W  P  + +  + +T++ D+WS G +  E+ + G RP +  S+ D
Sbjct: 183 IRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 227

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 7/159 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY 91
           + E  ++K L H +IV+L  ++  E    ++  +   +L  Y +     + +  +  +  
Sbjct: 73  MSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 132
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL--- 148
           Q+ + +A+  S N +HRD+  +N+L+     +KL DFGL+R        Y A V  L   
Sbjct: 133 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIK 191
Query: 149 WYRPPDVLFGAKLYTTSIDMWS-AGCIFAELANAGRPLF 186
           W  P  + F  + +TT+ D+W  A C++  L+   +P F
Sbjct: 192 WMSPESINF--RRFTTASDVWMFAVCMWEILSFGKQPFF 228

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 82/167 (49%), Gaps = 8/167 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           L E  ++ +  H NI+RL  V+   +   +V E+ +   L  +  + +G+  +  +   +
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGML 157
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYS---AEVV 146
             +  G+ +      +HRDL  +N+L++ N   K++DFGL+R     P   Y+    ++ 
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP 217
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAE-LANAGRPLFPGSDVD 192
             W  P  + F  + ++++ D+WS G +  E LA   RP +  ++ D
Sbjct: 218 IRWTAPEAIAF--RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD 262

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 7/159 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY 91
           + E  ++K L H +IV+L  ++  E    ++  +   +L  Y +     + +  +  +  
Sbjct: 61  MSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL--- 148
           Q+ + +A+  S N +HRD+  +N+L+     +KL DFGL+R        Y A V  L   
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIK 179
Query: 149 WYRPPDVLFGAKLYTTSIDMWS-AGCIFAELANAGRPLF 186
           W  P  + F  + +TT+ D+W  A C++  L+   +P F
Sbjct: 180 WMSPESINF--RRFTTASDVWMFAVCMWEILSFGKQPFF 216

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 103/239 (43%), Gaps = 20/239 (8%)
Query: 6   VDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           V   P T +AIK  +   +       L E  ++KE    ++VRL  V+   +   ++ E 
Sbjct: 44  VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 103
Query: 66  CDQ-DLKKYFDSLNGEID---------LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
             + DLK Y  SL  E++         L  +     ++  G+A+ ++   +HRDL  +N 
Sbjct: 104 MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 163
Query: 116 LINKNGELKLADFGLARAF---GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAG 172
           ++ ++  +K+ DFG+ R         K     +   W  P  +  G  ++TT  D+WS G
Sbjct: 164 MVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFG 221
Query: 173 CIFAELANAGRPLFPGSDVDDQLKRIFK--LLGTPTEDTWPGMNLLPDFKPFPMYHPSM 229
            +  E+A      + G   +  L+ + +  LL  P  D  P M L    +    Y+P M
Sbjct: 222 VVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP--DNCPDM-LFELMRMCWQYNPKM 277

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 100/233 (42%), Gaps = 51/233 (21%)
Query: 8   RTPNTALAIKGTHLVGNEGVPSSA---LREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
           R   T +A+K   ++     PS     L E  +LK++ H ++++LY     +  L L+ E
Sbjct: 50  RAGYTTVAVK---MLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVE 106
Query: 65  HCDQDLKKYFDSLNG------------------------------EIDLDIVKSFMYQLL 94
           +        + SL G                               + +  + SF +Q+ 
Sbjct: 107 YAK------YGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQIS 160
Query: 95  RGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVKCYSAEVVTLWYR 151
           +G+ +    +++HRDL  +N+L+ +  ++K++DFGL+R        VK     +   W  
Sbjct: 161 QGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWM- 219
Query: 152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
             + LF   +YTT  D+WS G +  E+   G   +PG   +    R+F LL T
Sbjct: 220 AIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE----RLFNLLKT 267

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 7/159 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMY 91
           + E  ++K L H +IV+L  ++  E    ++  +   +L  Y +     + +  +  +  
Sbjct: 57  MSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 116
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL--- 148
           Q+ + +A+  S N +HRD+  +N+L+     +KL DFGL+R        Y A V  L   
Sbjct: 117 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIK 175
Query: 149 WYRPPDVLFGAKLYTTSIDMWS-AGCIFAELANAGRPLF 186
           W  P  + F  + +TT+ D+W  A C++  L+   +P F
Sbjct: 176 WMSPESINF--RRFTTASDVWMFAVCMWEILSFGKQPFF 212

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 11/157 (7%)
Query: 29  SSALREICLLKELKHKNIVRLYDVL--HSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDI 85
           S   +EI +L+ L H++I++         EK L LV E+     L+ Y    +  I L  
Sbjct: 61  SGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQ 118
Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY---- 141
           +  F  Q+  G+A+ H+++ +HR+L  +N+L++ +  +K+ DFGLA+A     + Y    
Sbjct: 119 LLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 178
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
             +    WY  P+ L   K Y  S D+WS G    EL
Sbjct: 179 DGDSPVFWY-APECLKEYKFYYAS-DVWSFGVTLYEL 213

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/177 (23%), Positives = 88/177 (49%), Gaps = 10/177 (5%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH-CDQDLKKYFDSLNGEIDLDIVKSFM 90
           + E  ++  L H+ +V+LY V   ++ + ++ E+  +  L  Y   +        +    
Sbjct: 67  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 126
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW- 149
             +   + +  S+  LHRDL  +N L+N  G +K++DFGL+R   +    Y++ V + + 
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFP 184
Query: 150 --YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR---PLFPGSDVDDQLKRIFKL 201
             + PP+VL  +K +++  D+W+ G +  E+ + G+     F  S+  + + +  +L
Sbjct: 185 VRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 240

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 106/251 (42%), Gaps = 39/251 (15%)
Query: 32  LREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKY-------------FDS 76
           + E+ ++  L +H+NIV L         + ++ E+C   DL  +             F  
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 77  LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-- 134
            N  +    +  F  Q+ +G+AF  S+N +HRD+  +N+L+      K+ DFGLAR    
Sbjct: 157 ANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 135 --GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD 192
                VK  +A +   W  P  +     +YT   D+WS G +  E+ + G   +PG  V+
Sbjct: 217 DSNYIVKG-NARLPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273
Query: 193 DQLKRIFKLLGTPTEDTWPGMNLL-PDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLV 251
            +  ++ K           G  +  P F P  +Y    S  Q    L    R   Q+  +
Sbjct: 274 SKFYKLVK----------DGYQMAQPAFAPKNIY----SIMQACWALEPTHRPTFQQ--I 317
Query: 252 CNPVQRMSAED 262
           C+ +Q  + ED
Sbjct: 318 CSFLQEQAQED 328

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 99/233 (42%), Gaps = 51/233 (21%)
Query: 8   RTPNTALAIKGTHLVGNEGVPSSA---LREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
           R   T +A+K   ++     PS     L E  +LK++ H ++++LY     +  L L+ E
Sbjct: 50  RAGYTTVAVK---MLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVE 106
Query: 65  HCDQDLKKYFDSLNG------------------------------EIDLDIVKSFMYQLL 94
           +        + SL G                               + +  + SF +Q+ 
Sbjct: 107 YAK------YGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQIS 160
Query: 95  RGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVKCYSAEVVTLWYR 151
           +G+ +     ++HRDL  +N+L+ +  ++K++DFGL+R        VK     +   W  
Sbjct: 161 QGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWM- 219
Query: 152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
             + LF   +YTT  D+WS G +  E+   G   +PG   +    R+F LL T
Sbjct: 220 AIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE----RLFNLLKT 267

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 9/153 (5%)
Query: 33  REICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSF 89
           REI +LK L    IV+   V +     +L LV E+     L+ +       +D   +  +
Sbjct: 57  REIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLY 116
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGI----PVKCYSAEV 145
             Q+ +G+ +  SR  +HRDL  +N+L+     +K+ADFGLA+   +     V     + 
Sbjct: 117 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQS 176
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              WY P  +     +++   D+WS G +  EL
Sbjct: 177 PIFWYAPESL--SDNIFSRQSDVWSFGVVLYEL 207

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 103/239 (43%), Gaps = 20/239 (8%)
Query: 6   VDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           V   P T +AIK  +   +       L E  ++KE    ++VRL  V+   +   ++ E 
Sbjct: 41  VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 100
Query: 66  CDQ-DLKKYFDSLNGEID---------LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
             + DLK Y  SL  E++         L  +     ++  G+A+ ++   +HRDL  +N 
Sbjct: 101 MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 160
Query: 116 LINKNGELKLADFGLARAF---GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAG 172
           ++ ++  +K+ DFG+ R         K     +   W  P  +  G  ++TT  D+WS G
Sbjct: 161 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFG 218
Query: 173 CIFAELANAGRPLFPGSDVDDQLKRIFK--LLGTPTEDTWPGMNLLPDFKPFPMYHPSM 229
            +  E+A      + G   +  L+ + +  LL  P  D  P M L    +    Y+P M
Sbjct: 219 VVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP--DNCPDM-LFELMRMCWQYNPKM 274

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 103/239 (43%), Gaps = 20/239 (8%)
Query: 6   VDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           V   P T +AIK  +   +       L E  ++KE    ++VRL  V+   +   ++ E 
Sbjct: 43  VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 102
Query: 66  CDQ-DLKKYFDSLNGEID---------LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
             + DLK Y  SL  E++         L  +     ++  G+A+ ++   +HRDL  +N 
Sbjct: 103 MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 162
Query: 116 LINKNGELKLADFGLARAF---GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAG 172
           ++ ++  +K+ DFG+ R         K     +   W  P  +  G  ++TT  D+WS G
Sbjct: 163 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFG 220
Query: 173 CIFAELANAGRPLFPGSDVDDQLKRIFK--LLGTPTEDTWPGMNLLPDFKPFPMYHPSM 229
            +  E+A      + G   +  L+ + +  LL  P  D  P M L    +    Y+P M
Sbjct: 221 VVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP--DNCPDM-LFELMRMCWQYNPKM 276

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 103/239 (43%), Gaps = 20/239 (8%)
Query: 6   VDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           V   P T +AIK  +   +       L E  ++KE    ++VRL  V+   +   ++ E 
Sbjct: 37  VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 96
Query: 66  CDQ-DLKKYFDSLNGEID---------LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
             + DLK Y  SL  E++         L  +     ++  G+A+ ++   +HRDL  +N 
Sbjct: 97  MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 156
Query: 116 LINKNGELKLADFGLARAF---GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAG 172
            + ++  +K+ DFG+ R         K     +   W  P  +  G  ++TT  D+WS G
Sbjct: 157 XVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFG 214
Query: 173 CIFAELANAGRPLFPGSDVDDQLKRIFK--LLGTPTEDTWPGMNLLPDFKPFPMYHPSM 229
            +  E+A      + G   +  L+ + +  LL  P  D  P M LL   +    Y+P M
Sbjct: 215 VVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP--DNCPDM-LLELMRMCWQYNPKM 270

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 19/223 (8%)
Query: 6   VDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           V   P T +AIK  +   +       L E  ++KE    ++VRL  V+   +   ++ E 
Sbjct: 50  VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 109
Query: 66  CDQ-DLKKYFDSLNGEID---------LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
             + DLK Y  SL  E++         L  +     ++  G+A+ ++   +HRDL  +N 
Sbjct: 110 MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 169
Query: 116 LINKNGELKLADFGLARAF---GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAG 172
           ++ ++  +K+ DFG+ R         K     +   W  P  +  G  ++TT  D+WS G
Sbjct: 170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFG 227
Query: 173 CIFAELANAGRPLFPGSDVDDQLKRIFK--LLGTPTEDTWPGM 213
            +  E+A      + G   +  L+ + +  LL  P  D  P M
Sbjct: 228 VVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP--DNCPDM 268

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 103/239 (43%), Gaps = 20/239 (8%)
Query: 6   VDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           V   P T +AIK  +   +       L E  ++KE    ++VRL  V+   +   ++ E 
Sbjct: 44  VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 103
Query: 66  CDQ-DLKKYFDSLNGEID---------LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
             + DLK Y  SL  E++         L  +     ++  G+A+ ++   +HRDL  +N 
Sbjct: 104 MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 163
Query: 116 LINKNGELKLADFGLARAF---GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAG 172
           ++ ++  +K+ DFG+ R         K     +   W  P  +  G  ++TT  D+WS G
Sbjct: 164 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFG 221
Query: 173 CIFAELANAGRPLFPGSDVDDQLKRIFK--LLGTPTEDTWPGMNLLPDFKPFPMYHPSM 229
            +  E+A      + G   +  L+ + +  LL  P  D  P M L    +    Y+P M
Sbjct: 222 VVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP--DNCPDM-LFELMRMCWQYNPKM 277

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 103/239 (43%), Gaps = 20/239 (8%)
Query: 6   VDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           V   P T +AIK  +   +       L E  ++KE    ++VRL  V+   +   ++ E 
Sbjct: 43  VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 102
Query: 66  CDQ-DLKKYFDSLNGEID---------LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
             + DLK Y  SL  E++         L  +     ++  G+A+ ++   +HRDL  +N 
Sbjct: 103 MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 162
Query: 116 LINKNGELKLADFGLARAF---GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAG 172
           ++ ++  +K+ DFG+ R         K     +   W  P  +  G  ++TT  D+WS G
Sbjct: 163 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFG 220
Query: 173 CIFAELANAGRPLFPGSDVDDQLKRIFK--LLGTPTEDTWPGMNLLPDFKPFPMYHPSM 229
            +  E+A      + G   +  L+ + +  LL  P  D  P M L    +    Y+P M
Sbjct: 221 VVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP--DNCPDM-LFELMRMCWQYNPKM 276

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 87/177 (49%), Gaps = 10/177 (5%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH-CDQDLKKYFDSLNGEIDLDIVKSFM 90
           + E  ++  L H+ +V+LY V   ++ + ++ E+  +  L  Y   +        +    
Sbjct: 58  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 117
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW- 149
             +   + +  S+  LHRDL  +N L+N  G +K++DFGL+R   +    Y++ V + + 
Sbjct: 118 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFP 175
Query: 150 --YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR---PLFPGSDVDDQLKRIFKL 201
             + PP+VL  +K  + S D+W+ G +  E+ + G+     F  S+  + + +  +L
Sbjct: 176 VRWSPPEVLMYSKFSSKS-DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 231

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 104/253 (41%), Gaps = 43/253 (16%)
Query: 30  SALREICLLKELKHKN--IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVK 87
           S   EI  L +L+  +  I+RLYD   +++ + +V E  + DL  +       ID    K
Sbjct: 56  SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERK 114
Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY--SAEV 145
           S+   +L  +   H   ++H DLKP N LI  +G LKL DFG+A             ++V
Sbjct: 115 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 173
Query: 146 VTLWYRPPDVL----------FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL 195
            T+ Y PP+ +                +   D+WS GCI   +     P      + +Q+
Sbjct: 174 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQI 230
Query: 196 KRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPV 255
            ++  ++    E  +P +             P               +D+L+  L  +P 
Sbjct: 231 SKLHAIIDPNHEIEFPDI-------------PEKDL-----------QDVLKCCLKRDPK 266
Query: 256 QRMSAEDAMSHIY 268
           QR+S  + ++H Y
Sbjct: 267 QRISIPELLAHPY 279

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 57/96 (59%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +K+ADFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 57/96 (59%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +K+ADFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 104/253 (41%), Gaps = 43/253 (16%)
Query: 30  SALREICLLKELKHKN--IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVK 87
           S   EI  L +L+  +  I+RLYD   +++ + +V E  + DL  +       ID    K
Sbjct: 72  SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERK 130
Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY--SAEV 145
           S+   +L  +   H   ++H DLKP N LI  +G LKL DFG+A             ++V
Sbjct: 131 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 189
Query: 146 VTLWYRPPDVL----------FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL 195
            T+ Y PP+ +                +   D+WS GCI   +     P      + +Q+
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQI 246
Query: 196 KRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPV 255
            ++  ++    E  +P +             P               +D+L+  L  +P 
Sbjct: 247 SKLHAIIDPNHEIEFPDI-------------PEKDL-----------QDVLKCCLKRDPK 282
Query: 256 QRMSAEDAMSHIY 268
           QR+S  + ++H Y
Sbjct: 283 QRISIPELLAHPY 295

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 103/239 (43%), Gaps = 20/239 (8%)
Query: 6   VDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           V   P T +AIK  +   +       L E  ++KE    ++VRL  V+   +   ++ E 
Sbjct: 37  VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 96
Query: 66  CDQ-DLKKYFDSLNGEID---------LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
             + DLK Y  SL  E++         L  +     ++  G+A+ ++   +HRDL  +N 
Sbjct: 97  MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 156
Query: 116 LINKNGELKLADFGLARAF---GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAG 172
           ++ ++  +K+ DFG+ R         K     +   W  P  +  G  ++TT  D+WS G
Sbjct: 157 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFG 214
Query: 173 CIFAELANAGRPLFPGSDVDDQLKRIFK--LLGTPTEDTWPGMNLLPDFKPFPMYHPSM 229
            +  E+A      + G   +  L+ + +  LL  P  D  P M L    +    Y+P M
Sbjct: 215 VVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP--DNCPDM-LFELMRMCWQYNPKM 270

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 57/96 (59%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +K+ADFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 104/253 (41%), Gaps = 43/253 (16%)
Query: 30  SALREICLLKELKHKN--IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVK 87
           S   EI  L +L+  +  I+RLYD   +++ + +V E  + DL  +       ID    K
Sbjct: 52  SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERK 110
Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY--SAEV 145
           S+   +L  +   H   ++H DLKP N LI  +G LKL DFG+A             ++V
Sbjct: 111 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 169
Query: 146 VTLWYRPPDVL----------FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL 195
            T+ Y PP+ +                +   D+WS GCI   +     P      + +Q+
Sbjct: 170 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQI 226
Query: 196 KRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPV 255
            ++  ++    E  +P +             P               +D+L+  L  +P 
Sbjct: 227 SKLHAIIDPNHEIEFPDI-------------PEKDL-----------QDVLKCCLKRDPK 262
Query: 256 QRMSAEDAMSHIY 268
           QR+S  + ++H Y
Sbjct: 263 QRISIPELLAHPY 275

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 57/96 (59%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +K+ADFG A+     VK  +  +  T  Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKR----VKGRTWXLCGTPEY 205
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 103/239 (43%), Gaps = 20/239 (8%)
Query: 6   VDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           V   P T +AIK  +   +       L E  ++KE    ++VRL  V+   +   ++ E 
Sbjct: 72  VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 131
Query: 66  CDQ-DLKKYFDSLNGEID---------LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
             + DLK Y  SL  E++         L  +     ++  G+A+ ++   +HRDL  +N 
Sbjct: 132 MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 191
Query: 116 LINKNGELKLADFGLARAF---GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAG 172
           ++ ++  +K+ DFG+ R         K     +   W  P  +  G  ++TT  D+WS G
Sbjct: 192 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFG 249
Query: 173 CIFAELANAGRPLFPGSDVDDQLKRIFK--LLGTPTEDTWPGMNLLPDFKPFPMYHPSM 229
            +  E+A      + G   +  L+ + +  LL  P  D  P M L    +    Y+P M
Sbjct: 250 VVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP--DNCPDM-LFELMRMCWQYNPKM 305

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 87/177 (49%), Gaps = 10/177 (5%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH-CDQDLKKYFDSLNGEIDLDIVKSFM 90
           + E  ++  L H+ +V+LY V   ++ + ++ E+  +  L  Y   +        +    
Sbjct: 52  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 111
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW- 149
             +   + +  S+  LHRDL  +N L+N  G +K++DFGL+R   +    Y++ V + + 
Sbjct: 112 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFP 169
Query: 150 --YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR---PLFPGSDVDDQLKRIFKL 201
             + PP+VL  +K  + S D+W+ G +  E+ + G+     F  S+  + + +  +L
Sbjct: 170 VRWSPPEVLMYSKFSSKS-DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 225

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/167 (23%), Positives = 79/167 (47%), Gaps = 8/167 (4%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           L E  ++ +  H NI+RL  V+   +   +V E+ +   L  +  + +G+  +  +   +
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGML 157
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF----GIPVKCYSAEVV 146
             +  G+ +      +HRDL  +N+L++ N   K++DFGL+R               ++ 
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIP 217
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAE-LANAGRPLFPGSDVD 192
             W  P  + F  + ++++ D+WS G +  E LA   RP +  ++ D
Sbjct: 218 IRWTAPEAIAF--RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD 262

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 108/251 (43%), Gaps = 39/251 (15%)
Query: 32  LREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLNGEIDLD----I 85
           + E+ ++  L +H+NIV L         + ++ E+C   DL  +    +  ++ D    I
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 86  VKS---------FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-- 134
             S         F  Q+ +G+AF  S+N +HRD+  +N+L+      K+ DFGLAR    
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 135 --GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD 192
                VK  +A +   W  P  +     +YT   D+WS G +  E+ + G   +PG  V+
Sbjct: 217 DSNYIVKG-NARLPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273
Query: 193 DQLKRIFKLLGTPTEDTWPGMNLL-PDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLV 251
            +  ++ K           G  +  P F P  +Y    S  Q    L    R   Q+  +
Sbjct: 274 SKFYKLVK----------DGYQMAQPAFAPKNIY----SIMQACWALEPTHRPTFQQ--I 317
Query: 252 CNPVQRMSAED 262
           C+ +Q  + ED
Sbjct: 318 CSFLQEQAQED 328

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 87/177 (49%), Gaps = 10/177 (5%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH-CDQDLKKYFDSLNGEIDLDIVKSFM 90
           + E  ++  L H+ +V+LY V   ++ + ++ E+  +  L  Y   +        +    
Sbjct: 51  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 110
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW- 149
             +   + +  S+  LHRDL  +N L+N  G +K++DFGL+R   +    Y++ V + + 
Sbjct: 111 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFP 168
Query: 150 --YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR---PLFPGSDVDDQLKRIFKL 201
             + PP+VL  +K  + S D+W+ G +  E+ + G+     F  S+  + + +  +L
Sbjct: 169 VRWSPPEVLMYSKFSSKS-DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 224

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 99/233 (42%), Gaps = 51/233 (21%)
Query: 8   RTPNTALAIKGTHLVGNEGVPSSA---LREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
           R   T +A+K   ++     PS     L E  +LK++ H ++++LY     +  L L+ E
Sbjct: 50  RAGYTTVAVK---MLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVE 106
Query: 65  HCDQDLKKYFDSLNG------------------------------EIDLDIVKSFMYQLL 94
           +        + SL G                               + +  + SF +Q+ 
Sbjct: 107 YAK------YGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQIS 160
Query: 95  RGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVKCYSAEVVTLWYR 151
           +G+ +     ++HRDL  +N+L+ +  ++K++DFGL+R        VK     +   W  
Sbjct: 161 QGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWM- 219
Query: 152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
             + LF   +YTT  D+WS G +  E+   G   +PG   +    R+F LL T
Sbjct: 220 AIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE----RLFNLLKT 267

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 109/244 (44%), Gaps = 44/244 (18%)
Query: 38  LKELKHKNIVRLYDVLHS----EKKLTLVFE-HCDQDLKKYFDSLNGEIDLDIVKSFMYQ 92
           LK L+H NIVR YD   S    +K + LV E      LK Y         + +++S+  Q
Sbjct: 79  LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKV-XKIKVLRSWCRQ 137
Query: 93  LLRGLAFCHSRN--VLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVKCYSAEVV-TL 148
           +L+GL F H+R   ++HRDLK  N+ I    G +K+ D GLA    +    ++  V+ T 
Sbjct: 138 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKAVIGTP 194
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTED 208
            +  P+     + Y  S+D+++ G    E A +  P     +     +R+          
Sbjct: 195 EFXAPEXY--EEKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRV---------- 242
Query: 209 TWPGMNLLPDFKPFPMYHPSMSFSQVA-PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHI 267
                      KP        SF +VA P++    +++++  +  N  +R S +D ++H 
Sbjct: 243 -------TSGVKP-------ASFDKVAIPEV----KEIIEGCIRQNKDERYSIKDLLNHA 284
Query: 268 YFSD 271
           +F +
Sbjct: 285 FFQE 288

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 113/251 (45%), Gaps = 54/251 (21%)
Query: 37  LLKELKHKNIVRLYDVLHSEKKLTLVFEHC------DQDLKKYFDSLNGEIDLDIVKSFM 90
           LL+  +H NI+ L DV    K + LV E        D+ L++ F S   E +   V   +
Sbjct: 74  LLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFS---EREASFV---L 127
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLL-INKNGE---LKLADFGLARAFG-----IPVKCY 141
           + + + + + HS+ V+HRDLKP N+L ++++G    L++ DFG A+        +   CY
Sbjct: 128 HTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY 187
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG-SDVDDQ-LKRIF 199
           +A  V      P+VL   + Y    D+WS G +   +     P   G SD  ++ L RI 
Sbjct: 188 TANFVA-----PEVL-KRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIG 241
Query: 200 KLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
               T +   W                   + S+ A       +DL+ ++L  +P QR++
Sbjct: 242 SGKFTLSGGNW------------------NTVSETA-------KDLVSKMLHVDPHQRLT 276
Query: 260 AEDAMSHIYFS 270
           A+  + H + +
Sbjct: 277 AKQVLQHPWVT 287

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 70/133 (52%), Gaps = 4/133 (3%)
Query: 59  LTLVFEHCDQ-DLKKYFDSLNGE-IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLL 116
           L +  E CD+  L+++ +   GE +D  +      Q+ +G+ + HS+ ++HRDLKP N+ 
Sbjct: 109 LFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIF 168
Query: 117 INKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFA 176
           +    ++K+ DFGL  +     K   ++  TL Y  P+ +  ++ Y   +D+++ G I A
Sbjct: 169 LVDTKQVKIGDFGLVTSLKNDGKRTRSK-GTLRYMSPEQI-SSQDYGKEVDLYALGLILA 226
Query: 177 ELANAGRPLFPGS 189
           EL +     F  S
Sbjct: 227 ELLHVCDTAFETS 239

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 67/140 (47%), Gaps = 8/140 (5%)
Query: 47  VRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL---NGEIDLDIVKSFMYQLLRGLAFCHSR 103
           V  Y  L  E  + +  E  D  L K++  +      I  DI+      +++ L   HS+
Sbjct: 113 VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 172
Query: 104 -NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL---FGA 159
            +V+HRD+KP N+LIN  G++K+ DFG++  + +     + +     Y  P+ +      
Sbjct: 173 LSVIHRDVKPSNVLINALGQVKMCDFGIS-GYLVDSVAKTIDAGCKPYMAPERINPELNQ 231
Query: 160 KLYTTSIDMWSAGCIFAELA 179
           K Y+   D+WS G    ELA
Sbjct: 232 KGYSVKSDIWSLGITMIELA 251

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 111/251 (44%), Gaps = 54/251 (21%)
Query: 37  LLKELKHKNIVRLYDVLHSEKKLTLVFEHC------DQDLKKYFDSLNGEIDLDIVKSFM 90
           LL+  +H NI+ L DV    K + LV E        D+ L++ F S   E +   V   +
Sbjct: 74  LLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFS---EREASFV---L 127
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLL-INKNGE---LKLADFGLARAFG-----IPVKCY 141
           + + + + + HS+ V+HRDLKP N+L ++++G    L++ DFG A+        +   CY
Sbjct: 128 HTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY 187
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG-SDVDDQ-LKRIF 199
           +A  V      P+VL   + Y    D+WS G +   +     P   G SD  ++ L RI 
Sbjct: 188 TANFVA-----PEVL-KRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIG 241
Query: 200 KLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS 259
               T +   W                           ++   +DL+ ++L  +P QR++
Sbjct: 242 SGKFTLSGGNW-------------------------NTVSETAKDLVSKMLHVDPHQRLT 276
Query: 260 AEDAMSHIYFS 270
           A+  + H + +
Sbjct: 277 AKQVLQHPWVT 287

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 87/177 (49%), Gaps = 10/177 (5%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH-CDQDLKKYFDSLNGEIDLDIVKSFM 90
           + E  ++  L H+ +V+LY V   ++ + ++ E+  +  L  Y   +        +    
Sbjct: 47  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 106
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW- 149
             +   + +  S+  LHRDL  +N L+N  G +K++DFGL+R   +    Y++ V + + 
Sbjct: 107 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFP 164
Query: 150 --YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR---PLFPGSDVDDQLKRIFKL 201
             + PP+VL  +K  + S D+W+ G +  E+ + G+     F  S+  + + +  +L
Sbjct: 165 VRWSPPEVLMYSKFSSKS-DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 220

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 104/253 (41%), Gaps = 43/253 (16%)
Query: 30  SALREICLLKELKHKN--IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVK 87
           S   EI  L +L+  +  I+RLYD   +++ + +V E  + DL  +       ID    K
Sbjct: 53  SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERK 111
Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY--SAEV 145
           S+   +L  +   H   ++H DLKP N LI  +G LKL DFG+A             ++V
Sbjct: 112 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 170
Query: 146 VTLWYRPPDVL----------FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL 195
            T+ Y PP+ +                +   D+WS GCI   +     P      + +Q+
Sbjct: 171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQI 227
Query: 196 KRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPV 255
            ++  ++    E  +P +             P               +D+L+  L  +P 
Sbjct: 228 SKLHAIIDPNHEIEFPDI-------------PEKDL-----------QDVLKCCLKRDPK 263
Query: 256 QRMSAEDAMSHIY 268
           QR+S  + ++H Y
Sbjct: 264 QRISIPELLAHPY 276

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 104/253 (41%), Gaps = 43/253 (16%)
Query: 30  SALREICLLKELKHKN--IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVK 87
           S   EI  L +L+  +  I+RLYD   +++ + +V E  + DL  +       ID    K
Sbjct: 100 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERK 158
Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY--SAEV 145
           S+   +L  +   H   ++H DLKP N LI  +G LKL DFG+A             ++V
Sbjct: 159 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 146 VTLWYRPPDVL----------FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL 195
            T+ Y PP+ +                +   D+WS GCI   +     P      + +Q+
Sbjct: 218 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQI 274
Query: 196 KRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPV 255
            ++  ++    E  +P +             P               +D+L+  L  +P 
Sbjct: 275 SKLHAIIDPNHEIEFPDI-------------PEKDL-----------QDVLKCCLKRDPK 310
Query: 256 QRMSAEDAMSHIY 268
           QR+S  + ++H Y
Sbjct: 311 QRISIPELLAHPY 323

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 104/253 (41%), Gaps = 43/253 (16%)
Query: 30  SALREICLLKELKHKN--IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVK 87
           S   EI  L +L+  +  I+RLYD   +++ + +V E  + DL  +       ID    K
Sbjct: 100 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERK 158
Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY--SAEV 145
           S+   +L  +   H   ++H DLKP N LI  +G LKL DFG+A             ++V
Sbjct: 159 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 146 VTLWYRPPDVL----------FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL 195
            T+ Y PP+ +                +   D+WS GCI   +     P      + +Q+
Sbjct: 218 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQI 274
Query: 196 KRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPV 255
            ++  ++    E  +P +             P               +D+L+  L  +P 
Sbjct: 275 SKLHAIIDPNHEIEFPDI-------------PEKDL-----------QDVLKCCLKRDPK 310
Query: 256 QRMSAEDAMSHIY 268
           QR+S  + ++H Y
Sbjct: 311 QRISIPELLAHPY 323

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 11/157 (7%)
Query: 29  SSALREICLLKELKHKNIVRLYDVL--HSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDI 85
           S   REI +L+ L H++IV+         EK + LV E+     L+ Y       + L  
Sbjct: 56  SGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC--VGLAQ 113
Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY---- 141
           +  F  Q+  G+A+ H+++ +HR L  +N+L++ +  +K+ DFGLA+A     + Y    
Sbjct: 114 LLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 173
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
             +    WY  P+ L   K Y  S D+WS G    EL
Sbjct: 174 DGDSPVFWY-APECLKECKFYYAS-DVWSFGVTLYEL 208

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 11/157 (7%)
Query: 29  SSALREICLLKELKHKNIVRLYDVL--HSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDI 85
           S   REI +L+ L H++IV+         EK + LV E+     L+ Y       + L  
Sbjct: 55  SGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC--VGLAQ 112
Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY---- 141
           +  F  Q+  G+A+ H+++ +HR L  +N+L++ +  +K+ DFGLA+A     + Y    
Sbjct: 113 LLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 172
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
             +    WY  P+ L   K Y  S D+WS G    EL
Sbjct: 173 DGDSPVFWY-APECLKECKFYYAS-DVWSFGVTLYEL 207

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 104/253 (41%), Gaps = 43/253 (16%)
Query: 30  SALREICLLKELKHKN--IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVK 87
           S   EI  L +L+  +  I+RLYD   +++ + +V E  + DL  +       ID    K
Sbjct: 72  SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERK 130
Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVKCYSAEV 145
           S+   +L  +   H   ++H DLKP N LI  +G LKL DFG+A             ++V
Sbjct: 131 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQV 189
Query: 146 VTLWYRPPDVL----------FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL 195
            T+ Y PP+ +                +   D+WS GCI   +     P      + +Q+
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQI 246
Query: 196 KRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPV 255
            ++  ++    E  +P +             P               +D+L+  L  +P 
Sbjct: 247 SKLHAIIDPNHEIEFPDI-------------PEKDL-----------QDVLKCCLKRDPK 282
Query: 256 QRMSAEDAMSHIY 268
           QR+S  + ++H Y
Sbjct: 283 QRISIPELLAHPY 295

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 39/180 (21%), Positives = 84/180 (46%), Gaps = 12/180 (6%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           L E  ++ +  H N++ L  V+     + ++ E  +   L  +    +G+  +  +   +
Sbjct: 82  LSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGML 141
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG------IPVKCYSAE 144
             +  G+ +    N +HRDL  +N+L+N N   K++DFGL+R                 +
Sbjct: 142 RGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 201
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPLF--PGSDVDDQLKRIFKL 201
           +   W  P  + +  + +T++ D+WS G +  E+ + G RP +     DV + +++ ++L
Sbjct: 202 IPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL 259

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/237 (22%), Positives = 93/237 (39%), Gaps = 35/237 (14%)
Query: 46  IVRLYDVLHSEKKLTLVFEH-CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN 104
           I  L+     E  L LV ++    DL         ++  D+ + ++ +++  +   H  +
Sbjct: 136 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 195
Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWYRPPDVLF----GA 159
            +HRD+KP N+L++ NG ++LADFG            S+  V T  Y  P++L     G 
Sbjct: 196 YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGM 255
Query: 160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDF 219
             Y    D WS G    E+     P +  S                         L+  +
Sbjct: 256 GKYGPECDWWSLGVCMYEMLYGETPFYAES-------------------------LVETY 290
Query: 220 KPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA---EDAMSHIYFSDLN 273
                +     F      ++ + +DL+QR L+C+  +R+     ED   H +F  LN
Sbjct: 291 GKIMNHEERFQFPSHVTDVSEEAKDLIQR-LICSRERRLGQNGIEDFKKHAFFEGLN 346

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 113/266 (42%), Gaps = 48/266 (18%)
Query: 27  VPSSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFE---------HCDQDLKKYFDS 76
           + S   RE+ +L + + H+N++ L +    E +  LVFE         H  +  +++F+ 
Sbjct: 53  IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK--RRHFNE 110
Query: 77  LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARA 133
           L   + +  V S        L F H++ + HRDLKP+N+L    N+   +K+ DFGL   
Sbjct: 111 LEASVVVQDVAS-------ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSG 163
Query: 134 FGIPVKC---YSAEVVT----LWYRPPDVLFG----AKLYTTSIDMWSAGCIFAELANAG 182
             +   C    + E++T      Y  P+V+      A +Y    D+WS G I   L  +G
Sbjct: 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL-SG 222
Query: 183 RPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN--LLPDFKPFPMYHPSMSFSQVAPKLTA 240
            P F G        R     G    +  P     L    +      P   ++ +    + 
Sbjct: 223 YPPFVG--------RCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHI----SC 270
Query: 241 KGRDLLQRLLVCNPVQRMSAEDAMSH 266
             +DL+ +LLV +  QR+SA   + H
Sbjct: 271 AAKDLISKLLVRDAKQRLSAAQVLQH 296

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/237 (22%), Positives = 93/237 (39%), Gaps = 35/237 (14%)
Query: 46  IVRLYDVLHSEKKLTLVFEH-CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN 104
           I  L+     E  L LV ++    DL         ++  D+ + ++ +++  +   H  +
Sbjct: 152 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 211
Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWYRPPDVLF----GA 159
            +HRD+KP N+L++ NG ++LADFG            S+  V T  Y  P++L     G 
Sbjct: 212 YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGM 271
Query: 160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDF 219
             Y    D WS G    E+     P +  S                         L+  +
Sbjct: 272 GKYGPECDWWSLGVCMYEMLYGETPFYAES-------------------------LVETY 306
Query: 220 KPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA---EDAMSHIYFSDLN 273
                +     F      ++ + +DL+QR L+C+  +R+     ED   H +F  LN
Sbjct: 307 GKIMNHEERFQFPSHVTDVSEEAKDLIQR-LICSRERRLGQNGIEDFKKHAFFEGLN 362

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 81/185 (43%), Gaps = 26/185 (14%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSFM 90
           + E  ++ +L H  +V+LY V   +  + LV E  +   L  Y  +  G    + +    
Sbjct: 51  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMC 110
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR-----------AFGIPVK 139
             +  G+A+     V+HRDL  +N L+ +N  +K++DFG+ R               PVK
Sbjct: 111 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK 170
Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLK 196
             S EV           F    Y++  D+WS G +  E+ + G+  +     S+V + + 
Sbjct: 171 WASPEV-----------FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219
Query: 197 RIFKL 201
             F+L
Sbjct: 220 TGFRL 224

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 57/96 (59%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NL+I++ G +K+ DFGLA+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/175 (23%), Positives = 83/175 (47%), Gaps = 6/175 (3%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH-CDQDLKKYFDSLNGEIDLDIVKSFM 90
           + E  ++  L H+ +V+LY V   ++ + ++ E+  +  L  Y   +        +    
Sbjct: 67  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 126
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS-AEVVTLW 149
             +   + +  S+  LHRDL  +N L+N  G +K++DFGL+R      +  S      + 
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVR 186
Query: 150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR---PLFPGSDVDDQLKRIFKL 201
           + PP+VL  +K  + S D+W+ G +  E+ + G+     F  S+  + + +  +L
Sbjct: 187 WSPPEVLMYSKFSSKS-DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 240

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 80/179 (44%), Gaps = 24/179 (13%)
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF----GIPVKCYSAE 144
           F  Q+ +G+AF  S+N +HRD+  +N+L+      K+ DFGLAR         VK  +A 
Sbjct: 171 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG-NAR 229
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
           +   W  P  +     +YT   D+WS G +  E+ + G   +PG  V+ +  ++ K    
Sbjct: 230 LPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK---- 283
Query: 205 PTEDTWPGMNLL-PDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAED 262
                  G  +  P F P  +Y    S  Q    L    R   Q+  +C+ +Q  + ED
Sbjct: 284 ------DGYQMAQPAFAPKNIY----SIMQACWALEPTHRPTFQQ--ICSFLQEQAQED 330

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLA+  G   K Y AE   V   
Sbjct: 131 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 190
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 191 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 248

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 80/179 (44%), Gaps = 24/179 (13%)
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF----GIPVKCYSAE 144
           F  Q+ +G+AF  S+N +HRD+  +N+L+      K+ DFGLAR         VK  +A 
Sbjct: 163 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG-NAR 221
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
           +   W  P  +     +YT   D+WS G +  E+ + G   +PG  V+ +  ++ K    
Sbjct: 222 LPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK---- 275
Query: 205 PTEDTWPGMNLL-PDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAED 262
                  G  +  P F P  +Y    S  Q    L    R   Q+  +C+ +Q  + ED
Sbjct: 276 ------DGYQMAQPAFAPKNIY----SIMQACWALEPTHRPTFQQ--ICSFLQEQAQED 322

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 11/153 (7%)
Query: 33  REICLLKELKHKNIVRLYDVLH--SEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSF 89
           +EI +L+ L H++I++            L LV E+     L+ Y    +  I L  +  F
Sbjct: 82  QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLF 139
Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY----SAEV 145
             Q+  G+A+ H+++ +HRDL  +N+L++ +  +K+ DFGLA+A     + Y      + 
Sbjct: 140 AQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDS 199
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
              WY  P+ L   K Y  S D+WS G    EL
Sbjct: 200 PVFWY-APECLKEYKFYYAS-DVWSFGVTLYEL 230

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/175 (22%), Positives = 81/175 (46%), Gaps = 6/175 (3%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH-CDQDLKKYFDSLNGEIDLDIVKSFM 90
           + E  ++  L H+ +V+LY V   ++ + ++ E+  +  L  Y   +        +    
Sbjct: 52  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 111
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR-AFGIPVKCYSAEVVTLW 149
             +   + +  S+  LHRDL  +N L+N  G +K++DFGL+R                + 
Sbjct: 112 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVR 171
Query: 150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR---PLFPGSDVDDQLKRIFKL 201
           + PP+VL  +K  + S D+W+ G +  E+ + G+     F  S+  + + +  +L
Sbjct: 172 WSPPEVLMYSKFSSKS-DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 225

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLA+  G   K Y AE   V   
Sbjct: 126 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 186 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 243

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 70/150 (46%), Gaps = 9/150 (6%)
Query: 46  IVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN 104
           +V+L+     +K L +V E+    DL       N ++     K +  +++  L   HS  
Sbjct: 137 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS--NYDVPEKWAKFYTAEVVLALDAIHSMG 194
Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVL---FGA 159
           ++HRD+KP N+L++K+G LKLADFG          V C +A V T  Y  P+VL    G 
Sbjct: 195 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA-VGTPDYISPEVLKSQGGD 253
Query: 160 KLYTTSIDMWSAGCIFAELANAGRPLFPGS 189
             Y    D WS G    E+     P +  S
Sbjct: 254 GYYGRECDWWSVGVFLFEMLVGDTPFYADS 283

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLA+  G   K Y AE   V   
Sbjct: 150 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 209
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 210 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 267

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLA+  G   K Y AE   V   
Sbjct: 159 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 218
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 219 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 276

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 67/146 (45%), Gaps = 6/146 (4%)
Query: 43  HKNIVRLYDVLHSEKKLTLVFEHC--DQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFC 100
           H  ++RL D   +++   LV E     QDL  Y     G +     + F  Q++  +  C
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHC 155
Query: 101 HSRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA 159
           HSR V+HRD+K +N+LI+ + G  KL DFG         + Y+    T  Y PP+ +   
Sbjct: 156 HSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--EPYTDFDGTRVYSPPEWISRH 213
Query: 160 KLYTTSIDMWSAGCIFAELANAGRPL 185
           + +     +WS G +  ++     P 
Sbjct: 214 QYHALPATVWSLGILLYDMVCGDIPF 239

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLA+  G   K Y AE   V   
Sbjct: 135 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 194
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 195 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 252

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLA+  G   K Y AE   V   
Sbjct: 126 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 186 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 243

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLA+  G   K Y AE   V   
Sbjct: 132 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 192 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 249

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLA+  G   K Y AE   V   
Sbjct: 132 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 192 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 249

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLA+  G   K Y AE   V   
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 185 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 78/161 (48%), Gaps = 23/161 (14%)
Query: 59  LTLVFEHCDQDL----KKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSR-NVLHRDLKPQ 113
           + +VFE   ++L    KKY    +  I L  VK    QLL GL + H R  ++H D+KP+
Sbjct: 105 VVMVFEVLGENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPE 161
Query: 114 NLLINKNG------ELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSID 167
           N+L+          ++K+AD G A  +    + Y+  + T  YR P+VL GA  +    D
Sbjct: 162 NVLMEIVDSPENLIQIKIADLGNACWYD---EHYTNSIQTREYRSPEVLLGAP-WGCGAD 217
Query: 168 MWSAGCIFAELANAGRPLFPG-----SDVDDQLKRIFKLLG 203
           +WS  C+  EL        P      +  DD + +I +LLG
Sbjct: 218 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 258

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLA+  G   K Y AE   V   
Sbjct: 119 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 179 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 236

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLA+  G   K Y AE   V   
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 185 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLA+  G   K Y AE   V   
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 185 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 78/161 (48%), Gaps = 23/161 (14%)
Query: 59  LTLVFEHCDQDL----KKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSR-NVLHRDLKPQ 113
           + +VFE   ++L    KKY    +  I L  VK    QLL GL + H R  ++H D+KP+
Sbjct: 105 VVMVFEVLGENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPE 161
Query: 114 NLLINKNG------ELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSID 167
           N+L+          ++K+AD G A  +    + Y+  + T  YR P+VL GA  +    D
Sbjct: 162 NVLMEIVDSPENLIQIKIADLGNACWYD---EHYTNSIQTREYRSPEVLLGAP-WGCGAD 217
Query: 168 MWSAGCIFAELANAGRPLFPG-----SDVDDQLKRIFKLLG 203
           +WS  C+  EL        P      +  DD + +I +LLG
Sbjct: 218 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 258

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLA+  G   K Y AE   V   
Sbjct: 128 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 188 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 245

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLA+  G   K Y AE   V   
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 185 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLA+  G   K Y AE   V   
Sbjct: 132 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 192 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 249

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLA+  G   K Y AE   V   
Sbjct: 127 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 187 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 244

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLA+  G   K Y AE   V   
Sbjct: 127 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 187 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 244

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLA+  G   K Y AE   V   
Sbjct: 128 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 188 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 245

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 9/150 (6%)
Query: 46  IVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN 104
           +V+L+     ++ L +V E+    DL       N ++     + +  +++  L   HS  
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVLALDAIHSMG 188
Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVL---FGA 159
            +HRD+KP N+L++K+G LKLADFG          V+C +A V T  Y  P+VL    G 
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTPDYISPEVLKSQGGD 247
Query: 160 KLYTTSIDMWSAGCIFAELANAGRPLFPGS 189
             Y    D WS G    E+     P +  S
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPFYADS 277

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 73/162 (45%), Gaps = 26/162 (16%)
Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLA----FCH 101
           IV +Y+ L++ +K  L+   C  D  + F  +    D    +    ++ + +     + H
Sbjct: 120 IVDVYENLYAGRKCLLIVXEC-LDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLH 178
Query: 102 SRNVLHRDLKPQNLLINK---NGELKLADFGLARAF----GIPVKCYSAEVVTLWYRPPD 154
           S N+ HRD+KP+NLL      N  LKL DFG A+       +   CY     T +Y  P+
Sbjct: 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-----TPYYVAPE 233
Query: 155 VLFGAKLYTTSIDMWSAGCIFAEL--------ANAGRPLFPG 188
           VL G + Y  S D WS G I   L        +N G  + PG
Sbjct: 234 VL-GPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPG 274

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLA+  G   K Y AE   V   
Sbjct: 129 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 188
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 189 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 246

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 9/150 (6%)
Query: 46  IVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN 104
           +V+L+     ++ L +V E+    DL       N ++     + +  +++  L   HS  
Sbjct: 136 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVLALDAIHSMG 193
Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVL---FGA 159
            +HRD+KP N+L++K+G LKLADFG          V+C +A V T  Y  P+VL    G 
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTPDYISPEVLKSQGGD 252
Query: 160 KLYTTSIDMWSAGCIFAELANAGRPLFPGS 189
             Y    D WS G    E+     P +  S
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVGDTPFYADS 282

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 9/150 (6%)
Query: 46  IVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN 104
           +V+L+     ++ L +V E+    DL       N ++     + +  +++  L   HS  
Sbjct: 136 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVLALDAIHSMG 193
Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVL---FGA 159
            +HRD+KP N+L++K+G LKLADFG          V+C +A V T  Y  P+VL    G 
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTPDYISPEVLKSQGGD 252
Query: 160 KLYTTSIDMWSAGCIFAELANAGRPLFPGS 189
             Y    D WS G    E+     P +  S
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVGDTPFYADS 282

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLA+  G   K Y AE   V   
Sbjct: 128 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 188 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 245

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLA+  G   K Y AE   V   
Sbjct: 128 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 188 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 245

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 61/124 (49%), Gaps = 8/124 (6%)
Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE--- 144
           ++  Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLA+  G   K Y AE   
Sbjct: 121 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKL 201
           V   W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L
Sbjct: 181 VPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238
Query: 202 LGTP 205
              P
Sbjct: 239 PQPP 242

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 69/144 (47%), Gaps = 2/144 (1%)
Query: 43  HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHS 102
           H  +V L+    +E +L  V E+ +     +      ++  +  + +  ++   L + H 
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 171
Query: 103 RNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLY 162
           R +++RDLK  N+L++  G +KL D+G+ +    P    S    T  Y  P++L G   Y
Sbjct: 172 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-Y 230
Query: 163 TTSIDMWSAGCIFAELANAGRPLF 186
             S+D W+ G +  E+  AGR  F
Sbjct: 231 GFSVDWWALGVLMFEMM-AGRSPF 253

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 108/245 (44%), Gaps = 50/245 (20%)
Query: 37  LLKELKHKNIVRLYDVLHSEKKLTLVFEHC------DQDLKKYFDSLNGEIDLDIVKSFM 90
           LL+  +H NI+ L DV    K + +V E        D+ L++ F S           + +
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSERE------ASAVL 122
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLL-INKNG---ELKLADFGLARAFG-----IPVKCY 141
           + + + + + H++ V+HRDLKP N+L ++++G    +++ DFG A+        +   CY
Sbjct: 123 FTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY 182
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
           +A  V      P+VL   + Y  + D+WS G +   +     P   G   DD  + I   
Sbjct: 183 TANFVA-----PEVL-ERQGYDAACDIWSLGVLLYTMLTGYTPFANGP--DDTPEEILAR 234
Query: 202 LGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAE 261
           +G+              F     Y  S+S +          +DL+ ++L  +P QR++A 
Sbjct: 235 IGS------------GKFSLSGGYWNSVSDT---------AKDLVSKMLHVDPHQRLTAA 273
Query: 262 DAMSH 266
             + H
Sbjct: 274 LVLRH 278

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/175 (22%), Positives = 92/175 (52%), Gaps = 10/175 (5%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFMYQ 92
           E+ +L++ +H NI+ L+    ++ +L +V + C+   L  +  +   + ++  +     Q
Sbjct: 58  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQ 116
Query: 93  LLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT---LW 149
             RG+ + H+++++HRDLK  N+ ++++  +K+ DFGLA         +  E ++   LW
Sbjct: 117 TARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 176
Query: 150 YRPPDV-LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
             P  + +  +  Y+   D+++ G +  EL        P S+++++  +I +++G
Sbjct: 177 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG---QLPYSNINNR-DQIIEMVG 227

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/193 (24%), Positives = 85/193 (44%), Gaps = 38/193 (19%)
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA---RAFGIPVKCYSAEV 145
           +  Q++ GL   H RN+++RDLKP+N+L++ +G ++++D GLA   +A     K Y+   
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG-- 351
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
            T  +  P++L G + Y  S+D ++ G    E+  A  P              F+  G  
Sbjct: 352 -TPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGP--------------FRARGEK 395
Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA-- 263
            E+      +L     +P             K +   +D  + LL  +P +R+   D   
Sbjct: 396 VENKELKQRVLEQAVTYP------------DKFSPASKDFCEALLQKDPEKRLGFRDGSC 443
Query: 264 ---MSHIYFSDLN 273
               +H  F D++
Sbjct: 444 DGLRTHPLFRDIS 456

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/193 (24%), Positives = 85/193 (44%), Gaps = 38/193 (19%)
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA---RAFGIPVKCYSAEV 145
           +  Q++ GL   H RN+++RDLKP+N+L++ +G ++++D GLA   +A     K Y+   
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG-- 351
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
            T  +  P++L G + Y  S+D ++ G    E+  A  P              F+  G  
Sbjct: 352 -TPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGP--------------FRARGEK 395
Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA-- 263
            E+      +L     +P             K +   +D  + LL  +P +R+   D   
Sbjct: 396 VENKELKQRVLEQAVTYP------------DKFSPASKDFCEALLQKDPEKRLGFRDGSC 443
Query: 264 ---MSHIYFSDLN 273
               +H  F D++
Sbjct: 444 DGLRTHPLFRDIS 456

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLAGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/193 (24%), Positives = 85/193 (44%), Gaps = 38/193 (19%)
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA---RAFGIPVKCYSAEV 145
           +  Q++ GL   H RN+++RDLKP+N+L++ +G ++++D GLA   +A     K Y+   
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG-- 351
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
            T  +  P++L G + Y  S+D ++ G    E+  A  P              F+  G  
Sbjct: 352 -TPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGP--------------FRARGEK 395
Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA-- 263
            E+      +L     +P             K +   +D  + LL  +P +R+   D   
Sbjct: 396 VENKELKQRVLEQAVTYP------------DKFSPASKDFCEALLQKDPEKRLGFRDGSC 443
Query: 264 ---MSHIYFSDLN 273
               +H  F D++
Sbjct: 444 DGLRTHPLFRDIS 456

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/175 (22%), Positives = 92/175 (52%), Gaps = 10/175 (5%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFMYQ 92
           E+ +L++ +H NI+ L+    ++ +L +V + C+   L  +  +   + ++  +     Q
Sbjct: 70  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQ 128
Query: 93  LLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT---LW 149
             RG+ + H+++++HRDLK  N+ ++++  +K+ DFGLA         +  E ++   LW
Sbjct: 129 TARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188
Query: 150 YRPPDV-LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
             P  + +  +  Y+   D+++ G +  EL        P S+++++  +I +++G
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG---QLPYSNINNR-DQIIEMVG 239

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 8/140 (5%)
Query: 47  VRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL---NGEIDLDIVKSFMYQLLRGLAFCHSR 103
           V  Y  L  E  + +  E  D  L K++  +      I  DI+      +++ L   HS+
Sbjct: 69  VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 104 -NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL---FGA 159
            +V+HRD+KP N+LIN  G++K+ DFG++  + +       +     Y  P+ +      
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGIS-GYLVDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 160 KLYTTSIDMWSAGCIFAELA 179
           K Y+   D+WS G    ELA
Sbjct: 188 KGYSVKSDIWSLGITMIELA 207

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NL+I++ G +K+ DFG A+     VK  +  +  T  Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR----VKGRTWXLCGTPEY 205
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NL+I++ G +K+ DFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NL+I++ G +K+ DFG A+     VK  +  +  T  Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR----VKGRTWXLCGTPEY 205
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NL+I++ G +K+ DFG A+     VK  +  +  T  Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR----VKGRTWXLCGTPEY 205
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NL+I++ G +K+ DFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/193 (24%), Positives = 85/193 (44%), Gaps = 38/193 (19%)
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA---RAFGIPVKCYSAEV 145
           +  Q++ GL   H RN+++RDLKP+N+L++ +G ++++D GLA   +A     K Y+   
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG-- 351
Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
            T  +  P++L G + Y  S+D ++ G    E+  A  P              F+  G  
Sbjct: 352 -TPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGP--------------FRARGEK 395
Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA-- 263
            E+      +L     +P             K +   +D  + LL  +P +R+   D   
Sbjct: 396 VENKELKQRVLEQAVTYP------------DKFSPASKDFCEALLQKDPEKRLGFRDGSC 443
Query: 264 ---MSHIYFSDLN 273
               +H  F D++
Sbjct: 444 DGLRTHPLFRDIS 456

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NL+I++ G +K+ DFG A+     VK  +  +  T  Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR----VKGRTWXLCGTPEY 205
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 57/96 (59%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NL+I++ G +++ DFGLA+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 103/253 (40%), Gaps = 43/253 (16%)
Query: 30  SALREICLLKELKHKN--IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVK 87
           S   EI  L +L+  +  I+RLYD   +++ + +V E  + DL  +       ID    K
Sbjct: 100 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERK 158
Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY--SAEV 145
           S+   +L  +   H   ++H DLKP N LI  +G LKL DFG+A             ++V
Sbjct: 159 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 146 VTLWYRPPDVL----------FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL 195
             + Y PP+ +                +   D+WS GCI   +     P      + +Q+
Sbjct: 218 GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQI 274
Query: 196 KRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPV 255
            ++  ++    E  +P +             P               +D+L+  L  +P 
Sbjct: 275 SKLHAIIDPNHEIEFPDI-------------PEKDL-----------QDVLKCCLKRDPK 310
Query: 256 QRMSAEDAMSHIY 268
           QR+S  + ++H Y
Sbjct: 311 QRISIPELLAHPY 323

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLXGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 69/144 (47%), Gaps = 2/144 (1%)
Query: 43  HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHS 102
           H  +V L+    +E +L  V E+ +     +      ++  +  + +  ++   L + H 
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 128
Query: 103 RNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLY 162
           R +++RDLK  N+L++  G +KL D+G+ +    P    S    T  Y  P++L G   Y
Sbjct: 129 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED-Y 187
Query: 163 TTSIDMWSAGCIFAELANAGRPLF 186
             S+D W+ G +  E+  AGR  F
Sbjct: 188 GFSVDWWALGVLMFEMM-AGRSPF 210

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 58/120 (48%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+  G+ +   R ++HRDL  +N+L+     +K+ DFGLA+  G   K Y AE   V   
Sbjct: 122 QIAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 181
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 182 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 239

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 69/144 (47%), Gaps = 2/144 (1%)
Query: 43  HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHS 102
           H  +V L+    +E +L  V E+ +     +      ++  +  + +  ++   L + H 
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 124
Query: 103 RNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLY 162
           R +++RDLK  N+L++  G +KL D+G+ +    P    S    T  Y  P++L G   Y
Sbjct: 125 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED-Y 183
Query: 163 TTSIDMWSAGCIFAELANAGRPLF 186
             S+D W+ G +  E+  AGR  F
Sbjct: 184 GFSVDWWALGVLMFEMM-AGRSPF 206

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 69/144 (47%), Gaps = 2/144 (1%)
Query: 43  HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHS 102
           H  +V L+    +E +L  V E+ +     +      ++  +  + +  ++   L + H 
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 139
Query: 103 RNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLY 162
           R +++RDLK  N+L++  G +KL D+G+ +    P    S    T  Y  P++L G   Y
Sbjct: 140 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED-Y 198
Query: 163 TTSIDMWSAGCIFAELANAGRPLF 186
             S+D W+ G +  E+  AGR  F
Sbjct: 199 GFSVDWWALGVLMFEMM-AGRSPF 221

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 135 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTLCGTPEY 190
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 191 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 225

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 142 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 197
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 198 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 232

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 144 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 199
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 200 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 234

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 142 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 197
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 198 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 232

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVKCYSAEVVTLW 149
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+         C + E     
Sbjct: 170 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLCGTPE----- 224
Query: 150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           Y  P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 225 YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 260

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 205
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 170 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 225
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 226 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 260

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 205
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 205
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 205
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 205
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 205
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 170 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 225
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 226 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 260

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 57/99 (57%), Gaps = 6/99 (6%)
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-T 147
           +  Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGT 201
Query: 148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             Y  P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 136 QIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 191
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 192 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 226

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTLCGTPEY 205
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/175 (22%), Positives = 91/175 (52%), Gaps = 10/175 (5%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFMYQ 92
           E+ +L++ +H NI+ L+    +  +L +V + C+   L  +  +   + ++  +     Q
Sbjct: 70  EVGVLRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQ 128
Query: 93  LLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT---LW 149
             RG+ + H+++++HRDLK  N+ ++++  +K+ DFGLA         +  E ++   LW
Sbjct: 129 TARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188
Query: 150 YRPPDV-LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
             P  + +  +  Y+   D+++ G +  EL        P S+++++  +I +++G
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG---QLPYSNINNR-DQIIEMVG 239

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 75/158 (47%), Gaps = 8/158 (5%)
Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNV 105
           + +L+    +  +L  V E+ +     Y     G         +  ++  GL F  S+ +
Sbjct: 83  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 142
Query: 106 LHRDLKPQNLLINKNGELKLADFGLARAF---GIPVKCYSAEVVTLWYRPPDVLFGAKLY 162
           ++RDLK  N++++  G +K+ADFG+ +     G+  K +     T  Y  P+++   + Y
Sbjct: 143 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCG---TPDYIAPEII-AYQPY 198
Query: 163 TTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
             S+D W+ G +  E+  AG+  F G D D+  + I +
Sbjct: 199 GKSVDWWAFGVLLYEML-AGQAPFEGEDEDELFQSIME 235

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 95/227 (41%), Gaps = 51/227 (22%)
Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLL-INKNGEL------------------KLA 126
           V+   +QL + + F H   + H DLKP+N+L +N + EL                  ++ 
Sbjct: 139 VRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVV 198
Query: 127 DFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
           DFG A       + +S  V T  YR P+V+     ++   D+WS GCI  E    G  LF
Sbjct: 199 DFGSA---TFDHEHHSTIVSTRHYRAPEVILELG-WSQPCDVWSIGCIIFEYY-VGFTLF 253
Query: 187 PGSDVDDQLKRIFKLLG-TPT--------------------EDTWPGMNLLPDFKPFPMY 225
              D  + L  + ++LG  P+                    E+T  G  +  + KP   Y
Sbjct: 254 QTHDNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRY 313
Query: 226 HPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
             S +          +  DL++ +L   P +R++  +A+ H +F+ L
Sbjct: 314 LTSEAEEH------HQLFDLIESMLEYEPAKRLTLGEALQHPFFARL 354

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 101/239 (42%), Gaps = 20/239 (8%)
Query: 6   VDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           V   P T +AIK  +   +       L E  ++KE    ++VRL  V+   +   ++ E 
Sbjct: 40  VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 99
Query: 66  CDQ-DLKKYFDSLNGEI---------DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
             + DLK Y  SL   +          L  +     ++  G+A+ ++   +HRDL  +N 
Sbjct: 100 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 159
Query: 116 LINKNGELKLADFGLARAF---GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAG 172
           ++ ++  +K+ DFG+ R         K     +   W  P  +  G  ++TT  D+WS G
Sbjct: 160 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFG 217
Query: 173 CIFAELANAGRPLFPGSDVDDQLKRIFK--LLGTPTEDTWPGMNLLPDFKPFPMYHPSM 229
            +  E+A      + G   +  L+ + +  LL  P  D  P M L    +    Y+P M
Sbjct: 218 VVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP--DNCPDM-LFELMRMCWQYNPKM 273

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 75/158 (47%), Gaps = 8/158 (5%)
Query: 46  IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNV 105
           + +L+    +  +L  V E+ +     Y     G         +  ++  GL F  S+ +
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 463
Query: 106 LHRDLKPQNLLINKNGELKLADFGLARAF---GIPVKCYSAEVVTLWYRPPDVLFGAKLY 162
           ++RDLK  N++++  G +K+ADFG+ +     G+  K +     T  Y  P+++   + Y
Sbjct: 464 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCG---TPDYIAPEII-AYQPY 519
Query: 163 TTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
             S+D W+ G +  E+  AG+  F G D D+  + I +
Sbjct: 520 GKSVDWWAFGVLLYEML-AGQAPFEGEDEDELFQSIME 556

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 78/178 (43%), Gaps = 15/178 (8%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFE-HCDQDLKKYFDSLNGEID-------- 82
           L E  ++K     ++VRL  V+   +   +V E     DLK Y  SL  E +        
Sbjct: 68  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 83  -LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPV 138
            L  +     ++  G+A+ +++  +HRDL  +N ++  +  +K+ DFG+ R         
Sbjct: 128 TLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR 187
Query: 139 KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K     +   W  P  +  G  ++TTS DMWS G +  E+ +     + G   +  LK
Sbjct: 188 KGGKGLLPVRWMAPESLKDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 19/223 (8%)
Query: 6   VDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
           V   P T +AIK  +   +       L E  ++KE    ++VRL  V+   +   ++ E 
Sbjct: 50  VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 109
Query: 66  CDQ-DLKKYFDSLNGEI---------DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
             + DLK Y  SL   +          L  +     ++  G+A+ ++   +HRDL  +N 
Sbjct: 110 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 169
Query: 116 LINKNGELKLADFGLARAF---GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAG 172
           ++ ++  +K+ DFG+ R         K     +   W  P  +  G  ++TT  D+WS G
Sbjct: 170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFG 227
Query: 173 CIFAELANAGRPLFPGSDVDDQLKRIFK--LLGTPTEDTWPGM 213
            +  E+A      + G   +  L+ + +  LL  P  D  P M
Sbjct: 228 VVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP--DNCPDM 268

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 78/178 (43%), Gaps = 15/178 (8%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFE-HCDQDLKKYFDSLNGEID-------- 82
           L E  ++K     ++VRL  V+   +   +V E     DLK Y  SL  E +        
Sbjct: 68  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 83  -LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPV 138
            L  +     ++  G+A+ +++  +HRDL  +N ++  +  +K+ DFG+ R         
Sbjct: 128 TLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR 187
Query: 139 KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K     +   W  P  +  G  ++TTS DMWS G +  E+ +     + G   +  LK
Sbjct: 188 KGGKGLLPVRWMAPESLKDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 62/138 (44%), Gaps = 3/138 (2%)
Query: 42  KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH 101
           +H   VRL         L L  E C   L+++ ++    +    V  ++   L  LA  H
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 102 SRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKL 161
           S+ ++H D+KP N+ +   G  KL DFGL    G        +     Y  P++L G+  
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT-AGAGEVQEGDPRYMAPELLQGS-- 231
Query: 162 YTTSIDMWSAGCIFAELA 179
           Y T+ D++S G    E+A
Sbjct: 232 YGTAADVFSLGLTILEVA 249

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 78/178 (43%), Gaps = 15/178 (8%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFE-HCDQDLKKYFDSLNGEID-------- 82
           L E  ++K     ++VRL  V+   +   +V E     DLK Y  SL  E +        
Sbjct: 65  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 124
Query: 83  -LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPV 138
            L  +     ++  G+A+ +++  +HRDL  +N ++  +  +K+ DFG+ R         
Sbjct: 125 TLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR 184
Query: 139 KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K     +   W  P  +  G  ++TTS DMWS G +  E+ +     + G   +  LK
Sbjct: 185 KGGKGLLPVRWMAPESLKDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 240

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 78/178 (43%), Gaps = 15/178 (8%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFE-HCDQDLKKYFDSLNGEID-------- 82
           L E  ++K     ++VRL  V+   +   +V E     DLK Y  SL  E +        
Sbjct: 68  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 83  -LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPV 138
            L  +     ++  G+A+ +++  +HRDL  +N ++  +  +K+ DFG+ R         
Sbjct: 128 TLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYR 187
Query: 139 KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K     +   W  P  +  G  ++TTS DMWS G +  E+ +     + G   +  LK
Sbjct: 188 KGGKGLLPVRWMAPESLKDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 91/186 (48%), Gaps = 13/186 (6%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFM 90
           L E  ++++L +  IVR+  +  +E  + LV E  +   L KY        D +I++  +
Sbjct: 418 LAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE-LV 475
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW- 149
           +Q+  G+ +    N +HRDL  +N+L+      K++DFGL++A       Y A+    W 
Sbjct: 476 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 535
Query: 150 --YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKL--- 201
             +  P+ +   K +++  D+WS G +  E  + G+  +    GS+V   L++  ++   
Sbjct: 536 VKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 594
Query: 202 LGTPTE 207
            G P E
Sbjct: 595 AGCPRE 600

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 91/186 (48%), Gaps = 13/186 (6%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFM 90
           L E  ++++L +  IVR+  +  +E  + LV E  +   L KY        D +I++  +
Sbjct: 419 LAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE-LV 476
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW- 149
           +Q+  G+ +    N +HRDL  +N+L+      K++DFGL++A       Y A+    W 
Sbjct: 477 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 536
Query: 150 --YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKL--- 201
             +  P+ +   K +++  D+WS G +  E  + G+  +    GS+V   L++  ++   
Sbjct: 537 VKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 595
Query: 202 LGTPTE 207
            G P E
Sbjct: 596 AGCPRE 601

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 52/100 (52%), Gaps = 2/100 (2%)
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL 148
           F   + RG+ +   +  +HRDL  +N+L+ +N   K+ADFGL+R   + VK     +   
Sbjct: 147 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 206
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
           W     + +   +YTT+ D+WS G +  E+ + G   + G
Sbjct: 207 WMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 52/100 (52%), Gaps = 2/100 (2%)
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL 148
           F   + RG+ +   +  +HRDL  +N+L+ +N   K+ADFGL+R   + VK     +   
Sbjct: 137 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 196
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
           W     + +   +YTT+ D+WS G +  E+ + G   + G
Sbjct: 197 WMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 234

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 12/176 (6%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL---NGEIDLDIVKS 88
           +RE+  +  L H+N++RLY V+ +   + +V E     L    D L    G   L  +  
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAP--LGSLLDRLRKHQGHFLLGTLSR 125
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---- 144
           +  Q+  G+ +  S+  +HRDL  +NLL+     +K+ DFGL RA       Y  +    
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           V   W  P  +    + ++ + D W  G    E+   G+  + G +    L +I K
Sbjct: 186 VPFAWCAPESL--KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 12/176 (6%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL---NGEIDLDIVKS 88
           +RE+  +  L H+N++RLY V+ +   + +V E     L    D L    G   L  +  
Sbjct: 63  IREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAP--LGSLLDRLRKHQGHFLLGTLSR 119
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---- 144
           +  Q+  G+ +  S+  +HRDL  +NLL+     +K+ DFGL RA       Y  +    
Sbjct: 120 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 179
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           V   W  P  +    + ++ + D W  G    E+   G+  + G +    L +I K
Sbjct: 180 VPFAWCAPESL--KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NL+I++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIII-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NL+I++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 106/245 (43%), Gaps = 50/245 (20%)
Query: 37  LLKELKHKNIVRLYDVLHSEKKLTLVFEH------CDQDLKKYFDSLNGEIDLDIVKSFM 90
           LL+  +H NI+ L DV    K + +V E        D+ L++ F S           + +
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSERE------ASAVL 122
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLL-INKNG---ELKLADFGLARAFG-----IPVKCY 141
           + + + + + H++ V+HRDLKP N+L ++++G    +++ DFG A+        +   CY
Sbjct: 123 FTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY 182
Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
           +A  V      P+VL   + Y  + D+WS G +         P   G   DD  + I   
Sbjct: 183 TANFVA-----PEVL-ERQGYDAACDIWSLGVLLYTXLTGYTPFANGP--DDTPEEILAR 234
Query: 202 LGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAE 261
           +G+              F     Y  S+S +          +DL+ + L  +P QR++A 
Sbjct: 235 IGS------------GKFSLSGGYWNSVSDT---------AKDLVSKXLHVDPHQRLTAA 273
Query: 262 DAMSH 266
             + H
Sbjct: 274 LVLRH 278

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 12/176 (6%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL---NGEIDLDIVKS 88
           +RE+  +  L H+N++RLY V+ +   + +V E     L    D L    G   L  +  
Sbjct: 63  IREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAP--LGSLLDRLRKHQGHFLLGTLSR 119
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---- 144
           +  Q+  G+ +  S+  +HRDL  +NLL+     +K+ DFGL RA       Y  +    
Sbjct: 120 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 179
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           V   W  P  +    + ++ + D W  G    E+   G+  + G +    L +I K
Sbjct: 180 VPFAWCAPESL--KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 38/180 (21%), Positives = 83/180 (46%), Gaps = 12/180 (6%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           L E  ++ +  H N++ L  V+     + ++ E  +   L  +    +G+  +  +   +
Sbjct: 56  LSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGML 115
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG------IPVKCYSAE 144
             +  G+ +    N +HR L  +N+L+N N   K++DFGL+R                 +
Sbjct: 116 RGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 175
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG-RPLF--PGSDVDDQLKRIFKL 201
           +   W  P  + +  + +T++ D+WS G +  E+ + G RP +     DV + +++ ++L
Sbjct: 176 IPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL 233

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 112/266 (42%), Gaps = 48/266 (18%)
Query: 27  VPSSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFE---------HCDQDLKKYFDS 76
           + S   RE+ +L + + H+N++ L +    E +  LVFE         H  +  +++F+ 
Sbjct: 53  IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK--RRHFNE 110
Query: 77  LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARA 133
           L   + +  V S        L F H++ + HRDLKP+N+L    N+   +K+ DF L   
Sbjct: 111 LEASVVVQDVAS-------ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163
Query: 134 FGIPVKC---YSAEVVT----LWYRPPDVLFG----AKLYTTSIDMWSAGCIFAELANAG 182
             +   C    + E++T      Y  P+V+      A +Y    D+WS G I   L  +G
Sbjct: 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL-SG 222
Query: 183 RPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN--LLPDFKPFPMYHPSMSFSQVAPKLTA 240
            P F G        R     G    +  P     L    +      P   ++ +    + 
Sbjct: 223 YPPFVG--------RCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHI----SC 270
Query: 241 KGRDLLQRLLVCNPVQRMSAEDAMSH 266
             +DL+ +LLV +  QR+SA   + H
Sbjct: 271 AAKDLISKLLVRDAKQRLSAAQVLQH 296

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 112/253 (44%), Gaps = 43/253 (16%)
Query: 29  SSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKS 88
           +  L E  +L+  +H  +  L     +  +L  V E+ +     +  S       D  + 
Sbjct: 193 AHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF 252
Query: 89  FMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVKCYSAE 144
           +  +++  L + HS +NV++RDLK +NL+++K+G +K+ DFGL +     G  +K +   
Sbjct: 253 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG- 311
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
             T  Y  P+VL     Y  ++D W  G +  E+     P +     +   +++F+L+  
Sbjct: 312 --TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY-----NQDHEKLFELI-- 361
Query: 205 PTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM--SAED 262
                     L+ + + FP              L  + + LL  LL  +P QR+   +ED
Sbjct: 362 ----------LMEEIR-FPR------------TLGPEAKSLLSGLLKKDPKQRLGGGSED 398
Query: 263 A---MSHIYFSDL 272
           A   M H +F+ +
Sbjct: 399 AKEIMQHRFFAGI 411

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 78/178 (43%), Gaps = 15/178 (8%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFE-HCDQDLKKYFDSLNGEID-------- 82
           L E  ++K     ++VRL  V+   +   +V E     DLK Y  SL  E +        
Sbjct: 68  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 83  -LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPV 138
            L  +     ++  G+A+ +++  +HRDL  +N ++  +  +K+ DFG+ R         
Sbjct: 128 TLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR 187
Query: 139 KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K     +   W  P  +  G  ++TTS DMWS G +  E+ +     + G   +  LK
Sbjct: 188 KGGKGLLPVRWMAPESLKDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 78/178 (43%), Gaps = 15/178 (8%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFE-HCDQDLKKYFDSLNGEID-------- 82
           L E  ++K     ++VRL  V+   +   +V E     DLK Y  SL  E +        
Sbjct: 67  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 126
Query: 83  -LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPV 138
            L  +     ++  G+A+ +++  +HRDL  +N ++  +  +K+ DFG+ R         
Sbjct: 127 TLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR 186
Query: 139 KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
           K     +   W  P  +  G  ++TTS DMWS G +  E+ +     + G   +  LK
Sbjct: 187 KGGKGLLPVRWMAPESLKDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 242

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 12/176 (6%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL---NGEIDLDIVKS 88
           +RE+  +  L H+N++RLY V+ +   + +V E     L    D L    G   L  +  
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAP--LGSLLDRLRKHQGHFLLGTLSR 115
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---- 144
           +  Q+  G+ +  S+  +HRDL  +NLL+     +K+ DFGL RA       Y  +    
Sbjct: 116 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           V   W  P  +    + ++ + D W  G    E+   G+  + G +    L +I K
Sbjct: 176 VPFAWCAPESL--KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 12/176 (6%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL---NGEIDLDIVKS 88
           +RE+  +  L H+N++RLY V+ +   + +V E     L    D L    G   L  +  
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAP--LGSLLDRLRKHQGHFLLGTLSR 115
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---- 144
           +  Q+  G+ +  S+  +HRDL  +NLL+     +K+ DFGL RA       Y  +    
Sbjct: 116 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           V   W  P  +    + ++ + D W  G    E+   G+  + G +    L +I K
Sbjct: 176 VPFAWCAPESL--KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 112/253 (44%), Gaps = 43/253 (16%)
Query: 29  SSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKS 88
           +  L E  +L+  +H  +  L     +  +L  V E+ +     +  S       D  + 
Sbjct: 196 AHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF 255
Query: 89  FMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVKCYSAE 144
           +  +++  L + HS +NV++RDLK +NL+++K+G +K+ DFGL +     G  +K +   
Sbjct: 256 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG- 314
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
             T  Y  P+VL     Y  ++D W  G +  E+     P +     +   +++F+L+  
Sbjct: 315 --TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY-----NQDHEKLFELI-- 364
Query: 205 PTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM--SAED 262
                     L+ + + FP              L  + + LL  LL  +P QR+   +ED
Sbjct: 365 ----------LMEEIR-FPR------------TLGPEAKSLLSGLLKKDPKQRLGGGSED 401
Query: 263 A---MSHIYFSDL 272
           A   M H +F+ +
Sbjct: 402 AKEIMQHRFFAGI 414

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 91/186 (48%), Gaps = 13/186 (6%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSFM 90
           L E  ++++L +  IVR+  +  +E  + LV E  +   L KY        D +I++  +
Sbjct: 74  LAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE-LV 131
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW- 149
           +Q+  G+ +    N +HRDL  +N+L+      K++DFGL++A       Y A+    W 
Sbjct: 132 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 191
Query: 150 --YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKL--- 201
             +  P+ +   K +++  D+WS G +  E  + G+  +    GS+V   L++  ++   
Sbjct: 192 VKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 250
Query: 202 LGTPTE 207
            G P E
Sbjct: 251 AGCPRE 256

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 58/120 (48%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFG A+  G   K Y AE   V   
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 184
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 185 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 58/120 (48%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFG A+  G   K Y AE   V   
Sbjct: 127 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 187 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 244

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 91/186 (48%), Gaps = 13/186 (6%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSFM 90
           L E  ++++L +  IVR+  +  +E  + LV E  +   L KY        D +I++  +
Sbjct: 60  LAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE-LV 117
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW- 149
           +Q+  G+ +    N +HRDL  +N+L+      K++DFGL++A       Y A+    W 
Sbjct: 118 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWP 177
Query: 150 --YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKL--- 201
             +  P+ +   K +++  D+WS G +  E  + G+  +    GS+V   L++  ++   
Sbjct: 178 VKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 236
Query: 202 LGTPTE 207
            G P E
Sbjct: 237 AGCPRE 242

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 58/120 (48%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFG A+  G   K Y AE   V   
Sbjct: 127 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 187 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 244

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 58/120 (48%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFG A+  G   K Y AE   V   
Sbjct: 129 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 188
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 189 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 246

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 58/120 (48%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFG A+  G   K Y AE   V   
Sbjct: 127 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 187 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 244

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 86/173 (49%), Gaps = 10/173 (5%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSFM 90
           L E  ++++L +  IVR+  +  +E  + LV E  +   L KY        D +I++  +
Sbjct: 76  LAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE-LV 133
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW- 149
           +Q+  G+ +    N +HRDL  +N+L+      K++DFGL++A       Y A+    W 
Sbjct: 134 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 193
Query: 150 --YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKR 197
             +  P+ +   K +++  D+WS G +  E  + G+  +    GS+V   L++
Sbjct: 194 VKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 245

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 86/173 (49%), Gaps = 10/173 (5%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSFM 90
           L E  ++++L +  IVR+  +  +E  + LV E  +   L KY        D +I++  +
Sbjct: 76  LAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE-LV 133
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW- 149
           +Q+  G+ +    N +HRDL  +N+L+      K++DFGL++A       Y A+    W 
Sbjct: 134 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 193
Query: 150 --YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKR 197
             +  P+ +   K +++  D+WS G +  E  + G+  +    GS+V   L++
Sbjct: 194 VKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 245

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 91/186 (48%), Gaps = 13/186 (6%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSFM 90
           L E  ++++L +  IVR+  +  +E  + LV E  +   L KY        D +I++  +
Sbjct: 60  LAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE-LV 117
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW- 149
           +Q+  G+ +    N +HRDL  +N+L+      K++DFGL++A       Y A+    W 
Sbjct: 118 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 177
Query: 150 --YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKL--- 201
             +  P+ +   K +++  D+WS G +  E  + G+  +    GS+V   L++  ++   
Sbjct: 178 VKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 236
Query: 202 LGTPTE 207
            G P E
Sbjct: 237 AGCPRE 242

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 58/120 (48%), Gaps = 8/120 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE---VVTL 148
           Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFG A+  G   K Y AE   V   
Sbjct: 132 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 191
Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKLLGTP 205
           W     +L   ++YT   D+WS G    EL   G   +   P S++   L++  +L   P
Sbjct: 192 WMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 249

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 91/186 (48%), Gaps = 13/186 (6%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSFM 90
           L E  ++++L +  IVR+  +  +E  + LV E  +   L KY        D +I++  +
Sbjct: 54  LAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE-LV 111
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW- 149
           +Q+  G+ +    N +HRDL  +N+L+      K++DFGL++A       Y A+    W 
Sbjct: 112 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 171
Query: 150 --YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKRIFKL--- 201
             +  P+ +   K +++  D+WS G +  E  + G+  +    GS+V   L++  ++   
Sbjct: 172 VKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 230
Query: 202 LGTPTE 207
            G P E
Sbjct: 231 AGCPRE 236

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P+++  +K Y  ++D W+ G +  ++A    P F
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYQMAAGYPPFF 239

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 12/176 (6%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL---NGEIDLDIVKS 88
           +RE+  +  L H+N++RLY V+ +   + +V E     L    D L    G   L  +  
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAP--LGSLLDRLRKHQGHFLLGTLSR 125
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF----GIPVKCYSAE 144
           +  Q+  G+ +  S+  +HRDL  +NLL+     +K+ DFGL RA        V     +
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRK 185
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           V   W  P  +    + ++ + D W  G    E+   G+  + G +    L +I K
Sbjct: 186 VPFAWCAPESL--KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 86/173 (49%), Gaps = 10/173 (5%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSFM 90
           L E  ++++L +  IVR+  +  +E  + LV E  +   L KY        D +I++  +
Sbjct: 66  LAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE-LV 123
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW- 149
           +Q+  G+ +    N +HRDL  +N+L+      K++DFGL++A       Y A+    W 
Sbjct: 124 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 183
Query: 150 --YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKR 197
             +  P+ +   K +++  D+WS G +  E  + G+  +    GS+V   L++
Sbjct: 184 VKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 235

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 112/256 (43%), Gaps = 29/256 (11%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSE--KKLTLVFEH-CDQDLKKYFDSLNGEIDLDIVKS 88
           + E  ++  + H ++VRL  V  S   + +T +  H C   L +Y       I   ++ +
Sbjct: 65  MDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGC---LLEYVHEHKDNIGSQLLLN 121
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL 148
           +  Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLAR      K Y+A+   +
Sbjct: 122 WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 181
Query: 149 ---WYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN-AGRPL--FPGSDVDDQLKRIFKLL 202
              W     + +  + +T   D+WS G    EL    G+P    P  ++ D L++  +L 
Sbjct: 182 PIKWMALECIHY--RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLP 239
Query: 203 GTP--TEDTWPGM----NLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
             P  T D +  M     +  D +P         F ++A + +   RD  QR LV     
Sbjct: 240 QPPICTIDVYMVMVKCWMIDADSRP--------KFKELAAEFSRMARD-PQRYLVIQGDD 290
Query: 257 RMSAEDAMSHIYFSDL 272
           RM         +F +L
Sbjct: 291 RMKLPSPNDSKFFQNL 306

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 86/173 (49%), Gaps = 10/173 (5%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSFM 90
           L E  ++++L +  IVR+  +  +E  + LV E  +   L KY        D +I++  +
Sbjct: 56  LAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE-LV 113
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW- 149
           +Q+  G+ +    N +HRDL  +N+L+      K++DFGL++A       Y A+    W 
Sbjct: 114 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
Query: 150 --YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQLKR 197
             +  P+ +   K +++  D+WS G +  E  + G+  +    GS+V   L++
Sbjct: 174 VKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 55/96 (57%), Gaps = 6/96 (6%)
Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWY 150
           Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+     VK  +  +  T  Y
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWXLCGTPEY 204
Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
             P ++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 205 LAPAIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 12/176 (6%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL---NGEIDLDIVKS 88
           +RE+  +  L H+N++RLY V+ +   + +V E     L    D L    G   L  +  
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAP--LGSLLDRLRKHQGHFLLGTLSR 115
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF----GIPVKCYSAE 144
           +  Q+  G+ +  S+  +HRDL  +NLL+     +K+ DFGL RA        V     +
Sbjct: 116 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRK 175
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
           V   W  P  +    + ++ + D W  G    E+   G+  + G +    L +I K
Sbjct: 176 VPFAWCAPESL--KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 112/253 (44%), Gaps = 43/253 (16%)
Query: 29  SSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKS 88
           +  L E  +L+  +H  +  L     +  +L  V E+ +     +  S       D  + 
Sbjct: 55  AHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF 114
Query: 89  FMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVKCYSAE 144
           +  +++  L + HS +NV++RDLK +NL+++K+G +K+ DFGL +     G  +K +   
Sbjct: 115 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCG- 173
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
             T  Y  P+VL     Y  ++D W  G +  E+     P +     +   +++F+L+  
Sbjct: 174 --TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY-----NQDHEKLFELI-- 223
Query: 205 PTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM--SAED 262
                     L+ + + FP              L  + + LL  LL  +P QR+   +ED
Sbjct: 224 ----------LMEEIR-FPR------------TLGPEAKSLLSGLLKKDPKQRLGGGSED 260
Query: 263 A---MSHIYFSDL 272
           A   M H +F+ +
Sbjct: 261 AKEIMQHRFFAGI 273

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 112/253 (44%), Gaps = 43/253 (16%)
Query: 29  SSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKS 88
           +  L E  +L+  +H  +  L     +  +L  V E+ +     +  S       D  + 
Sbjct: 54  AHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF 113
Query: 89  FMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVKCYSAE 144
           +  +++  L + HS +NV++RDLK +NL+++K+G +K+ DFGL +     G  +K +   
Sbjct: 114 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCG- 172
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
             T  Y  P+VL     Y  ++D W  G +  E+     P +     +   +++F+L+  
Sbjct: 173 --TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY-----NQDHEKLFELI-- 222
Query: 205 PTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM--SAED 262
                     L+ + + FP              L  + + LL  LL  +P QR+   +ED
Sbjct: 223 ----------LMEEIR-FPR------------TLGPEAKSLLSGLLKKDPKQRLGGGSED 259
Query: 263 A---MSHIYFSDL 272
           A   M H +F+ +
Sbjct: 260 AKEIMQHRFFAGI 272

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 81/167 (48%), Gaps = 10/167 (5%)
Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSLNGEIDLDIVKSFM 90
            +E   + +L H  +V+ Y V   E  + +V E+     L  Y  S    ++   +    
Sbjct: 51  FQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMC 110
Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW- 149
           Y +  G+AF  S   +HRDL  +N L++++  +K++DFG+ R   +    Y + V T + 
Sbjct: 111 YDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSVGTKFP 168
Query: 150 --YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR---PLFPGSDV 191
             +  P+V    K Y++  D+W+ G +  E+ + G+    L+  S+V
Sbjct: 169 VKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV 214

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 112/253 (44%), Gaps = 43/253 (16%)
Query: 29  SSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKS 88
           +  L E  +L+  +H  +  L     +  +L  V E+ +     +  S       D  + 
Sbjct: 53  AHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF 112
Query: 89  FMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVKCYSAE 144
           +  +++  L + HS +NV++RDLK +NL+++K+G +K+ DFGL +     G  +K +   
Sbjct: 113 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCG- 171
Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
             T  Y  P+VL     Y  ++D W  G +  E+     P +     +   +++F+L+  
Sbjct: 172 --TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY-----NQDHEKLFELI-- 221
Query: 205 PTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM--SAED 262
                     L+ + + FP              L  + + LL  LL  +P QR+   +ED
Sbjct: 222 ----------LMEEIR-FPR------------TLGPEAKSLLSGLLKKDPKQRLGGGSED 258
Query: 263 A---MSHIYFSDL 272
           A   M H +F+ +
Sbjct: 259 AKEIMQHRFFAGI 271

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 65/140 (46%), Gaps = 8/140 (5%)
Query: 47  VRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL---NGEIDLDIVKSFMYQLLRGLAFCHSR 103
           V  Y  L  E  + +  E  D  L K++  +      I  DI+      +++ L   HS+
Sbjct: 96  VTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 155
Query: 104 -NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL---FGA 159
            +V+HRD+KP N+LIN  G++K  DFG++  + +       +     Y  P+ +      
Sbjct: 156 LSVIHRDVKPSNVLINALGQVKXCDFGIS-GYLVDDVAKDIDAGCKPYXAPERINPELNQ 214
Query: 160 KLYTTSIDMWSAGCIFAELA 179
           K Y+   D+WS G    ELA
Sbjct: 215 KGYSVKSDIWSLGITXIELA 234

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 56/100 (56%), Gaps = 8/100 (8%)
Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA-RAFGIPVK-CYSAEVV 146
           +  Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A R  G     C + E +
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEAL 205
Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
                 P+++  +K Y  ++D W+ G +  E+A    P F
Sbjct: 206 A-----PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/171 (22%), Positives = 88/171 (51%), Gaps = 9/171 (5%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFMYQ 92
           E+ +L++ +H NI+ L+    ++ +L +V + C+   L  +   +  + ++  +     Q
Sbjct: 56  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 114
Query: 93  LLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT---LW 149
             +G+ + H+++++HRDLK  N+ ++++  +K+ DFGLA         +  E ++   LW
Sbjct: 115 TAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 174
Query: 150 YRPPDVLFGAKL-YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF 199
             P  +    K  Y+   D+++ G +  EL        P S+++++ + IF
Sbjct: 175 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ---LPYSNINNRDQIIF 222

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/171 (22%), Positives = 88/171 (51%), Gaps = 9/171 (5%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFMYQ 92
           E+ +L++ +H NI+ L+    ++ +L +V + C+   L  +   +  + ++  +     Q
Sbjct: 81  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 139
Query: 93  LLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT---LW 149
             +G+ + H+++++HRDLK  N+ ++++  +K+ DFGLA         +  E ++   LW
Sbjct: 140 TAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 199
Query: 150 YRPPDVLFGAKL-YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF 199
             P  +    K  Y+   D+++ G +  EL        P S+++++ + IF
Sbjct: 200 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ---LPYSNINNRDQIIF 247

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/171 (22%), Positives = 88/171 (51%), Gaps = 9/171 (5%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFMYQ 92
           E+ +L++ +H NI+ L+    ++ +L +V + C+   L  +   +  + ++  +     Q
Sbjct: 82  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 140
Query: 93  LLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT---LW 149
             +G+ + H+++++HRDLK  N+ ++++  +K+ DFGLA         +  E ++   LW
Sbjct: 141 TAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 200
Query: 150 YRPPDVLFGAKL-YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF 199
             P  +    K  Y+   D+++ G +  EL        P S+++++ + IF
Sbjct: 201 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ---LPYSNINNRDQIIF 248

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/171 (22%), Positives = 88/171 (51%), Gaps = 9/171 (5%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFMYQ 92
           E+ +L++ +H NI+ L+    ++ +L +V + C+   L  +   +  + ++  +     Q
Sbjct: 59  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 117
Query: 93  LLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT---LW 149
             +G+ + H+++++HRDLK  N+ ++++  +K+ DFGLA         +  E ++   LW
Sbjct: 118 TAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 177
Query: 150 YRPPDVLFGAKL-YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF 199
             P  +    K  Y+   D+++ G +  EL        P S+++++ + IF
Sbjct: 178 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ---LPYSNINNRDQIIF 225

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/171 (22%), Positives = 88/171 (51%), Gaps = 9/171 (5%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFMYQ 92
           E+ +L++ +H NI+ L+    ++ +L +V + C+   L  +   +  + ++  +     Q
Sbjct: 59  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 117
Query: 93  LLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT---LW 149
             +G+ + H+++++HRDLK  N+ ++++  +K+ DFGLA         +  E ++   LW
Sbjct: 118 TAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 177
Query: 150 YRPPDVLFGAKL-YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF 199
             P  +    K  Y+   D+++ G +  EL        P S+++++ + IF
Sbjct: 178 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ---LPYSNINNRDQIIF 225

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/171 (22%), Positives = 88/171 (51%), Gaps = 9/171 (5%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFMYQ 92
           E+ +L++ +H NI+ L+    ++ +L +V + C+   L  +   +  + ++  +     Q
Sbjct: 54  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 112
Query: 93  LLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT---LW 149
             +G+ + H+++++HRDLK  N+ ++++  +K+ DFGLA         +  E ++   LW
Sbjct: 113 TAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 150 YRPPDVLFGAKL-YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF 199
             P  +    K  Y+   D+++ G +  EL        P S+++++ + IF
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ---LPYSNINNRDQIIF 220

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 82/197 (41%), Gaps = 12/197 (6%)
Query: 43  HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHS 102
           H  + +L+    +  +L  V E  +     +    +   D    + +  +++  L F H 
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD 142
Query: 103 RNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRP----PDVLFG 158
           + +++RDLK  N+L++  G  KLADFG+ +  GI   C      T    P    P++L  
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GI---CNGVTTATFCGTPDYIAPEIL-Q 197
Query: 159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPD 218
             LY  ++D W+ G +  E+     P F   + DD  + I  L       TW   +    
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAP-FEAENEDDLFEAI--LNDEVVYPTWLHEDATGI 254
Query: 219 FKPFPMYHPSMSFSQVA 235
            K F   +P+M    + 
Sbjct: 255 LKSFMTKNPTMRLGSLT 271

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/171 (22%), Positives = 88/171 (51%), Gaps = 9/171 (5%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFMYQ 92
           E+ +L++ +H NI+ L+    ++ +L +V + C+   L  +   +  + ++  +     Q
Sbjct: 82  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 140
Query: 93  LLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT---LW 149
             +G+ + H+++++HRDLK  N+ ++++  +K+ DFGLA         +  E ++   LW
Sbjct: 141 TAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 200
Query: 150 YRPPDVLFGAKL-YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF 199
             P  +    K  Y+   D+++ G +  EL        P S+++++ + IF
Sbjct: 201 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ---LPYSNINNRDQIIF 248

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/171 (22%), Positives = 88/171 (51%), Gaps = 9/171 (5%)
Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFMYQ 92
           E+ +L++ +H NI+ L+    ++ +L +V + C+   L  +   +  + ++  +     Q
Sbjct: 74  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 132
Query: 93  LLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT---LW 149
             +G+ + H+++++HRDLK  N+ ++++  +K+ DFGLA         +  E ++   LW
Sbjct: 133 TAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 192
Query: 150 YRPPDVLFGAKL-YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF 199
             P  +    K  Y+   D+++ G +  EL        P S+++++ + IF
Sbjct: 193 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ---LPYSNINNRDQIIF 240
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	282
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-170
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-170
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-163
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-163
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-161
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-160
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-160
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-158
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-157
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-156
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-147
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-147
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-138
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-136
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-123
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-115
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-113
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-109
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-102
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-100
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-91
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-89
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-88
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-88
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-88
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-88
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-86
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-85
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-84
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-83
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-83
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-54
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-52
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-51
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-51
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-50
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-50
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-49
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-49
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	7e-49
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-48
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-48
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-48
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-48
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-47
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-47
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-46
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-46
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-45
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-45
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-45
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-43
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-43
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-43
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-42
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-42
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-42
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-42
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-42
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-42
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-42
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-42
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-42
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-41
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-41
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	9e-41
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-40
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-40
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-40
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-40
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-40
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-40
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-40
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-40
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-40
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-40
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-39
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-39
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-39
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-39
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-39
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-39
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-39
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-39
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-39
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-39
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-39
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-39
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-39
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-38
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-38
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-38
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-37
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-37
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-37
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-37
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-37
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-37
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-37
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-37
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-36
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-36
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-36
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-36
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-36
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-36
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-36
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-35
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-35
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-35
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-34
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-33
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-33
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-32
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-31
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-28
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-28
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-28
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	6e-28
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-27
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-26
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-26
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-26
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-26
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-26
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-26
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-25
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-25
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-25
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-25
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-25
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	9e-25
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-24
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-24
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-24
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-24
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-23
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-23
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-23
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-23
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-23
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-23
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-23
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-23
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-23
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-23
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-23
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-23
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-22
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-22
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-22
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-22
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-22
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-21
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-21
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-21
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-21
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-21
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-21
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-21
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-21
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-21
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-21
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-21
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-21
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-21
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-21
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-21
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-21
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	9e-21
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-20
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-20
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-20
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-20
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-20
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-20
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-20
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-20
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-20
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-20
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-20
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-20
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-20
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-20
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-20
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	8e-20
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-19
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-19
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-19
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-19
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-19
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-19
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-19
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-19
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-19
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-19
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-19
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	8e-19
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-18
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-17
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-17
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-17
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-17
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-17
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-17
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-17
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-17
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	9e-17
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-16
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-16
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-16
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-16
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-16
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-16
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-16
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-16
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-16
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-15
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-13
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-11
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	9e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	9e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-10
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-10
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	8e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-07

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  471 bits (1215), Expect = e-170
 Identities = 147/271 (54%), Positives = 189/271 (69%), Gaps = 5/271 (1%)

Query: 5   GVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF 63
             +       A+K   L   +EG+PS+ +REI +LKELKH NIV+LYDV+H++K+L LVF
Sbjct: 21  AQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79

Query: 64  EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL 123
           EH DQDLKK  D   G ++    KSF+ QLL G+A+CH R VLHRDLKPQNLLIN+ GEL
Sbjct: 80  EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGEL 139

Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           K+ADFGLARAFGIPV+ Y+ E+VTLWYR PDVL G+K Y+T+ID+WS GCIFAE+ N G 
Sbjct: 140 KIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GT 198

Query: 184 PLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLTAKG 242
           PLFPG    DQL RIF++LGTP    WP +  LP + P F +Y P + +      L   G
Sbjct: 199 PLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP-LPWESFLKGLDESG 257

Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN 273
            DLL ++L  +P QR++A+ A+ H YF + N
Sbjct: 258 IDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  471 bits (1215), Expect = e-170
 Identities = 209/270 (77%), Positives = 235/270 (87%), Gaps = 1/270 (0%)

Query: 5   GVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF 63
             +R  +  +A+K   L   +EGVPSSALREICLLKELKHKNIVRL+DVLHS+KKLTLVF
Sbjct: 21  AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80

Query: 64  EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL 123
           E CDQDLKKYFDS NG++D +IVKSF++QLL+GL FCHSRNVLHRDLKPQNLLIN+NGEL
Sbjct: 81  EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGEL 140

Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           KLA+FGLARAFGIPV+CYSAEVVTLWYRPPDVLFGAKLY+TSIDMWSAGCIFAELANAGR
Sbjct: 141 KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

Query: 184 PLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGR 243
           PLFPG+DVDDQLKRIF+LLGTPTE+ WP M  LPD+KP+PMY  + S   V PKL A GR
Sbjct: 201 PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGR 260

Query: 244 DLLQRLLVCNPVQRMSAEDAMSHIYFSDLN 273
           DLLQ LL CNPVQR+SAE+A+ H YFSD  
Sbjct: 261 DLLQNLLKCNPVQRISAEEALQHPYFSDFC 290

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  454 bits (1171), Expect = e-163
 Identities = 150/261 (57%), Positives = 187/261 (71%), Gaps = 4/261 (1%)

Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYF 74
           A+K   L   EG P +A+RE+ LLK+LKH NIV L+D++H+EK LTLVFE+ D+DLK+Y 
Sbjct: 31  ALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYL 90

Query: 75  DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF 134
           D     I++  VK F++QLLRGLA+CH + VLHRDLKPQNLLIN+ GELKLADFGLARA 
Sbjct: 91  DDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAK 150

Query: 135 GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQ 194
            IP K Y  EVVTLWYRPPD+L G+  Y+T IDMW  GCIF E+A  GRPLFPGS V++Q
Sbjct: 151 SIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT-GRPLFPGSTVEEQ 209

Query: 195 LKRIFKLLGTPTEDTWPGMNLLPDFKP--FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVC 252
           L  IF++LGTPTE+TWPG+    +FK   +P Y    +    AP+L + G DLL +LL  
Sbjct: 210 LHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAE-ALLSHAPRLDSDGADLLTKLLQF 268

Query: 253 NPVQRMSAEDAMSHIYFSDLN 273
               R+SAEDAM H +F  L 
Sbjct: 269 EGRNRISAEDAMKHPFFLSLG 289

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  450 bits (1160), Expect = e-161
 Identities = 146/272 (53%), Positives = 186/272 (68%), Gaps = 6/272 (2%)

Query: 5   GVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF 63
             D      +A+K   L   +EG+PS+A+REI LLKEL H NIV L DV+HSE+ LTLVF
Sbjct: 40  AKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98

Query: 64  EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL 123
           E  ++DLKK  D     +    +K ++YQLLRG+A CH   +LHRDLKPQNLLIN +G L
Sbjct: 99  EFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGAL 158

Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           KLADFGLARAFGIPV+ Y+ EVVTLWYR PDVL G+K Y+TS+D+WS GCIFAE+   G+
Sbjct: 159 KLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT-GK 217

Query: 184 PLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP--FPMYHPSMSFSQVAPKLTAK 241
           PLFPG   DDQL +IF +LGTP    WP +  LP +K   F ++     +S + P    +
Sbjct: 218 PLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKK-PWSSIIPGFCQE 276

Query: 242 GRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN 273
           G DLL  +L  +P +R+SA DAM+H YF DL+
Sbjct: 277 GIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  448 bits (1156), Expect = e-160
 Identities = 113/272 (41%), Positives = 160/272 (58%), Gaps = 6/272 (2%)

Query: 5   GVDRTPNTALAIKGTHL----VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT 60
             D+  N  +AIK   L       +G+  +ALREI LL+EL H NI+ L D    +  ++
Sbjct: 29  ARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88

Query: 61  LVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN 120
           LVF+  + DL+      +  +    +K++M   L+GL + H   +LHRDLKP NLL+++N
Sbjct: 89  LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN 148

Query: 121 GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           G LKLADFGLA++FG P + Y+ +VVT WYR P++LFGA++Y   +DMW+ GCI AEL  
Sbjct: 149 GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL 208

Query: 181 AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA 240
              P  PG    DQL RIF+ LGTPTE+ WP M  LPD+  F  + P +    +      
Sbjct: 209 -RVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF-PGIPLHHIFSAAGD 266

Query: 241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
              DL+Q L + NP  R++A  A+   YFS+ 
Sbjct: 267 DLLDLIQGLFLFNPCARITATQALKMKYFSNR 298

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  446 bits (1149), Expect = e-160
 Identities = 149/278 (53%), Positives = 190/278 (68%), Gaps = 11/278 (3%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
           G+++T    +A+K   L   EG PS+A+REI L+KELKH+NIVRLYDV+H+E KLTLVFE
Sbjct: 24  GLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83

Query: 65  HCDQDLKKYFDSLN-----GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK 119
             D DLKKY DS         ++L++VK F +QLL+GLAFCH   +LHRDLKPQNLLINK
Sbjct: 84  FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINK 143

Query: 120 NGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELA 179
            G+LKL DFGLARAFGIPV  +S+EVVTLWYR PDVL G++ Y+TSID+WS GCI AE+ 
Sbjct: 144 RGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI 203

Query: 180 NAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV----- 234
             G+PLFPG++ ++QLK IF ++GTP E  WP +  LP + P     P     QV     
Sbjct: 204 T-GKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT 262

Query: 235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
              L     D L  LL  NP  R+SA+ A+ H +F++ 
Sbjct: 263 KEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  442 bits (1140), Expect = e-158
 Identities = 95/272 (34%), Positives = 138/272 (50%), Gaps = 4/272 (1%)

Query: 5   GVDRTPNTALAIKGTHLVG-NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF 63
             +R     +AIK       +  +   ALREI +LK+LKH N+V L +V   +++L LVF
Sbjct: 22  CRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81

Query: 64  EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL 123
           E+CD  +    D     +   +VKS  +Q L+ + FCH  N +HRD+KP+N+LI K+  +
Sbjct: 82  EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVI 141

Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           KL DFG AR    P   Y  EV T WYR P++L G   Y   +D+W+ GC+FAEL + G 
Sbjct: 142 KLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLS-GV 200

Query: 184 PLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP--FPMYHPSMSFSQVAPKLTAK 241
           PL+PG    DQL  I K LG          +    F     P            P ++  
Sbjct: 201 PLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYP 260

Query: 242 GRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN 273
              LL+  L  +P +R++ E  + H YF ++ 
Sbjct: 261 ALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  440 bits (1135), Expect = e-157
 Identities = 91/276 (32%), Positives = 144/276 (52%), Gaps = 4/276 (1%)

Query: 5   GVDRTPNTALAIKGTHLVG-NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF 63
             ++     +AIK       ++ V   A+REI LLK+L+H+N+V L +V   +K+  LVF
Sbjct: 44  CRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103

Query: 64  EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL 123
           E  D  +    +     +D  +V+ +++Q++ G+ FCHS N++HRD+KP+N+L++++G +
Sbjct: 104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVV 163

Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           KL DFG AR    P + Y  EV T WYR P++L G   Y  ++D+W+ GC+  E+   G 
Sbjct: 164 KLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM-GE 222

Query: 184 PLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP--FPMYHPSMSFSQVAPKLTAK 241
           PLFPG    DQL  I   LG          N  P F     P         +  PKL+  
Sbjct: 223 PLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEV 282

Query: 242 GRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIK 277
             DL ++ L  +P +R    + + H +F     A +
Sbjct: 283 VIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAER 318

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  437 bits (1127), Expect = e-156
 Identities = 130/275 (47%), Positives = 186/275 (67%), Gaps = 9/275 (3%)

Query: 5   GVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF 63
            +D   N  +AIK   L    EGVP +A+RE+ LLKEL+H+NI+ L  V+H   +L L+F
Sbjct: 53  AIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112

Query: 64  EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN--- 120
           E+ + DLKKY D  N ++ + ++KSF+YQL+ G+ FCHSR  LHRDLKPQNLL++ +   
Sbjct: 113 EYAENDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDAS 171

Query: 121 --GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
               LK+ DFGLARAFGIP++ ++ E++TLWYRPP++L G++ Y+TS+D+WS  CI+AE+
Sbjct: 172 ETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEM 231

Query: 179 ANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPK 237
                PLFPG    DQL +IF++LG P + TWPG+  LPD+K  FP +        +   
Sbjct: 232 LM-KTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGAL 290

Query: 238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
           L  +G DLL  +L  +PV+R+SA++A+ H YFS  
Sbjct: 291 LDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  414 bits (1067), Expect = e-147
 Identities = 117/281 (41%), Positives = 156/281 (55%), Gaps = 18/281 (6%)

Query: 5   GVDRTPNTALAIKGTHL----VGNEGVPSSALREICLLKELK---HKNIVRLYDVLHS-- 55
             D      +A+K   +     G  G+P S +RE+ LL+ L+   H N+VRL DV  +  
Sbjct: 28  ARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87

Query: 56  ---EKKLTLVFEHCDQDLKKYFDSLNGE-IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLK 111
              E K+TLVFEH DQDL+ Y D      +  + +K  M Q LRGL F H+  ++HRDLK
Sbjct: 88  TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLK 147

Query: 112 PQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           P+N+L+   G +KLADFGLAR +   +   +  VVTLWYR P+VL  +  Y T +DMWS 
Sbjct: 148 PENILVTSGGTVKLADFGLARIYSYQMA-LTPVVVTLWYRAPEVLLQST-YATPVDMWSV 205

Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSF 231
           GCIFAE+    +PLF G+   DQL +IF L+G P ED WP    LP    FP   P    
Sbjct: 206 GCIFAEMFR-RKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGA-FPPRGPR-PV 262

Query: 232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
             V P++   G  LL  +L  NP +R+SA  A+ H Y    
Sbjct: 263 QSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  415 bits (1069), Expect = e-147
 Identities = 119/268 (44%), Positives = 161/268 (60%), Gaps = 15/268 (5%)

Query: 15  AIKGTHL-VGNEGVPSSALREICLLKELK---HKNIVRLYDVLHS-----EKKLTLVFEH 65
           A+K   +  G EG+P S +RE+ +L+ L+   H N+VRL+DV        E KLTLVFEH
Sbjct: 41  ALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH 100

Query: 66  CDQDLKKYFDSL-NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELK 124
            DQDL  Y D +    +  + +K  M+QLLRGL F HS  V+HRDLKPQN+L+  +G++K
Sbjct: 101 VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK 160

Query: 125 LADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRP 184
           LADFGLAR +   +   ++ VVTLWYR P+VL  +  Y T +D+WS GCIFAE+    +P
Sbjct: 161 LADFGLARIYSFQMA-LTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFR-RKP 217

Query: 185 LFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRD 244
           LF GS   DQL +I  ++G P E+ WP    LP    F          +    +   G+D
Sbjct: 218 LFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA-FHSKSAQ-PIEKFVTDIDELGKD 275

Query: 245 LLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
           LL + L  NP +R+SA  A+SH YF DL
Sbjct: 276 LLLKCLTFNPAKRISAYSALSHPYFQDL 303

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  392 bits (1009), Expect = e-138
 Identities = 94/263 (35%), Positives = 141/263 (53%), Gaps = 18/263 (6%)

Query: 25  EGVPSSALREICLLKELKHKNIVRLYDVLHSEK--------KLTLVFEHCDQDLKKYFDS 76
           EG P +ALREI +L+ LKH+N+V L ++  ++          + LVF+ C+ DL     +
Sbjct: 57  EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN 116

Query: 77  LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGI 136
           +  +  L  +K  M  LL GL + H   +LHRD+K  N+LI ++G LKLADFGLARAF +
Sbjct: 117 VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 176

Query: 137 PVKC----YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD 192
                   Y+  VVTLWYRPP++L G + Y   ID+W AGCI AE+     P+  G+   
Sbjct: 177 AKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQ 235

Query: 193 DQLKRIFKLLGTPTEDTWPGMNLLPDFKP--FPMYHPSMSFSQVAPKL--TAKGRDLLQR 248
            QL  I +L G+ T + WP ++    ++                           DL+ +
Sbjct: 236 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKR-KVKDRLKAYVRDPYALDLIDK 294

Query: 249 LLVCNPVQRMSAEDAMSHIYFSD 271
           LLV +P QR+ ++DA++H +F  
Sbjct: 295 LLVLDPAQRIDSDDALNHDFFWS 317

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  390 bits (1003), Expect = e-136
 Identities = 101/301 (33%), Positives = 154/301 (51%), Gaps = 39/301 (12%)

Query: 7   DRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVL--HSEKKLTLVFE 64
           D   +   A+K    +   G+  SA REI LL+ELKH N++ L  V   H+++K+ L+F+
Sbjct: 44  DGKDDKDYALKQ---IEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 100

Query: 65  HCDQDLKKYFDSLNGE--------IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLL 116
           + + DL                  +   +VKS +YQ+L G+ + H+  VLHRDLKP N+L
Sbjct: 101 YAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANIL 160

Query: 117 I----NKNGELKLADFGLARAFGIPVKCYS---AEVVTLWYRPPDVLFGAKLYTTSIDMW 169
           +     + G +K+AD G AR F  P+K  +     VVT WYR P++L GA+ YT +ID+W
Sbjct: 161 VMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW 220

Query: 170 SAGCIFAELANAGRPLFPGSDVD---------DQLKRIFKLLGTPTEDTWPGMNLLPDFK 220
           + GCIFAEL     P+F     D         DQL RIF ++G P +  W  +  +P+  
Sbjct: 221 AIGCIFAELLT-SEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHS 279

Query: 221 ---------PFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD 271
                     +          +   K  +K   LLQ+LL  +P++R+++E AM   YF +
Sbjct: 280 TLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLE 339

Query: 272 L 272
            
Sbjct: 340 D 340

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  355 bits (914), Expect = e-123
 Identities = 97/252 (38%), Positives = 143/252 (56%), Gaps = 14/252 (5%)

Query: 32  LREICLLKELKHKNIVRLYDVLHS------EKKLTLVFEHCDQDLKKYFDS---LNGEID 82
            RE+ +++ +KH N+V L    +S      E  L LV E+  + + +       L   + 
Sbjct: 80  NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMP 139

Query: 83  LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVKCY 141
           + ++K +MYQLLR LA+ HS  + HRD+KPQNLL++   G LKL DFG A+   I  +  
Sbjct: 140 MLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-IAGEPN 198

Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
            + + + +YR P+++FGA  YTT+ID+WS GC+ AEL   G+PLFPG    DQL  I K+
Sbjct: 199 VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ-GQPLFPGESGIDQLVEIIKV 257

Query: 202 LGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV-APKLTAKGRDLLQRLLVCNPVQRMSA 260
           LGTP+ +    MN       FP   P   FS+V  P+      DL+ RLL   P  R++A
Sbjct: 258 LGTPSREQIKTMNPNYMEHKFPQIRP-HPFSKVFRPRTPPDAIDLISRLLEYTPSARLTA 316

Query: 261 EDAMSHIYFSDL 272
            +A+ H +F +L
Sbjct: 317 IEALCHPFFDEL 328

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  337 bits (866), Expect = e-115
 Identities = 92/254 (36%), Positives = 143/254 (56%), Gaps = 18/254 (7%)

Query: 32  LREICLLKELKHKNIVRLYDVLHS------EKKLTLVFEHCDQDLKKY---FDSLNGEID 82
            RE+ ++++L H NIVRL    +S      E  L LV ++  + + +    +      + 
Sbjct: 95  NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP 154

Query: 83  LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVKCY 141
           +  VK +MYQL R LA+ HS  + HRD+KPQNLL++ +   LKL DFG A+   +  +  
Sbjct: 155 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPN 213

Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
            + + + +YR P+++FGA  YT+SID+WSAGC+ AEL   G+P+FPG    DQL  I K+
Sbjct: 214 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKV 272

Query: 202 LGTPTEDTWPGMNLLPDFKP--FPMYHPSMSFSQV-APKLTAKGRDLLQRLLVCNPVQRM 258
           LGTPT +    MN  P++    FP       +++V  P+   +   L  RLL   P  R+
Sbjct: 273 LGTPTREQIREMN--PNYTEFKFPQIKA-HPWTKVFRPRTPPEAIALCSRLLEYTPTARL 329

Query: 259 SAEDAMSHIYFSDL 272
           +  +A +H +F +L
Sbjct: 330 TPLEACAHSFFDEL 343

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  327 bits (840), Expect = e-113
 Identities = 84/282 (29%), Positives = 145/282 (51%), Gaps = 22/282 (7%)

Query: 4   SGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK-HKNIVRLYDVLH--SEKKLT 60
             ++ T N  + +K    V  +       REI +L+ L+   NI+ L D++     +   
Sbjct: 54  EAINITNNEKVVVKILKPVKKK----KIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109

Query: 61  LVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN- 118
           LVFEH +  D K+ + +L        ++ +MY++L+ L +CHS  ++HRD+KP N++I+ 
Sbjct: 110 LVFEHVNNTDFKQLYQTLT----DYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 165

Query: 119 KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
           ++ +L+L D+GLA  F  P + Y+  V + +++ P++L   ++Y  S+DMWS GC+ A +
Sbjct: 166 EHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 224

Query: 179 ANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWP---GMNLLPDFKPFPMYHPSMSFSQVA 235
                P F G D  DQL RI K+LGT     +     + L P F      H    + +  
Sbjct: 225 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 284

Query: 236 PK-----LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
                  ++ +  D L +LL  +   R++A +AM H YF  +
Sbjct: 285 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  318 bits (817), Expect = e-109
 Identities = 92/290 (31%), Positives = 148/290 (51%), Gaps = 30/290 (10%)

Query: 4   SGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK---HKNIVRLYDVLHS----- 55
            G +++   ++AIK          P    RE+ ++++L    H NIV+L    ++     
Sbjct: 41  LGKEKSTGMSVAIKKVIQD-----PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95

Query: 56  --EKKLTLVFEHCDQDLKKYFDS---LNGEIDLDIVKSFMYQLLRGLAFCH--SRNVLHR 108
             +  L +V E+    L +   +           ++K F++QL+R +   H  S NV HR
Sbjct: 96  RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHR 155

Query: 109 DLKPQNLLINK-NGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSID 167
           D+KP N+L+N+ +G LKL DFG A+    P +   A + + +YR P+++FG + YTT++D
Sbjct: 156 DIKPHNVLVNEADGTLKLCDFGSAKKLS-PSEPNVAYICSRYYRAPELIFGNQHYTTAVD 214

Query: 168 MWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY-- 225
           +WS GCIFAE+   G P+F G +   QL  I ++LG P+ +    +N  P      +Y  
Sbjct: 215 IWSVGCIFAEMML-GEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN--PSHTDVDLYNS 271

Query: 226 --HP-SMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
              P S  FS  + K   +  DLL  LL   P +RM   +A+ H YF +L
Sbjct: 272 KGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  305 bits (783), Expect = e-102
 Identities = 98/335 (29%), Positives = 149/335 (44%), Gaps = 68/335 (20%)

Query: 4   SGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSE-----K 57
              D+     +AIK    V  +       LREI +L  L H ++V++ D++  +      
Sbjct: 71  EAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130

Query: 58  KLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI 117
           +L +V E  D D KK F +    +    +K+ +Y LL G+ + HS  +LHRDLKP N L+
Sbjct: 131 ELYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV 189

Query: 118 NKNGELKLADFGLARAFGIPVKCYSA---------------------------EVVTLWY 150
           N++  +K+ DFGLAR    P    S                             VVT WY
Sbjct: 190 NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWY 249

Query: 151 RPPDVLFGAKLYTTSIDMWSAGCIFAEL----------ANAGRPLFPGSDV--------- 191
           R P+++   + YT +ID+WS GCIFAEL               PLFPGS           
Sbjct: 250 RAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKA 309

Query: 192 -----------DDQLKRIFKLLGTPTEDTWPGMN--LLPDFKP-FPMYHPSMSFSQVAPK 237
                       DQL  IF +LGTP+E+    +       +   FP        ++  P 
Sbjct: 310 GNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFP-KREGTDLAERFPA 368

Query: 238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
            +A    LL+R+LV NP +R++  + ++H +F ++
Sbjct: 369 SSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  296 bits (760), Expect = e-100
 Identities = 96/312 (30%), Positives = 147/312 (47%), Gaps = 51/312 (16%)

Query: 4   SGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHS-------- 55
              D       A+K          P    RE+ ++K L H NI++L D  ++        
Sbjct: 25  EVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79

Query: 56  ------------------------------EKKLTLVFEHCDQDLKKY---FDSLNGEID 82
                                          K L ++ E+    L K    F      I 
Sbjct: 80  PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIP 139

Query: 83  LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCY 141
           ++++  ++YQL R + F HS  + HRD+KPQNLL+N K+  LKL DFG A+   IP +  
Sbjct: 140 MNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL-IPSEPS 198

Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
            A + + +YR P+++ GA  YT SID+WS GC+F EL   G+PLF G    DQL RI ++
Sbjct: 199 VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL-GKPLFSGETSIDQLVRIIQI 257

Query: 202 LGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT-AKGRDLLQRLLVCNPVQRMSA 260
           +GTPT++    MN       FP       + ++ P+ T +   DLL+++L   P  R++ 
Sbjct: 258 MGTPTKEQMIRMNPHYTEVRFPTLKA-KDWRKILPEGTPSLAIDLLEQILRYEPDLRINP 316

Query: 261 EDAMSHIYFSDL 272
            +AM+H +F  L
Sbjct: 317 YEAMAHPFFDHL 328

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  274 bits (702), Expect = 2e-91
 Identities = 91/290 (31%), Positives = 135/290 (46%), Gaps = 27/290 (9%)

Query: 4   SGVDRTPNTALAIKGTHLVGNEGVPSS----------ALREICLLKELKHKNIVRLYDVL 53
           +GVD      +AIK      ++G   +           LREI LL    H NI+ L D+ 
Sbjct: 40  AGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98

Query: 54  HSE-----KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHR 108
                    KL LV E    DL +        I    ++ FMY +L GL   H   V+HR
Sbjct: 99  VHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHR 158

Query: 109 DLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDM 168
           DL P N+L+  N ++ + DF LAR         +  V   WYR P+++   K +T  +DM
Sbjct: 159 DLHPGNILLADNNDITICDFNLAREDT-ADANKTHYVTHRWYRAPELVMQFKGFTKLVDM 217

Query: 169 WSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGM------NLLPDFKPF 222
           WSAGC+ AE+ N  + LF GS   +QL +I +++GTP  +           + L +    
Sbjct: 218 WSAGCVMAEMFN-RKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLS- 275

Query: 223 PMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
               P+ +++ V P       DL+ ++L  NP +R+S E A+ H YF  L
Sbjct: 276 --NVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  267 bits (686), Expect = 6e-89
 Identities = 96/282 (34%), Positives = 149/282 (52%), Gaps = 19/282 (6%)

Query: 4   SGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE-----KK 58
           S  D      +AIK      ++      LREI +L   +H+NI+ + D++ +      K 
Sbjct: 45  SAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104

Query: 59  LTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN 118
           + +V +  + DL K   +    +  D +  F+YQ+LRGL + HS NVLHRDLKP NLL+N
Sbjct: 105 VYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 162

Query: 119 KNGELKLADFGLARAFGIPVKCYSA---EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIF 175
              +LK+ DFGLAR               V T WYR P+++  +K YT SID+WS GCI 
Sbjct: 163 TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCIL 222

Query: 176 AELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM-----YHPSMS 230
           AE+ +  RP+FPG    DQL  I  +LG+P+++    +N + + K         +   + 
Sbjct: 223 AEMLS-NRPIFPGKHYLDQLNHILGILGSPSQED---LNCIINLKARNYLLSLPHKNKVP 278

Query: 231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
           ++++ P   +K  DLL ++L  NP +R+  E A++H Y    
Sbjct: 279 WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  266 bits (683), Expect = 1e-88
 Identities = 95/282 (33%), Positives = 148/282 (52%), Gaps = 24/282 (8%)

Query: 4   SGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT-- 60
           S +D+     +AIK       +E     A RE+ LLK ++H+N++ L DV      L   
Sbjct: 42  SAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101

Query: 61  ----LVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLL 116
               LV      DL+K    +  +   + ++  +YQ+L+GL + HS  V+HRDLKP NL 
Sbjct: 102 YDFYLVMPFMQTDLQKI---MGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLA 158

Query: 117 INKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFA 176
           +N++ ELK+ DFGLAR     +  Y   VVT WYR P+V+     Y  ++D+WS GCI A
Sbjct: 159 VNEDCELKILDFGLARHADAEMTGY---VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 215

Query: 177 ELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPD------FKPFPMYHPSMS 230
           E+   G+ LF G D  DQL +I K+ G P  +    +  L D       +  P   P   
Sbjct: 216 EMLT-GKTLFKGKDYLDQLTQILKVTGVPGTEF---VQKLNDKAAKSYIQSLP-QTPRKD 270

Query: 231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
           F+Q+ P+ + +  DLL+++L  +  +R++A  A++H +F   
Sbjct: 271 FTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  266 bits (681), Expect = 3e-88
 Identities = 99/285 (34%), Positives = 150/285 (52%), Gaps = 29/285 (10%)

Query: 4   SGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT-- 60
           S VD      +AIK  +    +E     A RE+ LLK ++H+N++ L DV   ++ L   
Sbjct: 43  SAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102

Query: 61  ----LVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLL 116
               LV      DL K       ++  D ++  +YQ+L+GL + H+  ++HRDLKP NL 
Sbjct: 103 TDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA 160

Query: 117 INKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFA 176
           +N++ ELK+ DFGLAR     +  Y   VVT WYR P+V+     YT ++D+WS GCI A
Sbjct: 161 VNEDCELKILDFGLARQADSEMTGY---VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 217

Query: 177 ELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPG---------MNLLPDFKPFPMYHP 227
           E+   G+ LF GSD  DQLK I K+ GTP  +             M  LP+ +       
Sbjct: 218 EMIT-GKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKD---- 272

Query: 228 SMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
              F+ +    +    +LL+++LV +  QR++A +A++H YF  L
Sbjct: 273 ---FASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  266 bits (681), Expect = 3e-88
 Identities = 94/288 (32%), Positives = 140/288 (48%), Gaps = 29/288 (10%)

Query: 1   MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKL 59
              +  D      +A+K       +        RE+ LLK +KH+N++ L DV    + L
Sbjct: 44  SVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 103

Query: 60  T------LVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQ 113
                  LV      DL         ++  D V+  +YQ+LRGL + HS +++HRDLKP 
Sbjct: 104 EEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPS 161

Query: 114 NLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           NL +N++ ELK+ DFGLAR     +  Y   V T WYR P+++     Y  ++D+WS GC
Sbjct: 162 NLAVNEDCELKILDFGLARHTADEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGC 218

Query: 174 IFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPG---------MNLLPDFKPFPM 224
           I AEL   GR LFPG+D  DQLK I +L+GTP  +             +  L        
Sbjct: 219 IMAELLT-GRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN- 276

Query: 225 YHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
                 F+ V         DLL+++LV +  +R++A  A++H YF+  
Sbjct: 277 ------FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  265 bits (680), Expect = 4e-88
 Identities = 97/294 (32%), Positives = 143/294 (48%), Gaps = 35/294 (11%)

Query: 4   SGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT--- 60
           S   +     +AIK              LREI +LK  KH+NI+ ++++   +       
Sbjct: 29  SATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88

Query: 61  --LVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN 118
             ++ E    DL +   +    +  D ++ F+YQ LR +   H  NV+HRDLKP NLLIN
Sbjct: 89  VYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN 146

Query: 119 KNGELKLADFGLARAFGIPVKCYSAE----------VVTLWYRPPDVLFGAKLYTTSIDM 168
            N +LK+ DFGLAR         S            V T WYR P+V+  +  Y+ ++D+
Sbjct: 147 SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDV 206

Query: 169 WSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPG----------MNLLPD 218
           WS GCI AEL    RP+FPG D   QL  IF ++GTP  D              +  LP 
Sbjct: 207 WSCGCILAELFL-RRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPM 265

Query: 219 FKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
           +   P         ++ P++  KG DLLQR+LV +P +R++A++A+ H Y    
Sbjct: 266 YPAAP-------LEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  259 bits (665), Expect = 2e-86
 Identities = 99/288 (34%), Positives = 153/288 (53%), Gaps = 23/288 (7%)

Query: 4   SGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT--- 60
           S VD   +  +AIK   L  +      ALREI +++ L H NIV+++++L          
Sbjct: 29  SAVDNDCDKRVAIKKIVL-TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87

Query: 61  -----------LVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRD 109
                      +V E+ + DL    +   G +  +  + FMYQLLRGL + HS NVLHRD
Sbjct: 88  VGSLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRD 145

Query: 110 LKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSA---EVVTLWYRPPDVLFGAKLYTTS 165
           LKP NL IN ++  LK+ DFGLAR               +VT WYR P +L     YT +
Sbjct: 146 LKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKA 205

Query: 166 IDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGM-NLLPDFKPFPM 224
           IDMW+AGCIFAE+   G+ LF G+   +Q++ I + +    E+    + +++P +    M
Sbjct: 206 IDMWAAGCIFAEMLT-GKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDM 264

Query: 225 YHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
             P    +Q+ P ++ +  D L+++L  +P+ R++AE+A+SH Y S  
Sbjct: 265 TEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  259 bits (663), Expect = 4e-85
 Identities = 85/284 (29%), Positives = 135/284 (47%), Gaps = 45/284 (15%)

Query: 31  ALREICLLKELK-HKNIVRLYDVLHSE--KKLTLVFEHCDQDLKKYFDSLNGEIDLDIVK 87
             REI +L EL  H+NIV L +VL ++  + + LVF++ + DL     +    ++    +
Sbjct: 55  TFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRA--NILEPVHKQ 112

Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE--- 144
             +YQL++ + + HS  +LHRD+KP N+L+N    +K+ADFGL+R+F    +  +     
Sbjct: 113 YVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172

Query: 145 ------------------VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF 186
                             V T WYR P++L G+  YT  IDMWS GCI  E+   G+P+F
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC-GKPIF 231

Query: 187 PGSDVDDQLKRIFKLLGTPTEDT------------------WPGMNLLPDFKPFPMYHPS 228
           PGS   +QL+RI  ++  P+ +                      +        F  +   
Sbjct: 232 PGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNL 291

Query: 229 MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
           +           +  DLL +LL  NP +R+SA DA+ H + S  
Sbjct: 292 LLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF 335

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  256 bits (656), Expect = 2e-84
 Identities = 82/261 (31%), Positives = 134/261 (51%), Gaps = 25/261 (9%)

Query: 31  ALREICLLKELKHKNIVRLYDVLHSEKKLT------LVFEHCDQDLKKYFDSLNGEIDLD 84
           A RE+ L+K + HKNI+ L +V   +K L       +V E  D +L +    +  E+D +
Sbjct: 71  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV---IQMELDHE 127

Query: 85  IVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE 144
            +   +YQ+L G+   HS  ++HRDLKP N+++  +  LK+ DFGLAR  G      +  
Sbjct: 128 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPY 186

Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
           VVT +YR P+V+ G   Y  ++D+WS GCI  E+   G  LFPG+D  DQ  ++ + LGT
Sbjct: 187 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIK-GGVLFPGTDHIDQWNKVIEQLGT 244

Query: 205 PTEDTWPGMN--------LLPDFKPFPM-----YHPSMSFSQVAPKLTAKGRDLLQRLLV 251
           P  +    +           P +  +            + S+      ++ RDLL ++LV
Sbjct: 245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 304

Query: 252 CNPVQRMSAEDAMSHIYFSDL 272
            +  +R+S ++A+ H Y +  
Sbjct: 305 IDASKRISVDEALQHPYINVW 325

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  257 bits (659), Expect = 1e-83
 Identities = 89/292 (30%), Positives = 143/292 (48%), Gaps = 26/292 (8%)

Query: 1   MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKL 59
           +  +  D   +  +AIK       N+     A RE+ L+K + HKNI+ L +V   +K L
Sbjct: 77  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136

Query: 60  T------LVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQ 113
                  LV E  D +L +    +  E+D + +   +YQ+L G+   HS  ++HRDLKP 
Sbjct: 137 EEFQDVYLVMELMDANLCQV---IQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193

Query: 114 NLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           N+++  +  LK+ DFGLAR  G      +  VVT +YR P+V+ G   Y  ++D+WS GC
Sbjct: 194 NIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGC 251

Query: 174 IFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN--------LLPDFKPFPMY 225
           I  E+    + LFPG D  DQ  ++ + LGTP  +    +           P +      
Sbjct: 252 IMGEMVR-HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFP 310

Query: 226 H-----PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
                    + S+      ++ RDLL ++LV +P +R+S +DA+ H Y +  
Sbjct: 311 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  256 bits (656), Expect = 1e-83
 Identities = 98/302 (32%), Positives = 140/302 (46%), Gaps = 65/302 (21%)

Query: 31  ALREICLLKELKHKNIVRLYDVLHSEKKLT-----LVFEHCDQDLKKYFDSLNGEIDLDI 85
            LREI +L  LK   I+RLYD++  +  L      +V E  D DLKK F +    +  + 
Sbjct: 72  ILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT-PIFLTEEH 130

Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE- 144
           +K+ +Y LL G  F H   ++HRDLKP N L+N++  +K+ DFGLAR             
Sbjct: 131 IKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190

Query: 145 ---------------------VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL----- 178
                                VVT WYR P+++   + YT SID+WS GCIFAEL     
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250

Query: 179 -----ANAGRPLFPGS-----------------DVDDQLKRIFKLLGTPTEDTWPGMNLL 216
                     PLFPGS                    DQL  IF ++GTPTED    +  +
Sbjct: 251 SHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDD---LKNI 307

Query: 217 PD------FKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
                    K FP +   ++  Q  P ++  G +LL+ +L  NP +R++ + A+ H Y  
Sbjct: 308 NKPEVIKYIKLFP-HRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLK 366

Query: 271 DL 272
           D+
Sbjct: 367 DV 368

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  176 bits (448), Expect = 7e-54
 Identities = 58/249 (23%), Positives = 100/249 (40%), Gaps = 43/249 (17%)

Query: 32  LREICLLKELKHKN--IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSF 89
             EI  L +L+  +  I+RLYD   +++ + +V E  + DL  +       ID    KS+
Sbjct: 74  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSY 132

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV--T 147
              +L  +   H   ++H DLKP N LI  +G LKL DFG+A            +    T
Sbjct: 133 WKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGT 191

Query: 148 LWYRPPDVLFGA----------KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
           + Y PP+ +                +   D+WS GCI   +   G+  F    + +Q+ +
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT-YGKTPF--QQIINQISK 248

Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQR 257
           +  ++    E  +P                               +D+L+  L  +P QR
Sbjct: 249 LHAIIDPNHEIEFP------------------------DIPEKDLQDVLKCCLKRDPKQR 284

Query: 258 MSAEDAMSH 266
           +S  + ++H
Sbjct: 285 ISIPELLAH 293

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  170 bits (432), Expect = 8e-52
 Identities = 65/243 (26%), Positives = 107/243 (44%), Gaps = 42/243 (17%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFMY 91
            E+ +  +LKH +I+ LY+       + LV E C   ++ +Y  +       +  + FM+
Sbjct: 60  NEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH 119

Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-----CYSAEVV 146
           Q++ G+ + HS  +LHRDL   NLL+ +N  +K+ADFGLA    +P +     C      
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCG----- 174

Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
           T  Y  P++      +    D+WS GC+F  L   GRP F    V + L ++        
Sbjct: 175 TPNYISPEIATR-SAHGLESDVWSLGCMFYTLL-IGRPPFDTDTVKNTLNKVVLA----- 227

Query: 207 EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                      D++  P +      S  A       +DL+ +LL  NP  R+S    + H
Sbjct: 228 -----------DYE-MPSF-----LSIEA-------KDLIHQLLRRNPADRLSLSSVLDH 263

Query: 267 IYF 269
            + 
Sbjct: 264 PFM 266

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  169 bits (431), Expect = 2e-51
 Identities = 63/293 (21%), Positives = 110/293 (37%), Gaps = 58/293 (19%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDV------------ 52
             +   +   AIK       E   S+ L E+ LL  L H+ +VR Y              
Sbjct: 25  ARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82

Query: 53  -LHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDL 110
            +  +  L +  E+C+   L     S N     D       Q+L  L++ HS+ ++HRDL
Sbjct: 83  AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDL 142

Query: 111 KPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV--------------TLWYRPPDVL 156
           KP N+ I+++  +K+ DFGLA+     +     +                T  Y   +VL
Sbjct: 143 KPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVL 202

Query: 157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLL 216
            G   Y   IDM+S G IF E+     P   G +  + LK++                  
Sbjct: 203 DGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRS---------------- 243

Query: 217 PDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
              +  P +  +    +         + +++ L+  +P +R  A   ++  + 
Sbjct: 244 VSIEFPPDFDDNKMKVE---------KKIIRLLIDHDPNKRPGARTLLNSGWL 287

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  169 bits (431), Expect = 5e-51
 Identities = 56/249 (22%), Positives = 96/249 (38%), Gaps = 43/249 (17%)

Query: 32  LREICLLKELKHKN--IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSF 89
             EI  L +L+  +  I+RLYD   +++ + +V E  + DL  +       ID    KS+
Sbjct: 55  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSY 113

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK---------- 139
              +L  +   H   ++H DLKP N LI  +G LKL DFG+A                  
Sbjct: 114 WKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172

Query: 140 -CYSA-EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
             Y   E +       +        +   D+WS GCI   +   G+  F    + +Q+ +
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT-YGKTPF--QQIINQISK 229

Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQR 257
           +  ++    E  +P                               +D+L+  L  +P QR
Sbjct: 230 LHAIIDPNHEIEFP------------------------DIPEKDLQDVLKCCLKRDPKQR 265

Query: 258 MSAEDAMSH 266
           +S  + ++H
Sbjct: 266 ISIPELLAH 274

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  168 bits (428), Expect = 5e-50
 Identities = 57/251 (22%), Positives = 97/251 (38%), Gaps = 47/251 (18%)

Query: 32  LREICLLKELKHKN--IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSF 89
             EI  L +L+  +  I+RLYD   +++ + +V E  + DL  +       ID    KS+
Sbjct: 102 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSY 160

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-------------GI 136
              +L  +   H   ++H DLKP N LI  +G LKL DFG+A                G 
Sbjct: 161 WKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219

Query: 137 PVKCYSA-EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL 195
               Y   E +       +        +   D+WS GCI   +   G+  F    + +Q+
Sbjct: 220 V--NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT-YGKTPF--QQIINQI 274

Query: 196 KRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPV 255
            ++  ++    E  +P                               +D+L+  L  +P 
Sbjct: 275 SKLHAIIDPNHEIEFP------------------------DIPEKDLQDVLKCCLKRDPK 310

Query: 256 QRMSAEDAMSH 266
           QR+S  + ++H
Sbjct: 311 QRISIPELLAH 321

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  165 bits (420), Expect = 8e-50
 Identities = 57/238 (23%), Positives = 102/238 (42%), Gaps = 33/238 (13%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFMY 91
            EI + + L H+++V  +        + +V E C  + L +        +     + ++ 
Sbjct: 64  MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLR 122

Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYR 151
           Q++ G  + H   V+HRDLK  NL +N++ E+K+ DFGLA       +       T  Y 
Sbjct: 123 QIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI 182

Query: 152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWP 211
            P+VL   K ++  +D+WS GCI   L   G+P F  S + +   RI K           
Sbjct: 183 APEVLSK-KGHSFEVDVWSIGCIMYTLL-VGKPPFETSCLKETYLRIKKN---------- 230

Query: 212 GMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
                 ++   P +      + VA         L+Q++L  +P  R +  + ++  +F
Sbjct: 231 ------EYS-IPKH-----INPVA-------ASLIQKMLQTDPTARPTINELLNDEFF 269

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  165 bits (420), Expect = 2e-49
 Identities = 57/238 (23%), Positives = 102/238 (42%), Gaps = 33/238 (13%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFMY 91
            EI + + L H+++V  +        + +V E C  + L +        +     + ++ 
Sbjct: 90  MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLR 148

Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYR 151
           Q++ G  + H   V+HRDLK  NL +N++ E+K+ DFGLA       +       T  Y 
Sbjct: 149 QIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI 208

Query: 152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWP 211
            P+VL   K ++  +D+WS GCI   L   G+P F  S + +   RI K           
Sbjct: 209 APEVLSK-KGHSFEVDVWSIGCIMYTLL-VGKPPFETSCLKETYLRIKKN---------- 256

Query: 212 GMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
                 ++   P +      + VA         L+Q++L  +P  R +  + ++  +F
Sbjct: 257 ------EYS-IPKH-----INPVA-------ASLIQKMLQTDPTARPTINELLNDEFF 295

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  166 bits (421), Expect = 2e-49
 Identities = 47/309 (15%), Positives = 80/309 (25%), Gaps = 59/309 (19%)

Query: 5   GVDRTPNTALAIK--GTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLH-------- 54
             D       A+K        +                L  ++     D           
Sbjct: 81  VRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140

Query: 55  ------------------SEKKLTLVFEHCDQDLKKYFDSL------NGEIDLDIVKSFM 90
                             +     L+      DL+  F +L       G+  +  +    
Sbjct: 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILT 200

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWY 150
            QL+R  A   S+ ++H    P NL I  +G L L D       G          V + Y
Sbjct: 201 AQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPAS---SVPVTY 257

Query: 151 RPPDVLFGAKL-YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDT 209
            P + L  +   +T +++ W  G     +       F       +       L  P  D+
Sbjct: 258 APREFLNASTATFTHALNAWQLGLSIYRVW-CLFLPFGLVTPGIKGSWKRPSLRVPGTDS 316

Query: 210 WPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
                          +                 + L+ R L  +  +R+   +AM    F
Sbjct: 317 LA-------------FGSCTPLPDFV-------KTLIGRFLNFDRRRRLLPLEAMETPEF 356

Query: 270 SDLNVAIKS 278
             L   I S
Sbjct: 357 LQLQNEISS 365

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  166 bits (422), Expect = 7e-49
 Identities = 61/254 (24%), Positives = 109/254 (42%), Gaps = 37/254 (14%)

Query: 29  SSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVK 87
           S A RE+ LL+E  +H N++R +      +   +  E C   L++Y +  +         
Sbjct: 62  SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPI 121

Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE-----LKLADFGLARAFGIPVKCYS 142
           + + Q   GLA  HS N++HRDLKP N+LI+           ++DFGL +   +    +S
Sbjct: 122 TLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFS 181

Query: 143 ---AEVVTLWYRPPDVLFGA--KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
                  T  +  P++L     +  T ++D++SAGC+F  + + G   F         ++
Sbjct: 182 RRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG----KSLQRQ 237

Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQR 257
              LLG                      HP      +A       R+L+++++  +P +R
Sbjct: 238 ANILLGAC---------------SLDCLHPEKHEDVIA-------RELIEKMIAMDPQKR 275

Query: 258 MSAEDAMSHIYFSD 271
            SA+  + H +F  
Sbjct: 276 PSAKHVLKHPFFWS 289

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  163 bits (414), Expect = 1e-48
 Identities = 55/278 (19%), Positives = 98/278 (35%), Gaps = 18/278 (6%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVL--HSEKKLTLV 62
           G  +      AIK  + +         +RE  +LK+L HKNIV+L+ +    + +   L+
Sbjct: 28  GRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87

Query: 63  FEHCDQ-DLKKYFDSLNGEIDL--DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI-- 117
            E C    L    +  +    L        +  ++ G+       ++HR++KP N++   
Sbjct: 88  MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVI 147

Query: 118 --NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA-------KLYTTSIDM 168
             +     KL DFG AR      +  S    T  Y  PD+   A       K Y  ++D+
Sbjct: 148 GEDGQSVYKLTDFGAARELEDDEQFVSL-YGTEEYLHPDMYERAVLRKDHQKKYGATVDL 206

Query: 169 WSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPS 228
           WS G  F   A  G   F   +   + K +   + T             +  P       
Sbjct: 207 WSIGVTFYHAA-TGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDM 265

Query: 229 MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                ++  L      +L  +L  +  +    +   + 
Sbjct: 266 PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  161 bits (410), Expect = 1e-48
 Identities = 69/249 (27%), Positives = 114/249 (45%), Gaps = 57/249 (22%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL--NGEIDLDIVKSF 89
           RE+ +   L+H NI+RLY   H   ++ L+ E+     +   +  L    + D     ++
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV---YRELQKLSKFDEQRTATY 114

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV--- 146
           + +L   L++CHS+ V+HRD+KP+NLL+   GELK+ADFG            S       
Sbjct: 115 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-----------SVHAPSSR 163

Query: 147 ------TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
                 TL Y PP+++ G +++   +D+WS G +  E    G+P F  +   +  KRI +
Sbjct: 164 RTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISR 221

Query: 201 LLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           +                +F  FP +      ++ A       RDL+ RLL  NP QR   
Sbjct: 222 V----------------EFT-FPDF-----VTEGA-------RDLISRLLKHNPSQRPML 252

Query: 261 EDAMSHIYF 269
            + + H + 
Sbjct: 253 REVLEHPWI 261

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  165 bits (420), Expect = 2e-48
 Identities = 63/273 (23%), Positives = 109/273 (39%), Gaps = 54/273 (19%)

Query: 29  SSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQDL------KKYFDSLNGEI 81
             AL EI LL E   H N++R Y    +++ L +  E C+ +L      K   D      
Sbjct: 53  DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQ 112

Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI-------------NKNGELKLADF 128
                 S + Q+  G+A  HS  ++HRDLKPQN+L+              +N  + ++DF
Sbjct: 113 KEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172

Query: 129 GLARAFGIPVKCYSAEVV----TLWYRPPDVLFGA------KLYTTSIDMWSAGCIFAEL 178
           GL +        +   +     T  +R P++L  +      +  T SID++S GC+F  +
Sbjct: 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232

Query: 179 ANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL 238
            + G+   P  D   +   I +           G+  L + K                  
Sbjct: 233 LSKGKH--PFGDKYSRESNIIR-----------GIFSLDEMKCLHDRSLIAE-------- 271

Query: 239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD 271
                DL+ +++  +P++R +A   + H  F  
Sbjct: 272 ---ATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  160 bits (408), Expect = 4e-48
 Identities = 73/246 (29%), Positives = 111/246 (45%), Gaps = 57/246 (23%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL--NGEIDLDIVKSF 89
           REI +   L+H NI+R+Y+  H  K++ L+ E   + +L   +  L  +G  D     +F
Sbjct: 63  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL---YKELQKHGRFDEQRSATF 119

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV--- 146
           M +L   L +CH R V+HRD+KP+NLL+   GELK+ADFG            S       
Sbjct: 120 MEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW-----------SVHAPSLR 168

Query: 147 ------TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
                 TL Y PP+++ G K +   +D+W AG +  E    G P F      +  +RI  
Sbjct: 169 RRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFL-VGMPPFDSPSHTETHRRIVN 226

Query: 201 LLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA 260
           +                D K FP +      S  +       +DL+ +LL  +P QR+  
Sbjct: 227 V----------------DLK-FPPF-----LSDGS-------KDLISKLLRYHPPQRLPL 257

Query: 261 EDAMSH 266
           +  M H
Sbjct: 258 KGVMEH 263

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  161 bits (408), Expect = 2e-47
 Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 32/239 (13%)

Query: 30  SALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE-IDLDIVK 87
            + RE+ +L  +KH NIV+  +       L +V ++C+  DL K  ++  G     D + 
Sbjct: 69  ESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQIL 128

Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT 147
            +  Q+   L   H R +LHRD+K QN+ + K+G ++L DFG+AR     V+   A + T
Sbjct: 129 DWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGT 188

Query: 148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTE 207
            +Y  P++    K Y    D+W+ GC+  EL    +  F    + + + +I         
Sbjct: 189 PYYLSPEICEN-KPYNNKSDIWALGCVLYELC-TLKHAFEAGSMKNLVLKIISG------ 240

Query: 208 DTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                      F P             +  L    R L+ +L   NP  R S    +  
Sbjct: 241 ----------SFPPVS--------LHYSYDL----RSLVSQLFKRNPRDRPSVNSILEK 277

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  161 bits (410), Expect = 4e-47
 Identities = 74/288 (25%), Positives = 122/288 (42%), Gaps = 60/288 (20%)

Query: 31  ALREICLLKELKHK------NIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE---- 80
           A  EI +L+ L+ +      N++ + +       + + FE    +L   ++ +       
Sbjct: 140 AAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNL---YELIKKNKFQG 196

Query: 81  IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG--ELKLADFGLARAFGIPV 138
             L +V+ F + +L+ L   H   ++H DLKP+N+L+ + G   +K+ DFG +       
Sbjct: 197 FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS------- 249

Query: 139 KCYSAE-----VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDD 193
            CY  +     + + +YR P+V+ GA+ Y   IDMWS GCI AEL   G PL PG D  D
Sbjct: 250 -CYEHQRVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLT-GYPLLPGEDEGD 306

Query: 194 QLKRIFKLLGTPTE---DTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGR------- 243
           QL  + +LLG P++   D           K +P Y    + S  +  L            
Sbjct: 307 QLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRG 366

Query: 244 --------------------DLLQRLLVCNPVQRMSAEDAMSHIYFSD 271
                               D L++ L  +P  RM+   A+ H +   
Sbjct: 367 PPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  157 bits (400), Expect = 5e-46
 Identities = 75/289 (25%), Positives = 118/289 (40%), Gaps = 57/289 (19%)

Query: 31  ALREICLLKELKH------KNIVRLYDVLHSEKKLTLVFEHCDQDL----KKYFDSLNGE 80
           A  E+ LL+ +          IV L         L LVFE    +L    +    +  G 
Sbjct: 97  AQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNT--NFRG- 153

Query: 81  IDLDIVKSFMYQLLRGLAFCHSR--NVLHRDLKPQNLLI--NKNGELKLADFGLARAFGI 136
           + L++ + F  Q+   L F  +   +++H DLKP+N+L+   K   +K+ DFG +   G 
Sbjct: 154 VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 213

Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK 196
            +  Y   + + +YR P+VL G   Y  +IDMWS GCI  E+   G PLF G++  DQ+ 
Sbjct: 214 RIYQY---IQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHT-GEPLFSGANEVDQMN 268

Query: 197 RIFKLLGTP--------------------------------TEDTWPGMNLLPDFKPFPM 224
           +I ++LG P                                 E   PG   L +      
Sbjct: 269 KIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVET 328

Query: 225 YHPSMSFSQVAPKLTAKGR---DLLQRLLVCNPVQRMSAEDAMSHIYFS 270
             P    +  +    A      DL+ R+L  +P  R+    A+ H +F 
Sbjct: 329 GGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  154 bits (392), Expect = 7e-46
 Identities = 56/258 (21%), Positives = 97/258 (37%), Gaps = 54/258 (20%)

Query: 30  SALREICLLKELKHKNIVRLYD----------------VLHSEKKLTLVFEHCDQ-DLKK 72
            A RE+  L +L H NIV                         K L +  E CD+  L++
Sbjct: 50  KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQ 109

Query: 73  YFDSLNGE-IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLA 131
           + +   GE +D  +      Q+ +G+ + HS+ +++RDLKP N+ +    ++K+ DFGL 
Sbjct: 110 WIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLV 169

Query: 132 RAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDV 191
            +     K   +   TL Y  P+ +   + Y   +D+++ G I AEL +     F  S  
Sbjct: 170 TSLKNDGKRTRS-KGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETSKF 227

Query: 192 DDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLV 251
              L+                                  F +         + LLQ+LL 
Sbjct: 228 FTDLRDG----------------------IISDI-----FDKKE-------KTLLQKLLS 253

Query: 252 CNPVQRMSAEDAMSHIYF 269
             P  R +  + +  +  
Sbjct: 254 KKPEDRPNTSEILRTLTV 271

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  156 bits (397), Expect = 2e-45
 Identities = 55/279 (19%), Positives = 98/279 (35%), Gaps = 18/279 (6%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVL--HSEKKLTLV 62
           G  +      AIK  + +         +RE  +LK+L HKNIV+L+ +    + +   L+
Sbjct: 28  GRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87

Query: 63  FEHCDQ-DLKKYFDSLNGEIDL--DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI-- 117
            E C    L    +  +    L        +  ++ G+       ++HR++KP N++   
Sbjct: 88  MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVI 147

Query: 118 --NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA-------KLYTTSIDM 168
             +     KL DFG AR      +  S    T  Y  PD+   A       K Y  ++D+
Sbjct: 148 GEDGQSVYKLTDFGAARELEDDEQFVSL-YGTEEYLHPDMYERAVLRKDHQKKYGATVDL 206

Query: 169 WSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPS 228
           WS G  F   A  G   F   +   + K +   + T             +  P       
Sbjct: 207 WSIGVTFYHAA-TGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDM 265

Query: 229 MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHI 267
                ++  L      +L  +L  +  +    +   +  
Sbjct: 266 PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  155 bits (393), Expect = 2e-45
 Identities = 51/259 (19%), Positives = 107/259 (41%), Gaps = 42/259 (16%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD--------QDLKKYFDSLNGEIDLD 84
            E+ ++ ++K++  +    ++ +  ++ +++E+ +        +       +    I + 
Sbjct: 92  NELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151

Query: 85  IVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA 143
           ++K  +  +L   ++ H+ +N+ HRD+KP N+L++KNG +KL+DFG            S 
Sbjct: 152 VIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGE-----------SE 200

Query: 144 EVV---------TLWYRPPDVLFGAKLY-TTSIDMWSAGCIFAELANAGRPLFPGSDVDD 193
            +V         T  + PP+       Y    +D+WS G     +       F       
Sbjct: 201 YMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF-YNVVPFSLKISLV 259

Query: 194 QL-KRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVC 252
           +L   I           +P      D   F     +   +     L+ +  D L+  L  
Sbjct: 260 ELFNNIRT-----KNIEYP-----LDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK 309

Query: 253 NPVQRMSAEDAMSHIYFSD 271
           NP +R+++EDA+ H + +D
Sbjct: 310 NPAERITSEDALKHEWLAD 328

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  152 bits (387), Expect = 4e-45
 Identities = 69/249 (27%), Positives = 100/249 (40%), Gaps = 43/249 (17%)

Query: 30  SALREICLLKELKHKNIVRLYDVLHSE--KKLTLVFEHCDQ-DLKKYFDSL---NGEIDL 83
             + E+ LL+ELKH NIVR YD +       L +V E+C+  DL             +D 
Sbjct: 51  MLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE 110

Query: 84  DIVKSFMYQLLRGLAFCHSRN-----VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 138
           + V   M QL   L  CH R+     VLHRDLKP N+ ++    +KL DFGLAR      
Sbjct: 111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 170

Query: 139 KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRI 198
                 V T +Y  P+ +     Y    D+WS GC+  EL  A  P F      +   +I
Sbjct: 171 SFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELC-ALMPPFTAFSQKELAGKI 228

Query: 199 FKLLGTPTEDTWPGMNLLPDFKPFP-MYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQR 257
            +                  F+  P  Y   +              +++ R+L      R
Sbjct: 229 REG----------------KFRRIPYRYSDEL-------------NEIITRMLNLKDYHR 259

Query: 258 MSAEDAMSH 266
            S E+ + +
Sbjct: 260 PSVEEILEN 268

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  148 bits (376), Expect = 3e-43
 Identities = 62/299 (20%), Positives = 111/299 (37%), Gaps = 61/299 (20%)

Query: 7   DRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDV------------LH 54
           ++  +   AIK   L   E      +RE+  L +L+H  IVR ++               
Sbjct: 26  NKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85

Query: 55  SEKKLTLVFEHCD-QDLKKYFDSLNG--EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLK 111
            +  L +  + C  ++LK + +      E +  +      Q+   + F HS+ ++HRDLK
Sbjct: 86  PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLK 145

Query: 112 PQNLLINKNGELKLADFGLARAF------------GIPVKCYSAEVVTLWYRPPDVLFGA 159
           P N+    +  +K+ DFGL  A                   ++ +V T  Y  P+ + G 
Sbjct: 146 PSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG- 204

Query: 160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDF 219
             Y+  +D++S G I  EL     P     +    L  +                    F
Sbjct: 205 NSYSHKVDIFSLGLILFELL---YPFSTQMERVRTLTDVRN----------------LKF 245

Query: 220 KP-FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIK 277
            P F   +P                 ++Q +L  +P++R  A + + +  F DL+   K
Sbjct: 246 PPLFTQKYPCE-------------YVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGK 291

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  148 bits (377), Expect = 3e-43
 Identities = 66/275 (24%), Positives = 118/275 (42%), Gaps = 41/275 (14%)

Query: 5   GVDRTPNTALAIK---GTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE--KKL 59
            +D       A+K      L       ++  +EI LL+ L+HKN+++L DVL++E  +K+
Sbjct: 24  VLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83

Query: 60  TLVFEHCDQDLKKYFDSL-NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN 118
            +V E+C   +++  DS+      +     +  QL+ GL + HS+ ++H+D+KP NLL+ 
Sbjct: 84  YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT 143

Query: 119 KNGELKLADFGLARAFGIPVKCYSAEVV--TLWYRPPDVLFGAKLYT-TSIDMWSAGCI- 174
             G LK++  G+A A        +      +  ++PP++  G   ++   +D+WSAG   
Sbjct: 144 TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203

Query: 175 FAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV 234
           +      G   F G ++    + I K           G   +P                 
Sbjct: 204 YNIT--TGLYPFEGDNIYKLFENIGK-----------GSYAIPGD-----------CGPP 239

Query: 235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
                    DLL+ +L   P +R S      H +F
Sbjct: 240 L-------SDLLKGMLEYEPAKRFSIRQIRQHSWF 267

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  155 bits (392), Expect = 4e-43
 Identities = 64/283 (22%), Positives = 110/283 (38%), Gaps = 24/283 (8%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT---- 60
            + +     +AIK      +         EI ++K+L H N+V   +V    +KL     
Sbjct: 33  WIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92

Query: 61  --LVFEHCDQ-DLKKYFDSLNGEIDL--DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
             L  E+C+  DL+KY +       L    +++ +  +   L + H   ++HRDLKP+N+
Sbjct: 93  PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENI 152

Query: 116 LINKNGE---LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAG 172
           ++    +    K+ D G A+       C    V TL Y  P++L   K YT ++D WS G
Sbjct: 153 VLQPGPQRLIHKIIDLGYAKELDQGELCTEF-VGTLQYLAPELLEQ-KKYTVTVDYWSFG 210

Query: 173 CIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTW--PGMNLLPDFKPFPMYHPSMS 230
            +  E     RP  P         ++ +             G        P P       
Sbjct: 211 TLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTP------- 263

Query: 231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN 273
            + ++  L  K    LQ +L+ +  QR +     +   F  L+
Sbjct: 264 -NHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  147 bits (373), Expect = 1e-42
 Identities = 51/238 (21%), Positives = 88/238 (36%), Gaps = 35/238 (14%)

Query: 30  SALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKS 88
             L E+   +++ +H   VRL         L L  E C   L+++ ++    +    V  
Sbjct: 102 RKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWG 161

Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL 148
           ++   L  LA  HS+ ++H D+KP N+ +   G  KL DFGL    G        +    
Sbjct: 162 YLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV-QEGDP 220

Query: 149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTED 208
            Y  P++L G+  Y T+ D++S G    E+A        G       +            
Sbjct: 221 RYMAPELLQGS--YGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPP------- 271

Query: 209 TWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                        F               L+++ R +L  +L  +P  R +AE  ++ 
Sbjct: 272 ------------EFT------------AGLSSELRSVLVMMLEPDPKLRATAEALLAL 305

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  148 bits (376), Expect = 1e-42
 Identities = 71/293 (24%), Positives = 110/293 (37%), Gaps = 66/293 (22%)

Query: 31  ALREICLLKELKHK------NIVRLYDVLHSEKKLTLVFEHCDQDL----KKY-FDSLNG 79
           A  EI +LK++K K        V + D  +    + + FE   ++     K+  F     
Sbjct: 63  ARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYP- 121

Query: 80  EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN-------------------KN 120
              L  V+   YQL   L F H   + H DLKP+N+L                     KN
Sbjct: 122 ---LPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKN 178

Query: 121 GELKLADFGLARAFGIPVKCYSAE-----VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIF 175
             +++ADFG A         +  E     V T  YRPP+V+     +    D+WS GCI 
Sbjct: 179 TSIRVADFGSA--------TFDHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCIL 229

Query: 176 AELANAGRPLFPGSDVDDQLKRIFKLLGTPTED----------------TWPGMNLLPDF 219
            E    G  LF   +  + L  + K+LG                      W   +     
Sbjct: 230 FEYYR-GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENS-SDGR 287

Query: 220 KPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
                  P  S+         +  DL++R+L  +P QR++  +A+ H +F+ L
Sbjct: 288 YVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  146 bits (371), Expect = 2e-42
 Identities = 47/256 (18%), Positives = 84/256 (32%), Gaps = 46/256 (17%)

Query: 31  ALREICLLKELKHKNIVRLYDVLHSEKKLT----LVFEHCD----QDLKKYFDSLNGEID 82
           A RE  + +   H NI+RL      E+       L+          +  +        + 
Sbjct: 73  AQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT 132

Query: 83  LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS 142
            D +   +  + RGL   H++   HRDLKP N+L+   G+  L D G      I V+   
Sbjct: 133 EDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSR 192

Query: 143 ---------AEVVTLWYRPPDVLFGAK--LYTTSIDMWSAGCIFAELANAGRPLFPGSDV 191
                    A+  T+ YR P++       +     D+WS GC+   +   G   +     
Sbjct: 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM-FGEGPYDMVFQ 251

Query: 192 DDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLV 251
                 +  +    +                P +  ++               LL  ++ 
Sbjct: 252 KGDSVAL-AVQNQLS------------IPQSPRHSSAL-------------WQLLNSMMT 285

Query: 252 CNPVQRMSAEDAMSHI 267
            +P QR      +S +
Sbjct: 286 VDPHQRPHIPLLLSQL 301

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  149 bits (379), Expect = 3e-42
 Identities = 75/270 (27%), Positives = 120/270 (44%), Gaps = 40/270 (14%)

Query: 5   GVDRTPNTALAIK--GTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLV 62
             D+      A+K      V  +    S LRE+ LLK+L H NI++LY+    +    LV
Sbjct: 45  CKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104

Query: 63  FEHCD-QDLKKYFDSL--NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI-- 117
            E     +L   FD +              + Q+L G+ + H   ++HRDLKP+NLL+  
Sbjct: 105 GEVYTGGEL---FDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLES 161

Query: 118 -NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFA 176
            +K+  +++ DFGL+  F    K    ++ T +Y  P+VL G   Y    D+WS G I  
Sbjct: 162 KSKDANIRIIDFGLSTHFE-ASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILY 218

Query: 177 ELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP 236
            L  +G P F G++  D LK++                    F+                
Sbjct: 219 ILL-SGCPPFNGANEYDILKKV--------------EKGKYTFELPQW-----------K 252

Query: 237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
           K++   +DL++++L   P  R+SA DA+ H
Sbjct: 253 KVSESAKDLIRKMLTYVPSMRISARDALDH 282

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  150 bits (380), Expect = 3e-42
 Identities = 66/253 (26%), Positives = 112/253 (44%), Gaps = 44/253 (17%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC------DQDLKKYFDSLNGEIDLDI 85
           L E+ +LK L H NI++LYD    ++   LV E        D+ + +   +   E+D   
Sbjct: 84  LEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFN---EVD--- 137

Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVKCYS 142
               + Q+L G+ + H  N++HRDLKP+NLL+    K+  +K+ DFGL+  F    K   
Sbjct: 138 AAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMK 196

Query: 143 AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
             + T +Y  P+VL     Y    D+WS G I   L  AG P F G    + L+++    
Sbjct: 197 ERLGTAYYIAPEVLRKK--YDEKCDVWSIGVILFILL-AGYPPFGGQTDQEILRKV---- 249

Query: 203 GTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAED 262
                           F                  ++   +DL++++L  +  +R+SA+ 
Sbjct: 250 ----------EKGKYTFDSPEW-----------KNVSEGAKDLIKQMLQFDSQRRISAQQ 288

Query: 263 AMSHIYFSDLNVA 275
           A+ H +  ++   
Sbjct: 289 ALEHPWIKEMCSK 301

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  146 bits (371), Expect = 3e-42
 Identities = 67/297 (22%), Positives = 111/297 (37%), Gaps = 66/297 (22%)

Query: 31  ALREICLLKELKHK------NIVRLYDVLHSEKKLTLVFEHCDQDL----KKY-FDSLNG 79
           A  EI +L+ L           V++ +       + +VFE          K+  F     
Sbjct: 58  ARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFR- 116

Query: 80  EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN-------------------KN 120
              LD ++   YQ+ + + F HS  + H DLKP+N+L                      N
Sbjct: 117 ---LDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLIN 173

Query: 121 GELKLADFGLARAFGIPVKCYSAE-----VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIF 175
            ++K+ DFG A         Y  E     V T  YR P+V+     ++   D+WS GCI 
Sbjct: 174 PDIKVVDFGSA--------TYDDEHHSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCIL 224

Query: 176 AELANAGRPLFPGSDVDDQLKRIFKLLGTPTED----------------TWPGMNLLPDF 219
            E    G  +FP  D  + L  + ++LG   +                  W   +    +
Sbjct: 225 IEYYL-GFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRY 283

Query: 220 KPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI 276
                  P   F         +  DL+Q++L  +P +R++  +A+ H +F  L  +I
Sbjct: 284 V-SRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI 339

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  145 bits (368), Expect = 5e-42
 Identities = 67/243 (27%), Positives = 99/243 (40%), Gaps = 35/243 (14%)

Query: 30  SALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLK---KYFDSLNGEIDLDI 85
             ++EI LLK+L H N+++ Y     + +L +V E  D  DL    K+F      I    
Sbjct: 78  DCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERT 137

Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEV 145
           V  +  QL   L   HSR V+HRD+KP N+ I   G +KL D GL R F        + V
Sbjct: 138 VWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV 197

Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQ--LKRIFKLLG 203
            T +Y  P+ +     Y    D+WS GC+  E+A A +  F G  ++     K+I +   
Sbjct: 198 GTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMA-ALQSPFYGDKMNLYSLCKKIEQC-- 253

Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
                         D+ P P  H S              R L+   +  +P +R      
Sbjct: 254 --------------DYPPLPSDHYSEEL-----------RQLVNMCINPDPEKRPDVTYV 288

Query: 264 MSH 266
              
Sbjct: 289 YDV 291

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  147 bits (372), Expect = 6e-42
 Identities = 72/291 (24%), Positives = 121/291 (41%), Gaps = 61/291 (20%)

Query: 30  SALREICLLKELK-----------HKNIVRLYD--------VLHSEKKLTLVFEHCDQDL 70
           +A  EI LL+ +              +I++L D         +H    + +VFE   ++L
Sbjct: 61  AAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVH----VVMVFEVLGENL 116

Query: 71  ----KKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSR-NVLHRDLKPQNLLIN------K 119
               KKY    +  I L  VK    QLL GL + H R  ++H D+KP+N+L+        
Sbjct: 117 LALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 173

Query: 120 NGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELA 179
             ++K+AD G A  +    + Y+  + T  YR P+VL GA  +    D+WS  C+  EL 
Sbjct: 174 LIQIKIADLGNACWYD---EHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELI 229

Query: 180 NAGRPLFPGSDV------DDQLKRIFKLLGTPTE-------------DTWPGMNLLPDFK 220
             G  LF   +       DD + +I +LLG                 ++   +  +   K
Sbjct: 230 -TGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLK 288

Query: 221 PFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD 271
            +P+        + +     +  D L  +L  +P +R  A   ++H +  D
Sbjct: 289 FWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  149 bits (377), Expect = 8e-42
 Identities = 64/244 (26%), Positives = 107/244 (43%), Gaps = 44/244 (18%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC------DQDLKKYFDSLNGEIDLDI 85
             EI LLK L H NI++L+DV   +K   LV E        +Q + ++      E D   
Sbjct: 94  YNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD---ECD--- 147

Query: 86  VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVKCYS 142
             + M Q+L G+ + H  N++HRD+KP+N+L+   N    +K+ DFGL+  F        
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS-KDYKLR 206

Query: 143 AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
             + T +Y  P+VL     Y    D+WS G I   L   G P F G +  D +K++    
Sbjct: 207 DRLGTAYYIAPEVLKKK--YNEKCDVWSCGVIMYILL-CGYPPFGGQNDQDIIKKV---- 259

Query: 203 GTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAED 262
                           F                  ++ + ++L++ +L  +  +R +AE+
Sbjct: 260 ----------EKGKYYFDFNDW-----------KNISDEAKELIKLMLTYDYNKRCTAEE 298

Query: 263 AMSH 266
           A++ 
Sbjct: 299 ALNS 302

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  145 bits (369), Expect = 1e-41
 Identities = 59/296 (19%), Positives = 111/296 (37%), Gaps = 71/296 (23%)

Query: 31  ALREICLLKELKH-----KNIVRLYDVLHSEKKLTLVFEHCDQDL----KKY-FDSLNGE 80
           A  E  +LK++++      NIV+ +        + L+FE     L     +  ++  +  
Sbjct: 78  AKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFH-- 135

Query: 81  IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN---------------------- 118
             ++ +K +  ++L+ L +    ++ H DLKP+N+L++                      
Sbjct: 136 --IEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193

Query: 119 ---KNGELKLADFGLARAFGIPVKCYSAE-----VVTLWYRPPDVLFGAKLYTTSIDMWS 170
              K+  +KL DFG A         + ++     + T  YR P+V+     +  S DMWS
Sbjct: 194 YRTKSTGIKLIDFGCA--------TFKSDYHGSIINTRQYRAPEVILNLG-WDVSSDMWS 244

Query: 171 AGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFK-----PFPMY 225
            GC+ AEL   G  LF   +  + L  +  ++    ++           K        + 
Sbjct: 245 FGCVLAELYT-GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLA 303

Query: 226 HPSMSFSQVAPKLTAKGR------------DLLQRLLVCNPVQRMSAEDAMSHIYF 269
            P  + S  + K   K              D L  +L  +P  R S  + + H + 
Sbjct: 304 WPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  147 bits (373), Expect = 3e-41
 Identities = 68/245 (27%), Positives = 110/245 (44%), Gaps = 46/245 (18%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDL------KKYFDSLNGEIDLD 84
           LRE+ LLK+L H NI++L+++L       +V E     +L      +K F     E D  
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS----EHD-- 122

Query: 85  IVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVKCY 141
                + Q+  G+ + H  N++HRDLKP+N+L+    K+ ++K+ DFGL+  F       
Sbjct: 123 -AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKM 180

Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
              + T +Y  P+VL G   Y    D+WSAG I   L  +G P F G +  D LKR+   
Sbjct: 181 KDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILL-SGTPPFYGKNEYDILKRV--- 234

Query: 202 LGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAE 261
                            F                  ++   +DL++++L  +P  R++A 
Sbjct: 235 -----------ETGKYAFDLPQW-----------RTISDDAKDLIRKMLTFHPSLRITAT 272

Query: 262 DAMSH 266
             + H
Sbjct: 273 QCLEH 277

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  143 bits (362), Expect = 9e-41
 Identities = 71/279 (25%), Positives = 118/279 (42%), Gaps = 53/279 (18%)

Query: 6   VDRTPNTALAIKG---THLVGNEGVPSSAL-REICLLKELKHKNIVRLYDVLHSEKKLTL 61
           ++R      A+K         + G+ +  L RE  +   LKH +IV L +   S+  L +
Sbjct: 44  INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103

Query: 62  VFEHCDQ-DLKKYFDSLNGEIDLDIV------KSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
           VFE  D  DL      +    D   V        +M Q+L  L +CH  N++HRD+KP  
Sbjct: 104 VFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHC 160

Query: 115 LLI---NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           +L+     +  +KL  FG+A   G         V T  +  P+V+   + Y   +D+W  
Sbjct: 161 VLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGC 219

Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFK--LLGTPT--EDTWPGMNLLPDFKPFPMYHP 227
           G I   L  +G   F G+      +R+F+  + G        W                 
Sbjct: 220 GVILFILL-SGCLPFYGTK-----ERLFEGIIKGKYKMNPRQW----------------S 257

Query: 228 SMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
            +S S       AK  DL++R+L+ +P +R++  +A++H
Sbjct: 258 HISES-------AK--DLVRRMLMLDPAERITVYEALNH 287

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  141 bits (357), Expect = 1e-40
 Identities = 75/248 (30%), Positives = 107/248 (43%), Gaps = 54/248 (21%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVK----- 87
           +EI ++K L H NI+RLY+       + LV E C            GE+   +V      
Sbjct: 55  QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCT----------GGELFERVVHKRVFR 104

Query: 88  -----SFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVK 139
                  M  +L  +A+CH  NV HRDLKP+N L    + +  LKL DFGLA  F  P K
Sbjct: 105 ESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGK 163

Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCI-FAELANAGRPLFPGSDVDDQLKRI 198
               +V T +Y  P VL G   Y    D WSAG + +  L   G P F      + + +I
Sbjct: 164 MMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLL--CGYPPFSAPTDSEVMLKI 219

Query: 199 FKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
               GT T               FP         +    ++ +   L++RLL  +P QR+
Sbjct: 220 --REGTFT---------------FP--------EKDWLNVSPQAESLIRRLLTKSPKQRI 254

Query: 259 SAEDAMSH 266
           ++  A+ H
Sbjct: 255 TSLQALEH 262

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  141 bits (358), Expect = 1e-40
 Identities = 61/274 (22%), Positives = 111/274 (40%), Gaps = 55/274 (20%)

Query: 8   RTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLH--SEKKLTLVFEH 65
           R P           +   G      +EI +LK+L H N+V+L +VL   +E  L +VFE 
Sbjct: 60  RPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFEL 119

Query: 66  CDQDLKKYFDSLNGEIDLDIVKS----------FMYQLLRGLAFCHSRNVLHRDLKPQNL 115
            +           G + +++             +   L++G+ + H + ++HRD+KP NL
Sbjct: 120 VN----------QGPV-MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168

Query: 116 LINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA-KLYT-TSIDMWSAGC 173
           L+ ++G +K+ADFG++  F       S  V T  +  P+ L    K+++  ++D+W+ G 
Sbjct: 169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGV 228

Query: 174 I-FAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS 232
             +  +   G+  F    +     +I                  PD              
Sbjct: 229 TLYCFV--FGQCPFMDERIMCLHSKIKS-----------QALEFPDQ------------- 262

Query: 233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
              P +    +DL+ R+L  NP  R+   +   H
Sbjct: 263 ---PDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  142 bits (359), Expect = 2e-40
 Identities = 68/251 (27%), Positives = 120/251 (47%), Gaps = 60/251 (23%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL--NGEIDLDIVKSFM 90
           REI  LK L+H +I++LYDV+ +   + +V E+   +L   FD +     +  D  + F 
Sbjct: 58  REISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGEL---FDYIVEKKRMTEDEGRRFF 114

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF----------GIPVKC 140
            Q++  + +CH   ++HRDLKP+NLL++ N  +K+ADFGL+             G P   
Sbjct: 115 QQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSP--N 172

Query: 141 YSAEVVTLWYRPPDVLFGAKLYT-TSIDMWSAGCI-FAELANAGRPLFPGSDVDDQLKRI 198
           Y+A         P+V+ G KLY    +D+WS G + +  L   GR  F    + +  K++
Sbjct: 173 YAA---------PEVING-KLYAGPEVDVWSCGIVLYVML--VGRLPFDDEFIPNLFKKV 220

Query: 199 FKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM 258
                         + ++PDF                  L+   + L++R++V +P+QR+
Sbjct: 221 NS-----------CVYVMPDF------------------LSPGAQSLIRRMIVADPMQRI 251

Query: 259 SAEDAMSHIYF 269
           + ++     +F
Sbjct: 252 TIQEIRRDPWF 262

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  143 bits (362), Expect = 2e-40
 Identities = 59/259 (22%), Positives = 109/259 (42%), Gaps = 45/259 (17%)

Query: 16  IKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC------DQD 69
           I   + +    V      EI ++ +L H  ++ L+D    + ++ L+ E        D+ 
Sbjct: 84  INTPYPLDKYTV----KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI 139

Query: 70  LKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI--NKNGELKLAD 127
             + +  ++ E +   V ++M Q   GL   H  +++H D+KP+N++    K   +K+ D
Sbjct: 140 AAEDY-KMS-EAE---VINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIID 194

Query: 128 FGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFP 187
           FGLA     P +       T  +  P+++   +      DMW+ G +   L  +G   F 
Sbjct: 195 FGLATKLN-PDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLL-SGLSPFA 251

Query: 188 GSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQ 247
           G D  + L+ +           W       +F          +FS V+P   AK  D ++
Sbjct: 252 GEDDLETLQNV-------KRCDW-------EF-------DEDAFSSVSP--EAK--DFIK 286

Query: 248 RLLVCNPVQRMSAEDAMSH 266
            LL   P +R++  DA+ H
Sbjct: 287 NLLQKEPRKRLTVHDALEH 305

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  143 bits (362), Expect = 3e-40
 Identities = 69/293 (23%), Positives = 117/293 (39%), Gaps = 49/293 (16%)

Query: 5   GVDRTPNTALAIK-------GTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK 57
             +R     +AI+                   +   EI +LK+L H  I+++ +     +
Sbjct: 154 AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAE 212

Query: 58  KLTLVFEHCDQ-DLKKYFDSL--NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
              +V E  +  +L   FD +  N  +     K + YQ+L  + + H   ++HRDLKP+N
Sbjct: 213 DYYIVLELMEGGEL---FDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 269

Query: 115 LLI---NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKL--YTTSIDMW 169
           +L+    ++  +K+ DFG ++  G           T  Y  P+VL       Y  ++D W
Sbjct: 270 VLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCW 328

Query: 170 SAGCI-FAELANAGRPLFPGSDVDDQL-KRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHP 227
           S G I F  L  +G P F        L  +I    G              +F P      
Sbjct: 329 SLGVILFICL--SGYPPFSEHRTQVSLKDQI--TSGK------------YNFIPEVWAEV 372

Query: 228 SMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKSER 280
           S           A   DL+++LLV +P  R + E+A+ H +  D ++  K + 
Sbjct: 373 SEK---------AL--DLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 414

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  141 bits (357), Expect = 4e-40
 Identities = 74/294 (25%), Positives = 118/294 (40%), Gaps = 73/294 (24%)

Query: 30  SALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-----QDLKKYFDSLNGEIDLD 84
               E+ L+K+L H NI RLY+V   E+ + LV E C        L  + D   G+  +D
Sbjct: 74  RIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMD 133

Query: 85  IV-----------------------------------KSFMYQLLRGLAFCHSRNVLHRD 109
           +V                                    + M Q+   L + H++ + HRD
Sbjct: 134 VVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRD 193

Query: 110 LKPQNLLI--NKNGELKLADFGLARAFGIPVKCYSAEVVTL----WYRPPDVLFGA-KLY 162
           +KP+N L   NK+ E+KL DFGL++ F          + T     ++  P+VL    + Y
Sbjct: 194 IKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY 253

Query: 163 TTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPF 222
               D WSAG +   L   G   FPG +  D + ++              +N    F   
Sbjct: 254 GPKCDAWSAGVLLHLLL-MGAVPFPGVNDADTISQV--------------LNKKLCF--- 295

Query: 223 PMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI 276
                + +++ ++P   A+  DLL  LL  N  +R  A  A+ H + S  +  I
Sbjct: 296 ----ENPNYNVLSP--LAR--DLLSNLLNRNVDERFDAMRALQHPWISQFSDKI 341

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  140 bits (354), Expect = 4e-40
 Identities = 68/276 (24%), Positives = 114/276 (41%), Gaps = 49/276 (17%)

Query: 6   VDRTPNTALA---IKGTHLVGNEGVPS--SALREICLLKELKHKNIVRLYDVLHSEKKLT 60
             +      A   IK   L  +    S     RE+ +L+E++H NI+ L+D+  ++  + 
Sbjct: 25  RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84

Query: 61  LVFEHC------DQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
           L+ E        D   +K   +   E +      F+ Q+L G+ + HS+ + H DLKP+N
Sbjct: 85  LILELVSGGELFDFLAEKESLT---EDE---ATQFLKQILDGVHYLHSKRIAHFDLKPEN 138

Query: 115 LLI----NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWS 170
           +++      N  +KL DFG+A         +     T  +  P+++   +      DMWS
Sbjct: 139 IMLLDKNVPNPRIKLIDFGIAHKIE-AGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWS 196

Query: 171 AGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMS 230
            G I   L  +G   F G    + L  I              +N   DF           
Sbjct: 197 IGVITYILL-SGASPFLGETKQETLTNISA------------VNY--DF-------DEEY 234

Query: 231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
           FS  +    AK  D ++RLLV +P +RM+   ++ H
Sbjct: 235 FSNTSE--LAK--DFIRRLLVKDPKRRMTIAQSLEH 266

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  140 bits (354), Expect = 4e-40
 Identities = 62/249 (24%), Positives = 105/249 (42%), Gaps = 53/249 (21%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-----------QDLKKYFDSLNGEI 81
            EI +LK L H NI+++++V      + +V E C+           Q   K       E 
Sbjct: 69  AEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALS----EG 124

Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPV 138
               V   M Q++  LA+ HS++V+H+DLKP+N+L    + +  +K+ DFGLA  F    
Sbjct: 125 Y---VAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-SD 180

Query: 139 KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCI-FAELANAGRPLFPGSDVDDQLKR 197
           +  +    T  Y  P+V       T   D+WSAG + +  L   G   F G+ +++  ++
Sbjct: 181 EHSTNAAGTALYMAPEVFKRD--VTFKCDIWSAGVVMYFLL--TGCLPFTGTSLEEVQQK 236

Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQR 257
                              P++        +           A   DLL+++L  +P +R
Sbjct: 237 A--------------TYKEPNYAVEC-RPLTPQ---------AV--DLLKQMLTKDPERR 270

Query: 258 MSAEDAMSH 266
            SA   + H
Sbjct: 271 PSAAQVLHH 279

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  139 bits (352), Expect = 6e-40
 Identities = 67/252 (26%), Positives = 111/252 (44%), Gaps = 61/252 (24%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL--NGEIDLDIVKSF 89
           REI  LK  +H +I++LY V+ +     +V E+    +L   FD +  +G ++    +  
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGEL---FDYICKHGRVEEMEARRL 116

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF----------GIPVK 139
             Q+L  + +CH   V+HRDLKP+N+L++ +   K+ADFGL+             G P  
Sbjct: 117 FQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSP-- 174

Query: 140 CYSAEVVTLWYRPPDVLFGAKLYT-TSIDMWSAGCI-FAELANAGRPLFPGSDVDDQLKR 197
            Y+A         P+V+ G +LY    +D+WS G I +A L   G   F    V    K+
Sbjct: 175 NYAA---------PEVISG-RLYAGPEVDIWSCGVILYALL--CGTLPFDDEHVPTLFKK 222

Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQR 257
           I             G+  +P++                  L      LL  +L  +P++R
Sbjct: 223 IRG-----------GVFYIPEY------------------LNRSVATLLMHMLQVDPLKR 253

Query: 258 MSAEDAMSHIYF 269
            + +D   H +F
Sbjct: 254 ATIKDIREHEWF 265

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  138 bits (349), Expect = 2e-39
 Identities = 72/249 (28%), Positives = 109/249 (43%), Gaps = 55/249 (22%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVK---- 87
           RE  + ++L+H NIVRL+D +  E    LVF+     +L   F+        DIV     
Sbjct: 54  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FE--------DIVAREFY 102

Query: 88  ------SFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPV 138
                   + Q+L  +A+CHS  ++HR+LKP+NLL+    K   +KLADFGLA       
Sbjct: 103 SEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DS 161

Query: 139 KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCI-FAELANAGRPLFPGSDVDDQLKR 197
           + +     T  Y  P+VL     Y+  +D+W+ G I +  L   G P F   D      +
Sbjct: 162 EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILL--VGYPPFWDEDQHRLYAQ 218

Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQR 257
           I                   D+       PS  +  V P   AK   L+  +L  NP +R
Sbjct: 219 I--------------KAGAYDY-------PSPEWDTVTP--EAK--SLIDSMLTVNPKKR 253

Query: 258 MSAEDAMSH 266
           ++A+ A+  
Sbjct: 254 ITADQALKV 262

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  138 bits (351), Expect = 2e-39
 Identities = 60/242 (24%), Positives = 107/242 (44%), Gaps = 41/242 (16%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC------DQDLKKYFDSLNGEIDLDIV 86
           +EI +L   +H+NI+ L++   S ++L ++FE        ++     F  LN E +   +
Sbjct: 50  KEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF-ELN-ERE---I 104

Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI--NKNGELKLADFGLARAFGIPVKCYSAE 144
            S+++Q+   L F HS N+ H D++P+N++    ++  +K+ +FG AR    P   +   
Sbjct: 105 VSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNFRLL 163

Query: 145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
                Y  P+V     + +T+ DMWS G +   L  +G   F        ++ I      
Sbjct: 164 FTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLL-SGINPFLAETNQQIIENI------ 215

Query: 205 PTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAM 264
                   MN    F          +F +++    A   D + RLLV     RM+A +A+
Sbjct: 216 --------MNAEYTF-------DEEAFKEISI--EAM--DFVDRLLVKERKSRMTASEAL 256

Query: 265 SH 266
            H
Sbjct: 257 QH 258

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  138 bits (349), Expect = 2e-39
 Identities = 69/249 (27%), Positives = 111/249 (44%), Gaps = 56/249 (22%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVK----- 87
           RE+ LLK+L H NI++L+++L       +V E              GE+  +I+K     
Sbjct: 70  REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYT----------GGELFDEIIKRKRFS 119

Query: 88  -----SFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVK 139
                  + Q+  G+ + H  N++HRDLKP+N+L+    K+ ++K+ DFGL+  F     
Sbjct: 120 EHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNT 178

Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIF 199
                + T +Y  P+VL     Y    D+WSAG I   L  +G P F G +  D LKR+ 
Sbjct: 179 KMKDRIGTAYYIAPEVL--RGTYDEKCDVWSAGVILYILL-SGTPPFYGKNEYDILKRV- 234

Query: 200 KLLGTPT--EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQR 257
              G        W                 ++S         AK  DL++++L  +P  R
Sbjct: 235 -ETGKYAFDLPQW----------------RTISDD-------AK--DLIRKMLTFHPSLR 268

Query: 258 MSAEDAMSH 266
           ++A   + H
Sbjct: 269 ITATQCLEH 277

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  138 bits (349), Expect = 2e-39
 Identities = 66/288 (22%), Positives = 112/288 (38%), Gaps = 65/288 (22%)

Query: 5   GVDRTPNTALAIK--------GTHLVGNEGVPSSALREICLLKELK-HKNIVRLYDVLHS 55
            + +      A+K               + +  + L+E+ +L+++  H NI++L D   +
Sbjct: 36  CIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95

Query: 56  EKKLTLVFEHCDQDLKKYFDSLNGEIDLD-IVK----------SFMYQLLRGLAFCHSRN 104
                LVF+              GE+  D + +            M  LL  +   H  N
Sbjct: 96  NTFFFLVFDLMK----------KGEL-FDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144

Query: 105 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA----- 159
           ++HRDLKP+N+L++ +  +KL DFG +     P +       T  Y  P+++  +     
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLREVCGTPSYLAPEIIECSMNDNH 203

Query: 160 KLYTTSIDMWSAGCI-FAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPD 218
             Y   +DMWS G I +  L  AG P F        L+ I  + G               
Sbjct: 204 PGYGKEVDMWSTGVIMYTLL--AGSPPFWHRKQMLMLRMI--MSGNYQ------------ 247

Query: 219 FKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
              F         S      +   +DL+ R LV  P +R +AE+A++H
Sbjct: 248 ---FG--------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  139 bits (353), Expect = 2e-39
 Identities = 72/249 (28%), Positives = 109/249 (43%), Gaps = 55/249 (22%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVK---- 87
           RE  + ++L+H NIVRL+D +  E    LVF+     +L   F+        DIV     
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FE--------DIVAREFY 125

Query: 88  ------SFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPV 138
                   + Q+L  +A+CHS  ++HR+LKP+NLL+    K   +KLADFGLA       
Sbjct: 126 SEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DS 184

Query: 139 KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCI-FAELANAGRPLFPGSDVDDQLKR 197
           + +     T  Y  P+VL     Y+  +D+W+ G I +  L   G P F   D      +
Sbjct: 185 EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILL--VGYPPFWDEDQHRLYAQ 241

Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQR 257
           I                   D+       PS  +  V P   AK   L+  +L  NP +R
Sbjct: 242 I--------------KAGAYDY-------PSPEWDTVTP--EAK--SLIDSMLTVNPKKR 276

Query: 258 MSAEDAMSH 266
           ++A+ A+  
Sbjct: 277 ITADQALKV 285

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  138 bits (351), Expect = 3e-39
 Identities = 65/276 (23%), Positives = 115/276 (41%), Gaps = 49/276 (17%)

Query: 6   VDRTPNTALA---IKGTHLVGNEGVPS--SALREICLLKELKHKNIVRLYDVLHSEKKLT 60
            +++     A   IK      +    S     RE+ +LKE++H N++ L++V  ++  + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90

Query: 61  LVFEHC------DQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
           L+ E        D   +K   +   E +      F+ Q+L G+ + HS  + H DLKP+N
Sbjct: 91  LILELVAGGELFDFLAEKESLT---EEE---ATEFLKQILNGVYYLHSLQIAHFDLKPEN 144

Query: 115 LLI----NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWS 170
           +++         +K+ DFGLA         +     T  +  P+++   +      DMWS
Sbjct: 145 IMLLDRNVPKPRIKIIDFGLAHKID-FGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWS 202

Query: 171 AGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMS 230
            G I   L  +G   F G    + L  +              +N   +F           
Sbjct: 203 IGVITYILL-SGASPFLGDTKQETLANVSA------------VNY--EF-------EDEY 240

Query: 231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
           FS  +    AK  D ++RLLV +P +RM+ +D++ H
Sbjct: 241 FSNTSAL--AK--DFIRRLLVKDPKKRMTIQDSLQH 272

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  139 bits (353), Expect = 3e-39
 Identities = 72/287 (25%), Positives = 116/287 (40%), Gaps = 64/287 (22%)

Query: 5   GVDRTPNTALAIK-------GTHLVGNEGVPSSALREICLLKELK-HKNIVRLYDVLHSE 56
            V R      A+K              E V  +  RE  +L+++  H +I+ L D   S 
Sbjct: 113 CVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172

Query: 57  KKLTLVFEHCDQDLKKYFDSLNGEIDLD-IVK----------SFMYQLLRGLAFCHSRNV 105
             + LVF+              GE+  D + +          S M  LL  ++F H+ N+
Sbjct: 173 SFMFLVFDLMR----------KGEL-FDYLTEKVALSEKETRSIMRSLLEAVSFLHANNI 221

Query: 106 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA-----K 160
           +HRDLKP+N+L++ N +++L+DFG +     P +       T  Y  P++L  +      
Sbjct: 222 VHRDLKPENILLDDNMQIRLSDFGFSCHLE-PGEKLRELCGTPGYLAPEILKCSMDETHP 280

Query: 161 LYTTSIDMWSAGCI-FAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDF 219
            Y   +D+W+ G I F  L  AG P F        L+ I  + G                
Sbjct: 281 GYGKEVDLWACGVILFTLL--AGSPPFWHRRQILMLRMI--MEGQYQ------------- 323

Query: 220 KPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
             F         S      ++  +DL+ RLL  +P  R++AE A+ H
Sbjct: 324 --FS--------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  141 bits (357), Expect = 3e-39
 Identities = 70/250 (28%), Positives = 105/250 (42%), Gaps = 56/250 (22%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVK---- 87
           RE  + + LKH NIVRL+D +  E    L+F+     +L   F+        DIV     
Sbjct: 59  REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---FE--------DIVAREYY 107

Query: 88  ------SFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPV 138
                   + Q+L  +  CH   V+HR+LKP+NLL+    K   +KLADFGLA       
Sbjct: 108 SEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167

Query: 139 KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRI 198
           + +     T  Y  P+VL     Y   +D+W+ G I   L   G P F   D     ++I
Sbjct: 168 QAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILL-VGYPPFWDEDQHRLYQQI 225

Query: 199 FKLLGTPT--EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQ 256
               G        W                 +++         AK  DL+ ++L  NP +
Sbjct: 226 --KAGAYDFPSPEW----------------DTVTPE-------AK--DLINKMLTINPSK 258

Query: 257 RMSAEDAMSH 266
           R++A +A+ H
Sbjct: 259 RITAAEALKH 268

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  139 bits (352), Expect = 5e-39
 Identities = 70/283 (24%), Positives = 123/283 (43%), Gaps = 48/283 (16%)

Query: 6   VDRTPNTALA---IKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLV 62
            +      LA   IK   +   E V      EI ++ +L H N+++LYD   S+  + LV
Sbjct: 109 EETATGLKLAAKIIKTRGMKDKEEV----KNEISVMNQLDHANLIQLYDAFESKNDIVLV 164

Query: 63  FEHC------DQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLL 116
            E+       D+ + + + +L  E+D      FM Q+  G+   H   +LH DLKP+N+L
Sbjct: 165 MEYVDGGELFDRIIDESY-NLT-ELD---TILFMKQICEGIRHMHQMYILHLDLKPENIL 219

Query: 117 -INKNG-ELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCI 174
            +N++  ++K+ DFGLAR +  P +       T  +  P+V+      +   DMWS G I
Sbjct: 220 CVNRDAKQIKIIDFGLARRYK-PREKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVI 277

Query: 175 FAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV 234
              L  +G   F G +  + L  I        ++ +  +                  S+ 
Sbjct: 278 AYMLL-SGLSPFLGDNDAETLNNILACRWDLEDEEFQDI------------------SEE 318

Query: 235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIK 277
           A       ++ + +LL+     R+SA +A+ H + SD  +  +
Sbjct: 319 A-------KEFISKLLIKEKSWRISASEALKHPWLSDHKLHSR 354

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  139 bits (351), Expect = 5e-39
 Identities = 67/280 (23%), Positives = 116/280 (41%), Gaps = 57/280 (20%)

Query: 6   VDRTPNTALA---IKGTHLVGNEGVPSSA--LREICLLKELKHKNIVRLYDVLHSEKKLT 60
            +++     A   IK      +          RE+ +L+++ H NI+ L+DV  +   + 
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91

Query: 61  LVFEHCDQDLKKYFDSLNGEIDLDIVK----------SFMYQLLRGLAFCHSRNVLHRDL 110
           L+ E              GE+   + +          SF+ Q+L G+ + H++ + H DL
Sbjct: 92  LILELVS----------GGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDL 141

Query: 111 KPQN-LLINKNGE---LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSI 166
           KP+N +L++KN     +KL DFGLA         +     T  +  P+++   +      
Sbjct: 142 KPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGTPEFVAPEIVNY-EPLGLEA 199

Query: 167 DMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYH 226
           DMWS G I   L  +G   F G    + L  I       T  ++       DF       
Sbjct: 200 DMWSIGVITYILL-SGASPFLGDTKQETLANI-------TAVSY-------DF------- 237

Query: 227 PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
               FSQ +    AK  D +++LLV    +R++ ++A+ H
Sbjct: 238 DEEFFSQTSE--LAK--DFIRKLLVKETRKRLTIQEALRH 273

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  138 bits (349), Expect = 5e-39
 Identities = 66/245 (26%), Positives = 108/245 (44%), Gaps = 42/245 (17%)

Query: 32  LREICLLKELKH-KNIVRLYDVLHSEKKLTLVFEHC------DQDLKKYFDSLNGEIDLD 84
           L EI +L+  K    ++ L++V  +  ++ L+ E+          L +  + ++ E D  
Sbjct: 76  LHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVS-END-- 132

Query: 85  IVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVKCY 141
            V   + Q+L G+ + H  N++H DLKPQN+L+      G++K+ DFG++R  G      
Sbjct: 133 -VIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACEL 190

Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
              + T  Y  P++L      TT+ DMW+ G I   L       F G D  +    I   
Sbjct: 191 REIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLL-THTSPFVGEDNQETYLNI--- 245

Query: 202 LGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAE 261
                        +  D+          +FS V+    A   D +Q LLV NP +R +AE
Sbjct: 246 -----------SQVNVDY-------SEETFSSVSQ--LAT--DFIQSLLVKNPEKRPTAE 283

Query: 262 DAMSH 266
             +SH
Sbjct: 284 ICLSH 288

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  137 bits (348), Expect = 5e-39
 Identities = 70/290 (24%), Positives = 119/290 (41%), Gaps = 49/290 (16%)

Query: 5   GVDRTPNTALAIK-------GTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK 57
             +R     +AIK                   +   EI +LK+L H  I+++ +     +
Sbjct: 29  AFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAE 87

Query: 58  KLTLVFEHCDQ-DLKKYFDSL--NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
              +V E  +  +L   FD +  N  +     K + YQ+L  + + H   ++HRDLKP+N
Sbjct: 88  DYYIVLELMEGGEL---FDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 144

Query: 115 LLINKNGE---LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKL--YTTSIDMW 169
           +L++   E   +K+ DFG ++  G           T  Y  P+VL       Y  ++D W
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCW 203

Query: 170 SAGCI-FAELANAGRPLFPGSDVDDQL-KRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHP 227
           S G I F  L  +G P F        L  +I    G               +  F     
Sbjct: 204 SLGVILFICL--SGYPPFSEHRTQVSLKDQI--TSG--------------KYN-FI---- 240

Query: 228 SMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIK 277
                +V  +++ K  DL+++LLV +P  R + E+A+ H +  D ++  K
Sbjct: 241 ----PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK 286

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  142 bits (359), Expect = 6e-39
 Identities = 59/243 (24%), Positives = 104/243 (42%), Gaps = 41/243 (16%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSL---NGEIDLDIVK 87
            +EI  +  L+H  +V L+D    + ++ +++E     +L   F+ +   + ++  D   
Sbjct: 202 RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDEAV 258

Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLI-NKNG-ELKLADFGLARAFGIPVKCYSAEV 145
            +M Q+ +GL   H  N +H DLKP+N++   K   ELKL DFGL      P +      
Sbjct: 259 EYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-PKQSVKVTT 317

Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
            T  +  P+V  G K      DMWS G +   L  +G   F G + D+ L+ +       
Sbjct: 318 GTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILL-SGLSPFGGENDDETLRNV--KSCDW 373

Query: 206 T--EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
              +  + G+                  S+         +D +++LL+ +P  RM+   A
Sbjct: 374 NMDDSAFSGI------------------SEDG-------KDFIRKLLLADPNTRMTIHQA 408

Query: 264 MSH 266
           + H
Sbjct: 409 LEH 411

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  137 bits (347), Expect = 1e-38
 Identities = 65/280 (23%), Positives = 115/280 (41%), Gaps = 57/280 (20%)

Query: 6   VDRTPNTALA---IKGTHLVGNEGVPSSA--LREICLLKELKHKNIVRLYDVLHSEKKLT 60
            +++     A   IK      +    S     RE+ +L+++ H N++ L+DV  +   + 
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91

Query: 61  LVFEHCDQDLKKYFDSLNGEIDLDIVK----------SFMYQLLRGLAFCHSRNVLHRDL 110
           L+ E              GE+   + +          SF+ Q+L G+ + H++ + H DL
Sbjct: 92  LILELVS----------GGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDL 141

Query: 111 KPQN-LLINKNGE---LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSI 166
           KP+N +L++KN     +KL DFGLA         +     T  +  P+++   +      
Sbjct: 142 KPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGTPEFVAPEIVNY-EPLGLEA 199

Query: 167 DMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYH 226
           DMWS G I   L  +G   F G    + L  I              ++   DF       
Sbjct: 200 DMWSIGVITYILL-SGASPFLGDTKQETLANITS------------VSY--DF------- 237

Query: 227 PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
               FS  +    AK  D +++LLV    +R++ ++A+ H
Sbjct: 238 DEEFFSHTSE--LAK--DFIRKLLVKETRKRLTIQEALRH 273

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  136 bits (344), Expect = 2e-38
 Identities = 64/239 (26%), Positives = 115/239 (48%), Gaps = 41/239 (17%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSL--NGEIDLDIVKSF 89
           RE+ ++K L H NIV+L++V+ +EK L L+ E+    ++   FD L  +G +     +S 
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEV---FDYLVAHGRMKEKEARSK 119

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW 149
             Q++  + +CH + ++HRDLK +NLL++ +  +K+ADFG +  F        A      
Sbjct: 120 FRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDAFCGAPP 178

Query: 150 YRPPDVLFGAKLYT-TSIDMWSAGCI-FAELANAGRPLFPGSDVDDQLKRIFKLLGTPTE 207
           Y  P++  G K Y    +D+WS G I +  +  +G   F G ++ +  +R+ +       
Sbjct: 179 YAAPELFQG-KKYDGPEVDVWSLGVILYTLV--SGSLPFDGQNLKELRERVLR------- 228

Query: 208 DTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
               G   +P +                  ++    +LL+R LV NP++R + E  M  
Sbjct: 229 ----GKYRIPFY------------------MSTDCENLLKRFLVLNPIKRGTLEQIMKD 265

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  137 bits (345), Expect = 3e-38
 Identities = 42/288 (14%), Positives = 86/288 (29%), Gaps = 59/288 (20%)

Query: 6   VDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT----- 60
           + +     L ++    + N+      LR I     +K     ++  V   E+ +      
Sbjct: 117 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRF 176

Query: 61  LVFEHCDQDLKKYFDSL------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
            ++     +L+ + + L      +  +          Q++R LA  H   ++H  L+P +
Sbjct: 177 FLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVD 236

Query: 115 LLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL----------FGAKLYTT 164
           +++++ G + L  F      G          V+  + PP++               L T 
Sbjct: 237 IVLDQRGGVFLTGFEHLVRDGA----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTF 292

Query: 165 SIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM 224
           S D W+ G +   +                 + IF+                        
Sbjct: 293 SFDAWALGLVIYWIW-CADLPITKDAALGGSEWIFR------------------------ 327

Query: 225 YHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
                +  Q         R LL+  L      R+    AM    +  L
Sbjct: 328 --SCKNIPQPV-------RALLEGFLRYPKEDRLLPLQAMETPEYEQL 366

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  137 bits (347), Expect = 1e-37
 Identities = 70/252 (27%), Positives = 113/252 (44%), Gaps = 61/252 (24%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL--NGEIDLDIVKSF 89
           REI  LK  +H +I++LY V+ +   + +V E+    +L   FD +  NG +D    +  
Sbjct: 65  REIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGEL---FDYICKNGRLDEKESRRL 121

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF----------GIPVK 139
             Q+L G+ +CH   V+HRDLKP+N+L++ +   K+ADFGL+             G P  
Sbjct: 122 FQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSP-- 179

Query: 140 CYSAEVVTLWYRPPDVLFGAKLYT-TSIDMWSAGCI-FAELANAGRPLFPGSDVDDQLKR 197
            Y+A         P+V+ G +LY    +D+WS+G I +A L   G   F    V    K+
Sbjct: 180 NYAA---------PEVISG-RLYAGPEVDIWSSGVILYALL--CGTLPFDDDHVPTLFKK 227

Query: 198 IFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQR 257
           I             G+   P +                  L      LL+ +L  +P++R
Sbjct: 228 ICD-----------GIFYTPQY------------------LNPSVISLLKHMLQVDPMKR 258

Query: 258 MSAEDAMSHIYF 269
            + +D   H +F
Sbjct: 259 ATIKDIREHEWF 270

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  133 bits (337), Expect = 1e-37
 Identities = 64/270 (23%), Positives = 108/270 (40%), Gaps = 39/270 (14%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSAL-REICLLKELKHKNIVRLYDVLHSEKKLTLVF 63
           G D +    +AIK      +       L  EI L K LKHKNIV+          + +  
Sbjct: 41  GRDLSNQVRIAIKEIPERDSRYS--QPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM 98

Query: 64  EHCDQD-----LKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN 118
           E          L+  +  L  + +   +  +  Q+L GL + H   ++HRD+K  N+LIN
Sbjct: 99  EQVPGGSLSALLRSKWGPL--KDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN 156

Query: 119 -KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKL-YTTSIDMWSAGCIFA 176
             +G LK++DFG ++       C      TL Y  P+++      Y  + D+WS GC   
Sbjct: 157 TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTII 216

Query: 177 ELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP 236
           E+A  G+P  P  ++ +    +FK+         P           P             
Sbjct: 217 EMAT-GKP--PFYELGEPQAAMFKV---GMFKVHP---------EIP------------E 249

Query: 237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
            ++A+ +  + +    +P +R  A D +  
Sbjct: 250 SMSAEAKAFILKCFEPDPDKRACANDLLVD 279

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  133 bits (337), Expect = 2e-37
 Identities = 49/258 (18%), Positives = 94/258 (36%), Gaps = 47/258 (18%)

Query: 30  SALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNG--EIDLDIV 86
           +   +I  +     KN V        +  L +  + C  ++LK + +      + +  + 
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166

Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC------ 140
                Q+   + F HS+ ++HRDLKP N+    +  +K+ DFGL  A     +       
Sbjct: 167 LHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226

Query: 141 ------YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQ 194
                 ++ +V T  Y  P+ + G   Y+  +D++S G I  EL           +    
Sbjct: 227 MPAYATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLY---SFSTQMERVRI 282

Query: 195 LKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNP 254
           +  +  L        +P          F   +P                 ++Q +L  +P
Sbjct: 283 ITDVRNL-------KFP--------LLFTQKYPQE-------------HMMVQDMLSPSP 314

Query: 255 VQRMSAEDAMSHIYFSDL 272
            +R  A D + +  F +L
Sbjct: 315 TERPEATDIIENAIFENL 332

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  133 bits (336), Expect = 4e-37
 Identities = 61/243 (25%), Positives = 98/243 (40%), Gaps = 52/243 (21%)

Query: 33  REICLLKELKHK--NIVRLYDVLHSEKKLTLVFEHCD--QDLKKYFD--SLNGEIDLDIV 86
            E+ LLK++      ++RL D         L+ E  +  QDL   FD  +  G +  ++ 
Sbjct: 95  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDL---FDFITERGALQEELA 151

Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVKCYSAEV 145
           +SF +Q+L  +  CH+  VLHRD+K +N+LI+ N GELKL DFG   A  +    Y+   
Sbjct: 152 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-AL-LKDTVYTDFD 209

Query: 146 VTLWYRPPDVLFGAKLYT-TSIDMWSAGCI-FAELANAGRPLFPGSDVDDQLKRIFKLLG 203
            T  Y PP+ +     Y   S  +WS G + +  +   G   F     +   + I +   
Sbjct: 210 GTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMV--CGDIPF-----EHD-EEIIR--- 257

Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA 263
                   G                   S          + L++  L   P  R + E+ 
Sbjct: 258 --------GQVFFRQR-----------VSSEC-------QHLIRWCLALRPSDRPTFEEI 291

Query: 264 MSH 266
            +H
Sbjct: 292 QNH 294

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  133 bits (336), Expect = 4e-37
 Identities = 62/255 (24%), Positives = 97/255 (38%), Gaps = 57/255 (22%)

Query: 33  REICLLKEL-KHKNIVRLYDV----LHSEKKLTLVFEHC------DQDLKKYFDSLNGEI 81
           +E+    +     +IV + DV     H ++ L ++ E         +  ++   +   E 
Sbjct: 70  QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFT-ER 128

Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPV 138
           +       M  +   + F HS N+ HRD+KP+NLL     K+  LKL DFG A+      
Sbjct: 129 E---AAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185

Query: 139 ---KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL 195
               CY+       Y  P+VL G + Y  S DMWS G I   L   G P F  +      
Sbjct: 186 LQTPCYTPY-----YVAPEVL-GPEKYDKSCDMWSLGVIMYILL-CGFPPFYSNTGQAIS 238

Query: 196 KRIFK--LLGTPT--EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLV 251
             + +   LG        W                  +S         AK   L++ LL 
Sbjct: 239 PGMKRRIRLGQYGFPNPEW----------------SEVSED-------AK--QLIRLLLK 273

Query: 252 CNPVQRMSAEDAMSH 266
            +P +R++    M+H
Sbjct: 274 TDPTERLTITQFMNH 288

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  132 bits (333), Expect = 4e-37
 Identities = 49/261 (18%), Positives = 89/261 (34%), Gaps = 60/261 (22%)

Query: 30  SALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCD----QDLKKYFDSLNGEIDLD 84
           +ALRE+     L +H ++VR +     +  + +  E+C+     D       +       
Sbjct: 56  NALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEA 115

Query: 85  IVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL-------------------KL 125
            +K  + Q+ RGL + HS +++H D+KP N+ I++                       K+
Sbjct: 116 ELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKI 175

Query: 126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
            D G       P      E     +   +VL     +    D+++        A    PL
Sbjct: 176 GDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAA-GAEPL 230

Query: 186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
                  DQ   I +               LP     P              L+ +  +L
Sbjct: 231 P---RNGDQWHEIRQ-------------GRLP---RIP------------QVLSQEFTEL 259

Query: 246 LQRLLVCNPVQRMSAEDAMSH 266
           L+ ++  +P +R SA   + H
Sbjct: 260 LKVMIHPDPERRPSAMALVKH 280

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  132 bits (335), Expect = 5e-37
 Identities = 70/256 (27%), Positives = 101/256 (39%), Gaps = 60/256 (23%)

Query: 33  REICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLD-IVK--- 87
           +EI  LK  + H NIV+L++V H +    LV E  +           GE+  + I K   
Sbjct: 54  KEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN----------GGEL-FERIKKKKH 102

Query: 88  -------SFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIP 137
                    M +L+  ++  H   V+HRDLKP+NLL    N N E+K+ DFG AR     
Sbjct: 103 FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162

Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLF---PGSDVDDQ 194
            +       TL Y  P++L     Y  S D+WS G I   +  +G+  F     S     
Sbjct: 163 NQPLKTPCFTLHYAAPELL-NQNGYDESCDLWSLGVILYTML-SGQVPFQSHDRSLTCTS 220

Query: 195 LKRIFK--LLGTP--TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLL 250
              I K    G      + W  +                  SQ      AK  DL+Q LL
Sbjct: 221 AVEIMKKIKKGDFSFEGEAWKNV------------------SQ-----EAK--DLIQGLL 255

Query: 251 VCNPVQRMSAEDAMSH 266
             +P +R+       +
Sbjct: 256 TVDPNKRLKMSGLRYN 271

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  131 bits (333), Expect = 7e-37
 Identities = 71/279 (25%), Positives = 109/279 (39%), Gaps = 63/279 (22%)

Query: 6   VDRTPNTALAIK--GTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF 63
             R      A+K         +   SS   EI +LK++KH+NIV L D+  S     LV 
Sbjct: 29  KQRLTGKLFALKCIKKSPAFRD---SSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85

Query: 64  EHCDQ-DLKKYFDSLNGEIDLDIVK----------SFMYQLLRGLAFCHSRNVLHRDLKP 112
           +     +L   FD         I++            + Q+L  + + H   ++HRDLKP
Sbjct: 86  QLVSGGEL---FD--------RILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKP 134

Query: 113 QNLLI---NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMW 169
           +NLL     +N ++ + DFGL++     +   S    T  Y  P+VL   K Y+ ++D W
Sbjct: 135 ENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVAPEVLAQ-KPYSKAVDCW 191

Query: 170 SAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT--EDTWPGMNLLPDFKPFPMYHP 227
           S G I   L   G P F         ++I    G        W                 
Sbjct: 192 SIGVITYILL-CGYPPFYEETESKLFEKI--KEGYYEFESPFWD---------------- 232

Query: 228 SMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
               S+ A       +D +  LL  +P +R + E A+SH
Sbjct: 233 --DISESA-------KDFICHLLEKDPNERYTCEKALSH 262

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  132 bits (334), Expect = 1e-36
 Identities = 67/251 (26%), Positives = 105/251 (41%), Gaps = 58/251 (23%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVK---- 87
            EI +L  L H NI++L ++  +  +++LV E     +L   FD         IV+    
Sbjct: 97  TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL---FD--------RIVEKGYY 145

Query: 88  ------SFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPV 138
                   + Q+L  +A+ H   ++HRDLKP+NLL      +  LK+ADFGL++      
Sbjct: 146 SERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQ 204

Query: 139 KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL-KR 197
                   T  Y  P++L G   Y   +DMWS G I   L   G   F     D  + +R
Sbjct: 205 VLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILL-CGFEPFYDERGDQFMFRR 262

Query: 198 IFKLLGTPT--EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPV 255
           I  L          W                  +S +       AK  DL+++L+V +P 
Sbjct: 263 I--LNCEYYFISPWW----------------DEVSLN-------AK--DLVRKLIVLDPK 295

Query: 256 QRMSAEDAMSH 266
           +R++   A+ H
Sbjct: 296 KRLTTFQALQH 306

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  132 bits (333), Expect = 1e-36
 Identities = 56/273 (20%), Positives = 92/273 (33%), Gaps = 50/273 (18%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
             D+      A+K   L          + E+     L    IV LY  +     + +  E
Sbjct: 77  MKDKQTGFQCAVKKVRL------EVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130

Query: 65  HCD-----QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK 119
             +     Q +K+      G +  D    ++ Q L GL + H+R +LH D+K  N+L++ 
Sbjct: 131 LLEGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSS 185

Query: 120 NG-ELKLADFGLARAFGIPVKCYSAEVV-----TLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +G    L DFG A          S         T  +  P+V+ G       +D+WS+ C
Sbjct: 186 DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCC 244

Query: 174 IFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ 233
           +   + N G    P +    +     K+   P               P           +
Sbjct: 245 MMLHMLN-GCH--PWTQY-FRGPLCLKIASEP--------------PPIR---------E 277

Query: 234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
           + P         +Q  L   PV R SA +    
Sbjct: 278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRK 310

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  130 bits (329), Expect = 1e-36
 Identities = 60/255 (23%), Positives = 97/255 (38%), Gaps = 61/255 (23%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL--NGEIDLDIVKSF 89
           +EIC+ K L H+N+V+ Y          L  E+C   +L   FD +  +  +     + F
Sbjct: 54  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRF 110

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-------------GI 136
            +QL+ G+ + H   + HRD+KP+NLL+++   LK++DFGLA  F             G 
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYT-TSIDMWSAGCI-FAELANAGRPLFPGSDVDDQ 194
               Y A         P++L   + +    +D+WS G +  A L  AG    P     D 
Sbjct: 171 L--PYVA---------PELLKR-REFHAEPVDVWSCGIVLTAML--AGE--LPWDQPSDS 214

Query: 195 LKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNP 254
            +                          P                     LL ++LV NP
Sbjct: 215 CQEYSD-------------WKEKKTYLNPWKK----IDSAP-------LALLHKILVENP 250

Query: 255 VQRMSAEDAMSHIYF 269
             R++  D     ++
Sbjct: 251 SARITIPDIKKDRWY 265

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  131 bits (331), Expect = 2e-36
 Identities = 60/255 (23%), Positives = 97/255 (38%), Gaps = 61/255 (23%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL--NGEIDLDIVKSF 89
           +EIC+ K L H+N+V+ Y          L  E+C   +L   FD +  +  +     + F
Sbjct: 54  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRIEPDIGMPEPDAQRF 110

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-------------GI 136
            +QL+ G+ + H   + HRD+KP+NLL+++   LK++DFGLA  F             G 
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

Query: 137 PVKCYSAEVVTLWYRPPDVLFGAKLYT-TSIDMWSAGCI-FAELANAGRPLFPGSDVDDQ 194
               Y A         P++L   + +    +D+WS G +  A L  AG    P     D 
Sbjct: 171 L--PYVA---------PELLKR-REFHAEPVDVWSCGIVLTAML--AGE--LPWDQPSDS 214

Query: 195 LKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNP 254
            +                          P                     LL ++LV NP
Sbjct: 215 CQEYSD-------------WKEKKTYLNPWKK----IDSAP-------LALLHKILVENP 250

Query: 255 VQRMSAEDAMSHIYF 269
             R++  D     ++
Sbjct: 251 SARITIPDIKKDRWY 265

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  131 bits (331), Expect = 3e-36
 Identities = 62/288 (21%), Positives = 100/288 (34%), Gaps = 60/288 (20%)

Query: 7   DRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK-HKNIVRLYDVLHSEKKLT----- 60
           D       A+K   L   E    + ++E+C +K+L  H NIV+        K+ +     
Sbjct: 49  DVGSGREYALKRL-LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107

Query: 61  ---LVFEHCDQDLKKYFD--SLNGEIDLDIVKSFMYQLLRGLAFCHSRN--VLHRDLKPQ 113
              L+ E C   L ++       G +  D V    YQ  R +   H +   ++HRDLK +
Sbjct: 108 EFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVE 167

Query: 114 NLLINKNGELKLADFGLARAFGIPVKCYS------------AEVVTLWYRPPDV--LFGA 159
           NLL++  G +KL DFG A                           T  YR P++  L+  
Sbjct: 168 NLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN 227

Query: 160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDF 219
                  D+W+ GCI   L    +  F          RI              +N     
Sbjct: 228 FPIGEKQDIWALGCILYLLC-FRQHPFEDGAK----LRI--------------VNGKYSI 268

Query: 220 KPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHI 267
            P    +                  L++ +L  NP +R+S  + +  +
Sbjct: 269 PPHDTQYTVF-------------HSLIRAMLQVNPEERLSIAEVVHQL 303

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  130 bits (329), Expect = 4e-36
 Identities = 61/274 (22%), Positives = 97/274 (35%), Gaps = 76/274 (27%)

Query: 33  REICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLD-IVK--- 87
           RE+ +L + + H+N++ L +    E +  LVFE              G I L  I K   
Sbjct: 59  REVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMR----------GGSI-LSHIHKRRH 107

Query: 88  -------SFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIP 137
                    +  +   L F H++ + HRDLKP+N+L    N+   +K+ DF L     + 
Sbjct: 108 FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167

Query: 138 VKCYSAEVV-------TLWYRPPDVL----FGAKLYTTSIDMWSAGCI----------FA 176
             C             +  Y  P+V+      A +Y    D+WS G I          F 
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227

Query: 177 ELANAGRPLFPGSDVDDQLKRIFK--LLGTPT--EDTWPGMNLLPDFKPFPMYHPSMSFS 232
               +      G         +F+    G     +  W                  +S +
Sbjct: 228 GRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDW----------------AHISCA 271

Query: 233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                  AK  DL+ +LLV +  QR+SA   + H
Sbjct: 272 -------AK--DLISKLLVRDAKQRLSAAQVLQH 296

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  130 bits (329), Expect = 6e-36
 Identities = 60/257 (23%), Positives = 99/257 (38%), Gaps = 59/257 (22%)

Query: 30  SALREI-CLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLD-IVK 87
               EI  LL+  +H NI+ L DV    K + +V E              GE+ LD I++
Sbjct: 61  DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK----------GGEL-LDKILR 109

Query: 88  ----------SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE----LKLADFGLARA 133
                     + ++ + + + + H++ V+HRDLKP N+L          +++ DFG A+ 
Sbjct: 110 QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169

Query: 134 FGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDD 193
                        T  +  P+VL   + Y  + D+WS G +   +   G   F     D 
Sbjct: 170 LRAENGLLMTPCYTANFVAPEVL-ERQGYDAACDIWSLGVLLYTML-TGYTPFANGPDDT 227

Query: 194 QLKRIFK--LLGTP--TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRL 249
             + I      G    +   W                   S S      TAK  DL+ ++
Sbjct: 228 P-EEILARIGSGKFSLSGGYWN------------------SVSD-----TAK--DLVSKM 261

Query: 250 LVCNPVQRMSAEDAMSH 266
           L  +P QR++A   + H
Sbjct: 262 LHVDPHQRLTAALVLRH 278

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  127 bits (321), Expect = 4e-35
 Identities = 57/245 (23%), Positives = 96/245 (39%), Gaps = 54/245 (22%)

Query: 33  REICLLKEL----KHKNIVRLYDVLHSEKKLTLVFEHCD--QDLKKYFD--SLNGEIDLD 84
            E+ LL ++     H  ++RL D   +++   LV E     QDL   FD  +  G +   
Sbjct: 83  LEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDL---FDYITEKGPLGEG 139

Query: 85  IVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSA 143
             + F  Q++  +  CHSR V+HRD+K +N+LI+ + G  KL DFG   A  +  + Y+ 
Sbjct: 140 PSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG-AL-LHDEPYTD 197

Query: 144 EVVTLWYRPPDVLFGAKLYT-TSIDMWSAGCI-FAELANAGRPLFPGSDVDDQLKRIFKL 201
              T  Y PP+ +     Y      +WS G + +  +   G   F      ++ + I + 
Sbjct: 198 FDGTRVYSPPEWISR-HQYHALPATVWSLGILLYDMV--CGDIPF------ERDQEILE- 247

Query: 202 LGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAE 261
                          P                    ++     L++R L   P  R S E
Sbjct: 248 ----------AELHFPAH------------------VSPDCCALIRRCLAPKPSSRPSLE 279

Query: 262 DAMSH 266
           + +  
Sbjct: 280 EILLD 284

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  128 bits (324), Expect = 7e-35
 Identities = 65/256 (25%), Positives = 94/256 (36%), Gaps = 58/256 (22%)

Query: 33  REICLLKEL-KHKNIVRLYDV----LHSEKKLTLVFEHC------DQDLKKYFDSLNGEI 81
           RE+ L     +  +IVR+ DV        K L +V E         +   +   +   E 
Sbjct: 103 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT-ER 161

Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAF---- 134
           +       M  +   + + HS N+ HRD+KP+NLL      N  LKL DFG A+      
Sbjct: 162 E---ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218

Query: 135 GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQ 194
            +   CY+       Y  P+VL G + Y  S DMWS G I   L   G P F  +     
Sbjct: 219 SLTTPCYTPY-----YVAPEVL-GPEKYDKSCDMWSLGVIMYILL-CGYPPFYSNHGLAI 271

Query: 195 LKRIFK--LLGTPT--EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLL 250
              +     +G        W                  +S          K   L++ LL
Sbjct: 272 SPGMKTRIRMGQYEFPNPEW----------------SEVSEE-------VK--MLIRNLL 306

Query: 251 VCNPVQRMSAEDAMSH 266
              P QRM+  + M+H
Sbjct: 307 KTEPTQRMTITEFMNH 322

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  127 bits (320), Expect = 8e-35
 Identities = 51/240 (21%), Positives = 94/240 (39%), Gaps = 48/240 (20%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ--DLKKYFD--SLNGEIDLDIVKS 88
            EI +L  ++H NI+++ D+  ++    LV E      DL   F     +  +D  +   
Sbjct: 78  LEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDL---FAFIDRHPRLDEPLASY 134

Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL 148
              QL+  + +   ++++HRD+K +N++I ++  +KL DFG A A+    K +     T+
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA-AYLERGKLFYTFCGTI 193

Query: 149 WYRPPDVLFGAKLYT-TSIDMWSAGCI-FAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
            Y  P+VL G   Y    ++MWS G   +  +       F       +L+   +      
Sbjct: 194 EYCAPEVLMG-NPYRGPELEMWSLGVTLYTLV--FEENPF------CELEETVE------ 238

Query: 207 EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                     P              S+           L+  LL   P +R + E  ++ 
Sbjct: 239 -----AAIHPPYL-----------VSKEL-------MSLVSGLLQPVPERRTTLEKLVTD 275

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  128 bits (323), Expect = 1e-34
 Identities = 41/289 (14%), Positives = 87/289 (30%), Gaps = 58/289 (20%)

Query: 4   SGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT--- 60
           + + +     L ++    + N+      LR I     +K     ++  V   E+ +    
Sbjct: 120 NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLS 179

Query: 61  --LVFEHCDQDLKKYFDSL------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKP 112
              ++     +L+ + + L      +  +          Q++R LA  H   ++H  L+P
Sbjct: 180 RFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRP 239

Query: 113 QNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL---------FGAKLYT 163
            ++++++ G + L  F      G          +   + PP+               L T
Sbjct: 240 VDIVLDQRGGVFLTGFEHLVRDGASAVS----PIGRGFAPPETTAERMLPFGQHHPTLMT 295

Query: 164 TSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFP 223
            + D W+ G     +                 + IF+        +   +       P P
Sbjct: 296 FAFDTWTLGLAIYWIW-CADLPNTDDAALGGSEWIFR--------SCKNI-------PQP 339

Query: 224 MYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
           +                  R LL+  L      R+    AM    +  L
Sbjct: 340 V------------------RALLEGFLRYPKEDRLLPLQAMETPEYEQL 370

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  124 bits (314), Expect = 1e-33
 Identities = 61/254 (24%), Positives = 103/254 (40%), Gaps = 57/254 (22%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL--NGEIDLDIVKSF 89
           REI   + L+H NIVR  +V+ +   L ++ E+    +L   ++ +   G    D  + F
Sbjct: 65  REIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL---YERICNAGRFSEDEARFF 121

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLI--NKNGELKLADFGLARAF----------GIP 137
             QLL G+++CHS  + HRDLK +N L+  +    LK+ DFG +++           G P
Sbjct: 122 FQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 181

Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYT-TSIDMWSAGCI-FAELANAGRPLFPGSDVDDQL 195
              Y A         P+VL   + Y     D+WS G   +  L   G   F   +     
Sbjct: 182 --AYIA---------PEVLLR-QEYDGKIADVWSCGVTLYVML--VGAYPFEDPEEPRDY 227

Query: 196 KRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPV 255
           ++  + +            L   +   P     +  S            L+ R+ V +P 
Sbjct: 228 RKTIQRI------------LSVKYS-IP---DDIRISPEC-------CHLISRIFVADPA 264

Query: 256 QRMSAEDAMSHIYF 269
            R+S  +  +H +F
Sbjct: 265 TRISIPEIKTHSWF 278

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  121 bits (306), Expect = 6e-33
 Identities = 58/252 (23%), Positives = 84/252 (33%), Gaps = 71/252 (28%)

Query: 33  REICLLKEL-KHKNIVRLYDV----LHSEKKLTLVFEHC------DQDLKKYFDSLNGEI 81
           RE+ L     +  +IVR+ DV        K L +V E         +   +   +   E 
Sbjct: 59  REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT-ER 117

Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPV 138
           +       M  +   + + HS N+ HRD+KP+NLL      N  LKL DFG A       
Sbjct: 118 E---ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------- 167

Query: 139 KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRI 198
                          +     + Y  S DMWS G I   L   G P F  +        +
Sbjct: 168 --------------KETT--GEKYDKSCDMWSLGVIMYILL-CGYPPFYSNHGLAISPGM 210

Query: 199 FK--LLGTPT--EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNP 254
                +G        W                  +S          K   L++ LL   P
Sbjct: 211 KTRIRMGQYEFPNPEW----------------SEVSEE-------VK--MLIRNLLKTEP 245

Query: 255 VQRMSAEDAMSH 266
            QRM+  + M+H
Sbjct: 246 TQRMTITEFMNH 257

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  121 bits (304), Expect = 3e-32
 Identities = 71/290 (24%), Positives = 115/290 (39%), Gaps = 44/290 (15%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
              +     +A K  HL     + +  +RE+ +L E     IV  Y   +S+ ++++  E
Sbjct: 52  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111

Query: 65  HCD----QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINK 119
           H D      + K      G I   I+      +++GL +      ++HRD+KP N+L+N 
Sbjct: 112 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS 167

Query: 120 NGELKLADFG--------LARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
            GE+KL DFG        +A +F          V T  Y  P+ L G   Y+   D+WS 
Sbjct: 168 RGEIKLCDFGVSGQLIDSMANSF----------VGTRSYMSPERLQGTH-YSVQSDIWSM 216

Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPG--MNLLPDFKPFPMYHPSM 229
           G    E+A  GR   P  D  +        +     +T P       P  K      P M
Sbjct: 217 GLSLVEMAV-GRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPM 275

Query: 230 SF--------SQVAPKLTAKG-----RDLLQRLLVCNPVQRMSAEDAMSH 266
           +         ++  PKL +       +D + + L+ NP +R   +  M H
Sbjct: 276 AIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  116 bits (292), Expect = 4e-31
 Identities = 59/278 (21%), Positives = 114/278 (41%), Gaps = 55/278 (19%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALR----EICLLKELKHKNIVRLY----DVLHSE 56
           G+D      +A      + +  +  S  +    E  +LK L+H NIVR Y      +  +
Sbjct: 45  GLDTETTVEVAWC---ELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101

Query: 57  KKLTLVFEHCD-----QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN--VLHRD 109
           K + LV E          LK++       + + +++S+  Q+L+GL F H+R   ++HRD
Sbjct: 102 KCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRD 156

Query: 110 LKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDM 168
           LK  N+ I    G +K+ D GLA          +  + T  +  P++    + Y  S+D+
Sbjct: 157 LKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKA-VIGTPEFMAPEM--YEEKYDESVDV 212

Query: 169 WSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPS 228
           ++ G    E+A       P S+      +I++ + +               KP       
Sbjct: 213 YAFGMCMLEMA-TSEY--PYSEC-QNAAQIYRRVTSGV-------------KPASFDK-- 253

Query: 229 MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                       + +++++  +  N  +R S +D ++H
Sbjct: 254 --------VAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  113 bits (284), Expect = 1e-29
 Identities = 59/278 (21%), Positives = 103/278 (37%), Gaps = 48/278 (17%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREI-CLLKELKHKNIVRLYDVLHSEKKLTLVF 63
            V +     +A+K      +E      L ++  +++      IV+ Y  L  E    +  
Sbjct: 41  MVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100

Query: 64  EHCD----QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLIN 118
           E       +  K  +  L+  I  +I+       ++ L        ++HRD+KP N+L++
Sbjct: 101 ELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD 160

Query: 119 KNGELKLADFG--------LARAFGIPVKCYSA-EVVTLWYRPPDVLFGAKLYTTSIDMW 169
           ++G +KL DFG        +A+      + Y A E +       D     + Y    D+W
Sbjct: 161 RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI-------DPSASRQGYDVRSDVW 213

Query: 170 SAGCIFAELANAGRPLFPGSD-VDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPS 228
           S G    ELA  GR  +P  + V DQL ++ K  G P           P          S
Sbjct: 214 SLGITLYELAT-GRFPYPKWNSVFDQLTQVVK--GDP-----------PQLSNSEEREFS 259

Query: 229 MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
            SF            + +   L  +  +R   ++ + H
Sbjct: 260 PSF-----------INFVNLCLTKDESKRPKYKELLKH 286

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  111 bits (279), Expect = 1e-28
 Identities = 33/260 (12%), Positives = 74/260 (28%), Gaps = 53/260 (20%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-----LKKYFDSLNGEIDLDIV 86
            + +  LK       ++ Y     +    LV E          +  Y ++    +   +V
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174

Query: 87  KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN-----------KNGELKLADFGLARAFG 135
            SF  ++L  +   H   ++H D+KP N ++             +  L L D G +    
Sbjct: 175 ISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 136 I--PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDD 193
           +      ++A+  T  ++  ++L   K +   ID +        +             + 
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293

Query: 194 QLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCN 253
           + + +F+    P  D W                                 +    +L   
Sbjct: 294 KPEGLFR--RLPHLDMWN--------------------------------EFFHVMLNIP 319

Query: 254 PVQRMSAEDAMSHIYFSDLN 273
               + + D +         
Sbjct: 320 DCHHLPSLDLLRQKLKKVFQ 339

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  111 bits (278), Expect = 2e-28
 Identities = 70/338 (20%), Positives = 120/338 (35%), Gaps = 99/338 (29%)

Query: 21  LVGNEGVPSSALREICLLKELK--------HKNIVRLYDV--------LHSEKKLTLVFE 64
           +   E    +AL EI LLK ++         + +V+L D          H    + +VFE
Sbjct: 70  VKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTH----ICMVFE 125

Query: 65  ---HCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSR-NVLHRDLKPQNLLIN-- 118
              H         +     + L  VK  + Q+L+GL + H++  ++H D+KP+N+L++  
Sbjct: 126 VLGHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN 183

Query: 119 -----------------------------------------------KNGELKLADFGLA 131
                                                          +  ++K+AD G A
Sbjct: 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA 243

Query: 132 RAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG--- 188
                  K ++ ++ T  YR  +VL G+  Y T  D+WS  C+  ELA  G  LF     
Sbjct: 244 C---WVHKHFTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELA-TGDYLFEPHSG 298

Query: 189 ---SDVDDQLKRIFKLLGTPTEDTWPGMNLLPDF-------KPFPMYHPSMSFSQVAPKL 238
              +  +D +  I +LLG              +F       K      P   F  +  K 
Sbjct: 299 EEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY 358

Query: 239 TAKGRD------LLQRLLVCNPVQRMSAEDAMSHIYFS 270
                +       L  +L   P +R +A + + H + +
Sbjct: 359 EWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  109 bits (274), Expect = 6e-28
 Identities = 47/298 (15%), Positives = 96/298 (32%), Gaps = 39/298 (13%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSAL----REICLLKELKHKNIVRLYDVLHSEKKLT 60
              +     + ++  +L   E   +  +     E+ + K   H NIV       ++ +L 
Sbjct: 46  ARYKPTGEYVTVRRINL---EACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102

Query: 61  LVFEHCD----QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLL 116
           +V         +DL          ++   +   +  +L+ L + H    +HR +K  ++L
Sbjct: 103 VVTSFMAYGSAKDLICT--HFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHIL 160

Query: 117 INKNGELKLADFGLARAFGIPVK-------CYSAEVVTLWYRPPDVLF-GAKLYTTSIDM 168
           I+ +G++ L+      +     +            V  L +  P+VL    + Y    D+
Sbjct: 161 ISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDI 220

Query: 169 WSAGCIFAELANAGRP----------LF-------PGSDVDDQLKRIFKLLGTPTEDTWP 211
           +S G    ELAN G            L        P       +      +         
Sbjct: 221 YSVGITACELAN-GHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANS 279

Query: 212 GMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
           G++           +            +      +++ L  NP  R SA   ++H +F
Sbjct: 280 GLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  108 bits (271), Expect = 6e-28
 Identities = 45/195 (23%), Positives = 88/195 (45%), Gaps = 17/195 (8%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
              R     + +K       E    + L+E+ +++ L+H N+++   VL+ +K+L  + E
Sbjct: 29  VTHRETGEVMVMKELIRFDEE-TQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87

Query: 65  HCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL 123
           +     L+    S++ +       SF   +  G+A+ HS N++HRDL   N L+ +N  +
Sbjct: 88  YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNV 147

Query: 124 KLADFGLAR-------------AFGIPVKCYS-AEVVTLWYRPPDVLFGAKLYTTSIDMW 169
            +ADFGLAR             +   P +      V   ++  P+++ G + Y   +D++
Sbjct: 148 VVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVF 206

Query: 170 SAGCIFAELANAGRP 184
           S G +  E+      
Sbjct: 207 SFGIVLCEIIGRVNA 221

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  107 bits (268), Expect = 2e-27
 Identities = 55/273 (20%), Positives = 97/273 (35%), Gaps = 43/273 (15%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREI-CLLKELKHKNIVRLYDVLHSEKKLTLVF 63
              R     +A+K     GN+      L ++  +LK      IV+ +    +   + +  
Sbjct: 44  MRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103

Query: 64  EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGE 122
           E      +K    + G I   I+      +++ L +      V+HRD+KP N+L+++ G+
Sbjct: 104 ELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ 163

Query: 123 LKLADFG--------LARAFGIPVKCYSA-EVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           +KL DFG         A+        Y A E +      P        Y    D+WS G 
Sbjct: 164 IKLCDFGISGRLVDDKAKDRSAGCAAYMAPERID-----PPDPTKPD-YDIRADVWSLGI 217

Query: 174 IFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ 233
              ELA  G+  +         K  F++L             +   +P P+    M FS 
Sbjct: 218 SLVELAT-GQFPYKN------CKTDFEVL-----------TKVLQEEP-PLLPGHMGFSG 258

Query: 234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                    +  ++  L  +  +R      + H
Sbjct: 259 DF-------QSFVKDCLTKDHRKRPKYNKLLEH 284

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  106 bits (266), Expect = 7e-27
 Identities = 60/275 (21%), Positives = 108/275 (39%), Gaps = 54/275 (19%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSAL--REICLLKELKHKNIVRLYDVLHSEKKLTLV 62
             D   +  +AIK     G +         +E+  L++L+H N ++       E    LV
Sbjct: 73  ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132

Query: 63  FEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
            E+C        +     +    + +  +  L+GLA+ HS N++HRD+K  N+L+++ G 
Sbjct: 133 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL 192

Query: 123 LKLADFGLA------RAF-GIPVKCY--SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAG- 172
           +KL DFG A       +F G P   Y  + EV+               Y   +D+WS G 
Sbjct: 193 VKLGDFGSASIMAPANSFVGTP---YWMAPEVILAMDEGQ--------YDGKVDVWSLGI 241

Query: 173 -CIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSF 231
            CI  ELA   +P  P  +++  +  ++ +      ++       P  +           
Sbjct: 242 TCI--ELAE-RKP--PLFNMN-AMSALYHI---AQNES-------PALQS---------- 275

Query: 232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                  +   R+ +   L   P  R ++E  + H
Sbjct: 276 ----GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  104 bits (261), Expect = 2e-26
 Identities = 67/280 (23%), Positives = 108/280 (38%), Gaps = 59/280 (21%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
             ++      A K       E +    + EI +L    H  IV+L    + + KL ++ E
Sbjct: 38  AKNKETGALAAAKVIETKSEEEL-EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96

Query: 65  HCD----QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN 120
            C       +      L+  +    ++    Q+L  L F HS+ ++HRDLK  N+L+   
Sbjct: 97  FCPGGAVDAIML---ELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLE 153

Query: 121 GELKLADFGLA----------RAF-GIPVKCY--SAEVVTLWYRPPDVLFGAKLYTTSID 167
           G+++LADFG++           +F G P   Y  + EVV               Y    D
Sbjct: 154 GDIRLADFGVSAKNLKTLQKRDSFIGTP---YWMAPEVVMCETMK------DTPYDYKAD 204

Query: 168 MWSAGCIFA-ELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYH 226
           +WS G I   E+A    P  P  ++ + ++ + K+      D        P         
Sbjct: 205 IWSLG-ITLIEMAQ-IEP--PHHEL-NPMRVLLKI---AKSDP-------PTLL-----T 244

Query: 227 PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
           PS        K + + RD L+  L  NP  R SA   + H
Sbjct: 245 PS--------KWSVEFRDFLKIALDKNPETRPSAAQLLEH 276

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  103 bits (260), Expect = 2e-26
 Identities = 50/151 (33%), Positives = 81/151 (53%), Gaps = 5/151 (3%)

Query: 40  ELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLA 98
           +L H+NIV + DV   +    LV E+ +   L +Y +S +G + +D   +F  Q+L G+ 
Sbjct: 67  QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIK 125

Query: 99  FCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWYRPPDVLF 157
             H   ++HRD+KPQN+LI+ N  LK+ DFG+A+A        +  V+ T+ Y  P+   
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK 185

Query: 158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
           G      + D++S G +  E+   G P F G
Sbjct: 186 GEATDECT-DIYSIGIVLYEML-VGEPPFNG 214

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  103 bits (260), Expect = 3e-26
 Identities = 61/276 (22%), Positives = 107/276 (38%), Gaps = 35/276 (12%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
                    +AIK  +L   +      L+EI  + +  H NIV  Y     + +L LV +
Sbjct: 34  AYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93

Query: 65  HCD----QDLKKYF----DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLL 116
                   D+ K+     +  +G +D   + + + ++L GL + H    +HRD+K  N+L
Sbjct: 94  LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNIL 153

Query: 117 INKNGELKLADFG----LARAFGIPVKCYSAEVV-TLWYRPPDVLFGAKLYTTSIDMWSA 171
           + ++G +++ADFG    LA    I         V T  +  P+V+   + Y    D+WS 
Sbjct: 154 LGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSF 213

Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFK-PFPMYHPSMS 230
           G    ELA  G    P       +K +     T   D        P  +           
Sbjct: 214 GITAIELAT-GAA--PYHKY-PPMKVLML---TLQNDP-------PSLETGVQDKEMLKK 259

Query: 231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
           + +         R ++   L  +P +R +A + + H
Sbjct: 260 YGKSF-------RKMISLCLQKDPEKRPTAAELLRH 288

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  103 bits (260), Expect = 3e-26
 Identities = 67/268 (25%), Positives = 115/268 (42%), Gaps = 42/268 (15%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            + +     +AIK    V  E      ++EI ++++    ++V+ Y        L +V E
Sbjct: 48  AIHKETGQIVAIK---QVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104

Query: 65  HCD----QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN 120
           +C      D+ +     N  +  D + + +   L+GL + H    +HRD+K  N+L+N  
Sbjct: 105 YCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTE 161

Query: 121 GELKLADFGLARAFGIPVKCYSAEVV-TLWYRPPDVLFGAKLYTTSIDMWSAGCIFA-EL 178
           G  KLADFG+A             V+ T ++  P+V+     Y    D+WS G I A E+
Sbjct: 162 GHAKLADFGVA-GQLTDTMAKRNTVIGTPFWMAPEVIQEIG-YNCVADIWSLG-ITAIEM 218

Query: 179 ANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL 238
           A  G+P  P +D+   ++ IF +   PT          P F+      P           
Sbjct: 219 AE-GKP--PYADI-HPMRAIFMI---PTNPP-------PTFR-----KPE--------LW 251

Query: 239 TAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
           +    D +++ LV +P QR +A   + H
Sbjct: 252 SDNFTDFVKQCLVKSPEQRATATQLLQH 279

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  103 bits (258), Expect = 4e-26
 Identities = 57/281 (20%), Positives = 93/281 (33%), Gaps = 58/281 (20%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREI-CLLKELKHKNIVRLYDVLHSEKKLTLVF 63
                    +A+K      N       L ++   ++ +     V  Y  L  E  + +  
Sbjct: 26  MRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85

Query: 64  EHCD---QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINK 119
           E  D       K        I  DI+      +++ L   HS  +V+HRD+KP N+LIN 
Sbjct: 86  ELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA 145

Query: 120 NGELKLADFGLARAFGIPVKCYSAEVV----------TLWYRPPDVLFGAKL---YTTSI 166
            G++K+ DFG+           S  +V             Y  P+ +        Y+   
Sbjct: 146 LGQVKMCDFGI-----------SGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKS 194

Query: 167 DMWSAGCIFAELANAGRPLFPGSD-VDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY 225
           D+WS G    ELA   R  +        QLK++                   +     + 
Sbjct: 195 DIWSLGITMIELAI-LRFPYDSWGTPFQQLKQV------------------VEEPSPQL- 234

Query: 226 HPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
            P+  FS           D   + L  N  +R +  + M H
Sbjct: 235 -PADKFSAEF-------VDFTSQCLKKNSKERPTYPELMQH 267

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  102 bits (257), Expect = 5e-26
 Identities = 33/162 (20%), Positives = 79/162 (48%), Gaps = 7/162 (4%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
             E+ +L++ +H NI+       +  +L +V + C+   L  +  +   + ++  +    
Sbjct: 68  KNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIA 126

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVKCYSAEVVTL 148
            Q  RG+ + H+++++HRDLK  N+ ++++  +K+ DFGLA   +       +     ++
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186

Query: 149 WYRPPDVLFG--AKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
            +  P+V+    +  Y+   D+++ G +  EL   G+  +  
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM-TGQLPYSN 227

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  106 bits (265), Expect = 7e-26
 Identities = 41/185 (22%), Positives = 83/185 (44%), Gaps = 17/185 (9%)

Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDV-----LHSEKKLTLVFEHCD-Q 68
            +KG    G+    + A+ E   L E+ H +IV++++       H +    +V E+   Q
Sbjct: 110 VLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQ 169

Query: 69  DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADF 128
            LK+       ++ +    +++ ++L  L++ HS  +++ DLKP+N+++ +   LKL D 
Sbjct: 170 SLKRS---KGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDL 225

Query: 129 GLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
           G           +     T  ++ P+++      T + D+++ G   A L     P   G
Sbjct: 226 GAVSRINS----FGYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALT-LDLPTRNG 278

Query: 189 SDVDD 193
             VD 
Sbjct: 279 RYVDG 283

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  102 bits (256), Expect = 1e-25
 Identities = 60/258 (23%), Positives = 107/258 (41%), Gaps = 55/258 (21%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN--GEIDLDIVKS 88
            RE  ++  L H   V+LY     ++KL     +    +L      +   G  D    + 
Sbjct: 78  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRF 134

Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-------CY 141
           +  +++  L + H + ++HRDLKP+N+L+N++  +++ DFG A+      K         
Sbjct: 135 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194

Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKL 201
           +A+     Y  P++L   K    S D+W+ GCI  +L  AG P F   +     ++I KL
Sbjct: 195 TAQ-----YVSPELLTE-KSACKSSDLWALGCIIYQLV-AGLPPFRAGNEYLIFQKIIKL 247

Query: 202 LGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM--- 258
                           ++  FP             K   K RDL+++LLV +  +R+   
Sbjct: 248 ----------------EYD-FP------------EKFFPKARDLVEKLLVLDATKRLGCE 278

Query: 259 ---SAEDAMSHIYFSDLN 273
                    +H +F  + 
Sbjct: 279 EMEGYGPLKAHPFFESVT 296

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  101 bits (254), Expect = 1e-25
 Identities = 43/184 (23%), Positives = 73/184 (39%), Gaps = 20/184 (10%)

Query: 11  NTALAIKGTHLVGNEGVPSSA------LREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            + +AIK   L  +EG            RE+ ++  L H NIV+LY +        +V E
Sbjct: 44  KSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL--MHNPPRMVME 101

Query: 65  HCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN--VLHRDLKPQNLLINKNG 121
                DL          I   +    M  +  G+ +  ++N  ++HRDL+  N+ +    
Sbjct: 102 FVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLD 161

Query: 122 E-----LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA-KLYTTSIDMWSAGCIF 175
           E      K+ADFGL++     V   S  +    +  P+ +    + YT   D +S   I 
Sbjct: 162 ENAPVCAKVADFGLSQQS---VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMIL 218

Query: 176 AELA 179
             + 
Sbjct: 219 YTIL 222

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  102 bits (255), Expect = 2e-25
 Identities = 35/202 (17%), Positives = 77/202 (38%), Gaps = 34/202 (16%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
            RE+   ++ +H+N+V       S   L ++   C    L          +D++  +   
Sbjct: 77  KREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIA 136

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL-- 148
            ++++G+ + H++ +LH+DLK +N+  + NG++ + DFGL    G+       + + +  
Sbjct: 137 QEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQN 195

Query: 149 -WYR----------PPDVLFGAKLYTTSIDMWSAGCIFAEL------------------- 178
            W             PD       ++   D+++ G I+ EL                   
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM 255

Query: 179 ANAGRPLFPGSDVDDQLKRIFK 200
               +P      +  ++  I  
Sbjct: 256 GTGMKPNLSQIGMGKEISDILL 277

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  100 bits (252), Expect = 4e-25
 Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 7/162 (4%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG--EIDLDIVKS 88
           LRE+ ++K L+H NIV     +     L++V E+  +  L +         ++D     S
Sbjct: 82  LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLS 141

Query: 89  FMYQLLRGLAFCHSRN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
             Y + +G+ + H+RN  ++HR+LK  NLL++K   +K+ DFGL+R          +   
Sbjct: 142 MAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAG 201

Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
           T  +  P+VL   +      D++S G I  ELA   +  +  
Sbjct: 202 TPEWMAPEVLRD-EPSNEKSDVYSFGVILWELA-TLQQPWGN 241

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  100 bits (251), Expect = 5e-25
 Identities = 67/271 (24%), Positives = 118/271 (43%), Gaps = 49/271 (18%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
           G+D      +AIK   L   E       +EI +L +     + + Y     + KL ++ E
Sbjct: 41  GIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100

Query: 65  HCD----QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN 120
           +       DL +      G +D   + + + ++L+GL + HS   +HRD+K  N+L++++
Sbjct: 101 YLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH 155

Query: 121 GELKLADFGLARAFGIPVKCYSAEVV-TLWYRPPDVLFGAKLYTTSIDMWSAGCIFA-EL 178
           GE+KLADFG+A       +      V T ++  P+V+  +  Y +  D+WS G I A EL
Sbjct: 156 GEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLG-ITAIEL 212

Query: 179 ANAGRPLFPGSDVDDQLKRIFKLL--GTPT-EDTWPGMNLLPDFKPFPMYHPSMSFSQVA 235
           A  G P  P S++   +K +F +     PT E  +                 S       
Sbjct: 213 AR-GEP--PHSEL-HPMKVLFLIPKNNPPTLEGNY-----------------SKPL---- 247

Query: 236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                  ++ ++  L   P  R +A++ + H
Sbjct: 248 -------KEFVEACLNKEPSFRPTAKELLKH 271

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  102 bits (256), Expect = 7e-25
 Identities = 57/268 (21%), Positives = 107/268 (39%), Gaps = 37/268 (13%)

Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLK-- 71
            +    L   +G    A+ E  +L ++  + IV L     ++  L LV    +  D++  
Sbjct: 217 KLNKKRLKKRKGY-QGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYH 275

Query: 72  -KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGL 130
               D  N          +  Q++ GL   H RN+++RDLKP+N+L++ +G ++++D GL
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335

Query: 131 ARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSD 190
           A               T  +  P++L G + Y  S+D ++ G    E+  A R  F    
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMI-AARGPFRARG 393

Query: 191 VDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLL 250
              + K + +              +L     +P             K +   +D  + LL
Sbjct: 394 EKVENKELKQ-------------RVLEQAVTYP------------DKFSPASKDFCEALL 428

Query: 251 VCNPVQRM-----SAEDAMSHIYFSDLN 273
             +P +R+     S +   +H  F D++
Sbjct: 429 QKDPEKRLGFRDGSCDGLRTHPLFRDIS 456

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 99.7 bits (249), Expect = 7e-25
 Identities = 69/268 (25%), Positives = 118/268 (44%), Gaps = 42/268 (15%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            +D      +AI+  +L          + EI +++E K+ NIV   D      +L +V E
Sbjct: 39  AMDVATGQEVAIRQMNLQQQPKK-ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97

Query: 65  HCD----QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN 120
           +       D+          +D   + +   + L+ L F HS  V+HRD+K  N+L+  +
Sbjct: 98  YLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD 152

Query: 121 GELKLADFGLARAFGIPVKCYSAEVV-TLWYRPPDVLFGAKLYTTSIDMWSAGCIFA-EL 178
           G +KL DFG   A   P +   + +V T ++  P+V+     Y   +D+WS G I A E+
Sbjct: 153 GSVKLTDFGFC-AQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLG-IMAIEM 209

Query: 179 ANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL 238
              G P  P  +  + L+ ++ +    T  T       P+ +     +P         KL
Sbjct: 210 IE-GEP--PYLNE-NPLRALYLI---ATNGT-------PELQ-----NPE--------KL 242

Query: 239 TAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
           +A  RD L R L  +  +R SA++ + H
Sbjct: 243 SAIFRDFLNRCLEMDVEKRGSAKELLQH 270

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 99.6 bits (247), Expect = 2e-24
 Identities = 49/263 (18%), Positives = 89/263 (33%), Gaps = 50/263 (19%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKK---------------LTLVFEHCDQDLKKYFDS 76
           L  +  ++      +++ +D  +S K                + L FE    DL++    
Sbjct: 97  LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK 156

Query: 77  LNGEIDLDIVKSFMYQLLRGLAFCHSR-NVLHRDLKPQNLLINKNGELKLADFGLARAFG 135
           L+    L   KS ++QL   LA   +     HRDL   N+L+ K    KL      ++  
Sbjct: 157 LS---SLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSST 213

Query: 136 IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL 195
           IP       ++               YT S        +F +++     LF G    D  
Sbjct: 214 IPSCGLQVSIID--------------YTLSRLERDGIVVFCDVSMD-EDLFTGD--GDYQ 256

Query: 196 KRIFKLLGTPTEDTW----PGMNL-----LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLL 246
             I++L+     + W    P  N+     L D     M   +   +    ++  K ++  
Sbjct: 257 FDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFH 316

Query: 247 QRLLVCNPVQRMSAEDAMSHIYF 269
           + +L  +     SA D +     
Sbjct: 317 RTMLNFS-----SATDLLCQHSL 334

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 99.4 bits (248), Expect = 2e-24
 Identities = 57/268 (21%), Positives = 118/268 (44%), Gaps = 42/268 (15%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
             ++     +A+K   L   +        E+ ++++ +H N+V +Y      ++L ++ E
Sbjct: 64  AREKHSGRQVAVKMMDLRKQQRR-ELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122

Query: 65  HCD----QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN 120
                   D+          ++ + + +    +L+ LA+ H++ V+HRD+K  ++L+  +
Sbjct: 123 FLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD 177

Query: 121 GELKLADFGLARAFGIPVKCYSAEVV-TLWYRPPDVLFGAKLYTTSIDMWSAGCIFA-EL 178
           G +KL+DFG   A           +V T ++  P+V+  +  Y T +D+WS G I   E+
Sbjct: 178 GRVKLSDFGFC-AQISKDVPKRKSLVGTPYWMAPEVISRSL-YATEVDIWSLG-IMVIEM 234

Query: 179 ANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL 238
            + G P  P       ++ + +L               P  K     +          K+
Sbjct: 235 VD-GEP--PYFSD-SPVQAMKRL---RDSPP-------PKLK-----NSH--------KV 267

Query: 239 TAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
           +   RD L+R+LV +P +R +A++ + H
Sbjct: 268 SPVLRDFLERMLVRDPQERATAQELLDH 295

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 98.9 bits (247), Expect = 2e-24
 Identities = 34/153 (22%), Positives = 65/153 (42%), Gaps = 5/153 (3%)

Query: 41  LKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAF 99
           L+  ++V ++D    + +L +     +  DL        G +      + + Q+   L  
Sbjct: 91  LQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDA 149

Query: 100 CHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV-TLWYRPPDVLFG 158
            H+    HRD+KP+N+L++ +    L DFG+A A            V TL+Y  P+    
Sbjct: 150 AHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE 209

Query: 159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDV 191
           +     + D+++  C+  E    G P + G  +
Sbjct: 210 SHATYRA-DIYALTCVLYECL-TGSPPYQGDQL 240

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 97.4 bits (243), Expect = 6e-24
 Identities = 47/171 (27%), Positives = 73/171 (42%), Gaps = 16/171 (9%)

Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY 73
           AIK    + +E    + + E+  L  + H NIV+LY        + LV E+ +   L   
Sbjct: 35  AIK---QIESESERKAFIVELRQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNV 89

Query: 74  FDSLN--GEIDLDIVKSFMYQLLRGLAFCHSRN---VLHRDLKPQNLLINKNGE-LKLAD 127
                           S+  Q  +G+A+ HS     ++HRDLKP NLL+   G  LK+ D
Sbjct: 90  LHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICD 149

Query: 128 FGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
           FG A          +    +  +  P+V  G   Y+   D++S G I  E+
Sbjct: 150 FGTAC---DIQTHMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEV 196

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 99.1 bits (247), Expect = 1e-23
 Identities = 54/258 (20%), Positives = 101/258 (39%), Gaps = 49/258 (18%)

Query: 30  SALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE---------HCDQDLKKYFDSLNGE 80
            AL E  +L+++  + +V L     ++  L LV           H     +  F      
Sbjct: 230 MALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP----- 284

Query: 81  IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC 140
                   +  ++  GL   H   +++RDLKP+N+L++ +G ++++D GLA         
Sbjct: 285 --EARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 342

Query: 141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
               V T+ Y  P+V+   + YT S D W+ GC+  E+  AG+  F       + + + +
Sbjct: 343 KGR-VGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMI-AGQSPFQQRKKKIKREEVER 399

Query: 201 LLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM-- 258
                         +    + +              + + + R L  +LL  +P +R+  
Sbjct: 400 -------------LVKEVPEEYS------------ERFSPQARSLCSQLLCKDPAERLGC 434

Query: 259 ---SAEDAMSHIYFSDLN 273
              SA +   H  F  LN
Sbjct: 435 RGGSAREVKEHPLFKKLN 452

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 97.1 bits (242), Expect = 1e-23
 Identities = 75/287 (26%), Positives = 112/287 (39%), Gaps = 67/287 (23%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYD------VLHSEK 57
           G         AIK   + G+E       +EI +LK+   H+NI   Y           + 
Sbjct: 43  GRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100

Query: 58  KLTLVFEHCD----QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQ 113
           +L LV E C      DL K   +    +  + +     ++LRGL+  H   V+HRD+K Q
Sbjct: 101 QLWLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ 158

Query: 114 NLLINKNGELKLADFGLARAF-----------GIPVKCY--SAEVVTLWYRPPDVLFGAK 160
           N+L+ +N E+KL DFG++              G P   Y  + EV+     P        
Sbjct: 159 NVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP---YWMAPEVIACDENPDAT----- 210

Query: 161 LYTTSIDMWSAGCIFA-ELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDF 219
            Y    D+WS G I A E+A  G P  P  D+   ++ +F +   P           P  
Sbjct: 211 -YDFKSDLWSLG-ITAIEMAE-GAP--PLCDM-HPMRALFLI---PRNPA-------PRL 254

Query: 220 KPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
           K                K + K +  ++  LV N  QR + E  M H
Sbjct: 255 KS--------------KKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 97.9 bits (244), Expect = 2e-23
 Identities = 59/251 (23%), Positives = 100/251 (39%), Gaps = 39/251 (15%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMY 91
           R++  L     K I  L+     +  L LV ++    DL          +  ++ + ++ 
Sbjct: 125 RDV--LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA 182

Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VKCYSAEVVTLW 149
           +++  +   H  + +HRD+KP N+L++ NG ++LADFG          V+   A V T  
Sbjct: 183 EMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA-VGTPD 241

Query: 150 YRPPDVL----FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
           Y  P++L     G   Y    D WS G    E+   G   F    + +   +I       
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKI------- 293

Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM---SAED 262
                  MN    F  FP     +S            +DL++RL+ C+   R+     ED
Sbjct: 294 -------MNHKERF-QFPTQVTDVS---------ENAKDLIRRLI-CSREHRLGQNGIED 335

Query: 263 AMSHIYFSDLN 273
              H +FS ++
Sbjct: 336 FKKHPFFSGID 346

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 96.9 bits (242), Expect = 2e-23
 Identities = 50/211 (23%), Positives = 88/211 (41%), Gaps = 32/211 (15%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSA----LREICLLKELKHKNIVRLYDVLHSEKKLT 60
           G  R  NT +A+K       E +P       L+E  +LK+  H NIVRL  V   ++ + 
Sbjct: 133 GRLRADNTLVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188

Query: 61  LVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK 119
           +V E     D   +  +    + +  +   +     G+ +  S+  +HRDL  +N L+ +
Sbjct: 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTE 248

Query: 120 NGELKLADFGLAR------------AFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSID 167
              LK++DFG++R               +PVK         W  P  + +G   Y++  D
Sbjct: 249 KNVLKISDFGMSREEADGVYAASGGLRQVPVK---------WTAPEALNYG--RYSSESD 297

Query: 168 MWSAGCIFAELANAGRPLFPGSDVDDQLKRI 198
           +WS G +  E  + G   +P        + +
Sbjct: 298 VWSFGILLWETFSLGASPYPNLSNQQTREFV 328

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 97.0 bits (242), Expect = 3e-23
 Identities = 53/254 (20%), Positives = 100/254 (39%), Gaps = 49/254 (19%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLV---------FEHCDQDLKKYFDSLNGEID 82
            +E+ +++ L+H  +V L+     E+ + +V           H    L++     N    
Sbjct: 63  FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYH----LQQ-----NVHFK 113

Query: 83  LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS 142
            + VK F+ +L+  L +  ++ ++HRD+KP N+L++++G + + DF +A       +  +
Sbjct: 114 EETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT 173

Query: 143 AEVVTLWYRPPDVLF--GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFK 200
               T  Y  P++        Y+ ++D WS G    EL   GR  +         K I  
Sbjct: 174 M-AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELL-RGRRPYHIRS-STSSKEIVH 230

Query: 201 LLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM-S 259
                                +P               + +   LL++LL  NP QR   
Sbjct: 231 -------------TFETTVVTYP------------SAWSQEMVSLLKKLLEPNPDQRFSQ 265

Query: 260 AEDAMSHIYFSDLN 273
             D  +  Y +D+N
Sbjct: 266 LSDVQNFPYMNDIN 279

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 95.4 bits (238), Expect = 3e-23
 Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 33/211 (15%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSA--LREICLLKELKHKNIVRLYDVLHSEKKLTLV 62
           GV +  +  +A+K       E        L+E  ++KE+KH N+V+L  V   E    ++
Sbjct: 32  GVWKKYSLTVAVK----TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87

Query: 63  FEHCDQ-DLKKYFDSLNGE-IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN 120
            E     +L  Y    N + +   ++     Q+   + +   +N +HRDL  +N L+ +N
Sbjct: 88  TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN 147

Query: 121 GELKLADFGLARAFG-----------IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMW 169
             +K+ADFGL+R               P+K         W   P+ L   K ++   D+W
Sbjct: 148 HLVKVADFGLSRLMTGDTYTAHAGAKFPIK---------WT-APESLAYNK-FSIKSDVW 196

Query: 170 SAGCIFAELANAGRPLFPG---SDVDDQLKR 197
           + G +  E+A  G   +PG   S V + L++
Sbjct: 197 AFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 95.4 bits (238), Expect = 4e-23
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 11/157 (7%)

Query: 40  ELKHKNIVRLYDVLHSEKKLT----LVFEHCD-QDLKKYFDSLNGEIDLDIVKSFMYQLL 94
            L H  IV +YD   +E        +V E+ D   L+    +  G +        +    
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADAC 126

Query: 95  RGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC--YSAEVV-TLWYR 151
           + L F H   ++HRD+KP N++I+    +K+ DFG+ARA          +A V+ T  Y 
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186

Query: 152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
            P+   G  +   S D++S GC+  E+   G P F G
Sbjct: 187 SPEQARGDSVDARS-DVYSLGCVLYEVL-TGEPPFTG 221

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 97.5 bits (243), Expect = 4e-23
 Identities = 48/202 (23%), Positives = 91/202 (45%), Gaps = 16/202 (7%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSA--LREICLLKELKHKNIVRLYDVLHSEKKLTLV 62
           GV +  +  +A+K       E        L+E  ++KE+KH N+V+L  V   E    ++
Sbjct: 239 GVWKKYSLTVAVK----TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294

Query: 63  FEHCDQ-DLKKYFDSLNGE-IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN 120
            E     +L  Y    N + +   ++     Q+   + +   +N +HR+L  +N L+ +N
Sbjct: 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN 354

Query: 121 GELKLADFGLARAFGIPVKCYSAEVVTL----WYRPPDVLFGAKLYTTSIDMWSAGCIFA 176
             +K+ADFGL+R   +    Y+A         W  P  + +    ++   D+W+ G +  
Sbjct: 355 HLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLW 410

Query: 177 ELANAGRPLFPGSDVDDQLKRI 198
           E+A  G   +PG D+    + +
Sbjct: 411 EIATYGMSPYPGIDLSQVYELL 432

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 96.7 bits (241), Expect = 4e-23
 Identities = 57/253 (22%), Positives = 98/253 (38%), Gaps = 41/253 (16%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMY 91
           R++  L     + I +L+     E  L LV E+    DL          I  ++ + ++ 
Sbjct: 112 RDV--LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA 169

Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGI--PVKCYSAEVVTLW 149
           +++  +   H    +HRD+KP N+L+++ G ++LADFG          V+   A V T  
Sbjct: 170 EIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA-VGTPD 228

Query: 150 YRPPDVL------FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
           Y  P++L       G   Y    D W+ G    E+   G+  F      +   +I     
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF-YGQTPFYADSTAETYGKI----- 282

Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM---SA 260
                    ++        P+    +           + RD +QRLL C P  R+    A
Sbjct: 283 ---------VHYKEHL-SLPLVDEGVP---------EEARDFIQRLL-CPPETRLGRGGA 322

Query: 261 EDAMSHIYFSDLN 273
            D  +H +F  L+
Sbjct: 323 GDFRTHPFFFGLD 335

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 96.7 bits (241), Expect = 5e-23
 Identities = 58/251 (23%), Positives = 100/251 (39%), Gaps = 43/251 (17%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSL-NGEIDLDIVKSFM 90
           R+I  +       +V+L+     ++ L +V E+    DL    + + N ++     + + 
Sbjct: 120 RDI--MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARFYT 174

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VKCYSAEVVTL 148
            +++  L   HS   +HRD+KP N+L++K+G LKLADFG          V+C +A V T 
Sbjct: 175 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTP 233

Query: 149 WYRPPDVLF---GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
            Y  P+VL    G   Y    D WS G    E+   G   F    +     +I       
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML-VGDTPFYADSLVGTYSKI------- 285

Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM---SAED 262
                  MN       FP              ++ + ++L+   L  +   R+     E+
Sbjct: 286 -------MNHKNSL-TFPDD----------NDISKEAKNLICAFL-TDREVRLGRNGVEE 326

Query: 263 AMSHIYFSDLN 273
              H++F +  
Sbjct: 327 IKRHLFFKNDQ 337

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 94.2 bits (235), Expect = 5e-23
 Identities = 30/155 (19%), Positives = 57/155 (36%), Gaps = 13/155 (8%)

Query: 33  REICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQ-DLKKY-FDSLNGEIDLDIVKS 88
            E   L+   H N++ +     S      TL+        L     +  N  +D      
Sbjct: 56  EECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVK 115

Query: 89  FMYQLLRGLAFCHSRN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV 146
           F   + RG+AF H+    +    L  ++++I+++   +++   +  +F  P + Y     
Sbjct: 116 FALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMY----- 170

Query: 147 TLWYRPPDVLFG--AKLYTTSIDMWSAGCIFAELA 179
              +  P+ L          S DMWS   +  EL 
Sbjct: 171 APAWVAPEALQKKPEDTNRRSADMWSFAVLLWELV 205

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 93.5 bits (233), Expect = 9e-23
 Identities = 52/170 (30%), Positives = 76/170 (44%), Gaps = 20/170 (11%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG-EIDLDIVKSF 89
            +E  L   LKH NI+ L  V   E  L LV E      L +    L+G  I  DI+ ++
Sbjct: 54  RQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRV---LSGKRIPPDILVNW 110

Query: 90  MYQLLRGLAFCHSRN---VLHRDLKPQNLLINK--------NGELKLADFGLARAFGIPV 138
             Q+ RG+ + H      ++HRDLK  N+LI +        N  LK+ DFGLAR      
Sbjct: 111 AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE--WHR 168

Query: 139 KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
               +      +  P+V+    +++   D+WS G +  EL   G   F G
Sbjct: 169 TTKMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELL-TGEVPFRG 216

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 94.9 bits (236), Expect = 4e-22
 Identities = 54/173 (31%), Positives = 90/173 (52%), Gaps = 11/173 (6%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE-IDLDIVKSF 89
           L+E  ++K+L+H+ +V+LY V+ SE+ + +V E+  +  L  +     G+ + L  +   
Sbjct: 310 LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 368

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL- 148
             Q+  G+A+    N +HRDL+  N+L+ +N   K+ADFGLAR   I    Y+A      
Sbjct: 369 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKF 426

Query: 149 ---WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRI 198
              W  P   L+G   +T   D+WS G +  EL   GR  +PG    + L ++
Sbjct: 427 PIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 94.4 bits (235), Expect = 4e-22
 Identities = 54/173 (31%), Positives = 90/173 (52%), Gaps = 11/173 (6%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE-IDLDIVKSF 89
           L+E  ++K+L+H+ +V+LY V+ SE+ + +V E+  +  L  +     G+ + L  +   
Sbjct: 227 LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 285

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL- 148
             Q+  G+A+    N +HRDL+  N+L+ +N   K+ADFGLAR   I    Y+A      
Sbjct: 286 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKF 343

Query: 149 ---WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRI 198
              W  P   L+G   +T   D+WS G +  EL   GR  +PG    + L ++
Sbjct: 344 PIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 95.0 bits (236), Expect = 4e-22
 Identities = 59/243 (24%), Positives = 102/243 (41%), Gaps = 36/243 (14%)

Query: 37  LLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLR 95
           L+       IV +    H+  KL+ + +  +  DL  Y  S +G      ++ +  +++ 
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH-YHLSQHGVFSEADMRFYAAEIIL 303

Query: 96  GLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDV 155
           GL   H+R V++RDLKP N+L++++G ++++D GLA  F    K   A V T  Y  P+V
Sbjct: 304 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF--SKKKPHASVGTHGYMAPEV 361

Query: 156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNL 215
           L     Y +S D +S GC+  +L   G   F      D+   I +               
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLL-RGHSPFRQHKTKDK-HEIDR-------------MT 406

Query: 216 LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFS 270
           L      P               + + R LL+ LL  +  +R+      A++     +F 
Sbjct: 407 LTMAVELP------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454

Query: 271 DLN 273
            L+
Sbjct: 455 SLD 457

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 91.1 bits (227), Expect = 6e-22
 Identities = 43/181 (23%), Positives = 80/181 (44%), Gaps = 26/181 (14%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           + E  ++ +L H  +V+LY V   +  + LV E  +   L  Y  +  G    + +    
Sbjct: 51  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMC 110

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG-----------IPVK 139
             +  G+A+     V+HRDL  +N L+ +N  +K++DFG+ R               PVK
Sbjct: 111 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK 170

Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLK 196
                    W   P+V   ++ Y++  D+WS G +  E+ + G+  +     S+V + + 
Sbjct: 171 ---------WA-SPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219

Query: 197 R 197
            
Sbjct: 220 T 220

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 91.1 bits (227), Expect = 7e-22
 Identities = 39/179 (21%), Positives = 76/179 (42%), Gaps = 23/179 (12%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
            +E   + +L H  +V+ Y V   E  + +V E+     L  Y  S    ++   +    
Sbjct: 51  FQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMC 110

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG-----------IPVK 139
           Y +  G+AF  S   +HRDL  +N L++++  +K++DFG+ R               PVK
Sbjct: 111 YDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK 170

Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRI 198
                    W  P    +    Y++  D+W+ G +  E+ + G+  +      + + ++
Sbjct: 171 ---------WSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 91.4 bits (227), Expect = 1e-21
 Identities = 48/190 (25%), Positives = 76/190 (40%), Gaps = 31/190 (16%)

Query: 33  REICLLKELKHKNIVRLY-----DVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIV 86
           + I  +  ++H NI R              +  LV E+     L KY        D    
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--LHTSDWVSS 113

Query: 87  KSFMYQLLRGLAFCHS---------RNVLHRDLKPQNLLINKNGELKLADFGLARAF--- 134
               + + RGLA+ H+           + HRDL  +N+L+  +G   ++DFGL+      
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 135 -----GIPVKCYSAEVVTLWYRPPDVLFGA------KLYTTSIDMWSAGCIFAELANAGR 183
                G       +EV T+ Y  P+VL GA      +     +DM++ G I+ E+     
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 184 PLFPGSDVDD 193
            LFPG  V +
Sbjct: 234 DLFPGESVPE 243

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 93.4 bits (232), Expect = 1e-21
 Identities = 48/179 (26%), Positives = 85/179 (47%), Gaps = 24/179 (13%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           L+E   +++  H +IV+L  V+ +E  + ++ E C   +L+ +       +DL  +  + 
Sbjct: 439 LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG-----------IPVK 139
           YQL   LA+  S+  +HRD+  +N+L++ N  +KL DFGL+R              +P+K
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557

Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRI 198
                    W  P  + F    +T++ D+W  G    E+   G   F G   +D + RI
Sbjct: 558 ---------WMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 93.1 bits (231), Expect = 1e-21
 Identities = 48/191 (25%), Positives = 85/191 (44%), Gaps = 11/191 (5%)

Query: 15  AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY 73
           AIK       +      +RE  ++ +L +  IVRL  V    + L LV E      L K+
Sbjct: 367 AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKF 425

Query: 74  FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARA 133
                 EI +  V   ++Q+  G+ +   +N +HR+L  +N+L+      K++DFGL++A
Sbjct: 426 LVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA 485

Query: 134 FGIPVKCYSAEVVTL----WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG- 188
            G     Y+A         WY P  + F    +++  D+WS G    E  + G+  +   
Sbjct: 486 LGADDSYYTARSAGKWPLKWYAPECINFRK--FSSRSDVWSYGVTMWEALSYGQKPYKKM 543

Query: 189 --SDVDDQLKR 197
              +V   +++
Sbjct: 544 KGPEVMAFIEQ 554

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 91.5 bits (228), Expect = 2e-21
 Identities = 69/279 (24%), Positives = 112/279 (40%), Gaps = 83/279 (29%)

Query: 34  EICLLKELKHKNIVRLYDVLH--SEKK-LTLVFEH--------CDQDLKK-YF--DSLNG 79
           +   +K LK   ++   DV     EK+ L+L +EH          Q  +  +F  + LNG
Sbjct: 43  QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNG 102

Query: 80  EIDLDIVKSFMYQLLR------------------GLAFCHSRNVLHRDLKPQNLLINKNG 121
             DL      MY +                    GL F HS+ +++RDLK  N+L++K+G
Sbjct: 103 G-DL------MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG 155

Query: 122 ELKLADFGLARAFGIPVK------CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIF 175
            +K+ADFG+ +   +         C + +     Y  P++L G + Y  S+D WS G + 
Sbjct: 156 HIKIADFGMCKE-NMLGDAKTNTFCGTPD-----YIAPEILLG-QKYNHSVDWWSFGVLL 208

Query: 176 AELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA 235
            E+   G+  F G D ++    I                   D   +P            
Sbjct: 209 YEML-IGQSPFHGQDEEELFHSI-----------------RMDNPFYP------------ 238

Query: 236 PKLTAKGRDLLQRLLVCNPVQRM-SAEDAMSHIYFSDLN 273
             L  + +DLL +L V  P +R+    D   H  F ++N
Sbjct: 239 RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 90.4 bits (225), Expect = 2e-21
 Identities = 36/179 (20%), Positives = 76/179 (42%), Gaps = 23/179 (12%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           + E  ++  L H+ +V+LY V   ++ + ++ E+     L  Y   +        +    
Sbjct: 67  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 126

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG-----------IPVK 139
             +   + +  S+  LHRDL  +N L+N  G +K++DFGL+R               PV+
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 186

Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRI 198
                    W  P  +++    +++  D+W+ G +  E+ + G+  +      +  + I
Sbjct: 187 ---------WSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 91.3 bits (227), Expect = 2e-21
 Identities = 46/169 (27%), Positives = 69/169 (40%), Gaps = 24/169 (14%)

Query: 33  REICLLKELKHKNIVRLY----DVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVK 87
            EI     ++H+NI+           S  +L L+ ++ +   L  Y  S    +D   + 
Sbjct: 80  TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSML 137

Query: 88  SFMYQLLRGLAFCHSRN--------VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK 139
              Y  + GL   H+          + HRDLK +N+L+ KNG   +AD GLA  F     
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197

Query: 140 CY----SAEVVTLWYRPPDVLFGA-----KLYTTSIDMWSAGCIFAELA 179
                 +  V T  Y PP+VL  +            DM+S G I  E+A
Sbjct: 198 EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 90.5 bits (225), Expect = 2e-21
 Identities = 43/170 (25%), Positives = 68/170 (40%), Gaps = 26/170 (15%)

Query: 33  REICLLKELKHKNIVRLY----DVLHSEKKLTLVFEHCDQ-DLKKYFDSL-NGEIDLDIV 86
            E+     L+H+NI+          HS  +L L+  + +   L  Y   L    +D    
Sbjct: 51  TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDY---LQLTTLDTVSC 107

Query: 87  KSFMYQLLRGLAFCHSR--------NVLHRDLKPQNLLINKNGELKLADFGLAR----AF 134
              +  +  GLA  H           + HRDLK +N+L+ KNG+  +AD GLA     + 
Sbjct: 108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 167

Query: 135 GIPVKCYSAEVVTLWYRPPDVL-----FGAKLYTTSIDMWSAGCIFAELA 179
                  +  V T  Y  P+VL              +D+W+ G +  E+A
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 90.4 bits (225), Expect = 2e-21
 Identities = 41/174 (23%), Positives = 73/174 (41%), Gaps = 11/174 (6%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           +RE+  +  L H+N++RLY V+     + +V E      L        G   L  +  + 
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 127

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL-- 148
            Q+  G+ +  S+  +HRDL  +NLL+     +K+ DFGL RA       Y  +      
Sbjct: 128 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187

Query: 149 --WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKR 197
             W  P  +      ++ + D W  G    E+   G+  + G   S +  ++ +
Sbjct: 188 FAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 90.4 bits (225), Expect = 3e-21
 Identities = 42/173 (24%), Positives = 76/173 (43%), Gaps = 10/173 (5%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           L E  ++  + + ++ RL  +      + L+ +      L  Y       I    + ++ 
Sbjct: 65  LDEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL-- 148
            Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLA+  G   K Y AE   +  
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183

Query: 149 -WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKR 197
            W     +L    +YT   D+WS G    EL   G   + G   S++   L++
Sbjct: 184 KWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 90.8 bits (226), Expect = 3e-21
 Identities = 53/252 (21%), Positives = 100/252 (39%), Gaps = 53/252 (21%)

Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-----QDLKKYFDSLNGEIDLDIVKS 88
           E  +L+ +    +V+L         L +V E+         L++      G       + 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARF 145

Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--CYSAEVV 146
           +  Q++    + HS ++++RDLKP+NLLI++ G +++ DFG A+         C + E  
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE-- 203

Query: 147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
                 P+++   K Y  ++D W+ G +  E+A AG P F         ++I  + G   
Sbjct: 204 ---ALAPEIILS-KGYNKAVDWWALGVLIYEMA-AGYPPFFADQPIQIYEKI--VSGKVR 256

Query: 207 EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM-----SAE 261
                          FP               ++  +DLL+ LL  +  +R         
Sbjct: 257 ---------------FP------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVN 289

Query: 262 DAMSHIYFSDLN 273
           D  +H +F+  +
Sbjct: 290 DIKNHKWFATTD 301

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 89.2 bits (222), Expect = 4e-21
 Identities = 48/179 (26%), Positives = 85/179 (47%), Gaps = 24/179 (13%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           L+E   +++  H +IV+L  V+ +E  + ++ E C   +L+ +       +DL  +  + 
Sbjct: 64  LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG-----------IPVK 139
           YQL   LA+  S+  +HRD+  +N+L++ N  +KL DFGL+R              +P+K
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 182

Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRI 198
                    W  P  + F    +T++ D+W  G    E+   G   F G   +D + RI
Sbjct: 183 ---------WMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 89.2 bits (222), Expect = 4e-21
 Identities = 46/177 (25%), Positives = 84/177 (47%), Gaps = 21/177 (11%)

Query: 32  LREICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQ-DLKKYFDSLNGE-IDLDIVKS 88
           L E  ++ +L+H N+V+L  V +  +  L +V E+  +  L  Y  S     +  D +  
Sbjct: 62  LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 121

Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR-----AFG--IPVKCY 141
           F   +   + +    N +HRDL  +N+L++++   K++DFGL +          +PVK  
Sbjct: 122 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-- 179

Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRI 198
                  W   P+ L   K ++T  D+WS G +  E+ + GR  +P   + D + R+
Sbjct: 180 -------WT-APEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 90.5 bits (225), Expect = 4e-21
 Identities = 41/181 (22%), Positives = 78/181 (43%), Gaps = 25/181 (13%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           L E  ++ +  H NI+RL  V+   K + +V E+ +   L  +    + +  +  +   +
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG-------------IP 137
             +  G+ +      +HRDL  +N+LIN N   K++DFGL R                IP
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213

Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
           ++         W  P  + +    +T++ D+WS G +  E+ + G   +      D +K 
Sbjct: 214 IR---------WTSPEAIAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA 262

Query: 198 I 198
           +
Sbjct: 263 V 263

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 89.7 bits (223), Expect = 5e-21
 Identities = 38/181 (20%), Positives = 78/181 (43%), Gaps = 25/181 (13%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           L E  ++ +  H NI+RL  V+   +   +V E+ +   L  +  + +G+  +  +   +
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGML 157

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG-------------IP 137
             +  G+ +      +HRDL  +N+L++ N   K++DFGL+R                IP
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP 217

Query: 138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKR 197
           ++         W  P  + F    ++++ D+WS G +  E+   G   +      D +  
Sbjct: 218 IR---------WTAPEAIAFRT--FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS 266

Query: 198 I 198
           +
Sbjct: 267 V 267

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 91.3 bits (227), Expect = 5e-21
 Identities = 46/177 (25%), Positives = 84/177 (47%), Gaps = 21/177 (11%)

Query: 32  LREICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQ-DLKKYFDSLNGE-IDLDIVKS 88
           L E  ++ +L+H N+V+L  V +  +  L +V E+  +  L  Y  S     +  D +  
Sbjct: 234 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 293

Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR-----AFG--IPVKCY 141
           F   +   + +    N +HRDL  +N+L++++   K++DFGL +          +PVK  
Sbjct: 294 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-- 351

Query: 142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRI 198
                  W   P+ L   K ++T  D+WS G +  E+ + GR  +P   + D + R+
Sbjct: 352 -------WT-APEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 89.0 bits (221), Expect = 9e-21
 Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 9/154 (5%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKK--LTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKS 88
            REI +LK L+H NIV+   V +S  +  L L+ E+     L+ Y       ID   +  
Sbjct: 90  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 149

Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL 148
           +  Q+ +G+ +  ++  +HRDL  +N+L+     +K+ DFGL +      + Y  +    
Sbjct: 150 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE 209

Query: 149 ----WYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
               WY  P+ L  +K ++ + D+WS G +  EL
Sbjct: 210 SPIFWY-APESLTESK-FSVASDVWSFGVVLYEL 241

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 88.1 bits (219), Expect = 1e-20
 Identities = 39/148 (26%), Positives = 72/148 (48%), Gaps = 9/148 (6%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKK--LTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKS 88
            +EI +L+ L H+NIV+   +   +    + L+ E      LK+Y      +I+L     
Sbjct: 71  KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK 130

Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL 148
           +  Q+ +G+ +  SR  +HRDL  +N+L+    ++K+ DFGL +A     + Y+ +    
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190

Query: 149 ----WYRPPDVLFGAKLYTTSIDMWSAG 172
               WY P  ++     +  + D+WS G
Sbjct: 191 SPVFWYAPECLMQSK--FYIASDVWSFG 216

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 87.7 bits (218), Expect = 2e-20
 Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 9/154 (5%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKK--LTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKS 88
            REI +LK L+H NIV+   V +S  +  L L+ E+     L+ Y       ID   +  
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118

Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL 148
           +  Q+ +G+ +  ++  +HRDL  +N+L+     +K+ DFGL +      + +  +    
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178

Query: 149 ----WYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
               WY  P+ L  +K ++ + D+WS G +  EL
Sbjct: 179 SPIFWY-APESLTESK-FSVASDVWSFGVVLYEL 210

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 88.1 bits (219), Expect = 2e-20
 Identities = 41/182 (22%), Positives = 76/182 (41%), Gaps = 28/182 (15%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
              +  +  L H +IVRL  +      L LV ++     L  +     G +   ++ ++ 
Sbjct: 63  TDHMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG 121

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG------------IPV 138
            Q+ +G+ +     ++HR+L  +N+L+    ++++ADFG+A                 P+
Sbjct: 122 VQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 181

Query: 139 KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQL 195
           K         W     + FG   YT   D+WS G    EL   G   + G   ++V D L
Sbjct: 182 K---------WMALESIHFG--KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230

Query: 196 KR 197
           ++
Sbjct: 231 EK 232

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 87.3 bits (217), Expect = 2e-20
 Identities = 45/183 (24%), Positives = 79/183 (43%), Gaps = 27/183 (14%)

Query: 32  LREICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSF 89
           L E  ++K+  H N++ L  + L SE    +V  +    DL+ +  +      +  +  F
Sbjct: 74  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 133

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR---------AFG----- 135
             Q+ +G+ +  S+  +HRDL  +N ++++   +K+ADFGLAR                 
Sbjct: 134 GLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193

Query: 136 IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL 195
           +PVK         W     +      +TT  D+WS G +  EL   G P +P  +  D  
Sbjct: 194 LPVK---------WMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 242

Query: 196 KRI 198
             +
Sbjct: 243 VYL 245

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 86.9 bits (216), Expect = 3e-20
 Identities = 52/182 (28%), Positives = 92/182 (50%), Gaps = 28/182 (15%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG-EIDLDIVKSF 89
           L E  L+K+L+H+ +VRLY V+ +++ + ++ E+ +   L  +  + +G ++ ++ +   
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG-----------IPV 138
             Q+  G+AF   RN +HRDL+  N+L++     K+ADFGLAR               P+
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 174

Query: 139 KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQL 195
           K         W  P  + +G   +T   D+WS G +  E+   GR  +PG    +V   L
Sbjct: 175 K---------WTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223

Query: 196 KR 197
           +R
Sbjct: 224 ER 225

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 86.9 bits (216), Expect = 3e-20
 Identities = 46/174 (26%), Positives = 81/174 (46%), Gaps = 11/174 (6%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           +RE  ++ +L +  IVRL  V    + L LV E      L K+      EI +  V   +
Sbjct: 58  MREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 116

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL-- 148
           +Q+  G+ +   +N +HRDL  +N+L+      K++DFGL++A G     Y+A       
Sbjct: 117 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 176

Query: 149 --WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKR 197
             WY P  + F    +++  D+WS G    E  + G+  +      +V   +++
Sbjct: 177 LKWYAPECINFRK--FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 86.9 bits (216), Expect = 3e-20
 Identities = 43/174 (24%), Positives = 81/174 (46%), Gaps = 12/174 (6%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           L E  ++++L +  IVR+  +    +   LV E  +   L KY    N  +    +   +
Sbjct: 66  LAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELV 123

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL-- 148
           +Q+  G+ +    N +HRDL  +N+L+      K++DFGL++A       Y A+      
Sbjct: 124 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 183

Query: 149 --WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKR 197
             WY P  + +    +++  D+WS G +  E  + G+  + G   S+V   L++
Sbjct: 184 VKWYAPECINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 235

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 87.5 bits (217), Expect = 4e-20
 Identities = 41/169 (24%), Positives = 67/169 (39%), Gaps = 24/169 (14%)

Query: 33  REICLLKELKHKNIVRLY----DVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVK 87
            EI     L+H+NI+           +  +L LV ++ +   L  Y +     + ++ + 
Sbjct: 85  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMI 142

Query: 88  SFMYQLLRGLAFCHSR--------NVLHRDLKPQNLLINKNGELKLADFGLARAF----G 135
                   GLA  H           + HRDLK +N+L+ KNG   +AD GLA        
Sbjct: 143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202

Query: 136 IPVKCYSAEVVTLWYRPPDVLFGA-----KLYTTSIDMWSAGCIFAELA 179
                 +  V T  Y  P+VL  +            D+++ G +F E+A
Sbjct: 203 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 88.6 bits (220), Expect = 4e-20
 Identities = 53/182 (29%), Positives = 87/182 (47%), Gaps = 28/182 (15%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE-IDLDIVKSF 89
           L E  ++K L+H  +V+L+ V+ +++ + ++ E   +  L  +  S  G    L  +  F
Sbjct: 231 LAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 289

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG-----------IPV 138
             Q+  G+AF   RN +HRDL+  N+L++ +   K+ADFGLAR               P+
Sbjct: 290 SAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI 349

Query: 139 KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQL 195
           K         W  P  + FG   +T   D+WS G +  E+   GR  +PG    +V   L
Sbjct: 350 K---------WTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398

Query: 196 KR 197
           +R
Sbjct: 399 ER 400

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 87.2 bits (217), Expect = 4e-20
 Identities = 67/271 (24%), Positives = 112/271 (41%), Gaps = 67/271 (24%)

Query: 34  EICLLKELKHKNIVRLYDVLH--SEKKLTLVFEH--------CDQDLKK-YF--DSLNG- 79
               +K LK + +VRL  V H   E+ +  +  H          QD ++ +   D + G 
Sbjct: 32  RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGG 91

Query: 80  EI----------DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFG 129
           E+             + K +  ++   L + HS+++++RDLKP+N+L++KNG +K+ DFG
Sbjct: 92  ELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFG 151

Query: 130 LARAFGIPVK--CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFP 187
            A+         C + +     Y  P+V+   K Y  SID WS G +  E+  AG   F 
Sbjct: 152 FAKYVPDVTYTLCGTPD-----YIAPEVVST-KPYNKSIDWWSFGILIYEML-AGYTPFY 204

Query: 188 GSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQ 247
            S+     ++I  L                    FP            P      +DLL 
Sbjct: 205 DSNTMKTYEKI--LNAELR---------------FP------------PFFNEDVKDLLS 235

Query: 248 RLLVCNPVQRM-----SAEDAMSHIYFSDLN 273
           RL+  +  QR+       ED  +H +F ++ 
Sbjct: 236 RLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 87.4 bits (217), Expect = 4e-20
 Identities = 47/212 (22%), Positives = 87/212 (41%), Gaps = 33/212 (15%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSA----LREICLLKELKHKNIVRLYDVLHSEKKLT 60
                    +AIK        G         L E  ++ +  H NI+RL  V+   K + 
Sbjct: 67  TSSGKKEVPVAIK----TLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122

Query: 61  LVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK 119
           ++ E+ +   L K+    +GE  +  +   +  +  G+ +  + N +HRDL  +N+L+N 
Sbjct: 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS 182

Query: 120 NGELKLADFGLARAFG-------------IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSI 166
           N   K++DFGL+R                IP++         W  P  + +    +T++ 
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR---------WTAPEAISYRK--FTSAS 231

Query: 167 DMWSAGCIFAELANAGRPLFPGSDVDDQLKRI 198
           D+WS G +  E+   G   +      + +K I
Sbjct: 232 DVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 87.3 bits (217), Expect = 5e-20
 Identities = 46/194 (23%), Positives = 84/194 (43%), Gaps = 43/194 (22%)

Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVKCYS----AEV 145
           +++  L   H   +++RD+K +N+L++ NG + L DFGL++ F      + Y      E 
Sbjct: 167 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE- 225

Query: 146 VTLWYRPPDVLFGAKL-YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGT 204
               Y  PD++ G    +  ++D WS G +  EL   G   F      +    I +    
Sbjct: 226 ----YMAPDIVRGGDSGHDKAVDWWSLGVLMYELL-TGASPFTVDGEKNSQAEISR---- 276

Query: 205 PTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM-----S 259
                     +L    P+P              ++A  +DL+QRLL+ +P +R+      
Sbjct: 277 ---------RILKSEPPYPQE------------MSALAKDLIQRLLMKDPKKRLGCGPRD 315

Query: 260 AEDAMSHIYFSDLN 273
           A++   H++F  +N
Sbjct: 316 ADEIKEHLFFQKIN 329

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 87.3 bits (217), Expect = 5e-20
 Identities = 58/282 (20%), Positives = 110/282 (39%), Gaps = 85/282 (30%)

Query: 34  EICLLKELKHKNIVRLYDVLH--SEKK-LTLVFEH--------CDQDLKK-YF--DSLNG 79
           E+  +K LK   +++  DV     EK+ L L  +         C Q + + YF  + +NG
Sbjct: 46  ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 105

Query: 80  EIDLDIVKSFMYQLLR------------------GLAFCHSRNVLHRDLKPQNLLINKNG 121
             DL      MY + +                  GL F  S+ +++RDLK  N++++  G
Sbjct: 106 -GDL------MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG 158

Query: 122 ELKLADFGLARAFGIPVK-----CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFA 176
            +K+ADFG+ +            C + +     Y  P+++   + Y  S+D W+ G +  
Sbjct: 159 HIKIADFGMCKENIWDGVTTKTFCGTPD-----YIAPEIIAY-QPYGKSVDWWAFGVLLY 212

Query: 177 ELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP 236
           E+  AG+  F G D D+  + I                 +     +P             
Sbjct: 213 EML-AGQAPFEGEDEDELFQSI-----------------MEHNVAYPKS----------- 243

Query: 237 KLTAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLN 273
            ++ +   + + L+  +P +R+        D   H +F  ++
Sbjct: 244 -MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 284

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 87.0 bits (216), Expect = 5e-20
 Identities = 42/173 (24%), Positives = 76/173 (43%), Gaps = 10/173 (5%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           L E  ++  + + ++ RL  +      + L+ +      L  Y       I    + ++ 
Sbjct: 65  LDEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL-- 148
            Q+ +G+ +   R ++HRDL  +N+L+     +K+ DFGLA+  G   K Y AE   +  
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183

Query: 149 -WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLKR 197
            W     +L    +YT   D+WS G    EL   G   + G   S++   L++
Sbjct: 184 KWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 87.0 bits (216), Expect = 5e-20
 Identities = 42/154 (27%), Positives = 69/154 (44%), Gaps = 9/154 (5%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKK--LTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKS 88
            REI +LK L    IV+   V +   +  L LV E+     L+ +       +D   +  
Sbjct: 72  QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 131

Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTL 148
           +  Q+ +G+ +  SR  +HRDL  +N+L+     +K+ADFGLA+   +    Y       
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191

Query: 149 ----WYRPPDVLFGAKLYTTSIDMWSAGCIFAEL 178
               WY P  +      ++   D+WS G +  EL
Sbjct: 192 SPIFWYAPESLSDNI--FSRQSDVWSFGVVLYEL 223

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 88.2 bits (218), Expect = 8e-20
 Identities = 58/282 (20%), Positives = 110/282 (39%), Gaps = 85/282 (30%)

Query: 34  EICLLKELKHKNIVRLYDVLH--SEKK-LTLVFEH--------CDQDLKK-YF--DSLNG 79
           E+  +K LK   +++  DV     EK+ L L  +         C Q + + YF  + +NG
Sbjct: 367 ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 426

Query: 80  EIDLDIVKSFMYQLLR------------------GLAFCHSRNVLHRDLKPQNLLINKNG 121
             DL      MY + +                  GL F  S+ +++RDLK  N++++  G
Sbjct: 427 -GDL------MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG 479

Query: 122 ELKLADFGLARAFGIPVK-----CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFA 176
            +K+ADFG+ +            C + +     Y  P+++   + Y  S+D W+ G +  
Sbjct: 480 HIKIADFGMCKENIWDGVTTKTFCGTPD-----YIAPEIIAY-QPYGKSVDWWAFGVLLY 533

Query: 177 ELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP 236
           E+  AG+  F G D D+  + I                 +     +P             
Sbjct: 534 EML-AGQAPFEGEDEDELFQSI-----------------MEHNVAYPKS----------- 564

Query: 237 KLTAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLN 273
            ++ +   + + L+  +P +R+        D   H +F  ++
Sbjct: 565 -MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 86.1 bits (214), Expect = 1e-19
 Identities = 60/255 (23%), Positives = 101/255 (39%), Gaps = 64/255 (25%)

Query: 38  LKELKHKNIVRLYDVLHSEKKLTLV---------FEHCDQDLKKYFDSLNGEIDLDIVKS 88
           L+E+KH  IV L     +  KL L+         F   +++         G    D    
Sbjct: 75  LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE---------GIFMEDTACF 125

Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-----CYSA 143
           ++ ++   L   H + +++RDLKP+N+++N  G +KL DFGL +            C + 
Sbjct: 126 YLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTI 185

Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
           E     Y  P++L     +  ++D WS G +  ++   G P F G +    + +I     
Sbjct: 186 E-----YMAPEILMR-SGHNRAVDWWSLGALMYDML-TGAPPFTGENRKKTIDKI----- 233

Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM----- 258
                       L      P Y            LT + RDLL++LL  N   R+     
Sbjct: 234 ------------LKCKLNLPPY------------LTQEARDLLKKLLKRNAASRLGAGPG 269

Query: 259 SAEDAMSHIYFSDLN 273
            A +  +H +F  +N
Sbjct: 270 DAGEVQAHPFFRHIN 284

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 86.1 bits (214), Expect = 1e-19
 Identities = 51/193 (26%), Positives = 85/193 (44%), Gaps = 48/193 (24%)

Query: 92  QLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK------CYSAEV 145
           +++  L + HSR+V++RD+K +NL+++K+G +K+ DFGL +  GI         C + E 
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPE- 170

Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
               Y  P+VL     Y  ++D W  G +  E+   GR  F   D +   + I       
Sbjct: 171 ----YLAPEVLEDND-YGRAVDWWGLGVVMYEMM-CGRLPFYNQDHERLFELI------- 217

Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM-----SA 260
                     L +   FP              L+ + + LL  LL  +P QR+      A
Sbjct: 218 ----------LMEEIRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDA 255

Query: 261 EDAMSHIYFSDLN 273
           ++ M H +F  +N
Sbjct: 256 KEVMEHRFFLSIN 268

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 85.9 bits (213), Expect = 1e-19
 Identities = 46/174 (26%), Positives = 73/174 (41%), Gaps = 25/174 (14%)

Query: 33  REICLLKELKHKNIVRLY----DVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE-IDLDIV 86
            E+  L  +KH+NI++           +  L L+    ++  L    D L    +  + +
Sbjct: 67  YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSL---SDFLKANVVSWNEL 123

Query: 87  KSFMYQLLRGLAFCHSR----------NVLHRDLKPQNLLINKNGELKLADFGLARAF-- 134
                 + RGLA+ H             + HRD+K +N+L+  N    +ADFGLA  F  
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183

Query: 135 GIPVKCYSAEVVTLWYRPPDVLFGA----KLYTTSIDMWSAGCIFAELANAGRP 184
           G        +V T  Y  P+VL GA    +     IDM++ G +  ELA+    
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 85.4 bits (212), Expect = 1e-19
 Identities = 37/211 (17%), Positives = 70/211 (33%), Gaps = 26/211 (12%)

Query: 3   TSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLV 62
                +   T + +K      +     S      ++ +L HK++V  Y V     +  LV
Sbjct: 32  VGDYGQLHETEVLLK-VLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILV 90

Query: 63  FEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG 121
            E      L  Y       I++        QL   + F     ++H ++  +N+L+ +  
Sbjct: 91  QEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREE 150

Query: 122 EL--------KLADFGLARAFG------IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSID 167
           +         KL+D G++            +          W  PP+ +   K    + D
Sbjct: 151 DRKTGNPPFIKLSDPGISITVLPKDILQERIP---------WV-PPECIENPKNLNLATD 200

Query: 168 MWSAGCIFAELANAGRPLFPGSDVDDQLKRI 198
            WS G    E+ + G       D   +L+  
Sbjct: 201 KWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 85.0 bits (211), Expect = 2e-19
 Identities = 50/205 (24%), Positives = 84/205 (40%), Gaps = 27/205 (13%)

Query: 10  PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQ 68
                AIK    +       + LRE  L++ L H N++ L  + L  E    ++  +   
Sbjct: 48  NRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCH 107

Query: 69  -DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLAD 127
            DL ++  S      +  + SF  Q+ RG+ +   +  +HRDL  +N +++++  +K+AD
Sbjct: 108 GDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVAD 167

Query: 128 FGLAR--------------AFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           FGLAR                 +PVK         W     +      +TT  D+WS G 
Sbjct: 168 FGLARDILDREYYSVQQHRHARLPVK---------WTALESLQTY--RFTTKSDVWSFGV 216

Query: 174 IFAELANAGRPLFPGSDVDDQLKRI 198
           +  EL   G P +   D  D    +
Sbjct: 217 LLWELLTRGAPPYRHIDPFDLTHFL 241

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 84.9 bits (211), Expect = 2e-19
 Identities = 42/181 (23%), Positives = 80/181 (44%), Gaps = 27/181 (14%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           + E  ++K L H +IV+L  ++  E+   ++ E     +L  Y +     + +  +  + 
Sbjct: 61  MSEAVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS 119

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG-----------IPVK 139
            Q+ + +A+  S N +HRD+  +N+L+     +KL DFGL+R              +P+K
Sbjct: 120 LQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK 179

Query: 140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG---SDVDDQLK 196
                    W  P  + F    +TT+ D+W       E+ + G+  F      DV   L+
Sbjct: 180 ---------WMSPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 228

Query: 197 R 197
           +
Sbjct: 229 K 229

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 86.2 bits (214), Expect = 2e-19
 Identities = 67/283 (23%), Positives = 104/283 (36%), Gaps = 86/283 (30%)

Query: 33  REICLLKELKHKNIVRLYDVLH--SEKK-LTLVFEH--------CDQDLKK-YF--DSLN 78
                +K L+ K I++  +  H  SE+  L    +H          Q   K YF  D +N
Sbjct: 63  EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 122

Query: 79  GEIDLDIVKSFMYQLLR------------------GLAFCHSRNVLHRDLKPQNLLINKN 120
           G  +L       Y L R                   L + HS N+++RDLKP+N+L++  
Sbjct: 123 GG-EL------FYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ 175

Query: 121 GELKLADFGLARAFGIPVK------CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCI 174
           G + L DFGL +   I         C + E     Y  P+VL   + Y  ++D W  G +
Sbjct: 176 GHIVLTDFGLCKE-NIEHNSTTSTFCGTPE-----YLAPEVLHK-QPYDRTVDWWCLGAV 228

Query: 175 FAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV 234
             E+   G P F   +  +    I                 L                  
Sbjct: 229 LYEML-YGLPPFYSRNTAEMYDNI-----------------LNKPLQLK----------- 259

Query: 235 APKLTAKGRDLLQRLLVCNPVQRM----SAEDAMSHIYFSDLN 273
            P +T   R LL+ LL  +  +R+       +  SH++FS +N
Sbjct: 260 -PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 85.7 bits (213), Expect = 2e-19
 Identities = 58/276 (21%), Positives = 106/276 (38%), Gaps = 72/276 (26%)

Query: 34  EICLLKELKHKNIVRLYDVLH--SEKK-LTLVFEH--------CDQDLKK-YF--DSLNG 79
           ++  +K LK   I++  DV    +EK+ L+L   H        C Q   + +F  + +NG
Sbjct: 49  DLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNG 108

Query: 80  -----------EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADF 128
                        D    + +  +++  L F H + +++RDLK  N+L++  G  KLADF
Sbjct: 109 GDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADF 168

Query: 129 GLARAFGIPVK-----CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           G+ +            C + +     Y  P++L    LY  ++D W+ G +  E+   G 
Sbjct: 169 GMCKEGICNGVTTATFCGTPD-----YIAPEILQE-MLYGPAVDWWAMGVLLYEML-CGH 221

Query: 184 PLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGR 243
             F   + DD  + I                 L D   +P +            L     
Sbjct: 222 APFEAENEDDLFEAI-----------------LNDEVVYPTW------------LHEDAT 252

Query: 244 DLLQRLLVCNPVQRM------SAEDAMSHIYFSDLN 273
            +L+  +  NP  R+           + H +F +++
Sbjct: 253 GILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 84.9 bits (211), Expect = 3e-19
 Identities = 64/255 (25%), Positives = 103/255 (40%), Gaps = 64/255 (25%)

Query: 38  LKELKHKNIVRLYDVLHSEKKLTLV---------FEHCDQDLKKYFDSLNGEIDLDIVKS 88
           L E+ H  IV+L+    +E KL L+         F      L K           + VK 
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTR----LSK-----EVMFTEEDVKF 130

Query: 89  FMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-----CYSA 143
           ++ +L   L   HS  +++RDLKP+N+L+++ G +KL DFGL++      K     C + 
Sbjct: 131 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190

Query: 144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLG 203
           E     Y  P+V+   + +T S D WS G +  E+   G   F G D  + +  I     
Sbjct: 191 E-----YMAPEVVNR-RGHTQSADWWSFGVLMFEML-TGTLPFQGKDRKETMTMI----- 238

Query: 204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM----- 258
                       L      P +            L+ + + LL+ L   NP  R+     
Sbjct: 239 ------------LKAKLGMPQF------------LSPEAQSLLRMLFKRNPANRLGAGPD 274

Query: 259 SAEDAMSHIYFSDLN 273
             E+   H +FS ++
Sbjct: 275 GVEEIKRHSFFSTID 289

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 85.6 bits (212), Expect = 3e-19
 Identities = 46/183 (25%), Positives = 79/183 (43%), Gaps = 27/183 (14%)

Query: 32  LREICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSF 89
           L E  ++K+  H N++ L  + L SE    +V  +    DL+ +  +      +  +  F
Sbjct: 138 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 197

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG-------------- 135
             Q+ +G+ F  S+  +HRDL  +N ++++   +K+ADFGLAR                 
Sbjct: 198 GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 257

Query: 136 IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL 195
           +PVK         W     +      +TT  D+WS G +  EL   G P +P  +  D  
Sbjct: 258 LPVK---------WMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 306

Query: 196 KRI 198
             +
Sbjct: 307 VYL 309

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 84.3 bits (209), Expect = 4e-19
 Identities = 41/189 (21%), Positives = 78/189 (41%), Gaps = 33/189 (17%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY---------FDSLNGEI 81
           L E  ++KE    ++VRL  V+   +   ++ E   + DLK Y          + +    
Sbjct: 76  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 135

Query: 82  DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY 141
            L  +     ++  G+A+ ++   +HRDL  +N ++ ++  +K+ DFG+ R        Y
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR------DIY 189

Query: 142 SAEVVTLWYR------------PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGS 189
             +     YR             P+ L     +TT  D+WS G +  E+A      + G 
Sbjct: 190 ETDY----YRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGL 244

Query: 190 DVDDQLKRI 198
             +  L+ +
Sbjct: 245 SNEQVLRFV 253

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 84.8 bits (210), Expect = 8e-19
 Identities = 61/253 (24%), Positives = 105/253 (41%), Gaps = 43/253 (16%)

Query: 30  SALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKS 88
             L E  +L+  +H  +  L     +  +L  V E+ +  +L   F  L+ E      ++
Sbjct: 194 HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRA 250

Query: 89  FMY--QLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEV 145
             Y  +++  L + HS +NV++RDLK +NL+++K+G +K+ DFGL +             
Sbjct: 251 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 310

Query: 146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP 205
            T  Y  P+VL     Y  ++D W  G +  E+   GR  F   D +   + I       
Sbjct: 311 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMM-CGRLPFYNQDHEKLFELI------- 361

Query: 206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRM-----SA 260
                     L +   FP              L  + + LL  LL  +P QR+      A
Sbjct: 362 ----------LMEEIRFPRT------------LGPEAKSLLSGLLKKDPKQRLGGGSEDA 399

Query: 261 EDAMSHIYFSDLN 273
           ++ M H +F+ + 
Sbjct: 400 KEIMQHRFFAGIV 412

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 81.6 bits (202), Expect = 4e-18
 Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 13/149 (8%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKK--LTLVFEHCDQ-DLKKYFDSLNG-EIDLDIVK 87
            +EI +L+ L H++I++            L LV E+     L+ Y   L    I L  + 
Sbjct: 81  KQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDY---LPRHSIGLAQLL 137

Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT 147
            F  Q+  G+A+ H+++ +HRDL  +N+L++ +  +K+ DFGLA+A     + Y      
Sbjct: 138 LFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 197

Query: 148 L----WYRPPDVLFGAKLYTTSIDMWSAG 172
                WY P  +      +  + D+WS G
Sbjct: 198 DSPVFWYAPECLKEYK--FYYASDVWSFG 224

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 79.8 bits (197), Expect = 1e-17
 Identities = 32/260 (12%), Positives = 64/260 (24%), Gaps = 57/260 (21%)

Query: 5   GVDRTPNTALAIK--GTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLV 62
            +D   +  +A+       V  + V    L     L  +    + R+ DV+H+     +V
Sbjct: 50  ALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109

Query: 63  FEHCD-QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG 121
            E      L+   +  +           M  L       H   V      P  + ++ +G
Sbjct: 110 AEWIRGGSLQ---EVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG 166

Query: 122 ELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANA 181
           ++ LA                         P              D+   G     L   
Sbjct: 167 DVVLAYPA--------------------TMPDA--------NPQDDIRGIGASLYALL-V 197

Query: 182 GRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAK 241
            R   P + V   L    +                      P        + +   +  +
Sbjct: 198 NRWPLPEAGVRSGLAPAERDTAGQP--------------IEP--------ADIDRDIPFQ 235

Query: 242 GRDLLQRLLVCNPVQRMSAE 261
              +  R +  +   R ++ 
Sbjct: 236 ISAVAARSVQGDGGIRSAST 255

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 79.7 bits (197), Expect = 2e-17
 Identities = 41/191 (21%), Positives = 72/191 (37%), Gaps = 35/191 (18%)

Query: 32  LREICLLKELKHKNIVRLYDV------LHSEKKLTLVFEHCDQ-DLKKY-----FDSLNG 79
           LRE   +KE  H ++ +L  V              ++       DL  +           
Sbjct: 73  LREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132

Query: 80  EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG---- 135
            + L  +  FM  +  G+ +  SRN +HRDL  +N ++ ++  + +ADFGL+R       
Sbjct: 133 NLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192

Query: 136 --------IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFP 187
                   +PVK         W     +     LYT   D+W+ G    E+   G+  + 
Sbjct: 193 YRQGCASKLPVK---------WLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYA 241

Query: 188 GSDVDDQLKRI 198
           G +  +    +
Sbjct: 242 GIENAEIYNYL 252

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 78.8 bits (195), Expect = 4e-17
 Identities = 46/194 (23%), Positives = 82/194 (42%), Gaps = 41/194 (21%)

Query: 32  LREICLLKEL-KHKNIVRLYDV-LHSEKKLTLVFEHCDQ-DLKKY--------------- 73
           + E+ +L  +  H N+V L          L ++ E C   +L  Y               
Sbjct: 78  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137

Query: 74  FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARA 133
            D     + L+ +  + +Q+ +G+ F  SR  +HRDL  +N+L+++   +K+ DFGLAR 
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR- 196

Query: 134 FGIPVKCYSAEVVTLWYR------------PPDVLFGAKLYTTSIDMWSAGCIFAELANA 181
                  Y        Y              P+ +F  ++YT   D+WS G +  E+ + 
Sbjct: 197 -----DIYKDPD----YVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSL 246

Query: 182 GRPLFPGSDVDDQL 195
           G   +PG  +D++ 
Sbjct: 247 GASPYPGVKIDEEF 260

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 78.9 bits (195), Expect = 4e-17
 Identities = 41/189 (21%), Positives = 71/189 (37%), Gaps = 33/189 (17%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY------FDSLNGEIDLD 84
           L E  ++ +  H+NIVR   V        ++ E     DLK +        S    + + 
Sbjct: 81  LMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAML 140

Query: 85  IVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVKCY 141
            +      +  G  +    + +HRD+  +N L+   G     K+ DFG+AR        Y
Sbjct: 141 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIY 194

Query: 142 SAEVVTLWYR------------PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGS 189
            A     +YR            PP+       +T+  D WS G +  E+ + G   +P  
Sbjct: 195 RAS----YYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 249

Query: 190 DVDDQLKRI 198
              + L+ +
Sbjct: 250 SNQEVLEFV 258

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 79.3 bits (196), Expect = 4e-17
 Identities = 48/196 (24%), Positives = 90/196 (45%), Gaps = 40/196 (20%)

Query: 32  LREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY---------------F 74
           + E+ ++K + KHKNI+ L      +  L ++ E+  + +L++Y                
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181

Query: 75  DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF 134
            +   ++    + S  YQ+ RG+ +  S+  +HRDL  +N+L+ ++  +K+ADFGLAR  
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-- 239

Query: 135 GIPVKCYSAEVVTLWYR------------PPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
                 +  +    +Y+             P+ LF    YT   D+WS G +  E+   G
Sbjct: 240 ----DIHHID----YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLG 290

Query: 183 RPLFPGSDVDDQLKRI 198
              +PG  V++  K +
Sbjct: 291 GSPYPGVPVEELFKLL 306

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 78.4 bits (194), Expect = 5e-17
 Identities = 53/195 (27%), Positives = 76/195 (38%), Gaps = 42/195 (21%)

Query: 32  LREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVK-- 87
           + E+ +L  L  H NIV L           ++ E+C   DL  +                
Sbjct: 74  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133

Query: 88  ---------------SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR 132
                          SF YQ+ +G+AF  S+N +HRDL  +N+L+      K+ DFGLAR
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 193

Query: 133 AFG------------IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
                          +PVK         W   P+ +F    YT   D+WS G    EL +
Sbjct: 194 DIKNDSNYVVKGNARLPVK---------WM-APESIFNCV-YTFESDVWSYGIFLWELFS 242

Query: 181 AGRPLFPGSDVDDQL 195
            G   +PG  VD + 
Sbjct: 243 LGSSPYPGMPVDSKF 257

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 79.0 bits (195), Expect = 6e-17
 Identities = 41/189 (21%), Positives = 71/189 (37%), Gaps = 33/189 (17%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY------FDSLNGEIDLD 84
           L E  ++ +  H+NIVR   V        ++ E     DLK +        S    + + 
Sbjct: 122 LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 181

Query: 85  IVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVKCY 141
            +      +  G  +    + +HRD+  +N L+   G     K+ DFG+AR        Y
Sbjct: 182 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIY 235

Query: 142 SAEVVTLWYR------------PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGS 189
            A     +YR            PP+       +T+  D WS G +  E+ + G   +P  
Sbjct: 236 RAG----YYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSK 290

Query: 190 DVDDQLKRI 198
              + L+ +
Sbjct: 291 SNQEVLEFV 299

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 78.5 bits (194), Expect = 6e-17
 Identities = 46/191 (24%), Positives = 78/191 (40%), Gaps = 38/191 (19%)

Query: 32  LREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY-------------FDS 76
           + E+ ++  L +H+NIV L         + ++ E+C   DL  +             F  
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156

Query: 77  LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGI 136
            N       +  F  Q+ +G+AF  S+N +HRD+  +N+L+      K+ DFGLAR    
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR---- 212

Query: 137 PVKCYSAEVVTLWYR------------PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRP 184
                +       Y              P+ +F    YT   D+WS G +  E+ + G  
Sbjct: 213 --DIMNDS----NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLN 265

Query: 185 LFPGSDVDDQL 195
            +PG  V+ + 
Sbjct: 266 PYPGILVNSKF 276

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 77.7 bits (192), Expect = 9e-17
 Identities = 44/190 (23%), Positives = 75/190 (39%), Gaps = 34/190 (17%)

Query: 32  LREICLLKELKHKNIVRLYDV-----LHSEKKLTLVFEHCDQ-DLKKY-----FDSLNGE 80
           L E   +K+  H N++RL  V          K  ++       DL  Y      ++    
Sbjct: 84  LSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKH 143

Query: 81  IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG----- 135
           I L  +  FM  +  G+ +  +RN LHRDL  +N ++  +  + +ADFGL++        
Sbjct: 144 IPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY 203

Query: 136 -------IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG 188
                  +PVK         W     +     +YT+  D+W+ G    E+A  G   +PG
Sbjct: 204 RQGRIAKMPVK---------WIAIESLADR--VYTSKSDVWAFGVTMWEIATRGMTPYPG 252

Query: 189 SDVDDQLKRI 198
               +    +
Sbjct: 253 VQNHEMYDYL 262

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 77.2 bits (191), Expect = 1e-16
 Identities = 36/169 (21%), Positives = 73/169 (43%), Gaps = 39/169 (23%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY---------------FD 75
             E  L   L+H N+V L  V+  ++ L+++F +C   DL ++                 
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119

Query: 76  SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR--- 132
           ++   ++       + Q+  G+ +  S +V+H+DL  +N+L+     +K++D GL R   
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY 179

Query: 133 ------AFG---IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAG 172
                   G   +P++         W  P  +++G   ++   D+WS G
Sbjct: 180 AADYYKLLGNSLLPIR---------WMAPEAIMYG--KFSIDSDIWSYG 217

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 77.3 bits (191), Expect = 1e-16
 Identities = 43/168 (25%), Positives = 74/168 (44%), Gaps = 38/168 (22%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY--------------FDS 76
            RE  LL  L+H++IVR + V    + L +VFE+    DL ++               D 
Sbjct: 91  QREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDV 150

Query: 77  LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR---- 132
             G + L  + +   Q+  G+ +    + +HRDL  +N L+ +   +K+ DFG++R    
Sbjct: 151 APGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 210

Query: 133 -----AFG---IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAG 172
                  G   +P++         W  P  +L+    +TT  D+WS G
Sbjct: 211 TDYYRVGGRTMLPIR---------WMPPESILYR--KFTTESDVWSFG 247

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 77.3 bits (191), Expect = 1e-16
 Identities = 50/196 (25%), Positives = 89/196 (45%), Gaps = 40/196 (20%)

Query: 32  LREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY---------------F 74
           + E+ ++K + KHKNI+ L      +  L ++ E+  + +L++Y                
Sbjct: 88  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147

Query: 75  DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF 134
                ++    + S  YQL RG+ +  S+  +HRDL  +N+L+ +N  +K+ADFGLAR  
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR-- 205

Query: 135 GIPVKCYSAEVVTLWYR------------PPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
                  + +    +Y+             P+ LF    YT   D+WS G +  E+   G
Sbjct: 206 ----DINNID----YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLG 256

Query: 183 RPLFPGSDVDDQLKRI 198
              +PG  V++  K +
Sbjct: 257 GSPYPGIPVEELFKLL 272

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 76.9 bits (190), Expect = 2e-16
 Identities = 47/169 (27%), Positives = 75/169 (44%), Gaps = 39/169 (23%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY---------------FD 75
            RE  LL  L+H++IV+ Y V      L +VFE+    DL K+                 
Sbjct: 65  QREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124

Query: 76  SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR--- 132
              GE+ L  +     Q+  G+ +  S++ +HRDL  +N L+  N  +K+ DFG++R   
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY 184

Query: 133 ------AFG---IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAG 172
                   G   +P++         W  PP+ +   K +TT  D+WS G
Sbjct: 185 STDYYRVGGHTMLPIR---------WM-PPESIMYRK-FTTESDVWSFG 222

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 77.3 bits (191), Expect = 2e-16
 Identities = 59/288 (20%), Positives = 103/288 (35%), Gaps = 87/288 (30%)

Query: 34  EICLLKELKHKNIVRLYDVLH--SEKK-LTLVFEH--------CDQDLKK-YF--DSLNG 79
            I  +K +K + +    D+    +EK        H        C Q   + +F  + +NG
Sbjct: 35  RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 94

Query: 80  EIDLDIVKSFMYQLLR------------------GLAFCHSRNVLHRDLKPQNLLINKNG 121
             DL      M+ + R                   L + H R +++RDLK  N+L++  G
Sbjct: 95  G-DL------MFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG 147

Query: 122 ELKLADFGLARAFGIPVK-----CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFA 176
            +KL D+G+ +    P       C +       Y  P++L G + Y  S+D W+ G +  
Sbjct: 148 HIKLTDYGMCKEGLRPGDTTSTFCGTPN-----YIAPEILRG-EDYGFSVDWWALGVLMF 201

Query: 177 ELANAGRPLFPGSDVDDQL-----KRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSF 231
           E+  AGR  F      D         +F+              +L      P        
Sbjct: 202 EMM-AGRSPFDIVGSSDNPDQNTEDYLFQ-------------VILEKQIRIP-------- 239

Query: 232 SQVAPKLTAKGRDLLQRLLVCNPVQRM------SAEDAMSHIYFSDLN 273
                 L+ K   +L+  L  +P +R+         D   H +F +++
Sbjct: 240 ----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 77.4 bits (191), Expect = 2e-16
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 40/196 (20%)

Query: 32  LREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY-------FDSLNGEID 82
           + E+ ++K + KHKNI+ L      +  L ++ E+  + +L++Y           + +I+
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 193

Query: 83  LDIVK--------SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF 134
               +        S  YQL RG+ +  S+  +HRDL  +N+L+ +N  +K+ADFGLAR  
Sbjct: 194 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR-- 251

Query: 135 GIPVKCYSAEVVTLWYR------------PPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
                  + +     Y+             P+ LF    YT   D+WS G +  E+   G
Sbjct: 252 ----DINNIDY----YKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLG 302

Query: 183 RPLFPGSDVDDQLKRI 198
              +PG  V++  K +
Sbjct: 303 GSPYPGIPVEELFKLL 318

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 77.4 bits (191), Expect = 2e-16
 Identities = 58/288 (20%), Positives = 103/288 (35%), Gaps = 87/288 (30%)

Query: 34  EICLLKELKHKNIVRLYDVLH--SEKK-LTLVFEH--------CDQDLKK-YF--DSLNG 79
            I  ++ +K + +    D+    +EK        H        C Q   + +F  + +NG
Sbjct: 78  RIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 137

Query: 80  EIDLDIVKSFMYQLLR------------------GLAFCHSRNVLHRDLKPQNLLINKNG 121
             DL      M+ + R                   L + H R +++RDLK  N+L++  G
Sbjct: 138 G-DL------MFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG 190

Query: 122 ELKLADFGLARAFGIPVK-----CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFA 176
            +KL D+G+ +    P       C +       Y  P++L G + Y  S+D W+ G +  
Sbjct: 191 HIKLTDYGMCKEGLRPGDTTSTFCGTPN-----YIAPEILRG-EDYGFSVDWWALGVLMF 244

Query: 177 ELANAGRPLFPGSDVDDQL-----KRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSF 231
           E+  AGR  F      D         +F+              +L      P        
Sbjct: 245 EMM-AGRSPFDIVGSSDNPDQNTEDYLFQ-------------VILEKQIRIPRS------ 284

Query: 232 SQVAPKLTAKGRDLLQRLLVCNPVQRM------SAEDAMSHIYFSDLN 273
                 L+ K   +L+  L  +P +R+         D   H +F +++
Sbjct: 285 ------LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 76.5 bits (189), Expect = 3e-16
 Identities = 38/177 (21%), Positives = 73/177 (41%), Gaps = 47/177 (26%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY----------------- 73
           L E  +LK++ H ++++LY     +  L L+ E+     L+ +                 
Sbjct: 74  LSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133

Query: 74  ------FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLAD 127
                        + +  + SF +Q+ +G+ +     ++HRDL  +N+L+ +  ++K++D
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISD 193

Query: 128 FGLARAFGIPVKCYSAEVVTLWYR------------PPDVLFGAKLYTTSIDMWSAG 172
           FGL+R        Y  +     Y               + LF   +YTT  D+WS G
Sbjct: 194 FGLSR------DVYEEDS----YVKRSQGRIPVKWMAIESLF-DHIYTTQSDVWSFG 239

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 76.5 bits (189), Expect = 3e-16
 Identities = 40/167 (23%), Positives = 67/167 (40%), Gaps = 37/167 (22%)

Query: 32  LREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY---------------F 74
             E+ +L +L  H NI+ L         L L  E+    +L  +                
Sbjct: 73  AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 132

Query: 75  DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF 134
           +S    +    +  F   + RG+ +   +  +HRDL  +N+L+ +N   K+ADFGL+R  
Sbjct: 133 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ 192

Query: 135 G---------IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAG 172
                     +PV+         W    + L  +  YTT+ D+WS G
Sbjct: 193 EVYVKKTMGRLPVR---------WM-AIESLNYSV-YTTNSDVWSYG 228

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 75.0 bits (185), Expect = 1e-15
 Identities = 49/200 (24%), Positives = 82/200 (41%), Gaps = 47/200 (23%)

Query: 32  LREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY--------------FD 75
           + E+ ++ +L  H+NIV L         + L+FE+C   DL  Y              ++
Sbjct: 96  MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 155

Query: 76  SLNGEIDLDIVK--------SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLAD 127
           +     + + +          F YQ+ +G+ F   ++ +HRDL  +N+L+     +K+ D
Sbjct: 156 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICD 215

Query: 128 FGLARAFGIPVKCYSAEVVTLWYR------------PPDVLFGAKLYTTSIDMWSAGCIF 175
           FGLAR         S       Y              P+ LF   +YT   D+WS G + 
Sbjct: 216 FGLAR------DIMSDSN----YVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILL 264

Query: 176 AELANAGRPLFPGSDVDDQL 195
            E+ + G   +PG  VD   
Sbjct: 265 WEIFSLGVNPYPGIPVDANF 284

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 73.1 bits (180), Expect = 5e-15
 Identities = 48/177 (27%), Positives = 73/177 (41%), Gaps = 47/177 (26%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY-------FDSLNGEIDL 83
            RE  L+ E  + NIV+L  V    K + L+FE+    DL ++               DL
Sbjct: 98  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157

Query: 84  DIVK----------------SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLAD 127
                                   Q+  G+A+   R  +HRDL  +N L+ +N  +K+AD
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIAD 217

Query: 128 FGLARAFGIPVKCYSAEVVTLWYR------------PPDVLFGAKLYTTSIDMWSAG 172
           FGL+R        YSA+     Y+            PP+ +F  + YTT  D+W+ G
Sbjct: 218 FGLSR------NIYSADY----YKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYG 263

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 66.5 bits (162), Expect = 9e-13
 Identities = 33/120 (27%), Positives = 58/120 (48%), Gaps = 23/120 (19%)

Query: 88  SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG------------ 135
            + +Q+ +G+ F  SR  +HRDL  +N+L+++   +K+ DFGLAR               
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256

Query: 136 IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL 195
           +P+K         W  P  +     +YT   D+WS G +  E+ + G   +PG  +D++ 
Sbjct: 257 LPLK---------WMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 305

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 62.9 bits (153), Expect = 2e-11
 Identities = 31/191 (16%), Positives = 57/191 (29%), Gaps = 24/191 (12%)

Query: 61  LVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN 120
           ++ +    DL+K +++         V     ++L  L + H    +H D+K  NLL+N  
Sbjct: 129 MIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK 188

Query: 121 GELK--LADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSI------------ 166
              +  L D+GLA  +     C           P     G   + TSI            
Sbjct: 189 NPDQVYLVDYGLAYRY-----CPEGVHKAYAADPKRCHDGTIEF-TSIDAHNGVAPSRRG 242

Query: 167 DMWSAGCIFAELANAGRP---LFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPD-FKPF 222
           D+   G    +      P              K  ++       D        P     +
Sbjct: 243 DLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKY 302

Query: 223 PMYHPSMSFSQ 233
                 + +++
Sbjct: 303 METVKLLDYTE 313

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 61.2 bits (149), Expect = 5e-11
 Identities = 31/134 (23%), Positives = 54/134 (40%), Gaps = 7/134 (5%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKH-KNIVRLYDVLHSEKKLTLVF 63
           G D      +AIK       +        E  + K ++    I  +           +V 
Sbjct: 28  GTDIAAGEEVAIKLEC---VKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84

Query: 64  EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKN 120
           E     L+  F+  + +  L  V     Q++  + + HS+N +HRD+KP N L+    K 
Sbjct: 85  ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG 144

Query: 121 GELKLADFGLARAF 134
             + + DFGLA+ +
Sbjct: 145 NLVYIIDFGLAKKY 158

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 60.9 bits (148), Expect = 6e-11
 Identities = 55/257 (21%), Positives = 89/257 (34%), Gaps = 47/257 (18%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKH-KNIVRLYDVLHSEKKLTLVF 63
           G +   N  +AIK   L   +        E    K+L     I ++Y      K   +V 
Sbjct: 28  GKNLYTNEYVAIK---LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84

Query: 64  EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI-----N 118
           E     L+  FD  +    L  V     QL+  + + HS+N+++RD+KP+N LI      
Sbjct: 85  ELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNK 144

Query: 119 KNGELKLADFGLARAFG-------IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSI----- 166
               + + DF LA+ +        IP            YR    L G   Y  SI     
Sbjct: 145 TQQVIHIIDFALAKEYIDPETKKHIP------------YREHKSLTGTARY-MSINTHLG 191

Query: 167 -------DMWSAGCIFAELANAGRP--LFPGSDVDDQLKRIFKL-LGTPTEDTWPGMNLL 216
                  D+ + G +F        P        + ++ ++I      TP E         
Sbjct: 192 KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCEN---F 248

Query: 217 PDFKPFPMYHPSMSFSQ 233
           P+   +  Y   + F +
Sbjct: 249 PEMATYLRYVRRLDFFE 265

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 60.3 bits (147), Expect = 9e-11
 Identities = 27/112 (24%), Positives = 57/112 (50%), Gaps = 18/112 (16%)

Query: 34  EICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY-FDSLNGEIDLD------I 85
           EI  L   +H ++V L        ++ L++++ +  +LK++ + S    + +       I
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144

Query: 86  VKSFMYQLL---RGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF 134
                   +   RGL + H+R ++HRD+K  N+L+++N   K+ DFG+++  
Sbjct: 145 C-------IGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 60.5 bits (147), Expect = 9e-11
 Identities = 22/76 (28%), Positives = 34/76 (44%), Gaps = 3/76 (3%)

Query: 61  LVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN 120
           +V E    DL+K     NG      V     ++L  L + H    +H D+K  NLL+   
Sbjct: 129 MVMERLGIDLQKISGQ-NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK 187

Query: 121 GELK--LADFGLARAF 134
              +  LAD+GL+  +
Sbjct: 188 NPDQVYLADYGLSYRY 203

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 60.4 bits (146), Expect = 1e-10
 Identities = 32/134 (23%), Positives = 57/134 (42%), Gaps = 7/134 (5%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVF 63
           G +   N  +AIK  +    +      L E  + + L+    I  +           LV 
Sbjct: 26  GTNIQTNEEVAIKLEN---VKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82

Query: 64  EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE- 122
           +     L+  F+  + ++ L  V     Q++  + F HS++ LHRD+KP N L+      
Sbjct: 83  DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142

Query: 123 --LKLADFGLARAF 134
             + + DFGLA+ +
Sbjct: 143 NQVYIIDFGLAKKY 156

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 58.9 bits (143), Expect = 2e-10
 Identities = 28/136 (20%), Positives = 48/136 (35%), Gaps = 9/136 (6%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKH-KNIVRLYDVLHSEKKLTLVF 63
           G +   N  +AIK                E    K L     I  +Y          LV 
Sbjct: 29  GTNLLNNQQVAIKFEP---RRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85

Query: 64  EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL 123
           +     L+   D    +  +  V     Q+L  +   H +++++RD+KP N LI +    
Sbjct: 86  DLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSK 145

Query: 124 K-----LADFGLARAF 134
                 + DFG+ + +
Sbjct: 146 NANMIYVVDFGMVKFY 161

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 59.0 bits (143), Expect = 3e-10
 Identities = 19/107 (17%), Positives = 37/107 (34%), Gaps = 4/107 (3%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLT-LVFEHCDQDLKKYFDSLNGEI-DLDIVKSF 89
           + +   L       I         + K   LV     + L+   D     +     V   
Sbjct: 105 VNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQV 164

Query: 90  MYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELK--LADFGLARAF 134
             +LL  L F H    +H ++  +N+ ++   + +  LA +G A  +
Sbjct: 165 ACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 57.6 bits (140), Expect = 6e-10
 Identities = 29/118 (24%), Positives = 49/118 (41%), Gaps = 25/118 (21%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFE-----------HCDQDLKKYFDSLNGE 80
            +EI ++ + +H+N+V L         L LV+             C          L+  
Sbjct: 78  DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP----LSWH 133

Query: 81  IDLDIVKSFMYQLL---RGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFG 135
           +   I             G+ F H  + +HRD+K  N+L+++    K++DFGLARA  
Sbjct: 134 MRCKIA-------QGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASE 184

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 54.5 bits (132), Expect = 8e-09
 Identities = 28/116 (24%), Positives = 51/116 (43%), Gaps = 23/116 (19%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH-----CDQDLKKYFDSLNGEIDLD-- 84
             E+ ++    H+N++RL     +  +  LV+ +         L    +    +  LD  
Sbjct: 75  QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL---RERPESQPPLDWP 131

Query: 85  -----IVKSFMYQLLRGLAFCH---SRNVLHRDLKPQNLLINKNGELKLADFGLAR 132
                 + S      RGLA+ H      ++HRD+K  N+L+++  E  + DFGLA+
Sbjct: 132 KRQRIALGS-----ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.4 bits (122), Expect = 2e-07
 Identities = 44/282 (15%), Positives = 83/282 (29%), Gaps = 87/282 (30%)

Query: 28  PSSAL----REICLLKELKHKNIVRLYDVLHSE-KKLTLVFEHC-----DQDLKKYFDSL 77
           P   L    R + ++ E     +    +  H    KLT + E         + +K FD L
Sbjct: 319 PREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRL 378

Query: 78  N-----------------GEIDLDIVKSFMYQLL-RGLAFCHSRNV------LHRDLKPQ 113
           +                  ++    V   + +L    L     +        ++ +LK +
Sbjct: 379 SVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVK 438

Query: 114 NLLINKNGEL--KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
              +     L   + D      + IP K +           P  L     Y         
Sbjct: 439 ---LENEYALHRSIVD-----HYNIP-KTFD-----SDDLIPPYLDQ---Y--------- 472

Query: 172 GCIFAELA-------NAGR-PLFPGSDVDDQ-LKRIFKLLGTPTEDTWPGMNLLPDFKPF 222
              ++ +        +  R  LF    +D + L++  +   T    +   +N L   K +
Sbjct: 473 --FYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFY 530

Query: 223 PMY----HPS--------MSFS-QVAPKL-TAKGRDLLQRLL 250
             Y     P         + F  ++   L  +K  DLL+  L
Sbjct: 531 KPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIAL 572

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	282
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.9
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.75
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.6
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.36
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.2
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.12
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.67
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.66
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.55
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.5
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.45
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.25
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.05
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.99
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.97
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.83
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.51
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.26
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.26
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.25
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.18
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.95
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.85
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.8
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.68
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.62
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.59
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.44
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.38
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.87
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	87.24
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	87.14
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	82.75

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.4e-61  Score=388.97  Aligned_cols=238  Identities=26%  Similarity=0.473  Sum_probs=199.3

Q ss_pred             CeeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      .||+|+++.+|+.||||++.+.  ........+.+|+.++++++||||+++++++.+++.+|+|||||+|++++.+.+ .
T Consensus        28 ~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g~L~~~l~~-~  106 (275)
T 3hyh_A           28 KVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQ-R  106 (275)
T ss_dssp             CEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCEEHHHHHHH-S
T ss_pred             EEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCCCCCHHHHHHH-c
Confidence            4999999999999999999872  333445678999999999999999999999999999999999999999998876 6


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++....... ......||+.|+|||++.+
T Consensus       107 ~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-~~~~~~GT~~Y~APE~~~~  185 (275)
T 3hyh_A          107 DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-FLKTSCGSPNYAAPEVISG  185 (275)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------------CTTSCHHHHSS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-ccCCeeECcccCChhhhcC
Confidence            789999999999999999999999999999999999999999999999999998765332 3344678999999999988


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      ..+++.++||||+||++|+|++|..| |.+.+..+....+....                             ..++..+
T Consensus       186 ~~y~~~~~DiwSlGvily~lltg~~P-F~~~~~~~~~~~i~~~~-----------------------------~~~p~~~  235 (275)
T 3hyh_A          186 KLYAGPEVDVWSCGVILYVMLCRRLP-FDDESIPVLFKNISNGV-----------------------------YTLPKFL  235 (275)
T ss_dssp             SSCCCTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHTC-----------------------------CCCCTTS
T ss_pred             CCCCCChhhhHHHHHHHHHHHHCCCC-CCCCCHHHHHHHHHcCC-----------------------------CCCCCCC
Confidence            77567899999999999999998888 67777777777776521                             1233458


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS  270 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  270 (282)
                      |+++++||++||+.||++|||++|+++||||+
T Consensus       236 s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k  267 (275)
T 3hyh_A          236 SPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK  267 (275)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHcCcccc
Confidence            99999999999999999999999999999997

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7.6e-62  Score=395.63  Aligned_cols=246  Identities=25%  Similarity=0.419  Sum_probs=213.0

Q ss_pred             CeeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL   77 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~   77 (282)
                      .||+|+++.+|+.||||++.+  .......+.+.+|++++++++||||+++++++++++.+|+|||||+| +|.+.+.+ 
T Consensus        47 ~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~-  125 (311)
T 4aw0_A           47 TVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-  125 (311)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-
T ss_pred             EEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH-
Confidence            389999999999999999986  22344567899999999999999999999999999999999999986 66665554 


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC--ccccccccccccccChhh
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDV  155 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~aPE~  155 (282)
                      .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...  .......+||+.|+|||+
T Consensus       126 ~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEv  205 (311)
T 4aw0_A          126 IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL  205 (311)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHH
Confidence            678999999999999999999999999999999999999999999999999999876533  223345679999999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      +.+.. ++.++||||+||++|+|++|..| |.+.+..+....+.+..                             ..++
T Consensus       206 l~~~~-y~~~~DiWSlGvilyeml~G~~P-F~~~~~~~~~~~i~~~~-----------------------------~~~p  254 (311)
T 4aw0_A          206 LTEKS-ACKSSDLWALGCIIYQLVAGLPP-FRAGNEGLIFAKIIKLE-----------------------------YDFP  254 (311)
T ss_dssp             HHHSC-BCHHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHTC-----------------------------CCCC
T ss_pred             HcCCC-CCcHHHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHcCC-----------------------------CCCC
Confidence            98766 79999999999999999998888 77777888888777631                             1233


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHH------HhcCCCccCCccchhh
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAED------AMSHIYFSDLNVAIKS  278 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~------ll~h~~~~~~~~~~~~  278 (282)
                      ..+|+++++||++||+.||++|||++|      |++||||+++++....
T Consensus       255 ~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~  303 (311)
T 4aw0_A          255 EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH  303 (311)
T ss_dssp             TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred             cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhc
Confidence            568999999999999999999999988      5899999999877543

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=9.6e-61  Score=394.70  Aligned_cols=245  Identities=21%  Similarity=0.392  Sum_probs=210.4

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||+|+++.+|+.||||++..... ...+.+.+|+.++++++||||+++++++.+++.+|||||||+|+.+..+.. .+.
T Consensus        89 ~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~-~~~  166 (346)
T 4fih_A           89 IVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTR  166 (346)
T ss_dssp             EEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHH-HSC
T ss_pred             EEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHH-cCC
Confidence            389999999999999999987432 345778999999999999999999999999999999999998754444444 367


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+..........+||+.|+|||++.+..
T Consensus       167 l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~  246 (346)
T 4fih_A          167 MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP  246 (346)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCC
Confidence            99999999999999999999999999999999999999999999999999988766655566678999999999997666


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                       |+.++|||||||++|+|++|..| |.+.+..+....+......                          ....+..+|+
T Consensus       247 -y~~~~DiWSlGvilyeml~G~~P-F~~~~~~~~~~~i~~~~~~--------------------------~~~~~~~~s~  298 (346)
T 4fih_A          247 -YGPEVDIWSLGIMVIEMVDGEPP-YFNEPPLKAMKMIRDNLPP--------------------------RLKNLHKVSP  298 (346)
T ss_dssp             -BCTHHHHHHHHHHHHHHHHSSCT-TTTSCHHHHHHHHHHSSCC--------------------------CCSCGGGSCH
T ss_pred             -CCcHHHHHHHHHHHHHHHHCCCC-CCCcCHHHHHHHHHcCCCC--------------------------CCCccccCCH
Confidence             79999999999999999998877 6667777777766553211                          1112346899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ++++||.+||+.||++|||++|+|+||||++...+
T Consensus       299 ~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p  333 (346)
T 4fih_A          299 SLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP  333 (346)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence            99999999999999999999999999999976543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=7.6e-61  Score=395.90  Aligned_cols=241  Identities=24%  Similarity=0.411  Sum_probs=208.6

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      .||+|+++.+|+.||||++... ......+.+.+|+.++++++||||+++++++++++.+|||||||+| +|.+.+....
T Consensus        39 ~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~  118 (350)
T 4b9d_A           39 KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQK  118 (350)
T ss_dssp             CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTT
T ss_pred             EEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcC
Confidence            4999999999999999999873 2333456789999999999999999999999999999999999975 7777765543


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          79 -GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 -~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                       ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.............||+.|+|||++.
T Consensus       119 ~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~  198 (350)
T 4b9d_A          119 GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICE  198 (350)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHT
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHC
Confidence             4579999999999999999999999999999999999999999999999999987764433344567899999999998


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. |+.++|||||||++|+|++|..| |.+.+..+....+.....                            ...+..
T Consensus       199 ~~~-y~~~~DiwSlGvilyemltG~~P-F~~~~~~~~~~~i~~~~~----------------------------~~~~~~  248 (350)
T 4b9d_A          199 NKP-YNNKSDIWALGCVLYELCTLKHA-FEAGSMKNLVLKIISGSF----------------------------PPVSLH  248 (350)
T ss_dssp             TCC-CCHHHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHTCC----------------------------CCCCTT
T ss_pred             CCC-CCcHHHHHHHHHHHHHHHHCCCC-CCCcCHHHHHHHHHcCCC----------------------------CCCCcc
Confidence            766 79999999999999999998877 777788888777766321                            123346


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD  271 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  271 (282)
                      +|+++.+||.+||+.||++|||++|+|+||||++
T Consensus       249 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          249 YSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence            8999999999999999999999999999999975

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=9.1e-61  Score=389.24  Aligned_cols=244  Identities=26%  Similarity=0.328  Sum_probs=201.6

Q ss_pred             eeeeeeC---CCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHh
Q psy6044           2 FTSGVDR---TPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDS   76 (282)
Q Consensus         2 vy~a~~~---~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~   76 (282)
                      ||+|++.   .+++.||||+++. .........+.+|+.++++++||||+++++++++++.+|+|||||+| +|.+.+. 
T Consensus        40 Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~-  118 (304)
T 3ubd_A           40 VFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS-  118 (304)
T ss_dssp             EEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHH-
T ss_pred             EEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHH-
Confidence            8999874   5789999999986 22223345688899999999999999999999999999999999986 5555554 


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhh
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~  156 (282)
                      ..+.+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++..............||+.|+|||++
T Consensus       119 ~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~  198 (304)
T 3ubd_A          119 KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV  198 (304)
T ss_dssp             HHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHH
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHh
Confidence            46789999999999999999999999999999999999999999999999999998765444444556899999999999


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       157 ~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      .+.. ++.++||||+||++|+|++|..| |.+.+..+....+.+..                             ...+.
T Consensus       199 ~~~~-y~~~~DiwSlGvilyemltG~~P-F~~~~~~~~~~~i~~~~-----------------------------~~~p~  247 (304)
T 3ubd_A          199 NRRG-HTQSADWWSFGVLMFEMLTGTLP-FQGKDRKETMTMILKAK-----------------------------LGMPQ  247 (304)
T ss_dssp             HTSC-CCTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHCC-----------------------------CCCCT
T ss_pred             ccCC-CCCCCcccchHHHHHHHHhCCCC-CCCcCHHHHHHHHHcCC-----------------------------CCCCC
Confidence            8776 79999999999999999998877 77888888888776621                             12345


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCccchh
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMS-----AEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~h~~~~~~~~~~~  277 (282)
                      .+|+++++||++||+.||++|||     ++|+++||||++++++..
T Consensus       248 ~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l  293 (304)
T 3ubd_A          248 FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKL  293 (304)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred             cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHH
Confidence            68999999999999999999998     589999999999987654

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.8e-59  Score=395.01  Aligned_cols=244  Identities=21%  Similarity=0.395  Sum_probs=210.1

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||+|+++.+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+++.+|||||||+|+.+..+.. .+.
T Consensus       166 ~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~-~~~  243 (423)
T 4fie_A          166 IVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTR  243 (423)
T ss_dssp             EEEEEEETTTCCEEEEEEEESTT-CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHH-HSC
T ss_pred             EEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHh-ccC
Confidence            38999999999999999998743 3345779999999999999999999999999999999999998754444544 467


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+..........+||+.|+|||++.+..
T Consensus       244 l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~  323 (423)
T 4fie_A          244 MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP  323 (423)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCC
Confidence            99999999999999999999999999999999999999999999999999988766655566678999999999997766


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                       |+.++|||||||++|+|++|..| |.+.+..+.+..+......                          .......+|+
T Consensus       324 -y~~~~DiWSlGvilyeml~G~~P-F~~~~~~~~~~~i~~~~~~--------------------------~~~~~~~~s~  375 (423)
T 4fie_A          324 -YGPEVDIWSLGIMVIEMVDGEPP-YFNEPPLKAMKMIRDNLPP--------------------------RLKNLHKVSP  375 (423)
T ss_dssp             -BCTHHHHHHHHHHHHHHHHSSCT-TTTSCHHHHHHHHHHSCCC--------------------------CCSCTTSSCH
T ss_pred             -CCcHHHHHHHHHHHHHHHHCCCC-CCCcCHHHHHHHHHcCCCC--------------------------CCcccccCCH
Confidence             79999999999999999998887 6677777777766553211                          0112345899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      ++++||.+||..||++|||++|+|+||||++...
T Consensus       376 ~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~  409 (423)
T 4fie_A          376 SLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  409 (423)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence            9999999999999999999999999999997643

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.4e-59  Score=377.55  Aligned_cols=240  Identities=25%  Similarity=0.364  Sum_probs=196.2

Q ss_pred             CeeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeee----CCeEEEEEecCcccHHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHS----EKKLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~----~~~~~iv~e~~~g~l~~~~~   75 (282)
                      .||+|+++.+|..||+|++.. .......+.+.+|+.++++++||||+++++++.+    +..+|||||||+|+.+..+.
T Consensus        41 ~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l  120 (290)
T 3fpq_A           41 TVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL  120 (290)
T ss_dssp             EEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHH
T ss_pred             EEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHH
Confidence            399999999999999999986 3333345678999999999999999999999875    35689999999864444444


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEcC-CCcEEEEecCCccccCCCccccccccccccccC
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSRN--VLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVKCYSAEVVTLWYRP  152 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~dl~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~a  152 (282)
                      ...+.+++..+..++.||+.||.|||++|  |+||||||+|||++. +|.+||+|||++......  ......||+.|+|
T Consensus       121 ~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~--~~~~~~GTp~YmA  198 (290)
T 3fpq_A          121 KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMA  198 (290)
T ss_dssp             HHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT--SBEESCSSCCCCC
T ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC--ccCCcccCccccC
Confidence            44678999999999999999999999998  999999999999974 799999999999765432  2334578999999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       153 PE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      ||++.+ . ++.++|||||||++|+|+||..||....+.......+....                           ...
T Consensus       199 PE~~~~-~-y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~---------------------------~~~  249 (290)
T 3fpq_A          199 PEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV---------------------------KPA  249 (290)
T ss_dssp             GGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC---------------------------CCG
T ss_pred             HHHcCC-C-CCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCC---------------------------CCC
Confidence            999865 3 79999999999999999999888544444444444443211                           111


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD  271 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  271 (282)
                      ..+...++++.+||.+||+.||++|||++|+|+||||++
T Consensus       250 ~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            233557899999999999999999999999999999985

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-58  Score=390.04  Aligned_cols=273  Identities=34%  Similarity=0.562  Sum_probs=222.8

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeee------CCeEEEEEecCcccHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHS------EKKLTLVFEHCDQDLKKY   73 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~------~~~~~iv~e~~~g~l~~~   73 (282)
                      .||+|+++.+|+.||||++... ........+++|+.+++.++||||+++++++..      .+.+|||||||+|++.+.
T Consensus        69 ~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~g~L~~~  148 (398)
T 4b99_A           69 VVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQI  148 (398)
T ss_dssp             EEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCSEEHHHH
T ss_pred             EEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCCCCHHHH
Confidence            3899999999999999999763 222334568899999999999999999998764      368999999999998887


Q ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC----cccccccccccc
Q psy6044          74 FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP----VKCYSAEVVTLW  149 (282)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~~~~  149 (282)
                      +.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+...    ........||+.
T Consensus       149 i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~  227 (398)
T 4b99_A          149 IHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW  227 (398)
T ss_dssp             HTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCT
T ss_pred             HHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChH
Confidence            765 678999999999999999999999999999999999999999999999999999866422    223345688999


Q ss_pred             ccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCC--CCCCCCC
Q psy6044         150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFK--PFPMYHP  227 (282)
Q Consensus       150 ~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  227 (282)
                      |+|||++.+...++.++||||+||++|+|++|..| |.+.+..+.+..+....+.++...+..........  .......
T Consensus       228 Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~p-F~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~  306 (398)
T 4b99_A          228 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQL-FPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQ  306 (398)
T ss_dssp             TCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCS-SCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCC
T ss_pred             hcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCC-CCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcC
Confidence            99999998877689999999999999999987766 88999999999999999988766554322111000  0011112


Q ss_pred             CCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         228 SMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       228 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ...+....+.+++++.+||++||..||++|||++|+|+||||++...+
T Consensus       307 ~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p  354 (398)
T 4b99_A          307 PVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP  354 (398)
T ss_dssp             CCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCG
T ss_pred             CCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCC
Confidence            234555667789999999999999999999999999999999987543

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=8.1e-58  Score=376.20  Aligned_cols=240  Identities=21%  Similarity=0.290  Sum_probs=199.5

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      .||+|+++.+|+.||||+++..      ....+|+.+++.++||||+++++++.+++.+|||||||+| +|.+.+ ...+
T Consensus        73 ~Vy~a~~~~~g~~vAiK~i~~~------~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l-~~~~  145 (336)
T 4g3f_A           73 EVHRMKDKQTGFQCAVKKVRLE------VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-KQMG  145 (336)
T ss_dssp             EEEEEEETTTCCEEEEEEEETT------TCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHH-HHHS
T ss_pred             EEEEEEECCCCCEEEEEEECHH------HhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHH-HHcC
Confidence            3899999999999999999753      2235799999999999999999999999999999999986 555555 4467


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC-cEEEEecCCccccCCCcc-----ccccccccccccCh
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG-ELKLADFGLARAFGIPVK-----CYSAEVVTLWYRPP  153 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~-~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~aP  153 (282)
                      .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||++........     ......||+.|+||
T Consensus       146 ~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAP  225 (336)
T 4g3f_A          146 CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP  225 (336)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCH
Confidence            899999999999999999999999999999999999999987 699999999987643221     12234689999999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      |++.+.. ++.++|||||||++|+|++|..| |.+.+..+....+....                          ....+
T Consensus       226 E~~~~~~-y~~~~DiwSlGvilyemltG~~P-f~~~~~~~~~~~i~~~~--------------------------~~~~~  277 (336)
T 4g3f_A          226 EVVMGKP-CDAKVDIWSSCCMMLHMLNGCHP-WTQYFRGPLCLKIASEP--------------------------PPIRE  277 (336)
T ss_dssp             HHHTTCC-CCTHHHHHHHHHHHHHHHHSSCS-STTTCCSCCHHHHHHSC--------------------------CGGGG
T ss_pred             HHHCCCC-CCcHHHHHHHHHHHHHHHHCcCC-CCCCCHHHHHHHHHcCC--------------------------CCchh
Confidence            9998766 79999999999999999998888 55555555555554421                          12334


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHH-------------hcCCCccCCccc
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDA-------------MSHIYFSDLNVA  275 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l-------------l~h~~~~~~~~~  275 (282)
                      +++.+|+.+.+||.+||+.||.+|||+.|+             ++|||++....+
T Consensus       278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P  332 (336)
T 4g3f_A          278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP  332 (336)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred             cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence            567799999999999999999999999998             679999987654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.7e-55  Score=359.66  Aligned_cols=273  Identities=77%  Similarity=1.270  Sum_probs=247.8

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      ||+|+++.+|+.||+|++... ........+.+|+.++++++||||+++++++.+++..++||||++|++++.+....+.
T Consensus        18 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~   97 (292)
T 3o0g_A           18 VFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD   97 (292)
T ss_dssp             EEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTC
T ss_pred             EEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCCCHHHHHHhCCCC
Confidence            899999999999999999873 3333456788999999999999999999999999999999999999999999888889


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+...+..........+++.|+|||.+.+..
T Consensus        98 l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  177 (292)
T 3o0g_A           98 LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK  177 (292)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCS
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCC
Confidence            99999999999999999999999999999999999999999999999999988765555556667899999999998776


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                      .++.++||||||+++|+|++|+.|+|.+.+..+....+....+.+....++........................+.+++
T Consensus       178 ~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (292)
T 3o0g_A          178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNA  257 (292)
T ss_dssp             CCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCH
T ss_pred             CcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccCh
Confidence            67999999999999999999999999999999999999999999999999888887777777777667677777888999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      .+.+||++||+.||++|||++|+++||||++...
T Consensus       258 ~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~p  291 (292)
T 3o0g_A          258 TGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC--
T ss_pred             HHHHHHHHHhccChhhCCCHHHHhcCcccccCCC
Confidence            9999999999999999999999999999998643

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4e-57  Score=369.07  Aligned_cols=243  Identities=23%  Similarity=0.424  Sum_probs=184.9

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC------------eEEEEEecCcc
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK------------KLTLVFEHCDQ   68 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~------------~~~iv~e~~~g   68 (282)
                      .||+|+++.+|+.||||++.........+.+.+|+.++++++||||+++++++.+.+            .+|+|||||+|
T Consensus        20 ~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~g   99 (299)
T 4g31_A           20 VVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRK   99 (299)
T ss_dssp             EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCS
T ss_pred             EEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCC
Confidence            389999999999999999987544444567899999999999999999999987544            47999999986


Q ss_pred             -cHHHHHHhcCCC---CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-----
Q psy6044          69 -DLKKYFDSLNGE---IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-----  139 (282)
Q Consensus        69 -~l~~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-----  139 (282)
                       ++.+.+.. .+.   .++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.......     
T Consensus       100 g~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~  178 (299)
T 4g31_A          100 ENLKDWMNG-RCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL  178 (299)
T ss_dssp             CCHHHHHHT-CCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC-------------
T ss_pred             CcHHHHHHh-cCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccc
Confidence             45555443 433   45677899999999999999999999999999999999999999999999987653221     


Q ss_pred             -------ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCC
Q psy6044         140 -------CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPG  212 (282)
Q Consensus       140 -------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  212 (282)
                             ..+...||+.|+|||++.+.. ++.++|||||||++|||++   | |..  ..+....+......        
T Consensus       179 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyell~---P-f~~--~~~~~~~~~~~~~~--------  243 (299)
T 4g31_A          179 TPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY---P-FST--QMERVRTLTDVRNL--------  243 (299)
T ss_dssp             -------------CCCTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHS---C-CSS--HHHHHHHHHHHHTT--------
T ss_pred             cccccccccCCcccCccccCHHHHcCCC-CCCHHHHHHHHHHHHHHcc---C-CCC--ccHHHHHHHHHhcC--------
Confidence                   123346899999999998766 7999999999999999994   5 332  22222222222111        


Q ss_pred             CCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         213 MNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                                       ..+......++.+.+||++||+.||++|||+.|+++||||++++++.
T Consensus       244 -----------------~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~  290 (299)
T 4g31_A          244 -----------------KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG  290 (299)
T ss_dssp             -----------------CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred             -----------------CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence                             11223345678889999999999999999999999999999998754

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.2e-54  Score=360.88  Aligned_cols=266  Identities=24%  Similarity=0.377  Sum_probs=203.0

Q ss_pred             CeeeeeeC---CCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHH
Q psy6044           1 MFTSGVDR---TPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFD   75 (282)
Q Consensus         1 ~vy~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~   75 (282)
                      .||+|+++   .+++.||+|++...   .....+.+|+++++.+ +||||+++++++.+++.+|+||||++| ++.+.+ 
T Consensus        36 ~Vy~a~~~~~~~~~~~vAiK~i~~~---~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~-  111 (361)
T 4f9c_A           36 SVYLATAQLQVGPEEKIALKHLIPT---SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDIL-  111 (361)
T ss_dssp             EEEEEEEEBTTSCEEEEEEEEECTT---SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHH-
T ss_pred             EEEEEEEcccCCCCCEEEEEEEccc---cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHH-
Confidence            38999875   56899999988642   2345688999999998 699999999999999999999999985 555544 


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC-CcEEEEecCCccccCCCc----------------
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPV----------------  138 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~-~~~~l~df~~~~~~~~~~----------------  138 (282)
                         +.+++.++..++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++.......                
T Consensus       112 ---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~  188 (361)
T 4f9c_A          112 ---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERC  188 (361)
T ss_dssp             ---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC---------
T ss_pred             ---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccccccccccccc
Confidence               369999999999999999999999999999999999999877 899999999997543221                


Q ss_pred             ------------cccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCC
Q psy6044         139 ------------KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT  206 (282)
Q Consensus       139 ------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~  206 (282)
                                  .......||+.|+|||++.+...++.++||||+||++|+|++|..||+.+.+..+.+..+...++.++
T Consensus       189 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~  268 (361)
T 4f9c_A          189 SQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRE  268 (361)
T ss_dssp             -----------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHH
T ss_pred             ccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCcc
Confidence                        11233468999999999987766899999999999999999999999999998888888877665321


Q ss_pred             CC--------------CCCCCC----------CCCCCCCC-CCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHH
Q psy6044         207 ED--------------TWPGMN----------LLPDFKPF-PMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAE  261 (282)
Q Consensus       207 ~~--------------~~~~~~----------~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  261 (282)
                      ..              ..+...          ........ ..........+....+|+++.+||++||+.||++|||++
T Consensus       269 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~  348 (361)
T 4f9c_A          269 TIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAE  348 (361)
T ss_dssp             HHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred             chhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHH
Confidence            10              000000          00000000 000000111223456899999999999999999999999


Q ss_pred             HHhcCCCccCCc
Q psy6044         262 DAMSHIYFSDLN  273 (282)
Q Consensus       262 ~ll~h~~~~~~~  273 (282)
                      |+|+||||++++
T Consensus       349 eaL~Hp~f~~i~  360 (361)
T 4f9c_A          349 EALLHPFFKDMS  360 (361)
T ss_dssp             HHHTSGGGTTC-
T ss_pred             HHhcCcccCCCC
Confidence            999999999986

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.1e-53  Score=345.43  Aligned_cols=270  Identities=52%  Similarity=0.932  Sum_probs=227.0

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      ||+|++ .+|+.||+|++... ........+.+|+.++++++||||+++++++.+++..++||||++|++.+.+....+.
T Consensus        18 V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~   96 (288)
T 1ob3_A           18 VYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG   96 (288)
T ss_dssp             EEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTC
T ss_pred             EEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCCCHHHHHHhcccC
Confidence            899999 78999999999763 3334457788999999999999999999999999999999999999999988877788


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+...+..........+++.|+|||.+.+..
T Consensus        97 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  176 (288)
T 1ob3_A           97 LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK  176 (288)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccccccccccCchheeCCC
Confidence            99999999999999999999999999999999999999999999999999987664444445557799999999997765


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                      .++.++|+||||+++|+|++|..| |.+.+..+....+....+.+....++.......+.+.........+......+++
T Consensus       177 ~~~~~~DiwslG~il~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (288)
T 1ob3_A          177 KYSTTIDIWSVGCIFAEMVNGTPL-FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDE  255 (288)
T ss_dssp             SCCTHHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCH
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCH
Confidence            579999999999999999988776 7788888888888888888888777766555544443333334455666778999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      .+.+||++||+.||++|||++++++||||++.+
T Consensus       256 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~n  288 (288)
T 1ob3_A          256 SGIDLLSKMLKLDPNQRITAKQALEHAYFKENN  288 (288)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC--
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHhcCcchhhcC
Confidence            999999999999999999999999999999754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-53  Score=348.36  Aligned_cols=236  Identities=18%  Similarity=0.257  Sum_probs=185.5

Q ss_pred             eeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      ||+|+.+.   .||||+++. .......+.+.+|+.++++++||||+++++++.+ +.++||||||+| +|.+.+....+
T Consensus        52 Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~  127 (307)
T 3omv_A           52 VYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQET  127 (307)
T ss_dssp             EEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCC
T ss_pred             EEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCC
Confidence            89998743   599999876 3333345679999999999999999999998865 468999999985 67777766667


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC--ccccccccccccccChhhhc
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~  157 (282)
                      .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  ........||+.|+|||++.
T Consensus       128 ~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~  207 (307)
T 3omv_A          128 KFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIR  207 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhh
Confidence            8999999999999999999999999999999999999999999999999999765422  22334457899999999996


Q ss_pred             CC--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         158 GA--KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       158 ~~--~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      ..  .+++.++|||||||++|||+||+.| |.+.+..+............+                       .....+
T Consensus       208 ~~~~~~y~~ksDVwS~Gvvl~Elltg~~P-f~~~~~~~~~~~~~~~~~~~p-----------------------~~~~~~  263 (307)
T 3omv_A          208 MQDNNPFSFQSDVYSYGIVLYELMTGELP-YSHINNRDQIIFMVGRGYASP-----------------------DLSKLY  263 (307)
T ss_dssp             CCSSCCCCHHHHHHHHHHHHHHHHHSSCT-TTTCCCHHHHHHHHHTTCCCC-----------------------CSTTSC
T ss_pred             ccCCCCCCcHHHhHhHHHHHHHHHHCCCC-CCCCChHHHHHHHHhcCCCCC-----------------------Cccccc
Confidence            43  3479999999999999999998888 555554444443333211111                       222344


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ..+++.+.+||.+||+.||++|||+.++++
T Consensus       264 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          264 KNCPKAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             TTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            568999999999999999999999998754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8.8e-55  Score=354.74  Aligned_cols=240  Identities=22%  Similarity=0.318  Sum_probs=197.7

Q ss_pred             CeeeeeeC-----CCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHH
Q psy6044           1 MFTSGVDR-----TPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~   74 (282)
                      .||+|++.     .+|..||||+++.. .....+.+.+|++++++++||||+++++++.+++.++||||||+| +|.+.+
T Consensus        28 ~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l  106 (299)
T 4asz_A           28 KVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFL  106 (299)
T ss_dssp             CEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHH
T ss_pred             EEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHH
Confidence            38999864     46899999998753 223356799999999999999999999999999999999999975 666666


Q ss_pred             Hhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc--cc
Q psy6044          75 DSL------------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--KC  140 (282)
Q Consensus        75 ~~~------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~--~~  140 (282)
                      ...            ...+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||+++......  ..
T Consensus       107 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~  186 (299)
T 4asz_A          107 RAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV  186 (299)
T ss_dssp             HHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEE
T ss_pred             HhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceee
Confidence            542            2469999999999999999999999999999999999999999999999999997654322  12


Q ss_pred             cccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCC
Q psy6044         141 YSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFK  220 (282)
Q Consensus       141 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (282)
                      .....+|+.|+|||.+.+.. ++.++|||||||++|||+|.+.+||.+.+..+....+..+..                 
T Consensus       187 ~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~-----------------  248 (299)
T 4asz_A          187 GGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV-----------------  248 (299)
T ss_dssp             TTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC-----------------
T ss_pred             cCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-----------------
Confidence            22345789999999998776 799999999999999999854555888888888877766422                 


Q ss_pred             CCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         221 PFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                                 ...+..+|+++.+||.+||+.||++|||+++++  +|++++
T Consensus       249 -----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~~  287 (299)
T 4asz_A          249 -----------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQNL  287 (299)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHHH
T ss_pred             -----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHHH
Confidence                       123356899999999999999999999999994  477655

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.5e-54  Score=352.01  Aligned_cols=236  Identities=21%  Similarity=0.311  Sum_probs=195.8

Q ss_pred             eeeeee-----CCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHH
Q psy6044           2 FTSGVD-----RTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFD   75 (282)
Q Consensus         2 vy~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~   75 (282)
                      ||+|..     ..+++.||||+++........+.|.+|+.++++++||||+++++++.+++.+++|||||+| +|.+++.
T Consensus        42 Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~  121 (308)
T 4gt4_A           42 VYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLV  121 (308)
T ss_dssp             EEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHH
T ss_pred             EEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHH
Confidence            899985     3578899999998655555567899999999999999999999999999999999999975 6666664


Q ss_pred             hc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC--c
Q psy6044          76 SL---------------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--V  138 (282)
Q Consensus        76 ~~---------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~--~  138 (282)
                      ..               ...+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||+++.....  .
T Consensus       122 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~  201 (308)
T 4gt4_A          122 MRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY  201 (308)
T ss_dssp             TTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCB
T ss_pred             hhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCce
Confidence            32               235899999999999999999999999999999999999999999999999999765322  2


Q ss_pred             cccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCC
Q psy6044         139 KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPD  218 (282)
Q Consensus       139 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (282)
                      ...+...||+.|+|||.+.+.. ++.++|||||||++|||+|.+.+||.+.+..+....+..+..               
T Consensus       202 ~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~---------------  265 (308)
T 4gt4_A          202 KLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQV---------------  265 (308)
T ss_dssp             CSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCC---------------
T ss_pred             eEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence            2234457789999999998776 799999999999999999855555888888887777654321               


Q ss_pred             CCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         219 FKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                                   ...+..+++.+.+|+.+||+.||++|||+.+|+++
T Consensus       266 -------------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          266 -------------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             -------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                         12345688999999999999999999999999874

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8.5e-54  Score=377.22  Aligned_cols=244  Identities=23%  Similarity=0.344  Sum_probs=200.5

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHH---HHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALRE---ICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e---~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~   75 (282)
                      ||+|+++.+|+.||||++.+.  ..........+|   +.+++.++||||++++++|++++.+|+|||||+| +|...+.
T Consensus       205 V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~  284 (689)
T 3v5w_A          205 VYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS  284 (689)
T ss_dssp             EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred             EEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHH
Confidence            899999999999999999861  122223334444   5667778999999999999999999999999986 5555554


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhh
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDV  155 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~  155 (282)
                       ..+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......  ....+||+.|+|||+
T Consensus       285 -~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~--~~t~~GTp~YmAPEv  361 (689)
T 3v5w_A          285 -QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGTHGYMAPEV  361 (689)
T ss_dssp             -HHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC--CCSCCSCGGGCCHHH
T ss_pred             -hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC--CCCccCCcCccCHHH
Confidence             46889999999999999999999999999999999999999999999999999998775433  234579999999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCC--ChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGS--DVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      +.....|+.++|+|||||++|+|++|..||....  +..+....+..                             ....
T Consensus       362 l~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~-----------------------------~~~~  412 (689)
T 3v5w_A          362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-----------------------------MAVE  412 (689)
T ss_dssp             HSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH-----------------------------CCCC
T ss_pred             HhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC-----------------------------CCCC
Confidence            9765558999999999999999999988854322  22333333333                             1122


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCccchh
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMS-----AEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~h~~~~~~~~~~~  277 (282)
                      ++..+|+++++||.+||+.||.+|++     +++|++||||+++++...
T Consensus       413 ~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l  461 (689)
T 3v5w_A          413 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV  461 (689)
T ss_dssp             CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHH
T ss_pred             CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHH
Confidence            34568999999999999999999998     799999999999988754

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.2e-53  Score=350.16  Aligned_cols=272  Identities=52%  Similarity=0.884  Sum_probs=225.6

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      ||+|++. +|+.||+|++... ........+.+|+.++++++||||+++++++.++...++||||++|++.+.+......
T Consensus        37 V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~  115 (311)
T 3niz_A           37 VYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTG  115 (311)
T ss_dssp             EEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSEEHHHHHHTCTTC
T ss_pred             EEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCCCHHHHHHhccCC
Confidence            8999995 5999999999763 3333456788999999999999999999999999999999999999999999887778


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||.+...+..........+++.|+|||.+.+..
T Consensus       116 ~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  195 (311)
T 3niz_A          116 LQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK  195 (311)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCC
Confidence            99999999999999999999999999999999999999999999999999988765555555667899999999997766


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCC-CCCCCCCCCccccCccCC
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP-FPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  239 (282)
                      .++.++||||||+++|+|++|..| |.+....+....+....+.+....++.......+.. .........+....+.++
T Consensus       196 ~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (311)
T 3niz_A          196 KYSTSVDIWSIGCIFAEMITGKPL-FPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFC  274 (311)
T ss_dssp             SCCTHHHHHHHHHHHHHHHHSSCS-CCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCC
T ss_pred             CCCchHHhHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccC
Confidence            689999999999999999988776 777777888888888888887766654333221111 111112224455667789


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      +++.+||++||+.||++|||++|+++||||++++..
T Consensus       275 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  310 (311)
T 3niz_A          275 QEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQ  310 (311)
T ss_dssp             HHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCTT
T ss_pred             HHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCcc
Confidence            999999999999999999999999999999998754

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.2e-52  Score=345.13  Aligned_cols=274  Identities=53%  Similarity=0.919  Sum_probs=229.5

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC---
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN---   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~---   78 (282)
                      ||+|.++.+|+.||+|++...........+.+|+.++++++||||+++++++.+++..++||||++|++.+.+....   
T Consensus        21 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~  100 (317)
T 2pmi_A           21 VYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGN  100 (317)
T ss_dssp             EEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCCCBHHHHHHHHHSSS
T ss_pred             EEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecCCCHHHHHHhccccc
Confidence            89999999999999999987555556678999999999999999999999999999999999999999888876542   


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhh
Q psy6044          79 --GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        79 --~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~  156 (282)
                        ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+..............+++.|+|||.+
T Consensus       101 ~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~  180 (317)
T 2pmi_A          101 TPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVL  180 (317)
T ss_dssp             CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHH
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHh
Confidence              458999999999999999999999999999999999999999999999999998776544444556779999999999


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCc-----
Q psy6044         157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSF-----  231 (282)
Q Consensus       157 ~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  231 (282)
                      .+...++.++||||||+++|+|++|..| |.+.+..+....+....+.+....++.......+............     
T Consensus       181 ~~~~~~~~~~DiwslG~il~el~~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (317)
T 2pmi_A          181 MGSRTYSTSIDIWSCGCILAEMITGKPL-FPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQ  259 (317)
T ss_dssp             TTCCCCCTHHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHG
T ss_pred             hCCCCCCcHHHHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhc
Confidence            7765579999999999999999988776 7888888888999998888877777655444433322211111111     


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      ......+++.+.+||++||+.||++|||++++++||||++.....
T Consensus       260 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~  304 (317)
T 2pmi_A          260 PHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHA  304 (317)
T ss_dssp             GGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC--
T ss_pred             ccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchh
Confidence            122346899999999999999999999999999999999875543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.2e-53  Score=350.02  Aligned_cols=234  Identities=22%  Similarity=0.344  Sum_probs=187.2

Q ss_pred             eeeeeeC-----CCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHH
Q psy6044           2 FTSGVDR-----TPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFD   75 (282)
Q Consensus         2 vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~   75 (282)
                      ||+|+.+     .+++.||||+++.. .....+.|.+|+.++++++||||+++++++.+++.++||||||+| +|.+++.
T Consensus        57 Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~  135 (329)
T 4aoj_A           57 VFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLR  135 (329)
T ss_dssp             EEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHH
T ss_pred             EEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHH
Confidence            8999854     47899999998753 223356799999999999999999999999999999999999985 6666554


Q ss_pred             hc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc--c
Q psy6044          76 SL--------------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--K  139 (282)
Q Consensus        76 ~~--------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~--~  139 (282)
                      ..              .+++++.++..++.||+.||.|||+++|+||||||+||+++.++.+||+|||+++......  .
T Consensus       136 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~  215 (329)
T 4aoj_A          136 SHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR  215 (329)
T ss_dssp             TSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred             hcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcce
Confidence            32              2458999999999999999999999999999999999999999999999999998664322  2


Q ss_pred             ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCC
Q psy6044         140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDF  219 (282)
Q Consensus       140 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (282)
                      ......+|+.|+|||.+.+.. ++.++|||||||++|||+|.+.++|.+.+..+....+..+...               
T Consensus       216 ~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~---------------  279 (329)
T 4aoj_A          216 VGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL---------------  279 (329)
T ss_dssp             ----CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCC---------------
T ss_pred             ecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence            223456799999999998776 7999999999999999998444447788888877777663211               


Q ss_pred             CCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         220 KPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                   ..+..+++++.+|+.+||+.||++|||+++|++
T Consensus       280 -------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~  312 (329)
T 4aoj_A          280 -------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA  312 (329)
T ss_dssp             -------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred             -------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                         123458999999999999999999999999987

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.1e-53  Score=374.71  Aligned_cols=246  Identities=24%  Similarity=0.399  Sum_probs=210.4

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      .||+|+++.+|+.||+|++.... ....+.+.+|+.+|+.++||||+++++++.+++.+|+|||||+| +|.+.+....+
T Consensus       172 ~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~  250 (573)
T 3uto_A          172 VVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN  250 (573)
T ss_dssp             EEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTS
T ss_pred             EEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCC
Confidence            38999999999999999987632 22246788999999999999999999999999999999999975 77777766667


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC--CcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN--GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      .+++..+..++.||+.||.|||++||+||||||+||+++.+  +.+||+|||++..+.... ......||+.|+|||++.
T Consensus       251 ~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~-~~~~~~GT~~y~APEv~~  329 (573)
T 3uto_A          251 KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-SVKVTTGTAEFAAPEVAE  329 (573)
T ss_dssp             CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-EEEEECSSGGGCCHHHHT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-ceeeeEECccccCHHHhC
Confidence            89999999999999999999999999999999999999854  899999999998876433 334457899999999998


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|||||||++|+|++|..| |.+.+..+.+..+.......+.                         .....
T Consensus       330 ~~~-y~~~~DiWSlGvilyeml~G~~P-f~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~  382 (573)
T 3uto_A          330 GKP-VGYYTDMWSVGVLSYILLSGLSP-FGGENDDETLRNVKSCDWNMDD-------------------------SAFSG  382 (573)
T ss_dssp             TCC-BCHHHHHHHHHHHHHHHHHSCCS-SCCSSHHHHHHHHHTTCCCCCS-------------------------GGGTT
T ss_pred             CCC-CCcHHHHHHHHHHHHHHHHCCCC-CCCcCHHHHHHHHHhCCCCCCc-------------------------ccccC
Confidence            766 79999999999999999988777 7777888877777653322211                         22346


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      +|+++++||++||+.||.+|||+.|+|+||||+..+.+
T Consensus       383 ~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~  420 (573)
T 3uto_A          383 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  420 (573)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence            89999999999999999999999999999999987654

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.1e-52  Score=347.24  Aligned_cols=274  Identities=53%  Similarity=0.899  Sum_probs=221.9

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEI   81 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~   81 (282)
                      ||+|+++.+|+.||+|++...........+.+|+.+++.++||||+++++++.+++..++||||++|++.+.+......+
T Consensus        18 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~   97 (324)
T 3mtl_A           18 VYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNII   97 (324)
T ss_dssp             EEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHHTTTCC
T ss_pred             EEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccccCHHHHHHhcCCCC
Confidence            89999999999999999987544444556678999999999999999999999999999999999999999998877789


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCCC
Q psy6044          82 DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKL  161 (282)
Q Consensus        82 ~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  161 (282)
                      ++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||.+..............+++.|+|||.+.+...
T Consensus        98 ~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  177 (324)
T 3mtl_A           98 NMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD  177 (324)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCC
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCC
Confidence            99999999999999999999999999999999999999999999999999876655555555677999999999987666


Q ss_pred             CCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCC-CCCCCCCccccCccCCH
Q psy6044         162 YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFP-MYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       162 ~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  240 (282)
                      ++.++||||||+++|+|++|..| |.+.+..+....+....+.+....++.......+.... ..............+++
T Consensus       178 ~~~~~DiwslG~il~~l~~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (324)
T 3mtl_A          178 YSTQIDMWGVGCIFYEMATGRPL-FPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDS  256 (324)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCH
T ss_pred             CCcHHHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCH
Confidence            89999999999999999988766 88888999999999999988887776543222111110 01111123344567899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      ++.+||++||+.||.+|||++|+|+||||+++....
T Consensus       257 ~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  292 (324)
T 3mtl_A          257 DGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI  292 (324)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTT
T ss_pred             HHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccc
Confidence            999999999999999999999999999999886543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.1e-51  Score=343.71  Aligned_cols=272  Identities=46%  Similarity=0.875  Sum_probs=217.0

Q ss_pred             eeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      ||+|++..+|+.||||++.. .........+.+|+.++++++||||+++++++.++...++||||++|++.+.+.. .+.
T Consensus        50 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~  128 (329)
T 3gbz_A           50 VYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDK-NPD  128 (329)
T ss_dssp             EEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH-CTT
T ss_pred             EEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCCCHHHHHhh-cCC
Confidence            89999999999999999986 3334446678899999999999999999999999999999999999998888766 567


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc-----CCCcEEEEecCCccccCCCccccccccccccccChhh
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN-----KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDV  155 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~-----~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~  155 (282)
                      +++..++.++.||+.||.|||++||+|+||||+||+++     .++.++|+|||.+...+..........+++.|+|||.
T Consensus       129 ~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~  208 (329)
T 3gbz_A          129 VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEI  208 (329)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHH
Confidence            99999999999999999999999999999999999994     4456999999999877655455555677999999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCC-CCCCCCcccc
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM-YHPSMSFSQV  234 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  234 (282)
                      +.+...++.++||||||+++|+|++|..| |......+....+....+.+....++.......+..... ..........
T Consensus       209 ~~~~~~~~~~~DiwslG~il~ell~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (329)
T 3gbz_A          209 LLGSRHYSTSVDIWSIACIWAEMLMKTPL-FPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVL  287 (329)
T ss_dssp             HTTCCCCCTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHH
T ss_pred             hcCCCCCCcHHHHHHHHHHHHHHHHCCCC-cCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhc
Confidence            98766679999999999999999987766 788888888888888888888877776554444433221 1111112223


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ...+++++.+||++||+.||.+|||++++|+||||++++++
T Consensus       288 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  328 (329)
T 3gbz_A          288 GALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD  328 (329)
T ss_dssp             GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred             ccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence            34589999999999999999999999999999999998753

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.2e-51  Score=340.10  Aligned_cols=240  Identities=27%  Similarity=0.475  Sum_probs=206.9

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      ||+|++..+|+.||||++... ........+.+|+.+++.++||||+++++++.+++..|+||||++| ++.+.+.. .+
T Consensus        31 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~  109 (328)
T 3fe3_A           31 VKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA-HG  109 (328)
T ss_dssp             EEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH-HC
T ss_pred             EEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHH-cC
Confidence            899999999999999999873 3333456788999999999999999999999999999999999975 66665544 67


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...... .......+++.|+|||.+.+.
T Consensus       110 ~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~  188 (328)
T 3fe3_A          110 RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYAAPELFQGK  188 (328)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-CGGGTTSSSGGGCCHHHHHTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-CccccccCCcceeCcccccCC
Confidence            8999999999999999999999999999999999999999999999999999776533 233455789999999999887


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      ...+.++||||+|+++|+|++|..| |.+.+..+....+....                             ...+..++
T Consensus       189 ~~~~~~~DiwslG~il~ell~g~~p-f~~~~~~~~~~~i~~~~-----------------------------~~~p~~~s  238 (328)
T 3fe3_A          189 KYDGPEVDVWSLGVILYTLVSGSLP-FDGQNLKELRERVLRGK-----------------------------YRIPFYMS  238 (328)
T ss_dssp             CCCSHHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHCC-----------------------------CCCCTTSC
T ss_pred             CcCCchhhhhhhHHHHHHHHhCCCC-CCCCCHHHHHHHHHhCC-----------------------------CCCCCCCC
Confidence            7556899999999999999988777 77877777777766521                             12334589


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      +++.+||++||+.||.+|||++++++||||+...
T Consensus       239 ~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          239 TDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            9999999999999999999999999999998754

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-50  Score=339.24  Aligned_cols=273  Identities=41%  Similarity=0.742  Sum_probs=228.9

Q ss_pred             eeeeeeCCCCceEEEeeeecCC----CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhc
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG----NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~   77 (282)
                      ||+|++..+|+.||+|++....    .......+.+|+.+++.++||||+++++++.+....++|+||++|++...+...
T Consensus        26 Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~  105 (346)
T 1ua2_A           26 VYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN  105 (346)
T ss_dssp             EEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTC
T ss_pred             EEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCCCHHHHHHhc
Confidence            8999999999999999998622    122346788999999999999999999999999999999999999998888776


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..............+++.|+|||.+.
T Consensus       106 ~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~  185 (346)
T 1ua2_A          106 SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF  185 (346)
T ss_dssp             CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHT
T ss_pred             CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhh
Confidence            67799999999999999999999999999999999999999999999999999987765555555667899999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +...++.++||||||+++|+|++|. |+|.+.+..+....+....+.+....|+......+...... ............
T Consensus       186 ~~~~~~~~~DiwslG~il~ell~g~-~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  263 (346)
T 1ua2_A          186 GARMYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS-FPGIPLHHIFSA  263 (346)
T ss_dssp             TCSCCCHHHHHHHHHHHHHHHHHSS-CSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC-CCCCCHHHHCTT
T ss_pred             CCCCCCchhhhHhHHHHHHHHHHCC-CCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccc-cCCCChHHhhcc
Confidence            7665799999999999999999865 55888888889999999999888888876655444332221 111233445577


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      +++++.+||++||+.||.+|||++|+++||||++...+.
T Consensus       264 ~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~  302 (346)
T 1ua2_A          264 AGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT  302 (346)
T ss_dssp             CCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred             CCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCC
Confidence            899999999999999999999999999999999875443

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.2e-50  Score=337.56  Aligned_cols=245  Identities=22%  Similarity=0.318  Sum_probs=208.4

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|+++.+|+.||+|++...  ........+.+|+.+++.++||||+++++++.+.+..|+||||++|+.+..+....+
T Consensus        21 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~  100 (337)
T 1o6l_A           21 VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER  100 (337)
T ss_dssp             EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS
T ss_pred             EEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC
Confidence            899999999999999999862  233445678899999999999999999999999999999999998744444444467


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .+++..++.++.||+.||.|||++||+|+||||+||+++.+|.++|+|||++..............|++.|+|||.+.+.
T Consensus       101 ~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~  180 (337)
T 1o6l_A          101 VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN  180 (337)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSS
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCC
Confidence            89999999999999999999999999999999999999999999999999998654444444556789999999999776


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      . ++.++|+||||+++|+|++|..| |.+.+..+....+...                             ...++..++
T Consensus       181 ~-~~~~~DiwslG~il~ell~g~~P-f~~~~~~~~~~~i~~~-----------------------------~~~~p~~~s  229 (337)
T 1o6l_A          181 D-YGRAVDWWGLGVVMYEMMCGRLP-FYNQDHERLFELILME-----------------------------EIRFPRTLS  229 (337)
T ss_dssp             C-BCTTHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHC-----------------------------CCCCCTTSC
T ss_pred             C-CCchhhcccchhHHHHHhcCCCC-CCCCCHHHHHHHHHcC-----------------------------CCCCCCCCC
Confidence            6 79999999999999999998888 5666666666666541                             112334689


Q ss_pred             HHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCccchh
Q psy6044         240 AKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~  277 (282)
                      +++.+||++||+.||++||     +++++++||||+++++...
T Consensus       230 ~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~  272 (337)
T 1o6l_A          230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV  272 (337)
T ss_dssp             HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred             HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHH
Confidence            9999999999999999999     9999999999999987644

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5.8e-51  Score=341.55  Aligned_cols=244  Identities=20%  Similarity=0.322  Sum_probs=204.8

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~   77 (282)
                      ||+|+++.+|+.||||++...  ........+..|..+++.+ +||||+++++++.+.+.+|+||||++| ++...+ ..
T Consensus        39 V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l-~~  117 (353)
T 3txo_A           39 VMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI-QK  117 (353)
T ss_dssp             EEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH-HH
T ss_pred             EEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHH-HH
Confidence            899999999999999999862  2333456788999999988 799999999999999999999999986 555554 44


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      .+.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..............||+.|+|||.+.
T Consensus       118 ~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~  197 (353)
T 3txo_A          118 SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQ  197 (353)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcC
Confidence            67899999999999999999999999999999999999999999999999999986544444445567899999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|+||||+++|+|++|..| |.+.+..+....+....                             ...+..
T Consensus       198 ~~~-~~~~~DiwslG~il~ell~G~~P-f~~~~~~~~~~~i~~~~-----------------------------~~~p~~  246 (353)
T 3txo_A          198 EML-YGPAVDWWAMGVLLYEMLCGHAP-FEAENEDDLFEAILNDE-----------------------------VVYPTW  246 (353)
T ss_dssp             HHH-CTTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHCC-----------------------------CCCCTT
T ss_pred             CCC-cCCccCCCcchHHHHHHHhCCCC-CCCCCHHHHHHHHHcCC-----------------------------CCCCCC
Confidence            766 69999999999999999998777 77777788777776621                             123345


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCH------HHHhcCCCccCCccchh
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSA------EDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~------~~ll~h~~~~~~~~~~~  277 (282)
                      +++.+.+||++||+.||.+||++      +++++||||+++++...
T Consensus       247 ~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l  292 (353)
T 3txo_A          247 LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQL  292 (353)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHH
T ss_pred             CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHH
Confidence            89999999999999999999999      89999999999987654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.8e-51  Score=342.20  Aligned_cols=235  Identities=22%  Similarity=0.364  Sum_probs=190.0

Q ss_pred             eeeeeeCCC-----CceEEEeeeecCCCCCCCccHHHHHHHHhhCCC-CCccceeeeeeeC-CeEEEEEecCcc-cHHHH
Q psy6044           2 FTSGVDRTP-----NTALAIKGTHLVGNEGVPSSALREICLLKELKH-KNIVRLYDVLHSE-KKLTLVFEHCDQ-DLKKY   73 (282)
Q Consensus         2 vy~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-~~i~~~~~~~~~~-~~~~iv~e~~~g-~l~~~   73 (282)
                      ||+|.+..+     ++.||||++.........+.+.+|+.++.+++| |||++++++|.++ +.++||||||+| +|.++
T Consensus        80 Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~  159 (353)
T 4ase_A           80 VIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY  159 (353)
T ss_dssp             EEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHH
T ss_pred             EEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHH
Confidence            899987654     468999998764444445679999999999976 8999999998764 578999999975 66666


Q ss_pred             HHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc
Q psy6044          74 FDSL---------------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  138 (282)
Q Consensus        74 ~~~~---------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~  138 (282)
                      +...               ...+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||+++.+....
T Consensus       160 L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~  239 (353)
T 4ase_A          160 LRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  239 (353)
T ss_dssp             HHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCT
T ss_pred             HHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCC
Confidence            6542               2348999999999999999999999999999999999999999999999999998764322


Q ss_pred             --cccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCC-hHHHHHHHHHHhCCCCCCCCCCCC
Q psy6044         139 --KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSD-VDDQLKRIFKLLGTPTEDTWPGMN  214 (282)
Q Consensus       139 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  214 (282)
                        .......+|+.|+|||.+.+.. ++.++|||||||++|||+| |..| |.+.. ..+....+..+..           
T Consensus       240 ~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~P-f~~~~~~~~~~~~i~~g~~-----------  306 (353)
T 4ase_A          240 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCRRLKEGTR-----------  306 (353)
T ss_dssp             TSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCS-STTCCCSHHHHHHHHHTCC-----------
T ss_pred             CceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCC-CCCCCHHHHHHHHHHcCCC-----------
Confidence              2233456789999999998776 7999999999999999998 5555 66544 4555555544321           


Q ss_pred             CCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         215 LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                                       ...+..+++++.++|.+||+.||++|||+.+|++|
T Consensus       307 -----------------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          307 -----------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             -----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence                             12334578999999999999999999999999987

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-50  Score=334.55  Aligned_cols=272  Identities=33%  Similarity=0.569  Sum_probs=210.8

Q ss_pred             eeeeeeCCCCceEEEeeeecCC-CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG-NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      ||+|.+..+|+.||+|++.... .....+.+.+|+.++++++||||+++++++.+.+..++|+||++|+++..+....+.
T Consensus        19 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~   98 (311)
T 4agu_A           19 VFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRG   98 (311)
T ss_dssp             EEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSC
T ss_pred             EEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcC
Confidence            8999999999999999987632 222345678899999999999999999999999999999999999988888877788


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+..
T Consensus        99 ~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  178 (311)
T 4agu_A           99 VPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT  178 (311)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------------GGGCCHHHHHTCS
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCC
Confidence            99999999999999999999999999999999999999999999999999987765544455567789999999998766


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCC---CCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPG---MNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      .++.++|+||||+++|++++|..| |.+....+....+....+...+.....   ...... ...+............+.
T Consensus       179 ~~~~~~Di~slG~il~~l~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  256 (311)
T 4agu_A          179 QYGPPVDVWAIGCVFAELLSGVPL-WPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG-VKIPDPEDMEPLELKFPN  256 (311)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT-CCCCCCSSCCCHHHHCTT
T ss_pred             CCCcchhhHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhccccccccccccccccccc-CcCCCccccchhhhhccc
Confidence            689999999999999999988766 777777777777776665432211000   000000 000111111122233456


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      +++.+.+||++||+.||.+|||++++++||||++++..
T Consensus       257 ~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  294 (311)
T 4agu_A          257 ISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI  294 (311)
T ss_dssp             CCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred             ccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence            89999999999999999999999999999999998654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7.4e-50  Score=338.67  Aligned_cols=246  Identities=20%  Similarity=0.319  Sum_probs=202.7

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||+|+++.+|+.||+|++.+  .........+..|..+++++ +||||+++++++.++..+|+||||++|+.+..+....
T Consensus        68 V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~  147 (396)
T 4dc2_A           68 VLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ  147 (396)
T ss_dssp             EEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH
T ss_pred             EEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHc
Confidence            89999999999999999987  33444567788999999887 8999999999999999999999999874444444446


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..............||+.|+|||++.+
T Consensus       148 ~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~  227 (396)
T 4dc2_A          148 RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG  227 (396)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcC
Confidence            78999999999999999999999999999999999999999999999999999864444444555678999999999987


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCC--------ChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGS--------DVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMS  230 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
                      .. ++.++|+||||+++|+|++|..|+....        ........+..                             .
T Consensus       228 ~~-~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~-----------------------------~  277 (396)
T 4dc2_A          228 ED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-----------------------------K  277 (396)
T ss_dssp             CC-BCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH-----------------------------C
T ss_pred             CC-CChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc-----------------------------c
Confidence            66 7999999999999999999888853221        11223333333                             1


Q ss_pred             ccccCccCCHHHHHHHHHhcccCCCCCCCH------HHHhcCCCccCCccchh
Q psy6044         231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSA------EDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~~ll~h~~~~~~~~~~~  277 (282)
                      ...++..+++++.+||++||+.||++||++      +++++||||+++++...
T Consensus       278 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l  330 (396)
T 4dc2_A          278 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM  330 (396)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHH
T ss_pred             ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHH
Confidence            122345689999999999999999999985      89999999999987654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-49  Score=325.97  Aligned_cols=269  Identities=41%  Similarity=0.707  Sum_probs=219.1

Q ss_pred             CeeeeeeCCCCceEEEeeeecCC----CCCCCccHHHHHHHHhhCC---CCCccceeeeeeeCC-----eEEEEEecCcc
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVG----NEGVPSSALREICLLKELK---HKNIVRLYDVLHSEK-----KLTLVFEHCDQ   68 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~---h~~i~~~~~~~~~~~-----~~~iv~e~~~g   68 (282)
                      .||+|+++.+|+.||+|++....    .......+.+|+.+++.++   ||||+++++++....     ..++|+|+++|
T Consensus        24 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~  103 (308)
T 3g33_A           24 TVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ  103 (308)
T ss_dssp             CEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCCC
T ss_pred             EEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhhc
Confidence            48999999999999999998622    2223456778888888775   999999999998765     58999999999


Q ss_pred             cHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccccccccc
Q psy6044          69 DLKKYFDSLNG-EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT  147 (282)
Q Consensus        69 ~l~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  147 (282)
                      ++.+.+..... .+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+...... .......++
T Consensus       104 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt  182 (308)
T 3g33_A          104 DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ-MALTPVVVT  182 (308)
T ss_dssp             BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTC-CCSGGGGCC
T ss_pred             CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCC-cccCCcccc
Confidence            99888876543 3999999999999999999999999999999999999999999999999999876533 233445779


Q ss_pred             ccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHP  227 (282)
Q Consensus       148 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (282)
                      +.|+|||.+.+.. ++.++||||||+++|+|++|..| |.+.+..+....+....+.++...|+.........  .....
T Consensus       183 ~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--~~~~~  258 (308)
T 3g33_A          183 LWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPL-FCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGA--FPPRG  258 (308)
T ss_dssp             CSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCS-CCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGG--SCCCC
T ss_pred             ccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCChhhccchhhccccc--cCCCC
Confidence            9999999998776 69999999999999999977666 88888888999999999888877776543322211  11122


Q ss_pred             CCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         228 SMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       228 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      ........+.+++.+.+||.+||+.||++|||+.++|+||||++.+.
T Consensus       259 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~  305 (308)
T 3g33_A          259 PRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  305 (308)
T ss_dssp             CCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred             CCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence            33445566789999999999999999999999999999999997643

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7.3e-50  Score=335.67  Aligned_cols=246  Identities=22%  Similarity=0.387  Sum_probs=205.7

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCC-----CCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEG-----VPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~   74 (282)
                      .||+|+++.+|+.||+|++.......     ....+.+|+.++++++||||+++++++.+...+++||||++| ++.+.+
T Consensus        27 ~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l  106 (361)
T 2yab_A           27 IVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL  106 (361)
T ss_dssp             EEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH
T ss_pred             EEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHH
Confidence            38999999999999999998733221     235688999999999999999999999999999999999975 555554


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC----cEEEEecCCccccCCCccccccccccccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG----ELKLADFGLARAFGIPVKCYSAEVVTLWY  150 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~  150 (282)
                       ...+.+++..+..++.||+.||.|||+.||+|+||||+||+++.++    .++|+|||++...... .......|++.|
T Consensus       107 -~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~-~~~~~~~gt~~y  184 (361)
T 2yab_A          107 -AQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEF  184 (361)
T ss_dssp             -TTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTT-CCCCCCCSCGGG
T ss_pred             -HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCC-CccccCCCCccE
Confidence             4467899999999999999999999999999999999999998777    7999999999876543 223445789999


Q ss_pred             cChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMS  230 (282)
Q Consensus       151 ~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
                      +|||.+.+.. ++.++|+||||+++|+|++|..| |.+.+..+....+.......+                        
T Consensus       185 ~aPE~~~~~~-~~~~~DiwslGvil~~ll~g~~P-f~~~~~~~~~~~i~~~~~~~~------------------------  238 (361)
T 2yab_A          185 VAPEIVNYEP-LGLEADMWSIGVITYILLSGASP-FLGDTKQETLANITAVSYDFD------------------------  238 (361)
T ss_dssp             CCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCS-SCCSSHHHHHHHHHTTCCCCC------------------------
T ss_pred             ECchHHcCCC-CCccccHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhcCCCCC------------------------
Confidence            9999997665 79999999999999999998877 666677776666654321111                        


Q ss_pred             ccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                       ......+++.+++||++||..||.+|||+.++++||||+.++..
T Consensus       239 -~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~  282 (361)
T 2yab_A          239 -EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQ  282 (361)
T ss_dssp             -HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSHH
T ss_pred             -chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCchh
Confidence             12234689999999999999999999999999999999987643

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.8e-49  Score=333.25  Aligned_cols=275  Identities=35%  Similarity=0.628  Sum_probs=222.7

Q ss_pred             CeeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeee--------CCeEEEEEecCcccHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHS--------EKKLTLVFEHCDQDLK   71 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~--------~~~~~iv~e~~~g~l~   71 (282)
                      .||+|+++.+|+.||+|++.. .........+.+|+.+++.++||||+++++++..        .+..++||||++|++.
T Consensus        32 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~  111 (351)
T 3mi9_A           32 EVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA  111 (351)
T ss_dssp             SEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSEEHH
T ss_pred             EEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCCCHH
Confidence            489999999999999999877 3344445678899999999999999999999987        4578999999999999


Q ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC----cccccccccc
Q psy6044          72 KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP----VKCYSAEVVT  147 (282)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~~  147 (282)
                      ..+......+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+......    ........++
T Consensus       112 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt  191 (351)
T 3mi9_A          112 GLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT  191 (351)
T ss_dssp             HHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSC
T ss_pred             HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccc
Confidence            999887788999999999999999999999999999999999999999999999999999765422    2223445678


Q ss_pred             ccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHP  227 (282)
Q Consensus       148 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (282)
                      +.|+|||.+.+...++.++||||||+++|+|++|..| |.+.+..+....+....+..+...++................
T Consensus       192 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (351)
T 3mi9_A          192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI-MQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKG  270 (351)
T ss_dssp             GGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSS
T ss_pred             cCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccc
Confidence            9999999997766579999999999999999987666 888888888999998888888777765433222221111100


Q ss_pred             CC-Ccccc--CccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         228 SM-SFSQV--APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       228 ~~-~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      .. .....  ....++.+.+||.+||+.||++|||++|+|+||||++...+.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  322 (351)
T 3mi9_A          271 QKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS  322 (351)
T ss_dssp             CCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred             cccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence            00 00000  012478899999999999999999999999999999765543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.9e-50  Score=336.11  Aligned_cols=244  Identities=25%  Similarity=0.375  Sum_probs=207.4

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~   77 (282)
                      ||+|+++.+|+.||+|++...  ........+..|..++..+ +||||+++++++.+...+|+||||++| ++.+.+. .
T Consensus        33 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~-~  111 (345)
T 1xjd_A           33 VFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-S  111 (345)
T ss_dssp             EEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH-H
T ss_pred             EEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHH-H
Confidence            899999999999999999872  2233456778899999877 999999999999999999999999976 5555544 4


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      .+.+++..+..++.||+.||.|||++||+|+||||+||+++.+|.++|+|||++..............|++.|+|||.+.
T Consensus       112 ~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~  191 (345)
T 1xjd_A          112 CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL  191 (345)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhc
Confidence            67899999999999999999999999999999999999999999999999999976543333345567899999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|+||||+++|+|++|..| |.+.+..+....+....                             ...+..
T Consensus       192 ~~~-~~~~~DiwslG~il~ell~g~~P-f~~~~~~~~~~~i~~~~-----------------------------~~~p~~  240 (345)
T 1xjd_A          192 GQK-YNHSVDWWSFGVLLYEMLIGQSP-FHGQDEEELFHSIRMDN-----------------------------PFYPRW  240 (345)
T ss_dssp             TCC-BCTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHCC-----------------------------CCCCTT
T ss_pred             CCC-CCChhhhHHHHHHHHHHhcCCCC-CCCCCHHHHHHHHHhCC-----------------------------CCCCcc
Confidence            766 79999999999999999998777 67777777777665521                             122345


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHH-HHhcCCCccCCccchh
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAE-DAMSHIYFSDLNVAIK  277 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~-~ll~h~~~~~~~~~~~  277 (282)
                      +++++.+||++||+.||++|||+. ++++||||+++++...
T Consensus       241 ~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l  281 (345)
T 1xjd_A          241 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEEL  281 (345)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHH
T ss_pred             cCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHH
Confidence            899999999999999999999998 9999999999987654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.9e-49  Score=325.47  Aligned_cols=242  Identities=26%  Similarity=0.345  Sum_probs=204.9

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~   80 (282)
                      ||+|.+..+|+.||+|++...... ....+.+|+.++++++||||+++++++...+..++||||++| ++.+.+..  ..
T Consensus        36 V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~  112 (297)
T 3fxz_A           36 VYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TC  112 (297)
T ss_dssp             EEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--SC
T ss_pred             EEEEEECCCCcEEEEEEeeccccc-HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh--cC
Confidence            899999999999999999864322 346788999999999999999999999999999999999975 55555443  46


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..............+++.|+|||.+.+..
T Consensus       113 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  192 (297)
T 3fxz_A          113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA  192 (297)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCC
Confidence            99999999999999999999999999999999999999999999999999987765555555667899999999998776


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                       ++.++||||||+++|+|++|..| |...+..+....+......                          ....+..+++
T Consensus       193 -~~~~~DiwslG~il~ell~g~~p-f~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~  244 (297)
T 3fxz_A          193 -YGPKVDIWSLGIMAIEMIEGEPP-YLNENPLRALYLIATNGTP--------------------------ELQNPEKLSA  244 (297)
T ss_dssp             -BCTHHHHHHHHHHHHHHHHSSCT-TTTSCHHHHHHHHHHHCSC--------------------------CCSCGGGSCH
T ss_pred             -CCcHHHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhCCCC--------------------------CCCCccccCH
Confidence             69999999999999999998888 5666655555554443211                          1112356899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      .+.+||.+||+.||.+|||++++++||||+....
T Consensus       245 ~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  278 (297)
T 3fxz_A          245 IFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP  278 (297)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence            9999999999999999999999999999997643

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-49  Score=328.87  Aligned_cols=241  Identities=23%  Similarity=0.353  Sum_probs=206.0

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      ||+|+++.+|+.||+|++...  ........+.+|..+++.++||||+++++++.+...+|+||||++| ++.+.+ ...
T Consensus        22 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l-~~~  100 (318)
T 1fot_A           22 VHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL-RKS  100 (318)
T ss_dssp             EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH-HHT
T ss_pred             EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHH-HHc
Confidence            899999999999999999862  2233456788999999999999999999999999999999999986 555554 446


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +.+++..++.++.||+.||.|||++||+|+||||+||+++.+|.++|+|||++......   .....|++.|+|||.+.+
T Consensus       101 ~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~  177 (318)
T 1fot_A          101 QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---TYTLCGTPDYIAPEVVST  177 (318)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---BCCCCSCTTTCCHHHHTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc---cccccCCccccCHhHhcC
Confidence            78999999999999999999999999999999999999999999999999999876532   233467999999999977


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||||+++|+|++|..| |...+..+....+....                             ...+..+
T Consensus       178 ~~-~~~~~DiwslG~il~ell~g~~p-f~~~~~~~~~~~i~~~~-----------------------------~~~p~~~  226 (318)
T 1fot_A          178 KP-YNKSIDWWSFGILIYEMLAGYTP-FYDSNTMKTYEKILNAE-----------------------------LRFPPFF  226 (318)
T ss_dssp             CC-BCTTHHHHHHHHHHHHHHHSSCT-TCCSSHHHHHHHHHHCC-----------------------------CCCCTTS
T ss_pred             CC-CCcccchhhhHHHHHHHHhCCCC-CCCCCHHHHHHHHHhCC-----------------------------CCCCCCC
Confidence            66 79999999999999999998888 66666666666665521                             1133458


Q ss_pred             CHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCccchh
Q psy6044         239 TAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~  277 (282)
                      ++++.++|++||..||++||     +++++++||||+++++...
T Consensus       227 ~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~  270 (318)
T 1fot_A          227 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL  270 (318)
T ss_dssp             CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHH
T ss_pred             CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHH
Confidence            99999999999999999999     9999999999999876543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.8e-50  Score=349.41  Aligned_cols=275  Identities=35%  Similarity=0.612  Sum_probs=209.6

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeee-----CCeEEEEEecCcccHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHS-----EKKLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~-----~~~~~iv~e~~~g~l~~~~   74 (282)
                      .||+|+++.+|+.||||++... ......+.+.+|+.+++.++||||+++++++..     ...+|+|||+++|++...+
T Consensus        68 ~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~  147 (458)
T 3rp9_A           68 HVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLF  147 (458)
T ss_dssp             CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCSEEHHHHH
T ss_pred             EEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccccchhhhc
Confidence            4899999999999999998752 222334678899999999999999999999853     3579999999999988877


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc----------------
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV----------------  138 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~----------------  138 (282)
                      .. ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.......                
T Consensus       148 ~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~  226 (458)
T 3rp9_A          148 RT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN  226 (458)
T ss_dssp             HS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------
T ss_pred             cc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccc
Confidence            65 6779999999999999999999999999999999999999999999999999998764221                


Q ss_pred             -----------cccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhc----------CCCCCCCCC-------
Q psy6044         139 -----------KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANA----------GRPLFPGSD-------  190 (282)
Q Consensus       139 -----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~----------~~p~~~~~~-------  190 (282)
                                 .......+|+.|+|||++.....++.++|||||||++|+|++|          +.|+|.+.+       
T Consensus       227 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~  306 (458)
T 3rp9_A          227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPD  306 (458)
T ss_dssp             ------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC----------
T ss_pred             cccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCcccccccc
Confidence                       1234456799999999876555589999999999999999974          666676654       


Q ss_pred             -------------hHHHHHHHHHHhCCCCCCCCCCCCCCC--CCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCC
Q psy6044         191 -------------VDDQLKRIFKLLGTPTEDTWPGMNLLP--DFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPV  255 (282)
Q Consensus       191 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~  255 (282)
                                   ..+.+..+.+.++.+..+.+.......  .+................+..++++.+||++||..||+
T Consensus       307 ~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~  386 (458)
T 3rp9_A          307 QKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPN  386 (458)
T ss_dssp             ----------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTT
T ss_pred             ccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCcc
Confidence                         246667777777776543332211000  00000011122244455667899999999999999999


Q ss_pred             CCCCHHHHhcCCCccCCccch
Q psy6044         256 QRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       256 ~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      +|||++|+|+||||+++.+..
T Consensus       387 ~R~t~~e~L~Hp~f~~~~~~~  407 (458)
T 3rp9_A          387 KRITINECLAHPFFKEVRIAE  407 (458)
T ss_dssp             TSCCHHHHHHSGGGTTTCCGG
T ss_pred             ccCCHHHHhcCHhhhhcCCCc
Confidence            999999999999999986654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.6e-49  Score=341.81  Aligned_cols=244  Identities=27%  Similarity=0.344  Sum_probs=208.0

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      .||+|.++.+|+.+|+|++... ........+.+|+.++++++||||+++++++.+++..|+||||+.| ++.+.+.. .
T Consensus        26 ~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~  104 (444)
T 3soa_A           26 VVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA-R  104 (444)
T ss_dssp             EEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHH-C
T ss_pred             EEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHH-c
Confidence            3899999999999999999863 2222345688999999999999999999999999999999999986 56566555 6


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc---CCCcEEEEecCCccccCCCccccccccccccccChhh
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN---KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDV  155 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~  155 (282)
                      +.+++..+..++.||+.||.|||++||+|+||||+||+++   .++.++|+|||++..............|++.|+|||.
T Consensus       105 ~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~  184 (444)
T 3soa_A          105 EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV  184 (444)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHH
Confidence            7899999999999999999999999999999999999998   4678999999999877655555556678999999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      +.+.. ++.++||||+|+++|+|++|..| |.+.+..+....+.......+...                         .
T Consensus       185 l~~~~-~~~~~DIwSlGvilyell~G~~P-f~~~~~~~~~~~i~~~~~~~~~~~-------------------------~  237 (444)
T 3soa_A          185 LRKDP-YGKPVDLWACGVILYILLVGYPP-FWDEDQHRLYQQIKAGAYDFPSPE-------------------------W  237 (444)
T ss_dssp             HTTCC-BCTHHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHTCCCCCTTT-------------------------T
T ss_pred             hcCCC-CCCccccHHHHHHHHHHHhCCCC-CCCccHHHHHHHHHhCCCCCCccc-------------------------c
Confidence            97765 79999999999999999988777 667777777777766443332222                         2


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      ..+++.+.+||.+||+.||.+|||+.++|+||||++.
T Consensus       238 ~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          238 DTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            3579999999999999999999999999999999754

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.2e-50  Score=346.28  Aligned_cols=275  Identities=37%  Similarity=0.617  Sum_probs=215.2

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC-----CeEEEEEecCcccHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSE-----KKLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~-----~~~~iv~e~~~g~l~~~~   74 (282)
                      .||+|+++.+|+.||||++... ........+.+|+.+++.++||||+++++++...     ...|+|||+++|++.+.+
T Consensus        41 ~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~  120 (432)
T 3n9x_A           41 YVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF  120 (432)
T ss_dssp             EEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSEEHHHHH
T ss_pred             EEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCcCHHHHH
Confidence            3899999999999999999762 2223346788999999999999999999999876     579999999999888877


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc---------------
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK---------------  139 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~---------------  139 (282)
                      .. ...+++..++.++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++........               
T Consensus       121 ~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~  199 (432)
T 3n9x_A          121 KT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP  199 (432)
T ss_dssp             HS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--------------------
T ss_pred             hc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccc
Confidence            65 67799999999999999999999999999999999999999999999999999987643321               


Q ss_pred             -------ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHh----------cCCCCCCCCC------------
Q psy6044         140 -------CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN----------AGRPLFPGSD------------  190 (282)
Q Consensus       140 -------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~----------~~~p~~~~~~------------  190 (282)
                             ......+|+.|+|||.+.....++.++|||||||++|+|++          ++.|+|.+.+            
T Consensus       200 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~  279 (432)
T 3n9x_A          200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKK  279 (432)
T ss_dssp             -----------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC---------
T ss_pred             cccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCccccccc
Confidence                   23556779999999997655558999999999999999996          4777777654            


Q ss_pred             -----hHHHHHHHHHHhCCCCCCCCCCCCCCCCC--CCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6044         191 -----VDDQLKRIFKLLGTPTEDTWPGMNLLPDF--KPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDA  263 (282)
Q Consensus       191 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  263 (282)
                           ..+.+..+...++.++.+.+.........  ................+.+++.+.+||++||+.||++|||++|+
T Consensus       280 ~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~  359 (432)
T 3n9x_A          280 VHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQA  359 (432)
T ss_dssp             -CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             ccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHH
Confidence                 35677777787777765433221100000  00001111223344456789999999999999999999999999


Q ss_pred             hcCCCccCCccch
Q psy6044         264 MSHIYFSDLNVAI  276 (282)
Q Consensus       264 l~h~~~~~~~~~~  276 (282)
                      |+||||+++..+.
T Consensus       360 L~Hp~f~~~~~~~  372 (432)
T 3n9x_A          360 LDHPYLKDVRKKK  372 (432)
T ss_dssp             HTCGGGTTTCCTT
T ss_pred             hcChhhhhccCcc
Confidence            9999999986543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.4e-49  Score=333.07  Aligned_cols=244  Identities=20%  Similarity=0.293  Sum_probs=208.4

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~   77 (282)
                      ||+|+++.+|+.||+|++...  ........+..|..++..+ +||+|+++++++.+.+..|+||||++| ++.+.+. .
T Consensus        36 V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~-~  114 (353)
T 2i0e_A           36 VMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-Q  114 (353)
T ss_dssp             EEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH-H
T ss_pred             EEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHH-h
Confidence            899999999999999999872  2334456788999999988 899999999999999999999999986 5555554 4


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      .+.+++..++.++.||+.||.|||++||+|+||||+||+++.+|.++|+|||++..............|++.|+|||.+.
T Consensus       115 ~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~  194 (353)
T 2i0e_A          115 VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA  194 (353)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhc
Confidence            57899999999999999999999999999999999999999999999999999986543434445567899999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|+||||+++|+|++|..| |.+.+..+....+....                             ..++..
T Consensus       195 ~~~-~~~~~DiwslG~il~ell~G~~P-f~~~~~~~~~~~i~~~~-----------------------------~~~p~~  243 (353)
T 2i0e_A          195 YQP-YGKSVDWWAFGVLLYEMLAGQAP-FEGEDEDELFQSIMEHN-----------------------------VAYPKS  243 (353)
T ss_dssp             TCC-BSTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHCC-----------------------------CCCCTT
T ss_pred             CCC-cCCcccccchHHHHHHHHcCCCC-CCCCCHHHHHHHHHhCC-----------------------------CCCCCC
Confidence            766 79999999999999999998877 67777777777776621                             123346


Q ss_pred             CCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCccchh
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMS-----AEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps-----~~~ll~h~~~~~~~~~~~  277 (282)
                      +++++.+||++||+.||.+||+     ++++++||||+++++...
T Consensus       244 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l  288 (353)
T 2i0e_A          244 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL  288 (353)
T ss_dssp             SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHH
T ss_pred             CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHH
Confidence            8999999999999999999994     699999999999987654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2e-49  Score=331.52  Aligned_cols=245  Identities=21%  Similarity=0.318  Sum_probs=201.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCC--CCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG--NEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~   77 (282)
                      ||+|+++.+|+.||+|++....  .......+.+|..+++++ +||||+++++++.++...|+||||++| ++...+. .
T Consensus        25 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~-~  103 (345)
T 3a8x_A           25 VLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-R  103 (345)
T ss_dssp             EEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-H
T ss_pred             EEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHH-H
Confidence            8999999999999999998732  222345678899999988 899999999999999999999999976 5555544 4


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      .+.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..............|++.|+|||.+.
T Consensus       104 ~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~  183 (345)
T 3a8x_A          104 QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR  183 (345)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccC
Confidence            67899999999999999999999999999999999999999999999999999986543434445567899999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCC--------CChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPG--------SDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSM  229 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
                      +.. ++.++|+|||||++|+|++|..|+...        .......+.+...                            
T Consensus       184 ~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~----------------------------  234 (345)
T 3a8x_A          184 GED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----------------------------  234 (345)
T ss_dssp             TCC-BCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC----------------------------
T ss_pred             CCC-CChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC----------------------------
Confidence            766 799999999999999999998885331        1122233333331                            


Q ss_pred             CccccCccCCHHHHHHHHHhcccCCCCCCCH------HHHhcCCCccCCccchh
Q psy6044         230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSA------EDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~~ll~h~~~~~~~~~~~  277 (282)
                       ...++..+++.+.++|++||+.||.+|||+      +++++||||+++++...
T Consensus       235 -~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~  287 (345)
T 3a8x_A          235 -QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM  287 (345)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHH
T ss_pred             -CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHH
Confidence             112345689999999999999999999995      89999999999986543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.4e-50  Score=336.92  Aligned_cols=239  Identities=23%  Similarity=0.436  Sum_probs=200.7

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|.+..+|+.||+|++..  .........+.+|+.+++.++||||+++++++.++...++||||++|++++.+.. .+
T Consensus        25 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g~l~~~l~~-~~  103 (336)
T 3h4j_B           25 VKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVE-KK  103 (336)
T ss_dssp             EEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCEEHHHHHHH-HC
T ss_pred             EEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECCCCcHHHHHHH-cC
Confidence            89999999999999999986  2233445688999999999999999999999999999999999999999998876 56


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++...... .......|++.|+|||.+.+.
T Consensus       104 ~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~  182 (336)
T 3h4j_B          104 RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVINGK  182 (336)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-BTTCCCTTSTTTSCGGGSCCS
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-cccccccCCcCcCCHHHHcCC
Confidence            8999999999999999999999999999999999999999999999999999876533 233445789999999999877


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      ...+.++||||||+++|+|++|..|+ .+....+.               ..              .........+..++
T Consensus       183 ~~~~~~~DiwslG~il~~ll~g~~Pf-~~~~~~~~---------------~~--------------~i~~~~~~~p~~~s  232 (336)
T 3h4j_B          183 LYAGPEVDVWSCGIVLYVMLVGRLPF-DDEFIPNL---------------FK--------------KVNSCVYVMPDFLS  232 (336)
T ss_dssp             GGGCHHHHHHHHHHHHHHHHHSSCSS-BCSSSTTC---------------BC--------------CCCSSCCCCCTTSC
T ss_pred             CCCCCccchhHHHHHHHHHHhCCCCC-CCccHHHH---------------HH--------------HHHcCCCCCcccCC
Confidence            64578999999999999999998884 33211100               00              00012223455689


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      +.+.+||++||+.||.+|||++++++||||+..
T Consensus       233 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          233 PGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            999999999999999999999999999999853

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.8e-49  Score=331.07  Aligned_cols=241  Identities=20%  Similarity=0.298  Sum_probs=207.1

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      ||+|+++.+|+.||+|++...  ........+.+|+.+++.++||||+++++++.++..+|+||||++| ++.+.+.. .
T Consensus        57 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~  135 (350)
T 1rdq_E           57 VMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-I  135 (350)
T ss_dssp             EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-H
T ss_pred             EEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHH-c
Confidence            899999999999999999762  2334456788999999999999999999999999999999999975 56555544 5


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......   ....|++.|+|||.+.+
T Consensus       136 ~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~---~~~~gt~~y~aPE~~~~  212 (350)
T 1rdq_E          136 GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEALAPEIILS  212 (350)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB---CCCEECGGGCCHHHHTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCCc---ccccCCccccCHHHhcC
Confidence            789999999999999999999999999999999999999999999999999998765332   33467999999999977


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||||+++|+|++|..| |...+..+....+....                             ...+..+
T Consensus       213 ~~-~~~~~DiwslG~il~ell~g~~P-f~~~~~~~~~~~i~~~~-----------------------------~~~p~~~  261 (350)
T 1rdq_E          213 KG-YNKAVDWWALGVLIYEMAAGYPP-FFADQPIQIYEKIVSGK-----------------------------VRFPSHF  261 (350)
T ss_dssp             CC-BCTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHCC-----------------------------CCCCTTC
T ss_pred             CC-CCCcCCEecccHhHhHHhhCCCC-CCCCCHHHHHHHHHcCC-----------------------------CCCCCCC
Confidence            66 79999999999999999998777 66667777777766521                             1233468


Q ss_pred             CHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCccchh
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMS-----AEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps-----~~~ll~h~~~~~~~~~~~  277 (282)
                      ++.+.++|++||+.||.+||+     ++++++||||+++++...
T Consensus       262 ~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~  305 (350)
T 1rdq_E          262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI  305 (350)
T ss_dssp             CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHH
T ss_pred             CHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHH
Confidence            999999999999999999998     999999999999887543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=6.7e-50  Score=333.20  Aligned_cols=272  Identities=32%  Similarity=0.564  Sum_probs=211.1

Q ss_pred             CeeeeeeCCCCceEEEeeeecCC-CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVG-NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      .||+|++..+|+.||+|++.... .......+.+|+.++++++||||+++++++.+.+..++||||++|+++..+.....
T Consensus        40 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~  119 (331)
T 4aaa_A           40 MVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN  119 (331)
T ss_dssp             SEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTT
T ss_pred             EEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhcc
Confidence            48999999999999999987632 22234557789999999999999999999999999999999999999998877778


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+.
T Consensus       120 ~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~  199 (331)
T 4aaa_A          120 GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGD  199 (331)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCC
Confidence            89999999999999999999999999999999999999999999999999998766554445556789999999999876


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCC--CCCCCCCCCCCCCCCccccCcc
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNL--LPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      ..++.++||||||+++|+|++|..| |......+....+....+...+........  .......+............+.
T Consensus       200 ~~~~~~~Di~slG~il~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (331)
T 4aaa_A          200 VKYGKAVDVWAIGCLVTEMFMGEPL-FPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPK  278 (331)
T ss_dssp             TTCCTHHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTT
T ss_pred             CCcchHHHHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccc
Confidence            5579999999999999999988766 777777777776666555432211000000  0000001111122233344567


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      +++.+.+||.+||+.||.+|||++++|+||||+..+
T Consensus       279 ~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  314 (331)
T 4aaa_A          279 LSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG  314 (331)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred             hhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence            899999999999999999999999999999998754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.3e-49  Score=341.45  Aligned_cols=245  Identities=23%  Similarity=0.317  Sum_probs=197.9

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|+++.+|+.||||++...  ........+.+|+.+++.++||||+++++++.+.+.+++||||++|+.+..+....+
T Consensus       164 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  243 (446)
T 4ejn_A          164 VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER  243 (446)
T ss_dssp             EEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHS
T ss_pred             EEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcC
Confidence            899999999999999999872  344456778899999999999999999999999999999999998744444444467


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      .+++..+..++.||+.||.|||+ .||+|+||||+||+++.++.++|+|||++..............|++.|+|||.+.+
T Consensus       244 ~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  323 (446)
T 4ejn_A          244 VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED  323 (446)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCC
Confidence            89999999999999999999998 99999999999999999999999999999765544444556678999999999987


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++||||||+++|+|++|..| |.+.+..+....+...                             ...++..+
T Consensus       324 ~~-~~~~~DiwslG~il~ell~g~~P-f~~~~~~~~~~~i~~~-----------------------------~~~~p~~~  372 (446)
T 4ejn_A          324 ND-YGRAVDWWGLGVVMYEMMCGRLP-FYNQDHEKLFELILME-----------------------------EIRFPRTL  372 (446)
T ss_dssp             SC-CCTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHC-----------------------------CCCCCTTS
T ss_pred             CC-CCCccchhhhHHHHHHHhhCCCC-CCCCCHHHHHHHHHhC-----------------------------CCCCCccC
Confidence            76 79999999999999999998888 6666666666666542                             11233458


Q ss_pred             CHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCccchh
Q psy6044         239 TAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~  277 (282)
                      ++.+.+||.+||+.||.+||     |++++++||||+++++...
T Consensus       373 ~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~  416 (446)
T 4ejn_A          373 GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHV  416 (446)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred             CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHH
Confidence            99999999999999999999     9999999999999976543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=9.5e-49  Score=325.55  Aligned_cols=244  Identities=25%  Similarity=0.394  Sum_probs=195.1

Q ss_pred             eeeeeeC---CCCceEEEeeeecCC---CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHH
Q psy6044           2 FTSGVDR---TPNTALAIKGTHLVG---NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         2 vy~a~~~---~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~   74 (282)
                      ||+|++.   .+|+.||+|++....   .......+.+|+.+++.++||||+++++++.+.+..|+||||++| ++.+.+
T Consensus        33 V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l  112 (327)
T 3a62_A           33 VFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL  112 (327)
T ss_dssp             EEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHH
T ss_pred             EEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHH
Confidence            8888875   689999999998632   233456688999999999999999999999999999999999985 555555


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChh
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPD  154 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE  154 (282)
                      . ..+.+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..............|++.|+|||
T Consensus       113 ~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE  191 (327)
T 3a62_A          113 E-REGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPE  191 (327)
T ss_dssp             H-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHH
T ss_pred             H-hCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHh
Confidence            4 467899999999999999999999999999999999999999999999999999876543433344557899999999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      .+.+.. ++.++|+||||+++|+|++|..| |.+.+..+....+....                             ...
T Consensus       192 ~~~~~~-~~~~~DiwslG~il~el~~g~~p-f~~~~~~~~~~~i~~~~-----------------------------~~~  240 (327)
T 3a62_A          192 ILMRSG-HNRAVDWWSLGALMYDMLTGAPP-FTGENRKKTIDKILKCK-----------------------------LNL  240 (327)
T ss_dssp             HHTTSC-CCTHHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHTC-----------------------------CCC
T ss_pred             hCcCCC-CCCcccchhHHHHHHHHHHCCCC-CCCCCHHHHHHHHHhCC-----------------------------CCC
Confidence            997766 69999999999999999998877 67777777777666521                             112


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCccchh
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~  277 (282)
                      +..+++.+.++|.+||+.||.+||     ++.++++||||+++++...
T Consensus       241 p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~  288 (327)
T 3a62_A          241 PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEEL  288 (327)
T ss_dssp             CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHH
T ss_pred             CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHH
Confidence            345899999999999999999999     8999999999999876543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.7e-49  Score=325.65  Aligned_cols=245  Identities=23%  Similarity=0.388  Sum_probs=204.3

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCC-----CCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEG-----VPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~   74 (282)
                      .||+|+++.+|+.||+|++.......     ....+.+|+.+++.++||||+++++++.+....++||||++| ++.+.+
T Consensus        26 ~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l  105 (326)
T 2y0a_A           26 VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL  105 (326)
T ss_dssp             EEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH
T ss_pred             EEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHH
Confidence            38999999999999999998733221     245688999999999999999999999999999999999976 555554


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC----cEEEEecCCccccCCCccccccccccccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG----ELKLADFGLARAFGIPVKCYSAEVVTLWY  150 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~  150 (282)
                       ...+.+++..++.++.||+.||.|||+.|++|+||||+||+++.++    .++|+|||++....... ......+++.|
T Consensus       106 -~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y  183 (326)
T 2y0a_A          106 -AEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEF  183 (326)
T ss_dssp             -TTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS-CCCCCCSCTTT
T ss_pred             -HhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC-ccccccCCcCc
Confidence             4467899999999999999999999999999999999999998887    89999999998765332 23345689999


Q ss_pred             cChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMS  230 (282)
Q Consensus       151 ~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
                      +|||.+.... ++.++|+||||+++|+|++|..| |.+....+....+.......                         
T Consensus       184 ~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~~~~~~~~~-------------------------  236 (326)
T 2y0a_A          184 VAPEIVNYEP-LGLEADMWSIGVITYILLSGASP-FLGDTKQETLANVSAVNYEF-------------------------  236 (326)
T ss_dssp             CCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCS-SCCSSHHHHHHHHHHTCCCC-------------------------
T ss_pred             CCceeecCCC-CCcHHHHHHHHHHHHHHHHCcCC-CCCCCHHHHHHHHHhcCCCc-------------------------
Confidence            9999997665 79999999999999999998887 66666666666655422111                         


Q ss_pred             ccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      .......+++.+.+||++||+.||.+|||+.++++||||+..+.
T Consensus       237 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  280 (326)
T 2y0a_A          237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  280 (326)
T ss_dssp             CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred             CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence            11223468899999999999999999999999999999998754

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7e-49  Score=333.81  Aligned_cols=272  Identities=32%  Similarity=0.543  Sum_probs=210.2

Q ss_pred             CeeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCC-CCCccceeeeeeeCC--eEEEEEecCcccHHHHHHh
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELK-HKNIVRLYDVLHSEK--KLTLVFEHCDQDLKKYFDS   76 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~--~~~iv~e~~~g~l~~~~~~   76 (282)
                      .||+|.++.+|+.||||++.. .........+.+|+.+++.+. ||||+++++++..++  .+|+||||++|++...+..
T Consensus        24 ~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~L~~~~~~  103 (388)
T 3oz6_A           24 IVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRA  103 (388)
T ss_dssp             CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCSEEHHHHHHH
T ss_pred             EEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccCcCHHHHHHc
Confidence            489999999999999999875 233334566889999999997 999999999997543  7999999999998887765


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCC--------------------
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGI--------------------  136 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~--------------------  136 (282)
                        ..+++..+..++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++.....                    
T Consensus       104 --~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~  181 (388)
T 3oz6_A          104 --NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD  181 (388)
T ss_dssp             --TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC-------
T ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccc
Confidence              5799999999999999999999999999999999999999999999999999976532                    


Q ss_pred             -CccccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCC
Q psy6044         137 -PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNL  215 (282)
Q Consensus       137 -~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  215 (282)
                       .........+|+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+....+.+..+.+.....
T Consensus       182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~p~~~~~~~~~~  260 (388)
T 3oz6_A          182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI-FPGSSTMNQLERIIGVIDFPSNEDVESIQS  260 (388)
T ss_dssp             --------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHHHCCCCHHHHHTSCC
T ss_pred             cccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHhcCCCCHHHHHhccC
Confidence             112233457899999999998765689999999999999999987666 888888888888888877765433221100


Q ss_pred             CCCCC---CC--CCCCCCCCcccc-------------CccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         216 LPDFK---PF--PMYHPSMSFSQV-------------APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       216 ~~~~~---~~--~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      -....   .+  ............             ....++.+.+||++||+.||++|||++++|+||||+....+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~  338 (388)
T 3oz6_A          261 PFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNP  338 (388)
T ss_dssp             SSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCCG
T ss_pred             HHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhcCC
Confidence            00000   00  000000000001             12578999999999999999999999999999999876443

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=9.3e-49  Score=330.85  Aligned_cols=247  Identities=21%  Similarity=0.330  Sum_probs=206.1

Q ss_pred             CeeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      .||+|.++.+|+.||+|++...  ........+.+|+.+++.++||||+++++++.+....|+|+||+.|+.+..+....
T Consensus        30 ~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~  109 (384)
T 4fr4_A           30 KVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN  109 (384)
T ss_dssp             CEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTT
T ss_pred             EEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhc
Confidence            4899999999999999999862  23444577889999999999999999999999999999999999875555555557


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +.+++..++.++.||+.||.|||+.||+|+||||+||+++.+|.++|+|||++...... .......||+.|+|||.+..
T Consensus       110 ~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~~~~~gt~~Y~aPE~~~~  188 (384)
T 4fr4_A          110 VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTMAGTKPYMAPEMFSS  188 (384)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-CCBCCCCSCGGGCCGGGTCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-CceeccCCCccccCCeeecc
Confidence            78999999999999999999999999999999999999999999999999999876533 33345678999999999964


Q ss_pred             C--CCCCchhhHHHHHHHHHHHHhcCCCCCCC--CChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         159 A--KLYTTSIDMWSAGCIFAELANAGRPLFPG--SDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       159 ~--~~~~~~~Di~slG~ll~~ll~~~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      .  ..++.++|+|||||++|+|++|..|+...  ....+....+..                             .....
T Consensus       189 ~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-----------------------------~~~~~  239 (384)
T 4fr4_A          189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET-----------------------------TVVTY  239 (384)
T ss_dssp             CSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH-----------------------------CCCCC
T ss_pred             CCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh-----------------------------cccCC
Confidence            2  34789999999999999999998885432  223333333333                             11223


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCC-HHHHhcCCCccCCccchh
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRMS-AEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rps-~~~ll~h~~~~~~~~~~~  277 (282)
                      +..+++.+.+||++||+.||.+||+ ++++++||||+++++...
T Consensus       240 p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~  283 (384)
T 4fr4_A          240 PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAV  283 (384)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHH
T ss_pred             CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHH
Confidence            4568999999999999999999998 999999999999987643

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.8e-49  Score=331.03  Aligned_cols=244  Identities=24%  Similarity=0.331  Sum_probs=198.1

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHH-HhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICL-LKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~-~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~   77 (282)
                      ||+|+++.+++.||+|++...  ........+..|..+ ++.++||||+++++++.+.+.+|+||||++| ++.+.+ ..
T Consensus        54 V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l-~~  132 (373)
T 2r5t_A           54 VLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHL-QR  132 (373)
T ss_dssp             EEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH-HH
T ss_pred             EEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHH-Hh
Confidence            899999999999999999872  233344566777776 5678999999999999999999999999987 555544 44


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      .+.+++..++.++.||+.||.|||++||+|+||||+||+++.+|.++|+|||++..............||+.|+|||.+.
T Consensus       133 ~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~  212 (373)
T 2r5t_A          133 ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLH  212 (373)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhC
Confidence            67899999999999999999999999999999999999999999999999999976443334445567899999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|+||||+++|+|++|..| |.+.+..+....+...                             ....+..
T Consensus       213 ~~~-~~~~~DiwslG~il~ell~G~~P-f~~~~~~~~~~~i~~~-----------------------------~~~~~~~  261 (373)
T 2r5t_A          213 KQP-YDRTVDWWCLGAVLYEMLYGLPP-FYSRNTAEMYDNILNK-----------------------------PLQLKPN  261 (373)
T ss_dssp             TCC-CCTHHHHHHHHHHHHHHHHSSCT-TCCSBHHHHHHHHHHS-----------------------------CCCCCSS
T ss_pred             CCC-CCchhhhHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHHhc-----------------------------ccCCCCC
Confidence            766 79999999999999999988877 6666777777776652                             1123356


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCccCCccchh
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSA----EDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~----~~ll~h~~~~~~~~~~~  277 (282)
                      +++.+.+||++||+.||.+||++    +++++||||+++++...
T Consensus       262 ~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l  305 (373)
T 2r5t_A          262 ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDL  305 (373)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHH
T ss_pred             CCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHH
Confidence            89999999999999999999986    69999999999987654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=7.3e-49  Score=330.28  Aligned_cols=243  Identities=26%  Similarity=0.364  Sum_probs=202.9

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      .||+|.++.+|+.||+|++... ........+.+|+.+++.++||||+++++++.+++..|+||||++| ++.+.+.. .
T Consensus        44 ~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~  122 (362)
T 2bdw_A           44 VVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA-R  122 (362)
T ss_dssp             EEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT-C
T ss_pred             EEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH-c
Confidence            3899999999999999999863 2223346788999999999999999999999999999999999986 56565544 6


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC---cEEEEecCCccccCCCccccccccccccccChhh
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG---ELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDV  155 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~  155 (282)
                      ..+++..+..++.||+.||.|||++||+|+||||+||+++.++   .++|+|||++...... .......+++.|+|||.
T Consensus       123 ~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~  201 (362)
T 2bdw_A          123 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEV  201 (362)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-CSCCCSCSCTTTCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-cccccCCCCccccCHHH
Confidence            7799999999999999999999999999999999999997654   5999999999876533 23344578999999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      +.+.. ++.++||||||+++|+|++|..| |.+.+..+....+.......+..                         ..
T Consensus       202 ~~~~~-~~~~~DiwslG~il~~ll~g~~P-f~~~~~~~~~~~i~~~~~~~~~~-------------------------~~  254 (362)
T 2bdw_A          202 LKKDP-YSKPVDIWACGVILYILLVGYPP-FWDEDQHRLYAQIKAGAYDYPSP-------------------------EW  254 (362)
T ss_dssp             HTTCC-CCTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHTCCCCCTT-------------------------GG
T ss_pred             HccCC-CCchhhHHHHHHHHHHHHHCCCC-CCCCCHHHHHHHHHhCCCCCCcc-------------------------cc
Confidence            97765 79999999999999999998877 66666666666666543222111                         12


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      ..+++.+.+||.+||+.||.+|||+.++|+||||++.
T Consensus       255 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          255 DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            4589999999999999999999999999999999754

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.3e-49  Score=332.47  Aligned_cols=267  Identities=33%  Similarity=0.519  Sum_probs=212.0

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeee-------------------------
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHS-------------------------   55 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~-------------------------   55 (282)
                      .||+|++..+|+.||||++....     ....+|+.+++.++||||+++++++..                         
T Consensus        22 ~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   96 (383)
T 3eb0_A           22 IVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGV   96 (383)
T ss_dssp             EEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------------------------
T ss_pred             EEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHHcCCCCccchhheeeecCccccccccccccccccccccccc
Confidence            38999999999999999987532     223479999999999999999999843                         


Q ss_pred             -------------CCeEEEEEecCcccHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc-
Q psy6044          56 -------------EKKLTLVFEHCDQDLKKYFD---SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN-  118 (282)
Q Consensus        56 -------------~~~~~iv~e~~~g~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~-  118 (282)
                                   ....++||||++|++.+.+.   ..+..+++..++.++.||+.||.|||+.||+|+||||+||+++ 
T Consensus        97 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~  176 (383)
T 3eb0_A           97 NNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS  176 (383)
T ss_dssp             -------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEET
T ss_pred             ccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcC
Confidence                         34589999999998665554   4467899999999999999999999999999999999999997 


Q ss_pred             CCCcEEEEecCCccccCCCccccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHH
Q psy6044         119 KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRI  198 (282)
Q Consensus       119 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~  198 (282)
                      .++.++|+|||.+....... ......+++.|+|||.+.+...++.++||||+||++|+|++|..| |.+.+..+....+
T Consensus       177 ~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p-f~~~~~~~~~~~i  254 (383)
T 3eb0_A          177 KDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPL-FSGETSIDQLVRI  254 (383)
T ss_dssp             TTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHH
T ss_pred             CCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCC-CCCCChHHHHHHH
Confidence            68899999999998765332 233456788999999998766579999999999999999988766 8888888888888


Q ss_pred             HHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         199 FKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      ....+.+..+.+...+.......++..........++...++.+.+||.+||+.||.+|||+.|+++||||++++.
T Consensus       255 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          255 IQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             HHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred             HHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence            8888776543322211111111111111221222345668999999999999999999999999999999998754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.6e-48  Score=320.12  Aligned_cols=244  Identities=22%  Similarity=0.398  Sum_probs=205.0

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEI   81 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~   81 (282)
                      ||+|+++.+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||||++|+.+..+.. ...+
T Consensus        61 V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~l  138 (321)
T 2c30_A           61 VCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QVRL  138 (321)
T ss_dssp             EEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-TCCC
T ss_pred             EEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH-hcCC
Confidence            8999999999999999987633 2335678899999999999999999999999999999999998755555544 4679


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCCC
Q psy6044          82 DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKL  161 (282)
Q Consensus        82 ~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  161 (282)
                      ++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..............+++.|+|||.+.+.. 
T Consensus       139 ~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-  217 (321)
T 2c30_A          139 NEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSL-  217 (321)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCC-
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCC-
Confidence            9999999999999999999999999999999999999999999999999987765544455567899999999997765 


Q ss_pred             CCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHH
Q psy6044         162 YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAK  241 (282)
Q Consensus       162 ~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (282)
                      ++.++|+||||+++|+|++|..| |......+....+......                          .......+++.
T Consensus       218 ~~~~~Dv~slG~il~el~~g~~p-f~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~  270 (321)
T 2c30_A          218 YATEVDIWSLGIMVIEMVDGEPP-YFSDSPVQAMKRLRDSPPP--------------------------KLKNSHKVSPV  270 (321)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCT-TTTSCHHHHHHHHHHSSCC--------------------------CCTTGGGSCHH
T ss_pred             CCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHhcCCCC--------------------------CcCccccCCHH
Confidence            79999999999999999998888 5555655555555442110                          00112457899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         242 GRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       242 l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      +.++|.+||+.||++|||+.++++||||++...+
T Consensus       271 l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  304 (321)
T 2c30_A          271 LRDFLERMLVRDPQERATAQELLDHPFLLQTGLP  304 (321)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCG
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcChhhccCCCc
Confidence            9999999999999999999999999999876544

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-49  Score=333.14  Aligned_cols=268  Identities=35%  Similarity=0.594  Sum_probs=216.2

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC------eEEEEEecCcccHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK------KLTLVFEHCDQDLKKY   73 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~------~~~iv~e~~~g~l~~~   73 (282)
                      .||+|.+..+|+.||||++... ........+.+|+.+++.++||||+++++++....      .+|+||||+++++.+.
T Consensus        40 ~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~  119 (367)
T 1cm8_A           40 AVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKL  119 (367)
T ss_dssp             CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHH
T ss_pred             EEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecCCCCHHHH
Confidence            4899999999999999998652 22223456789999999999999999999998663      4699999997777776


Q ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccCh
Q psy6044          74 FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP  153 (282)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aP  153 (282)
                      +..  ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++......   .....+++.|+||
T Consensus       120 ~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aP  194 (367)
T 1cm8_A          120 MKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MTGYVVTRWYRAP  194 (367)
T ss_dssp             HHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS---CCSSCSCGGGCCT
T ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc---cCcCcCCCCcCCH
Confidence            654  67999999999999999999999999999999999999999999999999999876532   3445679999999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCC--C-CCCCCCCCCCC
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPD--F-KPFPMYHPSMS  230 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~  230 (282)
                      |.+.+...++.++|+||+||++|+|++|..| |.+.+..+.+..+....+.++.+.+........  + ..++ ......
T Consensus       195 E~~~~~~~~~~~~DiwslG~il~ell~g~~p-f~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  272 (367)
T 1cm8_A          195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTL-FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLP-ELEKKD  272 (367)
T ss_dssp             HHHHTTTCCCTTHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSC-CCCCCC
T ss_pred             HHHhCCCCCChhhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCC-CCCCCC
Confidence            9998755589999999999999999988776 888888888888888888776543322110000  0 0000 111224


Q ss_pred             ccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      +.......++.+.+||.+||..||.+|||++++|+||||+++...
T Consensus       273 ~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          273 FASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  317 (367)
T ss_dssp             GGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             HHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence            455567789999999999999999999999999999999987654

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.3e-48  Score=324.20  Aligned_cols=244  Identities=25%  Similarity=0.387  Sum_probs=196.2

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEI   81 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~   81 (282)
                      ||+|+++.+|+.||+|++.........+.+.+|+.+++.++||||+++++++.+++..++||||++|+.+..+......+
T Consensus        23 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~  102 (323)
T 3tki_A           23 VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM  102 (323)
T ss_dssp             EEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTBC
T ss_pred             EEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCC
Confidence            89999999999999999987544455678999999999999999999999999999999999999875444444546679


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC--ccccccccccccccChhhhcCC
Q psy6044          82 DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        82 ~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      ++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++......  ........+++.|+|||.+.+.
T Consensus       103 ~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  182 (323)
T 3tki_A          103 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR  182 (323)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCS
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccC
Confidence            99999999999999999999999999999999999999999999999999765322  2223345779999999999877


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      ..++.++||||||+++|+|++|..|+.................                           ........++
T Consensus       183 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~  235 (323)
T 3tki_A          183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK---------------------------TYLNPWKKID  235 (323)
T ss_dssp             SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC---------------------------TTSTTGGGSC
T ss_pred             CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc---------------------------ccCCccccCC
Confidence            6558899999999999999998888543333222222222110                           0011124589


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      +.+.+||.+||+.||.+|||++|+++||||++.
T Consensus       236 ~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  268 (323)
T 3tki_A          236 SAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (323)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence            999999999999999999999999999999864

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.8e-48  Score=331.74  Aligned_cols=246  Identities=22%  Similarity=0.313  Sum_probs=205.7

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      ||+|+++.+|+.||+|++..  .........+.+|+.+++.++||||+++++++.++..+|+||||++| ++.+.+.  .
T Consensus        85 V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~--~  162 (410)
T 3v8s_A           85 VQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS--N  162 (410)
T ss_dssp             EEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH--H
T ss_pred             EEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHH--c
Confidence            89999999999999999986  22334457789999999999999999999999999999999999975 5555543  3


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~  157 (282)
                      ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++........ ......||+.|+|||++.
T Consensus       163 ~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~  242 (410)
T 3v8s_A          163 YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK  242 (410)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhh
Confidence            5799999999999999999999999999999999999999999999999999987654332 233557899999999997


Q ss_pred             CCC---CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         158 GAK---LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       158 ~~~---~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      ...   .++.++|+||||+++|+|++|..| |.+.+..+....+........-                         ..
T Consensus       243 ~~~~~~~~~~~~DiwSlGvilyell~G~~P-f~~~~~~~~~~~i~~~~~~~~~-------------------------p~  296 (410)
T 3v8s_A          243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTP-FYADSLVGTYSKIMNHKNSLTF-------------------------PD  296 (410)
T ss_dssp             TTTTTCEEETHHHHHHHHHHHHHHHHSSCT-TCCSSHHHHHHHHHTHHHHCCC-------------------------CT
T ss_pred             ccCCCcCCCCcceEecchHHHHHHHhCCCC-CCCCChhhHHHHHHhccccccC-------------------------CC
Confidence            653   157899999999999999998887 6677777777776653211100                         01


Q ss_pred             CccCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCCccc
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQ--RMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~h~~~~~~~~~  275 (282)
                      ...+|+.+++||++||..+|.+  ||++++|++||||+++++.
T Consensus       297 ~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~  339 (410)
T 3v8s_A          297 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA  339 (410)
T ss_dssp             TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred             cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence            1348999999999999999988  9999999999999999764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-49  Score=326.04  Aligned_cols=243  Identities=23%  Similarity=0.354  Sum_probs=205.1

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      .||+|.++.+|+.||+|.+...  ......+.+|+.+++.++||||+++++++.+....++||||++| ++.+.+.....
T Consensus        20 ~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~   97 (321)
T 1tki_A           20 IVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF   97 (321)
T ss_dssp             EEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSC
T ss_pred             EEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCC
Confidence            3899999999999999998742  22345678999999999999999999999999999999999986 67776665556


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC--CCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK--NGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      .+++..++.++.||+.||.|||++|++|+||||+||+++.  ++.++|+|||.+...... .......+++.|+|||.+.
T Consensus        98 ~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~  176 (321)
T 1tki_A           98 ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQ  176 (321)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CEEEEEESCGGGSCHHHHT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-CccccccCChhhcCcHHhc
Confidence            7999999999999999999999999999999999999987  789999999999876533 2334456789999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|+||||+++|+|++|..| |.+.+..+....+.......+                         ......
T Consensus       177 ~~~-~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~  229 (321)
T 1tki_A          177 HDV-VSTATDMWSLGTLVYVLLSGINP-FLAETNQQIIENIMNAEYTFD-------------------------EEAFKE  229 (321)
T ss_dssp             TCE-ECHHHHHHHHHHHHHHHHHSSCT-TCCSSHHHHHHHHHHTCCCCC-------------------------HHHHTT
T ss_pred             CCC-CCchhhHHHHHHHHHHHHhCCCC-CcCCCHHHHHHHHHcCCCCCC-------------------------hhhhcc
Confidence            765 68999999999999999998887 666777777777666332211                         112245


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      +++++.+||++||..||.+|||+.++|+||||++..
T Consensus       230 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence            899999999999999999999999999999998653

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-48  Score=320.55  Aligned_cols=241  Identities=25%  Similarity=0.393  Sum_probs=196.7

Q ss_pred             eeeeeeCCCCceEEEeeeecCCC-------------------------CCCCccHHHHHHHHhhCCCCCccceeeeeee-
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGN-------------------------EGVPSSALREICLLKELKHKNIVRLYDVLHS-   55 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~-------------------------~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~-   55 (282)
                      ||+|+++.+|+.||||++.....                         ....+.+.+|+.++++++||||+++++++.+ 
T Consensus        29 Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  108 (298)
T 2zv2_A           29 VKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDP  108 (298)
T ss_dssp             EEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             EEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            89999999999999999976321                         1224678999999999999999999999987 


Q ss_pred             -CCeEEEEEecCcccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCcccc
Q psy6044          56 -EKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF  134 (282)
Q Consensus        56 -~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~  134 (282)
                       ....++||||++|+.+..+.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus       109 ~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  187 (298)
T 2zv2_A          109 NEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF  187 (298)
T ss_dssp             SSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCcccc
Confidence             568999999998654444333 467999999999999999999999999999999999999999999999999999877


Q ss_pred             CCCccccccccccccccChhhhcCCCC--CCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCC
Q psy6044         135 GIPVKCYSAEVVTLWYRPPDVLFGAKL--YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPG  212 (282)
Q Consensus       135 ~~~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  212 (282)
                      ...........+++.|+|||.+.+...  ++.++||||||+++|+|++|..| |...........+.......+      
T Consensus       188 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~------  260 (298)
T 2zv2_A          188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP-FMDERIMCLHSKIKSQALEFP------  260 (298)
T ss_dssp             SSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHCCCCCC------
T ss_pred             ccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC-CCCccHHHHHHHHhcccCCCC------
Confidence            654444455678999999999866542  37889999999999999998888 555555555554443211100      


Q ss_pred             CCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q psy6044         213 MNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD  271 (282)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  271 (282)
                                           ....+++.+.++|.+||+.||++|||+.++++||||+.
T Consensus       261 ---------------------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          261 ---------------------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             ---------------------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             ---------------------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence                                 12358899999999999999999999999999999963

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3e-47  Score=316.47  Aligned_cols=271  Identities=43%  Similarity=0.762  Sum_probs=222.1

Q ss_pred             eeeeeeC-CCCceEEEeeeec-CCCCCCCccHHHHHHHHhhC---CCCCccceeeeee-----eCCeEEEEEecCcccHH
Q psy6044           2 FTSGVDR-TPNTALAIKGTHL-VGNEGVPSSALREICLLKEL---KHKNIVRLYDVLH-----SEKKLTLVFEHCDQDLK   71 (282)
Q Consensus         2 vy~a~~~-~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l---~h~~i~~~~~~~~-----~~~~~~iv~e~~~g~l~   71 (282)
                      ||+|++. .+|+.||+|++.. .........+.+|+.+++.+   +||||+++++++.     .....++|+||++|++.
T Consensus        27 V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~  106 (326)
T 1blx_A           27 VFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT  106 (326)
T ss_dssp             EEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHH
T ss_pred             EEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCCCCHH
Confidence            8999995 6789999999987 33444556788898888877   8999999999987     55789999999999998


Q ss_pred             HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccc
Q psy6044          72 KYFDSLN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWY  150 (282)
Q Consensus        72 ~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  150 (282)
                      +.+.... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+...... .......++..|
T Consensus       107 ~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y  185 (326)
T 1blx_A          107 TYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWY  185 (326)
T ss_dssp             HHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG-GGGCCCCCCCTT
T ss_pred             HHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCC-CCccccccccce
Confidence            8887653 34999999999999999999999999999999999999999999999999999766532 233445678999


Q ss_pred             cChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMS  230 (282)
Q Consensus       151 ~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
                      +|||.+.+.. ++.++||||||+++|+|++|..| |.+....+....+....+.+....++.........  ........
T Consensus       186 ~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  261 (326)
T 1blx_A          186 RAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPL-FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA--FHSKSAQP  261 (326)
T ss_dssp             CCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGG--SCCCCCCC
T ss_pred             eCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHHHHcCCCCcccCccccccchhh--hcccCcch
Confidence            9999997766 79999999999999999988766 78888888888888888877766665432221110  11112224


Q ss_pred             ccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccchh
Q psy6044         231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  277 (282)
                      .......+++.+.+||.+||+.||.+|||+.++++||||++++.+..
T Consensus       262 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~  308 (326)
T 1blx_A          262 IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE  308 (326)
T ss_dssp             GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred             hhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhhh
Confidence            45566789999999999999999999999999999999999876543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.6e-48  Score=337.74  Aligned_cols=241  Identities=26%  Similarity=0.418  Sum_probs=203.8

Q ss_pred             CeeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      .||+|++..+|+.||||++...  ........+.+|+.+++.++||||+++++++.+....++|+||++|+.+..+....
T Consensus        31 ~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~  110 (476)
T 2y94_A           31 KVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN  110 (476)
T ss_dssp             CEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSS
T ss_pred             EEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhc
Confidence            4899999999999999999862  22334567899999999999999999999999999999999999764444444446


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +.+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++...... .......+++.|+|||.+.+
T Consensus       111 ~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~  189 (476)
T 2y94_A          111 GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISG  189 (476)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-CCBCCCCSCSTTCCHHHHTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-ccccccCCCcCeEChhhccC
Confidence            78999999999999999999999999999999999999999999999999999876533 22344578999999999987


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      ....+.++||||||+++|+|++|..| |.+.+..+....+....                             ...+..+
T Consensus       190 ~~~~~~~~DiwSlGvil~elltG~~P-f~~~~~~~~~~~i~~~~-----------------------------~~~p~~~  239 (476)
T 2y94_A          190 RLYAGPEVDIWSSGVILYALLCGTLP-FDDDHVPTLFKKICDGI-----------------------------FYTPQYL  239 (476)
T ss_dssp             CCBCSHHHHHHHHHHHHHHHHHSSCS-SCCSSSHHHHHHHHTTC-----------------------------CCCCTTC
T ss_pred             CCCCCCcceehhhHHHHHHHhhCCCC-CCCCCHHHHHHHHhcCC-----------------------------cCCCccC
Confidence            76557899999999999999998887 66666666666654421                             1123457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      ++.+.+||++||+.||.+|||++++++||||++.
T Consensus       240 s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          240 NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             CHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            8999999999999999999999999999999853

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.1e-48  Score=332.73  Aligned_cols=251  Identities=21%  Similarity=0.315  Sum_probs=209.5

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      ||+|+++.+|+.||+|++..  .........+.+|..++..++||||+++++++.+++.+|+||||++| ++.+.+....
T Consensus        90 V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~  169 (437)
T 4aw2_A           90 VAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE  169 (437)
T ss_dssp             EEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTT
T ss_pred             EEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHcc
Confidence            89999999999999999986  22334456799999999999999999999999999999999999965 6666666556


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~  157 (282)
                      +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ......||+.|+|||.+.
T Consensus       170 ~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~  249 (437)
T 4aw2_A          170 DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ  249 (437)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHh
Confidence            7899999999999999999999999999999999999999999999999999976643322 233457899999999986


Q ss_pred             ----CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         158 ----GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       158 ----~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                          +...++.++|+||||+++|+|++|..| |.+.+..+....+.......                        ..+.
T Consensus       250 ~~~~~~~~~~~~~DvwSlGvil~elltG~~P-f~~~~~~~~~~~i~~~~~~~------------------------~~p~  304 (437)
T 4aw2_A          250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETP-FYAESLVETYGKIMNHKERF------------------------QFPT  304 (437)
T ss_dssp             HHHTSCCEECTHHHHHHHHHHHHHHHHSSCT-TCCSSHHHHHHHHHTHHHHC------------------------CCCS
T ss_pred             hcccCCCCCCCcCeeHHHHHHHHHHHhCCCC-CCCCChhHHHHhhhhccccc------------------------cCCc
Confidence                233479999999999999999998888 66777777777665432111                        1111


Q ss_pred             cCccCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCCccchh
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQ--RMSAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~h~~~~~~~~~~~  277 (282)
                      ....+++++++||++||..+|++  |++++++++||||++++++..
T Consensus       305 ~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l  350 (437)
T 4aw2_A          305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI  350 (437)
T ss_dssp             SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred             ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence            22458999999999999988888  999999999999999987765

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.7e-48  Score=325.78  Aligned_cols=245  Identities=24%  Similarity=0.429  Sum_probs=201.0

Q ss_pred             CeeeeeeCCCCceEEEeeeecC----CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV----GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFD   75 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~   75 (282)
                      .||+|.++.+|+.||||++...    ......+.+.+|+.+++.++||||+++++++.+++.+|+||||++| ++.+.+.
T Consensus        39 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~  118 (351)
T 3c0i_A           39 VVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIV  118 (351)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHH
T ss_pred             EEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHH
Confidence            3899999999999999999751    2222356789999999999999999999999999999999999985 6656554


Q ss_pred             hc---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc---EEEEecCCccccCCCcccccccccccc
Q psy6044          76 SL---NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVKCYSAEVVTLW  149 (282)
Q Consensus        76 ~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~  149 (282)
                      ..   ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.   ++|+|||++..............+++.
T Consensus       119 ~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~  198 (351)
T 3c0i_A          119 KRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPH  198 (351)
T ss_dssp             HHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGG
T ss_pred             HhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcC
Confidence            42   335899999999999999999999999999999999999987654   999999999887655444455678999


Q ss_pred             ccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSM  229 (282)
Q Consensus       150 ~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
                      |+|||.+.+.. ++.++||||||+++|+|++|..|+. +. ..+....+........                       
T Consensus       199 y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~-~~-~~~~~~~i~~~~~~~~-----------------------  252 (351)
T 3c0i_A          199 FMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFY-GT-KERLFEGIIKGKYKMN-----------------------  252 (351)
T ss_dssp             GCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSC-SS-HHHHHHHHHHTCCCCC-----------------------
T ss_pred             ccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCC-Cc-HHHHHHHHHcCCCCCC-----------------------
Confidence            99999997766 6999999999999999999988854 33 3444444444211111                       


Q ss_pred             CccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                        ......+++.+.+||++||+.||++|||+.++++||||++.+
T Consensus       253 --~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          253 --PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             --HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             --ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence              112245899999999999999999999999999999998754

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5.2e-48  Score=315.05  Aligned_cols=248  Identities=26%  Similarity=0.351  Sum_probs=206.4

Q ss_pred             eeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      ||+|.++.+|+.||+|++.. .........+.+|+.++++++||||+++++++.+++..++|+||++| ++.+.+.. ..
T Consensus        22 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~  100 (284)
T 3kk8_A           22 VRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA-RE  100 (284)
T ss_dssp             EEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HS
T ss_pred             EEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHh-cC
Confidence            89999999999999999987 33333446788999999999999999999999999999999999986 56565554 57


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc---EEEEecCCccccCCCccccccccccccccChhhh
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~  156 (282)
                      .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.   ++|+|||.+....... ......+++.|+|||.+
T Consensus       101 ~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~  179 (284)
T 3kk8_A          101 FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-AWHGFAGTPGYLSPEVL  179 (284)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC-BCCCSCSCGGGCCHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc-cccCCCCCcCCcCchhh
Confidence            7999999999999999999999999999999999999987655   9999999997765332 33445679999999999


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       157 ~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      .+.. ++.++||||||+++|++++|..| |.+....+....+.......+..                         ...
T Consensus       180 ~~~~-~~~~~Di~slG~~l~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~  232 (284)
T 3kk8_A          180 KKDP-YSKPVDIWACGVILYILLVGYPP-FWDEDQHRLYAQIKAGAYDYPSP-------------------------EWD  232 (284)
T ss_dssp             TTCC-BCTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHTCCCCCTT-------------------------TTT
T ss_pred             cCCC-CCcccchHHHHHHHHHHHHCCCC-CCCCchhHHHHHHHhccccCCch-------------------------hhc
Confidence            7766 69999999999999999998888 56666666666665533222211                         123


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccchhh
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKS  278 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~  278 (282)
                      .+++.+.+||.+||+.||.+|||++++++||||++.+.....
T Consensus       233 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~  274 (284)
T 3kk8_A          233 TVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASA  274 (284)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGS
T ss_pred             ccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhH
Confidence            578999999999999999999999999999999987654443

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.9e-48  Score=329.49  Aligned_cols=267  Identities=34%  Similarity=0.538  Sum_probs=208.9

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC------eEEEEEecCcccHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK------KLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~------~~~iv~e~~~g~l~~~~   74 (282)
                      .||+|++..+++ +|+|++....     ....+|+.+++.++||||+++++++....      .+++||||++++++..+
T Consensus        55 ~V~~a~~~~~~~-~aikk~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~  128 (394)
T 4e7w_A           55 VVFQAKLVESDE-VAIKKVLQDK-----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRAS  128 (394)
T ss_dssp             EEEEEEETTTEE-EEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHH
T ss_pred             EEEEEEECCCCe-EEEEEEecCc-----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHH
Confidence            389999987776 8888876422     22337999999999999999999996543      48899999999877665


Q ss_pred             Hh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc-CCCcEEEEecCCccccCCCccccccccccccc
Q psy6044          75 DS---LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLWY  150 (282)
Q Consensus        75 ~~---~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  150 (282)
                      ..   ....+++..++.++.||+.||+|||++||+|+||||+||+++ .++.++|+|||++........ .....+++.|
T Consensus       129 ~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~-~~~~~~t~~y  207 (394)
T 4e7w_A          129 RHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP-NVSYICSRYY  207 (394)
T ss_dssp             HHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC-CCSSCSCGGG
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC-CcccccCcCc
Confidence            43   356799999999999999999999999999999999999999 799999999999987643322 3345678999


Q ss_pred             cChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMS  230 (282)
Q Consensus       151 ~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
                      +|||.+.+...++.++||||+||++|+|++|..| |.+.+..+....+.+.++.+..+.+...+.......++.......
T Consensus       208 ~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~  286 (394)
T 4e7w_A          208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQPL-FPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPF  286 (394)
T ss_dssp             CCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCH
T ss_pred             cCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcH
Confidence            9999997766589999999999999999988766 888888888888888877765432221111000011111111111


Q ss_pred             ccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ...+...+++++.+||.+||+.||.+|||+.++++||||++++..
T Consensus       287 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  331 (394)
T 4e7w_A          287 SKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG  331 (394)
T ss_dssp             HHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred             HHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence            223345689999999999999999999999999999999988654

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.4e-49  Score=340.83  Aligned_cols=266  Identities=32%  Similarity=0.571  Sum_probs=206.1

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC------CeEEEEEecCcccHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSE------KKLTLVFEHCDQDLKKY   73 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~------~~~~iv~e~~~g~l~~~   73 (282)
                      .||+|.+..+|+.||||++... ........+.+|+.+++.++||||+++++++...      ..+|+||||++|++...
T Consensus        77 ~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~  156 (464)
T 3ttj_A           77 IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV  156 (464)
T ss_dssp             EEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHH
T ss_pred             EEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHH
Confidence            3899999999999999999862 2333456788999999999999999999999654      46899999999998887


Q ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccCh
Q psy6044          74 FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP  153 (282)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aP  153 (282)
                      +.   ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++...+.. .......+|+.|+||
T Consensus       157 ~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aP  232 (464)
T 3ttj_A          157 IQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAP  232 (464)
T ss_dssp             HT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C-CCC----CCCTTCCH
T ss_pred             Hh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC-cccCCCcccccccCH
Confidence            64   35999999999999999999999999999999999999999999999999999876533 233456789999999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCC-CCCCCCCCCCCCCcc
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLP-DFKPFPMYHPSMSFS  232 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  232 (282)
                      |++.+.. ++.++|||||||++|+|++|+.| |.+.+..+....+.+.++.+.++.+....... .+...........+.
T Consensus       233 E~~~~~~-~~~~~DiwSlG~il~ell~g~~p-F~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (464)
T 3ttj_A          233 EVILGMG-YKENVDIWSVGCIMGEMVRHKIL-FPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFP  310 (464)
T ss_dssp             HHHTTCC-CCTTHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHH
T ss_pred             HHHcCCC-CCHHHHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChH
Confidence            9998776 79999999999999999987766 88889999999999988887654433221000 000000000000111


Q ss_pred             ccC------------ccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         233 QVA------------PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       233 ~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      ...            ...++.+.+||++||+.||++|||++|+|+||||+..
T Consensus       311 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~  362 (464)
T 3ttj_A          311 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  362 (464)
T ss_dssp             HHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             HhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence            111            1126789999999999999999999999999999864

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5.8e-48  Score=330.93  Aligned_cols=268  Identities=34%  Similarity=0.491  Sum_probs=208.5

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC------CeEEEEEecCcccHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE------KKLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~------~~~~iv~e~~~g~l~~~~   74 (282)
                      .||+|+++.+|+.||||++....     ....+|+++++.++||||+++++++...      ..+++|+||+++++...+
T Consensus        69 ~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~  143 (420)
T 1j1b_A           69 VVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA  143 (420)
T ss_dssp             EEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCEEHHHHH
T ss_pred             EEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccccHHHHH
Confidence            38999999999999999987532     2344799999999999999999998542      347899999999877665


Q ss_pred             H---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC-CcEEEEecCCccccCCCccccccccccccc
Q psy6044          75 D---SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWY  150 (282)
Q Consensus        75 ~---~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  150 (282)
                      .   .....+++..++.++.||+.||.|||++||+|+||||+||+++.+ +.+||+|||++........ .....+++.|
T Consensus       144 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~-~~~~~~t~~y  222 (420)
T 1j1b_A          144 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-NVSYICSRYY  222 (420)
T ss_dssp             HHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC-CCSCCSCTTS
T ss_pred             HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC-ceeeeeCCCc
Confidence            4   335779999999999999999999999999999999999999965 5789999999987643322 2345679999


Q ss_pred             cChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMS  230 (282)
Q Consensus       151 ~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
                      +|||.+.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+.++.+..+.+...+.......++.......
T Consensus       223 ~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~p-f~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~  301 (420)
T 1j1b_A          223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI-FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPW  301 (420)
T ss_dssp             CCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCH
T ss_pred             CCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCH
Confidence            9999997765589999999999999999988766 788888888888888777665432221110000001111111111


Q ss_pred             ccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ...+....++++.+||++||..||.+|||+.++++||||+++...
T Consensus       302 ~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  346 (420)
T 1j1b_A          302 TKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  346 (420)
T ss_dssp             HHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             HHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccc
Confidence            112345689999999999999999999999999999999987654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=7.4e-48  Score=322.81  Aligned_cols=242  Identities=25%  Similarity=0.367  Sum_probs=187.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~   80 (282)
                      ||+|+++.+++.||||++....   ..+.+.+|+.++++++||||+++++++.+....++||||++| ++.+.+.. .+.
T Consensus        69 Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~  144 (349)
T 2w4o_A           69 VYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE-KGY  144 (349)
T ss_dssp             EEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT-CSS
T ss_pred             EEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHh-cCC
Confidence            8999999999999999998632   235678899999999999999999999999999999999976 55555544 677


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC---CCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK---NGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      +++..++.++.||+.||.|||+.|++|+||||+||+++.   ++.++|+|||++...... .......+++.|+|||.+.
T Consensus       145 ~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~  223 (349)
T 2w4o_A          145 YSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPEILR  223 (349)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----------------CGGGSCHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-cccccccCCCCccCHHHhc
Confidence            999999999999999999999999999999999999975   889999999998766432 2223456789999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++||||||+++|+|++|..|++...........+........                         ......
T Consensus       224 ~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~  277 (349)
T 2w4o_A          224 GCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFI-------------------------SPWWDE  277 (349)
T ss_dssp             TCC-CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCC-------------------------TTTTTT
T ss_pred             CCC-CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccC-------------------------Cchhhh
Confidence            766 799999999999999999999997666665555555544221111                         112245


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      ++..+.+||++||+.||++|||+.++++||||++...
T Consensus       278 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          278 VSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA  314 (349)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence            8999999999999999999999999999999997654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=9e-48  Score=319.04  Aligned_cols=246  Identities=22%  Similarity=0.379  Sum_probs=204.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCC-----CCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEG-----VPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~   75 (282)
                      ||+|+++.+|+.||+|++.......     ....+.+|+.++++++||||+++++++.+....++|+||++| ++.+.+ 
T Consensus        28 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l-  106 (321)
T 2a2a_A           28 VKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-  106 (321)
T ss_dssp             EEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH-
T ss_pred             EEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHH-
Confidence            8999999999999999998732221     245688999999999999999999999999999999999976 555555 


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC----cEEEEecCCccccCCCcccccccccccccc
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG----ELKLADFGLARAFGIPVKCYSAEVVTLWYR  151 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  151 (282)
                      ...+.+++..++.++.||+.||.+||+.|++|+||+|+||+++.++    .++|+|||.+....... ......+++.|+
T Consensus       107 ~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~gt~~y~  185 (321)
T 2a2a_A          107 AQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-EFKNIFGTPEFV  185 (321)
T ss_dssp             HTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC-CCCCCCSCGGGC
T ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccc-cccccCCCCCcc
Confidence            4467899999999999999999999999999999999999999887    79999999998765432 234456789999


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSF  231 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
                      |||.+.+.. ++.++|+||||+++|+|++|..| |.+....+....+......                         ..
T Consensus       186 aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p-f~~~~~~~~~~~i~~~~~~-------------------------~~  238 (321)
T 2a2a_A          186 APEIVNYEP-LGLEADMWSIGVITYILLSGASP-FLGDTKQETLANITSVSYD-------------------------FD  238 (321)
T ss_dssp             CHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCS-SCCSSHHHHHHHHHTTCCC-------------------------CC
T ss_pred             CcccccCCC-CCCccccHHHHHHHHHHHHCCCC-CCCCCHHHHHHHHHhcccc-------------------------cC
Confidence            999997665 69999999999999999998888 6666666666655442111                         11


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      ......+++.+.+||++||+.||.+|||+.++++||||++++...
T Consensus       239 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~~  283 (321)
T 2a2a_A          239 EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQ  283 (321)
T ss_dssp             HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHHH
T ss_pred             hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCccc
Confidence            122346889999999999999999999999999999999876543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-48  Score=322.29  Aligned_cols=236  Identities=22%  Similarity=0.282  Sum_probs=192.4

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|+++.+|+.||||++... ...........|+..+..+ +||||+++++++.+.+..++||||++|++.+.+.....
T Consensus        73 Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~  152 (311)
T 3p1a_A           73 VFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGA  152 (311)
T ss_dssp             EEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCCCBHHHHHHHHCS
T ss_pred             EEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEeccCCCHHHHHHhcCC
Confidence            899999999999999987652 2222233455555555555 99999999999999999999999999999999888778


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++...+... ......+++.|+|||.+.+ 
T Consensus       153 ~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-  230 (311)
T 3p1a_A          153 SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-AGEVQEGDPRYMAPELLQG-  230 (311)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-------CCCCCGGGCCGGGGGT-
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-CCcccCCCccccCHhHhcC-
Confidence            89999999999999999999999999999999999999999999999999987765332 2334467999999999876 


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      . ++.++||||||+++|+|++|..+++....    ...+....                           .....+..++
T Consensus       231 ~-~~~~~DiwslG~il~el~~g~~~~~~~~~----~~~~~~~~---------------------------~~~~~~~~~~  278 (311)
T 3p1a_A          231 S-YGTAADVFSLGLTILEVACNMELPHGGEG----WQQLRQGY---------------------------LPPEFTAGLS  278 (311)
T ss_dssp             C-CSTHHHHHHHHHHHHHHHHTCCCCSSHHH----HHHHTTTC---------------------------CCHHHHTTSC
T ss_pred             C-CCchhhHHHHHHHHHHHHhCCCCCCCccH----HHHHhccC---------------------------CCcccccCCC
Confidence            3 79999999999999999999887654321    11111100                           1122345689


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD  271 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  271 (282)
                      +.+.+||.+||+.||++|||++++++||||++
T Consensus       279 ~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          279 SELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            99999999999999999999999999999985

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-48  Score=329.38  Aligned_cols=250  Identities=23%  Similarity=0.311  Sum_probs=206.3

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~~   78 (282)
                      ||+|+++.+|+.||+|++.+  .........+.+|..++..++||||+++++++.+++.+|+||||++ |++.+.+....
T Consensus        77 V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~  156 (412)
T 2vd5_A           77 VAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG  156 (412)
T ss_dssp             EEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS
T ss_pred             EEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcC
Confidence            89999999999999999986  1223345678999999999999999999999999999999999996 56777766655


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~  157 (282)
                      ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........ ......||+.|+|||++.
T Consensus       157 ~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~  236 (412)
T 2vd5_A          157 ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ  236 (412)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHh
Confidence            6899999999999999999999999999999999999999999999999999987654332 223457899999999986


Q ss_pred             C------CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q psy6044         158 G------AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSF  231 (282)
Q Consensus       158 ~------~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
                      .      ...++.++|+|||||++|+|++|..| |.+.+..+....+.......                        ..
T Consensus       237 ~~~~~~~~~~~~~~~DiwSlGvilyelltG~~P-f~~~~~~~~~~~i~~~~~~~------------------------~~  291 (412)
T 2vd5_A          237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP-FYADSTAETYGKIVHYKEHL------------------------SL  291 (412)
T ss_dssp             HHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCT-TCCSSHHHHHHHHHTHHHHC------------------------CC
T ss_pred             hcccCcCCCCCChHHhhhHHhHHHHHHHhCCCC-CCCCCHHHHHHHHHhcccCc------------------------CC
Confidence            2      23378999999999999999998887 66667677666665422110                        11


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCC---CCHHHHhcCCCccCCccchh
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQR---MSAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~R---ps~~~ll~h~~~~~~~~~~~  277 (282)
                      ......+|+++++||++||. +|.+|   |+++++++||||++++++..
T Consensus       292 p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l  339 (412)
T 2vd5_A          292 PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL  339 (412)
T ss_dssp             C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred             CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence            11224589999999999999 99998   59999999999999987654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.2e-48  Score=328.02  Aligned_cols=270  Identities=34%  Similarity=0.591  Sum_probs=216.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC-----CeEEEEEecCcccHHHHHHh
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE-----KKLTLVFEHCDQDLKKYFDS   76 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~-----~~~~iv~e~~~g~l~~~~~~   76 (282)
                      ||+|++..+|+.||||++...........+.+|+.++++++||||+++++++...     ...++|+|+++|++.+.+..
T Consensus        43 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~  122 (364)
T 3qyz_A           43 VCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT  122 (364)
T ss_dssp             EEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSEEHHHHHHH
T ss_pred             EEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccCcCHHHHHHh
Confidence            8999999999999999987543333446788999999999999999999999765     47899999999998887765


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc---ccccccccccccCh
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK---CYSAEVVTLWYRPP  153 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~aP  153 (282)
                        ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+........   ......+++.|+||
T Consensus       123 --~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP  200 (364)
T 3qyz_A          123 --QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP  200 (364)
T ss_dssp             --CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCH
T ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCC
Confidence              5799999999999999999999999999999999999999999999999999977653321   12344779999999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCC--CCCCCCCCCCCCc
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPD--FKPFPMYHPSMSF  231 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  231 (282)
                      |.+.+...++.++||||||+++|+|++|..| |.+.+..+....+....+.+..+.+........  ............+
T Consensus       201 E~~~~~~~~~~~~DiwslG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (364)
T 3qyz_A          201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPI-FPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPW  279 (364)
T ss_dssp             HHHHTBCSCSTHHHHHHHHHHHHHHHHSSCS-SCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCH
T ss_pred             HHhcCCCCCCcchhHHHHHHHHHHHHHCCCC-CCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCH
Confidence            9987766679999999999999999988766 788888888888887777665432221100000  0000001112234


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      ....+.+++.+.+||++||+.||.+|||++++|+||||++...
T Consensus       280 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          280 NRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             HHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence            4556678999999999999999999999999999999998743

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.9e-48  Score=329.17  Aligned_cols=269  Identities=34%  Similarity=0.578  Sum_probs=212.3

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeE------EEEEecCcccHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKL------TLVFEHCDQDLKKYF   74 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~------~iv~e~~~g~l~~~~   74 (282)
                      ||+|.++.+|+.||||++... ........+.+|+.+++.++||||+++++++......      ++|+||++|++.+.+
T Consensus        58 Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~  137 (371)
T 4exu_A           58 VCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM  137 (371)
T ss_dssp             EEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHT
T ss_pred             EEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEccccccHHHHh
Confidence            899999999999999999763 2222356788999999999999999999999877654      999999999887765


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChh
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPD  154 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE  154 (282)
                         ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||.+......   .....+++.|+|||
T Consensus       138 ---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~~t~~y~aPE  211 (371)
T 4exu_A          138 ---GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPE  211 (371)
T ss_dssp             ---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----------CTTCCCTTSCHH
T ss_pred             ---hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC---cCCcccCccccCHH
Confidence               346999999999999999999999999999999999999999999999999999866533   23456789999999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCC--CCCCCCCCCCCCcc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPD--FKPFPMYHPSMSFS  232 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  232 (282)
                      .+.+...++.++||||||+++|+|++|..| |.+.+..+....+....+.++.+.+........  ..............
T Consensus       212 ~~~~~~~~~~~~DiwslG~il~el~~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (371)
T 4exu_A          212 VILSWMHYNQTVDIWSVGCIMAEMLTGKTL-FKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFT  290 (371)
T ss_dssp             HHSCCSCCCTTHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHH
T ss_pred             HhcCCCCCCcHHhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHH
Confidence            998755589999999999999999988777 788888888888888777665443322110000  00000011112334


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccchh
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  277 (282)
                      .....+++.+.+||++||+.||.+|||++++|+||||+.+..+..
T Consensus       291 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  335 (371)
T 4exu_A          291 QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEE  335 (371)
T ss_dssp             HHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGG
T ss_pred             HhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCccc
Confidence            455678999999999999999999999999999999998865543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=9.8e-48  Score=321.76  Aligned_cols=241  Identities=24%  Similarity=0.336  Sum_probs=202.4

Q ss_pred             eeeeeeCCCCceEEEeeeecCCC--CCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGN--EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|++..+|+.||||++.....  ......+.+|+.++++++||||+++++++.+++..++||||+.|++.+.+.....
T Consensus        70 Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~  149 (348)
T 1u5q_A           70 VYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK  149 (348)
T ss_dssp             EEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTS
T ss_pred             EEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCCCCHHHHHHHhcC
Confidence            89999999999999999976322  2223568899999999999999999999999999999999999999998877778


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC-
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG-  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-  158 (282)
                      .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......    ....+++.|+|||.+.. 
T Consensus       150 ~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~----~~~~gt~~y~aPE~~~~~  225 (348)
T 1u5q_A          150 PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILAM  225 (348)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----CCCCSCGGGCCHHHHHTT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC----CcccCCcceeCHhhhccc
Confidence            8999999999999999999999999999999999999999999999999999766432    23467999999999853 


Q ss_pred             -CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         159 -AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       159 -~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                       ...++.++||||||+++|+|++|..|+ ...+..+....+......                           ......
T Consensus       226 ~~~~~~~~~DiwslG~il~ell~g~~p~-~~~~~~~~~~~~~~~~~~---------------------------~~~~~~  277 (348)
T 1u5q_A          226 DEGQYDGKVDVWSLGITCIELAERKPPL-FNMNAMSALYHIAQNESP---------------------------ALQSGH  277 (348)
T ss_dssp             SSCCBCTHHHHHHHHHHHHHHHHSSCTT-TTSCHHHHHHHHHHSCCC---------------------------CCCCTT
T ss_pred             cCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHhcCCC---------------------------CCCCCC
Confidence             344789999999999999999988884 454554444444432110                           001235


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      +++.+.+||.+||+.||++|||++++++||||.....
T Consensus       278 ~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~  314 (348)
T 1u5q_A          278 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  314 (348)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred             CCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence            7899999999999999999999999999999986543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.7e-48  Score=327.99  Aligned_cols=246  Identities=25%  Similarity=0.363  Sum_probs=207.3

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      .||+|.+..+|+.||+|++..... .....+.+|+.++++++||||+++++++.+.+..++||||++| ++.+.+.....
T Consensus       104 ~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~  182 (373)
T 2x4f_A          104 QVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY  182 (373)
T ss_dssp             CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGG
T ss_pred             EEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCC
Confidence            489999999999999999876321 2346788999999999999999999999999999999999975 67777766566


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE--cCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI--NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~--~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      .+++..++.++.||+.||.|||+.||+|+||||+||++  +.++.++|+|||++....... ......+++.|+|||.+.
T Consensus       183 ~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~  261 (373)
T 2x4f_A          183 NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLKVNFGTPEFLAPEVVN  261 (373)
T ss_dssp             GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BCCCCCSSCTTCCHHHHT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-ccccccCCCcEeChhhcc
Confidence            79999999999999999999999999999999999999  567889999999998765432 233456899999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      ... ++.++||||||+++|+|++|..| |.+.+..+....+.......+.                         .....
T Consensus       262 ~~~-~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~  314 (373)
T 2x4f_A          262 YDF-VSFPTDMWSVGVIAYMLLSGLSP-FLGDNDAETLNNILACRWDLED-------------------------EEFQD  314 (373)
T ss_dssp             TCB-CCHHHHHHHHHHHHHHHHHSSCT-TCCSSHHHHHHHHHHTCCCSCS-------------------------GGGTT
T ss_pred             CCC-CCcHHhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhccCCCCh-------------------------hhhcc
Confidence            665 79999999999999999998877 6677777777777664322211                         12245


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      +++.+.+||.+||+.||.+|||+.++++||||++.+..
T Consensus       315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~~  352 (373)
T 2x4f_A          315 ISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLH  352 (373)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCchh
Confidence            89999999999999999999999999999999987543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=9.2e-48  Score=346.44  Aligned_cols=247  Identities=19%  Similarity=0.285  Sum_probs=211.3

Q ss_pred             CeeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhc
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL   77 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~   77 (282)
                      .||+|+++.+|+.||||++..  .........+..|..++..+ .||+|+++++++++.+.+|+||||++|+.+..+...
T Consensus       356 ~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~  435 (674)
T 3pfq_A          356 KVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ  435 (674)
T ss_dssp             CEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHH
T ss_pred             EEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHh
Confidence            389999999999999999986  22344567788999999988 799999999999999999999999986444444444


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      .+.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..............||+.|+|||++.
T Consensus       436 ~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~  515 (674)
T 3pfq_A          436 VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA  515 (674)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhc
Confidence            67899999999999999999999999999999999999999999999999999986544444455567899999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|+||||+++|+|++|..| |.+.+..+....+...                             ...++..
T Consensus       516 ~~~-~~~~~DvwSlGvilyelltG~~P-f~~~~~~~~~~~i~~~-----------------------------~~~~p~~  564 (674)
T 3pfq_A          516 YQP-YGKSVDWWAFGVLLYEMLAGQAP-FEGEDEDELFQSIMEH-----------------------------NVAYPKS  564 (674)
T ss_dssp             CCC-BSTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHSS-----------------------------CCCCCTT
T ss_pred             CCC-CCccceEechHHHHHHHHcCCCC-CCCCCHHHHHHHHHhC-----------------------------CCCCCcc
Confidence            766 79999999999999999998777 7777777777777552                             1223456


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCccCCccchhh
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSA-----EDAMSHIYFSDLNVAIKS  278 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~-----~~ll~h~~~~~~~~~~~~  278 (282)
                      +++++.+||++||+.||++||++     ++|++||||+++++....
T Consensus       565 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~  610 (674)
T 3pfq_A          565 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLE  610 (674)
T ss_dssp             SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHT
T ss_pred             CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHH
Confidence            89999999999999999999998     999999999999876543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7.5e-48  Score=327.64  Aligned_cols=273  Identities=16%  Similarity=0.185  Sum_probs=193.7

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc-C
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL-N   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~-~   78 (282)
                      ||+|+++.+|+.||||++... ........+.+|+.++++++||||+++++++.+++..++||||++| ++.+.+... .
T Consensus        43 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~  122 (389)
T 3gni_B           43 VNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFM  122 (389)
T ss_dssp             EEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCT
T ss_pred             EEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcc
Confidence            899999999999999999873 3333456778899999999999999999999999999999999985 555555443 2


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC-------cccccccccccccc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP-------VKCYSAEVVTLWYR  151 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~-------~~~~~~~~~~~~~~  151 (282)
                      ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+......       ........+++.|+
T Consensus       123 ~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  202 (389)
T 3gni_B          123 DGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL  202 (389)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGS
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccccccccccccccccccccccc
Confidence            66999999999999999999999999999999999999999999999999987544211       11112236688899


Q ss_pred             ChhhhcCC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCC-------CCCCCC--------CCCC
Q psy6044         152 PPDVLFGA-KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP-------TEDTWP--------GMNL  215 (282)
Q Consensus       152 aPE~~~~~-~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~--------~~~~  215 (282)
                      |||.+.+. ..++.++|||||||++|+|++|..|+ .+....+............       +.....        ....
T Consensus       203 aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (389)
T 3gni_B          203 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF-KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGL  281 (389)
T ss_dssp             CHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTT-TTCCSTTHHHHC--------------------------------
T ss_pred             CHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCC-CCCCHHHHHHHHhcCCCCcccccccccccccccccccccccccc
Confidence            99999764 34799999999999999999988884 4433333322222111000       000000        0000


Q ss_pred             CCCCCC--CCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         216 LPDFKP--FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       216 ~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ......  .............+..+++.+.+||++||+.||++|||++++|+||||+++...
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~~  343 (389)
T 3gni_B          282 SDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRR  343 (389)
T ss_dssp             ------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC---
T ss_pred             ccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhhc
Confidence            000000  000000111223456689999999999999999999999999999999988643

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=9.7e-49  Score=329.98  Aligned_cols=270  Identities=33%  Similarity=0.561  Sum_probs=205.0

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC------CeEEEEEecCcccHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSE------KKLTLVFEHCDQDLKKY   73 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~------~~~~iv~e~~~g~l~~~   73 (282)
                      .||+|.+..+|+.||||++... ........+.+|+.+++.++||||+++++++...      ...++++|++++++.+.
T Consensus        44 ~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~  123 (367)
T 2fst_X           44 SVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI  123 (367)
T ss_dssp             CEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCCEECC--
T ss_pred             EEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEecccCCCHHHH
Confidence            4899999999999999998752 2223346788999999999999999999998754      56899999998877766


Q ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccCh
Q psy6044          74 FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP  153 (282)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aP  153 (282)
                      +..  ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++......   .....++..|+||
T Consensus       124 ~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aP  198 (367)
T 2fst_X          124 VKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVATRWYRAP  198 (367)
T ss_dssp             -----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC------------------CCCTTCCH
T ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc---CCCcCcCcCccCh
Confidence            543  67999999999999999999999999999999999999999999999999999765432   3345679999999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCC--CCCCCCCCCCCCCc
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLP--DFKPFPMYHPSMSF  231 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  231 (282)
                      |.+.+...++.++|||||||++|+|++|..| |.+.+..+....+.+..+.+..+.+.......  .+...........+
T Consensus       199 E~~~~~~~~~~~~DiwslG~il~ell~g~~p-f~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (367)
T 2fst_X          199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTL-FPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNF  277 (367)
T ss_dssp             HHHTTCCSCCTTHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCH
T ss_pred             HHHcCCcCCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCH
Confidence            9998755589999999999999999988766 88888888899998888877654433221000  00000001112234


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      .......++.+.+||++||..||.+|||++++|+||||++...+.
T Consensus       278 ~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~  322 (367)
T 2fst_X          278 ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  322 (367)
T ss_dssp             HHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred             HHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCC
Confidence            445567899999999999999999999999999999999875543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5.9e-47  Score=309.03  Aligned_cols=240  Identities=27%  Similarity=0.440  Sum_probs=195.9

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc---
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL---   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~---   77 (282)
                      ||+|.++.+|..+|+|++...........+.+|+.++++++||||+++++++.+....++|+||++| ++.+.+...   
T Consensus        38 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~  117 (285)
T 3is5_A           38 VHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQAR  117 (285)
T ss_dssp             EEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHH
T ss_pred             EEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhc
Confidence            8999999999999999998855555567899999999999999999999999999999999999976 677666432   


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE---cCCCcEEEEecCCccccCCCccccccccccccccChh
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPD  154 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE  154 (282)
                      ...+++..++.++.||+.||.+||+.|++|+||+|+||++   +.++.++|+|||.+...... .......+++.|+|||
T Consensus       118 ~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE  196 (285)
T 3is5_A          118 GKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPE  196 (285)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----------CTTGGGCCHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc-ccCcCcccccCcCChH
Confidence            4679999999999999999999999999999999999999   45688999999999766533 2234456789999999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      .+..  .++.++|+||||+++|+|++|..| |.+....+...........                          ....
T Consensus       197 ~~~~--~~~~~~Di~slG~il~~ll~g~~p-f~~~~~~~~~~~~~~~~~~--------------------------~~~~  247 (285)
T 3is5_A          197 VFKR--DVTFKCDIWSAGVVMYFLLTGCLP-FTGTSLEEVQQKATYKEPN--------------------------YAVE  247 (285)
T ss_dssp             HHTT--CCCHHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHCCCC--------------------------CCC-
T ss_pred             Hhcc--CCCcccCeehHHHHHHHHHhCCCC-CCCCCHHHHHhhhccCCcc--------------------------cccc
Confidence            9854  368999999999999999998887 6666666655544432111                          0111


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD  271 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  271 (282)
                      ...+++.+.+||++||+.||++|||+.|+++||||++
T Consensus       248 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          248 CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             -CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             cCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            2347899999999999999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.1e-47  Score=323.76  Aligned_cols=271  Identities=33%  Similarity=0.516  Sum_probs=208.2

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCC----------CccHHHHHHHHhhCCCCCccceeeeeee-----CCeEEEEEecC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGV----------PSSALREICLLKELKHKNIVRLYDVLHS-----EKKLTLVFEHC   66 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~e~~~~~~l~h~~i~~~~~~~~~-----~~~~~iv~e~~   66 (282)
                      ||+|.+.. |+.||||++........          .+.+.+|+.++++++||||+++++++..     ....++||||+
T Consensus        38 V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  116 (362)
T 3pg1_A           38 VCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM  116 (362)
T ss_dssp             EEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECC
T ss_pred             EEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccC
Confidence            89999865 99999999977332222          1568899999999999999999999853     34789999999


Q ss_pred             cccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccc
Q psy6044          67 DQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV  146 (282)
Q Consensus        67 ~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  146 (282)
                      +|++.+.+......+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+...... .......+
T Consensus       117 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~  195 (362)
T 3pg1_A          117 RTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD-ANKTHYVT  195 (362)
T ss_dssp             SEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC----------------
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCcccccccc-cccceecc
Confidence            99999999887778999999999999999999999999999999999999999999999999999755433 22334567


Q ss_pred             cccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCC---CCCCCCCC
Q psy6044         147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNL---LPDFKPFP  223 (282)
Q Consensus       147 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  223 (282)
                      ++.|+|||.+.+...++.++|+||||+++|++++|..| |.+.+..+....+....+.+....+.....   ........
T Consensus       196 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (362)
T 3pg1_A          196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKAL-FRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSL  274 (362)
T ss_dssp             CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCC
T ss_pred             cceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhc
Confidence            88999999998755579999999999999999988777 778888888888877766654321110000   00000011


Q ss_pred             CCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         224 MYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      .......+....+..++.+.+||.+||+.||.+|||++++++||||+++..+
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  326 (362)
T 3pg1_A          275 SNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP  326 (362)
T ss_dssp             CCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             ccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence            1112224455567789999999999999999999999999999999988544

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.4e-47  Score=322.51  Aligned_cols=244  Identities=25%  Similarity=0.389  Sum_probs=185.8

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      .||+|+++.+|+.||+|++....  .....+.+|+.+++.++||||+++++++.+....++||||++| ++.+.+.. .+
T Consensus        35 ~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~  111 (361)
T 3uc3_A           35 VARLMRDKLTKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN-AG  111 (361)
T ss_dssp             SEEEEEETTTCCEEEEEEEESST--TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HS
T ss_pred             EEEEEEECCCCcEEEEEEEecCc--cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHh-cC
Confidence            48999999999999999997532  2346788999999999999999999999999999999999976 55555544 67


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc--EEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      .+++..++.++.||+.||+|||++|++|+||||+||+++.++.  ++|+|||++...... .......+++.|+|||.+.
T Consensus       112 ~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~  190 (361)
T 3uc3_A          112 RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLL  190 (361)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------------CTTSCHHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-CCCCCCcCCCCcCChhhhc
Confidence            8999999999999999999999999999999999999987765  999999998754322 2223456799999999998


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +....+.++||||||+++|+|++|..|+............+..........                        .....
T Consensus       191 ~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~  246 (361)
T 3uc3_A          191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI------------------------PDDIR  246 (361)
T ss_dssp             CSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCC------------------------CTTSC
T ss_pred             CCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCC------------------------CCcCC
Confidence            877445569999999999999999888543332222222222222111000                        01124


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      +++.+.+||++||+.||++|||+.++++||||...
T Consensus       247 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          247 ISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             CCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            78999999999999999999999999999999643

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.1e-48  Score=321.36  Aligned_cols=239  Identities=27%  Similarity=0.392  Sum_probs=178.7

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCC-CCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      ||+|.++.+|+.||||++...    ......+|+.+++.+. ||||+++++++.++...++||||++| ++.+.+.. .+
T Consensus        27 V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~  101 (325)
T 3kn6_A           27 CRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK-KK  101 (325)
T ss_dssp             EEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-CS
T ss_pred             EEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHh-cC
Confidence            899999999999999998752    2356788999999996 99999999999999999999999986 55555544 67


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC---cEEEEecCCccccCCCccccccccccccccChhhh
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG---ELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~  156 (282)
                      .+++..+..++.||+.||.|||++|++|+||||+||+++.++   .++|+|||++..............+++.|+|||.+
T Consensus       102 ~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~  181 (325)
T 3kn6_A          102 HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL  181 (325)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------------------
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHh
Confidence            899999999999999999999999999999999999998766   89999999998766554545556779999999999


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC-------hHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSD-------VDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSM  229 (282)
Q Consensus       157 ~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
                      .+.. ++.++||||||+++|+|++|..|+ ...+       ..+....+......                         
T Consensus       182 ~~~~-~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~~~~~~~~i~~~~~~-------------------------  234 (325)
T 3kn6_A          182 NQNG-YDESCDLWSLGVILYTMLSGQVPF-QSHDRSLTCTSAVEIMKKIKKGDFS-------------------------  234 (325)
T ss_dssp             --CC-CCHHHHHHHHHHHHHHHHHSSCTT-C-------CCCHHHHHHHHTTTCCC-------------------------
T ss_pred             cCCC-CCCccchHHHHHHHHHHHhCCCCC-CCCccccccccHHHHHHHHHcCCCC-------------------------
Confidence            7766 799999999999999999988884 4322       22333333221110                         


Q ss_pred             CccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      ........+++++.+||++||+.||.+|||++++++||||++.
T Consensus       235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence            0111224589999999999999999999999999999999875

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2e-47  Score=334.57  Aligned_cols=246  Identities=21%  Similarity=0.327  Sum_probs=205.0

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc-
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL-   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~-   77 (282)
                      ||+|+++.+|+.||+|++...  ........+.+|+.++++++||||+++++++.+...+|+||||++| ++...+... 
T Consensus       201 Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~  280 (543)
T 3c4z_A          201 VFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVD  280 (543)
T ss_dssp             EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSS
T ss_pred             EEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhh
Confidence            899999999999999999862  2333456788999999999999999999999999999999999986 555555443 


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhh
Q psy6044          78 --NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDV  155 (282)
Q Consensus        78 --~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~  155 (282)
                        ...+++..++.++.||+.||.|||++||+|+||||+||+++.+|.++|+|||++..............||+.|+|||+
T Consensus       281 ~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~  360 (543)
T 3c4z_A          281 EDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL  360 (543)
T ss_dssp             TTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHH
T ss_pred             cccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhh
Confidence              246999999999999999999999999999999999999999999999999999877644444444578999999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCC---ChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGS---DVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      +.+.. ++.++|+|||||++|+|++|..||....   ...+....+...                             ..
T Consensus       361 l~~~~-~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-----------------------------~~  410 (543)
T 3c4z_A          361 LLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-----------------------------AV  410 (543)
T ss_dssp             HTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-----------------------------CC
T ss_pred             hcCCC-CChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-----------------------------cc
Confidence            98765 7999999999999999999988854432   234444444441                             11


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCccchh
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMS-----AEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~h~~~~~~~~~~~  277 (282)
                      ..+..+++.+.+||++||+.||.+||+     ++++++||||+++++...
T Consensus       411 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l  460 (543)
T 3c4z_A          411 TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQL  460 (543)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHH
T ss_pred             CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHH
Confidence            233568999999999999999999996     589999999999876543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-47  Score=323.69  Aligned_cols=243  Identities=20%  Similarity=0.328  Sum_probs=202.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~   80 (282)
                      ||+|.++.+|+.||+|++..... .....+.+|+.+++.++||||+++++++.+....++||||++| ++.+.+......
T Consensus        67 Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~  145 (387)
T 1kob_A           67 VHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK  145 (387)
T ss_dssp             EEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCC
T ss_pred             EEEEEECCCCCEEEEEEecccch-hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCC
Confidence            89999999999999999875321 1234688999999999999999999999999999999999975 666666554557


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC--CCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK--NGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +++..++.++.||+.||.|||+.||+|+||||+||+++.  ++.++|+|||++........ .....+++.|+|||.+.+
T Consensus       146 l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~  224 (387)
T 1kob_A          146 MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-VKVTTATAEFAAPEIVDR  224 (387)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-EEEECSSGGGCCHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc-eeeeccCCCccCchhccC
Confidence            999999999999999999999999999999999999974  47899999999987754322 233467999999999977


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++||||||+++|+|++|..| |.+.+..+....+.......+.                         .....+
T Consensus       225 ~~-~~~~~DiwSlG~il~elltg~~P-f~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~  277 (387)
T 1kob_A          225 EP-VGFYTDMWAIGVLGYVLLSGLSP-FAGEDDLETLQNVKRCDWEFDE-------------------------DAFSSV  277 (387)
T ss_dssp             CC-BCHHHHHHHHHHHHHHHHHSCCS-SCCSSHHHHHHHHHHCCCCCCS-------------------------STTTTS
T ss_pred             CC-CCCcccEeeHhHHHHHHHhCCCC-CCCCCHHHHHHHHHhCCCCCCc-------------------------cccccC
Confidence            65 79999999999999999998877 6666766666666553222111                         122458


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      ++++.+||++||+.||.+|||+.++++||||++..
T Consensus       278 s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          278 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            99999999999999999999999999999998753

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.7e-48  Score=314.12  Aligned_cols=239  Identities=28%  Similarity=0.474  Sum_probs=200.0

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      ||+|.+..+++.||+|++...  ........+.+|+.++++++||||+++++++.+....++||||++| ++.+.+.. .
T Consensus        25 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~-~  103 (279)
T 3fdn_A           25 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-L  103 (279)
T ss_dssp             EEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-H
T ss_pred             EEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHh-c
Confidence            899999999999999998762  2233456788999999999999999999999999999999999986 55555544 5


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....+++.|+|||.+.+
T Consensus       104 ~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~  181 (279)
T 3fdn_A          104 SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--RTDLCGTLDYLPPEMIEG  181 (279)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----------CCCCTTCCHHHHTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc--ccccCCCCCccCHhHhcc
Confidence            789999999999999999999999999999999999999999999999999886554322  234467899999999977


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||||+++|+|++|..| |...+..+....+....                             ...+..+
T Consensus       182 ~~-~~~~~Di~slG~il~~l~~g~~p-~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~  230 (279)
T 3fdn_A          182 RM-HDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISRVE-----------------------------FTFPDFV  230 (279)
T ss_dssp             CC-CCTTHHHHHHHHHHHHHHHSSCT-TCCSSHHHHHHHHHHTC-----------------------------CCCCTTS
T ss_pred             CC-CCccchhHhHHHHHHHHHHCCCC-CCCCcHHHHHHHHHhCC-----------------------------CCCCCcC
Confidence            65 68999999999999999988777 77777777776665521                             1223458


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      ++.+.+||.+||+.||.+|||++++++||||++...
T Consensus       231 ~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~  266 (279)
T 3fdn_A          231 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS  266 (279)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred             CHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence            899999999999999999999999999999987543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.7e-47  Score=313.53  Aligned_cols=242  Identities=22%  Similarity=0.318  Sum_probs=203.9

Q ss_pred             eeeeeeCCCCceEEEeeeecCC--CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG--NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|.+..+++.||+|++....  .....+.+.+|+.+++.++||||+++++++.+++..++|+||++|+.+..+....+
T Consensus        31 Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~  110 (294)
T 2rku_A           31 CFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK  110 (294)
T ss_dssp             EEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC
T ss_pred             EEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcC
Confidence            8999999999999999998632  22335678889999999999999999999999999999999998644444445467


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+.
T Consensus       111 ~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  190 (294)
T 2rku_A          111 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK  190 (294)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTS
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccC
Confidence            89999999999999999999999999999999999999999999999999998765444444556778999999999776


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      . ++.++|+||||+++|+|++|..| |......+....+...                             ....+..++
T Consensus       191 ~-~~~~~Di~slG~~l~~l~~g~~p-~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~  239 (294)
T 2rku_A          191 G-HSFEVDVWSIGCIMYTLLVGKPP-FETSCLKETYLRIKKN-----------------------------EYSIPKHIN  239 (294)
T ss_dssp             C-BCTHHHHHHHHHHHHHHHHSSCT-TCCSSHHHHHHHHHTT-----------------------------CCCCCTTSC
T ss_pred             C-CCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHhhc-----------------------------cCCCccccC
Confidence            6 68999999999999999998877 6666665555444331                             111234578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      +.+.++|++||+.||++|||++++++||||++...
T Consensus       240 ~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  274 (294)
T 2rku_A          240 PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI  274 (294)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence            99999999999999999999999999999987644

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.6e-47  Score=320.28  Aligned_cols=271  Identities=35%  Similarity=0.610  Sum_probs=213.3

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC-----CeEEEEEecCcccHHHHHHh
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE-----KKLTLVFEHCDQDLKKYFDS   76 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~-----~~~~iv~e~~~g~l~~~~~~   76 (282)
                      ||+|++..+|+.||||++...........+.+|+.++++++||||+++++++...     ...++|+||++|++.+.+..
T Consensus        27 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~  106 (353)
T 2b9h_A           27 VCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST  106 (353)
T ss_dssp             EEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCSEEHHHHHHH
T ss_pred             EEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccCccHHHHHhh
Confidence            8999999999999999986533333345678999999999999999999988754     68999999999998887765


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc----------ccccccc
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK----------CYSAEVV  146 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~----------~~~~~~~  146 (282)
                        ..+++..+..++.||+.||.+||+.|++|+||||+||+++.++.++|+|||.+........          ......+
T Consensus       107 --~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~g  184 (353)
T 2b9h_A          107 --QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA  184 (353)
T ss_dssp             --CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCC
T ss_pred             --cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccc
Confidence              5799999999999999999999999999999999999999999999999999977643221          1222466


Q ss_pred             cccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCC----CCCC
Q psy6044         147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPD----FKPF  222 (282)
Q Consensus       147 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~  222 (282)
                      ++.|+|||.+.....++.++|+||||+++|+|++|..| |.+.+..+....+....+.+.............    ....
T Consensus       185 t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (353)
T 2b9h_A          185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPI-FPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSL  263 (353)
T ss_dssp             CGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTS
T ss_pred             cccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcc
Confidence            88999999987655589999999999999999987766 788887887777777777655322211100000    0000


Q ss_pred             CCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         223 PMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      + ...........+.+++.+.+||++||+.||++|||++++++||||+....+.
T Consensus       264 ~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  316 (353)
T 2b9h_A          264 P-MYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN  316 (353)
T ss_dssp             C-CCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             c-CCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence            0 0111233444567899999999999999999999999999999999876543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.2e-47  Score=334.04  Aligned_cols=241  Identities=28%  Similarity=0.427  Sum_probs=203.3

Q ss_pred             eeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      ||+|+++.++..||+|++.. .........+.+|+.+++.++||||+++++++.+.+..++||||++| ++.+.+.. ..
T Consensus        53 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~-~~  131 (494)
T 3lij_A           53 VLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH-RM  131 (494)
T ss_dssp             EEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HS
T ss_pred             EEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHH-cC
Confidence            89999999999999999987 33344567899999999999999999999999999999999999976 66666554 57


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC---CcEEEEecCCccccCCCccccccccccccccChhhh
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN---GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~  156 (282)
                      .+++..++.++.||+.||.|||++||+|+||||+||+++..   +.++|+|||++...... .......+++.|+|||++
T Consensus       132 ~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l  210 (494)
T 3lij_A          132 KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEVL  210 (494)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-BCBCCCCSCTTTCCHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-ccccccCCCcCeeCHHHH
Confidence            89999999999999999999999999999999999999764   55999999999776533 233445789999999998


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       157 ~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      ..  .++.++||||+|+++|+|++|..| |.+.+..+....+.......+..                         ...
T Consensus       211 ~~--~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~  262 (494)
T 3lij_A          211 RK--KYDEKCDVWSIGVILFILLAGYPP-FGGQTDQEILRKVEKGKYTFDSP-------------------------EWK  262 (494)
T ss_dssp             TT--CBCTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHTCCCCCSG-------------------------GGT
T ss_pred             cc--cCCCchhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhCCCCCCch-------------------------hcc
Confidence            64  379999999999999999988777 77778788777776643332211                         124


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      .+++.+.+||++||+.||.+|||+.++|+||||++.
T Consensus       263 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          263 NVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             cCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            589999999999999999999999999999999875

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.7e-47  Score=335.85  Aligned_cols=245  Identities=23%  Similarity=0.349  Sum_probs=202.3

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      ||+|+++.+|+.||+|++...  ........+.+|+.+++.++||||+++++++.+...+|+||||++| ++.+.+....
T Consensus       200 Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~  279 (576)
T 2acx_A          200 VCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG  279 (576)
T ss_dssp             EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSS
T ss_pred             EEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcC
Confidence            899999999999999999862  2333456788999999999999999999999999999999999975 5555554432


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          79 -GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 -~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                       ..+++..++.++.||+.||.|||++||+|+||||+||+++.+|.++|+|||++....... ......||+.|+|||++.
T Consensus       280 ~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APEvl~  358 (576)
T 2acx_A          280 QAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTVGYMAPEVVK  358 (576)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-CEECCCSCGGGCCHHHHT
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc-cccccCCCccccCHHHHc
Confidence             349999999999999999999999999999999999999999999999999998765332 233457899999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCC---ChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGS---DVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      +.. ++.++|+||||+++|+|++|..|+....   ...+....+...                             ....
T Consensus       359 ~~~-~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-----------------------------~~~~  408 (576)
T 2acx_A          359 NER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-----------------------------PEEY  408 (576)
T ss_dssp             TCE-ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-----------------------------CCCC
T ss_pred             CCC-CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-----------------------------cccC
Confidence            765 7999999999999999999888854432   223333333321                             1122


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCccchh
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~  277 (282)
                      +..+++.+.+||++||+.||.+||     |++++++||||+++++...
T Consensus       409 p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l  456 (576)
T 2acx_A          409 SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRL  456 (576)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHH
T ss_pred             CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHH
Confidence            356899999999999999999999     8999999999999876543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.7e-48  Score=313.52  Aligned_cols=242  Identities=26%  Similarity=0.452  Sum_probs=176.8

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      ||+|.+..+|+.||+|++...  ........+.+|+.++++++||||+++++++.+.+..++|+||+++ ++.+.+....
T Consensus        27 Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  106 (278)
T 3cok_A           27 VYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV  106 (278)
T ss_dssp             EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCS
T ss_pred             EEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhcc
Confidence            899999999999999999762  2333456789999999999999999999999999999999999975 6666666555


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+
T Consensus       107 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  186 (278)
T 3cok_A          107 KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR  186 (278)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----------------------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcC
Confidence            78999999999999999999999999999999999999999999999999999876544433344567899999999876


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||||+++|++++|..| |......+....+..                             .....+..+
T Consensus       187 ~~-~~~~~Di~slG~il~~l~~g~~p-~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~  235 (278)
T 3cok_A          187 SA-HGLESDVWSLGCMFYTLLIGRPP-FDTDTVKNTLNKVVL-----------------------------ADYEMPSFL  235 (278)
T ss_dssp             ------CTHHHHHHHHHHHHHHSSCS-SCCCSCC-----CCS-----------------------------SCCCCCTTS
T ss_pred             CC-CCchhhHHHHHHHHHHHHhCCCC-CCChhHHHHHHHHhh-----------------------------cccCCcccc
Confidence            65 68999999999999999998887 443332221111000                             011233458


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      +..+.++|.+||+.||++|||++++++||||++...
T Consensus       236 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  271 (278)
T 3cok_A          236 SIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSS  271 (278)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred             CHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCCC
Confidence            899999999999999999999999999999987643

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.6e-47  Score=334.41  Aligned_cols=244  Identities=27%  Similarity=0.454  Sum_probs=203.6

Q ss_pred             CeeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      .||+|+++.+|+.||||++.. .........+.+|+.++++++||||+++++++.+...+++|+||+.| ++.+.+.. .
T Consensus        37 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~  115 (486)
T 3mwu_A           37 EVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-R  115 (486)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-H
T ss_pred             EEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHh-c
Confidence            389999999999999999976 32333457889999999999999999999999999999999999976 66666555 5


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc---CCCcEEEEecCCccccCCCccccccccccccccChhh
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN---KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDV  155 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~  155 (282)
                      +.+++..+..++.||+.||.|||++||+|+||||+||+++   .++.++|+|||++...... .......+++.|+|||+
T Consensus       116 ~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~  194 (486)
T 3mwu_A          116 KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEV  194 (486)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-----CCTTGGGGCCGGG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-CccCCCcCCCCCCCHHH
Confidence            7899999999999999999999999999999999999995   4567999999999776533 23344578999999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      +.+.  ++.++||||+|+++|+|++|..| |.+.+..+....+.......+.                         ...
T Consensus       195 ~~~~--~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~-------------------------~~~  246 (486)
T 3mwu_A          195 LRGT--YDEKCDVWSAGVILYILLSGTPP-FYGKNEYDILKRVETGKYAFDL-------------------------PQW  246 (486)
T ss_dssp             GGSC--CCHHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHTCCCSCS-------------------------GGG
T ss_pred             hCCC--CCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhCCCCCCC-------------------------ccc
Confidence            9763  79999999999999999988777 6777777777776663222111                         122


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      ..+|+.+.+||++||+.||.+|||+.++|+||||++...
T Consensus       247 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence            458999999999999999999999999999999987643

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.7e-47  Score=319.44  Aligned_cols=239  Identities=22%  Similarity=0.345  Sum_probs=196.8

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      ||+|.++.+|+.||+|++....     ....+|++++.++ +||||+++++++.+....|+||||++| ++.+.+.. .+
T Consensus        38 V~~~~~~~~~~~~avK~~~~~~-----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~  111 (342)
T 2qr7_A           38 CKRCIHKATNMEFAVKIIDKSK-----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR-QK  111 (342)
T ss_dssp             EEEEEETTTTEEEEEEEEETTT-----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CT
T ss_pred             EEEEEECCCCCEEEEEEEEccc-----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH-cC
Confidence            8999999999999999997532     3456788988888 799999999999999999999999976 66665554 67


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC----CcEEEEecCCccccCCCccccccccccccccChhh
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN----GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDV  155 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~----~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~  155 (282)
                      .+++..+..++.||+.||.|||++||+|+||||+||++..+    +.++|+|||++..............+++.|+|||.
T Consensus       112 ~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~  191 (342)
T 2qr7_A          112 FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEV  191 (342)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHH
Confidence            89999999999999999999999999999999999998543    35999999999876544444445677999999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCC--CChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG--SDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      +.+.. ++.++|+||||+++|+|++|..|+...  .+..+....+.......+.                         .
T Consensus       192 ~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-------------------------~  245 (342)
T 2qr7_A          192 LERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG-------------------------G  245 (342)
T ss_dssp             HHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCS-------------------------T
T ss_pred             hcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCc-------------------------c
Confidence            97655 689999999999999999998885442  3445555555543222111                         1


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      .+..+++.+.+||++||+.||++|||+.++++||||.+.
T Consensus       246 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          246 YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence            224589999999999999999999999999999999653

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.1e-47  Score=310.37  Aligned_cols=245  Identities=29%  Similarity=0.411  Sum_probs=204.9

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~   80 (282)
                      ||+|.++.++..+|+|++...... ..+.+.+|+.++++++||||+++++++.+....++||||++| ++.+.+.. .+.
T Consensus        25 V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~  102 (277)
T 3f3z_A           25 VKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVH-KRV  102 (277)
T ss_dssp             EEEEEETTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HCS
T ss_pred             EEEEEeCCCCcEEEEEeehhhccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHH-cCC
Confidence            899999999999999999874322 356789999999999999999999999999999999999976 55555544 677


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE---cCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      +++..++.++.|++.||.+||++|++|+||+|+||++   +.++.++|+|||.+....... ......+++.|+|||.+.
T Consensus       103 ~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~  181 (277)
T 3f3z_A          103 FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-MMRTKVGTPYYVSPQVLE  181 (277)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-CBCCCCSCTTTCCHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-chhccCCCCCccChHHhc
Confidence            9999999999999999999999999999999999999   788999999999998765332 334456789999999986


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.  ++.++|+||||+++|+|++|..| |......+....+.......+.                         .....
T Consensus       182 ~~--~~~~~Di~slG~~l~~l~~g~~p-~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~  233 (277)
T 3f3z_A          182 GL--YGPECDEWSAGVMMYVLLCGYPP-FSAPTDSEVMLKIREGTFTFPE-------------------------KDWLN  233 (277)
T ss_dssp             TC--BCTTHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHCCCCCCH-------------------------HHHTT
T ss_pred             cc--CCchhhehhHHHHHHHHHHCCCC-CCCCCHHHHHHHHHhCCCCCCc-------------------------hhhhc
Confidence            54  69999999999999999998877 6777777776666553222111                         11135


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccchh
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  277 (282)
                      +++.+.++|++||+.||.+|||+.++++||||++.....+
T Consensus       234 ~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~  273 (277)
T 3f3z_A          234 VSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSP  273 (277)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCSG
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccccccc
Confidence            7899999999999999999999999999999987654443

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.3e-47  Score=318.31  Aligned_cols=242  Identities=22%  Similarity=0.319  Sum_probs=204.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCC--CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG--NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|.+..+++.||+|++....  .......+.+|+.+++.++||||+++++++.+.+..++||||++|+.+..+.....
T Consensus        57 Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~  136 (335)
T 2owb_A           57 CFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK  136 (335)
T ss_dssp             EEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC
T ss_pred             EEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccC
Confidence            8999999999999999998632  22345678899999999999999999999999999999999998644444444467


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+.
T Consensus       137 ~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  216 (335)
T 2owb_A          137 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK  216 (335)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTS
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccC
Confidence            89999999999999999999999999999999999999999999999999998775444444556778999999999877


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      . ++.++|+||||+++|+|++|..| |......+....+....                             ...+..++
T Consensus       217 ~-~~~~~Di~slG~il~~l~~g~~p-f~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~  265 (335)
T 2owb_A          217 G-HSFEVDVWSIGCIMYTLLVGKPP-FETSCLKETYLRIKKNE-----------------------------YSIPKHIN  265 (335)
T ss_dssp             C-BCTHHHHHHHHHHHHHHHHSSCT-TCCSSHHHHHHHHHHTC-----------------------------CCCCTTSC
T ss_pred             C-CCchhhHHHHHHHHHHHHHCcCC-CCCCCHHHHHHHHhcCC-----------------------------CCCCccCC
Confidence            6 68999999999999999998877 66666666555554421                             11234578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      +.+.+||++||+.||.+|||++++++||||++...
T Consensus       266 ~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~  300 (335)
T 2owb_A          266 PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI  300 (335)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence            99999999999999999999999999999987643

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.6e-47  Score=316.15  Aligned_cols=247  Identities=25%  Similarity=0.375  Sum_probs=201.9

Q ss_pred             eeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc-
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL-   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~-   77 (282)
                      ||+|+++.+|+.||+|++.. .........+.+|+.+++.+ .||||+++++++.+.+..++|+||+.| ++.+.+... 
T Consensus        45 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~  124 (327)
T 3lm5_A           45 VRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL  124 (327)
T ss_dssp             EEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC
T ss_pred             EEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhc
Confidence            89999999999999999987 33334456788999999999 569999999999999999999999987 454444322 


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC---CCcEEEEecCCccccCCCccccccccccccccChh
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK---NGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPD  154 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE  154 (282)
                      ...+++..++.++.||+.||.+||++|++|+||||+||+++.   ++.++|+|||.+....... ......+++.|+|||
T Consensus       125 ~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE  203 (327)
T 3lm5_A          125 AEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC-ELREIMGTPEYLAPE  203 (327)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----------CCCGGGCCHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc-ccccccCCcCccCCe
Confidence            366999999999999999999999999999999999999987   7899999999998765332 223456799999999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      .+.... ++.++|+||||+++|+|++|..| |...+..+....+.......+.                         ..
T Consensus       204 ~~~~~~-~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~-------------------------~~  256 (327)
T 3lm5_A          204 ILNYDP-ITTATDMWNIGIIAYMLLTHTSP-FVGEDNQETYLNISQVNVDYSE-------------------------ET  256 (327)
T ss_dssp             HHTTCC-CCTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHTCCCCCT-------------------------TT
T ss_pred             eecCCC-CCchhhHHHHHHHHHHHHhCCCC-CCCCCchHHHHHHHhcccccCc-------------------------hh
Confidence            997666 79999999999999999998887 6777777766666554322221                         12


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      ...+++.+.+||.+||+.||.+|||++++|+||||++.++..
T Consensus       257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~  298 (327)
T 3lm5_A          257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN  298 (327)
T ss_dssp             TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred             hcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence            245889999999999999999999999999999999886643

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.8e-47  Score=316.76  Aligned_cols=234  Identities=21%  Similarity=0.338  Sum_probs=195.3

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCC-------CCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-c-cHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGN-------EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-Q-DLK   71 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g-~l~   71 (282)
                      .||+|+++.+|+.||||++.....       ......+.+|+.++++++||||+++++++.+.+..++|+|++. | ++.
T Consensus        39 ~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~  118 (335)
T 3dls_A           39 FVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLF  118 (335)
T ss_dssp             SEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHH
T ss_pred             EEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHH
Confidence            489999999999999999987321       1245678899999999999999999999999999999999985 4 555


Q ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccccccccccccc
Q psy6044          72 KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYR  151 (282)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  151 (282)
                      +.+ ...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+........ .....+++.|+
T Consensus       119 ~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~~~~gt~~y~  196 (335)
T 3dls_A          119 AFI-DRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL-FYTFCGTIEYC  196 (335)
T ss_dssp             HHH-HTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCC-BCEECSCGGGC
T ss_pred             HHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCCCc-eeccCCCcccc
Confidence            554 4467899999999999999999999999999999999999999999999999999987654322 23456799999


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSF  231 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
                      |||.+.+....+.++||||||+++|+|++|..|+......       ..                             ..
T Consensus       197 aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~-----------------------------~~  240 (335)
T 3dls_A          197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------VE-----------------------------AA  240 (335)
T ss_dssp             CHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------TT-----------------------------TC
T ss_pred             ChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------Hh-----------------------------hc
Confidence            9999987765588999999999999999999885321100       00                             01


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      ...+..+++.+.+||++||+.||.+|||++++++||||++.
T Consensus       241 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          241 IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            11234489999999999999999999999999999999864

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.1e-47  Score=310.24  Aligned_cols=239  Identities=26%  Similarity=0.423  Sum_probs=194.6

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      ||+|.+..+|+.||+|++...  ........+.+|+.+++.++||||+++++++.+....++|+||++| ++.+.+.. .
T Consensus        27 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~  105 (276)
T 2h6d_A           27 VKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK-H  105 (276)
T ss_dssp             EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-H
T ss_pred             EEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhc-c
Confidence            899999999999999999762  2334456788999999999999999999999999999999999976 66665544 5


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +.+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......+++.|+|||.+.+
T Consensus       106 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~  184 (276)
T 2h6d_A          106 GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSCGSPNYAAPEVISG  184 (276)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--------------CCTGGGTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc-ceecccCCccccCHHHHcC
Confidence            779999999999999999999999999999999999999999999999999997765332 2234467889999999987


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      ....+.++|+||||+++|+|++|..| |......+....+....                             ...+..+
T Consensus       185 ~~~~~~~~Di~slG~~l~~l~~g~~p-~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~  234 (276)
T 2h6d_A          185 RLYAGPEVDIWSCGVILYALLCGTLP-FDDEHVPTLFKKIRGGV-----------------------------FYIPEYL  234 (276)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHCC-----------------------------CCCCTTS
T ss_pred             CCCCCccchHHHHHHHHHHHHhCCCC-CCCCcHHHHHHHhhcCc-----------------------------ccCchhc
Confidence            66457899999999999999998877 66666666665554421                             1123457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      +..+.++|.+||+.||.+|||++++++||||++.
T Consensus       235 ~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          235 NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            8999999999999999999999999999999864

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6e-47  Score=315.29  Aligned_cols=240  Identities=23%  Similarity=0.409  Sum_probs=190.5

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC-----------------------
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK-----------------------   57 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~-----------------------   57 (282)
                      .||+|+++.+|+.||||++.........+.+.+|+.++++++||||+++++++.+..                       
T Consensus        21 ~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  100 (332)
T 3qd2_B           21 VVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLS  100 (332)
T ss_dssp             EEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-------------
T ss_pred             EEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhcccccccccc
Confidence            389999999999999999987555555678999999999999999999999986543                       


Q ss_pred             ----------------------------------eEEEEEecCcc-cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHH
Q psy6044          58 ----------------------------------KLTLVFEHCDQ-DLKKYFDSLN--GEIDLDIVKSFMYQLLRGLAFC  100 (282)
Q Consensus        58 ----------------------------------~~~iv~e~~~g-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~l  100 (282)
                                                        ..++||||++| ++.+.+....  ...++..++.++.||+.||+||
T Consensus       101 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L  180 (332)
T 3qd2_B          101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL  180 (332)
T ss_dssp             -------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHH
T ss_pred             CCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHH
Confidence                                              38999999987 4555444322  2256777999999999999999


Q ss_pred             HhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc------------cccccccccccccChhhhcCCCCCCchhhH
Q psy6044         101 HSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV------------KCYSAEVVTLWYRPPDVLFGAKLYTTSIDM  168 (282)
Q Consensus       101 h~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  168 (282)
                      |++|++|+||||+||+++.++.++|+|||++.......            .......+++.|+|||.+.+.. ++.++||
T Consensus       181 H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di  259 (332)
T 3qd2_B          181 HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN-YSHKVDI  259 (332)
T ss_dssp             HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCC-CCTHHHH
T ss_pred             HhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCC-CcchhhH
Confidence            99999999999999999999999999999998775432            1223346799999999998776 7999999


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHH
Q psy6044         169 WSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQR  248 (282)
Q Consensus       169 ~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  248 (282)
                      ||||+++|+|++|..|.      .+...........                         .........++.+.++|.+
T Consensus       260 ~slG~il~el~~~~~~~------~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~li~~  308 (332)
T 3qd2_B          260 FSLGLILFELLYSFSTQ------MERVRIITDVRNL-------------------------KFPLLFTQKYPQEHMMVQD  308 (332)
T ss_dssp             HHHHHHHHHHHSCCCCH------HHHHHHHHHHHTT-------------------------CCCHHHHHHCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCh------hHHHHHHHHhhcc-------------------------CCCcccccCChhHHHHHHH
Confidence            99999999999765441      2222222221111                         1122234577889999999


Q ss_pred             hcccCCCCCCCHHHHhcCCCccCC
Q psy6044         249 LLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       249 ~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      ||+.||++|||++++++||||+++
T Consensus       309 ~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          309 MLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             HHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             HccCCCCcCCCHHHHhhchhhhcC
Confidence            999999999999999999999975

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.8e-47  Score=334.04  Aligned_cols=242  Identities=30%  Similarity=0.459  Sum_probs=204.5

Q ss_pred             eeeeeeCCCCceEEEeeeecCC--CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG--NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      ||+|+++.+|+.||||++....  .......+.+|+.++++++||||+++++++.+.+..++|+||+.| ++.+.+.. .
T Consensus        42 V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~  120 (484)
T 3nyv_A           42 VILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS-R  120 (484)
T ss_dssp             EEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-C
T ss_pred             EEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHh-c
Confidence            8999999999999999998732  234456789999999999999999999999999999999999975 55555544 6


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE---cCCCcEEEEecCCccccCCCccccccccccccccChhh
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDV  155 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~  155 (282)
                      +.+++..++.++.||+.||.|||++||+|+||||+||++   +.++.++|+|||++....... ......+++.|+|||.
T Consensus       121 ~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~  199 (484)
T 3nyv_A          121 KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-KMKDKIGTAYYIAPEV  199 (484)
T ss_dssp             SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC-SHHHHTTGGGTCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc-ccccCCCCccccCcee
Confidence            789999999999999999999999999999999999999   567899999999997765332 2334568999999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      +.+.  ++.++||||+|+++|+|++|..| |.+.+..+....+.......+.                         ...
T Consensus       200 ~~~~--~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~-------------------------~~~  251 (484)
T 3nyv_A          200 LHGT--YDEKCDVWSTGVILYILLSGCPP-FNGANEYDILKKVEKGKYTFEL-------------------------PQW  251 (484)
T ss_dssp             HHTC--CCTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHCCCCCCS-------------------------GGG
T ss_pred             ecCC--CCCcceeHHHHHHHHHHHHCCCC-CCCCCHHHHHHHHHcCCCCCCC-------------------------ccc
Confidence            9763  79999999999999999988777 7777777777777663222111                         122


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      ..+|+.+.+||++||+.||.+|||+.++|+||||+...
T Consensus       252 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          252 KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence            46899999999999999999999999999999998654

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.5e-47  Score=323.87  Aligned_cols=271  Identities=36%  Similarity=0.654  Sum_probs=203.8

Q ss_pred             eeeeeeC--CCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeee--CCeEEEEEecCcccHHHHHHhc
Q psy6044           2 FTSGVDR--TPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQDLKKYFDSL   77 (282)
Q Consensus         2 vy~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~--~~~~~iv~e~~~g~l~~~~~~~   77 (282)
                      ||+|+++  .+++.||||++...   .....+.+|+.++++++||||+++++++..  +..+++||||++|++++.+...
T Consensus        37 Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~  113 (405)
T 3rgf_A           37 VYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFH  113 (405)
T ss_dssp             EEEEEESSSSCCCCEEEEECSSS---SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSEEHHHHHHHH
T ss_pred             EEEEEEccCCCCeEEEEEEECCC---CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCCCHHHHHHHh
Confidence            8999965  67999999998642   334578899999999999999999999954  6789999999999988877532


Q ss_pred             --------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE----cCCCcEEEEecCCccccCCCc---cccc
Q psy6044          78 --------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI----NKNGELKLADFGLARAFGIPV---KCYS  142 (282)
Q Consensus        78 --------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~----~~~~~~~l~df~~~~~~~~~~---~~~~  142 (282)
                              ...+++..++.++.||+.||.|||++||+|+||||+||++    +.++.++|+|||++.......   ....
T Consensus       114 ~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  193 (405)
T 3rgf_A          114 RASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD  193 (405)
T ss_dssp             HHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC-------------
T ss_pred             ccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCC
Confidence                    1249999999999999999999999999999999999999    677899999999998765321   2233


Q ss_pred             cccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC--------hHHHHHHHHHHhCCCCCCCCCCCC
Q psy6044         143 AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSD--------VDDQLKRIFKLLGTPTEDTWPGMN  214 (282)
Q Consensus       143 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~  214 (282)
                      ...+++.|+|||.+.+...++.++|||||||++|+|++|..|+.....        ..+.+..+...++.+....|+...
T Consensus       194 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~  273 (405)
T 3rgf_A          194 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIK  273 (405)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGG
T ss_pred             CceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhh
Confidence            456789999999998766589999999999999999998877433222        257888888989888877765443


Q ss_pred             CCCCCCCCCC------CCCCC---CccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         215 LLPDFKPFPM------YHPSM---SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       215 ~~~~~~~~~~------~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ..........      .....   .........++.+.+||++||+.||.+|||++|+|+||||++...+
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~  343 (405)
T 3rgf_A          274 KMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLP  343 (405)
T ss_dssp             GSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCC
T ss_pred             cCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCCC
Confidence            2221100000      00000   0000112237889999999999999999999999999999976543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4e-47  Score=308.51  Aligned_cols=246  Identities=24%  Similarity=0.377  Sum_probs=199.5

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEI   81 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~   81 (282)
                      ||+|.++.+|+.||+|++...........+.+|+.+++.++||||+++++++.+++..++|+||++|+.+..+......+
T Consensus        23 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~  102 (276)
T 2yex_A           23 VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM  102 (276)
T ss_dssp             EEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBC
T ss_pred             EEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccCC
Confidence            89999999999999999987444445578899999999999999999999999999999999999874444444445679


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc--cccccccccccccChhhhcCC
Q psy6044          82 DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--KCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        82 ~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      ++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .......+++.|+|||.+.+.
T Consensus       103 ~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  182 (276)
T 2yex_A          103 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR  182 (276)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCS
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcC
Confidence            999999999999999999999999999999999999999999999999987653221  223345678899999999776


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      ...+.++|+||||+++|++++|..|+.................                           ........++
T Consensus       183 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~  235 (276)
T 2yex_A          183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK---------------------------TYLNPWKKID  235 (276)
T ss_dssp             SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC---------------------------TTSTTGGGSC
T ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc---------------------------cccCchhhcC
Confidence            6457899999999999999999888544333322222222110                           0001124589


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      +.+.++|.+||+.||.+|||++++++||||++...
T Consensus       236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          236 SAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence            99999999999999999999999999999997643

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.6e-47  Score=310.16  Aligned_cols=238  Identities=30%  Similarity=0.514  Sum_probs=201.4

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      ||+|++..+++.||+|++...  ........+.+|+.+++.++||||+++++++.+.+..++|+||++| ++.+.+.. .
T Consensus        30 Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~  108 (284)
T 2vgo_A           30 VYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK-H  108 (284)
T ss_dssp             EEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-H
T ss_pred             EEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHh-c
Confidence            899999999999999999762  2333456789999999999999999999999999999999999976 66666554 5


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +.+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .....+++.|+|||.+.+
T Consensus       109 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~  186 (284)
T 2vgo_A          109 GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR--RRTMCGTLDYLPPEMIEG  186 (284)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC--BCCCCSCGGGCCHHHHTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc--cccccCCCCcCCHHHhcc
Confidence            679999999999999999999999999999999999999999999999999987654322  234467899999999977


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||||+++|++++|..| |......+....+....                             ...+..+
T Consensus       187 ~~-~~~~~Di~slG~il~~l~~g~~p-f~~~~~~~~~~~~~~~~-----------------------------~~~~~~~  235 (284)
T 2vgo_A          187 KT-HDEKVDLWCAGVLCYEFLVGMPP-FDSPSHTETHRRIVNVD-----------------------------LKFPPFL  235 (284)
T ss_dssp             CC-BCTTHHHHHHHHHHHHHHHSSCT-TCCSSHHHHHHHHHTTC-----------------------------CCCCTTS
T ss_pred             CC-CCcccchhhHHHHHHHHHHCCCC-CCCCCHhHHHHHHhccc-----------------------------cCCCCcC
Confidence            66 68999999999999999998877 66666666555544311                             1123458


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      ++.+.++|.+||+.||.+|||++++++||||+...
T Consensus       236 ~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          236 SDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             CHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence            89999999999999999999999999999998643

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.5e-47  Score=318.67  Aligned_cols=271  Identities=31%  Similarity=0.488  Sum_probs=210.8

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC-------eEEEEEecCcccHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK-------KLTLVFEHCDQDLKKY   73 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~-------~~~iv~e~~~g~l~~~   73 (282)
                      .||+|+++.+|+.||||++...  ........+++..++.++||||+++++++....       ..++||||++|++...
T Consensus        38 ~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~  115 (360)
T 3e3p_A           38 TVQLGKEKSTGMSVAIKKVIQD--PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRC  115 (360)
T ss_dssp             -CEEEEETTTCCEEEEEEEECC--TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHH
T ss_pred             EEEEEEECCCCCEEEEEEEecC--ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccccHHHH
Confidence            3899999999999999988653  233467788889999999999999999987543       3899999999987765


Q ss_pred             HHh---cCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCcEEEcC-CCcEEEEecCCccccCCCcccccccccc
Q psy6044          74 FDS---LNGEIDLDIVKSFMYQLLRGLAFCH--SRNVLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVKCYSAEVVT  147 (282)
Q Consensus        74 ~~~---~~~~~~~~~~~~~~~qi~~~l~~lh--~~~i~H~dl~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~  147 (282)
                      +..   ....+++..++.++.|++.||.+||  +.||+|+||||+||+++. ++.++|+|||++....... ......++
T Consensus       116 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt  194 (360)
T 3e3p_A          116 CRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE-PNVAYICS  194 (360)
T ss_dssp             HHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS-CCCSTTSC
T ss_pred             HHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC-CcccccCC
Confidence            543   4667999999999999999999999  999999999999999996 8999999999998765433 23345678


Q ss_pred             ccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHP  227 (282)
Q Consensus       148 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (282)
                      +.|+|||.+.+...++.++||||||+++|+|++|..| |.+.+..+....+....+.++...+............. ...
T Consensus       195 ~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  272 (360)
T 3e3p_A          195 RYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPI-FRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLY-NSK  272 (360)
T ss_dssp             GGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGG-CCC
T ss_pred             cceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC-cCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhcccc-ccc
Confidence            9999999997766579999999999999999988776 77788888888888777665433221110000000000 000


Q ss_pred             CCCc----cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         228 SMSF----SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       228 ~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      ...+    .......++.+.+||.+||+.||.+|||+.++|+||||+++..+.
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~  325 (360)
T 3e3p_A          273 GIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA  325 (360)
T ss_dssp             CCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTT
T ss_pred             cCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcc
Confidence            0011    112233678999999999999999999999999999999986544

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.4e-46  Score=309.35  Aligned_cols=240  Identities=24%  Similarity=0.338  Sum_probs=203.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEI   81 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~   81 (282)
                      ||+|++..+|+.||+|++...........+.+|+.+++.++||||+++++++.++...++|+||++|+.+..+.. .+.+
T Consensus        38 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~  116 (303)
T 3a7i_A           38 VFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPL  116 (303)
T ss_dssp             EEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHT-TSCC
T ss_pred             EEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHh-cCCC
Confidence            899999999999999999875555556789999999999999999999999999999999999998744444444 4679


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCCC
Q psy6044          82 DLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKL  161 (282)
Q Consensus        82 ~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  161 (282)
                      ++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+.. 
T Consensus       117 ~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-  195 (303)
T 3a7i_A          117 DETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA-  195 (303)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCC-
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCC-
Confidence            9999999999999999999999999999999999999999999999999987654444445557789999999997766 


Q ss_pred             CCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHH
Q psy6044         162 YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAK  241 (282)
Q Consensus       162 ~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (282)
                      ++.++|+||||+++|++++|..| |......+....+....                            .......++..
T Consensus       196 ~~~~~Di~slG~il~~l~~g~~p-~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~  246 (303)
T 3a7i_A          196 YDSKADIWSLGITAIELARGEPP-HSELHPMKVLFLIPKNN----------------------------PPTLEGNYSKP  246 (303)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCT-TTTSCHHHHHHHHHHSC----------------------------CCCCCSSCCHH
T ss_pred             CCchhhhHHHHHHHHHHccCCCC-CCCcCHHHHHHHhhcCC----------------------------CCCCccccCHH
Confidence            68999999999999999988877 66666555554443311                            11123458899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         242 GRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       242 l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      +.++|.+||+.||.+|||+.++++||||...
T Consensus       247 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          247 LKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence            9999999999999999999999999999654

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.7e-46  Score=306.93  Aligned_cols=249  Identities=25%  Similarity=0.395  Sum_probs=201.8

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCC--------CCccHHHHHHHHhhCC-CCCccceeeeeeeCCeEEEEEecCcc-cH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEG--------VPSSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQ-DL   70 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~g-~l   70 (282)
                      .||+|.++.+|+.||||++.......        ..+.+.+|+.+++++. ||||+++++++.++...++|+||++| ++
T Consensus        32 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  111 (298)
T 1phk_A           32 VVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL  111 (298)
T ss_dssp             EEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBH
T ss_pred             EEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcH
Confidence            38999999999999999998632211        1345778999999995 99999999999999999999999985 66


Q ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccc
Q psy6044          71 KKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWY  150 (282)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  150 (282)
                      .+.+.. ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......+++.|
T Consensus       112 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y  189 (298)
T 1phk_A          112 FDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSY  189 (298)
T ss_dssp             HHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC-CBCCCCSCGGG
T ss_pred             HHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCCCc-ccccccCCccc
Confidence            665544 6789999999999999999999999999999999999999999999999999998765332 23345678999


Q ss_pred             cChhhhc-----CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         151 RPPDVLF-----GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY  225 (282)
Q Consensus       151 ~aPE~~~-----~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (282)
                      +|||.+.     ....++.++|+||||+++|+|++|..| |...+..+....+.......+.                  
T Consensus       190 ~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p-~~~~~~~~~~~~~~~~~~~~~~------------------  250 (298)
T 1phk_A          190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-FWHRKQMLMLRMIMSGNYQFGS------------------  250 (298)
T ss_dssp             CCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHTCCCCCT------------------
T ss_pred             cCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCC-CcCccHHHHHHHHhcCCcccCc------------------
Confidence            9999985     233468999999999999999998887 5566666666655553221111                  


Q ss_pred             CCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccchh
Q psy6044         226 HPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       226 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  277 (282)
                             .....+++.+.++|.+||+.||.+|||+.++++||||++...+..
T Consensus       251 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  295 (298)
T 1phk_A          251 -------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV  295 (298)
T ss_dssp             -------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC----
T ss_pred             -------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchhh
Confidence                   112458999999999999999999999999999999998866543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=322.09  Aligned_cols=268  Identities=33%  Similarity=0.577  Sum_probs=209.5

Q ss_pred             eeeeeeCCCCceEEEeeeecCC-CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCe------EEEEEecCcccHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG-NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKK------LTLVFEHCDQDLKKYF   74 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~------~~iv~e~~~g~l~~~~   74 (282)
                      ||+|.++.+|+.||||++.... .......+.+|+.+++.++||||+++++++.....      .++||||++|++.+.+
T Consensus        40 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~  119 (353)
T 3coi_A           40 VCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM  119 (353)
T ss_dssp             EEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCSEEGGGTT
T ss_pred             EEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEeccccCCHHHHh
Confidence            8999999999999999987632 22234567899999999999999999999987653      5999999998776654


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChh
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPD  154 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE  154 (282)
                         ...+++..+..++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+......   .....+++.|+|||
T Consensus       120 ---~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~t~~y~aPE  193 (353)
T 3coi_A          120 ---GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPE  193 (353)
T ss_dssp             ---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----------CCSBCCSCHH
T ss_pred             ---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC---ccccccCcCcCCHH
Confidence               346999999999999999999999999999999999999999999999999999765432   23446789999999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCC---CCCCCCCCCCCCc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPD---FKPFPMYHPSMSF  231 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  231 (282)
                      .+.+...++.++|+||||+++|+|++|..| |.+.+..+....+....+.++.+.+........   .... ........
T Consensus       194 ~~~~~~~~~~~~Di~slG~il~el~~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  271 (353)
T 3coi_A          194 VILSWMHYNQTVDIWSVGCIMAEMLTGKTL-FKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSL-PQTPRKDF  271 (353)
T ss_dssp             HHSCCSCCCTTHHHHHHHHHHHHHHHSSCS-SBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTS-CBCSSCCT
T ss_pred             HHhCcCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhC-cCCCCccH
Confidence            997755579999999999999999988777 777787888888877776655433222110000   0000 00111133


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccchh
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  277 (282)
                      ......+++.+.+||.+||+.||.+|||++++++||||+....+..
T Consensus       272 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~  317 (353)
T 3coi_A          272 TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEE  317 (353)
T ss_dssp             TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGG
T ss_pred             HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccc
Confidence            3445678999999999999999999999999999999998866543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.9e-47  Score=319.04  Aligned_cols=251  Identities=28%  Similarity=0.429  Sum_probs=199.3

Q ss_pred             CeeeeeeCCCCceEEEeeeecC----CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV----GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFD   75 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~   75 (282)
                      .||+|.+..+++.||+|++...    ........+.+|+.++++++||||+++++++.+.+..++||||++| ++.+.+.
T Consensus        41 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~  120 (345)
T 3hko_A           41 VVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN  120 (345)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEE
T ss_pred             EEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHH
Confidence            3899999999999999999762    2344567889999999999999999999999999999999999976 5555442


Q ss_pred             hc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy6044          76 SL---------------------------------------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLL  116 (282)
Q Consensus        76 ~~---------------------------------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil  116 (282)
                      ..                                       ...+++..++.++.||+.||.|||++|++|+||||+||+
T Consensus       121 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl  200 (345)
T 3hko_A          121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL  200 (345)
T ss_dssp             EEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             HhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEE
Confidence            10                                       112467889999999999999999999999999999999


Q ss_pred             EcCCC--cEEEEecCCccccCCC----ccccccccccccccChhhhcCC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCC
Q psy6044         117 INKNG--ELKLADFGLARAFGIP----VKCYSAEVVTLWYRPPDVLFGA-KLYTTSIDMWSAGCIFAELANAGRPLFPGS  189 (282)
Q Consensus       117 ~~~~~--~~~l~df~~~~~~~~~----~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~ll~~~~p~~~~~  189 (282)
                      ++.++  .++|+|||.+......    ........+++.|+|||.+.+. ..++.++||||||+++|+|++|..| |.+.
T Consensus       201 l~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~p-f~~~  279 (345)
T 3hko_A          201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP-FPGV  279 (345)
T ss_dssp             ESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCS-SCCS
T ss_pred             EecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCC-CCCC
Confidence            98776  8999999999765321    1123445678999999999652 4478999999999999999998887 7777


Q ss_pred             ChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         190 DVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                      ...+....+.......+                         ......+++.+.+||.+||+.||.+|||+.++++||||
T Consensus       280 ~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~  334 (345)
T 3hko_A          280 NDADTISQVLNKKLCFE-------------------------NPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWI  334 (345)
T ss_dssp             SHHHHHHHHHHCCCCTT-------------------------SGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHH
T ss_pred             ChHHHHHHHHhcccccC-------------------------CcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhh
Confidence            77777666655322111                         11224579999999999999999999999999999999


Q ss_pred             cCCccchh
Q psy6044         270 SDLNVAIK  277 (282)
Q Consensus       270 ~~~~~~~~  277 (282)
                      ++....+.
T Consensus       335 ~~~~~~~~  342 (345)
T 3hko_A          335 SQFSDKIY  342 (345)
T ss_dssp             HTTSSCSS
T ss_pred             ccChHhhE
Confidence            99876553

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.1e-47  Score=313.83  Aligned_cols=246  Identities=21%  Similarity=0.327  Sum_probs=188.8

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      ||+|++..+|+.||||++.... ......+.+|+.++.++ +||||+++++++.+++..++||||++| ++.+.+.. ..
T Consensus        29 V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~  106 (316)
T 2ac3_A           29 VQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK-RR  106 (316)
T ss_dssp             EEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-HS
T ss_pred             EEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhc-cC
Confidence            8999999999999999997642 33456789999999985 799999999999999999999999985 66666554 57


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc---EEEEecCCccccCCCc-------ccccccccccc
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPV-------KCYSAEVVTLW  149 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~---~~l~df~~~~~~~~~~-------~~~~~~~~~~~  149 (282)
                      .+++..++.++.||+.||.|||++|++|+||||+||+++.++.   ++|+|||++.......       .......+++.
T Consensus       107 ~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~  186 (316)
T 2ac3_A          107 HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE  186 (316)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcC
Confidence            8999999999999999999999999999999999999988776   9999999987653211       11223457899


Q ss_pred             ccChhhhcCC----CCCCchhhHHHHHHHHHHHHhcCCCCCCCCC--------------hHHHHHHHHHHhCCCCCCCCC
Q psy6044         150 YRPPDVLFGA----KLYTTSIDMWSAGCIFAELANAGRPLFPGSD--------------VDDQLKRIFKLLGTPTEDTWP  211 (282)
Q Consensus       150 ~~aPE~~~~~----~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~  211 (282)
                      |+|||.+...    ..++.++||||||+++|+|++|..|+.....              .......+.......+     
T Consensus       187 y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----  261 (316)
T 2ac3_A          187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFP-----  261 (316)
T ss_dssp             GCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCC-----
T ss_pred             ccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccC-----
Confidence            9999998641    2268899999999999999999888543322              1222333332111000     


Q ss_pred             CCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         212 GMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                                          ......+++.+.+||++||+.||.+|||++++++||||++...
T Consensus       262 --------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~  304 (316)
T 2ac3_A          262 --------------------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP  304 (316)
T ss_dssp             --------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred             --------------------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence                                0112357899999999999999999999999999999998754

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.1e-46  Score=306.35  Aligned_cols=243  Identities=22%  Similarity=0.359  Sum_probs=204.4

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~   80 (282)
                      ||+|.+..+|+.||+|++...   .....+.+|+.+++.++||||+++++++..++..++|+||++| ++.+.+......
T Consensus        45 Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~  121 (314)
T 3com_A           45 VYKAIHKETGQIVAIKQVPVE---SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT  121 (314)
T ss_dssp             EEEEEETTTCCEEEEEEEETT---SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCC
T ss_pred             EEEEEECCCCCEEEEEecCch---HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCC
Confidence            899999999999999998753   2357789999999999999999999999999999999999986 666666555778


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+..
T Consensus       122 ~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  201 (314)
T 3com_A          122 LTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG  201 (314)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCC
Confidence            99999999999999999999999999999999999999999999999999987655444445557789999999997766


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                       ++.++|+||||+++|+|++|..| |...........+....  .                        .....+..+++
T Consensus       202 -~~~~~Di~slG~il~~l~~g~~p-~~~~~~~~~~~~~~~~~--~------------------------~~~~~~~~~~~  253 (314)
T 3com_A          202 -YNCVADIWSLGITAIEMAEGKPP-YADIHPMRAIFMIPTNP--P------------------------PTFRKPELWSD  253 (314)
T ss_dssp             -BCTTHHHHHHHHHHHHHHHSSCT-TTTSCHHHHHHHHHHSC--C------------------------CCCSSGGGSCH
T ss_pred             -CCccccHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHhcCC--C------------------------cccCCcccCCH
Confidence             68999999999999999998887 55555544443333211  0                        00112345789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      .+.++|.+||+.||.+|||+.++++||||++....
T Consensus       254 ~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~  288 (314)
T 3com_A          254 NFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGV  288 (314)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCG
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcc
Confidence            99999999999999999999999999999987543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.3e-46  Score=313.16  Aligned_cols=266  Identities=30%  Similarity=0.522  Sum_probs=204.1

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCC-CCCccceeeeeee--CCeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK-HKNIVRLYDVLHS--EKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~--~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||+|++..+|+.||+|++..    ...+.+.+|+.++++++ ||||+++++++.+  ....++|+||++|+.+..+..  
T Consensus        52 V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--  125 (330)
T 3nsz_A           52 VFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ--  125 (330)
T ss_dssp             EEEEEETTTCCEEEEEEECS----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG--
T ss_pred             EEEEEECCCCcEEEEEEecc----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH--
Confidence            89999999999999999863    23467899999999997 9999999999998  678999999998765555543  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC-cEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG-ELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                       .+++..+..++.||+.||.|||++|++|+||||+||+++.++ .++|+|||.+....... ......++..|+|||.+.
T Consensus       126 -~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~  203 (330)
T 3nsz_A          126 -TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLV  203 (330)
T ss_dssp             -GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-CCCSCCSCGGGCCHHHHT
T ss_pred             -hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-ccccccccccccChhhhc
Confidence             489999999999999999999999999999999999999777 89999999997665332 234456788999999998


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCC-CC--CCCCCCCCCCCCCCCCCC----
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTW-PG--MNLLPDFKPFPMYHPSMS----  230 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~----  230 (282)
                      +...++.++||||||+++|+|++|..|++.+....+.+..+....+......+ ..  ......+...........    
T Consensus       204 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (330)
T 3nsz_A          204 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERF  283 (330)
T ss_dssp             TCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGG
T ss_pred             CCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhh
Confidence            75558999999999999999999999988888777776666554432110000 00  000000000000000000    


Q ss_pred             -ccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         231 -FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       231 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                       .......+++.+.+||++||+.||.+|||++++|+||||+++..+
T Consensus       284 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  329 (330)
T 3nsz_A          284 VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD  329 (330)
T ss_dssp             CCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC--
T ss_pred             ccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhccC
Confidence             111223489999999999999999999999999999999988653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=9.1e-48  Score=315.17  Aligned_cols=235  Identities=22%  Similarity=0.233  Sum_probs=169.4

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHH--HHHHHhhCCCCCccceeeeeeeCC----eEEEEEecCcc-cHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALR--EICLLKELKHKNIVRLYDVLHSEK----KLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~--e~~~~~~l~h~~i~~~~~~~~~~~----~~~iv~e~~~g-~l~~~~   74 (282)
                      ||+|+.  +|+.||||++....    ...+..  |+..+.+++||||+++++++.+++    .+||||||++| +|.+.+
T Consensus        19 Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l   92 (303)
T 3hmm_A           19 VWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL   92 (303)
T ss_dssp             EEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHH
T ss_pred             EEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHH
Confidence            899987  58999999987522    223344  555556789999999999998653    68999999985 566555


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc----ccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSR--------NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK----CYS  142 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~--------~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~----~~~  142 (282)
                      ..  ..++++.+..++.|++.||+|||++        +|+||||||+|||++.++.+||+|||++........    ...
T Consensus        93 ~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~  170 (303)
T 3hmm_A           93 NR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN  170 (303)
T ss_dssp             HH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC--
T ss_pred             Hh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecc
Confidence            43  5789999999999999999999987        999999999999999999999999999976643322    122


Q ss_pred             cccccccccChhhhcCCC-----CCCchhhHHHHHHHHHHHHhcCCCCCCCC--------------ChHHHHHHHHHHhC
Q psy6044         143 AEVVTLWYRPPDVLFGAK-----LYTTSIDMWSAGCIFAELANAGRPLFPGS--------------DVDDQLKRIFKLLG  203 (282)
Q Consensus       143 ~~~~~~~~~aPE~~~~~~-----~~~~~~Di~slG~ll~~ll~~~~p~~~~~--------------~~~~~~~~~~~~~~  203 (282)
                      ...||+.|+|||.+.+..     .++.++|||||||++|||+||..|+....              ...+....+.....
T Consensus       171 ~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  250 (303)
T 3hmm_A          171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL  250 (303)
T ss_dssp             ---CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC
T ss_pred             cccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccC
Confidence            346899999999996542     25679999999999999998865431111              11111111111000


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         204 TPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      .+                      ..+........+..+.+|+.+||+.||++|||+.++++.
T Consensus       251 rp----------------------~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          251 RP----------------------NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CC----------------------CCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             CC----------------------CCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            00                      000000112244678899999999999999999999873

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.5e-46  Score=316.70  Aligned_cols=242  Identities=27%  Similarity=0.411  Sum_probs=198.7

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCC-------CCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEG-------VPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKK   72 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~   72 (282)
                      ||+|+++.+|+.||||++.......       ....+.+|+.+++++ +||||+++++++......++||||++| ++.+
T Consensus       110 Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~  189 (365)
T 2y7j_A          110 VRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFD  189 (365)
T ss_dssp             EEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHH
T ss_pred             EEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHH
Confidence            8999999999999999988632211       134678899999999 899999999999999999999999987 5555


Q ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccC
Q psy6044          73 YFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRP  152 (282)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~a  152 (282)
                      .+. ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ......+++.|+|
T Consensus       190 ~l~-~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~-~~~~~~gt~~y~a  267 (365)
T 2y7j_A          190 YLT-EKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE-KLRELCGTPGYLA  267 (365)
T ss_dssp             HHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC-CBCCCCSCGGGCC
T ss_pred             HHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCCc-ccccCCCCCCccC
Confidence            554 46789999999999999999999999999999999999999999999999999988765332 2344578999999


Q ss_pred             hhhhcC-----CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         153 PDVLFG-----AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHP  227 (282)
Q Consensus       153 PE~~~~-----~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (282)
                      ||.+.+     ...++.++||||||+++|+|++|..| |......+....+........                     
T Consensus       268 PE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~---------------------  325 (365)
T 2y7j_A          268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP-FWHRRQILMLRMIMEGQYQFS---------------------  325 (365)
T ss_dssp             HHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHTCCCCC---------------------
T ss_pred             hhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCC-CCCCCHHHHHHHHHhCCCCCC---------------------
Confidence            999853     22368899999999999999998888 555566666555554221111                     


Q ss_pred             CCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q psy6044         228 SMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD  271 (282)
Q Consensus       228 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  271 (282)
                          ......+++.+.++|++||+.||++|||++++++||||+.
T Consensus       326 ----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          326 ----SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             ----HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             ----CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence                1112357899999999999999999999999999999973

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.8e-47  Score=321.96  Aligned_cols=266  Identities=32%  Similarity=0.554  Sum_probs=197.1

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC------eEEEEEecCcccHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK------KLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~------~~~iv~e~~~g~l~~~~   74 (282)
                      ||+|.+..+|+.||||++... ........+.+|+.+++.++||||+++++++....      ..++||||++|++.+.+
T Consensus        41 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~  120 (371)
T 2xrw_A           41 VCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI  120 (371)
T ss_dssp             EEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHH
T ss_pred             EEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCCCHHHHH
Confidence            899999999999999999863 22333456889999999999999999999998664      78999999999988877


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChh
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPD  154 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE  154 (282)
                      .   ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...... .......+++.|+|||
T Consensus       121 ~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE  196 (371)
T 2xrw_A          121 Q---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPE  196 (371)
T ss_dssp             H---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----------------CTTCCHH
T ss_pred             h---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc-cccCCceecCCccCHH
Confidence            4   46899999999999999999999999999999999999999999999999999766533 2233456789999999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCC--------CCCCCCCC---
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNL--------LPDFKPFP---  223 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~---  223 (282)
                      .+.+.. ++.++||||||+++|+|++|..| |.+.+..+....+....+.+.++.+.....        ...+....   
T Consensus       197 ~~~~~~-~~~~~DiwslG~il~el~~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (371)
T 2xrw_A          197 VILGMG-YKENVDIWSVGCIMGEMIKGGVL-FPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEK  274 (371)
T ss_dssp             HHTTCC-CCTTHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHH
T ss_pred             HhcCCC-CCchHhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhh
Confidence            998765 79999999999999999998877 777777777777776665543322211100        00000000   


Q ss_pred             --CCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         224 --MYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       224 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                        ...............++.+.+||++||..||.+|||++++|+||||+...
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  326 (371)
T 2xrw_A          275 LFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  326 (371)
T ss_dssp             HSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             hcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence              00000000001112367899999999999999999999999999998653

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=7.1e-47  Score=308.20  Aligned_cols=246  Identities=23%  Similarity=0.378  Sum_probs=200.2

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCC-----CCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEG-----VPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~   75 (282)
                      ||+|+++.+|+.||+|++.......     ..+.+.+|+.++++++||||+++++++.+....++|+||++| ++.+.+.
T Consensus        21 V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  100 (283)
T 3bhy_A           21 VRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA  100 (283)
T ss_dssp             EEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH
T ss_pred             EEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHH
Confidence            8999999999999999998732111     245688999999999999999999999999999999999975 5555554


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC----cEEEEecCCccccCCCcccccccccccccc
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG----ELKLADFGLARAFGIPVKCYSAEVVTLWYR  151 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  151 (282)
                      . ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++    .++|+|||.+....... ......+++.|+
T Consensus       101 ~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~  178 (283)
T 3bhy_A          101 E-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN-EFKNIFGTPEFV  178 (283)
T ss_dssp             H-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC---------CCCGGGC
T ss_pred             h-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC-cccccCCCcCcc
Confidence            4 67899999999999999999999999999999999999998877    89999999998765332 223446788999


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSF  231 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
                      |||.+.+.. ++.++|+||||+++|++++|..| |......+....+......                         ..
T Consensus       179 aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p-~~~~~~~~~~~~~~~~~~~-------------------------~~  231 (283)
T 3bhy_A          179 APEIVNYEP-LGLEADMWSIGVITYILLSGASP-FLGETKQETLTNISAVNYD-------------------------FD  231 (283)
T ss_dssp             CHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCT-TCCSSHHHHHHHHHTTCCC-------------------------CC
T ss_pred             CcceecCCC-CCcchhhhhHHHHHHHHHHCCCC-CCCcchHHHHHHhHhcccC-------------------------Cc
Confidence            999997665 69999999999999999998877 6666666655554432111                         11


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      ......+++.+.++|++||+.||.+|||+.++++||||+.++...
T Consensus       232 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          232 EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred             chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence            123346889999999999999999999999999999999875443

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=5.4e-47  Score=309.94  Aligned_cols=244  Identities=24%  Similarity=0.308  Sum_probs=185.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCC-CCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHh---c
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEG-VPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS---L   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~---~   77 (282)
                      ||+|++..+|+.||+|++....... ....+.++...++.++||||+++++++.+++..++|+||++|++.+.+..   .
T Consensus        23 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~  102 (290)
T 3fme_A           23 VEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDK  102 (290)
T ss_dssp             EEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSEEHHHHHHHHHHT
T ss_pred             EEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhccchHHHHHHHHhc
Confidence            8999999999999999997632222 22334445556788899999999999999999999999999988666543   4


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhh
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSR-NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~  156 (282)
                      ...+++..++.++.||+.||.+||++ |++|+||||+||+++.++.++|+|||.+........ .....+++.|+|||.+
T Consensus       103 ~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~  181 (290)
T 3fme_A          103 GQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA-KDIDAGCKPYMAPERI  181 (290)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC----------------CCCCCCSCHHHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccccc-ccccCCCccccChhhc
Confidence            67899999999999999999999998 999999999999999999999999999977653322 2334678899999997


Q ss_pred             c---CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         157 F---GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       157 ~---~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      .   ....++.++|+||||+++|++++|..|+...................                           ..
T Consensus       182 ~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~  234 (290)
T 3fme_A          182 NPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP---------------------------QL  234 (290)
T ss_dssp             SCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC---------------------------CC
T ss_pred             ChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC---------------------------Cc
Confidence            2   33447899999999999999999998854434544444444332110                           01


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      ....+++.+.++|.+||+.||++|||+.++++||||+...
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          235 PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence            1235789999999999999999999999999999998653

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=6.9e-47  Score=331.65  Aligned_cols=243  Identities=26%  Similarity=0.407  Sum_probs=203.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCC------------CCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNE------------GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-   68 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~------------~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-   68 (282)
                      ||+|.++.+++.||+|++......            ...+.+.+|+.++++++||||+++++++.+....++||||++| 
T Consensus        52 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg  131 (504)
T 3q5i_A           52 VLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGG  131 (504)
T ss_dssp             EEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             EEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCC
Confidence            899999999999999999863211            3346788999999999999999999999999999999999976 


Q ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC---cEEEEecCCccccCCCcccccccc
Q psy6044          69 DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG---ELKLADFGLARAFGIPVKCYSAEV  145 (282)
Q Consensus        69 ~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~  145 (282)
                      ++.+.+.. .+.+++..++.++.||+.||.|||+.||+|+||||+||+++.++   .++|+|||++...... .......
T Consensus       132 ~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~  209 (504)
T 3q5i_A          132 ELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRL  209 (504)
T ss_dssp             BHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTT-SCBCCCC
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCC-Ccccccc
Confidence            66666655 57899999999999999999999999999999999999998776   6999999999876543 2334457


Q ss_pred             ccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY  225 (282)
Q Consensus       146 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (282)
                      +++.|+|||.+.+  .++.++||||+|+++|+|++|..| |.+.+..+....+.......+                   
T Consensus       210 gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~-------------------  267 (504)
T 3q5i_A          210 GTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPP-FGGQNDQDIIKKVEKGKYYFD-------------------  267 (504)
T ss_dssp             SCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHCCCCCC-------------------
T ss_pred             CCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHcCCCCCC-------------------
Confidence            8999999999864  379999999999999999988777 777787777777766322111                   


Q ss_pred             CCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         226 HPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       226 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                            ......+|+.+.+||++||+.||.+|||++++|+||||+....
T Consensus       268 ------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          268 ------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             ------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             ------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence                  1112458999999999999999999999999999999987643

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.8e-46  Score=306.92  Aligned_cols=238  Identities=25%  Similarity=0.390  Sum_probs=194.4

Q ss_pred             eeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeee----CCeEEEEEecCcc-cHHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHS----EKKLTLVFEHCDQ-DLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~----~~~~~iv~e~~~g-~l~~~~~   75 (282)
                      ||+|.+..++..||+|++.. .......+.+.+|+.++++++||||+++++++..    ...+++|+||++| ++.+.+ 
T Consensus        42 Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l-  120 (290)
T 1t4h_A           42 VYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-  120 (290)
T ss_dssp             EEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHH-
T ss_pred             EEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHH-
Confidence            89999999999999999986 3333445678899999999999999999999875    4578999999976 555555 


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEc-CCCcEEEEecCCccccCCCccccccccccccccC
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSRN--VLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRP  152 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~dl~~~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~a  152 (282)
                      ...+.+++..++.++.||+.||.|||+.|  ++|+||+|+||+++ .++.++|+|||.+.......  .....+++.|+|
T Consensus       121 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~t~~y~a  198 (290)
T 1t4h_A          121 KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMA  198 (290)
T ss_dssp             HHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS--BEESCSSCCCCC
T ss_pred             HHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc--cccccCCcCcCC
Confidence            44678999999999999999999999999  99999999999997 78999999999997654332  233467899999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       153 PE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      ||.+.+.  ++.++|+||||+++|+|++|..|+............+....                           ...
T Consensus       199 PE~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~---------------------------~~~  249 (290)
T 1t4h_A          199 PEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV---------------------------KPA  249 (290)
T ss_dssp             GGGGGTC--CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC---------------------------CCG
T ss_pred             HHHHhcc--CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccC---------------------------Ccc
Confidence            9988643  69999999999999999999888544444444444332211                           112


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD  271 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  271 (282)
                      ......++.+.++|.+||+.||.+|||++++++||||++
T Consensus       250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            234457889999999999999999999999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=9.1e-47  Score=324.25  Aligned_cols=265  Identities=25%  Similarity=0.418  Sum_probs=207.8

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC------CCCCccceeeeeeeCCeEEEEEecCcccHHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL------KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l------~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~   75 (282)
                      ||+|.+..+|+.||||++...  ......+.+|+.+++.+      +|+||+++++++...+..++|+|+++|++.+.+.
T Consensus       113 V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~  190 (429)
T 3kvw_A          113 VVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIK  190 (429)
T ss_dssp             EEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCCCBHHHHHH
T ss_pred             EEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccCCCHHHHHH
Confidence            899999999999999998642  12234567788888877      5779999999999999999999999999999887


Q ss_pred             hcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc--EEEEecCCccccCCCccccccccccccccC
Q psy6044          76 SLN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVKCYSAEVVTLWYRP  152 (282)
Q Consensus        76 ~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~a  152 (282)
                      ... ..+++..++.++.||+.||+|||+.||+|+||||+||+++.++.  ++|+|||++......   .....+++.|+|
T Consensus       191 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~---~~~~~gt~~y~a  267 (429)
T 3kvw_A          191 KNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR---VYTYIQSRFYRA  267 (429)
T ss_dssp             HTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC---CCSSCSCGGGCC
T ss_pred             hccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCCc---ccccCCCCCccC
Confidence            754 35999999999999999999999999999999999999999887  999999999765432   233467899999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCC---------CC----
Q psy6044         153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLP---------DF----  219 (282)
Q Consensus       153 PE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~----  219 (282)
                      ||.+.+.. ++.++|||||||++|+|++|..| |.+.+..+.+..+....+.++...+.......         ..    
T Consensus       268 PE~~~~~~-~~~~~DiwSlG~il~elltG~~p-f~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (429)
T 3kvw_A          268 PEVILGAR-YGMPIDMWSLGCILAELLTGYPL-LPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVT  345 (429)
T ss_dssp             HHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEE
T ss_pred             hHHHhCCC-CCchHHHHhHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCccccccc
Confidence            99998877 79999999999999999988655 88888888888888887776543221110000         00    


Q ss_pred             ----------------CCCCCCCCCCCc-cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         220 ----------------KPFPMYHPSMSF-SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       220 ----------------~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                                      ...........+ ..+....++.+.+||++||+.||++|||++|+|+||||++..
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          346 TLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL  416 (429)
T ss_dssp             CCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred             ccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCC
Confidence                            000000000011 112334588999999999999999999999999999999764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.1e-47  Score=319.93  Aligned_cols=262  Identities=22%  Similarity=0.322  Sum_probs=204.1

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCC-----CCCccceeeeeeeCCeEEEEEecCcccHHHHHHh
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK-----HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS   76 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-----h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~   76 (282)
                      ||+|++..+|+.||||++...  ......+..|+.+++.+.     ||||+++++++......++|||++++++.+.+..
T Consensus        51 V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~  128 (360)
T 3llt_A           51 VLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITR  128 (360)
T ss_dssp             EEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCCCCBHHHHHHH
T ss_pred             EEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCCCCCHHHHHHh
Confidence            899999999999999998641  122356778999999996     9999999999999999999999998888888876


Q ss_pred             cC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-------------------------CCcEEEEecCC
Q psy6044          77 LN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK-------------------------NGELKLADFGL  130 (282)
Q Consensus        77 ~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~-------------------------~~~~~l~df~~  130 (282)
                      .. ..+++..+..++.||+.||.|||++||+|+||||+||+++.                         ++.++|+|||+
T Consensus       129 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~  208 (360)
T 3llt_A          129 NNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC  208 (360)
T ss_dssp             TTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTT
T ss_pred             cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccC
Confidence            54 35999999999999999999999999999999999999975                         78999999999


Q ss_pred             ccccCCCccccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCC
Q psy6044         131 ARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTW  210 (282)
Q Consensus       131 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (282)
                      +......   .....+++.|+|||.+.+.. ++.++||||||+++|+|++|..| |...+..+....+.......+....
T Consensus       209 a~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~p-f~~~~~~~~~~~~~~~~~~~p~~~~  283 (360)
T 3llt_A          209 ATFKSDY---HGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLL-FRTHEHMEHLAMMESIIQPIPKNML  283 (360)
T ss_dssp             CEETTSC---CCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHHTCCCCHHHH
T ss_pred             ceecCCC---CcCccCcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHCCCC-CCCCcHHHHHHHHHHhcCCCCHHHH
Confidence            9765432   23456789999999998776 79999999999999999998777 7777778888777776665543211


Q ss_pred             CCCCCC--------CCCC-CCCCCCCC--------CCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q psy6044         211 PGMNLL--------PDFK-PFPMYHPS--------MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS  270 (282)
Q Consensus       211 ~~~~~~--------~~~~-~~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  270 (282)
                      ......        .... ..+.....        ..........++.+.+||++||+.||++|||++++|+||||+
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          284 YEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             hhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence            100000        0000 00000000        000111223458889999999999999999999999999996

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.3e-46  Score=307.15  Aligned_cols=235  Identities=21%  Similarity=0.273  Sum_probs=190.2

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc-
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL-   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~-   77 (282)
                      ||+|.++.+|+.||+|++... ........+.+|+..+..+ +||||+++++++.+++..++|+||++| ++.+.+... 
T Consensus        27 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  106 (289)
T 1x8b_A           27 VFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENY  106 (289)
T ss_dssp             EEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHH
T ss_pred             EEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhc
Confidence            899999999999999999873 3333456788899999999 999999999999999999999999976 676666543 


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC-------------------CcEEEEecCCccccCC
Q psy6044          78 --NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-------------------GELKLADFGLARAFGI  136 (282)
Q Consensus        78 --~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~-------------------~~~~l~df~~~~~~~~  136 (282)
                        ...+++..++.++.||+.||.|||++|++|+||||+||+++.+                   ..++|+|||.+.....
T Consensus       107 ~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~  186 (289)
T 1x8b_A          107 RIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS  186 (289)
T ss_dssp             HHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTC
T ss_pred             ccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCC
Confidence              2679999999999999999999999999999999999999844                   4799999999987654


Q ss_pred             CccccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCC
Q psy6044         137 PVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLL  216 (282)
Q Consensus       137 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  216 (282)
                      ..    ...+++.|+|||.+.+...++.++||||||+++|++++|..+ +....   ....+...               
T Consensus       187 ~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~-~~~~~---~~~~~~~~---------------  243 (289)
T 1x8b_A          187 PQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL-PRNGD---QWHEIRQG---------------  243 (289)
T ss_dssp             SC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCC-CSSSH---HHHHHHTT---------------
T ss_pred             cc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCC-Ccchh---HHHHHHcC---------------
Confidence            32    235789999999998775567899999999999999966555 33322   12222211               


Q ss_pred             CCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         217 PDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                                   .....+..+++.+.++|.+||+.||.+|||+.++++||||++.
T Consensus       244 -------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          244 -------------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             -------------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             -------------CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence                         1122345689999999999999999999999999999999874

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.6e-46  Score=308.01  Aligned_cols=241  Identities=27%  Similarity=0.343  Sum_probs=199.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~   80 (282)
                      ||+|+++.+|+.||+|++..... .....+.+|+.++++++||||+++++++.+....++|+||++| ++.+.+.. .+.
T Consensus        25 V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~  102 (304)
T 2jam_A           25 VFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE-RGV  102 (304)
T ss_dssp             EEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HSC
T ss_pred             EEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHH-cCC
Confidence            89999999999999999986322 2345788999999999999999999999999999999999975 66666554 568


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE---cCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      +++..++.++.|++.||.+||+.|++|+||+|+||++   +.++.++|+|||.+......  ......+++.|+|||.+.
T Consensus       103 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~  180 (304)
T 2jam_A          103 YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--IMSTACGTPGYVAPEVLA  180 (304)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--TTHHHHSCCCBCCTTTBS
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--ccccccCCCCccChHHhc
Confidence            9999999999999999999999999999999999999   77899999999998755432  223345788999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|+||||+++|+|++|..| |......+....+.......+                         ......
T Consensus       181 ~~~-~~~~~Di~slG~il~~l~~g~~p-f~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~  233 (304)
T 2jam_A          181 QKP-YSKAVDCWSIGVITYILLCGYPP-FYEETESKLFEKIKEGYYEFE-------------------------SPFWDD  233 (304)
T ss_dssp             SCS-CCHHHHHHHHHHHHHHHHHSSCT-TTTSCHHHHHHHHHHCCCCCC-------------------------TTTTTT
T ss_pred             cCC-CCchhhHHHHHHHHHHHHHCCCC-CCCCCHHHHHHHHHcCCCCCC-------------------------cccccc
Confidence            665 79999999999999999998877 666666666666655322211                         112345


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      +++.+.+||.+||+.||.+|||++++++||||++..
T Consensus       234 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          234 ISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             SCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence            889999999999999999999999999999998653

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.1e-46  Score=307.19  Aligned_cols=247  Identities=24%  Similarity=0.334  Sum_probs=197.5

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      .||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+++..++|+||++| ++.+.+.....
T Consensus        34 ~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~  112 (302)
T 2j7t_A           34 KVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR  112 (302)
T ss_dssp             CEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTS
T ss_pred             EEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhcc
Confidence            38999999999999999987632 23457788999999999999999999999999999999999986 55555555567


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc--
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF--  157 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--  157 (282)
                      .+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.  
T Consensus       113 ~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  192 (302)
T 2j7t_A          113 GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE  192 (302)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccc
Confidence            899999999999999999999999999999999999999999999999998754322222223346788999999984  


Q ss_pred             --CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         158 --GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       158 --~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                        ....++.++|+||||+++|+|++|..| |...+..+....+......                          ....+
T Consensus       193 ~~~~~~~~~~~Di~slG~il~~l~~g~~p-~~~~~~~~~~~~~~~~~~~--------------------------~~~~~  245 (302)
T 2j7t_A          193 TMKDTPYDYKADIWSLGITLIEMAQIEPP-HHELNPMRVLLKIAKSDPP--------------------------TLLTP  245 (302)
T ss_dssp             HTTSTTTTTHHHHHHHHHHHHHHHHSSCT-TTTSCHHHHHHHHHHSCCC--------------------------CCSSG
T ss_pred             cCCCCCCchhhhHHHHHHHHHHHhcCCCC-CccCCHHHHHHHHhccCCc--------------------------ccCCc
Confidence              334478999999999999999988877 6666666555554442110                          01123


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ..++..+.++|.+||+.||.+|||+.++++||||+++...
T Consensus       246 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  285 (302)
T 2j7t_A          246 SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN  285 (302)
T ss_dssp             GGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred             cccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence            4578999999999999999999999999999999988654

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.1e-47  Score=313.22  Aligned_cols=255  Identities=22%  Similarity=0.337  Sum_probs=178.7

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHh---
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDS---   76 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~---   76 (282)
                      .||+|.+..+|+.||||++...........+.+|+.++++++||||+++++++..++..++|+||++| ++.+.+..   
T Consensus        30 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~  109 (303)
T 2vwi_A           30 VVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVA  109 (303)
T ss_dssp             CEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHH
T ss_pred             EEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhh
Confidence            48999999999999999987744445567888999999999999999999999999999999999975 66665543   


Q ss_pred             ----cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-----ccccccccc
Q psy6044          77 ----LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-----KCYSAEVVT  147 (282)
Q Consensus        77 ----~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~  147 (282)
                          ..+.+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......     .......++
T Consensus       110 ~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~  189 (303)
T 2vwi_A          110 KGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT  189 (303)
T ss_dssp             TTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CC
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCC
Confidence                24569999999999999999999999999999999999999999999999999886654221     112334578


Q ss_pred             ccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHP  227 (282)
Q Consensus       148 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (282)
                      +.|+|||.+.....++.++|+||||+++|+|++|..| |...............  ..+...                 .
T Consensus       190 ~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p-f~~~~~~~~~~~~~~~--~~~~~~-----------------~  249 (303)
T 2vwi_A          190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP-YHKYPPMKVLMLTLQN--DPPSLE-----------------T  249 (303)
T ss_dssp             CTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCT-TTTSCGGGHHHHHHTS--SCCCTT-----------------C
T ss_pred             ccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCC-CccCchhhHHHHHhcc--CCCccc-----------------c
Confidence            8999999986543478999999999999999998888 5544443333222211  110000                 0


Q ss_pred             CCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         228 SMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       228 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ..........+++.+.++|.+||+.||.+|||+.++++||||++.+..
T Consensus       250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  297 (303)
T 2vwi_A          250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK  297 (303)
T ss_dssp             -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred             ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence            001122345688999999999999999999999999999999987643

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=8.7e-47  Score=323.57  Aligned_cols=247  Identities=23%  Similarity=0.349  Sum_probs=187.7

Q ss_pred             eeeeeeCCCCceEEEeeeecCC-------CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG-------NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~   74 (282)
                      ||+|.++.+++.||+|++....       .......+.+|+.++++++||||+++++++.. +..++||||++|+.+...
T Consensus       151 V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~  229 (419)
T 3i6u_A          151 VKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDK  229 (419)
T ss_dssp             EEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGG
T ss_pred             EEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHH
Confidence            8999999999999999998621       22234568899999999999999999999854 558999999986444444


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC---cEEEEecCCccccCCCcccccccccccccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG---ELKLADFGLARAFGIPVKCYSAEVVTLWYR  151 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  151 (282)
                      ....+.+++..++.++.||+.||+|||++||+|+||||+||+++.++   .++|+|||++...+.. .......+++.|+
T Consensus       230 l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~  308 (419)
T 3i6u_A          230 VVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYL  308 (419)
T ss_dssp             TSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC------------CTTC
T ss_pred             HhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCC-ccccccCCCCCcc
Confidence            44467899999999999999999999999999999999999997554   5999999999876533 2233456799999


Q ss_pred             ChhhhcC--CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         152 PPDVLFG--AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSM  229 (282)
Q Consensus       152 aPE~~~~--~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
                      |||.+.+  ...++.++|+||||+++|+|++|..|+............+......                         
T Consensus       309 aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~-------------------------  363 (419)
T 3i6u_A          309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN-------------------------  363 (419)
T ss_dssp             CTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCC-------------------------
T ss_pred             CceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCC-------------------------
Confidence            9999853  3447889999999999999999888854333333333333221110                         


Q ss_pred             CccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ........+++.+.+||++||+.||++|||++++|+||||++.++.
T Consensus       364 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~  409 (419)
T 3i6u_A          364 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK  409 (419)
T ss_dssp             CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHHH
T ss_pred             CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhHH
Confidence            1122334689999999999999999999999999999999986554

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.1e-46  Score=308.75  Aligned_cols=272  Identities=36%  Similarity=0.617  Sum_probs=206.2

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeee--------------eCCeEEEEEecC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLH--------------SEKKLTLVFEHC   66 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~--------------~~~~~~iv~e~~   66 (282)
                      .||+|.+..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.              +....++|+||+
T Consensus        26 ~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~  104 (320)
T 2i6l_A           26 LVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM  104 (320)
T ss_dssp             CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECC
T ss_pred             EEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeecc
Confidence            48999999999999999987532 223467889999999999999999999874              447899999999


Q ss_pred             cccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc-CCCcEEEEecCCccccCCCc---cccc
Q psy6044          67 DQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPV---KCYS  142 (282)
Q Consensus        67 ~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~-~~~~~~l~df~~~~~~~~~~---~~~~  142 (282)
                      +|++.+.+.  .+.+++..++.++.||+.||++||++|++|+||||+||+++ .++.++|+|||.+.......   ....
T Consensus       105 ~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  182 (320)
T 2i6l_A          105 ETDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS  182 (320)
T ss_dssp             SEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCC
T ss_pred             CCCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccc
Confidence            998888765  46799999999999999999999999999999999999997 56799999999998764221   1223


Q ss_pred             cccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCC-CCCCCCC
Q psy6044         143 AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN-LLPDFKP  221 (282)
Q Consensus       143 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  221 (282)
                      ...++..|+|||.+.....++.++|+||||+++|++++|..| |.+.+..+....+.........+.+.... .......
T Consensus       183 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (320)
T 2i6l_A          183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTL-FAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIR  261 (320)
T ss_dssp             GGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHH
T ss_pred             cccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCccccc
Confidence            345588899999987755589999999999999999998877 77777777777666654332211100000 0000000


Q ss_pred             CCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         222 FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      ................+++.+.+||++||+.||.+|||++++++||||+..+++.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~  316 (320)
T 2i6l_A          262 NDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM  316 (320)
T ss_dssp             HHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred             ccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence            0000011133344567899999999999999999999999999999999887665

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=302.63  Aligned_cols=245  Identities=24%  Similarity=0.405  Sum_probs=194.3

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC-
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG-   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~-   79 (282)
                      ||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++|+||++| ++.+.+....+ 
T Consensus        38 Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~  116 (295)
T 2clq_A           38 VYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGP  116 (295)
T ss_dssp             EEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCC
T ss_pred             EEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccC
Confidence            8999999999999999987642 33457789999999999999999999999999999999999975 66665554332 


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-CCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          80 -EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        80 -~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                       .+++..++.++.||+.||.+||+.|++|+||+|+||+++. ++.++|+|||.+..............+++.|+|||.+.
T Consensus       117 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  196 (295)
T 2clq_A          117 LKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIID  196 (295)
T ss_dssp             CTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHH
T ss_pred             CCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhc
Confidence             4679999999999999999999999999999999999987 89999999999987654444344556789999999986


Q ss_pred             CC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         158 GA-KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       158 ~~-~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      +. ..++.++|+||||+++|+|++|..|+................ .                          .....+.
T Consensus       197 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~--------------------------~~~~~~~  249 (295)
T 2clq_A          197 KGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF-K--------------------------VHPEIPE  249 (295)
T ss_dssp             HGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH-C--------------------------CCCCCCT
T ss_pred             CCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc-c--------------------------ccccccc
Confidence            53 236899999999999999999888854433333332222111 1                          1112335


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      .+++.+.++|.+||+.||++|||+.++++||||+....
T Consensus       250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          250 SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             TSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence            68999999999999999999999999999999997654

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=6.3e-46  Score=305.78  Aligned_cols=244  Identities=25%  Similarity=0.422  Sum_probs=201.2

Q ss_pred             eeeeeeCCCCceEEEeeeecC---CCCCCCccHHHHHHHHhhCCCCCccceeeeee--eCCeEEEEEecCcccHHHHHHh
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV---GNEGVPSSALREICLLKELKHKNIVRLYDVLH--SEKKLTLVFEHCDQDLKKYFDS   76 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~--~~~~~~iv~e~~~g~l~~~~~~   76 (282)
                      ||+|.+..+|+.||+|++...   ........+.+|+.++++++||||+++++++.  +....++||||+++++.+.+..
T Consensus        21 V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~  100 (305)
T 2wtk_C           21 VKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDS  100 (305)
T ss_dssp             EEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEEHHHHHHH
T ss_pred             EEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCCHHHHHHh
Confidence            899999999999999999862   12334577899999999999999999999984  4568999999999987777665


Q ss_pred             c-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC--ccccccccccccccCh
Q psy6044          77 L-NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VKCYSAEVVTLWYRPP  153 (282)
Q Consensus        77 ~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~aP  153 (282)
                      . ...+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+......  ........+++.|+||
T Consensus       101 ~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  180 (305)
T 2wtk_C          101 VPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP  180 (305)
T ss_dssp             STTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCH
T ss_pred             CcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcCh
Confidence            4 356999999999999999999999999999999999999999999999999999776422  2222345678999999


Q ss_pred             hhhcCCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         154 DVLFGAK-LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       154 E~~~~~~-~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      |.+.+.. ..+.++||||||+++|+|++|..| |.+.+..+....+....                             .
T Consensus       181 E~~~~~~~~~~~~~Di~slG~il~~l~~g~~p-~~~~~~~~~~~~i~~~~-----------------------------~  230 (305)
T 2wtk_C          181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYP-FEGDNIYKLFENIGKGS-----------------------------Y  230 (305)
T ss_dssp             HHHTCCSCEESHHHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHCC-----------------------------C
T ss_pred             hhccCcccCCcchhhHHHHHHHHHHHHhCCCC-CCCchHHHHHHHHhcCC-----------------------------C
Confidence            9997643 247899999999999999998877 66666666666655421                             1


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ..+..+++.+.++|++||+.||.+|||++++++||||++....
T Consensus       231 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  273 (305)
T 2wtk_C          231 AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP  273 (305)
T ss_dssp             CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred             CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence            1234588999999999999999999999999999999876543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.3e-48  Score=329.36  Aligned_cols=240  Identities=16%  Similarity=0.246  Sum_probs=188.9

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHH---HHHhhCCCCCcccee-------eeeeeCC------------
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREI---CLLKELKHKNIVRLY-------DVLHSEK------------   57 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~---~~~~~l~h~~i~~~~-------~~~~~~~------------   57 (282)
                      ||+|+++.+|+.||||++...  ......+.+.+|+   ..++.++||||++++       +++.+++            
T Consensus        89 V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (377)
T 3byv_A           89 YLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDER  168 (377)
T ss_dssp             EEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC-----
T ss_pred             EEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCC
Confidence            899999999999999999863  2333456788999   455555899999998       6666553            


Q ss_pred             -----eEEEEEecCcccHHHHHHhcCCCCC-------HHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEE
Q psy6044          58 -----KLTLVFEHCDQDLKKYFDSLNGEID-------LDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL  125 (282)
Q Consensus        58 -----~~~iv~e~~~g~l~~~~~~~~~~~~-------~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l  125 (282)
                           ..|+||||++|++.+.+... +.++       +..++.++.||+.||+|||++||+|+||||+||+++.++.+||
T Consensus       169 ~~~i~~~~lv~E~~~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL  247 (377)
T 3byv_A          169 DMWVLSRFFLYPRMQSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFL  247 (377)
T ss_dssp             -CEEESEEEEEECCSEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEE
T ss_pred             ceEEEEEEEEEeccCCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEE
Confidence                 38999999999988887763 3333       4888899999999999999999999999999999999999999


Q ss_pred             EecCCccccCCCccccccccccccccChhhhcCC----------CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHH
Q psy6044         126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA----------KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL  195 (282)
Q Consensus       126 ~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----------~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~  195 (282)
                      +|||++...+.   ......+ +.|+|||.+.+.          ..++.++||||||+++|+|++|..|+ ......+..
T Consensus       248 ~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf-~~~~~~~~~  322 (377)
T 3byv_A          248 TGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI-TKDAALGGS  322 (377)
T ss_dssp             CCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC-------CCS
T ss_pred             EechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCC-cccccccch
Confidence            99999986543   2233455 889999999766          13799999999999999999988884 332211100


Q ss_pred             HHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         196 KRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      .                                 ........+++.+.+||.+||+.||.+|||+.++++||||+++...
T Consensus       323 ~---------------------------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~  369 (377)
T 3byv_A          323 E---------------------------------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE  369 (377)
T ss_dssp             G---------------------------------GGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHH
T ss_pred             h---------------------------------hhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHH
Confidence            0                                 1111224689999999999999999999999999999999998776


Q ss_pred             hhhhh
Q psy6044         276 IKSER  280 (282)
Q Consensus       276 ~~~~~  280 (282)
                      ..+..
T Consensus       370 ~~~~l  374 (377)
T 3byv_A          370 LSAAL  374 (377)
T ss_dssp             HHHHG
T ss_pred             HHHhh
Confidence            65543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.1e-46  Score=305.07  Aligned_cols=243  Identities=27%  Similarity=0.453  Sum_probs=201.0

Q ss_pred             eeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      ||+|+++.+|+.||+|++.. .........+.+|+.++++++||||+++++++.+....++|+|+++| ++.+.+.. ..
T Consensus        38 V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~  116 (287)
T 2wei_A           38 VLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RK  116 (287)
T ss_dssp             EEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HS
T ss_pred             EEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHh-cC
Confidence            89999999999999999987 33344567789999999999999999999999999999999999975 66666554 56


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC---CcEEEEecCCccccCCCccccccccccccccChhhh
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN---GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~  156 (282)
                      .+++..++.++.||+.||.+||+.|++|+||+|+||+++.+   +.++|+|||.+....... ......+++.|+|||.+
T Consensus       117 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~  195 (287)
T 2wei_A          117 RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPEVL  195 (287)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS-SCSCHHHHHTTCCHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC-ccccccCcccccChHHh
Confidence            79999999999999999999999999999999999999754   469999999987665332 22334568889999998


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       157 ~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      .+.  ++.++|+||||+++|+|++|..| |.+.+..+....+.......+                         .....
T Consensus       196 ~~~--~~~~~Di~slG~~l~~l~~g~~p-~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~  247 (287)
T 2wei_A          196 RGT--YDEKCDVWSAGVILYILLSGTPP-FYGKNEYDILKRVETGKYAFD-------------------------LPQWR  247 (287)
T ss_dssp             TTC--CCTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHCCCCCC-------------------------SGGGT
T ss_pred             cCC--CCCchhhHhHHHHHHHHHhCCCC-CCCCCHHHHHHHHHcCCCCCC-------------------------chhhh
Confidence            654  68999999999999999998877 666666666666555221111                         01123


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      .+++.+.++|++||+.||.+|||+.++++||||++...
T Consensus       248 ~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          248 TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             hcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence            57899999999999999999999999999999987654

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.1e-46  Score=309.19  Aligned_cols=245  Identities=25%  Similarity=0.395  Sum_probs=193.1

Q ss_pred             eeeeeeCCCCceEEEeeeecCC-------CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG-------NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY   73 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~   73 (282)
                      ||+|.++.+|+.||||++....       .......+.+|+.++++++||||+++++++..+. .++|+||++| ++.+.
T Consensus        26 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~  104 (322)
T 2ycf_A           26 VKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDK  104 (322)
T ss_dssp             EEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHH
T ss_pred             EEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHH
Confidence            8999999999999999987521       1223456889999999999999999999987665 8999999976 55555


Q ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc---EEEEecCCccccCCCccccccccccccc
Q psy6044          74 FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVKCYSAEVVTLWY  150 (282)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~~  150 (282)
                      +. ....+++..++.++.||+.||.+||++|++|+||+|+||+++.++.   ++|+|||.+....... ......+++.|
T Consensus       105 ~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~gt~~y  182 (322)
T 2ycf_A          105 VV-GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTY  182 (322)
T ss_dssp             HS-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH-HHHHHHSCCTT
T ss_pred             Hh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceeccccc-ccccccCCcCc
Confidence            54 4678999999999999999999999999999999999999987664   9999999998765332 22334578899


Q ss_pred             cChhhhc--CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         151 RPPDVLF--GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPS  228 (282)
Q Consensus       151 ~aPE~~~--~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
                      +|||.+.  ....++.++||||||+++|+|++|..|+............+......                        
T Consensus       183 ~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------------------  238 (322)
T 2ycf_A          183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN------------------------  238 (322)
T ss_dssp             CCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC------------------------
T ss_pred             cCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc------------------------
Confidence            9999974  23447899999999999999999988854433333333333332110                        


Q ss_pred             CCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         229 MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       229 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                       ........+++.+.+||++||+.||.+|||+.++++||||++.++
T Consensus       239 -~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~  283 (322)
T 2ycf_A          239 -FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM  283 (322)
T ss_dssp             -CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHH
T ss_pred             -cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHH
Confidence             112233468999999999999999999999999999999998654

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.2e-46  Score=317.15  Aligned_cols=269  Identities=23%  Similarity=0.370  Sum_probs=197.9

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~   80 (282)
                      ||+|.+..+|+.||+|++...........+.+|+.+++.++||||+++++++.+++..++||||++| ++.+.+. ..+.
T Consensus        49 V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~  127 (360)
T 3eqc_A           49 VFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGR  127 (360)
T ss_dssp             EEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHH-HHSS
T ss_pred             EEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHH-HcCC
Confidence            8999999999999999998754444456789999999999999999999999999999999999987 5555554 4678


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSR-NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      +++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||.+......  ......+++.|+|||.+.+.
T Consensus       128 ~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~  205 (360)
T 3eqc_A          128 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGT  205 (360)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--C----CCCCTTCCHHHHTTC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--cccCCCCCCCeECHHHHcCC
Confidence            99999999999999999999996 9999999999999999999999999998654321  12334678999999999776


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCC-CCCCCCCCCCCC------------
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN-LLPDFKPFPMYH------------  226 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~------------  226 (282)
                      . ++.++||||||+++|+|++|..| |...+..+....+............+... ............            
T Consensus       206 ~-~~~~~Di~slG~il~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (360)
T 3eqc_A          206 H-YSVQSDIWSMGLSLVEMAVGRYP-IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDY  283 (360)
T ss_dssp             C-CSHHHHHHHHHHHHHHHHHTSCC-SSCCCHHHHHHHHC------------------------------CCCHHHHHHH
T ss_pred             C-CCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhH
Confidence            6 79999999999999999999888 55555444332221111110000000000 000000000000            


Q ss_pred             --CCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         227 --PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       227 --~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                        ...........++..+.+||++||+.||++|||++++++||||++...+
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  334 (360)
T 3eqc_A          284 IVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE  334 (360)
T ss_dssp             HHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred             HhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence              0000011123478999999999999999999999999999999976543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=5.8e-46  Score=316.52  Aligned_cols=238  Identities=27%  Similarity=0.348  Sum_probs=185.3

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHh-hCCCCCccceeeeeee----CCeEEEEEecCcc-cHHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLK-ELKHKNIVRLYDVLHS----EKKLTLVFEHCDQ-DLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~-~l~h~~i~~~~~~~~~----~~~~~iv~e~~~g-~l~~~~~   75 (282)
                      ||+|.++.+|+.||||++..      ...+.+|+.++. ..+||||+++++++..    ...+|+||||++| ++.+.+.
T Consensus        78 V~~~~~~~~~~~vAiK~~~~------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~  151 (400)
T 1nxk_A           78 VLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ  151 (400)
T ss_dssp             EEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHH
T ss_pred             EEEEEECCCCCEEEEEEeCc------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHH
Confidence            89999999999999999863      356788998874 4589999999999876    5689999999975 6766665


Q ss_pred             hcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC---CCcEEEEecCCccccCCCcccccccccccccc
Q psy6044          76 SLN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK---NGELKLADFGLARAFGIPVKCYSAEVVTLWYR  151 (282)
Q Consensus        76 ~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  151 (282)
                      ... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.   ++.++|+|||++...... .......+++.|+
T Consensus       152 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~  230 (400)
T 1nxk_A          152 DRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYV  230 (400)
T ss_dssp             CC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC------------CTTC
T ss_pred             HhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC-CccccCCCCCCcc
Confidence            532 35999999999999999999999999999999999999987   789999999999866533 2234456799999


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChH---HHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD---DQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPS  228 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
                      |||++.+.. ++.++|||||||++|+|++|..||.......   .....+.......+.                     
T Consensus       231 aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~---------------------  288 (400)
T 1nxk_A          231 APEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN---------------------  288 (400)
T ss_dssp             CGGGSCCCC-SSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT---------------------
T ss_pred             CHhhcCCCC-CCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC---------------------
Confidence            999997665 7999999999999999999988865433211   122333322111111                     


Q ss_pred             CCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         229 MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       229 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                          .....+++++.+||++||+.||.+|||+.++++||||.+.
T Consensus       289 ----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          289 ----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             ----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             ----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence                1124589999999999999999999999999999999754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.1e-46  Score=304.78  Aligned_cols=241  Identities=28%  Similarity=0.421  Sum_probs=198.4

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeee--eCCeEEEEEecCcc-cHHHHHHhc
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLH--SEKKLTLVFEHCDQ-DLKKYFDSL   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~--~~~~~~iv~e~~~g-~l~~~~~~~   77 (282)
                      ||+|+++.+|+.||+|++... ......+.+.+|+.++++++||||+++++++.  .+...++|+||++| ++.+.+...
T Consensus        22 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  101 (279)
T 2w5a_A           22 CQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKG  101 (279)
T ss_dssp             EEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHH
T ss_pred             EEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhh
Confidence            899999999999999999863 23334567889999999999999999999875  46789999999976 676666543


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccccccccccc
Q psy6044          78 ---NGEIDLDIVKSFMYQLLRGLAFCHSRN-----VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW  149 (282)
Q Consensus        78 ---~~~~~~~~~~~~~~qi~~~l~~lh~~~-----i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~  149 (282)
                         ...+++..++.++.|++.||.+||+.|     ++|+||+|+||+++.++.++|+|||.+..............+++.
T Consensus       102 ~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  181 (279)
T 2w5a_A          102 TKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPY  181 (279)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCT
T ss_pred             cccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCcc
Confidence               234999999999999999999999999     999999999999999999999999998776544333334467889


Q ss_pred             ccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSM  229 (282)
Q Consensus       150 ~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
                      |+|||.+.+.. ++.++|+||||+++|+|++|..| |...+..+....+.....                          
T Consensus       182 y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p-~~~~~~~~~~~~i~~~~~--------------------------  233 (279)
T 2w5a_A          182 YMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPP-FTAFSQKELAGKIREGKF--------------------------  233 (279)
T ss_dssp             TCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHTCC--------------------------
T ss_pred             ccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCC-CcccCHHHHHHHHhhccc--------------------------
Confidence            99999998776 69999999999999999998777 666666666666655321                          


Q ss_pred             CccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                        ...+..+++.+.++|.+||+.||.+|||+.++++|+|+..-
T Consensus       234 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          234 --RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             --ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence              12334589999999999999999999999999999999864

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8e-46  Score=311.23  Aligned_cols=247  Identities=23%  Similarity=0.355  Sum_probs=197.9

Q ss_pred             eeeeeeC---CCCceEEEeeeecC---CCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHHH
Q psy6044           2 FTSGVDR---TPNTALAIKGTHLV---GNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY   73 (282)
Q Consensus         2 vy~a~~~---~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~   73 (282)
                      ||+|++.   .+|+.||||++...   ........+.+|+.+++.+ .||||+++++++..+...++||||++| ++.+.
T Consensus        70 Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  149 (355)
T 1vzo_A           70 VFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTH  149 (355)
T ss_dssp             EEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHH
T ss_pred             EEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHH
Confidence            8999884   58999999998752   2233456677899999999 699999999999999999999999986 55555


Q ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccC
Q psy6044          74 FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRP  152 (282)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~a  152 (282)
                      +.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... .......+++.|+|
T Consensus       150 l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~a  228 (355)
T 1vzo_A          150 LSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA  228 (355)
T ss_dssp             HHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCC
T ss_pred             HHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccC
Confidence            544 5689999999999999999999999999999999999999999999999999987654222 22233467999999


Q ss_pred             hhhhcCC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCC---ChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         153 PDVLFGA-KLYTTSIDMWSAGCIFAELANAGRPLFPGS---DVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPS  228 (282)
Q Consensus       153 PE~~~~~-~~~~~~~Di~slG~ll~~ll~~~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
                      ||.+.+. ..++.++||||||+++|+|++|..|+....   ........+..                            
T Consensus       229 PE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~----------------------------  280 (355)
T 1vzo_A          229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK----------------------------  280 (355)
T ss_dssp             HHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH----------------------------
T ss_pred             hhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc----------------------------
Confidence            9999753 336899999999999999999988854322   22233333322                            


Q ss_pred             CCccccCccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCccchhh
Q psy6044         229 MSFSQVAPKLTAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNVAIKS  278 (282)
Q Consensus       229 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~~  278 (282)
                       .....+..+++.+.+||.+||..||.+||     |++++++||||+++++....
T Consensus       281 -~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~  334 (355)
T 1vzo_A          281 -SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLA  334 (355)
T ss_dssp             -CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHH
T ss_pred             -cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhh
Confidence             11123356889999999999999999999     99999999999998765543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.1e-46  Score=318.41  Aligned_cols=257  Identities=19%  Similarity=0.180  Sum_probs=183.6

Q ss_pred             CeeeeeeCCCCceEEEeeeecCC--CCCCCccHHHHHHHHhhC--CCCCcccee-------eeeeeC-------------
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVG--NEGVPSSALREICLLKEL--KHKNIVRLY-------DVLHSE-------------   56 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l--~h~~i~~~~-------~~~~~~-------------   56 (282)
                      .||+|++..+|+.||||++....  .......+.+|+.+++.+  +||||++++       +++..+             
T Consensus        77 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~  156 (371)
T 3q60_A           77 VVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQD  156 (371)
T ss_dssp             EEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC--
T ss_pred             EEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcc
Confidence            38999999999999999998732  222345566775444444  699988755       444433             


Q ss_pred             ----CeEEEEEecCcccHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEE
Q psy6044          57 ----KKLTLVFEHCDQDLKKYFDSLNGEIDLDIV------KSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLA  126 (282)
Q Consensus        57 ----~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~------~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~  126 (282)
                          ..+++||||++|++.+.+...+..+++..+      ..++.||+.||+|||++||+|+||||+||+++.++.++|+
T Consensus       157 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~  236 (371)
T 3q60_A          157 DYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLG  236 (371)
T ss_dssp             -CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEEC
T ss_pred             cceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEE
Confidence                348999999999999988876555666666      6778999999999999999999999999999999999999


Q ss_pred             ecCCccccCCCccccccccccccccChhhhcCC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCC
Q psy6044         127 DFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA-KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTP  205 (282)
Q Consensus       127 df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~  205 (282)
                      |||++...+....   ...+++.|+|||.+.+. ..++.++||||||+++|+|++|..|+ .......            
T Consensus       237 DFG~a~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf-~~~~~~~------------  300 (371)
T 3q60_A          237 DVSALWKVGTRGP---ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF-GLVTPGI------------  300 (371)
T ss_dssp             CGGGEEETTCEEE---GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST-TBCCTTC------------
T ss_pred             ecceeeecCCCcc---CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC-CCcCccc------------
Confidence            9999987653321   33556899999999762 23799999999999999999988884 3332110            


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccchhhhhc
Q psy6044         206 TEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKSERC  281 (282)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~  281 (282)
                       ...+.....       ...............+++.+.+||.+||+.||++|||+.++++||||++++....+..+
T Consensus       301 -~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~s  368 (371)
T 3q60_A          301 -KGSWKRPSL-------RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSSLS  368 (371)
T ss_dssp             -TTCCCBCCT-------TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHHHHHHHC
T ss_pred             -ccchhhhhh-------hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHHHhhhhh
Confidence             000000000       00000001111234689999999999999999999999999999999999877665543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.9e-46  Score=309.71  Aligned_cols=241  Identities=26%  Similarity=0.383  Sum_probs=190.8

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCC--CCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKH--KNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h--~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||+|.+ .+++.||||++... ......+.+.+|+.+++.++|  |||+++++++.++...++|||+.+|++.+.+.. .
T Consensus        25 Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~  102 (343)
T 3dbq_A           25 VFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-K  102 (343)
T ss_dssp             EEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHH-S
T ss_pred             EEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeCCCCCHHHHHHh-c
Confidence            899998 46999999999863 223334678899999999976  999999999999999999999888888888776 6


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--ccccccccccccChhhh
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--CYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~  156 (282)
                      +.+++..+..++.||+.||.|||++||+|+||||+||+++ ++.++|+|||++........  ......+++.|+|||.+
T Consensus       103 ~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~  181 (343)
T 3dbq_A          103 KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI  181 (343)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHH
Confidence            7899999999999999999999999999999999999996 68899999999987643322  22345679999999998


Q ss_pred             cC----------CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         157 FG----------AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYH  226 (282)
Q Consensus       157 ~~----------~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (282)
                      .+          ...++.++||||||+++|+|++|..|+............+..   ..                     
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~---------------------  237 (343)
T 3dbq_A          182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---PN---------------------  237 (343)
T ss_dssp             HHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC---TT---------------------
T ss_pred             hhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc---CC---------------------
Confidence            54          234789999999999999999998885443443333333222   11                     


Q ss_pred             CCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         227 PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       227 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                         .....+...++.+.+||.+||+.||.+|||+.++++||||+.-
T Consensus       238 ---~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          238 ---HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             ---SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             ---cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence               1112234467899999999999999999999999999999854

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.6e-45  Score=312.93  Aligned_cols=242  Identities=26%  Similarity=0.375  Sum_probs=192.5

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCC--CCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELK--HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~--h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||+|.+.. |+.||||++... ........+.+|+.+++.++  ||||+++++++..+..+++|||+.+|++.+.+.. .
T Consensus        72 Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~~~~~L~~~l~~-~  149 (390)
T 2zmd_A           72 VFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-K  149 (390)
T ss_dssp             EEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHH-C
T ss_pred             EEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEecCCCCHHHHHHh-c
Confidence            89999865 999999999863 23334567889999999996  5999999999999999999999777788887766 5


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--ccccccccccccChhhh
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--CYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~  156 (282)
                      ..+++..+..++.||+.||.|||+.||+|+||||+||+++ ++.++|+|||++........  ......+++.|+|||.+
T Consensus       150 ~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~  228 (390)
T 2zmd_A          150 KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI  228 (390)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHh
Confidence            6899999999999999999999999999999999999994 68999999999987643321  22345689999999998


Q ss_pred             cCC----------CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         157 FGA----------KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYH  226 (282)
Q Consensus       157 ~~~----------~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (282)
                      .+.          ..++.++|||||||++|+|++|..|+............+...   ..                    
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~---~~--------------------  285 (390)
T 2zmd_A          229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP---NH--------------------  285 (390)
T ss_dssp             HCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT---TS--------------------
T ss_pred             hhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc---cc--------------------
Confidence            652          247899999999999999999988854444443433333221   10                    


Q ss_pred             CCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         227 PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       227 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                          ....+...++.+.+||++||+.||.+|||+.++++||||+...
T Consensus       286 ----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          286 ----EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             ----CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             ----cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence                0112234578999999999999999999999999999998654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3e-45  Score=304.49  Aligned_cols=244  Identities=26%  Similarity=0.386  Sum_probs=192.3

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeee------CCeEEEEEecCcc-cHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHS------EKKLTLVFEHCDQ-DLKKY   73 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~------~~~~~iv~e~~~g-~l~~~   73 (282)
                      ||+|++..+|+.||+|++....  .....+.+|+.+++++ +||||+++++++..      ....++||||++| ++.+.
T Consensus        40 Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~  117 (326)
T 2x7f_A           40 VYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL  117 (326)
T ss_dssp             EEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHH
T ss_pred             EEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHH
Confidence            8999999999999999987532  3357889999999999 89999999999987      5689999999986 66666


Q ss_pred             HHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccC
Q psy6044          74 FDSL-NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRP  152 (282)
Q Consensus        74 ~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~a  152 (282)
                      +... ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............+++.|+|
T Consensus       118 l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~a  197 (326)
T 2x7f_A          118 IKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA  197 (326)
T ss_dssp             HHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCC
T ss_pred             HHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccC
Confidence            6543 257999999999999999999999999999999999999999999999999998876544333444567899999


Q ss_pred             hhhhcC----CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         153 PDVLFG----AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPS  228 (282)
Q Consensus       153 PE~~~~----~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
                      ||.+..    ...++.++||||||+++|+|++|..| |...........+.....  +                      
T Consensus       198 PE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p-~~~~~~~~~~~~~~~~~~--~----------------------  252 (326)
T 2x7f_A          198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP-LCDMHPMRALFLIPRNPA--P----------------------  252 (326)
T ss_dssp             HHHHC--------CCTTHHHHHHHHHHHHHHHSSCT-TTTSCHHHHHHHHHHSCC--C----------------------
T ss_pred             hhhhccccccCcCCCccchHHHHHHHHHHHHhCCCC-CCCCcHHHHHHHhhcCcc--c----------------------
Confidence            999862    23378999999999999999998887 555555544444333110  0                      


Q ss_pred             CCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         229 MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       229 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                         ......+++.+.+||.+||+.||.+|||+.++++||||++....
T Consensus       253 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~  296 (326)
T 2x7f_A          253 ---RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNE  296 (326)
T ss_dssp             ---CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTTH
T ss_pred             ---cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCccc
Confidence               01124578999999999999999999999999999999987654

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.8e-46  Score=313.39  Aligned_cols=264  Identities=20%  Similarity=0.305  Sum_probs=201.4

Q ss_pred             CeeeeeeCCCCceEEEeeeecCC-CCC-CC--------------ccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEe
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVG-NEG-VP--------------SSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE   64 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~-~~~-~~--------------~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e   64 (282)
                      .||+|.+  +|+.||+|++.... ... ..              ..+.+|+.++++++||||+++++++.+++..++|||
T Consensus        46 ~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  123 (348)
T 2pml_X           46 KIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYE  123 (348)
T ss_dssp             CEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEE
T ss_pred             EEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            3899998  89999999998722 111 11              778999999999999999999999999999999999


Q ss_pred             cCcc-cHHHH------HHhc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEecCCccccC
Q psy6044          65 HCDQ-DLKKY------FDSL-NGEIDLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGLARAFG  135 (282)
Q Consensus        65 ~~~g-~l~~~------~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~  135 (282)
                      |++| ++.+.      +... ...+++..++.++.||+.||.+||+ .|++|+||+|+||+++.++.++|+|||.+....
T Consensus       124 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  203 (348)
T 2pml_X          124 YMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV  203 (348)
T ss_dssp             CCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECB
T ss_pred             ccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEeccccccccc
Confidence            9987 55443      2221 4679999999999999999999999 999999999999999999999999999998764


Q ss_pred             CCccccccccccccccChhhhcCCCCCCc-hhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCC
Q psy6044         136 IPVKCYSAEVVTLWYRPPDVLFGAKLYTT-SIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN  214 (282)
Q Consensus       136 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  214 (282)
                      ..  ......++..|+|||.+.+...++. ++|+||||+++|+|++|..|+.......+....+.......+...   ..
T Consensus       204 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~---~~  278 (348)
T 2pml_X          204 DK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDR---NH  278 (348)
T ss_dssp             TT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSS---SS
T ss_pred             cc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccch---hh
Confidence            33  3344567899999999977643555 999999999999999988885444443555555433221111100   00


Q ss_pred             CCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccchhh
Q psy6044         215 LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKS  278 (282)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~  278 (282)
                      ..       ..............+++.+.+||.+||+.||.+|||+.++++||||++.+.....
T Consensus       279 ~~-------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~~~~  335 (348)
T 2pml_X          279 FL-------YPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLR  335 (348)
T ss_dssp             ST-------TTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHHHHH
T ss_pred             hh-------ccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHHHHH
Confidence            00       0000111122335689999999999999999999999999999999998765543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-46  Score=308.69  Aligned_cols=261  Identities=20%  Similarity=0.278  Sum_probs=195.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC--eEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK--KLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~--~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      ||+|++..+|+.||||++.........+.+.+|++++++++||||+++++++....  ..++||||++| ++.+.+....
T Consensus        25 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  104 (319)
T 4euu_A           25 VFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS  104 (319)
T ss_dssp             EEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGG
T ss_pred             EEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhc
Confidence            89999999999999999987444444577889999999999999999999998765  88999999975 6666655432


Q ss_pred             C--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE----cCCCcEEEEecCCccccCCCccccccccccccccC
Q psy6044          79 G--EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI----NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRP  152 (282)
Q Consensus        79 ~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~----~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~a  152 (282)
                      .  .+++..++.++.||+.||.|||+.|++|+||||+||++    +.++.++|+|||.+....... ......+++.|+|
T Consensus       105 ~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~a  183 (319)
T 4euu_A          105 NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLH  183 (319)
T ss_dssp             GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC-CBCCCCSCGGGCC
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC-ceeecccCCCccC
Confidence            2  39999999999999999999999999999999999999    777889999999998765433 2334567999999


Q ss_pred             hhhhcC-------CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCh---HHHHHHHHHHhCCCCCCCCCCCCCCCCCCCC
Q psy6044         153 PDVLFG-------AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDV---DDQLKRIFKLLGTPTEDTWPGMNLLPDFKPF  222 (282)
Q Consensus       153 PE~~~~-------~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (282)
                      ||.+..       ...++.++||||||+++|+|++|..|+......   .+.+..+...   .+...+.......... .
T Consensus       184 PE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---~p~~~~~~~~~~~~~~-~  259 (319)
T 4euu_A          184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG---KPSGAISGVQKAENGP-I  259 (319)
T ss_dssp             HHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH---CCTTCCEEEECSTTCC-E
T ss_pred             HHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC---CCcccchhhhcccCCc-c
Confidence            999852       234789999999999999999998885433332   3344444433   2222221111100000 0


Q ss_pred             CCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q psy6044         223 PMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHI  267 (282)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~  267 (282)
                      ...............+++.+.++|++||+.||++|||++|+|+||
T Consensus       260 ~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          260 DWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             EEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             ccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            000000011133456778899999999999999999999999987

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.5e-45  Score=303.05  Aligned_cols=246  Identities=25%  Similarity=0.371  Sum_probs=191.1

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeee-------------CCeEEEEEecCcc
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHS-------------EKKLTLVFEHCDQ   68 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~-------------~~~~~iv~e~~~g   68 (282)
                      ||+|++..+|+.||+|++...  ......+.+|+.++++++||||+++++++.+             ....++|+||++|
T Consensus        22 V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~   99 (303)
T 1zy4_A           22 VVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCEN   99 (303)
T ss_dssp             EEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCS
T ss_pred             EEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCC
Confidence            899999999999999998752  1234678899999999999999999998865             4678999999975


Q ss_pred             -cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC----------
Q psy6044          69 -DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP----------  137 (282)
Q Consensus        69 -~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~----------  137 (282)
                       ++.+.+......+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+......          
T Consensus       100 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  179 (303)
T 1zy4_A          100 GTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN  179 (303)
T ss_dssp             CBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-----------
T ss_pred             CCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhcccccc
Confidence             777777665567899999999999999999999999999999999999999999999999998765422          


Q ss_pred             ----ccccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCC
Q psy6044         138 ----VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGM  213 (282)
Q Consensus       138 ----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  213 (282)
                          ........+++.|+|||.+.+...++.++|+||||+++|+|++   |+....+..+....+.......+       
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~-------  249 (303)
T 1zy4_A          180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFP-------  249 (303)
T ss_dssp             --------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCC-------
T ss_pred             ccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccC-------
Confidence                1122334568899999999766557999999999999999996   53333333333333322111110       


Q ss_pred             CCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccchh
Q psy6044         214 NLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  277 (282)
                                        .......++.+.++|++||+.||.+|||+.++++||||+...+...
T Consensus       250 ------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  295 (303)
T 1zy4_A          250 ------------------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEV  295 (303)
T ss_dssp             ------------------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHHHH
T ss_pred             ------------------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChHHH
Confidence                              1123457788999999999999999999999999999987655443

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.5e-45  Score=303.84  Aligned_cols=246  Identities=18%  Similarity=0.249  Sum_probs=189.6

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCC-CCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEG-VPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      .||+|.++.+|+.||||++....... ....+.++..+++.++||||+++++++.+++..++||||+++.+........+
T Consensus        40 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~~~l~~~~~~  119 (318)
T 2dyl_A           40 QVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG  119 (318)
T ss_dssp             CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHHTS
T ss_pred             eEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEeccCCcHHHHHHHhcc
Confidence            48999999999999999998633222 22334445557788899999999999999999999999997666665555577


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSR-NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      .+++..++.++.||+.||.+||++ |++|+||+|+||+++.++.++|+|||.+....... ......+++.|+|||.+..
T Consensus       120 ~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~  198 (318)
T 2dyl_A          120 PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-AKDRSAGCAAYMAPERIDP  198 (318)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---------------CCTTCCHHHHC-
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-cccccCCCccccChhhccc
Confidence            899999999999999999999996 99999999999999999999999999987654322 2233467889999999852


Q ss_pred             ----CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         159 ----AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       159 ----~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                          ...++.++||||||+++|+|++|..|+.......+....+.......                          ...
T Consensus       199 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------------------~~~  252 (318)
T 2dyl_A          199 PDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL--------------------------LPG  252 (318)
T ss_dssp             -------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC--------------------------CCS
T ss_pred             ccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC--------------------------CCc
Confidence                33478999999999999999999888555455666665555421110                          001


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      ...+++.+.++|.+||+.||.+|||++++++||||++.+
T Consensus       253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence            134789999999999999999999999999999998654

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5e-46  Score=317.11  Aligned_cols=264  Identities=28%  Similarity=0.413  Sum_probs=202.5

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCC--------CCCccceeeeee----eCCeEEEEEecCccc
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK--------HKNIVRLYDVLH----SEKKLTLVFEHCDQD   69 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~--------h~~i~~~~~~~~----~~~~~~iv~e~~~g~   69 (282)
                      ||+|++..+|+.||||++...  ......+.+|+.+++.++        |+||+++++++.    +....++||||++|+
T Consensus        53 V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~  130 (397)
T 1wak_A           53 VWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHH  130 (397)
T ss_dssp             EEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCCCB
T ss_pred             EEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccCcc
Confidence            899999999999999998642  223456889999999985        788999999988    556899999999999


Q ss_pred             HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEcCCC--------------------------
Q psy6044          70 LKKYFDSLN-GEIDLDIVKSFMYQLLRGLAFCHSR-NVLHRDLKPQNLLINKNG--------------------------  121 (282)
Q Consensus        70 l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~dl~~~nil~~~~~--------------------------  121 (282)
                      +++.+.... ..+++..++.++.||+.||.|||++ ||+|+||||+||+++.++                          
T Consensus       131 l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (397)
T 1wak_A          131 LLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV  210 (397)
T ss_dssp             HHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------
T ss_pred             HHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCcc
Confidence            999987754 5699999999999999999999998 999999999999998775                          


Q ss_pred             -----------------------cEEEEecCCccccCCCccccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHH
Q psy6044         122 -----------------------ELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAEL  178 (282)
Q Consensus       122 -----------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l  178 (282)
                                             .++|+|||.+......   .....+++.|+|||.+.+.. ++.++|||||||++|+|
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el  286 (397)
T 1wak_A          211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFEL  286 (397)
T ss_dssp             ------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHH
T ss_pred             ccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcCCC-CCcHHHHHHHHHHHHHH
Confidence                                   7999999999876532   34456799999999998876 79999999999999999


Q ss_pred             HhcCCCCCCCCC-----hHHHHHHHHHHhCCCCCCCCCCCCC-------CCCCCCCCCCCCCC------CccccCccCCH
Q psy6044         179 ANAGRPLFPGSD-----VDDQLKRIFKLLGTPTEDTWPGMNL-------LPDFKPFPMYHPSM------SFSQVAPKLTA  240 (282)
Q Consensus       179 l~~~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~------~~~~~~~~~~~  240 (282)
                      ++|..|+.....     ..+....+....+.++...+.....       ..............      .........++
T Consensus       287 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (397)
T 1wak_A          287 ATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAA  366 (397)
T ss_dssp             HHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHH
T ss_pred             hhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHH
Confidence            998888533222     4556666666666554321100000       00000000000000      00112344667


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD  271 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  271 (282)
                      .+.+||.+||+.||++|||++++|+||||++
T Consensus       367 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          367 GFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             HHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             HHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            8899999999999999999999999999974

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.5e-45  Score=311.26  Aligned_cols=265  Identities=27%  Similarity=0.429  Sum_probs=202.8

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCC-CC-----CccceeeeeeeCCeEEEEEecCcccHHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK-HK-----NIVRLYDVLHSEKKLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~-----~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~   75 (282)
                      ||+|+++.+|+.||||++...  ......+..|+.+++.++ |+     +++++++++...+..++||||++|++.+.+.
T Consensus        70 V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~  147 (382)
T 2vx3_A           70 VVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLR  147 (382)
T ss_dssp             EEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCCCBHHHHHH
T ss_pred             EEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCCCCHHHHHh
Confidence            899999999999999998642  122345667888888874 44     4999999999999999999999999999887


Q ss_pred             hcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCcEEEc--CCCcEEEEecCCccccCCCccccccccccccc
Q psy6044          76 SLN-GEIDLDIVKSFMYQLLRGLAFCH--SRNVLHRDLKPQNLLIN--KNGELKLADFGLARAFGIPVKCYSAEVVTLWY  150 (282)
Q Consensus        76 ~~~-~~~~~~~~~~~~~qi~~~l~~lh--~~~i~H~dl~~~nil~~--~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  150 (282)
                      ... ..+++..+..++.||+.||.|||  +.||+|+||||+||+++  .++.++|+|||++...+..   .....+++.|
T Consensus       148 ~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y  224 (382)
T 2vx3_A          148 NTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR---IYQYIQSRFY  224 (382)
T ss_dssp             HTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC---CCSSCSCGGG
T ss_pred             hcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc---cccccCCccc
Confidence            754 56999999999999999999999  57999999999999995  4778999999999876533   2345678999


Q ss_pred             cChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCC---------------
Q psy6044         151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNL---------------  215 (282)
Q Consensus       151 ~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------  215 (282)
                      +|||.+.+.. ++.++|||||||++|+|++|..| |.+.+..+....+....+.++...++....               
T Consensus       225 ~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (382)
T 2vx3_A          225 RSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPL-FSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNL  302 (382)
T ss_dssp             CCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEE
T ss_pred             cChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhcccccccc
Confidence            9999998776 79999999999999999988766 788888888888888777665432221100               


Q ss_pred             ---CCCCCCCCCCCCCCCcc------------------ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         216 ---LPDFKPFPMYHPSMSFS------------------QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       216 ---~~~~~~~~~~~~~~~~~------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                         .......... ....+.                  ......++.+.+||++||+.||++|||++|+|+||||++..+
T Consensus       303 ~~~~~~~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~~~  381 (382)
T 2vx3_A          303 KKTKDGKREYKPP-GTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD  381 (382)
T ss_dssp             CCCCTTCCCSCCT-TCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC---
T ss_pred             ccccccccccCCc-chhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccCCC
Confidence               0000000000 000000                  000111247899999999999999999999999999998654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.4e-46  Score=309.09  Aligned_cols=244  Identities=22%  Similarity=0.251  Sum_probs=191.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCC--CCCccHHHHHHHHhhCCCCCccceeeeeeeCC----eEEEEEecCcccHHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNE--GVPSSALREICLLKELKHKNIVRLYDVLHSEK----KLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~----~~~iv~e~~~g~l~~~~~   75 (282)
                      ||+|++..+|+.||||++......  .....+.+|+.++++++||||+++++++....    ..|+||||++|+.+..+.
T Consensus        28 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l  107 (311)
T 3ork_A           28 VHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV  107 (311)
T ss_dssp             EEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHH
T ss_pred             EEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHH
Confidence            899999999999999999763222  22346789999999999999999999987654    459999999764444444


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc---cccccccccccccC
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---KCYSAEVVTLWYRP  152 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~a  152 (282)
                      ...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+.......   .......+++.|+|
T Consensus       108 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  187 (311)
T 3ork_A          108 HTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS  187 (311)
T ss_dssp             HHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCC
T ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCC
Confidence            446789999999999999999999999999999999999999999999999999997664322   12223457899999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       153 PE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      ||.+.+.. ++.++||||||+++|+|++|..| |.+....+...........                         ...
T Consensus       188 PE~~~~~~-~~~~~Di~slG~~l~~ll~g~~p-f~~~~~~~~~~~~~~~~~~-------------------------~~~  240 (311)
T 3ork_A          188 PEQARGDS-VDARSDVYSLGCVLYEVLTGEPP-FTGDSPVSVAYQHVREDPI-------------------------PPS  240 (311)
T ss_dssp             HHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHCCCC-------------------------CHH
T ss_pred             HHHhcCCC-CCchHhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHhcCCCC-------------------------Ccc
Confidence            99998776 79999999999999999998877 6666666655544442111                         112


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      .....+++++.++|.+||+.||.+||++.+++.|+|++..
T Consensus       241 ~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          241 ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            2234589999999999999999999999999999999754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.6e-45  Score=300.98  Aligned_cols=239  Identities=23%  Similarity=0.311  Sum_probs=185.6

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      ||+|++  +|+.||+|++... ........+.+|+.++++++||||+++++++.+.+..++||||++| ++.+.+.. .+
T Consensus        53 V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~  129 (309)
T 3p86_A           53 VHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-SG  129 (309)
T ss_dssp             EEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHS-TT
T ss_pred             EEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhh-cC
Confidence            899986  6889999998763 2223345688999999999999999999999999999999999986 55555544 33


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChh
Q psy6044          80 ---EIDLDIVKSFMYQLLRGLAFCHSRN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPD  154 (282)
Q Consensus        80 ---~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE  154 (282)
                         .+++..++.++.||+.||+|||++|  ++|+||||+||+++.++.++|+|||++..............+++.|+|||
T Consensus       130 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE  209 (309)
T 3p86_A          130 AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE  209 (309)
T ss_dssp             HHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHH
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChh
Confidence               2999999999999999999999999  99999999999999999999999999976554444444567799999999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      .+.+.. ++.++||||||+++|++++|..| |...+..+....+....                           .....
T Consensus       210 ~~~~~~-~~~~~DiwslG~il~elltg~~P-f~~~~~~~~~~~~~~~~---------------------------~~~~~  260 (309)
T 3p86_A          210 VLRDEP-SNEKSDVYSFGVILWELATLQQP-WGNLNPAQVVAAVGFKC---------------------------KRLEI  260 (309)
T ss_dssp             HHTTCC-CCTTHHHHHHHHHHHHHHHCCCT-TTTSCHHHHHHHHHHSC---------------------------CCCCC
T ss_pred             hhcCCC-CCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhcC---------------------------CCCCC
Confidence            998776 69999999999999999999877 66666666555543311                           11123


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHhc--CCCccCC
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMS--HIYFSDL  272 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--h~~~~~~  272 (282)
                      +..+++.+.+||++||+.||.+|||+.++++  .+++++.
T Consensus       261 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            4568999999999999999999999999998  5555543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=5.9e-45  Score=304.03  Aligned_cols=266  Identities=25%  Similarity=0.408  Sum_probs=204.9

Q ss_pred             eeeeee-CCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCC------ccceeeeeeeCCeEEEEEecCcccHHHHH
Q psy6044           2 FTSGVD-RTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKN------IVRLYDVLHSEKKLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         2 vy~a~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~------i~~~~~~~~~~~~~~iv~e~~~g~l~~~~   74 (282)
                      ||+|.+ +.+|+.||+|++...  ......+.+|+.+++.++|++      ++++++++.+.+..++||||+++++.+.+
T Consensus        30 V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~l  107 (339)
T 1z57_A           30 VVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFI  107 (339)
T ss_dssp             EEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECCCCBHHHHH
T ss_pred             EEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCCCCCHHHHH
Confidence            899998 568999999998642  122456888999999987654      99999999999999999999998999988


Q ss_pred             HhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-------------------CCcEEEEecCCcccc
Q psy6044          75 DSLN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK-------------------NGELKLADFGLARAF  134 (282)
Q Consensus        75 ~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~-------------------~~~~~l~df~~~~~~  134 (282)
                      .... ..+++..+..++.||+.||+|||++|++|+||||+||+++.                   ++.++|+|||.+...
T Consensus       108 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~  187 (339)
T 1z57_A          108 KENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD  187 (339)
T ss_dssp             HHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEET
T ss_pred             HhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccC
Confidence            7644 36899999999999999999999999999999999999987                   668999999999765


Q ss_pred             CCCccccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCC
Q psy6044         135 GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN  214 (282)
Q Consensus       135 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  214 (282)
                      ...   .....+++.|+|||.+.+.. ++.++||||||+++|++++|..| |...+..+....+....+..+...+....
T Consensus       188 ~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p-f~~~~~~~~~~~~~~~~~~~p~~~~~~~~  262 (339)
T 1z57_A          188 DEH---HSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTV-FPTHDSKEHLAMMERILGPLPKHMIQKTR  262 (339)
T ss_dssp             TSC---CCSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCS-CCCSCHHHHHHHHHHHHCSCCHHHHHHCS
T ss_pred             ccc---cccccCCccccChHHhhCCC-CCcchhhHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcc
Confidence            432   23446789999999998766 79999999999999999988777 77777777777777766654432111000


Q ss_pred             CCC-------CCCCCC--------CCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         215 LLP-------DFKPFP--------MYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       215 ~~~-------~~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      ...       ++....        ...............++.+.+||++||+.||.+|||+.++++||||+.++.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          263 KRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK  337 (339)
T ss_dssp             CGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGGC
T ss_pred             chhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHHhc
Confidence            000       000000        000000001112335678999999999999999999999999999998764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5e-45  Score=298.85  Aligned_cols=242  Identities=25%  Similarity=0.336  Sum_probs=189.5

Q ss_pred             eeeeeeCCCCceEEEeeeecCC--CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG--NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      ||+|.+..+|+.||+|++....  .......+.+|+.++++++||||+++++++.+++..++||||++| ++.+.+ ...
T Consensus        27 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l-~~~  105 (294)
T 4eqm_A           27 VYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESH  105 (294)
T ss_dssp             EEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH-HHH
T ss_pred             EEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHH-Hhc
Confidence            8999999999999999987632  222346788999999999999999999999999999999999987 555544 446


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~  157 (282)
                      +.+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+....... .......+++.|+|||.+.
T Consensus       106 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  185 (294)
T 4eqm_A          106 GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK  185 (294)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhc
Confidence            789999999999999999999999999999999999999999999999999997765332 2223345789999999998


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|+||||+++|+|++|..| |.+.+..+..........                        ..........
T Consensus       186 ~~~-~~~~~Di~slG~~l~~ll~g~~p-f~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~  239 (294)
T 4eqm_A          186 GEA-TDECTDIYSIGIVLYEMLVGEPP-FNGETAVSIAIKHIQDSV------------------------PNVTTDVRKD  239 (294)
T ss_dssp             TCC-CCTTHHHHHHHHHHHHHHHSSCS-SCSSCHHHHHHHHHSSCC------------------------CCHHHHSCTT
T ss_pred             CCC-CCchHhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHhhccC------------------------CCcchhcccC
Confidence            776 69999999999999999998877 666555544333222100                        0011233456


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS  270 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  270 (282)
                      +++.+.++|.+||+.||.+||+..+.+.+.|..
T Consensus       240 ~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          240 IPQSLSNVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence            899999999999999999999655555555544

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.8e-44  Score=303.09  Aligned_cols=269  Identities=26%  Similarity=0.389  Sum_probs=207.2

Q ss_pred             eeeeeeCCCC-ceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCC------ccceeeeeeeCCeEEEEEecCcccHHHHH
Q psy6044           2 FTSGVDRTPN-TALAIKGTHLVGNEGVPSSALREICLLKELKHKN------IVRLYDVLHSEKKLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         2 vy~a~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~------i~~~~~~~~~~~~~~iv~e~~~g~l~~~~   74 (282)
                      ||+|.+..++ +.||+|++...  ......+.+|+.+++.++|++      ++.+++++...+..++||||++|++++.+
T Consensus        35 V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l  112 (355)
T 2eu9_A           35 VVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFL  112 (355)
T ss_dssp             EEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECCCCBHHHHH
T ss_pred             EEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEeccCCChHHHH
Confidence            8999998877 79999998642  123456788999999997655      89999999999999999999999999988


Q ss_pred             HhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE-------------------cCCCcEEEEecCCcccc
Q psy6044          75 DSLN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI-------------------NKNGELKLADFGLARAF  134 (282)
Q Consensus        75 ~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~-------------------~~~~~~~l~df~~~~~~  134 (282)
                      .... ..+++..++.++.||+.||.|||++||+|+||||+||++                   +.++.++|+|||.+...
T Consensus       113 ~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~  192 (355)
T 2eu9_A          113 KENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD  192 (355)
T ss_dssp             HHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEET
T ss_pred             HhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccc
Confidence            7754 469999999999999999999999999999999999999                   56789999999999765


Q ss_pred             CCCccccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCC
Q psy6044         135 GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN  214 (282)
Q Consensus       135 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  214 (282)
                      ...   .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..| |...+..+....+....+..+...+....
T Consensus       193 ~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p-f~~~~~~~~~~~~~~~~~~~p~~~~~~~~  267 (355)
T 2eu9_A          193 HEH---HTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTL-FQTHENREHLVMMEKILGPIPSHMIHRTR  267 (355)
T ss_dssp             TSC---CCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHHHCCCCHHHHHHCS
T ss_pred             ccc---ccCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHcCCCcHHHhhhcc
Confidence            432   23456789999999997766 79999999999999999988777 77777777777777776655432211100


Q ss_pred             CCCCCCC----CCC-----------CCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccchh
Q psy6044         215 LLPDFKP----FPM-----------YHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       215 ~~~~~~~----~~~-----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  277 (282)
                      ....+..    ...           ..............+..+.+||++||+.||++|||+.++++||||++++....
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  345 (355)
T 2eu9_A          268 KQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEER  345 (355)
T ss_dssp             CGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCCHHHH
T ss_pred             chhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCChhhc
Confidence            0000000    000           00000000111224568899999999999999999999999999999876544

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.8e-45  Score=305.95  Aligned_cols=248  Identities=19%  Similarity=0.320  Sum_probs=176.1

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHH-HHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHh----
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREIC-LLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS----   76 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~----   76 (282)
                      ||+|.++.+|+.||||++...........+..|.. +++.++||||+++++++.+++..++||||++|++.+.+..    
T Consensus        38 Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~  117 (327)
T 3aln_A           38 VNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSV  117 (327)
T ss_dssp             EEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHHHHT
T ss_pred             EEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCCChHHHHHHHHhh
Confidence            89999999999999999986433333345555665 6777899999999999999999999999999987776653    


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhh
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSR-NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDV  155 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~  155 (282)
                      ....+++..+..++.|++.||.+||+. |++|+||+|+||+++.++.++|+|||.+....... ......+++.|+|||.
T Consensus       118 ~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~  196 (327)
T 3aln_A          118 LDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPER  196 (327)
T ss_dssp             TCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----------------------
T ss_pred             hcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc-ccccCCCCccccCcee
Confidence            256799999999999999999999998 99999999999999999999999999997765332 2233467889999999


Q ss_pred             hc---CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         156 LF---GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       156 ~~---~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      +.   ....++.++||||||+++|+|++|..|+.......+....       ....                 .......
T Consensus       197 ~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-------~~~~-----------------~~~~~~~  252 (327)
T 3aln_A          197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ-------VVKG-----------------DPPQLSN  252 (327)
T ss_dssp             ---------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CC-------CCCS-----------------CCCCCCC
T ss_pred             eccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHH-------HhcC-----------------CCCCCCC
Confidence            83   2233789999999999999999988884322211111100       0000                 0000011


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      .....+++.+.+||++||+.||.+|||+.++++||||.....
T Consensus       253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  294 (327)
T 3aln_A          253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE  294 (327)
T ss_dssp             CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence            122458999999999999999999999999999999987654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.2e-45  Score=302.71  Aligned_cols=244  Identities=20%  Similarity=0.294  Sum_probs=178.2

Q ss_pred             eeeeeeCCCCc---eEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeE------EEEEecCcc-cH
Q psy6044           2 FTSGVDRTPNT---ALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKL------TLVFEHCDQ-DL   70 (282)
Q Consensus         2 vy~a~~~~~~~---~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~------~iv~e~~~g-~l   70 (282)
                      ||+|++..+++   .||+|++... ......+.+.+|+.++++++||||+++++++......      ++|+||++| ++
T Consensus        39 Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L  118 (323)
T 3qup_A           39 VREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDL  118 (323)
T ss_dssp             EEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBH
T ss_pred             EEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcH
Confidence            89999888776   8999999763 2334457789999999999999999999999877655      999999986 66


Q ss_pred             HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc--ccccc
Q psy6044          71 KKYFDSLN-----GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--KCYSA  143 (282)
Q Consensus        71 ~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~  143 (282)
                      .+.+....     ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+.......  .....
T Consensus       119 ~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  198 (323)
T 3qup_A          119 HAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA  198 (323)
T ss_dssp             HHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------------
T ss_pred             HHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeecccccccccccccccccc
Confidence            66554322     259999999999999999999999999999999999999999999999999997654322  12223


Q ss_pred             ccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCC
Q psy6044         144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFP  223 (282)
Q Consensus       144 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (282)
                      ..+++.|+|||.+.+.. ++.++||||||+++|+|++++.++|.+....+....+.....                    
T Consensus       199 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~--------------------  257 (323)
T 3qup_A          199 SKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR--------------------  257 (323)
T ss_dssp             --CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--------------------
T ss_pred             ccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC--------------------
Confidence            34467899999997766 799999999999999999955666887777766665544211                    


Q ss_pred             CCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCC-------HHHHhcCCCccCCcc
Q psy6044         224 MYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMS-------AEDAMSHIYFSDLNV  274 (282)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-------~~~ll~h~~~~~~~~  274 (282)
                              ...+..+++.+.++|.+||+.||.+|||       ++++++|||+.....
T Consensus       258 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~  307 (323)
T 3qup_A          258 --------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ  307 (323)
T ss_dssp             --------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred             --------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence                    1123458899999999999999999999       889999999987643

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.9e-45  Score=308.35  Aligned_cols=235  Identities=23%  Similarity=0.314  Sum_probs=195.1

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~~~~   80 (282)
                      ||+|+++.+|+.||||++...........+.+|+.++++++||||+++++++.+++..++||||++ |++.+.+......
T Consensus       130 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~  209 (377)
T 3cbl_A          130 VFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR  209 (377)
T ss_dssp             EEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGG
T ss_pred             EEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCC
Confidence            899999999999999998754333344678899999999999999999999999999999999997 5777777765667


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccc--ccccccccccChhhhcC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY--SAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~  158 (282)
                      +++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..........  ....++..|+|||.+..
T Consensus       210 ~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  289 (377)
T 3cbl_A          210 LRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY  289 (377)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhcc
Confidence            9999999999999999999999999999999999999999999999999987654322111  11234667999999976


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++||||||+++|++++++.++|......+....+......                            ..+..+
T Consensus       290 ~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~  340 (377)
T 3cbl_A          290 GR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL----------------------------PCPELC  340 (377)
T ss_dssp             CE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC----------------------------CCCTTC
T ss_pred             CC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------------------------CCCCCC
Confidence            65 6999999999999999998555558887777666555432111                            123457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ++.+.++|.+||+.||.+|||++++++
T Consensus       341 ~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          341 PDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            899999999999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.1e-44  Score=297.59  Aligned_cols=236  Identities=26%  Similarity=0.440  Sum_probs=196.5

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCC-----CCCccHHHHHHHHhhCC--CCCccceeeeeeeCCeEEEEEecCc--ccHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNE-----GVPSSALREICLLKELK--HKNIVRLYDVLHSEKKLTLVFEHCD--QDLKK   72 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~--h~~i~~~~~~~~~~~~~~iv~e~~~--g~l~~   72 (282)
                      ||+|++..+|+.||||++......     .....+.+|+.++++++  ||||+++++++.+++..++|+|++.  +++.+
T Consensus        59 Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~  138 (320)
T 3a99_A           59 VYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFD  138 (320)
T ss_dssp             EEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHH
T ss_pred             EEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHH
Confidence            899999999999999999873222     23467889999999996  5999999999999999999999996  56776


Q ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc-CCCcEEEEecCCccccCCCcccccccccccccc
Q psy6044          73 YFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLWYR  151 (282)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  151 (282)
                      .+.. .+.+++..++.++.||+.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.......  .....+++.|+
T Consensus       139 ~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~--~~~~~gt~~y~  215 (320)
T 3a99_A          139 FITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYS  215 (320)
T ss_dssp             HHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC--BCCCCSCGGGS
T ss_pred             HHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc--ccCCCCCccCC
Confidence            6655 67899999999999999999999999999999999999999 78999999999998765332  23446789999


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSF  231 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
                      |||.+.+....+.++||||||+++|+|++|..|+ ....      .+...                             .
T Consensus       216 aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf-~~~~------~~~~~-----------------------------~  259 (320)
T 3a99_A          216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDE------EIIRG-----------------------------Q  259 (320)
T ss_dssp             CHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC-CSHH------HHHHC-----------------------------C
T ss_pred             ChHHhccCCCCCccchHHhHHHHHHHHHHCCCCC-CChh------hhhcc-----------------------------c
Confidence            9999977664578999999999999999988884 3321      11110                             0


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      ......+++.+.+||++||+.||.+|||++++++||||++...+.
T Consensus       260 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~  304 (320)
T 3a99_A          260 VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ  304 (320)
T ss_dssp             CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCHH
T ss_pred             ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCcc
Confidence            112345889999999999999999999999999999999886543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=300.42  Aligned_cols=235  Identities=19%  Similarity=0.284  Sum_probs=192.6

Q ss_pred             eeeeeeCCCCc---eEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc
Q psy6044           2 FTSGVDRTPNT---ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL   77 (282)
Q Consensus         2 vy~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~   77 (282)
                      ||+|.+..+|+   .||||++...........+.+|+.++++++||||+++++++.+.+..++||||++| ++.+.+...
T Consensus        65 V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  144 (325)
T 3kul_A           65 VCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH  144 (325)
T ss_dssp             EEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTT
T ss_pred             EEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhc
Confidence            89999986665   49999997644444456789999999999999999999999999999999999976 666666565


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc---ccccccccccccChh
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK---CYSAEVVTLWYRPPD  154 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~aPE  154 (282)
                      .+.+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++........   ......+++.|+|||
T Consensus       145 ~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE  224 (325)
T 3kul_A          145 DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE  224 (325)
T ss_dssp             TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHh
Confidence            67899999999999999999999999999999999999999999999999999987653321   222234467899999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      .+.+.. ++.++||||||+++|++++++.++|......+....+......                            ..
T Consensus       225 ~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~  275 (325)
T 3kul_A          225 AIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL----------------------------PA  275 (325)
T ss_dssp             HHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC----------------------------CC
T ss_pred             HhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC----------------------------CC
Confidence            997665 6999999999999999998344447777777776666543211                            12


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      +..+++.+.++|..||+.||.+|||+.++++
T Consensus       276 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          276 PMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            3458899999999999999999999999987

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.8e-44  Score=288.93  Aligned_cols=233  Identities=19%  Similarity=0.305  Sum_probs=194.1

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~   80 (282)
                      ||+|.+. +++.||+|++....  ...+.+.+|+.++++++||||+++++++.+++..++||||++| ++.+.+....+.
T Consensus        26 V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~  102 (269)
T 4hcu_A           26 VHLGYWL-NKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL  102 (269)
T ss_dssp             EEEEEET-TTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTC
T ss_pred             EEEEEec-CCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcc
Confidence            8999986 57889999987532  2236789999999999999999999999999999999999976 566666665677


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccChhhhcCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      +++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+....... .......+++.|+|||.+.+.
T Consensus       103 ~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  182 (269)
T 4hcu_A          103 FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS  182 (269)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHC
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCC
Confidence            9999999999999999999999999999999999999999999999999997664332 222333456789999999766


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      . ++.++|+||+|+++|++++++.++|......+....+......                            ..+...+
T Consensus       183 ~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~  233 (269)
T 4hcu_A          183 R-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL----------------------------YKPRLAS  233 (269)
T ss_dssp             C-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC----------------------------CCCTTSC
T ss_pred             C-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC----------------------------CCCCcCC
Confidence            6 7999999999999999998556558888877777666543211                            1224478


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      +.+.+++.+||+.||++|||++++++|
T Consensus       234 ~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          234 THVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            999999999999999999999999974

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.7e-44  Score=304.64  Aligned_cols=236  Identities=25%  Similarity=0.377  Sum_probs=192.4

Q ss_pred             eeeeeeC-------CCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHH
Q psy6044           2 FTSGVDR-------TPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKK   72 (282)
Q Consensus         2 vy~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~   72 (282)
                      ||+|++.       .++..||+|++...........+.+|+.+++.+ +||||+++++++.+++.+|+||||++| ++.+
T Consensus        97 Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~  176 (370)
T 2psq_A           97 VVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE  176 (370)
T ss_dssp             EEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred             EEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHH
Confidence            8899864       456789999987644334456789999999999 899999999999999999999999976 6766


Q ss_pred             HHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC
Q psy6044          73 YFDSLN---------------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP  137 (282)
Q Consensus        73 ~~~~~~---------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~  137 (282)
                      .+....               ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus       177 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  256 (370)
T 2psq_A          177 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI  256 (370)
T ss_dssp             HHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCC
T ss_pred             HHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcc
Confidence            665532               24899999999999999999999999999999999999999999999999999866432


Q ss_pred             c--cccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCC
Q psy6044         138 V--KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNL  215 (282)
Q Consensus       138 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  215 (282)
                      .  .......+++.|+|||.+.+.. ++.++||||||+++|+|++++.++|.+....+....+.....            
T Consensus       257 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~------------  323 (370)
T 2psq_A          257 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR------------  323 (370)
T ss_dssp             CTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC------------
T ss_pred             cceecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC------------
Confidence            2  2223345578899999998776 799999999999999999845555777776666655443211            


Q ss_pred             CCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         216 LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                                      ...+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       324 ----------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          324 ----------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             ----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                            12234588999999999999999999999999873

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=297.62  Aligned_cols=239  Identities=21%  Similarity=0.312  Sum_probs=192.7

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~   80 (282)
                      ||+|.+..+|+.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++||||++| ++.+.+......
T Consensus        26 V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~  104 (310)
T 3s95_A           26 AIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ  104 (310)
T ss_dssp             EEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTT
T ss_pred             EEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCC
Confidence            899999999999999988542 233456788999999999999999999999999999999999976 666666665778


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccc--------------ccccc
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY--------------SAEVV  146 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--------------~~~~~  146 (282)
                      +++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+..........              ....|
T Consensus       105 ~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g  184 (310)
T 3s95_A          105 YPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG  184 (310)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCS
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCC
Confidence            9999999999999999999999999999999999999999999999999997764332211              13467


Q ss_pred             cccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHH----HHHHHHHHhCCCCCCCCCCCCCCCCCCCC
Q psy6044         147 TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDD----QLKRIFKLLGTPTEDTWPGMNLLPDFKPF  222 (282)
Q Consensus       147 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (282)
                      ++.|+|||.+.+.. ++.++||||||+++|++++|..|+........    .......                      
T Consensus       185 t~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~----------------------  241 (310)
T 3s95_A          185 NPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD----------------------  241 (310)
T ss_dssp             CGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH----------------------
T ss_pred             CcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc----------------------
Confidence            89999999997766 79999999999999999988777432211100    0011111                      


Q ss_pred             CCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         223 PMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                               ...+..+++.+.++|.+||+.||++|||+.++++  |++.+...
T Consensus       242 ---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~~~  283 (310)
T 3s95_A          242 ---------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRMH  283 (310)
T ss_dssp             ---------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHHH
T ss_pred             ---------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHHHh
Confidence                     1123457889999999999999999999999998  77766543

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.4e-44  Score=295.30  Aligned_cols=246  Identities=26%  Similarity=0.374  Sum_probs=190.1

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCC--CCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELK--HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~--h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||+|.+. +|+.||+|++... ........+.+|+.++++++  ||||+++++++.+++..++|||+.++++.+.+.. .
T Consensus        44 Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~  121 (313)
T 3cek_A           44 VFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-K  121 (313)
T ss_dssp             EEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHH-C
T ss_pred             EEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEecCCCcHHHHHHh-c
Confidence            8999985 5999999999763 33334567889999999997  5999999999999999999999878888888766 5


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--ccccccccccccChhhh
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--CYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~  156 (282)
                      ..+++..++.++.||+.||.+||+.|++|+||+|+||+++ ++.++|+|||.+........  ......+++.|+|||.+
T Consensus       122 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  200 (313)
T 3cek_A          122 KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI  200 (313)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHH
Confidence            6899999999999999999999999999999999999995 58999999999987643322  12334678999999998


Q ss_pred             cCC----------CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         157 FGA----------KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYH  226 (282)
Q Consensus       157 ~~~----------~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (282)
                      .+.          ..++.++||||||+++|+|++|..|+................   .                     
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~---~---------------------  256 (313)
T 3cek_A          201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP---N---------------------  256 (313)
T ss_dssp             TTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT---T---------------------
T ss_pred             hhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhc---c---------------------
Confidence            652          247899999999999999999998854444443333332221   0                     


Q ss_pred             CCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccchh
Q psy6044         227 PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       227 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  277 (282)
                         .....+...++.+.++|++||+.||.+|||+.++++||||+.-..+..
T Consensus       257 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~  304 (313)
T 3cek_A          257 ---HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN  304 (313)
T ss_dssp             ---SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-----
T ss_pred             ---cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCchh
Confidence               001123346889999999999999999999999999999997654443

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=305.71  Aligned_cols=241  Identities=18%  Similarity=0.266  Sum_probs=195.0

Q ss_pred             Ceeeee-----eCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHH
Q psy6044           1 MFTSGV-----DRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         1 ~vy~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~   74 (282)
                      .||+|.     +..+++.||||++...........+.+|+.++++++||||+++++++.+....++||||++| ++.+.+
T Consensus        86 ~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l  165 (367)
T 3l9p_A           86 EVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL  165 (367)
T ss_dssp             CEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHH
T ss_pred             EEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHH
Confidence            489999     55688899999987644444456788999999999999999999999999999999999965 777766


Q ss_pred             HhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC---cEEEEecCCccccCC--Ccccccc
Q psy6044          75 DSLN------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG---ELKLADFGLARAFGI--PVKCYSA  143 (282)
Q Consensus        75 ~~~~------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~---~~~l~df~~~~~~~~--~~~~~~~  143 (282)
                      ....      ..+++..++.++.||+.||.|||++||+|+||||+||+++.++   .++|+|||++.....  .......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~  245 (367)
T 3l9p_A          166 RETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC  245 (367)
T ss_dssp             HHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCG
T ss_pred             HhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCC
Confidence            6543      3589999999999999999999999999999999999998555   599999999865421  1122233


Q ss_pred             ccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCC
Q psy6044         144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFP  223 (282)
Q Consensus       144 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (282)
                      ..+++.|+|||.+.+.. ++.++||||||+++|+|++++.++|......+....+......                   
T Consensus       246 ~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~-------------------  305 (367)
T 3l9p_A          246 AMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM-------------------  305 (367)
T ss_dssp             GGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC-------------------
T ss_pred             cCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------------
Confidence            45688899999997766 7999999999999999998555558888877777666553211                   


Q ss_pred             CCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q psy6044         224 MYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS  270 (282)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  270 (282)
                               ..+..+++.+.+||.+||+.||.+|||+.+++++.|+-
T Consensus       306 ---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          306 ---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                     12345789999999999999999999999999987654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.9e-43  Score=287.50  Aligned_cols=236  Identities=17%  Similarity=0.162  Sum_probs=195.4

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      ||+|.+..+|+.||+|++...   .....+.+|+..++.+ .|+|++++++++.+....++|+||++|++.+.+......
T Consensus        26 V~~~~~~~~~~~vavK~~~~~---~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~  102 (298)
T 1csn_A           26 IFEGTNLLNNQQVAIKFEPRR---SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK  102 (298)
T ss_dssp             EEEEEETTTTEEEEEEEEECC---TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTC
T ss_pred             EEEEEECCCCcEEEEEEeccC---CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEecCCCHHHHHHHhccC
Confidence            899999999999999998643   2346789999999999 899999999999999999999999988888888776677


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc-----EEEEecCCccccCCCcc-------ccccccccc
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE-----LKLADFGLARAFGIPVK-------CYSAEVVTL  148 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~-----~~l~df~~~~~~~~~~~-------~~~~~~~~~  148 (282)
                      +++..+..++.||+.||.+||++|++|+||||+||+++.++.     ++|+|||.+........       ......+++
T Consensus       103 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~  182 (298)
T 1csn_A          103 FSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA  182 (298)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCc
Confidence            999999999999999999999999999999999999987776     99999999977643321       223456789


Q ss_pred             cccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCC--CChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG--SDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYH  226 (282)
Q Consensus       149 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (282)
                      .|+|||.+.+.. ++.++||||||+++|+|++|..|+...  ....+....+.......                     
T Consensus       183 ~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------  240 (298)
T 1csn_A          183 RYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST---------------------  240 (298)
T ss_dssp             TTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS---------------------
T ss_pred             ccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc---------------------
Confidence            999999997766 699999999999999999998885432  23444444443322111                     


Q ss_pred             CCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         227 PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       227 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                         ........+++.+.++|..||+.||.+|||++++++
T Consensus       241 ---~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          241 ---PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             ---CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ---cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence               222334568999999999999999999999999976

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.6e-44  Score=295.10  Aligned_cols=237  Identities=24%  Similarity=0.368  Sum_probs=185.9

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCC-----CCCccHHHHHHHHhhC----CCCCccceeeeeeeCCeEEEEEec-Cc-ccH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNE-----GVPSSALREICLLKEL----KHKNIVRLYDVLHSEKKLTLVFEH-CD-QDL   70 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l----~h~~i~~~~~~~~~~~~~~iv~e~-~~-g~l   70 (282)
                      ||+|.+..+|+.||+|++......     .....+.+|+.+++++    +||||+++++++.+.+..++|+|+ +. +++
T Consensus        47 Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L  126 (312)
T 2iwi_A           47 VFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDL  126 (312)
T ss_dssp             EEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEH
T ss_pred             EEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCH
Confidence            899999999999999999763211     2345677899999998    899999999999999999999998 55 466


Q ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc-CCCcEEEEecCCccccCCCcccccccccccc
Q psy6044          71 KKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLW  149 (282)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~  149 (282)
                      .+.+.. .+.+++..++.++.||+.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.......  .....++..
T Consensus       127 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~  203 (312)
T 2iwi_A          127 FDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--YTDFDGTRV  203 (312)
T ss_dssp             HHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC--BCCCCSCTT
T ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc--ccccCCccc
Confidence            666554 66799999999999999999999999999999999999999 88999999999998765332  234567889


Q ss_pred             ccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSM  229 (282)
Q Consensus       150 ~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
                      |+|||.+.+....+.++|+||||+++|++++|..|+ ...  .    .+...                            
T Consensus       204 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf-~~~--~----~~~~~----------------------------  248 (312)
T 2iwi_A          204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF-ERD--Q----EILEA----------------------------  248 (312)
T ss_dssp             TSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC-CSH--H----HHHHT----------------------------
T ss_pred             ccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCC-CCh--H----HHhhh----------------------------
Confidence            999999876664466999999999999999988884 332  1    11110                            


Q ss_pred             CccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccchh
Q psy6044         230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  277 (282)
                       ....+..+++.+.++|.+||+.||++|||++++++||||+......+
T Consensus       249 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~~  295 (312)
T 2iwi_A          249 -ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVP  295 (312)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC------
T ss_pred             -ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhccc
Confidence             11123458899999999999999999999999999999998766544

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.4e-44  Score=305.82  Aligned_cols=265  Identities=26%  Similarity=0.393  Sum_probs=200.2

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCC-----------CCCccceeeeeeeCC----eEEEEEecC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK-----------HKNIVRLYDVLHSEK----KLTLVFEHC   66 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-----------h~~i~~~~~~~~~~~----~~~iv~e~~   66 (282)
                      ||+|.+..+|+.||||++...  ......+.+|+.++++++           ||||+++++++...+    ..++++|++
T Consensus        35 V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~  112 (373)
T 1q8y_A           35 VWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL  112 (373)
T ss_dssp             EEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC
T ss_pred             EEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC
Confidence            899999999999999998642  122456788999999886           899999999998654    899999999


Q ss_pred             cccHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEcC------CCcEEEEecCCccccCCCc
Q psy6044          67 DQDLKKYFDSL-NGEIDLDIVKSFMYQLLRGLAFCHSR-NVLHRDLKPQNLLINK------NGELKLADFGLARAFGIPV  138 (282)
Q Consensus        67 ~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~dl~~~nil~~~------~~~~~l~df~~~~~~~~~~  138 (282)
                      ++++.+.+... ...+++..+..++.||+.||.|||++ ||+|+||||+||+++.      .+.++|+|||.+...... 
T Consensus       113 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-  191 (373)
T 1q8y_A          113 GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-  191 (373)
T ss_dssp             CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-
T ss_pred             CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-
Confidence            88888888764 34599999999999999999999998 9999999999999953      348999999999776532 


Q ss_pred             cccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC------hHHHHHHHHHHhCCCCCCCCCC
Q psy6044         139 KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSD------VDDQLKRIFKLLGTPTEDTWPG  212 (282)
Q Consensus       139 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~  212 (282)
                        .....+++.|+|||.+.+.. ++.++||||||+++|+|++|..|+ ....      ..+....+....+..+...+..
T Consensus       192 --~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~  267 (373)
T 1q8y_A          192 --YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLF-EPDEGHSYTKDDDHIAQIIELLGELPSYLLRN  267 (373)
T ss_dssp             --CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC----------CHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             --CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCC-CCCcccccCChHHHHHHHHHhcCCCCHHHHhc
Confidence              23446789999999998776 699999999999999999988884 4332      4556666666666554321110


Q ss_pred             C----------CCCCCCCCCCCCCC---CCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         213 M----------NLLPDFKPFPMYHP---SMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       213 ~----------~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      .          ..............   .......+...++.+.+||++||+.||.+|||++++++||||++..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  341 (373)
T 1q8y_A          268 GKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL  341 (373)
T ss_dssp             CTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred             cchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhccc
Confidence            0          00000000000000   0001123345778899999999999999999999999999999864

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.4e-44  Score=302.94  Aligned_cols=236  Identities=22%  Similarity=0.372  Sum_probs=188.3

Q ss_pred             Ceeeee-----eCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCC-eEEEEEecCcc-cHHH
Q psy6044           1 MFTSGV-----DRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEK-KLTLVFEHCDQ-DLKK   72 (282)
Q Consensus         1 ~vy~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~-~~~iv~e~~~g-~l~~   72 (282)
                      .||+|+     +..+++.||||++...........+.+|+.+++++ +||||+++++++.+.. ..++||||++| ++.+
T Consensus        37 ~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~  116 (359)
T 3vhe_A           37 QVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST  116 (359)
T ss_dssp             EEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHH
T ss_pred             eEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHH
Confidence            389998     67788999999997644333456789999999999 7899999999988764 58999999986 6666


Q ss_pred             HHHhcCC-----------------------------------------------------------------CCCHHHHH
Q psy6044          73 YFDSLNG-----------------------------------------------------------------EIDLDIVK   87 (282)
Q Consensus        73 ~~~~~~~-----------------------------------------------------------------~~~~~~~~   87 (282)
                      .+.....                                                                 .+++..++
T Consensus       117 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  196 (359)
T 3vhe_A          117 YLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLI  196 (359)
T ss_dssp             HHHTTTTSBCSCC------------------------------------------------------CTTTTCBCHHHHH
T ss_pred             HHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHH
Confidence            6554322                                                                 18999999


Q ss_pred             HHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC--ccccccccccccccChhhhcCCCCCCch
Q psy6044          88 SFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTS  165 (282)
Q Consensus        88 ~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~  165 (282)
                      .++.||+.||+|||++|++|+||||+||+++.++.++|+|||++......  ........+++.|+|||.+.+.. ++.+
T Consensus       197 ~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~  275 (359)
T 3vhe_A          197 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQ  275 (359)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCC-CCHH
T ss_pred             HHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCC-CCch
Confidence            99999999999999999999999999999999999999999999765332  22333455678899999997766 7999


Q ss_pred             hhHHHHHHHHHHHHh-cCCCCCCCCC-hHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHH
Q psy6044         166 IDMWSAGCIFAELAN-AGRPLFPGSD-VDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGR  243 (282)
Q Consensus       166 ~Di~slG~ll~~ll~-~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  243 (282)
                      +||||||+++|+|++ |..| |.+.. .......+....                            ....+..+++.+.
T Consensus       276 ~Di~slG~il~ellt~g~~p-~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~  326 (359)
T 3vhe_A          276 SDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCRRLKEGT----------------------------RMRAPDYTTPEMY  326 (359)
T ss_dssp             HHHHHHHHHHHHHTTTSCCS-STTCCCSHHHHHHHHHTC----------------------------CCCCCTTCCHHHH
T ss_pred             hhhhhHHHHHHHHHhcCCCC-CCccchhHHHHHHHHcCC----------------------------CCCCCCCCCHHHH
Confidence            999999999999998 6666 55554 444444443321                            1112345789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcC
Q psy6044         244 DLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       244 ~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      ++|..||+.||.+|||+.++++|
T Consensus       327 ~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          327 QTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCChhhCCCHHHHHHH
Confidence            99999999999999999999985

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.8e-44  Score=306.69  Aligned_cols=238  Identities=26%  Similarity=0.343  Sum_probs=182.7

Q ss_pred             eCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCCCCHHH
Q psy6044           7 DRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDI   85 (282)
Q Consensus         7 ~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~   85 (282)
                      ...+|+.||||++..    .....+.+|+.+++.+ +||||+++++++.+....|+|||+++|++.+.+.......++..
T Consensus        44 ~~~~~~~vAvK~~~~----~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g~L~~~l~~~~~~~~~~~  119 (432)
T 3p23_A           44 GMFDNRDVAVKRILP----ECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLE  119 (432)
T ss_dssp             EESSSSEEEEEEECT----TTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHSSSCCCCSSC
T ss_pred             EEeCCeEEEEEEECH----HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCCCHHHHHHhcCCCccchh
Confidence            346799999999864    2235678999999999 89999999999999999999999999999999887666677777


Q ss_pred             HHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-----CCcEEEEecCCccccCCCc---cccccccccccccChhhhc
Q psy6044          86 VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK-----NGELKLADFGLARAFGIPV---KCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        86 ~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~-----~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~  157 (282)
                      ++.++.||+.||.|||+.||+|+||||+||+++.     ...++|+|||++.......   .......|++.|+|||.+.
T Consensus       120 ~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~  199 (432)
T 3p23_A          120 PITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS  199 (432)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTS
T ss_pred             HHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhh
Confidence            8899999999999999999999999999999953     2358899999997764322   2233456899999999996


Q ss_pred             C--CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         158 G--AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       158 ~--~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      +  ...++.++|||||||++|++++++.++|...........    ......                      ......
T Consensus       200 ~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~----~~~~~~----------------------~~~~~~  253 (432)
T 3p23_A          200 EDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL----LGACSL----------------------DCLHPE  253 (432)
T ss_dssp             CC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH----TTCCCC----------------------TTSCTT
T ss_pred             cccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH----hccCCc----------------------cccCcc
Confidence            4  233678999999999999999955555655443332211    111100                      000111


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      ...+..+.+||.+||+.||.+|||++++++||||.++..
T Consensus       254 ~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~  292 (432)
T 3p23_A          254 KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK  292 (432)
T ss_dssp             CHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred             ccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence            235667899999999999999999999999999987654

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.5e-43  Score=292.51  Aligned_cols=236  Identities=19%  Similarity=0.244  Sum_probs=192.7

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      .||+|++..+|+.||||++....   ....+.+|+.+++++ +||||+++++++.+....++||||++|++.+.+.....
T Consensus        24 ~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~  100 (330)
T 2izr_A           24 ELRLGKNLYTNEYVAIKLEPMKS---RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDR  100 (330)
T ss_dssp             SEEEEEETTTTEEEEEEEEETTC---SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTT
T ss_pred             eEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeCCCCHHHHHHHcCC
Confidence            38999999999999999987532   345789999999999 99999999999999999999999997788888877667


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc-----EEEEecCCccccCCCcc-------cccccccc
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE-----LKLADFGLARAFGIPVK-------CYSAEVVT  147 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~-----~~l~df~~~~~~~~~~~-------~~~~~~~~  147 (282)
                      .+++..++.++.||+.||.|||+.||+|+||||+||+++.++.     ++|+|||++........       ......|+
T Consensus       101 ~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt  180 (330)
T 2izr_A          101 TFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT  180 (330)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCC
Confidence            8999999999999999999999999999999999999998887     99999999986543222       12345779


Q ss_pred             ccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCC--CChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG--SDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY  225 (282)
Q Consensus       148 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (282)
                      +.|+|||.+.+.. ++.++|+||||+++|+|++|..|+...  ....+....+.......+                   
T Consensus       181 ~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-------------------  240 (330)
T 2izr_A          181 ARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP-------------------  240 (330)
T ss_dssp             TTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC-------------------
T ss_pred             ccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC-------------------
Confidence            9999999998766 699999999999999999988884332  233344444433221111                   


Q ss_pred             CCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         226 HPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       226 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                           ........+ .+.++|..||+.||.+||+++++++
T Consensus       241 -----~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          241 -----IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             -----HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             -----HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                 111112244 8999999999999999999999887

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-44  Score=300.40  Aligned_cols=235  Identities=23%  Similarity=0.337  Sum_probs=191.9

Q ss_pred             eeeeeeC-----CCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHH
Q psy6044           2 FTSGVDR-----TPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFD   75 (282)
Q Consensus         2 vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~   75 (282)
                      ||+|++.     .+++.||+|++...........+.+|+.++++++||||+++++++.+.+..++||||++| ++.+.+.
T Consensus        63 Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  142 (343)
T 1luf_A           63 VFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR  142 (343)
T ss_dssp             EEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHH
T ss_pred             EEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHH
Confidence            8999987     456999999997644444456789999999999999999999999999999999999986 6666665


Q ss_pred             hcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCcc
Q psy6044          76 SLN-----------------------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR  132 (282)
Q Consensus        76 ~~~-----------------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~  132 (282)
                      ...                       ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+.
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~  222 (343)
T 1luf_A          143 SMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR  222 (343)
T ss_dssp             HTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHH
T ss_pred             HhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCc
Confidence            532                       569999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCc--cccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCC
Q psy6044         133 AFGIPV--KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTW  210 (282)
Q Consensus       133 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (282)
                      ......  .......+++.|+|||.+.+.. ++.++|+||||+++|+|++++.++|.+....+....+....        
T Consensus       223 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--------  293 (343)
T 1luf_A          223 NIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN--------  293 (343)
T ss_dssp             HHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC--------
T ss_pred             ccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCC--------
Confidence            654221  2223345678899999997666 79999999999999999983444477777766666554421        


Q ss_pred             CCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         211 PGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                          ....+..+++.+.++|++||+.||.+|||+.++++
T Consensus       294 --------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          294 --------------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             --------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                                11223468899999999999999999999999987

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.6e-44  Score=296.37  Aligned_cols=236  Identities=21%  Similarity=0.330  Sum_probs=191.3

Q ss_pred             eeeeee-----CCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHH
Q psy6044           2 FTSGVD-----RTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFD   75 (282)
Q Consensus         2 vy~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~   75 (282)
                      ||+|.+     +.+++.||+|++.........+.+.+|+.++++++||||+++++++.+++..++|+||++| ++.+.+.
T Consensus        39 V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  118 (314)
T 2ivs_A           39 VVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLR  118 (314)
T ss_dssp             EEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHH
T ss_pred             EEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHH
Confidence            899987     4567999999987644444456788999999999999999999999999999999999984 6666665


Q ss_pred             hcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCcc
Q psy6044          76 SLN-----------------------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR  132 (282)
Q Consensus        76 ~~~-----------------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~  132 (282)
                      ...                       ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+.
T Consensus       119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~  198 (314)
T 2ivs_A          119 ESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR  198 (314)
T ss_dssp             HTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCE
T ss_pred             HHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccc
Confidence            432                       238999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCcc--ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCC
Q psy6044         133 AFGIPVK--CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTW  210 (282)
Q Consensus       133 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (282)
                      .......  ......+++.|+|||.+.+.. ++.++||||||+++|+|++++.++|.+....+....+....        
T Consensus       199 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--------  269 (314)
T 2ivs_A          199 DVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGH--------  269 (314)
T ss_dssp             ECTTTSCEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC--------
T ss_pred             cccccccceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCC--------
Confidence            6643322  223344577899999997665 69999999999999999983444477766665555443321        


Q ss_pred             CCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         211 PGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                                          ....+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       270 --------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          270 --------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             --------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                111234589999999999999999999999999874

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-43  Score=290.00  Aligned_cols=235  Identities=21%  Similarity=0.261  Sum_probs=194.8

Q ss_pred             eeeeeeCCCCc---eEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeE-EEEEecCc-ccHHHHHHh
Q psy6044           2 FTSGVDRTPNT---ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKL-TLVFEHCD-QDLKKYFDS   76 (282)
Q Consensus         2 vy~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~-~iv~e~~~-g~l~~~~~~   76 (282)
                      ||+|.+..+++   .+|+|++.........+.+.+|+.+++.++||||+++++++.+.+.. ++|+||+. |++.+.+..
T Consensus        37 Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~  116 (298)
T 3pls_A           37 VYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS  116 (298)
T ss_dssp             EEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHC
T ss_pred             EEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhc
Confidence            89998655554   89999987644444456788999999999999999999999876554 99999996 577777766


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc----cccccccccccccC
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV----KCYSAEVVTLWYRP  152 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~~a  152 (282)
                      ....+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+.......    .......+++.|+|
T Consensus       117 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~a  196 (298)
T 3pls_A          117 PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA  196 (298)
T ss_dssp             TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSC
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccC
Confidence            56779999999999999999999999999999999999999999999999999997654321    22233455788999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       153 PE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      ||.+.+.. ++.++|+||||+++|+|++|+.|++...+..+....+......                            
T Consensus       197 PE~~~~~~-~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~----------------------------  247 (298)
T 3pls_A          197 LESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL----------------------------  247 (298)
T ss_dssp             HHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC----------------------------
T ss_pred             hhhhccCC-CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC----------------------------
Confidence            99997766 6999999999999999999999989888877766665543211                            


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ..+..+++.+.++|.+||+.||.+|||++++++
T Consensus       248 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          248 PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            123457899999999999999999999999987

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.9e-44  Score=297.30  Aligned_cols=244  Identities=22%  Similarity=0.340  Sum_probs=198.0

Q ss_pred             eeeeeeC-----CCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHH
Q psy6044           2 FTSGVDR-----TPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFD   75 (282)
Q Consensus         2 vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~   75 (282)
                      ||+|.++     .+++.||+|++...........+.+|+.+++.++||||+++++++.+.+..++||||++| ++.+.+.
T Consensus        41 Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  120 (322)
T 1p4o_A           41 VYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR  120 (322)
T ss_dssp             EEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHH
T ss_pred             EEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHH
Confidence            7888876     468899999987643333345688999999999999999999999999999999999975 6666655


Q ss_pred             hcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc--cccccc
Q psy6044          76 SLN---------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--KCYSAE  144 (282)
Q Consensus        76 ~~~---------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~  144 (282)
                      ...         ..+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+.......  ......
T Consensus       121 ~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  200 (322)
T 1p4o_A          121 SLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG  200 (322)
T ss_dssp             HHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSS
T ss_pred             HhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCC
Confidence            422         457999999999999999999999999999999999999999999999999987654322  122233


Q ss_pred             cccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM  224 (282)
Q Consensus       145 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (282)
                      .+++.|+|||.+.+.. ++.++||||||+++|+|++++.++|......+....+....                      
T Consensus       201 ~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----------------------  257 (322)
T 1p4o_A          201 LLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG----------------------  257 (322)
T ss_dssp             EECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC----------------------
T ss_pred             CCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC----------------------
Confidence            4577899999997666 69999999999999999996666688877777666554421                      


Q ss_pred             CCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC------CCccCCcc
Q psy6044         225 YHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH------IYFSDLNV  274 (282)
Q Consensus       225 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h------~~~~~~~~  274 (282)
                            ....+..+++.+.++|.+||+.||.+|||+.+++++      +||+.++.
T Consensus       258 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~  307 (322)
T 1p4o_A          258 ------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF  307 (322)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCS
T ss_pred             ------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccccc
Confidence                  111234588999999999999999999999999986      66665543

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=8e-44  Score=289.94  Aligned_cols=234  Identities=24%  Similarity=0.396  Sum_probs=180.7

Q ss_pred             eeeeeeCCC---CceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc
Q psy6044           2 FTSGVDRTP---NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL   77 (282)
Q Consensus         2 vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~   77 (282)
                      ||+|.+..+   +..||+|++...........+.+|+.++++++||||+++++++. ++..++||||++| ++.+.+...
T Consensus        31 Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~  109 (281)
T 1mp8_A           31 VHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVR  109 (281)
T ss_dssp             EEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHT
T ss_pred             EEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhc
Confidence            899998654   55799998876444444567889999999999999999999985 4568999999986 677766665


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccChhhh
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~  156 (282)
                      ...+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+........ ......+++.|+|||.+
T Consensus       110 ~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~  189 (281)
T 1mp8_A          110 KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI  189 (281)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhc
Confidence            56799999999999999999999999999999999999999999999999999977643321 12233456789999999


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       157 ~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      .... ++.++|+||||+++|++++++.++|.+....+....+.....                            ...+.
T Consensus       190 ~~~~-~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~----------------------------~~~~~  240 (281)
T 1mp8_A          190 NFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER----------------------------LPMPP  240 (281)
T ss_dssp             HHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----------------------------CCCCT
T ss_pred             ccCC-CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC----------------------------CCCCC
Confidence            7665 699999999999999999755555777776666655543211                            11234


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      .+++.+.++|.+||+.||.+|||+.++++
T Consensus       241 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~  269 (281)
T 1mp8_A          241 NCPPTLYSLMTKCWAYDPSRRPRFTELKA  269 (281)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            68999999999999999999999999987

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=300.14  Aligned_cols=236  Identities=24%  Similarity=0.370  Sum_probs=194.2

Q ss_pred             eeeeeeCC-------CCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHH
Q psy6044           2 FTSGVDRT-------PNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKK   72 (282)
Q Consensus         2 vy~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~   72 (282)
                      ||+|.+..       ++..||+|++...........+.+|+++++++ +||||+++++++.+++..++||||++| ++.+
T Consensus        85 Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~  164 (382)
T 3tt0_A           85 VVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE  164 (382)
T ss_dssp             EEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred             EEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHH
Confidence            89998653       44689999997654444456788999999999 999999999999999999999999976 6766


Q ss_pred             HHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC
Q psy6044          73 YFDSLN---------------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP  137 (282)
Q Consensus        73 ~~~~~~---------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~  137 (282)
                      .+....               ..+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++......
T Consensus       165 ~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~  244 (382)
T 3tt0_A          165 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI  244 (382)
T ss_dssp             HHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCC
T ss_pred             HHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccc
Confidence            665543               35999999999999999999999999999999999999999999999999999866432


Q ss_pred             c--cccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCC
Q psy6044         138 V--KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNL  215 (282)
Q Consensus       138 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  215 (282)
                      .  .......+++.|+|||.+.+.. ++.++||||||+++|+|++++.++|.+....+....+.....            
T Consensus       245 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~------------  311 (382)
T 3tt0_A          245 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR------------  311 (382)
T ss_dssp             CTTCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC------------
T ss_pred             cccccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------
Confidence            2  2233345578899999998766 799999999999999999844555887777776666544211            


Q ss_pred             CCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         216 LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                                      ...+..+++.+.+||++||+.||++|||+++++++
T Consensus       312 ----------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          312 ----------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             ----------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                            11234588999999999999999999999999974

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=9.3e-44  Score=300.35  Aligned_cols=234  Identities=22%  Similarity=0.325  Sum_probs=181.9

Q ss_pred             eeeeeeC---CCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc
Q psy6044           2 FTSGVDR---TPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL   77 (282)
Q Consensus         2 vy~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~   77 (282)
                      ||+|+++   .++..||||++...........+.+|+.++++++||||+++++++.+++..++||||++| ++.+.+...
T Consensus        61 Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~  140 (373)
T 2qol_A           61 VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH  140 (373)
T ss_dssp             EEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTT
T ss_pred             EEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhC
Confidence            8999887   568889999987644444456789999999999999999999999999999999999964 676666665


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc---cccccccccccChh
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC---YSAEVVTLWYRPPD  154 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~aPE  154 (282)
                      ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.........   .....++..|+|||
T Consensus       141 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE  220 (373)
T 2qol_A          141 DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE  220 (373)
T ss_dssp             TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChh
Confidence            567999999999999999999999999999999999999999999999999999776433211   11223356799999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      .+.+.. ++.++||||||+++|++++ |..| |......+....+......+                            
T Consensus       221 ~~~~~~-~~~~~Dv~SlG~il~ellt~g~~P-~~~~~~~~~~~~i~~~~~~~----------------------------  270 (373)
T 2qol_A          221 AIAYRK-FTSASDVWSYGIVLWEVMSYGERP-YWEMSNQDVIKAVDEGYRLP----------------------------  270 (373)
T ss_dssp             HHHHCC-CCHHHHHHHHHHHHHHHHTTC-CT-TTTCCHHHHHHHHHTTEECC----------------------------
T ss_pred             hhccCC-cCchhcHHHHHHHHHHHHhCCCCC-CCCCCHHHHHHHHHcCCCCC----------------------------
Confidence            997766 7999999999999999998 5555 66666666666554432111                            


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      .+..++..+.++|..||+.||.+|||+.++++
T Consensus       271 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          271 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            12347899999999999999999999999886

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.4e-43  Score=294.30  Aligned_cols=234  Identities=18%  Similarity=0.245  Sum_probs=188.5

Q ss_pred             eeeeeeCCCCce----EEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHh
Q psy6044           2 FTSGVDRTPNTA----LAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDS   76 (282)
Q Consensus         2 vy~a~~~~~~~~----vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~   76 (282)
                      ||+|++..+|+.    ||+|.+...........+.+|+.++++++||||+++++++. ++..++|+||+. |++.+.+..
T Consensus        29 Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~  107 (325)
T 3kex_A           29 VHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ  107 (325)
T ss_dssp             EEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHS
T ss_pred             EEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHH
Confidence            899999998887    66666655444555678889999999999999999999986 456889999997 577777766


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc--cccccccccccccChh
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--KCYSAEVVTLWYRPPD  154 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~aPE  154 (282)
                      ..+.+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.......  .......++..|+|||
T Consensus       108 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE  187 (325)
T 3kex_A          108 HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE  187 (325)
T ss_dssp             SGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHH
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChH
Confidence            55789999999999999999999999999999999999999999999999999998764332  2223345577899999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      .+.+.. ++.++|+||||+++|++++ |..| |.+....+....+.....                            ..
T Consensus       188 ~~~~~~-~~~~~Di~slG~~l~el~~~g~~p-~~~~~~~~~~~~~~~~~~----------------------------~~  237 (325)
T 3kex_A          188 SIHFGK-YTHQSDVWSYGVTVWELMTFGAEP-YAGLRLAEVPDLLEKGER----------------------------LA  237 (325)
T ss_dssp             HHHHCC-CCHHHHHHHHHHHHHHHHTTSCCT-TTTSCTTHHHHHHHTTCB----------------------------CC
T ss_pred             HhccCC-CChhhHhHHhHHHHHHHHhCCCCC-ccccCHHHHHHHHHcCCC----------------------------CC
Confidence            997666 7999999999999999998 5555 776666665555443211                            11


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      .+..++..+.++|.+||+.||.+|||+.+++++
T Consensus       238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          238 QPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            223467788999999999999999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.9e-43  Score=284.70  Aligned_cols=233  Identities=18%  Similarity=0.247  Sum_probs=192.2

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~   80 (282)
                      ||+|.++ ++..||+|++....  ...+.+.+|+.++++++||||+++++++.++...++||||++| ++.+.+......
T Consensus        24 V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~  100 (268)
T 3sxs_A           24 VKLGKWK-GQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG  100 (268)
T ss_dssp             EEEEEET-TTEEEEEEEECBTT--BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGG
T ss_pred             EEEEEec-CceeEEEEEeccCC--CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCC
Confidence            8999875 57789999987532  2246789999999999999999999999999999999999975 577777665567


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccChhhhcCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~  159 (282)
                      +++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+........ ......+++.|+|||.+.+.
T Consensus       101 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  180 (268)
T 3sxs_A          101 LEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYF  180 (268)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHS
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhcc
Confidence            99999999999999999999999999999999999999999999999999976654322 22333446789999999776


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      . ++.++|+||||+++|++++++.++|......+....+......                            ..+...+
T Consensus       181 ~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~  231 (268)
T 3sxs_A          181 K-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL----------------------------YRPHLAS  231 (268)
T ss_dssp             E-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC----------------------------CCCTTSC
T ss_pred             C-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC----------------------------CCCCcCh
Confidence            6 6899999999999999998445557777777666655442111                            1223478


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      +.+.++|..||+.||.+|||+.+++++
T Consensus       232 ~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          232 DTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            899999999999999999999999984

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.3e-42  Score=283.57  Aligned_cols=234  Identities=21%  Similarity=0.317  Sum_probs=188.5

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCC------CCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEG------VPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKY   73 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~------~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~   73 (282)
                      .||+|++..+++.||+|++.......      ..+.+.+|+.++++++||||+++++++.+..  ++||||++ |++.+.
T Consensus        34 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~  111 (287)
T 4f0f_A           34 LVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHR  111 (287)
T ss_dssp             CEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHH
T ss_pred             eEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHH
Confidence            48999999999999999987633222      1267889999999999999999999997776  79999998 577788


Q ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEcCCCc-----EEEEecCCccccCCCccccccccc
Q psy6044          74 FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN--VLHRDLKPQNLLINKNGE-----LKLADFGLARAFGIPVKCYSAEVV  146 (282)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~dl~~~nil~~~~~~-----~~l~df~~~~~~~~~~~~~~~~~~  146 (282)
                      +......+++..++.++.|++.||.+||+.|  ++|+||||+||+++.++.     ++|+|||.+.....   ......+
T Consensus       112 l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~g  188 (287)
T 4f0f_A          112 LLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLLG  188 (287)
T ss_dssp             HHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS---CEECCCC
T ss_pred             HhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc---cccccCC
Confidence            8776778999999999999999999999999  999999999999988776     99999999975543   2334567


Q ss_pred             cccccChhhhcC-CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         147 TLWYRPPDVLFG-AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY  225 (282)
Q Consensus       147 ~~~~~aPE~~~~-~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (282)
                      ++.|+|||.+.. ...++.++|+||||+++|+|++|..|+..................                      
T Consensus       189 ~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------------------  246 (287)
T 4f0f_A          189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG----------------------  246 (287)
T ss_dssp             CCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC----------------------
T ss_pred             CccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC----------------------
Confidence            899999999843 233688999999999999999988885433333322222222111                      


Q ss_pred             CCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         226 HPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       226 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                          .....+..+++.+.++|.+||+.||.+|||++++++
T Consensus       247 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          247 ----LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                111233568999999999999999999999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.1e-43  Score=285.44  Aligned_cols=233  Identities=20%  Similarity=0.289  Sum_probs=193.3

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~   80 (282)
                      ||+|.+. ++..||+|++....  ...+.+.+|+.++++++||||+++++++.+.+..++||||++| ++.+.+......
T Consensus        40 V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~  116 (283)
T 3gen_A           40 VKYGKWR-GQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR  116 (283)
T ss_dssp             EEEEEET-TTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGC
T ss_pred             EEEEEEc-CCCeEEEEEecCCC--CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccC
Confidence            8999875 68889999987532  2246789999999999999999999999999999999999965 677766665678


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccChhhhcCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      +++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+....... .......+++.|+|||.+.+.
T Consensus       117 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  196 (283)
T 3gen_A          117 FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS  196 (283)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccC
Confidence            9999999999999999999999999999999999999999999999999997664332 122233446789999999766


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      . ++.++|+||||+++|++++++.++|......+....+......                            ..+...+
T Consensus       197 ~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~  247 (283)
T 3gen_A          197 K-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL----------------------------YRPHLAS  247 (283)
T ss_dssp             C-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC----------------------------CCCTTCC
T ss_pred             C-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC----------------------------CCCCcCC
Confidence            6 6999999999999999998445558887777777666553221                            1223468


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      +.+.++|.+||+.||.+|||++++++|
T Consensus       248 ~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          248 EKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999999999975

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.8e-43  Score=289.58  Aligned_cols=239  Identities=21%  Similarity=0.346  Sum_probs=187.1

Q ss_pred             eeeee----eCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC--CeEEEEEecCcc-cHHHHH
Q psy6044           2 FTSGV----DRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE--KKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         2 vy~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~--~~~~iv~e~~~g-~l~~~~   74 (282)
                      ||+|+    +..+|+.||+|++...........+.+|+.+++.++||||+++++++.++  ...++||||++| ++.+.+
T Consensus        37 V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l  116 (302)
T 4e5w_A           37 VELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL  116 (302)
T ss_dssp             EEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHH
T ss_pred             EEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHH
Confidence            78888    77899999999998755555567889999999999999999999999877  678999999976 777777


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc---ccccccccccccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---KCYSAEVVTLWYR  151 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~  151 (282)
                      ......+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+.......   .......++..|+
T Consensus       117 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~  196 (302)
T 4e5w_A          117 PKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY  196 (302)
T ss_dssp             HHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGC
T ss_pred             HhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCcccc
Confidence            6667789999999999999999999999999999999999999999999999999998765433   2233445677899


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCC----------CChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCC
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPG----------SDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP  221 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (282)
                      |||.+.+.. ++.++|+||||+++|+|++|..|+...          .........+.......                
T Consensus       197 aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------  259 (302)
T 4e5w_A          197 APECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG----------------  259 (302)
T ss_dssp             CHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT----------------
T ss_pred             CCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhcc----------------
Confidence            999997766 689999999999999999987762111          00000111111111100                


Q ss_pred             CCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         222 FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                              .....+..+++.+.++|++||+.||.+|||+.++++
T Consensus       260 --------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          260 --------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             --------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             --------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence                    111233568999999999999999999999999986

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2e-43  Score=293.62  Aligned_cols=235  Identities=20%  Similarity=0.301  Sum_probs=188.5

Q ss_pred             CeeeeeeCCCCceE--EEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHh
Q psy6044           1 MFTSGVDRTPNTAL--AIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDS   76 (282)
Q Consensus         1 ~vy~a~~~~~~~~v--aiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~   76 (282)
                      .||+|+++.+|..+  |+|.+...........+.+|+.+++++ +||||+++++++.+.+..++||||++| ++.+.+..
T Consensus        40 ~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  119 (327)
T 1fvr_A           40 QVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK  119 (327)
T ss_dssp             EEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHT
T ss_pred             eEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHh
Confidence            38999999999866  999988755555677899999999999 999999999999999999999999975 67666654


Q ss_pred             cC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccc
Q psy6044          77 LN---------------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY  141 (282)
Q Consensus        77 ~~---------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  141 (282)
                      ..               ..+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++...... ...
T Consensus       120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~-~~~  198 (327)
T 1fvr_A          120 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKK  198 (327)
T ss_dssp             TCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE-CCC
T ss_pred             cccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCcccccc-ccc
Confidence            32               36999999999999999999999999999999999999999999999999998754322 122


Q ss_pred             ccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCC
Q psy6044         142 SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFK  220 (282)
Q Consensus       142 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (282)
                      ....+++.|+|||.+.+.. ++.++|+||||+++|+|++ |..| |.+.+..+....+.....                 
T Consensus       199 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p-f~~~~~~~~~~~~~~~~~-----------------  259 (327)
T 1fvr_A          199 TMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTP-YCGMTCAELYEKLPQGYR-----------------  259 (327)
T ss_dssp             ----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCT-TTTCCHHHHHHHGGGTCC-----------------
T ss_pred             cCCCCCccccChhhhcccc-CCchhcchHHHHHHHHHHcCCCCC-CCCCcHHHHHHHhhcCCC-----------------
Confidence            2334577899999997665 6899999999999999998 5555 777776666555433211                 


Q ss_pred             CCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         221 PFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                                 ...+..+++.+.++|.+||+.||.+|||+++++++
T Consensus       260 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          260 -----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             -----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                       11234578999999999999999999999999874

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=8.6e-43  Score=287.73  Aligned_cols=236  Identities=26%  Similarity=0.421  Sum_probs=180.2

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHh--
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDS--   76 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~--   76 (282)
                      ||+|.+..+|+.||+|++...  ........+.+|+.++++++||||+++++++.+++..++|+||++| ++.+.+..  
T Consensus        48 Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  127 (310)
T 2wqm_A           48 VYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFK  127 (310)
T ss_dssp             EEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHH
T ss_pred             EEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhc
Confidence            899999999999999998762  2222345688999999999999999999999999999999999986 55555433  


Q ss_pred             -cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhh
Q psy6044          77 -LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDV  155 (282)
Q Consensus        77 -~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~  155 (282)
                       ....+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.
T Consensus       128 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  207 (310)
T 2wqm_A          128 KQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER  207 (310)
T ss_dssp             HTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------------------CCSSCCHHH
T ss_pred             ccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHH
Confidence             3566999999999999999999999999999999999999999999999999998776544443444567889999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChH-HHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD-DQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      +.+.. ++.++|+||||+++|+|++|..|+....... .....+... ..+                          ...
T Consensus       208 ~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~--------------------------~~~  259 (310)
T 2wqm_A          208 IHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-DYP--------------------------PLP  259 (310)
T ss_dssp             HTTCC-CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT-CSC--------------------------CCC
T ss_pred             hCCCC-CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc-cCC--------------------------CCc
Confidence            97766 7999999999999999999999865544332 222222221 000                          001


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ...+++.+.++|.+||+.||.+|||+.++++
T Consensus       260 ~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          260 SDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            2357899999999999999999999999987

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-43  Score=288.37  Aligned_cols=235  Identities=23%  Similarity=0.313  Sum_probs=191.6

Q ss_pred             eeeeeeC--CCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDR--TPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      ||+|.++  .++..||+|++.........+.+.+|+.++++++||||+++++++ ..+..++|+||++| ++.+.+....
T Consensus        26 Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~  104 (287)
T 1u59_A           26 VRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR  104 (287)
T ss_dssp             EEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCT
T ss_pred             EEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCC
Confidence            8999753  578899999998654444456788999999999999999999999 55669999999986 6666665556


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc---cccccccccccChhh
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC---YSAEVVTLWYRPPDV  155 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~aPE~  155 (282)
                      ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........   .....+++.|+|||.
T Consensus       105 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  184 (287)
T 1u59_A          105 EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC  184 (287)
T ss_dssp             TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHH
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHH
Confidence            67999999999999999999999999999999999999999999999999999876533221   222344788999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      +.+.. ++.++|+||||+++|+|++ |..| |......+....+....                            ....
T Consensus       185 ~~~~~-~~~~~Di~slG~il~ellt~g~~p-~~~~~~~~~~~~i~~~~----------------------------~~~~  234 (287)
T 1u59_A          185 INFRK-FSSRSDVWSYGVTMWEALSYGQKP-YKKMKGPEVMAFIEQGK----------------------------RMEC  234 (287)
T ss_dssp             HHHCE-ECHHHHHHHHHHHHHHHHTTSCCT-TTTCCTHHHHHHHHTTC----------------------------CCCC
T ss_pred             hccCC-CCchhhHHHHHHHHHHHHcCCCCC-cccCCHHHHHHHHhcCC----------------------------cCCC
Confidence            97665 6899999999999999998 6555 77766666665554321                            1123


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHI  267 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~  267 (282)
                      +..+++.+.++|..||+.||.+|||+.+++++.
T Consensus       235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            356899999999999999999999999999853

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.4e-43  Score=288.01  Aligned_cols=234  Identities=23%  Similarity=0.340  Sum_probs=195.0

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHhc-C
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSL-N   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~-~   78 (282)
                      .||+|.++.++..||+|++...  ....+.+.+|+.++++++||||+++++++.+++..++|+||++ |++.+.+... .
T Consensus        28 ~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~  105 (288)
T 3kfa_A           28 EVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR  105 (288)
T ss_dssp             SEEEEEEGGGTEEEEEEEECSC--STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCT
T ss_pred             eEEEeEecCCCEEEEEEecCcC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhccc
Confidence            4899999999999999998742  2335678899999999999999999999999999999999998 5777766553 3


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~  157 (282)
                      ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+....... .......+++.|+|||.+.
T Consensus       106 ~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  185 (288)
T 3kfa_A          106 QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA  185 (288)
T ss_dssp             TTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHH
T ss_pred             CCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhc
Confidence            459999999999999999999999999999999999999999999999999998765432 2233344567899999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|+||||+++|+|++++.++|...+.......+.....                            ...+..
T Consensus       186 ~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~  236 (288)
T 3kfa_A          186 YNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR----------------------------MERPEG  236 (288)
T ss_dssp             HCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC----------------------------CCCCTT
T ss_pred             cCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC----------------------------CCCCCC
Confidence            766 699999999999999999855666877776666555543211                            112345


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      +++.+.++|+.||+.||.+|||++++++
T Consensus       237 ~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          237 CPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            7899999999999999999999999987

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4e-43  Score=284.26  Aligned_cols=231  Identities=25%  Similarity=0.321  Sum_probs=178.0

Q ss_pred             eeeeeeCCCCceEEEeeeecCCC---CCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGN---EGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||+|.+.  |+.||+|++.....   ....+.+.+|+.+++.++||||+++++++.+++..++||||++|+.+..+.. .
T Consensus        23 V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~   99 (271)
T 3dtc_A           23 VYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-G   99 (271)
T ss_dssp             EEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT-S
T ss_pred             EEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh-c
Confidence            8999974  89999999886322   2334678899999999999999999999999999999999998765555554 5


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCcEEEcC--------CCcEEEEecCCccccCCCcccccccccc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRN---VLHRDLKPQNLLINK--------NGELKLADFGLARAFGIPVKCYSAEVVT  147 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~dl~~~nil~~~--------~~~~~l~df~~~~~~~~~~~~~~~~~~~  147 (282)
                      ..+++..++.++.|++.||.+||++|   ++|+||||+||+++.        ++.++|+|||.+........  ....++
T Consensus       100 ~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~  177 (271)
T 3dtc_A          100 KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--MSAAGA  177 (271)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---------------CC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccccc--cCCCCc
Confidence            68999999999999999999999999   889999999999986        77899999999976653322  234678


Q ss_pred             ccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHP  227 (282)
Q Consensus       148 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (282)
                      +.|+|||.+.+.. ++.++|+||||+++|++++|..| |.+.+............                         
T Consensus       178 ~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p-~~~~~~~~~~~~~~~~~-------------------------  230 (271)
T 3dtc_A          178 YAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVP-FRGIDGLAVAYGVAMNK-------------------------  230 (271)
T ss_dssp             GGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHHHCCCT-TTTSCHHHHHHHHHTSC-------------------------
T ss_pred             cceeCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHhhhcCC-------------------------
Confidence            9999999997766 69999999999999999998887 66655555444333211                         


Q ss_pred             CCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         228 SMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       228 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                        .....+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       231 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          231 --LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence              0112235688999999999999999999999999874

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.5e-43  Score=287.55  Aligned_cols=232  Identities=19%  Similarity=0.269  Sum_probs=186.3

Q ss_pred             eeee--eeCCCCceEEEeeeecCC-CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc
Q psy6044           2 FTSG--VDRTPNTALAIKGTHLVG-NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL   77 (282)
Q Consensus         2 vy~a--~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~   77 (282)
                      ||+|  .+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++ ..+..++|+||++| ++.+.+ ..
T Consensus        33 Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l-~~  110 (291)
T 1xbb_A           33 VKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-QQ  110 (291)
T ss_dssp             EEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHH-HH
T ss_pred             eEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHH-Hh
Confidence            8999  556788999999998632 233356788999999999999999999999 56778999999986 555554 44


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc---cccccccccccChh
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC---YSAEVVTLWYRPPD  154 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~aPE  154 (282)
                      .+.+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........   .....+++.|+|||
T Consensus       111 ~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE  190 (291)
T 1xbb_A          111 NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE  190 (291)
T ss_dssp             CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHH
T ss_pred             CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChH
Confidence            678999999999999999999999999999999999999999999999999999776533221   12233467899999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      .+.+.. ++.++|+||||+++|+|++ |..| |......+....+....                            ...
T Consensus       191 ~~~~~~-~~~~~Di~slG~il~~l~~~g~~p-~~~~~~~~~~~~~~~~~----------------------------~~~  240 (291)
T 1xbb_A          191 CINYYK-FSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSEVTAMLEKGE----------------------------RMG  240 (291)
T ss_dssp             HHHHCE-EEHHHHHHHHHHHHHHHHTTTCCS-STTCCHHHHHHHHHTTC----------------------------CCC
T ss_pred             HhccCC-CChhhhHHHHHHHHHHHHhcCCCC-CCCCCHHHHHHHHHcCC----------------------------CCC
Confidence            997665 6899999999999999998 5555 77777666655544321                            112


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      .+..+++.+.++|.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          241 CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            23468999999999999999999999999987

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.2e-43  Score=289.89  Aligned_cols=237  Identities=24%  Similarity=0.378  Sum_probs=190.4

Q ss_pred             eeeee-----eCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHHHH
Q psy6044           2 FTSGV-----DRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         2 vy~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~   74 (282)
                      ||+|.     +..+++.||+|++.........+.+.+|+.+++++ +||||+++++++.+++..++|+||++| ++.+.+
T Consensus        39 V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l  118 (313)
T 1t46_A           39 VVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL  118 (313)
T ss_dssp             EEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHH
T ss_pred             eEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHH
Confidence            78887     45688999999997644333457788999999999 999999999999999999999999976 777766


Q ss_pred             HhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC
Q psy6044          75 DSLNG-----------------EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP  137 (282)
Q Consensus        75 ~~~~~-----------------~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~  137 (282)
                      .....                 .+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||.+......
T Consensus       119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  198 (313)
T 1t46_A          119 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND  198 (313)
T ss_dssp             HHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSC
T ss_pred             HhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEcccccccccccc
Confidence            65432                 4899999999999999999999999999999999999999999999999999776533


Q ss_pred             cc--ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCC
Q psy6044         138 VK--CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNL  215 (282)
Q Consensus       138 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  215 (282)
                      ..  ......+++.|+|||.+.+.. ++.++||||||+++|+|++++.++|...................          
T Consensus       199 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------  267 (313)
T 1t46_A          199 SNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM----------  267 (313)
T ss_dssp             TTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC----------
T ss_pred             ccceeccCCCCcceeeChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCC----------
Confidence            22  222344567899999987665 79999999999999999984444466555444333333321111          


Q ss_pred             CCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         216 LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                                       ..+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       268 -----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          268 -----------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             -----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence                             1124578999999999999999999999999873

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.3e-43  Score=289.82  Aligned_cols=229  Identities=20%  Similarity=0.262  Sum_probs=190.6

Q ss_pred             eeeeeeCCCC-------ceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHH
Q psy6044           2 FTSGVDRTPN-------TALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY   73 (282)
Q Consensus         2 vy~a~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~   73 (282)
                      ||+|+++.++       ..||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||++| ++.+.
T Consensus        24 V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  102 (289)
T 4fvq_A           24 IFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTY  102 (289)
T ss_dssp             EEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHH
T ss_pred             EEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHH
Confidence            8999998887       479999986532 22346789999999999999999999999999999999999985 77777


Q ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc--------EEEEecCCccccCCCcccccccc
Q psy6044          74 FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE--------LKLADFGLARAFGIPVKCYSAEV  145 (282)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~--------~~l~df~~~~~~~~~~~~~~~~~  145 (282)
                      +......+++..++.++.||+.||.|||++|++|+||||+||+++.++.        ++|+|||.+......    ....
T Consensus       103 l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~  178 (289)
T 4fvq_A          103 LKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK----DILQ  178 (289)
T ss_dssp             HHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH----HHHH
T ss_pred             HHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc----cccC
Confidence            6665555999999999999999999999999999999999999998887        999999998655422    2234


Q ss_pred             ccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         146 VTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY  225 (282)
Q Consensus       146 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (282)
                      ++..|+|||.+.+...++.++||||||+++|+|++|+.|++...............                        
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~------------------------  234 (289)
T 4fvq_A          179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR------------------------  234 (289)
T ss_dssp             HTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT------------------------
T ss_pred             CcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhcc------------------------
Confidence            57889999999874557999999999999999999888888877766555443221                        


Q ss_pred             CCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         226 HPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       226 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                            ...+...++.+.++|++||+.||.+|||+.++++
T Consensus       235 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  268 (289)
T 4fvq_A          235 ------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIR  268 (289)
T ss_dssp             ------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                  1122345777899999999999999999999998

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-43  Score=294.91  Aligned_cols=236  Identities=23%  Similarity=0.362  Sum_probs=186.8

Q ss_pred             eeeeee-----CCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHHHH
Q psy6044           2 FTSGVD-----RTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         2 vy~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~   74 (282)
                      ||+|.+     ..++..||+|++...........+.+|+.+++++ +||||+++++++...+..++||||++| ++.+.+
T Consensus        61 V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l  140 (344)
T 1rjb_A           61 VMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL  140 (344)
T ss_dssp             EEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHH
T ss_pred             eEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHH
Confidence            789986     4567899999998755555678899999999999 999999999999999999999999975 777766


Q ss_pred             HhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCcc
Q psy6044          75 DSLNG----------------------EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR  132 (282)
Q Consensus        75 ~~~~~----------------------~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~  132 (282)
                      .....                      .+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||.+.
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~  220 (344)
T 1rjb_A          141 RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR  220 (344)
T ss_dssp             HTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGS
T ss_pred             hhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCc
Confidence            65432                      27899999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCc--cccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy6044         133 AFGIPV--KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDT  209 (282)
Q Consensus       133 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  209 (282)
                      ......  .......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..| |.+....+...........     
T Consensus       221 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p-~~~~~~~~~~~~~~~~~~~-----  293 (344)
T 1rjb_A          221 DIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNP-YPGIPVDANFYKLIQNGFK-----  293 (344)
T ss_dssp             CGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCS-STTCCCSHHHHHHHHTTCC-----
T ss_pred             ccccCccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCCCC-cccCCcHHHHHHHHhcCCC-----
Confidence            654222  1223344577899999997665 7999999999999999998 6555 6555444333333331110     


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         210 WPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                                            ...+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       294 ----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          294 ----------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence                                  11234578999999999999999999999999984

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.7e-43  Score=294.97  Aligned_cols=240  Identities=23%  Similarity=0.309  Sum_probs=165.2

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHH-HHHhhCCCCCccceeeeeee----CCeEEEEEecCcc-cHHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREI-CLLKELKHKNIVRLYDVLHS----EKKLTLVFEHCDQ-DLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~-~~~~~l~h~~i~~~~~~~~~----~~~~~iv~e~~~g-~l~~~~~   75 (282)
                      ||+|+++.+|+.||||++...      ....+|+ ..++.+.||||+++++++..    ....++||||++| ++.+.+.
T Consensus        45 V~~~~~~~~~~~vavK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~  118 (336)
T 3fhr_A           45 VLECFHRRTGQKCALKLLYDS------PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ  118 (336)
T ss_dssp             EEEEEETTTCCEEEEEEEESS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHH
T ss_pred             EEEEEECCCCCEEEEEEecCc------HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHH
Confidence            899999999999999998642      2333343 34566799999999999986    4568999999976 7777666


Q ss_pred             hcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC---CCcEEEEecCCccccCCCcccccccccccccc
Q psy6044          76 SLN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK---NGELKLADFGLARAFGIPVKCYSAEVVTLWYR  151 (282)
Q Consensus        76 ~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  151 (282)
                      ... ..+++..++.++.||+.||.|||++|++|+||||+||+++.   ++.++|+|||.+.......  .....+++.|+
T Consensus       119 ~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~t~~y~  196 (336)
T 3fhr_A          119 ERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYV  196 (336)
T ss_dssp             TC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----------------
T ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccccc--cccCCCCcCcc
Confidence            543 36999999999999999999999999999999999999976   4559999999997665322  23346688999


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSF  231 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
                      |||.+.+.. ++.++||||||+++|+|++|..|+ ..................... .                    ..
T Consensus       197 aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~-~--------------------~~  253 (336)
T 3fhr_A          197 APEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPF-YSNTGQAISPGMKRRIRLGQY-G--------------------FP  253 (336)
T ss_dssp             -------CH-HHHHHHHHHHHHHHHHHHHSSCCC-----------------------C--------------------CC
T ss_pred             ChhhhCCCC-CCchhhHHHHHHHHHHHHHCCCCC-CCccchhhhhhHHHhhhcccc-c--------------------cC
Confidence            999986665 689999999999999999998885 333322221111110000000 0                    00


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      ......+++.+.+||++||+.||.+|||++++++||||++.
T Consensus       254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            11124589999999999999999999999999999999864

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.6e-43  Score=281.40  Aligned_cols=233  Identities=19%  Similarity=0.294  Sum_probs=193.3

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~   80 (282)
                      ||+|.+. +++.||+|++.....  ..+.+.+|+.++++++||||+++++++.+++..++|+||++| ++.+.+......
T Consensus        24 V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~  100 (267)
T 3t9t_A           24 VHLGYWL-NKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL  100 (267)
T ss_dssp             EEEEEET-TTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTC
T ss_pred             EEEEEec-CCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCccc
Confidence            8999986 688999999876322  236789999999999999999999999999999999999975 677777665677


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccChhhhcCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      +++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+.
T Consensus       101 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  180 (267)
T 3t9t_A          101 FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS  180 (267)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCC
Confidence            9999999999999999999999999999999999999999999999999987664321 122233456789999999766


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      . ++.++|+||||+++|+|++++.++|......+....+......                            ..+...+
T Consensus       181 ~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~----------------------------~~~~~~~  231 (267)
T 3t9t_A          181 R-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL----------------------------YKPRLAS  231 (267)
T ss_dssp             C-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC----------------------------CCCTTSC
T ss_pred             C-ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC----------------------------CCCccCc
Confidence            5 6999999999999999998555558887777766665442111                            1223478


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      +.+.+++.+||+.||.+|||+.+++++
T Consensus       232 ~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          232 THVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999999873

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.6e-43  Score=288.39  Aligned_cols=235  Identities=21%  Similarity=0.288  Sum_probs=190.6

Q ss_pred             eeeeeeCCC---CceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeee-eeCCeEEEEEecCcc-cHHHHHHh
Q psy6044           2 FTSGVDRTP---NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVL-HSEKKLTLVFEHCDQ-DLKKYFDS   76 (282)
Q Consensus         2 vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~-~~~~~~~iv~e~~~g-~l~~~~~~   76 (282)
                      ||+|.+..+   +..+|+|.+...........+.+|+.++++++||||+++++++ ..++..++|+||++| ++.+.+..
T Consensus        41 Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~  120 (298)
T 3f66_A           41 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN  120 (298)
T ss_dssp             EEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHC
T ss_pred             EEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHh
Confidence            899986543   3468999887644444456788999999999999999999985 456688999999986 67676665


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc----cccccccccccccC
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV----KCYSAEVVTLWYRP  152 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~~a  152 (282)
                      ....+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+.......    .......+++.|+|
T Consensus       121 ~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~a  200 (298)
T 3f66_A          121 ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA  200 (298)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSC
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccC
Confidence            56679999999999999999999999999999999999999999999999999997664322    12233445678999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       153 PE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      ||.+.+.. ++.++|+||||+++|++++|+.|+|......+....+......                            
T Consensus       201 PE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------  251 (298)
T 3f66_A          201 LESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL----------------------------  251 (298)
T ss_dssp             HHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC----------------------------
T ss_pred             hHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC----------------------------
Confidence            99997766 6999999999999999999888888887777666655442211                            


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ..+..+++.+.++|.+||+.||.+|||+.++++
T Consensus       252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          252 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            122447889999999999999999999999987

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.7e-43  Score=292.01  Aligned_cols=235  Identities=19%  Similarity=0.276  Sum_probs=183.1

Q ss_pred             eeeeeeCCCCceE----EEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHh
Q psy6044           2 FTSGVDRTPNTAL----AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDS   76 (282)
Q Consensus         2 vy~a~~~~~~~~v----aiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~   76 (282)
                      ||+|++..+|+.+    |+|.+...........+.+|+.++++++||||+++++++.++. .++|++++. |++.+.+..
T Consensus        31 Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~  109 (327)
T 3poz_A           31 VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE  109 (327)
T ss_dssp             EEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHH
T ss_pred             EEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHh
Confidence            8999998888765    6776655444455678999999999999999999999998765 667788876 678888777


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--ccccccccccccChh
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--CYSAEVVTLWYRPPD  154 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE  154 (282)
                      ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........  ......++..|+|||
T Consensus       110 ~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE  189 (327)
T 3poz_A          110 HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE  189 (327)
T ss_dssp             STTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHH
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChH
Confidence            677899999999999999999999999999999999999999999999999999977643322  222334577899999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      .+.+.. ++.++||||||+++|++++++.++|.+....+....+.....                            ...
T Consensus       190 ~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~  240 (327)
T 3poz_A          190 SILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER----------------------------LPQ  240 (327)
T ss_dssp             HHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----------------------------CCC
T ss_pred             HhccCC-CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC----------------------------CCC
Confidence            998766 799999999999999999834444777666665554443211                            112


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      +...+..+.+++.+||+.||.+|||+.+++++
T Consensus       241 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          241 PPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             CccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            34578999999999999999999999999874

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.8e-43  Score=290.39  Aligned_cols=234  Identities=23%  Similarity=0.336  Sum_probs=185.1

Q ss_pred             eeeeeeCCCC----ceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHh
Q psy6044           2 FTSGVDRTPN----TALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDS   76 (282)
Q Consensus         2 vy~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~   76 (282)
                      ||+|.++.++    ..||+|++...........+.+|+.++++++||||+++++++.+.+..++||||++| ++.+.+..
T Consensus        60 Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  139 (333)
T 1mqb_A           60 VYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE  139 (333)
T ss_dssp             EEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH
T ss_pred             EEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHh
Confidence            8999876654    459999987644333455788999999999999999999999999999999999986 66666666


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc---ccccccccccccCh
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK---CYSAEVVTLWYRPP  153 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~aP  153 (282)
                      ..+.+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||.+........   ......++..|+||
T Consensus       140 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  219 (333)
T 1mqb_A          140 KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP  219 (333)
T ss_dssp             TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCH
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCc
Confidence            567899999999999999999999999999999999999999999999999999977643221   11223346789999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      |.+.+.. ++.++||||||+++|++++ |..| |......+....+......                            
T Consensus       220 E~~~~~~-~~~~~Di~slG~il~ellt~g~~p-f~~~~~~~~~~~~~~~~~~----------------------------  269 (333)
T 1mqb_A          220 EAISYRK-FTSASDVWSFGIVMWEVMTYGERP-YWELSNHEVMKAINDGFRL----------------------------  269 (333)
T ss_dssp             HHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCT-TTTCCHHHHHHHHHTTCCC----------------------------
T ss_pred             hhcccCC-CCchhhhHHHHHHHHHHHcCCCCC-cccCCHHHHHHHHHCCCcC----------------------------
Confidence            9997766 7999999999999999998 5555 7776766666655442111                            


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ..+..+++.+.++|.+||+.||.+|||+.++++
T Consensus       270 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  302 (333)
T 1mqb_A          270 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  302 (333)
T ss_dssp             CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            112357899999999999999999999999987

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.5e-43  Score=289.89  Aligned_cols=235  Identities=20%  Similarity=0.257  Sum_probs=181.2

Q ss_pred             eeeeeeCCCCceEEEeeeecCC--CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG--NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      ||+|.+..+|+.||+|++....  .......+.+|+.++++++||||+++++++..++..++|+||++| ++.+.+. ..
T Consensus        50 Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~  128 (309)
T 2h34_A           50 VYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLR-RQ  128 (309)
T ss_dssp             EEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHH-HH
T ss_pred             EEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHH-hc
Confidence            8999999999999999987632  222246788999999999999999999999999999999999986 5555554 46


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~  157 (282)
                      +.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... .......+++.|+|||.+.
T Consensus       129 ~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  208 (309)
T 2h34_A          129 GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS  208 (309)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHc
Confidence            789999999999999999999999999999999999999999999999999987654332 2223456788999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|+||||+++|++++|..| |...........+ .....                         ........
T Consensus       209 ~~~-~~~~~Di~slG~il~~l~~g~~p-f~~~~~~~~~~~~-~~~~~-------------------------~~~~~~~~  260 (309)
T 2h34_A          209 ESH-ATYRADIYALTCVLYECLTGSPP-YQGDQLSVMGAHI-NQAIP-------------------------RPSTVRPG  260 (309)
T ss_dssp             C-----CCCHHHHHHHHHHHHHHSSCS-SCSCHHHHHHHHH-HSCCC-------------------------CGGGTSTT
T ss_pred             CCC-CCchHhHHHHHHHHHHHHHCCCC-CCCchHHHHHHHh-ccCCC-------------------------CccccCCC
Confidence            765 68999999999999999998877 5554443222222 21100                         12233456


Q ss_pred             CCHHHHHHHHHhcccCCCCCC-CHHHHhc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRM-SAEDAMS  265 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rp-s~~~ll~  265 (282)
                      +++.+.++|.+||+.||++|| |++++++
T Consensus       261 ~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          261 IPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             CCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             CCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            899999999999999999999 8888876

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.5e-43  Score=294.34  Aligned_cols=241  Identities=18%  Similarity=0.260  Sum_probs=191.9

Q ss_pred             Ceeeee-----eCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHH
Q psy6044           1 MFTSGV-----DRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYF   74 (282)
Q Consensus         1 ~vy~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~   74 (282)
                      .||+|+     +..+++.||+|++...........+.+|+.++++++||||+++++++.+....++||||++ |++.+.+
T Consensus        45 ~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l  124 (327)
T 2yfx_A           45 EVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL  124 (327)
T ss_dssp             CEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHH
T ss_pred             eEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHH
Confidence            389998     5678999999999754444445678899999999999999999999999999999999996 5777766


Q ss_pred             HhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC---CCcEEEEecCCccccCCCc--ccccc
Q psy6044          75 DSLN------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK---NGELKLADFGLARAFGIPV--KCYSA  143 (282)
Q Consensus        75 ~~~~------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~---~~~~~l~df~~~~~~~~~~--~~~~~  143 (282)
                      ....      ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.   +..++|+|||.+.......  .....
T Consensus       125 ~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  204 (327)
T 2yfx_A          125 RETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC  204 (327)
T ss_dssp             HHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCG
T ss_pred             HhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCC
Confidence            6543      34899999999999999999999999999999999999984   4469999999986543221  22233


Q ss_pred             ccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCC
Q psy6044         144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFP  223 (282)
Q Consensus       144 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (282)
                      ..+++.|+|||.+.+.. ++.++||||||+++|+|++++.++|......+....+.....                    
T Consensus       205 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--------------------  263 (327)
T 2yfx_A          205 AMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR--------------------  263 (327)
T ss_dssp             GGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--------------------
T ss_pred             cCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC--------------------
Confidence            45678899999997665 699999999999999999855555877777766665544211                    


Q ss_pred             CCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q psy6044         224 MYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS  270 (282)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  270 (282)
                              ...+..+++.+.++|.+||+.||.+|||+.+++++.|+-
T Consensus       264 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          264 --------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                    112345789999999999999999999999999988764

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.4e-43  Score=292.39  Aligned_cols=236  Identities=25%  Similarity=0.377  Sum_probs=191.2

Q ss_pred             eeeeeeC-------CCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHH
Q psy6044           2 FTSGVDR-------TPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKK   72 (282)
Q Consensus         2 vy~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~   72 (282)
                      ||+|.+.       .++..||+|++...........+.+|+.+++++ +||||+++++++.+.+..++|+||++| ++.+
T Consensus        51 Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  130 (334)
T 2pvf_A           51 VVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE  130 (334)
T ss_dssp             EEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHH
T ss_pred             EEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHH
Confidence            8999875       467899999987644444456788999999999 999999999999999999999999976 6666


Q ss_pred             HHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC
Q psy6044          73 YFDSLN---------------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP  137 (282)
Q Consensus        73 ~~~~~~---------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~  137 (282)
                      .+....               ..+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||.+......
T Consensus       131 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  210 (334)
T 2pvf_A          131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI  210 (334)
T ss_dssp             HHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTT
T ss_pred             HHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEcccccccccccc
Confidence            665432               23899999999999999999999999999999999999999999999999999776533


Q ss_pred             c--cccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCC
Q psy6044         138 V--KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNL  215 (282)
Q Consensus       138 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  215 (282)
                      .  .......+++.|+|||.+.+.. ++.++||||||+++|+|++++.++|.+....+....+.....            
T Consensus       211 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~------------  277 (334)
T 2pvf_A          211 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR------------  277 (334)
T ss_dssp             SSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC------------
T ss_pred             ccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCC------------
Confidence            2  1223334577899999997665 699999999999999999844555777777777666655321            


Q ss_pred             CCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         216 LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                                      ...+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       278 ----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          278 ----------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                            11234578999999999999999999999999873

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-42  Score=289.21  Aligned_cols=234  Identities=19%  Similarity=0.281  Sum_probs=184.7

Q ss_pred             eeeeeeCCCCceE----EEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHh
Q psy6044           2 FTSGVDRTPNTAL----AIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDS   76 (282)
Q Consensus         2 vy~a~~~~~~~~v----aiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~   76 (282)
                      ||+|.+..+|+.+    |+|.+...........+.+|+.++++++||||+++++++..+. .+++++++. |++.+.+..
T Consensus        31 Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~  109 (327)
T 3lzb_A           31 VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE  109 (327)
T ss_dssp             EEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHH
T ss_pred             EEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHh
Confidence            8999999998876    5555544444445678899999999999999999999998766 677778776 578888877


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--ccccccccccccChh
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--CYSAEVVTLWYRPPD  154 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE  154 (282)
                      ..+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........  ......+++.|+|||
T Consensus       110 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE  189 (327)
T 3lzb_A          110 HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE  189 (327)
T ss_dssp             TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHH
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHH
Confidence            677899999999999999999999999999999999999999999999999999977643322  222334567899999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      .+.+.. ++.++||||||+++|+|++++.++|.+....+....+.....                            ...
T Consensus       190 ~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~  240 (327)
T 3lzb_A          190 SILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER----------------------------LPQ  240 (327)
T ss_dssp             HHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----------------------------CCC
T ss_pred             HHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC----------------------------CCC
Confidence            998766 799999999999999999844455777776666555544211                            112


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      +..++..+.++|++||+.||.+|||+.++++
T Consensus       241 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          241 PPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            3458899999999999999999999999997

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5e-43  Score=289.51  Aligned_cols=237  Identities=20%  Similarity=0.287  Sum_probs=182.5

Q ss_pred             CeeeeeeCC---CCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC-----eEEEEEecCcc-cH
Q psy6044           1 MFTSGVDRT---PNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK-----KLTLVFEHCDQ-DL   70 (282)
Q Consensus         1 ~vy~a~~~~---~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~-----~~~iv~e~~~g-~l   70 (282)
                      .||+|.+..   ++..||+|++... ......+.+.+|+.++++++||||+++++++.+..     ..++|+||+++ ++
T Consensus        49 ~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L  128 (313)
T 3brb_A           49 SVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDL  128 (313)
T ss_dssp             CEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBH
T ss_pred             EEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCH
Confidence            389998765   5668999998763 23333466889999999999999999999998754     45999999986 66


Q ss_pred             HHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc--ccccc
Q psy6044          71 KKYFDS-----LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--KCYSA  143 (282)
Q Consensus        71 ~~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~  143 (282)
                      .+.+..     ....+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||.+.......  .....
T Consensus       129 ~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  208 (313)
T 3brb_A          129 HTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRI  208 (313)
T ss_dssp             HHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC--------------
T ss_pred             HHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccc
Confidence            665532     23569999999999999999999999999999999999999999999999999987664322  12223


Q ss_pred             ccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCC
Q psy6044         144 EVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFP  223 (282)
Q Consensus       144 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (282)
                      ..+++.|+|||.+.+.. ++.++|+||||+++|+|++++.++|......+....+.....                    
T Consensus       209 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--------------------  267 (313)
T 3brb_A          209 AKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR--------------------  267 (313)
T ss_dssp             --CCGGGSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--------------------
T ss_pred             cCCCccccCchhhcCCC-ccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC--------------------
Confidence            34577899999998766 799999999999999999966666887777666665544211                    


Q ss_pred             CCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         224 MYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                              ...+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       268 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          268 --------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             --------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             --------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                    11234588999999999999999999999999873

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=6.8e-43  Score=305.26  Aligned_cols=234  Identities=23%  Similarity=0.340  Sum_probs=195.0

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHhcC-
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLN-   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~~-   78 (282)
                      .||+|.++.++..||||++....  ...+.+.+|+.++++++||||+++++++.+....++||||++ |++.+.+.... 
T Consensus       235 ~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~  312 (495)
T 1opk_A          235 EVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR  312 (495)
T ss_dssp             SEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCT
T ss_pred             EEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCc
Confidence            38999999999999999987532  235779999999999999999999999999999999999998 57777776533 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~  157 (282)
                      ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....... .......++..|+|||.+.
T Consensus       313 ~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~  392 (495)
T 1opk_A          313 QEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA  392 (495)
T ss_dssp             TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHh
Confidence            459999999999999999999999999999999999999999999999999998764332 2222334467899999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      ... ++.++||||||+++|+|++++.++|.+.+..+....+.....                            ...+..
T Consensus       393 ~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~  443 (495)
T 1opk_A          393 YNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR----------------------------MERPEG  443 (495)
T ss_dssp             HCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC----------------------------CCCCTT
T ss_pred             cCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------------------------CCCCCC
Confidence            665 799999999999999999855555887776666655543211                            112345


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      +++.+.+||.+||+.||.+|||+.++++
T Consensus       444 ~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          444 CPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            8899999999999999999999999987

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=302.26  Aligned_cols=259  Identities=20%  Similarity=0.276  Sum_probs=191.8

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC--eEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK--KLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~--~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      ||+|+++.+|+.||||++.........+.+.+|++++++++||||+++++++....  ..++||||++| ++.+.+....
T Consensus        25 Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~  104 (396)
T 4eut_A           25 VFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS  104 (396)
T ss_dssp             EEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGG
T ss_pred             EEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhh
Confidence            89999999999999999987444444577889999999999999999999998765  78999999975 5555554422


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE----cCCCcEEEEecCCccccCCCccccccccccccccC
Q psy6044          79 --GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI----NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRP  152 (282)
Q Consensus        79 --~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~----~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~a  152 (282)
                        ..+++..++.++.||+.||.|||+.||+|+||||+||++    +.++.++|+|||.+....... ......+++.|+|
T Consensus       105 ~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~-~~~~~~gt~~y~a  183 (396)
T 4eut_A          105 NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLH  183 (396)
T ss_dssp             GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG-GSSCSSSCCTTCC
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC-ccccccCCccccC
Confidence              239999999999999999999999999999999999999    777889999999998765432 3334567999999


Q ss_pred             hhhhcCC-------CCCCchhhHHHHHHHHHHHHhcCCCCCCCC---ChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCC
Q psy6044         153 PDVLFGA-------KLYTTSIDMWSAGCIFAELANAGRPLFPGS---DVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPF  222 (282)
Q Consensus       153 PE~~~~~-------~~~~~~~Di~slG~ll~~ll~~~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (282)
                      ||.+...       ..++.++||||||+++|+|++|..|+....   ...+.+..+..   ..+...+.......+... 
T Consensus       184 PE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~---~~p~~~~~~~~~~~~~~~-  259 (396)
T 4eut_A          184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT---GKPSGAISGVQKAENGPI-  259 (396)
T ss_dssp             HHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH---SCCTTCCEEEECSTTCCE-
T ss_pred             HHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc---CCCcccchhheeccCCCc-
Confidence            9998541       236789999999999999999988854332   23334444333   222222211111000000 


Q ss_pred             CCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         223 PMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ...........+...+++.+.++|++||+.||++|||+.++++
T Consensus       260 ~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          260 DWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             EEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             ccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            0000000112234557788999999999999999999999865

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-43  Score=297.53  Aligned_cols=235  Identities=22%  Similarity=0.288  Sum_probs=182.7

Q ss_pred             eeeeeeCCC---CceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeee-eCCeEEEEEecCcc-cHHHHHHh
Q psy6044           2 FTSGVDRTP---NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLH-SEKKLTLVFEHCDQ-DLKKYFDS   76 (282)
Q Consensus         2 vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~-~~~~~~iv~e~~~g-~l~~~~~~   76 (282)
                      ||+|++..+   +..||+|.+...........+.+|+.++++++||||+++++++. .++..++||||++| ++.+.+..
T Consensus       105 Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  184 (373)
T 3c1x_A          105 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN  184 (373)
T ss_dssp             EEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHC
T ss_pred             EEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhh
Confidence            899987543   35689998876444445577899999999999999999999865 45688999999986 77777666


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc----cccccccccccccC
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV----KCYSAEVVTLWYRP  152 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~~a  152 (282)
                      ....+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......    .......+++.|+|
T Consensus       185 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~a  264 (373)
T 3c1x_A          185 ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA  264 (373)
T ss_dssp             TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSC
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccC
Confidence            56679999999999999999999999999999999999999999999999999997653221    11223345678999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       153 PE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      ||.+.+.. ++.++||||||+++|++++++.|+|...+..+....+......                            
T Consensus       265 PE~~~~~~-~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~----------------------------  315 (373)
T 3c1x_A          265 LESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL----------------------------  315 (373)
T ss_dssp             HHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC----------------------------
T ss_pred             hHHhcCCC-CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC----------------------------
Confidence            99997766 7999999999999999999888888877666555544332111                            


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ..+..+++.+.++|.+||+.||.+|||+.++++
T Consensus       316 ~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~  348 (373)
T 3c1x_A          316 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  348 (373)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            122457899999999999999999999999987

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.3e-42  Score=282.46  Aligned_cols=236  Identities=19%  Similarity=0.308  Sum_probs=175.9

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      ||+|++..   .+|+|++... ........+.+|+.++++++||||++++++. .....++|+||++| ++.+.+.....
T Consensus        40 Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~  115 (289)
T 3og7_A           40 VYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASET  115 (289)
T ss_dssp             EEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC--
T ss_pred             EEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccC
Confidence            89998643   5999998763 2333456788999999999999999999965 55668999999975 66666656567


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC--ccccccccccccccChhhhc
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~  157 (282)
                      .+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+......  ........+++.|+|||.+.
T Consensus       116 ~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  195 (289)
T 3og7_A          116 KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR  195 (289)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhc
Confidence            7999999999999999999999999999999999999999999999999998765421  22223346789999999986


Q ss_pred             --CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         158 --GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       158 --~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                        ....++.++||||||+++|++++|..|+............+......+                        ......
T Consensus       196 ~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~  251 (289)
T 3og7_A          196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP------------------------DLSKVR  251 (289)
T ss_dssp             ----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC------------------------CTTSSC
T ss_pred             ccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc------------------------chhhcc
Confidence              233478899999999999999998888444444444444443322111                        122234


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ..+++.+.+||..||+.||.+|||+.++++
T Consensus       252 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          252 SNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            568899999999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=7.6e-43  Score=284.42  Aligned_cols=231  Identities=23%  Similarity=0.392  Sum_probs=189.7

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeee----------------CCeEEEEEe
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHS----------------EKKLTLVFE   64 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~----------------~~~~~iv~e   64 (282)
                      .||+|.+..+|+.||+|++...     ...+.+|+.++++++||||+++++++..                ....++|||
T Consensus        26 ~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e  100 (284)
T 2a19_B           26 QVFKAKHRIDGKTYVIKRVKYN-----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQME  100 (284)
T ss_dssp             CEEEEEETTTCCEEEEEEEECC-----SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEEC
T ss_pred             EEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEe
Confidence            4899999999999999998753     2578899999999999999999998864                456899999


Q ss_pred             cCcc-cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccc
Q psy6044          65 HCDQ-DLKKYFDSL-NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS  142 (282)
Q Consensus        65 ~~~g-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  142 (282)
                      |++| ++.+.+... ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  179 (284)
T 2a19_B          101 FCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG-KRT  179 (284)
T ss_dssp             CCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCS-CCC
T ss_pred             ccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccc-ccc
Confidence            9986 777766543 3679999999999999999999999999999999999999999999999999988765432 223


Q ss_pred             cccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCC
Q psy6044         143 AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPF  222 (282)
Q Consensus       143 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (282)
                      ...+++.|+|||.+.+.. ++.++|+||||+++|+|++|..|++..   ......+..                      
T Consensus       180 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~~~~~----------------------  233 (284)
T 2a19_B          180 RSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAFET---SKFFTDLRD----------------------  233 (284)
T ss_dssp             CCCSCCTTSCHHHHHCSC-CCTHHHHHHHHHHHHHHHSCCSSHHHH---HHHHHHHHT----------------------
T ss_pred             ccCCcccccChhhhccCC-CcchhhhHHHHHHHHHHHhcCCcchhH---HHHHHHhhc----------------------
Confidence            446789999999998776 699999999999999999888774321   111111111                      


Q ss_pred             CCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         223 PMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                               ...+..+++.+.++|.+||+.||.+|||+.+++++.|.-.-
T Consensus       234 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          234 ---------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             ---------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             ---------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence                     01223478999999999999999999999999998776543

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.1e-42  Score=299.33  Aligned_cols=242  Identities=26%  Similarity=0.372  Sum_probs=178.3

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      ||.+ ...+|+.||||++...    ..+.+.+|+.+++++ +||||+++++++.+++..++|+||++|++.+.+......
T Consensus        31 V~~~-~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~  105 (434)
T 2rio_A           31 VVFQ-GSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVS  105 (434)
T ss_dssp             EEEE-EESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHTC---
T ss_pred             EEEE-EEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCCCCHHHHHhccCCC
Confidence            5544 3467999999998752    134678899999876 899999999999999999999999999888877653221


Q ss_pred             ------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC-------------CcEEEEecCCccccCCCcc--
Q psy6044          81 ------IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-------------GELKLADFGLARAFGIPVK--  139 (282)
Q Consensus        81 ------~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~-------------~~~~l~df~~~~~~~~~~~--  139 (282)
                            .++..++.++.||+.||.|||++||+|+||||+||+++.+             +.++|+|||++........  
T Consensus       106 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~  185 (434)
T 2rio_A          106 DENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF  185 (434)
T ss_dssp             ---------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC-----
T ss_pred             chhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccc
Confidence                  1333457899999999999999999999999999999754             4899999999987654322  


Q ss_pred             --ccccccccccccChhhhcC------CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCC
Q psy6044         140 --CYSAEVVTLWYRPPDVLFG------AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWP  211 (282)
Q Consensus       140 --~~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  211 (282)
                        ......+++.|+|||.+.+      ...++.++|||||||++|+|++++.++|......+  ..+.......+..   
T Consensus       186 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~---  260 (434)
T 2rio_A          186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEM---  260 (434)
T ss_dssp             ---------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCC---
T ss_pred             eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccc---
Confidence              1233467999999999965      23479999999999999999984444465544333  2222211111000   


Q ss_pred             CCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         212 GMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                                         .......+++++.++|.+||+.||.+|||+.++++||||...
T Consensus       261 -------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~  302 (434)
T 2rio_A          261 -------------------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK  302 (434)
T ss_dssp             -------------------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred             -------------------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence                               000123467889999999999999999999999999999754

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=9.1e-44  Score=315.48  Aligned_cols=267  Identities=22%  Similarity=0.327  Sum_probs=196.1

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeee------CCeEEEEEecCcc-cHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHS------EKKLTLVFEHCDQ-DLKKY   73 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~------~~~~~iv~e~~~g-~l~~~   73 (282)
                      .||+|.+..+|+.||||++...........+.+|+.++++++||||+++++++..      .+..++||||++| ++.+.
T Consensus        29 ~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~  108 (676)
T 3qa8_A           29 YVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKY  108 (676)
T ss_dssp             BCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHH
T ss_pred             EEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHH
Confidence            3899999999999999998764444445678899999999999999999999765      6788999999965 66665


Q ss_pred             HHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc---EEEEecCCccccCCCccccccccccc
Q psy6044          74 FDSLN--GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVKCYSAEVVTL  148 (282)
Q Consensus        74 ~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~  148 (282)
                      +....  ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.   ++|+|||.+....... ......+++
T Consensus       109 L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~-~~~~~~gt~  187 (676)
T 3qa8_A          109 LNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTEFVGTL  187 (676)
T ss_dssp             HHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC-CCCCCCSCC
T ss_pred             HHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccccccccc-ccccccCCc
Confidence            55432  25899999999999999999999999999999999999997765   9999999998765332 234457789


Q ss_pred             cccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCC-CCCCCC
Q psy6044         149 WYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP-FPMYHP  227 (282)
Q Consensus       149 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  227 (282)
                      .|+|||.+.+.. ++.++|+||||+++|++++|..|+............+    ......   .......... ......
T Consensus       188 ~Y~APE~l~~~~-~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i----~~~~~~---~~~~~~~l~g~~~~~~~  259 (676)
T 3qa8_A          188 QYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV----REKSNE---HIVVYDDLTGAVKFSSV  259 (676)
T ss_dssp             TTCSSCSSCCSC-CSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTC----C---------CCSCCCCSSSCCCCSS
T ss_pred             ccCChHHhccCC-CCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhh----hcccch---hhhhhhhhccccccccc
Confidence            999999997766 7999999999999999999988855443221110000    000000   0000000000 000011


Q ss_pred             CCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         228 SMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       228 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      ..........+++.+.++|+.||..||++|||+.++++||||+.++.-.
T Consensus       260 lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          260 LPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             SCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             cCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence            1122334556889999999999999999999999999999999876543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.3e-42  Score=282.70  Aligned_cols=234  Identities=20%  Similarity=0.266  Sum_probs=186.2

Q ss_pred             eeeeeeCC---CCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc
Q psy6044           2 FTSGVDRT---PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL   77 (282)
Q Consensus         2 vy~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~   77 (282)
                      ||+|++..   ++..||+|++.........+.+.+|+.+++.++||||+++++++.++ ..++|+||++| ++.+.+...
T Consensus        28 Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~  106 (281)
T 3cc6_A           28 VYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERN  106 (281)
T ss_dssp             EEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHH
T ss_pred             EEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhc
Confidence            89998543   45579999987644444457788999999999999999999998754 46899999985 677777666


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccChhhh
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~  156 (282)
                      ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........ ......+++.|+|||.+
T Consensus       107 ~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~  186 (281)
T 3cc6_A          107 KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI  186 (281)
T ss_dssp             TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHH
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhh
Confidence            67799999999999999999999999999999999999999999999999999876643321 22333457789999999


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         157 FGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       157 ~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      .+.. ++.++|+||||+++|++++ |..| |......+....+......                            ..+
T Consensus       187 ~~~~-~~~~~Di~slG~il~~llt~g~~p-~~~~~~~~~~~~~~~~~~~----------------------------~~~  236 (281)
T 3cc6_A          187 NFRR-FTTASDVWMFAVCMWEILSFGKQP-FFWLENKDVIGVLEKGDRL----------------------------PKP  236 (281)
T ss_dssp             HHCC-CCHHHHHHHHHHHHHHHHTTTCCT-TTTSCGGGHHHHHHHTCCC----------------------------CCC
T ss_pred             ccCC-CCchhccHHHHHHHHHHHhCCCCC-cccCChHHHHHHHhcCCCC----------------------------CCC
Confidence            7665 6999999999999999998 6666 5555555555554442111                            122


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      ..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            3478999999999999999999999999874

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.4e-43  Score=290.11  Aligned_cols=254  Identities=19%  Similarity=0.206  Sum_probs=189.9

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC--
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN--   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~--   78 (282)
                      ||+|++ .+|+.||+|++...........+.+|+.+++.++||||+++++++.+++..++|+||++| ++.+.+....  
T Consensus        46 V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~  124 (326)
T 3uim_A           46 VYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPES  124 (326)
T ss_dssp             EEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTT
T ss_pred             EEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhcccc
Confidence            899986 469999999998755455556799999999999999999999999999999999999976 6666555432  


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccCh
Q psy6044          79 -GEIDLDIVKSFMYQLLRGLAFCHSR---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPP  153 (282)
Q Consensus        79 -~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aP  153 (282)
                       ..+++..+..++.|++.||.+||+.   |++|+||||+||+++.++.++|+|||.+....... .......+++.|+||
T Consensus       125 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aP  204 (326)
T 3uim_A          125 QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP  204 (326)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCH
Confidence             2499999999999999999999999   99999999999999999999999999998765332 223334579999999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCC----CCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFP----GSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSM  229 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
                      |.+.+.. ++.++||||||+++|+|++|..|+..    ...............   ......            ......
T Consensus       205 E~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~------------~~~~~~  268 (326)
T 3uim_A          205 EYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL---KEKKLE------------ALVDVD  268 (326)
T ss_dssp             HHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT---SSCCST------------TSSCTT
T ss_pred             HHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh---hchhhh------------hhcChh
Confidence            9997766 69999999999999999999888421    111111111111100   000000            000011


Q ss_pred             CccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      .........+..+.+++..||+.||.+|||+.++++|-+-..+
T Consensus       269 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          269 LQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             CTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             hccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            1122344567889999999999999999999999997654444

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=7e-43  Score=288.91  Aligned_cols=235  Identities=23%  Similarity=0.388  Sum_probs=187.2

Q ss_pred             eeeee-----eCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCC-eEEEEEecCcc-cHHHH
Q psy6044           2 FTSGV-----DRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEK-KLTLVFEHCDQ-DLKKY   73 (282)
Q Consensus         2 vy~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~-~~~iv~e~~~g-~l~~~   73 (282)
                      ||+|.     +..+++.||+|++...........+.+|+.+++++ +||||+++++++...+ ..++|+||++| ++.+.
T Consensus        43 Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~  122 (316)
T 2xir_A           43 VIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY  122 (316)
T ss_dssp             EEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHH
T ss_pred             EEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHH
Confidence            88998     45678999999997644433456788999999999 7899999999988754 59999999986 66666


Q ss_pred             HHhcCCC---------------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc
Q psy6044          74 FDSLNGE---------------IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  138 (282)
Q Consensus        74 ~~~~~~~---------------~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~  138 (282)
                      +......               +++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||.+.......
T Consensus       123 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  202 (316)
T 2xir_A          123 LRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  202 (316)
T ss_dssp             HHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCT
T ss_pred             HHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCc
Confidence            6543322               8999999999999999999999999999999999999999999999999997664322


Q ss_pred             --cccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCC-hHHHHHHHHHHhCCCCCCCCCCCC
Q psy6044         139 --KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSD-VDDQLKRIFKLLGTPTEDTWPGMN  214 (282)
Q Consensus       139 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  214 (282)
                        .......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..| |.... .......+.....           
T Consensus       203 ~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p-~~~~~~~~~~~~~~~~~~~-----------  269 (316)
T 2xir_A          203 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCRRLKEGTR-----------  269 (316)
T ss_dssp             TSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCS-STTCCCSHHHHHHHHHTCC-----------
T ss_pred             cceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCC-CcccchhHHHHHHhccCcc-----------
Confidence              2223345577899999997766 6999999999999999998 5555 55544 3444444433211           


Q ss_pred             CCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         215 LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                                       ...+..+++.+.++|.+||+.||.+|||+.++++|
T Consensus       270 -----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          270 -----------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             -----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                             11234578999999999999999999999999985

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.3e-42  Score=289.49  Aligned_cols=243  Identities=21%  Similarity=0.321  Sum_probs=192.7

Q ss_pred             eeeeeeCCCCc-----eEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHHHH
Q psy6044           2 FTSGVDRTPNT-----ALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         2 vy~a~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~   74 (282)
                      ||+|.+..+++     .||+|++...........+.+|+.+++++ +||||+++++++.+++..++||||++| ++.+.+
T Consensus        62 Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l  141 (333)
T 2i1m_A           62 VVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL  141 (333)
T ss_dssp             EEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHH
T ss_pred             eEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHH
Confidence            89999887765     79999987644434456788999999999 899999999999999999999999975 777666


Q ss_pred             Hhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc--c
Q psy6044          75 DSL-------------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--K  139 (282)
Q Consensus        75 ~~~-------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~--~  139 (282)
                      ...             ...+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++.......  .
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  221 (333)
T 2i1m_A          142 RRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI  221 (333)
T ss_dssp             HHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSE
T ss_pred             HHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECcccccccccccccee
Confidence            543             3458999999999999999999999999999999999999999999999999997653221  1


Q ss_pred             ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCC
Q psy6044         140 CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDF  219 (282)
Q Consensus       140 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (282)
                      ......+++.|+|||.+.+.. ++.++||||||+++|+|++++.++|.+.................              
T Consensus       222 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--------------  286 (333)
T 2i1m_A          222 VKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM--------------  286 (333)
T ss_dssp             ECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCC--------------
T ss_pred             ecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCC--------------
Confidence            223344577899999987666 79999999999999999984555566655444444433322111              


Q ss_pred             CCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         220 KPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                                   ..+...++.+.++|..||+.||.+|||+.++++  +++++..
T Consensus       287 -------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~L~~~~~  326 (333)
T 2i1m_A          287 -------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS--FLQEQAQ  326 (333)
T ss_dssp             -------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHH
T ss_pred             -------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH--HHHHHHH
Confidence                         112346889999999999999999999999998  4554433

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.9e-41  Score=277.86  Aligned_cols=236  Identities=17%  Similarity=0.153  Sum_probs=189.0

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeee-eeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVL-HSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~-~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      ||+|++..+|+.||+|++....   ....+.+|+.+++.++|++++..+..+ ......++|+||++|++.+.+......
T Consensus        25 V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~  101 (296)
T 3uzp_A           25 IYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK  101 (296)
T ss_dssp             EEEEEETTTTEEEEEEEEESCS---SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTC
T ss_pred             EEEEEEcCCCcEEEEEEecCCc---chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEecCCCHHHHHHhhccC
Confidence            8999999999999999987532   345789999999999988866665554 567789999999988888888766778


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE---cCCCcEEEEecCCccccCCCcc-------ccccccccccc
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVK-------CYSAEVVTLWY  150 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~~  150 (282)
                      +++..++.++.||+.||.|||++|++|+||||+||++   +.++.++|+|||.+........       ......+++.|
T Consensus       102 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y  181 (296)
T 3uzp_A          102 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY  181 (296)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccccccccccccccccc
Confidence            9999999999999999999999999999999999999   4889999999999977653322       12345678999


Q ss_pred             cChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCC--ChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGS--DVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPS  228 (282)
Q Consensus       151 ~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
                      +|||.+.+.. ++.++||||||+++|+|++|..|+....  ...+....+.......                       
T Consensus       182 ~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------------------  237 (296)
T 3uzp_A          182 ASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-----------------------  237 (296)
T ss_dssp             CCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-----------------------
T ss_pred             CChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC-----------------------
Confidence            9999998776 7999999999999999999988854321  2222222222211110                       


Q ss_pred             CCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         229 MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       229 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                       ........+++.+.++|++||+.||.+|||++++++
T Consensus       238 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          238 -PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             -CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             -chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence             112233568999999999999999999999999987

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=9.6e-43  Score=285.48  Aligned_cols=237  Identities=22%  Similarity=0.303  Sum_probs=181.7

Q ss_pred             eeeee----eCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC--CeEEEEEecCcc-cHHHHH
Q psy6044           2 FTSGV----DRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE--KKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         2 vy~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~--~~~~iv~e~~~g-~l~~~~   74 (282)
                      ||+|+    +..+|+.||+|++.... ......+.+|+.++++++||||+++++++...  ..+++||||++| ++.+.+
T Consensus        26 V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l  104 (295)
T 3ugc_A           26 VEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL  104 (295)
T ss_dssp             EEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHH
T ss_pred             EEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHH
Confidence            78888    77899999999987532 22345788999999999999999999998653  568999999965 777777


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc---ccccccccccccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---KCYSAEVVTLWYR  151 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~  151 (282)
                      ......+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+.......   .......++..|+
T Consensus       105 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~  184 (295)
T 3ugc_A          105 QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY  184 (295)
T ss_dssp             HHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGC
T ss_pred             HhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCcccee
Confidence            6655669999999999999999999999999999999999999999999999999998764332   1222334567799


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCh------------HHHHHHHHHHhCCCCCCCCCCCCCCCCC
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDV------------DDQLKRIFKLLGTPTEDTWPGMNLLPDF  219 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (282)
                      |||.+.+.. ++.++||||||+++|++++|..|+ .....            ..............              
T Consensus       185 aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------  248 (295)
T 3ugc_A          185 APESLTESK-FSVASDVWSFGVVLYELFTYIEKS-KSPPAEFMRMIGNDKQGQMIVFHLIELLKNN--------------  248 (295)
T ss_dssp             CHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTT-CSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT--------------
T ss_pred             CcHHhcCCC-CChHHHHHHHHHHHHHHHhccccc-CCChHHHHhhhcCccccchhHHHHHHHHhcc--------------
Confidence            999997776 799999999999999999988774 22111            11111111111100              


Q ss_pred             CCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         220 KPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                .....+..+++.+.++|+.||+.||++|||+.++++
T Consensus       249 ----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          249 ----------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             ----------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ----------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                      111223568899999999999999999999999986

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4.3e-42  Score=297.03  Aligned_cols=227  Identities=22%  Similarity=0.345  Sum_probs=186.2

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC-eEEEEEecCcc-cHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK-KLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~-~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      ||+|.+.  |+.||||++...   ...+.+.+|+.++++++||||+++++++.+.. ..++||||++| ++.+.+.....
T Consensus       209 V~~~~~~--~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~  283 (450)
T 1k9a_A          209 VMLGDYR--GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR  283 (450)
T ss_dssp             EEEEEET--TEEEEEEEESSC---TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCT
T ss_pred             EEEEEec--CCeEEEEEeCCc---hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCC
Confidence            7999874  789999998753   24678999999999999999999999987665 79999999975 77777766543


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          80 -EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 -~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                       .+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++.......   ....++..|+|||.+.+
T Consensus       284 ~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~~~~~~y~aPE~~~~  360 (450)
T 1k9a_A          284 SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALRE  360 (450)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCCTTTSCHHHHHS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc---cCCCCCcceeCHHHhcC
Confidence             37999999999999999999999999999999999999999999999999997654322   12245788999999987


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++||||||+++|+|++.+.++|......+....+..+..                            ...+..+
T Consensus       361 ~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~----------------------------~~~p~~~  411 (450)
T 1k9a_A          361 KK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK----------------------------MDAPDGC  411 (450)
T ss_dssp             SC-CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC----------------------------CCCCTTC
T ss_pred             CC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------------------------CCCCCcC
Confidence            76 799999999999999999844444777666666655544211                            1123458


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ++.+.++|.+||+.||.+|||+.++++
T Consensus       412 ~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          412 PPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            899999999999999999999999986

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.6e-42  Score=307.36  Aligned_cols=233  Identities=23%  Similarity=0.315  Sum_probs=188.7

Q ss_pred             eeeeeeC--CCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDR--TPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      ||+|.++  .++..||||++.........+.+.+|+.++++++||||+++++++.. +..++||||++| ++.+.+....
T Consensus       352 Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~  430 (613)
T 2ozo_A          352 VRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR  430 (613)
T ss_dssp             EEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCT
T ss_pred             EEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhcc
Confidence            8998765  45678999999875445556789999999999999999999999976 569999999976 5666666556


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc---ccccccccccccChhh
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK---CYSAEVVTLWYRPPDV  155 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~aPE~  155 (282)
                      ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++........   ......+++.|+|||.
T Consensus       431 ~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~  510 (613)
T 2ozo_A          431 EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC  510 (613)
T ss_dssp             TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhh
Confidence            6799999999999999999999999999999999999999999999999999987643321   1122234578999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELAN-AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      +.... ++.++||||||+++|+|++ |..| |.+.+..+....+..+..                            ...
T Consensus       511 ~~~~~-~~~~sDvwSlGv~l~ellt~G~~P-f~~~~~~~~~~~i~~~~~----------------------------~~~  560 (613)
T 2ozo_A          511 INFRK-FSSRSDVWSYGVTMWEALSYGQKP-YKKMKGPEVMAFIEQGKR----------------------------MEC  560 (613)
T ss_dssp             HHHCC-CCHHHHHHHHHHHHHHHHTTSCCT-TTTCCSHHHHHHHHTTCC----------------------------CCC
T ss_pred             hcCCC-CCcHHHHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHcCCC----------------------------CCC
Confidence            97665 7999999999999999998 5555 777777777666654321                            123


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      +..+++.+.++|..||+.||.+|||+.++++
T Consensus       561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             CCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            3468999999999999999999999999865

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.8e-42  Score=310.16  Aligned_cols=234  Identities=18%  Similarity=0.239  Sum_probs=187.8

Q ss_pred             eeee--eeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSG--VDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a--~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||+|  .++.+++.||||++.. .......+.+.+|+.++++++||||+++++++.. +..++||||++|+.+..+....
T Consensus       385 Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~  463 (635)
T 4fl3_A          385 VKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQN  463 (635)
T ss_dssp             EEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHC
T ss_pred             EEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhC
Confidence            8999  4567789999999986 3333345779999999999999999999999965 4588999999864444444557


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc---cccccccccccccChhh
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---KCYSAEVVTLWYRPPDV  155 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~aPE~  155 (282)
                      ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.......   .......++..|+|||.
T Consensus       464 ~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~  543 (635)
T 4fl3_A          464 RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC  543 (635)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhh
Confidence            789999999999999999999999999999999999999999999999999997664332   12222344678999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      +.... ++.++||||||+++|+|++++.++|.+....+....+.....                            ...+
T Consensus       544 ~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~----------------------------~~~p  594 (635)
T 4fl3_A          544 INYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER----------------------------MGCP  594 (635)
T ss_dssp             HHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------------------------CCCC
T ss_pred             hcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------------------------CCCC
Confidence            97766 799999999999999999834444888887777766655321                            1223


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ..+++.+.+||..||+.||++|||++++++
T Consensus       595 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          595 AGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            458899999999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.5e-41  Score=277.00  Aligned_cols=236  Identities=17%  Similarity=0.153  Sum_probs=187.9

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeee-eeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVL-HSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~-~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      ||+|++..+|+.||+|++....   ....+.+|+.+++.++|++++..+..+ ......++||||++|++.+.+......
T Consensus        25 V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~  101 (296)
T 4hgt_A           25 IYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK  101 (296)
T ss_dssp             EEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTSC
T ss_pred             EEEEEEcCCCceEEEEeecccc---cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEccCCCHHHHHHHhcCC
Confidence            8999999999999999876532   235789999999999988776666655 667889999999988888888776778


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE---cCCCcEEEEecCCccccCCCcc-------ccccccccccc
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVK-------CYSAEVVTLWY  150 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~~  150 (282)
                      +++..++.++.||+.||.|||++|++|+||||+||++   +.++.++|+|||.+........       ......+++.|
T Consensus       102 ~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y  181 (296)
T 4hgt_A          102 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY  181 (296)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGG
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccc
Confidence            9999999999999999999999999999999999999   7889999999999977643322       22345678999


Q ss_pred             cChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC--hHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSD--VDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPS  228 (282)
Q Consensus       151 ~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
                      +|||.+.+.. ++.++||||||+++|++++|..|+.....  .......+.......                       
T Consensus       182 ~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------------------  237 (296)
T 4hgt_A          182 ASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-----------------------  237 (296)
T ss_dssp             CCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-----------------------
T ss_pred             cchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-----------------------
Confidence            9999998776 79999999999999999999888543221  112222222211100                       


Q ss_pred             CCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         229 MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       229 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                       ........+++.+.++|..||+.||++|||++++++
T Consensus       238 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          238 -PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             -CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             -hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence             122233567999999999999999999999999987

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.4e-42  Score=289.57  Aligned_cols=242  Identities=12%  Similarity=0.128  Sum_probs=182.7

Q ss_pred             eeeeeeCCC-----CceEEEeeeecCCCC----------CCCccHHHHHHHHhhCCCCCccceeeeeeeC----CeEEEE
Q psy6044           2 FTSGVDRTP-----NTALAIKGTHLVGNE----------GVPSSALREICLLKELKHKNIVRLYDVLHSE----KKLTLV   62 (282)
Q Consensus         2 vy~a~~~~~-----~~~vaiK~~~~~~~~----------~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~----~~~~iv   62 (282)
                      ||+|.+..+     ++.||||++......          ........|+..++.++||||+++++++...    ...++|
T Consensus        51 Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv  130 (364)
T 3op5_A           51 IYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMI  130 (364)
T ss_dssp             EEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEE
T ss_pred             EEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEE
Confidence            899988765     689999998753210          0112334455566677899999999998865    568999


Q ss_pred             EecCcccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc--CCCcEEEEecCCccccCCCcc-
Q psy6044          63 FEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN--KNGELKLADFGLARAFGIPVK-  139 (282)
Q Consensus        63 ~e~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~--~~~~~~l~df~~~~~~~~~~~-  139 (282)
                      |||++|++.+.+....+.+++..++.++.||+.||.|||++||+|+||||+||+++  .++.++|+|||++........ 
T Consensus       131 ~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~  210 (364)
T 3op5_A          131 MDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH  210 (364)
T ss_dssp             EECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCC
T ss_pred             EeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcc
Confidence            99997788887777667899999999999999999999999999999999999999  889999999999976542211 


Q ss_pred             ------ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCC
Q psy6044         140 ------CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGM  213 (282)
Q Consensus       140 ------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  213 (282)
                            ......+|+.|+|||.+.+.. ++.++||||||+++|+|++|..|+.......................     
T Consensus       211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-----  284 (364)
T 3op5_A          211 KAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIAS-----  284 (364)
T ss_dssp             CCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHH-----
T ss_pred             cccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHH-----
Confidence                  112334799999999997776 79999999999999999999888543333333332222211100000     


Q ss_pred             CCCCCCCCCCCCCCCCCcccc--CccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         214 NLLPDFKPFPMYHPSMSFSQV--APKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                      .....  ...+++.+.+++..||+.||.+|||+.+|++
T Consensus       285 ----------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          285 ----------------LMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             ----------------HHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ----------------HHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence                            00000  1357899999999999999999999999886

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.2e-42  Score=278.80  Aligned_cols=229  Identities=15%  Similarity=0.193  Sum_probs=186.3

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC--CeEEEEEecCcc-cHHHHHHhc
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSE--KKLTLVFEHCDQ-DLKKYFDSL   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~--~~~~iv~e~~~g-~l~~~~~~~   77 (282)
                      ||+|++.  |+.||+|++... ......+.+.+|+.++++++||||+++++++.+.  +..++|+||++| ++.+.+...
T Consensus        26 V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  103 (271)
T 3kmu_A           26 LWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG  103 (271)
T ss_dssp             EEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSC
T ss_pred             EEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhc
Confidence            8999984  899999999863 2333346789999999999999999999999887  789999999985 776666553


Q ss_pred             CC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChh
Q psy6044          78 NG-EIDLDIVKSFMYQLLRGLAFCHSRN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPD  154 (282)
Q Consensus        78 ~~-~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE  154 (282)
                      .. .+++..++.++.||+.||.|||++|  ++|+||+|+||+++.++.++|+||++......     ....+++.|+|||
T Consensus       104 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-----~~~~~t~~y~aPE  178 (271)
T 3kmu_A          104 TNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-----PGRMYAPAWVAPE  178 (271)
T ss_dssp             SSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-----TTCBSCGGGSCHH
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc-----cCccCCccccChh
Confidence            33 4899999999999999999999999  99999999999999999999998887754332     2345688999999


Q ss_pred             hhcCCCC--CCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         155 VLFGAKL--YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       155 ~~~~~~~--~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      .+.+...  ++.++||||||+++|++++|..| |......+..........                           ..
T Consensus       179 ~~~~~~~~~~~~~~Di~slG~il~el~~g~~p-~~~~~~~~~~~~~~~~~~---------------------------~~  230 (271)
T 3kmu_A          179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVP-FADLSNMEIGMKVALEGL---------------------------RP  230 (271)
T ss_dssp             HHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCT-TTTSCHHHHHHHHHHSCC---------------------------CC
T ss_pred             hhccCCCCCCCchhhHHHHHHHHHHHHhCCCC-ccccChHHHHHHHHhcCC---------------------------CC
Confidence            9976532  33489999999999999998877 666666655554443211                           11


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ..+..+++.+.++|.+||+.||++|||++++++
T Consensus       231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          231 TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            233568999999999999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.5e-42  Score=287.30  Aligned_cols=237  Identities=14%  Similarity=0.129  Sum_probs=184.5

Q ss_pred             eeeeeeCC--------CCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccc---------------eeeeeee-CC
Q psy6044           2 FTSGVDRT--------PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVR---------------LYDVLHS-EK   57 (282)
Q Consensus         2 vy~a~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~---------------~~~~~~~-~~   57 (282)
                      ||+|++..        +++.||+|++...      ..+.+|+.++++++||||++               +++++.. +.
T Consensus        58 Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~  131 (352)
T 2jii_A           58 LYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDK  131 (352)
T ss_dssp             EEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTT
T ss_pred             EEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCc
Confidence            89999988        4899999998743      57899999999999999988               5667665 68


Q ss_pred             eEEEEEecCcccHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC--cEEEEecCCcccc
Q psy6044          58 KLTLVFEHCDQDLKKYFDSL-NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG--ELKLADFGLARAF  134 (282)
Q Consensus        58 ~~~iv~e~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~--~~~l~df~~~~~~  134 (282)
                      ..++||||+.|+|.+.+... ...+++..++.++.||+.||.|||++|++|+||||+||+++.++  .++|+|||++...
T Consensus       132 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~  211 (352)
T 2jii_A          132 YRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY  211 (352)
T ss_dssp             EEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCS
T ss_pred             EEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeec
Confidence            89999999977888777654 36799999999999999999999999999999999999999998  9999999999765


Q ss_pred             CCCcc-------ccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCC-ChHHHHHHHHHHhCCCC
Q psy6044         135 GIPVK-------CYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGS-DVDDQLKRIFKLLGTPT  206 (282)
Q Consensus       135 ~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~-~~~~~~~~~~~~~~~~~  206 (282)
                      .....       ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..|+.... ...............+.
T Consensus       212 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  290 (352)
T 2jii_A          212 CPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-PSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPG  290 (352)
T ss_dssp             SGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCC
T ss_pred             cCCCccccccccccccccCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChh
Confidence            43211       113346789999999997766 7999999999999999999988854443 33333333322221111


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         207 EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      . ..                   ........+++.+.++|..||+.||++|||++++++
T Consensus       291 ~-~~-------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          291 P-FV-------------------GPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             C-EE-------------------CTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             h-hh-------------------hhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            0 00                   000012357899999999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=6.2e-42  Score=286.65  Aligned_cols=241  Identities=15%  Similarity=0.109  Sum_probs=187.1

Q ss_pred             CeeeeeeCC---CCceEEEeeeecCCCC----------CCCccHHHHHHHHhhCCCCCccceeeeeee----CCeEEEEE
Q psy6044           1 MFTSGVDRT---PNTALAIKGTHLVGNE----------GVPSSALREICLLKELKHKNIVRLYDVLHS----EKKLTLVF   63 (282)
Q Consensus         1 ~vy~a~~~~---~~~~vaiK~~~~~~~~----------~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~----~~~~~iv~   63 (282)
                      .||+|++..   ++..+|+|+.......          .....+.+|+..++.++||||+++++++..    ....++||
T Consensus        52 ~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~  131 (345)
T 2v62_A           52 LIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVM  131 (345)
T ss_dssp             CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEE
T ss_pred             EEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEE
Confidence            489999987   8999999998753211          123446778888999999999999999988    78899999


Q ss_pred             ecCcccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC--cEEEEecCCccccCCCc---
Q psy6044          64 EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG--ELKLADFGLARAFGIPV---  138 (282)
Q Consensus        64 e~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~--~~~l~df~~~~~~~~~~---  138 (282)
                      ||+++++.+.+.. .+.+++..++.++.||+.||+|||+.||+|+||||+||+++.++  .++|+|||++.......   
T Consensus       132 e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~  210 (345)
T 2v62_A          132 ERLGIDLQKISGQ-NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK  210 (345)
T ss_dssp             ECEEEEHHHHCBG-GGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCC
T ss_pred             eccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccc
Confidence            9996666665544 45899999999999999999999999999999999999999887  99999999997653221   


Q ss_pred             ----cccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHh-CCCCCCCCCCC
Q psy6044         139 ----KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL-GTPTEDTWPGM  213 (282)
Q Consensus       139 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  213 (282)
                          .......+++.|+|||.+.+.. ++.++||||||+++|+|++|..|+................. ...+.      
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------  283 (345)
T 2v62_A          211 QYQENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQ------  283 (345)
T ss_dssp             CCCCCGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTH------
T ss_pred             cchhccccccCCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccH------
Confidence                1123446789999999998776 79999999999999999999888534333333222222211 11110      


Q ss_pred             CCCCCCCCCCCCCCCCCccccC--ccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         214 NLLPDFKPFPMYHPSMSFSQVA--PKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                      ......  ..+++.+.++|..||+.||.+|||++++++
T Consensus       284 ----------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          284 ----------------SVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             ----------------HHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ----------------HHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                            000111  158899999999999999999999999987

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=8e-42  Score=295.75  Aligned_cols=231  Identities=23%  Similarity=0.344  Sum_probs=190.3

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC-C
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-G   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~-~   79 (282)
                      ||+|.+. ++..||||++....  ...+.+.+|+.++++++||||+++++++. .+..++||||++| ++.+.+.... .
T Consensus       204 V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~  279 (454)
T 1qcf_A          204 VWMATYN-KHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGS  279 (454)
T ss_dssp             EEEEEET-TTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHH
T ss_pred             EEEEEEC-CccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCC
Confidence            8999985 47889999987532  34578999999999999999999999987 5678999999975 7777665432 3


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~  158 (282)
                      .+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++....... .......++..|+|||.+..
T Consensus       280 ~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~  359 (454)
T 1qcf_A          280 KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF  359 (454)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhcc
Confidence            68999999999999999999999999999999999999999999999999998764322 11223344678999999976


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++||||||+++|+|++++.++|.+.+..+....+......+                            .+..+
T Consensus       360 ~~-~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~  410 (454)
T 1qcf_A          360 GS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP----------------------------RPENC  410 (454)
T ss_dssp             CC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC----------------------------CCTTS
T ss_pred             CC-CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCCCC
Confidence            65 79999999999999999984555588888887777766542221                            12457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ++.+.++|.+||+.||.+|||++++++
T Consensus       411 ~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          411 PEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            899999999999999999999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.3e-41  Score=276.59  Aligned_cols=231  Identities=23%  Similarity=0.363  Sum_probs=186.9

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC-C
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN-G   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~-~   79 (282)
                      ||+|.+. ++..||+|++....  ...+.+.+|++++++++||||+++++++.+ +..++|+||++| ++.+.+.... .
T Consensus        29 Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~  104 (279)
T 1qpc_A           29 VWMGYYN-GHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI  104 (279)
T ss_dssp             EEEEEET-TTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHH
T ss_pred             EEEEEEc-CCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCC
Confidence            8999975 57889999987532  235678999999999999999999999874 458999999975 6655554322 2


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~  158 (282)
                      .+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+
T Consensus       105 ~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  184 (279)
T 1qpc_A          105 KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY  184 (279)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhcc
Confidence            699999999999999999999999999999999999999999999999999987653322 2223345678999999976


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||||+++|+|++++.++|.+....+....+.....                            ...+..+
T Consensus       185 ~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~  235 (279)
T 1qpc_A          185 GT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR----------------------------MVRPDNC  235 (279)
T ss_dssp             CE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------------------------CCCCTTC
T ss_pred             CC-CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC----------------------------CCCcccc
Confidence            55 689999999999999999855555887777776665544211                            1122457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ++.+.++|.+||+.||++|||+.++++
T Consensus       236 ~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          236 PEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            899999999999999999999999987

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.3e-42  Score=287.23  Aligned_cols=237  Identities=22%  Similarity=0.332  Sum_probs=186.1

Q ss_pred             eeeee----eCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeee--eCCeEEEEEecCcc-cHHHHH
Q psy6044           2 FTSGV----DRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLH--SEKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         2 vy~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~--~~~~~~iv~e~~~g-~l~~~~   74 (282)
                      ||+|+    +..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.  +....++||||++| ++.+.+
T Consensus        39 V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l  117 (327)
T 3lxl_A           39 VELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL  117 (327)
T ss_dssp             EEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHH
T ss_pred             EEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHH
Confidence            88998    67899999999987532 222456889999999999999999999886  45679999999965 666666


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc---cccccccccccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK---CYSAEVVTLWYR  151 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~  151 (282)
                      ......+++..++.++.||+.||++||+.|++|+||||+||+++.++.++|+|||.+........   ......++..|+
T Consensus       118 ~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~  197 (327)
T 3lxl_A          118 QRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY  197 (327)
T ss_dssp             HHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGS
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCcccccc
Confidence            66566799999999999999999999999999999999999999999999999999987653322   223345677899


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHH-----------HHHHHHHhCCCCCCCCCCCCCCCCCC
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQ-----------LKRIFKLLGTPTEDTWPGMNLLPDFK  220 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (282)
                      |||.+.+.. ++.++||||||+++|+|++|..|+... .....           ...+.......               
T Consensus       198 aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------  260 (327)
T 3lxl_A          198 APESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSP-SAEFLRMMGCERDVPALSRLLELLEEG---------------  260 (327)
T ss_dssp             CHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSH-HHHHHHHCC----CCHHHHHHHHHHTT---------------
T ss_pred             CHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccc-cchhhhhcccccccccHHHHHHHhhcc---------------
Confidence            999997765 699999999999999999988885332 11100           01111111000               


Q ss_pred             CCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         221 PFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                               .....+..+++.+.++|++||+.||.+|||+.++++
T Consensus       261 ---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  296 (327)
T 3lxl_A          261 ---------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP  296 (327)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                     111223568999999999999999999999999965

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.7e-42  Score=284.93  Aligned_cols=240  Identities=22%  Similarity=0.307  Sum_probs=184.1

Q ss_pred             eeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC--CeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           3 TSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE--KKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         3 y~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~--~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      |++.+..+|+.||||++...........+.+|+.++++++||||+++++++.+.  ..+++||||++| ++.+.+..  .
T Consensus        52 ~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~  129 (318)
T 3lxp_A           52 YDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR--H  129 (318)
T ss_dssp             ECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG--S
T ss_pred             EccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhh--C
Confidence            556677899999999998654334456789999999999999999999999874  689999999986 55554433  4


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc---ccccccccccccChhhh
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK---CYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~aPE~~  156 (282)
                      .+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||.+........   ......++..|+|||.+
T Consensus       130 ~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~  209 (318)
T 3lxp_A          130 SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL  209 (318)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHh
Confidence            599999999999999999999999999999999999999999999999999987654322   22334557789999999


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChH-----------HHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD-----------DQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMY  225 (282)
Q Consensus       157 ~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (282)
                      .+.. ++.++||||||+++|+|++|..|+ ......           .....+.......                    
T Consensus       210 ~~~~-~~~~~Di~slG~il~~ll~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------  267 (318)
T 3lxp_A          210 KEYK-FYYASDVWSFGVTLYELLTHCDSS-QSPPTKFLELIGIAQGQMTVLRLTELLERG--------------------  267 (318)
T ss_dssp             HHCE-EEHHHHHHHHHHHHHHHHTTTCGG-GSHHHHHHHHHCSCCHHHHHHHHHHHHHTT--------------------
T ss_pred             cCCC-CCcHHHHHHHHHHHHHHHhCCCcc-cccchhhhhhhcccccchhHHHHHHHHhcc--------------------
Confidence            7766 689999999999999999988874 322111           1111111111100                    


Q ss_pred             CCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         226 HPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       226 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                          .....+..+++.+.+||++||+.||.+|||+.++++  +|+.+
T Consensus       268 ----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~--~L~~l  308 (318)
T 3lxp_A          268 ----ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP--ILKTV  308 (318)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             ----cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH--HHHHH
Confidence                111223568899999999999999999999999996  44443

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6e-42  Score=285.68  Aligned_cols=232  Identities=24%  Similarity=0.384  Sum_probs=170.3

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCC-CCCccceeeeee--------eCCeEEEEEecCcccHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK-HKNIVRLYDVLH--------SEKKLTLVFEHCDQDLKK   72 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~--------~~~~~~iv~e~~~g~l~~   72 (282)
                      ||+|++..+|+.||+|++.... ......+.+|+.+++++. ||||+++++++.        ....+++++||++|++.+
T Consensus        44 V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~  122 (337)
T 3ll6_A           44 VYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVE  122 (337)
T ss_dssp             EEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCSEEHHH
T ss_pred             EEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecCCCHHH
Confidence            8999999999999999986532 223457889999999995 999999999983        445689999999999988


Q ss_pred             HHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc--------
Q psy6044          73 YFDS--LNGEIDLDIVKSFMYQLLRGLAFCHSRN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC--------  140 (282)
Q Consensus        73 ~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~--------  140 (282)
                      .+..  ..+.+++..++.++.||+.||.|||+.|  ++|+||||+||+++.++.++|+|||.+.........        
T Consensus       123 ~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  202 (337)
T 3ll6_A          123 FLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRA  202 (337)
T ss_dssp             HHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC----------
T ss_pred             HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccc
Confidence            8765  3567999999999999999999999999  999999999999999999999999999776532211        


Q ss_pred             ----cccccccccccChhhhc--CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCC
Q psy6044         141 ----YSAEVVTLWYRPPDVLF--GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN  214 (282)
Q Consensus       141 ----~~~~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  214 (282)
                          .....+++.|+|||.+.  ....++.++||||||+++|+|++|..|+ .........    .....          
T Consensus       203 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~-~~~~~~~~~----~~~~~----------  267 (337)
T 3ll6_A          203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF-EDGAKLRIV----NGKYS----------  267 (337)
T ss_dssp             ---------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------------CC----------
T ss_pred             cchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCC-cchhHHHhh----cCccc----------
Confidence                11334688899999983  2334789999999999999999998884 332221111    10000          


Q ss_pred             CCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         215 LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                                       .......+..+.+||++||+.||.+|||+.+++++
T Consensus       268 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  302 (337)
T 3ll6_A          268 -----------------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ  302 (337)
T ss_dssp             -----------------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                             01123466778999999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.1e-42  Score=288.52  Aligned_cols=247  Identities=19%  Similarity=0.218  Sum_probs=186.4

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC--
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN--   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~--   78 (282)
                      ||+|++ .+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|+||++| ++.+.+....  
T Consensus        55 Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~  132 (321)
T 2qkw_B           55 VYKGVL-RDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP  132 (321)
T ss_dssp             EEEEEC-TTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCC
T ss_pred             EEEEEE-CCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCC
Confidence            899997 469999999876532 23356788999999999999999999999999999999999986 5555443322  


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc--cccccccccccccChhh
Q psy6044          79 -GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--KCYSAEVVTLWYRPPDV  155 (282)
Q Consensus        79 -~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~aPE~  155 (282)
                       ..+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+.......  .......+++.|+|||.
T Consensus       133 ~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~  212 (321)
T 2qkw_B          133 TMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEY  212 (321)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHH
T ss_pred             ccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHH
Confidence             248999999999999999999999999999999999999999999999999987653221  12233457889999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChH--HHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD--DQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      +.+.. ++.++||||||+++|+|++|+.|+.......  ..............   .            ...........
T Consensus       213 ~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~------------~~~~~~~~~~~  276 (321)
T 2qkw_B          213 FIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ---L------------EQIVDPNLADK  276 (321)
T ss_dssp             HHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC---C------------CSSSSSSCTTC
T ss_pred             hcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc---H------------HHhcChhhccc
Confidence            97665 6999999999999999999998865432211  11111111111000   0            00000111123


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      .....+..+.+++.+||+.||++|||+.+++++
T Consensus       277 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          277 IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            345677889999999999999999999999975

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=8.5e-42  Score=277.52  Aligned_cols=227  Identities=22%  Similarity=0.324  Sum_probs=177.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC-CeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE-KKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~-~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      ||+|.+  +|+.||+|++...   ...+.+.+|+.++++++||||+++++++.+. +..++|+||++| ++.+.+.....
T Consensus        37 V~~~~~--~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~  111 (278)
T 1byg_A           37 VMLGDY--RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR  111 (278)
T ss_dssp             EEEEEE--TTEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHH
T ss_pred             EEEEEE--cCCEEEEEEecch---hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc
Confidence            789987  4899999998642   2457789999999999999999999987554 578999999986 77776655332


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          80 -EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 -~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                       .+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.......   ....+++.|+|||.+.+
T Consensus       112 ~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~  188 (278)
T 1byg_A          112 SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALRE  188 (278)
T ss_dssp             HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------------CCTTTSCHHHHHH
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc---cCCCccccccCHHHhCC
Confidence             38999999999999999999999999999999999999999999999999987654322   22345778999999976


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|+||||+++|++++++.++|......+....+....                            ....+..+
T Consensus       189 ~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~  239 (278)
T 1byg_A          189 KK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------------------------KMDAPDGC  239 (278)
T ss_dssp             CC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC----------------------------CCCCCTTC
T ss_pred             CC-CCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----------------------------CCCCcccC
Confidence            65 69999999999999999984444477766655554443211                            11123458


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ++.+.++|++||+.||.+|||+.++++
T Consensus       240 ~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          240 PPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            899999999999999999999999986

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.3e-41  Score=294.26  Aligned_cols=238  Identities=25%  Similarity=0.377  Sum_probs=188.8

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc-CC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL-NG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~-~~   79 (282)
                      ||+|.+.. +..||||++....  ...+.+.+|+.++++++||||+++++++.+ +..++||||++| ++.+.+... ..
T Consensus       200 Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~  275 (452)
T 1fmk_A          200 VWMGTWNG-TTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK  275 (452)
T ss_dssp             EEEEEETT-TEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHT
T ss_pred             EEEEEECC-CceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCC
Confidence            89999865 5679999987532  234678999999999999999999999876 678999999975 777776543 35


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~  158 (282)
                      .+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++....... .......++..|+|||.+..
T Consensus       276 ~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~  355 (452)
T 1fmk_A          276 YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY  355 (452)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhc
Confidence            69999999999999999999999999999999999999999999999999997664321 12223345678999999976


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++||||||+++|+|++++.++|.+....+....+......                            ..+..+
T Consensus       356 ~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~----------------------------~~~~~~  406 (452)
T 1fmk_A          356 GR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----------------------------PCPPEC  406 (452)
T ss_dssp             CC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----------------------------CCCTTS
T ss_pred             CC-CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------------------------CCCCCC
Confidence            65 7999999999999999999555558888877777666443211                            123457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc--CCCccCC
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMS--HIYFSDL  272 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~--h~~~~~~  272 (282)
                      ++.+.++|.+||+.||.+|||++++++  ..+++..
T Consensus       407 ~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence            899999999999999999999999987  4555544

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=7.6e-42  Score=281.65  Aligned_cols=245  Identities=21%  Similarity=0.247  Sum_probs=185.9

Q ss_pred             eeeeeeCCCCceEEEeeeecCC---CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG---NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL   77 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~   77 (282)
                      ||+|.+  +++.||+|++....   .......+.+|+.++++++||||+++++++.+.+..++|+||++| ++.+.+...
T Consensus        47 Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  124 (307)
T 2nru_A           47 VYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL  124 (307)
T ss_dssp             EEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG
T ss_pred             EEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhc
Confidence            899986  68899999987632   233356788999999999999999999999999999999999964 666666533


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc--cccccccccccccCh
Q psy6044          78 --NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--KCYSAEVVTLWYRPP  153 (282)
Q Consensus        78 --~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~aP  153 (282)
                        ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .......+++.|+||
T Consensus       125 ~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aP  204 (307)
T 2nru_A          125 DGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAP  204 (307)
T ss_dssp             GGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCH
T ss_pred             cCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCCh
Confidence              3469999999999999999999999999999999999999999999999999987654322  122334678999999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      |.+.+.  ++.++|+||||+++|+|++|..| |...........+.......... ..      +.       .......
T Consensus       205 E~~~~~--~~~~~Dv~slG~il~~l~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~-~~------~~-------~~~~~~~  267 (307)
T 2nru_A          205 EALRGE--ITPKSDIYSFGVVLLEIITGLPA-VDEHREPQLLLDIKEEIEDEEKT-IE------DY-------IDKKMND  267 (307)
T ss_dssp             HHHTTE--ECTHHHHHHHHHHHHHHHHCCCS-BCTTBSSSBTTHHHHHHHTTSCC-HH------HH-------SCSSCSC
T ss_pred             HHhcCC--CCccchhHHHHHHHHHHHHCCCC-cccCcchHHHHHHHHHhhhhhhh-hh------hh-------ccccccc
Confidence            998653  68999999999999999998777 44433222222221111110000 00      00       0001122


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      .....++.+.+++..||+.||.+|||+.++++
T Consensus       268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~  299 (307)
T 2nru_A          268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ  299 (307)
T ss_dssp             CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             cchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            33456788999999999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.4e-41  Score=277.84  Aligned_cols=241  Identities=20%  Similarity=0.307  Sum_probs=186.9

Q ss_pred             CeeeeeeCC-CCc--eEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHH
Q psy6044           1 MFTSGVDRT-PNT--ALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~-~~~--~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~   74 (282)
                      .||+|.+.. +++  .||+|++...  ......+.+.+|+.++++++||||+++++++.++. .++|+||++ |++.+.+
T Consensus        33 ~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l  111 (291)
T 1u46_A           33 VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRL  111 (291)
T ss_dssp             CCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHH
T ss_pred             eEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHH
Confidence            389998543 333  6999998763  22334567889999999999999999999998765 889999997 5788877


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc---cccccccccccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK---CYSAEVVTLWYR  151 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~  151 (282)
                      ....+.+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+........   ......++..|+
T Consensus       112 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~  191 (291)
T 1u46_A          112 RKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC  191 (291)
T ss_dssp             HHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGC
T ss_pred             HhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceee
Confidence            77667899999999999999999999999999999999999999999999999999977653322   122234567899


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSF  231 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
                      |||.+.+.. ++.++|+||||+++|+|++++.++|...+..+....+......                           
T Consensus       192 aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------------------  243 (291)
T 1u46_A          192 APESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER---------------------------  243 (291)
T ss_dssp             CHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC---------------------------
T ss_pred             CchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCC---------------------------
Confidence            999997665 6899999999999999998344447777766666555432111                           


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      ...+..+++.+.++|.+||+.||.+|||+.++++  +|+++
T Consensus       244 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~l~~~  282 (291)
T 1u46_A          244 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEA  282 (291)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH--HHHHh
Confidence            1122458899999999999999999999999997  44433

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.5e-40  Score=285.35  Aligned_cols=248  Identities=17%  Similarity=0.177  Sum_probs=197.9

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCC-CCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKH-KNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      ||+|.+..+|+.||||++....   ....+..|+++++.++| +++..+..++......++||||+.+++.+.+......
T Consensus        23 Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~g~sL~~ll~~~~~~   99 (483)
T 3sv0_A           23 IYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK   99 (483)
T ss_dssp             EEEEEETTTCCEEEEEEEETTC---SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTC
T ss_pred             EEEEEECCCCcEEEEEEecccc---ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECCCCCHHHHHHhhcCC
Confidence            8999999999999999877532   23568999999999977 5666667777788899999999988888888877788


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE---cCCCcEEEEecCCccccCCCcc-------ccccccccccc
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVK-------CYSAEVVTLWY  150 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~~  150 (282)
                      +++..++.++.||+.||.|||++||+|+||||+||++   +.++.++|+|||++........       ......++..|
T Consensus       100 l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y  179 (483)
T 3sv0_A          100 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY  179 (483)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccc
Confidence            9999999999999999999999999999999999999   6889999999999977643322       12245678999


Q ss_pred             cChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCC--ChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGS--DVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPS  228 (282)
Q Consensus       151 ~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
                      +|||.+.+.. ++.++||||||+++|+|++|..|+....  ...+....+.......                       
T Consensus       180 ~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~-----------------------  235 (483)
T 3sv0_A          180 ASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT-----------------------  235 (483)
T ss_dssp             CCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS-----------------------
T ss_pred             cCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc-----------------------
Confidence            9999998776 7999999999999999999988854322  2233333333221100                       


Q ss_pred             CCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc----------CCCccCCccchh
Q psy6044         229 MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS----------HIYFSDLNVAIK  277 (282)
Q Consensus       229 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~----------h~~~~~~~~~~~  277 (282)
                       ....+...+++++.+||..||+.||.+||++.+|++          ++|+..+++...
T Consensus       236 -~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~  293 (483)
T 3sv0_A          236 -SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTIL  293 (483)
T ss_dssp             -CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHH
T ss_pred             -cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhh
Confidence             222333568999999999999999999999998765          677766666543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=7.6e-41  Score=274.70  Aligned_cols=221  Identities=25%  Similarity=0.312  Sum_probs=172.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHH-hhCCCCCccceeeeeee----CCeEEEEEecCcc-cHHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLL-KELKHKNIVRLYDVLHS----EKKLTLVFEHCDQ-DLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~-~~l~h~~i~~~~~~~~~----~~~~~iv~e~~~g-~l~~~~~   75 (282)
                      ||+|.++.+|+.||+|++..      ...+.+|+.++ +..+||||+++++++..    ....++||||++| ++.+.+.
T Consensus        34 V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  107 (299)
T 3m2w_A           34 VLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ  107 (299)
T ss_dssp             EEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHH
T ss_pred             EEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHH
Confidence            89999999999999999863      35678899988 56699999999999987    6789999999976 7777776


Q ss_pred             hcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC---CCcEEEEecCCccccCCCcccccccccccccc
Q psy6044          76 SLN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK---NGELKLADFGLARAFGIPVKCYSAEVVTLWYR  151 (282)
Q Consensus        76 ~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  151 (282)
                      ... ..+++..++.++.||+.||.|||++|++|+||||+||+++.   ++.++|+|||++.....               
T Consensus       108 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~---------------  172 (299)
T 3m2w_A          108 DRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG---------------  172 (299)
T ss_dssp             HCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT---------------
T ss_pred             hccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccccc---------------
Confidence            643 36999999999999999999999999999999999999998   78999999998864331               


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSF  231 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
                              ..++.++|+||||+++|+|++|..|+ ......+.....       .          ...    ........
T Consensus       173 --------~~~~~~~DiwslG~il~el~tg~~pf-~~~~~~~~~~~~-------~----------~~~----~~~~~~~~  222 (299)
T 3m2w_A          173 --------EKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAISPGM-------K----------TRI----RMGQYEFP  222 (299)
T ss_dssp             --------CGGGGHHHHHHHHHHHHHHHHSSCSC-CC-------CCS-------C----------CSS----CTTCCSSC
T ss_pred             --------ccCCchhhHHHHHHHHHHHHHCCCCC-CCCcchhhhHHH-------H----------HHH----hhccccCC
Confidence                    12688999999999999999988885 332221110000       0          000    00000001


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      ......+++.+.+||.+||+.||.+|||+.++++||||++..
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            111246899999999999999999999999999999998653

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-42  Score=297.17  Aligned_cols=239  Identities=16%  Similarity=0.213  Sum_probs=181.6

Q ss_pred             CeeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCC-CCccc---------ee------------eeeee-
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKH-KNIVR---------LY------------DVLHS-   55 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h-~~i~~---------~~------------~~~~~-   55 (282)
                      .||+|.+..+|+.||||++..  .......+.+.+|+.+++.++| +|...         ..            .++.. 
T Consensus        93 ~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (413)
T 3dzo_A           93 AYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDE  172 (413)
T ss_dssp             EEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-----------
T ss_pred             EEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCC
Confidence            389999999999999999885  2333446789999999999977 32211         11            11111 


Q ss_pred             ----CCeEEEEEecCcccHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEE
Q psy6044          56 ----EKKLTLVFEHCDQDLKKYFDSL------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL  125 (282)
Q Consensus        56 ----~~~~~iv~e~~~g~l~~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l  125 (282)
                          ....+++++.+.+++.+.+...      ...+++..+..++.||+.||+|||++||+|+||||+||+++.++.+||
T Consensus       173 ~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL  252 (413)
T 3dzo_A          173 RDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFL  252 (413)
T ss_dssp             ----CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEE
T ss_pred             ccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEE
Confidence                2357899999999888877422      345788899999999999999999999999999999999999999999


Q ss_pred             EecCCccccCCCccccccccccccccChhhhc---------CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHH
Q psy6044         126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF---------GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLK  196 (282)
Q Consensus       126 ~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---------~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~  196 (282)
                      +|||++...+..   .....+ +.|+|||.+.         ....++.++|||||||++|+|++|..|+ ......+...
T Consensus       253 ~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf-~~~~~~~~~~  327 (413)
T 3dzo_A          253 TGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN-TDDAALGGSE  327 (413)
T ss_dssp             CCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCC-CTTGGGSCSG
T ss_pred             EeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCC-CCcchhhhHH
Confidence            999998776533   334456 8999999993         3333688999999999999999988884 4332211100


Q ss_pred             HHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         197 RIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      .                                 .......+++.+.+||.+||+.||++|||+.++++||||+.+....
T Consensus       328 ~---------------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~~~  374 (413)
T 3dzo_A          328 W---------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL  374 (413)
T ss_dssp             G---------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHHH
T ss_pred             H---------------------------------HHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHHHH
Confidence            0                                 0011135789999999999999999999999999999999886554


Q ss_pred             h
Q psy6044         277 K  277 (282)
Q Consensus       277 ~  277 (282)
                      .
T Consensus       375 ~  375 (413)
T 3dzo_A          375 S  375 (413)
T ss_dssp             H
T ss_pred             H
Confidence            3

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.1e-42  Score=283.49  Aligned_cols=236  Identities=21%  Similarity=0.277  Sum_probs=183.0

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeee----CCeEEEEEecCcc-cHHHHHHh
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHS----EKKLTLVFEHCDQ-DLKKYFDS   76 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~----~~~~~iv~e~~~g-~l~~~~~~   76 (282)
                      ||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++..    ....++|+||++| ++.+.+..
T Consensus        45 V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  123 (317)
T 2buj_A           45 VDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIER  123 (317)
T ss_dssp             EEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHH
T ss_pred             EEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHH
Confidence            8999999999999999987532 2335678899999999999999999999873    3578999999986 66666554


Q ss_pred             ---cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc---------cccc
Q psy6044          77 ---LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC---------YSAE  144 (282)
Q Consensus        77 ---~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~---------~~~~  144 (282)
                         ....+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........         ....
T Consensus       124 ~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~  203 (317)
T 2buj_A          124 LKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ  203 (317)
T ss_dssp             HHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHH
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccc
Confidence               3567999999999999999999999999999999999999999999999999988765321110         1123


Q ss_pred             cccccccChhhhcCCC--CCCchhhHHHHHHHHHHHHhcCCCCCCCCC-hHHHHHHHHHHhCCCCCCCCCCCCCCCCCCC
Q psy6044         145 VVTLWYRPPDVLFGAK--LYTTSIDMWSAGCIFAELANAGRPLFPGSD-VDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP  221 (282)
Q Consensus       145 ~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~ll~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (282)
                      .+++.|+|||.+....  .++.++||||||+++|+|++|..|+ .... ..+..........                  
T Consensus       204 ~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~-~~~~~~~~~~~~~~~~~~------------------  264 (317)
T 2buj_A          204 RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY-DMVFQKGDSVALAVQNQL------------------  264 (317)
T ss_dssp             HSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTT-HHHHHTTSCHHHHHHCC-------------------
T ss_pred             cCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCCh-hhhhcccchhhHHhhccC------------------
Confidence            4588899999986543  2578999999999999999998884 2110 0000111111000                  


Q ss_pred             CCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         222 FPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                               .......+++.+.++|.+||+.||.+|||+.+++++
T Consensus       265 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          265 ---------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             ----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence                     001124578999999999999999999999999984

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.9e-41  Score=278.48  Aligned_cols=238  Identities=23%  Similarity=0.297  Sum_probs=177.7

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhh--CCCCCccceeeeeee----CCeEEEEEecCcc-cHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKE--LKHKNIVRLYDVLHS----EKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~--l~h~~i~~~~~~~~~----~~~~~iv~e~~~g-~l~~~~   74 (282)
                      ||+|++  +|+.||||++...    ....+..|.+++..  ++||||+++++++..    ....++|+||++| ++.+.+
T Consensus        24 V~~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l   97 (301)
T 3q4u_A           24 VWRGSW--QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL   97 (301)
T ss_dssp             EEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHH
T ss_pred             EEEEEE--CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHH
Confidence            899987  6999999998642    23456667777777  799999999998654    3568999999986 666655


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc----cc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCH--------SRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC----YS  142 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh--------~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~----~~  142 (282)
                       + ...+++..++.++.||+.||.|||        +.|++|+||||+||+++.++.++|+|||++.........    ..
T Consensus        98 -~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  175 (301)
T 3q4u_A           98 -Q-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN  175 (301)
T ss_dssp             -T-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCC
T ss_pred             -h-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeeccccccccccccc
Confidence             3 467999999999999999999999        999999999999999999999999999998765433221    22


Q ss_pred             cccccccccChhhhcCCCC-----CCchhhHHHHHHHHHHHHhc----------CCCCCCCCChHHHHHHHHHHhCCCCC
Q psy6044         143 AEVVTLWYRPPDVLFGAKL-----YTTSIDMWSAGCIFAELANA----------GRPLFPGSDVDDQLKRIFKLLGTPTE  207 (282)
Q Consensus       143 ~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~ll~~ll~~----------~~p~~~~~~~~~~~~~~~~~~~~~~~  207 (282)
                      ...+++.|+|||.+.+...     ++.++||||||+++|+|++|          ..|++...........+.........
T Consensus       176 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~  255 (301)
T 3q4u_A          176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ  255 (301)
T ss_dssp             CCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC
T ss_pred             ccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCC
Confidence            3467899999999976532     34799999999999999998          66654432222222222221111000


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         208 DTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                        .............++.+.++|.+||+.||++|||+.++++
T Consensus       256 ------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          256 ------------------RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             ------------------CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence                              0000111123346788999999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6e-41  Score=277.73  Aligned_cols=237  Identities=19%  Similarity=0.293  Sum_probs=185.7

Q ss_pred             eeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      ||+|.+..   .+|+|++.. .......+.+.+|+.++++++||||+++++++.+++..++|+||++| ++.+.+.....
T Consensus        49 V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~  125 (319)
T 2y4i_B           49 VYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI  125 (319)
T ss_dssp             EEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCC
T ss_pred             EEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCC
Confidence            89998754   599999887 34445567888999999999999999999999999999999999985 55555554445


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC-----ccccccccccccccChh
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP-----VKCYSAEVVTLWYRPPD  154 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~~~~~~aPE  154 (282)
                      .+++..++.++.||+.||.+||+.|++|+||+|+||+++ ++.++|+|||++......     ........+++.|+|||
T Consensus       126 ~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE  204 (319)
T 2y4i_B          126 VLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE  204 (319)
T ss_dssp             CCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChH
Confidence            799999999999999999999999999999999999997 789999999987654311     12223345688999999


Q ss_pred             hhcC--------CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         155 VLFG--------AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYH  226 (282)
Q Consensus       155 ~~~~--------~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (282)
                      .+..        ...++.++||||||+++|+|++|..| |......+....+.......                     
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p-~~~~~~~~~~~~~~~~~~~~---------------------  262 (319)
T 2y4i_B          205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP-FKTQPAEAIIWQMGTGMKPN---------------------  262 (319)
T ss_dssp             HHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCS-SSSCCHHHHHHHHHTTCCCC---------------------
T ss_pred             HhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHhccCCCCC---------------------
Confidence            9864        23468999999999999999998888 66666666555543321110                     


Q ss_pred             CCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         227 PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       227 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                            .....++..+.++|..||+.||.+|||+.++++  .|+.+
T Consensus       263 ------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l  300 (319)
T 2y4i_B          263 ------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKL  300 (319)
T ss_dssp             ------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC
T ss_pred             ------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHH
Confidence                  011247888999999999999999999999998  44444

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.3e-41  Score=282.01  Aligned_cols=238  Identities=22%  Similarity=0.227  Sum_probs=176.5

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC----eEEEEEecCcc-cHHHHHHh
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK----KLTLVFEHCDQ-DLKKYFDS   76 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~----~~~iv~e~~~g-~l~~~~~~   76 (282)
                      ||+|++.  |+.||||++....  ........|+.++++++||||+++++++.+..    .+++||||++| ++.+.+..
T Consensus        40 Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  115 (322)
T 3soc_A           40 VWKAQLL--NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA  115 (322)
T ss_dssp             EEEEEET--TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH
T ss_pred             EEEEEEC--CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh
Confidence            8999875  8999999987532  12234566888899999999999999998743    47999999976 66666544


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhC----------CccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--ccccc
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSR----------NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--CYSAE  144 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~----------~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~  144 (282)
                        ..+++..++.++.|++.||+|||+.          |++|+||||+||+++.++.++|+|||.+........  .....
T Consensus       116 --~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~  193 (322)
T 3soc_A          116 --NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ  193 (322)
T ss_dssp             --CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTC
T ss_pred             --cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccC
Confidence              5699999999999999999999999          999999999999999999999999999976643322  22335


Q ss_pred             cccccccChhhhcCCC----CCCchhhHHHHHHHHHHHHhcCCCCCCCCChH-----H------HHHHHHHHhCCCCCCC
Q psy6044         145 VVTLWYRPPDVLFGAK----LYTTSIDMWSAGCIFAELANAGRPLFPGSDVD-----D------QLKRIFKLLGTPTEDT  209 (282)
Q Consensus       145 ~~~~~~~aPE~~~~~~----~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~-----~------~~~~~~~~~~~~~~~~  209 (282)
                      .+++.|+|||.+.+..    .++.++||||||+++|+|++|..|+.......     .      ....+.........  
T Consensus       194 ~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  271 (322)
T 3soc_A          194 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKK--  271 (322)
T ss_dssp             CCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCC--
T ss_pred             ccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccC--
Confidence            6799999999997632    24668899999999999999888853321100     0      01111111100000  


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCccc--cCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         210 WPGMNLLPDFKPFPMYHPSMSFSQ--VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                        ......  .....++.+.+||++||+.||++|||+.++++
T Consensus       272 ------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          272 ------------------RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             ------------------CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                              000001  11224566999999999999999999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=273.56  Aligned_cols=225  Identities=26%  Similarity=0.355  Sum_probs=172.8

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC-
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG-   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~-   79 (282)
                      ||+|++.  ++.||+|++..   ....+.+.+|+.++++++||||+++++++.+.  .++||||++| ++.+.+..... 
T Consensus        24 V~~~~~~--~~~vavK~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~lv~e~~~~~~L~~~l~~~~~~   96 (307)
T 2eva_A           24 VCKAKWR--AKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPL   96 (307)
T ss_dssp             EEEEEET--TEEEEEEECSS---TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--TEEEEECCTTCBHHHHHHCSSSE
T ss_pred             EEEEEEC--CeeEEEEEecC---hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--cEEEEEcCCCCCHHHHHhccCCC
Confidence            8999874  78999998853   23346788999999999999999999998744  7899999976 66665554322 


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCCCcEEEcCCCc-EEEEecCCccccCCCccccccccccccccChh
Q psy6044          80 -EIDLDIVKSFMYQLLRGLAFCHS---RNVLHRDLKPQNLLINKNGE-LKLADFGLARAFGIPVKCYSAEVVTLWYRPPD  154 (282)
Q Consensus        80 -~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~dl~~~nil~~~~~~-~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE  154 (282)
                       .+++..++.++.|++.||.|||+   +|++|+||||+||+++.++. ++|+|||.+......   .....+++.|+|||
T Consensus        97 ~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE  173 (307)
T 2eva_A           97 PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPE  173 (307)
T ss_dssp             ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------------CCTTSSCHH
T ss_pred             CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---cccCCCCCceEChh
Confidence             37899999999999999999999   89999999999999998887 799999998765432   22345789999999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHH-HHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDD-QLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      .+.+.. ++.++||||||+++|+|++|..|+........ .......  .                          ....
T Consensus       174 ~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~--------------------------~~~~  224 (307)
T 2eva_A          174 VFEGSN-YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--G--------------------------TRPP  224 (307)
T ss_dssp             HHTCCC-CCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--T--------------------------CCCC
T ss_pred             hhCCCC-CCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--C--------------------------CCCC
Confidence            997765 79999999999999999999888543332222 2211111  1                          1112


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ....+++.+.++|.+||+.||.+|||++++++
T Consensus       225 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            23458899999999999999999999999988

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.2e-40  Score=299.40  Aligned_cols=235  Identities=24%  Similarity=0.392  Sum_probs=190.2

Q ss_pred             CeeeeeeCCC---CceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHh
Q psy6044           1 MFTSGVDRTP---NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDS   76 (282)
Q Consensus         1 ~vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~   76 (282)
                      .||+|.+..+   +..||+|.+...........+.+|+.++++++||||+++++++. ++..++||||++ |++.+.+..
T Consensus       405 ~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~  483 (656)
T 2j0j_A          405 DVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV  483 (656)
T ss_dssp             CEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHH
T ss_pred             EEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHh
Confidence            3899988654   56799998875444444567899999999999999999999985 456899999998 467776666


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-ccccccccccccChhh
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-CYSAEVVTLWYRPPDV  155 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~  155 (282)
                      ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........ ......+++.|+|||.
T Consensus       484 ~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~  563 (656)
T 2j0j_A          484 RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES  563 (656)
T ss_dssp             TTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHH
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHH
Confidence            556799999999999999999999999999999999999999999999999999987643321 1223345678999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      +.+.. ++.++||||||+++|+|++++.++|.+....+....+......                            ..+
T Consensus       564 ~~~~~-~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~----------------------------~~~  614 (656)
T 2j0j_A          564 INFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----------------------------PMP  614 (656)
T ss_dssp             HHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC----------------------------CCC
T ss_pred             hcCCC-CCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC----------------------------CCC
Confidence            97665 7999999999999999998556668888887777776553211                            123


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ..+++.+.++|.+||+.||.+|||+.++++
T Consensus       615 ~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          615 PNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            458899999999999999999999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=6.7e-41  Score=295.15  Aligned_cols=238  Identities=25%  Similarity=0.377  Sum_probs=193.1

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc-CC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL-NG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~-~~   79 (282)
                      ||+|.+.. +..||||++....  ...+.+.+|+.++++++||||+++++++.+ +..++||||+.| +|.+.+... ..
T Consensus       283 Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~  358 (535)
T 2h8h_A          283 VWMGTWNG-TTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK  358 (535)
T ss_dssp             EEEEEETT-TEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHT
T ss_pred             EEEEEECC-CceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCC
Confidence            89999865 5679999987532  234679999999999999999999999876 678999999975 777776543 35


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~  158 (282)
                      .+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... .......++..|+|||.+..
T Consensus       359 ~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~  438 (535)
T 2h8h_A          359 YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY  438 (535)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhcc
Confidence            69999999999999999999999999999999999999999999999999997764321 11223344678999999976


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++||||||+++|+|++++.++|.+....+....+......                            ..+..+
T Consensus       439 ~~-~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~----------------------------~~~~~~  489 (535)
T 2h8h_A          439 GR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----------------------------PCPPEC  489 (535)
T ss_dssp             CC-CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC----------------------------CCCTTC
T ss_pred             CC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------------------------CCCCCC
Confidence            65 7999999999999999999555558888877777666543211                            123457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc--CCCccCC
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMS--HIYFSDL  272 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~--h~~~~~~  272 (282)
                      ++.+.+||.+||+.||++|||+++|++  ..++...
T Consensus       490 ~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          490 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence            899999999999999999999999987  3555544

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=275.64  Aligned_cols=238  Identities=21%  Similarity=0.287  Sum_probs=184.8

Q ss_pred             eeeee----eCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC--eEEEEEecCcc-cHHHHH
Q psy6044           2 FTSGV----DRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK--KLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         2 vy~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~--~~~iv~e~~~g-~l~~~~   74 (282)
                      ||+|+    +..+|+.||+|++... .......+.+|+.++++++||||+++++++...+  ..++|+||++| ++.+.+
T Consensus        57 V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l  135 (326)
T 2w1i_A           57 VEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL  135 (326)
T ss_dssp             EEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHH
T ss_pred             EEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHH
Confidence            78888    6778999999998753 2233467889999999999999999999987654  78999999975 777777


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc---ccccccccccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC---YSAEVVTLWYR  151 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~  151 (282)
                      ......+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||.+.........   .....++..|+
T Consensus       136 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~  215 (326)
T 2w1i_A          136 QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY  215 (326)
T ss_dssp             HHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGC
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEE
Confidence            665567999999999999999999999999999999999999999999999999999876543221   22334567799


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCC-----------ChHHHHHHHHHHhCCCCCCCCCCCCCCCCCC
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGS-----------DVDDQLKRIFKLLGTPTEDTWPGMNLLPDFK  220 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (282)
                      |||.+.+.. ++.++||||||+++|+|++|..|+....           ........+.......               
T Consensus       216 aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------  279 (326)
T 2w1i_A          216 APESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN---------------  279 (326)
T ss_dssp             CHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT---------------
T ss_pred             CchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC---------------
Confidence            999997765 6899999999999999999887743210           0011111111111100               


Q ss_pred             CCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         221 PFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                               .....+..+++.+.++|++||+.||.+|||+.++++
T Consensus       280 ---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          280 ---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---------CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                     001123458899999999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-40  Score=273.60  Aligned_cols=238  Identities=25%  Similarity=0.313  Sum_probs=174.4

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC--CCCCccceeeeeeeC----CeEEEEEecCcc-cHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL--KHKNIVRLYDVLHSE----KKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l--~h~~i~~~~~~~~~~----~~~~iv~e~~~g-~l~~~~   74 (282)
                      ||+|++.  |+.||||++...    .......|.+++...  +||||+++++++...    ...++||||++| ++.+.+
T Consensus        53 V~~~~~~--~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l  126 (337)
T 3mdy_A           53 VWMGKWR--GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL  126 (337)
T ss_dssp             EEEEEET--TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHH
T ss_pred             EEEEEEC--CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHh
Confidence            8999874  899999998642    124455666766665  899999999999887    789999999976 666666


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc----cc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSR--------NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC----YS  142 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~--------~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~----~~  142 (282)
                      ..  ..+++..++.++.|++.||.|||+.        |++|+||||+||+++.++.++|+|||.+.........    ..
T Consensus       127 ~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  204 (337)
T 3mdy_A          127 KS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN  204 (337)
T ss_dssp             HH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CC
T ss_pred             hc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCC
Confidence            43  5799999999999999999999998        9999999999999999999999999999766433221    12


Q ss_pred             cccccccccChhhhcCCCCCCc------hhhHHHHHHHHHHHHhc----------CCCCCCCCChHHHHHHHHHHhCCCC
Q psy6044         143 AEVVTLWYRPPDVLFGAKLYTT------SIDMWSAGCIFAELANA----------GRPLFPGSDVDDQLKRIFKLLGTPT  206 (282)
Q Consensus       143 ~~~~~~~~~aPE~~~~~~~~~~------~~Di~slG~ll~~ll~~----------~~p~~~~~~~~~~~~~~~~~~~~~~  206 (282)
                      ...+++.|+|||.+.+... ..      ++||||||+++|+|++|          ..|+.....................
T Consensus       205 ~~~gt~~y~aPE~~~~~~~-~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  283 (337)
T 3mdy_A          205 TRVGTKRYMPPEVLDESLN-RNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKK  283 (337)
T ss_dssp             SSCSCGGGCCHHHHTTCCC-TTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC
T ss_pred             CCccCcceeChhhcccccC-CccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhc
Confidence            3467899999999976652 33      49999999999999998          4553322111111111111111000


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         207 EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      .                  ............+++.+.++|.+||+.||.+|||+.+++++
T Consensus       284 ~------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          284 L------------------RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             C------------------CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             c------------------CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            0                  00001111123567889999999999999999999999984

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.2e-40  Score=274.61  Aligned_cols=261  Identities=22%  Similarity=0.278  Sum_probs=175.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHh--hCCCCCccceeeeeee-----CCeEEEEEecCcc-cHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLK--ELKHKNIVRLYDVLHS-----EKKLTLVFEHCDQ-DLKKY   73 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~--~l~h~~i~~~~~~~~~-----~~~~~iv~e~~~g-~l~~~   73 (282)
                      ||+|++  +|+.||||++....    ...+..|.++..  .++||||+++++.+..     ...+++||||++| ++.+.
T Consensus        29 Vy~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~  102 (336)
T 3g2f_A           29 VYKGSL--DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKY  102 (336)
T ss_dssp             EEEEEE--TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHH
T ss_pred             EEEEEE--CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHH
Confidence            899976  68999999987532    234455555544  4799999999985542     3467999999975 66666


Q ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccCCCCCcEEEcCCCcEEEEecCCccccCCC-------
Q psy6044          74 FDSLNGEIDLDIVKSFMYQLLRGLAFCHSR---------NVLHRDLKPQNLLINKNGELKLADFGLARAFGIP-------  137 (282)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---------~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~-------  137 (282)
                      +..  ...++..++.++.||+.||.|||+.         |++|+||||+||+++.++.++|+|||++......       
T Consensus       103 l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~  180 (336)
T 3g2f_A          103 LSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE  180 (336)
T ss_dssp             HHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC----
T ss_pred             Hhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccc
Confidence            544  4558999999999999999999999         9999999999999999999999999999766422       


Q ss_pred             -ccccccccccccccChhhhcCC------CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCC-
Q psy6044         138 -VKCYSAEVVTLWYRPPDVLFGA------KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDT-  209 (282)
Q Consensus       138 -~~~~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  209 (282)
                       ........+++.|+|||.+.+.      ..++.++||||||+++|+|++|+.|++......+............+... 
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (336)
T 3g2f_A          181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFED  260 (336)
T ss_dssp             -----CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHH
T ss_pred             cccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHH
Confidence             1122234678999999999763      22567899999999999999999988776442211111111000000000 


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHh------cCCCccCCccc
Q psy6044         210 WPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAM------SHIYFSDLNVA  275 (282)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll------~h~~~~~~~~~  275 (282)
                      ...........+    ..+ .........++.+.+||.+||+.||++|||+++++      -++|-++-...
T Consensus       261 ~~~~~~~~~~~~----~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~~~  327 (336)
T 3g2f_A          261 MQVLVSREKQRP----KFP-EAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS  327 (336)
T ss_dssp             HHHHHTTSCCCC----CCC-TTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-----
T ss_pred             HHhhhcccccCC----CCC-cccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcccCC
Confidence            000000000000    000 00001123566899999999999999999999994      47777765433

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.5e-39  Score=270.47  Aligned_cols=238  Identities=21%  Similarity=0.254  Sum_probs=179.3

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhh--CCCCCccceeeeeeeCC----eEEEEEecCcc-cHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKE--LKHKNIVRLYDVLHSEK----KLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~--l~h~~i~~~~~~~~~~~----~~~iv~e~~~g-~l~~~~   74 (282)
                      ||+|.+  +|+.||||++...    ....+.+|.+++..  ++||||+++++++....    ..++|+||++| ++.+.+
T Consensus        58 Vy~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l  131 (342)
T 1b6c_B           58 VWRGKW--RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL  131 (342)
T ss_dssp             EEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHH
T ss_pred             EEEEEE--cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHH
Confidence            899987  5999999998642    23567889999888  79999999999998875    89999999986 666666


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc----ccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCH--------SRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK----CYS  142 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh--------~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~----~~~  142 (282)
                      ..  ..+++..++.++.|++.||.+||        +.|++|+||||+||+++.++.++|+|||.+........    ...
T Consensus       132 ~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~  209 (342)
T 1b6c_B          132 NR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN  209 (342)
T ss_dssp             HH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCC
T ss_pred             hc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccc
Confidence            44  57999999999999999999999        89999999999999999999999999999976643322    223


Q ss_pred             cccccccccChhhhcCCCC-----CCchhhHHHHHHHHHHHHhc----------CCCCCCCCChHHHHHHHHHHhCCC-C
Q psy6044         143 AEVVTLWYRPPDVLFGAKL-----YTTSIDMWSAGCIFAELANA----------GRPLFPGSDVDDQLKRIFKLLGTP-T  206 (282)
Q Consensus       143 ~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~ll~~ll~~----------~~p~~~~~~~~~~~~~~~~~~~~~-~  206 (282)
                      ...+++.|+|||.+.+...     ++.++||||||+++|+|++|          ..|+............+....... .
T Consensus       210 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  289 (342)
T 1b6c_B          210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL  289 (342)
T ss_dssp             SCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC
T ss_pred             cCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHh
Confidence            4467899999999976532     23689999999999999998          566544322111111111111100 0


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         207 EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      ....                   .........++.+.++|.+||+.||.+|||+.++++|
T Consensus       290 ~~~~-------------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          290 RPNI-------------------PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CCCC-------------------CGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             CCCC-------------------cccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            0000                   0000112355789999999999999999999999984

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=7.4e-40  Score=276.12  Aligned_cols=225  Identities=15%  Similarity=0.164  Sum_probs=177.2

Q ss_pred             eeee-----eeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCC---CCCccceeeeeeeCCeEEEEEecCcc-cHHH
Q psy6044           2 FTSG-----VDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK---HKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKK   72 (282)
Q Consensus         2 vy~a-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~---h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~   72 (282)
                      ||+|     .+..+++.||+|++...    ....+..|+.+++.+.   |+||+++++++..++..++||||++| ++.+
T Consensus        81 Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~  156 (365)
T 3e7e_A           81 VYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLN  156 (365)
T ss_dssp             EEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHH
T ss_pred             EEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHH
Confidence            8999     57789999999998642    3457888999999887   89999999999999999999999974 6666


Q ss_pred             HHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-----------CCcEEEEecCCccccC--
Q psy6044          73 YFDS----LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK-----------NGELKLADFGLARAFG--  135 (282)
Q Consensus        73 ~~~~----~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~-----------~~~~~l~df~~~~~~~--  135 (282)
                      .+..    ....+++..++.++.||+.||+|||++||+|+||||+||+++.           ++.++|+|||++..+.  
T Consensus       157 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~  236 (365)
T 3e7e_A          157 AINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF  236 (365)
T ss_dssp             HHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGS
T ss_pred             HHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhcc
Confidence            6654    3467999999999999999999999999999999999999998           8999999999996543  


Q ss_pred             CCccccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCC
Q psy6044         136 IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNL  215 (282)
Q Consensus       136 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  215 (282)
                      ..........||+.|+|||.+.+.. ++.++||||||+++|+|++|..|+.........                    .
T Consensus       237 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--------------------~  295 (365)
T 3e7e_A          237 PKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK--------------------P  295 (365)
T ss_dssp             CTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--------------------E
T ss_pred             CCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCcee--------------------e
Confidence            2233445567899999999998776 799999999999999999999886433221000                    0


Q ss_pred             CCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         216 LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ..            ...  ....++.+.+++..||+.+|.+|++..+.+.
T Consensus       296 ~~------------~~~--~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          296 EG------------LFR--RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             CS------------CCT--TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             ch------------hcc--ccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence            00            000  0124678899999999999999975544444

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=6e-41  Score=279.71  Aligned_cols=230  Identities=21%  Similarity=0.209  Sum_probs=172.8

Q ss_pred             eeeeeeCCCCceEEEeeeecCCC-------CCCCccHHHHHHHHhhCC---------CCCcc-----------------c
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGN-------EGVPSSALREICLLKELK---------HKNIV-----------------R   48 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~~~~l~---------h~~i~-----------------~   48 (282)
                      ||+|++  +|+.||||++.....       ....+.+.+|+.+++.++         ||||+                 +
T Consensus        36 V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~  113 (336)
T 2vuw_A           36 VFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLK  113 (336)
T ss_dssp             EEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHH
T ss_pred             EEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHH
Confidence            899998  789999999987432       222367889999999886         55554                 4


Q ss_pred             eeeeeee-------------CCeEEEEEecCcc-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCC
Q psy6044          49 LYDVLHS-------------EKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH-SRNVLHRDLKPQ  113 (282)
Q Consensus        49 ~~~~~~~-------------~~~~~iv~e~~~g-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh-~~~i~H~dl~~~  113 (282)
                      +++++.+             ....|+||||++| ++++.+..  ..+++..++.++.||+.||.||| ++||+|+||||+
T Consensus       114 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~  191 (336)
T 2vuw_A          114 AWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWG  191 (336)
T ss_dssp             HHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGG
T ss_pred             HHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHH
Confidence            4444443             6889999999965 46666643  67899999999999999999999 999999999999


Q ss_pred             cEEEcCCC--------------------cEEEEecCCccccCCCccccccccccccccChhhhcCCCCCCchhhHHHHHH
Q psy6044         114 NLLINKNG--------------------ELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC  173 (282)
Q Consensus       114 nil~~~~~--------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~  173 (282)
                      ||+++.++                    .+||+|||++......     ...||+.|+|||++.+..  +.++||||+|+
T Consensus       192 NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~~~g~~--~~~~Diwsl~~  264 (336)
T 2vuw_A          192 NVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDLFTGDG--DYQFDIYRLMK  264 (336)
T ss_dssp             GEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGGGCCCS--SHHHHHHHHHH
T ss_pred             HEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhhhcCCC--ccceehhhhhC
Confidence            99999887                    8999999999866532     236789999999997654  88999999877


Q ss_pred             H-HHHHHhcCCCCCCCCCh-HHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcc
Q psy6044         174 I-FAELANAGRPLFPGSDV-DDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLV  251 (282)
Q Consensus       174 l-l~~ll~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  251 (282)
                      + .+++++|..| |..... ......+........                      .........+++++.+||++||+
T Consensus       265 ~~~~~~~~g~~p-~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~s~~~~dli~~~L~  321 (336)
T 2vuw_A          265 KENNNRWGEYHP-YSNVLWLHYLTDKMLKQMTFKT----------------------KCNTPAMKQIKRKIQEFHRTMLN  321 (336)
T ss_dssp             HHHTTCTTSCCT-HHHHHHHHHHHHHHHHTCCCSS----------------------CCCSHHHHHHHHHHHHHHHHGGG
T ss_pred             CCCcccccccCC-CcchhhhhHHHHhhhhhhccCc----------------------ccchhhhhhcCHHHHHHHHHHhc
Confidence            7 6677766666 422111 112222222111000                      01122345688999999999999


Q ss_pred             cCCCCCCCHHHHh-cCCCcc
Q psy6044         252 CNPVQRMSAEDAM-SHIYFS  270 (282)
Q Consensus       252 ~dp~~Rps~~~ll-~h~~~~  270 (282)
                      .|     |++|+| +||||+
T Consensus       322 ~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          322 FS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             SS-----SHHHHHHHCGGGC
T ss_pred             cC-----CHHHHHhcCCCcC
Confidence            77     999999 999996

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.7e-40  Score=295.67  Aligned_cols=226  Identities=22%  Similarity=0.305  Sum_probs=180.1

Q ss_pred             eeeeeeCC-CCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCe-----EEEEEecCcccHHHHHH
Q psy6044           2 FTSGVDRT-PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKK-----LTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~-----~~iv~e~~~g~l~~~~~   75 (282)
                      ||+|.+.. +|+.||||++...........+.+|+.++++++||||+++++++...+.     .|+||||++|+.+....
T Consensus        96 Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~  175 (681)
T 2pzi_A           96 IYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK  175 (681)
T ss_dssp             EEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC---
T ss_pred             EEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHH
Confidence            89999976 7999999988754333344568899999999999999999999987655     79999999875555444


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhh
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDV  155 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~  155 (282)
                      .  ..+++..++.++.||+.||.|||++||+|+||||+||+++.+ .++|+|||++......    ....||+.|+|||.
T Consensus       176 ~--~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~----~~~~gt~~y~aPE~  248 (681)
T 2pzi_A          176 G--QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF----GYLYGTPGFQAPEI  248 (681)
T ss_dssp             ---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC----SCCCCCTTTSCTTH
T ss_pred             h--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC----CccCCCccccCHHH
Confidence            3  379999999999999999999999999999999999999875 8999999999876533    34467999999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      +.+.  .+.++||||||+++|+|++|..| +.+....                ..                   ......
T Consensus       249 ~~~~--~~~~sDi~slG~~l~~l~~g~~~-~~~~~~~----------------~~-------------------~~~~~~  290 (681)
T 2pzi_A          249 VRTG--PTVATDIYTVGRTLAALTLDLPT-RNGRYVD----------------GL-------------------PEDDPV  290 (681)
T ss_dssp             HHHC--SCHHHHHHHHHHHHHHHHSCCCE-ETTEECS----------------SC-------------------CTTCHH
T ss_pred             HcCC--CCCceehhhhHHHHHHHHhCCCC-Ccccccc----------------cc-------------------cccccc
Confidence            8654  38999999999999999977555 4321100                00                   000011


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      ...++.+.++|.+||+.||.+||+..+.+.|+|+.-+
T Consensus       291 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          291 LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence            2357889999999999999999999999999887644

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.3e-38  Score=259.42  Aligned_cols=210  Identities=17%  Similarity=0.138  Sum_probs=162.8

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCC--CCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNE--GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|.+..+|+.||||++......  .....+.+|+..+.+++||||+++++++.+++..|+||||++|+.+..+.. .+
T Consensus        47 Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~-~~  125 (286)
T 3uqc_A           47 FWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD-TS  125 (286)
T ss_dssp             EEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHT-TC
T ss_pred             EEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHh-cC
Confidence            899999999999999999863221  223678999999999999999999999999999999999998644444443 23


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                       .....+..++.||+.||.|||++||+|+||||+||+++.++.++|++++                    |++       
T Consensus       126 -~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~--------------------~~~-------  177 (286)
T 3uqc_A          126 -PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA--------------------TMP-------  177 (286)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC--------------------CCT-------
T ss_pred             -CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc--------------------ccC-------
Confidence             4666788999999999999999999999999999999999999997443                    222       


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                       +++.++||||||+++|+|++|..|+ .+.+..+...              ....        ...............++
T Consensus       178 -~~~~~~Di~slG~il~elltg~~Pf-~~~~~~~~~~--------------~~~~--------~~~~~~~~~~~~~~~~~  233 (286)
T 3uqc_A          178 -DANPQDDIRGIGASLYALLVNRWPL-PEAGVRSGLA--------------PAER--------DTAGQPIEPADIDRDIP  233 (286)
T ss_dssp             -TCCHHHHHHHHHHHHHHHHHSEECS-CCCSBCCCSE--------------ECCB--------CTTSCBCCHHHHCTTSC
T ss_pred             -CCCchhHHHHHHHHHHHHHHCCCCC-CcCCcchhhH--------------HHHH--------HhccCCCChhhcccCCC
Confidence             2689999999999999999998884 4322110000              0000        00000112234456789


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      +.+.++|.+||+.||.+| |+.++++
T Consensus       234 ~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          234 FQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             HHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             HHHHHHHHHHcccCCccC-CHHHHHH
Confidence            999999999999999999 9999987

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=8.9e-35  Score=256.95  Aligned_cols=173  Identities=17%  Similarity=0.073  Sum_probs=129.5

Q ss_pred             eeeeCCCCceEEEeeeecCCCCC---------CCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHH
Q psy6044           4 SGVDRTPNTALAIKGTHLVGNEG---------VPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKY   73 (282)
Q Consensus         4 ~a~~~~~~~~vaiK~~~~~~~~~---------~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~   73 (282)
                      .++..-.|+.+++|++.......         ..+.+.+|+++|+++ .|+||+++++++++++..||||||++|+.|..
T Consensus       252 ~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d  331 (569)
T 4azs_A          252 RSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSD  331 (569)
T ss_dssp             CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHH
T ss_pred             ccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHH
Confidence            34555679999999998743222         234588999999999 79999999999999999999999999866666


Q ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccCh
Q psy6044          74 FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP  153 (282)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aP  153 (282)
                      +....+++++.   .++.||+.||+|+|++||+||||||+|||++.+|.+||+|||+++.............||+.|+||
T Consensus       332 ~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAP  408 (569)
T 4azs_A          332 MLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVN  408 (569)
T ss_dssp             HHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHH
T ss_pred             HHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccH
Confidence            66667888875   478999999999999999999999999999999999999999998776555555566789999999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhc
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANA  181 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~  181 (282)
                      |.+.+.  +..++|+|++|++++.+.++
T Consensus       409 E~l~g~--~~~~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          409 ELFAEN--KSWNGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             HHC-------------------CCCCTT
T ss_pred             HHhCCC--CCCcccccccccchhhhccc
Confidence            999765  46789999999988776544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.90  E-value=4.9e-25  Score=193.78  Aligned_cols=170  Identities=17%  Similarity=0.158  Sum_probs=131.0

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCC-C------CCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNE-G------VPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKY   73 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~-~------~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~   73 (282)
                      ||+|.  ..++.+++|+....... .      ..+.+.+|++++++++||||+++..++......++||||++| ++.+.
T Consensus       352 Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~  429 (540)
T 3en9_A          352 IKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDV  429 (540)
T ss_dssp             EEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHH
T ss_pred             EEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHH
Confidence            78883  56889999987652111 1      123478999999999999999666666677777999999985 55554


Q ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccc-------cccccc
Q psy6044          74 FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKC-------YSAEVV  146 (282)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~-------~~~~~~  146 (282)
                      +..         +..++.|++.||.|||++||+|+||||+||+++.  .++|+|||++.........       .....+
T Consensus       430 l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~G  498 (540)
T 3en9_A          430 IED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLS  498 (540)
T ss_dssp             STT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHH
T ss_pred             HHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcC
Confidence            432         5689999999999999999999999999999988  9999999999887643221       123467


Q ss_pred             cccccChhhhcCC-CCCCchhhHHHHHHHHHHHHhcCCC
Q psy6044         147 TLWYRPPDVLFGA-KLYTTSIDMWSAGCIFAELANAGRP  184 (282)
Q Consensus       147 ~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~ll~~~~p  184 (282)
                      |+.|+|||.+... ..|+..+|+|+..+-..+-+..+.+
T Consensus       499 T~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~r  537 (540)
T 3en9_A          499 THHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRAR  537 (540)
T ss_dssp             HCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred             CCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccc
Confidence            8999999999652 2267788999988887777655444

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=9.5e-22  Score=159.26  Aligned_cols=129  Identities=16%  Similarity=0.095  Sum_probs=99.5

Q ss_pred             eeeeeeCCCCceEEEeeeecCCC-CC----------------CCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEe
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGN-EG----------------VPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE   64 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~-~~----------------~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e   64 (282)
                      ||+|.+ .+|+.||+|++..... ..                ....+.+|+.++++++  | +++.+++.. +..++|||
T Consensus       106 Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE  180 (282)
T 1zar_A          106 VFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLME  180 (282)
T ss_dssp             EEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEE
T ss_pred             EEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEE
Confidence            899999 8899999999975211 10                1235789999999999  5 666666544 45699999


Q ss_pred             cCcccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccc
Q psy6044          65 HCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAE  144 (282)
Q Consensus        65 ~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  144 (282)
                      |++|+.+..+ .      ......++.|++.||.+||+.|++|+||||+||+++ ++.++|+|||.+...          
T Consensus       181 ~~~g~~L~~l-~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~~----------  242 (282)
T 1zar_A          181 LIDAKELYRV-R------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEV----------  242 (282)
T ss_dssp             CCCCEEGGGC-C------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEET----------
T ss_pred             ecCCCcHHHc-c------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeEC----------
Confidence            9987433322 1      133557999999999999999999999999999999 999999999998633          


Q ss_pred             cccccccChhhh
Q psy6044         145 VVTLWYRPPDVL  156 (282)
Q Consensus       145 ~~~~~~~aPE~~  156 (282)
                         ..+.|||.+
T Consensus       243 ---~~~~a~e~l  251 (282)
T 1zar_A          243 ---GEEGWREIL  251 (282)
T ss_dssp             ---TSTTHHHHH
T ss_pred             ---CCCCHHHHH
Confidence               235778876

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.75  E-value=4.3e-18  Score=136.14  Aligned_cols=123  Identities=16%  Similarity=0.162  Sum_probs=92.7

Q ss_pred             eeeeeeCCCCce--EEEeeeecCCCC-CC----------------------CccHHHHHHHHhhCCCCCc--cceeeeee
Q psy6044           2 FTSGVDRTPNTA--LAIKGTHLVGNE-GV----------------------PSSALREICLLKELKHKNI--VRLYDVLH   54 (282)
Q Consensus         2 vy~a~~~~~~~~--vaiK~~~~~~~~-~~----------------------~~~~~~e~~~~~~l~h~~i--~~~~~~~~   54 (282)
                      ||+|.+..+|+.  ||||+++..... ..                      ...+.+|+..+..+.|+++  +.+++.  
T Consensus        63 Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~--  140 (258)
T 1zth_A           63 VFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTY--  140 (258)
T ss_dssp             EEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCCCCEEEE--
T ss_pred             EEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCCCeEEEc--
Confidence            899998788999  999987642111 00                      0257889999999988764  334432  


Q ss_pred             eCCeEEEEEecCcc------cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCcEEEcCCCcEEEEe
Q psy6044          55 SEKKLTLVFEHCDQ------DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH-SRNVLHRDLKPQNLLINKNGELKLAD  127 (282)
Q Consensus        55 ~~~~~~iv~e~~~g------~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh-~~~i~H~dl~~~nil~~~~~~~~l~d  127 (282)
                        ...++||||+++      .+.+. ..   ..++..+..++.|++.||.+|| +.|++|+||||.||+++.  .++|+|
T Consensus       141 --~~~~lVmE~~g~~g~~~~~L~~~-~~---~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~--~~~liD  212 (258)
T 1zth_A          141 --MKNVLLMEFIGEDELPAPTLVEL-GR---ELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFID  212 (258)
T ss_dssp             --ETTEEEEECCEETTEECCBHHHH-GG---GGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--SEEECC
T ss_pred             --CCCEEEEEecCCCCCccccHHHH-hh---ccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEE
Confidence              245899999953      34433 22   1235567889999999999999 999999999999999988  999999


Q ss_pred             cCCcccc
Q psy6044         128 FGLARAF  134 (282)
Q Consensus       128 f~~~~~~  134 (282)
                      ||++...
T Consensus       213 FG~a~~~  219 (258)
T 1zth_A          213 MGQAVTL  219 (258)
T ss_dssp             CTTCEET
T ss_pred             CcccccC
Confidence            9998654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.60  E-value=3.6e-16  Score=130.24  Aligned_cols=127  Identities=15%  Similarity=0.096  Sum_probs=82.0

Q ss_pred             eeeeeeCCCCceEEEeeeecCC-C-CCC-----------CccHHHHHHHHhhCCCCCccceeeeeeeC------CeEEEE
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG-N-EGV-----------PSSALREICLLKELKHKNIVRLYDVLHSE------KKLTLV   62 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~-~-~~~-----------~~~~~~e~~~~~~l~h~~i~~~~~~~~~~------~~~~iv   62 (282)
                      ||+|.+. +|+.||||+++... . ...           ....+.+..+.....|+|+.+++......      ...+||
T Consensus       111 VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p~~~~~~~LV  189 (397)
T 4gyi_A          111 IMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEPIAQSRHTIV  189 (397)
T ss_dssp             EEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCEEEEETTEEE
T ss_pred             EEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeeccCceEE
Confidence            8999984 69999999986411 0 000           01122222232223344443333221111      122699


Q ss_pred             EecCcccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC----------cEEEEecCCcc
Q psy6044          63 FEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG----------ELKLADFGLAR  132 (282)
Q Consensus        63 ~e~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~----------~~~l~df~~~~  132 (282)
                      |||++|..+..+.      .......++.||+.+|.+||+.|++|+||||.|||++.++          .+.|+||+.+.
T Consensus       190 ME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          190 MSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMV  263 (397)
T ss_dssp             EECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred             EEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcc
Confidence            9999986543221      1223457889999999999999999999999999998876          38999999876


Q ss_pred             ccC
Q psy6044         133 AFG  135 (282)
Q Consensus       133 ~~~  135 (282)
                      ...
T Consensus       264 ~~~  266 (397)
T 4gyi_A          264 SMD  266 (397)
T ss_dssp             ETT
T ss_pred             cCC
Confidence            544

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.36  E-value=5.9e-12  Score=100.67  Aligned_cols=123  Identities=17%  Similarity=0.114  Sum_probs=94.9

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      ||++..  .|+.+++|+...... .....+.+|+.+++.+ .+..++++++++.+.+..|+|||+++|..+.....    
T Consensus        30 v~~~~~--~~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~----  102 (263)
T 3tm0_A           30 VYKLVG--ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE----  102 (263)
T ss_dssp             EEEEEC--SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC----
T ss_pred             EEEEEC--CCCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC----
Confidence            677764  378999999875221 2245799999999998 46778899999999999999999999965554311    


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHh----------------------------------------------------------
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHS----------------------------------------------------------  102 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~----------------------------------------------------------  102 (282)
                       +......++.+++.+|+.||+                                                          
T Consensus       103 -~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~  181 (263)
T 3tm0_A          103 -DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEE  181 (263)
T ss_dssp             -TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCC
T ss_pred             -CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCC
Confidence             122234678899999999998                                                          


Q ss_pred             -CCccccCCCCCcEEEcCCCcEEEEecCCcc
Q psy6044         103 -RNVLHRDLKPQNLLINKNGELKLADFGLAR  132 (282)
Q Consensus       103 -~~i~H~dl~~~nil~~~~~~~~l~df~~~~  132 (282)
                       ..++|+|++|.||+++.++.+.|+||+.+.
T Consensus       182 ~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          182 ELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence             448999999999999776556799998663

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.20  E-value=9.9e-11  Score=93.30  Aligned_cols=118  Identities=13%  Similarity=0.037  Sum_probs=88.4

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCC--ccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKN--IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~--i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||++.. .+|..+++|+....    ....+..|+.+++.+.+.+  +++++++...++..++|||+++|..+. .    .
T Consensus        36 v~~~~~-~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-~----~  105 (264)
T 1nd4_A           36 VFRLSA-QGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-S----S  105 (264)
T ss_dssp             EEEEEC-TTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-T----S
T ss_pred             EEEEec-CCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-c----C
Confidence            677754 56788999986532    3467889999999985434  567888888888899999999986543 1    1


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------------------
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRN-------------------------------------------------------  104 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~-------------------------------------------------------  104 (282)
                      ..+   ...++.+++..|+.||+..                                                       
T Consensus       106 ~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  182 (264)
T 1nd4_A          106 HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE  182 (264)
T ss_dssp             CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred             cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCC
Confidence            122   2256677888888888643                                                       


Q ss_pred             ---ccccCCCCCcEEEcCCCcEEEEecCCcc
Q psy6044         105 ---VLHRDLKPQNLLINKNGELKLADFGLAR  132 (282)
Q Consensus       105 ---i~H~dl~~~nil~~~~~~~~l~df~~~~  132 (282)
                         ++|+|++|.||+++.++.+.|+||+.+.
T Consensus       183 ~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          183 DLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             CEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence               9999999999999876666799998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.12  E-value=2.6e-10  Score=95.33  Aligned_cols=128  Identities=13%  Similarity=0.158  Sum_probs=94.1

Q ss_pred             eeeeeeCCCCceEEEeeee--cCCCCCCCccHHHHHHHHhhCC--CCCccceeeeeeeC---CeEEEEEecCcccHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTH--LVGNEGVPSSALREICLLKELK--HKNIVRLYDVLHSE---KKLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~--~~~~~~~~~~~~~e~~~~~~l~--h~~i~~~~~~~~~~---~~~~iv~e~~~g~l~~~~   74 (282)
                      ||+....  +..+++|+..  ..........+.+|+.+++.+.  +..+++++.++.+.   +..|+|||+++|..+.. 
T Consensus        54 ~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~-  130 (359)
T 3dxp_A           54 TFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWD-  130 (359)
T ss_dssp             EEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCC-
T ss_pred             EEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCC-
Confidence            5766643  4678888876  3221223468889999999996  45578888888776   45899999999854421 


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------------
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHS----------------------------------------------------  102 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~----------------------------------------------------  102 (282)
                       ..-..++......++.+++..|+.||+                                                    
T Consensus       131 -~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  209 (359)
T 3dxp_A          131 -QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIP  209 (359)
T ss_dssp             -TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCC
T ss_pred             -CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCC
Confidence             112347788888999999999999997                                                    


Q ss_pred             ------CCccccCCCCCcEEEcCCCc--EEEEecCCccc
Q psy6044         103 ------RNVLHRDLKPQNLLINKNGE--LKLADFGLARA  133 (282)
Q Consensus       103 ------~~i~H~dl~~~nil~~~~~~--~~l~df~~~~~  133 (282)
                            .+++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       210 ~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          210 QEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             STTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                  35899999999999987753  68999998754

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.67  E-value=1.6e-08  Score=82.46  Aligned_cols=167  Identities=14%  Similarity=0.044  Sum_probs=103.4

Q ss_pred             ceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCC--ccceeeeeeeCC---eEEEEEecCcccHHHHHHhcCCCCCHHH
Q psy6044          12 TALAIKGTHLVGNEGVPSSALREICLLKEL-KHKN--IVRLYDVLHSEK---KLTLVFEHCDQDLKKYFDSLNGEIDLDI   85 (282)
Q Consensus        12 ~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~--i~~~~~~~~~~~---~~~iv~e~~~g~l~~~~~~~~~~~~~~~   85 (282)
                      ..+++|+....   .....+.+|+.+++.+ .+..  +++++.......   ..|+||++++|..+.....  ..++.++
T Consensus        41 ~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~--~~l~~~~  115 (304)
T 3sg8_A           41 RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL--NNLPKQS  115 (304)
T ss_dssp             TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH--HTSCHHH
T ss_pred             CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc--ccCCHHH
Confidence            46888875421   2245688999999887 3333  445555443333   4589999999854432111  3567777


Q ss_pred             HHHHHHHHHHHHHHHHh----------------------------------------------------------CCccc
Q psy6044          86 VKSFMYQLLRGLAFCHS----------------------------------------------------------RNVLH  107 (282)
Q Consensus        86 ~~~~~~qi~~~l~~lh~----------------------------------------------------------~~i~H  107 (282)
                      ...++.+++..++.||+                                                          ..++|
T Consensus       116 ~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~H  195 (304)
T 3sg8_A          116 QNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIH  195 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEEC
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEe
Confidence            88888888888888885                                                          13699


Q ss_pred             cCCCCCcEEEcC--CCcEEEEecCCccccCCCccccccccccccccChhhhc------CCCC-------CCchhhHHHHH
Q psy6044         108 RDLKPQNLLINK--NGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF------GAKL-------YTTSIDMWSAG  172 (282)
Q Consensus       108 ~dl~~~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~-------~~~~~Di~slG  172 (282)
                      +|++|.||+++.  .+.+.|+||+.+..-... ...........-.+|+...      +...       .....+.|++|
T Consensus       196 gD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~  274 (304)
T 3sg8_A          196 NDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFE  274 (304)
T ss_dssp             SCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHH
Confidence            999999999988  456789999987643211 1111100000002222210      0000       12236899999


Q ss_pred             HHHHHHHhcCCC
Q psy6044         173 CIFAELANAGRP  184 (282)
Q Consensus       173 ~ll~~ll~~~~p  184 (282)
                      .+++.+.+|..+
T Consensus       275 ~~~~~~~~g~~~  286 (304)
T 3sg8_A          275 KIIYGKEYGYMD  286 (304)
T ss_dssp             HHHHHHHTTCHH
T ss_pred             HHHHHHHcCCHH
Confidence            999999977655

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.66  E-value=1.3e-07  Score=75.64  Aligned_cols=123  Identities=15%  Similarity=0.063  Sum_probs=88.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCC-CCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      ||+......+..+++|+-...    ....+..|...++.+. +--+++++.++.+.+..++|||+++|..+.......  
T Consensus        41 v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~--  114 (272)
T 4gkh_A           41 IYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY--  114 (272)
T ss_dssp             EEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC--
T ss_pred             EEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC--
Confidence            577666667788999986532    2456788999998883 334788899999999999999999985444332211  


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------------------
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSR---------------------------------------------------------  103 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~---------------------------------------------------------  103 (282)
                        ......+..++...|+.||+.                                                         
T Consensus       115 --~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  192 (272)
T 4gkh_A          115 --PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPD  192 (272)
T ss_dssp             --GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCC
T ss_pred             --HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCC
Confidence              122334556666666677641                                                         


Q ss_pred             -CccccCCCCCcEEEcCCCcEEEEecCCcc
Q psy6044         104 -NVLHRDLKPQNLLINKNGELKLADFGLAR  132 (282)
Q Consensus       104 -~i~H~dl~~~nil~~~~~~~~l~df~~~~  132 (282)
                       .++|||+.+.||+++.++.+-|+||+.+.
T Consensus       193 ~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          193 SVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             EEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence             16899999999999887777799998764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.50  E-value=4.5e-06  Score=63.21  Aligned_cols=135  Identities=16%  Similarity=0.095  Sum_probs=94.0

Q ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccccccccc
Q psy6044          69 DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVT  147 (282)
Q Consensus        69 ~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  147 (282)
                      +|.+.+...+.+++|+++|.++.|.+.+|..+-. +.-...-+.|..|++..+|.+.+.+= .+.            ...
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~~-~s~------------~~~  100 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAPA-ADD------------AGE  100 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECCC-------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceecccc-ccc------------ccc
Confidence            6888888889999999999999999999877632 22223345678999999999887641 110            012


Q ss_pred             ccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHP  227 (282)
Q Consensus       148 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (282)
                      ..+.+||....  ..+.+.-|||||+++|..+..+.|.                                          
T Consensus       101 ~~~~~pe~~~~--~~te~~~IysLG~tLY~ALDygL~e------------------------------------------  136 (229)
T 2yle_A          101 PPPVAGKLGYS--QCMETEVIESLGIIIYKALDYGLKE------------------------------------------  136 (229)
T ss_dssp             ------CCSSS--SSCHHHHHHHHHHHHHHHHTTTCCT------------------------------------------
T ss_pred             cCCCChhhccc--cchHHHHHHHHHHHHHHHhhcCCCc------------------------------------------
Confidence            23567877632  2478999999999999999665551                                          


Q ss_pred             CCCccccCccCCHHHHHHHHHhccc-------------------------CCCCCCCHHHHhc
Q psy6044         228 SMSFSQVAPKLTAKGRDLLQRLLVC-------------------------NPVQRMSAEDAMS  265 (282)
Q Consensus       228 ~~~~~~~~~~~~~~l~~li~~~l~~-------------------------dp~~Rps~~~ll~  265 (282)
                           .-...+|+.|.+||..|..-                         .+..|+|+++|++
T Consensus       137 -----~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          137 -----NEERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             -----TEEECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHH
T ss_pred             -----ccchhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHH
Confidence                 12245899999999988765                         3468889998875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.45  E-value=7.2e-07  Score=72.70  Aligned_cols=118  Identities=19%  Similarity=0.155  Sum_probs=79.5

Q ss_pred             CceEEEeeeecCCCCCCCccHHHHHHHHhhCCCC---Cccceeeeee-eCCeEEEEEecCcccHHHHHHhcCCCCCHHHH
Q psy6044          11 NTALAIKGTHLVGNEGVPSSALREICLLKELKHK---NIVRLYDVLH-SEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIV   86 (282)
Q Consensus        11 ~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~---~i~~~~~~~~-~~~~~~iv~e~~~g~l~~~~~~~~~~~~~~~~   86 (282)
                      |..+++|+...   ......+..|+.+++.+.+.   .+++.+.+.. ..+..++|||+++|..+....-  ..++....
T Consensus        39 g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~--~~l~~~~~  113 (306)
T 3tdw_A           39 NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM--AVLPDDAK  113 (306)
T ss_dssp             TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH--TTSCHHHH
T ss_pred             CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh--hhCCHHHH
Confidence            56788887421   12245788999999999642   3566666664 4566889999999864443211  23455555


Q ss_pred             HHHHHHHHHHHHHHHhC------------------------------------------------------------Ccc
Q psy6044          87 KSFMYQLLRGLAFCHSR------------------------------------------------------------NVL  106 (282)
Q Consensus        87 ~~~~~qi~~~l~~lh~~------------------------------------------------------------~i~  106 (282)
                      ..+..++...|+.||+.                                                            .++
T Consensus       114 ~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~  193 (306)
T 3tdw_A          114 DRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLI  193 (306)
T ss_dssp             HHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEE
T ss_pred             HHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeE
Confidence            55566666665555532                                                            358


Q ss_pred             ccCCCCCcEEEcC---CCcE-EEEecCCccc
Q psy6044         107 HRDLKPQNLLINK---NGEL-KLADFGLARA  133 (282)
Q Consensus       107 H~dl~~~nil~~~---~~~~-~l~df~~~~~  133 (282)
                      |+|+++.||+++.   ++.+ .|+||+.+..
T Consensus       194 HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          194 HGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             CSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             eCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence            9999999999987   4554 8999998754

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.05  E-value=2e-05  Score=66.50  Aligned_cols=65  Identities=17%  Similarity=0.059  Sum_probs=40.1

Q ss_pred             eeeeeeCCCCceEEEeeeecCCC------CCCCccHHHHHHHHhhCCC--C-CccceeeeeeeCCeEEEEEecCcc
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGN------EGVPSSALREICLLKELKH--K-NIVRLYDVLHSEKKLTLVFEHCDQ   68 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~~~~l~h--~-~i~~~~~~~~~~~~~~iv~e~~~g   68 (282)
                      ||++.+..+++.+++|.......      ......+..|.++++.+..  | .+++++.+  +....++|||+++|
T Consensus        46 vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lvmE~l~g  119 (397)
T 2olc_A           46 VFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVMEDLSH  119 (397)
T ss_dssp             EEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEECCCTT
T ss_pred             EEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEEEEeCCC
Confidence            78887766788999998653111      1234567889999988732  3 34556644  34445899999976

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.99  E-value=5.1e-05  Score=62.51  Aligned_cols=30  Identities=23%  Similarity=0.387  Sum_probs=27.1

Q ss_pred             CCccccCCCCCcEEEcCCCcEEEEecCCcc
Q psy6044         103 RNVLHRDLKPQNLLINKNGELKLADFGLAR  132 (282)
Q Consensus       103 ~~i~H~dl~~~nil~~~~~~~~l~df~~~~  132 (282)
                      .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            579999999999999888899999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.97  E-value=1.3e-05  Score=66.64  Aligned_cols=59  Identities=3%  Similarity=-0.080  Sum_probs=40.6

Q ss_pred             CceEEEeeeecCC--CCCCCccHHHHHHHHhhCC-C--CCccceeeeeeeC---CeEEEEEecCccc
Q psy6044          11 NTALAIKGTHLVG--NEGVPSSALREICLLKELK-H--KNIVRLYDVLHSE---KKLTLVFEHCDQD   69 (282)
Q Consensus        11 ~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h--~~i~~~~~~~~~~---~~~~iv~e~~~g~   69 (282)
                      ++.+++|......  .......+..|+.+++.+. +  -.+++++.+..+.   +..++|||+++|.
T Consensus        52 ~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~  118 (357)
T 3ats_A           52 QQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGV  118 (357)
T ss_dssp             EEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCB
T ss_pred             CceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCC
Confidence            6678888754321  0112367889999999884 2  3577888877655   4578999999874

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.51  E-value=0.0004  Score=56.16  Aligned_cols=29  Identities=17%  Similarity=0.257  Sum_probs=24.8

Q ss_pred             CccccCCCCCcEEEcCCCcEEEEecCCccc
Q psy6044         104 NVLHRDLKPQNLLINKNGELKLADFGLARA  133 (282)
Q Consensus       104 ~i~H~dl~~~nil~~~~~~~~l~df~~~~~  133 (282)
                      .++|+|+.+.||+ ..++.+.++||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            3899999999999 6677889999987753

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.26  E-value=0.0022  Score=53.54  Aligned_cols=117  Identities=15%  Similarity=0.135  Sum_probs=71.6

Q ss_pred             CCceEEEeeeecCCCCCCCccHHHHHHHHhhCC-CCCccceeeeeeeCCeEEEEEecCcccHH-----------------
Q psy6044          10 PNTALAIKGTHLVGNEGVPSSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQDLK-----------------   71 (282)
Q Consensus        10 ~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~g~l~-----------------   71 (282)
                      +++.+++|+.-..  ........+|..+++.+. +.-.+++++.+.+    .+|+||++|..+                 
T Consensus        81 ~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~  154 (379)
T 3feg_A           81 EPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATK  154 (379)
T ss_dssp             CCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHH
T ss_pred             CCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHH
Confidence            4578888875321  123455668999998883 3334667766543    389999987321                 


Q ss_pred             -HHHHhcCCC----C--CHHHHHHHHHHHHH-------------------HHHHHH----h----CCccccCCCCCcEEE
Q psy6044          72 -KYFDSLNGE----I--DLDIVKSFMYQLLR-------------------GLAFCH----S----RNVLHRDLKPQNLLI  117 (282)
Q Consensus        72 -~~~~~~~~~----~--~~~~~~~~~~qi~~-------------------~l~~lh----~----~~i~H~dl~~~nil~  117 (282)
                       ..++....+    .  -...+..+..++..                   .+..|.    .    ..++|+|+.+.||++
T Consensus       155 La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~  234 (379)
T 3feg_A          155 MAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILL  234 (379)
T ss_dssp             HHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEE
T ss_pred             HHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEE
Confidence             112222111    1  13556666655422                   123332    2    248999999999999


Q ss_pred             cCC----CcEEEEecCCcc
Q psy6044         118 NKN----GELKLADFGLAR  132 (282)
Q Consensus       118 ~~~----~~~~l~df~~~~  132 (282)
                      +.+    +.+.++||..+.
T Consensus       235 ~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          235 LSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             ESCC---CCEEECCCTTCE
T ss_pred             cCCCCccCcEEEEecccCC
Confidence            876    789999998875

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.26  E-value=0.0011  Score=53.81  Aligned_cols=62  Identities=18%  Similarity=0.051  Sum_probs=46.9

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCC---CCCccceeeeeeeCCeEEEEEecCccc
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK---HKNIVRLYDVLHSEKKLTLVFEHCDQD   69 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~---h~~i~~~~~~~~~~~~~~iv~e~~~g~   69 (282)
                      +|+...  ++..+++|+....    ....+..|+..++.+.   ...+++++.+....+..++|||+++|.
T Consensus        52 ~y~v~~--~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           52 IWLIND--EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEEES--SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eeEEEE--CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            455553  4678889987642    2456888999998883   366888898888888999999999863

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.25  E-value=0.0025  Score=54.08  Aligned_cols=31  Identities=13%  Similarity=0.351  Sum_probs=27.1

Q ss_pred             hCCccccCCCCCcEEEcCCCcEEEEecCCccc
Q psy6044         102 SRNVLHRDLKPQNLLINKNGELKLADFGLARA  133 (282)
Q Consensus       102 ~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~  133 (282)
                      ...++|||++|.||+++.++ +.++||+.+..
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            46799999999999998776 99999988754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.18  E-value=0.002  Score=52.77  Aligned_cols=32  Identities=31%  Similarity=0.359  Sum_probs=27.1

Q ss_pred             CCccccCCCCCcEEEcCC----CcEEEEecCCcccc
Q psy6044         103 RNVLHRDLKPQNLLINKN----GELKLADFGLARAF  134 (282)
Q Consensus       103 ~~i~H~dl~~~nil~~~~----~~~~l~df~~~~~~  134 (282)
                      ..++|||+++.||+++.+    +.+.|+||+.+..-
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            469999999999999874    68999999987543

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.95  E-value=0.0087  Score=48.73  Aligned_cols=64  Identities=13%  Similarity=0.018  Sum_probs=39.0

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCC--Cccceeee-----eeeCCeEEEEEecCcc
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHK--NIVRLYDV-----LHSEKKLTLVFEHCDQ   68 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~--~i~~~~~~-----~~~~~~~~iv~e~~~g   68 (282)
                      ||+... .+|+.+++|..+..  ......+..|..+++.+...  .+++++..     ....+..++++++++|
T Consensus        41 ~y~v~~-~~g~~~vlK~~~~~--~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G  111 (328)
T 1zyl_A           41 VYQFQD-EDRRRFVVKFYRPE--RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  111 (328)
T ss_dssp             EEEECC-TTCCCEEEEEECTT--TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             eEEEEc-CCCCEEEEEEcCCC--CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence            455543 34678999987631  11235677788888877321  23444432     2235567899999987

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.85  E-value=0.0038  Score=53.12  Aligned_cols=51  Identities=12%  Similarity=0.098  Sum_probs=33.5

Q ss_pred             CceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCC-ccceeeeeeeCCeEEEEEecCcc
Q psy6044          11 NTALAIKGTHLVGNEGVPSSALREICLLKELKHKN-IVRLYDVLHSEKKLTLVFEHCDQ   68 (282)
Q Consensus        11 ~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~-i~~~~~~~~~~~~~~iv~e~~~g   68 (282)
                      +..+++|+....   .....+..|..+++.+...+ .+++++.+.  +  .+|+||++|
T Consensus       105 ~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~l~G  156 (429)
T 1nw1_A          105 PNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEYIPS  156 (429)
T ss_dssp             CSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECCCCE
T ss_pred             CceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEEeCC
Confidence            578889887321   11156668999998884333 366776553  2  389999986

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.80  E-value=0.0052  Score=49.96  Aligned_cols=126  Identities=12%  Similarity=0.002  Sum_probs=69.4

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCC--ccceeee------eeeCCeEEEEEecCcccH---
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKN--IVRLYDV------LHSEKKLTLVFEHCDQDL---   70 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~--i~~~~~~------~~~~~~~~iv~e~~~g~l---   70 (282)
                      +|+...  ++..+++|.....   .....+..|..+++.+....  +++++..      ....+..++++++++|..   
T Consensus        38 ~~~v~~--~~g~~vlk~~~~~---~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~  112 (322)
T 2ppq_A           38 NFLLHT--TKDPLILTLYEKR---VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRK  112 (322)
T ss_dssp             EEEEEE--SSCCEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSS
T ss_pred             eEEEEe--CCccEEEEEeCCC---CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCC
Confidence            355543  2336888887642   23456777888887773212  3333321      123467899999998742   


Q ss_pred             ------------HHHHHhcCCC--------CCHHHHHHH---------------HHHHHHHHHHHHh-------CCcccc
Q psy6044          71 ------------KKYFDSLNGE--------IDLDIVKSF---------------MYQLLRGLAFCHS-------RNVLHR  108 (282)
Q Consensus        71 ------------~~~~~~~~~~--------~~~~~~~~~---------------~~qi~~~l~~lh~-------~~i~H~  108 (282)
                                  +..++.....        .........               ...+...+..+.+       .+++|+
T Consensus       113 ~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHg  192 (322)
T 2ppq_A          113 PEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHA  192 (322)
T ss_dssp             CCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECS
T ss_pred             CCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCC
Confidence                        1122221111        111100000               0113334455542       369999


Q ss_pred             CCCCCcEEEcCCCcEEEEecCCcc
Q psy6044         109 DLKPQNLLINKNGELKLADFGLAR  132 (282)
Q Consensus       109 dl~~~nil~~~~~~~~l~df~~~~  132 (282)
                      |+++.||+++.++.+.|+||+.+.
T Consensus       193 Dl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          193 DLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             CCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CCCccCEEEeCCceEEEecchhcc
Confidence            999999999877666899998764

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.68  E-value=0.025  Score=46.46  Aligned_cols=31  Identities=16%  Similarity=0.318  Sum_probs=27.2

Q ss_pred             CCccccCCCCCcEEEcCCCcEEEEecCCccc
Q psy6044         103 RNVLHRDLKPQNLLINKNGELKLADFGLARA  133 (282)
Q Consensus       103 ~~i~H~dl~~~nil~~~~~~~~l~df~~~~~  133 (282)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3589999999999999888899999987754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.62  E-value=0.073  Score=45.58  Aligned_cols=61  Identities=18%  Similarity=0.071  Sum_probs=38.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCc-cceeeeeeeCCeEEEEEecCcc
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNI-VRLYDVLHSEKKLTLVFEHCDQ   68 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i-~~~~~~~~~~~~~~iv~e~~~g   68 (282)
                      +|+.....++..+++|+....  ....-.-..|+.+++.+...++ +++++.+.  +  ..|+||++|
T Consensus       124 ~y~v~~~~~~~~~vLRi~g~~--~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G  185 (458)
T 2qg7_A          124 LIKVKDMSKQAKYLIRLYGPK--TDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG  185 (458)
T ss_dssp             EEEEEETTTTEEEEEEEECC---CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred             EEEEEECCCCceEEEEECCCC--hhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence            566665444578888876432  1112233689999999864444 56777663  2  359999986

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.59  E-value=0.0054  Score=50.98  Aligned_cols=28  Identities=29%  Similarity=0.485  Sum_probs=23.5

Q ss_pred             CccccCCCCCcEEEcCCCcEEEEecCCcc
Q psy6044         104 NVLHRDLKPQNLLINKNGELKLADFGLAR  132 (282)
Q Consensus       104 ~i~H~dl~~~nil~~~~~~~~l~df~~~~  132 (282)
                      .++|+|+.+.||+++.++ +.|+||..+.
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            589999999999997554 8999998774

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.38  E-value=0.042  Score=43.79  Aligned_cols=61  Identities=16%  Similarity=0.035  Sum_probs=39.8

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCC---CCccceeeeeeeCCeEEEEEecCcc
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKH---KNIVRLYDVLHSEKKLTLVFEHCDQ   68 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h---~~i~~~~~~~~~~~~~~iv~e~~~g   68 (282)
                      ||+... .+|+.|++|+..... ......+..|+..|+.+..   --+++++.+  ..  .++|||++.+
T Consensus        31 vyrv~l-~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~l~~   94 (288)
T 3f7w_A           31 LYRVEL-ADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEWVDE   94 (288)
T ss_dssp             EEEEEE-TTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEECCCC
T ss_pred             EEEEEE-CCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEEeecc
Confidence            677765 579999999765422 2234567889999998842   224455543  22  3788999863

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.87  E-value=0.27  Score=41.54  Aligned_cols=29  Identities=24%  Similarity=0.509  Sum_probs=25.6

Q ss_pred             CccccCCCCCcEEEcCCCcEEEEecCCccc
Q psy6044         104 NVLHRDLKPQNLLINKNGELKLADFGLARA  133 (282)
Q Consensus       104 ~i~H~dl~~~nil~~~~~~~~l~df~~~~~  133 (282)
                      .++|+|+.+.||+ +.++.+.++||..+..
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            4899999999999 7888999999998753

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=87.24  E-value=0.28  Score=41.18  Aligned_cols=29  Identities=28%  Similarity=0.461  Sum_probs=24.7

Q ss_pred             ccccCCCCCcEEE------cCCCcEEEEecCCccc
Q psy6044         105 VLHRDLKPQNLLI------NKNGELKLADFGLARA  133 (282)
Q Consensus       105 i~H~dl~~~nil~------~~~~~~~l~df~~~~~  133 (282)
                      ++|+|+.+.||++      +.++.+.++||..+..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            7899999999999      3457799999998753

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=87.14  E-value=2  Score=32.57  Aligned_cols=83  Identities=19%  Similarity=0.113  Sum_probs=58.5

Q ss_pred             CCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q psy6044          42 KHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN  120 (282)
Q Consensus        42 ~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~  120 (282)
                      .||++  -..+-.+++.+.+.++.-+ +.....+    ...+....++++..|+.... -|...-+|--++|+|++++.+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~-~~~~~r~tf~l~P~NL~f~~~  120 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVK-HHSARRLIFIVCPENLMFNRA  120 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHS-SCCSSSEECCCCGGGEEECTT
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHH-HhhhCceeEEEeCceEEEeCC
Confidence            67888  4445566777777777663 3333333    35778889998888887544 122445677899999999999


Q ss_pred             CcEEEEecCCc
Q psy6044         121 GELKLADFGLA  131 (282)
Q Consensus       121 ~~~~l~df~~~  131 (282)
                      +.+++.-.|.-
T Consensus       121 ~~p~i~hRGi~  131 (219)
T 4ano_A          121 LEPFFLHVGVK  131 (219)
T ss_dssp             CCEEESCCEET
T ss_pred             CcEEEEEcCCc
Confidence            99999877654

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=82.75  E-value=1.3  Score=33.39  Aligned_cols=91  Identities=11%  Similarity=0.144  Sum_probs=62.7

Q ss_pred             HHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy6044          33 REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLK  111 (282)
Q Consensus        33 ~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~  111 (282)
                      .|+.++.. .||+++.. .+-.++..+.+.++.-+ +.....    -...+....++++..|+....++  ..-+|--++
T Consensus        35 ~el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~----ik~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~  106 (215)
T 4ann_A           35 HLMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN----IKSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLA  106 (215)
T ss_dssp             GGGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG----GGGSCHHHHHHHHHHGGGGGGGG--GSSEECCCS
T ss_pred             HHHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHH----HHhcCHHHHHHHHHHHHHHHHHh--cCceEEEEe
Confidence            44555544 68988877 56666676777676554 222222    23578888999999988866333  334577899


Q ss_pred             CCcEEEcCCCcEEEEecCCc
Q psy6044         112 PQNLLINKNGELKLADFGLA  131 (282)
Q Consensus       112 ~~nil~~~~~~~~l~df~~~  131 (282)
                      |+|++++.++.+++.-.|..
T Consensus       107 P~NL~f~~~~~p~i~~RGik  126 (215)
T 4ann_A          107 PDELFFTRDGLPIAKTRGLQ  126 (215)
T ss_dssp             GGGEEECTTSCEEESCCEET
T ss_pred             cceEEEcCCCCEEEEEccCc
Confidence            99999999999999866643

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	282
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-81
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-73
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-72
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-72
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-64
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-64
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-63
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-62
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-60
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-59
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-59
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-59
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	9e-58
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-56
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-55
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-55
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-55
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-54
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-53
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-52
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-52
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-50
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-50
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-49
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-47
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-46
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-46
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-45
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-44
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-44
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-44
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-43
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-42
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-42
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-42
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-42
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	8e-42
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-41
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-41
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-40
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-40
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-40
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-40
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	9e-40
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-39
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-39
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-39
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-38
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-38
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-37
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-37
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-37
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-36
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	8e-35
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-34
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-34
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-33
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-33
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-32
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-32
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-29
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	9e-17

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  244 bits (623), Expect = 4e-81
 Identities = 209/269 (77%), Positives = 235/269 (87%), Gaps = 1/269 (0%)

Query: 5   GVDRTPNTALAIKGTHLVG-NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF 63
             +R  +  +A+K   L   +EGVPSSALREICLLKELKHKNIVRL+DVLHS+KKLTLVF
Sbjct: 21  AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80

Query: 64  EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL 123
           E CDQDLKKYFDS NG++D +IVKSF++QLL+GL FCHSRNVLHRDLKPQNLLIN+NGEL
Sbjct: 81  EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGEL 140

Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           KLA+FGLARAFGIPV+CYSAEVVTLWYRPPDVLFGAKLY+TSIDMWSAGCIFAELANAGR
Sbjct: 141 KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

Query: 184 PLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGR 243
           PLFPG+DVDDQLKRIF+LLGTPTE+ WP M  LPD+KP+PMY  + S   V PKL A GR
Sbjct: 201 PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGR 260

Query: 244 DLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
           DLLQ LL CNPVQR+SAE+A+ H YFSD 
Sbjct: 261 DLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (569), Expect = 7e-73
 Identities = 113/272 (41%), Positives = 160/272 (58%), Gaps = 6/272 (2%)

Query: 5   GVDRTPNTALAIK----GTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT 60
             D+  N  +AIK    G      +G+  +ALREI LL+EL H NI+ L D    +  ++
Sbjct: 17  ARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 76

Query: 61  LVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN 120
           LVF+  + DL+      +  +    +K++M   L+GL + H   +LHRDLKP NLL+++N
Sbjct: 77  LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN 136

Query: 121 GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           G LKLADFGLA++FG P + Y+ +VVT WYR P++LFGA++Y   +DMW+ GCI AEL  
Sbjct: 137 GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL- 195

Query: 181 AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA 240
              P  PG    DQL RIF+ LGTPTE+ WP M  LPD+  F  + P +    +      
Sbjct: 196 LRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF-PGIPLHHIFSAAGD 254

Query: 241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
              DL+Q L + NP  R++A  A+   YFS+ 
Sbjct: 255 DLLDLIQGLFLFNPCARITATQALKMKYFSNR 286

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (565), Expect = 4e-72
 Identities = 147/271 (54%), Positives = 189/271 (69%), Gaps = 3/271 (1%)

Query: 5   GVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF 63
             ++     +A+K   L    EGVPS+A+REI LLKEL H NIV+L DV+H+E KL LVF
Sbjct: 21  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80

Query: 64  EHCDQDLKKYFD-SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           E   QDLKK+ D S    I L ++KS+++QLL+GLAFCHS  VLHRDLKPQNLLIN  G 
Sbjct: 81  EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 140

Query: 123 LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
           +KLADFGLARAFG+PV+ Y+ EVVTLWYR P++L G K Y+T++D+WS GCIFAE+    
Sbjct: 141 IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-R 199

Query: 183 RPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKG 242
           R LFPG    DQL RIF+ LGTP E  WPG+  +PD+KP         FS+V P L   G
Sbjct: 200 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 259

Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN 273
           R LL ++L  +P +R+SA+ A++H +F D+ 
Sbjct: 260 RSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  220 bits (562), Expect = 6e-72
 Identities = 143/268 (53%), Positives = 185/268 (69%), Gaps = 3/268 (1%)

Query: 5   GVDRTPNTALAIKGTHLVG-NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF 63
             +       A+K   L   +EG+PS+ +REI +LKELKH NIV+LYDV+H++K+L LVF
Sbjct: 21  AQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79

Query: 64  EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL 123
           EH DQDLKK  D   G ++    KSF+ QLL G+A+CH R VLHRDLKPQNLLIN+ GEL
Sbjct: 80  EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGEL 139

Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           K+ADFGLARAFGIPV+ Y+ E+VTLWYR PDVL G+K Y+T+ID+WS GCIFAE+ N G 
Sbjct: 140 KIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GT 198

Query: 184 PLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGR 243
           PLFPG    DQL RIF++LGTP    WP +  LP + P    +  + +      L   G 
Sbjct: 199 PLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGI 258

Query: 244 DLLQRLLVCNPVQRMSAEDAMSHIYFSD 271
           DLL ++L  +P QR++A+ A+ H YF +
Sbjct: 259 DLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 3e-64
 Identities = 98/283 (34%), Positives = 150/283 (53%), Gaps = 17/283 (6%)

Query: 5   GVDRTPNTALAIKGTHLVG-NEGVPSSALREICLLKELKHKNIVRLYDVLHS-------- 55
              R     +A+K   +    EG P +ALREI +L+ LKH+N+V L ++  +        
Sbjct: 29  ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88

Query: 56  EKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNL 115
           +  + LVF+ C+ DL     ++  +  L  +K  M  LL GL + H   +LHRD+K  N+
Sbjct: 89  KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANV 148

Query: 116 LINKNGELKLADFGLARAFGIP----VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
           LI ++G LKLADFGLARAF +        Y+  VVTLWYRPP++L G + Y   ID+W A
Sbjct: 149 LITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA 208

Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM---YHPS 228
           GCI AE+     P+  G+    QL  I +L G+ T + WP ++    ++   +       
Sbjct: 209 GCIMAEMW-TRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRK 267

Query: 229 MSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD 271
           +     A        DL+ +LLV +P QR+ ++DA++H +F  
Sbjct: 268 VKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 6e-64
 Identities = 64/284 (22%), Positives = 117/284 (41%), Gaps = 18/284 (6%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
              +     +A K  HL     + +  +RE+ +L E     IV  Y   +S+ ++++  E
Sbjct: 25  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84

Query: 65  HCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN-VLHRDLKPQNLLINKNGEL 123
           H D           G I   I+      +++GL +   ++ ++HRD+KP N+L+N  GE+
Sbjct: 85  HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 144

Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGR 183
           KL DFG++          ++ V T  Y  P+ L G   Y+   D+WS G    E+A    
Sbjct: 145 KLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRY 201

Query: 184 PLFPGSDVDDQLKRIFKLLGTPTED-TWPGMNLLPDFKPFPMYHPSMSFSQV-------- 234
           P+ P    + +L    ++ G   E    P     P         P M+  ++        
Sbjct: 202 PIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEP 261

Query: 235 -----APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN 273
                +   + + +D + + L+ NP +R   +  M H +    +
Sbjct: 262 PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 7e-63
 Identities = 90/250 (36%), Positives = 135/250 (54%), Gaps = 12/250 (4%)

Query: 33  REICLLKELKHKNIVRLYDVLHS------EKKLTLVFEHCDQ---DLKKYFDSLNGEIDL 83
           RE+ ++++L H NIVRL    +S      E  L LV ++  +    + +++      + +
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121

Query: 84  DIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL-KLADFGLARAFGIPVKCYS 142
             VK +MYQL R LA+ HS  + HRD+KPQNLL++ +  + KL DFG A+         S
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181

Query: 143 AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLL 202
             + + +YR P+++FGA  YT+SID+WSAGC+ AEL   G+P+FPG    DQL  I K+L
Sbjct: 182 -YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIKVL 239

Query: 203 GTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAED 262
           GTPT +    MN       FP            P+   +   L  RLL   P  R++  +
Sbjct: 240 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299

Query: 263 AMSHIYFSDL 272
           A +H +F +L
Sbjct: 300 ACAHSFFDEL 309

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 2e-62
 Identities = 95/278 (34%), Positives = 145/278 (52%), Gaps = 13/278 (4%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE-----KKL 59
             D      +AIK      ++      LREI +L   +H+NI+ + D++ +      K +
Sbjct: 27  AYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86

Query: 60  TLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK 119
            LV      DL K        +  D +  F+YQ+LRGL + HS NVLHRDLKP NLL+N 
Sbjct: 87  YLVTHLMGADLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 144

Query: 120 NGELKLADFGLARAF---GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFA 176
             +LK+ DFGLAR            +  V T WYR P+++  +K YT SID+WS GCI A
Sbjct: 145 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILA 204

Query: 177 ELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLP--DFKPFPMYHPSMSFSQV 234
           E+  + RP+FPG    DQL  I  +LG+P+++    +  L   ++     +   + ++++
Sbjct: 205 EML-SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL 263

Query: 235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
            P   +K  DLL ++L  NP +R+  E A++H Y    
Sbjct: 264 FPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (487), Expect = 2e-60
 Identities = 122/285 (42%), Positives = 167/285 (58%), Gaps = 21/285 (7%)

Query: 8   RTPNTALAIKGTHL-VGNEGVPSSALREICLLKELK---HKNIVRLYDVLHS-----EKK 58
           +     +A+K   +  G EG+P S +RE+ +L+ L+   H N+VRL+DV        E K
Sbjct: 30  KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 89

Query: 59  LTLVFEHCDQDLKKYFDSLNGE-IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI 117
           LTLVFEH DQDL  Y D +    +  + +K  M+QLLRGL F HS  V+HRDLKPQN+L+
Sbjct: 90  LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV 149

Query: 118 NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAE 177
             +G++KLADFGLAR +   +   S  VVTLWYR P+VL  +  Y T +D+WS GCIFAE
Sbjct: 150 TSSGQIKLADFGLARIYSFQMALTSV-VVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAE 207

Query: 178 LANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK 237
           +    +PLF GS   DQL +I  ++G P E+ WP    LP  +       +    +    
Sbjct: 208 MF-RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP--RQAFHSKSAQPIEKFVTD 264

Query: 238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKSERCQ 282
           +   G+DLL + L  NP +R+SA  A+SH YF DL      ERC+
Sbjct: 265 IDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL------ERCK 303

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  190 bits (484), Expect = 3e-59
 Identities = 61/279 (21%), Positives = 115/279 (41%), Gaps = 32/279 (11%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
             +R      A K   +  +E    +  +EI  +  L+H  +V L+D    + ++ +++E
Sbjct: 45  VTERATGNNFAAK-FVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103

Query: 65  HCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN--KNG 121
                +L +     + ++  D    +M Q+ +GL   H  N +H DLKP+N++    ++ 
Sbjct: 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSN 163

Query: 122 ELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANA 181
           ELKL DFGL      P +       T  +  P+V  G        DMWS G +   L  +
Sbjct: 164 ELKLIDFGLTAHLD-PKQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILL-S 220

Query: 182 GRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAK 241
           G   F G + D+ L+ +        +  + G                         ++  
Sbjct: 221 GLSPFGGENDDETLRNVKSCDWNMDDSAFSG-------------------------ISED 255

Query: 242 GRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKSER 280
           G+D +++LL+ +P  RM+   A+ H + +  N   +  +
Sbjct: 256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQ 294

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 5e-59
 Identities = 72/268 (26%), Positives = 119/268 (44%), Gaps = 35/268 (13%)

Query: 5   GVDRTPNTALAIK--GTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLV 62
             ++     LA+K      +   GV     RE+ +   L+H NI+RLY   H   ++ L+
Sbjct: 25  AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84

Query: 63  FEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
            E+              + D     +++ +L   L++CHS+ V+HRD+KP+NLL+   GE
Sbjct: 85  LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE 144

Query: 123 LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
           LK+ADFG +     P    +    TL Y PP+++ G +++   +D+WS G +  E    G
Sbjct: 145 LKIADFGWSVH--APSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL-VG 200

Query: 183 RPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKG 242
           +P F  +   +  KRI ++                    FP              +T   
Sbjct: 201 KPPFEANTYQETYKRISRVEF-----------------TFP------------DFVTEGA 231

Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
           RDL+ RLL  NP QR    + + H + +
Sbjct: 232 RDLISRLLKHNPSQRPMLREVLEHPWIT 259

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 7e-59
 Identities = 57/271 (21%), Positives = 105/271 (38%), Gaps = 33/271 (12%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
             ++  +   A K       E +    + EI +L    H NIV+L D  + E  L ++ E
Sbjct: 31  AQNKETSVLAAAKVIDTKSEEEL-EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89

Query: 65  HCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGEL 123
            C    +      L   +    ++    Q L  L + H   ++HRDLK  N+L   +G++
Sbjct: 90  FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDI 149

Query: 124 KLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG----AKLYTTSIDMWSAGCIFAELA 179
           KLADFG++      ++   + + T ++  P+V+       + Y    D+WS G    E+A
Sbjct: 150 KLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 209

Query: 180 NAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT 239
               P     +    L +I K                   +P  +  P         + +
Sbjct: 210 -EIEPPHHELNPMRVLLKIAK------------------SEPPTLAQP--------SRWS 242

Query: 240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
           +  +D L++ L  N   R +    + H + +
Sbjct: 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 9e-58
 Identities = 62/268 (23%), Positives = 109/268 (40%), Gaps = 29/268 (10%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            V+R    A+A+K   +      P +  +EIC+ K L H+N+V+ Y          L  E
Sbjct: 24  AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83

Query: 65  HCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELK 124
           +C           +  +     + F +QL+ G+ + H   + HRD+KP+NLL+++   LK
Sbjct: 84  YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLK 143

Query: 125 LADFGLARAFGIPV--KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
           ++DFGLA  F      +  +    TL Y  P++L   + +   +D+WS G +   +  AG
Sbjct: 144 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML-AG 202

Query: 183 RPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKG 242
              +       Q    +K   T                                K+ +  
Sbjct: 203 ELPWDQPSDSCQEYSDWKEKKTYLNPW--------------------------KKIDSAP 236

Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
             LL ++LV NP  R++  D     +++
Sbjct: 237 LALLHKILVENPSARITIPDIKKDRWYN 264

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 4e-56
 Identities = 94/278 (33%), Positives = 149/278 (53%), Gaps = 15/278 (5%)

Query: 5   GVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT--- 60
            VD      +AIK  +    +E     A RE+ LLK ++H+N++ L DV   ++ L    
Sbjct: 37  AVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96

Query: 61  ---LVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI 117
              LV      DL K     + ++  D ++  +YQ+L+GL + H+  ++HRDLKP NL +
Sbjct: 97  DFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV 154

Query: 118 NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAE 177
           N++ ELK+ DFGLAR         +  VVT WYR P+V+     YT ++D+WS GCI AE
Sbjct: 155 NEDCELKILDFGLARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 211

Query: 178 LANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGM--NLLPDFKPFPMYHPSMSFSQVA 235
           +   G+ LF GSD  DQLK I K+ GTP  +    +  +   ++           F+ + 
Sbjct: 212 MI-TGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASIL 270

Query: 236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN 273
              +    +LL+++LV +  QR++A +A++H YF  L+
Sbjct: 271 TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  180 bits (456), Expect = 1e-55
 Identities = 81/282 (28%), Positives = 142/282 (50%), Gaps = 22/282 (7%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK-HKNIVRLYDVLHS--EKKLTL 61
            ++ T N  + +K    +          REI +L+ L+   NI+ L D++     +   L
Sbjct: 54  AINITNNEKVVVK----ILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109

Query: 62  VFEHCD-QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI-NK 119
           VFEH +  D K+ + +L        ++ +MY++L+ L +CHS  ++HRD+KP N++I ++
Sbjct: 110 VFEHVNNTDFKQLYQTLT----DYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE 165

Query: 120 NGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELA 179
           + +L+L D+GLA  +  P + Y+  V + +++ P++L   ++Y  S+DMWS GC+ A + 
Sbjct: 166 HRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 224

Query: 180 NAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMS--------F 231
               P F G D  DQL RI K+LGT     +     +     F       S         
Sbjct: 225 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH 284

Query: 232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN 273
           S+    ++ +  D L +LL  +   R++A +AM H YF  + 
Sbjct: 285 SENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  180 bits (458), Expect = 2e-55
 Identities = 57/283 (20%), Positives = 112/283 (39%), Gaps = 36/283 (12%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            V++        K  +         +   EI ++ +L H  ++ L+D    + ++ L+ E
Sbjct: 48  CVEKATGRVFVAKFINT-PYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106

Query: 65  HCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI--NKNG 121
                +L     + + ++    V ++M Q   GL   H  +++H D+KP+N++    K  
Sbjct: 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKAS 166

Query: 122 ELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANA 181
            +K+ DFGLA     P +       T  +  P+++          DMW+ G +   L  +
Sbjct: 167 SVKIIDFGLATKLN-PDEIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLL-S 223

Query: 182 GRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAK 241
           G   F G D  + L+ + +      ED +                           ++ +
Sbjct: 224 GLSPFAGEDDLETLQNVKRCDWEFDEDAF-------------------------SSVSPE 258

Query: 242 GRDLLQRLLVCNPVQRMSAEDAMSHIYF----SDLNVAIKSER 280
            +D ++ LL   P +R++  DA+ H +     S+L   I S R
Sbjct: 259 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSR 301

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 2e-55
 Identities = 65/265 (24%), Positives = 107/265 (40%), Gaps = 30/265 (11%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            +D      +AI+  +L   +      + EI +++E K+ NIV   D      +L +V E
Sbjct: 39  AMDVATGQEVAIRQMNL-QQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97

Query: 65  HCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELK 124
           +          +    +D   + +   + L+ L F HS  V+HRD+K  N+L+  +G +K
Sbjct: 98  YLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVK 156

Query: 125 LADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRP 184
           L DFG            S  V T ++  P+V+   K Y   +D+WS G +  E+   G P
Sbjct: 157 LTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMI-EGEP 214

Query: 185 LFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRD 244
            +   +    L  I    GTP                               KL+A  RD
Sbjct: 215 PYLNENPLRALYLIAT-NGTPELQNP-------------------------EKLSAIFRD 248

Query: 245 LLQRLLVCNPVQRMSAEDAMSHIYF 269
            L R L  +  +R SA++ + H + 
Sbjct: 249 FLNRCLDMDVEKRGSAKELLQHQFL 273

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 5e-55
 Identities = 95/278 (34%), Positives = 145/278 (52%), Gaps = 15/278 (5%)

Query: 5   GVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT--- 60
             D      +A+K       +        RE+ LLK +KH+N++ L DV    + L    
Sbjct: 37  AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96

Query: 61  ---LVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI 117
              LV      DL         ++  D V+  +YQ+LRGL + HS +++HRDLKP NL +
Sbjct: 97  DVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 154

Query: 118 NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAE 177
           N++ ELK+ DFGLAR     +  Y   V T WYR P+++     Y  ++D+WS GCI AE
Sbjct: 155 NEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211

Query: 178 LANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLP--DFKPFPMYHPSMSFSQVA 235
           L   GR LFPG+D  DQLK I +L+GTP  +    ++     ++       P M+F+ V 
Sbjct: 212 LL-TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF 270

Query: 236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN 273
                   DLL+++LV +  +R++A  A++H YF+  +
Sbjct: 271 IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 2e-54
 Identities = 56/268 (20%), Positives = 113/268 (42%), Gaps = 33/268 (12%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
            V+ +       K   + G +       +EI +L   +H+NI+ L++   S ++L ++FE
Sbjct: 24  CVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81

Query: 65  HCD-QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI--NKNG 121
                D+ +  ++   E++   + S+++Q+   L F HS N+ H D++P+N++    ++ 
Sbjct: 82  FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSS 141

Query: 122 ELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANA 181
            +K+ +FG AR                +Y P   +    + +T+ DMWS G +   L  +
Sbjct: 142 TIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE--VHQHDVVSTATDMWSLGTLVYVLL-S 198

Query: 182 GRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAK 241
           G   F        ++ I     T  E+ +                          +++ +
Sbjct: 199 GINPFLAETNQQIIENIMNAEYTFDEEAF-------------------------KEISIE 233

Query: 242 GRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
             D + RLLV     RM+A +A+ H + 
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQHPWL 261

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  172 bits (438), Expect = 5e-53
 Identities = 58/269 (21%), Positives = 104/269 (38%), Gaps = 36/269 (13%)

Query: 5   GVDRTPNTALAIKGTHLVG--NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLV 62
             D   +  +AIK     G  +       ++E+  L++L+H N ++       E    LV
Sbjct: 34  ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93

Query: 63  FEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
            E+C        +     +    + +  +  L+GLA+ HS N++HRD+K  N+L+++ G 
Sbjct: 94  MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL 153

Query: 123 LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA--KLYTTSIDMWSAGCIFAELAN 180
           +KL DFG A          ++ V T ++  P+V+       Y   +D+WS G    ELA 
Sbjct: 154 VKLGDFGSASIM----APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA- 208

Query: 181 AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA 240
             +P     +    L  I +             N  P  +                  + 
Sbjct: 209 ERKPPLFNMNAMSALYHIAQ-------------NESPALQS--------------GHWSE 241

Query: 241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
             R+ +   L   P  R ++E  + H + 
Sbjct: 242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  172 bits (436), Expect = 1e-52
 Identities = 66/270 (24%), Positives = 111/270 (41%), Gaps = 33/270 (12%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
             D+     +AIK       EG   S   EI +L ++KH NIV L D+  S   L L+ +
Sbjct: 28  AEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87

Query: 65  HCD-QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI---NKN 120
                +L        G          ++Q+L  + + H   ++HRDLKP+NLL    +++
Sbjct: 88  LVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDED 146

Query: 121 GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
            ++ ++DFGL++    P    S    T  Y  P+VL   K Y+ ++D WS G I   L  
Sbjct: 147 SKIMISDFGLSKMED-PGSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILL- 203

Query: 181 AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA 240
            G P F   +     ++I K         W                           ++ 
Sbjct: 204 CGYPPFYDENDAKLFEQILKAEYEFDSPYW-------------------------DDISD 238

Query: 241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFS 270
             +D ++ L+  +P +R + E A+ H + +
Sbjct: 239 SAKDFIRHLMEKDPEKRFTCEQALQHPWIA 268

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 5e-52
 Identities = 62/279 (22%), Positives = 109/279 (39%), Gaps = 41/279 (14%)

Query: 5   GVDRTPNTALAIK--GTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLV 62
             +   +   AIK      +  E       RE  ++  L H   V+LY     ++KL   
Sbjct: 27  ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86

Query: 63  FEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
             +        +    G  D    + +  +++  L + H + ++HRDLKP+N+L+N++  
Sbjct: 87  LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH 146

Query: 123 LKLADFGLARAFGIPVKCYSAEVVT--LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELAN 180
           +++ DFG A+      K   A        Y  P++L        S D+W+ GCI  +L  
Sbjct: 147 IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLV- 204

Query: 181 AGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA 240
           AG P F   +     ++I KL     E  +P                             
Sbjct: 205 AGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----------------------------- 235

Query: 241 KGRDLLQRLLVCNPVQRMSAEDA------MSHIYFSDLN 273
           K RDL+++LLV +  +R+  E+        +H +F  + 
Sbjct: 236 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  166 bits (420), Expect = 1e-50
 Identities = 64/280 (22%), Positives = 110/280 (39%), Gaps = 43/280 (15%)

Query: 5   GVDRTPNTALAIK--------GTHLVGNEGVPSSALREICLLKELK-HKNIVRLYDVLHS 55
            + +      A+K               + +  + L+E+ +L+++  H NI++L D   +
Sbjct: 22  CIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81

Query: 56  EKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
                LVF+   + +L  Y       +     +  M  LL  +   H  N++HRDLKP+N
Sbjct: 82  NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPEN 140

Query: 115 LLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKL-----YTTSIDMW 169
           +L++ +  +KL DFG +     P +       T  Y  P+++  +       Y   +DMW
Sbjct: 141 ILLDDDMNIKLTDFGFSCQLD-PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW 199

Query: 170 SAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSM 229
           S G I   L  AG P F        L+ I           W                   
Sbjct: 200 STGVIMYTLL-AGSPPFWHRKQMLMLRMIMSGNYQFGSPEW------------------- 239

Query: 230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
                    +   +DL+ R LV  P +R +AE+A++H +F
Sbjct: 240 ------DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 2e-50
 Identities = 73/274 (26%), Positives = 108/274 (39%), Gaps = 42/274 (15%)

Query: 5   GVDRTPNTALAIKGTHLVG-NEGVPSSALREICLLKELKHKNIVRLYDVLHSE--KKLTL 61
              ++    L  K        E      + E+ LL+ELKH NIVR YD +       L +
Sbjct: 23  IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82

Query: 62  VFEHCD-QDLKKYFDSLNGE---IDLDIVKSFMYQLLRGLAFCHSRN-----VLHRDLKP 112
           V E+C+  DL         E   +D + V   M QL   L  CH R+     VLHRDLKP
Sbjct: 83  VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKP 142

Query: 113 QNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAG 172
            N+ ++    +KL DFGLAR          A V T +Y  P+ +     Y    D+WS G
Sbjct: 143 ANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLG 201

Query: 173 CIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS 232
           C+  EL  A  P F      +   +I +                  F+  P         
Sbjct: 202 CLLYEL-CALMPPFTAFSQKELAGKIRE----------------GKFRRIP--------- 235

Query: 233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
               + + +  +++ R+L      R S E+ + +
Sbjct: 236 ---YRYSDELNEIITRMLNLKDYHRPSVEEILEN 266

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 8e-49
 Identities = 88/288 (30%), Positives = 144/288 (50%), Gaps = 26/288 (9%)

Query: 5   GVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLT--- 60
             D   +  +AIK       N+     A RE+ L+K + HKNI+ L +V   +K L    
Sbjct: 36  AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95

Query: 61  ---LVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI 117
              LV E  D +       +  E+D + +   +YQ+L G+   HS  ++HRDLKP N+++
Sbjct: 96  DVYLVMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 152

Query: 118 NKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAE 177
             +  LK+ DFGLAR  G      +  VVT +YR P+V+ G   Y  ++D+WS GCI  E
Sbjct: 153 KSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGE 210

Query: 178 LANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN-LLPDFKPFPMYHPSMSFSQVAP 236
           +    + LFPG D  DQ  ++ + LGTP  +    +   + ++      +  ++F ++ P
Sbjct: 211 MV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP 269

Query: 237 K------------LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
                          ++ RDLL ++LV +P +R+S +DA+ H Y +  
Sbjct: 270 DSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 4e-47
 Identities = 57/278 (20%), Positives = 110/278 (39%), Gaps = 37/278 (13%)

Query: 5   GVDRTPNTALAIK-----GTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKL 59
             +++     A K      T             RE+ +LKE++H N++ L++V  ++  +
Sbjct: 29  CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88

Query: 60  TLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK 119
            L+ E         F +    +  +    F+ Q+L G+ + HS  + H DLKP+N+++  
Sbjct: 89  ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 148

Query: 120 NGE----LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIF 175
                  +K+ DFGLA         +     T  +  P+++          DMWS G I 
Sbjct: 149 RNVPKPRIKIIDFGLAHKID-FGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVIT 206

Query: 176 AELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA 235
             L  +G   F G    + L  +  +     ++ +                         
Sbjct: 207 YILL-SGASPFLGDTKQETLANVSAVNYEFEDEYF------------------------- 240

Query: 236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN 273
              +A  +D ++RLLV +P +RM+ +D++ H +    +
Sbjct: 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 1e-46
 Identities = 63/273 (23%), Positives = 115/273 (42%), Gaps = 35/273 (12%)

Query: 5   GVDRTPNTALAIK---GTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTL 61
              +  N   AIK      ++ ++ V  + + +  L    +H  +  ++    +++ L  
Sbjct: 21  AEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80

Query: 62  VFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG 121
           V E+ +     Y      + DL     +  +++ GL F HS+ +++RDLK  N+L++K+G
Sbjct: 81  VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG 140

Query: 122 ELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANA 181
            +K+ADFG+ +   +     +    T  Y  P++L G K Y  S+D WS G +  E+   
Sbjct: 141 HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEML-I 198

Query: 182 GRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAK 241
           G+  F G D ++    I                   D   +P              L  +
Sbjct: 199 GQSPFHGQDEEELFHSIRM-----------------DNPFYP------------RWLEKE 229

Query: 242 GRDLLQRLLVCNPVQRMSAE-DAMSHIYFSDLN 273
            +DLL +L V  P +R+    D   H  F ++N
Sbjct: 230 AKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (389), Expect = 4e-46
 Identities = 42/241 (17%), Positives = 96/241 (39%), Gaps = 30/241 (12%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFM 90
             E+ +L++ +H NI+       +  +L +V + C+   L  +   +  + ++  +    
Sbjct: 52  KNEVGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 110

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVV--TL 148
            Q  +G+ + H+++++HRDLK  N+ ++++  +K+ DFGLA         +  E +  ++
Sbjct: 111 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170

Query: 149 WYRPPDVLFGAKL--YTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPT 206
            +  P+V+       Y+   D+++ G +  EL   G+  +   +  DQ+  +        
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM-TGQLPYSNINNRDQIIFMVG------ 223

Query: 207 EDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
                   L PD                        + L+   L     +R      ++ 
Sbjct: 224 -----RGYLSPDLSKVR------------SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

Query: 267 I 267
           I
Sbjct: 267 I 267

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  154 bits (390), Expect = 3e-45
 Identities = 58/279 (20%), Positives = 106/279 (37%), Gaps = 39/279 (13%)

Query: 5   GVDRTPNTALAIK-----GTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKL 59
                     A+K        +   E +  +    + L+       IV +    H+  KL
Sbjct: 23  CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82

Query: 60  TLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK 119
           + + +  +     Y  S +G      ++ +  +++ GL   H+R V++RDLKP N+L+++
Sbjct: 83  SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE 142

Query: 120 NGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELA 179
           +G ++++D GLA  F       S  V T  Y  P+VL     Y +S D +S GC+  +L 
Sbjct: 143 HGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 200

Query: 180 NAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT 239
             G   F      D+ +     L                    P               +
Sbjct: 201 -RGHSPFRQHKTKDKHEIDRMTLTMAV--------------ELP------------DSFS 233

Query: 240 AKGRDLLQRLLVCNPVQRMS-----AEDAMSHIYFSDLN 273
            + R LL+ LL  +  +R+      A++     +F  L+
Sbjct: 234 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 1e-44
 Identities = 60/273 (21%), Positives = 109/273 (39%), Gaps = 39/273 (14%)

Query: 5   GVDRTPNTALAIKGTHLVG-NEGVPSSALREICLLKELKHKNIVRLYDVLHS----EKKL 59
           G+D      +A          +        E  +LK L+H NIVR YD   S    +K +
Sbjct: 28  GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87

Query: 60  TLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRN--VLHRDLKPQNLLI 117
            LV E       K +      + + +++S+  Q+L+GL F H+R   ++HRDLK  N+ I
Sbjct: 88  VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 147

Query: 118 N-KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFA 176
               G +K+ D GLA           A + T  +  P++      Y  S+D+++ G    
Sbjct: 148 TGPTGSVKIGDLGLATLK--RASFAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCML 203

Query: 177 ELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP 236
           E+A      +       Q   I++ + +  +        +P+ K                
Sbjct: 204 EMA-TSEYPYSECQNAAQ---IYRRVTSGVKPASFDKVAIPEVK---------------- 243

Query: 237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF 269
                  ++++  +  N  +R S +D ++H +F
Sbjct: 244 -------EIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  151 bits (381), Expect = 2e-44
 Identities = 59/276 (21%), Positives = 107/276 (38%), Gaps = 41/276 (14%)

Query: 5   GVDRTPNTALAIK--GTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLV 62
              R      A+K     +V           E  +L  + H  I+R++      +++ ++
Sbjct: 23  IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82

Query: 63  FEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
            ++ +          +      + K +  ++   L + HS+++++RDLKP+N+L++KNG 
Sbjct: 83  MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH 142

Query: 123 LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
           +K+ DFG A+              T  Y  P+V+     Y  SID WS G +  E+  AG
Sbjct: 143 IKITDFGFAKYVPDVTYTL---CGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEML-AG 197

Query: 183 RPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKG 242
              F  S+     ++I                       FP            P      
Sbjct: 198 YTPFYDSNTMKTYEKILN--AEL---------------RFP------------PFFNEDV 228

Query: 243 RDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLN 273
           +DLL RL+  +  QR+       ED  +H +F ++ 
Sbjct: 229 KDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 7e-44
 Identities = 57/276 (20%), Positives = 110/276 (39%), Gaps = 38/276 (13%)

Query: 5   GVDRTPNTALAIK--GTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLV 62
             ++      A+K     ++  +   +  + E  +L+  +H  +  L     +  +L  V
Sbjct: 24  VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83

Query: 63  FEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
            E+ +     +  S       +  + +  +++  L + HSR+V++RD+K +NL+++K+G 
Sbjct: 84  MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH 143

Query: 123 LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
           +K+ DFGL +              T  Y  P+VL     Y  ++D W  G +  E+   G
Sbjct: 144 IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMM-CG 201

Query: 183 RPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKG 242
           R  F   D +   + I                   +   FP              L+ + 
Sbjct: 202 RLPFYNQDHERLFELILM-----------------EEIRFP------------RTLSPEA 232

Query: 243 RDLLQRLLVCNPVQRMS-----AEDAMSHIYFSDLN 273
           + LL  LL  +P QR+      A++ M H +F  +N
Sbjct: 233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 1e-43
 Identities = 67/277 (24%), Positives = 106/277 (38%), Gaps = 40/277 (14%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREI-CLLKELKHKNIVRLYDVLHS----EKKL 59
             ++      A+K             A RE+    +  +  +IVR+ DV  +     K L
Sbjct: 31  IFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84

Query: 60  TLVFEHCDQ-DLKKYF-DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLI 117
            +V E  D  +L     D  +           M  +   + + HS N+ HRD+KP+NLL 
Sbjct: 85  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 144

Query: 118 NK---NGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCI 174
                N  LKL DFG A+         +    T +Y  P+VL   K Y  S DMWS G I
Sbjct: 145 TSKRPNAILKLTDFGFAKETTSHNSLTTPC-YTPYYVAPEVLGPEK-YDKSCDMWSLGVI 202

Query: 175 FAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV 234
              L   G P F  +        +   +     +                  P+  +S+V
Sbjct: 203 MYIL-LCGYPPFYSNHGLAISPGMKTRIRMGQYE-----------------FPNPEWSEV 244

Query: 235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD 271
           + ++    + L++ LL   P QRM+  + M+H +   
Sbjct: 245 SEEV----KMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (363), Expect = 2e-42
 Identities = 52/260 (20%), Positives = 102/260 (39%), Gaps = 38/260 (14%)

Query: 11  NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK-KLTLVFEHCDQ- 68
              +A+K    + N+    + L E  ++ +L+H N+V+L  V+  EK  L +V E+  + 
Sbjct: 30  GNKVAVK---CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86

Query: 69  DLKKY-FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLAD 127
            L  Y        +  D +  F   +   + +    N +HRDL  +N+L++++   K++D
Sbjct: 87  SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD 146

Query: 128 FGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFP 187
           FGL +             + + +  P+ L   K ++T  D+WS G +  E+ + GR  +P
Sbjct: 147 FGLTKEAS---STQDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYP 202

Query: 188 GSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQ 247
              + D + R+ K       D  P     P                          ++++
Sbjct: 203 RIPLKDVVPRVEKGYKMDAPDGCP-----PAVY-----------------------EVMK 234

Query: 248 RLLVCNPVQRMSAEDAMSHI 267
                +   R S       +
Sbjct: 235 NCWHLDAAMRPSFLQLREQL 254

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 4e-42
 Identities = 56/271 (20%), Positives = 98/271 (36%), Gaps = 37/271 (13%)

Query: 7   DRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC 66
            R     +AIK       +      +RE  ++ +L +  IVRL  V    + L LV E  
Sbjct: 32  MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMA 90

Query: 67  DQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
               L K+      EI +  V   ++Q+  G+ +   +N +HRDL  +N+L+      K+
Sbjct: 91  GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKI 150

Query: 126 ADFGLARAFG---IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
           +DFGL++A G         SA    L +  P+ +   K +++  D+WS G    E  + G
Sbjct: 151 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYG 209

Query: 183 RPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKG 242
           +  +      + +  I +                      P            P+   + 
Sbjct: 210 QKPYKKMKGPEVMAFIEQ----------------GKRMECP------------PECPPEL 241

Query: 243 RDLLQRLLVCNPVQRMSAED---AMSHIYFS 270
             L+    +     R         M   Y+S
Sbjct: 242 YALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 5e-42
 Identities = 60/277 (21%), Positives = 112/277 (40%), Gaps = 47/277 (16%)

Query: 5   GVDRTPNTALAIK---GTHLVGNEGVPSSA--LREICLLKELK--HKNIVRLYDVLHSEK 57
           G+  + N  +AIK      +     +P+      E+ LLK++      ++RL D      
Sbjct: 23  GIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82

Query: 58  KLTLVFEHCD-QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLL 116
              L+ E  +       F +  G +  ++ +SF +Q+L  +  CH+  VLHRD+K +N+L
Sbjct: 83  SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENIL 142

Query: 117 INKN-GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIF 175
           I+ N GELKL DFG           Y+    T  Y PP+ +   + +  S  +WS G + 
Sbjct: 143 IDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 200

Query: 176 AELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA 235
            ++   G   F   +   + +  F+                                   
Sbjct: 201 YDMV-CGDIPFEHDEEIIRGQVFFR----------------------------------- 224

Query: 236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
            +++++ + L++  L   P  R + E+  +H +  D+
Sbjct: 225 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 7e-42
 Identities = 57/283 (20%), Positives = 105/283 (37%), Gaps = 54/283 (19%)

Query: 11  NTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ- 68
           +  +A+K      +     + + E+ ++ +L  H+NIV L         + L+FE+C   
Sbjct: 67  SIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYG 126

Query: 69  DLKKY----------------------FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVL 106
           DL  Y                       +     +  + +  F YQ+ +G+ F   ++ +
Sbjct: 127 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV 186

Query: 107 HRDLKPQNLLINKNGELKLADFGLARAF--GIPVKCYSAEVVTLWYRPPDVLFGAKLYTT 164
           HRDL  +N+L+     +K+ DFGLAR               + + +  P+ LF    YT 
Sbjct: 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTI 245

Query: 165 SIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM 224
             D+WS G +  E+ + G   +PG  VD    ++ +                     F M
Sbjct: 246 KSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ-------------------NGFKM 286

Query: 225 YHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHI 267
             P           T +   ++Q     +  +R S  +  S +
Sbjct: 287 DQP--------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 8e-42
 Identities = 50/263 (19%), Positives = 92/263 (34%), Gaps = 35/263 (13%)

Query: 11  NTALAIK--GTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD- 67
             ++A+K     ++         +RE+  +  L H+N++RLY V+     + +V E    
Sbjct: 36  TVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPL 94

Query: 68  QDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLAD 127
             L        G   L  +  +  Q+  G+ +  S+  +HRDL  +NLL+     +K+ D
Sbjct: 95  GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGD 154

Query: 128 FGLARAFGIPVKCY---SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRP 184
           FGL RA       Y       V   +  P+ L   + ++ + D W  G    E+   G+ 
Sbjct: 155 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQE 213

Query: 185 LFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRD 244
            + G +    L +I K                    P P                    +
Sbjct: 214 PWIGLNGSQILHKIDKEGERL---------------PRP------------EDCPQDIYN 246

Query: 245 LLQRLLVCNPVQRMSAEDAMSHI 267
           ++ +     P  R +       +
Sbjct: 247 VMVQCWAHKPEDRPTFVALRDFL 269

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (355), Expect = 4e-41
 Identities = 60/271 (22%), Positives = 108/271 (39%), Gaps = 38/271 (14%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
           G     +T +A+K   L      P + L E  L+K+L+H+ +VRLY V  +++ + ++ E
Sbjct: 32  GYYNG-HTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIYIITE 87

Query: 65  HCDQDLKKYFDSLNGEIDLDI--VKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
           + +      F      I L I  +     Q+  G+AF   RN +HRDL+  N+L++    
Sbjct: 88  YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS 147

Query: 123 LKLADFGLARAFGIPVKCYSAEVV-TLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANA 181
            K+ADFGLAR                + +  P+ +     +T   D+WS G +  E+   
Sbjct: 148 CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTH 206

Query: 182 GRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAK 241
           GR  +PG    + ++ + +       D  P                             +
Sbjct: 207 GRIPYPGMTNPEVIQNLERGYRMVRPDNCP----------------------------EE 238

Query: 242 GRDLLQRLLVCNPVQRMSAEDAMSHI--YFS 270
              L++      P  R + +   S +  +F+
Sbjct: 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 6e-41
 Identities = 58/277 (20%), Positives = 109/277 (39%), Gaps = 35/277 (12%)

Query: 7   DRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC 66
              P  A+AIK      ++ V    L+E   +++  H +IV+L  V  +E  + ++ E C
Sbjct: 31  PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELC 89

Query: 67  DQ-DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
              +L+ +       +DL  +  + YQL   LA+  S+  +HRD+  +N+L++ N  +KL
Sbjct: 90  TLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL 149

Query: 126 ADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPL 185
            DFGL+R         +++               + +T++ D+W  G    E+   G   
Sbjct: 150 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 209

Query: 186 FPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDL 245
           F G   +D + RI                   +  P P            P        L
Sbjct: 210 FQGVKNNDVIGRIEN----------------GERLPMP------------PNCPPTLYSL 241

Query: 246 LQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIKSERCQ 282
           + +    +P +R    +  +      L+  ++ E+ Q
Sbjct: 242 MTKCWAYDPSRRPRFTELKAQ-----LSTILEEEKAQ 273

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 2e-40
 Identities = 42/238 (17%), Positives = 90/238 (37%), Gaps = 31/238 (13%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           + E  ++  L H+ +V+LY V   ++ + ++ E+     L  Y   +        +    
Sbjct: 47  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 106

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYSAEVVTLW 149
             +   + +  S+  LHRDL  +N L+N  G +K++DFGL+R                + 
Sbjct: 107 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 166

Query: 150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDT 209
           + PP+VL  +K +++  D+W+ G +  E+ + G+  +      +  + I + L       
Sbjct: 167 WSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHL 225

Query: 210 WPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHI 267
                                          K   ++         +R + +  +S+I
Sbjct: 226 AS----------------------------EKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  139 bits (350), Expect = 3e-40
 Identities = 57/271 (21%), Positives = 91/271 (33%), Gaps = 36/271 (13%)

Query: 5   GVDRTPNTALAIK--GTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKK---- 58
             D   +  +A+K     L  +        RE      L H  IV +YD   +E      
Sbjct: 26  ARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85

Query: 59  LTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN 118
             +V E+ D    +      G +        +    + L F H   ++HRD+KP N++I+
Sbjct: 86  PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 145

Query: 119 KNGELKLADFGLARAFGIPVKCY---SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIF 175
               +K+ DFG+ARA           +A + T  Y  P+   G        D++S GC+ 
Sbjct: 146 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVL 204

Query: 176 AELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA 235
            E+   G P F G        +  +    P      G                       
Sbjct: 205 YEVL-TGEPPFTGDSPVSVAYQHVREDPIPPSARHEG----------------------- 240

Query: 236 PKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH 266
             L+A    ++ + L  NP  R      M  
Sbjct: 241 --LSADLDAVVLKALAKNPENRYQTAAEMRA 269

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 6e-40
 Identities = 62/267 (23%), Positives = 105/267 (39%), Gaps = 37/267 (13%)

Query: 11  NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD- 69
            T +AIK   L      P + L+E  ++K+L+H+ +V+LY V+  E  + +V E+  +  
Sbjct: 41  TTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGS 97

Query: 70  -LKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADF 128
            L          + L  +     Q+  G+A+    N +HRDL+  N+L+ +N   K+ADF
Sbjct: 98  LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF 157

Query: 129 GLARAF-GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFP 187
           GLAR                + +  P+     + +T   D+WS G +  EL   GR  +P
Sbjct: 158 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYP 216

Query: 188 GSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQ 247
           G    + L ++ +    P     P                                DL+ 
Sbjct: 217 GMVNREVLDQVERGYRMPCPPECP----------------------------ESLHDLMC 248

Query: 248 RLLVCNPVQRMSAED--AMSHIYFSDL 272
           +     P +R + E   A    YF+  
Sbjct: 249 QCWRKEPEERPTFEYLQAFLEDYFTST 275

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 8e-40
 Identities = 41/238 (17%), Positives = 86/238 (36%), Gaps = 31/238 (13%)

Query: 32  LREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVKSFM 90
           + E  ++ +L H  +V+LY V   +  + LVFE  +   L  Y  +  G    + +    
Sbjct: 48  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 107

Query: 91  YQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVKCYSAEVVTLW 149
             +  G+A+     V+HRDL  +N L+ +N  +K++DFG+ R          +     + 
Sbjct: 108 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK 167

Query: 150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDT 209
           +  P+V   ++ Y++  D+WS G +  E+ + G+  +      + ++ I           
Sbjct: 168 WASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRL 226

Query: 210 WPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHI 267
                                              ++       P  R +    +  +
Sbjct: 227 AS----------------------------THVYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 9e-40
 Identities = 54/274 (19%), Positives = 98/274 (35%), Gaps = 15/274 (5%)

Query: 7   DRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC 66
                  +AIK      +       L E  ++  + + ++ RL  +  +     +     
Sbjct: 34  GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMP 93

Query: 67  DQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLA 126
              L  Y       I    + ++  Q+ +G+ +   R ++HRDL  +N+L+     +K+ 
Sbjct: 94  FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKIT 153

Query: 127 DFGLARAFGIPVKCYSAE--VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRP 184
           DFGLA+  G   K Y AE   V + +   + +   ++YT   D+WS G    EL   G  
Sbjct: 154 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSK 212

Query: 185 LFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM----YHPSM--SFSQVAPKL 238
            + G    +    + K    P            D     +            F ++  + 
Sbjct: 213 PYDGIPASEISSILEKGERLPQPPICT-----IDVYMIMVKCWMIDADSRPKFRELIIEF 267

Query: 239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL 272
           +   RD  QR LV    +RM         ++  L
Sbjct: 268 SKMARD-PQRYLVIQGDERMHLPSPTDSNFYRAL 300

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 1e-39
 Identities = 46/274 (16%), Positives = 99/274 (36%), Gaps = 37/274 (13%)

Query: 7   DRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEH 65
            +     +A+K       +  +    L E  ++++L +  IVR+  +  +E  + LV E 
Sbjct: 30  MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEM 88

Query: 66  CDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
            +      +   N  +    +   ++Q+  G+ +    N +HRDL  +N+L+      K+
Sbjct: 89  AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKI 148

Query: 126 ADFGLARAFGIPVKCYSAE---VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
           +DFGL++A       Y A+      + +  P+ +   K +++  D+WS G +  E  + G
Sbjct: 149 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYG 207

Query: 183 RPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKG 242
           +  + G    +    + K          P      +                        
Sbjct: 208 QKPYRGMKGSEVTAMLEKGERMGCPAGCP-----REMY---------------------- 240

Query: 243 RDLLQRLLVCNPVQRMSAED---AMSHIYFSDLN 273
            DL+      +   R         + + Y+  +N
Sbjct: 241 -DLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  136 bits (344), Expect = 4e-39
 Identities = 44/263 (16%), Positives = 93/263 (35%), Gaps = 35/263 (13%)

Query: 11  NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-D 69
              +AIK       E      L E  ++ +  H N++ L  V+     + ++ E  +   
Sbjct: 54  EIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGS 113

Query: 70  LKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFG 129
           L  +    +G+  +  +   +  +  G+ +    N +HRDL  +N+L+N N   K++DFG
Sbjct: 114 LDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFG 173

Query: 130 LARAFGIPVKCYS-----AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRP 184
           L+R         +        + + +  P+ +   K +T++ D+WS G +  E+ + G  
Sbjct: 174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVMSYGER 232

Query: 185 LFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRD 244
            +      D +  I +    P     P                            +    
Sbjct: 233 PYWDMTNQDVINAIEQDYRLPPPMDCP----------------------------SALHQ 264

Query: 245 LLQRLLVCNPVQRMSAEDAMSHI 267
           L+      +   R      ++ +
Sbjct: 265 LMLDCWQKDRNHRPKFGQIVNTL 287

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  137 bits (346), Expect = 5e-39
 Identities = 53/276 (19%), Positives = 98/276 (35%), Gaps = 41/276 (14%)

Query: 5   GVDRTPNTALAIK--GTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLV 62
              +      A+K      V         L E  +L+ +    +V+L         L +V
Sbjct: 60  VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119

Query: 63  FEHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
            E+             G       + +  Q++    + HS ++++RDLKP+NLLI++ G 
Sbjct: 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 179

Query: 123 LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
           +++ DFG A+                    P+++   K Y  ++D W+ G +  E+A AG
Sbjct: 180 IQVTDFGFAKRVKGRTWTLCGTP---EALAPEIILS-KGYNKAVDWWALGVLIYEMA-AG 234

Query: 183 RPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKG 242
            P F         ++I                       FP               ++  
Sbjct: 235 YPPFFADQPIQIYEKIVS-----------------GKVRFP------------SHFSSDL 265

Query: 243 RDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLN 273
           +DLL+ LL  +  +R         D  +H +F+  +
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 1e-38
 Identities = 56/266 (21%), Positives = 110/266 (41%), Gaps = 34/266 (12%)

Query: 16  IKGTHLVGNEGVPSSALREICLLKELKHK-NIVRLYDVLHSEKKLTLVFEHCDQDLKKYF 74
           +K   +V           E  +L+ ++    +V L+    +E KL L+ ++ +       
Sbjct: 60  LKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTH 119

Query: 75  DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF 134
            S         V+ ++ +++  L   H   +++RD+K +N+L++ NG + L DFGL++ F
Sbjct: 120 LSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179

Query: 135 GIPV--KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVD 192
                 + Y       +  P  V  G   +  ++D WS G +  EL   G   F      
Sbjct: 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL-TGASPFTVDGEK 238

Query: 193 DQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVC 252
           +    I +              +L    P+P             +++A  +DL+QRLL+ 
Sbjct: 239 NSQAEISR-------------RILKSEPPYP------------QEMSALAKDLIQRLLMK 273

Query: 253 NPVQRMS-----AEDAMSHIYFSDLN 273
           +P +R+      A++   H++F  +N
Sbjct: 274 DPKKRLGCGPRDADEIKEHLFFQKIN 299

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  133 bits (335), Expect = 5e-38
 Identities = 52/265 (19%), Positives = 96/265 (36%), Gaps = 32/265 (12%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFE 64
           GV +  +  +A+K   L  +       L+E  ++KE+KH N+V+L  V   E    ++ E
Sbjct: 36  GVWKKYSLTVAVK--TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93

Query: 65  HCDQDLKKYF--DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGE 122
                    +  +    E+   ++     Q+   + +   +N +HRDL  +N L+ +N  
Sbjct: 94  FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 153

Query: 123 LKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
           +K+ADFGL+R          A                  ++   D+W+ G +  E+A  G
Sbjct: 154 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 213

Query: 183 RPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKG 242
              +PG D+    + + K       +  P                             K 
Sbjct: 214 MSPYPGIDLSQVYELLEKDYRMERPEGCP----------------------------EKV 245

Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHI 267
            +L++     NP  R S  +     
Sbjct: 246 YELMRACWQWNPSDRPSFAEIHQAF 270

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  134 bits (336), Expect = 2e-37
 Identities = 71/309 (22%), Positives = 116/309 (37%), Gaps = 49/309 (15%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE-KKLTLVF 63
             D   NT +A+K   + G++    +A  EI LL+ +   +  +   +  +   KL   F
Sbjct: 32  AKDMVNNTHVAMK--IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89

Query: 64  EHCDQD---------------LKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCH-SRNVLH 107
            H   +               L       +  I L  VK    QLL GL + H    ++H
Sbjct: 90  NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIH 149

Query: 108 RDLKPQNLLINKNG------ELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKL 161
            D+KP+N+L+          ++K+AD G A  +          + T  YR P+VL GA  
Sbjct: 150 TDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS---IQTREYRSPEVLLGAP- 205

Query: 162 YTTSIDMWSAGCIFAELANAGRPLFPGSDV------DDQLKRIFKLLGTPTEDTWPGMNL 215
           +    D+WS  C+  EL   G  LF   +       DD + +I +LLG            
Sbjct: 206 WGCGADIWSTACLIFELI-TGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKY 264

Query: 216 LPDF-------------KPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAED 262
              F             K +P+        + +     +  D L  +L  +P +R  A  
Sbjct: 265 TRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324

Query: 263 AMSHIYFSD 271
            ++H +  D
Sbjct: 325 LVNHPWLKD 333

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  131 bits (331), Expect = 3e-37
 Identities = 56/289 (19%), Positives = 105/289 (36%), Gaps = 55/289 (19%)

Query: 3   TSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLV 62
              +   P T +A+K      +  + +   RE  L+ E  + NIV+L  V    K + L+
Sbjct: 35  PGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94

Query: 63  FEHCD-QDLKKYFDSLNGE-----------------------IDLDIVKSFMYQLLRGLA 98
           FE+    DL ++  S++                         +          Q+  G+A
Sbjct: 95  FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMA 154

Query: 99  FCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVKCYSAEVVTLWYRPPDVL 156
           +   R  +HRDL  +N L+ +N  +K+ADFGL+R        K    + + + + PP+ +
Sbjct: 155 YLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI 214

Query: 157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLL 216
           F  + YTT  D+W+ G +  E+ + G   + G   ++ +  +                  
Sbjct: 215 FYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD---------------- 257

Query: 217 PDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS 265
            +    P                 +  +L++      P  R S      
Sbjct: 258 GNILACP------------ENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 3e-37
 Identities = 62/283 (21%), Positives = 110/283 (38%), Gaps = 49/283 (17%)

Query: 6   VDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFE 64
           +       +A+K      +     + + E+ +L  L  H NIV L           ++ E
Sbjct: 48  IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107

Query: 65  HCDQ-DLKKY-----------------FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVL 106
           +C   DL  +                  +     +DL+ + SF YQ+ +G+AF  S+N +
Sbjct: 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI 167

Query: 107 HRDLKPQNLLINKNGELKLADFGLARAFGIPVK--CYSAEVVTLWYRPPDVLFGAKLYTT 164
           HRDL  +N+L+      K+ DFGLAR               + + +  P+ +F   +YT 
Sbjct: 168 HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTF 226

Query: 165 SIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM 224
             D+WS G    EL + G   +PG  VD +  ++ K                   + F M
Sbjct: 227 ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK-------------------EGFRM 267

Query: 225 YHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHI 267
             P            A+  D+++     +P++R + +  +  I
Sbjct: 268 LSP--------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 1e-36
 Identities = 58/263 (22%), Positives = 108/263 (41%), Gaps = 35/263 (13%)

Query: 11  NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCD-Q 68
               A+K  + + + G  S  L E  ++K+  H N++ L  + L SE    +V  +    
Sbjct: 55  KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 114

Query: 69  DLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADF 128
           DL+ +  +      +  +  F  Q+ +G+ F  S+  +HRDL  +N ++++   +K+ADF
Sbjct: 115 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADF 174

Query: 129 GLARAFGIP----VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRP 184
           GLAR         V   +   + + +   + L   K +TT  D+WS G +  EL   G P
Sbjct: 175 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAP 233

Query: 185 LFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRD 244
            +P  +  D    + +  G             P++ P P+Y                  +
Sbjct: 234 PYPDVNTFDITVYLLQ--GRRLLQ--------PEYCPDPLY------------------E 265

Query: 245 LLQRLLVCNPVQRMSAEDAMSHI 267
           ++ +        R S  + +S I
Sbjct: 266 VMLKCWHPKAEMRPSFSELVSRI 288

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 8e-35
 Identities = 52/265 (19%), Positives = 98/265 (36%), Gaps = 33/265 (12%)

Query: 7   DRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC 66
                  +AIK       E      L E  ++ +  H NI+RL  V+   K + ++ E+ 
Sbjct: 32  SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 91

Query: 67  DQDLK-KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKL 125
           +     K+    +GE  +  +   +  +  G+ +  + N +HRDL  +N+L+N N   K+
Sbjct: 92  ENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKV 151

Query: 126 ADFGLARAFGIPVKCY---SAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAG 182
           +DFGL+R      +     S   + + +  P+ +   K  + S D+WS G +  E+   G
Sbjct: 152 SDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSAS-DVWSFGIVMWEVMTYG 210

Query: 183 RPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKG 242
              +      + +K I      PT    P                            +  
Sbjct: 211 ERPYWELSNHEVMKAINDGFRLPTPMDCP----------------------------SAI 242

Query: 243 RDLLQRLLVCNPVQRMSAEDAMSHI 267
             L+ +       +R    D +S +
Sbjct: 243 YQLMMQCWQQERARRPKFADIVSIL 267

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 2e-34
 Identities = 50/274 (18%), Positives = 97/274 (35%), Gaps = 47/274 (17%)

Query: 11  NTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ- 68
               AIK      ++        E+ +L +L  H NI+ L         L L  E+    
Sbjct: 37  RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 96

Query: 69  DLKKY---------------FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQ 113
           +L  +                +S    +    +  F   + RG+ +   +  +HRDL  +
Sbjct: 97  NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 156

Query: 114 NLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
           N+L+ +N   K+ADFGL+R   + VK      + + +   + L  +  YTT+ D+WS G 
Sbjct: 157 NILVGENYVAKIADFGLSRGQEVYVKKTMG-RLPVRWMAIESLNYSV-YTTNSDVWSYGV 214

Query: 174 IFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ 233
           +  E+ + G   + G    +  +++ +                                 
Sbjct: 215 LLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD---------------------- 252

Query: 234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHI 267
                  +  DL+++     P +R S    +  +
Sbjct: 253 ------DEVYDLMRQCWREKPYERPSFAQILVSL 280

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 3e-34
 Identities = 55/257 (21%), Positives = 95/257 (36%), Gaps = 32/257 (12%)

Query: 33  REICLLKELKHKNIVRLYDVLHSE----KKLTLVFEHCDQ-DLKKYFDSLNGEIDLDIVK 87
            EI     L+H+NI+      + +     +L LV ++ +   L  Y +     + ++ + 
Sbjct: 46  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMI 103

Query: 88  SFMYQLLRGLAFCHS--------RNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK 139
                   GLA  H           + HRDLK +N+L+ KNG   +AD GLA        
Sbjct: 104 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 163

Query: 140 CYSAE----VVTLWYRPPDVLFGAKL-----YTTSIDMWSAGCIFAELANAGRPLFPGSD 190
                    V T  Y  P+VL  +            D+++ G +F E+  A R    G  
Sbjct: 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI--ARRCSIGGIH 221

Query: 191 VDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLL 250
            D QL     +   P+ +    +      +P     P+   S  A ++ A    +++   
Sbjct: 222 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNI---PNRWQSCEALRVMA---KIMRECW 275

Query: 251 VCNPVQRMSAEDAMSHI 267
             N   R++A      +
Sbjct: 276 YANGAARLTALRIKKTL 292

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 1e-33
 Identities = 53/270 (19%), Positives = 103/270 (38%), Gaps = 41/270 (15%)

Query: 10  PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ- 68
           P T +AIK  +   +       L E  ++KE    ++VRL  V+   +   ++ E   + 
Sbjct: 49  PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRG 108

Query: 69  DLKKY---------FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK 119
           DLK Y          + +     L  +     ++  G+A+ ++   +HRDL  +N ++ +
Sbjct: 109 DLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 168

Query: 120 NGELKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAE 177
           +  +K+ DFG+ R        +     ++ + +  P+ L     +TT  D+WS G +  E
Sbjct: 169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWE 227

Query: 178 LANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK 237
           +A      + G   +  L+ + +                      P   P M        
Sbjct: 228 IATLAEQPYQGLSNEQVLRFVME----------------GGLLDKPDNCPDML------- 264

Query: 238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHI 267
                 +L++     NP  R S  + +S I
Sbjct: 265 -----FELMRMCWQYNPKMRPSFLEIISSI 289

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  121 bits (303), Expect = 3e-33
 Identities = 48/264 (18%), Positives = 89/264 (33%), Gaps = 26/264 (9%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKH-KNIVRLYDVLHSEKKLTLVF 63
           G +   N  +AIK                E    K L     I  +Y          LV 
Sbjct: 24  GTNLLNNQQVAIK---FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80

Query: 64  EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK---- 119
           +     L+   D    +  +  V     Q+L  +   H +++++RD+KP N LI +    
Sbjct: 81  DLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSK 140

Query: 120 -NGELKLADFGLARAFGIPV-------KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSA 171
               + + DFG+ + +  PV       +       T  Y   +   G +  +   D+ + 
Sbjct: 141 NANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEAL 199

Query: 172 GCIFAELANAGRPLFPGSDVDDQLKRIFKLLG----TPTEDTWPGMNLLPDFKPFPMYHP 227
           G +F      G   + G       ++  ++      TP  +   G     +F  +  Y  
Sbjct: 200 GHVFMYFL-RGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFP--EEFYKYMHYAR 256

Query: 228 SMSFSQ--VAPKLTAKGRDLLQRL 249
           +++F        L      +L+RL
Sbjct: 257 NLAFDATPDYDYLQGLFSKVLERL 280

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  118 bits (297), Expect = 2e-32
 Identities = 43/281 (15%), Positives = 85/281 (30%), Gaps = 40/281 (14%)

Query: 5   GVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKK-LTLVF 63
           G D      +AIK   L   +        E  + K ++    +       +E     +V 
Sbjct: 26  GTDIAAGEEVAIK---LECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82

Query: 64  EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG-- 121
           E     L+  F+  + +  L  V     Q++  + + HS+N +HRD+KP N L+      
Sbjct: 83  ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG 142

Query: 122 -ELKLADFGLARAFG-------IPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGC 173
             + + DFGLA+ +        IP +       T  Y   +   G +  +   D+ S G 
Sbjct: 143 NLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGY 201

Query: 174 IFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ 233
           +       G   + G     + ++  +                           S     
Sbjct: 202 VLMYFN-LGSLPWQGLKAATKRQKYER---------------------ISEKKMSTPIEV 239

Query: 234 VAPKLTAKGRDLLQRLLVCNPVQRMSAE---DAMSHIYFSD 271
           +     ++    L          +           +++   
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 2e-32
 Identities = 57/275 (20%), Positives = 109/275 (39%), Gaps = 48/275 (17%)

Query: 12  TALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-D 69
           T +A+K       E   S  + E+ ++K + KHKNI+ L      +  L ++ E+  + +
Sbjct: 46  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 105

Query: 70  LKKY---------------FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQN 114
           L++Y                 +   ++    + S  YQ+ RG+ +  S+  +HRDL  +N
Sbjct: 106 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165

Query: 115 LLINKNGELKLADFGLARAFGIPVKCYSAEV--VTLWYRPPDVLFGAKLYTTSIDMWSAG 172
           +L+ ++  +K+ADFGLAR               + + +  P+ LF    YT   D+WS G
Sbjct: 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFG 224

Query: 173 CIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS 232
            +  E+   G   +PG  V++  K + +                      P         
Sbjct: 225 VLLWEIFTLGGSPYPGVPVEELFKLLKE----------------GHRMDKP--------- 259

Query: 233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHI 267
                 T +   +++      P QR + +  +  +
Sbjct: 260 ---SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 2e-29
 Identities = 55/273 (20%), Positives = 98/273 (35%), Gaps = 48/273 (17%)

Query: 15  AIKGTHLVGNEGVPSSALREI-CLLKELKHKNIVRLYDV-LHSEKKLTLVFEHCDQDLKK 72
           A+K            + + E+  L+    H N+V L          L ++ E C      
Sbjct: 47  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 106

Query: 73  YF----------------DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLL 116
            +                D     + L+ +  + +Q+ +G+ F  SR  +HRDL  +N+L
Sbjct: 107 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 166

Query: 117 INKNGELKLADFGLARAF--GIPVKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCI 174
           +++   +K+ DFGLAR               + L +  P+ +F    YT   D+WS G +
Sbjct: 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVL 225

Query: 175 FAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV 234
             E+ + G   +PG  +D++  R  K                PD+    MY         
Sbjct: 226 LWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR---------APDYTTPEMY--------- 267

Query: 235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHI 267
                      +       P QR +  + + H+
Sbjct: 268 ---------QTMLDCWHGEPSQRPTFSELVEHL 291

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 74.4 bits (182), Expect = 9e-17
 Identities = 23/144 (15%), Positives = 52/144 (36%), Gaps = 24/144 (16%)

Query: 33  REICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGEIDLDIVKSFMYQ 92
            E   L++L+   + ++Y      +   ++ E  D               ++     +  
Sbjct: 63  NEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAKELYRVR-------VENPDEVLDM 111

Query: 93  LLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCY----SAEVVTL 148
           +L  +A  + R ++H DL   N+L+++ G + + DF  +   G              +  
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNIIT 170

Query: 149 WYRPPDVLFGAKLYTTSIDMWSAG 172
           ++         + Y T  D+ SA 
Sbjct: 171 YFS--------RTYRTEKDINSAI 186

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	282
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.83
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.52
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.3
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.98
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.49
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.86
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.57

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-59  Score=383.41  Aligned_cols=275  Identities=41%  Similarity=0.742  Sum_probs=233.6

Q ss_pred             CeeeeeeCCCCceEEEeeeecCC----CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHh
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVG----NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS   76 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~   76 (282)
                      .||+|+++.+|+.||||++....    .......+.+|+.++++++||||+++++++.+++.+|+||||+.|+++..+..
T Consensus        13 ~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~   92 (299)
T d1ua2a_          13 TVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD   92 (299)
T ss_dssp             EEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTT
T ss_pred             EEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhh
Confidence            38999999999999999997622    22335678999999999999999999999999999999999999999888888


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhh
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~  156 (282)
                      ....+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||.+..............+|+.|+|||.+
T Consensus        93 ~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~  172 (299)
T d1ua2a_          93 NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL  172 (299)
T ss_dssp             CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHH
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccceecChhhccHHHH
Confidence            77889999999999999999999999999999999999999999999999999998776655555556789999999999


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       157 ~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      .....++.++||||+||++|+|++|. ++|.+.+..+.+..+.+..+.+..+.++.............. ..........
T Consensus       173 ~~~~~~~~~~DiwSlGvil~el~~g~-~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  250 (299)
T d1ua2a_         173 FGARMYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF-PGIPLHHIFS  250 (299)
T ss_dssp             TTCSCCCHHHHHHHHHHHHHHHHHSS-CSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCC-CCCCHHHHCT
T ss_pred             ccCCCCChhhhhhhcchHHHHHHhCc-CCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccC-CCCChHHhcc
Confidence            77766899999999999999999876 558899999999999999999888877765544444333222 2224445566


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccchh
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  277 (282)
                      .+++++.+||++||+.||++|||++|+|+||||++.+.+.+
T Consensus       251 ~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~  291 (299)
T d1ua2a_         251 AAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP  291 (299)
T ss_dssp             TCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCC
Confidence            78999999999999999999999999999999998766543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-58  Score=377.73  Aligned_cols=275  Identities=52%  Similarity=0.921  Sum_probs=238.3

Q ss_pred             eeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhc-CC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSL-NG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~-~~   79 (282)
                      ||+|+++.+|+.||||++.. .........+.+|++++++++||||+++++++.++..+|+||||+.|+++..+... ..
T Consensus        18 Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~   97 (298)
T d1gz8a_          18 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT   97 (298)
T ss_dssp             EEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTT
T ss_pred             EEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchhhhhhhhccc
Confidence            89999999999999999976 33344567899999999999999999999999999999999999999888877554 45


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||.+..............+++.|+|||.+...
T Consensus        98 ~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~  177 (298)
T d1gz8a_          98 GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC  177 (298)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccceeecccceeeehhhhccc
Confidence            69999999999999999999999999999999999999999999999999998877666666667889999999998877


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      ..++.++|+||+||++|+|++|..| |.+.+..+....+....+.+....++..........................+|
T Consensus       178 ~~~~~~~DiwSlGvily~m~~G~~P-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  256 (298)
T d1gz8a_         178 KYYSTAVDIWSLGCIFAEMVTRRAL-FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD  256 (298)
T ss_dssp             SSCCTHHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCC
T ss_pred             cCCCccccccccchhhhHHhhCCCC-CCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCC
Confidence            7678999999999999999998777 788888888889999888888877776655555554444444445556667899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccchh
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  277 (282)
                      +++.+||++||+.||++|||++|+++||||++++.+++
T Consensus       257 ~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~p  294 (298)
T d1gz8a_         257 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP  294 (298)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCCC
Confidence            99999999999999999999999999999999998876

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-59  Score=376.28  Aligned_cols=242  Identities=25%  Similarity=0.417  Sum_probs=197.4

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~   80 (282)
                      ||+|+++.+|+.||||++.........+.+.+|+.++++++||||+++++++.+++.+|+|||||+| +|.+. ....+.
T Consensus        21 V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~-l~~~~~   99 (271)
T d1nvra_          21 VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDR-IEPDIG   99 (271)
T ss_dssp             EEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGG-SBTTTB
T ss_pred             EEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHH-HhcCCC
Confidence            8999999999999999998754445567899999999999999999999999999999999999986 55554 444678


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC--ccccccccccccccChhhhcC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......  ........||+.|+|||.+.+
T Consensus       100 l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~  179 (271)
T d1nvra_         100 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR  179 (271)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcC
Confidence            999999999999999999999999999999999999999999999999999876432  222345678999999999988


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      ...++.++||||+||++|+|++|..|+................ .                          ........+
T Consensus       180 ~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~-~--------------------------~~~~~~~~~  232 (271)
T d1nvra_         180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-K--------------------------TYLNPWKKI  232 (271)
T ss_dssp             SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT-C--------------------------TTSTTGGGS
T ss_pred             CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-C--------------------------CCCCccccC
Confidence            7755788999999999999999988854443333333222211 0                          111122468


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD  271 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  271 (282)
                      |+++.+||.+||+.||++|||++|+++||||++
T Consensus       233 s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         233 DSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence            999999999999999999999999999999974

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-59  Score=374.38  Aligned_cols=238  Identities=29%  Similarity=0.454  Sum_probs=204.6

Q ss_pred             CeeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      .||+|+++.+|+.||+|++..  .........+.+|+.++++++||||+++++++.+++.+|+|||||+|+.+..+....
T Consensus        21 ~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~  100 (263)
T d2j4za1          21 NVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL  100 (263)
T ss_dssp             EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH
T ss_pred             EEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhc
Confidence            389999999999999999986  233445677899999999999999999999999999999999999864444444446


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......  .....||+.|+|||++.+
T Consensus       101 ~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~--~~~~~Gt~~Y~APE~~~~  178 (263)
T d2j4za1         101 SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--RTTLCGTLDYLPPEMIEG  178 (263)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC--CEETTEEGGGCCHHHHTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc--ccccCCCCcccCHHHHcC
Confidence            789999999999999999999999999999999999999999999999999997765332  234578999999999987


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++|||||||++|+|++|..| |.+.+..+....+....                             ..++..+
T Consensus       179 ~~-~~~~~DiwSlGvilyell~G~~P-f~~~~~~~~~~~i~~~~-----------------------------~~~p~~~  227 (263)
T d2j4za1         179 RM-HDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISRVE-----------------------------FTFPDFV  227 (263)
T ss_dssp             CC-CCTTHHHHHHHHHHHHHHHSSCT-TCCSSHHHHHHHHHTTC-----------------------------CCCCTTS
T ss_pred             CC-CCchhhhhhHhHHHHHHhcCCCC-CCCCCHHHHHHHHHcCC-----------------------------CCCCccC
Confidence            66 79999999999999999998888 77777777776665421                             1133458


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD  271 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  271 (282)
                      |+++.+||.+||+.||++|||++|+|+||||++
T Consensus       228 s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         228 TEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence            999999999999999999999999999999974

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-58  Score=373.94  Aligned_cols=242  Identities=25%  Similarity=0.329  Sum_probs=206.7

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||+|+++.+|+.||||++...... ..+.+.+|+.++++++||||+++++++.+++.+|+|||||+|+.+..+.. .+.
T Consensus        35 ~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~-~~~  112 (293)
T d1yhwa1          35 TVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETC  112 (293)
T ss_dssp             EEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHH-HSC
T ss_pred             EEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhh-ccC
Confidence            3899999999999999999864322 34679999999999999999999999999999999999998755555544 357


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..............||+.|+|||.+.+..
T Consensus       113 l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~  192 (293)
T d1yhwa1         113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA  192 (293)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCC
Confidence            99999999999999999999999999999999999999999999999999988765555556678899999999998765


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                       ++.++||||+||++|+|++|..| |.+.+..+....+......                          ....+..+|+
T Consensus       193 -~~~~~DiwSlGvilyemltG~~P-f~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~s~  244 (293)
T d1yhwa1         193 -YGPKVDIWSLGIMAIEMIEGEPP-YLNENPLRALYLIATNGTP--------------------------ELQNPEKLSA  244 (293)
T ss_dssp             -BCTHHHHHHHHHHHHHHHHSSCT-TTTSCHHHHHHHHHHHCSC--------------------------CCSSGGGSCH
T ss_pred             -CCchhceehHhHHHHHHhhCCCC-CCCCCHHHHHHHHHhCCCC--------------------------CCCCcccCCH
Confidence             79999999999999999998877 6666666666555543211                          1122356899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      .+++||++||+.||.+|||++|+|+||||+..
T Consensus       245 ~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         245 IFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            99999999999999999999999999999753

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-58  Score=374.45  Aligned_cols=246  Identities=25%  Similarity=0.412  Sum_probs=207.2

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      ||+|+++.+|+.||||++..  .......+.+.+|++++++++||||+++++++.+++.+|+||||++| ++.+. ....
T Consensus        24 Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~-~~~~  102 (288)
T d1uu3a_          24 VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKY-IRKI  102 (288)
T ss_dssp             EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHH-HHHH
T ss_pred             EEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHh-hhcc
Confidence            89999999999999999986  22344457799999999999999999999999999999999999986 55554 4446


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc--cccccccccccccChhhh
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--KCYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~aPE~~  156 (282)
                      +.+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++..+....  .......||+.|+|||++
T Consensus       103 ~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~  182 (288)
T d1uu3a_         103 GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL  182 (288)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceee
Confidence            889999999999999999999999999999999999999999999999999998765332  223345789999999999


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       157 ~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      .+.. ++.++|||||||++|+|++|..| |.+.+..+....+.+..                             ..++.
T Consensus       183 ~~~~-~~~~~DiwSlGvilyell~g~~P-f~~~~~~~~~~~i~~~~-----------------------------~~~p~  231 (288)
T d1uu3a_         183 TEKS-ACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKIIKLE-----------------------------YDFPE  231 (288)
T ss_dssp             HTCC-CCHHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHTTC-----------------------------CCCCT
T ss_pred             ccCC-CCcccceehhhHHHHHHhhCCCC-CCCcCHHHHHHHHHcCC-----------------------------CCCCc
Confidence            8776 79999999999999999998877 77777777777665421                             11334


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHH------HhcCCCccCCccchhhh
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAED------AMSHIYFSDLNVAIKSE  279 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~------ll~h~~~~~~~~~~~~~  279 (282)
                      .+|+++++||++||+.||++|||++|      +++||||+++++.....
T Consensus       232 ~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~  280 (288)
T d1uu3a_         232 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ  280 (288)
T ss_dssp             TCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGG
T ss_pred             cCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhc
Confidence            68999999999999999999999998      58899999998765443

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-58  Score=369.75  Aligned_cols=242  Identities=23%  Similarity=0.336  Sum_probs=205.0

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~   80 (282)
                      ||+|+++.+|+.||||++.... ....+.+.+|++++++++||||+++++++.+++.+++|||||+| ++.+.+.+..+.
T Consensus        28 Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~  106 (288)
T d2jfla1          28 VYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP  106 (288)
T ss_dssp             EEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSC
T ss_pred             EEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCC
Confidence            8999999999999999987642 33467899999999999999999999999999999999999986 555555655678


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC--
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG--  158 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--  158 (282)
                      +++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..............||+.|+|||++..  
T Consensus       107 l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~  186 (288)
T d2jfla1         107 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET  186 (288)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCS
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcc
Confidence            999999999999999999999999999999999999999999999999999765433334445678999999999842  


Q ss_pred             --CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         159 --AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       159 --~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                        ...++.++|||||||++|+|++|..| |.+.+..+....+.....                          .....+.
T Consensus       187 ~~~~~y~~k~DiwSlGvilyemltg~~P-f~~~~~~~~~~~i~~~~~--------------------------~~~~~~~  239 (288)
T d2jfla1         187 SKDRPYDYKADVWSLGITLIEMAEIEPP-HHELNPMRVLLKIAKSEP--------------------------PTLAQPS  239 (288)
T ss_dssp             TTTSSTTTHHHHHHHHHHHHHHHHSSCT-TTTSCGGGHHHHHHHSCC--------------------------CCCSSGG
T ss_pred             cCCCCCChhhhHHHHHHHHHHHhhCCCC-CCCCCHHHHHHHHHcCCC--------------------------CCCCccc
Confidence              33478999999999999999998877 666666666666655211                          1112235


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD  271 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  271 (282)
                      .+|+++.+||++||+.||++|||++|+++||||+.
T Consensus       240 ~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         240 RWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            68999999999999999999999999999999984

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-57  Score=375.00  Aligned_cols=245  Identities=22%  Similarity=0.318  Sum_probs=212.7

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|+++.+|+.||||++.+.  ........+.+|+.++++++||||+++++++++++.+|+||||++|+.+..+....+
T Consensus        21 V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~  100 (337)
T d1o6la_          21 VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER  100 (337)
T ss_dssp             EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS
T ss_pred             EEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhccc
Confidence            899999999999999999862  233445778999999999999999999999999999999999998755555555578


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .++++.++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++..............||+.|+|||++.+.
T Consensus       101 ~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~  180 (337)
T d1o6la_         101 VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN  180 (337)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSS
T ss_pred             CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCC
Confidence            89999999999999999999999999999999999999999999999999998776555555567889999999999877


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      . ++.++|+||+||++|+|++|..| |.+.+..+....+...                             ...++..+|
T Consensus       181 ~-y~~~~DiwSlGvilyeml~G~~p-f~~~~~~~~~~~i~~~-----------------------------~~~~p~~~s  229 (337)
T d1o6la_         181 D-YGRAVDWWGLGVVMYEMMCGRLP-FYNQDHERLFELILME-----------------------------EIRFPRTLS  229 (337)
T ss_dssp             C-BCTTHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHC-----------------------------CCCCCTTSC
T ss_pred             C-CChhhcccchhhHHHHHHHCCCC-CCCcCHHHHHHHHhcC-----------------------------CCCCCccCC
Confidence            6 79999999999999999998766 7777777777776652                             122345689


Q ss_pred             HHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCccchh
Q psy6044         240 AKGRDLLQRLLVCNPVQRMS-----AEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps-----~~~ll~h~~~~~~~~~~~  277 (282)
                      +++++||++||+.||.+|++     ++++++||||+++++...
T Consensus       230 ~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l  272 (337)
T d1o6la_         230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV  272 (337)
T ss_dssp             HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred             HHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHH
Confidence            99999999999999999994     999999999999876543

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.2e-57  Score=366.39  Aligned_cols=268  Identities=52%  Similarity=0.937  Sum_probs=233.3

Q ss_pred             eeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      ||+|+++ +|+.||||++.. .........+.+|+.++++++||||+++++++.+++..++++|++.|+++..+....+.
T Consensus        18 Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~   96 (286)
T d1ob3a_          18 VYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG   96 (286)
T ss_dssp             EEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTC
T ss_pred             EEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCC
Confidence            8999995 789999999977 33444567899999999999999999999999999999999999999999999888889


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGAK  160 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  160 (282)
                      +++..+..++.||+.||+|||++||+|+||||+||+++.++.+|++|||.+..............+++.|+|||.+.+..
T Consensus        97 l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~  176 (286)
T d1ob3a_          97 LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK  176 (286)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCC
T ss_pred             cchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCC
Confidence            99999999999999999999999999999999999999999999999999988765555555556789999999998877


Q ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCCH
Q psy6044         161 LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLTA  240 (282)
Q Consensus       161 ~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
                      +++.++|+||+||++|+|++|..| |.+.+..+....+....+.+....++..........................+++
T Consensus       177 ~~~~~~DiwslGv~l~el~~G~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  255 (286)
T d1ob3a_         177 KYSTTIDIWSVGCIFAEMVNGTPL-FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDE  255 (286)
T ss_dssp             SCCTHHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCH
T ss_pred             CCCcceeehhcCcHHHHHHHCCCC-CCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCH
Confidence            789999999999999999998766 7888888889999999999888888776666655555555555667777888999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q psy6044         241 KGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD  271 (282)
Q Consensus       241 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  271 (282)
                      .+.+||++||+.||++|||++|+|+||||++
T Consensus       256 ~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         256 SGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            9999999999999999999999999999985

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-57  Score=370.98  Aligned_cols=243  Identities=26%  Similarity=0.383  Sum_probs=189.1

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      .||+|+++.+|+.||||++...........+.+|+.++++++||||+++++++.+++.+|+|||||+| +|.+.+.. .+
T Consensus        24 ~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~-~~  102 (307)
T d1a06a_          24 EVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE-KG  102 (307)
T ss_dssp             GEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CS
T ss_pred             EEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhc-cc
Confidence            38999999999999999998744444456788999999999999999999999999999999999985 66665544 77


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc---CCCcEEEEecCCccccCCCccccccccccccccChhhh
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN---KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~  156 (282)
                      .+++..+..++.||+.||.|||++||+|+||||+||++.   .++.+||+|||++...... .......||+.|+|||.+
T Consensus       103 ~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~-~~~~~~~GT~~y~APE~~  181 (307)
T d1a06a_         103 FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVL  181 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------------------CTTSCHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC-CeeeeeeeCccccCcHHH
Confidence            899999999999999999999999999999999999995   4789999999999766533 233445789999999999


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       157 ~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      .+.. ++.++|||||||++|+|++|..| |.+....+....+.......+                         .....
T Consensus       182 ~~~~-~~~~~DiwSlGvilyell~g~~P-f~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~  234 (307)
T d1a06a_         182 AQKP-YSKAVDCWSIGVIAYILLCGYPP-FYDENDAKLFEQILKAEYEFD-------------------------SPYWD  234 (307)
T ss_dssp             TTCC-CCTHHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHTTCCCCC-------------------------TTTTT
T ss_pred             cCCC-CCcHHHhhhhhHHHHHHHhCCCC-CCCCCHHHHHHHHhccCCCCC-------------------------Ccccc
Confidence            8766 79999999999999999998877 677777776666655322211                         11234


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      .+|+++.+||++||+.||.+|||++|+++||||++.
T Consensus       235 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         235 DISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             CCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            689999999999999999999999999999999853

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-58  Score=367.08  Aligned_cols=238  Identities=29%  Similarity=0.448  Sum_probs=190.6

Q ss_pred             eeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeee--CCeEEEEEecCcc-cHHHHHHh-
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHS--EKKLTLVFEHCDQ-DLKKYFDS-   76 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~--~~~~~iv~e~~~g-~l~~~~~~-   76 (282)
                      ||+|+++.+|+.||+|++... ..+...+.+.+|++++++++||||+++++++.+  ++.+|+|||||+| +|.+.+.. 
T Consensus        20 Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~   99 (269)
T d2java1          20 CQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKG   99 (269)
T ss_dssp             EEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHH
T ss_pred             EEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhc
Confidence            899999999999999999873 233345668899999999999999999999865  4678999999985 66665543 


Q ss_pred             --cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccccccccccc
Q psy6044          77 --LNGEIDLDIVKSFMYQLLRGLAFCHSRN-----VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW  149 (282)
Q Consensus        77 --~~~~~~~~~~~~~~~qi~~~l~~lh~~~-----i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~  149 (282)
                        .+..+++..++.++.||+.||.|||++|     |+||||||+||+++.++.+||+|||++..............||+.
T Consensus       100 ~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~  179 (269)
T d2java1         100 TKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPY  179 (269)
T ss_dssp             HHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-----------CCCS
T ss_pred             cccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcc
Confidence              2567999999999999999999999976     999999999999999999999999999887655444555678999


Q ss_pred             ccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSM  229 (282)
Q Consensus       150 ~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
                      |+|||.+.+.. ++.++|||||||++|+|++|..| |.+.+..+....+....                           
T Consensus       180 Y~APE~l~~~~-~~~~~DIwSlGvilyel~tg~~P-f~~~~~~~~~~~i~~~~---------------------------  230 (269)
T d2java1         180 YMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPP-FTAFSQKELAGKIREGK---------------------------  230 (269)
T ss_dssp             CCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHTC---------------------------
T ss_pred             cCCHHHHcCCC-CChHHHHHhhCHHHHHHhhCCCC-CCCCCHHHHHHHHHcCC---------------------------
Confidence            99999997766 79999999999999999998877 77777777777766531                           


Q ss_pred             CccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy6044         230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYF  269 (282)
Q Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  269 (282)
                       ...++..+|+++.+||++||+.||++|||++|+++|||+
T Consensus       231 -~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         231 -FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             -CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence             122345689999999999999999999999999999996

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.1e-57  Score=369.76  Aligned_cols=241  Identities=23%  Similarity=0.342  Sum_probs=211.5

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|+++.+|+.||||++..  .......+.+.+|+.++++++||||+++++++.+++.+|+||||+.|+.+..+.....
T Consensus        20 Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~   99 (316)
T d1fota_          20 VHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ   99 (316)
T ss_dssp             EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS
T ss_pred             EEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccc
Confidence            89999999999999999986  2334456788999999999999999999999999999999999999877777777688


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.......   ....||+.|+|||++.+.
T Consensus       100 ~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~---~~~~Gt~~Y~APE~l~~~  176 (316)
T d1fota_         100 RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPEVVSTK  176 (316)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB---CCCCSCTTTCCHHHHTTC
T ss_pred             cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccc---ccccCcccccCHHHHcCC
Confidence            89999999999999999999999999999999999999999999999999998765332   345789999999999776


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      . ++.++|||||||++|+|++|..| |.+.+..+....+....                             ...+..+|
T Consensus       177 ~-y~~~~DiwSlGvilyemltG~~P-f~~~~~~~~~~~i~~~~-----------------------------~~~p~~~s  225 (316)
T d1fota_         177 P-YNKSIDWWSFGILIYEMLAGYTP-FYDSNTMKTYEKILNAE-----------------------------LRFPPFFN  225 (316)
T ss_dssp             C-BCTTHHHHHHHHHHHHHHHSSCT-TCCSSHHHHHHHHHHCC-----------------------------CCCCTTSC
T ss_pred             C-CCchhhccccchhHHHHHhCCCC-CCCcCHHHHHHHHHcCC-----------------------------CCCCCCCC
Confidence            6 79999999999999999998887 77777777777776621                             12345689


Q ss_pred             HHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCccch
Q psy6044         240 AKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~  276 (282)
                      +++.++|++||..||.+|+     |++++++||||++++++.
T Consensus       226 ~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~  267 (316)
T d1fota_         226 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEK  267 (316)
T ss_dssp             HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHH
T ss_pred             HHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHH
Confidence            9999999999999999996     999999999999997664

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-56  Score=362.00  Aligned_cols=274  Identities=76%  Similarity=1.264  Sum_probs=246.3

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      .||+|+++.+|+.||||+++.. ........+.+|+.+++.++||||+++++++.+....+++++++.|+.+..+....+
T Consensus        17 ~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~   96 (292)
T d1unla_          17 TVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG   96 (292)
T ss_dssp             EEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTT
T ss_pred             EEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccccccccccc
Confidence            3899999999999999999873 334456788999999999999999999999999999999999999998888888888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||.+..............++..|.|||.+...
T Consensus        97 ~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~  176 (292)
T d1unla_          97 DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA  176 (292)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTC
T ss_pred             ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccC
Confidence            99999999999999999999999999999999999999999999999999998876555555556678889999999877


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      ..++.++||||+||++|+|++|+.|++.+.+..+....+....+.+....++..........................++
T Consensus       177 ~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  256 (292)
T d1unla_         177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLN  256 (292)
T ss_dssp             SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCC
T ss_pred             CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCC
Confidence            76799999999999999999999999999999999999999999998888887777777766666666666777778899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      +.+.+||++||+.||++|||++|+|+||||++..+
T Consensus       257 ~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         257 ATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence            99999999999999999999999999999998654

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.8e-57  Score=369.16  Aligned_cols=240  Identities=23%  Similarity=0.334  Sum_probs=204.2

Q ss_pred             CeeeeeeCCCCceEEEeeeecCC--CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVG--NEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      .||+|+++.+|+.||||++....  .....+.+.+|+.++++++||||+++++++.+++.+|+|||||.|+++..+....
T Consensus        30 ~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~  109 (309)
T d1u5ra_          30 AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK  109 (309)
T ss_dssp             EEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHT
T ss_pred             EEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhC
Confidence            38999999999999999998632  2223456889999999999999999999999999999999999998888777778


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......    ....||+.|+|||++.+
T Consensus       110 ~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~----~~~~GT~~Y~APE~~~~  185 (309)
T d1u5ra_         110 KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILA  185 (309)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----CCCCSCGGGCCHHHHTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC----CccccCccccCHHHHhc
Confidence            88999999999999999999999999999999999999999999999999999865432    34578999999999864


Q ss_pred             C--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         159 A--KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       159 ~--~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      .  ..++.++|||||||++|+|++|..| |.+.+..+....+.......                           ....
T Consensus       186 ~~~~~y~~~~DiwSlGvilyel~~g~~P-f~~~~~~~~~~~i~~~~~~~---------------------------~~~~  237 (309)
T d1u5ra_         186 MDEGQYDGKVDVWSLGITCIELAERKPP-LFNMNAMSALYHIAQNESPA---------------------------LQSG  237 (309)
T ss_dssp             TTSCCBCTHHHHHHHHHHHHHHHHSSCT-TTTSCHHHHHHHHHHSCCCC---------------------------CSCT
T ss_pred             cCCCCcCchhhhhhHHHHHHHHHHCCCC-CCCCCHHHHHHHHHhCCCCC---------------------------CCCC
Confidence            2  3478999999999999999998888 55566666555555421110                           1123


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      .+|+.+.+||.+||+.||.+|||++++|+||||+.-
T Consensus       238 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             CCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence            579999999999999999999999999999999754

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-57  Score=362.54  Aligned_cols=239  Identities=24%  Similarity=0.359  Sum_probs=196.6

Q ss_pred             CeeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeee----CCeEEEEEecCcccHHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHS----EKKLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~----~~~~~iv~e~~~g~l~~~~~   75 (282)
                      .||+|+++.+++.||+|++.. .......+.+.+|++++++++||||+++++++.+    +..+|+||||++|+.+..+.
T Consensus        24 ~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l  103 (270)
T d1t4ha_          24 TVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL  103 (270)
T ss_dssp             EEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHH
T ss_pred             EEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHH
Confidence            389999999999999999987 3333345678899999999999999999999875    45789999999875444444


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEc-CCCcEEEEecCCccccCCCccccccccccccccC
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSRN--VLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRP  152 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~dl~~~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~a  152 (282)
                      .....+++..+..++.||+.||+|||++|  |+||||||+||+++ .++.+||+|||++.......  .....||+.|+|
T Consensus       104 ~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~--~~~~~GT~~Y~a  181 (270)
T d1t4ha_         104 KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMA  181 (270)
T ss_dssp             HHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS--BEESCSSCCCCC
T ss_pred             hccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc--cCCcccCccccC
Confidence            44678999999999999999999999998  99999999999996 57899999999997654332  234578999999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       153 PE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      ||.+.+.  ++.++|||||||++|+|++|..||....+..+....+....                           ...
T Consensus       182 PE~~~~~--~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~---------------------------~~~  232 (270)
T d1t4ha_         182 PEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV---------------------------KPA  232 (270)
T ss_dssp             GGGGGTC--CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC---------------------------CCG
T ss_pred             HHHhCCC--CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCC---------------------------CCc
Confidence            9998653  79999999999999999999988544455555544443311                           111


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS  270 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  270 (282)
                      ......++++.+||.+||+.||++|||++|+|+||||+
T Consensus       233 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            23455789999999999999999999999999999996

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-57  Score=374.62  Aligned_cols=271  Identities=23%  Similarity=0.350  Sum_probs=200.7

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      .||+|+++.+|+.||+|+++..........+.+|+.++++++||||+++++++.+++.+|+||||++|+.+..+....+.
T Consensus        21 ~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~  100 (322)
T d1s9ja_          21 VVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR  100 (322)
T ss_dssp             CEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSS
T ss_pred             EEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCC
Confidence            49999999999999999998755555567889999999999999999999999999999999999987544444444678


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSR-NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      +++..+..++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++......  ......||+.|+|||++.+.
T Consensus       101 l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~~~~~~GT~~Y~APEvl~~~  178 (322)
T d1s9ja_         101 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGT  178 (322)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--TC---CCSSCCCCHHHHHCS
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--ccccccCCccccCchHHcCC
Confidence            99999999999999999999975 9999999999999999999999999999865322  22345789999999999887


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCC-CCCCCCCC---------
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKP-FPMYHPSM---------  229 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---------  229 (282)
                      . ++.++||||+||++|+|++|+.||.................+.................. ........         
T Consensus       179 ~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (322)
T d1s9ja_         179 H-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYI  257 (322)
T ss_dssp             C-CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHH
T ss_pred             C-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhh
Confidence            6 799999999999999999999996655544333322222221111000000000000000 00000000         


Q ss_pred             ---Ccccc-CccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         230 ---SFSQV-APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       230 ---~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                         ..... ...+|+++.+||++||+.||++|||++|+|+||||++.+.
T Consensus       258 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~  306 (322)
T d1s9ja_         258 VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  306 (322)
T ss_dssp             HTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             hccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence               00011 1237899999999999999999999999999999997654

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-56  Score=363.48  Aligned_cols=247  Identities=23%  Similarity=0.378  Sum_probs=203.7

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCC-----CCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNE-----GVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~   74 (282)
                      .||+|+++.+|+.||||++......     ...+.+.+|+.++++++||||+++++++.+++.+|+|||||+| ++.+.+
T Consensus        25 ~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i  104 (293)
T d1jksa_          25 VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL  104 (293)
T ss_dssp             EEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH
T ss_pred             EEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchh
Confidence            3899999999999999999872211     1245688999999999999999999999999999999999986 555544


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC----cEEEEecCCccccCCCccccccccccccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG----ELKLADFGLARAFGIPVKCYSAEVVTLWY  150 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~  150 (282)
                       ...+.+++..++.++.||+.||+|||++||+|+||||+||+++.++    .+|++|||++....... ......+++.|
T Consensus       105 -~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~-~~~~~~~t~~y  182 (293)
T d1jksa_         105 -AEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEF  182 (293)
T ss_dssp             -HHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC-BCSCCCCCGGG
T ss_pred             -ccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCc-cccccCCCCcc
Confidence             4467899999999999999999999999999999999999998776    59999999998775433 23445778999


Q ss_pred             cChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMS  230 (282)
Q Consensus       151 ~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
                      +|||.+.+.. ++.++||||+||++|+|++|..| |.+.+..+....+......                         .
T Consensus       183 ~APE~~~~~~-~~~~~DiwSlGvilyell~g~~P-f~~~~~~~~~~~i~~~~~~-------------------------~  235 (293)
T d1jksa_         183 VAPEIVNYEP-LGLEADMWSIGVITYILLSGASP-FLGDTKQETLANVSAVNYE-------------------------F  235 (293)
T ss_dssp             CCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHTTCCC-------------------------C
T ss_pred             cCHHHHcCCC-CCCcccchhhhHHHHHHHcCCCC-CCCCCHHHHHHHHHhcCCC-------------------------C
Confidence            9999997765 79999999999999999998877 6777777777666543211                         1


Q ss_pred             ccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      ....+..+|+.+++||++||+.||.+|||++|+++||||+..++..
T Consensus       236 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~  281 (293)
T d1jksa_         236 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ  281 (293)
T ss_dssp             CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-----
T ss_pred             CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhH
Confidence            1223456899999999999999999999999999999999876544

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4e-56  Score=369.19  Aligned_cols=243  Identities=20%  Similarity=0.276  Sum_probs=209.4

Q ss_pred             eeeeeeCCCCceEEEeeeec--CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL--VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      ||+|+++.+|+.||||++..  .......+.+.+|+.+++.++||||+++++++.+....++|+||+.|+.+.......+
T Consensus        57 Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~  136 (350)
T d1rdqe_          57 VMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG  136 (350)
T ss_dssp             EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC
T ss_pred             EEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcC
Confidence            89999999999999999976  2334445678999999999999999999999999999999999998654444444467


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcCC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      .+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++..+....   ....||+.|+|||++.+.
T Consensus       137 ~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~---~~~~Gt~~Y~APE~~~~~  213 (350)
T d1rdqe_         137 RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEALAPEIILSK  213 (350)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB---CCCEECGGGCCHHHHTTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc---ccccCccccCCHHHHcCC
Confidence            89999999999999999999999999999999999999999999999999998775332   345789999999999876


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      . ++.++|||||||++|+|++|..| |.+.+..+....+....                             ...+..+|
T Consensus       214 ~-~~~~~DiwSlGvilyemltG~~P-f~~~~~~~~~~~i~~~~-----------------------------~~~p~~~s  262 (350)
T d1rdqe_         214 G-YNKAVDWWALGVLIYEMAAGYPP-FFADQPIQIYEKIVSGK-----------------------------VRFPSHFS  262 (350)
T ss_dssp             C-BCTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHCC-----------------------------CCCCTTCC
T ss_pred             C-CCccccccchhHHHHHHHhCCCC-CCCcCHHHHHHHHhcCC-----------------------------CCCCccCC
Confidence            6 79999999999999999998887 67777777777776621                             12335689


Q ss_pred             HHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCccchhh
Q psy6044         240 AKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNVAIKS  278 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~~  278 (282)
                      +++.+||++||+.||.+|+     |++++++||||+++++....
T Consensus       263 ~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~  306 (350)
T d1rdqe_         263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY  306 (350)
T ss_dssp             HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHH
T ss_pred             HHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHH
Confidence            9999999999999999995     99999999999999876543

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.7e-56  Score=369.12  Aligned_cols=245  Identities=24%  Similarity=0.397  Sum_probs=209.2

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      .||+|+++.+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+++.+|+|||||+| +|.+.+....+
T Consensus        41 ~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~  119 (350)
T d1koaa2          41 VVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN  119 (350)
T ss_dssp             EEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTS
T ss_pred             EEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcC
Confidence            38999999999999999987532 22346788999999999999999999999999999999999975 66677766567


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC--CCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK--NGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      .+++..+..++.||+.||.|||++||+||||||+||+++.  ++.+||+|||++..+..... .....||+.|+|||++.
T Consensus       120 ~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~-~~~~~gT~~Y~aPEv~~  198 (350)
T d1koaa2         120 KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-VKVTTGTAEFAAPEVAE  198 (350)
T ss_dssp             CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC-EEEECSCTTTCCHHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc-cceecCcccccCHHHHc
Confidence            8999999999999999999999999999999999999964  57899999999987764433 33457799999999998


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|||||||++|+|++|..| |.+.+..+....+.......+                         ......
T Consensus       199 ~~~-~~~~~DiwSlGvilyell~G~~P-f~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~  251 (350)
T d1koaa2         199 GKP-VGYYTDMWSVGVLSYILLSGLSP-FGGENDDETLRNVKSCDWNMD-------------------------DSAFSG  251 (350)
T ss_dssp             TCC-BCHHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHTCCCSC-------------------------CGGGGG
T ss_pred             CCC-CChhHhhhhhhHHHHHHHhCCCC-CCCCCHHHHHHHHHhCCCCCC-------------------------cccccC
Confidence            776 69999999999999999998887 777788888877766432221                         123356


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      +|+++++||++||+.||++|||++|+|+||||+..+.
T Consensus       252 ~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~  288 (350)
T d1koaa2         252 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  288 (350)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            8999999999999999999999999999999997754

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-56  Score=364.81  Aligned_cols=244  Identities=25%  Similarity=0.371  Sum_probs=208.9

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHHHHHHh-hCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALREICLLK-ELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~-~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||+|+++.+|+.||||++.+.  ........+..|..++. .++||||+++++++.+++.+|+||||++|+.+..+....
T Consensus        18 Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~   97 (320)
T d1xjda_          18 VFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC   97 (320)
T ss_dssp             EEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH
T ss_pred             EEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhcc
Confidence            899999999999999999862  22333456667777654 689999999999999999999999999875444455557


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhcC
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      +.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+..............||+.|+|||++.+
T Consensus        98 ~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  177 (320)
T d1xjda_          98 HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG  177 (320)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcC
Confidence            88999999999999999999999999999999999999999999999999999877666666666788999999999987


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++||||+||++|+|++|..| |.+.+..+....+...                             ....+..+
T Consensus       178 ~~-~~~~~DiwSlGvilyemltG~~P-F~~~~~~~~~~~i~~~-----------------------------~~~~p~~~  226 (320)
T d1xjda_         178 QK-YNHSVDWWSFGVLLYEMLIGQSP-FHGQDEEELFHSIRMD-----------------------------NPFYPRWL  226 (320)
T ss_dssp             CC-BCTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHC-----------------------------CCCCCTTS
T ss_pred             CC-CCchhhhhhhhHHHHHHHhCCCC-CCCCCHHHHHHHHHcC-----------------------------CCCCCccC
Confidence            76 79999999999999999998877 7777777777776552                             11233568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHH-HHhcCCCccCCccch
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAE-DAMSHIYFSDLNVAI  276 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~-~ll~h~~~~~~~~~~  276 (282)
                      |+++.+||++||+.||.+|||+. ++++||||++++++.
T Consensus       227 s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~  265 (320)
T d1xjda_         227 EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEE  265 (320)
T ss_dssp             CHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHH
T ss_pred             CHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHHH
Confidence            99999999999999999999996 899999999987654

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6.7e-56  Score=367.87  Aligned_cols=243  Identities=21%  Similarity=0.333  Sum_probs=207.0

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      .||+|+++.+|+.||||++..... .....+.+|+.++++++||||+++++++.+++.+|+|||||+| +|.+.+.....
T Consensus        44 ~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~  122 (352)
T d1koba_          44 VVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY  122 (352)
T ss_dssp             EEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTC
T ss_pred             EEEEEEECCCCCEEEEEEECCcch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCC
Confidence            389999999999999999876322 1245678999999999999999999999999999999999985 56666666566


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc--CCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLIN--KNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~--~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      .+++.+++.++.||+.||.|||++||+||||||+||+++  .++.+||+|||++........ .....+++.|+|||++.
T Consensus       123 ~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~-~~~~~gt~~y~aPE~~~  201 (352)
T d1koba_         123 KMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-VKVTTATAEFAAPEIVD  201 (352)
T ss_dssp             CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-EEEECSSGGGCCHHHHT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc-eeeccCcccccCHHHHc
Confidence            799999999999999999999999999999999999997  578999999999988764432 33456799999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++|||||||++|+|++|..| |.+.+..+....+......++.                         .....
T Consensus       202 ~~~-~~~~~DiwSlGvilyelltG~~P-f~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~  254 (352)
T d1koba_         202 REP-VGFYTDMWAIGVLGYVLLSGLSP-FAGEDDLETLQNVKRCDWEFDE-------------------------DAFSS  254 (352)
T ss_dssp             TCC-BCHHHHHHHHHHHHHHHHHSCCS-SCCSSHHHHHHHHHHCCCCCCS-------------------------STTTT
T ss_pred             CCC-CCCccchHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhCCCCCCc-------------------------ccccC
Confidence            766 79999999999999999998877 7777878877777664332222                         22346


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      +|+++.+||++||+.||.+|||++|+|+||||++.
T Consensus       255 ~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         255 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            89999999999999999999999999999999864

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.7e-55  Score=353.08  Aligned_cols=242  Identities=25%  Similarity=0.403  Sum_probs=204.8

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCC--------CccHHHHHHHHhhCC-CCCccceeeeeeeCCeEEEEEecCcc-cHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGV--------PSSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQ-DLK   71 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~   71 (282)
                      ||+|+++.+|+.||||++........        .+.+.+|+.++++++ ||||+++++++.+++.+|+||||++| +|.
T Consensus        19 V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~   98 (277)
T d1phka_          19 VRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF   98 (277)
T ss_dssp             EEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHH
T ss_pred             EEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHH
Confidence            89999999999999999987332221        235889999999996 99999999999999999999999975 666


Q ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccccccccccccc
Q psy6044          72 KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYR  151 (282)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  151 (282)
                      +.+.. .+.++++.+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++..++... ......||+.|.
T Consensus        99 ~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~  176 (277)
T d1phka_          99 DYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYL  176 (277)
T ss_dssp             HHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC-CBCCCCSCGGGC
T ss_pred             HHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccCCC-ceeeeeccCCCC
Confidence            66554 6789999999999999999999999999999999999999999999999999998876433 334467899999


Q ss_pred             ChhhhcC-----CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         152 PPDVLFG-----AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYH  226 (282)
Q Consensus       152 aPE~~~~-----~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (282)
                      |||.+.+     ...++.++||||+||++|+|++|..| |.+.+..+....+......++.                   
T Consensus       177 ~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~P-f~~~~~~~~~~~i~~~~~~~~~-------------------  236 (277)
T d1phka_         177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-FWHRKQMLMLRMIMSGNYQFGS-------------------  236 (277)
T ss_dssp             CHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHTCCCCCT-------------------
T ss_pred             CHHHhhccccccCCCCCchheEcccchhhhhhccCCCC-CCCCCHHHHHHHHHhCCCCCCC-------------------
Confidence            9999852     33468899999999999999998877 7777777777777664222111                   


Q ss_pred             CCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q psy6044         227 PSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD  271 (282)
Q Consensus       227 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  271 (282)
                            .....+|+++.+||++||+.||++|||++|+|+||||+.
T Consensus       237 ------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         237 ------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             ------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             ------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence                  123468999999999999999999999999999999985

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-54  Score=354.25  Aligned_cols=270  Identities=43%  Similarity=0.764  Sum_probs=221.6

Q ss_pred             CeeeeeeCCC-CceEEEeeeec-CCCCCCCccHHHHHHHHhhC---CCCCccceeeeeee-----CCeEEEEEecCcccH
Q psy6044           1 MFTSGVDRTP-NTALAIKGTHL-VGNEGVPSSALREICLLKEL---KHKNIVRLYDVLHS-----EKKLTLVFEHCDQDL   70 (282)
Q Consensus         1 ~vy~a~~~~~-~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l---~h~~i~~~~~~~~~-----~~~~~iv~e~~~g~l   70 (282)
                      .||+|++..+ ++.||||++.. .........+.+|+.+++.+   +||||+++++++..     ....++++|+++|+.
T Consensus        22 ~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~  101 (305)
T d1blxa_          22 KVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL  101 (305)
T ss_dssp             EEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBH
T ss_pred             EEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCc
Confidence            3899999765 67899999987 44455566788898888776   79999999999863     357899999999887


Q ss_pred             HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccccccccccc
Q psy6044          71 KKYFDSL-NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLW  149 (282)
Q Consensus        71 ~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~  149 (282)
                      +...... ...+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||.+..... ........||+.
T Consensus       102 ~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~-~~~~~~~~gT~~  180 (305)
T d1blxa_         102 TTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF-QMALTSVVVTLW  180 (305)
T ss_dssp             HHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCG-GGGGCCCCCCCT
T ss_pred             hhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhcc-cccCCCcccChh
Confidence            7655443 45699999999999999999999999999999999999999999999999999876543 334455688999


Q ss_pred             ccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         150 YRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSM  229 (282)
Q Consensus       150 ~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
                      |+|||.+.+.. ++.++||||+||++|+|++|..| |.+.+..+.+..+....+.+....++.........  .......
T Consensus       181 Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  256 (305)
T d1blxa_         181 YRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPL-FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA--FHSKSAQ  256 (305)
T ss_dssp             TCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGG--SCCCCCC
T ss_pred             hcCcchhcCCC-CChhehhhchHHHHHHHHHCCCC-CCCCCHHHHHHHHHHhhCCCchhcccccccchhhh--hcccccc
Confidence            99999997766 79999999999999999988766 78888899999999988888776665433222211  1122223


Q ss_pred             CccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         230 SFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ........+++.+.+||++||+.||++|||++|+|+||||++++.+
T Consensus       257 ~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~  302 (305)
T d1blxa_         257 PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  302 (305)
T ss_dssp             CGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             chhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhh
Confidence            4555667899999999999999999999999999999999998654

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.6e-55  Score=364.64  Aligned_cols=246  Identities=24%  Similarity=0.324  Sum_probs=197.6

Q ss_pred             eeeeeeCCCCceEEEeeeecC--CCCCCCccHHHH---HHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHh
Q psy6044           2 FTSGVDRTPNTALAIKGTHLV--GNEGVPSSALRE---ICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDS   76 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e---~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~   76 (282)
                      ||+|+++.+|+.||||++...  ........+.+|   +.+++.++||||+++++++.+++.+|+||||++|+.+..+..
T Consensus        20 Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~   99 (364)
T d1omwa3          20 VYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS   99 (364)
T ss_dssp             EEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred             EEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHH
Confidence            899999999999999999751  112222334444   667777889999999999999999999999998644444444


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhh
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~  156 (282)
                      ....+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.......  .....||+.|+|||.+
T Consensus       100 ~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~--~~~~~GT~~y~APE~~  177 (364)
T d1omwa3         100 QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGTHGYMAPEVL  177 (364)
T ss_dssp             HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC--CCSCCSCGGGCCHHHH
T ss_pred             hcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc--ccccccccccchhHHh
Confidence            47889999999999999999999999999999999999999999999999999998765432  2345789999999999


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       157 ~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      .....++.++|||||||++|+|++|..|| .+....+....... ...                         .....+.
T Consensus       178 ~~~~~~~~~~DiwSlGvilyemltG~~Pf-~~~~~~~~~~~~~~-~~~-------------------------~~~~~~~  230 (364)
T d1omwa3         178 QKGVAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRM-TLT-------------------------MAVELPD  230 (364)
T ss_dssp             STTCCCCTHHHHHHHHHHHHHHHHSSCSS-CSSCSSCHHHHHHH-SSS-------------------------CCCCCCS
T ss_pred             hcCCCCCcccchhHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHh-ccc-------------------------CCCCCCC
Confidence            76655899999999999999999998885 44332222222211 111                         1112345


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCccch
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMS-----AEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~h~~~~~~~~~~  276 (282)
                      .+|+++.+||.+||+.||++|||     ++++++||||+++++..
T Consensus       231 ~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~  275 (364)
T d1omwa3         231 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM  275 (364)
T ss_dssp             SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHH
T ss_pred             CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHH
Confidence            68999999999999999999999     79999999999997654

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=354.87  Aligned_cols=267  Identities=34%  Similarity=0.490  Sum_probs=211.4

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeee------CCeEEEEEecCcccHHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHS------EKKLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~------~~~~~iv~e~~~g~l~~~~~   75 (282)
                      ||+|+++.+|+.||||++....     ....+|+.++++++||||+++++++..      ..++++||||++|++...+.
T Consensus        36 Vy~a~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~  110 (350)
T d1q5ka_          36 VYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR  110 (350)
T ss_dssp             EEEEEETTTCCEEEEEEEECCS-----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHH
T ss_pred             EEEEEECCCCCEEEEEEECccc-----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHH
Confidence            8999999999999999997532     234489999999999999999999854      34689999999988766553


Q ss_pred             ---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC-cEEEEecCCccccCCCcccccccccccccc
Q psy6044          76 ---SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG-ELKLADFGLARAFGIPVKCYSAEVVTLWYR  151 (282)
Q Consensus        76 ---~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  151 (282)
                         .....+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||++....... ......++..|+
T Consensus       111 ~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~  189 (350)
T d1q5ka_         111 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRYYR  189 (350)
T ss_dssp             HHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS-CCCSCCSCTTSC
T ss_pred             hhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCc-cccccccccccc
Confidence               3456799999999999999999999999999999999999999775 89999999998765433 233457889999


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSF  231 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
                      |||.+.+...++.++||||+||++|+|++|..| |...+..+.+..+.+..+.+..+.+...........++........
T Consensus       190 aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~p-f~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (350)
T d1q5ka_         190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPI-FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWT  268 (350)
T ss_dssp             CHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCS-SCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGG
T ss_pred             ChHHhhcccCCCcceeecccceEEEehhhCCCC-CCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchh
Confidence            999987766689999999999999999988766 7888888888888887777654333221111111111111111122


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      .......++++.+||.+||+.||++|||+.|+|+||||+++..+
T Consensus       269 ~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  312 (350)
T d1q5ka_         269 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  312 (350)
T ss_dssp             GTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             hhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence            23345689999999999999999999999999999999987554

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-54  Score=355.50  Aligned_cols=241  Identities=23%  Similarity=0.374  Sum_probs=204.5

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      .||+|+++.+|+.||||++.....  ....+.+|++++++++||||+++++++.+++.+|+|||||+| +|.+.+.....
T Consensus        20 ~Vy~~~~~~~~~~~AiK~i~~~~~--~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~   97 (321)
T d1tkia_          20 IVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF   97 (321)
T ss_dssp             EEEEEEETTTTEEEEEEEECCCTH--HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSC
T ss_pred             EEEEEEECCCCcEEEEEEEcCCcc--cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCC
Confidence            389999999999999999976322  234678999999999999999999999999999999999986 67776666556


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC--CcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN--GELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      .+++.++..++.||+.||.|||++||+||||||+||+++.+  ..++|+|||++........ .....+++.|+|||...
T Consensus        98 ~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~-~~~~~~t~~y~ape~~~  176 (321)
T d1tkia_          98 ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLFTAPEYYAPEVHQ  176 (321)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE-EEEEESCGGGSCHHHHT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCc-ccccccccccccchhcc
Confidence            89999999999999999999999999999999999999854  4899999999987654332 33446789999999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++||||+||++|+|++|..| |.+.+..+....+......++                         ......
T Consensus       177 ~~~-~~~~~DiWSlGvily~ll~G~~P-f~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~  229 (321)
T d1tkia_         177 HDV-VSTATDMWSLGTLVYVLLSGINP-FLAETNQQIIENIMNAEYTFD-------------------------EEAFKE  229 (321)
T ss_dssp             TCE-ECHHHHHHHHHHHHHHHHHSSCT-TCCSSHHHHHHHHHHTCCCCC-------------------------HHHHTT
T ss_pred             CCC-CCchhhcccHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhCCCCCC-------------------------hhhccC
Confidence            776 79999999999999999998777 777788888887776432211                         122346


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD  271 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  271 (282)
                      +|+++++||++||..||.+|||++|+++||||++
T Consensus       230 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence            8999999999999999999999999999999974

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=345.84  Aligned_cols=272  Identities=36%  Similarity=0.635  Sum_probs=216.0

Q ss_pred             CeeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeee--------CCeEEEEEecCcccHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHS--------EKKLTLVFEHCDQDLK   71 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~--------~~~~~iv~e~~~g~l~   71 (282)
                      .||+|+++.+|+.||||++.. .........+.+|++++++++|||++++++++..        ++.+++|||++.++++
T Consensus        25 ~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~  104 (318)
T d3blha1          25 EVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA  104 (318)
T ss_dssp             EEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHH
T ss_pred             EEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCcc
Confidence            389999999999999999877 4445556778999999999999999999999865        3568999999999999


Q ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc----ccccccccc
Q psy6044          72 KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV----KCYSAEVVT  147 (282)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~  147 (282)
                      .........+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......    .......+|
T Consensus       105 ~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT  184 (318)
T d3blha1         105 GLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT  184 (318)
T ss_dssp             HHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSC
T ss_pred             chhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecC
Confidence            8887777889999999999999999999999999999999999999999999999999997654321    122234679


Q ss_pred             ccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHP  227 (282)
Q Consensus       148 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (282)
                      +.|+|||.+.+...++.++||||+||++|+|++|..| |.+.+..+....+....+.+....+.................
T Consensus       185 ~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (318)
T d3blha1         185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI-MQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKG  263 (318)
T ss_dssp             GGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSS
T ss_pred             HHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCC-CCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhccccc
Confidence            9999999998776689999999999999999998755 788888899999999888887766555433322222111111


Q ss_pred             CC-Ccccc--CccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCc
Q psy6044         228 SM-SFSQV--APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLN  273 (282)
Q Consensus       228 ~~-~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  273 (282)
                      .. .....  ....++.+.+||.+||+.||++|||++|+|+||||+.-.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p  312 (318)
T d3blha1         264 QKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  312 (318)
T ss_dssp             CCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSS
T ss_pred             ccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCC
Confidence            10 11110  122578889999999999999999999999999999643

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=343.94  Aligned_cols=236  Identities=25%  Similarity=0.426  Sum_probs=195.1

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCC-----CCCCccHHHHHHHHhhCC--CCCccceeeeeeeCCeEEEEEecCcc--cHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGN-----EGVPSSALREICLLKELK--HKNIVRLYDVLHSEKKLTLVFEHCDQ--DLK   71 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~e~~~~~~l~--h~~i~~~~~~~~~~~~~~iv~e~~~g--~l~   71 (282)
                      .||+|+++.+|+.||||++.....     ......+.+|+.++++++  ||||+++++++.+++..++|||++.|  ++.
T Consensus        19 ~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~   98 (273)
T d1xwsa_          19 SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF   98 (273)
T ss_dssp             EEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHH
T ss_pred             EEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHH
Confidence            389999999999999999986221     123456789999999996  89999999999999999999999964  444


Q ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC-CcEEEEecCCccccCCCccccccccccccc
Q psy6044          72 KYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVKCYSAEVVTLWY  150 (282)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  150 (282)
                      +.+ .....+++..++.++.||+.||.|||++||+||||||+||+++.+ +.++|+|||++......  ......||+.|
T Consensus        99 ~~~-~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~--~~~~~~GT~~y  175 (273)
T d1xwsa_          99 DFI-TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVY  175 (273)
T ss_dssp             HHH-HHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSS--CBCCCCSCGGG
T ss_pred             HHH-hccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecccc--cccccccCCCc
Confidence            444 446789999999999999999999999999999999999999854 79999999999765433  23445789999


Q ss_pred             cChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMS  230 (282)
Q Consensus       151 ~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
                      +|||.+.+...++.++||||+||++|+|++|..|+ ...  .    .+...                             
T Consensus       176 ~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf-~~~--~----~i~~~-----------------------------  219 (273)
T d1xwsa_         176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHD--E----EIIRG-----------------------------  219 (273)
T ss_dssp             SCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC-CSH--H----HHHHC-----------------------------
T ss_pred             CCHHHHcCCCCCCcccccccceeeehhHhhCCCCC-CCc--h----HHhhc-----------------------------
Confidence            99999987765678899999999999999998884 332  1    12221                             


Q ss_pred             ccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      ...++..+|+++.+||++||+.||++|||++|+++||||+++..+
T Consensus       220 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~p  264 (273)
T d1xwsa_         220 QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP  264 (273)
T ss_dssp             CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCCC
Confidence            112335689999999999999999999999999999999987544

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-54  Score=356.96  Aligned_cols=268  Identities=34%  Similarity=0.567  Sum_probs=215.6

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC------eEEEEEecCcccHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEK------KLTLVFEHCDQDLKKY   73 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~------~~~iv~e~~~g~l~~~   73 (282)
                      .||+|+++.+|+.||||++... ......+.+.+|+.++++++||||+++++++...+      .+|+||||+++++...
T Consensus        33 ~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~  112 (346)
T d1cm8a_          33 AVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKL  112 (346)
T ss_dssp             CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHH
T ss_pred             EEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecccccHHHH
Confidence            4999999999999999999762 23333567889999999999999999999998654      5799999997776665


Q ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccCh
Q psy6044          74 FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP  153 (282)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aP  153 (282)
                      ..  .+.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++++|||.+......   .+...+++.|+||
T Consensus       113 ~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aP  187 (346)
T d1cm8a_         113 MK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MTGYVVTRWYRAP  187 (346)
T ss_dssp             HH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS---CCSSCSCGGGCCT
T ss_pred             HH--hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc---cccccccccccCH
Confidence            54  467999999999999999999999999999999999999999999999999999877533   3456789999999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCC--CCCCCCCCCCCCc
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPD--FKPFPMYHPSMSF  231 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  231 (282)
                      |.+.+...++.++||||+||++|+|++|..| |.+.+..+....+....+.++...+........  .............
T Consensus       188 E~~~~~~~~~~~~DiwSlGvil~ell~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (346)
T d1cm8a_         188 EVILNWMRYTQTVDIWSVGCIMAEMITGKTL-FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF  266 (346)
T ss_dssp             HHHHTTTCCCTTHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG
T ss_pred             HHHcCCCCCCccchhhcchHHHHHHHHCcCC-CCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccch
Confidence            9998776679999999999999999988766 777788888888777777665433221110000  0000001112244


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCcc
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNV  274 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  274 (282)
                      .......++.+.+||++||..||.+|||++|+|+||||+++..
T Consensus       267 ~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~  309 (346)
T d1cm8a_         267 ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  309 (346)
T ss_dssp             GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence            5556778999999999999999999999999999999998754

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.6e-53  Score=340.21  Aligned_cols=234  Identities=23%  Similarity=0.340  Sum_probs=199.3

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHhc-C
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSL-N   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~-~   78 (282)
                      .||+|+++.+|+.||||+++..  ....+.+.+|+.++++++||||+++++++.+++.+++||||++ |++.+.+... .
T Consensus        32 ~Vy~a~~~~~~~~vAvK~i~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~  109 (287)
T d1opja_          32 EVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR  109 (287)
T ss_dssp             SEEEEEEGGGTEEEEEEECCTT--CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCT
T ss_pred             EEEEEEECCCCeEEEEEEECCc--cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccc
Confidence            4899999999999999998753  2335679999999999999999999999999999999999998 4666666543 4


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~  157 (282)
                      ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .......+++.|+|||.+.
T Consensus       110 ~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~  189 (287)
T d1opja_         110 QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA  189 (287)
T ss_dssp             TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHH
T ss_pred             cchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHc
Confidence            569999999999999999999999999999999999999999999999999998765432 2333345688899999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++||||||+++|+|++++.|++.+.+..+..+.+.....                            ...+..
T Consensus       190 ~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~----------------------------~~~~~~  240 (287)
T d1opja_         190 YNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR----------------------------MERPEG  240 (287)
T ss_dssp             HCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC----------------------------CCCCTT
T ss_pred             CCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC----------------------------CCCCcc
Confidence            776 799999999999999999999998888887776665543211                            123356


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      +++.+.+||.+||+.||++|||++++++
T Consensus       241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         241 CPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            8999999999999999999999999987

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=334.74  Aligned_cols=234  Identities=19%  Similarity=0.305  Sum_probs=191.3

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      .||+|+++ +++.||||+++..  ....+.+.+|++++++++||||+++++++.+++..++||||+++ ++.+.+.....
T Consensus        20 ~Vy~~~~~-~~~~vAvK~i~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~   96 (263)
T d1sm2a_          20 LVHLGYWL-NKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG   96 (263)
T ss_dssp             CEEEEEET-TTEEEEEEECCSS--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTT
T ss_pred             EEEEEEEC-CCCEEEEEEECCC--cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhcccc
Confidence            48999985 5788999998752  22346799999999999999999999999999999999999975 66666666567


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~  158 (282)
                      .+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||++....... .......+|+.|+|||.+.+
T Consensus        97 ~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~  176 (263)
T d1sm2a_          97 LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF  176 (263)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTT
T ss_pred             CCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcC
Confidence            79999999999999999999999999999999999999999999999999997765332 22233567889999999987


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++||||||+++|||+|++.|++...+..+....+.......                            .+...
T Consensus       177 ~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~----------------------------~p~~~  227 (263)
T d1sm2a_         177 SR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY----------------------------KPRLA  227 (263)
T ss_dssp             CC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC----------------------------CCTTS
T ss_pred             CC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC----------------------------Ccccc
Confidence            76 79999999999999999998899899888888887776643221                            22457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      ++++.+||.+||+.||++|||++++++|
T Consensus       228 ~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         228 STHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            8999999999999999999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-53  Score=341.87  Aligned_cols=240  Identities=18%  Similarity=0.255  Sum_probs=192.4

Q ss_pred             eeeeee--CCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVD--RTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~--~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||+|..  .++++.||||++... .+....+.+.+|+.++++++||||+++++++.++ ..++||||++|+.+..+....
T Consensus        23 Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~~  101 (277)
T d1xbba_          23 VKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQN  101 (277)
T ss_dssp             EEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHC
T ss_pred             EEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhhc
Confidence            899975  456789999999763 3333456799999999999999999999998654 578999999865555455557


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc---ccccccccccccChhh
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK---CYSAEVVTLWYRPPDV  155 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~aPE~  155 (282)
                      ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++........   ......+|+.|+|||.
T Consensus       102 ~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~  181 (277)
T d1xbba_         102 RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC  181 (277)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHH
T ss_pred             cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchh
Confidence            8899999999999999999999999999999999999999999999999999987643322   2233467889999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      +.+.. ++.++||||||+++|||+|.+.+||.+.+..+....+.++..                            ...+
T Consensus       182 l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~----------------------------~~~p  232 (277)
T d1xbba_         182 INYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER----------------------------MGCP  232 (277)
T ss_dssp             HHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------------------------CCCC
T ss_pred             hcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC----------------------------CCCC
Confidence            97766 799999999999999999855555888887776666654211                            1233


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHH---hcCCCccC
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAEDA---MSHIYFSD  271 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~l---l~h~~~~~  271 (282)
                      ..+|+++.+||.+||+.||++|||+++|   |+|+|++-
T Consensus       233 ~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  271 (277)
T d1xbba_         233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  271 (277)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence            5689999999999999999999999998   46666543

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-52  Score=333.12  Aligned_cols=236  Identities=18%  Similarity=0.294  Sum_probs=187.5

Q ss_pred             eeeeeeCCCCceEEEeeeec-CCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHL-VGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLNG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~   79 (282)
                      ||+|+.+   ..||||+++. ..+....+.+.+|+.++++++||||+++++++.+ +.+++||||++| +|.+.+....+
T Consensus        24 Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~   99 (276)
T d1uwha_          24 VYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIET   99 (276)
T ss_dssp             EEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCC
T ss_pred             EEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccC
Confidence            8999863   3599999976 3344456788999999999999999999998754 568999999985 67777766667


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC--ccccccccccccccChhhhc
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~  157 (282)
                      .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++......  ........||+.|+|||.+.
T Consensus       100 ~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~  179 (276)
T d1uwha_         100 KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR  179 (276)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHh
Confidence            8999999999999999999999999999999999999999999999999999766432  22334456799999999986


Q ss_pred             CC--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHH-HHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         158 GA--KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL-KRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       158 ~~--~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      ..  ..++.++|||||||++|||+||+.| |.+.+..+.. ..+......+                        .....
T Consensus       180 ~~~~~~~~~~sDiwS~Gv~l~el~tg~~P-f~~~~~~~~~~~~~~~~~~~p------------------------~~~~~  234 (276)
T d1uwha_         180 MQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQIIFMVGRGYLSP------------------------DLSKV  234 (276)
T ss_dssp             TCSSCCCCHHHHHHHHHHHHHHHHHSSCT-TTTCCCHHHHHHHHHHTSCCC------------------------CGGGS
T ss_pred             cccCCCCCchhhhhhhHHHHHHHHHCCCC-CCCCChHHHHHHHHhcCCCCC------------------------cchhc
Confidence            43  3478999999999999999999888 5554444444 3333322111                        23344


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      +..+++.+.+||.+||+.||.+|||+++++++
T Consensus       235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         235 RSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            56789999999999999999999999999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=339.20  Aligned_cols=239  Identities=24%  Similarity=0.331  Sum_probs=195.9

Q ss_pred             eeeeeeCC--CCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           2 FTSGVDRT--PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      ||+|.++.  ++..||||++.........+.+.+|+.++++++||||+++++++.++ .+|+||||++| ++.+.+....
T Consensus        25 Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~  103 (285)
T d1u59a_          25 VRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKR  103 (285)
T ss_dssp             EEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHTTCT
T ss_pred             EEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEEEeCCCCcHHHHhhccc
Confidence            89997654  45689999997654444567799999999999999999999998754 58999999986 5656556556


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc---ccccccccccccChhh
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK---CYSAEVVTLWYRPPDV  155 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~aPE~  155 (282)
                      ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++..+.....   ......+++.|+|||.
T Consensus       104 ~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~  183 (285)
T d1u59a_         104 EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC  183 (285)
T ss_dssp             TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHH
Confidence            7899999999999999999999999999999999999999999999999999987754322   2233456889999999


Q ss_pred             hcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccC
Q psy6044         156 LFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVA  235 (282)
Q Consensus       156 ~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
                      +.... ++.++|||||||++|||+|.+.+||.+.+..+....+.++..                            ...+
T Consensus       184 ~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~----------------------------~~~p  234 (285)
T d1u59a_         184 INFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR----------------------------MECP  234 (285)
T ss_dssp             HHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC----------------------------CCCC
T ss_pred             HhCCC-CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------------------------CCCC
Confidence            97765 799999999999999999854555777777777766654221                            1234


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCCHHHH---hcCCCcc
Q psy6044         236 PKLTAKGRDLLQRLLVCNPVQRMSAEDA---MSHIYFS  270 (282)
Q Consensus       236 ~~~~~~l~~li~~~l~~dp~~Rps~~~l---l~h~~~~  270 (282)
                      ..+|+++.+||.+||+.||++|||+.+|   |+|+|+.
T Consensus       235 ~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            5689999999999999999999999988   5577763

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.8e-52  Score=337.98  Aligned_cols=236  Identities=19%  Similarity=0.296  Sum_probs=185.3

Q ss_pred             eeeeeeCCCCc---eEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCccc-HHHHHHhc
Q psy6044           2 FTSGVDRTPNT---ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSL   77 (282)
Q Consensus         2 vy~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~-l~~~~~~~   77 (282)
                      ||+|+++.+|+   .||||.+.........+.+.+|+.++++++||||+++++++.+++.+++||||++|+ +.+.+...
T Consensus        42 Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~  121 (299)
T d1jpaa_          42 VCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN  121 (299)
T ss_dssp             EEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT
T ss_pred             EEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccc
Confidence            89999987765   588888776444445567999999999999999999999999999999999999865 55555554


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc-----ccccccccccccC
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK-----CYSAEVVTLWYRP  152 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~a  152 (282)
                      .+.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++........     ......+++.|+|
T Consensus       122 ~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~a  201 (299)
T d1jpaa_         122 DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA  201 (299)
T ss_dssp             TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccC
Confidence            66799999999999999999999999999999999999999999999999999976643221     1122346889999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       153 PE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      ||.+.+.. ++.++|||||||++|||+|++.++|.+....+....+......+                           
T Consensus       202 PE~~~~~~-~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~---------------------------  253 (299)
T d1jpaa_         202 PEAIQYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP---------------------------  253 (299)
T ss_dssp             HHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---------------------------
T ss_pred             HHHHhcCC-CCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---------------------------
Confidence            99998776 79999999999999999985555588888777777665432211                           


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                       .+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus       254 -~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         254 -PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             -CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             -CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence             234578999999999999999999999999874

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=327.01  Aligned_cols=233  Identities=19%  Similarity=0.278  Sum_probs=199.2

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~~~~   80 (282)
                      ||+|+. ++++.||||+++...  ...+.+.+|+.++++++||||+++++++.+++.+++||||++ |++...+......
T Consensus        20 Vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~   96 (258)
T d1k2pa_          20 VKYGKW-RGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR   96 (258)
T ss_dssp             EEEEEE-TTTEEEEEEEEESSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGC
T ss_pred             EEEEEE-CCCCEEEEEEECcCc--CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccC
Confidence            899998 478899999998633  234689999999999999999999999999999999999997 5666666666778


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccChhhhcCC
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPPDVLFGA  159 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~  159 (282)
                      +++..+..++.||+.||+|||+.||+|+||||+||+++.++.+||+|||++....... .......+++.|+|||.+.+.
T Consensus        97 ~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~  176 (258)
T d1k2pa_          97 FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS  176 (258)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHC
T ss_pred             CcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCC
Confidence            9999999999999999999999999999999999999999999999999997654332 223345678899999999877


Q ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccCC
Q psy6044         160 KLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKLT  239 (282)
Q Consensus       160 ~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
                      . ++.++||||||+++|||+|++.++|.+.+..+....+......+                            .+...+
T Consensus       177 ~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~----------------------------~p~~~~  227 (258)
T d1k2pa_         177 K-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY----------------------------RPHLAS  227 (258)
T ss_dssp             C-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC----------------------------CCTTCC
T ss_pred             C-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC----------------------------Cccccc
Confidence            6 79999999999999999986666689888888877776532211                            234578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         240 AKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       240 ~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      +.+.+||++||+.||++|||+++|++|
T Consensus       228 ~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         228 EKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            899999999999999999999999987

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-52  Score=344.81  Aligned_cols=272  Identities=35%  Similarity=0.580  Sum_probs=212.9

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC-----CeEEEEEecCcccHHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSE-----KKLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~-----~~~~iv~e~~~g~l~~~~~   75 (282)
                      .||+|+++.+|+.||||++.........+.+++|+.++++++||||+++++++..+     ...++++++++|+|.+.+.
T Consensus        23 ~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~  102 (345)
T d1pmea_          23 MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK  102 (345)
T ss_dssp             CEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHH
T ss_pred             EEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhh
Confidence            48999999999999999997644444456788999999999999999999998765     3477888777788888775


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc---ccccccccccccC
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK---CYSAEVVTLWYRP  152 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~a  152 (282)
                      .  ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++........   ......+++.|+|
T Consensus       103 ~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~a  180 (345)
T d1pmea_         103 T--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA  180 (345)
T ss_dssp             H--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCC
T ss_pred             c--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceech
Confidence            4  5799999999999999999999999999999999999999999999999999976543221   2344567899999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCC--CCCCCCCCCCC
Q psy6044         153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDF--KPFPMYHPSMS  230 (282)
Q Consensus       153 PE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  230 (282)
                      ||.+.....++.++||||+||++|+|++|..| |.+.+..+...........+..............  ...........
T Consensus       181 PE~l~~~~~~~~~~DiwSlG~il~eml~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (345)
T d1pmea_         181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI-FPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVP  259 (345)
T ss_dssp             GGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCC
T ss_pred             HHHhhcCCCCCchhhhhccCceehHHhhCCCC-CCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCC
Confidence            99997776689999999999999999988776 7777777777766666555432211110000000  00001112223


Q ss_pred             ccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                      +....+.+|+++.+||.+||+.||.+|||++|+|+||||+....+
T Consensus       260 ~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         260 WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             HHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             HHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence            445566789999999999999999999999999999999977554

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=336.73  Aligned_cols=237  Identities=23%  Similarity=0.371  Sum_probs=197.8

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCccc-HHHHHHhc-CC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQD-LKKYFDSL-NG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g~-l~~~~~~~-~~   79 (282)
                      ||+|+++ +++.||||++...  ....+.+.+|+.++++++||||+++++++.+ +..++||||++++ +.+.+... ..
T Consensus        29 Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~  104 (272)
T d1qpca_          29 VWMGYYN-GHTKVAVKSLKQG--SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI  104 (272)
T ss_dssp             EEEEEET-TTEEEEEEEECTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHH
T ss_pred             EEEEEEC-CCCEEEEEEEccC--cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCC
Confidence            8999985 6789999998752  2334679999999999999999999998765 4578999999864 44444332 23


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~  158 (282)
                      .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .......+++.|+|||.+..
T Consensus       105 ~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~  184 (272)
T d1qpca_         105 KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY  184 (272)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhC
Confidence            59999999999999999999999999999999999999999999999999998775432 23334567889999999976


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++||||||+++|||+|++.|++...+..+....+......                            ..+..+
T Consensus       185 ~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~----------------------------~~p~~~  235 (272)
T d1qpca_         185 GT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM----------------------------VRPDNC  235 (272)
T ss_dssp             CE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----------------------------CCCTTC
T ss_pred             CC-CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC----------------------------CCcccC
Confidence            65 7999999999999999999999989988888877776553221                            123458


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc--CCCccC
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMS--HIYFSD  271 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~--h~~~~~  271 (282)
                      ++++.+||.+||+.||++|||++++++  ++||.+
T Consensus       236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            899999999999999999999999998  788864

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=345.25  Aligned_cols=241  Identities=26%  Similarity=0.318  Sum_probs=189.5

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhh-CCCCCccceeeeeee----CCeEEEEEecCcc-cHHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKE-LKHKNIVRLYDVLHS----EKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~-l~h~~i~~~~~~~~~----~~~~~iv~e~~~g-~l~~~~   74 (282)
                      .||+|+++.+|+.||||++..      ...+.+|+.++.+ .+||||+++++++++    +..+|+|||||+| +|.+.+
T Consensus        27 ~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i  100 (335)
T d2ozaa1          27 KVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI  100 (335)
T ss_dssp             EEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHH
T ss_pred             EEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHH
Confidence            389999999999999999863      3578899998655 589999999999876    4679999999975 777766


Q ss_pred             HhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC---CCcEEEEecCCccccCCCccccccccccccc
Q psy6044          75 DSLN-GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK---NGELKLADFGLARAFGIPVKCYSAEVVTLWY  150 (282)
Q Consensus        75 ~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  150 (282)
                      .... ..+++.+++.++.||+.||+|||++||+||||||+||+++.   ++.+||+|||++....... ......||+.|
T Consensus       101 ~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~-~~~~~~gt~~y  179 (335)
T d2ozaa1         101 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYY  179 (335)
T ss_dssp             HSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC-CCCCCSCCCSS
T ss_pred             HhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCC-ccccccCCccc
Confidence            6543 46999999999999999999999999999999999999975   5679999999998765433 33455789999


Q ss_pred             cChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMS  230 (282)
Q Consensus       151 ~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
                      +|||++.+.. ++.++|||||||++|+|+||..| |.+.+..+....+........ ..                    .
T Consensus       180 ~aPE~~~~~~-y~~~~DiwSlGvily~lltg~~P-f~~~~~~~~~~~~~~~i~~~~-~~--------------------~  236 (335)
T d2ozaa1         180 VAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPP-FYSNHGLAISPGMKTRIRMGQ-YE--------------------F  236 (335)
T ss_dssp             CCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSSCS-CEETTCC--------CCCSCS-SS--------------------C
T ss_pred             CCcHHHcCCC-CCHHHHHHhhchhHHHHhhCCCC-CCCCCHHHHHHHHHHHHhcCC-CC--------------------C
Confidence            9999997666 79999999999999999998888 444433332222221100000 00                    0


Q ss_pred             ccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q psy6044         231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSD  271 (282)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  271 (282)
                      .......+|+++.+||++||+.||++|||+.|+++||||++
T Consensus       237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence            01122468999999999999999999999999999999964

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.1e-52  Score=343.26  Aligned_cols=266  Identities=30%  Similarity=0.534  Sum_probs=204.6

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCC-CCCccceeeeeee--CCeEEEEEecCcccHHHHHHhcC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK-HKNIVRLYDVLHS--EKKLTLVFEHCDQDLKKYFDSLN   78 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~--~~~~~iv~e~~~g~l~~~~~~~~   78 (282)
                      ||+|+++.+|+.||||++...    ..+.+.+|+++++.++ ||||+++++++..  ...+++||||++++.+..+   .
T Consensus        51 V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~---~  123 (328)
T d3bqca1          51 VFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL---Y  123 (328)
T ss_dssp             EEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGT---T
T ss_pred             EEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHH---h
Confidence            899999999999999998642    2467889999999995 9999999999974  4579999999987655433   4


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC-cEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          79 GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNG-ELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                      ..+++..+..++.||+.||.|||++||+|+||||+||+++.++ .++|+|||.+...... .......+|+.|+|||.+.
T Consensus       124 ~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~  202 (328)
T d3bqca1         124 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLV  202 (328)
T ss_dssp             TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-CCCCSCCSCGGGCCHHHHT
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC-CcccccccCccccCccccc
Confidence            5799999999999999999999999999999999999998765 6899999999876533 2334557789999999998


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCC---CCCCCCCCCCCCCCCCCC----
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPG---MNLLPDFKPFPMYHPSMS----  230 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~----  230 (282)
                      +...++.++|+||+||++|++++|+.|+....+..+....+...++.+....+..   ......+...........    
T Consensus       203 ~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (328)
T d3bqca1         203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERF  282 (328)
T ss_dssp             TCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGG
T ss_pred             CCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhc
Confidence            8776899999999999999999999998777777766666655544221000000   000000000000000001    


Q ss_pred             -ccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccc
Q psy6044         231 -FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVA  275 (282)
Q Consensus       231 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  275 (282)
                       .......+++++.+||++||+.||++|||++|+|+||||+++..+
T Consensus       283 ~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~~  328 (328)
T d3bqca1         283 VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD  328 (328)
T ss_dssp             CCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCCC
T ss_pred             ccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence             111234588999999999999999999999999999999998653

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-51  Score=329.14  Aligned_cols=235  Identities=22%  Similarity=0.316  Sum_probs=191.0

Q ss_pred             eeeeeeCCCC----ceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHh
Q psy6044           2 FTSGVDRTPN----TALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDS   76 (282)
Q Consensus         2 vy~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~   76 (282)
                      ||+|..+.++    ..||||++...........+++|+.++++++||||+++++++.+.+..++|+||+.+ .+.+.+..
T Consensus        23 Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~  102 (283)
T d1mqba_          23 VYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE  102 (283)
T ss_dssp             EEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH
T ss_pred             EEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhc
Confidence            8999987665    479999987644444456789999999999999999999999999999999999976 45555556


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc---cccccccccccccCh
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---KCYSAEVVTLWYRPP  153 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~aP  153 (282)
                      ..+.+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++......   .......+|+.|+||
T Consensus       103 ~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~AP  182 (283)
T d1mqba_         103 KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP  182 (283)
T ss_dssp             TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCH
T ss_pred             ccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCH
Confidence            56789999999999999999999999999999999999999999999999999997764321   122334568899999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQ  233 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
                      |.+.+.. ++.++||||||+++|||++++.|++......+....+......                            .
T Consensus       183 E~l~~~~-~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~----------------------------~  233 (283)
T d1mqba_         183 EAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL----------------------------P  233 (283)
T ss_dssp             HHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC----------------------------C
T ss_pred             HHHccCC-CCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC----------------------------C
Confidence            9998776 7999999999999999999999988888887777666543221                            1


Q ss_pred             cCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         234 VAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       234 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      .+..+++.+.+||.+||+.||++|||+.+|++
T Consensus       234 ~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         234 TPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            23457899999999999999999999999987

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-51  Score=336.97  Aligned_cols=237  Identities=23%  Similarity=0.353  Sum_probs=189.2

Q ss_pred             eeeeeeCCCCc-----eEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHHHH
Q psy6044           2 FTSGVDRTPNT-----ALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         2 vy~a~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~   74 (282)
                      ||+|+++.+++     .||+|.+...........+.+|+.+++++ +||||+++++++.+++.+++|||||+| ++.+.+
T Consensus        53 Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l  132 (325)
T d1rjba_          53 VMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL  132 (325)
T ss_dssp             EEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHH
T ss_pred             EEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHH
Confidence            89999876654     69999987755556677899999999998 899999999999999999999999975 666666


Q ss_pred             HhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCcc
Q psy6044          75 DSLN----------------------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR  132 (282)
Q Consensus        75 ~~~~----------------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~  132 (282)
                      ....                      ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus       133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~  212 (325)
T d1rjba_         133 RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR  212 (325)
T ss_dssp             HTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGS
T ss_pred             HhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccc
Confidence            5432                      248999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCc--cccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCC
Q psy6044         133 AFGIPV--KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTW  210 (282)
Q Consensus       133 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (282)
                      ......  .......+|+.|+|||.+.+.. ++.++|||||||++|||+|++.++|.+.+..+.+..+......      
T Consensus       213 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~------  285 (325)
T d1rjba_         213 DIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK------  285 (325)
T ss_dssp             CGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCC------
T ss_pred             cccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC------
Confidence            654322  2223445689999999997766 7999999999999999998555557766555544444432111      


Q ss_pred             CCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         211 PGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                                           ...+..+|+++.+||.+||+.||++|||++||++|
T Consensus       286 ---------------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         286 ---------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                 11234588999999999999999999999999975

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-51  Score=340.61  Aligned_cols=266  Identities=32%  Similarity=0.531  Sum_probs=202.7

Q ss_pred             CeeeeeeCCCCceEEEeeeecCC-CCCCCccHHHHHHHHhhCCCCCccceeeeeee------CCeEEEEEecCcccHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVG-NEGVPSSALREICLLKELKHKNIVRLYDVLHS------EKKLTLVFEHCDQDLKKY   73 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~------~~~~~iv~e~~~g~l~~~   73 (282)
                      .||+|+++.+|+.||||++.... .......+.+|+.++++++||||+++++++..      ...+|+||||+.|+++..
T Consensus        32 ~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~  111 (355)
T d2b1pa1          32 IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV  111 (355)
T ss_dssp             EEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHH
T ss_pred             EEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHHh
Confidence            39999999999999999998732 23334568899999999999999999999964      468999999999998887


Q ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccCh
Q psy6044          74 FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP  153 (282)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aP  153 (282)
                      +   ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++++|||.+...... .......+|+.|+||
T Consensus       112 ~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~-~~~~~~~~t~~y~aP  187 (355)
T d2b1pa1         112 I---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAP  187 (355)
T ss_dssp             H---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------------CCTTCCH
T ss_pred             h---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc-cccccccccccccCh
Confidence            6   357999999999999999999999999999999999999999999999999998766533 333445678999999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCC-----CCCCCC------
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLL-----PDFKPF------  222 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~------  222 (282)
                      |.+.+.. ++.++||||+||++++|++|..| |.+.+.......+......+..+.+......     .+....      
T Consensus       188 E~l~~~~-~~~~~DiwSlG~~l~ell~g~~p-F~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (355)
T d2b1pa1         188 EVILGMG-YKENVDIWSVGCIMGEMVRHKIL-FPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFP  265 (355)
T ss_dssp             HHHTTCC-CCTTHHHHHHHHHHHHHHHSSCS-SCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHH
T ss_pred             hhhcCCC-CCCCcccccccchHHHHhhCCCC-CCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccc
Confidence            9998765 79999999999999999988755 8888888888888877776554433321100     000000      


Q ss_pred             --CCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         223 --PMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       223 --~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                        ................++++.+||++||..||++|||++|+|+||||+..
T Consensus       266 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         266 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             HHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             cccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence              00000001111123467889999999999999999999999999999874

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.9e-51  Score=330.74  Aligned_cols=242  Identities=22%  Similarity=0.260  Sum_probs=189.7

Q ss_pred             eeeeeeCCCCceEEEeeeecCC--CCCCCccHHHHHHHHhhCCCCCccceeeeeeeCC----eEEEEEecCcccHHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVG--NEGVPSSALREICLLKELKHKNIVRLYDVLHSEK----KLTLVFEHCDQDLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~----~~~iv~e~~~g~l~~~~~   75 (282)
                      ||+|+++.+|+.||||++....  +......+.+|+.+++.++||||+++++++..+.    .+|+||||++|+.+..+.
T Consensus        23 Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~  102 (277)
T d1o6ya_          23 VHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV  102 (277)
T ss_dssp             EEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHH
T ss_pred             EEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhh
Confidence            8999999999999999998632  2233456889999999999999999999988653    489999999976555555


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc---cccccccccccccC
Q psy6044          76 SLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---KCYSAEVVTLWYRP  152 (282)
Q Consensus        76 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~a  152 (282)
                      ...+.+++.++..++.||+.||.|||++||+||||||+||+++.++..+++|||.+.......   .......||+.|+|
T Consensus       103 ~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~a  182 (277)
T d1o6ya_         103 HTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS  182 (277)
T ss_dssp             HHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCC
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccC
Confidence            557889999999999999999999999999999999999999999999999999886553222   23334567999999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       153 PE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      ||++.+.. ++.++|||||||++|+|+||..| |.+.+..+....+......                         ...
T Consensus       183 PE~~~~~~-~~~~~DiwSlGvilyelltG~~P-f~~~~~~~~~~~~~~~~~~-------------------------~~~  235 (277)
T d1o6ya_         183 PEQARGDS-VDARSDVYSLGCVLYEVLTGEPP-FTGDSPVSVAYQHVREDPI-------------------------PPS  235 (277)
T ss_dssp             HHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHCCCC-------------------------CGG
T ss_pred             HHHHcCCC-CCcceecccchHHHHHHHhCCCC-CCCcCHHHHHHHHHhcCCC-------------------------CCc
Confidence            99997765 79999999999999999998877 7777777766665542211                         112


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFS  270 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  270 (282)
                      .....+|+.+.+||++||+.||.+||+..+.+.|+|.+
T Consensus       236 ~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         236 ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            23356899999999999999999999444444455553

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-51  Score=328.27  Aligned_cols=239  Identities=25%  Similarity=0.376  Sum_probs=195.0

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc-CC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL-NG   79 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~-~~   79 (282)
                      ||+|+++.+ +.||||++....  ...+.+.+|+.++++++||||+++++++.+ +..++||||+++ ++...+... ..
T Consensus        33 Vy~~~~~~~-~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~  108 (285)
T d1fmka3          33 VWMGTWNGT-TRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK  108 (285)
T ss_dssp             EEEEEETTT-EEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHT
T ss_pred             EEEEEECCC-CEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccc
Confidence            899998654 679999987532  234679999999999999999999999865 457899999986 455555433 35


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC-ccccccccccccccChhhhcC
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP-VKCYSAEVVTLWYRPPDVLFG  158 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~  158 (282)
                      .+++.+++.++.||+.||+|||+.|++|+||||+||+++.++.+||+|||++...... ........+++.|+|||.+..
T Consensus       109 ~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~  188 (285)
T d1fmka3         109 YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY  188 (285)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHH
T ss_pred             cchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhC
Confidence            6999999999999999999999999999999999999999999999999999766422 223334567899999999987


Q ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCccC
Q psy6044         159 AKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPKL  238 (282)
Q Consensus       159 ~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
                      .. ++.++||||||+++|||++|+.|++......+....+.....                            ...+..+
T Consensus       189 ~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~----------------------------~~~~~~~  239 (285)
T d1fmka3         189 GR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR----------------------------MPCPPEC  239 (285)
T ss_dssp             CC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------------------------CCCCTTS
T ss_pred             CC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC----------------------------CCCCccc
Confidence            76 699999999999999999999999999888888777654321                            1233568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc--CCCccCCc
Q psy6044         239 TAKGRDLLQRLLVCNPVQRMSAEDAMS--HIYFSDLN  273 (282)
Q Consensus       239 ~~~l~~li~~~l~~dp~~Rps~~~ll~--h~~~~~~~  273 (282)
                      ++++.+||.+||+.||++|||+++|++  ++||++..
T Consensus       240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            999999999999999999999999998  89998764

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=332.08  Aligned_cols=235  Identities=19%  Similarity=0.268  Sum_probs=191.2

Q ss_pred             eeeeeeCCCCc----eEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecC-cccHHHHHHh
Q psy6044           2 FTSGVDRTPNT----ALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHC-DQDLKKYFDS   76 (282)
Q Consensus         2 vy~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~-~g~l~~~~~~   76 (282)
                      ||+|.+..+|+    .||+|++.........+.+.+|+.++++++||||+++++++.+++. +++++++ .|++++.+..
T Consensus        25 Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~-~~v~e~~~~~~l~~~~~~  103 (317)
T d1xkka_          25 VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVRE  103 (317)
T ss_dssp             EEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSE-EEEEECCTTCBHHHHHHH
T ss_pred             EEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe-eEEEEeccCCcccccccc
Confidence            89999988887    5778877654455556789999999999999999999999987665 4555555 5788888888


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--ccccccccccccChh
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--CYSAEVVTLWYRPPD  154 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE  154 (282)
                      ....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........  ......+|+.|+|||
T Consensus       104 ~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE  183 (317)
T d1xkka_         104 HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE  183 (317)
T ss_dssp             TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHH
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChH
Confidence            778899999999999999999999999999999999999999999999999999987643322  223345689999999


Q ss_pred             hhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q psy6044         155 VLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQV  234 (282)
Q Consensus       155 ~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
                      .+.+.. ++.++||||||+++|||+|++.++|.+.+..+....+..+...                            ..
T Consensus       184 ~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~----------------------------~~  234 (317)
T d1xkka_         184 SILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL----------------------------PQ  234 (317)
T ss_dssp             HHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC----------------------------CC
T ss_pred             HHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC----------------------------CC
Confidence            997776 7999999999999999999778879888877777766553221                            12


Q ss_pred             CccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         235 APKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       235 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      +..+++.+.+||.+||+.||.+|||+.++++|
T Consensus       235 p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         235 PPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            34588999999999999999999999999987

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-51  Score=339.79  Aligned_cols=270  Identities=33%  Similarity=0.557  Sum_probs=207.3

Q ss_pred             CeeeeeeCCCCceEEEeeeecC-CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeC------CeEEEEEecCcccHHHH
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLV-GNEGVPSSALREICLLKELKHKNIVRLYDVLHSE------KKLTLVFEHCDQDLKKY   73 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~------~~~~iv~e~~~g~l~~~   73 (282)
                      .||+|+++.+|+.||||++... .+....+.+.+|+.++++++|||++++++++...      ...++++++.+|+|.+.
T Consensus        33 ~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~  112 (348)
T d2gfsa1          33 SVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI  112 (348)
T ss_dssp             SEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHH
T ss_pred             EEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhh
Confidence            4999999999999999999863 2223345688999999999999999999998643      34566665556676665


Q ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccCh
Q psy6044          74 FDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPP  153 (282)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aP  153 (282)
                      +.  .+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++++|||.+....   .......+++.|+||
T Consensus       113 ~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~---~~~~~~~g~~~y~ap  187 (348)
T d2gfsa1         113 VK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAP  187 (348)
T ss_dssp             HT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT---GGGSSSCHHHHTSCH
T ss_pred             cc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC---cccccccccccccCc
Confidence            53  4679999999999999999999999999999999999999999999999999987654   223445678999999


Q ss_pred             hhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCC--CCCCCCCCCCCCc
Q psy6044         154 DVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPD--FKPFPMYHPSMSF  231 (282)
Q Consensus       154 E~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  231 (282)
                      |...+...++.++||||+||++|+|++|..| |.+.+.......+....+.+..+..........  .............
T Consensus       188 E~~~~~~~~~~~~DiwSlGv~l~~ll~g~~p-F~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (348)
T d2gfsa1         188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTL-FPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNF  266 (348)
T ss_dssp             HHHTTCSCCCTTHHHHHHHHHHHHHHHSSCS-CCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCH
T ss_pred             hhhcCCccCCcccchhhhhHHHHHHHhCCCC-CCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcch
Confidence            9987776678999999999999999988766 888888888888888777654432221100000  0000011112233


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCccch
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDLNVAI  276 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  276 (282)
                      ......+++++.+||++||+.||++|||++|+|+||||++..++.
T Consensus       267 ~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~  311 (348)
T d2gfsa1         267 ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  311 (348)
T ss_dssp             HHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             hhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCc
Confidence            444567899999999999999999999999999999999876543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-51  Score=335.32  Aligned_cols=250  Identities=22%  Similarity=0.325  Sum_probs=199.5

Q ss_pred             eeeeee---CCCCceEEEeeeecC---CCCCCCccHHHHHHHHhhCCC-CCccceeeeeeeCCeEEEEEecCcccHHHHH
Q psy6044           2 FTSGVD---RTPNTALAIKGTHLV---GNEGVPSSALREICLLKELKH-KNIVRLYDVLHSEKKLTLVFEHCDQDLKKYF   74 (282)
Q Consensus         2 vy~a~~---~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~~~~l~h-~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~   74 (282)
                      ||+|++   +.+|+.||||+++..   .+....+.+.+|++++++++| |||+++++++.+...+++++||+.|+.+..+
T Consensus        40 Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~  119 (322)
T d1vzoa_          40 VFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTH  119 (322)
T ss_dssp             EEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHH
T ss_pred             EEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHH
Confidence            899986   557999999998752   233446778899999999977 8999999999999999999999986444444


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC-ccccccccccccccCh
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP-VKCYSAEVVTLWYRPP  153 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~aP  153 (282)
                      ....+.+++..+..++.||+.||.|+|++|++|+||||+||+++.++.++|+|||++..+... ........+++.|++|
T Consensus       120 i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~p  199 (322)
T d1vzoa_         120 LSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP  199 (322)
T ss_dssp             HHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCH
T ss_pred             HHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchh
Confidence            444678899999999999999999999999999999999999999999999999999766433 2223445678999999


Q ss_pred             hhhcCCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         154 DVLFGAK-LYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       154 E~~~~~~-~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      |.+.+.. .++.++|||||||++|+|++|..| |.+.+..+....+......                         ...
T Consensus       200 e~~~~~~~~~~~ksDIWSlG~iLyelltG~~P-F~~~~~~~~~~~i~~~~~~-------------------------~~~  253 (322)
T d1vzoa_         200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASP-FTVDGEKNSQAEISRRILK-------------------------SEP  253 (322)
T ss_dssp             HHHTTCC---CTHHHHHHHHHHHHHHHHSSCT-TSCTTSCCCHHHHHHHHHH-------------------------CCC
T ss_pred             HHhhcCCcCCCchhhhHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHhccc-------------------------CCC
Confidence            9997553 468899999999999999999888 5444433333333322111                         111


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCccchh
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRM-----SAEDAMSHIYFSDLNVAIK  277 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~  277 (282)
                      .++..+|+.+.+||++||+.||.+||     |++|+++||||+++++...
T Consensus       254 ~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l  303 (322)
T d1vzoa_         254 PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL  303 (322)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHH
T ss_pred             CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHH
Confidence            23456899999999999999999999     5899999999999876543

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-51  Score=327.05  Aligned_cols=235  Identities=24%  Similarity=0.396  Sum_probs=186.6

Q ss_pred             eeeeeeCCC---CceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc
Q psy6044           2 FTSGVDRTP---NTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL   77 (282)
Q Consensus         2 vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~   77 (282)
                      ||+|++..+   +..||||.+...........+.+|+.++++++||||+++++++. ++.+++||||++| ++.+.+...
T Consensus        23 Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~  101 (273)
T d1mp8a_          23 VHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVR  101 (273)
T ss_dssp             EEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHT
T ss_pred             EEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhcc
Confidence            899998654   45688888866444444567999999999999999999999996 4678999999985 566666666


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc-cccccccccccccChhhh
Q psy6044          78 NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-KCYSAEVVTLWYRPPDVL  156 (282)
Q Consensus        78 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~  156 (282)
                      .+.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++....... .......+|+.|+|||.+
T Consensus       102 ~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l  181 (273)
T d1mp8a_         102 KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI  181 (273)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHH
T ss_pred             CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHh
Confidence            7789999999999999999999999999999999999999999999999999997764332 223344668899999999


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCc
Q psy6044         157 FGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAP  236 (282)
Q Consensus       157 ~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
                      .+.. ++.++||||||+++|||++++.|||.+.+..+....+.....                            ...++
T Consensus       182 ~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~----------------------------~~~~~  232 (273)
T d1mp8a_         182 NFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER----------------------------LPMPP  232 (273)
T ss_dssp             HHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----------------------------CCCCT
T ss_pred             ccCC-CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----------------------------CCCCC
Confidence            7766 799999999999999999877777888888877777654311                            12345


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         237 KLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       237 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      .+|+.+.+||.+||+.||.+|||+++|++|
T Consensus       233 ~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            689999999999999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=325.11  Aligned_cols=235  Identities=20%  Similarity=0.286  Sum_probs=193.3

Q ss_pred             eeeeeeCCCCce--EEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHHhc
Q psy6044           2 FTSGVDRTPNTA--LAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFDSL   77 (282)
Q Consensus         2 vy~a~~~~~~~~--vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~   77 (282)
                      ||+|+++.+|..  ||||++.........+.+.+|+++++++ +||||+++++++.+++..++||||++| ++.+.+...
T Consensus        26 Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~  105 (309)
T d1fvra_          26 VLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKS  105 (309)
T ss_dssp             EEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTT
T ss_pred             EEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhc
Confidence            899999988874  6777776644555677899999999999 799999999999999999999999985 566655432


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccc
Q psy6044          78 ---------------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYS  142 (282)
Q Consensus        78 ---------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  142 (282)
                                     ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++....... ...
T Consensus       106 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~-~~~  184 (309)
T d1fvra_         106 RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKT  184 (309)
T ss_dssp             CHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC-CC-
T ss_pred             cccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEccccccccccccc-ccc
Confidence                           3569999999999999999999999999999999999999999999999999987654222 223


Q ss_pred             cccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCC
Q psy6044         143 AEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPF  222 (282)
Q Consensus       143 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (282)
                      ...++..|+|||.+.+.. ++.++||||||+++|||++|+.|+|.+.+..+....+..+..                   
T Consensus       185 ~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~-------------------  244 (309)
T d1fvra_         185 MGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR-------------------  244 (309)
T ss_dssp             ---CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC-------------------
T ss_pred             ceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC-------------------
Confidence            345788999999997776 799999999999999999999888998888887776644211                   


Q ss_pred             CCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         223 PMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                               ...+..+++++.+||.+||+.||++|||+++|+++
T Consensus       245 ---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         245 ---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             ---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                     12334589999999999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-49  Score=317.29  Aligned_cols=236  Identities=21%  Similarity=0.310  Sum_probs=188.7

Q ss_pred             CeeeeeeCCC---CceEEEeeeecC--CCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCc-ccHHHHH
Q psy6044           1 MFTSGVDRTP---NTALAIKGTHLV--GNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCD-QDLKKYF   74 (282)
Q Consensus         1 ~vy~a~~~~~---~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~   74 (282)
                      .||+|+...+   +..||||++...  ......+.+.+|+.++++++||||+++++++.++ ..++|+||++ |++.+.+
T Consensus        23 ~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv~e~~~~~~l~~~~  101 (273)
T d1u46a_          23 VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRL  101 (273)
T ss_dssp             CCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHH
T ss_pred             EEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chheeeeeecCcchhhhh
Confidence            3899985433   347899998763  2333456789999999999999999999999764 6789999997 5777777


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc---cccccccccccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK---CYSAEVVTLWYR  151 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~  151 (282)
                      ....+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........   ......++..|+
T Consensus       102 ~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~  181 (273)
T d1u46a_         102 RKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC  181 (273)
T ss_dssp             HHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGC
T ss_pred             hcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccC
Confidence            77677899999999999999999999999999999999999999999999999999987654322   222334577899


Q ss_pred             ChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q psy6044         152 PPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSF  231 (282)
Q Consensus       152 aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
                      |||.+.+.. ++.++||||||+++|||+|++.+||.+.+..+....+.....                           .
T Consensus       182 aPE~~~~~~-~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~---------------------------~  233 (273)
T d1u46a_         182 APESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE---------------------------R  233 (273)
T ss_dssp             CHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC---------------------------C
T ss_pred             CHHHHhCCC-CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCC---------------------------C
Confidence            999998765 799999999999999999855666888888888777654211                           1


Q ss_pred             cccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         232 SQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       232 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                      ...+..+|+.+.+||.+||+.||++|||+.+|++
T Consensus       234 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            1233568899999999999999999999999975

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-49  Score=322.30  Aligned_cols=235  Identities=23%  Similarity=0.337  Sum_probs=195.9

Q ss_pred             eeeeeeC-----CCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHH
Q psy6044           2 FTSGVDR-----TPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFD   75 (282)
Q Consensus         2 vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~   75 (282)
                      ||+|+.+     .+++.||||+++........+.+.+|+.++++++||||+++++++.+.+..++++||+++ ++.+.+.
T Consensus        29 Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~  108 (301)
T d1lufa_          29 VFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR  108 (301)
T ss_dssp             EEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHH
T ss_pred             EEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHH
Confidence            8999865     467899999987654444456799999999999999999999999999999999999974 6666554


Q ss_pred             hcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCcc
Q psy6044          76 SLN-----------------------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLAR  132 (282)
Q Consensus        76 ~~~-----------------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~  132 (282)
                      ...                       ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.
T Consensus       109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~  188 (301)
T d1lufa_         109 SMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR  188 (301)
T ss_dssp             HTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHH
T ss_pred             hcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhhe
Confidence            321                       237899999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCc--cccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCC
Q psy6044         133 AFGIPV--KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTW  210 (282)
Q Consensus       133 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (282)
                      .+....  ...+...+++.|+|||.+.+.. ++.++||||||+++|||++++.|+|.+.+..+....+.+..        
T Consensus       189 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~--------  259 (301)
T d1lufa_         189 NIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN--------  259 (301)
T ss_dssp             HHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC--------
T ss_pred             eccCCccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCC--------
Confidence            654322  2223345678999999998776 79999999999999999999888899998888877765532        


Q ss_pred             CCCCCCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         211 PGMNLLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                          ....+..+++++.+||.+||+.||++|||+.+|++
T Consensus       260 --------------------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         260 --------------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             --------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                11234568899999999999999999999999975

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-49  Score=314.77  Aligned_cols=233  Identities=21%  Similarity=0.324  Sum_probs=185.6

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeee-CCeEEEEEecCcc-cHHHHHHhcC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHS-EKKLTLVFEHCDQ-DLKKYFDSLN   78 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~-~~~~~iv~e~~~g-~l~~~~~~~~   78 (282)
                      .||+|+.  +|..||||+++.   ....+.+.+|++++++++||||+++++++.+ ++.+++||||+++ ++.+++....
T Consensus        22 ~Vy~~~~--~~~~vAvK~i~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~   96 (262)
T d1byga_          22 DVMLGDY--RGNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG   96 (262)
T ss_dssp             EEEEEEE--TTEEEEEEECCC---CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHH
T ss_pred             EEEEEEE--CCeEEEEEEECc---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcC
Confidence            3899998  478999999864   3345789999999999999999999998854 5678999999975 6666654432


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCccccccccccccccChhhhc
Q psy6044          79 -GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSAEVVTLWYRPPDVLF  157 (282)
Q Consensus        79 -~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  157 (282)
                       ..+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||.+.......   ....++..|+|||.+.
T Consensus        97 ~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~---~~~~~~~~y~aPE~l~  173 (262)
T d1byga_          97 RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALR  173 (262)
T ss_dssp             HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------------CCTTTSCHHHHH
T ss_pred             CCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCC---ccccccccCCChHHHh
Confidence             358999999999999999999999999999999999999999999999999998655332   2335678899999997


Q ss_pred             CCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCcc
Q psy6044         158 GAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFSQVAPK  237 (282)
Q Consensus       158 ~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
                      +.. ++.++||||||+++|||+|++.|++...+..+....+....                            ..+++..
T Consensus       174 ~~~-~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~----------------------------~~~~~~~  224 (262)
T d1byga_         174 EKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------------------------KMDAPDG  224 (262)
T ss_dssp             HCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC----------------------------CCCCCTT
T ss_pred             CCC-CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC----------------------------CCCCCcc
Confidence            766 79999999999999999997788788888777776664321                            1223456


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         238 LTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       238 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      .++.+.+||++||+.||.+|||+.++++  +|+++
T Consensus       225 ~~~~~~~li~~cl~~dP~~Rps~~~l~~--~L~~i  257 (262)
T d1byga_         225 CPPAVYEVMKNCWHLDAAMRPSFLQLRE--QLEHI  257 (262)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             CCHHHHHHHHHHcccCHhHCcCHHHHHH--HHHHH
Confidence            8899999999999999999999999988  35444

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=318.67  Aligned_cols=236  Identities=21%  Similarity=0.286  Sum_probs=189.8

Q ss_pred             eeeeeeCCCC---ceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeee-CCeEEEEEecCcc-cHHHHHHh
Q psy6044           2 FTSGVDRTPN---TALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHS-EKKLTLVFEHCDQ-DLKKYFDS   76 (282)
Q Consensus         2 vy~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~-~~~~~iv~e~~~g-~l~~~~~~   76 (282)
                      ||+|++..++   ..||||+++..........+.+|++++++++||||+++++++.+ ++..++|||||++ ++.+.+..
T Consensus        43 Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~  122 (311)
T d1r0pa_          43 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN  122 (311)
T ss_dssp             EEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHC
T ss_pred             EEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhcc
Confidence            8999986654   36999998764444456779999999999999999999999875 5689999999986 45555555


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc----cccccccccccccC
Q psy6044          77 LNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV----KCYSAEVVTLWYRP  152 (282)
Q Consensus        77 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~~a  152 (282)
                      .....++..+..++.|++.||.|||+.||+||||||+||++++++.+||+|||++.......    .......++..|+|
T Consensus       123 ~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~a  202 (311)
T d1r0pa_         123 ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA  202 (311)
T ss_dssp             TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSC
T ss_pred             ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccC
Confidence            55668899999999999999999999999999999999999999999999999998764332    12223456889999


Q ss_pred             hhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q psy6044         153 PDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMSFS  232 (282)
Q Consensus       153 PE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
                      ||.+.... ++.++||||||+++||+++++.|++...+..+....+..+...                            
T Consensus       203 PE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~----------------------------  253 (311)
T d1r0pa_         203 LESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL----------------------------  253 (311)
T ss_dssp             HHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC----------------------------
T ss_pred             hHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC----------------------------
Confidence            99998776 6999999999999999999999988777666666555443211                            


Q ss_pred             ccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         233 QVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       233 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                      ..+..+++.+.+||.+||+.||++|||+.|+++|
T Consensus       254 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         254 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            1234578999999999999999999999999997

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=319.11  Aligned_cols=236  Identities=22%  Similarity=0.383  Sum_probs=180.4

Q ss_pred             eeeeeeCC-----CCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeC-CeEEEEEecCcc-cHHHH
Q psy6044           2 FTSGVDRT-----PNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSE-KKLTLVFEHCDQ-DLKKY   73 (282)
Q Consensus         2 vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~-~~~~iv~e~~~g-~l~~~   73 (282)
                      ||+|.+..     +++.||||++...........+.+|...+.++ .|+||+.+++++.++ ..+++|||||+| ++.+.
T Consensus        29 Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~  108 (299)
T d1ywna1          29 VIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY  108 (299)
T ss_dssp             EEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHH
T ss_pred             EEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHH
Confidence            89998654     45789999987644444456677888888777 689999999987754 578999999985 66665


Q ss_pred             HHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCc
Q psy6044          74 FDSL---------------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  138 (282)
Q Consensus        74 ~~~~---------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~  138 (282)
                      +...               ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus       109 l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  188 (299)
T d1ywna1         109 LRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  188 (299)
T ss_dssp             HHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCT
T ss_pred             HHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccc
Confidence            5432               2348999999999999999999999999999999999999999999999999997654322


Q ss_pred             --cccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHH-HHHHHHhCCCCCCCCCCCCC
Q psy6044         139 --KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQL-KRIFKLLGTPTEDTWPGMNL  215 (282)
Q Consensus       139 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  215 (282)
                        .......||+.|+|||.+.+.. ++.++|||||||++|||++++.++|.+....+.. ..+.....            
T Consensus       189 ~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~------------  255 (299)
T d1ywna1         189 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR------------  255 (299)
T ss_dssp             TSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC------------
T ss_pred             cccccCceeeCccccchhHhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC------------
Confidence              2233456799999999998766 7999999999999999999888777766544444 33333211            


Q ss_pred             CCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy6044         216 LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSH  266 (282)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  266 (282)
                                      ...+..+++++.++|.+||+.||++|||++++++|
T Consensus       256 ----------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         256 ----------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                            12334588999999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=319.69  Aligned_cols=246  Identities=22%  Similarity=0.318  Sum_probs=203.8

Q ss_pred             eeeeeeCC-----CCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEEecCcc-cHHHHHH
Q psy6044           2 FTSGVDRT-----PNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYFD   75 (282)
Q Consensus         2 vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~   75 (282)
                      ||+|.++.     ++..||||+++..........+.+|+.++++++||||+++++++..++..++||||+++ ++.+.+.
T Consensus        36 Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~  115 (308)
T d1p4oa_          36 VYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR  115 (308)
T ss_dssp             EEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHH
T ss_pred             EEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHH
Confidence            89998753     46899999987644444445689999999999999999999999999999999999974 5656554


Q ss_pred             hcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc--ccccc
Q psy6044          76 SLN---------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK--CYSAE  144 (282)
Q Consensus        76 ~~~---------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~  144 (282)
                      ...         ..+++..+..++.|++.||.|||+++|+||||||+||+++.++++||+|||++........  .....
T Consensus       116 ~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~  195 (308)
T d1p4oa_         116 SLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG  195 (308)
T ss_dssp             HHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSS
T ss_pred             hcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccce
Confidence            321         3478999999999999999999999999999999999999999999999999976643322  22334


Q ss_pred             cccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         145 VVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM  224 (282)
Q Consensus       145 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (282)
                      .+++.|+|||.+.+.. ++.++||||||+++|||+|++.++|.+.+..+....+.++..                     
T Consensus       196 ~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~---------------------  253 (308)
T d1p4oa_         196 LLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL---------------------  253 (308)
T ss_dssp             EECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC---------------------
T ss_pred             ecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC---------------------
Confidence            5689999999998776 689999999999999999998888999998888877765321                     


Q ss_pred             CCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc------CCCccCCccch
Q psy6044         225 YHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS------HIYFSDLNVAI  276 (282)
Q Consensus       225 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~------h~~~~~~~~~~  276 (282)
                             ...+..+++.+.++|.+||+.||.+|||+++|++      +|+|++++...
T Consensus       254 -------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~~~~~  304 (308)
T d1p4oa_         254 -------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYY  304 (308)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCSTT
T ss_pred             -------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCCCCCC
Confidence                   1233568899999999999999999999999998      88887765543

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-48  Score=314.57  Aligned_cols=236  Identities=24%  Similarity=0.372  Sum_probs=195.1

Q ss_pred             CeeeeeeCCCC-------ceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHH
Q psy6044           1 MFTSGVDRTPN-------TALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLK   71 (282)
Q Consensus         1 ~vy~a~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~   71 (282)
                      .||+|++..++       ..||||+++..........+.+|...+.++ +||||+++++++.+++..++||||+++ ++.
T Consensus        28 ~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~  107 (299)
T d1fgka_          28 QVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR  107 (299)
T ss_dssp             CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHH
T ss_pred             EEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHH
Confidence            48999876554       479999998755544567788898988888 899999999999999999999999975 566


Q ss_pred             HHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCC
Q psy6044          72 KYFDSLN---------------GEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGI  136 (282)
Q Consensus        72 ~~~~~~~---------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~  136 (282)
                      +.+....               ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||.+.....
T Consensus       108 ~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~  187 (299)
T d1fgka_         108 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH  187 (299)
T ss_dssp             HHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGG
T ss_pred             HHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccc
Confidence            6554332               3489999999999999999999999999999999999999999999999999976643


Q ss_pred             Cc--cccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCC
Q psy6044         137 PV--KCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMN  214 (282)
Q Consensus       137 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  214 (282)
                      ..  .......+++.|+|||.+.+.. ++.++||||||+++|+|++++.++|.+.+..+....+..+..           
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~l~~~~-y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~-----------  255 (299)
T d1fgka_         188 IDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR-----------  255 (299)
T ss_dssp             CCTTCCCTTSCCGGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC-----------
T ss_pred             cccccccccCCCChhhhhhhHhcCCC-CCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence            22  2233456688999999997766 799999999999999999977887988888776665544211           


Q ss_pred             CCCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         215 LLPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                       ...+..+++++.+||.+||+.||++|||+.|+++
T Consensus       256 -----------------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         256 -----------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             -----------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence                             1233568999999999999999999999999987

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-48  Score=314.59  Aligned_cols=236  Identities=25%  Similarity=0.372  Sum_probs=195.5

Q ss_pred             eeeeee-----CCCCceEEEeeeecCCCCCCCccHHHHHHHHhhC-CCCCccceeeeeeeCCeEEEEEecCcc-cHHHHH
Q psy6044           2 FTSGVD-----RTPNTALAIKGTHLVGNEGVPSSALREICLLKEL-KHKNIVRLYDVLHSEKKLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         2 vy~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~   74 (282)
                      ||+|+.     ..+++.||||+++..........+.+|+.+++.+ +||||+++++++.+....++|||||+| ++.+.+
T Consensus        39 Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l  118 (311)
T d1t46a_          39 VVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL  118 (311)
T ss_dssp             EEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHH
T ss_pred             EEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHH
Confidence            888874     4578899999998754444556789999999999 799999999999999999999999985 555554


Q ss_pred             Hhc-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCC
Q psy6044          75 DSL-----------------NGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP  137 (282)
Q Consensus        75 ~~~-----------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~  137 (282)
                      ...                 ...+++..+..++.||+.||+|||++|++||||||+||+++.++.++++|||.+......
T Consensus       119 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~  198 (311)
T d1t46a_         119 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND  198 (311)
T ss_dssp             HHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSC
T ss_pred             HhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCC
Confidence            432                 125899999999999999999999999999999999999999999999999999876532


Q ss_pred             --ccccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCC
Q psy6044         138 --VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNL  215 (282)
Q Consensus       138 --~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  215 (282)
                        ........+++.|+|||.+.... ++.++||||||+++|+|+|++.|++......+....+......+          
T Consensus       199 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~----------  267 (311)
T d1t46a_         199 SNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM----------  267 (311)
T ss_dssp             TTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC----------
T ss_pred             CcceEeeecccChHHcCHHHhcCCC-CCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC----------
Confidence              23334456789999999997766 79999999999999999998898888877766665555432111          


Q ss_pred             CCCCCCCCCCCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         216 LPDFKPFPMYHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                       ..+...++.+.+||.+||+.||++|||+++|++
T Consensus       268 -----------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         268 -----------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             -----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                             123457899999999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.9e-45  Score=296.56  Aligned_cols=243  Identities=16%  Similarity=0.191  Sum_probs=189.2

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCC-ccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKN-IVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~-i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      ||+|++..+|+.||||++....   ....+..|+++++.++|++ |+.+.+++.+++..++||||++|++...+......
T Consensus        23 Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~~~l~~~~~~~~~~   99 (299)
T d1ckia_          23 IYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK   99 (299)
T ss_dssp             EEEEEETTTTEEEEEEEEESCT---TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTC
T ss_pred             EEEEEECCCCCEEEEEEEchhc---cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcCCchhhhhhhccCC
Confidence            8999999999999999987632   2356889999999998766 55556667788899999999999999988887888


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC---CCcEEEEecCCccccCCCc-------cccccccccccc
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK---NGELKLADFGLARAFGIPV-------KCYSAEVVTLWY  150 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~---~~~~~l~df~~~~~~~~~~-------~~~~~~~~~~~~  150 (282)
                      +++..+..++.|++.||+|||++||+||||||+||+++.   +..++|+|||++.......       .......||+.|
T Consensus       100 ~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y  179 (299)
T d1ckia_         100 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY  179 (299)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSS
T ss_pred             CcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccc
Confidence            999999999999999999999999999999999999853   5579999999998764322       122344689999


Q ss_pred             cChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         151 RPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGSDVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPMYHPSMS  230 (282)
Q Consensus       151 ~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
                      +|||.+.+.. ++.++|||||||++|+|++|..| |......+.............                     ...
T Consensus       180 ~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P-~~~~~~~~~~~~~~~~~~~~~---------------------~~~  236 (299)
T d1ckia_         180 ASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLP-WQGLKAATKRQKYERISEKKM---------------------STP  236 (299)
T ss_dssp             CCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCT-TCCCC-------HHHHHHHHH---------------------HSC
T ss_pred             cCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCc-ccccchHHHHHHHHHhhcccC---------------------CCC
Confidence            9999998776 79999999999999999999888 444333322221111100000                     002


Q ss_pred             ccccCccCCHHHHHHHHHhcccCCCCCCCHH---HHhcCCCcc
Q psy6044         231 FSQVAPKLTAKGRDLLQRLLVCNPVQRMSAE---DAMSHIYFS  270 (282)
Q Consensus       231 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~---~ll~h~~~~  270 (282)
                      .......+|+++.+||..||+.||.+||+++   ++|+|+|.+
T Consensus       237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            2334456899999999999999999999987   456777654

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.1e-43  Score=286.49  Aligned_cols=236  Identities=17%  Similarity=0.189  Sum_probs=192.5

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCC-CCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCC
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKH-KNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNG   79 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~   79 (282)
                      .||+|++..+|+.||||++....   ....+.+|++.++.++| +|++.+++++..+...++|||+++|++.+.+.....
T Consensus        20 ~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~~~~l~~~~~~~~~   96 (293)
T d1csna_          20 VIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR   96 (293)
T ss_dssp             EEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTT
T ss_pred             EEEEEEECCCCCEEEEEEEcccc---CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEecCCCHHHHHHhhcc
Confidence            38999999999999999886532   34578899999999965 899999999999999999999999999998887777


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-----CCcEEEEecCCccccCCCc-------ccccccccc
Q psy6044          80 EIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINK-----NGELKLADFGLARAFGIPV-------KCYSAEVVT  147 (282)
Q Consensus        80 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~-----~~~~~l~df~~~~~~~~~~-------~~~~~~~~~  147 (282)
                      .+++..+..++.|++.||.+||++||+||||||+||+++.     ++.++|+|||++.......       .......||
T Consensus        97 ~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT  176 (293)
T d1csna_          97 KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT  176 (293)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSC
T ss_pred             chhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEc
Confidence            8999999999999999999999999999999999999964     5789999999997654221       122345689


Q ss_pred             ccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCC---ChHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCC
Q psy6044         148 LWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGS---DVDDQLKRIFKLLGTPTEDTWPGMNLLPDFKPFPM  224 (282)
Q Consensus       148 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (282)
                      +.|+|||.+.+.. ++.++||||||+++|+|++|..| |.+.   ...+....+.......                   
T Consensus       177 ~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~P-f~~~~~~~~~~~~~~i~~~~~~~-------------------  235 (293)
T d1csna_         177 ARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLP-WQGLKAATNKQKYERIGEKKQST-------------------  235 (293)
T ss_dssp             TTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCT-TSSCCSCCHHHHHHHHHHHHHHS-------------------
T ss_pred             hhhcCHHHhcCCC-CChHHHHHHhhHHHHHHHhCCCc-CCCccchhHHHHHHHHHhccCCC-------------------
Confidence            9999999998766 79999999999999999999888 4432   2333333333221110                   


Q ss_pred             CCCCCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         225 YHPSMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       225 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                           ...+....+|+++.+++..|+..+|.+||+++.+.+
T Consensus       236 -----~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         236 -----PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             -----CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             -----ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                 223344668999999999999999999998777654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-44  Score=290.33  Aligned_cols=236  Identities=22%  Similarity=0.227  Sum_probs=169.2

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHH--HHhhCCCCCccceeeeeeeCC----eEEEEEecCcc-cHHHHH
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREIC--LLKELKHKNIVRLYDVLHSEK----KLTLVFEHCDQ-DLKKYF   74 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~--~~~~l~h~~i~~~~~~~~~~~----~~~iv~e~~~g-~l~~~~   74 (282)
                      ||+|+.  +|+.||||++....    ...+..|.+  .+.+++||||+++++++.+++    .+++||||+++ ++.+.+
T Consensus        19 Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l   92 (303)
T d1vjya_          19 VWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL   92 (303)
T ss_dssp             EEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHH
T ss_pred             EEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHH
Confidence            899986  68999999986532    233444544  445679999999999998653    68999999975 566665


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcc----ccc
Q psy6044          75 DSLNGEIDLDIVKSFMYQLLRGLAFCHS--------RNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVK----CYS  142 (282)
Q Consensus        75 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~--------~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~----~~~  142 (282)
                      .+  ..+++..+..++.|++.||.|+|+        .||+|+||||+||+++.++.+||+|||++........    ...
T Consensus        93 ~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~  170 (303)
T d1vjya_          93 NR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN  170 (303)
T ss_dssp             HH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC---
T ss_pred             hc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceecccc
Confidence            44  478999999999999999999996        5999999999999999999999999999977643321    223


Q ss_pred             cccccccccChhhhcCCC-----CCCchhhHHHHHHHHHHHHhcCCCCCCCCCh----------HHHHHHHHHHhCCCCC
Q psy6044         143 AEVVTLWYRPPDVLFGAK-----LYTTSIDMWSAGCIFAELANAGRPLFPGSDV----------DDQLKRIFKLLGTPTE  207 (282)
Q Consensus       143 ~~~~~~~~~aPE~~~~~~-----~~~~~~Di~slG~ll~~ll~~~~p~~~~~~~----------~~~~~~~~~~~~~~~~  207 (282)
                      ...||+.|+|||.+.+..     .++.++|||||||++|||+||..|+......          ......+........ 
T Consensus       171 ~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  249 (303)
T d1vjya_         171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK-  249 (303)
T ss_dssp             -CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC-
T ss_pred             ceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccc-
Confidence            456799999999986542     1467899999999999999886653221110          001111111110000 


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCcccc--CccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q psy6044         208 DTWPGMNLLPDFKPFPMYHPSMSFSQV--APKLTAKGRDLLQRLLVCNPVQRMSAEDAMS  265 (282)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  265 (282)
                                         .++.....  .......+.+++.+||+.||++|||+.||++
T Consensus       250 -------------------~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         250 -------------------LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             -------------------CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             -------------------cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence                               00011111  1223456899999999999999999999987

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.7e-43  Score=293.34  Aligned_cols=266  Identities=26%  Similarity=0.374  Sum_probs=190.0

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCC-----------CCCccceeeeeeeC--CeEEEEEecC-
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK-----------HKNIVRLYDVLHSE--KKLTLVFEHC-   66 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-----------h~~i~~~~~~~~~~--~~~~iv~e~~-   66 (282)
                      .||+|+++.+|+.||||+++...  ...+.+.+|+.+++.++           |+||+++++++...  ...+++++++ 
T Consensus        28 ~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~  105 (362)
T d1q8ya_          28 TVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEV  105 (362)
T ss_dssp             EEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECC
T ss_pred             EEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecc
Confidence            38999999999999999987521  12356778999888875           57899999988643  4555555555 


Q ss_pred             -cccHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCC------cEEEEecCCccccCCC
Q psy6044          67 -DQDLKKYF-DSLNGEIDLDIVKSFMYQLLRGLAFCHS-RNVLHRDLKPQNLLINKNG------ELKLADFGLARAFGIP  137 (282)
Q Consensus        67 -~g~l~~~~-~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~dl~~~nil~~~~~------~~~l~df~~~~~~~~~  137 (282)
                       .++..... ......+++..++.++.||+.||.|||+ .||+|+||||+||+++.++      .++++|||.+..... 
T Consensus       106 ~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~-  184 (362)
T d1q8ya_         106 LGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-  184 (362)
T ss_dssp             CCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB-
T ss_pred             cccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc-
Confidence             34433333 3334679999999999999999999998 8999999999999998765      499999999876542 


Q ss_pred             ccccccccccccccChhhhcCCCCCCchhhHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHHHHHHhCCCCCCCCCC
Q psy6044         138 VKCYSAEVVTLWYRPPDVLFGAKLYTTSIDMWSAGCIFAELANAGRPLFPGS-----DVDDQLKRIFKLLGTPTEDTWPG  212 (282)
Q Consensus       138 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ll~~~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  212 (282)
                        ......+++.|+|||.+.... ++.++|+||+||++++|++|..||....     ...+........++.++......
T Consensus       185 --~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~  261 (362)
T d1q8ya_         185 --HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRN  261 (362)
T ss_dssp             --CCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             --ccccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhc
Confidence              234457899999999998776 6999999999999999999888843321     23445555666666543322211


Q ss_pred             CC----------CCCCCCCCCCCCC---CCCccccCccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q psy6044         213 MN----------LLPDFKPFPMYHP---SMSFSQVAPKLTAKGRDLLQRLLVCNPVQRMSAEDAMSHIYFSDL  272 (282)
Q Consensus       213 ~~----------~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  272 (282)
                      ..          .............   ...........++.+.+||.+||..||.+|||++|+|+||||+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~  334 (362)
T d1q8ya_         262 GKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT  334 (362)
T ss_dssp             CTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred             ccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence            10          0000000000000   000112234567889999999999999999999999999999966

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.83  E-value=3.9e-21  Score=145.04  Aligned_cols=150  Identities=17%  Similarity=0.123  Sum_probs=106.1

Q ss_pred             CeeeeeeCCCCceEEEeeeecCCCC--CC---------------CccHHHHHHHHhhCCCCCccceeeeeeeCCeEEEEE
Q psy6044           1 MFTSGVDRTPNTALAIKGTHLVGNE--GV---------------PSSALREICLLKELKHKNIVRLYDVLHSEKKLTLVF   63 (282)
Q Consensus         1 ~vy~a~~~~~~~~vaiK~~~~~~~~--~~---------------~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~iv~   63 (282)
                      .||+|++. +|+.||||+++.....  ..               ......|...+.++.|++++..+++.  .  .+++|
T Consensus        15 ~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~--~--~~lvm   89 (191)
T d1zara2          15 AVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE--G--NAVLM   89 (191)
T ss_dssp             EEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE--T--TEEEE
T ss_pred             EEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec--C--CEEEE
Confidence            38999984 6999999987641110  00               11234578888999999999887653  2  27999


Q ss_pred             ecCcccHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEecCCccccCCCcccccc
Q psy6044          64 EHCDQDLKKYFDSLNGEIDLDIVKSFMYQLLRGLAFCHSRNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVKCYSA  143 (282)
Q Consensus        64 e~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  143 (282)
                      |++++....       .++...+..++.|++.++++||++||+|+||||+||+++++ .++|+|||.+.....+...   
T Consensus        90 e~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~---  158 (191)
T d1zara2          90 ELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWR---  158 (191)
T ss_dssp             ECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHH---
T ss_pred             Eeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcccCCCCCcH---
Confidence            999875322       34556667899999999999999999999999999999865 5899999998766533211   


Q ss_pred             ccccccccC------hhhhcCCCCCCchhhHHHHHH
Q psy6044         144 EVVTLWYRP------PDVLFGAKLYTTSIDMWSAGC  173 (282)
Q Consensus       144 ~~~~~~~~a------PE~~~~~~~~~~~~Di~slG~  173 (282)
                           .|..      .+.+ .. .|+.++|+||+.-
T Consensus       159 -----~~l~rd~~~~~~~f-~r-~y~~~~d~~s~~~  187 (191)
T d1zara2         159 -----EILERDVRNIITYF-SR-TYRTEKDINSAID  187 (191)
T ss_dssp             -----HHHHHHHHHHHHHH-HH-HHCCCCCHHHHHH
T ss_pred             -----HHHHHHHHHHHHHH-cC-CCCCcccHHHHHH
Confidence                 1111      1222 12 2688999999653

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.52  E-value=2.4e-07  Score=71.77  Aligned_cols=123  Identities=17%  Similarity=0.121  Sum_probs=82.0

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCC-CCCccceeeeeeeCCeEEEEEecCcccHHHHHHhcCCC
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQDLKKYFDSLNGE   80 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~   80 (282)
                      ||+..  .+++.+++|+..... ......+.+|...++.+. +--+++++.+..+++..++||++++|..+.....  ..
T Consensus        30 v~rv~--~~~~~~vlk~~~~~~-~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~--~~  104 (263)
T d1j7la_          30 VYKLV--GENENLYLKMTDSRY-KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE--DE  104 (263)
T ss_dssp             EEEEE--CSSCEEEEEEECGGG-TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTT--TC
T ss_pred             EEEEE--eCCCeEEEEEcCCCc-ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccc--cc
Confidence            45543  456778888776532 223456888999988773 3346788888888899999999999865543221  11


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHh----------------------------------------------------------
Q psy6044          81 IDLDIVKSFMYQLLRGLAFCHS----------------------------------------------------------  102 (282)
Q Consensus        81 ~~~~~~~~~~~qi~~~l~~lh~----------------------------------------------------------  102 (282)
                      ..   ...++.++...++.||+                                                          
T Consensus       105 ~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  181 (263)
T d1j7la_         105 QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEE  181 (263)
T ss_dssp             SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCC
T ss_pred             cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcC
Confidence            11   22234444455555553                                                          


Q ss_pred             -CCccccCCCCCcEEEcCCCcEEEEecCCcc
Q psy6044         103 -RNVLHRDLKPQNLLINKNGELKLADFGLAR  132 (282)
Q Consensus       103 -~~i~H~dl~~~nil~~~~~~~~l~df~~~~  132 (282)
                       ..++|+|+.|.||+++.++.+.|+||+.+.
T Consensus       182 ~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         182 ELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CcEEEEeeccCcceeecCCceEEEeechhcc
Confidence             126899999999999877666799998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.30  E-value=2.3e-06  Score=65.63  Aligned_cols=63  Identities=14%  Similarity=0.047  Sum_probs=46.0

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCC--CCccceeeeeeeCCeEEEEEecCccc
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKH--KNIVRLYDVLHSEKKLTLVFEHCDQD   69 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h--~~i~~~~~~~~~~~~~~iv~e~~~g~   69 (282)
                      ||+... .+|..+++|....    .....+..|+..++.+..  -.+++++.+..+++..++||++++|.
T Consensus        27 v~r~~~-~~~~~~vlK~~~~----~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~   91 (255)
T d1nd4a_          27 VFRLSA-QGRPVLFVKTDLS----GALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ   91 (255)
T ss_dssp             EEEEEC-TTSCCEEEEEECS----CTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred             EEEEEe-CCCCEEEEEeCCc----cCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence            566665 4577788887543    234568889999888733  33677888888888999999999874

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.98  E-value=1.2e-05  Score=65.73  Aligned_cols=65  Identities=20%  Similarity=0.087  Sum_probs=39.5

Q ss_pred             eeeeeeCCCCceEEEeeeec---CC---CCCCCccHHHHHHHHhhC-CC--CCccceeeeeeeCCeEEEEEecCcc
Q psy6044           2 FTSGVDRTPNTALAIKGTHL---VG---NEGVPSSALREICLLKEL-KH--KNIVRLYDVLHSEKKLTLVFEHCDQ   68 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~---~~---~~~~~~~~~~e~~~~~~l-~h--~~i~~~~~~~~~~~~~~iv~e~~~g   68 (282)
                      ||+..+..+|+.+++|.-..   ..   ..........|++.++.+ .+  ..+++++.+  ++...++|||++++
T Consensus        42 vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvmE~L~~  115 (392)
T d2pula1          42 VFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVMEDLSH  115 (392)
T ss_dssp             EEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEECCCTT
T ss_pred             EEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEEEeccCC
Confidence            78888878888999996542   11   122345567788888876 22  345666654  34445789999975

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.49  E-value=7.7e-05  Score=59.18  Aligned_cols=64  Identities=13%  Similarity=0.042  Sum_probs=41.7

Q ss_pred             eeeeeeCCCCceEEEeeeecCCCCCCCccHHHHHHHHhhCCCCCcc--cee-----eeeeeCCeEEEEEecCcc
Q psy6044           2 FTSGVDRTPNTALAIKGTHLVGNEGVPSSALREICLLKELKHKNIV--RLY-----DVLHSEKKLTLVFEHCDQ   68 (282)
Q Consensus         2 vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~--~~~-----~~~~~~~~~~iv~e~~~g   68 (282)
                      ||++.. .+|+.|++|+.+.  .......+..|...+..|....+.  ...     ..+...+..+.++++++|
T Consensus        38 vy~v~~-~dg~~~VlK~~rp--~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          38 VYQFQD-EDRRRFVVKFYRP--ERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             EEEECC-TTCCCEEEEEECT--TTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             eEEEEc-CCCCEEEEEEeCC--CCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            677776 5689999998763  222346688898888887422221  111     123456778899999876

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.86  E-value=0.0019  Score=52.37  Aligned_cols=52  Identities=12%  Similarity=0.073  Sum_probs=32.9

Q ss_pred             CceEEEeeeecCCCCCCCccHHHHHHHHhhCC-CCCccceeeeeeeCCeEEEEEecCccc
Q psy6044          11 NTALAIKGTHLVGNEGVPSSALREICLLKELK-HKNIVRLYDVLHSEKKLTLVFEHCDQD   69 (282)
Q Consensus        11 ~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~g~   69 (282)
                      .+.|++++.-.   ........+|..+++.+. +.-.+++++++.+    ++|+||++|.
T Consensus        74 ~~~vllRi~g~---~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~  126 (395)
T d1nw1a_          74 PNKVLLRVYFN---PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSR  126 (395)
T ss_dssp             CSEEEEEEECS---CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEE
T ss_pred             CCcEEEEecCC---cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccc
Confidence            34566655431   222345668999998884 4445677777643    6889999873

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.57  E-value=0.0046  Score=48.20  Aligned_cols=30  Identities=30%  Similarity=0.340  Sum_probs=26.9

Q ss_pred             CCccccCCCCCcEEEcCCCcEEEEecCCcc
Q psy6044         103 RNVLHRDLKPQNLLINKNGELKLADFGLAR  132 (282)
Q Consensus       103 ~~i~H~dl~~~nil~~~~~~~~l~df~~~~  132 (282)
                      .|++|+|+.++|++++.+...-++||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            569999999999999988777999999874